FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Franco, RA
   Nguyen, TH
   Lee, BT
AF Franco, Rose Ann
   Thi Hiep Nguyen
   Lee, Byong-Taek
TI Preparation and characterization of electrospun PCL/PLGA membranes and
   chitosan/gelatin hydrogels for skin bioengineering applications
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID WATER-SOLUBLE CARBODIIMIDE; CROSS-LINKING; IN-VITRO; BIOMEDICAL
   APPLICATIONS; GELATIN SCAFFOLDS; GLUTARALDEHYDE; FILMS; FABRICATION;
   DELIVERY; DRUG
AB In this study, two distinct systems of biomaterials were fabricated and their potential use as a bilayer scaffold (BS) for skin bioengineering applications was assessed. The initial biomaterial was a polycaprolactone/poly(lacto-co-glycolic acid) (PCL/PLGA) membrane fabricated using the electrospinning method. The PCL/PLGA membrane M-12 (12% PCL/10% PLGA, 80:20) displayed strong mechanical properties (stress/strain values of 3.01 +/- A 0.23 MPa/225.39 +/- A 7.63%) and good biocompatibility as demonstrated by adhesion of keratinocyte cells on the surface and ability to support cell proliferation. The second biomaterial was a hydrogel composed of 2% chitosan and 15% gelatin (50:50) crosslinked with 5% glutaraldehyde. The CG-3.5 hydrogel (with 3.5% glutaraldehyde (v/v)) displayed a high porosity, a parts per thousand yen97%, good compressive strength (2.23 +/- A 0.25 MPa), ability to swell more than 500% of its dry weight and was able to support fibroblast cell proliferation. A BS was fabricated by underlaying the membrane and hydrogel casting method to combine these two materials. The physical properties and biocompatibility were preliminarily investigated and the properties of the two biomaterials were shown to be complementary when combined. The upper layer membrane provided mechanical support in the scaffold and reduced the degradation rate of the hydrogel layer. Cell viability was similar to that in the hydrogel layer which suggests that addition of the membrane layer did not affect the biocompatibility.
C1 [Franco, Rose Ann; Thi Hiep Nguyen; Lee, Byong-Taek] Soonchunhyang Univ, Dept Biomed Engn & Mat, Coll Med, Cheonan 330090, South Korea.
RP Lee, BT (reprint author), Soonchunhyang Univ, Dept Biomed Engn & Mat, Coll Med, Cheonan 330090, South Korea.
EM lbt@sch.ac.kr
OI Franco, Rose Ann/0000-0001-9772-714X
FU NRF; MEST [2009-0092808]
FX This work was supported by Mid-career Research Program through NRF grant
   funded by MEST (NO 2009-0092808).
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Azab AK, 2006, J CONTROL RELEASE, V111, P281, DOI 10.1016/j.jconrel.2005.12.014
   Bigi A, 2002, BIOMATERIALS, V23, P4827, DOI 10.1016/S0142-9612(02)00235-1
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Bottcher-Haberzeth S, 2010, BURNS, V36, P450, DOI 10.1016/j.burns.2009.08.016
   Chang YH, 2009, J APPL POLYM SCI, V113, P400, DOI 10.1002/app.29954
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   Deiber JA, 2009, POLYMER, V50, P6065, DOI 10.1016/j.polymer.2009.10.046
   Eshraghi S, 2010, ACTA BIOMATER, V6, P2467, DOI 10.1016/j.actbio.2010.02.002
   GORMAN SP, 1980, J APPL BACTERIOL, V48, P161, DOI 10.1111/j.1365-2672.1980.tb01217.x
   Hu XH, 2008, J MECH BEHAV BIOMED, V1, P352, DOI 10.1016/j.jmbbm.2008.02.001
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Khor HL, 2002, MAT SCI ENG C-BIO S, V20, P71, DOI 10.1016/S0928-4931(02)00015-2
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Lee SB, 2003, BIOMATERIALS, V24, P2503, DOI 10.1016/S0142-9612(03)00003-6
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Liang HC, 2004, J APPL POLYM SCI, V91, P4017, DOI 10.1002/app.13563
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Mao JS, 2003, J BIOMED MATER RES A, V64A, P301, DOI 10.1002/jbm.a.10223
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Mi FL, 2002, BIOMATERIALS, V23, P3257, DOI 10.1016/S0142-9612(02)00084-4
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   NANGIA A, 1991, Clinical Materials, V7, P3, DOI 10.1016/0267-6605(91)90050-P
   Nguyen TH, 2010, J MATER SCI-MATER M, V21, P1969, DOI 10.1007/s10856-010-4048-y
   Noorjahan SE, 2004, J BIOMED MATER RES B, V71B, P305, DOI 10.1002/jbm.b.30094
   Rohindra D. R., 2004, S PACIFIC J NATURAL, V22, P32, DOI DOI 10.1071/SP04005
   Sahoo S, 2010, CARBOHYD POLYM, V79, P106, DOI 10.1016/j.carbpol.2009.07.042
   Saraf A, 2009, TISSUE ENG PART C-ME, V15, P333, DOI 10.1089/ten.tec.2008.0422
   Shen F, 2000, POLYM INT, V49, P1596, DOI 10.1002/1097-0126(200012)49:12<1596::AID-PI553>3.3.CO;2-J
   Song F, 2009, INT J PHARMACEUT, V373, P41, DOI 10.1016/j.ijpharm.2009.02.005
   Sung HW, 1996, J BIOMED MATER RES, V31, P511, DOI 10.1002/(SICI)1097-4636(199608)31:4<511::AID-JBM11>3.0.CO;2-J
   Tabata Y, 2001, DRUG DISCOV TODAY, V6, P483, DOI 10.1016/S1359-6446(01)01753-6
   van der Veen VC, 2010, BURNS, V36, P305, DOI 10.1016/j.burns.2009.07.012
   Venugopal J, 2005, APPL BIOCHEM BIOTECH, V125, P147, DOI 10.1385/ABAB:125:3:147
   Woodruff MA, 2010, PROG POLYM SCI, V35, P1217, DOI 10.1016/j.progpolymsci.2010.04.002
   Xu JB, 2003, J MEMBRANE SCI, V218, P131, DOI 10.1016/S0376-7388(03)00165-0
   Zeiger E, 2005, MUTAT RES-REV MUTAT, V589, P136, DOI 10.1016/j.mrrev.2005.01.001
NR 41
TC 39
Z9 40
U1 4
U2 134
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2011
VL 22
IS 10
BP 2207
EP 2218
DI 10.1007/s10856-011-4402-8
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 831EX
UT WOS:000295712600007
PM 21805330
DA 2018-10-20
ER

PT J
AU Doostmohammadi, A
   Monshi, A
   Fathi, MH
   Karbasi, S
   Braissant, O
   Daniels, AU
AF Doostmohammadi, A.
   Monshi, A.
   Fathi, M. H.
   Karbasi, S.
   Braissant, O.
   Daniels, A. U.
TI Direct cytotoxicity evaluation of 63S bioactive glass and bone-derived
   hydroxyapatite particles using yeast model and human chondrocyte cells
   by microcalorimetry
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VIVO; SACCHAROMYCES-CEREVISIAE; BIOCOMPATIBILITY; OSTEOBLASTS;
   ATTACHMENT; INVITRO
AB In this study, the cytotoxicity evaluation of prepared 63S bioactive glass and bone-derived hydroxyapatite particles with yeast and human chondrocyte cells was carried out using isothermal micro-nano calorimetry (IMNC), which is a new method for studying cell/biomaterial interactions. Bioactive glass particles were made via sol-gel method and hydroxyapatite was obtained from bovine bone. Elemental analysis was carried out by XRF and EDXRF. Amorphous structure of the glass and completely crystalline structure of HA were detected by XRD analysis. Finally, the cytotoxicity of bioactive glass and bone-derived HA particles with yeast and cultured human chondrocyte cells was evaluated using IMNC. The results confirmed the viability, growth and proliferation of human chondrocyte cells in contact with 63S bioactive glass, and bone-derived HA particles. Also the results indicated that yeast model which is much easier to handle, can be considered as a good proxy and can provide a rapid primary estimate of the ranges to be used in assays involving human cells. All of these results confirmed that IMNC is a convenient method which caters to measuring the cell-biomaterial interactions alongside the current methods.
C1 [Doostmohammadi, A.; Monshi, A.; Fathi, M. H.] Isfahan Univ Technol, Dept Mat Engn, Biomat Grp, Esfahan 8415683111, Iran.
   [Karbasi, S.] Isfahan Univ Med Sci, Med Phys & Biomed Engn Grp, Sch Med, Esfahan 8174673461, Iran.
   [Braissant, O.; Daniels, A. U.] Univ Basel, Lab Biomech & Biocalorimetry, Coalit Clin Morphol & Biomed Engn, Fac Med, Basel, Switzerland.
RP Doostmohammadi, A (reprint author), Isfahan Univ Technol, Dept Mat Engn, Biomat Grp, Esfahan 8415683111, Iran.
EM alidm14@ma.iut.ac.ir
RI Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; karbasi,
   saead/0000-0002-5045-177X
CR ALLIOTLICHT B, 1991, BIOMATERIALS, V12, P752, DOI 10.1016/0142-9612(91)90025-6
   Balamurugan A, 2007, ACTA BIOMATER, V3, P255, DOI 10.1016/j.actbio.2006.09.005
   Beezer A. E., 1980, BIOL MICROCALORIMETR
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Bigi A, 2004, J SOLID STATE CHEM, V177, P3092, DOI 10.1016/j.jssc.2004.05.018
   Braissant O, 2009, FEMS MICROBIOL LETT, V303, P1
   Buschini A, 2003, MUTAGENESIS, V18, P25, DOI 10.1093/mutage/18.1.25
   CERVINKA M, 1994, TOXICOL IN VITRO, V8, P783, DOI 10.1016/0887-2333(94)90067-1
   DANIELS AU, 2009, Patent No. 0317859
   Esteban S. L., 2003, J EUR CERAM SOC, V23, P2921
   FARBER JL, 1990, ENVIRON HEALTH PERSP, V84, P107, DOI 10.2307/3430711
   Fathi MH, 2008, MAT SCI ENG A-STRUCT, V474, P128, DOI 10.1016/j.msea.2007.05.041
   FERGUSON LR, 1992, MUTAT RES, V265, P103, DOI 10.1016/0027-5107(92)90042-Z
   FONTANA AJ, 1990, THERMOCHIM ACTA, V172, P105, DOI 10.1016/0040-6031(90)80564-F
   Forsburg Susan L, 2005, Gravit Space Biol Bull, V18, P3
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   James AM., 1987, THERMAL ENERGETIC ST, P147
   Kemp R, 1999, HDB THERMAL ANAL CAL
   Kemp RB, 2000, THERMOCHIM ACTA, V349, P23, DOI 10.1016/S0040-6031(99)00493-1
   Li P, 2005, KEY ENG MATER, V284, P431
   MALIK MA, 1992, BIOMATERIALS, V13, P123, DOI 10.1016/0142-9612(92)90008-C
   Moretti M, 2005, TISSUE ENG, V11, P1421, DOI 10.1089/ten.2005.11.1421
   NAGASE M, 1992, BIOMATERIALS, V13, P172, DOI 10.1016/0142-9612(92)90067-X
   Nair M.B., 2006, TRENDS BIOMATER ARTI, V19, P108
   Niiranen H, 1999, J MATER SCI-MATER M, V10, P707, DOI 10.1023/A:1008966820264
   PRIMIO CD, 2005, NUCLEIC ACIDS RES, V33, P4639
   QUTEISH D, 1991, J CLIN PERIODONTOL, V18, P305, DOI 10.1111/j.1600-051X.1991.tb00433.x
   Ruksudjarit A, 2007, CURR APPL PHYS, V8, P270
   Sandstrom B., 1998, NUTR RES, V23, P1745
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Tian M, 2009, J MATER SCI-MATER M, V20, P1505, DOI 10.1007/s10856-009-3713-5
   TRAMPUZ A, 2007, TRANSFUSION, V47, P150
   Xie Y, 2000, J MATER SCI-MATER M, V11, P587, DOI 10.1023/A:1008984304821
   Yamamoto A, 2004, J BIOMED MATER RES A, V68A, P244, DOI 10.1002/jbm.a.20020
   ZHANG H, 2009, BIOMED MATER, V4, P353
   Zhang K, 2005, BIOMATERIALS, V26, P4532, DOI 10.1016/j.biomaterials.2004.11.030
NR 38
TC 12
Z9 12
U1 0
U2 11
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2011
VL 22
IS 10
BP 2293
EP 2300
DI 10.1007/s10856-011-4400-x
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 831EX
UT WOS:000295712600015
PM 21786131
DA 2018-10-20
ER

PT J
AU Slaughter, MS
   Pederson, B
   Graham, JD
   Sobieski, MA
   Koenig, SC
AF Slaughter, Mark S.
   Pederson, Brian
   Graham, Joel D.
   Sobieski, Michael A.
   Koenig, Steven C.
TI Evaluation of new Forcefield technology: Reducing platelet adhesion and
   cell coverage of pyrolytic carbon surfaces
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID DRUG-ELUTING STENTS; ALBUMIN
AB Introduction: Platelet adhesion and activation are a significant source of clinical complications. Preventing foreign surface-platelet interaction may improve biocompatibility of implantable medical devices. This study evaluated efficacy of novel technique for electrically modifying surface of conductive biomaterial and attaching blood components to prevent thrombogenesis. Specifically, this new surface modification technology, Forcefield (ATS Medical, Inc, Minneapolis, Minn), was designed to prevent platelet adhesion on pyrolytic carbon. A modulated low-voltage current is directly applied to pyrolytic carbon surfaces to stimulate adherence of a layer of charged proteins from circulating blood components that is resistive to platelet deposition.
   Methods: Feasibility of Forcefield technology was tested in line with cardiopulmonary bypass circuit in patients undergoing standard cardiac surgery (n = 6). Forcefield treatment was applied to segment of pyrolytic carbon with 15 minutes (n = 3) and 30 minutes (n = 3) of electrically stimulated exposure time, and resulting segments were compared with untreated pyrolytic carbon segment. Platelet adhesion confluence was then quantified by scanning electron microscopy.
   Results: Confluence of the Forcefield-treated pyrolytic carbon segments (3.3% +/- 2.2%) was significantly reduced relative to untreated pyrolytic carbon control segments (81.7% +/- 24%, P < .001). There were no discernible differences in cell confluence with Forcefield-treated segments as function of exposure time (15 or 30 minutes).
   Conclusions: Forcefield technology may enable modification of pyrolytic carbon surfaces to prevent platelet adhesion and thrombogenesis of implanted medical devices, including heart valves, stents, catheters, and ventricular assist devices, and may eliminate the need for anticoagulant and antiplatelet therapies. (J Thorac Cardiovasc Surg 2011;142:921-5)
C1 [Slaughter, Mark S.; Sobieski, Michael A.; Koenig, Steven C.] Univ Louisville, Div Thorac & Cardiovasc Surg, Louisville, KY 40292 USA.
   [Graham, Joel D.; Koenig, Steven C.] Univ Louisville, Dept Surg, Louisville, KY 40292 USA.
   [Graham, Joel D.; Koenig, Steven C.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA.
   [Pederson, Brian] ATS Med Inc, Minneapolis, MN USA.
RP Slaughter, MS (reprint author), Univ Louisville, Div Cardiothorac Surg, Louisville, KY 40292 USA.
EM mark.slaughter@louisville.edu
CR Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319
   Chinn JA, 1996, J COLLOID INTERF SCI, V184, P11, DOI 10.1006/jcis.1996.0592
   Goodman SL, 1996, J BIOMED MATER RES, V32, P249, DOI 10.1002/(SICI)1097-4636(199610)32:2<249::AID-JBM15>3.0.CO;2-E
   Goodman SL, 2007, J BIOMED MATER RES A, V83A, P64, DOI 10.1002/jbm.a.31206
   Gott VL, 2003, ANN THORAC SURG, V76, pS2230, DOI 10.1016/S0003-4975(03)01815-0
   Hetherington Vincent J, 2004, J Foot Ankle Surg, V43, P16, DOI 10.1053/j.jfas.2003.11.007
   Houska M, 2008, J BIOMED MATER RES A, V86A, P769, DOI 10.1002/ibm.a.31663
   Mantero S, 2002, J BIOMED MATER RES, V59, P329, DOI 10.1002/jbm.1249
   Shishehbor MH, 2008, J AM COLL CARDIOL, V52, P1041, DOI 10.1016/j.jacc.2008.06.030
   Smith RN, 2001, J CLIN PERIODONTOL, V28, P1158, DOI 10.1034/j.1600-051X.2001.281211.x
   Tsai C C, 1990, ASAIO Trans, V36, pM307
   Varbella F, 2008, J CARDIOVASC MED, V9, P1088, DOI 10.2459/JCM.0b013e328304ab09
   Zapanta CM, 2006, ASAIO J, V52, P17, DOI 10.1097/01.mat.0000189726.87077.ad
   Zhang J, 2008, ARCH BIOCHEM BIOPHYS, V471, P240, DOI 10.1016/j.abb.2007.12.009
NR 14
TC 3
Z9 3
U1 1
U2 7
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD OCT
PY 2011
VL 142
IS 4
BP 921
EP 925
DI 10.1016/j.jtcvs.2011.01.012
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 825FF
UT WOS:000295255700028
PM 21329945
OA Bronze
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Luo, DM
AF Zhou, Ying-Long
   Luo, Dong-Mei
TI Microstructures and mechanical properties of Ti-Mo alloys cold-rolled
   and heat treated
SO MATERIALS CHARACTERIZATION
LA English
DT Article
DE Ti-Mo alloy; Microstructure; Mechanical property; Elastic modulus;
   Metallic biomaterial; Stress-induced martensite transformation
ID DEFORMATION-INDUCED MARTENSITE; BETA TINBSN ALLOYS; BIOMEDICAL
   APPLICATIONS; TITANIUM-ALLOYS; YOUNGS MODULUS; TENSILE PROPERTIES; TA
   ALLOYS; HIP-ARTHROPLASTY; TI-6AL-4V ALLOYS; BEHAVIOR
AB In this study, the microstructures and mechanical properties of Ti-10Mo and Ti-20Mo alloys (mass%) are investigated to assess the potential use in biomedical applications. The microstructures are examined by X-ray diffraction analysis (XRD) and scanning electron microscopy (SEM). The mechanical properties are determined from uniaxial tensile tests. The experimental results indicate that the microstructures and mechanical properties of Ti-Mo alloys are dependent upon the cold rolling, solution heat treatment, and Mo content. The Ti-10Mo alloy exhibits (alpha"+beta) and (beta+omega) phases under the cold rolling (CR) and solution treatment (ST), respectively. By contrast, the Ti-20Mo alloy comprises only beta phase under such conditions. The quenched Ti-20Mo alloy has the lowest elastic modulus and CR Ti-20Mo alloy has the highest tensile strength. The quenched Ti-10Mo alloy exhibits the excellent ductility and two-stage yielding from stress-strain curves due to the stress-induced martensite transformation from beta to alpha" during tensile deformation. These Ti-Mo alloys exhibit low yield strength and good ductility, and they are more suitable for biomedical applications than the conventional metallic biomaterials from the viewpoint of better mechanical compatibility. The quenched Ti-10Mo alloy has some advantages over the other beta binary Ti-Mo alloys for biomedical applications. beta type Ti-Mo-Sn alloys are expected to be promising candidates for novel metallic biomaterials. (C) 2011 Elsevier inc. All rights reserved.
C1 [Zhou, Ying-Long] Foshan Univ, Dept Mechatron Engn, Foshan 528000, Guangdong, Peoples R China.
   [Luo, Dong-Mei] Foshan Univ, Dept Civil Engn, Foshan 528000, Guangdong, Peoples R China.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, 18 Jiangwan Yi Rd, Foshan 528000, Guangdong, Peoples R China.
EM yinglongzhou@126.com; ylzhou@fosu.edu.cn
FU Scientific Research Foundation for the Returned Overseas Chinese
   Scholars; State Education Ministry of PR China [2008/890]
FX lThe work was financially supported by the Scientific Research
   Foundation for the Returned Overseas Chinese Scholars, State Education
   Ministry of PR China (Grant No. 2008/890). Kind help from Dr S.J. Li,
   Associate Professor of the Institute of Metal Research, Chinese Academy
   of Sciences, PR China was also greatly acknowledged.
CR ASTM, 2002, E11197 ASTM, P1
   BAGARIATSKII IA, 1958, DOKL AKAD NAUK SSSR, V122, P593
   BOPHCOBA EA, 1986, METALLOGRAPHY TITANI
   BOWEN AW, 1980, TITANIUM 80 SCI TECH, P1318
   CHEAL EJ, 1992, J ORTHOPAED RES, V10, P405, DOI 10.1002/jor.1100100314
   Chen YY, 2006, T NONFERR METAL SOC, V16, pS824, DOI 10.1016/S1003-6326(06)60308-7
   Collings E. W., 1984, PHYS METALLURGY TITA
   Cui Z., 2000, METALLOGRAPHY HEAT T
   DAVIS R, 1979, J MATER SCI, V14, P712
   Delvat E, 2008, J MECH BEHAV BIOMED, V1, P345, DOI 10.1016/j.jmbbm.2008.01.006
   Dieter G. E., 1976, MECH METALLURGY
   Dujovne A R, 1993, J Arthroplasty, V8, P7, DOI 10.1016/S0883-5403(06)80102-6
   ENGH CA, 1988, CLIN ORTHOP RELAT R, P7
   FAN ZY, 1993, SCRIPTA METALL MATER, V29, P1427, DOI 10.1016/0956-716X(93)90331-L
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   Ferrandini PL, 2007, J ALLOY COMPD, V433, P207, DOI 10.1016/j.jallcom.2006.06.094
   Furuhara T, 1998, MATER T JIM, V39, P31, DOI 10.2320/matertrans1989.39.31
   Gordin DM, 2004, J MATER SCI-MATER M, V15, P885, DOI 10.1023/B:JMSM.0000036276.32211.31
   Grosdidier T, 2000, MAT SCI ENG A-STRUCT, V291, P218, DOI 10.1016/S0921-5093(00)00921-7
   Grosdidier T, 2000, METALL MATER TRANS A, V31, P1095, DOI 10.1007/s11661-000-0105-3
   Hanada S., 2005, INT C SER, V1284, P239, DOI DOI 10.1016/J.ICS.2005.06.084
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   Hao YL, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037192
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   Hida M., 1982, ACTA METALL, V30, P1421
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Hon YH, 2003, MATER TRANS, V44, P2384, DOI 10.2320/matertrans.44.2384
   HUNT M, 1991, MATER ENG, V113, P27
   Karasevskaya OP, 2003, MAT SCI ENG A-STRUCT, V354, P121, DOI 10.1016/S0921-5093(02)00935-8
   LEE YT, 1990, MAT SCI ENG A-STRUCT, V128, P77, DOI 10.1016/0921-5093(90)90097-M
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Matsumoto H, 2007, J ALLOY COMPD, V439, P146, DOI 10.1016/j.jallcom.2006.08.267
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Ping DH, 2006, SCRIPTA MATER, V54, P1305, DOI 10.1016/j.scriptamat.2005.12.022
   PRENDERGAST PJ, 1990, J BIOMED ENG, V12, P379, DOI 10.1016/0141-5425(90)90020-N
   Rao S, 1996, BIO-MED MATER ENG, V6, P79
   ROBARE EW, 1997, MINERALS, P283
   Silva HM, 2004, MAT SCI ENG C-BIO S, V24, P679, DOI 10.1016/j.msec.2004.08.051
   Song Y, 1999, MAT SCI ENG A-STRUCT, V260, P269, DOI 10.1016/S0921-5093(98)00886-7
   STEINEMANN SG, 1980, EVALUATION BIOMATERI, V1, P1
   Takemoto Y, 2004, MATER TRANS, V45, P1571, DOI 10.2320/matertrans.45.1571
   WALKER PR, 1989, BIOCHEMISTRY-US, V28, P3911, DOI 10.1021/bi00435a043
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2009, MAT SCI ENG C-BIO S, V29, P1061, DOI 10.1016/j.msec.2008.09.012
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 52
TC 47
Z9 52
U1 4
U2 63
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1044-5803
J9 MATER CHARACT
JI Mater. Charact.
PD OCT
PY 2011
VL 62
IS 10
BP 931
EP 937
DI 10.1016/j.matchar.2011.07.010
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Materials Science, Characterization & Testing
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 827PH
UT WOS:000295439900002
DA 2018-10-20
ER

PT J
AU Rockwood, DN
   Preda, RC
   Yucel, T
   Wang, XQ
   Lovett, ML
   Kaplan, DL
AF Rockwood, Danielle N.
   Preda, Rucsanda C.
   Yucel, Tuna
   Wang, Xiaoqin
   Lovett, Michael L.
   Kaplan, David L.
TI Materials fabrication from Bombyx mori silk fibroin
SO NATURE PROTOCOLS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; ENGINEERED VASCULAR GRAFTS; IN-VITRO;
   POLY(ETHYLENE OXIDE); ADENOSINE RELEASE; 3-D SCAFFOLDS; 3D SCAFFOLDS;
   BONE-MARROW; BIOMATERIALS; POLYMER
AB Silk fibroin, derived from Bombyx mori cocoons, is a widely used and studied protein polymer for biomaterial applications. Silk fibroin has remarkable mechanical properties when formed into different materials, demonstrates biocompatibility, has controllable degradation rates from hours to years and can be chemically modified to alter surface properties or to immobilize growth factors. A variety of aqueous or organic solvent-processing methods can be used to generate silk biomaterials for a range of applications. In this protocol, we include methods to extract silk from B. mori cocoons to fabricate hydrogels, tubes, sponges, composites, fibers, microspheres and thin films. These materials can be used directly as biomaterials for implants, as scaffolding in tissue engineering and in vitro disease models, as well as for drug delivery.
C1 [Rockwood, Danielle N.; Preda, Rucsanda C.; Yucel, Tuna; Wang, Xiaoqin; Lovett, Michael L.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU National Institutes of Health [P41 EB002520]; National Science
   Foundation; Air Force Office of Scientific Research
FX The authors acknowledge the following researchers for their
   contributions to these protocols: E.S. Gil, C. Wittmer, H. J. Kim, E.A.
   Pritchard, X. Wang, J.A. Kluge and F. Omenetto. This work was supported
   by the National Institutes of Health (P41 EB002520-Tissue Engineering
   Resource Center), the National Science Foundation and the Air Force
   Office of Scientific Research.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Craig CL, 2002, COMP BIOCHEM PHYS B, V133, P493, DOI 10.1016/S1096-4959(02)00095-7
   Etienne O, 2009, J PERIODONTOL, V80, P1852, DOI 10.1902/jop.2009.090231
   Ghosh S, 2009, BIOMATERIALS, V30, P6530, DOI 10.1016/j.biomaterials.2009.08.019
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   House M, 2010, TISSUE ENG PT A, V16, P2101, DOI [10.1089/ten.tea.2009.0457, 10.1089/ten.TEA.2009.0457]
   Hu X, 2011, BIOMACROMOLECULES, V12, P1686, DOI 10.1021/bm200062a
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kakade MV, 2007, J AM CHEM SOC, V129, P2777, DOI 10.1021/ja065043f
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kojthung A, 2008, INT BIODETER BIODEGR, V62, P487, DOI 10.1016/j.ibiod.2007.12.012
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lovett M, 2010, TISSUE ENG PART C-ME, V16, P1565, DOI [10.1089/ten.tec.2010.0241, 10.1089/ten.TEC.2010.0241]
   Lovett ML, 2008, BIOMATERIALS, V29, P4650, DOI 10.1016/j.biomaterials.2008.08.025
   Mauney JR, 2007, BIOMATERIALS, V28, P5280, DOI 10.1016/j.biomaterials.2007.08.017
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Moreau JE, 2008, TISSUE ENG PT A, V14, P1161, DOI [10.1089/ten.tea.2007.0147, 10.1089/tea.2007.0147]
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   Rockwood DN, 2011, ACTA BIOMATER, V7, P144, DOI 10.1016/j.actbio.2010.07.020
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Subramanian B, 2010, TISSUE ENG PT A, V16, P2821, DOI [10.1089/ten.tea.2009.0595, 10.1089/ten.TEA.2009.0595]
   Sung NY, 2009, FOOD SCI BIOTECHNOL, V18, P228
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari C, 2010, J BIOMED MATER RES A, V93A, P595, DOI 10.1002/jbm.a.32565
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang XL, 2009, TISSUE ENG PT A, V15, P3087, DOI [10.1089/ten.tea.2008.0670, 10.1089/ten.TEA.2008.0670]
   Wang XL, 2010, BIOMATERIALS, V31, P3920, DOI 10.1016/j.biomaterials.2010.01.118
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wharram SE, 2010, MACROMOL BIOSCI, V10, P246, DOI 10.1002/mabi.200900274
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang XH, 2009, BIOMATERIALS, V30, P3213, DOI 10.1016/j.biomaterials.2009.02.002
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
NR 71
TC 714
Z9 736
U1 63
U2 483
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
J9 NAT PROTOC
JI Nat. Protoc.
PD OCT
PY 2011
VL 6
IS 10
BP 1612
EP 1631
DI 10.1038/nprot.2011.379
PG 20
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 826OS
UT WOS:000295364100009
PM 21959241
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Bigham, AS
   Shadkhast, M
   Sadegh, AB
   Shafiei, Z
   Lakzian, A
   Khalegi, MR
AF Bigham, A. S.
   Shadkhast, M.
   Sadegh, A. Bigham
   Shafiei, Z.
   Lakzian, A.
   Khalegi, M. R.
TI Evaluation of osteoinduction properties of the demineralized bovine
   foetal growth plate powder as a new xenogenic biomaterial in rat
SO RESEARCH IN VETERINARY SCIENCE
LA English
DT Article
DE Ectopic; Osteoinductionin rat; Bovine; Demineralized fetus growth plate
ID BONE MORPHOGENETIC PROTEINS; FACTOR-BETA; BIOMECHANICAL EVALUATION;
   ALKALINE-PHOSPHATASE; ARTICULAR-CARTILAGE; INDUCTION; CELLS; EXPRESSION;
   COLLAGEN; BMP
AB The aim of this study was evaluation of osteoinductive properties of demineralized bovine foetal growth plate in submuscular transplantation (ectopic osteoinduction) as a new xenogenic biomaterial in rat model. Demineralized bovine foetal growth plate was ectopically implanted in 18 male Sprague-Dawley rats. In 18 of the animals under aseptic conditions two submuscular pouches were created between external and internal oblique abdominal muscles in the two flanks: the right was left empty (sham) and the left was filled with 20 mg of demineralized bovine foetal growth plate powder. Radiographs were taken in 2,4 and 6 weeks after the surgery, then six animals were pharmacologically euthanized after 2,4 and 6 weeks for histopathological evaluation. Results showed: (1) osteoinductivity of xenogenic demineralized bovine foetal growth plate powder, and (2) earlier mineralization of ectopically implanted demineralized bovine foetal growth plate in the submuscular implanted area. Our results show that submuscular implantation of xenogenic demineralized bovine foetal growth plate has osteoinductive properties in a rat model. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Bigham, A. S.; Lakzian, A.; Khalegi, M. R.] Shahrekord Univ, Dept Vet Surg & Radiol, Fac Vet Med, Shahrekord, Iran.
   [Shadkhast, M.] Shahrekord Univ, Dept Vet Anat & Embryol, Fac Vet Med, Shahrekord, Iran.
   [Sadegh, A. Bigham] Shiraz Med Univ, Sch Med, Dept Otolaryngol, Shiraz, Iran.
   [Shafiei, Z.] Shiraz Univ, Dept Vet Surg & Radiol, Fac Vet Med, Shiraz, Iran.
RP Bigham, AS (reprint author), Shahrekord Univ, Dept Vet Surg & Radiol, Fac Vet Med, POB 115, Shahrekord, Iran.
EM dr.bigham@gmail.com
CR Anderson HC, 2000, J HISTOCHEM CYTOCHEM, V48, P1493, DOI 10.1177/002215540004801106
   Bahamonde ME, 2001, J BONE JOINT SURG AM, V83A, pS56
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Bigham AS, 2009, CELL TISSUE BANK, V10, P33, DOI 10.1007/s10561-008-9107-y
   CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27
   Dehghani SN, 2008, CELL TISSUE BANK, V9, P91, DOI 10.1007/s10561-008-9062-7
   EMERY SE, 1994, J BONE JOINT SURG AM, V76A, P540, DOI 10.2106/00004623-199404000-00008
   Flecknell P., 2009, LAB ANIMAL ANAESTHES, P187
   HAGEN JW, 1992, J BIOMED MATER RES, V26, P897, DOI 10.1002/jbm.820260706
   HARRIS SE, 1994, J BONE MINER RES, V9, P855
   Hochberg Z, 2002, BEST PRACT RES CL EN, V16, P399, DOI 10.1053/beem.2002.0208
   HUGHES FJ, 1995, ENDOCRINOLOGY, V136, P2671, DOI 10.1210/en.136.6.2671
   Jin DD, 1991, CHUNG HUA WAI KO TSA, V29, P312
   JONES CM, 1992, DEVELOPMENT, V115, P639
   LAZOWSKI DA, 1994, BONE, V15, P563, DOI 10.1016/8756-3282(94)90282-8
   Mao WH, 2008, ASIAN AUSTRAL J ANIM, V21, P640, DOI 10.5713/ajas.2008.70293
   Miralles-Flores C.M., 1990, CELLS TISSUES ORGANS, V139, P209
   NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991
   OHTA S, 1992, FEBS LETT, V314, P356, DOI 10.1016/0014-5793(92)81505-G
   Oshin AO, 2007, VET COMP ORTHOPAED, V20, P151, DOI 10.1160/VCOT-07-02-0018
   PARALKAR VM, 1992, J CELL BIOL, V119, P1721, DOI 10.1083/jcb.119.6.1721
   Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027
   REDDI AH, 1972, P NATL ACAD SCI USA, V69, P1601, DOI 10.1073/pnas.69.6.1601
   REDDI AH, 1995, CLIN ORTHOP RELAT R, P115
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   RIPAMONTI U, 1992, CRIT REV ORAL BIOL M, V3, P1
   Riviere J.E., 2009, VET PHARM THERAPEUTI, P404
   Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294
   Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5
   TAKUWA Y, 1991, BIOCHEM BIOPH RES CO, V174, P96, DOI 10.1016/0006-291X(91)90490-X
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   VAINIO S, 1993, CELL, V75, P45, DOI 10.1016/S0092-8674(05)80083-2
   Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738
NR 35
TC 8
Z9 9
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0034-5288
EI 1532-2661
J9 RES VET SCI
JI Res. Vet. Sci.
PD OCT
PY 2011
VL 91
IS 2
BP 306
EP 310
DI 10.1016/j.rvsc.2010.12.001
PG 5
WC Veterinary Sciences
SC Veterinary Sciences
GA 825WI
UT WOS:000295312400026
PM 21216415
DA 2018-10-20
ER

PT J
AU Faraj, KA
   Brouwer, KM
   Geutjes, PJ
   Versteeg, EM
   Wismans, RG
   Deprest, JA
   Chajra, H
   Tiemessen, DM
   Feitz, WFJ
   Oosterwijk, E
   Daamen, WF
   Kuppevelt, TH
AF Faraj, Kaeuis A.
   Brouwer, Katrien M.
   Geutjes, Paul J.
   Versteeg, Elly M.
   Wismans, Ronnie G.
   Deprest, Jan A.
   Chajra, Hanane
   Tiemessen, Dorien M.
   Feitz, Wout F. J.
   Oosterwijk, Egbert
   Daamen, Willeke F.
   van Kuppevelt, Toin H.
TI The Effect of Ethylene Oxide Sterilisation, Beta Irradiation and Gamma
   Irradiation on Collagen Fibril-Based Scaffolds
SO TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE collagen; scaffolds; sterilisation; beta irradiation; gamma irradiation;
   ethylene oxide
ID IN-VITRO; MECHANICAL-PROPERTIES; CONSTRUCTION; BIOMATERIAL; DEGRADATION;
   MOLECULES; PROTEINS; BEHAVIOR; TISSUES; DESIGN
AB Ethylene oxide (EtO) gassing and beta- and gamma-irradiation are currently used for sterilising collagen scaffolds. During the process, scaffolds may undergo chemical and physical alterations that may compromise their structural integrity and functional characteristics. In this study, we compared the effects of EtO gassing, and beta- and gamma-irradiation at 15 and 25 kGy on type I collagen fibril-based scaffolds with and without crosslinking, and with and without heparin. Evaluation was performed using a wide range of biophysical, biochemical, morphological and biological parameters. EtO treatment, beta-irradiation and gamma-irradiation did not induce morphological changes, nor did they have an effect on the amount of primary amine groups, or the amount of heparin covalently attached to the scaffolds. Cytocompatibility was also not affected. Irradiation, however, did result in collagen degradation products, a decrease in collagen denaturation temperature, and an increase in proteolytic degradation, all in a dose dependent fashion. These parameters were hardly influenced by EtO treatment. Sterilisation methods had hardly any effect on tensile strength of crosslinked scaffolds, but -surprisingly- they increased the tensile strength of non-crosslinked scaffolds. In conclusion, a number of the collagen scaffold parameters were influenced by sterilisation, whereas others were not. Irradiation had a much larger effect than EtO. However, tensile strength and cytocompatibility, important in tissue engineering, were not negatively influenced by any of the methods. Therefore, aspects like costs, safety and practicality of use may be taken into account in the choice of sterilisation method.
C1 [Faraj, Kaeuis A.; Brouwer, Katrien M.; Versteeg, Elly M.; Wismans, Ronnie G.; Daamen, Willeke F.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem 280, NCMLS, NL-6500 HB Nijmegen, Netherlands.
   [Faraj, Kaeuis A.] EMCM BV, Aap Bioimplant, NL-6545 CH Nijmegen, Netherlands.
   [Geutjes, Paul J.; Tiemessen, Dorien M.; Feitz, Wout F. J.; Oosterwijk, Egbert] Radboud Univ Nijmegen, Med Ctr, Dept Urol 659, NL-6500 HB Nijmegen, Netherlands.
   [Deprest, Jan A.] Katholieke Univ Leuven, Fac Med, Ctr Surg Technol, B-3000 Louvain, Belgium.
   [Chajra, Hanane] ZI Les Troques, Symatese Biomat, F-69630 Chaponost, France.
   [Faraj, Kaeuis A.] Univ Salahaddin, Dept Chem, Coll Educ Sci, Erbil, Kurdistan Regio, Iraq.
RP Kuppevelt, TH (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biochem 280, NCMLS, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM A.vanKuppevelt@ncmls.ru.nl
RI Oosterwijk, Egbert/P-5466-2014; Geutjes, P.J./L-4320-2015; Daamen,
   Willeke/D-5854-2015; Brouwer, Katrien/K-6168-2012; Kuppevelt,
   A.H.M.S.M./L-4463-2015; Feitz, W.F.J./H-8028-2014; Tiemessen,
   Theodora/G-6233-2016
OI Daamen, Willeke/0000-0003-3155-3030; Brouwer,
   Katrien/0000-0002-6768-3358; Tiemessen, Theodora/0000-0002-5529-9113
FU EU [LSHB-CT-2006-037409]; NWO CASIMIR program [018.003.023.2008]
FX Paul van Rensch is kindly acknowledged for his work on the tensiometric
   measurements. The Microscopical Imaging Centre (NCMLS, RUNMC) is
   acknowledged for facilitating electron microscopical services. This work
   was financially supported by EU-FP6 project EuroSTEC (soft tissue
   engineering for congenital birth defects in children;
   LSHB-CT-2006-037409); parts were supported by NWO CASIMIR program
   018.003.023.2008. The authors have no conflicting financial interests.
CR *ASTM INT, 2009, STAND GUID CHAR TYP
   BAILEY AJ, 1964, RADIAT RES, V23, P145, DOI 10.2307/3571687
   Bancroft J, 1996, THEORY PRACTICE HIST
   BERTHOD F, 1994, CLIN MATER, V15, P259, DOI 10.1016/0267-6605(94)90055-8
   CHEUNG DT, 1985, CONNECT TISSUE RES, V13, P109, DOI 10.3109/03008208509152389
   CHEUNG DT, 1990, J BIOMED MATER RES, V24, P581, DOI 10.1002/jbm.820240505
   Cilurzo F, 2005, AAPS PHARMSCITECH, V6, pE586, DOI 10.1208/pt060473
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824
   Faraj KA, 2007, TISSUE ENG, V13, P2387, DOI 10.1089/ten.2006.0320
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Friess W, 1999, PHARM DEV TECHNOL, V4, P387, DOI 10.1081/PDT-100101374
   FRIESS W, 1997, PHARM RES, V14, P154
   Friess W, 2006, EUR J PHARM BIOPHARM, V63, P176, DOI 10.1016/j.ejpb.2005.11.007
   Geutjes PJ, 2006, ADV EXP MED BIOL, V585, P279
   GILBERT DL, 1990, J BIOMED MATER RES, V24, P1221, DOI 10.1002/jbm.820240907
   GORHAM SD, 1993, J MATER SCI-MATER M, V4, P40, DOI 10.1007/BF00122976
   Gouk SS, 2008, J BIOMED MATER RES B, V84B, P205, DOI 10.1002/jbm.b.30862
   GRANT RA, 1973, J ANAT, V115, P29
   Hosper NA, 2010, BIOMATERIALS, V31, P3910, DOI 10.1016/j.biomaterials.2010.01.129
   Inoue N, 2006, J BIOMAT SCI-POLYM E, V17, P837, DOI 10.1163/156856206777996835
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MONBOISSE JC, 1988, BIOCHIM BIOPHYS ACTA, V965, P29, DOI 10.1016/0304-4165(88)90147-X
   Noah EM, 2002, BIOMATERIALS, V23, P2855, DOI 10.1016/S0142-9612(01)00412-4
   Nuininga JE, 2010, TISSUE ENG PT A, V16, P3319, DOI 10.1089/ten.tea.2010.0053
   Ohan MP, 2003, J BIOMED MATER RES A, V67A, P1188, DOI 10.1002/jbm.a.20018
   Ozog Y, 2009, INT UROGYNECOL J, V20, P435, DOI 10.1007/s00192-008-0793-6
   Peacock R, 1999, Med Device Technol, V10, P24
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Roelofs LAJ, 2008, TISSUE ENG PT A, V14, P2033, DOI 10.1089/ten.tea.2007.0191
   Salehpour A, 1995, J ORTHOP RES, V13, P898, DOI 10.1002/jor.1100130614
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   Woo L, 2002, RADIAT PHYS CHEM, V63, P845, DOI 10.1016/S0969-806X(01)00664-8
   Woolston J, 1999, Med Device Technol, V10, P20
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 36
TC 15
Z9 15
U1 2
U2 17
PU KOREAN TISSUE ENGINEERING REGENERATIVE MEDICINE SOC
PI JONGRO-GU
PA 199-1, DONGSUNG-DONG,, JONGRO-GU, SEOUL 110-810, SOUTH KOREA
SN 1738-2696
J9 TISSUE ENG REGEN MED
JI Tissue Eng. Regen. Med.
PD OCT
PY 2011
VL 8
IS 5
BP 460
EP 470
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 828JH
UT WOS:000295496800005
DA 2018-10-20
ER

PT J
AU Peng, BL
   Dhar, N
   Liu, HL
   Tam, KC
AF Peng, B. L.
   Dhar, N.
   Liu, H. L.
   Tam, K. C.
TI CHEMISTRY AND APPLICATIONS OF NANOCRYSTALLINE CELLULOSE AND ITS
   DERIVATIVES: A NANOTECHNOLOGY PERSPECTIVE
SO CANADIAN JOURNAL OF CHEMICAL ENGINEERING
LA English
DT Article
DE nanocrystalline cellulose; chemical modification; applications
ID CHIRAL NEMATIC PHASE; TRANSFER RADICAL POLYMERIZATION; TEMPO-MEDIATED
   OXIDATION; CRYSTALLITE-GEL-MODEL; MICROCRYSTALLINE CELLULOSE; NATIVE
   CELLULOSE; ACID-HYDROLYSIS; POLYSACCHARIDE NANOCRYSTALS; BIOBASED
   NANOCOMPOSITES; BACTERIAL CELLULOSE
AB Nanocrystalline cellulose (NCC) is an emerging renewable nanomaterial that holds promise in many different applications, such as in personal care, chemicals, foods, pharmaceuticals, etc. By appropriate modification of NCC, various functional nanomaterials with outstanding properties, or significantly improved physical, chemical, biological, as well as electronic properties can be developed. The nanoparticles are stabilised in aqueous suspension by negative charges on the surface, which are produced during the acid hydrolysis process. NCC suspensions can form a chiral nematic ordered phase beyond a critical concentration, i.e. NCC suspensions transform from an isotropic to an anisotropic chiral nematic liquid crystalline phase. Due to its nanoscale dimension and intrinsic physicochemical properties, NCC is a promising renewable biomaterial that can be used as a reinforcing component in high performance nanocomposites. Many new nanocomposite materials with attractive properties were obtained by the physical incorporation of NCC into a natural or synthetic polymeric matrix. Simple chemical modification on NCC surface can improve its dispersability in different solvents and expand its utilisation in nano-related applications, such as drug delivery, protein immobilisation, and inorganic reaction template. This review paper provides an overview on this emerging nanomaterial, focusing on the surface modification, properties and applications of NCC.
C1 [Peng, B. L.; Dhar, N.; Tam, K. C.] Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, Waterloo, ON N2L 3G1, Canada.
   [Peng, B. L.; Liu, H. L.] E China Univ Sci & Technol, State Key Lab Chem Engn, Shanghai 200237, Peoples R China.
   [Peng, B. L.; Liu, H. L.] E China Univ Sci & Technol, Dept Chem, Shanghai 200237, Peoples R China.
RP Tam, KC (reprint author), Univ Waterloo, Dept Chem Engn, Waterloo Inst Nanotechnol, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM mkctam@uwaterloo.ca
RI Tam, Michael/G-4813-2010
OI Tam, Michael/0000-0002-7603-5635
FU China Scholarship Council; CFI; NSERC; National Natural Science
   Foundation of China [20736002]; 111 Project of China [B08021];
   Domtar-FPInnovations Joint Venture Company
FX B. L. Peng thanks the China Scholarship Council for supporting his
   research at University of Waterloo, Canada. K. C. Tam would like to
   acknowledge the support from CFI and NSERC. H. L. Liu would like to
   acknowledge the financial support from the National Natural Science
   Foundation of China (20736002) and the 111 Project of China (B08021). We
   wish to thank Dr. Richard Berry (Domtar-FPInnovations Joint Venture
   Company) for his support and encouragement in the research on NCC.
CR Araki J, 1998, COLLOID SURFACE A, V142, P75, DOI 10.1016/S0927-7757(98)00404-X
   Araki J, 2001, LANGMUIR, V17, P21, DOI 10.1021/la001070m
   Aulin C, 2010, BIOMACROMOLECULES, V11, P872, DOI 10.1021/bm100075e
   Azzam F, 2010, BIOMACROMOLECULES, V11, P3652, DOI 10.1021/bm101106c
   Bai W, 2009, CELLULOSE, V16, P455, DOI 10.1007/s10570-009-9277-1
   Beck S, 2011, BIOMACROMOLECULES, V12, P167, DOI 10.1021/bm1010905
   Beck-Candanedo S, 2005, BIOMACROMOLECULES, V6, P1048, DOI 10.1021/bm049300p
   Beck-Candanedo S, 2007, MACROMOLECULES, V40, P3429, DOI 10.1021/ma0704818
   Beck-Candanedo S, 2006, CELLULOSE, V13, P629, DOI 10.1007/s10570-006-9084-x
   Berlioz S, 2009, BIOMACROMOLECULES, V10, P2144, DOI 10.1021/bm900319k
   Bondeson D, 2006, CELLULOSE, V13, P171, DOI 10.1007/s10570-006-9061-4
   Bondeson D, 2007, COMPOS PART A-APPL S, V38, P2486, DOI 10.1016/j.compositesa.2007.08.001
   Bordel D, 2006, LANGMUIR, V22, P4899, DOI 10.1021/la0600402
   Braun B, 2009, BIOMACROMOLECULES, V10, P334, DOI 10.1021/bm8011117
   Cao XD, 2009, J MATER CHEM, V19, P7137, DOI 10.1039/b910517d
   Cetin NS, 2009, MACROMOL BIOSCI, V9, P997, DOI 10.1002/mabi.200900073
   Chen GJ, 2009, MACROMOL MATER ENG, V294, P59, DOI 10.1002/mame.200800261
   COFFEY DG, 1995, FOOD POLYSACCHARIDES, P124
   Cranston ED, 2006, SCI TECHNOL ADV MAT, V7, P319, DOI 10.1016/j.stam.2006.02.007
   Cranston ED, 2008, COLLOID SURFACE A, V325, P44, DOI 10.1016/j.colsurfa.2008.04.042
   Cranston ED, 2006, BIOMACROMOLECULES, V7, P2522, DOI 10.1021/bm0602886
   de Menezes AJ, 2009, POLYMER, V50, P4552, DOI 10.1016/j.polymer.2009.07.038
   de Mesquita JP, 2010, BIOMACROMOLECULES, V11, P473, DOI 10.1021/bm9011985
   de Rodriguez NLG, 2006, CELLULOSE, V13, P261, DOI 10.1007/s10570-005-9039-7
   Dong SP, 2007, J AM CHEM SOC, V129, P13810, DOI 10.1021/ja076196l
   Dong XM, 1997, LANGMUIR, V13, P2404, DOI 10.1021/la960724h
   Dong XM, 1996, LANGMUIR, V12, P2076, DOI 10.1021/la950133b
   Dubief D, 1999, MACROMOLECULES, V32, P5765, DOI 10.1021/ma990274a
   Dufresne A, 2008, CAN J CHEM, V86, P484, DOI 10.1139/V07-152
   Dufresne A, 2010, MOLECULES, V15, P4111, DOI 10.3390/molecules15064111
   Dukic-Ott A, 2009, EUR J PHARM BIOPHARM, V71, P38, DOI 10.1016/j.ejpb.2008.08.005
   Edgar CD, 2002, MACROMOLECULES, V35, P7400, DOI 10.1021/ma0204195
   Ek R, 1998, PHARMACEUT RES, V15, P509, DOI 10.1023/A:1011905222168
   Elazzouzi-Hafraoui S, 2008, BIOMACROMOLECULES, V9, P57, DOI 10.1021/bm700769p
   Elazzouzi-Hafraoui S, 2009, J PHYS CHEM B, V113, P11069, DOI 10.1021/jp900122t
   Magalhaes WLE, 2009, LANGMUIR, V25, P13250, DOI 10.1021/la901928j
   FAVIER V, 1995, MACROMOLECULES, V28, P6365, DOI 10.1021/ma00122a053
   FIELDEN KE, 1988, J PHARM PHARMACOL, V40, P674, DOI 10.1111/j.2042-7158.1988.tb06993.x
   Filson PB, 2009, GREEN CHEM, V11, P1808, DOI 10.1039/b915746h
   Fleming K, 2000, J AM CHEM SOC, V122, P5224, DOI 10.1021/ja000764e
   Fleming K, 2001, CHEM-EUR J, V7, P1831, DOI 10.1002/1521-3765(20010504)7:9<1831::AID-CHEM1831>3.0.CO;2-S
   Gousse C, 2002, POLYMER, V43, P2645, DOI 10.1016/S0032-3861(02)00051-4
   Grunert M, 2002, J POLYM ENVIRON, V10, P27, DOI 10.1023/A:1021065905986
   Ha CS, 2005, CHEM REV, V105, P4205, DOI 10.1021/cr040419y
   Habibi Y, 2008, J MATER CHEM, V18, P5002, DOI 10.1039/b809212e
   Habibi Y, 2008, J POLYM SCI POL PHYS, V46, P1430, DOI 10.1002/polb.21479
   Habibi Y, 2008, BIOMACROMOLECULES, V9, P1974, DOI 10.1021/bm8001717
   Habibi Y, 2007, J COLLOID INTERF SCI, V316, P388, DOI 10.1016/j.jcis.2007.08.041
   Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y
   Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w
   Habibi Y, 2010, LANGMUIR, V26, P990, DOI 10.1021/la902444x
   Hasani M, 2008, SOFT MATTER, V4, P2238, DOI 10.1039/b806789a
   Henriksson M, 2007, J APPL POLYM SCI, V106, P2817, DOI 10.1002/app.26946
   Heux L, 2000, LANGMUIR, V16, P8210, DOI 10.1021/la9913957
   Iwamoto S, 2008, BIOMACROMOLECULES, V9, P1022, DOI 10.1021/bm701157n
   Jean B, 2008, LANGMUIR, V24, P3452, DOI 10.1021/la703045f
   Jean B, 2009, LANGMUIR, V25, P3920, DOI 10.1021/la802801q
   Jiang B, 2007, COMPOS PART B-ENG, V38, P24, DOI 10.1016/j.compositesb.2006.05.002
   Kim J, 2009, POLYM ENG SCI, V49, P2054, DOI 10.1002/pen.21417
   Kimura F, 2005, LANGMUIR, V21, P2034, DOI 10.1021/la0475728
   Kleinebudde P, 1997, PHARMACEUT RES, V14, P804, DOI 10.1023/A:1012166809583
   Kovacs T, 2010, NANOTOXICOLOGY, V4, P255, DOI 10.3109/17435391003628713
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lima MMD, 2004, MACROMOL RAPID COMM, V25, P771, DOI 10.1002/marc.200300268
   Lima MMD, 2002, LANGMUIR, V18, P992, DOI 10.1021/la0105127
   Lin N, 2009, J APPL POLYM SCI, V113, P3417, DOI 10.1002/app.30308
   Ljungberg N, 2005, BIOMACROMOLECULES, V6, P2732, DOI 10.1021/bm050222v
   Mahmoud KA, 2009, ACS APPL MATER INTER, V1, P1383, DOI 10.1021/am900331d
   Mangalam AP, 2009, BIOMACROMOLECULES, V10, P497, DOI 10.1021/bm800925x
   Marchessault RH, 2006, POLYSACCHARIDES DRUG
   Miller AF, 2003, BIOMACROMOLECULES, V4, P510, DOI 10.1021/bm0200837
   Montanari S, 2005, MACROMOLECULES, V38, P1665, DOI 10.1021/ma048396c
   Morandi G, 2009, LANGMUIR, V25, P8280, DOI 10.1021/la900452a
   Nakagaito AN, 2008, CELLULOSE, V15, P323, DOI 10.1007/s10570-007-9168-2
   Nogi M., 2005, APPL PHYS LETT, V87
   Oksman K, 2006, COMPOS SCI TECHNOL, V66, P2776, DOI 10.1016/j.compscitech.2006.03.002
   Pan JH, 2010, MACROMOLECULES, V43, P3851, DOI 10.1021/ma902383k
   Park WI, 2007, MACROMOL SYMP, V249, P289, DOI 10.1002/masy.200750347
   Peresin MS, 2010, BIOMACROMOLECULES, V11, P674, DOI 10.1021/bm901254n
   Podsiadlo P, 2005, BIOMACROMOLECULES, V6, P2914, DOI 10.1021/bm050333u
   Pranger L, 2008, MACROMOLECULES, V41, P8682, DOI 10.1021/ma8020213
   Ranby B.G., 1951, FARADAY SOC, V11, P150
   Revol J.F., 1997, US, Patent No. [US 5629055 A, 5629055, 5629055A]
   Revol J.F., 1982, CARBOHYD POLYM, V2, P123, DOI DOI 10.1016/0144-8617(82)90058-3
   REVOL JF, 1994, LIQ CRYST, V16, P127, DOI 10.1080/02678299408036525
   REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X
   Revol JF, 1998, 1331 PPR
   Rojas OJ, 2009, J APPL POLYM SCI, V113, P927, DOI 10.1002/app.30011
   Roman M, 2004, BIOMACROMOLECULES, V5, P1671, DOI 10.1021/bm034519+
   Roman M., 2010, POLYSACCHARIDE MAT P, P81
   Roy D, 2009, CHEM SOC REV, V38, P2046, DOI 10.1039/b808639g
   Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769
   Saito T, 2010, J WOOD SCI, V56, P227, DOI 10.1007/s10086-009-1092-7
   Samir MASA, 2004, ELECTROCHIM ACTA, V49, P4667, DOI 10.1016/j.electacta.2004.05.021
   Samir MASA, 2004, J PHYS CHEM B, V108, P10845, DOI 10.1021/jp0494483
   Samir MASA, 2005, BIOMACROMOLECULES, V6, P612, DOI 10.1021/bm0493685
   Samir MASFA, 2004, MACROMOLECULES, V37, P4839
   SASSI JF, 1995, CELLULOSE, V2, P111, DOI 10.1007/BF00816384
   Schroers M, 2004, J APPL POLYM SCI, V93, P2883, DOI 10.1002/app.20870
   Seydibeyoglu MO, 2008, COMPOS SCI TECHNOL, V68, P908, DOI 10.1016/j.compscitech.2007.08.008
   Shi HQG, 2003, PHARMACEUT RES, V20, P479, DOI 10.1023/A:1022676709565
   Shimazaki Y, 2007, BIOMACROMOLECULES, V8, P2976, DOI 10.1021/bm7004998
   Shin Y, 2008, J PHYS CHEM C, V112, P4844, DOI 10.1021/jp710767w
   Shin Y, 2007, MATER LETT, V61, P3215, DOI 10.1016/j.matlet.2006.11.036
   Shin Y, 2007, MATER LETT, V61, P2594, DOI 10.1016/j.matlet.2006.10.005
   Shopsowitz KE, 2010, NATURE, V468, P422, DOI 10.1038/nature09540
   Siqueira G, 2010, LANGMUIR, V26, P402, DOI 10.1021/la9028595
   STROOBANTS A, 1986, MACROMOLECULES, V19, P2232, DOI 10.1021/ma00162a020
   SUGIYAMA J, 1992, MACROMOLECULES, V25, P4232, DOI 10.1021/ma00042a032
   Terech P, 1999, MACROMOLECULES, V32, P1872, DOI 10.1021/ma9810621
   Van Eerdenbrugh B, 2008, EUR J PHARM BIOPHARM, V70, P590, DOI 10.1016/j.ejpb.2008.06.007
   WANG JS, 1995, J AM CHEM SOC, V117, P5614, DOI 10.1021/ja00125a035
   Wang N, 2008, LANGMUIR, V24, P5, DOI 10.1021/la702923w
   Wong J. T., 2003, LANGMUIR, V19, P24
   Wong KKH, 2009, CARBON, V47, P2571, DOI 10.1016/j.carbon.2009.05.006
   Xu QX, 2008, EUR POLYM J, V44, P2830, DOI 10.1016/j.eurpolymj.2008.06.010
   Yi J, 2008, POLYMER, V49, P4406, DOI 10.1016/j.polymer.2008.08.008
   Yi J, 2009, CELLULOSE, V16, P989, DOI 10.1007/s10570-009-9350-9
   Yuan HH, 2006, BIOMACROMOLECULES, V7, P696, DOI 10.1021/bm050828j
   Zhang JG, 2007, CARBOHYD POLYM, V69, P607, DOI 10.1016/j.carbpol.2007.01.019
   Zhang XL, 2010, POLYMER, V51, P4398, DOI 10.1016/j.polymer.2010.07.025
   Zhou Q, 2009, MACROMOLECULES, V42, P5430, DOI 10.1021/ma901175j
   Zhou Y, 2007, MATER LETT, V61, P5050, DOI 10.1016/j.matlet.2007.04.001
   Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705
NR 124
TC 294
Z9 302
U1 15
U2 295
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0008-4034
J9 CAN J CHEM ENG
JI Can. J. Chem. Eng.
PD OCT
PY 2011
VL 89
IS 5
SI SI
BP 1191
EP 1206
DI 10.1002/cjce.20554
PG 16
WC Engineering, Chemical
SC Engineering
GA 824TA
UT WOS:000295223800023
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Akar, T
   Celik, S
AF Akar, Tamer
   Celik, Sema
TI Efficient biosorption of a reactive dye from contaminated media by
   Neurospora sitophila cells - Zea mays silk tissue biomass system
SO JOURNAL OF CHEMICAL TECHNOLOGY AND BIOTECHNOLOGY
LA English
DT Article
DE Neurospora sitophila; biosorbent system; isotherms; kinetics;
   regeneration
ID AQUEOUS-SOLUTION; METHYLENE-BLUE; WASTE BIOMASS; FUNGAL BIOMASS;
   SILICA-GEL; AZO-DYE; REMOVAL; EQUILIBRIUM; ADSORPTION; BATCH
AB BACKGROUND: A filamentous fungus Neurospora sitophila was immobilized in Zea mays silk tissue and the prepared system was employed as a new biosorbent for the treatment of reactive dye contaminated solutions.
   RESULTS: Decolorization potential of the biosorbent system was investigated in batch and continuous mode operations. Design parameters such as pH, biomass dosage, contact time, temperature, dye concentration and flow rate were investigated. Batch mode equilibrium data were analyzed kinetically to determine the rate constants. The process followed the pseudo-second-order kinetic model. The thermodynamics of the biosorption indicated the spontaneous and endothermic nature of the process. Biosorption was well described by the Langmuir isotherm model, with a maximum monolayer biosorption capacity of 105.33 mg g(-1). Relatively good dynamic flow decolorization potential was observed for the biosorbent system in synthetic and real wastewater conditions. Flow mode regeneration studies over ten consecutive cycles indicated that the suggested biosorbent maintained consistently high biosorption yield, above 70%. The possible dye-biosorbent interaction mechanism was also confirmed by zeta potential, FTIR, SEM and EDX analysis.
   CONCLUSION: High biosorption capacity and regeneration potential suggest that the new biosorbent system can be used as an alternative and low-cost biomaterial for the treatment of reactive dye contaminated solutions. (C) 2011 Society of Chemical Industry
C1 [Akar, Tamer] Eskisehir Osmangazi Univ, Dept Chem, Fac Arts & Sci, TR-26480 Eskisehir, Turkey.
   [Celik, Sema] Eskisehir Osmangazi Univ, Grad Sch Nat & Appl Sci, Dept Chem, TR-26480 Eskisehir, Turkey.
RP Akar, T (reprint author), Eskisehir Osmangazi Univ, Dept Chem, Fac Arts & Sci, TR-26480 Eskisehir, Turkey.
EM takar@ogu.edu.tr
CR Abu Al-Rub FA, 2004, PROCESS BIOCHEM, V39, P1767, DOI 10.1016/j.procbio.2003.08.002
   Akar ST, 2011, CHEM ENG J, V168, P125, DOI 10.1016/j.cej.2010.12.049
   Akar ST, 2009, CHEM ENG J, V148, P26, DOI 10.1016/j.cej.2008.07.027
   Akar T, 2009, J HAZARD MATER, V163, P1134, DOI 10.1016/j.jhazmat.2008.07.084
   Akar T, 2010, BIORESOURCE TECHNOL, V101, P7271, DOI 10.1016/j.biortech.2010.04.044
   Akar T, 2009, J HAZARD MATER, V171, P865, DOI 10.1016/j.jhazmat.2009.06.085
   Akar T, 2009, J HAZARD MATER, V166, P1217, DOI 10.1016/j.jhazmat.2008.12.029
   Aksakal O, 2010, J HAZARD MATER, V181, P666, DOI 10.1016/j.jhazmat.2010.05.064
   Aksu Z, 2009, J HAZARD MATER, V168, P310, DOI 10.1016/j.jhazmat.2009.02.027
   Aravindhan R, 2007, J HAZARD MATER, V142, P68, DOI 10.1016/j.jhazmat.2006.07.058
   Asgher M, 2010, ECOL ENG, V36, P1660, DOI 10.1016/j.ecoleng.2010.07.003
   Binupriya AR, 2010, COLLOID SURFACE B, V76, P179, DOI 10.1016/j.colsurfb.2009.10.031
   Cabuk A, 2007, CHEM ENG J, V131, P293, DOI 10.1016/j.cej.2006.12.011
   Cabuk A, 2006, J HAZARD MATER, V136, P317, DOI 10.1016/j.jhazmat.2005.12.019
   Dubinin M.M., 1947, P ACAD SCI USSR PHYS, V55, P331
   Ergene A, 2009, DESALINATION, V249, P1308, DOI 10.1016/j.desal.2009.06.027
   Fernandez ME, 2010, BIORESOURCE TECHNOL, V101, P9500, DOI 10.1016/j.biortech.2010.07.102
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Gupta VK, 2009, J HAZARD MATER, V163, P396, DOI 10.1016/j.jhazmat.2008.06.104
   HALL KR, 1966, IND ENG CHEM FUND, V5, P212, DOI 10.1021/i160018a011
   Hasany SM, 1996, APPL RADIAT ISOTOPES, V47, P467, DOI 10.1016/0969-8043(95)00310-X
   Ho YS, 1998, PROCESS SAF ENVIRON, V76, P183, DOI 10.1205/095758298529326
   HOBSON JP, 1969, J PHYS CHEM-US, V73, P2720, DOI 10.1021/j100842a045
   HOUK VS, 1992, MUTAT RES, V277, P91, DOI 10.1016/0165-1110(92)90001-P
   Iqbal M, 2007, PROCESS BIOCHEM, V42, P1160, DOI 10.1016/j.procbio.2007.05.014
   Kannan N, 2001, DYES PIGMENTS, V51, P25, DOI 10.1016/S0143-7208(01)00056-0
   KUYUCAK N, 1989, BIOTECHNOL BIOENG, V33, P823, DOI 10.1002/bit.260330705
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Largergren S., 1898, HANDLINGAR, V24, P1, DOI DOI 10.1007/BF01501332
   Loukidou MX, 2004, COLLOID SURFACE A, V242, P93, DOI 10.1016/j.colsurfa.2004.03.030
   Mezener N.Y., 2010, DESALINATION, V262, P251
   Mohan SV, 2002, J HAZARD MATER, V90, P189
   O'Mahony T, 2002, ENZYME MICROB TECH, V31, P456, DOI 10.1016/S0141-0229(02)00110-2
   Oei BC, 2009, BIORESOURCE TECHNOL, V100, P4292, DOI 10.1016/j.biortech.2009.03.063
   Padmesh TVN, 2006, DYES PIGMENTS, V71, P77, DOI 10.1016/j.dyepig.2005.06.003
   Pandey A, 2007, INT BIODETER BIODEGR, V59, P73, DOI 10.1016/j.ibiod.2006.08.006
   Peter ALJ, 2008, BIORESOURCE TECHNOL, V99, P618, DOI 10.1016/j.biortech.2006.12.038
   Couto SR, 2009, BIOTECHNOL ADV, V27, P227, DOI 10.1016/j.biotechadv.2008.12.001
   Rubin E, 2005, J CHEM TECHNOL BIOT, V80, P291, DOI 10.1002/jctb.1192
   Russo ME, 2010, CHEM ENG J, V162, P537, DOI 10.1016/j.cej.2010.05.058
   Saeed A, 2009, J HAZARD MATER, V168, P406, DOI 10.1016/j.jhazmat.2009.02.058
   Shojaosadati SA, 1999, RESOUR CONSERV RECY, V27, P73, DOI 10.1016/S0921-3449(98)00086-X
   Thangamani KS, 2007, BIORESOURCE TECHNOL, V98, P1265, DOI 10.1016/j.biortech.2006.05.010
   Tunali S, 2007, J ENVIRON SCI HEAL A, V42, P591, DOI 10.1080/10934520701244359
   Tuzen M, 2009, J HAZARD MATER, V169, P263, DOI 10.1016/j.jhazmat.2009.03.096
   Vijayaraghavan K, 2009, IND ENG CHEM RES, V48, P3589, DOI 10.1021/ie801570v
   Wang BE, 2008, BIORESOURCE TECHNOL, V99, P794, DOI 10.1016/j.biortech.2007.01.043
   WEBER TW, 1974, AICHE J, V20, P228, DOI 10.1002/aic.690200204
   Weber WJ, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   Won SW, 2006, CHEM ENG J, V121, P37, DOI 10.1016/j.cej.2006.04.005
NR 50
TC 8
Z9 8
U1 0
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0268-2575
J9 J CHEM TECHNOL BIOT
JI J. Chem. Technol. Biotechnol.
PD OCT
PY 2011
VL 86
IS 10
BP 1332
EP 1341
DI 10.1002/jctb.2639
PG 10
WC Biotechnology & Applied Microbiology; Chemistry, Multidisciplinary;
   Engineering, Environmental; Engineering, Chemical
SC Biotechnology & Applied Microbiology; Chemistry; Engineering
GA 824XN
UT WOS:000295235600013
DA 2018-10-20
ER

PT J
AU Stavropoulos, A
   Becker, J
   Capsius, B
   Acil, Y
   Wagner, W
   Terheyden, H
AF Stavropoulos, Andreas
   Becker, Juergen
   Capsius, Bjoern
   Acil, Yahya
   Wagner, Wilfried
   Terheyden, Hendrik
TI Histological evaluation of maxillary sinus floor augmentation with
   recombinant human growth and differentiation factor-5-coated
   beta-tricalcium phosphate: results of a multicenter randomized clinical
   trial
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE autogenous bone; bone substitutes; histology; human; rhGDF-5; sinus
   augmentation; beta-TCP; tissue engineering
ID HUMAN GROWTH/DIFFERENTIATION FACTOR-5; HUMAN OSTEOGENIC PROTEIN-1; BONE
   MORPHOGENETIC PROTEIN-7; GOETTINGEN MINIATURE PIG; AUTOGENOUS BONE;
   DENTAL IMPLANTS; SIMULTANEOUS PLACEMENT; SURVIVAL RATES; RHGDF-5;
   DEFECTS
AB Objectives: The aim of this prospective, multicenter, randomized clinical trial was to evaluate histologically the outcome of maxillary sinus lift augmentation with a recombinant human growth and differentiation factor-5-coated beta-tricalcium phosphate (rhGDF-5/beta-TCP) or with a beta-TCP and autogenous bone (beta-TCP/AB) composite.
   Material and Methods: Thirty-one patients requiring unilateral maxillary sinus floor augmentation (residual alveolar bone height <5 mm) were randomly allocated in three treatment groups: (a) rhGDF-5/beta-TCP and a 3-month healing period, (b) rhGDF-5/beta-TCP and a 4-month healing period, and (c) beta-TCP and intra-oral corticocancellous autologous bone (at 1:1) and a 4-month healing period. Cylindrical biopsies were harvested by means of a trephine bur during implant site preparation and evaluated histologically and histometrically.
   Results: One patient withdrew from the study before implant placement; 66 implants were inserted in the remaining 30 patients. Four out of 47 (8.5%) implants failed in patients treated with rhGDF-5/beta-TCP. The proportion of newly formed bone was similar among groups and averaged 31.4% (+/-17%) in the rhGDF-5/beta-TCP/3-month healing group, 28% (+/-15.5%) in the rhGDF-5/beta-TCP/4-month healing group, and 31.8% (+/-17.9%) in the beta-TCP/AB group. The proportion of remaining beta-TCP averaged 12.6% (+/-4.4%) in the rhGDF-5/beta-TCP/3-month group, 6.6% (+/-6.3%) in the rhGDF-5/beta-TCP/4-month group, and 16.5% (+/-12.3%) in the beta-TCP/AB group. The new bone was primarily woven and characterized by slender trabeculae and narrow osteoid zones, and in many instances bone was in contact with residual biomaterial particles. Presence of AB particle remnants was only trivial, while minimal amounts of inflammation were observed only in a few cases.
   Conclusion: Sinus augmentation with rhGDF-5/beta-TCP resulted in comparable amounts of new bone and of similar quality as those obtained with a beta-TCP/AB composite graft.
C1 [Stavropoulos, Andreas] Univ Aarhus, Dept Periodontol, Sch Dent, DK-8000 Aarhus C, Denmark.
   [Stavropoulos, Andreas] CEPBR, Athens, Greece.
   [Becker, Juergen] Univ Dusseldorf, Dept Oral Surg, Dusseldorf, Germany.
   [Capsius, Bjoern] Scil Technol GmbH, Martinsried, Germany.
   [Wagner, Wilfried] Johannes Gutenberg Univ Mainz, Dept Oral & Maxillofacial Surg, Univ Med Ctr, Mainz, Germany.
   [Terheyden, Hendrik] Red Cross Hosp, Clin Oral & Maxillofacial Surg, Kassel, Germany.
RP Stavropoulos, A (reprint author), Univ Aarhus, Dept Periodontol, Sch Dent, Vennelyst Blvd 9, DK-8000 Aarhus C, Denmark.
EM stavropoulos@odont.au.dk
FU Scil Technology GmbH
FX This research was funded by Scil Technology GmbH.
CR Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   Boyne PJ, 2005, J ORAL MAXIL SURG, V63, P1693, DOI 10.1016/j.joms.2005.08.018
   Del Fabbro M, 2004, INT J PERIODONT REST, V24, P565
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Gruber RM, 2008, CLIN ORAL IMPLAN RES, V19, P522, DOI 10.1111/j.1600-0501.2007.01494.x
   Gruber RM, 2009, CLIN ORAL IMPLAN RES, V20, P175, DOI 10.1111/j.1600-0501.2008.01628.x
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Hanisch O, 1997, INT J ORAL MAX IMPL, V12, P785
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Jensen SS, 2009, INT J ORAL MAX IMPL, V24, P218
   Kakudo N, 2007, LIFE SCI, V81, P137, DOI 10.1016/j.lfs.2007.04.038
   KirkerHead CA, 1997, INT J ORAL MAX IMPL, V12, P403
   Klijn RJ, 2010, TISSUE ENG PART B-RE, V16, P493, DOI [10.1089/ten.teb.2010.0035, 10.1089/ten.TEB.2010.0035]
   Koch K. P., 2010, CLIN ORAL IMPLAN RES, V21, P1301
   Koo KT, 2007, J PERIODONTOL, V78, P723, DOI 10.1902/jop.2007.060336
   Kuniyasu H, 2003, CLIN ORAL IMPLAN RES, V14, P490, DOI 10.1034/j.1600-0501.2003.00817.x
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   McAllister BS, 1998, INT J PERIODONT REST, V18, P227
   Nevins M, 1996, Int J Periodontics Restorative Dent, V16, P8
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   POEHLING S, 2002, 2 EUR C BON MORPH PR
   Poehling S, 2006, J PERIODONTOL, V77, P1582, DOI 10.1902/jop.2006.050328
   Polimeni G, 2010, J CLIN PERIODONTOL, V37, P759, DOI 10.1111/j.1600-051X.2010.01579.x
   Roldan JC, 2004, CLIN ORAL IMPLAN RES, V15, P716, DOI 10.1111/j.1600-0501.2004.01070.x
   Schwarz F, 2008, CLIN ORAL IMPLAN RES, V19, P642, DOI 10.1111/j.1600-0501.2008.01537.x
   Simank HG, 2006, BIOMATERIALS, V27, P3988, DOI 10.1016/j.biomaterials.2006.02.041
   Spiro RC, 2000, BIOCHEM SOC T, V28, P362, DOI 10.1042/0300-5127:0280362
   Szabo G, 2001, INT J ORAL MAX IMPL, V16, P681
   Tan WC, 2008, J CLIN PERIODONTOL, V35, P241, DOI 10.1111/j.1600-051X.2008.01273.x
   Terheyden H, 1999, CLIN ORAL IMPLAN RES, V10, P510, DOI 10.1034/j.1600-0501.1999.100609.x
   Tong DC, 1998, INT J ORAL MAX IMPL, V13, P175
   Triplett RG, 2009, J ORAL MAXIL SURG, V67, P1947, DOI 10.1016/j.joms.2009.04.085
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Weng D, 2009, INT J ORAL MAX IMPL, V24, P31
   Wikesjo Ulf M E, 2002, Clin Implant Dent Relat Res, V4, P174, DOI 10.1111/j.1708-8208.2002.tb00169.x
   WIKESJO UME, 1994, J PERIODONTOL, V65, P1151, DOI 10.1902/jop.1994.65.12.1151
   Yoshimoto T, 2006, J PERIODONTAL RES, V41, P140, DOI 10.1111/j.1600-0765.2005.00847.x
   Zerbo IR, 2004, CLIN ORAL IMPLAN RES, V15, P724, DOI 10.1111/j.1600-0501.2004.01055.x
NR 40
TC 24
Z9 27
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD OCT
PY 2011
VL 38
IS 10
BP 966
EP 974
DI 10.1111/j.1600-051X.2011.01754.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 822AD
UT WOS:000295014700011
PM 21797917
DA 2018-10-20
ER

PT J
AU Costa-Pinto, AR
   Reis, RL
   Neves, NM
AF Costa-Pinto, Ana Rita
   Reis, Rui L.
   Neves, Nuno M.
TI Scaffolds Based Bone Tissue Engineering: The Role of Chitosan
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; FIBER-MESH SCAFFOLDS;
   CALCIUM-PHOSPHATE BIOCERAMICS; SOLID FREEFORM FABRICATION;
   BETA-TRICALCIUM PHOSPHATE; N-CARBOXYBUTYL CHITOSAN; STARCH-BASED
   SCAFFOLDS; OSTEOBLAST-LIKE CELLS; CRITICAL-SIZE DEFECTS
AB As life expectancy increases, malfunction or loss of tissue caused by injury or disease leads to reduced quality of life in many patients at significant socioeconomic cost. Even though major progress has been made in the field of bone tissue engineering, present therapies, such as bone grafts, still have limitations. Current research on biodegradable polymers is emerging, combining these structures with osteogenic cells, as an alternative to autologous bone grafts. Different types of biodegradable materials have been proposed for the preparation of three-dimensional porous scaffolds for bone tissue engineering. Among them, natural polymers are one of the most attractive options, mainly due to their similarities with extracellular matrix, chemical versatility, good biological performance, and inherent cellular interactions. In this review, special attention is given to chitosan as a biomaterial for bone tissue engineering applications. An extensive literature survey was performed on the preparation of chitosan scaffolds and their in vitro biological performance as well as their potential to facilitate in vivo bone regeneration. The present review also aims to offer the reader a general overview of all components needed to engineer new bone tissue. It gives a brief background on bone biology, followed by an explanation of all components in bone tissue engineering, as well as describing different tissue engineering strategies. Moreover, also discussed are the typical models used to evaluate in vitro functionality of a tissue-engineered construct and in vivo models to assess the potential to regenerate bone tissue are discussed.
C1 [Costa-Pinto, Ana Rita; Reis, Rui L.; Neves, Nuno M.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Costa-Pinto, Ana Rita; Reis, Rui L.; Neves, Nuno M.] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal.
RP Neves, NM (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM nuno@dep.uminho.pt
RI Group, 3Bs/E-4374-2012; Neves, Nuno/B-4685-2008; Reis, Rui
   L./A-8938-2008; Pinto, Ana Rita/I-7483-2013
OI Group, 3Bs/0000-0002-5195-3456; Neves, Nuno/0000-0003-3041-0687; Reis,
   Rui L./0000-0002-4295-6129; Pinto, Ana Rita/0000-0002-4764-8539
FU FCT [SFRH/24735/2005]
FX This review was supported by the FCT grant (SFRH/24735/2005) to Ana
   Costa-Pinto. The authors also want to acknowledge the precious help of
   Ana M. Martins in the revision of the article.
CR AABOE M, 1995, BRIT J ORAL MAX SURG, V33, P312, DOI 10.1016/0266-4356(95)90045-4
   Abbah SA, 2008, J MATER SCI-MATER M, V19, P2113, DOI 10.1007/s10856-006-0013-1
   Abdel-Fattah WI, 2007, ACTA BIOMATER, V3, P503, DOI 10.1016/j.actbio.2006.12.004
   Akman AC, 2010, ARTIF ORGANS, V34, P65, DOI 10.1111/j.1525-1594.2009.00798.x
   Al-Sayyad MJ, 2006, SAUDI MED J, V27, P254
   Amaral IF, 2006, J BIOMED MATER RES A, V76A, P335, DOI 10.1002/jbm.a.30522
   Ang TH, 2002, MAT SCI ENG C-BIO S, V20, P35, DOI 10.1016/S0928-4931(02)00010-3
   Arpornmaeklong P, 2008, INT J ORAL MAX SURG, V37, P357, DOI 10.1016/j.ijom.2007.11.014
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Azevedo HS, 2003, BIOMACROMOLECULES, V4, P1703, DOI 10.1021/bm0300397
   Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Baran ET, 2004, J MATER SCI-MATER M, V15, P759, DOI 10.1023/B:JMSM.0000032815.86972.5e
   BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K
   Bertram U, 2006, EUR J PHARM SCI, V27, P62, DOI 10.1016/j.ejps.2005.08.005
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bianco P, 1998, MATRIX BIOL, V17, P185, DOI 10.1016/S0945-053X(98)90057-9
   Bonfield W, 2006, PHILOS T ROY SOC A, V364, P227, DOI 10.1098/rsta.2005.1692
   Borenstein JT, 2007, TISSUE ENG, V13, P1837, DOI 10.1089/ten.2006.0156
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 2002, CALCIFIED TISSUE INT, V71, P519, DOI 10.1002/s00223-001-1114-y
   BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cai KY, 2008, J MATER SCI-MATER M, V19, P499, DOI 10.1007/s10856-007-3184-5
   Cai KY, 2002, J BIOMED MATER RES, V60, P398, DOI 10.1002/jbm.10008
   Cai XX, 2007, CELL BIOL INT, V31, P776, DOI 10.1016/j.cellbi.2007.01.011
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Canalis E, 1996, CALCIFIED TISSUE INT, V58, P133, DOI 10.1007/s002239900023
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chen YC, 2006, HEAD NECK-J SCI SPEC, V28, P496, DOI 10.1002/hed.20452
   Chen ZG, 2007, MATER LETT, V61, P3490, DOI 10.1016/j.matlet.2006.11.104
   Chesnutt BM, 2009, TISSUE ENG PT A, V15, P2571, DOI 10.1089/ten.tea.2008.0054
   CHOU L, 2007, STRESS FRACTURE COMP
   Chu TMG, 2007, BIOMATERIALS, V28, P459, DOI 10.1016/j.biomaterials.2006.09.004
   Claase MB, 2007, J MATER SCI-MATER M, V18, P1299, DOI 10.1007/s10856-006-0077-y
   Cook SD, 1998, J ORTHOP TRAUMA, V12, P407, DOI 10.1097/00005131-199808000-00007
   Correlo V., 2009, J BIOMED MATER RES A, V91, P498
   Correlo VM, 2010, MACROMOL BIOSCI, V10, P1495, DOI 10.1002/mabi.201000011
   Correlo VM, 2005, MACROMOL MATER ENG, V290, P1157, DOI 10.1002/mame.200500163
   Costa-Pinto AR, 2012, J TISSUE ENG REGEN M, V6, P21, DOI 10.1002/term.391
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   Costa-Pinto AR, 2008, TISSUE ENG PT A, V14, P1049, DOI [10.1089/ten.tea.2007.0153, 10.1089/tea.2007.0153]
   Coutinho DF, 2008, BIOMACROMOLECULES, V9, P1139, DOI 10.1021/bm701268s
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Vrieze S, 2007, J MATER SCI, V42, P8029, DOI 10.1007/s10853-006-1485-6
   Dean D, 2005, TISSUE ENG, V11, P923, DOI 10.1089/ten.2005.11.923
   Denuziere A, 1998, BIOMATERIALS, V19, P1275, DOI 10.1016/S0142-9612(98)00036-2
   Desai Bharat M, 2007, Am J Orthop (Belle Mead NJ), V36, P8
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Duan B, 2004, J BIOMAT SCI-POLYM E, V15, P797, DOI 10.1163/156856204774196171
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Finisie MR, 2001, AN ACAD BRAS CIENC, V73, P525, DOI 10.1590/S0001-37652001000400006
   Finkenzeller G, 2006, TISSUE ENG, V12, P2889, DOI 10.1089/ten.2006.12.2889
   FRIEDENSTEIN AJ, 1974, EXP HEMATOL, V2, P83
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Fuji T, 2009, TISSUE ENG PT A, V15, P3525, DOI [10.1089/ten.tea.2009.0048, 10.1089/ten.TEA.2009.0048]
   Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649
   Geng L, 2005, RAPID PROTOTYPING J, V11, P90, DOI 10.1108/13552540510589458
   Geng XY, 2005, BIOMATERIALS, V26, P5427, DOI 10.1016/j.biomaterials.2005.01.066
   George J, 2006, BIOTECHNOL BIOENG, V95, P404, DOI 10.1002/bit.20938
   GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9
   Giannoni P, 2008, J TISSUE ENG REGEN M, V2, P253, DOI 10.1002/term.90
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gomez G, 2006, J CRANIOFAC SURG, V17, P935
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Govinden R, 2003, PHARMACOL THERAPEUT, V98, P257, DOI 10.1016/S0163-7258(03)00035-4
   Gravel M, 2006, BIOMATERIALS, V27, P1899, DOI 10.1016/j.biomaterials.2005.10.020
   Gugala Z, 2002, INJURY, V33, P71, DOI 10.1016/S0020-1383(02)00135-3
   HANKIEWICZ J, 1974, CLIN CHIM ACTA, V57, P205, DOI 10.1016/0009-8981(74)90398-2
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Heath CA, 2000, TRENDS BIOTECHNOL, V18, P17, DOI 10.1016/S0167-7799(99)01396-7
   Heinemann C, 2008, BIOMACROMOLECULES, V9, P2913, DOI 10.1021/bm800693d
   Hirano S, 2001, MACROMOL SYMP, V168, P21, DOI 10.1002/1521-3900(200103)168:1<21::AID-MASY21>3.0.CO;2-D
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   Holmbom J, 2005, J BIOMED MATER RES A, V75A, P308, DOI 10.1002/jbm.a.30418
   Holtorf HL, 2005, BIOMATERIALS, V26, P6208, DOI 10.1016/j.biomaterials.2005.04.006
   Horton W. A., 1990, GROWTH GENET HORM, V6, P1
   Hsieh CY, 2007, CARBOHYD POLYM, V67, P124, DOI 10.1016/j.carbpol.2006.05.002
   HSIEH CY, 2007, ANAL FREEZE GELATION, V67, P9
   Huss R, 2000, STEM CELLS, V18, P252, DOI 10.1634/stemcells.18-4-252
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   JAMEELA SR, 1994, J BIOMAT SCI-POLYM E, V6, P621, DOI 10.1163/156856294X00563
   JEE WSS, 2001, BONE MECH HDB, P1
   Jiang T, 2006, BIOMATERIALS, V27, P4894, DOI 10.1016/j.biomaterials.2006.05.025
   Jiang T, 2010, ACTA BIOMATER, V6, P3457, DOI 10.1016/j.actbio.2010.03.023
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kaplan D.L., 1998, BIOPOLYMERS RENEWABL
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kim HW, 2008, J BIOMATER APPL, V22, P485, DOI 10.1177/0885328207078075
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim SJ, 2009, TISSUE ENG REGEN MED, V6, P63
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Knaul JZ, 1999, J APPL POLYM SCI, V72, P1721, DOI 10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   KOSHIHARA Y, 1987, BIOCHEM BIOPH RES CO, V145, P651, DOI 10.1016/0006-291X(87)91014-X
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Kruyt MC, 2004, J ORTHOPAED RES, V22, P544, DOI 10.1016/j.orthres.2003.10.010
   Kuo YC, 2009, BIOMATERIALS, V30, P6604, DOI 10.1016/j.biomaterials.2009.08.028
   Kurita K, 1998, POLYM DEGRAD STABIL, V59, P117, DOI 10.1016/S0141-3910(97)00160-2
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin C, 2006, EXPERT REV MED DEVIC, V3, P49, DOI 10.1586/17434440.3.1.49
   Lee JY, 2002, J CONTROL RELEASE, V78, P187, DOI 10.1016/S0168-3659(01)00498-9
   Lee YM, 2000, J PERIODONTOL, V71, P418, DOI 10.1902/jop.2000.71.3.418
   Lee YM, 2000, J PERIODONTOL, V71, P410, DOI 10.1902/jop.2000.71.3.410
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Lewandrowski KU, 2000, J BIOMAT SCI-POLYM E, V11, P879, DOI 10.1163/156856200744075
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li L, 2006, CARBOHYD RES, V341, P374, DOI 10.1016/j.carres.2005.11.028
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   LIAN JB, 1992, CRIT REV ORAL BIOL M, V3, P269, DOI 10.1177/10454411920030030501
   Lindsey RW, 2006, J ORTHOP RES, V24, P1438, DOI 10.1002/jor.20154
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Loke WK, 2000, J BIOMED MATER RES, V53, P8
   Lucarelli E, 2004, TRANSFUS APHER SCI, V30, P169, DOI 10.1016/j.transci.2003.11.008
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Manjubala I, 2005, J MATER SCI-MATER M, V16, P1111, DOI 10.1007/s10856-005-4715-6
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Martins AM, 2008, ACTA BIOMATER, V4, P1637, DOI 10.1016/j.actbio.2008.06.004
   Maruyama M, 1996, J BIOMED MATER RES, V32, P527, DOI 10.1002/(SICI)1097-4636(199612)32:4<527::AID-JBM5>3.0.CO;2-T
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Mastrogiacomo M, 2006, TISSUE ENG, V12, P1261, DOI 10.1089/ten.2006.12.1261
   Meinel L, 2006, BONE, V39, P922, DOI 10.1016/j.bone.2006.04.019
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mendes SC, 2003, TISSUE ENG, V9, pS91, DOI 10.1089/10763270360697003
   Mendes SC, 1998, J MATER SCI-MATER M, V9, P855, DOI 10.1023/A:1008904413859
   Mohammadi Y, 2007, INT J ARTIF ORGANS, V30, P204
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   Montjovent MO, 2007, J BIOMED MATER RES A, V83A, P41, DOI 10.1002/jbm.a.31208
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Mukherjee DP, 2003, J BIOMED MATER RES B, V67B, P603, DOI 10.1002/jbm.b.10050
   Muramatsu K, 2003, ACTA ORTHOP SCAND, V74, P95, DOI 10.1080/00016470310013734
   Muschler GF, 1996, CLIN ORTHOP RELAT R, P250
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI RAA, 1993, CARBOHYD POLYM, V20, P7, DOI 10.1016/0144-8617(93)90027-2
   MUZZARELLI RAA, 1994, BIOMATERIALS, V15, P1075, DOI 10.1016/0142-9612(94)90093-0
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P925, DOI 10.1016/0142-9612(93)90134-N
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   NAKAHARA H, 1991, J ORTHOP RES, V9, P465, DOI 10.1002/jor.1100090402
   Nakamatsu J, 2006, BIOMACROMOLECULES, V7, P3345, DOI 10.1021/bm0605311
   Nasser NJ, 2005, INJURY, V36, P1460, DOI 10.1016/j.injury.2005.05.016
   Nishimura K, 1984, Vaccine, V2, P93, DOI 10.1016/S0264-410X(98)90039-1
   No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6
   Nomura S, 2000, MATRIX BIOL, V19, P91, DOI 10.1016/S0945-053X(00)00050-0
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253
   OKAMOTO Y, 1995, J VET MED SCI, V57, P851, DOI 10.1292/jvms.57.851
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   Oliveira JT, 2010, J ORTHOP RES, V28, P1193, DOI 10.1002/jor.21114
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   OWEN M, 1988, J CELL SCI, P63
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Park WH, 2004, POLYMER, V45, P7151, DOI 10.1016/j.polymer.2004.08.045
   Pearce AI, 2007, EUR CELLS MATER, V13, P1
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pritsch T, 2007, CLIN ORTHOP RELAT R, P159, DOI 10.1097/BLO.0b013e318038fc3d
   PRUDDEN JF, 1970, AM J SURG, V119, P560, DOI 10.1016/0002-9610(70)90175-3
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m
   Rios CN, 2009, TISSUE ENG PT A, V15, P2717, DOI 10.1089/ten.TEA.2008.0360
   ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826
   RODAN GA, 1992, BONE, V13, pS3, DOI 10.1016/S8756-3282(09)80003-3
   Rouget C., 1859, CR HEBD ACAD SCI, V48, P792
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Salgado AJ, 2007, J BIOMED MATER RES A, V80A, P983, DOI 10.1002/jbm.a.30946
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166
   Schantz JT, 2002, CELL TRANSPLANT, V11, P125
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   Schumann Detlef, 2007, V140, P101
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Seol YJ, 2004, BIOTECHNOL LETT, V26, P1037, DOI 10.1023/B:BILE.0000032962.79531.fd
   Shen F, 2000, POLYM INT, V49, P1596, DOI 10.1002/1097-0126(200012)49:12<1596::AID-PI553>3.3.CO;2-J
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]
   Silva SS, 2008, BIOMACROMOLECULES, V9, P2764, DOI 10.1021/bm800874q
   Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300
   Silva SS, 2005, J MATER SCI-MATER M, V16, P575, DOI 10.1007/s10856-005-0534-z
   SIMMONS PJ, 1991, BLOOD, V78, P2848
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Stephan SJ, 2010, LARYNGOSCOPE, V120, P895, DOI 10.1002/lary.20624
   SUBRAMANIAM M, 1992, J CELL BIOCHEM, V50, P411, DOI 10.1002/jcb.240500410
   Subramanian Anu, 2004, Biomed Sci Instrum, V40, P117
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Takahashi Y, 2007, TISSUE ENG, V13, P293, DOI 10.1089/ten.2006.0088
   Takamizawa S, 2004, CELL BIOL INT, V28, P255, DOI 10.1016/j.cellbi.2004.01.010
   Teijon C, 2003, TOXICOLOGY, V191, P245, DOI 10.1016/S0300-483X(03)00209-9
   TOMIHATA K, 1997, BIOMATERIALS, V18, P261
   Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.0.CO;2-P
   Torsteinsdottir I, 1999, RHEUMATOLOGY, V38, P1249, DOI 10.1093/rheumatology/38.12.1249
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Tuzlakoglu K, 2007, J MATER SCI-MATER M, V18, P1279, DOI 10.1007/s10856-006-0063-4
   Tuzlakoglu K, 2004, MACROMOL BIOSCI, V4, P811, DOI 10.1002/mabi.200300100
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Umeda H, 2007, LARYNGOSCOPE, V117, P997, DOI 10.1097/MLG.0b013e3180471459
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   van der Donk S, 2001, COMPARATIVE MED, V51, P336
   Varum KM, 1997, CARBOHYD RES, V299, P99, DOI 10.1016/S0008-6215(96)00332-1
   VARUM KM, 1991, CARBOHYD RES, V211, P17, DOI 10.1016/0008-6215(91)84142-2
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Whang K, 1999, TISSUE ENG, V5, P35, DOI 10.1089/ten.1999.5.35
   Willers C, 2005, TISSUE ENG, V11, P1065, DOI 10.1089/ten.2005.11.1065
   Wu H, 2010, J BIOMED MATER RES A, V92A, P238, DOI 10.1002/jbm.a.32376
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Xiao Y, 2002, J DENT RES, V81, pA128
   Xu HHK, 2004, J BIOMED MATER RES A, V68A, P725, DOI 10.1002/jbm.a.20093
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XC, 2009, BIOMACROMOLECULES, V10, P2772, DOI 10.1021/bm900623j
   Yeo A, 2010, J BIOMED MATER RES A, V93A, P1358, DOI 10.1002/jbm.a.32633
   Yeo YJ, 2005, J BIOMED MATER RES B, V72B, P86, DOI 10.1002/jbm.b.30121
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Yokoyama A, 2005, J BIOMED MATER RES B, V75B, P464, DOI 10.1002/jbm.b.30331
   Yuehuei H., 1999, ANIMAL MODELS ORTHOP
   Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041
   Zhang Y, 2006, J MATER SCI-MATER M, V17, P437, DOI [10.1007/s10856-006-8471-z, 10.1007/s10856-006-8471-7]
   Zhang Y, 2004, J MATER SCI-MATER M, V15, P255, DOI 10.1023/B:JMSM.0000015485.94665.25
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zheng JP, 2007, REACT FUNCT POLYM, V67, P780, DOI 10.1016/j.reactfunctpolym.2006.12.002
   Zhu L, 2006, TISSUE ENG, V12, P423, DOI 10.1089/ten.2006.12.423
NR 255
TC 135
Z9 141
U1 2
U2 88
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT
PY 2011
VL 17
IS 5
BP 331
EP 347
DI 10.1089/ten.teb.2010.0704
PG 17
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 822VQ
UT WOS:000295078600004
PM 21810029
DA 2018-10-20
ER

PT J
AU Hanson, SE
   King, SN
   Kim, J
   Chen, X
   Thibeault, SL
   Hematti, P
AF Hanson, Summer E.
   King, Suzanne N.
   Kim, Jaehyup
   Chen, Xia
   Thibeault, Susan L.
   Hematti, Peiman
TI The Effect of Mesenchymal Stromal Cell-Hyaluronic Acid Hydrogel
   Constructs on Immunophenotype of Macrophages
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID SYNTHETIC EXTRACELLULAR-MATRIX; FOLD LAMINA PROPRIA; VOCAL FOLD;
   STEM-CELLS; REGENERATIVE MEDICINE; IN-VITRO; FIBROBLASTS; ACTIVATION;
   SCAFFOLDS; THERAPY
AB During the past several years, multipotent mesenchymal stromal cells (MSCs) have rapidly moved from in vitro and animal studies into clinical trials as a therapeutic modality potentially applicable to a wide range of disorders. It has been proposed that ex vivo culture-expanded MSCs exert their tissue regeneration potential through their immunomodulatory and anti-inflammatory properties, and paracrine effects more than their ability to differentiate into multiple tissue lineages. Since extracellular matrix (ECM) deposition and tissue support is also one of many physiological roles of MSCs, there is increasing interest in their potential use for tissue engineering, particularly in combination with ECM-based scaffolds such as hyaluronic acid (HA). We investigated the effect of MSCs on immunophenotype of macrophages in the presence of an HA-hydrogel scaffold using a unique 3D coculture system. MSCs were encapsulated in the hydrogel and peripheral blood CD14+ monocyte-derived macrophages plated in direct contact with the MSC-gel construct. To determine the immunophenotype of macrophages, we looked at the expression of cell surface markers CD14, CD16, CD206, and human leukocyte antigen (HLA)-DR by flow cytometry. MSCs and macrophages cultured on the HA-hydrogel remained viable and were able to be recovered from the construct. There was a significant difference in the immunophenotype observed between monocyte-derived macrophages cultured on the HA scaffold compared to tissue culture polystyrene. Macrophages cultured on gels with MSCs expressed lower CD16 and HLA-DR with higher expression of CD206, indicating the least inflammatory profile overall, compatible with the immunophenotype of alternatively activated macrophages. Development of macrophages, with this immunophenotype, upon interaction with the MSC-hydrogel constructs may play a potentially significant role in tissue repair when using a cellular-biomaterial therapeutic approach.
C1 [King, Suzanne N.; Chen, Xia; Thibeault, Susan L.] Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Sch Med & Publ Hlth, Madison, WI 53705 USA.
   [Hanson, Summer E.] Univ Wisconsin, Div Plast & Reconstruct Surg, Sch Med & Publ Hlth, Madison, WI 53705 USA.
   [Kim, Jaehyup; Thibeault, Susan L.; Hematti, Peiman] Univ Wisconsin, Div Hematol Oncol, Sch Med & Publ Hlth, Dept Med, Madison, WI 53705 USA.
   [Hematti, Peiman] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA.
RP Thibeault, SL (reprint author), Univ Wisconsin, Div Otolaryngol Head & Neck Surg, Sch Med & Publ Hlth, WIMR 5107,1111 Highland Ave, Madison, WI 53705 USA.
EM thibeault@surgery.wisc.edu; pxh@medicine.wisc.edu
RI Kim, Jaehyup/N-5800-2015
OI Kim, Jaehyup/0000-0003-0373-5080
FU NIH/NIDCD [R01 DC4336, R01 DC4336 S1, DC009401]; NIH/NHLBI [HL081076
   K08, W81XWH-09-1-0532]; NIH [CA009614]; AAO-HNSF Resident Grant;
   NIDCD-NIH [R01 DC4336, R01 DC4336S1, T32 DC009401]; NHLBI-NIH [K08
   HL081076, DoD W81XWH-09-1-0532]; AAO-HNSF CORE
FX This work was supported in part by NIH/NIDCD Grant R01 DC4336, R01
   DC4336 S1 (S.L. Thibeault), NIH/NHLBI HL081076 K08, W81XWH-09-1-0532 (P.
   Hematti), NIH/NIDCD T32 Voice Science Training Grant DC009401 (S.N.
   King), NIH T32 Physician-Scientist Training Grant CA009614 (S.E.
   Hanson), and AAO-HNSF Resident Grant (S. E. Hanson). We thank Glen
   Leverson, Ph.D., Department of Surgery University of Wisconsin-Madison,
   for statistical assistance.; NIDCD-NIH grants R01 DC4336, R01 DC4336S1,
   T32 DC009401; NHLBI-NIH grant K08 HL081076; DoD W81XWH-09-1-0532; and
   AAO-HNSF CORE grant.
CR Allen ML, 2002, CRIT CARE MED, V30, P1140, DOI 10.1097/00003246-200205000-00031
   Battiwalla M, 2009, CYTOTHERAPY, V11, P503, DOI 10.1080/14653240903193806
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Chen X, 2010, ACTA BIOMATER, V6, P2940, DOI 10.1016/j.actbio.2010.01.032
   Chen X, 2009, TISSUE ENG PART C-ME, V15, P201, DOI 10.1089/ten.tec.2008.0390
   Christensen LH, 2009, DERMATOL SURG, V35, P1612, DOI 10.1111/j.1524-4725.2009.01338.x
   DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Duflo S, 2006, TISSUE ENG, V12, P3201, DOI 10.1089/ten.2006.12.3201
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007
   Hanson SE, 2010, CURR STEM CELL RES T, V5, P268
   Hanson SE, 2010, LARYNGOSCOPE, V120, P546, DOI 10.1002/lary.20797
   Hanson SE, 2010, PLAST RECONSTR SURG, V125, P510, DOI 10.1097/PRS.0b013e3181c722bb
   Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002
   Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004
   Laurila JP, 2009, CYTOTHERAPY, V11, P726, DOI 10.3109/14653240903067299
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716
   Noel D, 2008, EXP CELL RES, V314, P1575, DOI 10.1016/j.yexcr.2007.12.022
   Payen D, 2000, Minerva Anestesiol, V66, P757
   Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528
   Prestwich GD, 2008, CURR PHARM BIOTECHNO, V9, P242, DOI 10.2174/138920108785161523
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Sanchez-Torres C, 2001, INT IMMUNOL, V13, P1571, DOI 10.1093/intimm/13.12.1571
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Thibeault S. L., 2010, J VOICE, V25, P249
   Thibeault SL, 2009, TISSUE ENG PT A, V15, P1481, DOI 10.1089/ten.tea.2008.0299
   Thibeault SL, 2008, OTOLARYNG HEAD NECK, V139, P816, DOI 10.1016/j.otohns.2008.09.009
   Tolar J, 2010, STEM CELLS, V28, P1446, DOI 10.1002/stem.459
   Uccelli A, 2007, TRENDS IMMUNOL, V28, P219, DOI 10.1016/j.it.2007.03.001
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510
NR 41
TC 30
Z9 30
U1 0
U2 17
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD OCT
PY 2011
VL 17
IS 19-20
BP 2463
EP 2471
DI 10.1089/ten.tea.2010.0716
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 823VW
UT WOS:000295155800010
PM 21554192
OA Green Published
DA 2018-10-20
ER

PT J
AU Appel, A
   Anastasio, MA
   Brey, EM
AF Appel, Alyssa
   Anastasio, Mark A.
   Brey, Eric M.
TI Potential for Imaging Engineered Tissues with X-Ray Phase Contrast
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID COMPUTED-TOMOGRAPHY; THIN BIOMATERIALS; RADIOGRAPHY; AGENTS;
   MICROTOMOGRAPHY; SCAFFOLDS; BONE; NEOVASCULARIZATION; IMPLEMENTATION;
   INTERFEROMETER
AB As the field of tissue engineering advances, it is crucial to develop imaging methods capable of providing detailed three-dimensional information on tissue structure. X-ray imaging techniques based on phase-contrast (PC) have great potential for a number of biomedical applications due to their ability to provide information about soft tissue structure without exogenous contrast agents. X-ray PC techniques retain the excellent spatial resolution, tissue penetration, and calcified tissue contrast of conventional X-ray techniques while providing drastically improved imaging of soft tissue and biomaterials. This suggests that X-ray PC techniques are very promising for evaluation of engineered tissues. In this review, four different implementations of X-ray PC imaging are described and applications to tissues of relevance to tissue engineering reviewed. In addition, recent applications of X-ray PC to the evaluation of biomaterial scaffolds and engineered tissues are presented and areas for further development and application of these techniques are discussed. Imaging techniques based on X-ray PC have significant potential for improving our ability to image and characterize engineered tissues, and their continued development and optimization could have significant impact on the field of tissue engineering.
C1 [Appel, Alyssa; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Appel, Alyssa; Brey, Eric M.] IIT, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA.
   [Appel, Alyssa; Brey, Eric M.] Edward Hines Vet Adm Med Ctr, Res Serv, Hines, IL USA.
   [Anastasio, Mark A.] Washington Univ, Dept Biomed Engn, St Louis, MO USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, 3255 S Dearborn St, Chicago, IL 60616 USA.
EM brey@iit.edu
FU Veterans Administration; National Science Foundation [0854430, 0731201,
   0546113]; National Institute of Health [R01EB009715]
FX Research described here has been supported in part by the Veterans
   Administration, the National Science Foundation (0854430, 0731201,
   0546113), and the National Institute of Health (R01EB009715). The
   authors would like to thank Jeffery Larson for assistance with the
   acquisition of CT data and production of the imaging schematics.
CR Albertini G, 2009, TISSUE ENG PART C-ME, V15, P403, DOI 10.1089/ten.tec.2008.0270
   *AM SOC PLAST SURG, 2010, PLAST REC SURG
   Anastasio MA, 2010, J OPT SOC AM A, V27, P2648, DOI 10.1364/JOSAA.27.002648
   Ando M, 2002, JPN J APPL PHYS 2, V41, pL1016, DOI 10.1143/JJAP.41.L1016
   Arfelli F, 1998, PHYS MED BIOL, V43, P2845, DOI 10.1088/0031-9155/43/10/013
   Arfelli F, 2010, PHYS MED BIOL, V55, P1643, DOI 10.1088/0031-9155/55/6/008
   Baruchel J, 2001, BIOMATERIALS, V22, P1515, DOI 10.1016/S0142-9612(00)00307-0
   Bech M, 2010, Z MED PHYS, V20, P7, DOI 10.1016/j.zemedi.2009.11.003
   Brankov JG, 2006, MED PHYS, V33, P278, DOI 10.1118/1.2150788
   Brey EM, 2010, TISSUE ENG PART C-ME, V16, P1597, DOI 10.1089/ten.tec.2010.0150
   Cancedda R, 2007, BIOMATERIALS, V28, P2505, DOI 10.1016/j.biomaterials.2007.01.022
   Chapman D, 1997, PHYS MED BIOL, V42, P2015, DOI 10.1088/0031-9155/42/11/001
   Chen GH, 2010, OPT EXPRESS, V18, P12960, DOI 10.1364/OE.18.012960
   Chou CY, 2007, PHYS MED BIOL, V52, P1923, DOI 10.1088/0031-9155/52/7/011
   COAN P, 2008, EUR J RADIOL, V68, P16074
   Cooper DML, 2011, CAN ASSOC RADIOL J, V62, P251, DOI 10.1016/j.carj.2010.04.015
   Crittell S, 2007, NUCL INSTRUM METH A, V573, P126, DOI 10.1016/j.nima.2006.11.044
   Dilmanian FA, 2000, PHYS MED BIOL, V45, P933, DOI 10.1088/0031-9155/45/4/309
   Faraj KA, 2009, TISSUE ENG PART C-ME, V15, P493, DOI 10.1089/ten.tec.2008.0436
   Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115
   Francis-Sedlak ME, 2010, MICROVASC RES, V80, P3, DOI 10.1016/j.mvr.2009.12.005
   Guldberg RE, 2008, BIOMATERIALS, V29, P3757, DOI 10.1016/j.biomaterials.2008.06.018
   Ho ST, 2006, BIOMATERIALS, V27, P1362, DOI 10.1016/j.biomaterials.2005.08.035
   Hwu Y, 2005, NUCL INSTRUM METH A, V551, P108, DOI 10.1016/j.nima.2005.07.066
   Hwu Y, 2004, PHYS MED BIOL, V49, P501, DOI 10.1088/0031-9155/49/4/002
   Hwu Y, 2004, BIOPHYS J, V87, P4180, DOI 10.1529/biophysj.103.034991
   Ismail EC, 2010, APPL RADIAT ISOTOPES, V68, P767, DOI 10.1016/j.apradiso.2009.09.042
   JIANG M, 2008, INT J BIOMED IMAGING, P27152
   Khelashvili G, 2006, PHYS MED BIOL, V51, P221, DOI 10.1088/0031-9155/51/2/003
   Kitchen MJ, 2011, PHYS MED BIOL, V56, P515, DOI 10.1088/0031-9155/56/3/001
   Komlev VS, 2009, TISSUE ENG PART C-ME, V15, P425, DOI 10.1089/ten.tec.2008.0428
   Kunisada T, 2008, EUR J RADIOL, V68, pS18, DOI 10.1016/j.ejrad.2008.04.034
   Laperle CM, 2008, PHYS MED BIOL, V53, P6911, DOI 10.1088/0031-9155/53/23/017
   Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005
   Li J, 2009, OSTEOARTHR CARTILAGE, V17, P1193, DOI 10.1016/j.joca.2009.03.005
   Mayo SC, 2003, OPT EXPRESS, V11, P2289, DOI 10.1364/OE.11.002289
   McDonald SA, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012043
   Menk RH, 2005, NUCL INSTRUM METH A, V548, P213, DOI 10.1016/j.nima.2005.03.092
   Mizutani R, 2008, TISSUE ENG PART C-ME, V14, P359, DOI 10.1089/ten.tec.2008.0274
   Momose A, 2000, RADIOLOGY, V217, P593, DOI 10.1148/radiology.217.2.r00oc14593
   Momose A, 2003, OPT EXPRESS, V11, P2303, DOI 10.1364/OE.11.002303
   Mondy WL, 2009, TISSUE ENG PART C-ME, V15, P729, DOI [10.1089/ten.tec.2008.0583, 10.1089/ten.TEC.2008.0583]
   Muehleman C, 2006, J ANAT, V208, P115, DOI 10.1111/j.1469-7580.2006.00502.x
   Muehleman C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P369
   Muehleman C, 2010, CLIN ANAT, V23, P530, DOI 10.1002/ca.20993
   Nam SY, 2009, P SOC PHOTO-OPT INS, V7179, DOI 10.1117/12.812382
   *ORG PROC TRANSPL, 2009, US PROC TRANSPL NETW
   Paganin D., 2006, COHERENT XRAY OPTICS
   Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265
   Rigon L, 2003, J PHYS D APPL PHYS, V36, pA107, DOI 10.1088/0022-3727/36/10A/322
   Rigon L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2713147
   Rustichelli F, 2004, J MATER SCI-MATER M, V15, P1053, DOI 10.1023/B:JMSM.0000042692.34537.8e
   Shimao D, 2008, EUR J RADIOL, V68, pS27, DOI 10.1016/j.ejrad.2008.04.037
   Takeda T, 2002, CIRCULATION, V105, P1708, DOI 10.1161/01.CIR.0000012752.35225.6C
   Thurner P, 2005, MICROSC RES TECHNIQ, V66, P289, DOI 10.1002/jemt.20170
   Thurner P, 2003, NUCL INSTRUM METH B, V200, P397, DOI 10.1016/S0168-583X(02)01729-9
   Wagner A, 2006, PHYS MED BIOL, V51, P1313, DOI 10.1088/0031-9155/51/5/019
   Wagner A, 2004, NUCL INSTRUM METH A, V548, P47, DOI 10.1016/j.nima.2005.03.064
   Wang ZL, 2010, ANAL BIOANAL CHEM, V397, P2091, DOI 10.1007/s00216-010-3632-9
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Wernick MN, 2003, PHYS MED BIOL, V48, P3875, DOI 10.1088/0031-9155/48/23/006
   Wu XZ, 2003, MED PHYS, V30, P2169, DOI 10.1118/1.1593836
   Yan AM, 2008, OPT EXPRESS, V16, P13330, DOI 10.1364/OE.16.013330
   Yeom J, 2010, TISSUE ENG PART C-ME, V16, P1059, DOI [10.1089/ten.tec.2009.0759, 10.1089/ten.TEC.2009.0759]
   Yoneyama A, 2002, J SYNCHROTRON RADIAT, V9, P277, DOI 10.1107/S090904950201350X
   Young S, 2008, TISSUE ENG PT B-REV, V14, P295, DOI 10.1089/ten.teb.2008.0153
   Zehbe R, 2010, ACTA BIOMATER, V6, P2097, DOI 10.1016/j.actbio.2009.11.020
   Zehbe R, 2010, J R SOC INTERFACE, V7, P49, DOI 10.1098/rsif.2008.0539
   Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006
   Zhu PP, 2010, P NATL ACAD SCI USA, V107, P13576, DOI 10.1073/pnas.1003198107
NR 70
TC 25
Z9 25
U1 1
U2 12
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT
PY 2011
VL 17
IS 5
BP 321
EP 330
DI 10.1089/ten.teb.2011.0230
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 822VQ
UT WOS:000295078600003
PM 21682604
OA Green Published
DA 2018-10-20
ER

PT J
AU Yuan, ZL
   Nie, HM
   Wang, S
   Lee, CH
   Li, A
   Fu, SY
   Zhou, H
   Chen, LL
   Mao, JJ
AF Yuan, Zhenglin
   Nie, Hemin
   Wang, Shuang
   Lee, Chang Hun
   Li, Ang
   Fu, Susan Y.
   Zhou, Hong
   Chen, Lili
   Mao, Jeremy J.
TI Biomaterial Selection for Tooth Regeneration
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TISSUE ENGINEERING APPLICATIONS; BETA-TRICALCIUM
   PHOSPHATE; SYNTHETIC EXTRACELLULAR-MATRIX; BONE MORPHOGENIC PROTEIN-2;
   HYALURONIC-ACID; IN-VITRO; ALGINATE HYDROGELS; CALCIUM-PHOSPHATE;
   PERIODONTAL REGENERATION
AB Biomaterials are native or synthetic polymers that act as carriers for drug delivery or scaffolds for tissue regeneration. When implanted in vivo, biomaterials should be nontoxic and exert intended functions. For tooth regeneration, biomaterials have primarily served as a scaffold for (1) transplanted stem cells and/or (2) recruitment of endogenous stem cells. This article critically synthesizes our knowledge of biomaterial use in tooth regeneration, including the selection of native and/or synthetic polymers, three- dimensional scaffold fabrication, stem cell transplantation, and stem cell homing. A tooth is a complex biological organ. Tooth loss represents the most common organ failure. Tooth regeneration encompasses not only regrowth of an entire tooth as an organ, but also biological restoration of individual components of the tooth including enamel, dentin, cementum, or dental pulp. Regeneration of tooth root represents perhaps more near-term opportunities than the regeneration of the whole tooth. In the adult, a tooth owes its biological vitality, arguably more, to the root than the crown. Biomaterials are indispensible for the regeneration of tooth root, tooth crown, dental pulp, or an entire tooth.
C1 [Yuan, Zhenglin; Chen, Lili] Huazhong Univ Sci & Technol, Dept Stomatol, Union Hosp, Tongji Med Coll, Wuhan 430022, Peoples R China.
   [Nie, Hemin; Lee, Chang Hun; Fu, Susan Y.; Mao, Jeremy J.] Columbia Univ, Ctr Craniofacial Regenerat, New York, NY 10032 USA.
   [Wang, Shuang; Li, Ang; Zhou, Hong] Xi An Jiao Tong Univ, Sch Stomatol, Dept Basic Sci, Xian 710049, Shaanxi, Peoples R China.
RP Chen, LL (reprint author), Huazhong Univ Sci & Technol, Dept Stomatol, Union Hosp, Tongji Med Coll, 1277 Jiefang Ave, Wuhan 430022, Peoples R China.
EM chenlili@whuh.com; jmao@columbia.edu
RI Nie, Hemin/F-4295-2012
OI Nie, Hemin/0000-0002-3657-7333
FU NIH National Institute of Dental and Craniofacial Research (NIDCR)
   [5RC2DE020767]
FX The authors thank F. Guo and K. Hua for technical and administrative
   assistance. This work was supported by the NIH Grant 5RC2DE020767 from
   the National Institute of Dental and Craniofacial Research (NIDCR).
CR Abukawa H, 2009, J ORAL MAXIL SURG, V67, P335, DOI 10.1016/j.joms.2008.09.002
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Ahmed TAE, 2007, TISSUE ENG, V13, P1469, DOI 10.1089/ten.2006.0354
   Al-Nasassrah MA, 1998, EUR J PHARM BIOPHARM, V46, P31, DOI 10.1016/S0939-6411(97)00151-3
   Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003
   BELLAMKONDA R, 1995, J NEUROSCI RES, V41, P501, DOI 10.1002/jnr.490410409
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bohl KS, 1998, J BIOMAT SCI-POLYM E, V9, P749, DOI 10.1163/156856298X00127
   Bouler JM, 1996, J BIOMED MATER RES, V32, P603, DOI 10.1002/(SICI)1097-4636(199612)32:4<603::AID-JBM13>3.0.CO;2-E
   Bow JS, 2004, BIOMATERIALS, V25, P3155, DOI 10.1016/j.biomaterials.2003.10.046
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Cooke JW, 2006, TISSUE ENG, V12, P1441, DOI 10.1089/ten.2006.12.1441
   Crisan M, 2009, ANN NY ACAD SCI, V1176, P118, DOI 10.1111/j.1749-6632.2009.04967.x
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   DELMAGE JM, 1986, ANN CLIN LAB SCI, V16, P303
   Dobie K, 2002, CONNECT TISSUE RES, V43, P387, DOI 10.1080/03008200290000574
   Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703
   Duailibi SE, 2008, J DENT RES, V87, P745, DOI 10.1177/154405910808700811
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Erisken C, 2008, BIOMATERIALS, V29, P4065, DOI 10.1016/j.biomaterials.2008.06.022
   Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Fu Q, 2008, J BIOMED MATER RES B, V86B, P125, DOI 10.1002/jbm.b.30997
   Golub EE, 2009, BBA-GEN SUBJECTS, V1790, P1592, DOI 10.1016/j.bbagen.2009.09.006
   Gunn JW, 2005, J BIOMED MATER RES A, V72A, P91, DOI 10.1002/jbm.a.30203
   HAHN GV, 1992, GENOMICS, V14, P759, DOI 10.1016/S0888-7543(05)80181-8
   Herberg S, 2008, J CLIN PERIODONTOL, V35, P976, DOI 10.1111/j.1600-051X.2008.01323.x
   Herodin F, 2003, BLOOD, V101, P2609, DOI 10.1182/blood-2002-06-1634
   Hsu YH, 2007, J MATER SCI-MATER M, V18, P2319, DOI 10.1007/s10856-007-3136-0
   Huang GTJ, 2010, TISSUE ENG PT A, V16, P605, DOI 10.1089/ten.TEA.2009.0518
   Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45
   Huang Z, 2008, J BONE MINER RES, V23, P1995, DOI 10.1359/JBMR.080705
   Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106
   Inuyama Y, 2010, J BIOMED MATER RES B, V92B, P120, DOI 10.1002/jbm.b.31497
   Itoh F, 2001, EMBO J, V20, P4132, DOI 10.1093/emboj/20.15.4132
   Jeong B, 2000, J CONTROL RELEASE, V63, P155, DOI 10.1016/S0168-3659(99)00194-7
   Jeong JH, 2004, PHARM RES, V21, P50, DOI 10.1023/B:PHAM.0000012151.05441.bf
   Jia XQ, 2006, BIOMACROMOLECULES, V7, P3336, DOI 10.1021/bm0604956
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Jung SH, 2011, J ORAL REHABIL, V38, P517, DOI 10.1111/j.1365-2842.2010.02178.x
   Kaufmann PM, 1997, TRANSPLANT P, V29, P2032, DOI 10.1016/S0041-1345(97)00218-2
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P240, DOI 10.1002/jbm.b.30038
   Kim JY, 2010, TISSUE ENG PT A, V16, P3023, DOI 10.1089/ten.TEA.2010.0181
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Kim K, 2010, J DENT RES, V89, P842, DOI 10.1177/0022034510370803
   Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330
   KONGTAWELERT P, 1990, ANAL BIOCHEM, V185, P313, DOI 10.1016/0003-2697(90)90300-X
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Kuo TF, 2008, J BIOMED MATER RES A, V86A, P1062, DOI 10.1002/jbm.a.31.746
   Kwon DH, 2010, J CLIN PERIODONTOL, V37, P390, DOI 10.1111/j.1600-051X.2010.01546.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawson MA, 2004, TISSUE ENG, V10, P1480, DOI 10.1089/ten.2004.10.1480
   Lead JR, 2003, ENVIRON SCI TECHNOL, V37, P482, DOI 10.1021/es025840n
   Lechguer AN, 2008, J DENT RES, V87, P1138, DOI 10.1177/154405910808701216
   Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI [10.1089/ten.tea.2008.0653, 10.1089/ten.TEA.2008.0653]
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee PY, 2003, PHARM RES, V20, P1995, DOI 10.1023/B:PHAM.0000008048.58777.da
   Lee YB, 2010, EXP NEUROL, V223, P645, DOI 10.1016/j.expneurol.2010.02.014
   Lewus KE, 2005, TISSUE ENG, V11, P1015, DOI 10.1089/ten.2005.11.1015
   Li SH, 2002, J BIOMED MATER RES, V61, P109, DOI 10.1002/jbm.10163
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004
   Lin NH, 2009, PERIODONTOL 2000, V51, P239, DOI 10.1111/j.1600-0757.2009.00303.x
   LINDE A, 1995, CALCIFIED TISSUE INT, V56, P549, DOI 10.1007/BF00298588
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   Liu YX, 2010, J BIOMED MATER RES A, V92A, P997, DOI 10.1002/jbm.a.32443
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Mantesso A, 2009, EXPERT OPIN BIOL TH, V9, P1143, DOI 10.1517/14712590903103795
   Mao JJ, 2010, TISSUE ENG PART B-RE, V16, P257, DOI [10.1089/ten.teb.2009.0496, 10.1089/ten.TEB.2009.0496]
   Modino SAC, 2005, ARCH ORAL BIOL, V50, P255, DOI 10.1016/j.archoralbio.2005.01.002
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Montjovent MO, 2005, TISSUE ENG, V11, P1640, DOI 10.1089/ten.2005.11.1640
   Moutos FT, 2010, TISSUE ENG PT A, V16, P1291, DOI [10.1089/ten.tea.2009.0480, 10.1089/ten.TEA.2009.0480]
   Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012
   Nakashima M, 2003, NAT BIOTECHNOL, V21, P1025, DOI 10.1038/nbt864
   Nasseri BA, 2001, SURGERY, V130, P781, DOI 10.1067/msy.2001.112960
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Ohara T, 2010, J BIOMED MATER RES A, V94A, P800, DOI 10.1002/jbm.a.32749
   Ohazama A, 2004, J DENT RES, V83, P518, DOI 10.1177/154405910408300702
   Ostberg AL, 2009, SCAND J PUBLIC HEALT, V37, P427, DOI 10.1177/1403494808099964
   Palmer LC, 2008, CHEM REV, V108, P4754, DOI 10.1021/cr8004422
   Papadopoulos A, 2011, TISSUE ENG PT A, V17, P161, DOI [10.1089/ten.tea.2010.0253, 10.1089/ten.TEA.2010.0253]
   Park KH, 2009, J BIOSCI BIOENG, V108, P530, DOI 10.1016/j.jbiosc.2009.05.021
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Pellegrini G, 2009, J DENT RES, V88, P1065, DOI 10.1177/0022034509349748
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8
   Polzer I, 2010, INT DENT J, V60, P143, DOI 10.1922/IDJ_2184Polzer13
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P370, DOI 10.1021/bc00028a015
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247
   RICHTER AW, 1979, INT ARCH ALLER A IMM, V59, P45, DOI 10.1159/000232238
   Richter W, 2009, J INTERN MED, V266, P390, DOI 10.1111/j.1365-2796.2009.02153.x
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Sakai S, 2007, ACTA BIOMATER, V3, P495, DOI 10.1016/j.actbio.2006.12.002
   Sannino A, 2004, BIOMACROMOLECULES, V5, P92, DOI 10.1021/bm0341881
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Sarasam A, 2005, BIOMATERIALS, V26, P5500, DOI 10.1016/j.biomaterials.2005.01.071
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Sepulveda P, 2000, J BIOMED MATER RES, V50, P27, DOI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
   Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Sjoberg H, 1999, J CONTROL RELEASE, V59, P391, DOI 10.1016/S0168-3659(99)00013-9
   Sonoki K, 2008, COMMUNITY DENT HLTH, V25, P243, DOI 10.1922/CDH_2167Sonoki05
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Steinhardt Y, 2008, TISSUE ENG PT A, V14, P1763, DOI 10.1089/ten.tea.2008.0007
   Stosich MS, 2007, TISSUE ENG, V13, P2881, DOI 10.1089/ten.2007.0078
   Stosich MS, 2009, METHODS, V47, P116, DOI 10.1016/j.ymeth.2008.10.013
   Sun GM, 2010, J BIOMED MATER RES A, V93A, P1080, DOI 10.1002/jbm.a.32604
   Tan KH, 2005, BIO-MED MATER ENG, V15, P113
   Tancred DC, 1998, BIOMATERIALS, V19, P2303, DOI 10.1016/S0142-9612(98)00141-0
   Thesleff I, 2007, NOVART FDN SYMP, V284, P153
   Thesleff Irma, 2007, Novartis Found Symp, V284, P142
   Torres-Lugo M, 2000, BIOMATERIALS, V21, P1191, DOI 10.1016/S0142-9612(00)00011-9
   Venugopal J, 2005, NANOTECHNOLOGY, V16, P2138, DOI 10.1088/0957-4484/16/10/028
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Wahl DA, 2007, J MATER SCI-MATER M, V18, P201, DOI 10.1007/s10856-006-0682-9
   Weinand C, 2006, BONE, V38, P555, DOI 10.1016/j.bone.2005.10.016
   Weinand C, 2007, ANN PLAS SURG, V59, P46, DOI 10.1097/01.sap.0000264887.30392.72
   Weinand C, 2007, TISSUE ENG, V13, P757, DOI 10.1089/ten.2006.0083
   Wiria FE, 2007, ACTA BIOMATER, V3, P1, DOI 10.1016/j.actbio.2006.07.008
   Wu XM, 2007, J BIOMED MATER RES A, V81A, P59, DOI 10.1002/jbm.a.31003
   Xu WP, 2008, TISSUE ENG PT A, V14, P549, DOI 10.1089/tea.2007.0227
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yang RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013547
   Yelick Pamela C, 2006, Dent Clin North Am, V50, P191, DOI 10.1016/j.cden.2005.11.005
   Young CS, 2005, TISSUE ENG, V11, P1599, DOI 10.1089/ten.2005.11.1599
   Young CS, 2002, J DENT RES, V81, P695, DOI 10.1177/154405910208101008
   Yu L, 2008, CHEM SOC REV, V37, P1473, DOI 10.1039/b713009k
   Yu L, 2008, INT J PHARM, V348, P95, DOI 10.1016/j.ijpharm.2007.07.026
   Zeichner-David M, 2006, PERIODONTOL 2000, V41, P196, DOI 10.1111/j.1600-0757.2006.00162.x
   Zentner GM, 2001, J CONTROL RELEASE, V72, P203, DOI 10.1016/S0168-3659(01)00276-0
   Zhang F, 2007, ACTA BIOMATER, V3, P896, DOI 10.1016/j.actbio.2007.05.008
   Zhang HG, 2007, J MATER SCI-MATER M, V18, P1825, DOI 10.1007/s10856-007-3036-3
   Zhang JL, 2010, LANGMUIR, V26, P2989, DOI 10.1021/la9043649
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
NR 151
TC 31
Z9 34
U1 3
U2 38
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
EI 1937-3376
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD OCT
PY 2011
VL 17
IS 5
BP 373
EP 388
DI 10.1089/ten.teb.2011.0041
PG 16
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 822VQ
UT WOS:000295078600007
PM 21699433
OA Green Published
DA 2018-10-20
ER

PT J
AU McNamara, LE
   Sjostrom, T
   Burgess, KEV
   Kim, JJW
   Liu, E
   Gordonov, S
   Moghe, PV
   Meek, RMD
   Oreffo, ROC
   Su, B
   Dalby, MJ
AF McNamara, Laura E.
   Sjoestroem, Terje
   Burgess, Karl E. V.
   Kim, Joseph J. W.
   Liu, Er
   Gordonov, Simon
   Moghe, Prabhas V.
   Meek, R. M. Dominic
   Oreffo, Richard O. C.
   Su, Bo
   Dalby, Matthew J.
TI Skeletal stem cell physiology on functionally distinct titania
   nanotopographies
SO BIOMATERIALS
LA English
DT Article
DE Nanotopography; Titanium; Mesenchymal stem cell; Osteogenesis; Molecular
   biology; Image analysis
ID POLYMER-DEMIXED NANOTOPOGRAPHY; ACID-ETCHED MICROTEXTURE; NANOSCALE
   TOPOGRAPHY; ADHESION FORMATION; BONE-GROWTH; LIPOIC ACID; LINEAGE;
   DIFFERENTIATION; IMPLANTS; QUANTIFICATION
AB Functionalisation of the surface of orthopaedic implants with nanotopographies that could stimulate in situ osteogenic differentiation of the patient's stem or osteoprogenitor cells would have significant therapeutic potential. Mesenchymal stem cell (MSC) responses to titanium substrates patterned with nanopillar structures were investigated in this study. Focal adhesions were quantified in S-phase cells, the bone-related transcription factor Runx2 was examined, osteocalcin production was noted, and Haralick computational analysis was used to assess the relatedness of the cell responses to each of the titanium substrata based on cytoskeletal textural features. Metabolomics was used as a novel means of assessing cellular responses to the biomaterial substrates by analysing the global metabolite profile of the cells on the substrata, and shows promise as a technique with high data yield for evaluating cell interactions with materials of different surface chemistry or topography. The cell response to 15 nm high nanopillars was distinct, consistent with a transition from a more quiescent phenotype on the planar substrate, to an 'active' phenotype on the pillars. These studies illustrate the potential for clinically relevant titania nanopillared substrata to modulate MSCs, with implications for orthopaedic device design and application. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [McNamara, Laura E.; Dalby, Matthew J.] Univ Glasgow, Sch Mol Cell & Syst Biol, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
   [Sjoestroem, Terje; Su, Bo] Univ Bristol, Sch Oral & Dent Sci, Bristol BS1 2LY, Avon, England.
   [Burgess, Karl E. V.] Univ Glasgow, Scottish Metab Facil, Glasgow G12 8QQ, Lanark, Scotland.
   [Kim, Joseph J. W.; Liu, Er; Gordonov, Simon; Moghe, Prabhas V.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Meek, R. M. Dominic] So Gen Hosp, Dept Orthopaed, Glasgow G51 4TF, Lanark, Scotland.
   [Oreffo, Richard O. C.] Univ Southampton, Sch Med, Inst Dev Sci, Bone & Joint Res Grp,Ctr Human Dev Stem Cells & R, Southampton SO16 6YD, Hants, England.
RP McNamara, LE (reprint author), Univ Glasgow, Sch Mol Cell & Syst Biol, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
EM laura.mcnamara@glasgow.ac.uk
RI Dalby, Matthew/G-2426-2012; Oreffo, Richard/A-4615-2011; Liu,
   Er/H-8441-2012
OI Oreffo, Richard/0000-0001-5995-6726; Liu, Er/0000-0001-7858-1333;
   Burgess, Karl/0000-0002-0881-715X; Dalby, Matthew/0000-0002-0528-3359
FU EPSRC [EP/G048703/1]; National Institutes of Health [EB001046];
   Engineering and Physical Sciences Research Council [EP/G048703/1,
   EP/G049076/1]
FX This work was supported by EPSRC grant EP/G048703/1 (M.J. Dalby, R.M.D.
   Meek and B. Su). The study was partially supported by National
   Institutes of Health Grant # EB001046 (RESBIO, Integrated Resources for
   Polymeric Biomaterials) (P. Moghe). We thank Kate Murawski (Bone and
   Joint Research Group) for the skeletal stem cell isolations, Andrew Hart
   for help with microscopy, David Leader and Darren Creek (University of
   Glasgow) for use of their metabolomics analysis software (Pathos and
   IDEOM), and all in CCE for advice and helpful discussion.
CR Affrossman S, 1996, MACROMOLECULES, V29, P5010, DOI 10.1021/ma9516910
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   BERSHADSKY AD, 1985, EXP CELL RES, V158, P433, DOI 10.1016/0014-4827(85)90467-7
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Cho SA, 2003, BIOMATERIALS, V24, P3611, DOI 10.1016/S0142-9612(03)00218-7
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Daugaard H, 2008, J BIOMED MATER RES A, V87A, P434, DOI 10.1002/jbm.a.31748
   DEVASAGAYAM TPA, 1993, CHEM-BIOL INTERACT, V86, P79, DOI 10.1016/0009-2797(93)90113-D
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   Golub EE, 2007, CURR OPIN, V18, P444, DOI [DOI 10.1097/BCO.0B013E3282630851, 10.1097/BCO.0b013e3282630851]
   Hacking SA, 2003, J BONE JOINT SURG BR, V85B, P1182, DOI 10.1302/0301-620X.85B8.14233
   HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314
   Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Meredith DO, 2004, EXP CELL RES, V293, P58, DOI 10.1016/j.yexcr.2003.10.005
   Mirmalek-Sani SH, 2006, STEM CELLS, V24, P1042, DOI 10.1634/stemcells.2005-0368
   Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Oreffo ROC, 2005, STEM CELL REV, V1, P169, DOI 10.1385/SCR:1:2:169
   PACKER L, 1995, FREE RADICAL BIO MED, V19, P227, DOI 10.1016/0891-5849(95)00017-R
   Packer L, 2011, J CLIN BIOCHEM NUTR, V48, P26, DOI 10.3164/jcbn.11-005FR
   Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395
   Reyes JMG, 2006, STEM CELLS, V24, P1213, DOI 10.1634/stemcells.2004-0324
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364
   Yang GL, 2008, ORAL SURG ORAL MED O, V106, P516, DOI 10.1016/j.tripleo.2008.03.017
NR 37
TC 64
Z9 65
U1 1
U2 81
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2011
VL 32
IS 30
BP 7403
EP 7410
DI 10.1016/j.biomaterials.2011.06.063
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 819LW
UT WOS:000294829300013
PM 21820172
DA 2018-10-20
ER

PT J
AU Habib, M
   Shapira-Schweitzer, K
   Caspi, O
   Gepstein, A
   Arbel, G
   Aronson, D
   Seliktar, D
   Gepstein, L
AF Habib, Manhal
   Shapira-Schweitzer, Keren
   Caspi, Oren
   Gepstein, Amira
   Arbel, Gil
   Aronson, Doron
   Seliktar, Dror
   Gepstein, Lior
TI A combined cell therapy and in-situ tissue-engineering approach for
   myocardial repair
SO BIOMATERIALS
LA English
DT Article
DE Cardiac tissue engineering; Hydrogel; Cardiomyocyte; Stem cells
ID ASSEMBLING PEPTIDE NANOFIBERS; INFARCTED RAT HEARTS; EMBRYONIC
   STEM-CELLS; HYDROGEL SCAFFOLDS; CARDIAC REPAIR; CARDIOMYOCYTES;
   TRANSPLANTATION; BIOMATERIAL; FIBRINOGEN; INJECTION
AB Myocardial cell-replacement strategies are hampered by limited sources for human cardiomyocytes and by significant cell loss following transplantation. We tested the hypothesis that a combined delivery of cardiomyocytes with an in-situ polymerizable hydrogel into a post-MI rat heart will result in better functional outcomes than each intervention alone. A photopolymerizable, biodegradable, PEGylated-fibrinogen (PF) hydrogel matrix was used as the carrier for the cardiomyocytes [neonatal rat ventricular cardiomyocytes (NRVCMs) or human embryonic stem cell-derived cardiomyocytes (hESC-CMs)]. Infarcted rat hearts (LAD ligation) were randomized to injection of saline, NRVCMs, biopolymer, or combined biopolymer-cell delivery. Echocardiography revealed typical post-infarction remodeling after 30 days in the saline-injected control group [deterioration of fractional shortening (FS) by 31.0 +/- 3.6%]. Injection of NRVCMs or PF alone significantly (p < 0.01) altered this remodeling process (slightly increasing FS by 3.1 +/- 6.6% and 0.5 +/- 5.3% respectively). Co-injection of the NRVCMs with PF matrix resulted in a significant increase in the cell-graft area (by 144%) and in the highest improvements in FS (by 26.3 +/- 6.6%). Finally, feasibility studies were performed with the PF matrix and hESC-CMs. We conclude that an injectable in-situ forming hydrogel can act as a cardiomyocyte cell-carrier and add to the beneficial effects of the grafted cells in preventing unfavorable post-infarction cardiac remodeling. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Gepstein, Lior] Technion Israel Inst Technol, Fac Med, IL-31096 Haifa, Israel.
   [Habib, Manhal; Caspi, Oren; Gepstein, Amira; Arbel, Gil; Aronson, Doron; Gepstein, Lior] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel.
   [Shapira-Schweitzer, Keren; Seliktar, Dror] Technion Israel Inst Technol, Fac Biomed Engn, IL-31096 Haifa, Israel.
RP Gepstein, L (reprint author), Technion Israel Inst Technol, Fac Med, POB 9649, IL-31096 Haifa, Israel.
EM mdlior@tx.technion.ac.il
RI Gepstein, Lior/H-9458-2012
OI Seliktar, Dror/0000-0001-6964-8567
FU Israel Science Foundation [1449/10]; Grand Family Research Fund; Israel
   Ministry of Science; Rambam Medical Center
FX This study was supported in part by the Israel Science Foundation
   (#1449/10), the Grand Family Research Fund, the Eshkol Scholarship of
   the Israel Ministry of Science (M.H), and the Rambam Medical Center
   Atidim program (M.H).
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Dikovsky D, 2008, BIOPHYS J, V94, P2914, DOI 10.1529/biophysj.107.105841
   Dow J, 2005, CARDIOVASC RES, V67, P301, DOI 10.1016/j.cardiores.2005.04.011
   Frisman I, 2010, J MATER SCI-MATER M, V21, P73, DOI 10.1007/s10856-009-3848-4
   Garbern JC, 2011, BIOMATERIALS, V32, P2407, DOI 10.1016/j.biomaterials.2010.11.075
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kehat I, 2003, HEART FAIL REV, V8, P229, DOI 10.1023/A:1024709332039
   Kofidis T, 2002, EUR J CARDIO-THORAC, V22, P238, DOI 10.1016/S1010-7940(02)00256-7
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Li R.K., 1999, CIRCULATION S, V100, P1163
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Nelson DM, 2011, ACTA BIOMATER, V7, P1, DOI 10.1016/j.actbio.2010.06.039
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Peled E, 2007, J BIOMED MATER RES A, V80A, P874, DOI 10.1002/jbm.a.30928
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Satin J, 2008, STEM CELLS, V26, P1961, DOI 10.1634/stemcells.2007-0591
   Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800
   Shapira K, 2008, BIO-MED MATER ENG, V18, P309, DOI 10.3233/BME-2008-0544
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wall ST, 2010, J BIOMED MATER RES A, V95A, P1055, DOI 10.1002/jbm.a.32904
   Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001
   Wu J, 2011, BIOMATERIALS, V32, P579, DOI 10.1016/j.biomaterials.2010.08.098
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 38
TC 58
Z9 60
U1 0
U2 28
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2011
VL 32
IS 30
BP 7514
EP 7523
DI 10.1016/j.biomaterials.2011.06.049
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 819LW
UT WOS:000294829300022
PM 21783246
DA 2018-10-20
ER

PT J
AU Scarano, A
   Carinci, F
   Assenza, B
   Piattelli, M
   Murmura, G
   Piattelli, A
AF Scarano, Antonio
   Carinci, Francesco
   Assenza, Bartolomeo
   Piattelli, Maurizio
   Murmura, Giovanna
   Piattelli, Adriano
TI Vertical ridge augmentation of atrophic posterior mandible using an
   inlay technique with a xenograft without miniscrews and miniplates: case
   series
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE atrophic mandible; inlay; vertical ridge augmentation
ID DENTAL IMPLANT PLACEMENT; BONE-GRAFTS
AB Background: Rehabilitation of partially or totally edentulous posterior mandible with implant-supported prosthesis has become a common practice in the last few decades, with reliable long-term results. The use of miniscrews and miniplates have been reported to increase the risk of fracture of the osteotomy segments. The purpose of this case series was to use an inlay technique, without the use of miniscrews and miniplates for stabilization of the transported bone fragments.
   Materials and methods: Nine consecutive patients (six men and three women) aged between 26 and 51 years (mean 44 years) were enrolled in this study. A horizontal osteotomy was performed 2-3 mm above the mandibular canal, and two oblique cuts were made using a piezosurgery device. The final phase of the osteotomy was performed with chisels. The osteotomized segment was then raised in the coronal direction, sparing the lingual periosteum. Two miniblocks of xenograft without miniscrews and miniplates were inserted mesially and distally between the cranial osteotomized segment and the mandibular basal bone. The residual space was filled with particles of cortico-cancellous porcine bone. Four months after surgery, a panoramic X-ray was taken before implant insertion. A bone trephine with an internal diameter of 2 mm was used as the second dental drill to take a bone core biopsy during preparation of the #35 and #37 or #45 and #47 implant sites.
   Results: The postoperative course was uneventful in seven of the nine patients. No dehiscence of the mucosa was observed at the marginal ridge of the mobilized fragment. Newly formed bone was present near the osteotomized segments, and was observed in the bottom half of the specimens and was identified by its higher affinity toward the staining. Newly formed bone was observed to be in close contact with the particles of biomaterials. No gaps or connective tissue were present at the bone-biomaterial interface. Histomorphometry demonstrated that 44 +/- 2.1% of the specimens was composed by newly formed bone, 18 +/- 0.8% by marrow spaces, and 33 +/- 2.4% by the residual grafted biomaterial.
   Conclusion: The rigidity of the equine collagenated block allowed to eliminate the use of miniscrews and miniplates and simplified the technique. Moreover, the rigidity of the block allowed maintenance of the space.
C1 [Scarano, Antonio; Piattelli, Maurizio] Univ G dAnnunzio, Sch Dent, Dept Oral Surg, I-66100 Chieti, Italy.
   [Carinci, Francesco] Univ Ferrara, Dept Oral Maxillofacial Surg, I-44100 Ferrara, Italy.
   [Piattelli, Adriano] Univ G dAnnunzio, Sch Dent, Dept Oral Pathol & Med, I-66100 Chieti, Italy.
RP Scarano, A (reprint author), Univ G dAnnunzio, Sch Dent, Dept Oral Surg, Via Frentani 98-B, I-66100 Chieti, Italy.
EM ascarano@unich.it
RI Scarano, Antonio/F-6961-2017
OI Scarano, Antonio/0000-0003-1374-6146
CR Becker W, 1996, J PERIODONTOL, V67, P1025, DOI 10.1902/jop.1996.67.10.1025
   Cardaropoli D, 2009, INT J PERIODONT REST, V29, P289
   CAWOOD JI, 1988, INT J ORAL MAX SURG, V17, P232, DOI 10.1016/S0901-5027(88)80047-X
   Esposito M., 2008, COCHRANE DATABASE SY
   Feichtinger M, 2003, INT J PROSTHODONT, V16, P19
   Felice P, 2009, CLIN IMPLANT DENT S1, V11, P69
   Misch C M, 1996, Pract Periodontics Aesthet Dent, V8, P127
   Misch C M, 1995, Implant Dent, V4, P261, DOI 10.1097/00008505-199500440-00006
   NISSAN J, CLIN IMPLANT DENT R, DOI DOI 10.1111/J.1708-8208.2809-00193.X
   Rocchietta I, 2008, J CLIN PERIODONTOL, V35, P203, DOI 10.1111/j.1600-051X.2008.01271.x
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Stellingsma C, 1998, BRIT J ORAL MAX SURG, V36, P290, DOI 10.1016/S0266-4356(98)90713-6
   STOELINGA PJW, 1978, J ORAL SURG, V36, P30
   Tamimi F, 2009, BIOMATERIALS, V30, P6318, DOI 10.1016/j.biomaterials.2009.07.049
   Tonetti MS, 2008, J CLIN PERIODONTOL, V35, P168, DOI 10.1111/j.1600-051X.2008.01268.x
   Uchida T, 2008, INT J PERIODONT REST, V28, P181
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Wang SY, 2009, BIOMATERIALS, V30, P2489, DOI 10.1016/j.biomaterials.2008.12.067
   ZINS JE, 1984, PLAST RECONSTR SURG, V73, P371, DOI 10.1097/00006534-198403000-00005
NR 19
TC 28
Z9 32
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2011
VL 22
IS 10
BP 1125
EP 1130
DI 10.1111/j.1600-0501.2010.02083.x
PG 6
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 820ST
UT WOS:000294926400003
PM 21251081
DA 2018-10-20
ER

PT J
AU Wray, LS
   Hu, X
   Gallego, J
   Georgakoudi, I
   Omenetto, FG
   Schmidt, D
   Kaplan, DL
AF Wray, Lindsay S.
   Hu, Xiao
   Gallego, Jabier
   Georgakoudi, Irene
   Omenetto, Fiorenzo G.
   Schmidt, Daniel
   Kaplan, David L.
TI Effect of processing on silk-based biomaterials: Reproducibility and
   biocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE silk fibroin; sericin; biomaterial; biocompatibility; regenerative
   medicine
ID BOMBYX-MORI; PROTEIN ADSORPTION; FIBROUS PROTEINS; IN-VITRO; SERICIN;
   CHAIN; DEGRADATION; COCOON; CRYSTALLIZATION; SPECTROSCOPY
AB Silk fibroin has been successfully used as a biomaterial for tissue regeneration. To prepare silk fibroin biomaterials for human implantation a series of processing steps are required to purify the protein. Degumming to remove inflammatory sericin is a crucial step related to biocompatibility and variability in the material. Detailed characterization of silk fibroin degumming is reported. The degumming conditions significantly affected cell viability on the silk fibroin material and the ability to form three-dimensional porous scaffolds from the silk fibroin, but did not affect macrophage activation or beta-sheet content in the materials formed. Methods are also provided to determine the content of residual sericin in silk fibroin solutions and to assess changes in silk fibroin molecular weight. Amino acid composition analysis was used to detect sericin residuals in silk solutions with a detection limit between 1.0 and 10% wt/wt, while fluorescence spectroscopy was used to reproducibly distinguish between silk samples with different molecular weights. Both methods are simple and require minimal sample volume, providing useful quality control tools for silk fibroin preparation processes. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 99B: 89-101, 2011.
C1 [Wray, Lindsay S.; Hu, Xiao; Gallego, Jabier; Georgakoudi, Irene; Omenetto, Fiorenzo G.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Schmidt, Daniel] Univ Massachusetts Lowell, Dept Plast Engn, Lowell, MA 01854 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820; Schmidt, Daniel/0000-0003-2511-1906
FU NIH Tissue Engineering Resource Center (TERC) [NIH P41 EB002520];
   National Science Foundation [NSF DGE 0806676, ECS-0335765]
FX Contract grant sponsor: NIH Tissue Engineering Resource Center (TERC);
   contract grant number: NIH P41 EB002520; Contract grant sponsor:
   National Science Foundation Graduate Research Fellowship Program;
   contract grant number: NSF DGE 0806676; Contract grant sponsor: National
   Science Foundation; contract grant number: ECS-0335765
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Dash R, 2006, INT J BIOL MACROMOL, V38, P255, DOI 10.1016/j.ijbiomac.2006.03.001
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   GEORGAKOUDI I, 2004, BIOMACROMOLECULES, V5, P718
   Gil ES, 2006, BIOMACROMOLECULES, V7, P728, DOI 10.1021/bm050622i
   Gulrajani M., 1992, REV PROG COLOR RELAT, V22, P79, DOI DOI 10.1111/J.14784408.1992.TB00091.X
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   HOLLANDER DH, 1994, MED HYPOTHESES, V43, P155, DOI 10.1016/0306-9877(94)90142-2
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Jiang P, 2006, MATER LETT, V60, P919, DOI 10.1016/j.matlet.2005.10.056
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Mattews JD, 1913, TEXTILE FIBRES THEIR, P63
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MITA K, 1994, J MOL EVOL, V38, P583
   MORI K, 1995, J MOL BIOL, V251, P217, DOI 10.1006/jmbi.1995.0429
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rudolph AS, 1997, CRIT CARE MED, V25, P460, DOI 10.1097/00003246-199703000-00015
   Sahoo S, 2010, J BIOMED MATER RES B, V95B, P19, DOI 10.1002/jbm.b.31678
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Takasu Yoko, 2005, Journal of Insect Biotechnology and Sericology, V74, P103
   Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Terada S, 2002, CYTOTECHNOLOGY, V40, P3, DOI 10.1023/A:1023993400608
   Teramoto H, 2006, MACROMOLECULES, V39, P6, DOI 10.1021/ma0521147
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Tsubouchi Kozo, 2003, Journal of Insect Biotechnology and Sericology, V72, P65
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wu JH, 2007, FOOD CHEM, V103, P1255, DOI 10.1016/j.foodchem.2006.10.042
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Zaoming Wen, 1996, Journal of Investigational Allergology and Clinical Immunology, V6, P237
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
NR 52
TC 107
Z9 110
U1 5
U2 102
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2011
VL 99B
IS 1
BP 89
EP 101
DI 10.1002/jbm.b.31875
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820NJ
UT WOS:000294912400011
PM 21695778
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Di Virgilio, AL
   Reigosa, M
   de Mele, MFL
AF Di Virgilio, Ana L.
   Reigosa, Miguel
   Fernandez Lorenzo de Mele, Monica
TI Biocompatibility of magnesium particles evaluated by in vitro
   cytotoxicity and genotoxicity assays
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE degradation; cell-material interaction; toxicity; metal ions; corrosion
ID ORTHOPEDIC IMPLANTS; OXIDE NANOPARTICLES; INDIVIDUAL CELLS; VIVO
   CORROSION; COMET ASSAY; DNA-DAMAGE; ALLOYS; BONE; DEGRADATION; TOXICITY
AB Mg is a biodegradable biomaterial which may release particles (MP) to the environment. The possible cyto- and genotoxic effects of MP derived from magnesium powder (mesh 325) were analyzed on rat osteosarcoma UMR106 cells in order simulate the effect of Mg debris. Neutral red (NR) incorporation and acridine orange/ethidium bromide (AO/EB) staining techniques were used as endpoints to analyze the cytotoxic effects at 25-1000 mu g/mL concentration range. Genotoxicity was estimated according to micronucleus (MN) formation and the Comet assay (CA). Results showed that MP size changes with time due to corrosion. Changes in lysosomal activity were observed after 24 h only at 1000 mu g/mL. Accordingly, AO/EB staining showed a significant decrease in the number of living cells at 500 mu g/mL. Transmission electronic microscopy showed MP internalization (60 and 200 nm diameter) in cells after 2-h treatment, whereas no MP was detected after 24 h. A significant dose-dependent increase in MN frequencies was observed at 25-100 mu g/mL range (nontoxic range). DNA damage induction was assessed by CA only at 500 mu g/mL. Results showed dose-dependent cytotoxic and genotoxic effects of MP on UMR106 cells with different threshold values of MP concentration. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 99B: 111-119, 2011.
C1 [Di Virgilio, Ana L.; Fernandez Lorenzo de Mele, Monica] Inst Res Theoret & Appl Phys Chem INIFTA, RA-1900 La Plata, Buenos Aires, Argentina.
   [Reigosa, Miguel] Multidisciplinary Inst Cellular Biol IMBICE, RA-1900 La Plata, Buenos Aires, Argentina.
   [Fernandez Lorenzo de Mele, Monica] Natl Univ La Plata, Fac Engn, La Plata, Buenos Aires, Argentina.
RP de Mele, MFL (reprint author), Inst Res Theoret & Appl Phys Chem INIFTA, Diag 113 & 64, RA-1900 La Plata, Buenos Aires, Argentina.
EM mmele@inifta.unlp.edu.ar
RI Fernandez Lorenzo de Mele, Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551
FU National Agency of Scientific and Technological Promotion (ANPCyT) [BID
   1728 OC/AR PICT 0533225, PICT 05-32906, PAE 22771]; National University
   of La Plata (UNLP) [11-I129]; National Council for Scientific and
   Technological Research (CONICET)
FX Grant sponsor: National Agency of Scientific and Technological Promotion
   (ANPCyT); Project numbers: BID 1728 OC/AR PICT 0533225, PICT 05-32906,
   PAE 22771; Grant sponsor: National University of La Plata (UNLP);
   Project number: 11-I129; Grant sponsor: National Council for Scientific
   and Technological Research (CONICET)
CR BABICH H, 1992, IN VITRO METHODS TOX
   Baril G, 2001, CORROS SCI, V43, P471, DOI 10.1016/S0010-938X(00)00095-0
   Bednarek A, 2003, MAGNESIUM RES, V16, P271
   Bhakta G, 2009, J BIOMED NANOTECHNOL, V5, P106, DOI 10.1166/jbn.2009.029
   Brunner TJ, 2006, ENVIRON SCI TECHNOL, V40, P4374, DOI 10.1021/es052069i
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   COHEN JJ, 1993, IMMUNOL TODAY, V14, P126, DOI 10.1016/0167-5699(93)90214-6
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Di Virgilio AL, 2010, J HAZARD MATER, V177, P711, DOI 10.1016/j.jhazmat.2009.12.089
   Di Virgilio A. L., 2009, J BIOMEDICAL MAT R A, V92A, P80
   Donaldson K, 2002, J AEROSOL MED, V15, P213, DOI 10.1089/089426802320282338
   DUNCAN RL, 1995, CALCIFIED TISSUE INT, V57, P344, DOI 10.1007/BF00302070
   Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8
   Gojova A, 2007, ENVIRON HEALTH PERSP, V115, P403, DOI 10.1289/ehp.8497
   Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   HESTERBERG TW, 1986, CANCER RES, V46, P5795
   Hong YC, 1997, ENVIRON HEALTH PERSP, V105, P744, DOI 10.1289/ehp.97105744
   Huan ZG, 2010, J MATER SCI-MATER M, V21, P2623, DOI 10.1007/s10856-010-4111-8
   Jacobs JJ, 2003, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000096810.78689.62
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Kubota T, 2005, BBA-MOL CELL RES, V1744, P19, DOI 10.1016/j.bbamer.2004.10.013
   Liao WJ, 2009, METHODS, V48, P46, DOI 10.1016/j.ymeth.2009.02.016
   Mouchet F, 2005, ENVIRON TOXICOL, V20, P74, DOI 10.1002/tox.20080
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   Nagels J, 2003, J SHOULDER ELB SURG, V12, P35, DOI 10.1067/mse.2003.22
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   OBERDORSTER G, 2000, RES REP HLTH EFF I, V96, P5
   Papageorgiou I, 2007, BIOMATERIALS, V28, P2946, DOI 10.1016/j.biomaterials.2007.02.034
   Peuster M, 2006, CARDIOL YOUNG, V16, P107, DOI 10.1017/S1047951106000011
   Pietak A, 2008, J MATER SCI-MATER M, V19, P407, DOI 10.1007/s10856-007-3172-9
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   Ratner B.D., 2004, BIOMATERIALS SCI
   Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k
   Saris NEL, 2000, CLIN CHIM ACTA, V294, P1, DOI 10.1016/S0009-8981(99)00258-2
   Simon-Deckers A, 2008, TOXICOLOGY, V253, P137, DOI 10.1016/j.tox.2008.09.007
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0
   Soghomonyan D, 2011, APPL BIOCHEM MICRO+, V47, P27, DOI 10.1134/S0003683811010157
   Stone V, 1998, TOXICOL IN VITRO, V12, P649, DOI 10.1016/S0887-2333(98)00050-2
   Vormann Juergen, 2003, Molecular Aspects of Medicine, V24, P27, DOI 10.1016/S0098-2997(02)00089-4
   Williams David, 2006, Med Device Technol, V17, P9
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Wolf Federica I., 2003, Molecular Aspects of Medicine, V24, P3, DOI 10.1016/S0098-2997(02)00087-0
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 46
TC 12
Z9 12
U1 0
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2011
VL 99B
IS 1
BP 111
EP 119
DI 10.1002/jbm.b.31877
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820NJ
UT WOS:000294912400013
PM 21714077
DA 2018-10-20
ER

PT J
AU Cortez, PP
   Atayde, LM
   Silva, MA
   Armada-da-Silva, P
   Fernandes, MH
   Afonso, A
   Lopes, MA
   Mauricio, AC
   Santos, JD
AF Cortez, P. P.
   Atayde, L. M.
   Silva, M. A.
   Armada-da-Silva, P.
   Fernandes, M. H.
   Afonso, A.
   Lopes, M. A.
   Mauricio, A. C.
   Santos, J. D.
TI Characterization and preliminary in vivo evaluation of a novel modified
   hydroxyapatite produced by extrusion and spheronization techniques
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioactive glass; in vivo; hydroxyapatite; biocompatibility/hard tissue;
   bone graft
ID GLASS-REINFORCED-HYDROXYAPATITE; PLASMA-SPRAYED COATINGS; BONE-GRAFT
   SUBSTITUTES; FLOW-CYTOMETRY ANALYSIS; OSTEOBLAST-LIKE CELLS;
   MARROW-CELLS; BONELIKE((R))/PLGA HYBRID; BIOMEDICAL APPLICATIONS;
   HISTOLOGICAL ANALYSIS; BONELIKE(R) GRAFT
AB A glass-reinforced hydroxyapatite (HA) composite, recently registered as Bonelike (R), was developed for bone grafting. This biomaterial is composed of a modified HA matrix with alpha- and beta-tricalcium phosphate secondary phases and ionic species that mimic the chemical composition of human bone. Several in vitro and in vivo studies have confirmed the benefits of these properties. However, these studies were all executed with Bonelike (R) polygonal granules obtained by crushing. In this study, Bonelike (R) pellets were produced through a patented process, which required the use of techniques such as extrusion and spheronization. The final product presented a homogeneous size, a 55.1% global porosity and a spherical shape. This spherical shape permitted a better adaptation to the implantation site and improved injectability. Additionally, it also may contribute to formation of macropores as pellets packaging leaves open spaces. After implantation of Bonelike (R) polygonal granules and Bonelike (R) pellets in monocortical defects in sheep for 8 and 12 weeks, light microscopy and scanning electron microscopy showed extensive osteointegration simultaneously with bone regeneration for both presentations. Histomorphometric analysis did not reveal statistically significant differences between defects treated with Bonelike (R) polygonal granules and Bonelike (R) pellets, which suggests similar in vivo performances. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 99B: 170-179, 2011.
C1 [Cortez, P. P.; Atayde, L. M.; Mauricio, A. C.] Univ Porto, Inst Ciencias & Tecnol Agr & Agroalimentares ICET, CECA, P-4485661 Vairao, Portugal.
   [Cortez, P. P.; Atayde, L. M.; Mauricio, A. C.] Univ Porto, ICBAS, P-4099003 Oporto, Portugal.
   [Silva, M. A.] Univ Porto, Fac Engn, Dept Met & Mat Engn, P-4200465 Oporto, Portugal.
   [Armada-da-Silva, P.] Univ Tecn Lisboa, Fac Motricidade Humana, CIPER, P-1499002 Lisbon, Portugal.
   [Fernandes, M. H.; Afonso, A.] Univ Porto, Fac Med Dent, P-4200393 Oporto, Portugal.
   [Lopes, M. A.; Santos, J. D.] Univ Porto, CEMUC, Dept Met & Mat Engn, P-4200465 Oporto, Portugal.
RP Cortez, PP (reprint author), Univ Porto, Inst Ciencias & Tecnol Agr & Agroalimentares ICET, CECA, P-4485661 Vairao, Portugal.
EM pcortez@mail.icav.up.pt
RI Lopes, Cristina/A-4241-2010; Fernandes, Maria Helena/K-6917-2014; Lopes,
   Maria A./P-4442-2014; Armada-da-Silva, Paulo/L-5675-2013
OI Lopes, Maria A./0000-0003-4105-8148; Armada-da-Silva,
   Paulo/0000-0002-3814-6879; Fernandes, Maria Helena/0000-0001-9391-9574;
   Santos, Jose Domingos/0000-0002-6871-9850; Mauricio, Ana
   Colette/0000-0002-0018-9363; Silva, Marta/0000-0002-4833-3686; Cortez,
   Paulo/0000-0001-7132-6786
FU Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/31842/2006,
   PTDC/CVT/64220/2006]; European Regional Development Fund [1372]
FX Contract grant sponsor: Fundacao para a Ciencia e Tecnologia (FCT);
   contract grant numbers: SFRH/BD/31842/2006 (through the PhD grant),
   PTDC/CVT/64220/2006 (through financing of the research project);
   Contract grant sponsor: European Regional Development Fund (through the
   QREN Project BIOMAT&CELL No. 1372)
CR Afonso A, 1996, J MATER SCI-MATER M, V7, P507, DOI 10.1007/BF00705433
   Aoki S, 2004, J CERAM SOC JPN, V112, P193, DOI 10.2109/jcersj.112.193
   BENHAMOU CL, 2008, OSTEOPOROSIS INT, V19, P853
   Chevalier E, 2008, J PHARM SCI-US, V97, P1135, DOI 10.1002/jps.21059
   CORTEZ PP, J BIOMATER IN PRESS
   Costa MA, 2004, KEY ENG MAT, V254-2, P821, DOI 10.4028/www.scientific.net/KEM.254-256.821
   COSTANTINO PD, 1994, OTOLARYNG CLIN N AM, V27, P1037
   da Silva MHP, 2002, J NON-CRYST SOLIDS, V304, P286, DOI 10.1016/S0022-3093(02)01036-0
   Ferraz MP, 1999, J MATER SCI-MATER M, V10, P567, DOI 10.1023/A:1008924516146
   Ferraz MP, 2000, KEY ENG MAT, V192-1, P449
   Ferraz MP, 2001, J MATER SCI-MATER M, V12, P629, DOI 10.1023/A:1011245828046
   Ferraz MP, 2000, BIOMATERIALS, V21, P813, DOI 10.1016/S0142-9612(99)00249-5
   Ferraz MP, 1999, J BIOMED MATER RES, V47, P603, DOI 10.1002/(SICI)1097-4636(19991215)47:4<603::AID-JBM18>3.0.CO;2-6
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Gomes PS, 2008, ACTA BIOMATER, V4, P630, DOI 10.1016/j.actbio.2007.12.006
   Heymann D, 2001, HISTOL HISTOPATHOL, V16, P37, DOI 10.14670/HH-16.37
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Hing KA, 2007, SPINE J, V7, P475, DOI 10.1016/j.spinee.2006.07.017
   Hong MH, 2011, J MATER SCI-MATER M, V22, P349, DOI 10.1007/s10856-010-4197-z
   Horch HH, 2006, INT J ORAL MAX SURG, V35, P708, DOI 10.1016/j.ijom.2006.03.017
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Ishikawa K, 2003, KEY ENG MAT, V240-2, P369, DOI 10.4028/www.scientific.net/KEM.240-242.369
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Lobato JV, 2006, THIN SOLID FILMS, V515, P362, DOI 10.1016/j.tsf.2005.12.153
   Lobato JV, 2005, KEY ENG MAT, V284-286, P877, DOI 10.4028/www.scientific.net/KEM.284-286.877
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   Lopes MA, 2001, J BIOMED MATER RES, V54, P463, DOI 10.1002/1097-4636(20010315)54:4<463::AID-JBM10>3.0.CO;2-Y
   Lopes MA, 2000, BIOMATERIALS, V21, P1905, DOI 10.1016/S0142-9612(00)00068-5
   Lopes MA, 2000, BIOMATERIALS, V21, P1165, DOI 10.1016/S0142-9612(00)00007-7
   Lopes MA, 1998, J BIOMED MATER RES, V39, P244, DOI 10.1002/(SICI)1097-4636(199802)39:2<244::AID-JBM11>3.0.CO;2-D
   Lopes MA, 1998, J BIOMED MATER RES, V41, P649, DOI 10.1002/(SICI)1097-4636(19980915)41:4<649::AID-JBM17>3.0.CO;2-9
   Lopes MA, 2000, BIOMATERIALS, V21, P749, DOI 10.1016/S0142-9612(99)00248-3
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   MISIEK DJ, 1984, J ORAL MAXIL SURG, V42, P150, DOI 10.1016/S0278-2391(84)80025-7
   Navarro M, 2004, BIOMATERIALS, V25, P4233, DOI 10.1016/j.biomaterials.2003.11.012
   Oliveira JM, 2004, KEY ENG MAT, V254-2, P565, DOI 10.4028/www.scientific.net/KEM.254-256.565
   Oliveira JM, 2004, MATER SCI FORUM, V455-456, P374, DOI 10.4028/www.scientific.net/MSF.455-456.374
   Oliveira SM, 2008, J BIOMED MATER RES B, V87B, P49, DOI 10.1002/jbm.b.31066
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Qiu QQ, 2000, J BIOMED MATER RES, V52, P66, DOI 10.1002/1097-4636(200010)52:1<66::AID-JBM9>3.0.CO;2-2
   Ribeiro CC, 2006, J MATER SCI-MATER M, V17, P455, DOI 10.1007/s10856-006-8473-x
   RUBIN PAD, 1994, OPHTHALMIC PLAST REC, V10, P96, DOI 10.1097/00002341-199406000-00005
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   SANTOS JD, 2010, Patent No. 2010021559
   SANTOS JD, 2000, Patent No. 2000068164
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Sunny MC, 2002, J MATER SCI-MATER M, V13, P623, DOI 10.1023/A:1015709705074
   Uchino T, 2010, J MATER SCI-MATER M, V21, P1921, DOI 10.1007/s10856-010-4042-4
   Yamada M, 2007, J BIOMED MATER RES B, V82B, P139, DOI 10.1002/jbm.b.30715
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yuan HP, 2000, BIOMATERIALS, V21, P1283, DOI 10.1016/S0142-9612(00)00016-8
   Zyman Z, 2004, J MATER SCI-MATER M, V15, P551, DOI 10.1023/B:JMSM.0000026099.74563.db
NR 55
TC 10
Z9 10
U1 2
U2 11
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2011
VL 99B
IS 1
BP 170
EP 179
DI 10.1002/jbm.b.31884
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 820NJ
UT WOS:000294912400020
PM 21714082
DA 2018-10-20
ER

PT J
AU Wezel, F
   Southgate, J
   Thomas, DFM
AF Wezel, Felix
   Southgate, Jennifer
   Thomas, David F. M.
TI Regenerative medicine in urology
SO BJU INTERNATIONAL
LA English
DT Review
DE regenerative medicine; tissue engineering; stem cells; biomaterial;
   urothelium; bladder reconstruction
ID PLURIPOTENT STEM-CELLS; SMOOTH-MUSCLE-CELLS; STRESS
   URINARY-INCONTINENCE; SMALL-INTESTINAL SUBMUCOSA; HUMAN UROTHELIAL
   CELLS; ACELLULAR MATRIX GRAFT; ACUTE-RENAL-FAILURE; IN-VITRO; BLADDER
   TISSUE; RADICAL CYSTECTOMY
AB The term 'regenerative medicine' encompasses strategies for restoring or renewing tissue or organ function by: (i) in vivo tissue repair by in-growth of host cells into an acellular natural or synthetic biomaterial, (ii) implantation of tissue 'engineered' in vitro by seeding cultured cells into a biomaterial scaffold, and (iii) therapeutic cloning and stem cell-based tissue regeneration. In this article, we review recent developments underpinning the emerging science of regenerative medicine and critically assess where successful implementation of novel regenerative medicine approaches into urology practice might genuinely transform the quality of life of affected individuals. We advocate the need for an evidence-based approach supported by strong science and clinical objectivity.
C1 [Wezel, Felix; Southgate, Jennifer] Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.
   [Thomas, David F. M.] St James Univ Hosp, Leeds, W Yorkshire, England.
   [Wezel, Felix] Univ Med Ctr Mannheim, Dept Urol, Mannheim, Germany.
RP Southgate, J (reprint author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England.
EM js35@york.ac.uk
OI Southgate, Jennifer/0000-0002-0135-480X
FU European Association of Urology (EAU); Yorkshire Kidney Research Fund
   (YKRF); York Against Cancer
FX Felix Wezel is funded by the European Urological Scholarship Programme
   (EUSP) offered by the European Association of Urology (EAU) and by the
   Yorkshire Kidney Research Fund (YKRF). Jennifer Southgate holds a
   research chair funded by York Against Cancer.
CR Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503
   Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202
   Akbal C, 2006, J UROLOGY, V176, P1706, DOI 10.1016/j.juro.2006.04.085
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Atiyeh BS, 2007, BURNS, V33, P405, DOI 10.1016/j.burns.2006.11.002
   Baker SC, 2008, BIOMATERIALS, V29, P3357, DOI 10.1016/j.biomaterials.2008.04.033
   Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Barbieri CE, 2007, J UROLOGY, V178, P1418, DOI 10.1016/j.juro.2007.05.156
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   Bent AE, 2001, NEUROUROL URODYNAM, V20, P157, DOI 10.1002/1520-6777(2001)20:2<157::AID-NAU18>3.0.CO;2-A
   Bhargava S, 2004, BJU INT, V93, P1191, DOI 10.1111/j.1464-410X.2004.04860.x
   Bhargava S, 2008, EUR UROL, V53, P1263, DOI 10.1016/j.eururo.2008.01.061
   Bolland F, 2008, EXPERT OPIN BIOL TH, V8, P1039, DOI [10.1517/14712598.8.8.1039 , 10.1517/14712590802181405]
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Boruch AV, 2010, J SURG RES, V161, P217, DOI 10.1016/j.jss.2009.02.014
   Cain MP, 2010, J UROLOGY, V183, P2124, DOI 10.1016/j.juro.2010.03.067
   Carr LK, 2008, INT UROGYNECOL J, V19, P881, DOI 10.1007/s00192-007-0553-z
   Chen BSS, 2009, INT J ARTIF ORGANS, V32, P159
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen KL, 2010, P NATL ACAD SCI USA, V107, P3346, DOI 10.1073/pnas.0909367106
   Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008
   Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589
   Clark PE, 2005, CANCER, V104, P36, DOI 10.1002/cncr.21126
   Cloutier F, 2006, REGEN MED, V1, P469, DOI 10.2217/17460751.1.4.469
   Cross WR, 2005, AM J PHYSIOL-RENAL, V289, pF459, DOI 10.1152/ajprenal.00040.2005
   da Costa FDA, 2009, J HEART VALVE DIS, V18, P84
   Dahms SE, 1998, BRIT J UROL, V82, P411
   Davis NF, 2010, J UROLOGY, V184, P2246, DOI 10.1016/j.juro.2010.07.038
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x
   Dorin RP, 2008, WORLD J UROL, V26, P323, DOI 10.1007/s00345-008-0316-6
   Drewa T, 2009, TRANSPL P, V41, P4345, DOI 10.1016/j.transproceed.2009.08.059
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   Engelhardt EM, 2010, J TISSUE ENG REGEN M, V4, P123, DOI 10.1002/term.222
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Falke G, 2003, TISSUE ENG, V9, P871, DOI 10.1089/107632703322495529
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   FELDMAN HA, 1994, J UROLOGY, V151, P54, DOI 10.1016/S0022-5347(17)34871-1
   Fossum M, 2007, J Pediatr Urol, V3, P10, DOI 10.1016/j.jpurol.2006.01.018
   Fraser M, 2004, BJU INT, V93, P609, DOI 10.1111/j.1464-410X.2004.04675.x
   French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252
   Froehner M, 2009, EUR UROL, V56, P443, DOI 10.1016/j.eururo.2009.05.008
   Frudinger A, 2010, GUT, V59, P55, DOI 10.1136/gut.2009.181347
   Fu Q, 2007, BJU INT, V99, P1162, DOI 10.1111/j.1464-410X.2006.06691.x
   Fu Q, 2010, UROLOGY, V75, P718, DOI 10.1016/j.urology.2009.10.003
   Furuta A, 2007, NEUROUROL URODYNAM, V26, P966, DOI 10.1002/nau.20448
   Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Hafez AT, 2003, J UROLOGY, V169, P2316, DOI 10.1097/01.ju.0000067485.51252.f5
   Hall VJ, 2006, STEM CELL REV, V2, P301, DOI 10.1007/BF02698057
   Harousseau JL, 2007, HEMATOL ONCOL CLIN N, V21, P1157, DOI 10.1016/j.hoc.2007.08.001
   Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718
   Hochedlinger K, 2004, HEMATOL J, V5, pS114, DOI 10.1038/sj.thj.6200435
   Hoshi A, 2008, TRANSPLANTATION, V85, P1617, DOI 10.1097/TP.0b013e318170572b
   Hosper NA, 2010, BIOMATERIALS, V31, P3910, DOI 10.1016/j.biomaterials.2010.01.129
   Humes HD, 2004, KIDNEY INT, V66, P1578, DOI 10.1111/j.1523-1755.2004.00923.x
   HUTTON KAR, 1993, J UROLOGY, V150, P721, DOI 10.1016/S0022-5347(17)35597-0
   Imai N, 2009, SEMIN DIALYSIS, V22, P629, DOI 10.1111/j.1525-139X.2009.00654.x
   Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035
   Jayo MJ, 2008, REGEN MED, V3, P671, DOI 10.2217/17460751.3.5.671
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/nmeth.1426, 10.1038/NMETH.1426]
   Kanatani I, 2007, TISSUE ENG, V13, P2933, DOI 10.1089/ten.2007.0052
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Kinebuchi Y, 2008, CELL TISSUE RES, V331, P605, DOI 10.1007/s00441-007-0553-9
   Kleinert S, 2008, LANCET, V372, P789, DOI 10.1016/S0140-6736(08)61320-3
   Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37
   Korossis S, 2006, TISSUE ENG, V12, P635, DOI 10.1089/ten.2006.12.635
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Kropp BP, 1996, J UROLOGY, V156, P599, DOI 10.1016/S0022-5347(01)65761-6
   Kropp BP, 2007, CLIN PEDIAT UROLOGY, P871
   Kurzrock EA, 2008, AM J PHYSIOL-RENAL, V294, pF1415, DOI 10.1152/ajprenal.00533.2007
   Kwon TG, 2002, J UROLOGY, V168, P1754, DOI 10.1097/01.ju.0000030103.53181.7d
   Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015
   LARSEN WJ, 1998, ESSENTIALS HUMAN EMB
   Lauer G, 2001, PLAST RECONSTR SURG, V107, P25, DOI 10.1097/00006534-200101000-00005
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lin HK, 2004, J UROLOGY, V171, P1348, DOI 10.1097/01.ju.0000108800.47594.8b
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Magnan M, 2009, TISSUE ENG PT A, V15, P197, DOI 10.1089/ten.tea.2007.0303
   Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014
   Martin I, 2010, TISSUE ENG PT A, V16, P2419, DOI 10.1089/ten.TEA.2010.0056
   McAteer H, 2007, J TISSUE ENG REGEN M, V1, P343, DOI 10.1002/term.36
   Meeks JJ, 2010, J UROLOGY, V183, P1880, DOI 10.1016/j.juro.2010.01.029
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072
   Novotny V, 2007, EUR UROL, V51, P397, DOI 10.1016/j.eururo.2006.06.014
   Nuininga JE, 2010, TISSUE ENG PT A, V16, P3319, DOI 10.1089/ten.tea.2010.0053
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270
   Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010
   Piscaglia AC, 2008, MINIM INVASIV THER, V17, P100, DOI 10.1080/13645700801969980
   Praud C, 2007, CELL TRANSPLANT, V16, P741, DOI 10.3727/000000007783465118
   Probst M, 2000, BJU INT, V85, P362, DOI 10.1046/j.1464-410x.2000.00442.x
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206
   Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103
   Rohman G, 2007, BIOMATERIALS, V28, P2264, DOI 10.1016/j.biomaterials.2007.01.032
   Rohman G, 2009, J MATER CHEM, V19, P9265, DOI 10.1039/b911625g
   Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039
   Santucci RA, 2007, J UROLOGY, V177, P1667, DOI 10.1016/j.juro.2007.01.041
   Santucci Richard A., 2005, Int. braz j urol., V31, P192, DOI 10.1590/S1677-55382005000300002
   Scriven SD, 1997, J UROLOGY, V158, P1147, DOI 10.1016/S0022-5347(01)64407-0
   Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y
   SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313
   Smythe GM, 2000, CELL TRANSPLANT, V9, P379, DOI 10.1177/096368970000900309
   Song JH, 2009, SEMIN DIALYSIS, V22, P603, DOI 10.1111/j.1525-139X.2009.00663.x
   Song LJ, 2009, INT J ANDROL, V32, P514, DOI 10.1111/j.1365-2605.2008.00888.x
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   SOUTHGATE J, 1987, LAB INVEST, V56, P211
   Southgate J, 2002, CULTURE EPITHELIAL C, P381, DOI DOI 10.1002/0471221201.CH12
   Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494
   Stenzl A, 2009, EUR UROL, V55, P815, DOI 10.1016/j.eururo.2009.01.002
   Subramaniam R, 2011, J UROL IN PRESS, V186
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tanaka ST, 2010, TISSUE ENG PT A, V16, P2121, DOI 10.1089/ten.TEA.2009.0557
   THOMAS ED, 1959, J CLIN INVEST, V38, P1709, DOI 10.1172/JCI103949
   Thomas JC, 2008, J UROLOGY, V180, P1784, DOI 10.1016/j.juro.2008.03.098
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001
   Trivedi H, 2010, ADV CHRONIC KIDNEY D, V17, P265, DOI 10.1053/j.ackd.2010.03.007
   Tsai SY, 2010, STEM CELLS, V28, P221, DOI 10.1002/stem.281
   Tumlin J, 2008, J AM SOC NEPHROL, V19, P1034, DOI 10.1681/ASN.2007080895
   Turner AM, 2007, WOODHEAD PUBL MATER, P445, DOI 10.1533/9781845693817.2.445
   Turner A, 2011, EUR UROL, V59, P447, DOI 10.1016/j.eururo.2010.12.004
   Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783
   Vajta G, 2007, REPROD BIOMED ONLINE, V15, P582, DOI 10.1016/S1472-6483(10)60391-4
   Varley C, 2005, EXP CELL RES, V306, P216, DOI 10.1016/j.yexer.2005.02.004
   Varley CL, 2009, CELL DEATH DIFFER, V16, P103, DOI 10.1038/cdd.2008.116
   Varley CL, 2006, J CELL PHYSIOL, V208, P407, DOI 10.1002/jcp.20676
   Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042
   Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6
   Wang AY, 2008, BIOMACROMOLECULES, V9, P2929, DOI 10.1021/bm800727z
   Wiesmann HP, 2009, FUNDAMENTALS TISSUE, P457
   Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0
   Wood D, 2008, CURR OPIN UROL, V18, P564, DOI 10.1097/MOU.0b013e32830f9402
   Wood DN, 2004, J UROLOGY, V172, P753, DOI 10.1097/01.ju.0000130494.02572.5f
   Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034
   Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhang YY, 2008, J UROLOGY, V180, P2226, DOI 10.1016/j.juro.2008.07.023
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
   Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5
NR 155
TC 14
Z9 14
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD OCT
PY 2011
VL 108
IS 7
BP 1046
EP 1065
DI 10.1111/j.1464-410X.2011.10206.x
PG 20
WC Urology & Nephrology
SC Urology & Nephrology
GA 819WS
UT WOS:000294865100007
PM 21895928
OA Bronze
DA 2018-10-20
ER

PT J
AU Borg, DJ
   Bonifacio, E
AF Borg, Danielle J.
   Bonifacio, Ezio
TI The Use of Biomaterials in Islet Transplantation
SO CURRENT DIABETES REPORTS
LA English
DT Article
DE Type 1 diabetes; Islet transplantation; Islet niche; Biomaterial;
   Encapsulation
ID ENDOTHELIAL GROWTH-FACTOR; ARTIFICIAL ENDOCRINE PANCREAS; BETA-CELL
   PROLIFERATION; STEM-CELLS; BONE-MARROW; DIABETES-MELLITUS;
   BASEMENT-MEMBRANE; BIOARTIFICIAL PANCREAS; STROMAL CELLS; NOD MICE
AB Pancreatic islet transplantation is a therapeutic option to replace destroyed beta cells in autoimmune diabetes. Islets are transplanted into the liver via the portal vein; however, inflammation, the required immunosuppression, and lack of vasculature decrease early islet viability and function. Therefore, the use of accessory therapy and biomaterials to protect islets and improve islet function has definite therapeutic potential. Here we review the application of niche accessory cells and factors, as well as the use of biomaterials as carriers or capsules, for pancreatic islet transplantation.
C1 [Borg, Danielle J.; Bonifacio, Ezio] Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany.
RP Bonifacio, E (reprint author), Tech Univ Dresden, DFG Ctr Regenerat Therapies Dresden, Tatzberg 47-49, D-01307 Dresden, Germany.
EM ezio.bonifacio@crt-dresden.de
RI Bonifacio, Ezio/E-7700-2010; Borg, Danielle/B-3040-2014
OI Bonifacio, Ezio/0000-0002-8704-4713; Borg, Danielle/0000-0001-6126-7583
FU DFG-Center for Regenerative Therapies Dresden, Cluster of Excellence
   [FZT 111]; Federal Ministry of Education and Research, Germany
   [01GN0945]
FX This work was supported by the DFG-Center for Regenerative Therapies
   Dresden, Cluster of Excellence (FZT 111) and the Federal Ministry of
   Education and Research, Germany (01GN0945). D. J. Borg is enrolled in
   the Regenerative Medicine PhD Program of the Dresden International
   Graduate School for Biomedicine & Bioengineering (DIGS-BB) as part of
   the Technical University of Dresden.
CR Ahren B, 2000, DIABETOLOGIA, V43, P393, DOI 10.1007/s001250051322
   Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Bosco D, 2000, DIABETES, V49, P233, DOI 10.2337/diabetes.49.2.233
   Bosco D, 2010, DIABETES, V59, P1202, DOI 10.2337/db09-1177
   Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690
   Cabric S, 2007, DIABETES, V56, P2008, DOI 10.2337/db07-0358
   Cabric S, 2010, TISSUE ENG PT A, V16, P961, DOI 10.1089/ten.tea.2009.0429
   Calafiore R, 2001, ANN NY ACAD SCI, V944, P240
   Calafiore R, 1997, ANN NY ACAD SCI, V831, P313
   Calafiore R, 2004, BIOTECHNOL APPL BIOC, V39, P159, DOI 10.1042/BA20030151
   Cantaluppi V, 2006, AM J TRANSPLANT, V6, P2601, DOI 10.1111/j.1600-6143.2006.01534.x
   Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391
   CHICK WL, 1975, SCIENCE, V187, P847, DOI 10.1126/science.187.4179.847
   Chow LW, 2010, BIOMATERIALS, V31, P6154, DOI 10.1016/j.biomaterials.2010.04.002
   Clark H, 2000, J BIOMED MATER RES, V52, P183, DOI 10.1002/1097-4636(200010)52:1<183::AID-JBM24>3.0.CO;2-D
   Contreras JL, 2003, SURGERY, V134, P390, DOI 10.1067/msy.2003.250
   Cronin KJ, 2004, PLAST RECONSTR SURG, V113, P260, DOI 10.1097/01.PRS.0000095942.71618.9D
   Cui H, 2009, TRANSPLANTATION, V88, P160, DOI 10.1097/TP.0b013e3181abbfc1
   de Vos P, 2006, BIOMATERIALS, V27, P5603, DOI 10.1016/j.biomaterials.2006.07.010
   Desai NM, 2003, TRANSPLANTATION, V76, P1623, DOI 10.1097/01.TP.0000081043.23751.81
   DeVos P, 1997, DIABETOLOGIA, V40, P262
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977, DOI DOI 10.1056/NEJM199309303291401
   Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317
   Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Dulong JL, 2002, BIOTECHNOL BIOENG, V78, P576, DOI 10.1002/bit.10230.abs
   Eberhard D, 2009, CURR OPIN GENET DEV, V19, P469, DOI 10.1016/j.gde.2009.07.003
   *EXP COMM DIAGN CL, 2002, DIABETES CARE, V25, pS5, DOI DOI 10.2337/DIACARE.25.2007.S5
   Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006
   FAN MY, 1990, DIABETES, V39, P519, DOI 10.2337/diabetes.39.4.519
   Figliuzzi M, 2006, ACTA BIOMATER, V2, P221, DOI 10.1016/j.actbio.2005.12.002
   Figliuzzi M, 2009, TRANSPL P, V41, P1797, DOI 10.1016/j.transproceed.2008.11.015
   Freudenberg U, 2009, BIOMATERIALS, V30, P5049, DOI 10.1016/j.biomaterials.2009.06.002
   Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009
   Hammar E, 2004, DIABETES, V53, P2034, DOI 10.2337/diabetes.53.8.2034
   Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841
   Hirshberg B, 2002, J CLIN ENDOCR METAB, V87, P5424, DOI 10.1210/jc.2002-020684
   Hussey AJ, 2010, CELLS TISSUES ORGANS, V191, P382, DOI 10.1159/000276595
   Hussey AJ, 2009, TISSUE ENG PT A, V15, P3823, DOI [10.1089/ten.tea.2008.0682, 10.1089/ten.TEA.2008.0682]
   Huypens P, 2000, DIABETOLOGIA, V43, P1012, DOI 10.1007/s001250051484
   Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502
   Ito M, 2009, ACTA BIOMATER, V5, P2945, DOI 10.1016/j.actbio.2009.04.015
   Jacobson S, 2008, ANN NY ACAD SCI, V1150, P213, DOI 10.1196/annals.1447.042
   Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4
   Johansson U, 2005, AM J TRANSPLANT, V5, P2632, DOI 10.1111/j.1600-6143.2005.01076.x
   Kawakami Y, 2000, CELL TRANSPLANT, V9, P729, DOI 10.1177/096368970000900523
   Kin T, 2008, ARTIF ORGANS, V32, P990, DOI 10.1111/j.1525-1594.2008.00688.x
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65
   Lanza RP, 1996, NAT BIOTECHNOL, V14, P1107, DOI 10.1038/nbt0996-1107
   Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103
   LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628
   Lu YR, 2010, CELL BIOCHEM FUNCT, V28, P637, DOI 10.1002/cbf.1701
   Ludwig B, 2010, HORM METAB RES, V42, P918, DOI 10.1055/s-0030-1267916
   LUM ZP, 1991, DIABETES, V40, P1511, DOI 10.2337/diabetes.40.11.1511
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Madec AM, 2009, DIABETOLOGIA, V52, P1391, DOI 10.1007/s00125-009-1374-z
   MAKI T, 1993, TRANSPLANTATION, V55, P713, DOI 10.1097/00007890-199304000-00005
   Maki T, 1996, DIABETES, V45, P342, DOI 10.2337/diabetes.45.3.342
   Mei Y, 2010, BIOMATERIALS, V31, P8989, DOI 10.1016/j.biomaterials.2010.08.029
   MENGER MD, 1992, J CLIN INVEST, V90, P1361, DOI 10.1172/JCI116002
   Merani S, 2006, CLIN SCI, V110, P611, DOI 10.1042/CS20050342
   Miller R, 2008, DIABETES, V57, P2402, DOI 10.2337/db08-0244
   Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015
   Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005
   Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287
   Otonkoski T, 2008, DIABETES OBES METAB, V10, P119, DOI 10.1111/j.1463-1326.2008.00955.x
   Park KS, 2009, TRANSPL P, V41, P3813, DOI 10.1016/j.transproceed.2009.06.193
   Parnaud G, 2009, MOL ENDOCRINOL, V23, P1264, DOI 10.1210/me.2009-0008
   Pileggi A, 2006, TRANSPLANTATION, V81, P1318, DOI 10.1097/01.tp.0000203858.41105.88
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Safley SA, 2005, TRANSPLANTATION, V79, P409, DOI 10.1097/01.TP.0000150021.06027.DC
   Safley SA, 2002, CELL TRANSPLANT, V11, P695, DOI 10.3727/000000002783985413
   Sakurai T, 2003, CELL TRANSPLANT, V12, P527, DOI 10.3727/000000003108746984
   SCHARP DW, 1984, WORLD J SURG, V8, P221, DOI 10.1007/BF01655139
   SCHARP DW, 1994, DIABETES, V43, P1167, DOI 10.2337/diabetes.43.9.1167
   Shimizu H, 2009, BIOMATERIALS, V30, P5943, DOI 10.1016/j.biomaterials.2009.07.042
   Sodergard A, 2002, PROG POLYM SCI, V27, P1123, DOI 10.1016/S0079-6700(02)00012-6
   SOONSHIONG P, 1993, P NATL ACAD SCI USA, V90, P5843, DOI 10.1073/pnas.90.12.5843
   SOONSHIONG P, 1994, LANCET, V343, P950, DOI 10.1016/S0140-6736(94)90067-1
   Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood2004-09-3507
   Sordi V, 2009, CURR DIABETES REP, V9, P119, DOI 10.1007/s11892-009-0021-x
   Stendahl JC, 2008, TRANSPLANTATION, V86, P478, DOI 10.1097/TP.0b013e3181806d9d
   SULLIVAN SJ, 1991, SCIENCE, V252, P718, DOI 10.1126/science.2024124
   SUN AM, 1977, DIABETES, V26, P1136, DOI 10.2337/diabetes.26.12.1136
   Teramura Y, 2010, ADV DRUG DELIVER REV, V62, P827, DOI 10.1016/j.addr.2010.01.005
   Totani T, 2008, BIOMATERIALS, V29, P2878, DOI 10.1016/j.biomaterials.2008.03.024
   Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107
   VAJKOCZY P, 1995, AM J PATHOL, V146, P1397
   Vasir B, 1998, DIABETES, V47, P1894, DOI 10.2337/diabetes.47.12.1894
   Virtanen I, 2008, DIABETOLOGIA, V51, P1181, DOI 10.1007/s00125-008-0997-9
   Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181
   Williams SJ, 2009, BIOPOLYMERS, V91, P676, DOI 10.1002/bip.21196
   Wojtusciszyn A, 2008, DIABETOLOGIA, V51, P1843, DOI 10.1007/s00125-008-1103-z
   Yang XD, 2010, J BIOMED MATER RES A, V92A, P548, DOI 10.1002/jbm.a.32379
   Zahr E, 2007, TRANSPLANTATION, V84, P1576, DOI 10.1097/01.tp.0000296035.48728.28
   Zhang N, 2006, DIABETES, V55, P2429, DOI 10.2337/db06-0173
NR 98
TC 25
Z9 25
U1 0
U2 19
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1534-4827
EI 1539-0829
J9 CURR DIABETES REP
JI Curr. Diabetes Rep.
PD OCT
PY 2011
VL 11
IS 5
BP 434
EP 444
DI 10.1007/s11892-011-0210-2
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 817VQ
UT WOS:000294705100011
PM 21748257
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Gibly, RF
   Graham, JG
   Luo, X
   Lowe, WL
   Hering, BJ
   Shea, LD
AF Gibly, R. F.
   Graham, J. G.
   Luo, X.
   Lowe, W. L., Jr.
   Hering, B. J.
   Shea, L. D.
TI Advancing islet transplantation: from engraftment to the immune response
SO DIABETOLOGIA
LA English
DT Review
DE Biomaterial; Biotechnology; Diabetes; Extrahepatic; Immunomodulation;
   Islet transplantation; Review; Scaffold; Tissue engineering; Tolerance
ID REGULATORY T-CELLS; TYPE-1 DIABETES-MELLITUS; LONG-TERM SURVIVAL;
   MEDIATED INFLAMMATORY REACTION; PLASMACYTOID DENDRITIC CELLS;
   DONOR-SPECIFIC TRANSFUSION; MESENCHYMAL STEM-CELLS; MONOCLONAL-ANTIBODY;
   INSULIN-SECRETION; BIOARTIFICIAL PANCREAS
AB The promise and progress of islet transplantation for treating type 1 diabetes has been challenged by obstacles to patient accessibility and long-term graft function that may be overcome by integrating emerging technologies in biomaterials, drug delivery and immunomodulation. The hepatic microenvironment and traditional systemic immunosuppression stress the vulnerable islets and contribute to the limited success of transplantation. Locally delivering extracellular matrix proteins and trophic factors can enhance transplantation at extrahepatic sites by promoting islet engraftment, revascularisation and long-term function while avoiding unintended systemic effects. Cell- and cytokine-based therapies for immune cell recruitment and reprogramming can inhibit local and systemic immune system activation that normally attacks transplanted islets. Combined with antigen-specific immunotherapies, states of operational tolerance may be achievable, reducing or eliminating the long-term pharmaceutical burden. Integration of these technologies to enhance engraftment and combat rejection may help to advance the therapeutic efficacy and availability of islet transplantation.
C1 [Shea, L. D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
   [Gibly, R. F.; Graham, J. G.; Shea, L. D.] Northwestern Univ, Inst Bionanotechnol Med IBNAM, Chicago, IL 60611 USA.
   [Gibly, R. F.; Graham, J. G.] Northwestern Univ, Integrated Grad Program, Chicago, IL 60611 USA.
   [Luo, X.; Lowe, W. L., Jr.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA.
   [Hering, B. J.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA.
   [Hering, B. J.] Univ Minnesota, Schulze Diabet Inst, Minneapolis, MN USA.
   [Shea, L. D.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.
   [Shea, L. D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd,E136, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIH NIDDK [F30 DK846492, R21 EB009502, R01 EB009910, DP2 DK083099, U01
   AI089316]
FX Financial support was provided by grants from NIH & NIDDK, including:
   F30 DK846492, R21 EB009502, R01 EB009910, DP2 DK083099 and U01 AI089316.
CR ADAMS DO, 1989, IMMUNOL TODAY, V10, P33, DOI 10.1016/0167-5699(89)90298-3
   Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274
   Akima S, 2009, AM J TRANSPLANT, V9, P1533, DOI 10.1111/j.1600-6143.2009.02673.x
   Al Ghofaili K, 2007, TRANSPLANTATION, V83, P24, DOI 10.1097/01.tp.0000251379.46596.2d
   Arnush M, 1998, J IMMUNOL, V160, P2684
   Aviles MO, 2010, BIOMATERIALS, V31, P1140, DOI 10.1016/j.biomaterials.2009.10.035
   Balamurugan AN, 2003, PANCREAS, V26, P279, DOI 10.1097/00006676-200304000-00012
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
   Battaglia M, 2006, DIABETES, V55, P40, DOI 10.2337/diabetes.55.01.06.db05-0613
   Beck J, 2007, TISSUE ENG, V13, P589, DOI 10.1089/ten.2006.0183
   Belkaid Y, 2007, NAT REV IMMUNOL, V7, P875, DOI 10.1038/nri2189
   Bennet W, 2000, UPSALA J MED SCI, V105, P125, DOI 10.1517/03009734000000059
   Berman DM, 2009, AM J TRANSPLANT, V9, P91, DOI 10.1111/j.1600-6143.2008.02489.x
   Berman DM, 2010, DIABETES, V59, P2558, DOI 10.2337/db10-0136
   Blomeier H, 2006, TRANSPLANTATION, V82, P452, DOI 10.1097/01.tp.0000231708.19937.21
   Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084
   BRALEYMULLEN H, 1980, CELL IMMUNOL, V51, P408, DOI 10.1016/0008-8749(80)90272-5
   CASSATELLA MA, 1993, J EXP MED, V178, P2207, DOI 10.1084/jem.178.6.2207
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141
   Contreras JL, 2004, DIABETES, V53, P2804, DOI 10.2337/diabetes.53.11.2804
   Contreras JL, 2008, XENOTRANSPLANTATION, V15, P99, DOI 10.1111/j.1399-3089.2008.00461.x
   CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731
   Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084
   Cui W, 2009, AM J TRANSPLANT, V9, P1308, DOI 10.1111/j.1600-6143.2009.02652.x
   Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838
   DUA HS, 1992, CELL IMMUNOL, V139, P292, DOI 10.1016/0008-8749(92)90072-W
   Dufour JM, 2007, CELL TRANSPLANT, V16, P1029, DOI 10.3727/000000007783472417
   Echeverria GJ, 2009, AM J TRANSPLANT, V9, P2485, DOI 10.1111/j.1600-6143.2009.02815.x
   Fu FM, 1996, TRANSPLANTATION, V62, P659, DOI 10.1097/00007890-199609150-00021
   Gangemi A, 2008, AM J TRANSPLANT, V8, P1250, DOI 10.1111/j.1600-6143.2008.02234.x
   Garrovillo M, 1999, TRANSPLANTATION, V68, P1827, DOI 10.1097/00007890-199912270-00001
   Giannoukakis N, 2000, GENE THER, V7, P2015, DOI 10.1038/sj.gt.3301333
   Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978
   Hering B, 2010, AM J TRANSPLANT, V10, P141
   Hering BJ, 2009, TRANSPL IMMUNOL, V21, P81, DOI 10.1016/j.trim.2009.05.001
   Hering BJ, 2005, JAMA-J AM MED ASSOC, V293, P830, DOI 10.1001/jama.293.7.830
   HILLER WFA, 1991, DIABETES, V40, P134, DOI 10.2337/diabetes.40.1.134
   Hiscox AM, 2008, TISSUE ENG PT A, V14, P433, DOI 10.1089/tea.2007.0099
   Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660
   Johansson M, 2009, ENDOCRINOLOGY, V150, P1646, DOI 10.1210/en.2008-1318
   Kaido T, 2004, J BIOL CHEM, V279, P53762, DOI 10.1074/jbc.M411202200
   Kheradmand T, 2011, BIOMATERIALS, V32, P4517, DOI 10.1016/j.biomaterials.2011.03.009
   Kimura F, 2002, DIABETOLOGIA, V45, P831, DOI 10.1007/s00125-002-0844-3
   Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65
   Lau J, 2009, TRANSPLANTATION, V87, P322, DOI 10.1097/TP.0b013e3181943b3d
   Lee Y, 2007, DIABETES, V56, P2295, DOI 10.2337/db07-0460
   Lim JY, 2009, ACTA DIABETOL, V46, P243, DOI 10.1007/s00592-008-0073-4
   Luo XR, 2008, P NATL ACAD SCI USA, V105, P14527, DOI 10.1073/pnas.0805204105
   Luo XR, 2007, P NATL ACAD SCI USA, V104, P2821, DOI 10.1073/pnas.0611646104
   Maccario R, 2005, HAEMATOL-HEMATOL J, V90, P516
   Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233
   Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391
   Miller SD, 2007, NAT REV IMMUNOL, V7, P665, DOI 10.1038/nri2153
   Murua A, 2008, J CONTROL RELEASE, V132, P76, DOI 10.1016/j.jconrel.2008.08.010
   NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7
   Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629
   Nanji SA, 2004, BIODRUGS, V18, P315, DOI 10.2165/00063030-200418050-00004
   Nano R, 2005, DIABETOLOGIA, V48, P906, DOI 10.1007/s00125-005-1725-3
   Noguchi H, 2010, CURR DIABETES REV, V6, P184, DOI 10.2174/157339910791162934
   Olson JK, 2001, VIRAL IMMUNOL, V14, P227, DOI 10.1089/088282401753266756
   Olsson R, 2006, TRANSPLANTATION, V82, P340, DOI 10.1097/01.tp.0000229418.60236.87
   Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423
   Papeta N, 2007, TRANSPLANTATION, V83, P174, DOI 10.1097/01.tp.0000250658.00925.c8
   PEARSON TC, 1992, TRANSPLANTATION, V54, P475, DOI 10.1097/00007890-199209000-00018
   Perez VL, 2011, DIABETOLOGIA, V54, P1121, DOI 10.1007/s00125-011-2091-y
   Perez-Basterrechea M, 2009, TISSUE ENG PT A, V15, P569, DOI 10.1089/ten.tea.2008.0088
   Piccirillo CA, 2004, TRENDS IMMUNOL, V25, P374, DOI 10.1016/j.it.2004.04.009
   Pinkse GGM, 2006, DIABETES, V55, P312, DOI 10.2337/diabetes.55.02.06.db04-0195
   Pollauf EJ, 2005, J PHARM SCI-US, V94, P2013, DOI 10.1002/jps.20408
   Posselt AM, 2010, AM J TRANSPLANT, V10, P1870, DOI 10.1111/j.1600-6143.2010.03073.x
   Pothoven KL, 2010, AM J TRANSPLANT, V10, P1774, DOI 10.1111/j.1600-6143.2010.03199.x
   Punch JD, 1998, J IMMUNOL, V161, P1156
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI 10.1038/nbtl332
   Rivas-Carrillo JD, 2007, DIABETES, V56, P1259, DOI 10.2337/db06-1679
   Rives CB, 2009, BIOMATERIALS, V30, P394, DOI 10.1016/j.biomaterials.2008.09.013
   Salvay DM, 2008, TRANSPLANTATION, V85, P1456, DOI 10.1097/TP.0b013e31816fc0ea
   Sato K, 2003, IMMUNITY, V18, P367, DOI 10.1016/S1074-7613(03)00055-4
   Sato K, 2003, BLOOD, V101, P3581, DOI 10.1182/blood-2002-09-2712
   Shapiro AMJ, 2005, THER DRUG MONIT, V27, P35, DOI 10.1097/00007691-200502000-00008
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010
   Shields JD, 2010, SCIENCE, V328, P749, DOI 10.1126/science.1185837
   Soedamah-Muthu SS, 2006, DIABETOLOGIA, V49, P660, DOI 10.1007/s00125-005-0120-4
   Song HJ, 2010, TRANSPL P, V42, P2662, DOI 10.1016/j.transproceed.2010.06.003
   Sun L, 2009, AM J RESP CELL MOL, V41, P76, DOI 10.1165/rcmb.2008-0202OC
   Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1016/S0039-6060(99)70169-8
   TZE WJ, 1989, TRANSPLANTATION, V47, P1053, DOI 10.1097/00007890-198906000-00027
   van Duivenvoorde LM, 2006, IMMUNOBIOLOGY, V211, P627, DOI 10.1016/j.imbio.2006.05.014
   Vandenbark AA, 1996, J NEUROSCI RES, V45, P430
   Viney JL, 1998, J IMMUNOL, V160, P5815
   Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181
   Wang WJ, 2002, TRANSPLANTATION, V73, P122, DOI 10.1097/00007890-200201150-00023
   Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052
   WHITTINGTON KB, 1991, ENDOCRINOLOGY, V128, P2671, DOI 10.1210/endo-128-6-2671
   Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027
   Xu LK, 2001, CELL IMMUNOL, V208, P107, DOI 10.1006/cimm.2001.1777
   Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022
   Zheng XX, 1999, J IMMUNOL, V162, P4983
NR 100
TC 54
Z9 54
U1 0
U2 42
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0012-186X
EI 1432-0428
J9 DIABETOLOGIA
JI Diabetologia
PD OCT
PY 2011
VL 54
IS 10
BP 2494
EP 2505
DI 10.1007/s00125-011-2243-0
PG 12
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 817OF
UT WOS:000294683000004
PM 21830149
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Revaux, A
   Roupret, M
   Seringe, E
   Misrai, V
   Cour, F
   Chartier-Kastler, E
AF Revaux, Aurelie
   Roupret, Morgan
   Seringe, Elise
   Misrai, Vincent
   Cour, Florence
   Chartier-Kastler, Emmanuel
TI Is the implantation of an artificial urinary sphincter with a large cuff
   in women with severe urinary incontinence associated with worse
   perioperative complications and functional outcomes than usual?
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Article
DE Urinary incontinence; Artificial device; Urinary sphincter; Biomaterial
ID MANAGEMENT
AB As the subsequent risks of complications and explantation increase with the size of the cuff, we aimed to assess functional outcomes after the implantation of an artificial urinary sphincter (AUS) with a large cuff (a parts per thousand yen8 cm) in women with severe urinary incontinence.
   Fifty women underwent an AUS placement with a large cuff between 1984 and 2007. Forty-three (86%) had previously undergone anti-incontinence procedures. The AUS was implanted with an open surgical technique using a transverse abdominal approach. The cuff was placed around the bladder neck between the periurethral fascia and the vagina. Perioperative complications were reviewed. To assess the resolution of urinary incontinence, all patients were seen at 1, 3, 6 and 12 months and yearly thereafter.
   The mean age was 59 +/- 12.4 years (26-81). The mean BMI was 27.3 +/- 5.1 (19-37). The mean pre-operative closure pressure was 19.1 +/- 9.4 cmH(2)O (3-46). The mean hospital stay was 14.1 +/- 5 days (5-28). The mean follow-up was 8 +/- 5.6 years. Incontinence was completely resolved in 34 women (68%). The protective factors to avoid explantation were a number of gestations less than two (p = 0.04), a closure pressure higher than 19 cmH(2)O (p = 0.04) and a cuff size equivalent to 8 cm (p = 0.005).
   Specific anatomical conditions can sometimes lead to AUS implantation with a large cuff with encouraging outcomes. Thus, surgeons should not be reluctant to place a large cuff when the situation requires it.
C1 [Roupret, Morgan] Univ Paris 06, Hosp Pitie Salpetriere, Fac Med Pierre & Marie Curie, Grp Hosp Univ EST,AP HP,Acad Dept Urol, F-75013 Paris, France.
   [Seringe, Elise] Univ Paris 06, Fac Med Pierre & Marie Curie, Hosp Pitie Salpetriere, Grp Hosp Univ EST,AP HP,Dept Stat, Paris, France.
RP Roupret, M (reprint author), Univ Paris 06, Hosp Pitie Salpetriere, Fac Med Pierre & Marie Curie, Grp Hosp Univ EST,AP HP,Acad Dept Urol, 47-83 Blvd Hop, F-75013 Paris, France.
EM morgan.roupret@psl.aphp.fr
CR APPELL RA, 1988, NEUROUROL URODYNAM, V7, P613, DOI 10.1002/nau.1930070611
   Costa P, 2001, J UROLOGY, V165, P1172, DOI 10.1016/S0022-5347(05)66459-2
   DIOKNO AC, 1987, J UROLOGY, V138, P778, DOI 10.1016/S0022-5347(17)43370-2
   DONOVAN MG, 1985, SURG GYNECOL OBSTET, V161, P17
   DUNCAN HJ, 1992, BRIT J UROL, V69, P141, DOI 10.1111/j.1464-410X.1992.tb15484.x
   Lee R, 2009, J UROLOGY, V181, P2622, DOI 10.1016/j.juro.2009.01.113
   LIGHT JK, 1985, J UROLOGY, V134, P476, DOI 10.1016/S0022-5347(17)47245-4
   Mandron E, 2010, BJU INT, V106, P1194, DOI 10.1111/j.1464-410X.2010.09206.x
   Papatsoris AG, 2007, AGING CLIN EXP RES, V19, P334
   Petero VG, 2006, J UROLOGY, V175, P605, DOI 10.1016/S0022-5347(05)00243-0
   Petrou SP, 2000, UROLOGY, V56, P353, DOI 10.1016/S0090-4295(00)00683-X
   Richard Francois, 1996, Journal of Urology, V155, p703A
   Roupret M, 2005, PROG UROL, V15, P489
   Roupret M, 2010, EUR UROL, V57, P499, DOI 10.1016/j.eururo.2009.03.045
   Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066
   Thomas K, 2002, J UROLOGY, V167, P1720, DOI 10.1016/S0022-5347(05)65185-3
   Venn SN, 2000, J UROLOGY, V164, P702, DOI 10.1016/S0022-5347(05)67285-0
   Venn SN, 2000, J UROLOGY, V164, P706
   WEBSTER GD, 1992, UROLOGY, V39, P499, DOI 10.1016/0090-4295(92)90001-D
NR 19
TC 6
Z9 6
U1 0
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD OCT
PY 2011
VL 22
IS 10
BP 1319
EP 1324
DI 10.1007/s00192-011-1425-0
PG 6
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 817PR
UT WOS:000294686800017
PM 21528393
DA 2018-10-20
ER

PT J
AU Fosso-Kankeu, E
   Mulaba-Bafubiandi, AF
   Mamba, BB
   Barnard, TG
AF Fosso-Kankeu, E.
   Mulaba-Bafubiandi, A. F.
   Mamba, B. B.
   Barnard, T. G.
TI Prediction of metal-adsorption behaviour in the remediation of water
   contamination using indigenous microorganisms
SO JOURNAL OF ENVIRONMENTAL MANAGEMENT
LA English
DT Article
DE Mine wastewater; Heavy metals; Light metals; Binding affinity;
   Biosorbent behaviour; Adsorption kinetics
ID SACCHAROMYCES-CEREVISIAE; HEAVY-METALS; BIOSORPTION EQUILIBRIA; PB(II);
   REMOVAL; BIOMASS; CELLS
AB In recent years, the adsorption of heavy metal cations onto bacterial surfaces has been studied extensively. This paper reports the findings of a study conducted on the heavy metal ions found in mine effluents from a mining plant where Co2+ and Ni2+ bearing minerals are processed. Heavy metal ions are reported to be occasionally present in these mine effluents, and the proposed microbial sorption technique offers an acceptable solution for the removal of these heavy metals. The sorption affinity of microorganisms for metal ions can be used to select a suitable microbial sorbent for any particular bioremediation process. Interactions of heavy metal ions (Co2+ and Ni2+) and light metal ions (Mg2+ and Ca2+) with indigenous microbial cells (Brevundimonas spp., Bacillaceae bacteria and Pseudomonas aeruginosa) were investigated using the Langmuir adsorption isotherm, pseudo second-order reaction kinetics model and a binary-metal system. Equilibrium constants and adsorption capacities derived from these models allowed delineation of the effect of binding affinity and metal concentration ratios on the overall adsorption behaviour of microbial sorbents, as well as prediction of performance in bioremediation systems. Although microbial sorbents used in this study preferentially bind to heavy metal ions, it was observed that higher concentrations (>90 mg/l) of light metal ions in multi-metal solutions inhibit the adsorption of heavy metal ions to the bacterial cell wall. However, the microbial sorbents reduced Ni2+ levels in the mine-water used (93-100% Ni2+ removal) to below the maximum acceptable limit of 350 mu g/l, established by the South African Bureau of Standards. Competition among metal ions for binding sites on the biomaterial surface can occur during the bioremediation process, but microbial sorption affinity for heavy metal ions can enhance their remediation in dilute (<5 mg/l heavy metal) wastewaters. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Fosso-Kankeu, E.; Mulaba-Bafubiandi, A. F.] Univ Johannesburg, Fac Engn & Built Environm, Dept Met, Minerals Proc & Technol Res Ctr, ZA-2050 Wits, Johannesburg, South Africa.
   [Mamba, B. B.] Univ Johannesburg, Fac Sci, Dept Chem Technol, Johannesburg, South Africa.
   [Barnard, T. G.] Univ Johannesburg, Fac Hlth Sci, Water & Hlth Res Ctr, Johannesburg, South Africa.
RP Fosso-Kankeu, E (reprint author), Univ Johannesburg, Fac Engn & Built Environm, Dept Met, Minerals Proc & Technol Res Ctr, POB 526, ZA-2050 Wits, Johannesburg, South Africa.
EM elvisf@uj.ac.za
RI Mamba, Bhekie/P-4940-2014
OI Mamba, Bhekie/0000-0003-2534-2579
FU National Research Foundation (NRF-under the profile MULI-I); University
   of Johannesburg (Faculty of Engineering and the Built Environment)
FX Funding for this project received from the National Research Foundation
   (NRF-under the profile MULI-I) and the University of Johannesburg
   (Faculty of Engineering and the Built Environment) is gratefully
   acknowledged. Mine-water used in this study is from Nkomati Nickel Mines
   (South Africa). The authors are grateful to Mintek (South Africa) for
   their contribution to the SEM study.
CR Allen J. A., 1995, J CHEM TECHNOL BIOT, V62, P17
   Baysal Z, 2009, J HAZARD MATER, V161, P62, DOI 10.1016/j.jhazmat.2008.02.122
   Bishop P. L., 2002, POLLUTION PREVENTION
   BRADY D, 1994, BIOTECHNOL LETT, V16, P543, DOI 10.1007/BF01023341
   BRADY D, 1994, ENZYME MICROB TECH, V16, P633, DOI 10.1016/0141-0229(94)90131-7
   Cabuk A, 2006, J HAZARD MATER, V136, P317, DOI 10.1016/j.jhazmat.2005.12.019
   Choi J, 2009, J HAZARD MATER, V161, P157, DOI 10.1016/j.jhazmat.2008.03.065
   CHONG KH, 1995, BIOTECHNOL BIOENG, V47, P451, DOI 10.1002/bit.260470406
   Ferraz AI, 1999, BIOPROCESS ENG, V21, P431, DOI 10.1007/PL00009083
   Fosso-Kankeu E, 2010, PHYS CHEM EARTH, V35, P672, DOI 10.1016/j.pce.2010.07.008
   Fosso-Kankeu E, 2009, PHYS CHEM EARTH, V34, P825, DOI 10.1016/j.pce.2009.07.005
   Gabr RM, 2008, INT BIODETER BIODEGR, V62, P195, DOI 10.1016/j.ibiod.2008.01.008
   Hassan SHA, 2008, J BASIC MICROB, V48, P168, DOI 10.1002/jobm.200700338
   Liu R.X., 2002, PROGR CHEM, V14, P187
   MATTUSCHKA B, 1993, J CHEM TECHNOL BIOT, V58, P57
   Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457
   Pauling L, 1932, J AM CHEM SOC, V54, P3570, DOI 10.1021/ja01348a011
   Roane TM, 2000, ENVIRON MICROBIOL, P403
   SABS (South African Bureau of Standards), 2005, 241 SABS SANS
   Sadler WR, 1967, MINER DEPOSITA, V2, P158
   Sag Y, 2002, SEPAR SCI TECHNOL, V37, P279, DOI 10.1081/SS-120000789
   Stumm W., 1996, AQUATIC CHEM
   Van Vuuren L., 2007, WATER WHEEL, V6, P30
   Vijver MG, 2004, ENVIRON SCI TECHNOL, V38, P4705, DOI 10.1021/es040354g
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Wang JL, 2006, BIOTECHNOL ADV, V24, P427, DOI 10.1016/j.biotechadv.2006.03.001
   Yahaya YA, 2009, J HAZARD MATER, V161, P189, DOI 10.1016/j.jhazmat.2008.03.104
NR 27
TC 24
Z9 25
U1 4
U2 36
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0301-4797
EI 1095-8630
J9 J ENVIRON MANAGE
JI J. Environ. Manage.
PD OCT
PY 2011
VL 92
IS 10
BP 2786
EP 2793
DI 10.1016/j.jenvman.2011.06.025
PG 8
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA 816GE
UT WOS:000294585900052
PM 21737198
DA 2018-10-20
ER

PT J
AU Huang, GS
   Dai, LG
   Yen, BL
   Hsu, SH
AF Huang, Guo-Shiang
   Dai, Lien-Guo
   Yen, Betty L.
   Hsu, Shan-hui
TI Spheroid formation of mesenchymal stem cells on chitosan and
   chitosan-hyaluronan membranes
SO BIOMATERIALS
LA English
DT Article
DE MSC; Hyaluronan; Spheroid; Sternness gene; Chondrogenesis
ID MULTIPOTENT CELLS; HUMAN PLACENTA; CHONDROGENIC DIFFERENTIATION; STROMAL
   CELLS; IN-VITRO; CULTURE-SYSTEM; SELF-RENEWAL; ADIPOSE; SCAFFOLDS; ADULT
AB Stem cells can lose their primitive properties during in vitro culture. The culture substrate may affect the behavior of stem cells as a result of cell substrate interaction. The maintenance of self-renewal for adult human mesenchymal stem cells (MSCs) by a biomaterial substrate, however, has not been reported in literature. In this study, MSCs isolated from human adipose (hADAS) and placenta (hPDMC) were cultured on chitosan membranes and those further modified by hyaluronan (chitosan-HA). It was observed that the MSCs of either origin formed three-dimensional spheroids that kept attached on the membranes. Spheroid formation was associated with the increased MMP-2 expression. Cells on chitosan-HA formed spheroids more quickly and the size of spheroids were larger than on chitosan alone. The expression of sternness marker genes (Oct4, Sox2, and Nanog) for MSCs on the materials was analyzed by the real-time RT-PCR. It was found that formation of spheroids on chitosan and chitosan-HA membranes helped to maintain the expression of sternness marker genes of MSCs compared to culturing cells on polystyrene dish. The maintenance of sternness marker gene expression was especially remarkable in hPDMC spheroids (vs. hADAS spheroids). Blocking CD44 by antibodies prevented the spheroid formation and decreased the sternness gene expression moderately; while treatment by Y-27632 compound inhibited the spheroid formation and significantly decreased the stemness gene expression. Upon chondrogenic induction, the MSC spheroids showed higher levels of Sox9, aggrecan, and collagen type 11 gene expression and were stained positive for glycosaminoglycan and collagen type II. hPDMC had better chondrogenic differentiation potential than hADAS upon induction. Our study suggested that the formation of adhered spheroids on chitosan and chitosan-HA membranes may sustain the expression of sternness marker genes of MSCs and increase their chondrogenic differentiation capacity. The Rho/Rho-associated kinase (ROCK) signaling pathway may be involved in spheroid formation. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Huang, Guo-Shiang; Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
   [Dai, Lien-Guo] Kuang Tien Gen Hosp, Dept Orthoped, Taichung, Taiwan.
   [Dai, Lien-Guo] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
   [Yen, Betty L.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan.
   [Hsu, Shan-hui] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10617, Taiwan.
   [Hsu, Shan-hui] Natl Chung Hsing Univ, Inst Biomed Engn, Taichung 40227, Taiwan.
RP Hsu, SH (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4,Roosevelt Rd, Taipei 10617, Taiwan.
EM shhsu@ntu.edu.tw
RI Yen, B. Lin-Ju/B-1088-2010
OI Hsu, Shan-hui/0000-0003-3399-055X
FU National Science Council of Taiwan, R.O.C.
FX This work was supported by National Science Council of Taiwan, R.O.C.
CR Abraham S, 2009, REGEN MED, V4, P561, DOI [10.2217/rme.09.23, 10.2217/RME.09.23]
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   Baer PC, 2010, CYTOTHERAPY, V12, P96, DOI 10.3109/14653240903377045
   Bartosh TJ, 2010, P NATL ACAD SCI USA, V107, P13724, DOI 10.1073/pnas.1008117107
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200
   BRAFMAN DA, BIOMATERIALS, V31, P9135
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Cancedda R, 2000, INT J DEV BIOL, V44, P707
   Chang CJ, 2006, STEM CELLS, V24, P2466, DOI 10.1634/stemcells.2006-0071
   Chang JC, 2008, BIOMATERIALS, V29, P925, DOI 10.1016/j.biomaterials.2007.10.046
   Chang JC, 2009, BIOMATERIALS, V30, P6265, DOI 10.1016/j.biomaterials.2009.07.064
   Chiao E, 2008, METHOD CELL BIOL, V86, P1, DOI 10.1016/S0091-679X(08)00001-0
   Chien CC, 2006, STEM CELLS, V24, P1759, DOI 10.1634/stemcells.2005-0521
   CHOU MT, BIOMATERIALS, V31, P4367
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Estes BT, 2010, NAT PROTOC, V5, P1294, DOI 10.1038/nprot.2010.81
   Fortunel NO, 2003, SCIENCE, V302, P393
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Griffon DJ, 2006, ACTA BIOMATER, V2, P313, DOI 10.1016/j.actbio.2005.12.007
   Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001
   Heydarkhan-Hagvall S, 2008, BIOMATERIALS, V29, P2907, DOI 10.1016/j.biomaterials.2008.03.034
   Hwang NS, 2006, BIOMATERIALS, V27, P6015, DOI 10.1016/j.biomaterials.2006.06.033
   Jung Y, 2009, BIOMATERIALS, V30, P4657, DOI 10.1016/j.biomaterials.2009.05.034
   Kim SY, 2009, TISSUE ENG REGEN MED, V6, P595
   Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951
   Lee ST, 2010, BIOMATERIALS, V31, P1219, DOI 10.1016/j.biomaterials.2009.10.054
   Lisignoli G, 2005, BIOMATERIALS, V26, P5677, DOI 10.1016/j.biomaterials.2005.02.031
   Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   MAHMOUDIFAR N, BIOMATERIALS, V31, P3858
   Martinez-Diaz S, 2010, AM J SPORT MED, V38, P509, DOI 10.1177/0363546509352448
   Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009
   Miyagawa Y, 2011, TISSUE ENG PT A, V17, P513, DOI 10.1089/ten.TEA.2009.0810
   Montesinos JJ, 2009, CYTOTHERAPY, V11, P163, DOI 10.1080/14653240802582075
   Nur E. K. A., 2006, STEM CELLS, V24, P426, DOI DOI 10.1634/STEMCELLS.2005-0170)
   Quintana L, 2009, TISSUE ENG PART B-RE, V15, P29, DOI 10.1089/ten.teb.2008.0329
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9
   Sokolov MV, 2010, GENE, V455, P8, DOI 10.1016/j.gene.2010.01.006
   Tang SQ, 2007, BIOMED MATER, V2, pS135, DOI 10.1088/1748-6041/2/3/S10
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   TORRE C, ARCH OTOLARYNGOL HEA, V136, P493
   Wang WJ, 2009, BIOMATERIALS, V30, P2705, DOI 10.1016/j.biomaterials.2009.01.030
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Whu SW, 2009, J MED BIOL ENG, V29, P52
   Wu CC, 2008, J BIOMECH, V41, P813, DOI 10.1016/j.jbiomech.2007.11.008
   WU SC, BIOMATERIALS, V31, P631
   Ye C, 2009, BIOMATERIALS, V30, P4401, DOI 10.1016/j.biomaterials.2009.05.001
   Yen BL, 2008, TISSUE ENG PT A, V14, P9, DOI 10.1089/ten.a.2006.0352
   Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Zavan B, 2010, NEUROL RES, V32, P47, DOI 10.1179/174313209X385743
   Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020
   Zhang XH, 2006, BIOCHEM BIOPH RES CO, V340, P944, DOI 10.1016/j.bbrc.2005.12.091
NR 56
TC 97
Z9 101
U1 5
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2011
VL 32
IS 29
BP 6929
EP 6945
DI 10.1016/j.biomaterials.2011.05.092
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 815FZ
UT WOS:000294512800007
PM 21762982
DA 2018-10-20
ER

PT J
AU Nguyen, LH
   Kudva, AK
   Saxena, NS
   Roy, K
AF Nguyen, Lonnissa H.
   Kudva, Abhijith K.
   Saxena, Neha S.
   Roy, Krishnendu
TI Engineering articular cartilage with spatially-varying matrix
   composition and mechanical properties from a single stem cell population
   using a multi-layered hydrogel
SO BIOMATERIALS
LA English
DT Article
DE Hydrogels; Layer-by-layer; Bone marrow stem cells; Articular cartilage;
   Composite tissue engineering
ID BONE-MARROW; CHONDROGENIC DIFFERENTIATION; CHONDROITIN SULFATE;
   CHONDROCYTES; SCAFFOLDS; COLLAGEN; MODULUS
AB Despite significant advances in stem cell differentiation and tissue engineering, directing progenitor cells into three-dimensionally (3D) organized, native-like complex structures with spatially-varying mechanical properties and extra-cellular matrix (ECM) composition has not yet been achieved. The key innovations needed to achieve this would involve methods for directing a single stem cell population into multiple, spatially distinct phenotypes or lineages within a 3D scaffold structure. We have previously shown that specific combinations of natural and synthetic biomaterials can direct marrow-derived stem cells (MSC) into varying phenotypes of chondrocytes that resemble cells from the superficial, transitional, and deep zones of articular cartilage. In this current study, we demonstrate that layer-by-layer organization of these specific biomaterial compositions creates 3D niches that allow a single MSC population to differentiate into zone-specific chondrocytes and organize into a complex tissue structure. Our results indicate that a three-layer polyethylene glycol (PEG)-based hydrogel with chondroitin sulfate (CS) and matrix metalloproteinase-sensitive peptides (MMP-pep) incorporated into the top layer (superficial zone, PEG:CS:MMP-pep), CS incorporated into the middle layer (transitional zone, PEG:CS) and hyaluronic acid incorporated in the bottom layer (deep zone, PEG:HA), creates native-like articular cartilage with spatially-varying mechanical and biochemical properties. Specifically, collagen II levels decreased gradually from the superficial to the deep zone, while collagen X and proteoglycan levels increased, leading to an increasing gradient of compressive modulus from the superficial to the deep zone. We conclude that spatially-varying biomaterial compositions within single 3D scaffolds can stimulate efficient regeneration of multi-layered complex tissues from a single stem cell population. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Nguyen, Lonnissa H.; Kudva, Abhijith K.; Saxena, Neha S.; Roy, Krishnendu] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP Roy, K (reprint author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
EM kroy@mail.utexas.edu
CR ARMSTRONG CG, 1982, J BONE JOINT SURG AM, V64, P88, DOI 10.2106/00004623-198264010-00013
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025
   Boschetti F, 2008, BIORHEOLOGY, V45, P337, DOI 10.3233/BIR-2008-0479
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Dahir GA, 2000, CLIN ORTHOP RELAT R, pS134
   Einhorn T.A., 2007, ORTHOPAEDIC BASIC SC
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   EYRE DR, 1983, FEBS LETT, V158, P265, DOI 10.1016/0014-5793(83)80592-4
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   HALL BK, 2005, BONES CARTILAGE DEV
   KLEIN TJ, 2009, TISSUE ENG B
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee HJ, 2006, BIOMATERIALS, V27, P5268, DOI 10.1016/j.biomaterials.2006.06.001
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Ng KW, 2009, TISSUE ENG PT A, V15, P2315, DOI 10.1089/ten.tea.2008.0391
   Nguyen LH, 2011, BIOMATERIALS, V32, P1327, DOI 10.1016/j.biomaterials.2010.10.009
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x
   ROSENER B, 2006, FUNDAMENTALS BIOSTAT
   Schinagl RM, 1997, J ORTHOPAED RES, V15, P499, DOI 10.1002/jor.1100150404
   Sharma B, 2007, TISSUE ENG, V13, P405, DOI 10.1089/ten.2006.0068
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259
NR 25
TC 110
Z9 112
U1 7
U2 104
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2011
VL 32
IS 29
BP 6946
EP 6952
DI 10.1016/j.biomaterials.2011.06.014
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 815FZ
UT WOS:000294512800008
PM 21723599
DA 2018-10-20
ER

PT J
AU Zhang, J
   Wang, GY
   Xiao, YP
   Fan, LY
   Wang, Q
AF Zhang, Jian
   Wang, Guan Yu
   Xiao, Yi Pin
   Fan, Lie Ying
   Wang, Qiang
TI The biomechanical behavior and host response to porcine-derived small
   intestine submucosa, pericardium and dermal matrix acellular grafts in a
   rat abdominal defect model
SO BIOMATERIALS
LA English
DT Article
DE Porcine-derived biologic grafts; Small intestine submucosa; Pericardium;
   Dermal matrix; Abdominal defect repair
ID VENTRAL HERNIA REPAIR; EXTRACELLULAR-MATRIX; DIAPHRAGMATIC DEFECTS; WALL
   RECONSTRUCTION; COLLAGEN IMPLANT; MESH; STERILIZATION; ARCHITECTURE;
   BIOMATERIAL; PROSTHESES
AB Several porcine-derived acellular biologic grafts are increasingly used in abdominal wall reconstruction due to the limitations of synthetic meshes in many clinical situations. However, relatively little is known so far about their comparative mechanical characteristics and performance after defect repair. We therefore investigated three most commonly used porcine-derived acellular biomaterials, small intestine submucosa (P-SIS), pericardium (P-PC) and acellular dermal matrix (P-ADM) immediately after prepared, and their effectiveness, biomechanical and histological characteristics in repairing full-thickness abdominal defect in a rat model. P-PC had the best native performance in the burst strength, tensile strength and ball burst among the three porcine-derived scaffolds. P-SIS showed a significantly higher water vapor transmission in comparison with P-PC or P-ADM. Abdominal wall defects in rats were all satisfied repaired with P-SIS, P-PC or P-ADM. No laxity or fistula was observed in the repaired abdominal wall in the P-SIS group up to 8 weeks after surgery. However, there was a tendency for high postoperative abdominal eventration in the P-ADM and P-PC groups as compared with the P-SIS group. With regard to overall aspects of the postoperative laxity, intra-abdominal adhesion formation, tensile stress, stretchability, and degree of tissue ingrowth in terms of collagen deposition and neovascularization, P-SIS exhibits clear advantages over P-PC as well as P-ADM after large abdominal wall defect reconstruction. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zhang, Jian; Wang, Guan Yu; Xiao, Yi Pin; Wang, Qiang] Second Mil Med Univ, Zhabei Dist Cent Hosp, Zhabei Branch Hosp, Shanghai Chang Zheng Hosp,Dept Gen Surg, Shanghai 200072, Peoples R China.
   [Fan, Lie Ying] Tongji Univ, Shanghai E Hosp, Dept Clin Lab, Shanghai 200120, Peoples R China.
RP Wang, Q (reprint author), Second Mil Med Univ, Zhabei Dist Cent Hosp, Zhabei Branch Hosp, Shanghai Chang Zheng Hosp,Dept Gen Surg, 619 Zhong Hua Xin Rd, Shanghai 200072, Peoples R China.
EM wang2929@hotmail.com
RI wang, Qiang/K-4994-2013
FU National Natural Science Foundation of China [30801128]; Shanghai
   Science and Technology Development Fund [10QA1408600]; PLA [08G070,
   2010gxjs060]
FX This study was supported in part by grants from the National Natural
   Science Foundation of China (no. 30801128) (to J.Z.), Shanghai Science
   and Technology Development Fund (10QA1408600) (to J.Z.), and the Medical
   and Health Research Funds of PLA (08G070 and 2010gxjs060) (to Q.W.).
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Ayubi FS, 2008, HERNIA, V12, P373, DOI 10.1007/s10029-008-0359-z
   Blatnik J, 2008, AM J SURG, V196, P47, DOI 10.1016/j.amjsurg.2007.06.035
   Bluebond-Langner R, 2008, ANN PLAS SURG, V60, P76, DOI 10.1097/SAP.0b013e31804efcbc
   BODNAR E, 1986, THORAC CARDIOV SURG, V34, P82, DOI 10.1055/s-2007-1020381
   Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296
   Butler CE, 2004, PLAST RECONSTR SURG, V114, P464, DOI 10.1097/01.PRS.0000132670.81794.7E
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   CLARKE JA, 1987, LANCET, V329, P8539
   Cobb GA, 2005, INT SURG, V90, pS24
   Conze J, 2007, LANGENBECK ARCH SURG, V392, P453, DOI 10.1007/s00423-006-0065-1
   Cook JL, 2008, AM J VET RES, V69, P148, DOI 10.2460/ajvr.69.1.148
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   d'Acampora AJ, 2007, ACTA CIR BRAS, V22, P47, DOI 10.1590/S0102-86502007000100009
   Dufrane D, 2008, BIOMATERIALS, V29, P2237, DOI 10.1016/j.biomaterials.2008.01.027
   Engelsman AF, 2007, BIOMATERIALS, V28, P2314, DOI 10.1016/j.biomaterials.2007.01.028
   Gaertner WB, 2007, J GASTROINTEST SURG, V11, P1275, DOI 10.1007/s11605-007-0242-8
   GALLO JI, 1982, J THORAC CARDIOV SUR, V83, P905
   Gilbert TW, 2006, J BIOMECH ENG-T ASME, V128, P890, DOI 10.1115/1.2354200
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2
   Hammond TM, 2008, BRIT J SURG, V95, P438, DOI 10.1002/bjs.5883
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   HILES M, 2010, GEN SURG NEWS, V37, P26
   Hiles M, 2009, SURG INNOV, V16, P26, DOI 10.1177/1553350609331397
   Hodde J, 2007, J MATER SCI-MATER M, V18, P537, DOI 10.1007/s10856-007-2300-x
   Hodde J, 2007, J MATER SCI-MATER M, V18, P545, DOI 10.1007/s10856-007-2301-9
   Hoeppner J, 2010, WORLD J GASTROENTERO, V16, P4031, DOI 10.3748/wjg.v16.i32.4031
   Hsu PW, 2009, J PLAST RECONSTR AES, V62, P1484, DOI 10.1016/j.bjps.2008.04.060
   Jin J, 2007, J AM COLL SURGEONS, V205, P654, DOI 10.1016/j.jamcollsurg.2007.06.012
   Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003
   Junge K, 2009, SURG ENDOSC, V23, P327, DOI 10.1007/s00464-008-9923-y
   Klinge U, 1996, LANGENBECK ARCH CHIR, V381, P323
   Kumar N, 2002, J VET MED A, V49, P161, DOI 10.1046/j.1439-0442.2002.00424.x
   Lomas R. J., 2004, Cell and Tissue Banking, V5, P149, DOI 10.1023/B:CATB.0000046071.11459.bd
   Macleod TM, 2005, BRIT J PLAST SURG, V58, P518, DOI 10.1016/j.bjps.2004.12.012
   Melman L, 2011, HERNIA, V15, P157, DOI 10.1007/s10029-010-0770-0
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   Reilingh TSD, 2003, J AM COLL SURGEONS, V196, P32, DOI 10.1016/S1072-7515(02)01478-3
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   RODGERS BM, 1981, ANN SURG, V193, P606, DOI 10.1097/00000658-198105000-00010
   Braga-Vilela AS, 2008, J MEMBRANE BIOL, V221, P15, DOI 10.1007/s00232-007-9081-5
   Saxena A, 2009, CARBOHYD POLYM, V78, P357, DOI 10.1016/j.carbpol.2009.03.039
   SHAPIRO SD, 1991, J CLIN INVEST, V87, P1828, DOI 10.1172/JCI115204
   Silverman R P, 2004, Hernia, V8, P336, DOI 10.1007/s10029-004-0241-6
   Torres-Villalobos G, 2010, JSLS-J SOC LAPAROEND, V14, P95, DOI 10.4293/108680810X12674612014824
   Trevino J M, 2006, Hernia, V10, P253, DOI 10.1007/s10029-006-0085-3
   WALKER AP, 1993, J SURG RES, V55, P32, DOI 10.1006/jsre.1993.1104
   Westerhoff M, 2010, AM J SURG PATHOL, V34, P494, DOI 10.1097/PAS.0b013e3181d38f0a
   Zhou HY, 2011, ANN SURG, V253, P1033, DOI 10.1097/SLA.0b013e31821260f3
NR 50
TC 26
Z9 27
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2011
VL 32
IS 29
BP 7086
EP 7095
DI 10.1016/j.biomaterials.2011.06.016
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 815FZ
UT WOS:000294512800023
PM 21741703
DA 2018-10-20
ER

PT J
AU Di, WH
   Ren, XG
   Zhao, HF
   Shirahata, N
   Sakka, Y
   Qin, WP
AF Di, Weihua
   Ren, Xinguang
   Zhao, Haifeng
   Shirahata, Naoto
   Sakka, Yoshio
   Qin, Weiping
TI Single-phased luminescent mesoporous nanoparticles for simultaneous cell
   imaging and anticancer drug delivery
SO BIOMATERIALS
LA English
DT Article
DE Lanthanide oxides; Mesopore; Luminescence; Cell imaging; Drug delivery;
   Cytotoxicity
ID UP-CONVERSION LUMINESCENCE; FLUORESCENT; GADOLINIUM; PRECIPITATION;
   NANOSPHERES; PARTICLES; CARRIERS; EUROPIUM; SPHERES; SHELL
AB Multifunctional materials for biological use have mostly been designed with composite or hybrid nanostructures in which two or more components are incorporated. The present work reports on a multifunctional biomaterial based on single-phased luminescent mesoporous lanthanide oxide nanoparticles that combine simultaneous drug delivery and cell imaging. A simple strategy based on solid-state-chemistry thermal decomposition process was employed to fabricate the spherical mesoporous Gd2O3:Eu nanoparticles with homogeneous size distribution. The porous nanoparticles developed by this strategy possess well-defined mesopores, large pore size and volume, and high specific surface area. The mesoporous features of nanoparticles impart the material with capabilities of loading and releasing the drug with a relatively high loading efficiency and a sustained release behavior of drugs. The DOX-loaded porous Gd2O3 nanoparticles are able to kill the cancer cells efficiently upon incubation with the human cervical carcinoma (HeLa) cells, indicating the potential for treatment of cancer cells. Meanwhile, the intrinsic luminescence of Gd2O3:Eu nanoparticles gives the function of optical imaging. Therefore, the drug release activity and effect of drugs on the cells can be effectively monitored via luminescence of nanoparticles themselves, realizing multifunctionality of simultaneous cell imaging and anticancer drug delivery in a single-phased nanoparticle. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Di, Weihua; Qin, Weiping] Jilin Univ, Coll Elect Sci & Engn, State Key Lab Integrated Optoelect, Changchun 130012, Peoples R China.
   [Di, Weihua; Sakka, Yoshio] Natl Inst Mat Sci, World Premier Int Res WPI Ctr Initiat Mat Nanoarc, Tsukuba, Ibaraki 3050047, Japan.
   [Di, Weihua; Shirahata, Naoto; Sakka, Yoshio] Natl Inst Mat Sci, Adv Mat Proc Unit, Adv Ceram Grp, Tsukuba, Ibaraki 3050047, Japan.
   [Ren, Xinguang; Zhao, Haifeng] Chinese Acad Sci, Changchun Inst Opt Fine Mech & Phys, Key Lab Excited State Proc, Changchun 130033, Peoples R China.
   [Shirahata, Naoto] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan.
RP Di, WH (reprint author), Jilin Univ, Coll Elect Sci & Engn, State Key Lab Integrated Optoelect, Changchun 130012, Peoples R China.
EM weihdi@yahoo.com.cn; SAKKA.Yoshio@nims.go.jp; wpqin@jlu.edu.cn
RI Shirahata, Naoto/D-7866-2011
OI Sakka, Yoshio/0000-0001-8357-5843; Qin, Weiping/0000-0002-5763-5846
FU JSPS; World Premier International Research (WPI) Center Initiative on
   Materials Nanoarchitronics (MANA), MEXT, Japan; National High Technology
   Research and Development Program of China (863 program) [2009AA03Z309]
FX This study was partly supported by the Grant-in Aid for Scientific
   Research of the JSPS and the World Premier International Research (WPI)
   Center Initiative on Materials Nanoarchitronics (MANA), MEXT, Japan and
   the National High Technology Research and Development Program of China
   (863 program: 2009AA03Z309).
CR Bai X, 2007, J PHYS CHEM C, V111, P13611, DOI 10.1021/jp070122e
   Chen Y, 2010, ACS NANO, V4, P6001, DOI 10.1021/nn1015117
   Cho HS, 2010, ACS NANO, V4, P5398, DOI 10.1021/nn101000e
   Di WH, 2011, NANOSCALE, V3, P1263, DOI 10.1039/c0nr00673d
   Di WH, 2005, J PHYS CHEM B, V109, P13154, DOI 10.1021/jp051894i
   Foy SP, 2010, ACS NANO, V4, P5217, DOI 10.1021/nn101427t
   Hartmann M, 2005, CHEM MATER, V17, P4577, DOI 10.1021/cm0485658
   Hifumi H, 2006, J AM CHEM SOC, V128, P15090, DOI 10.1021/ja066442d
   Jiang S, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/15/155101
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lechevallier S, 2010, CHEM MATER, V22, P6153, DOI 10.1021/cm102134k
   Liong M, 2008, ACS NANO, V2, P889, DOI 10.1021/nn800072t
   Lu SZ, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/36/365709
   MATIJEVIC E, 1987, J COLLOID INTERF SCI, V118, P506, DOI 10.1016/0021-9797(87)90486-3
   Mi CC, 2010, NANOSCALE, V2, P1141, DOI 10.1039/c0nr00102c
   Qian HS, 2009, SMALL, V5, P2285, DOI 10.1002/smll.200900692
   Setua S, 2010, BIOMATERIALS, V31, P714, DOI 10.1016/j.biomaterials.2009.09.090
   Shen J, 2010, ADV FUNCT MATER, V20, P3708, DOI 10.1002/adfm.201001264
   Shi DL, 2009, ADV MATER, V21, P2170, DOI 10.1002/adma.200803159
   Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0
   Xia GD, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/34/345601
   Yang PP, 2009, BIOMATERIALS, V30, P4786, DOI [10.1016/j.biomaterials.2009.05.038, 10.1016/j.biomatetials.2009.05.038]
   Yu CC, 2008, ADV FUNCT MATER, V18, P1544, DOI 10.1002/adfm.200701052
   Zhang CM, 2010, CHEM-EUR J, V16, P5672, DOI 10.1002/chem.200903137
   Zhang F, 2010, ACS NANO, V4, P99, DOI 10.1021/nn901057y
   Zhelev Z, 2006, J AM CHEM SOC, V128, P6324, DOI 10.1021/ja061137d
   Zhou J, 2010, BIOMATERIALS, V31, P3287, DOI 10.1016/j.biomaterials.2010.01.040
   Zhu YF, 2010, SMALL, V6, P471, DOI 10.1002/smll.200901403
NR 28
TC 56
Z9 56
U1 3
U2 146
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2011
VL 32
IS 29
BP 7226
EP 7233
DI 10.1016/j.biomaterials.2011.06.019
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 815FZ
UT WOS:000294512800037
PM 21745687
DA 2018-10-20
ER

PT J
AU Mi, SL
   Khutoryanskiy, VV
   Jones, RR
   Zhu, XP
   Hamley, IW
   Connon, CJ
AF Mi, Shengli
   Khutoryanskiy, Vitaliy V.
   Jones, Roanne Razalia
   Zhu, Xiuping
   Hamley, Ian William
   Connon, Che John
TI Photochemical cross-linking of plastically compressed collagen gel
   produces an optimal scaffold for corneal tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE photochemical cross-linking; collagen; hydrogel; scaffold; corneal
   tissue engineering
ID DENUDED AMNIOTIC MEMBRANE; LIMBAL EPITHELIAL-CELLS; STEM-CELLS;
   KERATOCONUS; SURFACE; DIFFERENTIATION; RECONSTRUCTION; SUBSTRATE;
   MATRICES; CULTURE
AB The experiments were designed to use photochemically cross-linked plastically compressed collagen (PCPCC) gel to support corneal epithelial cells. A plastically compressed collagen (PCC) scaffold was photo cross-linked by UVA in the presence of riboflavin to form a biomaterial with optimal mechanical properties. The breaking force, rheology, surgical suture strength, transparency, ultrastructure, and cell-based biocompatibility were compared between PCPCC and PCC gels. The breaking force increased proportionally with an increased concentration of riboflavin. The stress required to reach breaking point of the PCPCC scaffolds was over two times higher compared to the stress necessary to break PCC scaffolds in the presence of 0.1% riboflavin. Rheology results indicated that the structural properties of PCC remain unaltered after UVA cross-linking. The PCC gels were more easily broken than PCPCC gels when sutured on to bovine corneas. The optical density values of PCPCC and PCC showed no significant differences (p > 0.05). SEM analyses showed that the collagen fibres within the PCPCC gels were similar in morphology to PCC gels. No difference in cell-based biocompatibility was seen between the PCPCC and PCC scaffolds in terms of their ability to support the ex vivo expansion of corneal epithelial cells or their subsequent differentiation evidenced by similar levels of cytokeratin 14. In conclusion, PCPCC scaffold is an optimal biomaterial for use in therapeutic tissue engineering of the cornea. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 1-8, 2011.
C1 [Mi, Shengli; Jones, Roanne Razalia; Connon, Che John] Univ Reading, Sch Chem Food & Pharm, Reading Sch Pharm, Stem Cells & Nanomat Lab, Reading RG6 6UB, Berks, England.
   [Jones, Roanne Razalia; Hamley, Ian William] Univ Reading, Sch Chem Food & Pharm, Dept Chem, Reading RG6 6UB, Berks, England.
   [Zhu, Xiuping] Shaanxi Inst Ophthalmol, Dept Ophthalmol, Xian 710002, Peoples R China.
RP Connon, CJ (reprint author), Univ Reading, Sch Chem Food & Pharm, Reading Sch Pharm, Stem Cells & Nanomat Lab, Reading RG6 6UB, Berks, England.
EM c.j.connon@reading.ac.uk
RI Khutoryanskiy, Vitaliy/D-3712-2012; Connon, Che/B-3128-2012; Hamley,
   Ian/D-1643-2009
OI Khutoryanskiy, Vitaliy/0000-0002-7221-2630; Connon,
   Che/0000-0001-8264-6531; Hamley, Ian/0000-0002-4549-0926
FU Biotechnology and Biological Sciences Research Council of United Kingdom
   [BB/F019742/1]; Biotechnology and Biological Sciences Research Council
   [BB/F019742/1]
FX Contract grant sponsor: Biotechnology and Biological Sciences Research
   Council of United Kingdom; contract grant number: BB/F019742/1
CR Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Chandran PL, 2004, J BIOMECH ENG-T ASME, V126, P152, DOI 10.1115/1.1688774
   Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711
   Cho KS, 1999, INVEST OPHTH VIS SCI, V40, P911
   Connon CJ, 2010, BRIT J OPHTHALMOL, V94, P1057, DOI 10.1136/bjo.2008.153064
   Connon CJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001147
   Connon CJ, 2006, CELL TISSUE RES, V323, P177, DOI 10.1007/s00441-005-0059-2
   DOLLERY C, 1991, THERAPEUTIC DRUGS
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Hopkinson A, 2006, INVEST OPHTH VIS SCI, V47, P4316, DOI 10.1167/iovs.05-1415
   Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Koizumi N, 2000, CORNEA, V19, P65, DOI 10.1097/00003226-200001000-00013
   Koizumi N, 2007, GRAEF ARCH CLIN EXP, V245, P123, DOI 10.1007/s00417-005-0095-3
   Kolozsvari L, 2002, INVEST OPHTH VIS SCI, V43, P2165
   Lee JE, 2001, YONSEI MED J, V42, P172, DOI 10.3349/ymj.2001.42.2.172
   Matsuda S, 2009, J OLEO SCI, V58, P437, DOI 10.5650/jos.58.437
   Mi SL, 2008, MOL REPROD DEV, V75, P1607, DOI 10.1002/mrd.20900
   Mi SL, 2010, J BIOMED MATER RES A, V95A, P447, DOI 10.1002/jbm.a.32861
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Seiler T, 2000, GRAEF ARCH CLIN EXP, V238, P822, DOI 10.1007/s004179900111
   Seyedjafari E, 2010, BIOMACROMOLECULES, V11, P3118, DOI 10.1021/bm1009238
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   Spoerl E, 2000, OPHTHALMOLOGE, V97, P203, DOI 10.1007/s003470050515
   Tseng SCG, 1996, MOL BIOL REP, V23, P47, DOI 10.1007/BF00357072
   Vollers Sabrina S, 2005, Methods Mol Biol, V299, P11
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Wollensak G, 2003, OPHTHALMOLOGE, V100, P44, DOI 10.1007/s00347-002-0700-3
   Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2006, CURR OPIN OPHTHALMOL, V17, P356, DOI 10.1097/01.icu.0000233954.86723.25
NR 34
TC 31
Z9 32
U1 1
U2 33
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2011
VL 99A
IS 1
BP 1
EP 8
DI 10.1002/jbm.a.33152
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811VG
UT WOS:000294243600001
PM 21732526
DA 2018-10-20
ER

PT J
AU Hume, PS
   Anseth, KS
AF Hume, Patrick S.
   Anseth, Kristi S.
TI Polymerizable superoxide dismutase mimetic protects cells encapsulated
   in poly(ethylene glycol) hydrogels from reactive oxygen species-mediated
   damage
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE reactive oxygen species; superoxide; hydrogel; beta-cell; superoxide
   dismutase
ID PANCREATIC-ISLETS; MATRIX INTERACTIONS; INSULIN-SECRETION; NITRIC-OXIDE;
   BIOARTIFICIAL LIVER; OXIDATIVE STRESS; PORCINE ISLETS; RAT ISLETS;
   IN-VITRO; TRANSPLANTATION
AB A polymerizable superoxide dismutase mimetic (SODm) was incorporated into poly(ethylene glycol) (PEG) hydrogels to protect encapsulated cells from superoxide-mediated damage. Superoxide and other small reactive oxygen species (ROS) can cause oxidative damage to donor tissue encapsulated within size exclusion barrier materials. To enzymatically breakdown ROS within biomaterial cell encapsulation systems, Mn(III) Tetrakis[1-(3-acryloxy-propyl)-4-pyridyl] porphyrin (MnTTPyP-acryl), a polymerizable manganese metalloporphyrin SOD mimetic, was photopolymerized with PEG diacrylate (PEGDA) to create functional gels. In unmodified PEG hydrogels, a significant reduction in metabolic activity was observed when encapsulated Min6 beta-cells were challenged with chemically generated superoxide. Cells encapsulated within MnTPPyP-co-PEG hydrogels, however, demonstrated greatly improved metabolic activity following various superoxide challenges. Further, cells were encapsulated and cultured for 10 days within MnTPPyP-co-PEG hydrogels and challenged with superoxide on days 4, 6, and 8. At the conclusion of this study, cells in blank PEG hydrogels had no observable metabolic activity but when encapsulated in MnTPPyP-functionalized hydrogels, cells retained 60 +/- 5% of the metabolic activity compared to untreated controls. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 29-37, 2011.
C1 [Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Howard Hughes Med Inst, Boulder, CO 80309 USA.
RP Anseth, KS (reprint author), Univ Colorado, Dept Chem & Biol Engn, Howard Hughes Med Inst, 424 UCB, Boulder, CO 80309 USA.
EM Kristi.Anseth@Colorado.edu
FU National Institute of Health [RO1DK076084]; Howard Hughes Medical
   Institute; Department of Education
FX Contract grant sponsor: The National Institute of Health; contract grant
   number: RO1DK076084; Contract grant sponsor: The Howard Hughes Medical
   Institute; Contract grant sponsor: The Department of Education's
   Graduate Assistance in Areas of National Need fellowship
CR Benov L, 2005, FREE RADICAL RES, V39, P81, DOI 10.1080/10715760400022368
   Bertuzzi F, 2007, ACTA DIABETOL, V44, P171, DOI 10.1007/s00592-007-0020-9
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Cheung CY, 2008, ADV FUNCT MATER, V18, P3119, DOI 10.1002/adfm.200800566
   Cheung CY, 2006, BIOCONJUGATE CHEM, V17, P1036, DOI 10.1021/bc060023o
   Chiumiento A, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1324, DOI 10.1134/S0006297906120066
   Chiumiento A, 2006, J MATER SCI-MATER M, V17, P427, DOI 10.1007/s10856-006-8470-0
   Choi SY, 2000, J IMMUNOL, V165, P3992, DOI 10.4049/jimmunol.165.7.3992
   COHEN HJ, 1978, J CLIN INVEST, V61, P1081, DOI 10.1172/JCI109007
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Cui H, 2009, TRANSPLANTATION, V88, P160, DOI 10.1097/TP.0b013e3181abbfc1
   Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341
   de Vos P, 2002, TRENDS MOL MED, V8, P363, DOI 10.1016/S1471-4914(02)02381-X
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   Delaney CA, 1996, FEBS LETT, V394, P300, DOI 10.1016/0014-5793(96)00977-5
   DiMatteo MA, 1997, APOPTOSIS, V2, P164, DOI 10.1023/A:1026412414666
   Emerich DF, 2001, CRIT REV THER DRUG, V18, P265
   Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002
   GABLER WL, 1986, J DENT RES, V65, P1159, DOI 10.1177/00220345860650090901
   GRANKVIST K, 1981, NATURE, V294, P158, DOI 10.1038/294158a0
   Hadjivassiliou V, 1998, NITRIC OXIDE-BIOL CH, V2, P429, DOI 10.1006/niox.1998.0203
   Haskins K, 2003, ANN NY ACAD SCI, V1005, P43, DOI 10.1196/annals.1288.006
   Hume PS, 2010, BIOMATERIALS, V31, P3166, DOI 10.1016/j.biomaterials.2010.01.035
   HUME PS, BIOMATERIAL IN PRESS
   Jang JY, 2004, BIOMATERIALS, V25, P3663, DOI 10.1016/j.biomaterials.2003.10.062
   Kavdia M, 2002, ANN BIOMED ENG, V30, P721, DOI 10.1114/1.1481054
   Kojima Y, 1996, J BIOACT COMPAT POL, V11, P169, DOI 10.1177/088391159601100301
   Lee MK, 2000, ADV DRUG DELIVER REV, V42, P103, DOI 10.1016/S0169-409X(00)00056-9
   Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5
   Li Z, 2009, BIOMACROMOLECULES, V10, P3306, DOI 10.1021/bm900900e
   LIN CC, P NATL ACAD IN PRESS
   Lin CC, 2010, J CONTROL RELEASE, V142, P384, DOI 10.1016/j.jconrel.2009.11.022
   Lin CC, 2009, BIOMACROMOLECULES, V10, P2460, DOI 10.1021/bm900420f
   Lin CC, 2009, BIOMATERIALS, V30, P4907, DOI 10.1016/j.biomaterials.2009.05.083
   MCCORD JM, 1969, J BIOL CHEM, V244, P6049
   Monfared SSMS, 2009, WORLD J GASTROENTERO, V15, P1153, DOI 10.3748/wjg.15.1153
   Muscoli C, 2003, BRIT J PHARMACOL, V140, P445, DOI 10.1038/sj.bjp.0705430
   Nakaoka R, 1997, J CONTROL RELEASE, V46, P253, DOI 10.1016/S0168-3659(96)01605-7
   NOMIKOS IN, 1989, IMMUNOL CELL BIOL, V67, P85, DOI 10.1038/icb.1989.12
   Nyberg SL, 2003, LIVER TRANSPLANT, V9, P298, DOI 10.1053/jlts.2003.50024
   PASTERNACK RF, 1981, J INORG BIOCHEM, V15, P261, DOI 10.1016/S0162-0134(00)80161-0
   Pavlakis Martha, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P146, DOI 10.1097/MED.0b013e32807f2ac8
   Pedulla M, 2007, J CELL PHYSIOL, V212, P432, DOI 10.1002/jcp.21034
   Piganelli JD, 2002, DIABETES, V51, P347, DOI 10.2337/diabetes.51.2.347
   Salvemini D, 2002, NAT REV DRUG DISCOV, V1, P367, DOI 10.1038/nrd796
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Shi XL, 2011, ARTIF ORGANS, V35, pE40, DOI 10.1111/j.1525-1594.2011.01201.x
   Su J, 2010, BIOMATERIALS, V31, P308, DOI 10.1016/j.biomaterials.2009.09.045
   Sun LT, 2010, WOUND REPAIR REGEN, V18, P302, DOI 10.1111/j.1524-475X.2010.00591.x
   Szabo C, 1996, FEBS LETT, V381, P82, DOI 10.1016/0014-5793(96)00087-7
   Thiruchelvam M, 2005, J BIOL CHEM, V280, P22530, DOI 10.1074/jbc.M500417200
   Uchiyama T, 2003, BIOMATERIALS, V24, P5183, DOI 10.1016/S0142-9612(03)00441-1
   Weber LM, 2007, BIOMATERIALS, V28, P3004, DOI 10.1016/j.biomaterials.2007.03.005
   Weber LM, 2008, MATRIX BIOL, V27, P667, DOI 10.1016/j.matbio.2008.08.001
   Weber LM, 2008, TISSUE ENG PT A, V14, P1959, DOI 10.1089/ten.tea.2007.0238
   White SA, 2009, LANCET, V373, P1808, DOI 10.1016/S0140-6736(09)60609-7
   Wilson JT, 2008, ADV DRUG DELIVER REV, V60, P124, DOI 10.1016/j.addr.2007.08.034
NR 58
TC 12
Z9 12
U1 1
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2011
VL 99A
IS 1
BP 29
EP 37
DI 10.1002/jbm.a.33160
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811VG
UT WOS:000294243600004
PM 21793194
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cornelius, RM
   Macri, J
   Brash, JL
AF Cornelius, Rena M.
   Macri, Joseph
   Brash, John L.
TI Interfacial interactions of apolipoprotein AI and high density
   lipoprotein: Overlooked phenomena in blood-material contact
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE apolipoprotein AI; lipoproteins; protein adsorption; plasma; SDS-PAGE;
   immunoblot
ID AMPHIPATHIC PEPTIDE ANALOGS; MYOCARDIAL-INFARCTION; PROTEIN ADSORPTION;
   ALGINATE MICROCAPSULES; BIOMATERIAL SURFACES; PROTEOMIC ANALYSIS;
   APOA-I; PLASMA; POLYURETHANE; FIBRINOGEN
AB Apolipoprotein AI (apo AI) is the major protein component of high density lipoprotein (HDL), and represents similar to 1% of the total protein content of plasma. In previous work, apo AI was identified as a major component of the protein layers adsorbed from plasma to biomaterials having a wide range of surface properties. Notwithstanding such indications of the major contribution of lipoprotein interactions, these phenomena have been largely overlooked in the blood-contacting biomaterials area. In this communication, detailed quantitative data on the adsorption of apo AI to typical "biomedical" segmented polyurethane (PU) are reported. Using radiolabeled apo AI, adsorption levels from buffer and plasma were found to be similar to 0.5 and similar to 0.2 mu g/cm(2), respectively. Albumin adsorption from plasma was comparable at about similar to 0.17 mu g/cm(2). Since, it is unknown how much of the adsorbed apo AI is associated with HDL versus how much is in the free state, the corresponding molar quantities cannot be determined with certainty. However, if it is assumed that all of the adsorbed apo AI is free, the molar quantities adsorbed from plasma were in the ratio apo AI: albumin 2.77, compared with 0.00063 in plasma. Immunoblot data showed similar trends with respect both to the variation in adsorbed quantity with plasma concentration and to the relative adsorbed quantities of apo AI and albumin. These data show unequivocally the very strong surface activity of apo AI and suggest that a key future focus for blood compatibility research should be lipoprotein interactions. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 109-115, 2011.
C1 [Cornelius, Rena M.; Brash, John L.] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   [Cornelius, Rena M.; Macri, Joseph] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.
   [Brash, John L.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.
RP Brash, JL (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM brashjl@mcmaster.ca
FU Natural Sciences and Engineering Research Council (NSERC, Canada);
   Canadian Institutes of Health Research (CIHR)
FX Contract grant sponsors: Natural Sciences and Engineering Research
   Council (NSERC, Canada); The Canadian Institutes of Health Research
   (CIHR)
CR Ajees AA, 2006, P NATL ACAD SCI USA, V103, P2126, DOI 10.1073/pnas.0506877103
   Alonsa-Villaverde C, 2003, AIDS, V17, P1173, DOI 10.1097/01.aids.0000060360.78202.05
   Archambault JG, 2004, COLLOID SURFACE B, V33, P111, DOI 10.1016/j.colsurfb.2003.09.004
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   BRASH JL, 1984, THROMB HAEMOSTASIS, V51, P326
   Bresnihan B, 2004, ARTHRITIS RES THER, V6, pR563, DOI 10.1186/ar1443
   BREWER HB, 1978, BIOCHEM BIOPH RES CO, V80, P623, DOI 10.1016/0006-291X(78)91614-5
   Burger D, 2002, ANN NY ACAD SCI, V966, P464, DOI 10.1111/j.1749-6632.2002.tb04248.x
   Cavigiolio G, 2010, J BIOL CHEM, V285, P18847, DOI 10.1074/jbc.M109.098434
   Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B
   Chiesa Giulia, 2002, Curr Opin Investig Drugs, V3, P420
   Chmielewski M, 2009, J INTERN MED, V265, P708, DOI 10.1111/j.1365-2796.2009.02074.x
   Cho CKJ, 2007, MOL CELL PROTEOMICS, V6, P1406, DOI 10.1074/mcp.M700090-MCP200
   Cornelius RM, 2002, ASAIO J, V48, P300, DOI 10.1097/00002480-200205000-00017
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   CORNELIUS RM, 2009, ANN M SOC BIOM SAN A
   Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a
   Du YJ, 2007, J BIOMED MATER RES A, V80A, P216, DOI 10.1002/jbm.a.30977
   Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806
   Jamoussi K, 2005, PATHOL BIOL, V53, P217, DOI 10.1016/j.patbio.2004.07.015
   Jin ZL, 2009, J BIOMED MATER RES A, V91A, P1189, DOI 10.1002/jbm.a.32319
   Kim JK, 2005, J BIOMED MATER RES A, V75A, P199, DOI 10.1002/jbm.a.30424
   Kim SS, 2007, J PROTEOME RES, V6, P180, DOI 10.1021/pr060323f
   Kipnis E, 2008, CHEST, V134, P338, DOI 10.1378/chest.07-1643
   Knetsch MLW, 2006, BIOMATERIALS, V27, P2813, DOI 10.1016/j.biomaterials.2005.12.025
   KNIGHT LC, 1981, THROMB HAEMOSTASIS, V46, P593
   Meisinger C, 2005, EUR HEART J, V26, P271, DOI 10.1093/eurheartj/ehi003
   Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292
   Noel-Georis I, 2002, J CHROMATOGR B, V771, P221, DOI 10.1016/S1570-0232(02)00114-9
   OWENS RJ, 1990, J CLIN INVEST, V86, P1142
   Ozsavci D, 2001, THROMB RES, V103, P117, DOI 10.1016/S0049-3848(01)00279-1
   *PIERC CHEM CO, 1993, IODO GEN IOD REAG
   Provost PR, 2009, J ENDOCRINOL, V200, P321, DOI 10.1677/JOE-08-0238
   Rader DJ, 2003, JAMA-J AM MED ASSOC, V290, P2322, DOI 10.1001/jama.290.17.2322
   Regoeczi E., 1984, IODINE LABELED PLASM, V1
   SCANU AM, 1984, CLIN PHYSIOL BIOCH, V2, P111
   Shen F, 2005, J BIOMED MATER RES B, V75B, P425, DOI 10.1002/jbm.b.30323
   SHOULDERS CC, 1983, NUCLEIC ACIDS RES, V11, P2827, DOI 10.1093/nar/11.9.2827
   SRINIVAS RV, 1990, VIROLOGY, V176, P48, DOI 10.1016/0042-6822(90)90229-K
   SRINIVAS RV, 1991, J CELL BIOCHEM, V45, P224, DOI 10.1002/jcb.240450214
   STANISLAWSKI L, 1995, J BIOMED MATER RES, V29, P315, DOI 10.1002/jbm.820290306
   Tian L, 2008, CLIN CHIM ACTA, V388, P148, DOI 10.1016/j.cca.2007.10.028
   Van Raamsdonk JM, 2002, J BIOMAT SCI-POLYM E, V13, P863, DOI 10.1163/156856202320401933
   Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD
   VROMAN L, 1980, BLOOD, V55, P156
   Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2
   Walldius G, 2004, J INTERN MED, V255, P188, DOI 10.1046/j.1365-2796.2003.01276.x
   WOODHOUSE KA, 1992, BIOMATERIALS, V13, P1103, DOI 10.1016/0142-9612(92)90143-C
   Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9
NR 49
TC 9
Z9 9
U1 1
U2 14
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2011
VL 99A
IS 1
BP 109
EP 115
DI 10.1002/jbm.a.33169
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811VG
UT WOS:000294243600013
PM 21800421
DA 2018-10-20
ER

PT J
AU Nagai, A
   Tanaka, K
   Tanaka, Y
   Nakamura, M
   Hashimoto, K
   Yamashita, K
AF Nagai, Akiko
   Tanaka, Kazumasa
   Tanaka, Yumi
   Nakamura, Miho
   Hashimoto, Kazuaki
   Yamashita, Kimihiro
TI Electric polarization and mechanism of B-type carbonated apatite
   ceramics
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE carbonated apatite; electric polarization; TSDC; stored charges; ion
   conductivity
ID HYDROXYAPATITE; BONE; CHARGE; DIFFRACTION; IONS
AB B-type carbonated apatite (CAp) ceramics, nonstoichiometric hydroxyapatites (HAp) with carbonate ions (CO32-) substituting for phosphate ions, are the major inorganic components of vertebrate bones. Due to the carbonate substitution, CAp is more biodegradable than HAp and has been expected a next generation biomaterial. We have reported the electric polarization of HAp, and induced stored electric charges and electric fields in poling HAp could promote bone healing. Here, we applied electric polarization to CAp and showed the role of substituted CO32- concentrations in CAp in its electric polarization and polarization mechanisms. We found that the electrical conductivities (sigma) and stored charges (Q) of poling CAp dramatically increased with carbonate ion contents. We also found that CAp showed higher activation energy both for conduction and for depolarization than HAp, even though the values of sigma and Q are much higher than those of HAp. These results suggested that the substitution of a small amount of CO32- for PO43- resulted in a change in the conduction and polarization mechanisms in CAp compared with HAp. Our study showed that the poling CAp has the potential to be a new functional biomaterial with biodegradation and large stored electric charges. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 116-124, 2011.
C1 [Nagai, Akiko; Tanaka, Kazumasa; Nakamura, Miho; Yamashita, Kimihiro] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
   [Tanaka, Kazumasa; Hashimoto, Kazuaki] Chiba Inst Technol, Grad Sch Engn, Chiba, Japan.
   [Tanaka, Yumi] Kyushu Univ, Dept Appl Chem, Fukuoka 812, Japan.
RP Nagai, A (reprint author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
EM nag-bcr@tmd.ac.jp
RI Nakamura, Miho/T-3166-2017
FU Japan Society for the Promotion of Science [20500405]; Kazuchika Okura
   Memorial Foundation
FX Contract grant sponsor: Japan Society for the Promotion of Science;
   contract grant number: 20500405; Contract grant sponsor: Kazuchika Okura
   Memorial Foundation
CR Akkus O, 2004, BONE, V34, P443, DOI 10.1016/j.bone.2003.11.003
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Bushinsky DA, 2001, EUR J NUTR, V40, P238, DOI 10.1007/s394-001-8351-5
   Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470
   Doi Y, 1998, J BIOMED MATER RES, V39, P603, DOI 10.1002/(SICI)1097-4636(19980315)39:4<603::AID-JBM15>3.3.CO;2-8
   DOI Y, 1982, J DENT RES, V61, P429, DOI 10.1177/00220345820610021301
   FEATHERSTONE JDB, 1984, CARIES RES, V18, P63, DOI 10.1159/000260749
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Itoh S, 2006, BIOMATERIALS, V27, P5572, DOI 10.1016/j.biomaterials.2006.07.007
   Kobayashi T, 2007, J BIOMED MATER RES A, V82A, P145, DOI 10.1002/jbm.a.31080
   Kumar D, 2010, ACTA BIOMATER, V6, P1549, DOI 10.1016/j.actbio.2009.11.008
   Lee JS, 2001, J MATER RES, V16, P2739, DOI 10.1557/JMR.2001.0374
   LEGEROS RZ, 1967, SCIENCE, V155, P1409, DOI 10.1126/science.155.3768.1409
   LEGEROS RZ, 1965, NATURE, V206, P403, DOI DOI 10.1038/206403A0
   McCreadie BR, 2006, BONE, V39, P1190, DOI 10.1016/j.bone.2006.06.008
   Merry JC, 1998, J MATER SCI-MATER M, V9, P779, DOI 10.1023/A:1008975507498
   Nagai A, 2008, LIFE SCI, V82, P1162, DOI 10.1016/j.lfs.2008.03.017
   Nakamura M, 2009, ACS APPL MATER INTER, V1, P2181, DOI 10.1021/am900341v
   Nakamura S, 2002, J BIOMED MATER RES, V61, P593, DOI 10.1002/jbm.10224
   Okabayashi R, 2009, J BIOMED MATER RES B, V90B, P641, DOI 10.1002/jbm.b.31329
   Penel G, 1998, CALCIFIED TISSUE INT, V63, P475, DOI 10.1007/s002239900561
   PIENKOWSKI D, 1983, Journal of Orthopaedic Research, V1, P30, DOI 10.1002/jor.1100010105
   TANAKA K, 2004, PHOS RES B, V17, P126
   Tanaka Y, 2010, J AM CERAM SOC, V93, P3577, DOI 10.1111/j.1551-2916.2010.04105.x
   Tanaka Y, 2010, J APPL PHYS, V107, DOI 10.1063/1.3265429
   TERMINE JD, 1973, CALC TISS RES, V13, P73, DOI 10.1007/BF02013723
   Ueshima M, 2002, ADV MATER, V14, P591, DOI 10.1002/1521-4095(20020418)14:8<591::AID-ADMA591>3.0.CO;2-7
   Veljovic D, 2009, CERAM INT, V35, P1407, DOI 10.1016/j.ceramint.2008.07.007
   Wang W, 2010, ACTA BIOMATER, V6, P4027, DOI 10.1016/j.actbio.2010.04.027
   Wang W, 2010, J AM CERAM SOC, V93, P2175, DOI 10.1111/j.1551-2916.2010.03710.x
   Wilson RM, 2004, BIOMATERIALS, V25, P2205, DOI 10.1016/j.biomaterials.2003.08.057
   YAMASHITA K, 1995, J AM CERAM SOC, V78, P1191, DOI 10.1111/j.1151-2916.1995.tb08468.x
NR 32
TC 7
Z9 7
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2011
VL 99A
IS 1
BP 116
EP 124
DI 10.1002/jbm.a.33131
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811VG
UT WOS:000294243600014
PM 21812092
DA 2018-10-20
ER

PT J
AU Persheyev, S
   Fan, YC
   Irving, A
   Rose, MJ
AF Persheyev, Saydulla
   Fan, Yongchang
   Irving, Andrew
   Rose, Mervyn J.
TI BV-2 microglial cells sense micro-nanotextured silicon surface topology
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell adhesion; cell signaling and interactions; BV-2 microglia cells;
   micro-nanotextured silicon; cytoskeleton; actin
ID OSTEOPROGENITOR RESPONSE; STEM-CELLS; EXCIMER; NANOTOPOGRAPHY; DYNAMICS;
   CNS
AB Artificial biomimetic substrates provide useful models for studying cell adhesion, signaling, and differentiation. This article describes biological interactions with a new type of tunable, micro-nanotextured silicon substrate, generated by irradiation of a hydrogenated amorphous silicon film with a large beam, excimer laser (248 nm). In this study, we demonstrate that BV-2 microglial cells can sense differences in laser processed silicon surface topology over the range of 30 nm to 2 mu m, where they undergo marked morphogenic changes with increasing feature size. The cells adopt a more elongated shape in the presence of the modified surface structure and exhibit increased levels of actin-rich microdomains, suggesting enhanced adhesion. The excimer laser modification of hydrogenated amorphous silicon to generate micro-nanostructures realizes large area benefits as well as providing a biomaterial where the external and internal structure can be altered and tuned for various applications. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 135-140, 2011.
C1 [Persheyev, Saydulla; Fan, Yongchang; Rose, Mervyn J.] Univ Dundee, Carnegie Lab Phys Elect Engn Phys & Renewable Ene, Dundee, Scotland.
   [Irving, Andrew] Univ Dundee, Div Med Sci, Ctr Neurosci, Dundee, Scotland.
RP Persheyev, S (reprint author), Univ Dundee, Carnegie Lab Phys Elect Engn Phys & Renewable Ene, Dundee, Scotland.
EM s.persheyev@dundee.ac.uk
CR Adikaari AADT, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2731664
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V
   Crouch CH, 2004, APPL PHYS A-MATER, V79, P1635, DOI 10.1007/s00339-004-2676-0
   Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dassow R, 2000, SEMICOND SCI TECH, V15, P31
   FAN Y, 2009, 10 INT C LAS ABL COL
   FAN Y, 2009, 2009 IEEE C EXPRESS
   Fu J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/15/155502
   HALIM M, 2010, CLEO QELS 2010 SAN H
   Hart A, 2007, J MATER SCI-MATER M, V18, P1211, DOI 10.1007/s10856-007-0157-7
   Herbst L, 2006, PHOTON SPECTRA, V40, P68
   Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e
   KANTAWONG F, 2009, ACTA BIOMATER, V6, P3694
   Kantawong F, 2009, J R SOC INTERFACE, V6, P1075, DOI 10.1098/rsif.2008.0447
   Leung BK, 2008, BIOMATERIALS, V29, P3289, DOI 10.1016/j.biomaterials.2008.03.045
   Parkhurst CN, 2010, CURR OPIN NEUROBIOL, V20, P595, DOI 10.1016/j.conb.2010.07.002
   Persheyev SK, 2010, PHYS STATUS SOLIDI C, V7, P968, DOI 10.1002/pssc.200982875
   PORTE H, 2010, 35 INT C INFR MILL T
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Shaikh MZ, 2006, THIN SOLID FILMS, V501, P125, DOI 10.1016/j.tsf.2005.07.138
   TANG F, 2002, APPL PHYS LETT, V80, P4154
NR 25
TC 8
Z9 8
U1 0
U2 5
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2011
VL 99A
IS 1
BP 135
EP 140
DI 10.1002/jbm.a.33159
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811VG
UT WOS:000294243600016
PM 21812094
DA 2018-10-20
ER

PT J
AU Ereifej, ES
   Khan, S
   Newaz, G
   Zhang, JS
   Auner, GW
   VandeVord, PJ
AF Ereifej, Evon S.
   Khan, Saida
   Newaz, Golam
   Zhang, Jinsheng
   Auner, Gregory W.
   VandeVord, Pamela J.
TI Characterization of astrocyte reactivity and gene expression on
   biomaterials for neural electrodes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE astrocyte; biocompatibility; poly methyl methacrylate; SU-8; neural
   electrode
ID IN-VITRO; CELL-ADHESION; SU-8; DEVICES; CNS; PROLIFERATION;
   REGENERATION; INTERFACES; PLATINUM; INJURY
AB Neural electrode devices hold great promise to help people with the restoration of lost functions. However, research is lacking in the biomaterial design of a stable, long-term device. Glial scarring is initiated when a device is inserted into brain tissue and an inflammatory response ensues. Astrocytes become hypertrophic, hyperplastic, and upregulate glial-fibrillary acidic protein. This study was designed to investigate the astrocyte proliferation, viability, morphology, and gene expression to assess the reactive state of the cells on different material surfaces. Although platinum and silicon have been extensively characterized both in vivo and in vitro for their biocompatibility with neuronal cells, this study used the novel usage of PMMA and SU-8 in neural electrodes by comparative analysis of materials' biocompatibility. This study has shown evidence of noncytotoxicity of SU-8. We have also confirmed the biocompatibility of PMMA with astrocytes. Moreover, we have established sound guidelines of which neural implant materials should meet to be depicted biocompatible. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 99A: 141-150, 2011.
C1 [Ereifej, Evon S.; VandeVord, Pamela J.] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
   [Khan, Saida] Wayne State Univ, Inst Mfg Res, Detroit, MI USA.
   [Newaz, Golam] Wayne State Univ, Dept Mech Engn, Detroit, MI 48202 USA.
   [Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol, Detroit, MI 48201 USA.
   [Auner, Gregory W.] Wayne State Univ, Dept Biomed Engn Smart Sensor & Integrated Micros, Detroit, MI USA.
   [VandeVord, Pamela J.] John D Dingell VA Med Ctr, Res & Dev Serv, Detroit, MI USA.
RP VandeVord, PJ (reprint author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.
EM pvord@wayne.edu
RI VandeVord, Pamela/B-4606-2012
FU Wayne State University; Anthony and Joyce Danielski Kales Scholarship
FX Contract grant sponsors: The Wayne State University President's
   Translational Enhancement Award; The Anthony and Joyce Danielski Kales
   Scholarship
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   ALBERTS AJB, 2008, P WALTER MOL BIOL CE
   BEWIG KW, 1965, J PHYS CHEM-US, V69, P4238, DOI 10.1021/j100782a029
   Bhushan B, 2008, PHILOS T R SOC A, V366, P1499, DOI 10.1098/rsta.2007.2170
   Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014
   Burton Z, 2005, NANO LETT, V5, P1607, DOI 10.1021/nl050861b
   Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518
   De Boeck M, 2003, MUTAGENESIS, V18, P177, DOI 10.1093/mutage/18.2.177
   Dupont-Gillain CC, 2004, BIO-MED MATER ENG, V14, P281
   ERIC J, 2001, MOL NEUROPHARMACOLOG
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Frampton JP, 2010, ANN BIOMED ENG, V38, P1031, DOI 10.1007/s10439-010-9911-y
   Frazer Robert Q, 2005, J Long Term Eff Med Implants, V15, P629
   Gervasi NM, 2008, REGEN MED, V3, P907, DOI 10.2217/17460751.3.6.907
   Griffith RW, 2006, NEUROSCI LETT, V406, P81, DOI 10.1016/j.neulet.2006.07.018
   Grill WM, 2009, ANNU REV BIOMED ENG, V11, P1, DOI 10.1146/annurev-bioeng-061008-124927
   Hennemeyer M, 2008, MICROELECTRON ENG, V85, P1298, DOI 10.1016/j.mee.2008.01.026
   Hopcroft M, 2005, FATIGUE FRACT ENG M, V28, P735, DOI 10.1111/j.1460-2695.2005.00873.x
   HOWARD MA, 1997, Patent No. 5697975
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984
   Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8
   KUHNEL W, 2003, COLOR ATLAS CYTOLOGY, P257
   Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/056003
   Ni M, 2009, INT J MOL SCI, V10, P5411, DOI 10.3390/ijms10125411
   Polikov VS, 2006, BIOMATERIALS, V27, P5368, DOI 10.1016/j.biomaterials.2006.06.018
   Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015
   SALAKHUTDINOV I, 2008, J NANOMATER, P1
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Seil JT, 2008, INT J NANOMED, V3, P523
   Shirtcliffe NJ, 2004, J MICROMECH MICROENG, V14, P1384, DOI 10.1088/0960-1317/14/10/013
   Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8
   Squire B., 2003, FUNDAMENTAL NEUROSCI
   Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3
   Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983
   Vernekar VN, 2009, J BIOMED MATER RES A, V89A, P138, DOI 10.1002/jbm.a.31839
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Wang L, 2009, SENSOR ACTUAT B-CHEM, V140, P349, DOI 10.1016/j.snb.2009.05.009
   Wu ZZ, 2006, COLLOID SURFACE B, V52, P14, DOI 10.1016/j.colsurfb.2006.06.001
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zorba V, 2006, NANOTECHNOLOGY, V17, P3234, DOI 10.1088/0957-4484/17/13/026
NR 43
TC 13
Z9 13
U1 0
U2 10
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2011
VL 99A
IS 1
BP 141
EP 150
DI 10.1002/jbm.a.33170
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811VG
UT WOS:000294243600017
PM 21812095
DA 2018-10-20
ER

PT J
AU Henni, AH
   Schmitt, C
   Tremblay, ME
   Hamdine, M
   Heuzey, MC
   Carreau, P
   Cloutier, G
AF Henni, Anis Hadj
   Schmitt, Cedric
   Tremblay, Marie-Elise
   Hamdine, Melina
   Heuzey, Marie-Claude
   Carreau, Pierre
   Cloutier, Guy
TI Hyper-frequency viscoelastic spectroscopy of biomaterials
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterials; Viscoelasticity measurements; Hyper-frequency; Rheology;
   Mechanical testing; Instrumentation
ID MAGNETIC-RESONANCE ELASTOGRAPHY; VOCAL FOLD TISSUES; TRANSIENT
   ELASTOGRAPHY; RHEOLOGICAL PROPERTIES; MECHANICAL-PROPERTIES; CHITOSAN;
   MODULUS; PHANTOM; REPLACEMENT; VALIDATION
AB With the emergence of new biomaterials and elastography imaging techniques, there is a need for innovative instruments dedicated to viscoelasticity measurements. In this work, we introduce a novel hyper-frequency viscoelastic spectroscopy (HFVS) technique dedicated to characterize soft media subjected to mid-to-very-high frequency stress ranges (or, equivalently, to probe short-to-very-short relaxation times). HFVS, which has been implemented in an analytical instrument performing non-contact Measurements in less than 1 s between 10 and 1000 Hz, is a suitable tool to study viscoelasticity for bio-applications. In this context, HFVS has been compared to classical oscillatory rheometry on several classes of soft materials currently encountered in tissue repair, bioengineering and elastography imaging on a frequency range between 10 and 100 Hz. After having demonstrated the good correspondence between HFVS and rheometry, this study has been completed by exploring the sensitivity of HFVS to physicochemically induced variations of viscoelasticity. HFVS opens promising perspectives in the challenging field of biomaterial science and for viscoelasticity-based quality control of materials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Henni, Anis Hadj; Schmitt, Cedric; Cloutier, Guy] Univ Montreal, Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, Montreal, PQ H2L 2W5, Canada.
   [Henni, Anis Hadj; Schmitt, Cedric] Rheolution Inc, Montreal, PQ H2S 2S4, Canada.
   [Schmitt, Cedric; Cloutier, Guy] Univ Montreal, Inst Biomed Engn, Montreal, PQ H3C 3J7, Canada.
   [Tremblay, Marie-Elise; Hamdine, Melina; Heuzey, Marie-Claude; Carreau, Pierre] Ecole Polytech, Dept Chem Engn, CREPEC, Montreal, PQ H3C 3A7, Canada.
   [Cloutier, Guy] Univ Montreal, Dept Radiol Radiooncol & Nucl Med, Montreal, PQ H3T 1J4, Canada.
RP Henni, AH (reprint author), Univ Montreal, Hosp Res Ctr CRCHUM, Lab Biorheol & Med Ultrason, 2099 Alexandre de Seve, Montreal, PQ H2L 2W5, Canada.
EM anis.hadjhenni@rheolution.com; guy.cloutier@umontreal.ca
FU Natural Sciences and Engineering Research Council of Canada
   [CHRP-365656-09]; Canadian Institutes of Health Research [CPG-95288]
FX The authors thank Thidachanh Keomaniphet for her contribution to the
   achievement of this work. This work was financed by the Collaborative
   Health Research Program of the Natural Sciences and Engineering Research
   Council of Canada (grant #CHRP-365656-09) and the Canadian Institutes of
   Health Research (grant #CPG-95288).
CR Baghani A, 2009, IEEE T ULTRASON FERR, V56, P1405, DOI 10.1109/TUFFC.2009.1196
   Catheline S, 2004, J ACOUST SOC AM, V116, P3734, DOI 10.1121/1.1815075
   Chan RW, 2008, J ACOUST SOC AM, V124, P1207, DOI 10.1121/1.2946715
   Cho J, 2007, MACROMOL MATER ENG, V292, P571, DOI 10.1002/mame.200700009
   CLARK AH, 1983, MACROMOLECULES, V16, P1367, DOI 10.1021/ma00242a019
   Doyley MM, 2010, MED PHYS, V37, P3970, DOI 10.1118/1.3454738
   Duflo S, 2006, TISSUE ENG, V12, P2171, DOI 10.1089/ten.2006.12.2171
   Dumont D, 2009, IEEE T ULTRASON FERR, V56, P931, DOI 10.1109/TUFFC.2009.1126
   FERRY JD, 1980, VISCOELASTIC PROPERT
   Fromageau J, 2007, IEEE T ULTRASON FERR, V54, P498, DOI 10.1109/TUFFC.2007.273
   Ghanbari H, 2009, TRENDS BIOTECHNOL, V27, P359, DOI 10.1016/j.tibtech.2009.03.002
   Goodyer E, 2009, J VOICE, V23, P151, DOI 10.1016/j.jvoice.2007.09.006
   Greenleaf JF, 2003, ANNU REV BIOMED ENG, V5, P57, DOI 10.1146/annurev.bioeng.5.040202.121623
   Henni AH, 2008, J ACOUST SOC AM, V124, P2394, DOI 10.1121/1.2973194
   Henni AH, 2010, J BIOMECH, V43, P1488, DOI 10.1016/j.jbiomech.2010.01.045
   Kidane AG, 2009, J BIOMED MATER RES B, V88B, P290, DOI 10.1002/jbm.b.31151
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kiss MZ, 2009, J BIOMECH, V42, P959, DOI 10.1016/j.jbiomech.2009.03.002
   Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006
   Le Floc'h S, 2010, PHYS MED BIOL, V55, P5701, DOI 10.1088/0031-9155/55/19/006
   Madsen EL, 2005, PHYS MED BIOL, V50, P5597, DOI 10.1088/0031-9155/50/23/013
   Mariappan YK, 2010, CLIN ANAT, V23, P497, DOI 10.1002/ca.21006
   Oudry J, 2009, ULTRASOUND MED BIOL, V35, P1185, DOI 10.1016/j.ultrasmedbio.2009.01.012
   Oudry J, 2009, J MAGN RESON IMAGING, V30, P1145, DOI 10.1002/jmri.21929
   Park JS, 2001, J APPL POLYM SCI, V82, P1816, DOI 10.1002/app.2023
   Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189
   Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310
   Schmitt C, 2011, J BIOMECH, V44, P622, DOI 10.1016/j.jbiomech.2010.11.015
   Sepehr M, 2004, J RHEOL, V48, P1023, DOI 10.1122/1.1773783
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Svec JG, 2008, J ACOUST SOC AM, V123, P347, DOI 10.1121/1.2804939
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   Tanter M, 2008, ULTRASOUND MED BIOL, V34, P1373, DOI 10.1016/j.ultrasmedbio.2008.02.002
   Thibeault SL, 2011, J VOICE, V25, P249, DOI 10.1016/j.jvoice.2009.10.003
   Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007
   Vappou J, 2009, PHYS MED BIOL, V54, P3579, DOI 10.1088/0031-9155/54/11/020
   WATASE M, 1980, RHEOL ACTA, V19, P220, DOI 10.1007/BF01521934
NR 37
TC 25
Z9 25
U1 1
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD OCT
PY 2011
VL 4
IS 7
BP 1115
EP 1122
DI 10.1016/j.jmbbm.2011.03.020
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811EX
UT WOS:000294187500020
PM 21783120
DA 2018-10-20
ER

PT J
AU Nakai, M
   Niinomi, M
   Ishii, D
AF Nakai, Masaaki
   Niinomi, Mitsuo
   Ishii, Daisuke
TI Mechanical and biodegradable properties of porous titanium filled with
   poly-L-lactic acid by modified in situ polymerization technique
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Biomaterial; Porous material; Titanium; Poly-L-lactic acid; Mechanical
   property; Biodegradable property; Low Young's modulus
ID BIOMEDICAL APPLICATIONS; YOUNGS MODULUS; BONE INGROWTH; ALLOYS;
   DEFORMATION; FIXATION
AB Porous titanium (pTi) can possess a low Young's modulus equal to that of human bone, depending on its porosity. However, the mechanical strength of pTi deteriorates greatly with increasing porosity. On the other hand, certain medical polymers exhibit biofunctionalities, which are not possessed intrinsically by metallic materials. Therefore, a biodegradable medical polymer, poly-L-lactic acid (PLLA), was used to fill in the pTi pores using a modified in-situ polymerization technique. The mechanical and biodegradable properties of pTi filled with PLLA (pTi/PLLA) as fabricated by this technique and the effects of the PLLA filling were evaluated in this study.
   The pTi pores are almost completely filled with PLLA by the developed process (i.e., technique). The tensile strength and tensile Young's modulus of pTi barely changes with the PLLA filling. However, the PLLA filling improves the compressive 0.2% proof stress of pTi having any porosity and increases the compressive Young's modulus of pTi having relatively high porosity. This difference between the tensile and compressive properties of pTi/PLLA is considered to be caused by the differing resistances of PLLA in the pores to tensile and compressive deformations. The PLLA filled into the pTi pores degrades during immersion in Hanks' solution at 310 K. The weight loss due to PLLA degradation increases with increasing immersion time. However, the rate of weight loss of pTi/PLLA during immersion decreases with increasing immersion time. Hydroxyapatite formation is observed on the surface of pTi/PLLA after immersion for >= 8 weeks. The decrease in the weight-loss rate may be caused by weight gain due to hydroxyapatite formation and/or the decrease in contact area with Hanks' solution caused by its formation on the surface of pTi/PLLA. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Nakai, Masaaki; Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan.
   [Ishii, Daisuke] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM nakai@imr.tohoku.ac.jp
RI Niinomi, Mitsuo/B-5965-2011; Nakai, Masaaki/C-1919-2009
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT)
   (Tokyo, Japan); Advanced Research Center of Metallic Glasses, Institute
   for Materials Research, Tohoku University (Sendai, Japan)
FX This work was supported in part by the Global COE Program "Materials
   Integration International Center of Education and Research, Tohoku
   University", Ministry of Education, Culture, Sports, Science and
   Technology (MEXT) (Tokyo, Japan), the inter-university cooperative
   research program "Highly-functional Interface Science: Innovation of
   Biomaterials with Highly-functional Interface to Host and Parasite,
   Tohoku University and Kyushu University", MEXT (Tokyo, Japan), and the
   cooperative research program of the Advanced Research Center of Metallic
   Glasses, Institute for Materials Research, Tohoku University (Sendai,
   Japan).
CR Ahmed T., 1996, TITANIUM 95 SCI TECH, P1760
   Bohner M, 2009, BIOMATERIALS, V30, P2175, DOI 10.1016/j.biomaterials.2009.01.008
   CAMERON HU, 1976, J BIOMED MATER RES, V10, P295
   Drumright RE, 2000, ADV MATER, V12, P1841, DOI 10.1002/1521-4095(200012)12:23<1841::AID-ADMA1841>3.3.CO;2-5
   Erk KA, 2008, ACTA MATER, V56, P5147, DOI 10.1016/j.actamat.2008.06.035
   Esen Z, 2007, SCRIPTA MATER, V56, P341, DOI 10.1016/j.scriptamat.2006.11.010
   Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051
   HONDA K, 1961, AKURIRU JUSHI
   IMAI Y, 1976, J MATER SCI, V11, P417, DOI 10.1007/BF00540922
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070
   Murray NGD, 2006, J MATER RES, V21, P1175, DOI 10.1557/JMR.2006.0140
   Nakai M., 2008, J JPN SOC POWDER POW, V55, P312
   Nakai M, 2008, J JPN I MET, V72, P839, DOI 10.2320/jinstmet.72.839
   Nakai M, 2010, J MECH BEHAV BIOMED, V3, P41, DOI 10.1016/j.jmbbm.2009.03.003
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Oh IH, 2003, SCRIPTA MATER, V49, P1197, DOI 10.1016/j.scriptamat.2003.08.018
   Oh IH, 2002, MATER TRANS, V43, P443, DOI 10.2320/matertrans.43.443
   Onishi T, 2007, MATER SCI FORUM, V534-536, P993, DOI 10.4028/www.scientific.net/MSF.534-536.993
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Serro AP, 2003, BIOMATERIALS, V24, P4749, DOI 10.1016/S0142-9612(03)00372-7
   SHIRAISHI H, 1995, MAT JAPAN, V34, P792
   Sumitomo N, 2008, J MATER SCI-MATER M, V19, P1581, DOI 10.1007/s10856-008-3372-y
   YOUNG RJ, 1976, POLYMER, V17, P717, DOI 10.1016/0032-3861(76)90215-9
NR 26
TC 10
Z9 12
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD OCT
PY 2011
VL 4
IS 7
BP 1206
EP 1218
DI 10.1016/j.jmbbm.2011.04.003
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811EX
UT WOS:000294187500029
PM 21783129
DA 2018-10-20
ER

PT J
AU Jiang, S
   Liu, S
   Feng, WH
AF Jiang, Shan
   Liu, Sha
   Feng, Wenhao
TI PVA hydrogel properties for biomedical application
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Polyvinyl alcohol (PVA) hydrogel; Micro-structure; Deformation;
   Mechanical properties; Soft tissue; Liver
ID POLY(VINYL ALCOHOL); CRYOGEL; PHANTOMS; MR
AB PVA has been proposed as a promising biomaterial suitable for tissue mimicking, vascular cell culturing and vascular implanting. In this research, a kind of transparent PVA hydrogel has been investigated in order to mimic the creatural soft tissue deformation during mini-invasive surgery with needle intervention, such as brachytherapy. Three kinds of samples with the same composition of 3 g PVA, 17 g de-ionized water, 80 g dimethyl-sulfoxide but different freeze/thaw cycles have been prepared. In order to investigate the structure and properties of polyvinyl alcohol hydrogel, micro-structure, mechanical property and deformation measurement have been conducted. As the SEM image comparison results show, with the increase of freeze/thaw cycles, PVA hydrogel revealed the similar microstructure to porcine liver tissue. With uniaxial tensile strength test, the above composition with a five freeze/thaw cycle sample resulted in Young's modulus similar to that of porcine liver's property. Through the comparison of needle insertion deformation experiment and the clinical experiment during brachytherapy, results show that the PVA hydrogel had the same deformation property as prostate tissue. These transparent hydrogel phantom. materials can be suitable soft tissue substitutes in needle intervention precision or pre-operation planning studies, particularly in the cases of mimicking creatural tissue deformation and analysing video camera images. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Jiang, Shan; Liu, Sha; Feng, Wenhao] Tianjin Univ, Sch Mech Engn, Ctr Adv Mech & Robot CAMAR, Tianjin 300072, Peoples R China.
RP Jiang, S (reprint author), Tianjin Univ, Sch Mech Engn, Ctr Adv Mech & Robot CAMAR, 92 Weijin Rd, Tianjin 300072, Peoples R China.
EM shanjiang@tju.edu.cn
FU National Natural Science Foundation of People's Republic of China
   [60703045]; Scientific Research Foundation for the Returned Overseas
   Chinese Scholars, State Education Ministry
FX The fund for this project was provided by the National Natural Science
   Foundation of People's Republic of China, grant No. 60703045 and also
   the project was sponsored by the Scientific Research Foundation for the
   Returned Overseas Chinese Scholars, State Education Ministry.
CR BUSHBERG JT, 1994, ESSENTIAL PHYS MED I
   Chanthasopeephan T, 2007, IEEE T BIO-MED ENG, V54, P349, DOI 10.1109/TBME.2006.886937
   Chu KC, 1997, MAGNET RESON MED, V37, P314, DOI 10.1002/mrm.1910370230
   Gobbi DG, 2003, COMPUT MED IMAG GRAP, V27, P255, DOI 10.1016/S0895-6111(02)00091-5
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   Hubbell JA, 1998, CURR OPIN SOLID ST M, V3, P246, DOI 10.1016/S1359-0286(98)80098-3
   HYON SH, 1989, POLYM BULL, V22, P119, DOI 10.1007/BF00255200
   Jiang HJ, 2004, MED ENG PHYS, V26, P269, DOI 10.1016/j.medengphy.2003.10.007
   MANO I, 1986, MAGNET RESON MED, V3, P921, DOI 10.1002/mrm.1910030612
   Nuttelman CR, 2001, J BIOMED MATER RES, V57, P217, DOI 10.1002/1097-4636(200111)57:2<217::AID-JBM1161>3.0.CO;2-I
   Paradossi G, 2003, J MATER SCI-MATER M, V14, P687, DOI 10.1023/A:1024907615244
   PODDER TK, 2006, C P IEEE ENG MED BIO, P3652
   Stammen JA, 2001, BIOMATERIALS, V22, P799, DOI 10.1016/S0142-9612(00)00242-8
   Stone Nelson N, 2002, Brachytherapy, V1, P154, DOI 10.1016/S1538-4721(02)00058-2
   SURLY KJM, 2002, MED IMAGE ANAL, V6, P301
   Surry KJM, 2004, PHYS MED BIOL, V49, P5529, DOI 10.1088/0031-9155/49/24/009
   Vijayasekaran S, 1998, BIOMATERIALS, V19, P2255, DOI 10.1016/S0142-9612(98)00128-8
   Vrana NE, 2008, MACROMOL SYMP, V269, P106, DOI 10.1002/masy.200850913
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
NR 19
TC 105
Z9 115
U1 12
U2 119
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD OCT
PY 2011
VL 4
IS 7
BP 1228
EP 1233
DI 10.1016/j.jmbbm.2011.04.005
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 811EX
UT WOS:000294187500031
PM 21783131
DA 2018-10-20
ER

PT J
AU Franz, S
   Rammelt, S
   Scharnweber, D
   Simon, JC
AF Franz, Sandra
   Rammelt, Stefan
   Scharnweber, Dieter
   Simon, Jan C.
TI Immune responses to implants - A review of the implications for the
   design of immunomodulatory biomaterials
SO BIOMATERIALS
LA English
DT Review
DE Immune response to biomaterials; Immunomodulation; Extracellular matrix;
   Biomaterial integration
ID FOREIGN-BODY RESPONSE; GIANT-CELL FORMATION; HUMAN DENDRITIC CELLS;
   ACUTE INFLAMMATORY RESPONSES; SELF-ASSEMBLED MONOLAYERS; OXYGEN RADICAL
   PRODUCTION; MANNOSE RECEPTOR-ACTIVITY; ENDOTHELIAL GROWTH-FACTOR; TISSUE
   FACTOR EXPRESSION; MESENCHYMAL STEM-CELLS
AB A key for long-term survival and function of biomaterials is that they do not elicit a detrimental immune response. As biomaterials can have profound impacts on the host immune response the concept emerged to design biomaterials that are able to trigger desired immunological outcomes and thus support the healing process. However, engineering such biomaterials requires an in-depth understanding of the host inflammatory and wound healing response to implanted materials.
   One focus of this review is to outline the up-to-date knowledge on immune responses to biomaterials. Understanding the complex interactions of host response and material implants reveals the need for and also the potential of "immunomodulating" biomaterials. Based on this knowledge, we discuss strategies of triggering appropriate immune responses by functional biomaterials and highlight recent approaches of biomaterials that mimic the physiological extracellular matrix and modify cellular immune responses. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Franz, Sandra] Univ Leipzig, Dept Dermatol Venerol & Allergol, Max Burger Res Ctr, D-04103 Leipzig, Germany.
   [Rammelt, Stefan] Dresden Univ Hosp Carl Gustav Carus, Dept Trauma & Reconstruct Surg, D-01307 Dresden, Germany.
   [Scharnweber, Dieter] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Franz, Sandra; Rammelt, Stefan; Scharnweber, Dieter; Simon, Jan C.] Collaborat Res Ctr SFB TR67, Dept Dermatol Venereol & Allergol, D-04103 Leipzig, Germany.
RP Franz, S (reprint author), Univ Leipzig, Dept Dermatol Venerol & Allergol, Max Burger Res Ctr, Johannisallee 30, D-04103 Leipzig, Germany.
EM sandra.franz@medizin.uni-leipzig.de
RI Franz, Sandra/G-6730-2011
OI Scharnweber, Dieter/0000-0003-0369-5189; Franz,
   Sandra/0000-0002-3449-2723
FU German Research Council (DFG) [SFB-TR67, A3, B3, B5]
FX This work was funded by the German Research Council (DFG SFB-TR67,
   projects A3, B3, B5). We thank Markus Karsten for his outstanding help
   in designing the graphics.
CR Acharya AP, 2008, BIOMATERIALS, V29, P4736, DOI 10.1016/j.biomaterials.2008.08.040
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2007, BIOMATERIALS, V28, P5114, DOI [10.1016/j.biomaterials.2007.07.010, 10.1016/j.biornaterials.2007.07.010]
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   Babensee JE, 2002, ANN NY ACAD SCI, V961, P360, DOI 10.1111/j.1749-6632.2002.tb03124.x
   Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081
   Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   Becker D, 2002, J BIOMED MATER RES, V59, P516, DOI 10.1002/jbm.1265
   Bellingan GJ, 2002, J EXP MED, V196, P1515, DOI 10.1084/jem.20011794
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bergers G, 2000, NAT CELL BIOL, V2, P737
   Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164
   Bierbaum S, 2006, J BIOMED MATER RES A, V77A, P551, DOI 10.1002/jbm.a.30572
   Bogdan C, 2011, METHODS MOL BIOL, V677, P375, DOI 10.1007/978-1-60761-869-0_24
   Bollyky PL, 2009, J LEUKOCYTE BIOL, V86, P567, DOI 10.1189/jlb.0109001
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   BRADLEY SG, 1994, DRUG CHEM TOXICOL, V17, P221, DOI 10.3109/01480549409017861
   Brand U, 1998, EUR J IMMUNOL, V28, P1673, DOI 10.1002/(SICI)1521-4141(199805)28:05<1673::AID-IMMU1673>3.0.CO;2-J
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Broughton G, 2006, PLAST RECONSTR SURG, V117, p12S, DOI 10.1097/01.prs.0000225430.42531.c2
   Campo GM, 2003, FREE RADICAL RES, V37, P257, DOI 10.1080/1071576021000046640
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V89A, P490, DOI 10.1002/jbm.a.31981
   Chen Q, 2007, J BIOL CHEM, V282, P26418, DOI 10.1074/jbc.M703341200
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chen XY, 2007, ANAL BIOANAL CHEM, V388, P65, DOI 10.1007/s00216-006-0999-8
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Chung AS, 2009, J BIOMED MATER RES A, V89A, P841, DOI 10.1002/jbm.a.32431
   Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902
   Daamen WF, 2003, BIOMATERIALS, V24, P4001, DOI 10.1016/S0142-9612(03)00273-4
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Dallas SL, 2002, J BIOL CHEM, V277, P21352, DOI 10.1074/jbc.M111663200
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Day AJ, 2005, TRENDS IMMUNOL, V26, P637, DOI 10.1016/j.it.2005.09.009
   de Fougerolles AR, 2002, IMMUNOL REV, V186, P208, DOI 10.1034/j.1600-065X.2002.18617.x
   De la Riva B, 2010, J CONTROL RELEASE, V143, P45, DOI 10.1016/j.jconrel.2009.11.026
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DELLA BS, 2004, BLOOD, V104, P4020
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   Dinnes DLM, 2007, J BIOMED MATER RES A, V80A, P895, DOI 10.1002/jbm.a.30967
   du Souich P, 2009, J CELL MOL MED, V13, P1451, DOI 10.1111/j.1582-4934.2009.00826.x
   Dudhia J, 2005, CELL MOL LIFE SCI, V62, P2241, DOI 10.1007/s00018-005-5217-x
   Duggal S, 2009, TISSUE ENG PT A, V15, P1763, DOI 10.1089/ten.tea.2008.0306
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200
   Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Fischer M, 2010, J MATER SCI-MATER M, V21, P931, DOI 10.1007/s10856-009-3912-0
   Fischer M, 2010, BIOMATERIALS, V31, P2498, DOI 10.1016/j.biomaterials.2009.12.016
   Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297
   Franchimont D, 2002, NEUROIMMUNOMODULAT, V10, P247, DOI 10.1159/000069969
   Franz S, 2009, AUTOIMMUNITY, V42, P275, DOI 10.1080/08916930902828080
   Frick JS, 2010, INT J MED MICROBIOL, V300, P19, DOI 10.1016/j.ijmm.2009.08.010
   Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/hh0302.105345
   Geissler U, 2000, J BIOMED MATER RES, V51, P752, DOI 10.1002/1097-4636(20000915)51:4<752::AID-JBM25>3.0.CO;2-7
   Geissmann F, 1999, J IMMUNOL, V162, P4567
   Gerber JS, 2001, J IMMUNOL, V166, P6861, DOI 10.4049/jimmunol.166.11.6861
   Geutjes PJ, 2006, ADV EXP MED BIOL, V585, P279
   Gifford R, 2005, J BIOMED MATER RES A, V75A, P755, DOI 10.1002/jbm.a.30359
   GILROY DW, 2004, DRUG DISCOV TODAY TH, V1, P313
   Gorbet MB, 2003, J BIOMED MATER RES A, V67A, P792, DOI 10.1002/jbm.a.10155
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Grandjean-Laquerriere A, 2007, BIOMATERIALS, V28, P400, DOI 10.1016/j.biomaterials.2006.09.015
   Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x
   Gratchev A, 2005, SCAND J IMMUNOL, V61, P10, DOI 10.1111/j.0300-9475.2005.01524.x
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Hamilton JA, 2003, J LEUKOCYTE BIOL, V73, P702, DOI 10.1189/jlb.0103037
   Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200
   Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5
   Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769
   HED J, 1984, IMMUNOL LETT, V8, P295, DOI 10.1016/0165-2478(84)90013-0
   Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186
   Helming L, 2007, EUR J IMMUNOL, V37, P33, DOI 10.1002/eji.200636788
   Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005
   Herrero-Beaumont G, 2008, BRIT J PHARMACOL, V154, P843, DOI 10.1038/bjp.2008.113
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hetrick EM, 2007, BIOMATERIALS, V28, P4571, DOI 10.1016/j.biomaterials.2007.06.036
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   Hintze V, 2009, BIOMACROMOLECULES, V10, P3290, DOI 10.1021/bm9008827
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   HOSGOOD G, 1993, VET SURG, V22, P490, DOI 10.1111/j.1532-950X.1993.tb00426.x
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315
   Johne J, 2006, BIOL CHEM, V387, P173, DOI 10.1515/BC.2006.023
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   Jonuleit H, 2000, J EXP MED, V192, P1213, DOI 10.1084/jem.192.9.1213
   Kalbacova M, 2007, BIOMATERIALS, V28, P3263, DOI 10.1016/j.biomaterials.2007.02.026
   Kao WJ, 2001, FRONT BIOSCI, V6, pD992, DOI 10.2741/Kao
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Kao WYJ, 2001, BIOMATERIALS, V22, P2901, DOI 10.1016/S0142-9612(01)00037-0
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769
   Katzin WE, 1996, CLIN DIAGN LAB IMMUN, V3, P156
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505
   Kohl K, 2007, EUR J CELL BIOL, V86, P719, DOI 10.1016/j.ejcb.2007.06.007
   Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215
   Korpos E, 2010, CELL TISSUE RES, V339, P47, DOI 10.1007/s00441-009-0853-3
   Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Labow RS, 2001, J CELL PHYSIOL, V186, P95, DOI 10.1002/1097-4652(200101)186:1<95::AID-JCP1008>3.0.CO;2-0
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Li B, 2009, BIOMATERIALS, V30, P3486, DOI 10.1016/j.biomaterials.2009.03.008
   Liu Y, 2009, DIABETES CARE, V32, P117, DOI [10.2337/dc08-0763, 10.2337/dc09-1394]
   Lowell CA, 1999, J LEUKOCYTE BIOL, V65, P313
   Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0
   MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Marques AP, 2004, J BIOMED MATER RES A, V71A, P419, DOI 10.1002/jbm.a.30155
   Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   McNally AK, 1996, AM J PATHOL, V149, P975
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341
   Mirza R, 2009, AM J PATHOL, V175, P2454, DOI 10.2353/ajpath.2009.090248
   Monchaux E, 2007, BIOMACROMOLECULES, V8, P3668, DOI 10.1021/bm7007907
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058
   MORLEY DJ, 1989, THROMB HAEMOSTASIS, V62, P1023
   Morra M, 2005, INT J ORAL MAX IMPL, V20, P23
   Moseley R, 2004, WOUND REPAIR REGEN, V12, P419, DOI 10.1111/j.1067-1927.2004.12406.x
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325
   Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010
   Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671
   Murphy G, 2008, MOL ASPECTS MED, V29, P290, DOI 10.1016/j.mam.2008.05.002
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   Nakamura HK, 2007, J DENT RES, V86, P147, DOI 10.1177/154405910708600208
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nimeri G, 2003, J BIOMED MATER RES A, V67A, P439, DOI 10.1002/jbm.a.10081
   Nimeri G, 2002, BIOMATERIALS, V23, P1785, DOI 10.1016/S0142-9612(01)00305-2
   Norton LW, 2007, J BIOMED MATER RES A, V81A, P858, DOI 10.1002/jbm.a.31088
   Oshikawa K, 2003, BIOCHEM BIOPH RES CO, V312, P650, DOI 10.1016/j.bbrc.2003.10.166
   Padovan E, 2007, TRENDS IMMUNOL, V28, P308, DOI 10.1016/j.it.2007.05.002
   Park CJ, 2009, BIOMATERIALS, V30, P436, DOI 10.1016/j.biomaterials.2008.09.060
   Patel JD, 2007, J BIOMED MATER RES A, V80A, P381, DOI 10.1002/jbm.a.30907
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   Patil Siddhesh D, 2004, Diabetes Technol Ther, V6, P887, DOI 10.1089/dia.2004.6.887
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Pirila E, 2003, BIOCHEM BIOPH RES CO, V303, P1012, DOI 10.1016/S0006-291X(03)00452-2
   Prantl L, 2008, PLAST RECONSTR SURG, V121, P25, DOI 10.1097/01.prs.0000293758.61624.68
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   Rammelt S, 2004, J ORTHOPAED RES, V22, P1025, DOI 10.1016/j.orthres.2004.02.011
   Rammelt S, 2007, J ORTHOP RES, V25, P1052, DOI 10.1002/jor.20403
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Rodriguez A, 2010, J BIOMED MATER RES A, V92A, P214, DOI 10.1002/jbm.a.32362
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Rogers TH, 2010, BIOMATERIALS, V31, P594, DOI 10.1016/j.biomaterials.2009.09.077
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Rungsiyakull C, 2010, BIOMATERIALS, V31, P7196, DOI 10.1016/j.biomaterials.2010.05.077
   Rutella S, 2004, EUR J IMMUNOL, V34, P1291, DOI 10.1002/eji.200324651
   Rutella S, 2006, BLOOD, V108, P1435, DOI 10.1182/blood-2006-03-006403
   Rutella S, 2006, BLOOD, V108, P218, DOI 10.1182/blood-2005-08-3141
   Saalbach A, 2010, J INVEST DERMATOL, V130, P444, DOI 10.1038/jid.2009.253
   Salek-Ardakani S, 2000, BLOOD, V96, P1879
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0
   Sato K, 2002, CELL IMMUNOL, V215, P186, DOI 10.1016/S0008-8749(02)00021-7
   SAVAGE B, 1995, J BIOL CHEM, V270, P28812, DOI 10.1074/jbc.270.48.28812
   Scapini P, 2000, IMMUNOL REV, V177, P195, DOI 10.1034/j.1600-065X.2000.17706.x
   SCHIRMER C, 2010, BLOOD
   Schmaier AH, 1997, THROMB HAEMOSTASIS, V78, P101
   Schmidmaier Gerhard, 2006, J Long Term Eff Med Implants, V16, P61
   Schmidt DR, 2007, J BIOMED MATER RES A, V83A, P617, DOI 10.1002/jbm.a.31270
   Schneiders W, 2009, J ORTHOP RES, V27, P15, DOI 10.1002/jor.20719
   Schneiders W, 2008, J BIOMED MATER RES A, V85A, P638, DOI 10.1002/jbm.a.31611
   Schneiders W, 2007, BONE, V40, P1048, DOI 10.1016/j.bone.2006.11.019
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110
   Schwentker A, 2002, NITRIC OXIDE-BIOL CH, V7, P1, DOI 10.1016/S1089-8603(02)00002-2
   Sconocchia G, 2001, BLOOD, V97, P3621, DOI 10.1182/blood.V97.11.3621
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   Sefton MV, 2008, SEMIN IMMUNOL, V20, P83, DOI 10.1016/j.smim.2007.12.008
   Shen MC, 2001, J BIOMAT SCI-POLYM E, V12, P961, DOI 10.1163/156856201753252507
   Sheu BC, 2001, CANCER RES, V61, P237
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Smeets TJM, 2001, ANN RHEUM DIS, V60, P561, DOI 10.1136/ard.60.6.561
   Smith MJ, 2010, J BIOMED MATER RES A, V93A, P793, DOI 10.1002/jbm.a.32579
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Sperling C, 2009, BIOMATERIALS, V30, P4447, DOI 10.1016/j.biomaterials.2009.05.044
   Stadlinger B, 2008, INT J ORAL MAX SURG, V37, P54, DOI 10.1016/j.ijom.2007.05.024
   Stadlinger B, 2008, J MATER SCI-MATER M, V19, P1043, DOI 10.1007/s10856-007-3077-7
   Stefonek TJ, 2007, WOUND REPAIR REGEN, V15, P847, DOI 10.1111/j.1524-475X.2007.00288.x
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x
   Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Sundararaj KP, 2009, J BIOL CHEM, V284, P13714, DOI 10.1074/jbc.M806573200
   Tang LP, 1998, J BIOMAT SCI-POLYM E, V9, P1257
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Vallieres M, 2010, OSTEOARTHR CARTILAGE, V18, pS1, DOI 10.1016/j.joca.2010.02.017
   Vancheri C, 2001, AM J RESP CELL MOL, V25, P592, DOI 10.1165/ajrcmb.25.5.4609
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vigouroux S, 2004, BLOOD, V104, P26, DOI 10.1182/blood-2004-01-0182
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Werr J, 2000, J LEUKOCYTE BIOL, V68, P553
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WITT DP, 1994, CURR BIOL, V4, P394, DOI 10.1016/S0960-9822(00)00088-9
   Wollenweber M, 2006, TISSUE ENG, V12, P345, DOI 10.1089/ten.2006.12.345
   XIA ZD, 1994, CHINESE MED J-PEKING, V107, P845
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050615
   Yamashiro S, 2001, J LEUKOCYTE BIOL, V69, P698
   Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798
   Yu Q, 2000, GENE DEV, V14, P163
   Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2
   Zdolsek J, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-31
   Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v
   Zhuo R, 2007, BIOMATERIALS, V28, P4355, DOI 10.1016/j.biomaterials.2007.06.019
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 257
TC 419
Z9 426
U1 16
U2 227
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2011
VL 32
IS 28
BP 6692
EP 6709
DI 10.1016/j.biomaterials.2011.05.078
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 807ZK
UT WOS:000293941400006
PM 21715002
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Shin, YM
   Lee, YB
   Shin, H
AF Shin, Young Min
   Lee, Yu Bin
   Shin, Heungsoo
TI Time-dependent mussel-inspired functionalization of
   poly(L-lactide-co-epsilon-caprolactone) substrates for tunable cell
   behaviors
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polydopamine; Bio-inspired material;
   Poly(L-lactide-co-epsilon-caprolactone); Surface modification; Myoblasts
ID MESENCHYMAL STEM-CELLS; SURFACE MODIFICATION; PLCL SCAFFOLDS;
   ACRYLIC-ACID; ADHESION; IMMOBILIZATION; MEMBRANE; COLLAGEN; FILMS;
   DIFFERENTIATION
AB Surface properties of biomaterials, such as hydrophobic/hydrophilic balance, chemical group distribution, and topography play important roles in regulation of many cellular behaviors. In this study, we present a bio-inspired coating of synthetic biodegradable poly(L-lactide-co-epsilon-caprolactone)(PLCL) films by using polydopamine for tunable cell behaviors such as adhesion and proliferation. Polydopamine coating decreased the water contact angles of the PLCL film from 75 degrees to 40 degrees, while the amount of coated polydopamine increased from 0.6 mu/cm(2) to 177.9 mu g/cm(2). During the process, dopamine could be directly polymerized on the surface of the PLCL film to form a thin layer or nanosized particles of self-aggregates, which resulted in increase of overall roughness in a time-dependent manner. Characterization of surface atomic composition revealed an increase in signals from nitrogen and the C-N bond, both suggesting homogeneous polydopamine coating with prolonged coating time. The mechanical properties were similar following reaction with polydopamine for a time shorter than 30 min, while alterations in elongation and Young's modulus were observed when the coating time exceeded 240 min. Cell adhesion and proliferation on the polydopamine-coated films were significantly greater than those on the non-coated films. Interestingly, these cell behaviors were significantly improved even under the minimal coating time (5 min). In summary, the bio-inspired coating is of use to generate modular surface of biomaterial based on synthetic poly(alpha-hydroxy ester)s for tunable cell behaviors with optimization of coating time within the range in which their mechanical properties are not compromised. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Shin, Young Min; Lee, Yu Bin; Shin, Heungsoo] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
   [Shin, Heungsoo] Hanyang Univ, Inst Bioengn & Biopharmaceut Res, Seoul 133791, South Korea.
   [Shin, Heungsoo] Hanyang Univ, Inst Aging Soc, Seoul 133791, South Korea.
RP Shin, H (reprint author), Hanyang Univ, Dept Bioengn, 17 Haengdang Dong, Seoul 133791, South Korea.
EM hshin@hanyang.ac.kr
FU Ministry of Education, Science and Technology, Korea [2010-0003961,
   R332009000100360]
FX This work was partially supported by the WCU program (R332009000100360)
   and Basic Science Research Program through the National Research
   Foundation of Korea (NRF) (2010-0003961) funded by the Ministry of
   Education, Science and Technology, Korea.
CR Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Cho EH, 2005, CURR APPL PHYS, V5, P475, DOI 10.1016/j.cap.2005.01.013
   Chong MSK, 2007, MAT SCI ENG C-BIO S, V27, P309, DOI 10.1016/j.msec.2006.03.008
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   De Bartolo L, 2007, BIOMOL ENG, V24, P23, DOI 10.1016/j.bioeng.2006.07.001
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   He T, 2009, BIOMATERIALS, V30, P317, DOI 10.1016/j.biomaterials.2008.09.049
   Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906
   Jeong SI, 2005, BIOMATERIALS, V26, P1405, DOI 10.1016/j.biomaterials.2004.04.036
   Jiang JH, 2010, J MEMBRANE SCI, V364, P194, DOI 10.1016/j.memsci.2010.08.017
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Kim TG, 2010, INT J PHARMACEUT, V384, P181, DOI 10.1016/j.ijpharm.2009.09.042
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Li B, 2009, LANGMUIR, V25, P7368, DOI 10.1021/la900262p
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Matsumura K, 2000, J BIOMED MATER RES, V50, P512, DOI 10.1002/(SICI)1097-4636(20000615)50:4<512::AID-JBM6>3.3.CO;2-7
   Ou JF, 2009, APPL SURF SCI, V256, P894, DOI 10.1016/j.apsusc.2009.08.081
   Pan FS, 2009, J MEMBRANE SCI, V341, P279, DOI 10.1016/j.memsci.2009.06.020
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Santiago LY, 2006, BIOMATERIALS, V27, P2962, DOI 10.1016/j.biomaterials.2006.01.011
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin YM, 2008, BIOMACROMOLECULES, V9, P1772, DOI 10.1021/bm701410g
   Shin YM, 2010, MACROMOL RES, V18, P472, DOI 10.1007/s13233-010-0507-z
   SLOCUM TL, 1991, ANAL BIOCHEM, V195, P14, DOI 10.1016/0003-2697(91)90287-4
   Tao CH, 2009, APPL SURF SCI, V256, P294, DOI 10.1016/j.apsusc.2009.08.024
   Volcker N, 2001, J MATER SCI-MATER M, V12, P111, DOI 10.1023/A:1008938525489
   Wavhal DS, 2003, LANGMUIR, V19, P79, DOI 10.1021/la020653o
   Zhu LP, 2009, COLLOID SURFACE B, V69, P152, DOI 10.1016/j.colsurfb.2008.11.011
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 34
TC 53
Z9 53
U1 2
U2 53
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2011
VL 87
IS 1
BP 79
EP 87
DI 10.1016/j.colsurfb.2011.05.004
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 796MN
UT WOS:000293055500013
PM 21605961
DA 2018-10-20
ER

PT J
AU Shalumon, KT
   Anulekha, KH
   Nair, SV
   Nair, SV
   Chennazhi, KP
   Jayakumar, R
AF Shalumon, K. T.
   Anulekha, K. H.
   Nair, Sreeja V.
   Nair, S. V.
   Chennazhi, K. P.
   Jayakumar, R.
TI Sodium alginate/poly(vinyl alcohol)/nano ZnO composite nanofibers for
   antibacterial wound dressings
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Alginate; Nanofibers; Wound dressing; Cytotoxicity; Antibacterial
   activity; Nanoparticles
ID BIOMEDICAL APPLICATIONS; POLY(ETHYLENE OXIDE); CHITOSAN-ALGINATE;
   DRUG-DELIVERY; TISSUE; SCAFFOLDS; COMPATIBILITY
AB Sodium alginate (SA)/poly (vinyl alcohol) (PVA) fibrous mats were prepared by electrospinning technique. ZnO nanoparticles of size similar to 160 nm was synthesized and characterized by UV spectroscopy, dynamic light scattering (DLS), XRD and infrared spectroscopy (IR). SA/PVA electrospinning was further carried out with ZnO with different concentrations (0.5, 1,2 and 5%) to get SA/PVA/ZnO composite nanofibers. The prepared composite nanofibers were characterized using FT-IR, XRD, TGA and SEM studies. Cytotoxicity studies performed to examine the cytocompatibility of bare and composite SA/PVA fibers indicate that those with 0.5 and 1% ZnO concentrations are less toxic where as those with higher concentrations of ZnO is toxic in nature. Cell adhesion potential of this mats were further proved by studying with L929 cells for different time intervals. Antibacterial activity of SA/PVA/ZnO mats were examined with two different bacteria strains: Staphylococcus aureus and Escherichia coli, and found that SA/PVA/ZnO mats shows antibacterial activity due to the presence of ZnO. Our results suggest that this could be an ideal biomaterial for wound dressing applications once the optimal concentration of ZnO which will give least toxicity while providing maximum antibacterial activity is identified.f (C) 2011 Elsevier B.V. All rights reserved.
C1 [Nair, S. V.] Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci, Kochi 682041, India.
   Amrita Vishwa Vidyapeetham Univ, Res Ctr, Kochi 682041, India.
RP Nair, SV (reprint author), Amrita Vishwa Vidyapeetham Univ, Amrita Ctr Nanosci & Mol Med, Amrita Inst Med Sci, Kochi 682041, India.
EM nairshanti@gmail.com; jayakumar77@yahoo.com
OI Chennazhi, Krishna Prasad/0000-0002-9390-0328
FU Nanomission, Department of Science and Technology (DST), Govt. of India;
   Fast Track Scheme for Young Investigators [SR/FT/CS-005/2008]; Council
   of Scientific and Industrial Research (CSIR)
FX The authors are thankful to the Nanomission, Department of Science and
   Technology (DST), Govt. of India and Fast Track Scheme for Young
   Investigators (Ref. No. SR/FT/CS-005/2008) for the financial support.
   The author Shalumon K.T. is grateful to Council of Scientific and
   Industrial Research (CSIR) for awarding Senior Research Fellowship
   (SRF). We are also grateful to Mr. Sajin P. Ravi, Ms. Soumya and Ms.
   Chandini for their assistance in characterization and cellular studies.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   BADWAN AA, 1985, DRUG DEV IND PHARM, V11, P239, DOI 10.3109/03639048509056869
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bhattarai N, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455601
   Bolgen N, 2007, J BIOMED MATER RES B, V81B, P530, DOI 10.1002/jbm.b.30694
   DIVYARANI VV, 2010, CARBOHYD POLYM, V83, P858
   GINZBERG MD, 2003, TISSUE ENG, V9, P757
   Ignatious F, 2010, PHARM RES-DORDR, V27, P576, DOI 10.1007/s11095-010-0061-6
   Jayakumar R, 2010, CARBOHYD POLYM, V82, P227, DOI 10.1016/j.carbpol.2010.04.074
   Kong QS, 2009, MATER SCI FORUM, V610-613, P1188, DOI 10.4028/www.scientific.net/MSF.610-613.1188
   Krevelen D. W. V., 1975, POLYMER, V16, P615
   Lakshmi R.L., 2010, J MACROMOLECULAR SCI, V47, P1012
   Lee YJ, 2007, J APPL POLYM SCI, V106, P1337, DOI 10.1002/app.26568
   Li ZS, 2005, J BIOMED MATER RES A, V75A, P485, DOI 10.1002/jbm.a.30449
   Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062
   Lin WC, 2006, COLLOID SURFACE B, V47, P43, DOI 10.1016/j.colsurfb.2005.11.013
   Lu JW, 2006, POLYMER, V47, P8026, DOI 10.1016/j.polymer.2006.09.027
   MIYAZAKI S, 1994, BIOL PHARM BULL, V17, P745
   Mohan N, 2008, J BIOMED MATER RES B, V84B, P584, DOI 10.1002/jbm.b.30906
   Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5
   Nie HR, 2008, BIOMACROMOLECULES, V9, P1362, DOI 10.1021/bm701349j
   Paul W., 2004, ARTIF ORGANS, V18, P18
   Safi S, 2007, J APPL POLYM SCI, V104, P3245, DOI 10.1002/app.25696
   SENNERBY L, 1987, BIOMATERIALS, V8, P49, DOI 10.1016/0142-9612(87)90029-9
   Shalumon KT, 2010, CARBOHYD POLYM, V80, P413, DOI 10.1016/j.carbpol.2009.11.039
   Shalumon KT, 2009, CARBOHYD POLYM, V77, P863, DOI 10.1016/j.carbpol.2009.03.009
   Yang J, 2001, BIOTECHNOL LETT, V23, P1385, DOI 10.1023/A:1011600414225
NR 28
TC 161
Z9 173
U1 17
U2 172
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
EI 1879-0003
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD OCT 1
PY 2011
VL 49
IS 3
BP 247
EP 254
DI 10.1016/j.ijbiomac.2011.04.005
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 793WF
UT WOS:000292853900001
PM 21635916
DA 2018-10-20
ER

PT J
AU Tee, LK
   Ling, CS
   Chua, MJ
   Abdullah, S
   Rosli, R
   Chowdhury, EH
AF Tee, Lau Khye
   Ling, Chong Siew
   Chua, Ming Jang
   Abdullah, Syahril
   Rosli, Rozita
   Chowdhury, Ezharul Hogue
TI Purification of transcriptionally active multimeric plasmid DNA using
   zwitterionic detergent and carbonate apatite nano-particles
SO PLASMID
LA English
DT Article
DE Carbonate apatite; Nano-crystals; Particle size; NaCl; Glucose;
   Transfection
ID EXPRESSION; EFFICIENT; DELIVERY
AB Plasmid DNA is one of the indispensable components in molecular biology research and a potential biomaterial for gene therapy and DNA vaccination. Both quality and quantity of extracted plasmid DNA are of the great interests in cloning and subsequent expression of genes in vitro and in vivo for basic research and therapeutic interventions. Bacteria with extremely short generation times are the valuable source of plasmid DNA that can be isolated through a number of existing techniques. However, the current methods have some limitations in isolating high quality plasmid DNA since the multimeric plasmid which is believed to be more efficiently transcribed by RNA polymerase than the monomeric form, is almost lost during the extraction process. Recently, we developed a rapid isolation technique for multimeric plasmid based on generation of a 'protein aggregate' using a zwitterionic detergent and alkali. Here we have investigated the roles of different parameters in the whole extraction process to optimise the production of high quality multimeric plasmid DNA. Moreover, we have showed the advantageous effects of nanoparticles to effectively sediment the 'protein aggregate' for smooth elution of multimeric plasmid DNA from it. Finally, quality assessment study has revealed that the isolated multimeric DNA is at least 10 times more transcriptionally active than the monomeric form isolated by the commercially available Qiaget kit. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Tee, Lau Khye; Ling, Chong Siew; Chua, Ming Jang; Chowdhury, Ezharul Hogue] Int Med Univ IMU, Fac Med & Hlth Sci, Kuala Lumpur 57000, Malaysia.
   [Abdullah, Syahril; Rosli, Rozita] Univ Putra Malaysia, Fac Med & Hlth Sci, Upm Serdang 43400, Selangor Darul, Malaysia.
   [Chowdhury, Ezharul Hogue] Monash Univ Sunway Campus, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Selangor Darul, Malaysia.
RP Chowdhury, EH (reprint author), Int Med Univ IMU, Fac Med & Hlth Sci, 126,Jalan 19-155B, Kuala Lumpur 57000, Malaysia.
EM md.ezharul.hoque@med.monash.edu.my
OI Chowdhury, Ezharul Hoque/0000-0002-5705-841X; Abdullah,
   Syahril/0000-0003-2718-6266
CR BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513
   Chowdhury EH, 2007, INT J NANOMED, V2, P101, DOI 10.2147/nano.2007.2.1.101
   Chowdhury EH, 2006, GENE, V376, P87, DOI 10.1016/j.gene.2006.02.028
   Chowdhury EH, 2005, J BIOTECHNOL, V119, P343, DOI 10.1016/j.jbiotec.2005.05.013
   Ehrt Sabine, 2003, Methods Mol Biol, V235, P75
   Kutsuzawa K, 2008, BIOMATERIALS, V29, P370, DOI 10.1016/j.biomaterials.2007.09.011
   Mourich DV, 2003, J IMMUNOL METHODS, V274, P257, DOI 10.1016/S0022-1759(02)00516-1
   Prazeres DMF, 1999, TRENDS BIOTECHNOL, V17, P169, DOI 10.1016/S0167-7799(98)01291-8
   SAMBROOK J, 2001, MOL CLONING LAB MANU, V1, P131
   Tada S, 2010, BIOMATERIALS, V31, P1453, DOI 10.1016/j.biomaterials.2009.10.016
   Voss C, 2003, J BIOTECHNOL, V105, P205, DOI 10.1016/j.jbiotec.2003.07.004
   Zohra FT, 2009, BIOMATERIALS, V30, P4006, DOI 10.1016/j.biomaterials.2009.02.050
NR 12
TC 0
Z9 0
U1 1
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0147-619X
J9 PLASMID
JI Plasmid
PD OCT
PY 2011
VL 66
IS 1
BP 38
EP 46
DI 10.1016/j.plasmid.2011.03.001
PG 9
WC Genetics & Heredity; Microbiology
SC Genetics & Heredity; Microbiology
GA 783CS
UT WOS:000292059700005
PM 21419794
DA 2018-10-20
ER

PT J
AU Zhao, CQ
   Yang, QH
   Chen, WY
   Li, H
   Zhang, H
AF Zhao, Changqing
   Yang, Qinhuan
   Chen, Wuyong
   Li, Hui
   Zhang, Hao
TI Isolation of a sulfate reducing bacterium and its application in sulfate
   removal from tannery wastewater
SO AFRICAN JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Tannery wastewater; sulfate; Citrobacter freundii
ID ANAEROBIC TREATMENT
AB In order to remove sulfate in tannery wastewater efficiently, a sulfate reducing bacterium (SRB) was isolated in tannery anaerobic activated sludge. With biochemical and genetics method, the isolated bacterium was identified as Citrobacter freundii. Then, the isolate was inoculated to tubes containing sulfate in simulated tannery wastewater to optimize the process. The results show that the effect of C. freundii in removing sulfate was best when the temperature was 32 degrees C, pH was 7.0, COD/SO(4)(2-) was 5.0 and the initial SO(4)(2-) concentration was 1500 mg/L. Also, the SRB was inoculated onto an up-flow anaerobic sludge bed (UASB) to remove sulfate in actual tannery wastewater. It was found that the removal rate of sulfate in actual tannery wastewater reached 89.66% which was 12.13% higher than the treatment without inoculating the isolated SRB when the initial SO(4)(2-) concentration was 1069 mg/L. The experiment demonstrates that C. freundii could be selected as a new biomaterial to remove sulfate in tannery wastewater.
C1 [Zhao, Changqing] Sichuan Univ Sci & Engn, Coll Bioengn, Zigong 643000, Peoples R China.
   [Yang, Qinhuan] Sichuan Univ Sci & Engn, Coll Mat & Chem Engn, Zigong 643000, Peoples R China.
   [Zhao, Changqing; Chen, Wuyong; Li, Hui; Zhang, Hao] Sichuan Univ, Natl Engn Lab Clean Technol Leather Mfg, Chengdu 610065, Peoples R China.
RP Zhao, CQ (reprint author), Sichuan Univ Sci & Engn, Coll Bioengn, Zigong 643000, Peoples R China.
EM zhaocq2010@163.com
FU Scientific Research for Sichuan University of Science and Engineering
   [2010XJKRL003]; Chinese Ministry of Education [211161]
FX This work was financially supported by the Startup Project of the
   Scientific Research for Sichuan University of Science and Engineering
   (Item No. 2010XJKRL003) and the Key Project of Chinese Ministry of
   Education (Item No. 211161).
CR [Anonymous], 2006, 227432006 ISO
   Boshoff G, 2004, WATER RES, V38, P2651, DOI 10.1016/j.watres.2004.03.030
   BUCHANAN RE, 1984, BERGEYS MANUAL
   *ISO, 1992, 105301992 ISO
   Jiang YongRong, 2009, Environmental Science & Technology (China), V32, P13
   Kjeldsen KU, 2009, FEMS MICROBIOL ECOL, V69, P481, DOI 10.1111/j.1574-6941.2009.00715.x
   Li WX, 2005, TREATMENT TANNERY PO
   MA F, 2002, MICROORGANISM EXPT P
   MA XY, 2008, THESIS SHANXI U SCI
   Shin HS, 1996, ENVIRON TECHNOL, V17, P361, DOI 10.1080/09593331708616395
   Tadesse I, 2003, BIODEGRADATION, V14, P219, DOI 10.1023/A:1024347721050
NR 11
TC 4
Z9 4
U1 0
U2 9
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1684-5315
J9 AFR J BIOTECHNOL
JI Afr. J. Biotechnol.
PD SEP 26
PY 2011
VL 10
IS 56
BP 11966
EP 11971
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 868QL
UT WOS:000298538400023
DA 2018-10-20
ER

PT J
AU Londin, ER
   Keller, MA
   D'Andrea, MR
   Delgrosso, K
   Ertel, A
   Surrey, S
   Fortina, P
AF Londin, Eric R.
   Keller, Margaret A.
   D'Andrea, Michael R.
   Delgrosso, Kathleen
   Ertel, Adam
   Surrey, Saul
   Fortina, Paolo
TI Whole-exome sequencing of DNA from peripheral blood mononuclear cells
   (PBMC) and EBV-transformed lymphocytes from the same donor
SO BMC GENOMICS
LA English
DT Article
ID EPSTEIN-BARR-VIRUS; LINES; MUTATIONS; ASSOCIATION; IMMORTALIZATION
AB Background: The creation of lymphoblastoid cell lines (LCLs) through Epstein-Barr virus (EBV) transformation of B-lymphocytes can result in a valuable biomaterial for cell biology research and a renewable source of DNA. While LCLs have been used extensively in cellular and genetic studies, the process of cell transformation and expansion during culturing may introduce genomic changes that may impact their use and the interpretation of subsequent genetic findings.
   Results: We performed whole exome sequencing on a tetrad family using DNA derived from peripheral blood mononuclear cells (PBMCs) and LCLs from each individual. We generated over 4.7 GB of mappable sequence to a 125X read coverage per sample. An average of 19,354 genetic variants were identified. Comparison of the two DNA sources from each individual showed an average concordance rate of 95.69%. By lowering the variant calling parameters, the concordance rate between the paired samples increased to 99.82%. Sanger sequencing of a subset of the remaining discordant variants did confirm the presence of de novo mutations arising in LCLs.
   Conclusions: By varying software stringency parameters, we identified 99% concordance between DNA sequences derived from the two different sources from the same donors. These results suggest that LCLs are an appropriate representation of the genetic material of the donor and suggest that EBV transformation can result in low-level generation of de novo mutations. Therefore, use of PBMC or early passage EBV-transformed cells is recommended. These findings have broad-reaching implications, as there are thousands of LCLs in public biorepositories and individual laboratories.
C1 [Londin, Eric R.] Thomas Jefferson Univ, Jefferson Med Coll, Computat Med Ctr, Philadelphia, PA 19107 USA.
   [Keller, Margaret A.] Amer Red Cross, Natl Mol Lab, Philadelphia, PA USA.
   [D'Andrea, Michael R.] Coriell Inst Med Res, Camden, NJ USA.
   [Delgrosso, Kathleen; Ertel, Adam; Fortina, Paolo] Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Dept Canc Biol, Philadelphia, PA 19107 USA.
   [Surrey, Saul] Thomas Jefferson Univ, Jefferson Med Coll, Cardeza Fdn Hematol Res, Dept Med, Philadelphia, PA 19107 USA.
   [Fortina, Paolo] Univ Roma La Sapienza, Sch Med, Dept Mol Med, Rome, Italy.
RP Londin, ER (reprint author), Thomas Jefferson Univ, Jefferson Med Coll, Computat Med Ctr, Philadelphia, PA 19107 USA.
EM eric.londin@jefferson.edu; paolo.fortina@jefferson.edu
FU National Institute of Neurological Disorders and Stroke Repository
   [HH271200800033C]; Kimmel Cancer Center at Thomas Jefferson University
   Jefferson Medical College
FX The authors would like to thank the NINDS Repository for the use of the
   samples in this study. This study was funded as part of the National
   Institute of Neurological Disorders and Stroke Repository contract
   HH271200800033C and the Kimmel Cancer Center at Thomas Jefferson
   University Jefferson Medical College. The sponsors had no role in the
   study design, data collection and analysis, decision to publish or
   preparation of the manuscript.
CR Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Amoli MM, 2008, INT J EPIDEMIOL, V37, P41, DOI 10.1093/ije/dym285
   Anastasio N, 2010, AM J HUM GENET, V87, P553, DOI 10.1016/j.ajhg.2010.09.005
   Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019
   Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024
   Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107
   Herbeck JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006915
   Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010
   Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036
   Krawitz P, 2010, BIOINFORMATICS, V26, P722, DOI 10.1093/bioinformatics/btq027
   Latourelle JC, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-98
   Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570
   Montgomery GW, 2005, TWIN RES HUM GENET, V8, P346, DOI 10.1375/1832427054936673
   Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646
   Ng SB, 2009, NAT GENET, V42, P30
   O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835
   Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090
   Sie L, 2009, J NEUROSCI RES, V87, P1953, DOI 10.1002/jnr.22000
   Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436
   Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487
   Stark AL, 2010, AM J HUM GENET, V87, P829, DOI 10.1016/j.ajhg.2010.10.018
   Sugimoto M, 2004, CANCER RES, V64, P3361, DOI 10.1158/0008-5472.CAN-04-0079
   Toda T, 2003, J CHROMATOGR B, V787, P197, DOI 10.1016/S1570-0232(02)00495-6
   Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712
NR 24
TC 27
Z9 27
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD SEP 26
PY 2011
VL 12
AR 464
DI 10.1186/1471-2164-12-464
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 838NO
UT WOS:000296299500002
PM 21943378
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Eberth, JF
   Cardamone, L
   Humphrey, JD
AF Eberth, J. F.
   Cardamone, L.
   Humphrey, J. D.
TI Evolving biaxial mechanical properties of mouse carotid arteries in
   hypertension
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Pulse pressure; Stiffness; Wall stress; Distensibility; Remodeling
ID WALL MECHANICS; MODEL; GROWTH; BEHAVIOR; QUANTIFICATION; PULSATILITY;
   ADAPTATIONS; PRESSURE; ELASTIN; MEDIA
AB Quantifying the time course of load-induced changes in arterial wall geometry, microstructure, and properties is fundamental to developing mathematical models of growth and remodeling. Arteries adapt to altered pressure and flow by modifying wall thickness, inner diameter, and axial length via marked cell and matrix turnover. To estimate particular biomaterial implications of such adaptations, we used a 4-fiber family constitutive relation to quantify passive biaxial mechanical behaviors of mouse carotid arteries 0 (control), 7-10,10-14, or 35-56 days after an aortic arch banding surgery that increased pulse pressure and pulsatile flow in the right carotid artery. In vivo circumferential and axial stretches at mean arterial pressure were, for example, 11% and 26% lower, respectively, in hypertensive carotids 35-56 days after banding than in normotensive controls; this finding is consistent with observations that hypertension decreases distensibility. Interestingly, the strain energy W stored in the carotids at individual in vivo conditions was also less in hypertensive compared with normotensive carotids. For example, at 35-56 days after banding, W was 24%, 39%, and 47% of normal values at diastolic, mean, and systolic pressures, respectively. The energy stored during the cardiac cycle, W(sys)-W(dias), also tended to be less, but this reduction did not reach significance. When computed at normal in vivo values of biaxial stretch, however, W was well above normal for the hypertensive carotids. This net increase resulted from an overall increase in the collagen-related anisotropic contribution to W despite a decrease in the elastin-related isotropic contribution. The latter was consistent with observed decreases in the mass fraction of elastin. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Eberth, J. F.] Univ Houston, Dept Engn Technol, Houston, TX 77204 USA.
   [Eberth, J. F.] Methodist Hosp, Res Inst, Houston, TX 77030 USA.
   [Cardamone, L.] SISSA, Sect Funct Anal & Applicat, I-34014 Trieste, Italy.
   [Humphrey, J. D.] Yale Univ, Dept Biomed Engn, New Haven, CT USA.
RP Eberth, JF (reprint author), Univ Houston, Dept Engn Technol, Houston, TX 77204 USA.
EM jeberth@uh.edu
OI Eberth, John/0000-0003-1053-9045
FU NIH [HL-105297]
FX This work was supported, in part, by a grant from the NIH (HL-105297).
CR Arribas SM, 2006, PHARMACOL THERAPEUT, V111, P771, DOI 10.1016/j.pharmthera.2005.12.003
   Avolio A, 1998, HYPERTENSION, V32, P170, DOI 10.1161/01.HYP.32.1.170
   Boutouyrie P, 1999, CIRCULATION, V100, P1387, DOI 10.1161/01.CIR.100.13.1387
   Cardamone L, 2010, MATH MED BIOL, V27, P343, DOI 10.1093/imammb/dqq001
   Dajnowiec D, 2007, CLIN SCI, V113, P15, DOI 10.1042/CS200602337
   Driessen NJB, 2004, J THEOR BIOL, V226, P53, DOI 10.1016/j.jtbi.2003.08.004
   Eberth JF, 2009, ANN BIOMED ENG, V37, P1093, DOI 10.1007/s10439-009-9686-1
   Eberth JF, 2010, AM J PHYSIOL-HEART C, V299, pH1875, DOI 10.1152/ajpheart.00872.2009
   Eberth JF, 2009, J HYPERTENS, V27, P2010, DOI 10.1097/HJH.0b013e32832e8dc8
   Ferruzzi J, 2011, J R SOC INTERFACE, V8, P435, DOI 10.1098/rsif.2010.0299
   Fonck E, 2007, AM J PHYSIOL-HEART C, V292, pH2754, DOI 10.1152/ajpheart.01108.2006
   Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073
   Gleason RL, 2008, J BIOMECH, V41, P3213, DOI 10.1016/j.jbiomech.2008.08.012
   Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101
   GUYTON JR, 1985, AM J PHYSIOL, V248, pH540
   Hayashi K, 2009, J MECH BEHAV BIOMED, V2, P3, DOI 10.1016/j.jmbbm.2008.05.002
   Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564
   Li Q, 1998, J VASC RES, V35, P93, DOI 10.1159/000025570
   Ning JF, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002700
   Ogden RW, 2007, BIOMECH MODEL MECHAN, V6, P333, DOI 10.1007/s10237-006-0064-8
   ROCKMAN HA, 1993, CIRCULATION, V87, P14
   Sasamura H, 2005, CURR HYPERTENS REV, V1, P51, DOI 10.2174/1573402052952834
   Strauss BH, 2000, AM J RESP CELL MOL, V22, P1
   Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387
   Tsamis A, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3192142
   Wan W, 2010, ANN BIOMED ENG, V38, P3605, DOI 10.1007/s10439-010-0114-3
   WUYTS FL, 1995, PHYS MED BIOL, V40, P1577, DOI 10.1088/0031-9155/40/10/002
   Zeinali-Davarani S, 2009, J BIOMECH, V42, P524, DOI 10.1016/j.jbiomech.2008.11.022
   Zulliger MA, 2007, J BIOMECH, V40, P3061, DOI 10.1016/j.jbiomech.2007.03.011
NR 29
TC 16
Z9 16
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PD SEP 23
PY 2011
VL 44
IS 14
BP 2532
EP 2537
DI 10.1016/j.jbiomech.2011.07.018
PG 6
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 831TU
UT WOS:000295754800002
PM 21851943
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Jiang, H
   Wang, XB
   Li, CY
   Li, JS
   Xu, FJ
   Mao, C
   Yang, WT
   Shen, J
AF Jiang, H.
   Wang, X. B.
   Li, C. Y.
   Li, J. S.
   Xu, F. J.
   Mao, C.
   Yang, W. T.
   Shen, J.
TI Improvement of Hemocompatibility of Polycaprolactone Film Surfaces with
   Zwitterionic Polymer Brushes
SO LANGMUIR
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; NANOPOROUS POLY(EPSILON-CAPROLACTONE)
   MEMBRANE; POLY(ETHYLENE GLYCOL); BLOOD COMPATIBILITY; PROTEIN
   ADSORPTION; STRONG RESISTANCE; IMMOBILIZATION; COPOLYMERS; LAYER
AB Polycaprolactone (PCL) has been widely,adopted as scaffold biomaterial, but further: improvement of the hemocompatibility of a PCL film surface is still needed for wide biomedical applications In this work, the PCL film surface Was functionalized (3-dimethyl(methacryloyloxyethyl) ammonium propane sulfonate) (P(DMA PS)) brushes via; surface-initiated atom transfer radical polymerization (ATRP) for enhancing hemocompatibility. Kinetics study revealed an approximately linear increase in yield of the functional P(DMAPS) brushes with polymerization time: The blood compatibilities of the modified PCL film surfaces were studied by platelet adhesion tests of: platelet-rich plasma and human whole blood, hemolysis assay, and plasma; recalcification time (PRT) assay. The improvement of hemocompatibility is dependent on the coverage of the grafted P(DMAPS) brushes on the PCL film. Lower or no platelet and blood cell adhesion was observed on the P(DMAPS)-grafted film surfaces. The P(DMAPS) grafting can further decrease hemolysis and enhance the PRT of the PCL surface With the versatility of surface initiated ATRP and the excellent hemocompatibility of zwitterionic polymer brushes, PCL films with desirable blood properties can be readily tailored to cater to various biomedical applications.
C1 [Jiang, H.; Li, C. Y.; Xu, F. J.; Yang, W. T.] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Key Lab Carbon Fiber & Funct Polymers, Minist Educ,Coll Mat Sci & Engn, Beijing 100029, Peoples R China.
   [Wang, X. B.; Mao, C.; Shen, J.] Nanjing Normal Univ, Coll Chem & Mat Sci, Jiangsu Key Lab Biofunct Mat, Nanjing 210046, Peoples R China.
   [Li, J. S.] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
RP Xu, FJ (reprint author), Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Key Lab Carbon Fiber & Funct Polymers, Minist Educ,Coll Mat Sci & Engn, Beijing 100029, Peoples R China.
EM xufj@mail.buct.edu.cn; maochun127@yahoo.cn
RI Xu, Fu-Jian/U-8024-2017
OI Li, Jianshu/0000-0002-1522-7326
FU National Natural Science Foundation of China [50903007, 20874047,
   21075065]; Fok Ying Tung Education Foundation [121048]; Program for New
   Century Excellent Talents in University [NCET-10-0203]
FX This work was supported in part by the National Natural Science
   Foundation of China (Grant Numbers 50903007, 20874047, and 21075065),
   the Fok Ying Tung Education Foundation (Project No. 121048), and the
   Program for New Century Excellent Talents in University (NCET-10-0203).
CR Aldenhoff YBJ, 1997, BIOMATERIALS, V18, P167, DOI 10.1016/S0142-9612(96)00095-6
   Autian J., 1975, POLYM SCI TECHNOL, V8, P181
   CHAN SHO, 1992, MACROMOLECULES, V25, P6209
   Chang Y, 2006, LANGMUIR, V22, P2222, DOI 10.1021/la052692v
   Chen SF, 2005, J AM CHEM SOC, V127, P14473, DOI 10.1021/ja054169u
   Chen SF, 2008, ADV MATER, V20, P335, DOI 10.1002/adma.200701164
   Chen SF, 2006, LANGMUIR, V22, P8186, DOI 10.1021/la061012m
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Fu L, 2008, LANGMUIR, V24, P6100, DOI 10.1021/la703661z
   Greisler HP, 1996, BIOMATERIALS, V17, P329, DOI 10.1016/0142-9612(96)85571-2
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Khandwekar AP, 2011, J BIOMATER APPL, V26, P227, DOI 10.1177/0885328210367442
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   Liu L, 2008, J BIOMED MATER RES B, V87B, P244, DOI 10.1002/jbm.b.31103
   Mao C, 2004, ADV COLLOID INTERFAC, V110, P5, DOI 10.1016/j.cis.2004.02.001
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Nakayama Y, 2007, LANGMUIR, V23, P8206, DOI 10.1021/1a700323m
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Singhal JP, 2002, BIOMATERIALS, V23, P1139, DOI 10.1016/S0142-9612(01)00228-9
   Tugulu S, 2007, MACROMOLECULES, V40, P168, DOI 10.1021/ma060739e
   Werner C, 1999, COLLOID SURFACE A, V159, P519, DOI 10.1016/S0927-7757(99)00290-3
   Xu FJ, 2011, MACROMOLECULES, V44, P2371, DOI 10.1021/ma200160h
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   Xu FJ, 2009, PROG POLYM SCI, V34, P719, DOI 10.1016/j.progpolymsci.2009.04.005
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   Yen C, 2010, INT J POLYM MATER, V59, P923, DOI 10.1080/00914037.2010.504162
   Yen C, 2010, INT J POLYM MATER, V59, P943, DOI 10.1080/00914037.2010.504164
   Yu QA, 2011, ACTA BIOMATER, V7, P1550, DOI 10.1016/j.actbio.2010.12.021
   Zhang Z, 2006, BIOMACROMOLECULES, V7, P3311, DOI 10.1021/bm060750m
   Zhang Z, 2006, LANGMUIR, V22, P10072, DOI 10.1021/la062175d
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
NR 33
TC 96
Z9 99
U1 4
U2 117
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD SEP 20
PY 2011
VL 27
IS 18
BP 11575
EP 11581
DI 10.1021/la202101q
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 818XR
UT WOS:000294790500038
PM 21851101
DA 2018-10-20
ER

PT J
AU Ekdahl, KN
   Lambris, JD
   Elwing, H
   Ricklin, D
   Nilsson, PH
   Teramura, Y
   Nicholls, IA
   Nilsson, B
AF Ekdahl, Kristina N.
   Lambris, John D.
   Elwing, Hans
   Ricklin, Daniel
   Nilsson, Per H.
   Teramura, Yuji
   Nicholls, Ian A.
   Nilsson, Bo
TI Innate immunity activation on biomaterial surfaces: A mechanistic model
   and coping strategies
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Autoprotection; Biomaterial; Coagulation; Complement; Contact
   activation; Inflammation; Innate immunity
ID SELF-ASSEMBLED MONOLAYERS; MOLECULARLY IMPRINTED POLYMERS; COATED
   CARDIOPULMONARY BYPASS; REDUCED COMPLEMENT ACTIVATION; HUMAN C4B-BINDING
   PROTEIN; PEO TRIBLOCK COPOLYMERS; STREPTOCOCCAL M-PROTEIN; FACTOR-H;
   IN-VITRO; NEISSERIA-MENINGITIDIS
AB When an artificial biomaterial (e.g., a stent or implantable pump) is exposed to blood, plasma proteins immediately adhere to the surface, creating a new interface between the biomaterial and the blood. The recognition proteins within the complement and contact activation/coagulation cascade systems of the blood will be bound to, or inserted into, this protein film and generate different mediators that will activate polymorphonuclear leukocytes and monocytes, as well as platelets. Under clinical conditions, the ultimate outcome of these processes may be thrombotic and inflammatory reactions, and consequently the composition and conformation of the proteins in the initial layer formed on the surface will to a large extent determine the outcome of a treatment involving the biomaterial, affecting both the functionality of the material and the patient's life quality. This review presents models of biomaterial-induced activation processes and describes various strategies to attenuate potential adverse reactions by conjugating bioactive molecules to surfaces or by introducing nanostructures. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Ekdahl, Kristina N.; Teramura, Yuji; Nilsson, Bo] Uppsala Univ, Dept Immunol Genet & Pathol IGP, Rudbeck Lab C5 3, SE-75185 Uppsala, Sweden.
   [Ekdahl, Kristina N.; Nilsson, Per H.; Nicholls, Ian A.] Linnaeus Univ, Sch Nat Sci, SE-39182 Kalmar, Sweden.
   [Lambris, John D.; Ricklin, Daniel] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Elwing, Hans] Univ Gothenburg, Gothenburg, Sweden.
   [Nicholls, Ian A.] Uppsala Univ, Dept Biochem & Organ Chem, SE-75185 Uppsala, Sweden.
RP Ekdahl, KN (reprint author), Uppsala Univ, Dept Immunol Genet & Pathol IGP, Rudbeck Lab C5 3, SE-75185 Uppsala, Sweden.
EM Kristina.Nilsson_Ekdahl@igp.uu.se
RI Nilsson, Bo/B-3102-2012; Ricklin, Daniel/F-5104-2011; Nilsson Ekdahl,
   Kristina/B-5301-2012
OI Nilsson, Bo/0000-0003-0057-2730; Ricklin, Daniel/0000-0001-6140-0233;
   Lambris, John/0000-0002-9370-5776
FU Swedish Research Council (VR) [2009-4675, 2009-4462]; Swedish Research
   Council; Swedish Research Council/SSF/Vinnova [60761701]; U.S. National
   Institutes of Health [AI068730, AI030040, AI072106, EB3968, GM062134];
   Linnaeus University
FX This work was supported by grants from the Swedish Research Council (VR)
   2009-4675, 2009-4462, from the Swedish Research Council, and Swedish
   Research Council/SSF/Vinnova contract grant number 60761701, by U.S.
   National Institutes of Health grants AI068730, AI030040, AI072106,
   EB3968, and GM062134, and by faculty grants from the Linnaeus
   University. We thank Dr. Deborah McClellan for excellent editorial
   assistance and Mr Hans Nilsson for preparing the artwork in Fig. 2.
CR Alexander C, 2006, J MOL RECOGNIT, V19, P106, DOI 10.1002/jmr.760
   Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andersen TE, 2011, BIOMATERIALS, V32, P4481, DOI 10.1016/j.biomaterials.2011.03.002
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Andrade J, 1986, PROTEIN ADSORPTION M
   Arima Y, 2008, BIOMATERIALS, V29, P551, DOI 10.1016/j.biomaterials.2007.10.015
   Back J, 2010, BIOCHEM BIOPH RES CO, V391, P11, DOI 10.1016/j.bbrc.2009.10.123
   Back J, 2009, BIOMATERIALS, V30, P6573, DOI 10.1016/j.biomaterials.2009.07.052
   Baksaas ST, 1999, PERFUSION-UK, V14, P119, DOI 10.1177/026765919901400205
   Banda NK, 2009, J IMMUNOL, V183, P5928, DOI 10.4049/jimmunol.0901826
   Berglin M, 2009, LANGMUIR, V25, P5602, DOI 10.1021/la803686m
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Donaldson J A, 1980, Gold Bull, V13, P117
   Donaldson J.A., 1980, GOLD BULL, V13, P114
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   ELWING H, 1988, J COLLOID INTERF SCI, V125, P139, DOI 10.1016/0021-9797(88)90062-8
   Engberg A.E., 2011, J BIOMED MATER RES A, V94A, P74
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Ferraz N, 2010, MICROSC RES TECHNIQ, V73, P1101, DOI 10.1002/jemt.20854
   Fischer M, 2010, BIOMATERIALS, V31, P2498, DOI 10.1016/j.biomaterials.2009.12.016
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   GHEBREHIWET B, 1983, J CLIN INVEST, V71, P1450, DOI 10.1172/JCI110898
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   GOLDBERGER G, 1981, J BIOL CHEM, V256, P2617
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hamad O.A., ADV EXP MED BIOL, V946, P185
   Hamad O.A., 2010, J IMMUNOL, V185, P2686
   Hamad OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012889
   HAMMERSCHMIDT DE, 1978, BLOOD, V51, P721
   Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x
   Haupt K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000250
   Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Ikeda K, 1997, THROMB HAEMOSTASIS, V77, P394
   Inoue Y, 2010, COLLOID SURFACE B, V81, P350, DOI 10.1016/j.colsurfb.2010.07.030
   Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C
   IVANOVICH P, 1983, KIDNEY INT, V24, P758, DOI 10.1038/ki.1983.224
   Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jin RC, 2005, MICROCIRCULATION, V12, P247, DOI 10.1080/10739680590925493
   Kaklamani G., 2010, BIOMED MAT, V5
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   LACHMANN PJ, 1982, J EXP MED, V156, P205, DOI 10.1084/jem.156.1.205
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501
   Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513
   Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006
   Marwick C, 2000, JAMA-J AM MED ASSOC, V283, P869, DOI 10.1001/jama.283.7.869
   Moen O, 1997, ANN THORAC SURG, V63, P105
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Murthy R, 2009, BIOMATERIALS, V30, P2433, DOI 10.1016/j.biomaterials.2009.01.051
   NORDE W, 1986, ADV COLLOID INTERFAC, V25, P267, DOI 10.1016/0001-8686(86)80012-4
   Norell MC, 1998, J MOL RECOGNIT, V11, P98, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<98::AID-JMR399>3.0.CO;2-Y
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Persson J, 2006, PLOS PATHOG, V2, P442, DOI 10.1371/journal.ppat.0020047
   Piletsky SA, 1999, MACROMOLECULES, V32, P633, DOI 10.1021/ma9812736
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   Qu HC, 2011, MOL IMMUNOL, V48, P481, DOI 10.1016/j.molimm.2010.10.004
   Qu H, 2009, MOL IMMUNOL, V47, P185, DOI 10.1016/j.molimm.2009.08.032
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Ratner BD, 2007, POLYM INT, V56, P1183, DOI 10.1002/pi.2319
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Ritis K, 2006, J IMMUNOL, V177, P4794, DOI 10.4049/jimmunol.177.7.4794
   Rosengren-Holmberg J.P., 2011, ATTENUATION CO UNPUB
   Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566
   Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769
   Schousboe I, 2008, FEBS J, V275, P5161, DOI 10.1111/j.1742-4658.2008.06647.x
   Schrezenmeier H, 2009, EXPERT REV HEMATOL, V2, P7, DOI 10.1586/17474086.2.1.7
   Sellborn A, 2005, MOL IMMUNOL, V42, P569, DOI 10.1016/j.molimm.2004.09.015
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   SPATH P, 1976, CLIN CHIM ACTA, V73, P171, DOI 10.1016/0009-8981(76)90319-3
   Sperling C, 2005, BIOMATERIALS, V26, P6547, DOI 10.1016/j.biomaterials.2005.04.042
   Svenson J, 2001, ANAL CHIM ACTA, V435, P19, DOI 10.1016/S0003-2670(00)01396-9
   TAN JS, 1993, BIOMATERIALS, V14, P823, DOI 10.1016/0142-9612(93)90004-L
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   THERN A, 1995, J IMMUNOL, V154, P375
   THOMAN ML, 1984, J IMMUNOL, V133, P2629
   Vanderah DJ, 2009, LANGMUIR, V25, P5026, DOI 10.1021/la803896a
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0
   Wennerberg A, 2009, CLIN ORAL IMPLAN RES, V20, P172, DOI 10.1111/j.1600-0501.2009.01775.x
   Wettero J, 2001, J BIOMED MATER RES, V57, P550, DOI 10.1002/1097-4636(20011215)57:4<550::AID-JBM1201>3.0.CO;2-T
   White CJ, 2010, EXPERT OPIN DRUG DEL, V7, P765, DOI 10.1517/17425241003770098
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Wu YQ, 2011, J IMMUNOL, V186, P4269, DOI 10.4049/jimmunol.1003802
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Yang W, 2009, LANGMUIR, V25, P11911, DOI 10.1021/la9015788
   Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620
NR 106
TC 80
Z9 80
U1 2
U2 58
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD SEP 16
PY 2011
VL 63
IS 12
BP 1042
EP 1050
DI 10.1016/j.addr.2011.06.012
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 833DI
UT WOS:000295861600009
PM 21771620
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chang, JW
   Wang, CG
   Huang, CY
   Tsai, TD
   Guo, TF
   Wen, TC
AF Chang, Jer-Wei
   Wang, Cheng-Guang
   Huang, Chong-Yu
   Tsai, Tzung-Da
   Guo, Tzung-Fang
   Wen, Ten-Chin
TI Chicken Albumen Dielectrics in Organic Field-Effect Transistors
SO ADVANCED MATERIALS
LA English
DT Article
ID THIN-FILM TRANSISTORS; DENATURATION; MORPHOLOGY; OVALBUMIN
AB The application of the biomaterial dielectrics made of thermally crosslinking natural proteins without any additives in fabricating organic electronics is highlighted. The gate dielectrics of organic field-effect transistors (OFETs) are prepared by the thermal treatment of the chicken albumen film taken directly from a fresh egg. Flexible OFETs and the complementary inverters fabricated with albumen dielectrics are demonstrated.
C1 [Chang, Jer-Wei; Wang, Cheng-Guang; Huang, Chong-Yu; Tsai, Tzung-Da; Guo, Tzung-Fang] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Inst Electroopt Sci & Engn, Tainan 701, Taiwan.
   [Wen, Ten-Chin] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 701, Taiwan.
RP Guo, TF (reprint author), Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Inst Electroopt Sci & Engn, Tainan 701, Taiwan.
EM guotf@mail.ncku.edu.tw
RI Wen, Ten-Chin/F-8884-2010
FU National Science Council (NSC) of Taiwan [NSC99-2113-M-006-008-MY3];
   Asian Office of Aerospace Research and Development [AOARD-10-4054]; NCKU
FX The authors thank the National Science Council (NSC) of Taiwan
   (NSC99-2113-M-006-008-MY3), the Asian Office of Aerospace Research and
   Development (AOARD-10-4054), and NCKU Landmark project for financially
   supporting this research. T.-F.G. is grateful for the sabbatical at The
   University of Tennessee, Knoxville, Department of Materials Science and
   Engineering.
CR Bettinger CJ, 2010, POLYM INT, V59, P563, DOI 10.1002/pi.2827
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Burch RR, 2004, SYNTHETIC MET, V146, P43, DOI 10.1016/j.synthmet.2004.06.014
   Chang JW, 2010, ORG ELECTRON, V11, P1613, DOI 10.1016/j.orgel.2010.07.003
   DARIUSZ W, 2008, SYNTHESIS-STUTTGART, V16, P2491
   HOLME J, 1963, J PHYS CHEM-US, V67, P782, DOI 10.1021/j100798a016
   Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6
   Irimia-Vladu M, 2011, J MATER CHEM, V21, P1350, DOI 10.1039/c0jm02444a
   Irimia-Vladu M, 2010, ORG ELECTRON, V11, P1974, DOI 10.1016/j.orgel.2010.09.007
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim YS, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3299022
   Knipp D, 2003, APPL PHYS LETT, V82, P3907, DOI 10.1063/1.1578536
   Lu YJ, 1998, INT J FOOD SCI TECH, V33, P393, DOI 10.1046/j.1365-2621.1998.00161.x
   SELA M, 1959, BIOCHIM BIOPHYS ACTA, V36, P471, DOI 10.1016/0006-3002(59)90188-X
   SHIMADA K, 1980, J AGR FOOD CHEM, V28, P409, DOI 10.1021/jf60228a044
   Shtein M, 2002, APPL PHYS LETT, V81, P268, DOI 10.1063/1.1491009
   Singh B, 2006, J APPL PHYS, V100, DOI 10.1063/1.2220488
   Singh TB, 2010, ADV POLYM SCI, V223, P189, DOI 10.1007/12_2009_6
   STADELMAN WJ, 1995, EGG SCI TECHNOLOGY, P120
   Sze S., 2007, PHYS SEMICONDUCTOR D, V303
   Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5
   Wang CH, 2011, ADV MATER, V23, P1630, DOI 10.1002/adma.201004071
   Yumusak C, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3278592
NR 23
TC 86
Z9 89
U1 9
U2 73
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD SEP 15
PY 2011
VL 23
IS 35
BP 4077
EP +
DI 10.1002/adma.201102124
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 824UP
UT WOS:000295228000010
PM 21809399
DA 2018-10-20
ER

PT J
AU Ibrahim, WM
AF Ibrahim, Wael M.
TI Biosorption of heavy metal ions from aqueous solution by red macroalgae
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE Biosorption; Heavy metals; Langmuir isotherm; Red macroalgae
ID ALGAE CERAMIUM-VIRGATUM; MARINE-ALGAE; PRETREATED BIOMASS;
   ULVA-FASCIATA; SARGASSUM SP; GREEN; REMOVAL; BROWN; LEAD; EQUILIBRIUM
AB Biosorption is an effective process for the removal and recovery of heavy metal ions from aqueous solutions. The biomass of marine algae has been reported to have high biosorption capacities for a number of heavy metal ions. In this study, four species of red seaweeds Corallina mediterranea, Galaxaura oblongata, Jania rubens and Pterocladia capillacea were examined to remove Co(II), Cd(II), Cr(III) and Pb(II) ions from aqueous solution. The experimental parameters that affect the biosorption process such as pH, contact time and biomass dosage were studied. The maximum biosorption capacity of metal ions was 105.2 mg/g at biomass dosage 10 g/L, pH 5 and contact time 60 min. The biosorption efficiency of algal biomass for the removal of heavy metal ions from industrial wastewater was evaluated for two successive cycles. Galaxaura oblongata biomass was relatively more efficient to remove metal ions with mean biosorption efficiency of 84%. This study demonstrated that these seaweeds constitute a promising, efficient, cheap and biodegradable sorbent biomaterial for lowering the heavy metal pollution in the environment. (C) 2011 Elsevier B.V. All rights reserved.
C1 Fayoum Univ, Fac Sci, Dept Bot, Al Fayyum, Egypt.
RP Ibrahim, WM (reprint author), Fayoum Univ, Fac Sci, Dept Bot, Al Fayyum, Egypt.
EM wms01@fayoum.edu.eg
CR Anjana K, 2007, J HAZARD MATER, V148, P383, DOI 10.1016/j.jhazmat.2007.02.051
   Chatterjee SK, 2010, J HAZARD MATER, V175, P117, DOI 10.1016/j.jhazmat.2009.09.136
   Chen JP, 2002, LANGMUIR, V18, P9413, DOI 10.1021/la026060v
   COSTODES V C T, 2003, J HAZARD MATER, V105, P121
   Dursun G, 2005, J HAZARD MATER, V125, P175, DOI 10.1016/j.jhazmat.2005.05.023
   Ekmekyapar F, 2006, J HAZARD MATER, V137, P293, DOI 10.1016/j.jhazmat.2006.02.003
   Figueira MM, 1999, ENVIRON SCI TECHNOL, V33, P1840, DOI 10.1021/es981111p
   Gupta VK, 2008, J HAZARD MATER, V154, P347, DOI 10.1016/j.jhazmat.2007.10.032
   Hashim MA, 2004, CHEM ENG J, V97, P249, DOI 10.1016/S1385-8947(03)00216-X
   Herrero R, 2008, BIORESOURCE TECHNOL, V99, P4138, DOI 10.1016/j.biortech.2007.08.065
   HOLAN ZR, 1994, BIOTECHNOL BIOENG, V43, P1001, DOI 10.1002/bit.260431102
   Jalali R, 2002, J HAZARD MATER, V92, P253, DOI 10.1016/S0304-3894(02)00021-3
   Kaewsarn P, 2001, ENVIRON POLLUT, V112, P209, DOI 10.1016/S0269-7491(00)00114-7
   Karthikeyan S, 2007, BIORESOURCE TECHNOL, V98, P452, DOI 10.1016/j.biortech.2006.01.010
   Kumar YP, 2006, J HAZARD MATER, V137, P367, DOI 10.1016/j.jhazmat.2006.02.010
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   Liu YH, 2009, J HAZARD MATER, V163, P931, DOI 10.1016/j.jhazmat.2008.07.046
   Maresova J, 2011, DESALINATION, V266, P134, DOI 10.1016/j.desal.2010.08.014
   Martins BL, 2006, BIOCHEM ENG J, V27, P310, DOI 10.1016/j.bej.2005.08.007
   Mata YN, 2008, J HAZARD MATER, V158, P316, DOI 10.1016/j.jhazmat.2008.01.084
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   Murphy V, 2008, CHEMOSPHERE, V70, P1128, DOI 10.1016/j.chemosphere.2007.08.015
   Murphy V, 2007, WATER RES, V41, P731, DOI 10.1016/j.watres.2006.11.032
   Pavasant P, 2006, BIORESOURCE TECHNOL, V97, P2321, DOI 10.1016/j.biortech.2005.10.032
   Rao PS, 2005, SEPAR SCI TECHNOL, V40, P3149, DOI 10.1080/01496390500385350
   Sar P, 2002, BIOTECHNOL LETT, V24, P239, DOI 10.1023/A:1014153913287
   Sari A, 2008, J HAZARD MATER, V157, P448, DOI 10.1016/j.jhazmat.2008.01.008
   Sari A, 2008, J HAZARD MATER, V152, P302, DOI 10.1016/j.jhazmat.2007.06.097
   Sari A, 2008, J HAZARD MATER, V160, P349, DOI 10.1016/j.jhazmat.2008.03.005
   Unlu N, 2006, J HAZARD MATER, V136, P272, DOI 10.1016/j.jhazmat.2005.12.013
   Vijayaraghavan K, 2005, SEP PURIF TECHNOL, V44, P53, DOI 10.1016/j.seppur.2004.12.003
   Vilar VJP, 2008, BIORESOURCE TECHNOL, V99, P750, DOI 10.1016/j.biortech.2007.01-042
   Vilar VJR, 2008, CHEM ENG J, V144, P420, DOI 10.1016/j.cej.2008.02.020
   Wang XS, 2006, J HAZARD MATER, V138, P582, DOI 10.1016/j.jhazmat.2006.05.091
   Yipmantin A, 2011, J HAZARD MATER, V185, P922, DOI 10.1016/j.jhazmat.2010.09.108
   Yu QM, 1999, WATER RES, V33, P1534, DOI 10.1016/S0043-1354(98)00363-7
   Zhang YS, 2010, J HAZARD MATER, V178, P1085, DOI 10.1016/j.jhazmat.2010.02.051
NR 37
TC 59
Z9 61
U1 2
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD SEP 15
PY 2011
VL 192
IS 3
BP 1827
EP 1835
DI 10.1016/j.jhazmat.2011.07.019
PG 9
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 824XZ
UT WOS:000295236800112
PM 21798665
DA 2018-10-20
ER

PT J
AU Naik, AJT
   Ismail, S
   Kay, C
   Wilson, M
   Parkin, IP
AF Naik, Anupriya J. T.
   Ismail, Salim
   Kay, Christopher
   Wilson, Michael
   Parkin, Ivan P.
TI Antimicrobial activity of polyurethane embedded with methylene blue,
   toluidene blue and gold nanoparticles against Staphylococcus aureus;
   illuminated with white light
SO MATERIALS CHEMISTRY AND PHYSICS
LA English
DT Article
DE Polymer; Biomaterial; Antimicrobial; Methylene blue; Toluidene blue;
   Nanogold
ID CATHETER-RELATED INFECTIONS; GRAM-NEGATIVE BACTERIA; PHOTODYNAMIC
   THERAPY; BLOOD COMPONENTS; LETHAL PHOTOSENSITIZATION; MICROBIAL
   INFECTIONS; SINGLET OXYGEN; PHOTODECONTAMINATION; INACTIVATION;
   PREVENTION
AB Polyurethane polymer sheets were embedded with methylene blue (MB), toluidine blue (TBO) and 2 nm gold nanoparticles by a swell-shrink encapsulation process using an acetone water mixture. The polymers were characterised by IR, UV-vis, SEM/WDX and mechanical testing. The dye impregnated polymers were potent at killing suspensions of Staphylococcus aureus under white illumination with a hospital light source (2000 lux) showing a 2.8 log(10) kill (MB) and a 4.3 log(10) kill (TBO) compared to controls when exposed to 24 h of illumination. Notably the incorporation of gold nanoparticles with the dyes enhanced the observed kill to 3.8 log(10) (MB) and 4.8 log(10) (TBO). This is the first time that a derivatised polyurethane polymer used in catheters has been shown to be effective in killing bacteria using white light illumination. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Naik, Anupriya J. T.; Parkin, Ivan P.] UCL, Mat Chem Res Ctr, Dept Chem, London WC1H OAJ, England.
   [Kay, Christopher] UCL, Dept Biol, London WC1H OAJ, England.
   [Ismail, Salim; Wilson, Michael] UCL, Div Microbial Dis, UCL Eastman Dent Inst, London WC1X 8LD, England.
RP Parkin, IP (reprint author), UCL, Mat Chem Res Ctr, Dept Chem, 20 Gordon St, London WC1H OAJ, England.
EM i.p.parkin@ucl.ac.uk
RI Kay, Christopher/C-2467-2008
OI Kay, Christopher/0000-0002-5200-6004; Parkin, Ivan/0000-0002-4072-6610
CR BenHur E, 1996, TRANSFUS MED REV, V10, P15, DOI 10.1016/S0887-7963(96)80119-2
   BEZMAN P, 1978, PHOTOCHEM PHOTOBIOL, V28, P325
   DAHL TA, 1987, PHOTOCHEM PHOTOBIOL, V46, P345, DOI 10.1111/j.1751-1097.1987.tb04779.x
   Eggimann P, 2004, MICROBES INFECT, V6, P1033, DOI 10.1016/j.micinf.2004.05.018
   Gil-Tomas J, 2011, J MATER CHEM, V21, P4189, DOI 10.1039/c0jm03555f
   Hampton Sylvie, 2004, Br J Nurs, V13, P1180
   He JH, 2008, CHAOS SOLITON FRACT, V38, P1390, DOI 10.1016/j.chaos.2008.04.018
   His R.A., 1999, DRUGS, V57, P725
   Jori G, 2006, J ENVIRON PATHOL TOX, V25, P505, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.320
   Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361
   Junqueira HC, 2002, PHYS CHEM CHEM PHYS, V4, P2320, DOI 10.1039/b109753a
   Kalsi J, 2003, INT J CLIN PRACT, V57, P388
   Kunin CM, 1997, URINARY TRACT INFECT, P227
   MACROBERT AJ, 1989, CIBA F SYMP, V146, P4
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Maki DG, 1998, HOSP INFECT, P689
   MALIK Z, 1990, J PHOTOCH PHOTOBIO B, V5, P281, DOI 10.1016/1011-1344(90)85044-W
   MOHR H, 1995, IMMUNOL INVEST, V24, P73, DOI 10.3109/08820139509062763
   NARBAND N, 2009, NANOTECHNOLOGY, V19, P1
   Narband N, 2009, PHYS CHEM CHEM PHYS, V11, P10513, DOI 10.1039/b909714g
   Narband N, 2008, CURR NANOSCI, V4, P409, DOI 10.2174/157341308786306134
   NITZAN Y, 1992, PHOTOCHEM PHOTOBIOL, V55, P89, DOI 10.1111/j.1751-1097.1992.tb04213.x
   NOIMARK S, 2009, CHEM SOC REV     DEC
   OLEINICK NL, 1998, RADIAT RES, V150, P146
   PAGE C, 2009, J MATER CHEM, V19, P7381
   Perni S, 2009, BIOMATERIALS, V30, P89, DOI 10.1016/j.biomaterials.2008.09.020
   Raad I, 1998, LANCET, V351, P893, DOI 10.1016/S0140-6736(97)10006-X
   Santus R, 1998, CLIN HEMORHEOL MICRO, V18, P299
   Tambyah PA, 2004, INT J ANTIMICROB AG, V24, P44
   Tardivo JP, 2005, PHOTODIAGN PHOTODYN, V2, P175, DOI 10.1016/S1572-1000(05)00097-9
   Tomas J. G-, 2007, J MATER CHEM, V17, P3739
   Trautner BW, 2004, ARCH INTERN MED, V164, P842, DOI 10.1001/archinte.164.8.842
   VALDUGA G, 1993, J PHOTOCH PHOTOBIO B, V21, P81, DOI 10.1016/1011-1344(93)80168-9
   Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554
   Wainwright M, 1998, J ANTIMICROB CHEMOTH, V42, P13, DOI 10.1093/jac/42.1.13
   Warren JW, 1997, INFECT DIS CLIN N AM, V11, P609, DOI 10.1016/S0891-5520(05)70376-7
   Wilson M, 2004, PHOTOCH PHOTOBIO SCI, V3, P412, DOI 10.1039/b211266c
   Wilson M, 2003, INFECT CONT HOSP EP, V24, P782, DOI 10.1086/502136
NR 38
TC 36
Z9 36
U1 1
U2 29
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0254-0584
J9 MATER CHEM PHYS
JI Mater. Chem. Phys.
PD SEP 15
PY 2011
VL 129
IS 1-2
BP 446
EP 450
DI 10.1016/j.matchemphys.2011.04.040
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 790WJ
UT WOS:000292621200072
DA 2018-10-20
ER

PT J
AU Neuss, S
   Denecke, B
   Gan, L
   Lin, Q
   Bovi, M
   Apel, C
   Woltje, M
   Dhanasingh, A
   Salber, J
   Knuchel, R
   Zenke, M
AF Neuss, Sabine
   Denecke, Bernd
   Gan, Lin
   Lin, Qiong
   Bovi, Manfred
   Apel, Christian
   Woeltje, Michael
   Dhanasingh, Anandhan
   Salber, Jochen
   Knuechel, Ruth
   Zenke, Martin
TI Transcriptome Analysis of MSC and MSC-Derived Osteoblasts on Resomer (R)
   LT706 and PCL: Impact of Biomaterial Substrate on Osteogenic
   Differentiation
SO PLOS ONE
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; BIODEGRADABLE POLYMERS; REGENERATIVE MEDICINE;
   SKIN SUBSTITUTE; EXPRESSION; SCAFFOLD; PROTEIN; CYTOCOMPATIBILITY;
   DEGRADATION; COPOLYMERS
AB Background: Mesenchymal stem cells (MSC) represent a particularly attractive cell type for bone tissue engineering because of their ex vivo expansion potential and multipotent differentiation capacity. MSC are readily differentiated towards mature osteoblasts with well-established protocols. However, tissue engineering frequently involves three-dimensional scaffolds which (i) allow for cell adhesion in a spatial environment and (ii) meet application-specific criteria, such as stiffness, degradability and biocompatibility.
   Methodology/Principal Findings: In the present study, we analysed two synthetic, long-term degradable polymers for their impact on MSC-based bone tissue engineering: PLLA-co-TMC (Resomer (R) LT706) and poly(epsilon-caprolactone) (PCL). Both polymers enhance the osteogenic differentiation compared to tissue culture polystyrene (TCPS) as determined by Alizarin red stainings, scanning electron microscopy, PCR and whole genome expression analysis. Resomer (R) LT706 and PCL differ in their influence on gene expression, with Resomer (R) LT706 being more potent in supporting osteogenic differentiation of MSC. The major trigger on the osteogenic fate, however, is from osteogenic induction medium.
   Conclusion: This study demonstrates an enhanced osteogenic differentiation of MSC on Resome (R) LT706 and PCL compared to TCPS. MSC cultured on Resomer (R) LT706 showed higher numbers of genes involved in skeletal development and bone formation. This identifies Resomer (R) LT706 as particularly attractive scaffold material for bone tissue engineering.
C1 [Neuss, Sabine; Knuechel, Ruth] Rhein Westfal TH Aachen Univ, Inst Pathol, Aachen, Germany.
   [Neuss, Sabine] Rhein Westfal TH Aachen Univ, Biointerface Grp, Inst Biomed Engn, Aachen, Germany.
   [Neuss, Sabine; Lin, Qiong; Zenke, Martin] Rhein Westfal TH Aachen Univ, Helmholtz Inst Biomed Engn, Aachen, Germany.
   [Denecke, Bernd; Gan, Lin; Woeltje, Michael] Rhein Westfal TH Aachen Univ, Interdisciplinary Ctr Clin Res, IZKF Aachen, Aachen, Germany.
   [Lin, Qiong; Zenke, Martin] Rhein Westfal TH Aachen Univ, Dept Cell Biol, Inst Biomed Engn, Aachen, Germany.
   [Bovi, Manfred] Univ Clin Aachen, Electron Microscop Facil, Aachen, Germany.
   [Apel, Christian] Rhein Westfal TH Aachen Univ, Dept Conservat Dent Periodontol & Prevent Dent, Aachen, Germany.
   [Dhanasingh, Anandhan; Salber, Jochen] Rhein Westfal TH Aachen Univ, DWI eV, Aachen, Germany.
   [Dhanasingh, Anandhan; Salber, Jochen] Rhein Westfal TH Aachen Univ, Inst Tech & Macromol Chem, Aachen, Germany.
   [Salber, Jochen] Ruhr Univ Bochum, Chirurg Klin & Poliklin, BG Univ Klinikum Bergmannsheil, Bochum, Germany.
RP Neuss, S (reprint author), Rhein Westfal TH Aachen Univ, Inst Pathol, Aachen, Germany.
EM sneuss-stein@ukaachen.de
RI Lin, Qiong/J-6880-2015
OI Lin, Qiong/0000-0002-7964-6191
FU Interdisciplinary Centre for Clinical Research (IZKF) Aachen from the
   faculty of Medicine at RWTH Aachen University [VVB-110]
FX This work was supported by a grant from the Interdisciplinary Centre for
   Clinical Research (IZKF) Aachen from the faculty of Medicine at RWTH
   Aachen University (VVB-110). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Artham T, 2008, MACROMOL BIOSCI, V8, P14, DOI 10.1002/mabi.200700106
   BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639
   Breitling R, 2004, FEBS LETT, P57383
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Cappi B, 2010, J BIOMED MATER RES A, V93A, P67, DOI 10.1002/jbm.a.32527
   Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   da Silva Meirelles L, 2008, STEM CELLS, V26, P2287, DOI DOI 10.1634/STEMCELLS.2007-1122
   Di Cesare PE, 2000, J ORTHOPAED RES, V18, P713, DOI 10.1002/jor.1100180506
   Fabbri P, 2010, J MATER SCI-MATER M, V21, P343, DOI 10.1007/s10856-009-3839-5
   Garlet TP, 2008, CYTOKINE, V42, P330, DOI 10.1016/j.cyto.2008.03.003
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9
   Hofmann A, 2008, J TRAUMA, V65, P1402, DOI 10.1097/TA.0b013e318173e7c2
   HOLLAND SJ, 1992, ADV PHARM SCI, V6, P101
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Ji LJ, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045009
   Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002
   KRONENTHAL RL, 1975, POLYM MED SURG, P119
   Lee K, 2009, J BIOMED MATER RES B, V89B, P252, DOI 10.1002/jbm.b.31199
   Li XM, 2006, J BIOMED MATER RES B, V77B, P219, DOI 10.1002/jbm.b.30425
   Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037
   Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007
   Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405
   Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Neuss S, 2010, CELLS TISSUES ORGANS, V191, P36, DOI 10.1159/000215579
   Neuss S, 2009, BIOMATERIALS, V30, P1697, DOI 10.1016/j.biomaterials.2008.12.027
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   Pospiech D, 2005, BIOMACROMOLECULES, V6, P439, DOI 10.1021/bm049393a
   R Development Core Team, 2005, R LANG ENV STAT COMP
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rim NG, 2009, MACROMOL BIOSCI, V9, P795, DOI 10.1002/mabi.200800358
   Schwarze H, 2008, ANN PLAS SURG, V60, P181, DOI 10.1097/SAP.0b013e318056bbf6
   Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007060930
   Tae SK, 2006, BIOMED MATER, V1, P63, DOI 10.1088/1748-6041/1/2/003
   TANZI MC, 2006, BASIC APPL MYOL, V16, P117
   Uhlig C, 2007, BURNS, V33, P221, DOI 10.1016/j.burns.2006.04.024
   Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591
   Weinand C, 2007, TISSUE ENG, V13, P757, DOI 10.1089/ten.2006.0083
   Yang J, 2010, EUR POLYM J, V46, P783, DOI 10.1016/j.eurpolymj.2009.12.017
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015
NR 51
TC 14
Z9 14
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 14
PY 2011
VL 6
IS 9
AR e23195
DI 10.1371/journal.pone.0023195
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 822JC
UT WOS:000295039700001
PM 21935359
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Subbiahdoss, G
   Fernandez, ICS
   Domingues, JFD
   Kuijer, R
   van der Mei, HC
   Busscher, HJ
AF Subbiahdoss, Guruprakash
   Fernandez, Isabel C. Saldarriaga
   Domingues, Joana F. da Silva
   Kuijer, Roel
   van der Mei, Henny C.
   Busscher, Henk J.
TI In Vitro Interactions between Bacteria, Osteoblast-Like Cells and
   Macrophages in the Pathogenesis of Biomaterial-Associated Infections
SO PLOS ONE
LA English
DT Article
ID MICROBIAL BIOFILM GROWTH; STAPHYLOCOCCUS-AUREUS; TISSUE INTEGRATION;
   EPIDERMIDIS; PHAGOCYTOSIS; PERSISTENCE; COMPLEXITY; EVOLUTION; SURVIVAL;
   SEQUENCE
AB Biomaterial-associated infections constitute a major clinical problem that is difficult to treat and often necessitates implant replacement. Pathogens can be introduced on an implant surface during surgery and compete with host cells attempting to integrate the implant. The fate of a biomaterial implant depends on the outcome of this race for the surface. Here we studied the competition between different bacterial strains and human U2OS osteoblast-like cells (ATCC HTB-94) for a poly(methylmethacrylate) surface in the absence or presence of macrophages in vitro using a peri-operative contamination model. Bacteria were seeded on the surface at a shear rate of 11 1/s prior to adhesion of U2OS cells and macrophages. Next, bacteria, U2OS cells and macrophages were allowed to grow simultaneously under low shear conditions (0.14 1/s). The outcome of the competition between bacteria and U2OS cells for the surface critically depended on bacterial virulence. In absence of macrophages, highly virulent Staphylococcus aureus or Pseudomonas aeruginosa stimulated U2OS cell death within 18 h of simultaneous growth on a surface. Moreover, these strains also caused cell death despite phagocytosis of adhering bacteria in presence of murine macrophages. Thus U2OS cells are bound to loose the race for a biomaterial surface against S. aureus or P. aeruginosa, even in presence of macrophages. In contrast, low-virulent Staphylococcus epidermidis did not cause U2OS cell death even after 48 h, regardless of the absence or presence of macrophages. Clinically, S. aureus and P. aeruginosa are known to yield acute and severe biomaterial-associated infections in contrast to S. epidermidis, mostly known to cause more low-grade infection. Thus it can be concluded that the model described possesses features concurring with clinical observations and therewith has potential for further studies on the simultaneous competition for an implant surface between tissue cells and pathogenic bacteria in presence of immune system components.
C1 [Subbiahdoss, Guruprakash] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
   Univ Groningen, Groningen, Netherlands.
RP Subbiahdoss, G (reprint author), Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.
EM h.c.van.der.mei@med.umcg.nl
RI Kuijer, Roel/A-6690-2015
OI Kuijer, Roel/0000-0002-7637-4944; Subbiahdoss,
   Guruprakash/0000-0002-6684-7322
FU University of Medical Center Groningen
FX This work was funded by the University of Medical Center Groningen. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   BABIOR BM, 1984, BLOOD, V64, P959
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   BONVENTRE P F, 1970, Infection and Immunity, V2, P89
   BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342
   DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102
   Fernandez ICS, 2011, EUR CELLS MATER, V21, P73, DOI 10.22203/eCM.v021a06
   FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772
   FITZGERALD RH, 1985, AM J MED, V78, P225, DOI 10.1016/0002-9343(85)90389-4
   Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005
   GRISTINA A G, 1988, Medical Progress Through Technology, V14, P205
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GUENTHER F, 2009, MOL IMMUNOL, V46, P1805
   JOHNSON GM, 1986, INFECT IMMUN, V54, P13
   Kaplan SS, 1999, INFECT IMMUN, V67, P1640
   Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002
   Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409
   Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002
   LYNN M, 1984, BRIT J EXP PATHOL, V65, P275
   Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551
   MCKEVITT AI, 1990, INFECT IMMUN, V58, P1473
   Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263
   PETERS G, 1987, PATHOGENICITY CLIN S, P15
   Raad I, 1998, CLIN INFECT DIS, V26, P1182, DOI 10.1086/520285
   Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x
   SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205
   Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002
   Subbiahdoss G, 2010, J BIOMED MATER RES A, V94A, P533, DOI 10.1002/jbm.a.32731
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   TOFTE RW, 1980, INFECT IMMUN, V27, P693
   Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185
   Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744
   Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405
   Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305
NR 41
TC 20
Z9 20
U1 5
U2 24
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 13
PY 2011
VL 6
IS 9
AR e24827
DI 10.1371/journal.pone.0024827
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 825ZV
UT WOS:000295321800069
PM 21931858
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Fetsch, C
   Grossmann, A
   Holz, L
   Nawroth, JF
   Luxenhofer, R
AF Fetsch, Corinna
   Grossmann, Arlett
   Holz, Lisa
   Nawroth, Jonas F.
   Luxenhofer, Robert
TI Polypeptoids from N-Substituted Glycine N-Carboxyanhydrides:
   Hydrophilic, Hydrophobic, and Amphiphilic Polymers with Poisson
   Distribution
SO MACROMOLECULES
LA English
DT Article
ID AMINO ACID DERIVATIVES; ZUM ISOTOPIE-EFFEKT; NCA-POLYMERIZATION;
   SYNTHETIC POLYPEPTIDES; BLOCK COPOLYPEPTIDES; SECONDARY STRUCTURE;
   DRUG-DELIVERY; SARCOSINE-NCA; CHEMISTRY; PHENYLALANINE
AB Preparation of defined and functional polymers has been one of the hottest topics in polymer science and drug delivery in the recent decade. Also, research on (bio)degradable polymers gains more and more interest, in particular at the interface of these two disciplines. However, in the majority of cases, combination of definition, functionality and degradability, is problematic. Here we present the preparation and characterization (MALDI-ToF MS, NMR, GPC) of nonionic hydrophilic, hydrophobic, and amphiphilic N-substituted polyglycines (polypeptoids), which are expected to be main-chain degradable and are able to disperse a hydrophobic model compound in aqueous media. Polymerization kinetics suggest that the polymerization is well controlled with strictly linear pseudo first-order kinetic plots to high monomer consumption. Moreover, molar mass distributions of products are Poisson-type and molar mass can be controlled by the monomer to initiator ratio. The presented polymer platform is nonionic, backbone degradable, and synthetically highly flexible and may therefore be valuable for a broad range of applications, in particular as a biomaterial.
C1 [Fetsch, Corinna; Grossmann, Arlett; Holz, Lisa; Nawroth, Jonas F.; Luxenhofer, Robert] Tech Univ Dresden, Dept Chem, D-01062 Dresden, Germany.
RP Luxenhofer, R (reprint author), Tech Univ Dresden, Dept Chem, Zellescher Weg 19, D-01062 Dresden, Germany.
EM robert.luxenhofer@chemie.tu-dresden.de
RI Luxenhofer, Robert/C-2825-2008
OI Luxenhofer, Robert/0000-0001-5567-7404
FU King Abdullah University of Science and Technology (KAUST)
   [KUK-F1-029-32]
FX This publication is based on work supported by Award No. KUK-F1-029-32,
   made by King Abdullah University of Science and Technology (KAUST). We
   would like to acknowledge helpful discussions on infra red spectroscopy
   and ongoing support by Prof. Rainer Jordan.
CR Aliferis T, 2004, BIOMACROMOLECULES, V5, P1653, DOI 10.1021/bm0497217
   Ballard D. G., 1953, NATURE, V4365, P907
   BALLARD DGH, 1964, BIOPOLYMERS, V2, P463, DOI 10.1002/bip.1964.360020505
   BALLARD DGH, 1956, PROC R SOC LON SER-A, V236, P384, DOI 10.1098/rspa.1956.0143
   BALLARD DGH, 1960, MAKROMOLEKUL CHEM, V35, P222
   BAMFORD CH, 1966, BIOPOLYMERS, V4, P1067, DOI 10.1002/bip.1966.360041003
   Barz M, 2011, POLYM CHEM-UK, V2, P1900, DOI 10.1039/c0py00406e
   Bellomo EG, 2004, NAT MATER, V3, P244, DOI 10.1038/nmat1093
   Deming TJ, 2007, PROG POLYM SCI, V32, P858, DOI 10.1016/j.progpolymsci.2007.05.010
   Deming TJ, 2002, ADV DRUG DELIVER REV, V54, P1145, DOI 10.1016/S0169-409X(02)00062-5
   Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084
   Dimitrov I, 2003, CHEM COMMUN, P2944, DOI 10.1039/b308990h
   Guo L, 2009, J AM CHEM SOC, V131, P18072, DOI 10.1021/ja907380d
   Habraken GJM, 2010, POLYM CHEM-UK, V1, P514, DOI 10.1039/b9py00337a
   HABRAKEN GJM, 2011, POLYM CHEM, DOI DOI 10.1039/CLPY00079A
   HANKE H, 1960, Pharm Zentralhalle Dtschl, V99, P318
   HEYNS K, 1958, LIEBIGS ANN CHEM, V611, P40
   HEYNS K, 1958, LIEBIGS ANN CHEM, V611, P33
   Huber S, 2008, COLLOID POLYM SCI, V286, P1653, DOI 10.1007/s00396-008-1942-7
   JASIN HE, 1965, IMMUNOLOGY, V8, P95
   Jordan R, 2001, MACROMOLECULES, V34, P8858, DOI 10.1021/ma011573e
   Kanzaki T, 2008, MACROMOL BIOSCI, V8, P1026, DOI 10.1002/mabi.200800071
   Kidchob T, 1996, J CONTROL RELEASE, V40, P285, DOI 10.1016/0168-3659(95)00196-4
   Kidchob T, 1998, J CONTROL RELEASE, V50, P205, DOI 10.1016/S0168-3659(97)00135-1
   Kidchob T, 1997, J APPL POLYM SCI, V63, P453, DOI 10.1002/(SICI)1097-4628(19970124)63:4<453::AID-APP6>3.3.CO;2-Q
   KIM KS, 2001, Patent No. 200140163
   KIRSCHKE H, 1969, H-S Z PHYSIOL CHEM, V350, P1437, DOI 10.1515/bchm2.1969.350.2.1437
   Kirshenbaum K, 1998, P NATL ACAD SCI USA, V95, P4303, DOI 10.1073/pnas.95.8.4303
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   KOPPLE KD, 1957, J AM CHEM SOC, V79, P6442, DOI 10.1021/ja01581a022
   Kricheldorf H. R., 1987, ALPHA AMINOACID N CA
   Kricheldorf HR, 2006, ANGEW CHEM INT EDIT, V45, P5752, DOI 10.1002/anie.200600693
   KRICHELDORF HR, 1971, CHEM BER-RECL, V104, P87, DOI 10.1002/cber.19711040114
   Kricheldorf HR, 2005, MACROMOL CHEM PHYSIC, V206, P282, DOI 10.1002/macp.200400417
   Kricheldorf HR, 2004, MACROMOL CHEM PHYSIC, V205, P918, DOI 10.1002/macp.200400021
   KRICHELDORF HR, 1976, MAKROMOL CHEM, V177, P1243
   Lu H, 2009, J AM CHEM SOC, V131, P13582, DOI 10.1021/ja903425x
   Luxenhofer R, 2010, BIOMATERIALS, V31, P4972, DOI 10.1016/j.biomaterials.2010.02.057
   Makino A, 2009, BIOMATERIALS, V30, P5156, DOI 10.1016/j.biomaterials.2009.05.046
   MEYER M, 2006, THESIS U POTSDAM
   Murnen HK, 2010, J AM CHEM SOC, V132, P16112, DOI 10.1021/ja106340f
   Nakamura R, 2006, MACROMOL RAPID COMM, V27, P1725, DOI 10.1002/marc.200600455
   Nam KT, 2010, NAT MATER, V9, P454, DOI [10.1038/nmat2742, 10.1038/NMAT2742]
   Nottelet B, 2010, J POLYM SCI POL CHEM, V48, P3244, DOI 10.1002/pola.24100
   Novaki LP, 2000, LANGMUIR, V16, P35, DOI 10.1021/la981768o
   Pasut G, 2006, ADV POLYM SCI, V192, P95, DOI 10.1007/12_022
   Pickel DL, 2009, MACROMOLECULES, V42, P7781, DOI 10.1021/ma901340y
   Reichardt C, 2005, GREEN CHEM, V7, P339, DOI 10.1039/b500106b
   RUDE E, 1968, CARBOHYD RES, V8, P219, DOI 10.1016/S0008-6215(00)80158-5
   RUDE E, 1970, ANGEW CHEM, V82, P202
   Scholz C., 2008, Int. Pat. Application, Patent No. [2008/012258, 2008012258]
   SELA M, 1959, ADV PROTEIN CHEM, V14, P391, DOI 10.1016/S0065-3233(08)60614-2
   SELA MICHAEL, 1966, ADVANCE IMMUNOL, V5, P29, DOI 10.1016/S0065-2776(08)60272-2
   Seo J, 2009, ORG LETT, V11, P5210, DOI 10.1021/ol9021468
   SHALITIN Y, 1960, J AM CHEM SOC, V82, P1630, DOI 10.1021/ja01492a028
   Sinkeldam RW, 2007, ORG BIOMOL CHEM, V5, P2523, DOI 10.1039/b707719j
   SISIDO M, 1977, MAKROMOL CHEM, V178, P3107
   SISIDO M, 1970, BIOPOLYMERS, V9, P791, DOI 10.1002/bip.1970.360090705
   SISIDO M, 1969, BIOPOLYMERS, V7, P937, DOI 10.1002/bip.1969.360070609
   Sisido M, 1970, POLYM J, V1, P198
   SKOOG DA, 1994, PRINCIPLES INSTRUMEN
   Statz AR, 2008, SOFT MATTER, V4, P131, DOI 10.1039/b711944e
   Statz AR, 2009, BIOINTERPHASES, V4, pFA22, DOI 10.1116/1.3115103
   Statz AR, 2005, J AM CHEM SOC, V127, P7972, DOI 10.1021/ja0522534
   Stepto RFT, 2010, POLYM INT, V59, P23, DOI 10.1002/pi.2748
   Tang HY, 2010, BIOMACROMOLECULES, V11, P1585, DOI 10.1021/bm1002174
   Tanisaka H, 2008, BIOCONJUGATE CHEM, V19, P109, DOI 10.1021/bc7001665
   Vayaboury W, 2004, MACROMOL RAPID COMM, V25, P1221, DOI 10.1002/marc.200400111
   Vayaboury W, 2008, MACROMOL CHEM PHYS, V209, P1628, DOI 10.1002/macp.200800096
   WALEY SG, 1949, PROC R SOC LON SER-A, V199, P499, DOI 10.1098/rspa.1949.0151
   Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419
   WESSELY F, 1950, MONATSH CHEM, V81, P861, DOI 10.1007/BF00899328
   Yu M, 1999, J AM CHEM SOC, V121, P12210, DOI 10.1021/ja993637v
NR 73
TC 79
Z9 81
U1 4
U2 84
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0024-9297
J9 MACROMOLECULES
JI Macromolecules
PD SEP 13
PY 2011
VL 44
IS 17
BP 6746
EP 6758
DI 10.1021/ma201015y
PG 13
WC Polymer Science
SC Polymer Science
GA 816GB
UT WOS:000294585600017
DA 2018-10-20
ER

PT J
AU Masters, KS
AF Masters, Kristyn S.
TI Covalent Growth Factor Immobilization Strategies for Tissue Repair and
   Regeneration
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biomaterials; biomimetic; growth factors; stem cells; tissue engineering
ID EMBRYONIC STEM-CELLS; BONE MORPHOGENETIC PROTEIN-2; ARTIFICIAL
   JUXTACRINE STIMULATION; POLY(ETHYLENE GLYCOL) HYDROGELS; MARROW STROMAL
   CELLS; OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX;
   PHOTO-IMMOBILIZATION; NEURITE OUTGROWTH; ENDOTHELIAL-CELLS
AB Growth factors play a critical role in regulating processes involved in cellular differentiation and tissue regeneration, and are therefore considered essential elements in many tissue engineering strategies. The covalent immobilization of growth factors to biomaterial matrices addresses many of the challenges associated with delivering freely-diffusible growth factors and has thus emerged as a promising method of achieving localized and sustained growth factor delivery. This Feature Article discusses methods that have been used to immobilize growth factors to substrates, followed by an overview of several tissue repair and regeneration applications in which immobilized growth factors have been used.
C1 Univ Wisconsin Madison, Dept Biomed Engn, Madison, WI 53706 USA.
RP Masters, KS (reprint author), Univ Wisconsin Madison, Dept Biomed Engn, 1550 Engn Dr 2152, Madison, WI 53706 USA.
EM kmasters@wisc.edu
CR Achyuta AKH, 2009, BIOTECHNOL PROGR, V25, P227, DOI [10.1002/btpr.58, 10.1021/bp.58]
   Aizawa Y, 2008, BIOMATERIALS, V29, P4676, DOI 10.1016/j.biomaterials.2008.08.018
   Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222
   Anderson SM, 2009, BIOMATERIALS, V30, P4618, DOI 10.1016/j.biomaterials.2009.05.030
   Backer MV, 2006, BIOMATERIALS, V27, P5452, DOI 10.1016/j.biomaterials.2006.06.025
   Balasundaram G, 2008, J BIOMED MATER RES A, V84A, P447, DOI 10.1002/jbm.a.31388
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   BENNETT NT, 1993, AM J SURG, V166, P74, DOI 10.1016/S0002-9610(05)80589-6
   Boucher C, 2009, BIOCONJUGATE CHEM, V20, P1569, DOI 10.1021/bc9001147
   Brose C, 2009, ANN ANAT, V191, P83, DOI 10.1016/j.aanat.2008.09.004
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Cetinkaya G, 2007, J BIOMED MATER RES A, V81A, P911, DOI 10.1002/jbm.a.31107
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   Chen L, 2009, BIOMACROMOLECULES, V10, P3193, DOI 10.1021/bm900850q
   Chiang CK, 2010, ACTA BIOMATER, V6, P1904, DOI 10.1016/j.actbio.2009.12.005
   Chiu LLY, 2011, J TISSUE ENG REGEN M, V5, P69, DOI 10.1002/term.292
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Chou CH, 2006, J BIOMED MATER RES B, V77B, P338, DOI 10.1002/jbm.b.30432
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Driessen RL, 2003, EXP HEMATOL, V31, P1284, DOI 10.1016/j.exphem.2003.08.015
   Fan HB, 2010, J BIOMED MATER RES A, V95A, P982, DOI 10.1002/jbm.a.32899
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590
   FINETTI G, 1992, FARMACO, V47, P967
   Fonder MA, 2008, J AM ACAD DERMATOL, V58, P185, DOI 10.1016/j.jaad.2007.08.048
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   Goldman Robert, 2004, Adv Skin Wound Care, V17, P24, DOI 10.1097/00129334-200401000-00012
   Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047
   Goncalves R, 2010, J BIOMED MATER RES A, V94A, P576, DOI 10.1002/jbm.a.32723
   Grazul-Bilska AT, 2003, DRUGS TODAY, V39, P787, DOI 10.1358/dot.2003.39.10.799472
   He QF, 2011, ACTA BIOMATER, V7, P1084, DOI 10.1016/j.actbio.2010.10.022
   He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Horne MK, 2010, STEM CELLS DEV, V19, P843, DOI 10.1089/scd.2009.0158
   Il Cho Y, 2010, ACTA BIOMATER, V6, P4725, DOI 10.1016/j.actbio.2010.06.019
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   Ito Y, 1997, J BIOCHEM-TOKYO, V121, P514
   Ito Y, 2001, J BIOCHEM-TOKYO, V129, P733, DOI 10.1093/oxfordjournals.jbchem.a002913
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Ito Y, 1998, J BIOMAT SCI-POLYM E, V9, P879, DOI 10.1163/156856298X00217
   Ito Y, 2008, SOFT MATTER, V4, P46, DOI 10.1039/b708359a
   Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821
   Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kirkwood Keith, 2003, J Oral Implantol, V29, P57, DOI 10.1563/1548-1336(2003)029<0057:IVMSWS>2.3.CO;2
   Klenkler BJ, 2010, J BIOMED MATER RES A, V93A, P1043, DOI 10.1002/jbm.a.32578
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074
   Leipzig ND, 2011, BIOMATERIALS, V32, P57, DOI 10.1016/j.biomaterials.2010.09.031
   Leslie-Barbick JE, 2011, TISSUE ENG PT A, V17, P221, DOI [10.1089/ten.tea.2010.0202, 10.1089/ten.TEA.2010.0202]
   Leslie-Barbick JE, 2009, J BIOMAT SCI-POLYM E, V20, P1763, DOI 10.1163/156856208X386381
   Liberelle B, 2010, BIOCONJUGATE CHEM, V21, P2257, DOI 10.1021/bc1002604
   Lin CC, 2009, PHARM RES-DORD, V26, P631, DOI 10.1007/s11095-008-9801-2
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Makino H, 2004, J BIOSCI BIOENG, V98, P374, DOI 10.1263/jbb.98.374
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   Moore NM, 2010, BIOMATERIALS, V31, P1604, DOI [10.1016/j.biomatetials.2009.11.011, 10.1016/j.biomaterials.2009.11.011]
   Morisada T, 2006, ENDOTHELIUM-J ENDOTH, V13, P71, DOI 10.1080/10623320600697989
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   Niu G, 2010, CURR DRUG TARGETS, V11, P1000, DOI 10.2174/138945010791591395
   Ogiwara K, 2006, BIOCHEM BIOPH RES CO, V345, P255, DOI 10.1016/j.bbrc.2006.04.001
   Papanas N, 2010, DRUG SAFETY, V33, P455, DOI 10.2165/11534570-000000000-00000
   Park YJ, 2006, BIOTECHNOL APPL BIOC, V43, P17, DOI 10.1042/BA20050075
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042
   Pompe T, 2010, NAT PROTOC, V5, P1042, DOI 10.1038/nprot.2010.70
   Puccinelli TJ, 2010, ACTA BIOMATER, V6, P3415, DOI 10.1016/j.actbio.2010.04.006
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rahman N, 2010, BIOMATERIALS, V31, P8262, DOI 10.1016/j.biomaterials.2010.07.040
   RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T
   Reichelt J, 2007, EUR J CELL BIOL, V86, P807, DOI 10.1016/j.ejcb.2007.06.004
   Sahni A, 1998, J BIOL CHEM, V273, P7554, DOI 10.1074/jbc.273.13.7554
   Saik JE, 2011, ACTA BIOMATER, V7, P133, DOI 10.1016/j.actbio.2010.08.018
   Salinas CN, 2007, TISSUE ENG, V13, P1025, DOI 10.1089/ten.2006.0126
   Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307
   Sharon JL, 2008, ACTA BIOMATER, V4, P1016, DOI 10.1016/j.actbio.2008.02.017
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Shen H, 2009, BIOMATERIALS, V30, P3150, DOI 10.1016/j.biomaterials.2009.02.004
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   Shi ZL, 2009, BIOMACROMOLECULES, V10, P1603, DOI 10.1021/bm900203w
   Stadelmann WK, 1998, AM J SURG, V176, p26S, DOI 10.1016/S0002-9610(98)00183-4
   Stefonek TJ, 2007, WOUND REPAIR REGEN, V15, P847, DOI 10.1111/j.1524-475X.2007.00288.x
   Stefonek-Puccinelli TJ, 2008, ANN BIOMED ENG, V36, P2121, DOI 10.1007/s10439-008-9581-1
   Tigli RS, 2008, INT J BIOL MACROMOL, V43, P121, DOI 10.1016/j.ijbiomac.2008.04.003
   Tigli RS, 2011, J BIOMAT SCI-POLYM E, V22, P207, DOI 10.1163/092050609X12591500475424
   Uebersax L, 2009, TISSUE ENG PART B-RE, V15, P263, DOI 10.1089/ten.TEB.2008.0668
   Vogelin E, 2000, TISSUE ENG, V6, P449, DOI 10.1089/107632700418155
   Watanabe K, 2003, ZOOL SCI, V20, P429, DOI 10.2108/zsj.20.429
   White R, 2009, J Wound Care, V18, P335
   WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0
   Yamachika E, 2009, J BIOMED MATER RES A, V88A, P599, DOI 10.1002/jbm.a.31833
   Zacchigna S, 2007, HUM GENE THER, V18, P515, DOI 10.1089/hum.2006.162
   Zhang HN, 2010, TISSUE ENG PT A, V16, P3441, DOI [10.1089/ten.tea.2010.0132, 10.1089/ten.TEA.2010.0132]
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zouani OF, 2010, BIOMATERIALS, V31, P8245, DOI 10.1016/j.biomaterials.2010.07.042
NR 105
TC 84
Z9 85
U1 1
U2 39
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD SEP 9
PY 2011
VL 11
IS 9
BP 1149
EP 1163
DI 10.1002/mabi.201000505
PG 15
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 821OV
UT WOS:000294985200001
PM 21509937
DA 2018-10-20
ER

PT J
AU Kolender, AA
   Arce, SM
   Varela, O
AF Kolender, Adriana A.
   Arce, Silvina M.
   Varela, Oscar
TI Synthesis and characterization of poly-O-methyl-[n]-polyurethane from a
   D-glucamine-based monomer
SO CARBOHYDRATE RESEARCH
LA English
DT Article
DE [n]-Polyurethane; Chiral; Biomaterial; D-Glucamine; Alditol isocyanate;
   alpha-Amino-omega-phenylcarbonate
ID PENDANT HYDROXY-GROUPS; LINEAR POLYURETHANES; POLYMERS; POLYMERIZATION;
   DIISOCYANATES; DIAMINES; SUGAR; POLYCONDENSATION; CONFORMATIONS;
   POLYADDITION
AB Aminoalditol 1-amino-1-deoxy-D-sorbitol (1) was readily converted into 2,3,4,5-tetra-O-methyl derivative 5, a key precursor of a sugar-based [n]-polyurethane. For the polymerization, the free amino or primary hydroxyl groups of 5 were selectively activated and employed as starting monomers in two alternative procedures. Thus, the amino function of 5 was converted into the isocyanate derivative by treatment with di-tert-butyltricarbonate, and polymerized in situ in the presence of Zr(IV) acetylacetonate. The resulting poly(1-amino-1-deoxy-2,3,4,5-tetra-O-methyl-D-sorbitol)urethane (8) had a moderate molecular weight and showed the presence of urea units. The alternative synthesis of 8 involved the activation of the free hydroxyl group of 5 as the corresponding phenylcarbonate. The polymerization of this alpha-amino-omega-phenylcarbonate alditol monomer does not require a metal catalyst. The resulting material exhibited an improved molecular weight and higher purity than that obtained via the isocyanate. [n]-polyurethane 8 was highly soluble in water as well as in common organic solvents (chloroform, acetone, ethyl acetate, etc) and was obtained as an amorphous material which was characterized thermally and spectroscopically. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kolender, Adriana A.; Arce, Silvina M.; Varela, Oscar] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR CONICET, RA-1428 Buenos Aires, DF, Argentina.
RP Varela, O (reprint author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, CIHIDECAR CONICET, Pabellon 2,Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.
EM varela@qo.fcen.uba.ar
OI Kolender, Adriana/0000-0001-9933-6556
FU University of Buenos Aires [X227]; National Research Council of
   Argentina (CONICET) [PIP 2008-0064]; National Agency for Promotion of
   Science and Technology (ANPCyT) [PICT 2007-00291]
FX Support of this work by the University of Buenos Aires (Project X227),
   the National Research Council of Argentina (CONICET, Project PIP
   2008-0064) and the National Agency for Promotion of Science and
   Technology (ANPCyT, PICT 2007-00291) is gratefully acknowledged. O.V.
   and A.A.K. are Research Members from CONICET.
CR ANGYAL SJ, 1972, CARBOHYD RES, V23, P121, DOI 10.1016/S0008-6215(00)81583-9
   Arce SM, 2010, POLYM INT, V59, P1212, DOI 10.1002/pi.2850
   Bachmann F, 2001, J POLYM SCI POL CHEM, V39, P2332
   Bachmann F, 1998, MACROMOL RAPID COMM, V19, P21, DOI 10.1002/(SICI)1521-3927(19980101)19:1<21::AID-MARC21>3.0.CO;2-T
   BLANCMUESSER M, 1980, CARBOHYD RES, V87, P71, DOI 10.1016/S0008-6215(00)85192-7
   BRAUN D, 1992, ANGEW MAKROMOL CHEM, V199, P191, DOI 10.1002/apmc.1992.051990115
   Breitmaier E., 1987, CARBON 13 NMR SPECTR
   Dwan'Isa JPL, 2005, NATURAL FIBERS, BIOPOLYMERS, AND BIOCOMPOSITES, P775
   Galbis JA, 2010, TOP CURR CHEM, V295, P147, DOI 10.1007/128_2010_57
   Garcon R, 2001, CARBOHYD POLYM, V45, P123, DOI 10.1016/S0144-8617(00)00323-4
   GILLIES DG, 1985, J CHEM SOC P2, V87, P1155
   Gomez RV, 2009, MACROMOLECULES, V42, P8112, DOI 10.1021/ma9014643
   Hashimoto K, 2005, POLYM J, V37, P384, DOI 10.1295/polymj.37.3841
   HASHIMOTO K, 1995, J POLYM SCI POL CHEM, V33, P1495, DOI 10.1002/pola.1995.080330911
   Marin R, 2009, J APPL POLYM SCI, V114, P3723, DOI 10.1002/app.30924
   Marin R, 2009, MACROMOL CHEM PHYSIC, V210, P486, DOI 10.1002/macp.200800517
   Marin R, 2008, J POLYM SCI POL CHEM, V46, P7996, DOI 10.1002/pola.23099
   Neffgen S, 2000, MACROMOL CHEM PHYSIC, V201, P2108, DOI 10.1002/1521-3935(20001101)201:16<2108::AID-MACP2108>3.0.CO;2-7
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Paz M. V., 2007, J POLYM SCI A, V45, P4109
   Paz M. V., 2008, J CARBOHYD CHEM, V27, P120
   POPE BM, 1978, ORG SYNTH, V57, P45
   Prompers G, 2006, GREEN CHEM, V8, P467, DOI 10.1039/b600254d
   Prompers G, 2005, DES MONOMERS POLYM, V8, P547, DOI 10.1163/156855505774597830
   Rokicki G, 2002, POLYMER, V43, P2927, DOI 10.1016/S0032-3861(02)00071-X
   Satoh T, 2007, MACROMOL BIOSCI, V7, P999, DOI 10.1002/mabi.200700057
   THIEM J, 1986, MAKROMOL CHEM, V187, P2775
   van de Manakker F, 2009, BIOMACROMOLECULES, V10, P3157, DOI 10.1021/bm901065f
   VARELA O, 1999, ADV CARBOHYD CHEM BI, V55, P137
   Versteegen RM, 1999, ANGEW CHEM INT EDIT, V38, P2917, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2917::AID-ANIE2917>3.0.CO;2-7
   Yamanaka C, 2002, J POLYM SCI POL CHEM, V40, P4158, DOI 10.1002/pola.10496
NR 31
TC 7
Z9 7
U1 3
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
J9 CARBOHYD RES
JI Carbohydr. Res.
PD SEP 6
PY 2011
VL 346
IS 12
SI SI
BP 1398
EP 1405
DI 10.1016/j.carres.2011.02.022
PG 8
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 793VN
UT WOS:000292852100006
PM 21645884
DA 2018-10-20
ER

PT J
AU Legentil, L
   Audic, JL
   Daniellou, R
   Nugier-Chauvin, C
   Ferrieres, V
AF Legentil, Laurent
   Audic, Jean-Luc
   Daniellou, Richard
   Nugier-Chauvin, Caroline
   Ferrieres, Vincent
TI Studies of a furanoside as antimycobacterial agent loaded into a
   biodegradable PBAT/sodium caseinate support
SO CARBOHYDRATE RESEARCH
LA English
DT Article
ID SYNTHETIC UDP-FURANOSES; INHIBITORS; TUBERCULOSIS; TRIAZOLES; GROWTH
AB An improved synthesis of n-octyl beta-D-galactofuranoside was described using micro-wave activation. The resulting alkyl furanoside showed antibacterial activity against Mycobacterium smegmatis, a non-pathogenic model of Mycobacterium tuberculosis. It was further incorporated into a biodegradable PBAT/sodium caseinate polymer. The resulting biomaterial loaded with 5% of the pharmacophore retained the mycobacteriostatic properties and developed a mycobactericidal activity on contact and at the periphery of the film. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Legentil, Laurent] Ecole Natl Super Chim Rennes, CNR, UMR 6226, F-35708 Rennes 7, France.
   Univ Europeenne Bretagne, Bretagne, France.
RP Legentil, L (reprint author), Ecole Natl Super Chim Rennes, CNR, UMR 6226, Ave Gen Leclerc,CS 50837, F-35708 Rennes 7, France.
EM vincent.ferrieres@ensc-rennes.fr
RI Daniellou, Richard/A-3047-2009
OI Daniellou, Richard/0000-0001-7296-3736; FERRIERES,
   Vincent/0000-0002-2780-7774
FU CNRS; Ministere de l'Enseignement Superieur et de la Recherche;
   Universite Europeenne de Bretagne; workshop Bresmat
FX We are grateful to Valentin Bobet for his valuable help in the
   formulation and test of the modified polymers, Peggy Thomar and Sophie
   Schmid for their help in the development of biological evaluations. We
   are also grateful to Professor Katarina Mikusova for providing strains
   of Mycobacterium smegmatis. We finally thank the CNRS and the Ministere
   de l'Enseignement Superieur et de la Recherche, the Universite
   Europeenne de Bretagne and the workshop Bresmat for financial supports.
CR Adelmann R, 2009, EUR POLYM J, V45, P3093, DOI 10.1016/j.eurpolymj.2009.08.013
   Allam A, 2010, CARBOHYD RES, V345, P731, DOI 10.1016/j.carres.2010.01.009
   AUDIC JL, 2010, Patent No. 1002815
   BASS JB, 1994, AM J RESP CRIT CARE, V149, P1359, DOI 10.1164/ajrccm.149.5.8173779
   BRADY RF, 2007, SMART COATINGS, V957, P3
   Brochu Heidi, 2004, Current Drug Delivery, V1, P299, DOI 10.2174/1567201043334678
   Cioffi N, 2005, CHEM MATER, V17, P5255, DOI 10.1021/cm0505244
   CLEMANS DL, 2007, SMART COATINGS, V957
   Cohen J, 2006, SCIENCE, V313, P1554
   Davis CB, 2007, CARBOHYD RES, V342, P1773, DOI 10.1016/j.carres.2007.04.027
   Dureau R, 2010, CARBOHYD RES, V345, P1299, DOI 10.1016/j.carres.2010.02.020
   Eppe G, 2009, BIOORG MED CHEM LETT, V19, P814, DOI 10.1016/j.bmcl.2008.12.014
   Extremina CI, 2010, INT J ANTIMICROB AG, V35, P164, DOI 10.1016/j.ijantimicag.2009.09.017
   FERRIERES V, 1995, TETRAHEDRON LETT, V36, P2749, DOI 10.1016/0040-4039(95)00356-H
   Ferrieres V, 1998, CARBOHYD RES, V311, P25, DOI 10.1016/S0008-6215(98)00197-9
   Goodby JW, 1995, J MATER CHEM, V5, P2209, DOI 10.1039/jm9950502209
   Hufschmid A, 2003, CHEMOSPHERE, V50, P171, DOI 10.1016/S0045-6535(02)00553-2
   Kebir N, 2007, BIOMATERIALS, V28, P4200, DOI 10.1016/j.biomaterials.2007.06.006
   Mizerska U, 2009, EUR POLYM J, V45, P779, DOI 10.1016/j.eurpolymj.2008.11.045
   Naresh K, 2010, ORG BIOMOL CHEM, V8, P592, DOI 10.1039/b917070g
   *NAT COMM CLIN LAB, 2000, M2A7 NAT COMM CLIN L
   Pathak AK, 2001, BIOORGAN MED CHEM, V9, P3129, DOI 10.1016/S0968-0896(01)00179-1
   Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010
   Peltier P, 2010, CHEM BIOL, V17, P1356, DOI 10.1016/j.chembiol.2010.10.014
   Sanki AK, 2008, BIOORGAN MED CHEM, V16, P5672, DOI 10.1016/j.bmc.2008.03.062
   Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006
   Singh BK, 2008, CARBOHYD RES, V343, P1153, DOI 10.1016/j.carres.2008.02.013
   Tripathi A., 2010, INT J PHARM TECH RES, V2, P2116
   ul-Ain Q, 2003, ANTIMICROB AGENTS CH, V47, P3005, DOI 10.1128/AAC.47.9.3005-3007.2003
   Wilkinson BL, 2008, BIOORG MED CHEM LETT, V18, P6265, DOI 10.1016/j.bmcl.2008.09.082
NR 30
TC 11
Z9 11
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0008-6215
J9 CARBOHYD RES
JI Carbohydr. Res.
PD SEP 6
PY 2011
VL 346
IS 12
SI SI
BP 1541
EP 1545
DI 10.1016/j.carres.2011.04.025
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 793VN
UT WOS:000292852100021
PM 21592464
DA 2018-10-20
ER

PT J
AU Hahn, A
   Brandes, G
   Wagener, P
   Barcikowski, S
AF Hahn, Anne
   Brandes, Gudrun
   Wagener, Philipp
   Barcikowski, Stephan
TI Metal ion release kinetics from nanoparticle silicone composites
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Silver; Copper; Nanoparticle; Nanocomposite; Ion release
ID CONTROLLED DRUG-RELEASE; RUBBER MEMBRANES; DELIVERY SYSTEMS;
   LASER-ABLATION; SILVER; NANOCOMPOSITES; DISSOLUTION; POLYMERS;
   BIOMATERIAL; ELASTOMERS
AB Metal ion release kinetics from silver and copper nanoparticle silicone composites generated by laser ablation in liquids are investigated. The metal ion transport mechanism is studied by using different model equations and their fit to experimental data. Results indicate that during the first 30 days of immersion, Fickian diffusion is the dominant transport mechanism. After this time period, the oxidation and dissolution of nanoparticles from the bulk determine the ion release. This second mechanism is very slow since the dissolution of the nanoparticle is found to be anisotropic. Silver ion release profile is best described by pseudo-first order exponential equation. Copper ion release profile is best described by a second order exponential equation. For practical purposes, the in vitro release characteristics of the bioactive metal ions are evaluated as a function of nanoparticle loading density, the chemistry and the texture of the silicone. Based on the proposed two-step release model, a prediction of the release characteristics over a time course of 84 days is possible and a long-term ion release could be demonstrated. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Barcikowski, Stephan] Univ Duisburg Essen, D-45141 Essen, Germany.
   [Hahn, Anne; Wagener, Philipp; Barcikowski, Stephan] Laser Zentrum Hannover eV, D-30419 Hannover, Germany.
   [Brandes, Gudrun] Hannover Med Sch, Inst Cell Biol, Ctr Anat, D-30625 Hannover, Germany.
RP Barcikowski, S (reprint author), Univ Duisburg Essen, Univ Str 5-7, D-45141 Essen, Germany.
EM stephan.barcikowski@uni-due.de
RI Barcikowski, Stephan/I-4754-2012; Wagener, Philipp/H-1582-2012
OI Barcikowski, Stephan/0000-0002-9739-7272; 
FU German Research Foundation within the Collaborative Research Centre
   [TransRegio 37]; German Research Foundation within the excellence
   cluster "REBIRTH"
FX The authors thank the German Research Foundation for funding this work
   within the Collaborative Research Centre TransRegio 37 "Micro- and
   Nanosystems in Medicine-Reconstruction of Biological Functions" and
   within the excellence cluster "REBIRTH." Additionally, authors thank
   Swen Maas of the Material Analytischer Service in Freiburg for carrying
   out the transmission electron microscope image of the colloidal
   nanoparticles.
CR Amikura K, 2008, APPL SURF SCI, V254, P6976, DOI 10.1016/j.apsusc.2008.05.091
   Andreopoulos AG, 1998, J BIOMATER APPL, V12, P258, DOI 10.1177/088532829801200306
   Avent AG, 2003, J NON-CRYST SOLIDS, V328, P31, DOI 10.1016/S0022-3093(03)00476-9
   Barsch N, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/44/445603
   BAKER R, 1987, CONTROLLED RELEASE B
   BARRER RM, 1965, J POLYM SCI POL SYM, P111
   Boyd D, 2006, J MATER SCI-MATER M, V17, P489, DOI 10.1007/s10856-006-8930-6
   Bromberg LE, 2000, J CONTROL RELEASE, V68, P63, DOI 10.1016/S0168-3659(00)00233-9
   Cai SZ, 2005, BIOMATERIALS, V26, P2671, DOI 10.1016/j.biomaterials.2004.08.003
   CHANDRA RK, 1982, NUTR RES, V2, P721, DOI 10.1016/S0271-5317(82)80116-4
   Compagnini G, 2002, PHYS CHEM CHEM PHYS, V4, P2787, DOI 10.1039/b109490d
   Couloigner V, 2006, PFLUG ARCH EUR J PHY, V453, P11, DOI 10.1007/s00424-006-0103-4
   Cussler E. L., 2009, DIFFUSION MASS TRANS
   Damm C, 2008, APPL PHYS A-MATER, V91, P479, DOI 10.1007/s00339-008-4434-1
   Damm C, 2005, POLYM POLYM COMPOS, V13, P649, DOI 10.1177/096739110501300701
   Damm C, 2007, J MATER SCI, V42, P6067, DOI 10.1007/s10853-006-1158-5
   Dokoumetzidis A, 2006, INT J PHARM, V321, P1, DOI 10.1016/j.ijpharm.2006.07.011
   Hahn A, 2011, J MATER CHEM, V21, P10287, DOI 10.1039/c0jm04480f
   Hahn A, 2010, ADV ENG MATER, V12, pB156, DOI 10.1002/adem.200980071
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   HIGUCHI T, 1961, J PHARM SCI, V50, P874, DOI 10.1002/jps.2600501018
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hu SH, 2007, J CONTROL RELEASE, V121, P181, DOI 10.1016/j.jconrel.2007.06.002
   JOUWERSMA C, 1959, CHEM INGENIEUR TECHN, P652
   Kawasaki M, 2008, J PHYS CHEM C, V112, P15647, DOI 10.1021/jp8056916
   Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p
   Kittler S, 2010, J MATER CHEM, V20, P512, DOI 10.1039/b914875b
   Kumar R, 2005, BIOMATERIALS, V26, P2081, DOI 10.1016/j.biomaterials.2004.05.030
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Malcolm K, 2003, J CONTROL RELEASE, V90, P217, DOI 10.1016/S0168-3659(03)00178-0
   Malcolm RK, 2004, J CONTROL RELEASE, V97, P313, DOI 10.1016/j.jconrel.2004.03.029
   Mashak A, 2009, IRAN POLYM J, V18, P279
   Mc Cullagh SD, 2004, J MATER CHEM, V14, P1093, DOI 10.1039/b313483k
   MINOURA N, 1978, J APPL POLYM SCI, V22, P833, DOI 10.1002/app.1978.070220320
   PEPPAS NA, 1985, PHARM ACTA HELV, V60, P110
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   ROSEMAN TJ, 1972, J PHARM SCI, V61, P46, DOI 10.1002/jps.2600610106
   RUNGBY J, 1987, ARCH TOXICOL, V59, P408, DOI 10.1007/BF00316206
   Schmal F, 1999, HNO, V47, P107, DOI 10.1007/s001060050366
   Serra L, 2006, BIOMATERIALS, V27, P5440, DOI 10.1016/j.biomaterials.2006.06.011
   Shoaib M Harris, 2006, Pak J Pharm Sci, V19, P119
   SINCLAIR GW, 1984, J MEMBRANE SCI, V17, P329, DOI 10.1016/S0376-7388(00)83223-8
   SPOENDLIN H, 1984, ANN OTOL RHINOL LA S, V112, P76
   Stelzig SH, 2011, EUR POLYM J, V47, P662, DOI 10.1016/j.eurpolymj.2010.10.018
   Wagener P, 2011, PHYS CHEM CHEM PHYS, V13, P5120, DOI 10.1039/c0cp02262d
   Xu TW, 2000, INT J PHARM, V197, P23, DOI 10.1016/S0378-5173(99)00373-7
   Yamamoto A, 1998, J BIOMED MATER RES, V39, P331, DOI 10.1002/(SICI)1097-4636(199802)39:2<331::AID-JBM22>3.0.CO;2-E
   Yang FC, 2009, MATER CHEM PHYS, V113, P474, DOI 10.1016/j.matchemphys.2008.07.126
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
NR 49
TC 39
Z9 40
U1 0
U2 49
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD SEP 5
PY 2011
VL 154
IS 2
BP 164
EP 170
DI 10.1016/j.jconrel.2011.05.023
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 822RM
UT WOS:000295067300008
PM 21645564
DA 2018-10-20
ER

PT J
AU Emerich, DF
   Orive, G
   Borlongan, C
AF Emerich, Dwaine F.
   Orive, Gorka
   Borlongan, Cesar
TI Tales of Biomaterials, Molecules, and Cells for Repairing and Treating
   Brain Dysfunction
SO CURRENT STEM CELL RESEARCH & THERAPY
LA English
DT Review
DE Biomaterials; central nervous system; polymer; stem cells
ID SOLID LIPID NANOPARTICLES; CENTRAL-NERVOUS-SYSTEM;
   AMYOTROPHIC-LATERAL-SCLEROSIS; CILIARY NEUROTROPHIC FACTOR; IRON-OXIDE
   NANOPARTICLES; 80-COATED POLYBUTYLCYANOACRYLATE NANOPARTICLES;
   NEUROPROTECTIVE GENE-THERAPY; CONVECTION-ENHANCED DELIVERY; EMBRYONIC
   STEM-CELLS; ACUTE-PHASE RESPONSE
AB Current therapies have limited or no capacity to restore lost function, slow ongoing neurodegeneration, or promote regeneration following damage to the brain. Biomaterials are playing an increasingly important role in the development of novel, potentially efficacious approaches to brain treatment and repair. Programmable biomaterials enable and augment the targeted delivery of drugs into the brain and allow cell/tissue transplants to be effectively delivered and integrate into the brain, to serve as delivery vehicles for therapeutic proteins, and rebuild damaged circuits. Similarly, biomaterials are being increasingly used to recapitulate specific aspects of brain niches to promote regeneration and/or repair damaged neuronal pathways with stem cell therapies. Many of these approaches are gaining momentum because nanotechnology allows greater control over material-cell interactions that induce specific developmental processes and cellular responses including differentiation, migration, and outgrowth. This review discusses the state of the art and new directions in the convergence of biomaterial science, drug delivery, and stem cell biology in the treatment of degenerative and malignant brain diseases.
C1 [Emerich, Dwaine F.] InCytu Inc, Lincoln, RI 02865 USA.
   [Orive, Gorka] Univ Basque Country, Fac Pharm, Lab Pharm & Pharmaceut Technol, Vitoria, Spain.
   [Orive, Gorka] Inst Eduardo Anitua, Biotechnol Inst BTI, Vitoria 10005, Spain.
   [Orive, Gorka] SLFPB EHU, CIBER BBN, Networking Biomed Res Ctr Bioengn Biomat & Nanome, Vitoria 01006, Spain.
   [Borlongan, Cesar] Univ S Florida, Dept Neurosurg & Brain Repair, Tampa, FL USA.
RP Emerich, DF (reprint author), InCytu Inc, 701 George Washington Highway, Lincoln, RI 02865 USA.
EM ED3FJM@aol.com
OI Borlongan, Cesar/0000-0002-2966-9782
CR Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696
   AEBISCHER P, 1994, TRANSPLANTATION, V58, P1275, DOI 10.1097/00007890-199412150-00025
   Allard E, 2009, BIOMATERIALS, V30, P2302, DOI 10.1016/j.biomaterials.2009.01.003
   ALLEN TM, 1994, TRENDS PHARMACOL SCI, V15, P215, DOI 10.1016/0165-6147(94)90314-X
   Alyautdin RN, 1997, PHARMACEUT RES, V14, P325, DOI 10.1023/A:1012098005098
   Alyautdin RN, 1998, J MICROENCAPSUL, V15, P67, DOI 10.3109/02652049809006836
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Bachoud-Levi AC, 2000, HUM GENE THER, V11, P1723, DOI 10.1089/10430340050111377
   Bargoni A, 2001, PHARMACOL RES, V43, P497, DOI 10.1006/phrs.2001.0813
   Beduneau A, 2007, BIOMATERIALS, V28, P4947, DOI 10.1016/j.biomaterials.2007.06.011
   Begley DJ, 2004, PHARMACOL THERAPEUT, V104, P29, DOI 10.1016/j.pharmthera.2004.08.001
   Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711
   Bible E, 2009, BIOMATERIALS, V30, P2985, DOI 10.1016/j.biomaterials.2009.02.012
   Blasi P, 2007, ADV DRUG DELIVER REV, V59, P454, DOI 10.1016/j.addr.2007.04.011
   Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968
   Borlongan CV, 2007, CURR MOL MED, V7, P609, DOI 10.2174/156652407782564381
   Brannvall K, 2007, J NEUROSCI RES, V85, P2138, DOI 10.1002/jnr.21358
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   Brioschi A, 2007, NEUROL RES, V29, P324, DOI 10.1179/016164107X187017
   Britz GW, 2002, J NEURO-ONCOL, V56, P227, DOI 10.1023/A:1015035213228
   Buchser E, 1996, ANESTHESIOLOGY, V85, P1005, DOI 10.1097/00000542-199611000-00007
   CEDARBAUM JM, 1995, CLIN NEUROPHARMACOL, V18, P500
   CEDARBAUM JM, 1995, CLIN NEUROPHARMACOL, V18, P515
   CHAPAT S, 1991, BRAIN RES BULL, V26, P339, DOI 10.1016/0361-9230(91)90004-4
   Chattopadhyay N, 2008, PHARM RES-DORDR, V25, P2262, DOI 10.1007/s11095-008-9615-2
   Chekhonin V P, 2003, Dokl Biochem Biophys, V391, P236, DOI 10.1023/A:1025173711353
   CZECH KA, 1995, PROG NEUROBIOL, V46, P507, DOI 10.1016/0301-0082(95)00011-J
   de Vos P, 2009, BIOMATERIALS, V30, P2559, DOI 10.1016/j.biomaterials.2009.01.014
   Denora N, 2009, CURR TOP MED CHEM, V9, P182, DOI 10.2174/156802609787521571
   Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989
   DITTRICH F, 1994, ANN NEUROL, V35, P151, DOI 10.1002/ana.410350206
   Dobson J, 2006, DRUG DEVELOP RES, V67, P55, DOI 10.1002/ddr.20067
   Doi A, 2008, J NEURO-ONCOL, V87, P287, DOI 10.1007/s11060-008-9522-8
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Emerich DF, 1997, NATURE, V386, P395, DOI 10.1038/386395a0
   Emerich DF, 2006, NEUROBIOL DIS, V23, P471, DOI 10.1016/j.nbd.2006.01.014
   Emerich DF, 2009, NEUROTOX RES, V15, P205, DOI 10.1007/s12640-009-9021-5
   Ewend MG, 2007, CLIN CANCER RES, V13, P3637, DOI 10.1158/1078-0432.CCR-06-2095
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fitch MT, 1999, J NEUROSCI, V19, P8182
   FRESTA M, 1994, J PHARM PHARMACOL, V46, P974, DOI 10.1111/j.2042-7158.1994.tb03252.x
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003
   Garbayo E, 2009, J CONTROL RELEASE, V135, P119, DOI 10.1016/j.jconrel.2008.12.010
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Gelperina S, 2000, P 3 WORLD M APV APGI, P441
   GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004
   Gu HG, 2009, NEUROSCI LETT, V453, P204, DOI 10.1016/j.neulet.2009.02.027
   Gulyaev AE, 1999, PHARMACEUT RES, V16, P1564, DOI 10.1023/A:1018983904537
   Halberstadt C., 2007, CELLULAR TRANSPLANTS
   Hung CH, 2006, BIOMATERIALS, V27, P4461, DOI 10.1016/j.biomaterials.2006.04.021
   Huwyler J, 2002, J DRUG TARGET, V10, P73, DOI 10.1080/10611860290007559
   IMAIZUMI S, 1990, STROKE, V21, P1312, DOI 10.1161/01.STR.21.9.1312
   Itoh S, 2003, ARTIF ORGANS, V27, P1079, DOI 10.1111/j.1525-1594.2003.07208.x
   Jackson H, 2007, NEUROSURGERY, V60, P524, DOI 10.1227/01.NEU.0000255334.95532.DD
   Jain S, 2003, INT J PHARM, V261, P43, DOI 10.1016/S0378-5173(03)00269-2
   Jiang C, 2003, HUM GENE THER, V14, P1181, DOI 10.1089/104303403322168019
   JUCKER M, 1991, J NEUROSCI RES, V28, P507, DOI 10.1002/jnr.490280407
   Kakinuma K, 1996, INT J HYPERTHER, V12, P157, DOI 10.3109/02656739609023698
   Kaur IP, 2008, J CONTROL RELEASE, V127, P97, DOI 10.1016/j.jconrel.2007.12.018
   Kircher MF, 2003, CANCER RES, V63, P8122
   Kohler N, 2006, SMALL, V2, P785, DOI 10.1002/smll.200600009
   Kohler N, 2005, LANGMUIR, V21, P8858, DOI 10.1021/la0503451
   Koo YEL, 2007, APPL OPTICS, V46, P1924, DOI 10.1364/AO.46.001924
   Koziara JM, 2004, J CONTROL RELEASE, V99, P259, DOI 10.1016/j.jconrel.2004.07.006
   Kreuter J, 2004, J NANOSCI NANOTECHNO, V4, P484, DOI 10.1166/jnn.2003.077
   Kreuter J, 2003, PHARMACEUT RES, V20, P409, DOI 10.1023/A:1022604120952
   KREUTER J, 1995, BRAIN RES, V674, P171, DOI 10.1016/0006-8993(95)00023-J
   Kreuter J, 1997, J CONTROL RELEASE, V49, P81, DOI 10.1016/S0168-3659(97)00061-8
   Kulbatski I, 2005, CURR DRUG TARGETS, V6, P111, DOI 10.2174/1389450053345037
   Kuroda JI, 2009, INT J CANCER, V124, P2505, DOI 10.1002/ijc.24171
   Lee K. Y., 2001, FIBER POLYM, V2, P51
   Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li LH, 2008, BIOMATERIALS, V29, P1509, DOI 10.1016/j.biomaterials.2007.11.014
   Lian T, 2001, J PHARM SCI-US, V90, P667, DOI 10.1002/jps.1023
   Lockman PR, 2002, DRUG DEV IND PHARM, V28, P1, DOI 10.1081/DDC-120001481
   LOEB C, 1982, NEUROLOGY, V32, P1234
   Mahoney MJ, 2001, NAT BIOTECHNOL, V19, P934, DOI 10.1038/nbt1001-934
   Manninger SP, 2005, AM J NEURORADIOL, V26, P2290
   MCRAE A, 1994, NEUROCHEM INT, V25, P27, DOI 10.1016/0197-0186(94)90049-3
   Menei P, 2000, EXP NEUROL, V161, P259, DOI 10.1006/exnr.1999.7253
   Misra A, 2003, J PHARM PHARM SCI, V6, P252
   Moore A, 2000, RADIOLOGY, V214, P568, DOI 10.1148/radiology.214.2.r00fe19568
   Mori N, 1995, BRAIN RES, V703, P184, DOI 10.1016/0006-8993(95)01095-5
   Neuwelt EA, 2004, NEUROPATH APPL NEURO, V30, P456, DOI 10.1111/j.1365-2990.2004.00557.x
   Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5
   Nisbet DR, 2007, J NEURAL ENG, V4, P35, DOI 10.1088/1741-2560/4/2/004
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   ONODERA H, 1983, TOHOKU J EXP MED, V140, P1, DOI 10.1620/tjem.140.1
   Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   Ou ZM, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/10/105102
   Ozawa T, 2005, NEUROSURGERY, V57, P1041, DOI 10.1227/01.NEU.0000180036.42193.f6
   Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094
   Pardridge WM, 2007, PHARM RES, V24, P1733, DOI 10.1007/s11095-007-9324-2
   Pardridge WM, 2005, MOL BIOTECHNOL, V30, P57, DOI 10.1385/MB:30:1:057
   PARDRIDGE WM, 1992, WESTERN J MED, V156, P281
   Pardridge WM, 2005, NEURORX, P3
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Pean JM, 2000, BIOMATERIALS, V21, P2097, DOI 10.1016/S0142-9612(00)00141-1
   Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020
   Popovic N, 2006, INT J PHARM, V314, P120, DOI 10.1016/j.ijpharm.2005.09.040
   POSTMES TJ, 1980, J PHARM PHARMACOL, V32, P722, DOI 10.1111/j.2042-7158.1980.tb13051.x
   Potter W, 2008, FRONT BIOSCI-LANDMRK, V13, P806, DOI 10.2741/2721
   Ramge P, 1999, CHRONOBIOL INT, V16, P767, DOI 10.3109/07420529909016944
   Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946
   Remsen LG, 1996, AM J NEURORADIOL, V17, P411
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Sagen J, 1998, Adv Pharmacol, V42, P579
   Sahoo SK, 2003, DRUG DISCOV TODAY, V8, P1112, DOI 10.1016/S1359-6446(03)02903-9
   Sajadi A, 2006, NEUROBIOL DIS, V22, P119, DOI 10.1016/j.nbd.2005.10.006
   SCHACKERT G, 1989, SELECT CANCER THER, V5, P73, DOI 10.1089/sct.1989.5.73
   Schnyder Anita, 2005, NeuroRx, V2, P99
   Schroder U, 1996, BRAIN RES, V710, P121, DOI 10.1016/0006-8993(95)01375-X
   Schroeder U, 1998, J PHARM SCI-US, V87, P1305, DOI 10.1021/js980084y
   Schubert D, 2006, BIOCHEM BIOPH RES CO, V342, P86, DOI 10.1016/j.bbrc.2006.01.129
   Sheleg SV, 2002, J NEURO-ONCOL, V60, P53, DOI 10.1023/A:1020288015457
   Shi NY, 2001, P NATL ACAD SCI USA, V98, P12754, DOI 10.1073/pnas.221450098
   Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103
   Silva GA, 2005, SURG NEUROL, V63, P301, DOI 10.1016/j.surneu.2004.06.008
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sinha J, 2001, BIOMED PHARMACOTHER, V55, P264, DOI 10.1016/S0753-3322(01)00060-9
   Siwak DR, 2002, CLIN CANCER RES, V8, P955
   Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151
   Soni V, 2008, J DRUG TARGET, V16, P73, DOI [10.1080/10611860701725381, 10.1080/10611860701725381 ]
   Steiniger SCJ, 2004, INT J CANCER, V109, P759, DOI 10.1002/ijc.20048
   Tan SA, 1996, CELL TRANSPLANT, V5, P577, DOI 10.1016/0963-6897(96)00081-4
   Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154
   Tate MC, 2002, CELL TRANSPLANT, V11, P283
   Teixeira AI, 2007, CELL RES, V17, P56, DOI 10.1038/sj.cr.7310414
   Tiwari Sandip B., 2006, Current Drug Delivery, V3, P219, DOI 10.2174/156720106776359230
   TOKES ZA, 1980, BRAIN RES, V188, P282, DOI 10.1016/0006-8993(80)90578-8
   TR Flanagan, 1994, METHODS NEUROSCIENCE, V21
   Trehin R, 2006, NEOPLASIA, V8, P302, DOI 10.1593/neo.05751
   Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687
   Varallyay CG, 2009, J CEREBR BLOOD F MET, V29, P853, DOI 10.1038/jcbfm.2008.162
   Varallyay P, 2002, AM J NEURORADIOL, V23, P510
   Veiseh O, 2005, NANO LETT, V5, P1003, DOI 10.1021/nl0502569
   Veiseh O, 2009, CANCER RES, V69, P6200, DOI 10.1158/0008-5472.CAN-09-1157
   Visted T, 2003, EXPERT OPIN BIOL TH, V3, P551
   Voges J, 2003, ANN NEUROL, V54, P479, DOI 10.1002/ana.10688
   Vukelja SJ, 2007, ANTI-CANCER DRUG, V18, P283, DOI 10.1097/CAD.0b013e328011a51d
   Wang XY, 2007, J CONTROL RELEASE, V119, P236, DOI 10.1016/j.jconrel.2007.02.010
   Webb K, 2001, BIOMATERIALS, V22, P1017, DOI 10.1016/S0142-9612(00)00353-7
   WEINSTEIN JN, 1978, BIOCHIM BIOPHYS ACTA, V509, P272, DOI 10.1016/0005-2736(78)90047-0
   Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/S1522851702000236
   Wieder ME, 2006, PHOTOCH PHOTOBIO SCI, V5, P727, DOI 10.1039/b602830f
   Willerth SM, 2006, BIOMATERIALS, V27, P5990, DOI 10.1016/j.biomaterials.2006.07.036
   WINN SR, 1994, P NATL ACAD SCI USA, V91, P2324, DOI 10.1073/pnas.91.6.2324
   Woerly S., 2001, BIOMATERIALS, V20, P2213
   Wong DY, 2008, J NEUROSURG, V109, P715, DOI 10.3171/JNS/2008/109/10/0715
   Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440
   Xiang LZ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3078809
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   Yasuhara T, 2005, J NEUROSURG, V102, P80, DOI 10.3171/jns.2005.102.1.0080
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zara GP, 2002, J DRUG TARGET, V10, P327, DOI 10.1080/10611860290031868
   Zara GP, 2002, J PHARM SCI, V91, P1324, DOI 10.1002/jps.10129
   Zhang HZ, 2008, CURR NEUROVASC RES, V5, P112, DOI 10.2174/156720208784310204
   Zhang Y, 2003, HUM GENE THER, V14, P1, DOI 10.1089/10430340360464660
   Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071
   Zurn AD, 2000, CELL TRANSPLANT, V9, P471, DOI 10.1177/096368970000900404
NR 165
TC 6
Z9 7
U1 0
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-888X
EI 2212-3946
J9 CURR STEM CELL RES T
JI Curr. Stem Cell Res. Ther.
PD SEP
PY 2011
VL 6
IS 3
BP 171
EP 189
PG 19
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA 910LX
UT WOS:000301639800002
PM 21476979
DA 2018-10-20
ER

PT J
AU Montanaro, L
   Testoni, F
   Poggi, A
   Visai, L
   Speziale, P
   Arciola, CR
AF Montanaro, Lucio
   Testoni, Francesca
   Poggi, Alessandro
   Visai, Livia
   Speziale, Pietro
   Arciola, Carla Renata
TI Emerging pathogenetic mechanisms of the implant-related osteomyelitis by
   Staphylococcus aureus
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE Implant-related osteomyelitis; Staphylococcus aureus; FnBPA; SpA;
   Osteoblasts; Internalization
ID FIBRONECTIN-BINDING PROTEINS; ANTIBIOTIC-RESISTANCE; BIOFILM FORMATION;
   IN-VITRO; PERSISTENT INFECTIONS; ORTHOPEDIC INFECTIONS;
   ENTEROCOCCUS-FAECALIS; BACTERIAL ADHERENCE; HUMAN OSTEOBLASTS;
   HOST-DEFENSE
AB Implant-related osteomyelitis is a severe and deep infection of bone that arises and develops all around an implant. Staphylococcus aureus is the first cause of osteomyelitis, whether implant-related or not. Bone is an optimal substratum for S. aureus, since this bacterium expresses various adhesins by which can adhere to bone proteins and to the biomaterial surfaces coated with the proteins of the host extracellular matrix. S. aureus is able not only to colonize bone tissues, but also to invade and disrupt them by entering bone cells and inducing cell death and osteolysis. Here we illustrate the pathogenetic mechanisms that can explain how the osteomyelitis sets in and develops around an implant.
C1 [Montanaro, Lucio; Testoni, Francesca; Poggi, Alessandro; Arciola, Carla Renata] Rizzoli Orthopaed Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   [Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   [Poggi, Alessandro] Univ Modena & Reggio Emilia, Med & Surg Sch, Modena, Italy.
   [Visai, Livia; Speziale, Pietro] Univ Pavia, Dept Biochem, I-27100 Pavia, Italy.
   [Visai, Livia] Univ Pavia, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Visai, Livia] Salvatore Maugeri Fdn IRCCS, Pavia, Italy.
   [Visai, Livia] Int Ctr Studies & Res Biomed ICB, Luxembourg, Luxembourg.
RP Arciola, CR (reprint author), Rizzoli Orthopaed Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
CR Agerer F, 2003, J BIOL CHEM, V278, P42524, DOI 10.1074/jbc.M302096200
   Ahmed S, 2001, INFECT IMMUN, V69, P2872, DOI 10.1128/IAI.69.5.2872-2877.2001
   Alexander EH, 2001, APPL MICROBIOL BIOT, V56, P361, DOI 10.1007/s002530100703
   Arciola CR, 2010, INT J ARTIF ORGANS, V33, P565
   Arciola CR, 2009, INT J ARTIF ORGANS, V32, P635
   Arciola CR, 2009, INT J ARTIF ORGANS, V32, P533
   Arciola CR, 2006, INT J ARTIF ORGANS, V29, P395
   Arciola CR, 2006, J BIOMED MATER RES A, V76A, P425, DOI 10.1002/jbm.a.30552
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Arciola CR, 2003, BIOMATERIALS, V24, P3013, DOI 10.1016/S0142-9612(03)00133-9
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Arciola CR, 1999, BIOMATERIALS, V20, P323, DOI 10.1016/S0142-9612(98)00168-9
   Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305
   Beech IB, 2006, INT J ARTIF ORGANS, V29, P443
   Bost KL, 1999, J INFECT DIS, V180, P1912, DOI 10.1086/315138
   Bruellhoff K, 2010, INT J ARTIF ORGANS, V33, P646
   Campoccia D, 2003, BIOMATERIALS, V24, P587, DOI 10.1016/S0142-9612(02)00373-3
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   Campoccia D, 2010, INT J ARTIF ORGANS, V33, P575
   Campoccia D, 2010, BIOMATERIALS, V31, P6363, DOI 10.1016/j.biomaterials.2010.05.005
   Campoccia D, 2009, BIOMATERIALS, V30, P6621, DOI 10.1016/j.biomaterials.2009.08.032
   Claro T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018748
   Costerton J, 2007, INT J ARTIF ORGANS, V30, P757
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Costerton WJ, 2009, INT J ARTIF ORGANS, V32, P699
   Creti R, 2009, INT J ARTIF ORGANS, V32, P611
   Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x
   Di Rosa R, 2006, FEMS MICROBIOL LETT, V256, P145, DOI 10.1111/j.1574-6968.2006.00112.x
   Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964
   Ellington JK, 2003, J BONE JOINT SURG BR, V85B, P918, DOI 10.1302/0301-620X.85B6.13509
   Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363
   Fowler T, 2000, EUR J CELL BIOL, V79, P672, DOI 10.1078/0171-9335-00104
   Groll J, 2009, INT J ARTIF ORGANS, V32, P655
   Guenther F, 2009, INT J ARTIF ORGANS, V32, P565
   Henderson B, 2003, TRENDS MICROBIOL, V11, P570, DOI 10.1016/j.tim.2003.10.005
   HERRMANN M, 1988, J INFECT DIS, V158, P693, DOI 10.1093/infdis/158.4.693
   Jones SM, 2001, LANCET, V357, P40, DOI 10.1016/S0140-6736(00)03572-8
   Jorge LS, 2010, BRAZ J INFECT DIS, V14, P310, DOI 10.1590/S1413-86702010000300020
   Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545
   Klenerman L, 2007, J BONE JOINT SURG BR, V89B, P667, DOI 10.1302/0301-620X.89B5.19170
   LAGIER R, 1983, VIRCHOWS ARCH A, V401, P153, DOI 10.1007/BF00692640
   Lerner UH, 1998, CLIN ORTHOP RELAT R, P244
   Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406
   Lew DP, 2004, LANCET, V364, P369, DOI 10.1016/S0140-6736(04)16727-5
   Lopez-Leban F, 2010, INT J ARTIF ORGANS, V33, P582
   McNamara PJ, 2000, INT J ANTIMICROB AG, V14, P117, DOI 10.1016/S0924-8579(99)00170-3
   Menzies BE, 1998, INFECT IMMUN, V66, P5994
   Meyle E, 2010, INT J ARTIF ORGANS, V33, P608
   Montanaro L, 2011, INT J ARTIF ORGANS, V34, P824, DOI 10.5301/ijao.5000051
   Nuzzo I, 2000, FEMS IMMUNOL MED MIC, V27, P235, DOI 10.1016/S0928-8244(99)00190-X
   OGAWA SK, 1985, INFECT IMMUN, V50, P218
   PATTI JM, 1994, CURR OPIN CELL BIOL, V6, P752, DOI 10.1016/0955-0674(94)90104-X
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PATTI JM, 1994, INFECT IMMUN, V62, P152
   Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657
   Provenza G, 2010, FEBS J, V277, P4490, DOI 10.1111/j.1742-4658.2010.07835.x
   Ruoslahti E., 1991, CELL BIOL EXTRACELLU, P343
   RYDEN C, 1987, LANCET, V2, P515
   Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x
   Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004
   Shinji H, 2011, INFECT IMMUN, V79, P2215, DOI 10.1128/IAI.00133-11
   Sinha B, 2000, INFECT IMMUN, V68, P6871, DOI 10.1128/IAI.68.12.6871-6878.2000
   Somayaji SN, 2008, INFECT IMMUN, V76, P5120, DOI 10.1128/IAI.00228-08
   Speziale P, 2009, FUTURE MICROBIOL, V4, P1337, DOI [10.2217/fmb.09.102, 10.2217/FMB.09.102]
   Testoni F, 2011, INT J ARTIF ORGANS, V34, P789, DOI 10.5301/ijao.5000058
   Trampuz A, 2005, SWISS MED WKLY, V135, P243
   Tucker KA, 2000, FEMS MICROBIOL LETT, V186, P151, DOI 10.1111/j.1574-6968.2000.tb09096.x
   Uckay I, 2009, J INFECTION, V59, P337, DOI 10.1016/j.jinf.2009.08.015
   USUI A, 1992, MICROBIOL IMMUNOL, V36, P545, DOI 10.1111/j.1348-0421.1992.tb02054.x
   Von Eiff C, 2006, INT J ARTIF ORGANS, V29, P360
   von Eiff C, 2006, INJURY, V37, P26, DOI 10.1016/j.injury.2006.04.006
   Wesson CA, 2000, INFECT IMMUN, V68, P2998, DOI 10.1128/IAI.68.5.2998-3001.2000
   Wright JA, 2010, INT J MED MICROBIOL, V300, P193, DOI 10.1016/j.ijmm.2009.10.003
NR 74
TC 43
Z9 47
U1 0
U2 26
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2011
VL 34
IS 9
BP 781
EP 788
DI 10.5301/ijao.5000052
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 887GX
UT WOS:000299916000007
PM 22094557
DA 2018-10-20
ER

PT J
AU Ravaioli, S
   Campoccia, D
   Visai, L
   Pirini, V
   Cangini, I
   Corazzari, T
   Maso, A
   Poggio, C
   Pegreffi, F
   Montanaro, L
   Arciola, CR
AF Ravaioli, Stefano
   Campoccia, Davide
   Visai, Livia
   Pirini, Valter
   Cangini, Ilaria
   Corazzari, Tolmino
   Maso, Alessandra
   Poggio, Claudio
   Pegreffi, Francesco
   Montanaro, Lucio
   Arciola, Carla Renata
TI Biofilm extracellular-DNA in 55 Staphylococcus epidermidis clinical
   isolates from implant infections
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Staphylococcus epidermidis; Implant orthopedic infections; Biofilm;
   Exopopolysaccaride; Extracellular DNA
ID INTERCELLULAR-ADHESION; ORTHOPEDIC INFECTIONS; BACTERIAL BIOFILMS;
   POLYSACCHARIDE; RESISTANCE; STRAINS
AB Biofilm formation is broadly recognized as an important virulence factor in many bacterial species implicated in implant-related opportunistic infections. In spite of a long history of research and many investigative efforts aimed at elucidating their chemical composition, structure, and function, the nature of bacterial biofilms still remains only partly revealed. Over the years, different extracellular polymeric substances (EPS) have been described that contribute functionally and structurally to the organization of biofilms. Recently extracellular DNA (eDNA) has emerged as a quantitatively conspicuous and potentially relevant structural component of microbial biofilms of many microbial species, Staphylococcus aureus and S. epidermidis among them. The present study aims at comparatively investigating the amount of eDNA present in the biofilm of 55 clinical isolates of S. epidermidis from postsurgical and biomaterial-related orthopedic infections. Quantification of eDNA was performed by a non-destructive method directly on bacterial biofilms formed under static conditions on the plastic surface of 96-well plates.
C1 [Ravaioli, Stefano; Campoccia, Davide; Pirini, Valter; Cangini, Ilaria; Pegreffi, Francesco; Montanaro, Lucio; Arciola, Carla Renata] Rizzoli Orthoped Inst, Res Unit Implant Infect, I-40136 Bologna, Italy.
   [Ravaioli, Stefano; Cangini, Ilaria; Montanaro, Lucio; Arciola, Carla Renata] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   [Visai, Livia] Univ Pavia, Dept Biochem, Salvatore Maugeri Fdn IRCCS, I-27100 Pavia, Italy.
   [Visai, Livia] Univ Pavia, Ctr Tissue Engn CIT, Salvatore Maugeri Fdn IRCCS, I-27100 Pavia, Italy.
   [Visai, Livia] Int Ctr Studies & Res Biomed ICB, Luxembourg, Luxembourg.
   [Corazzari, Tolmino] Univ Modena & Reggio Emilia, Lab Med Phys, Modena, Italy.
   [Maso, Alessandra] Rizzoli Orthoped Inst, Microbiol Anal Sect, Musculoskeletal Tissue Bank, I-40136 Bologna, Italy.
   [Poggio, Claudio] Univ Pavia, Policlin San Matteo, Dept Endodont, I-27100 Pavia, Italy.
RP Arciola, CR (reprint author), Rizzoli Orthoped Inst, Res Unit Implant Infect, Via Barbiano 1-10, I-40136 Bologna, Italy.
EM carlarenata.arciola@ior.it
RI Campoccia, Davide/K-5348-2018
OI Campoccia, Davide/0000-0002-3336-0219; Poggio,
   Claudio/0000-0002-9606-6930
CR Arciola CR, 2008, BIOMATERIALS, V29, P580, DOI 10.1016/j.biomaterials.2007.10.008
   Arciola CR, 2009, INT J ARTIF ORGANS, V32, P533
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1091
   Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   Arciola CR, 2002, J BIOMED MATER RES, V59, P557, DOI 10.1002/jbm.10006
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Bruellhoff K, 2010, INT J ARTIF ORGANS, V33, P646
   Campoccia D, 2011, INT J ARTIF ORGANS, V34, P832, DOI 10.5301/ijao.5000048
   Campoccia D, 2010, INT J ARTIF ORGANS, V33, P575
   Carnpoccia D, 2009, J BIOMED MATER RES A, V88A, P664, DOI 10.1002/jbm.a.32090
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Costerton WJ, 2009, INT J ARTIF ORGANS, V32, P699
   Fey PD, 2010, CURR OPIN MICROBIOL, V13, P610, DOI 10.1016/j.mib.2010.09.007
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1
   Groll J, 2009, INT J ARTIF ORGANS, V32, P655
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hoiby N, 2011, INT J ORAL SCI, V3, P55, DOI 10.4248/IJOS11026
   Izano EA, 2008, APPL ENVIRON MICROB, V74, P470, DOI 10.1128/AEM.02073-07
   Jager S, 2009, INT J ARTIF ORGANS, V32, P584
   Kaplan JB, 2011, RES MICROBIOL, V162, P535, DOI 10.1016/j.resmic.2011.03.008
   Kaplan JB, 2009, INT J ARTIF ORGANS, V32, P545
   Lou Q, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-146
   Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213
   Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Thomas VC, 2009, INT J ARTIF ORGANS, V32, P537
   Vuong Cuong, 2008, V431, P97
   Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487
   WINGENDER J, 1999, MICROBIAL EXTRACELLU, P1, DOI DOI 10.1007/978-3-642-60147-7_1
NR 30
TC 13
Z9 13
U1 2
U2 22
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2011
VL 34
IS 9
BP 840
EP 846
DI 10.5301/ijao.5000057
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 887GX
UT WOS:000299916000014
PM 22094564
DA 2018-10-20
ER

PT J
AU Visai, L
   De Nardo, L
   Punta, C
   Melone, L
   Cigada, A
   Imbriani, M
   Arciola, CR
AF Visai, Livia
   De Nardo, Luigi
   Punta, Carlo
   Melone, Lucio
   Cigada, Alberto
   Imbriani, Marcello
   Arciola, Carla Renata
TI Titanium oxide antibacterial surfaces in biomedical devices
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE Biomaterial surface modifications; Titanium oxide; Antibacterial
   properties; Infection-resistant materials
ID TIO2 THIN-FILMS; SUNLIGHT-INDUCED FUNCTIONALIZATION;
   CHEMICAL-VAPOR-DEPOSITION; DIOXIDE PHOTOCATALYTIC OXIDATION; REFLECTANCE
   FLASH-PHOTOLYSIS; STAINLESS-STEEL SUBSTRATE; VISIBLE-LIGHT IRRADIATION;
   ONE-ELECTRON OXIDATION; ESCHERICHIA-COLI; DRUG-DELIVERY
AB Titanium oxide is a heterogeneous catalyst whose efficient photoinduced activity, related to some of its allotropic forms, paved the way for its widespread technological use. Here, we offer a comparative analysis of the use of titanium oxide as coating for materials in biomedical devices. First, we introduce the photoinduced catalytic mechanisms of TiO2 and their action on biological environment and bacteria. Second, we overview the main physical and chemical technologies for structuring suitable TiO2 coatings on biomedical devices. We then present the approaches for in vitro characterization of these surfaces. Finally, we discuss the main aspects of TiO2 photoactivated antimicrobial activity on medical devices and limitations for these types of applications.
C1 [De Nardo, Luigi; Punta, Carlo; Melone, Lucio; Cigada, Alberto] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy.
   [De Nardo, Luigi; Punta, Carlo; Cigada, Alberto] Politecn Milan, INSTM Nat Consortium Mat Sci & Technol Local Unit, I-20133 Milan, Italy.
   [Arciola, Carla Renata] Univ Bologna, Res Unit Implant Infect, Rizzoli Orthopaed Inst, Bologna, Italy.
   [Arciola, Carla Renata] Univ Bologna, Dept Expt Pathol, I-40126 Bologna, Italy.
   [Visai, Livia] Int Ctr Studies & Res Biomed ICB, Luxembourg, Luxembourg.
   [Visai, Livia] Salvatore Maugeri Fdn IRCCS, Pavia, Italy.
   [Visai, Livia] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy.
   [Visai, Livia] Univ Pavia, Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
   [Imbriani, Marcello] Maugeri Fdn IRCCS, Pavia, Italy.
   [Imbriani, Marcello] Dept Publ Hlth & Neurosci, Pavia, Italy.
RP De Nardo, L (reprint author), Politecn Milan, Dept Chem Mat & Chem Engn G Natta, Piazza L da Vinci 32, I-20133 Milan, Italy.
EM luigi.denardo@polimi.it
RI Punta, Carlo/C-2657-2008; De Nardo, Luigi/B-7523-2009
OI Punta, Carlo/0000-0002-7239-9554; De Nardo, Luigi/0000-0002-7492-6012;
   IMBRIANI, MARCELLO/0000-0002-2752-1565; Cigada,
   Alberto/0000-0002-0925-5558
FU INSTM - National Institute for Materials Science and Technology; MIUR -
   FIRB Futuro in ricerca (Surface-associated selective transfection -
   SAST) [RBFR08XH0H]; Politecnico di Milano [5 per Mille Junior]; Italian
   Institute of Technology (IIT)
FX Luigi De Nardo, C. Punta, and L. Me lone acknowledge (i) INSTM -
   National Institute for Materials Science and Technology for financial
   support; (ii) MIUR - FIRB Futuro in ricerca (Surface-associated
   selective transfection - SAST, RBFR08XH0H) for a grant. L. De Nardo and
   A. Cigada also acknowledge Politecnico di Milano (Grant: 5 per Mille
   Junior) and the Italian Institute of Technology (IIT) for economic
   support.
CR Abe R, 2010, J PHOTOCH PHOTOBIO C, V11, P179, DOI 10.1016/j.jphotochemrev.2011.02.003
   Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   Akhavan O, 2009, CARBON, V47, P3280, DOI 10.1016/j.carbon.2009.07.046
   Akhavan O, 2009, J COLLOID INTERF SCI, V336, P117, DOI 10.1016/j.jcis.2009.03.018
   ALADJEM A, 1973, J MATER SCI, V8, P688, DOI 10.1007/BF00561225
   Alexandrov P, 1996, VACUUM, V47, P1333, DOI 10.1016/S0042-207X(96)00196-0
   Alfieri I, 2010, J APPL BIOMATER BIOM, V8, P14
   Altomare L, 2008, J APPL BIOMATER BIOM, V6, P132
   Amezaga-Madrid P, 2003, J PHOTOCH PHOTOBIO B, V70, P45, DOI 10.1016/S1011-1344(03)00054-X
   Arana J, 2002, CATAL TODAY, V76, P279, DOI 10.1016/S0920-5861(02)00226-2
   Arcos D, 2009, J MATER SCI-MATER M, V20, P447, DOI 10.1007/s10856-008-3616-x
   Armon R, 1998, J ADV OXID TECHNOL, V3, P145
   Ashkarran AA, 2011, CURR APPL PHYS, V11, P1048, DOI 10.1016/j.cap.2011.01.042
   ASK M, 1989, APPL SURF SCI, V35, P283, DOI 10.1016/0169-4332(89)90013-5
   Baba K, 2001, SURF COAT TECH, V136, P241, DOI 10.1016/S0257-8972(00)01022-7
   Blackwood DJ, 2003, CORROS REV, V21, P97
   Brinker CJ, 1989, SOL GEL SCI PHYS CHE
   Brook LA, 2007, J PHOTOCH PHOTOBIO A, V187, P53, DOI 10.1016/j.jphotochem.2006.09.014
   Bruellhoff K, 2010, INT J ARTIF ORGANS, V33, P646
   Brunski JB, 1996, BIOMATERIALS SCI INT, P37
   Caronna T, 2005, J PHOTOCH PHOTOBIO A, V171, P237, DOI 10.1016/j.jphotochem.2004.10.017
   Caronna T, 2003, CHEM COMMUN, P2350, DOI 10.1039/b306140j
   Caronna T, 2007, J PHOTOCH PHOTOBIO A, V189, P322, DOI 10.1016/j.jphotochem.2007.02.022
   Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001
   Catauro M, 2010, J APPL BIOMATER BIOM, V8, P42
   Chiesa R, 2003, J Appl Biomater Biomech, V1, P91
   Cho M, 2005, APPL ENVIRON MICROB, V71, P270, DOI 10.1128/AEM.71.1.270-275.2005
   Cho M, 2004, WATER RES, V38, P1069, DOI 10.1016/j.watres.2003.10.029
   Cho M, 2007, J FOOD PROTECT, V70, P97, DOI 10.4315/0362-028X-70.1.97
   Choi JY, 2007, J BIOMED MATER RES B, V80B, P353, DOI 10.1002/jbm.b.30604
   Chu PK, 2007, IEEE T PLASMA SCI, V35, P181, DOI 10.1109/TPS.2006.888587
   Chun MJ, 2007, ANGLE ORTHOD, V77, P483, DOI 10.2319/052406-211
   Chung CJ, 2009, SURF COAT TECH, V203, P1081, DOI 10.1016/j.surfcoat.2008.09.036
   Cigada A, 2008, J APPL BIOMATER BIOM, V6, P127
   CIGADA A, 1992, J MATER SCI-MATER M, V3, P408, DOI 10.1007/BF00701236
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dalrymple OK, 2010, APPL CATAL B-ENVIRON, V98, P27, DOI 10.1016/j.apcatb.2010.05.001
   Daoud WA, 2004, J AM CERAM SOC, V87, P953, DOI 10.1111/j.1551-2916.2004.00953.x
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   De Nardo L, 2010, WOODHEAD PUBL MATER, P102
   De Nardo L, 2004, 7 WORLD BIOM C, P1116
   De Nardo L, 2010, J MATER SCI-MATER M, V21, P2067, DOI 10.1007/s10856-010-4082-9
   De Nardo L, 2009, ACTA BIOMATER, V5, P1508, DOI 10.1016/j.actbio.2008.11.017
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   DELPLANCKE JL, 1982, SURF TECHNOL, V16, P153, DOI 10.1016/0376-4583(82)90033-4
   DELPLANCKE JL, 1988, ELECTROCHIM ACTA, V33, P1551, DOI 10.1016/0013-4686(88)80224-X
   DELPLANCKE JL, 1988, ELECTROCHIM ACTA, V33, P1539, DOI 10.1016/0013-4686(88)80223-8
   Ding XG, 2005, KEY ENG MATER, V208-283, P801
   Ditta IB, 2008, APPL MICROBIOL BIOT, V79, P127, DOI 10.1007/s00253-008-1411-8
   DRAPER RB, 1990, LANGMUIR, V6, P1396, DOI 10.1021/la00098a013
   DRAPER RB, 1990, J PHYS CHEM-US, V94, P4628, DOI 10.1021/j100374a048
   Dumitriu D, 2000, APPL CATAL B-ENVIRON, V25, P83, DOI 10.1016/S0926-3373(99)00123-X
   Dunlop PSM, 2010, J PHOTOCH PHOTOBIO A, V216, P303, DOI 10.1016/j.jphotochem.2010.07.004
   Erdem A, 2006, 2006 NSTI NAN C TRAD, P588
   Fagnoni M, 2007, CHEM REV, V107, P2725, DOI 10.1021/cr068352X
   Foster HA, 2011, APPL MICROBIOL BIOT, V90, P1847, DOI 10.1007/s00253-011-3213-7
   Freese HL, 2001, ENG MAT SER, P25
   Frojd V, 2011, BMC ORAL HEALTH, V11, DOI 10.1186/1472-6831-11-8
   Fu X, 1997, STUD SURF SCI CATAL, V103, P445, DOI 10.1016/S0167-2991(97)81114-7
   Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001
   Gage JP, 2005, BIOFILMS, V2, P155, DOI 10.1017/S1479050505001857
   Gagliardi M, 2010, J BIOMED MATER RES B, V93B, P375, DOI 10.1002/jbm.b.31592
   Gambarotti C, PHOTOSYNTHE IN PRESS
   Gambarotti C, 2010, CURR ORG CHEM, V14, P1153, DOI 10.2174/138527210791317111
   Gartner M, 2008, B KOREAN CHEM SOC, V29, P1038
   Gartner M, 2009, CERAM ENG SCI PROC, V29, P67
   Gaya UI, 2008, J PHOTOCH PHOTOBIO C, V9, P1, DOI 10.1016/j.jphotochemrev.2007.12.003
   Gelover S, 2006, WATER RES, V40, P3274, DOI 10.1016/j.watres.2006.07.006
   Giordano C, 2011, COLLOID SURFACE B, V88, P648, DOI 10.1016/j.colsurfb.2011.07.054
   Gogniat G, 2006, FEMS MICROBIOL LETT, V258, P18, DOI 10.1111/j.1574-6968.2006.00190.x
   Gupta R, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034005
   GUTIERREZ C, 1986, J ELECTROCHEM SOC, V133, P924, DOI 10.1149/1.2108764
   Haenle M, 2011, J MATER SCI-MATER M, V22, P381, DOI 10.1007/s10856-010-4204-4
   Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Henderson MA, 2011, SURF SCI REP, V66, P185, DOI 10.1016/j.surfrep.2011.01.001
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hu C, 2007, LANGMUIR, V23, P4982, DOI 10.1021/la063626x
   HURLEN T, 1994, ELECTROCHIM ACTA, V39, P2169, DOI 10.1016/S0013-4686(94)85069-0
   IRELAND JC, 1993, APPL ENVIRON MICROB, V59, P1668
   Iwasaki M, 2004, MATER TRANS, V45, P1607, DOI 10.2320/matertrans.45.1607
   Jing FJ, 2007, SURF COAT TECH, V201, P6874, DOI 10.1016/j.surfcoat.2006.09.088
   Kalyanasundaram K, 2010, CURR OPIN BIOTECH, V21, P298, DOI 10.1016/j.copbio.2010.03.021
   Kambala VSR, 2009, J BIOMED NANOTECHNOL, V5, P121, DOI 10.1166/jbn.2009.1002
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5
   Kuhn KP, 2003, CHEMOSPHERE, V53, P71, DOI 10.1016/S0045-6535(03)00362-X
   Kulkarni RV, 2007, J APPL BIOMATER BIOM, V5, P125
   LAUSMAA J, 1990, APPL SURF SCI, V45, P189, DOI 10.1016/0169-4332(90)90002-H
   Li B, 2007, J BIOMED MATER RES A, V83A, P923, DOI 10.1002/jbm.a.31414
   Li BE, 2009, MATER CHEM PHYS, V118, P99, DOI 10.1016/j.matchemphys.2009.07.011
   Li YJ, 2008, J ENVIRON SCI-CHINA, V20, P1527, DOI 10.1016/S1001-0742(08)62561-9
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Liu Y, 2007, J PHOTOCH PHOTOBIO A, V190, P94, DOI 10.1016/j.jphotochem.2007.03.017
   Macyk W, 2001, CHEM-EUR J, V7, P1862, DOI 10.1002/1521-3765(20010504)7:9<1862::AID-CHEM1862>3.3.CO;2-7
   Malato S, 2007, CATAL TODAY, V122, P137, DOI 10.1016/j.cattod.2007.01.034
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Marugan J, 2009, APPL CATAL B-ENVIRON, V89, P273, DOI 10.1016/j.apcatb.2009.02.007
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   Matsunaga T., 1985, J ANTIBACT ANTIFUNG, V13, P211
   Miki-Yoshida M, 2002, THIN SOLID FILMS, V419, P60, DOI 10.1016/S0040-6090(02)00786-1
   Miron C, 2005, J OPTOELECTRON ADV M, V7, P915
   Miyagi T, 2004, CHEM PHYS LETT, V390, P399, DOI 10.1016/j.cplett.2004.04.042
   Nadtochenko V, 2006, J PHOTOCH PHOTOBIO A, V181, P401, DOI 10.1016/j.jphotochem.2005.12.028
   Nadtochenko VA, 2008, RUSS J PHYS CHEM B+, V2, P105, DOI 10.1007/s11826-008-1016-0
   Nadtochenko VA, 2005, J PHOTOCH PHOTOBIO A, V169, P131, DOI 10.1016/j.photochem.2004.06.011
   Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n
   Navarro M, 2008, J R SOC INTERFACE, V5, P1137, DOI 10.1098/rsif.2008.0151
   Niinomi M, 2008, J ARTIF ORGANS, V11, P105, DOI 10.1007/s10047-008-0422-7
   Nishimura I, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/24/245101
   Palmisano G, 2007, CHEM COMMUN, P3425, DOI 10.1039/b700395c
   Paspaltsis I, 2006, J GEN VIROL, V87, P3125, DOI 10.1099/vir.0.81746-0
   Pelletier J, 2005, IEEE T PLASMA SCI, V33, P1944, DOI 10.1109/TPS.2005.860079
   Qiu Y, 2007, INT J ARTIF ORGANS, V30, P828
   Rauscher H., 2010, PLASMA TECHNOLOGY HY
   Ravelli D, 2009, CHEM SOC REV, V38, P1999, DOI 10.1039/b714786b
   SAITO T, 1992, J PHOTOCH PHOTOBIO B, V14, P369, DOI 10.1016/1011-1344(92)85115-B
   Salih FM, 2002, J APPL MICROBIOL, V92, P920, DOI 10.1046/j.1365-2672.2002.01601.x
   SALVADOR P, 1981, J ELECTROCHEM SOC, V128, P1895, DOI 10.1149/1.2127760
   Sanchez E, 2008, J THERM SPRAY TECHN, V17, P329, DOI 10.1007/s11666-008-9181-5
   Santillan MJ, 2010, SURF COAT TECH, V205, P2562, DOI 10.1016/j.surfcoat.2010.10.001
   Shah RR, 2008, J BIOMED NANOTECHNOL, V4, P339, DOI 10.1166/jbn.2008.324
   Shiraishi K, 2009, SURF INTERFACE ANAL, V41, P17, DOI 10.1002/sia.2965
   Simchi A, 2011, NANOMED-NANOTECHNOL, V7, P22, DOI 10.1016/j.nano.2010.10.005
   Sirghi L, 2003, SURF SCI, V530, pL323, DOI 10.1016/S0039-6028(03)00397-2
   Song WH, 2009, J BIOMED MATER RES A, V88A, P246, DOI 10.1002/jbm.a.31877
   Suketa N, 2005, CLIN IMPLANT DENT R, V7, P105, DOI 10.1111/j.1708-8208.2005.tb00053.x
   Sun CX, 2010, J AM CERAM SOC, V93, P531, DOI 10.1111/j.1551-2916.2009.03388.x
   Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3
   Sunada K, 1998, ENVIRON SCI TECHNOL, V32, P726, DOI 10.1021/es970860o
   Suwalsky M, 2005, J PHOTOCH PHOTOBIO B, V78, P253, DOI 10.1016/j.jphotobiol.2004.11.016
   Szymanowski H, 2007, THIN SOLID FILMS, V515, P5275, DOI 10.1016/j.tsf.2006.12.183
   Tachikawa T, 2004, J PHYS CHEM B, V108, P5859, DOI 10.1021/jp037003t
   Tachikawa T, 2004, LANGMUIR, V20, P2753, DOI 10.1021/la0361262
   Tanzi MC, 2011, J APPL BIOMATER BIOM, V9, P87, DOI 10.5301/JABB.2011.8563
   Textor M, 2001, ENG MAT SER, P171
   Vacaroiu C, 2009, WORLD J MICROB BIOT, V25, P27, DOI 10.1007/s11274-008-9856-6
   van Grieken R, 2010, APPL CATAL B-ENVIRON, V100, P212, DOI 10.1016/j.apcatb.2010.07.034
   Variola F, 2011, NANOSCALE, V3, P335, DOI 10.1039/c0nr00485e
   Vasilev K, 2009, EXPERT REV MED DEVIC, V6, P553, DOI [10.1586/erd.09.36, 10.1586/ERD.09.36]
   Visai L, 2007, INT J ARTIF ORGANS, V30, P813
   Visai L, 2008, J APPL BIOMATER BIOM, V6, P170
   Visai L, 2011, INT J ARTIF ORGANS, V34, P929, DOI 10.5301/ijao.5000050
   Voros J, 2001, ENG MAT SER, P87
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wu PG, 2008, J AM CERAM SOC, V91, P2957, DOI 10.1111/j.1551-2916.2008.02573.x
   Yates HM, 2008, J PHOTOCH PHOTOBIO A, V197, P197, DOI 10.1016/j.jphotochem.2007.12.023
   Yates HM, 2008, THIN SOLID FILMS, V517, P517, DOI 10.1016/j.tsf.2008.06.071
   Yerokhin AL, 1999, SURF COAT TECH, V122, P73, DOI 10.1016/S0257-8972(99)00441-7
   Yu JC, 2003, ENVIRON SCI TECHNOL, V37, P2296, DOI 10.1021/es0259483
   Yuan WY, 2008, J BIOMED MATER RES B, V85B, P556, DOI 10.1002/jbm.b.30979
   Zaleska A., 2008, RECENT PAT ENG, V2, P157, DOI DOI 10.2174/187221208786306289
   Zhang F, 1998, NUCL INSTRUM METH B, V142, P61, DOI 10.1016/S0168-583X(98)00211-0
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zhao XJ, 2008, J NON-CRYST SOLIDS, V354, P1424, DOI 10.1016/j.jnoncrysol.2006.10.093
   Zheng H, 2000, J PHOTOCH PHOTOBIO A, V130, P163
   Zhitomirsky I, 2002, ADV COLLOID INTERFAC, V97, P279, DOI 10.1016/S0001-8686(01)00068-9
   Zhitomirsky I, 2006, J MATER SCI, V41, P8186, DOI 10.1007/s10853-006-0994-7
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
   Zhitomirsky I, 2000, MATER LETT, V42, P262, DOI 10.1016/S0167-577X(99)00197-4
NR 161
TC 102
Z9 102
U1 5
U2 133
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2011
VL 34
IS 9
BP 929
EP 946
DI 10.5301/ijao.5000050
PG 18
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 887GX
UT WOS:000299916000026
PM 22094576
OA Green Published
DA 2018-10-20
ER

PT J
AU Nevins, ML
   Camelo, M
   Schupbach, P
   Nevins, M
   Kim, SW
   Kim, DM
AF Nevins, Marc L.
   Camelo, Marcelo
   Schupbach, Peter
   Nevins, Myron
   Kim, Soo-Woo
   Kim, David M.
TI Human Buccal Plate Extraction Socket Regeneration with Recombinant Human
   Platelet-Derived Growth Factor BB or Enamel Matrix Derivative
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID VERTICAL RIDGE AUGMENTATION; HUMAN HISTOLOGIC EVALUATION; CASE SERIES;
   PERIODONTAL REGENERATION; CLINICAL-TRIAL; RHPDGF-BB; BONE; DEFECTS;
   COMBINATION; ALLOGRAFT
AB The objective of this study was to assess the osseous healing of buccal plate extraction socket defects. There were four cohorts: group A (mineral collagen bone substitute [MCBS] scaffold alone), group B (MCBS with recombinant human platelet-derived growth factor BB [rhPDGF-BB; 0.3 mg/mL]), group C (MCBS with enamel matrix derivative [EMD]), and group D (combination of EMD with bone ceramic). The primary outcome of bone quality was evaluated using light microscopy, backscatter scanning electron microscopy, and histomorphometrics. Reentry surgery provided an opportunity for clinical observation of the healed ridge morphology. Sixteen patients with buccal wall extraction socket defects were randomized into four treatment groups of equal size. Grafting was provided at the time of extraction with advancement of the buccal flap for primary closure. A trephine core biopsy of the implant site preparation was performed after 5 months for implant placement. Histologic examination identified new bone healing around the biomaterial scaffolds. Statistically significant differences in new bone formation were not observed among the treatment groups. There was a histomorphometric trend toward more new bone for the rhPDGF-BB-treated group (group B). This group had the most favorable ridge morphology for optimal implant placement. (Int J Periodontics Restorative Dent 2011; 31:481-492.)
C1 [Nevins, Marc L.; Nevins, Myron; Kim, Soo-Woo; Kim, David M.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Div Periodontol, Boston, MA 02115 USA.
   [Camelo, Marcelo] Inst Adv Dent Studies, Belo Horizonte, MG, Brazil.
   [Schupbach, Peter] Res Lab Implants & Biomat, Horgen, Switzerland.
RP Nevins, ML (reprint author), Boston Periodont & Dent Implants, 175 Cambridge St,Suite 310, Boston, MA 02114 USA.
EM marc_nevins@hms.harvard.edu
FU Osteohealth
FX This study was sponsored by Osteohealth.
CR Camelo M, 2003, INT J PERIODONT REST, V23, P213
   Esposito M, 2009, EUR J ORAL IMPLANTOL, V2, P247
   Fagan MC, 2008, INT J PERIODONT REST, V28, P37
   Giannobile William V, 2003, Ann Periodontol, V8, P193, DOI 10.1902/annals.2003.8.1.193
   Grusovin MG, 2009, EUR J ORAL IMPLANTOL, V2, P43
   Howell TH, 1997, J PERIODONTOL, V68, P1186, DOI 10.1902/jop.1997.68.12.1186
   Listl S, 2010, J CLIN PERIODONTOL, V37, P920, DOI 10.1111/j.1600-051X.2010.01611.x
   McGuire MK, 2009, INT J PERIODONT REST, V29, P7
   Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205
   Nevins M, 2003, J PERIODONTOL, V74, P1282, DOI 10.1902/jop.2003.74.9.1282
   Nevins ML, 2009, INT J PERIODONT REST, V29, P129
   Nevins M, 2009, INT J PERIODONT REST, V29, P583
   Rosen PS, 2011, INT J PERIODONT REST, V31, P335
   Sculean A, 2008, INT J PERIODONT REST, V28, P153
   Simion M, 2008, INT J PERIODONT REST, V28, P239
   Simion M, 2007, INT J PERIODONT REST, V27, P109
   Simion M, 2006, INT J PERIODONT REST, V26, P415
   Simion M, 2009, INT J PERIODONT REST, V29, P245
NR 18
TC 16
Z9 17
U1 1
U2 5
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD SEP-OCT
PY 2011
VL 31
IS 5
BP 481
EP U153
PG 13
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 861CQ
UT WOS:000297997000010
PM 21845243
DA 2018-10-20
ER

PT J
AU Chu, CH
   Wang, YC
   Wu, LC
   Yang, CS
AF Chu, Chih-Hang
   Wang, Yu-Chao
   Wu, Li-Chen
   Yang, Chung-Shi
TI Size separation of ultrafine PEG-coated polycaprolactone nanoparticle
   and morphological studies by AFM
SO OPTOELECTRONICS AND ADVANCED MATERIALS-RAPID COMMUNICATIONS
LA English
DT Article
DE Polymeric composites; Nanoparticles; Atomic force microscopy;
   Biomaterial
ID DRUG-DELIVERY; POLYMERIC NANOPARTICLES; PLGA NANOPARTICLES; IN-VIVO;
   BIODISTRIBUTION; PARTICLES; PLATFORM
AB Novel ultrafine polycaprolactone nanoparticles (PCL NPs) were prepared using poly(ethyleneglycol)(2000)-distearyl phosphoethanolamine (PEGPE) as the oily phase emulsifier in the emulsion process, resulting in PEG-coated PCL NPs (PEGPE-PCL), which could be reduced and confined in size to below 50 nm. Size separation of PEG-coated polymer NPs remain significant challenges in the preparation for fundamental studies and applications. We used a gel filtration chromatography method for the rapid size separation of PEGPE-PCL and studied the physicochemical characteristics. The morphology of the core-shell PEGPE-PCL on a mica surface followed by NP concentration was observed by atomic force microscopy (AFM). It is important to separate size and define PEGPE-PCL structure for further potential in drug delivery application.
C1 [Chu, Chih-Hang; Wu, Li-Chen; Yang, Chung-Shi] Natl Chi Nan Univ, Dept Appl Chem, Puli, Taiwan.
   [Chu, Chih-Hang; Wu, Li-Chen; Yang, Chung-Shi] Natl Chi Nan Univ, Grad Inst Biomed & Biomed Technol, Puli, Taiwan.
   [Wang, Yu-Chao; Yang, Chung-Shi] Natl Hlth Res Inst, Ctr Nanomed Res, Mialoli 350, Taiwan.
RP Yang, CS (reprint author), Natl Chi Nan Univ, Dept Appl Chem, Puli, Taiwan.
EM cyang@nhri.org.tw
RI Yang, Chung-Shi/E-3999-2010
FU National Health Research Institutes, Taiwan [NHRI-99-NM-PP-05]
FX This research was supported by an intramural grant from the National
   Health Research Institutes (NHRI-99-NM-PP-05), Taiwan.
CR Astete CE, 2006, J BIOMAT SCI-POLYM E, V17, P247, DOI 10.1163/156856206775997322
   Beletsi A, 2005, INT J PHARM, V298, P233, DOI 10.1016/j.ijpharm.2005.03.024
   Cheng J, 2007, BIOMATERIALS, V28, P869, DOI 10.1016/j.biomaterials.2006.09.047
   Chu CH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/18/185601
   Cohen-Sela E, 2009, J CONTROL RELEASE, V133, P90, DOI 10.1016/j.jconrel.2008.09.073
   D'Acunto M, 2007, MATER LETT, V61, P3305, DOI 10.1016/j.matlet.2006.11.067
   D'Acunto M, 2005, MATER LETT, V59, P1627, DOI 10.1016/j.matlet.2005.01.028
   Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30
   Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q
   Muranaka M, 2010, MATER LETT, V64, P969, DOI 10.1016/j.matlet.2010.01.076
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   RAVIKUMAR MNV, 2004, BIOMATERIALS, V25, P1771
   Ren J, 2005, MATER LETT, V59, P2655, DOI 10.1016/j.matlet.2005.04.013
   Yamamoto T, 2004, CHEM LETT, V33, P1440, DOI 10.1246/cl.2004.1440
   Zhang LF, 2008, ACS NANO, V2, P1696, DOI 10.1021/nn800275r
NR 18
TC 0
Z9 0
U1 2
U2 19
PU NATL INST OPTOELECTRONICS
PI BUCHAREST-MAGURELE
PA 1 ATOMISTILOR ST, PO BOX MG-5, BUCHAREST-MAGURELE 76900, ROMANIA
SN 1842-6573
J9 OPTOELECTRON ADV MAT
JI Optoelectron. Adv. Mater.-Rapid Commun.
PD SEP
PY 2011
VL 5
IS 9
BP 969
EP 972
PG 4
WC Materials Science, Multidisciplinary; Optics
SC Materials Science; Optics
GA 856JY
UT WOS:000297637400017
DA 2018-10-20
ER

PT J
AU Hanna, HM
   Jarboe, DH
AF Hanna, H. M.
   Jarboe, D. H.
TI EFFECTS OF FULL, ABBREVIATED, AND NO CLEAN-OUTS ON COMMINGLED GRAIN
   DURING COMBINE HARVEST
SO APPLIED ENGINEERING IN AGRICULTURE
LA English
DT Article
DE Clean; Clean-out; Combine; Commingle; Corn; Grain; Harvester;
   Identity-preserved; Labor; Residual; Soybean
ID COUNTRY ELEVATOR
AB Growers of identity-preserved crops desire to keep grain separate throughout the production process. Earlier research has demonstrated that some locations in a combine such as cleaning and threshing areas harbor relatively smaller amounts of grain, but require relatively large amounts of time to clean. Omitting clean-out in some areas and flushing residual grain with new grain in the first grain tank full may lower commingled grain concentration to acceptable levels for some customers.
   A Case IH 7010 combine alternating harvest between corn and soybean crops received either a full, abbreviated, or no clean-out before harvesting the subsequent crop. During unloading of the first grain tank full in the new crop, grain samples were collected. Commingled grain concentration with full clean-out was at or below 0.1% in the first 35 L (bushel) and 700 L (20 bu) harvested and less than 0.01% after 3500 L (100 bu) had been harvested. Abbreviated and no clean-outs reached below 0.7% commingled concentration after 700 L (20 bu) were harvested, below 0.05% after 3500 L (100 bu) harvested, and below 0.035% after 11,300 L (320 bu) harvested, although commingled concentration did not always consistently decrease with increased flushing after low concentrations were obtained. Clean-out time required was 6.5 person-h (person-hour) and 2.5 person-h for full and abbreviated clean-outs, respectively. Thirty-two kg (70 lb) of biomaterial were collected during full clean-out with the greatest amounts in the rotor and head areas.
C1 [Hanna, H. M.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50010 USA.
   [Jarboe, D. H.] Iowa State Univ, Ctr Crop Utilizat Res, Ames, IA 50010 USA.
RP Hanna, HM (reprint author), Iowa State Univ, Dept Agr & Biosyst Engn, 200B Davidson Hall, Ames, IA 50010 USA.
EM hmhanna@iastate.edu
FU Hatch Act; State of Iowa Funds; AGCO; CNN
FX This journal paper of the Iowa Agriculture and Home Economics Experiment
   Station, Ames, Iowa, was supported by Hatch Act and State of Iowa Funds.
   Trade and company names are included in this paper for the benefit of
   the reader and do not infer endorsement or preferential treatment or
   imply criticism of the product named by Iowa State University.; Grateful
   acknowledgement is given to AGCO, CNN, and John Deere for joint
   sponsorship of this project to advance development of identity-preserved
   grain, food, and oilseed markets. AGCO and John Deere provided direct
   support for labor, supplies, and other resources. CNI-1 provided the
   combine used for data collection along with technical support from Herb
   Farley and Jim Minnihan. Student interns Christopher Bone, Adam Morford,
   and Alex Vanwyngarden were day-to-day project leaders doing the work of
   combine clean-outs, sorting and cleaning of samples, and preliminary
   data analysis. Data collected was gathered to support ASABE standards
   development discussions of statistically measured ranges with a
   prescribed clean-out procedure and in the spirit of a collective
   industry effort are not to be used for comparative marketing purposes.
CR GREENLEES WJ, 2000, MC00103 ASAE
   HACKLEMAN JC, 1990, HIST SEED CERTIFICAT
   Hanna HM, 2009, APPL ENG AGRIC, V25, P851
   HURBURGH CR, 1994, J AM OIL CHEM SOC, V71, P1073, DOI 10.1007/BF02675899
   Ingles MEA, 2006, APPL ENG AGRIC, V22, P713
   Ingles MEA, 2003, T ASAE, V46, P1625
   *OECD, 2010, 2010 OECD SCHEM VAR
   QUICK GR, 1977, P INT GRAIN FOR HARV, P76
   Robinson J.L., 1963, STORY IOWA CROP IMPR
NR 9
TC 0
Z9 1
U1 0
U2 3
PU AMER SOC AGRICULTURAL & BIOLOGICAL ENGINEERS
PI ST JOSEPH
PA 2950 NILES RD, ST JOSEPH, MI 49085-9659 USA
SN 0883-8542
J9 APPL ENG AGRIC
JI Appl. Eng. Agric.
PD SEP
PY 2011
VL 27
IS 5
BP 687
EP 695
PG 9
WC Agricultural Engineering
SC Agriculture
GA 847UC
UT WOS:000296997000002
DA 2018-10-20
ER

PT J
AU Sedaghati, T
   Yang, SY
   Mosahebi, A
   Alavijeh, MS
   Seifalian, AM
AF Sedaghati, Tina
   Yang, Shi Yu
   Mosahebi, Afshin
   Alavijeh, Mohammad S.
   Seifalian, Alexander M.
TI Nerve regeneration with aid of nanotechnology and cellular engineering
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Review
DE peripheral nerve regeneration; nerve conduit; stem cell; nerve growth
   factor; biomaterial; regenerative medicine; nanotechnology
ID NEURAL STEM-CELLS; MARROW STROMAL CELLS; AUTOLOGOUS SCHWANN-CELLS; HUMAN
   MEDIAN NERVE; RAT SCIATIC-NERVE; PERIPHERAL-NERVE; IN-VIVO;
   GROWTH-FACTOR; NEUROTROPHIC FACTORS; EXTRACELLULAR-MATRIX
AB Repairing nerve defects with large gaps remains one of the most operative challenges for surgeons. Incomplete recovery from peripheral nerve injuries can produce a diversity of negative outcomes, including numbness, impairment of sensory or motor function, possibility of developing chronic pain, and devastating permanent disability. In the last few years, numerous microsurgical techniques, such as coaptation, nerve autograft, and different biological or polymeric nerve conduits, have been developed to reconstruct a long segment of damaged peripheral nerve. A few of these techniques are promising and have become popular among surgeons. Advancements in the field of tissue engineering have led to development of synthetic nerve conduits as an alternative for the nerve autograft technique, which is the current practice to bridge nerve defects with gaps larger than 30 mm. However, to date, despite significant progress in this field, no material has been found to be an ideal alternative to the nerve autograft. This article briefly reviews major up-to-date published studies using different materials as an alternative to the nerve autograft to bridge peripheral nerve gaps in an attempt to assess their ability to support and enhance nerve regeneration and their prospective drawbacks, and also highlights the promising hope for nerve regeneration with the next generation of nerve conduits, which has been significantly enhanced with the tissue engineering approach, especially with the aid of nanotechnology in development of the three-dimensional scaffold. The goal is to determine potential alternatives for nerve regeneration and repair that are simply and directly applicable in clinical conditions.
C1 [Sedaghati, Tina; Yang, Shi Yu; Mosahebi, Afshin; Seifalian, Alexander M.] UCL, UCL Ctr Nanotechnol & Regenerat Med, UCL Div Surg & Intervent Sci, London NW3 2QG, England.
   [Mosahebi, Afshin] Royal Free Hampstead NHS Trust Hosp, London, England.
   [Alavijeh, Mohammad S.] Pharmidex Pharmaceut Serv, London, England.
RP Seifalian, AM (reprint author), UCL, UCL Ctr Nanotechnol & Regenerat Med, UCL Div Surg & Intervent Sci, London NW3 2QG, England.
EM a.seifalian@ucl.ac.uk
RI Yang, Shi Yu/B-3160-2011; Seifalian, Alexander/I-6028-2013
OI Yang, Shi Yu/0000-0001-8517-9238; Seifalian,
   Alexander/0000-0002-1180-3322; mosahebi, afshin/0000-0001-5940-4446
CR Ahmed Z, 2003, TISSUE ENG, V9, P219, DOI 10.1089/107632703764664693
   Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102
   Amoh Y, 2010, J DERMATOL SCI, V60, P131, DOI 10.1016/j.jdermsci.2010.09.007
   Amoh Y, 2010, J CELL BIOCHEM, V110, P272, DOI 10.1002/jcb.22534
   Antoniadou EV, 2010, IEEE ENG MED BIO, P815, DOI 10.1109/IEMBS.2010.5626760
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   ARCHIBALD SJ, 1995, J NEUROSCI, V15, P4109
   Armstrong SJ, 2007, TISSUE ENG, V13, P2863, DOI 10.1089/ten.2007.0055
   Ashley WW, 2006, J NEUROSURG, V105, P452, DOI 10.3171/ped.2006.105.6.452
   Baguneid M, 2011, BIOTECHNOL APPL BIOC, V58, P14, DOI 10.1002/bab.8
   Baiguera S, 2010, TRANSPLANTATION, V89, P485, DOI 10.1097/TP.0b013e3181cd4ad3
   Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Belkas JS, 2005, RESTOR NEUROL NEUROS, V23, P19
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Bertram JP, 2010, PHARM RES-DORD, V27, P82, DOI 10.1007/s11095-009-0009-x
   Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018
   Bhandari PS, 2007, INDIAN J NEUROTRAUM, V4, P21, DOI 10.1016/S0973-0508(07)80006-2
   Boyd JG, 2003, MOL NEUROBIOL, V27, P277, DOI 10.1385/MN:27:3:277
   Bryan DJ, 2003, J RECONSTR MICROSURG, V19, P125, DOI 10.1055/s-2003-37820
   BUNGE MB, 1986, ANN NY ACAD SCI, V486, P241
   Bushnell BD, 2008, J HAND SURG-AM, V33A, P1081, DOI 10.1016/j.jhsa.2008.03.015
   Cai S, 2011, CNS NEUROL DISORD-DR, V10, P500, DOI 10.2174/187152711795563930
   Casanas J, 2000, J HAND SURG B, V25, P44
   Chang CJ, 2009, TISSUE ENG PT A, V15, P547, DOI 10.1089/ten.tea.2007.0342
   Chehrehasa F, 2010, MOL CELL NEUROSCI, V45, P277, DOI 10.1016/j.mcn.2010.07.002
   Chen CJ, 2007, EXP NEUROL, V204, P443, DOI 10.1016/j.expneurol.2006.12.004
   Chernousov MA, 2000, HISTOL HISTOPATHOL, V15, P593, DOI 10.14670/HH-15.593
   Chi GF, 2010, EXP NEUROL, V222, P304, DOI 10.1016/j.expneurol.2010.01.008
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Dellon AL, 2006, J HAND SURG-AM, V31A, P1495, DOI 10.1016/j.jhsa.2006.07.003
   DEMEDINACELI L, 1993, MICROSURG, V14, P244, DOI 10.1002/micr.1920140406
   den Dunnen WFA, 2001, BIOMATERIALS, V22, P1171, DOI 10.1016/S0142-9612(00)00339-2
   DENDUNNEN WFA, 1995, J BIOMED MATER RES, V29, P757, DOI 10.1002/jbm.820290612
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   Donoghoe N, 2007, MICROSURG, V27, P595, DOI 10.1002/micr.20408
   Ducic I, 2005, J RECONSTR MICROSURG, V21, P29, DOI 10.1055/s-2005-862777
   Durgam H, 2010, J BIOMAT SCI-POLYM E, V21, P1265, DOI 10.1163/092050609X12481751806330
   Eich BS, 2000, J RECONSTR MICROSURG, V16, P329
   EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223
   Erba P, 2010, J PLAST RECONSTR AES, V63, pE811, DOI 10.1016/j.bjps.2010.08.013
   Farole A, 2008, J ORAL MAXIL SURG, V66, P2058, DOI 10.1016/j.joms.2008.06.017
   Fu KY, 2011, ARTIF ORGANS, V35, P363, DOI 10.1111/j.1525-1594.2010.01105.x
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   George PM, 2009, J BIOMED MATER RES A, V91A, P519, DOI 10.1002/jbm.a.32226
   Geremia NM, 2010, EXP NEUROL, V223, P128, DOI 10.1016/j.expneurol.2009.07.022
   Ghanbari H, 2011, MACROMOL RAPID COMM, V32, P1032, DOI 10.1002/marc.201100126
   Ghanbari H, 2011, INT J NANOMED, V6, P775, DOI 10.2147/IJN.S14881
   Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3
   Goto E, 2010, J BIOSCI BIOENG, V109, P512, DOI 10.1016/j.jbiosc.2009.11.002
   GUENARD V, 1992, J NEUROSCI, V12, P3310
   Guerout N, 2011, MUSCLE NERVE, V43, P543, DOI 10.1002/mus.21907
   GULATI AK, 1989, J NEUROSURG, V70, P115, DOI 10.3171/jns.1989.70.1.0115
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hazari A, 1999, BRIT J PLAST SURG, V52, P653, DOI 10.1054/bjps.1999.3184
   Heine W, 2004, EXP NEUROL, V189, P231, DOI 10.1016/j.expneurol.2004.06.014
   Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4
   Hu JG, 2011, INDIAN J EXP BIOL, V49, P177
   Hu J, 2007, EXP NEUROL, V204, P658, DOI 10.1016/j.expneurol.2006.11.018
   Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511
   Hudson TW, 2000, ORTHOP CLIN N AM, V31, P485, DOI 10.1016/S0030-5898(05)70166-8
   Hung V, 2008, J HAND SURG-AM, V33A, P313, DOI 10.1016/j.jhsa.2007.12.008
   Ignazio M, 2010, J HAND SURG-AM, V35A, P1418, DOI 10.1016/j.jhsa.2010.05.019
   Jain KK, 2006, NANOMEDICINE-UK, V1, P9, DOI 10.2217/17435889.1.1.9
   Jessen KR, 1999, TRENDS NEUROSCI, V22, P402, DOI 10.1016/S0166-2236(98)01391-5
   Jesuraj NJ, 2011, J NEUROSCI METH, V197, P209, DOI 10.1016/j.jneumeth.2011.02.015
   Juliano RL, 2004, BIOCHEM SOC T, V32, P443, DOI 10.1042/BST0320443
   Kalbermatten DF, 2008, J HAND SURG-EUR VOL, V33E, P587, DOI 10.1177/1753193408090755
   Kalbermatten DF, 2009, J RECONSTR MICROSURG, V25, P27, DOI 10.1055/s-0028-1090619
   Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137
   Keilhoff G, 2006, TISSUE ENG, V12, P1451, DOI 10.1089/ten.2006.12.1451
   Kim J, 2001, J Foot Ankle Surg, V40, P318
   Kim SM, 2007, J CRANIOFAC SURG, V18, P475, DOI 10.1097/01.scs.0000249362.41170.f3
   Kokai LE, 2010, BIOMATERIALS, V31, P2313, DOI 10.1016/j.biomaterials.2009.11.075
   Krejci E, 2010, FOLIA BIOL-PRAGUE, V56, P149
   Laveaux C, 2010, ANN CHIR PLAST ESTH, V55, P19, DOI 10.1016/j.anplas.2009.03.003
   Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lee Y, 2008, MICROSURG, V28, P436, DOI 10.1002/micr.20517
   LEVI ADO, 1994, J NEUROSCI, V14, P1309
   Li BC, 2010, J BIOMED MATER RES A, V94A, P769, DOI 10.1002/jbm.a.32727
   Lin HY, 2011, TISSUE ENG PT A, V17, P1691, DOI 10.1089/ten.tea.2010.0514
   Liu JJ, 2011, J BIOMED MATER RES A, V96A, P13, DOI 10.1002/jbm.a.32946
   Lohmeyer JA, 2009, J RECONSTR MICROSURG, V25, P55, DOI 10.1055/s-0028-1103505
   Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899
   LUNDBORG G, 1991, SCAND J PLAST RECONS, V25, P79, DOI 10.3109/02844319109034927
   Mackinnon SE, 2001, PLAST RECONSTR SURG, V107, P1419, DOI 10.1097/00006534-200105000-00016
   MACKINNON SE, 1990, PLAST RECONSTR SURG, V85, P419, DOI 10.1097/00006534-199003000-00015
   Mahay D, 2008, BIOTECHNOL APPL BIOC, V51, P167, DOI 10.1042/BA20070212
   MANTHORPE M, 1983, J CELL BIOL, V97, P1882, DOI 10.1083/jcb.97.6.1882
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Matsumoto K, 2000, ASAIO J, V46, P415, DOI 10.1097/00002480-200007000-00009
   Meek MF, 2007, BIO-MED MATER ENG, V17, P329
   Meek MF, 2009, J BIOMED MATER RES A, V89A, P734, DOI 10.1002/jbm.a.32024
   Meek MF, 2006, J RECONSTR MICROSURG, V22, P149, DOI 10.1055/s-2006-939959
   MEEK MF, 1997, CELLS MAT, V7, P53
   Mersa Berkan, 2004, Kulak Burun Bogaz Ihtis Derg, V13, P103
   Millesi H, 2000, HAND CLIN, V16, P73
   Moore Amy M, 2009, Hand (N Y), V4, P239, DOI 10.1007/s11552-009-9183-x
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Mosahebi A, 2001, TISSUE ENG, V7, P525, DOI 10.1089/107632701753213156
   Navissano M, 2005, MICROSURG, V25, P268, DOI 10.1002/micr.20128
   Neto HS, 2004, MICROSURG, V24, P188, DOI 10.1002/micr.20046
   Nijhuis THJ, 2010, MICROSURG, V30, P639, DOI 10.1002/micr.20818
   Nisbet DR, 2008, J BIOMAT SCI-POLYM E, V19, P623, DOI 10.1163/156856208784089652
   NORRIS RW, 1988, J BONE JOINT SURG BR, V70, P530
   Ohta M, 2004, J BIOMED MATER RES A, V71A, P661, DOI 10.1002/jbm.a.30194
   OTTO D, 1987, NEUROSCI LETT, V83, P156, DOI 10.1016/0304-3940(87)90233-3
   Patel M, 2007, J TISSUE ENG REGEN M, V1, P360, DOI 10.1002/term.44
   Patel M, 2009, J BIOMED MATER RES A, V90A, P154, DOI 10.1002/jbm.a.32072
   Lopes FRP, 2010, MICRON, V41, P783, DOI 10.1016/j.micron.2010.05.010
   Pierucci A, 2009, J MATER SCI-MATER M, V20, P489, DOI 10.1007/s10856-008-3614-z
   Platt CI, 2003, J NEUROSCI RES, V74, P417, DOI 10.1002/jnr.10783
   Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200
   Radtke C, 2010, J RECONSTR MICROSURG, V26, P211, DOI 10.1055/s-0029-1238221
   Raghunath J, 2009, BIOTECHNOL APPL BIOC, V52, P1, DOI 10.1042/BA20070256
   Ray WZ, 2011, J NEUROSURG, V114, P256, DOI 10.3171/2010.5.JNS10111
   Ristic S, 2000, CLIN ORTHOP RELAT R, P138
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   ROSEN J M, 1989, Journal of Rehabilitation Research and Development, V26, P1
   Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580
   Ruggieri MR, 2006, J NEUROTRAUM, V23, P1125, DOI 10.1089/neu.2006.23.1125
   Runge MB, 2010, BIOMATERIALS, V31, P5916, DOI 10.1016/j.biomaterials.2010.04.012
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santiago LY, 2009, CELL TRANSPLANT, V18, P145, DOI 10.3727/096368909788341289
   Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SECKEL BR, 1984, PLAST RECONSTR SURG, V74, P173, DOI 10.1097/00006534-198408000-00001
   Shin RH, 2009, J BONE JOINT SURG AM, V91A, P2194, DOI 10.2106/JBJS.H.01301
   Sinis N, 2005, J NEUROSURG, V103, P1067, DOI 10.3171/jns.2005.103.6.1067
   Stabenfeldt SE, 2006, J BIOMED MATER RES A, V77A, P718, DOI 10.1002/jbm.a.30638
   Taras John S, 2008, Tech Hand Up Extrem Surg, V12, P100, DOI 10.1097/BTH.0b013e31815e6334
   Terenghi G, 1999, J ANAT, V194, P1, DOI 10.1046/j.1469-7580.1999.19410001.x
   Thalhammer A, 2010, BIOMATERIALS, V31, P2097, DOI 10.1016/j.biomaterials.2009.11.109
   Thornton MR, 2008, BIOTECHNOL APPL BIOC, V49, P165, DOI 10.1042/BA20070040
   Tohill M, 2004, BIOTECHNOL APPL BIOC, V40, P17, DOI 10.1042/BA20030173
   Tosun Z, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066002
   Tse KH, 2010, J BIOMED MATER RES A, V95A, P701, DOI 10.1002/jbm.a.32889
   Tucker BA, 2008, CAN J NEUROL SCI, V35, P551, DOI 10.1017/S0317167100009331
   Ulkur E, 2008, J RECONSTR MICROSURG, V24, P137, DOI 10.1055/s-2008-1076087
   Varejao Artur S. P., 2003, Italian Journal of Anatomy and Embryology, V108, P77
   Vogelin E, 2006, EXP NEUROL, V199, P348, DOI 10.1016/j.expneurol.2005.12.029
   Walsh S, 2009, NEUROSCIENCE, V164, P1097, DOI 10.1016/j.neuroscience.2009.08.072
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013
   Wei Y, 2010, CELL PROLIFERAT, V43, P606, DOI 10.1111/j.1365-2184.2010.00710.x
   WHITWORTH IH, 1995, J HAND SURG-BRIT EUR, V20B, P429, DOI 10.1016/S0266-7681(05)80148-2
   Wilson A, 2011, CELL PROLIFERAT, V44, P86, DOI 10.1111/j.1365-2184.2010.00736.x
   Wood MD, 2010, BIOTECHNOL BIOENG, V106, P970, DOI 10.1002/bit.22766
   YOSHINO JE, 1990, GLIA, V3, P315, DOI 10.1002/glia.440030502
   Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1111/j.1460-9568.2000.01312.x
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang Yongjie, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P394
NR 154
TC 17
Z9 19
U1 0
U2 47
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD SEP-OCT
PY 2011
VL 58
IS 5
SI SI
BP 288
EP 300
DI 10.1002/bab.51
PG 13
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 842ND
UT WOS:000296605300002
PM 21995532
DA 2018-10-20
ER

PT J
AU Barsotti, MC
   Felice, F
   Balbarini, A
   Di Stefano, R
AF Barsotti, Maria Chiara
   Felice, Francesca
   Balbarini, Alberto
   Di Stefano, Rossella
TI Fibrin as a scaffold for cardiac tissue engineering
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Review
DE fibrin; myocardium; tissue engineering; scaffold; cell injection;
   implantation
ID ENDOTHELIAL PROGENITOR CELLS; LEFT-VENTRICULAR FUNCTION; IN-VITRO;
   MYOCARDIAL-INFARCTION; GROWTH-FACTOR; STEM-CELLS; CONTROLLED-RELEASE;
   HEART-VALVES; NEOVASCULATURE FORMATION; ISCHEMIC-MYOCARDIUM
AB Fibrin is a natural biopolymer with many interesting properties, such as biocompatibility, bioresorbability, ease of processing, ability to be tailored to modify the conditions of polymerization, and potential for incorporation of both cells and cell mediators. Moreover, the fibrin network has a nanometric fibrous structure, mimicking extracellular matrix, and it can also be used in autologous applications. Therefore, fibrin has found many applications in tissue engineering, combined with cells, growth factors, or drugs. Because a major limitation of cardiac cell therapy is low cell engraftment, the use of biodegradable scaffolds for specific homing and in situ cell retention is desirable. Thus, fibrin-based injectable cardiac tissue engineering may enhance cell therapy efficacy. Fibrin-based biomaterials can also be used for engineering heart valves or cardiac patches. The aim of this review is to show cardiac bioengineering uses of fibrin, both as a cell delivery vehicle and as an implantable biomaterial.
C1 [Barsotti, Maria Chiara; Felice, Francesca; Di Stefano, Rossella] Univ Pisa, Cardiovasc Res Lab, Cardiac Thorac & Vasc Dept, I-56124 Pisa, Italy.
   [Balbarini, Alberto; Di Stefano, Rossella] Univ Pisa, Angiol Unit, Cardiac Thorac & Vasc Dept, I-56124 Pisa, Italy.
RP Barsotti, MC (reprint author), Univ Pisa, Cardiovasc Res Lab, Cardiac Thorac & Vasc Dept, Via Paradisa 2, I-56124 Pisa, Italy.
EM mariachiarab@yahoo.com
RI Balbarini, Alberto/G-8753-2011; Di Stefano, Rossella/C-3880-2009;
   Felice, Francesca/C-3882-2009; Barsotti, Maria Chiara/C-5222-2009
OI Barsotti, Maria Chiara/0000-0002-7957-0131; Felice,
   Francesca/0000-0001-8968-2228
FU Regione Toscana; Fondazione Cassa di Risparmio di Pisa
FX The authors would like to acknowledge the financial support of Regione
   Toscana for the Integrated Research Projects "Development of a new
   technology for 3D nanostructured scaffolds with potential cardiovascular
   application" and "Nanostructured materials containing fibrin and
   platelet-derived factors for angiogenesis promotion" and Fondazione
   Cassa di Risparmio di Pisa for the Research Project "Self-assembling
   nanostructured systems for regenerative therapy of ischemic tissues."
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Anitua E, 2010, ADV DRUG DELIVER REV, V62, P741, DOI 10.1016/j.addr.2010.01.001
   Atar D, 2009, J AM COLL CARDIOL, V53, P720, DOI 10.1016/j.jacc.2008.12.017
   Baguneid M, 2011, BIOTECHNOL APPL BIOC, V58, P14, DOI 10.1002/bab.8
   Barsotti MC, 2011, CELL PROLIFERAT, V44, P33, DOI 10.1111/j.1365-2184.2010.00715.x
   Birla RK, 2009, BIOTECHNOL LETT, V31, P191, DOI 10.1007/s10529-008-9859-2
   Birla RK, 2005, TISSUE ENG, V11, P803, DOI 10.1089/ten.2005.11.803
   Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029
   Brown KJ, 1996, LAB INVEST, V75, P539
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Bruns H, 2005, TISSUE ENG, V11, P1718, DOI 10.1089/ten.2005.11.1718
   Buijtenhuijs P, 2004, BIOTECHNOL APPL BIOC, V39, P141, DOI 10.1042/BA20030105
   Caiado F, 2011, BIOMATERIALS, V32, P7096, DOI 10.1016/j.biomaterials.2011.06.022
   Chekanov V, 2003, PACE, V26, P496, DOI 10.1046/j.1460-9592.2003.00080.x
   Chen ZW, 2011, J MICROENCAPSUL, V28, P344, DOI 10.3109/02652048.2011.569764
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   CONRADI L, 2011, J VIS EXP, V52, P2605
   Cornwell KG, 2007, J BIOMED MATER RES A, V82A, P104, DOI 10.1002/jbm.a.31057
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Danoviz ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012077
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Erb MA, 2009, EUR J CARDIO-THORAC, V36, P703, DOI 10.1016/j.ejcts.2009.04.028
   Evers R, 2011, ARTIF ORGANS, V35, P69, DOI 10.1111/j.1525-1594.2010.01007.x
   Eyrich D, 2006, ADV EXP MED BIOL, V585, P379
   Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x
   Filova E, 2009, PHYSIOL RES, V58, pS141
   Filova E, 2009, J BIOMED MATER RES A, V90A, P55, DOI 10.1002/jbm.a.32065
   Flanagan TC, 2007, BIOMATERIALS, V28, P3388, DOI 10.1016/j.biomaterials.2007.04.012
   Flanagan TC, 2009, TISSUE ENG PT A, V15, P2965, DOI [10.1089/ten.tea.2009.0018, 10.1089/ten.TEA.2009.0018]
   Godier-Furnemont AFG, 2011, P NATL ACAD SCI USA, V108, P7974, DOI 10.1073/pnas.1104619108
   Goerler H, 2007, EUR J CARDIO-THORAC, V32, P560, DOI 10.1016/j.ejcts.2007.01.071
   Goncalves GA, 2010, GENE THER, V17, P305, DOI 10.1038/gt.2009.146
   Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]
   Hall H, 2007, CURR PHARM DESIGN, V13, P3597, DOI 10.2174/138161207782794158
   Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074
   Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458
   Hecker L, 2008, BIOTECHNOL APPL BIOC, V50, P155, DOI 10.1042/BA20070139
   HOBEN G, 2011, AESTHETIC PLAST SURG
   Huang YC, 2008, ANN BIOMED ENG, V36, P1372, DOI 10.1007/s10439-008-9517-9
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Janmey PA, 2009, J R SOC INTERFACE, V6, P1, DOI 10.1098/rsif.2008.0327
   JENNEWEIN C, 2011, MOL MED, V5, P568
   Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8
   Kaijzel EL, 2006, J THROMB HAEMOST, V4, P1975, DOI 10.1111/j.1538-7836.2006.02081.x
   Kaminski A, 2011, TISSUE ENG PART C-ME, V17, P299, DOI [10.1089/ten.tec.2010.0051, 10.1089/ten.TEC.2010.0051]
   Kelly WJ, 2008, BIOTECHNOL APPL BIOC, V49, P225, DOI 10.1042/BA20070177
   KHAIT L, 2011, CELL TRANSPLANT
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   Le Nihouannen D, 2008, J MATER SCI-MATER M, V19, P667, DOI 10.1007/s10856-007-3206-3
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Motwani MS, 2011, BIOTECHNOL APPL BIOC, V58, P2, DOI 10.1002/bab.10
   Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005
   Nie SP, 2010, J ZHEJIANG UNIV-SC B, V11, P895, DOI 10.1631/jzus.B1000302
   PAGE RL, 2011, TISSUE ENG A
   PARK SH, 2011, TISSUE ENG A
   Petzelbauer P, 2005, NAT MED, V11, P298, DOI 10.1038/nm1198
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Prasad C.K., 2005, BIOMATERIALS, V26, P5658, DOI DOI 10.1016/J.BIOMATERIALS.2005.02.024
   Prater DN, 2007, LEUKEMIA, V21, P1141, DOI 10.1038/sj.leu.2404676
   Raghunath J, 2009, BIOTECHNOL APPL BIOC, V52, P1, DOI 10.1042/BA20070256
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Sarig U, 2011, EXPERT OPIN BIOL TH, V11, P1055, DOI 10.1517/14712598.2011.578574
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   SKODACEK D, 2011, HEAD NECK
   Spotnitz WD, 2010, WORLD J SURG, V34, P632, DOI 10.1007/s00268-009-0252-7
   Sreerekha PR, 2006, CELL PROLIFERAT, V39, P301, DOI 10.1111/j.1365-2184.2006.00389.x
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P49, DOI 10.1042/BA20030109
   Syedain ZH, 2011, BIOMATERIALS, V32, P714, DOI 10.1016/j.biomaterials.2010.09.019
   Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027
   Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097
   Uibo R, 2009, BBA-MOL CELL RES, V1793, P924, DOI 10.1016/j.bbamcr.2009.01.007
   van Susante JLC, 1999, BIOMATERIALS, V20, P1167, DOI 10.1016/S0142-9612(97)00190-7
   Vinatier C, 2011, M S-MED SCI, V27, P289, DOI 10.1051/medsci/2011273289
   Walpoth BH, 2007, J THORAC CARDIOV SUR, V133, P1163, DOI 10.1016/j.jtcvs.2007.01.029
   Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001
   Wechselberger G, 2002, PLAST RECONSTR SURG, V110, P123, DOI 10.1097/00006534-200207000-00022
   Weinbaum JS, 2010, TISSUE ENG PART C-ME, V16, P459, DOI [10.1089/ten.tec.2009.0112, 10.1089/ten.TEC.2009.0112]
   Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
   Wiedemann D, 2010, TRANSPLANTATION, V89, P824, DOI 10.1097/TP.0b013e3181ccd822
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Wozniak G, 2003, CARDIOVASC SURG, V11, P17, DOI 10.1016/S0967-2109(03)00067-X
   Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580
   Yang Y, 2006, EXPERT OPIN BIOL TH, V6, P485, DOI 10.1517/14712598.6.5.485
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Yeo Y, 2007, J BIOMED MATER RES B, V81B, P312, DOI 10.1002/jbm.b.30667
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhang XL, 2010, EXP BIOL MED, V235, P1505, DOI 10.1258/ebm.2010.010175
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 100
TC 34
Z9 34
U1 1
U2 49
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD SEP-OCT
PY 2011
VL 58
IS 5
SI SI
BP 301
EP 310
DI 10.1002/bab.49
PG 10
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 842ND
UT WOS:000296605300003
PM 21995533
DA 2018-10-20
ER

PT J
AU Solouk, A
   Cousins, BG
   Mirzadeh, H
   Seifalian, AM
AF Solouk, Atefeh
   Cousins, Brian G.
   Mirzadeh, Hamid
   Seifalian, Alexander M.
TI Application of plasma surface modification techniques to improve
   hemocompatibility of vascular grafts: A review
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Review
DE surface modification; blood compatibility; hemocompatibility; vascular
   grafts; plasma technology
ID IMMERSION ION-IMPLANTATION; IN-SITU ENDOTHELIALIZATION; ACRYLIC-ACID;
   BLOOD COMPATIBILITY; RF PLASMA; COVALENT IMMOBILIZATION; COLLAGEN
   IMMOBILIZATION; BIOMEDICAL APPLICATIONS; POLYURETHANE SURFACE;
   CO-POLYMERIZATION
AB Surface modification using plasma processing can significantly change the chemical and physical characteristics of biomaterial surfaces. When used in combination with additional modification techniques such as direct chemical or biochemical methods, it can produce novel biomaterial surfaces, which are anticoagulant, bioactive, and biomimetic in nature. This article reviews recent advances in improving hemocompatibility of biomaterials by plasma surface modification (PSM). The focus of this review is on PSM of the most commonly used polymers for vascular prostheses such as expanded polytetrafluoroethylene (PTFE), polyethylene terephthalate (Dacron (R)), and next generation of biomaterials, including polyhedral oligomeric silsesquioxane nanocomposite.
C1 [Solouk, Atefeh; Mirzadeh, Hamid] Amirkabir Univ Technol, Fac Polymer Engn, Tehran Polytech, Tehran, Iran.
   [Cousins, Brian G.; Seifalian, Alexander M.] UCL, Ctr Nanotechnol & Regenerat Med, London, England.
   [Seifalian, Alexander M.] Royal Free Hampstead Natl Hlth Serv Trust Hosp, London, England.
RP Mirzadeh, H (reprint author), Amirkabir Univ Technol, Fac Polymer Engn, Tehran Polytech, 424 Hafez Ave, Tehran, Iran.
EM mirzadeh@aut.ac.ir
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR Abbasi F, 2001, POLYM INT, V50, P1279, DOI 10.1002/pi.783
   AHMED M, 2011, ACTA BIOMATER   0702
   Alobaid N, 2006, EUR J VASC ENDOVASC, V32, P76, DOI 10.1016/j.ejvs.2005.11.034
   Armstrong J., 2004, J PHYS CONDENS MATT, V16, P2483
   BAIER RE, 1972, B NEW YORK ACAD MED, V48, P257
   Baquey C, 1999, NUCL INSTRUM METH B, V151, P255, DOI 10.1016/S0168-583X(99)00106-8
   BHUVANESH G, 2001, J APPL POLYM SCI, V81, P2993
   Bisson I, 2002, BIOMATERIALS, V23, P3149, DOI 10.1016/S0142-9612(02)00061-3
   Cao L, 2007, J BIOMED MATER RES A, V81A, P827, DOI 10.1002/jbm.a.31091
   Cen Lian, 2004, Biomacromolecules, V5, P2238, DOI 10.1021/bm040048v
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chen JY, 2007, SURF COAT TECH, V201, P6901, DOI 10.1016/j.surfcoat.2006.09.110
   Chen JP, 2006, J MEMBRANE SCI, V270, P212, DOI 10.1016/j.memsci.2005.11.015
   Choi HS, 2004, SURF COAT TECH, V182, P55, DOI 10.1016/S0257-8972(02)00880-6
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Chu PK, 2007, SURF COAT TECH, V201, P5601, DOI 10.1016/j.surfcoat.2006.07.003
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Chuang TW, 2009, BIOMATERIALS, V30, P5341, DOI 10.1016/j.biomaterials.2009.06.029
   Conn G, 2006, EXPERT REV MED DEVIC, V3, P245, DOI 10.1586/17434440.3.2.245
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   de Mel Achala, 2008, Expert Rev Cardiovasc Ther, V6, P1259, DOI 10.1586/14779072.6.9.1259
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Fridman A, 2008, PLASMA CHEMISTRY, P1, DOI 10.1017/CBO9780511546075
   FU RK, 2005, INFORM HEALTHCARE, V3, P1
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gomathi N, 2008, CURR SCI INDIA, V94, P1478
   GOMBOTZ WR, 1987, CRIT REV BIOCOMPAT, V4, P1
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gorna K, 2003, POLYM DEGRAD STABIL, V79, P475, DOI 10.1016/S0141-3910(02)00363-4
   Grace JM, 2003, J DISPER SCI TECHNOL, V24, P305, DOI 10.1081/DIS-120021793
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Gupta B, 2000, J APPL POLYM SCI, V78, P1083, DOI 10.1002/1097-4628(20001031)78:5<1083::AID-APP170>3.0.CO;2-5
   Hanson AD, 2007, J BIOMAT SCI-POLYM E, V18, P1387, DOI 10.1163/156856207782246812
   Hasebe T, 2007, NEW DIAM FRONT C TEC, V17, P263
   Henkelman S, 2009, MAT SCI ENG C-BIO S, V29, P1650, DOI 10.1016/j.msec.2009.01.002
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirose M, 2000, PROG ORG COAT, V38, P27, DOI 10.1016/S0300-9440(99)00081-8
   Hoffman AS, 2004, BIOMATERIALS SCI INT
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Hung HS, 2009, BIOMATERIALS, V30, P1502, DOI 10.1016/j.biomaterials.2008.12.003
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Inagaki N., 1996, PLASMA SURFACE MODIF
   Jing FJ, 2007, SURF COAT TECH, V201, P6874, DOI 10.1016/j.surfcoat.2006.09.088
   Jing FJ, 2007, DIAM RELAT MATER, V16, P550, DOI 10.1016/j.diamond.2006.11.051
   JINGRUN R, 2008, APPL SURF SCI, V255, P263
   Karkhaneh A, 2007, J APPL POLYM SCI, V105, P2208, DOI 10.1002/app.26216
   Kerri J.P., 1989, J BIOMED MATER RES, V23, P1131
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Keshvari H, 2008, IRAN POLYM J, V17, P171
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Khorasani MT, 2007, RADIAT PHYS CHEM, V76, P1011, DOI 10.1016/j.radphyschem.2006.10.002
   Kidane AG, 2009, ACTA BIOMATER, V5, P2409, DOI 10.1016/j.actbio.2009.02.025
   KO TM, 1993, J APPL POLYM SCI, V47, P1601, DOI 10.1002/app.1993.070470908
   LASSEN B, 1992, Clinical Materials, V11, P99, DOI 10.1016/0267-6605(92)90034-Q
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   LEE JH, 2000, COLLOID SURFACE B, V205, P323
   Lee SD, 1996, BIOMATERIALS, V17, P1599, DOI 10.1016/0142-9612(95)00316-9
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Li C, 2005, J BIOMAT SCI-POLYM E, V16, P875, DOI 10.1163/1568562054255754
   Li Cheng, 2004, Hemodial Int, V8, P360, DOI 10.1111/j.1492-7535.2004.80412.x
   LIANG H, 2005, LASER SURFACE TREATM
   Lim HR, 2008, SURF COAT TECH, V202, P5768, DOI 10.1016/j.surfcoat.2008.06.115
   Lin CH, 2009, COLLOID SURFACE B, V70, P132, DOI 10.1016/j.colsurfb.2008.12.020
   Liu Y, 2010, APPL SURF SCI, V256, P3977, DOI 10.1016/j.apsusc.2010.01.060
   Lopez LC, 2005, SURF COAT TECH, V200, P1000, DOI 10.1016/j.surfcoat.2005.02.003
   McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039
   MEKRAS CI, 1989, POLYMER, V30, P745, DOI 10.1016/0032-3861(89)90166-3
   MEL AD, 2009, BIOMED MAT ENG, V19, P317
   MIRZADEH H, 1996, IRAN POLYM J, V5, P225
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Morent R, 2011, PLASMA PROCESS POLYM, V8, P171, DOI 10.1002/ppap.201000153
   Motwani MS, 2011, BIOTECHNOL APPL BIOC, V58, P2, DOI 10.1002/bab.10
   MULLER AM, 2010, EUR CELLS MATER, V3, P127
   Nitschke M, 2004, SURF COAT TECH, V185, P120, DOI 10.1016/j.surfcoat.2003.12.006
   Nurdin N., 2003, European Cells & Materials, V5, P17
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   OEHR C, 2005, PLASMA PROCESS POLYM, P309
   Ozeki K, 2010, J MATER SCI-MATER M, V21, P1641, DOI 10.1007/s10856-010-3994-8
   Podlaha J, 2009, ACTA VET BRNO, V78, P115, DOI 10.2754/avb200978010115
   Poncin-Epaillard F, 2003, J BIOMAT SCI-POLYM E, V14, P1005, DOI 10.1163/156856203769231538
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Punshon G, 2005, BIOMATERIALS, V26, P6271, DOI 10.1016/j.biomaterials.2005.03.034
   RATNER B D, 1992, Clinical Materials, V11, P25, DOI 10.1016/0267-6605(92)90027-Q
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Ren CS, 2006, SURF COAT TECH, V201, P2867, DOI 10.1016/j.surfcoat.2006.05.039
   Rhodes NP, 2007, BIOMATERIALS, V28, P4561, DOI 10.1016/j.biomaterials.2007.07.008
   Sanchis MR, 2008, POLYM TEST, V27, P75, DOI 10.1016/j.polymertesting.2007.09.002
   Sanchis MR, 2006, EUR POLYM J, V42, P1558, DOI 10.1016/j.eurpolymj.2006.02.001
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002
   SCHAKENRAAD JM, 1998, J CELL BIOPHYS, V13, P75
   Sciarratta V, 2003, SURF COAT TECH, V174, P805, DOI 10.1016/S0257-8972(03)00564-4
   Sefton MV, 2000, J BIOMAT SCI-POLYM E, V11, P1165
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   Shih MF, 2006, INT J PHARM, V327, P117, DOI 10.1016/j.ijpharm.2006.07.043
   Siow KS, 2006, PLASMA PROCESS POLYM, V3, P392, DOI 10.1002/ppap.200600021
   Solouk A, 2011, BIOTECHNOL APPL BIOC, V58, P147, DOI 10.1002/bab.22
   Solouk A, 2011, IRAN POLYM J, V20, P91
   Stohr U, 2010, PLASMA PROCESS POLYM, V7, P9, DOI 10.1002/ppap.200900063
   STOFFELS E, 2006, PLASMA SOURCES SCI T, V15, P517
   Su CY, 2006, SURF COAT TECH, V200, P3380, DOI 10.1016/j.surfcoat.2005.07.056
   SYLVIE IE, 1990, J BIOMED MATER RES, V24, P1637
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   VANKOOTEN TG, 1992, BIOMATERIALS, V13, P897, DOI 10.1016/0142-9612(92)90112-2
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Vilani C, 2007, APPL SURF SCI, V254, P131, DOI 10.1016/j.apsusc.2007.07.060
   Wang L, 2010, J BIOMED MATER RES A, V93A, P1260, DOI 10.1002/jbm.a.32621
   Ward LJ, 2003, CHEM MATER, V15, P1466, DOI 10.1021/cm020289e
   Weibel DE, 2007, J MEMBRANE SCI, V293, P124, DOI 10.1016/j.memsci.2007.02.005
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Yang LQ, 2009, APPL SURF SCI, V255, P4446, DOI 10.1016/j.apsusc.2008.11.048
   Yang ZL, 2010, BIOMATERIALS, V31, P2072, DOI 10.1016/j.biomaterials.2009.11.091
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
   Yuan J, 2008, COLLOID SURFACE B, V66, P90, DOI 10.1016/j.colsurfb.2008.05.020
   Zhang W, 2006, BIOMATERIALS, V27, P44, DOI 10.1016/j.biomaterials.2005.05.067
NR 119
TC 21
Z9 21
U1 5
U2 106
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD SEP-OCT
PY 2011
VL 58
IS 5
SI SI
BP 311
EP 327
DI 10.1002/bab.50
PG 17
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 842ND
UT WOS:000296605300004
PM 21995534
DA 2018-10-20
ER

PT J
AU Doi, A
   Blanchard, F
   Tanaka, T
   Tanaka, K
AF Doi, Atsushi
   Blanchard, Francois
   Tanaka, Tomoko
   Tanaka, Koichiro
TI Improving Spatial Resolution of Real-Time Terahertz Near-Field
   Microscope
SO JOURNAL OF INFRARED MILLIMETER AND TERAHERTZ WAVES
LA English
DT Article
DE Submillimeter wave; Microscope; Ultrafast optics; Near field; Imaging;
   Spectroscopy
ID ELECTROOPTIC DETECTION; THZ; TECHNOLOGY; GENERATION; RADIATION; PULSES;
   LINBO3
AB Terahertz (THz) wave imaging for biomaterial samples such as cells requires real-time acquisition and high spatial resolution beyond the diffraction limit. The existing THz near-field microscopes are based on raster-scanning techniques, and are therefore not able to image and trace morphological changes in a large area. With the recent advances in high-power THz sources, we demonstrated how to achieve high spatial resolution over a large size using a conventional charge-coupled-device (CCD) camera with the electro-optic (EO) sampling technique. In this paper, we determine a limiting factor that restricts spatial resolution in our near-field microscope. By calculating the imaging performance of the probe beam together with THz wave diffraction, we show that the most relevant factor is the diffraction inside the EO crystal. Near-field imaging of metal patterns using EO crystals with different thicknesses supports this calculation. A thin EO crystal is essential for achieving THz images with high spatial resolution.
C1 [Doi, Atsushi; Blanchard, Francois; Tanaka, Tomoko; Tanaka, Koichiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan.
   [Doi, Atsushi] Olympus Corp, Hachioji, Tokyo 1928512, Japan.
   [Blanchard, Francois; Tanaka, Tomoko; Tanaka, Koichiro] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto 6068501, Japan.
   [Tanaka, Koichiro] Kyoto Univ, Dept Phys, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.
RP Doi, A (reprint author), Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan.
EM atsushi_doi@ot.olympus.co.jp
RI Tanaka, Koichiro/A-7085-2016
FU JSPS [21760038]; MEXT of Japan [18GS0208, 20104007]; Le Fonds Quebecois
   de la Recherche sur la Nature et les Technologies (FQRNT) [138131]
FX We are grateful to Hideaki Tanaka and Yutaka Kadoya for creating
   metallic line-and-space samples and also to Mitsuru Namiki for valuable
   discussions. This study was supported by a Grant-in-Aid for Scientific
   Research from JSPS (Grant No. 21760038) and from MEXT of Japan (Grant
   Nos. 18GS0208 and 20104007). F. B. thanks Le Fonds Quebecois de la
   Recherche sur la Nature et les Technologies (FQRNT) for support provided
   through contract no. 138131.
CR Adam AJL, 2008, OPT EXPRESS, V16, P7407, DOI 10.1364/OE.16.007407
   Bitzer A, 2010, APPL OPTICS, V49, pE1, DOI 10.1364/AO.49.0000E1
   Blanchard F, 2011, OPT EXPRESS, V19, P8277, DOI 10.1364/OE.19.008277
   Chen HT, 2003, APPL PHYS LETT, V83, P3009, DOI 10.1063/1.1616668
   Chen Q, 2000, OPT LETT, V25, P1122, DOI 10.1364/OL.25.001122
   Doi A, 2010, OPT EXPRESS, V18, P18419, DOI 10.1364/OE.18.018419
   Fitzgerald AJ, 2002, PHYS MED BIOL, V47, pR67, DOI 10.1088/0031-9155/47/7/201
   Hebling J, 2008, J OPT SOC AM B, V25, pB6, DOI 10.1364/JOSAB.25.0000B6
   Hirori H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560062
   HU BB, 1995, OPT LETT, V20, P1716, DOI 10.1364/OL.20.001716
   Huber AJ, 2008, NANO LETT, V8, P3766, DOI 10.1021/nl802086x
   Hunsche S, 1998, OPT COMMUN, V150, P22, DOI 10.1016/S0030-4018(98)00044-3
   Jewariya M, 2009, J OPT SOC AM B, V26, pA101, DOI 10.1364/JOSAB.26.00A101
   Kawase K, 2004, OPT PHOTONICS NEWS, V15, P34, DOI 10.1364/OPN.15.10.000034
   Markelz AG, 2000, CHEM PHYS LETT, V320, P42, DOI 10.1016/S0009-2614(00)00227-X
   Mitrofanov O, 2001, IEEE J SEL TOP QUANT, V7, P600, DOI 10.1109/2944.974231
   Mittleman DM, 1999, APPL PHYS B-LASERS O, V68, P1085, DOI 10.1007/s003400050750
   MITTLEMAN DM, 2002, SENSING TERAHERTZ RA
   Palik E. D., 1985, HDB OPTICAL CONSTANT
   Seo MA, 2007, OPT EXPRESS, V15, P11781, DOI 10.1364/OE.15.011781
   Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI [10.1109/TMTT.2004.835916, 10.1109/TMTT.2004.83516]
   Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3
   van der Valk NCJ, 2004, PHILOS T ROY SOC A, V362, P315, DOI 10.1098/rsta.2003.1316
   Wang XK, 2010, OPT COMMUN, V283, P4626, DOI 10.1016/j.optcom.2010.07.010
   Wang XK, 2009, OPT COMMUN, V282, P4683, DOI 10.1016/j.optcom.2009.09.004
   Winnewisser C, 1997, APPL PHYS LETT, V70, P3069, DOI 10.1063/1.119093
   WU Q, 1995, APPL PHYS LETT, V67, P3523, DOI 10.1063/1.114909
   Zhang XC, 2002, PHYS MED BIOL, V47, P3667, DOI 10.1088/0031-9155/47/21/301
NR 28
TC 8
Z9 8
U1 1
U2 28
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1866-6892
J9 J INFRARED MILLIM TE
JI J. Infrared Millim. Terahertz Waves
PD SEP
PY 2011
VL 32
IS 8-9
SI SI
BP 1043
EP 1051
DI 10.1007/s10762-011-9812-7
PG 9
WC Engineering, Electrical & Electronic; Optics; Physics, Applied
SC Engineering; Optics; Physics
GA 843IS
UT WOS:000296666100005
DA 2018-10-20
ER

PT J
AU Crespi, R
   Cappare, P
   Gherlone, E
AF Crespi, Roberto
   Cappare, Paolo
   Gherlone, Enrico
TI Comparison of Magnesium-Enriched Hydroxyapatite and Porcine Bone in
   Human Extraction Socket Healing: A Histologic and Histomorphometric
   Evaluation
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE alveolar ridge preservation; hydroxyapatite; porcine bone; tooth
   extraction; wound healing
ID MAXILLARY SINUS AUGMENTATION; SINGLE-TOOTH EXTRACTION; RIDGE
   PRESERVATION; POROUS HYDROXYAPATITE; ALLOGRAFT; EXPRESSION; XENOGRAFT;
   SITES
AB Purpose: Different graft materials have been proposed to minimize the reduction in ridge volume after tooth extraction. The aim of the present study was to compare the use of synthetic magnesium-enriched hydroxyapatite (MHA) with porcine bone (PB) grafts in fresh sockets by histologic and histomorphometric analyses. Materials and Methods: Forty-five fresh extraction sockets were selected in 15 patients. A split-mouth design was used: 15 sockets received MHA in one side of the jaw (MHA group), 15 sockets on the other side received PB (PB group), and 15 random unfilled sockets were considered the control group. Four months after surgery, cylindric bone specimens were harvested for histologic and histomorphometric analyses. Results: Histologic examinations revealed an absence of inflammatory cells, bone formation in all treated sites, and the presence of biomaterial particles and connective tissue. Mean vital bone measurements for the MHA, PB, and control groups were 36.5% +/- 2.6%, 38.0% +/- 16.2%, and 30.3% +/- 4.8%, respectively. Statistically significant differences were found between the MHA and control groups and between the PB and control groups; differences between the MHA and PB groups were not significant. Connective tissue percentages averaged 33.3% +/- 1.5% for the MHA group, 25.3% +/- 9.4% for the PB group, and 58.3% +/- 7.1% for the control group. Statistically significant differences were found between all groups. Residual graft material occupied 32.2% +/- 3.2% of the MHA-grafted sites and 36.6% +/- 4.8% of the PB sites. This difference was not statistically significant. Conclusions: Within the limits of this study, histologic examination showed the same biologic behavior in bone formation and resorption processes for the two examined biomaterials. INT J ORAL MAXILLOFAC IMPLANTS 2011;26:1057-1062
C1 [Crespi, Roberto; Cappare, Paolo; Gherlone, Enrico] Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, I-20123 Milan, Italy.
RP Crespi, R (reprint author), Univ Vita Salute San Raffaele, Hosp San Raffaele, Dept Dent, Via Olgettina 48, I-20123 Milan, Italy.
EM robcresp@libero.it
RI Cappare, Paolo/A-2025-2016; Gherlone, Enrico/M-7376-2016
OI Cappare, Paolo/0000-0002-7277-6583; 
CR Araujo MG, 2005, J CLIN PERIODONTOL, V32, P212, DOI 10.1111/j.1600-051X.2005.00642.x
   Artzi Z, 2000, J PERIODONTOL, V71, P1015, DOI 10.1902/jop.2000.71.6.1015
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2008, J PERIODONTOL, V79, P1370, DOI 10.1902/jop.2008.070628 
   Becker W, 1994, Int J Oral Maxillofac Implants, V9, P31
   BENQUE EP, 1985, J BIOL BUCCALE, V13, P271
   Cammack GV, 2005, INT J PERIODONT REST, V25, P231
   Cardaropoli G, 2003, J CLIN PERIODONTOL, V30, P809, DOI 10.1034/j.1600-051X.2003.00366.x
   Crespi R, 2009, J PERIODONTOL, V80, P586, DOI 10.1902/jop.2009.080466
   Froum S, 2002, J PERIODONTOL, V73, P94, DOI 10.1902/jop.2002.73.1.94
   Karabuda C, 2001, J PERIODONTOL, V72, P1436, DOI 10.1902/jop.2001.72.10.1436
   Kubler Alexander, 2004, Implant Dent, V13, P171
   Lekovic V, 1997, J PERIODONTOL, V68, P563, DOI 10.1902/jop.1997.68.6.563
   Mangano C, 2007, INT J ORAL MAX IMPL, V22, P980
   Neiva RF, 2008, J PERIODONTOL, V79, P291, DOI [10.1902/jop.2008.070038, 10.1902/jop.2008.070038 ]
   NEVINS M, 1992, INT J PERIODONT REST, V12, P97
   Norman Maria E., 1994, Clinical Materials, V17, P85, DOI 10.1016/0267-6605(94)90016-7
   Okumura M, 1997, J BIOMED MATER RES, V37, P122, DOI 10.1002/(SICI)1097-4636(199710)37:1<122::AID-JBM15>3.0.CO;2-I
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   RIPAMONTI U, 1991, J BONE JOINT SURG AM, V73A, P692, DOI 10.2106/00004623-199173050-00007
   Schropp L, 2003, INT J PERIODONT REST, V23, P313
   Sclar AG, 2004, J ORAL MAXIL SURG, V62, P90, DOI 10.1016/j.joms.2004.06.041
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P630, DOI 10.1111/j.1600-051X.2008.01246.x
   Vance GS, 2004, INT J ORAL MAX IMPL, V19, P491
   Yuan H, 1997, BIOMED ENG-APP BAS C, V9, P274
   Zhang XD, 1991, BIOCERAMICS HUMAN BO, P408
   Zubillaga G, 2003, J PERIODONTOL, V74, P965, DOI 10.1902/jop.2003.74.7.965
NR 27
TC 15
Z9 15
U1 0
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD SEP-OCT
PY 2011
VL 26
IS 5
BP 1057
EP 1062
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 837WB
UT WOS:000296237700020
PM 22010090
DA 2018-10-20
ER

PT J
AU Rachev, A
   Felden, L
   Ku, DN
AF Rachev, Alexander
   Felden, Luc
   Ku, David N.
TI Design and Fabrication of a Mechanically Matched Vascular Graft
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
DE arterial grafts; optimal design; nonlinear solid mechanics;
   mechanic-matching
ID ELASTIC PROPERTIES; DIMENSIONAL ADAPTATION; AORTIC CONSTRICTION;
   ARTERIAL PROSTHESIS; PULSATILE FLOW; RAT AORTA; STRESS; HYPERTENSION;
   HYPERTROPHY; BIFURCATION
AB The study provides a pathway to design a mechanics-matching vascular graft for an end-to-end anastomosis to a host artery. For functional equivalence, we submit that the graft and a host artery should have equal inner deformed diameters, equal pressure-radius module, and experience equal axial forces when subjected to mean arterial pressure. These criteria for mechanical equivalence are valid for a large class of materials that can be considered as elastic incompressible and orthotropic solids. As an example, specific known artery properties were used to design or select a graft made from a new synthetic biomaterial to demonstrate that reliable and robust technology for graft fabrication is possible. [DOI: 10.1115/1.4004533]
C1 [Rachev, Alexander; Felden, Luc; Ku, David N.] GA Inst Technol, GWW Sch Mech Engn, Atlanta, GA 30332 USA.
RP Ku, DN (reprint author), GA Inst Technol, GWW Sch Mech Engn, Atlanta, GA 30332 USA.
EM david.ku@me.gatech.edu
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   ABBOTT WM, 1978, GRAFT MATERIALS VASC, P59
   BINNS RL, 1989, J VASC SURG, V10, P326
   CHANDRAN KB, 1992, MED BIOL ENG COMPUT, V30, P413, DOI 10.1007/BF02446179
   Clayson K. R., 1976, ARCH SURG-CHICAGO, V11, P1276
   DARLING RC, 1972, AM J SURG, V123, P472, DOI 10.1016/0002-9610(72)90202-4
   DECOSSART L, 1989, J CARDIOVASC SURG, V30, P388
   Edwards W. S., 1996, SURG GYNECOL OBSTET, V122, P1
   Elshazly T., 2004, THESIS GEORGIA I TEC
   Feldan L, 2005, THESIS GEORGIA I TEC
   FUNG YC, 1989, CIRC RES, V65, P1340, DOI 10.1161/01.RES.65.5.1340
   Glagov S., 1991, VASCULAR ACCESS HEMO, P37
   Glagov Seymour, 1993, Frontiers of Medical and Biological Engineering, V5, P37
   Green AE, 1960, LARGE ELASTIC DEFORM
   Greenwald SE, 2000, J PATHOL, V190, P292, DOI 10.1002/(SICI)1096-9896(200002)190:3<292::AID-PATH528>3.0.CO;2-S
   HAYASHI K, 2001, BIOMECHANICAL SYSTEM
   Hayashi K., 2001, P 2001 SUMM BIOENG C, P819
   He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948
   HOW TV, 1984, J BIOMECH, V17, P597, DOI 10.1016/0021-9290(84)90091-5
   Humphrey JD, 2002, CARDIOVASCULAR SOLID
   KAMIYA A, 1980, AM J PHYSIOL, V239, pH14
   KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293
   KU DN, 1995, BIOMEDICAL ENG HDB, P1871
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   Langille B. L., 1995, FLOW DEPENDENT REGUL, P227
   LANGILLE BL, 1986, SCIENCE, V231, P405, DOI 10.1126/science.3941904
   LANGILLE BL, 1993, J CARDIOVASC PHARM, V21, pS11
   LIU SQ, 1989, J BIOMECH ENG-T ASME, V111, P325, DOI 10.1115/1.3168386
   Matsumoto T, 1999, MED BIOL ENG COMPUT, V37, P252, DOI 10.1007/BF02513295
   MATSUMOTO T, 1994, J APPL BIOMATER, V5, P79, DOI 10.1002/jab.770050110
   MATSUMOTO T, 1994, J BIOMECH ENG-T ASME, V116, P278, DOI 10.1115/1.2895731
   Matthew W., 1996, J BIOMECH, V29, P187
   PAASCHE PE, 1973, J BIOMECH, V6, P253, DOI 10.1016/0021-9290(73)90047-X
   PETERSON LH, 1960, CIRC RES, V8, P622, DOI 10.1161/01.RES.8.3.622
   Rachev A, 2000, J THEOR BIOL, V206, P429, DOI 10.1006/jtbi.2000.2143
   Rachev A., 2009, J BIOMECH ENG, V131
   Rachev A., 2003, CISM COURSES LECT CO, V441, P100
   Rachev A., 2004, P IMECE04 ASME INT M
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Salam TA, 1996, J VASC INVEST, V2, P12
   Sonoda H, 2001, J BIOMED MATER RES, V55, P266, DOI 10.1002/1097-4636(20010605)55:3<266::AID-JBM1014>3.0.CO;2-C
   STEWART SFC, 1988, J BIOMECH ENG-T ASME, V110, P344, DOI 10.1115/1.3108451
   Stewart SFC, 1987, MODERN VASCULAR GRAF, P117
   TAKAMIZAWA K, 1987, J BIOMECH, V20, P7, DOI 10.1016/0021-9290(87)90262-4
   Thom T, 2006, CIRCULATION, V113, pE85, DOI 10.1161/CIRCULATIONAHA.105.171600
   VAISHNAV RN, 1990, J BIOMECH ENG-T ASME, V112, P70, DOI 10.1115/1.2891128
   van Oijen C.H.G.A., 2003, THESIS TU EINDHOVEN
   WALDEN R, 1980, ARCH SURG-CHICAGO, V115, P1166
   WEIZSACKER HW, 1990, BIOMED TECH, V35, P224, DOI 10.1515/bmte.1990.35.10.224
   Williams S., 1998, THESIS GEORGIA I TEC
NR 50
TC 4
Z9 4
U1 0
U2 2
PU ASME
PI NEW YORK
PA TWO PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
EI 1528-8951
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD SEP
PY 2011
VL 133
IS 9
AR 091004
DI 10.1115/1.4004533
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 833JY
UT WOS:000295882200004
PM 22010739
DA 2018-10-20
ER

PT J
AU Yamada, Y
   Hozumi, K
   Nomizu, M
AF Yamada, Yuji
   Hozumi, Kentaro
   Nomizu, Motoyoshi
TI Construction and Activity of a Synthetic Basement Membrane with Active
   Laminin Peptides and Polysaccharides
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE cell adhesion; laminin; membranes; peptides; polysaccharide; tissue
   engineering
ID CONGENITAL MUSCULAR-DYSTROPHY; CELL-BINDING SEQUENCES; CHAIN LG4 MODULE;
   ALPHA-1 CHAIN; EXTRACELLULAR-MATRIX; G-DOMAIN; BIOLOGICAL-ACTIVITIES;
   TISSUE MORPHOGENESIS; TARGETED DISRUPTION; ALGINATE HYDROGELS
AB Cell-adhesive peptides derived from extracellular matrix (ECM) proteins are potential candidates for incorporating cell-binding activities into materials for tissue engineering. We have identified a number of cell adhesive peptides from laminins, which are major components of basement membrane ECM. Our goal is the development of synthetic basement membranes using the peptides on scaffolds. We review peptide-polysaccharide complexes, which were prepared by conjugation of the peptides to chitosan and alginate, and the biological activities of the resulting matrices. The peptide-polysaccharide matrices can also be used as a biomaterial for cell transplantation. These studies suggest that the peptide-polysaccharide complexes have the potential to mimic the multifunctional basement membrane and may be useful for tissue engineering.
C1 [Yamada, Yuji; Hozumi, Kentaro; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, Tokyo 1920392, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [22390017]
FX We are grateful to Dr. Hynda K. Kleinman (National Institute of Dental
   and Craniofacial Research, National Institutes of Health, Bethesda, MD)
   for critical reading of this manuscript. This work was supported by
   Grants-in-Aid for Scientific Research from the Ministry of Education,
   Cultures, Sports, Science and Technology of Japan (22390017).
CR Araki E, 2009, MOL BIOL CELL, V20, P3012, DOI 10.1091/mbc.E08-09-0977
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Chiu CT, 2008, J MATER SCI-MATER M, V19, P2503, DOI 10.1007/s10856-008-3389-2
   Dar A, 2002, BIOTECHNOL BIOENG, V80, P305, DOI 10.1002/bit.10372
   Dhoot NO, 2003, J PHARM SCI, V92, P679, DOI 10.1002/jps.19104
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   George M, 2006, J CONTROL RELEASE, V114, P1, DOI 10.1016/j.jconrel.2006.04.017
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Hejcl A, 2010, STEM CELLS DEV, V19, P1535, DOI 10.1089/scd.2009.0378
   Hibino S, 2004, CANCER RES, V64, P4810, DOI 10.1158/0008-5472.CAN-04-0129
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hosoya K, 2004, J BIOMED MATER RES A, V71A, P596, DOI 10.1002/jbm.a.30189
   Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200
   Hozumi K, 2010, ARCH BIOCHEM BIOPHYS, V503, P213, DOI 10.1016/j.abb.2010.08.012
   Hozumi K, 2010, FEBS LETT, V584, P3381, DOI 10.1016/j.febslet.2010.06.032
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Jiang HL, 2004, J BIOMAT SCI-POLYM E, V15, P279, DOI 10.1163/156856204322977184
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Koide T, 2007, PHILOS T R SOC B, V362, P1281, DOI 10.1098/rstb.2007.2115
   Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   Liu JP, 2010, MACROMOL BIOSCI, V10, P1164, DOI 10.1002/mabi.200900450
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713
   Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Newman KD, 2006, INT J ARTIF ORGANS, V29, P1082
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Owen SC, 2010, J BIOMED MATER RES A, V94A, P1321, DOI 10.1002/jbm.a.32834
   Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Renner L, 2004, J MATER SCI-MATER M, V15, P387, DOI 10.1023/B:JMSM.0000021107.12809.8d
   Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Ryan MC, 1999, J CELL BIOL, V145, P1309, DOI 10.1083/jcb.145.6.1309
   Smith IO, 2009, WIRES NANOMED NANOBI, V1, P226, DOI 10.1002/wnan.026
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Suzuki N, 2010, MATRIX BIOL, V29, P143, DOI 10.1016/j.matbio.2009.09.006
   Suzuki Y, 1999, J BIOMED MATER RES, V48, P522, DOI 10.1002/(SICI)1097-4636(1999)48:4<522::AID-JBM18>3.0.CO;2-O
   Takeda A, 1999, J INVEST DERMATOL, V113, P38, DOI 10.1046/j.1523-1747.1999.00645.x
   Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002
   Timpl R, 1989, Adv Nephrol Necker Hosp, V18, P59
   Urushibata S, 2010, ARCH BIOCHEM BIOPHYS, V497, P43, DOI 10.1016/j.abb.2010.03.006
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yamada Y, 2010, BIOPOLYMERS, V94, P711, DOI 10.1002/bip.21429
   Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044
   Zustiak SP, 2010, ACTA BIOMATER, V6, P3404, DOI 10.1016/j.actbio.2010.03.040
NR 62
TC 15
Z9 15
U1 1
U2 13
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0947-6539
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD SEP
PY 2011
VL 17
IS 38
BP 10500
EP 10508
DI 10.1002/chem.201101064
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 833JH
UT WOS:000295880300001
PM 22003504
DA 2018-10-20
ER

PT J
AU Chang, YC
   Wu, KC
   Zhao, JH
AF Chang, Yu-Chao
   Wu, Kuo-Chin
   Zhao, Jiing-Huei
TI Clinical application of platelet-rich fibrin as the sole grafting
   material in periodontal intrabony defects
SO JOURNAL OF DENTAL SCIENCES
LA English
DT Article
DE periodontal intrabony defects; periodontitis; platelet-rich fibrin;
   regeneration
ID HISTOLOGIC EVALUATIONS; BONE ALLOGRAFT; REGENERATION; MEMBRANE; PRF
AB Background/purpose: Platelet-rich fibrin (PRF) obtained by Choukroun's technique is a healing biomaterial that concentrates in a single autologous fibrin membrane, mostly of platelets and cytokines from blood harvest, and without any artificial biochemical modification. However, no data are presently available concerning the use of PRF for the treatment of periodontal intrabony defects. This report was to present the clinical and radiographic changes of a patient with periodontal intrabony defects treated with PRF.
   Material and methods: The left mandibular first molar (#36) and left maxillary second molar (#27) with intrabony defects were filled with PRF as the sole grafting material in a 38-year-old female patient. The primary outcomes evaluated in this study included changes in probing depth, attachment level, and radiographic bone density between baseline and 6 months post-operatively.
   Results: The results showed that the application of PRF as the sole grafting material in intrabony defects exhibited pocket reduction and gain in clinical attachment after 3 months and 6 months. Using National institute of health program, the 6 months postoperative radiographic density of images for #27 and #36 showed an increase of 1.6 and 1.3 fold compared with each preoperative radiography, respectively.
   Conclusions: From a clinical and radiologic point of view at 6 months after surgery, the use of PRF as the sole grafting material seems to be an effective modality of regenerative treatment for periodontal intrabony defects. Copyright (C) 2011, Association for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.
C1 [Chang, Yu-Chao; Wu, Kuo-Chin; Zhao, Jiing-Huei] Chung Shan Med Univ, Sch Dent, Taichung, Taiwan.
   [Chang, Yu-Chao] Chung Shan Med Univ Hosp, Dept Periodont, Taichung 40201, Taiwan.
RP Chang, YC (reprint author), Chung Shan Med Univ Hosp, Dept Dent, 110 Chien Kuo N Rd,Sect 1, Taichung 40201, Taiwan.
EM cyc@csmu.edu.tw
CR ANDEREGG CR, 1991, J PERIODONTOL, V62, P264, DOI 10.1902/jop.1991.62.4.264
   Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
   Chang IC, 2010, J BIOMED MATER RES A, V95A, P327, DOI 10.1002/jbm.a.32839
   CHEN CC, 1995, J PERIODONTOL, V66, P838, DOI 10.1902/jop.1995.66.10.838
   Choukroun J, 2006, ORAL SURG ORAL MED O, V101, P299, DOI 10.1016/j.tripleo.2005.07.012
   Choukroun J, 2000, IMPLANTODONTIE, V42, P55
   Diss A, 2008, ORAL SURG ORAL MED O, V105, P572, DOI 10.1016/j.tripleo.2007.08.021
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe45, DOI 10.1016/j.tripleo.2005.07.009
   Ehrenfest DMD, 2009, TRENDS BIOTECHNOL, V27, P158, DOI 10.1016/j.tibtech.2008.11.009
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Giannobile WV, 1996, J PERIODONTOL, V67, P545
   GUILLEMIN MR, 1993, J CLIN PERIODONTOL, V20, P528, DOI 10.1111/j.1600-051X.1993.tb00402.x
   Huang FM, 2010, J ENDODONT, V36, P1628, DOI 10.1016/j.joen.2010.07.004
   LEKOVIC V, 1990, J PERIODONTOL, V61, P575, DOI 10.1902/jop.1990.61.9.575
   LISTGARTEN MA, 1979, J PERIODONTOL, V50, P333, DOI 10.1902/jop.1979.50.7.333
   Lundquist R, 2008, WOUND REPAIR REGEN, V16, P356, DOI 10.1111/j.1524-475X.2007.00344.x
   Mazor Z, 2009, J PERIODONTOL, V80, P2056, DOI 10.1902/jop.2009.090252
   McClain P K, 1993, Int J Periodontics Restorative Dent, V13, P9
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   Tsai CH, 2009, J DENT SCI, V4, P130, DOI 10.1016/S1991-7902(09)60018-0
   Zhao JH, 2011, J DENT SCI, V6, P116, DOI 10.1016/j.jds.2011.03.004
NR 22
TC 16
Z9 16
U1 0
U2 16
PU ELSEVIER TAIWAN
PI TAIPEI
PA RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2,
   TAIPEI, 10449, TAIWAN
SN 1991-7902
J9 J DENT SCI
JI J. Dental Sci.
PD SEP
PY 2011
VL 6
IS 3
BP 181
EP 188
DI 10.1016/j.jds.2011.05.010
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 833SR
UT WOS:000295905700010
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Kouris, NA
   Squirrell, JM
   Jung, JP
   Pehlke, CA
   Hacker, T
   Eliceiri, KW
   Ogle, BM
AF Kouris, Nicholas A.
   Squirrell, Jayne M.
   Jung, Jangwook P.
   Pehlke, Carolyn A.
   Hacker, Timothy
   Eliceiri, Kevin W.
   Ogle, Brenda M.
TI A nondenatured, noncrosslinked collagen matrix to deliver stem cells to
   the heart
SO REGENERATIVE MEDICINE
LA English
DT Article
DE biomaterial; cardiac patch; cardiac regeneration; collagen; mesenchymal
   stem cells
ID ACUTE MYOCARDIAL-INFARCTION; IMPROVES CARDIAC-FUNCTION;
   SMOOTH-MUSCLE-CELLS; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; IMMUNE
   MODULATION; VASCULAR REPAIR; ARTERIAL INJURY; STROMAL CELLS;
   TRANSPLANTATION
AB Aims: Stem cell transplantation holds promise as a therapeutic approach for the repair of damaged myocardial tissue. One challenge of this approach is efficient delivery and long-term retention of the stem cells. Although several synthetic and natural biomaterials have been developed for this purpose, the ideal formulation has yet to be identified. Materials & methods: Here we investigate the utility of a nondenatured, noncrosslinked, commercially available natural biomaterial (TissueMend (R) [TEI Biosciences, Boston, MA, USA]) for delivery of human mesenchymal stem cells (MSCs) to the murine heart. Results: We found that MSCs attached, proliferated and migrated within and out of the TissueMend matrix in vitro. Human MSCs delivered to damaged murine myocardium via the matrix (2.3 x 10(4) +/- 0.8 x 10(4) CD73(+) cells/matrix) were maintained in vivo for 3 weeks and underwent at least three population doublings during that period (21.9 x 10(4) +/- 14.4 x 10(4) CD73(+) cells/matrix). In addition, collagen within the TissueMend matrix could be remodeled by MSCs in vivo, resulting in a significant decrease in the coefficient of alignment of fibers (0.12 +/- 0.12) compared with the matrix alone (0.28 +/- 0.07), and the MSCs were capable of migrating out of the matrix and into the host tissue. Conclusion: Thus, TissueMend matrix offers a commercially available, biocompatible and malleable vehicle for the delivery and retention of stem cells to the heart.
C1 [Kouris, Nicholas A.; Jung, Jangwook P.; Pehlke, Carolyn A.; Eliceiri, Kevin W.; Ogle, Brenda M.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Squirrell, Jayne M.; Pehlke, Carolyn A.; Eliceiri, Kevin W.; Ogle, Brenda M.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI 53706 USA.
   [Hacker, Timothy] Univ Wisconsin, Dept Med, Cardiovasc Physiol Core Facil, Madison, WI 53706 USA.
   [Ogle, Brenda M.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA.
RP Ogle, BM (reprint author), 2-114 Engn Ctr Bldg,1550 Engn Dr, Madison, WI 53706 USA.
EM ogle@wisc.edu
OI Eliceiri, Kevin/0000-0001-8678-670X
FU NHLBI NIH HHS [R21 HL089679, R21 HL089679-02, R21 HL089679-01A2S1]
CR Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295
   Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   [Anonymous], DEF HEART DIS MAYO C
   [Anonymous], TISSUEMEND
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Baig MK, 1998, AM HEART J, V135, pS216, DOI 10.1016/S0002-8703(98)70252-2
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Berry MF, 2006, AM J PHYSIOL-HEART C, V290, pH2196, DOI 10.1152/ajpheart.01017.2005
   Bhana B, 2010, BIOTECHNOL BIOENG, V105, P1148, DOI 10.1002/bit.22647
   Bryant SJ, 2008, PHARM RES-DORDR, V25, P2379, DOI 10.1007/s11095-008-9619-y
   Bunnell BA, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt34
   Bursac N, 2007, BIOCHEM BIOPH RES CO, V361, P847, DOI 10.1016/j.bbrc.2007.07.138
   Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020
   Candes E.J., 2000, CURVES SURFACE FITTI
   Chakraborty S, 2009, DIFFERENTIATION, V78, P143, DOI 10.1016/j.diff.2009.05.006
   CHAUDHURI S, 1987, IEEE T BIO-MED ENG, V34, P509, DOI 10.1109/TBME.1987.325980
   Choi EW, 2011, J GENE MED, V13, P3, DOI 10.1002/jgm.1531
   Dawn B, 2005, P NATL ACAD SCI USA, V102, P3766, DOI 10.1073/pnas.0405957102
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Fibbe WE, 2007, ANN NY ACAD SCI, V1106, P272, DOI 10.1196/annals.1392.025
   Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818
   Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095
   Guddati AK, 2009, INT HEART J, V50, P783, DOI 10.1536/ihj.50.783
   Guo YL, 2007, DEV DYNAM, V236, P3383, DOI 10.1002/dvdy.21374
   Haddad E, 2011, J YOUTH ADOLESCENCE, V40, P310, DOI 10.1007/s10964-010-9543-4
   Horton RE, 2009, REGEN MED, V4, P721, DOI 10.2217/RME.09.48
   Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462
   Kenar H, 2010, J MATER SCI-MATER M, V21, P989, DOI 10.1007/s10856-009-3917-8
   Kenealey JD, 2011, J AGR FOOD CHEM, V59, P4979, DOI 10.1021/jf104901g
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Krause K, 2009, HEART, V95, P1145, DOI 10.1136/hrt.2008.155077
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lee J, 2009, AM J PHYSIOL-HEART C, V296, pH927, DOI 10.1152/ajpheart.00931.2008
   Li FR, 2010, CLIN EXP IMMUNOL, V161, P357, DOI 10.1111/j.1365-2249.2010.04178.x
   Li MC, 2010, CELL REPROGRAM, V12, P405, DOI 10.1089/cell.2009.0088
   Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Makela J, 2009, SCAND CARDIOVASC J, V43, P366, DOI 10.3109/14017430903045350
   MARIJIANOWSKI MMH, 1995, J AM COLL CARDIOL, V25, P1263, DOI 10.1016/0735-1097(94)00557-7
   Marquez JP, 2006, INT J SOLIDS STRUCT, V43, P6413, DOI 10.1016/j.ijsolstr.2005.11.003
   Mavroudis C, 2002, ANN THORAC SURG, V73, P1926
   Mazo M, 2008, EUR J HEART FAIL, V10, P454, DOI 10.1016/j.ejheart.2008.03.017
   Michael LH, 1995, AM J PHYSIOL-HEART C, V269, pH2147
   Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Ogle Brenda M., 2004, FASEB Journal, V18, P548
   Orsini E, 2010, J CARDIOVASC MED, V11, P469, DOI 10.2459/JCM.0b013e328336ecde
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pasha Z, 2008, CARDIOVASC RES, V77, P134, DOI 10.1093/cvr/cvm025
   Potapova IA, 2008, AM J PHYSIOL-HEART C, V295, pH2257, DOI 10.1152/ajpheart.00219.2008
   Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299
   Qiao H, 2009, MOL IMAGING BIOL, V11, P408, DOI 10.1007/s11307-009-0222-3
   Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386
   Roche S, 2001, BIOMATERIALS, V22, P9, DOI 10.1016/S0142-9612(00)00084-3
   Schneider C, 2009, J AM SOC ECHOCARDIOG, V22, P1180, DOI 10.1016/j.echo.2009.06.011
   Schneider C, 2008, J CARD FAIL, V14, P861, DOI 10.1016/j.cardfail.2008.08.005
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   Shapira K, 2008, BIO-MED MATER ENG, V18, P309, DOI 10.3233/BME-2008-0544
   Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Sui RQ, 2011, STEM CELL REV REP, V7, P172, DOI 10.1007/s12015-010-9131-8
   Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a
   Suzuki K, 2004, FASEB J, V18, P1153, DOI 10.1096/fj.03-1308fje
   Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   van der Loo JJ, 2008, 0845 BMTE TU EINDH
   Varghese S, 2008, MATRIX BIOL, V27, P12, DOI 10.1016/j.matbio.2007.07.002
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001
   Wang T, 2009, ACTA BIOMATER, V5, P2939, DOI 10.1016/j.actbio.2009.04.040
   Wang T, 2009, BIOMATERIALS, V30, P4161, DOI 10.1016/j.biomaterials.2009.04.033
   Wang T, 2009, J MOL CELL CARDIOL, V46, P378, DOI 10.1016/j.yjmcc.2008.11.014
   Wolf D, 2009, SCAND CARDIOVASC J, V43, P39, DOI 10.1080/14017430802100280
   Xiao QZ, 2006, ARTERIOSCL THROM VAS, V26, P2244, DOI 10.1161/01.ATV.0000240251.50215.50
   Xu YL, 2010, INT J CARDIOL, V138, P182, DOI 10.1016/j.ijcard.2009.03.071
   Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027
   Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhang SN, 2011, J CELL MOL MED, V15, P2245, DOI 10.1111/j.1582-4934.2010.01217.x
   Zhao TM, 2009, AM J PHYSIOL-HEART C, V296, pH976, DOI 10.1152/ajpheart.01134.2008
   Zhou Q, 2010, J THORAC CARDIOVASC, V140, P1388
   Zhou YF, 2009, BIOCHEM BIOPH RES CO, V390, P902, DOI 10.1016/j.bbrc.2009.10.074
   Zhu JM, 2009, BIOCONJUGATE CHEM, V20, P333, DOI 10.1021/bc800441v
NR 91
TC 17
Z9 17
U1 0
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0751
EI 1746-076X
J9 REGEN MED
JI Regen. Med.
PD SEP
PY 2011
VL 6
IS 5
BP 569
EP 582
DI 10.2217/RME.11.48
PG 14
WC Cell & Tissue Engineering; Engineering, Biomedical
SC Cell Biology; Engineering
GA 832FC
UT WOS:000295786800011
PM 21916593
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Rech, C
   Rosencrantz, RR
   Krenek, K
   Pelantova, H
   Bojarova, P
   Romer, CE
   Hanisch, FG
   Kren, V
   Elling, L
AF Rech, Claudia
   Rosencrantz, Ruben R.
   Krenek, Karel
   Pelantova, Helena
   Bojarova, Pavla
   Roemer, Christiane E.
   Hanisch, Franz-Georg
   Kren, Vladimir
   Elling, Lothar
TI Combinatorial One-Pot Synthesis of Poly-N-acetyllactosamine
   Oligosaccharides with Leloir-Glycosyltransferases
SO ADVANCED SYNTHESIS & CATALYSIS
LA English
DT Article
DE biocatalysis; carbohydrates; combinatorial chemistry; glycoconjugates;
   glycosylation
ID I-EXTENSION ENZYME; CHEMOENZYMATIC SYNTHESIS; ESCHERICHIA-COLI;
   BLOOD-GROUP; LINKED OLIGOSACCHARIDES; ERYTHROCYTE-MEMBRANE; RECOMBINANT
   PROTEIN; CELL-ADHESION; HEAT-SHOCK; GALECTINS
AB Poly-N-acetyllactosamine (Poly-LacNAc, [3Gal beta 1,4GlcNAc beta 1](n)) glycans play an essential role in carbohydrate-protein interactions. The synthesis of poly-LacNAc, both chemical and enzymatic, is typically characterized by high losses of product during sequential synthesis, due to deprotection and/or purification steps. In this work we present a one-pot synthesis of poly-LacNAc oligosaccharides by combining recombinant glycosyltransferases. By fractionation of the poly-LacNAc glycan mixture we were able to isolate glycans with up to six N-acetyllactosamine (LacNAc) units. Activity measurements of the involved recombinant beta 1,4-galactosyltransferase-1 (beta 4GalT-1) and beta 1,3-N-acetylglucosaminyltransferase (beta 3GlcNAcT) with isolated glycan substrates of up to eight sugar units revealed a preference of beta 3GlcNAcT for the tetrasaccharide and no preference of beta 4GalT-1 for a specific glycan length. These findings led us to the optimization of combinatorial one-pot synthesis by variation of substrate and enzyme ratios, as well as starting the synthesis with various poly-LacNAc chain lengths. Consequently, we present here an optimized poly-LacNAc synthesis by the combination of two glycosyltransferases and a uridine-diphospho-glucose/N-acetylglucosamine 4'-epimerase as one-pot strategy resulting in long poly-LacNAc glycans with up to six LacNAc units in high yields while minimizing reaction time and product loss. The obtained products are important ligands for the biofunctionalization of biomaterial surfaces and the construction of an artificial extracellular matrix for tissue engineering.
C1 [Rech, Claudia; Rosencrantz, Ruben R.; Roemer, Christiane E.; Elling, Lothar] Rhein Westfal TH Aachen, Lab Biomat, Inst Biotechnol, D-52074 Aachen, Germany.
   [Rech, Claudia; Rosencrantz, Ruben R.; Roemer, Christiane E.; Elling, Lothar] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany.
   [Krenek, Karel; Pelantova, Helena; Bojarova, Pavla; Kren, Vladimir] Acad Sci Czech Republ, Inst Microbiol, CZ-14220 Prague 4, Czech Republic.
   [Hanisch, Franz-Georg] Univ Cologne, Inst Biochem 2, D-50931 Cologne, Germany.
RP Elling, L (reprint author), Rhein Westfal TH Aachen, Lab Biomat, Inst Biotechnol, Worringer Weg 1, D-52074 Aachen, Germany.
EM l.elling@biotec.rwth-aachen.de
RI Bojarova, Pavla/R-4742-2017; Pelantova, Helena/R-4974-2017; Kren,
   Vladimir/H-8461-2014; Elling, Lothar/B-3711-2013
OI Bojarova, Pavla/0000-0001-7069-0973; Pelantova,
   Helena/0000-0002-2523-7413; Elling, Lothar/0000-0002-3654-0397
FU DFG within the Research Training Group [1035]; excellence initiative of
   the German federal and state governments through ERS@RWTH Aachen
   University; DFG [EL 135/10-1]; EU [CM0701, MSMT OC09045]
FX L.E. and C.R, and C.E.R acknowledge financial support by the DFG within
   the Research Training Group 1035 "Biointerface" and by the excellence
   initiative of the German federal and state governments through ERS@RWTH
   Aachen University. L.E. acknowledges financial support by the DFG
   (project EL 135/10-1). L.E. and V.K thank for financial support by the
   EU-COST action CM0701 (MSMT OC09045). The authors thank Dr. W. W.
   Wakarchuck (National Research Council of Canada) for providing the
   plasmids for beta 3GlcNAcT and UDP-Glc 4'-epimerase and Prof. B. Ernst
   (University of Basel) for providing UDP-Gal.
CR ALAIS J, 1990, CARBOHYD RES, V207, P11, DOI 10.1016/0008-6215(90)80002-K
   BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7
   Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200
   BIDONWAGNER N, 2004, GLYCOCONJUGATE J, P557
   BLACKWELL JR, 1991, FEBS LETT, V295, P10, DOI 10.1016/0014-5793(91)81372-F
   Blixt O, 1999, GLYCOBIOLOGY, V9, P1061, DOI 10.1093/glycob/9.10.1061
   Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025
   Campbell CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-236
   CUMMINGS RD, 1984, J BIOL CHEM, V259, P6253
   Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X
   Di Virgilio S, 1999, GLYCOBIOLOGY, V9, P353, DOI 10.1093/glycob/9.4.353
   Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8
   FUKUDA M, 1986, J BIOL CHEM, V261, P2796
   Hidari KIPJ, 2008, GLYCOBIOLOGY, V18, P779, DOI 10.1093/glycob/cwn067
   Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2
   Hoffmann F, 2000, BIOTECHNOL PROGR, V16, P1000, DOI 10.1021/bp0000959
   Hughes RC, 2001, BIOCHIMIE, V83, P667
   KRUSIUS T, 1978, EUR J BIOCHEM, V92, P289, DOI 10.1111/j.1432-1033.1978.tb12747.x
   Lahm H, 2003, GLYCOCONJUGATE J, V20, P227, DOI 10.1023/B:GLYC.0000025817.24297.17
   LEFFLER H, 2004, GLYCOCONJUGATE J, P433
   Logan SM, 2005, GLYCOBIOLOGY, V15, P721, DOI 10.1093/glycob/cwi057
   LUSK JE, 1968, J BIOL CHEM, V243, P2618
   MATSUZAKI Y, 1993, TETRAHEDRON LETT, V34, P1061, DOI 10.1016/S0040-4039(00)77492-2
   McAuliffe JC, 1999, BIOORG MED CHEM LETT, V9, P2855, DOI 10.1016/S0960-894X(99)00485-0
   MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025
   Mong TKK, 2003, J ORG CHEM, V68, P2135, DOI 10.1021/jo0206420
   Namdjou DJ, 2007, ADV SYNTH CATAL, V349, P314, DOI 10.1002/adsc.200606169
   Naruchi K, 2006, J ORG CHEM, V71, P9609, DOI 10.1021/jo0617161
   Oganesyan N, 2007, PROTEIN EXPRES PURIF, V52, P280, DOI 10.1016/j.pep.2006.09.015
   OGATA M, 2010, JPN SOC APPL GLYCOSC, V57, P137
   Paulson JC, 2006, NAT CHEM BIOL, V2, P238, DOI 10.1038/nchembio785
   Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536
   Sauerzapfe B, 2008, J MOL CATAL B-ENZYM, V50, P128, DOI 10.1016/j.molcatb.2007.09.009
   Sauerzapfe B, 2009, GLYCOCONJUGATE J, V26, P141, DOI 10.1007/s10719-008-9172-2
   Schein C. H., 1989, NAT BIOTECHNOL, V7, P1141
   Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008
   Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823
   Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004
   Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R
   Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200
   Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018
   TAKENAKA Y, 2004, GLYCOCONJUGATE J, P543
   Ueki A, 2010, TETRAHEDRON, V66, P1742, DOI 10.1016/j.tet.2009.12.031
   Ujita M, 2000, J BIOL CHEM, V275, P15868, DOI 10.1074/jbc.M001034200
   Ujita M, 1999, J BIOL CHEM, V274, P9296, DOI 10.1074/jbc.274.14.9296
   Vasiliu D, 2006, CARBOHYD RES, V341, P1447, DOI 10.1016/j.carres.2006.03.043
   WANG Y, 1994, BIOCHEM BIOPH RES CO, V204, P701, DOI 10.1006/bbrc.1994.2516
   Zhou DP, 2003, CURR PROTEIN PEPT SC, V4, P1, DOI 10.2174/1389203033380304
NR 48
TC 34
Z9 34
U1 1
U2 51
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1615-4150
EI 1615-4169
J9 ADV SYNTH CATAL
JI Adv. Synth. Catal.
PD SEP
PY 2011
VL 353
IS 13
BP 2492
EP 2500
DI 10.1002/adsc.201100375
PG 9
WC Chemistry, Applied; Chemistry, Organic
SC Chemistry
GA 824VS
UT WOS:000295230900028
DA 2018-10-20
ER

PT J
AU Malekafzali, B
   Shekarchi, F
   Asgary, S
AF Malekafzali, B.
   Shekarchi, F.
   Asgary, S.
TI Treatment outcomes of pulpotomy in primary molars using two endodontic
   biomaterials. A 2-year randomised clinical trial
SO EUROPEAN JOURNAL OF PAEDIATRIC DENTISTRY
LA English
DT Article
DE Calcium enriched mixture; CEM cement; Dental cements; Mineral trioxide
   aggregate; Pulpotomy; Primary tooth
ID MINERAL TRIOXIDE AGGREGATE; CALCIUM-ENRICHED MIXTURE; END FILLING
   MATERIAL; ROOT-CANAL THERAPY; IRREVERSIBLE PULPITIS; PERMANENT MOLARS;
   CEMENT; FORMOCRESOL; APEXOGENESIS
AB Aim To compare the treatment outcomes of calcium-enriched mixture (CEM) cement and mineral trioxide aggregate (MTA) as pulp dressing biomaterials in vital pulpotomy of carious primary molars. Study design: split-mouth randomised clinical trial.
   Materials and methods Forty children aged 4-8 years with 2 carious teeth requiring pulpotomy were selected and randomly assigned to MTA (n=40) or CEM (n=40) groups. After coronal pulp removal, the remaining radicular pulp was covered with an appropriate biomaterial; the teeth were then permanently restored. Clinical/radiographic success/failures were blindly evaluated at 6-, 12- and 24-month follow-ups. Statistics: the recorded data were analyzed with McNemar test and GEE.
   Results A total of 36, 33 and 35 patients were available for 6-, 12- and 24-month follow-ups, respectively At the 12-month follow-up only one and three teeth the CEM and MTA groups had pathologic external root resorption, respectively The resorbed teeth were then missed due to extraction/exfoliation at the 24-month follow-up; all other treated teeth were sign/symptom-free. Ova-all, clinical and radiographic outcomes in both MTA/CEM groups were comparable at the three follow-ups without significant differences. Time had no significant effect or the success.
   Conclusion MTA and CEM demonstrated favourable treatment outcomes for pulpotomy of carious primary molars; CEM may be an effective pulp dressing biomaterial.
C1 [Malekafzali, B.; Asgary, S.] Shahid Beheshti Med Univ, Sch Dent, Dent Res Ctr, Iranian Ctr Endodont Res, Tehran, Iran.
RP Malekafzali, B (reprint author), Shahid Beheshti Med Univ, Sch Dent, Dent Res Ctr, Iranian Ctr Endodont Res, Tehran, Iran.
EM saasgary@yahoo.com
FU Iran National Science Foundation; Iranian Center for Endodontic
   Research, Shahid Beheshti Medical University, Tehran, Iran
FX This trial was supported by Iran National Science Foundation and Iranian
   Center for Endodontic Research, Shahid Beheshti Medical University,
   Tehran, Iran.
CR Aeinehchi M, 2007, INT ENDOD J, V40, P261, DOI 10.1111/j.1365-2591.2007.01209.x
   Asgary S, 2010, J DENT RES, V89, P1080, DOI 10.1177/0022034510374057
   Asgary S, 2008, J BIOMED MATER RES A, V87A, P706, DOI 10.1002/jbm.a.31678
   Asgary S, 2008, ORAL SURG ORAL MED O, V106, P609, DOI 10.1016/j.tripleo.2008.06.006
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary Saeed, 2006, Aust Endod J, V32, P26
   Asgary Saeed, 2011, J Conserv Dent, V14, P90, DOI 10.4103/0972-0707.80733
   Asgary S, 2011, J ENDODONT, V37, P411, DOI 10.1016/j.joen.2010.11.015
   Asgary Saeed, 2010, J Conserv Dent, V13, P156, DOI 10.4103/0972-0707.71650
   Asgary S, 2010, ODONTOLOGY, V98, P126, DOI 10.1007/s10266-010-0127-2
   Asgary Saeed, 2009, J Conserv Dent, V12, P31, DOI 10.4103/0972-0707.53340
   Asgary S, 2010, J ENDODONT, V36, P837, DOI 10.1016/j.joen.2010.03.005
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026
   BLOCK RM, 1978, ORAL SURG ORAL MED O, V45, P282, DOI 10.1016/0030-4220(78)90096-8
   Cardoso-Silva C, 2011, J DENT, V39, P187, DOI [10.1016/j.jdent.2010.11.010, 10.1016/j.jdent.201.0.11.010]
   Eghbal MJ, 2009, AUST ENDOD J, V35, P4, DOI 10.1111/j.1747-4477.2009.00166.x
   Fuks A B, 2002, Eur J Paediatr Dent, V3, P115
   Ghoddusi Jamileh, 2008, Iran Endod J, V3, P17
   Holan G, 2005, PEDIATR DENT, V27, P129
   Innes Nicola, 2007, Evid Based Dent, V8, P11, DOI 10.1038/sj.ebd.6400464
   Lewis B, 1998, J Clin Pediatr Dent, V22, P167
   Maroto M, 2007, AM J DENT, V20, P283
   Matsuo T, 1996, J ENDODONT, V22, P551, DOI 10.1016/S0099-2399(96)80017-3
   Mozayeni MA, 2011, AUST ENDOD IN PRESS
   Nosrat A, 2010, INT ENDOD J, V43, P940, DOI 10.1111/j.1365-2591.2010.01777.x
   Nosrat A, 2011, J ENDODONT, V37, P562, DOI 10.1016/j.joen.2011.01.011
   Nosrat A, 2010, J ENDODONT, V36, P912, DOI 10.1016/j.joen.2009.11.025
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Peng Li, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe40, DOI 10.1016/j.tripleo.2006.05.017
   Samiee M, 2010, CLIN ORAL INVEST, V14, P653, DOI 10.1007/s00784-009-0351-8
   Tabarsi B, 2010, INT ENDOD J, V43, P565, DOI 10.1111/j.1365-2591.2010.01711.x
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010
   Tziafas D, 2000, J DENT, V28, P77, DOI 10.1016/S0300-5712(99)00047-0
   Zealand CM, 2010, PEDIATR DENT, V32, P393
NR 37
TC 25
Z9 27
U1 1
U2 17
PU ARIESDUE SRL
PI CARIMATE
PA VIA AIROLDI, CARIMATE, 11-22060, ITALY
SN 1591-996X
J9 EUR J PAEDIATR DENT
JI Eur. J. Paediatr. Dent.
PD SEP
PY 2011
VL 12
IS 3
BP 189
EP 193
PG 5
WC Dentistry, Oral Surgery & Medicine; Pediatrics
SC Dentistry, Oral Surgery & Medicine; Pediatrics
GA 827KN
UT WOS:000295427500012
PM 22077689
DA 2018-10-20
ER

PT J
AU Calori, GM
   Mazza, E
   Colombo, M
   Ripamonti, C
AF Calori, G. M.
   Mazza, E.
   Colombo, M.
   Ripamonti, C.
TI The use of bone-graft substitutes in large bone defects: Any specific
   needs?
SO INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
LA English
DT Article
DE Bone substitutes; Large bone defect; Biomaterials; Scaffolds; BMPs; Long
   bone non-unions
ID CALCIUM-PHOSPHATE CERAMICS; NON-UNIONS; MORPHOGENETIC PROTEINS;
   PROGENITOR CELLS; DIAMOND CONCEPT; FUSION MODEL; CEMENTED CUP;
   HYDROXYAPATITE; ACETABULUM; REVISION
AB Introduction: The gold standard for restoring bone defects is still considered to be autologous bone grafting. However, clinical benefits are not guaranteed and donor-site complications and morbidity is not infrequent. Research is on-going for the development of alternative bone substitutes of both biological and synthetic origin. The purpose of this study was to evaluate the type of materials used and their efficacy for the treatment of large bone defects in traumatology and orthopaedic surgery.
   Materials and method: A literature review was carried out of Embase and PubMed databases. Inclusion criteria were articles in English language focusing on the use of bone substitutes in trauma and orthopaedic surgery for the treatment of bone defects and included details on the structural, biological or biomechanical properties of the pure product. Furthermore, based on two clinical challenges, fracture non-union and impaction grafting we elaborated on the use of polytherapy for large bone defects as guided by the diamond concept.
   Results: All the products indicated in this manuscript possess osteoconductive activities but have different resorption times and biomechanical properties. Bone graft substitute materials are used for a wide range of clinical applications even when the level of clinical evidence is low. The size and location of the defect and the local biological and mechanical environment as well as the biomechanical characteristics of the material determine the type of device that can be implanted in a bone defect.
   Conclusion: Proper assessment of the biological and mechanical environment and accurate patient selection are necessary to judge the extent of therapy the injury warrants. A sound understanding of various aspects of biomaterial properties and their relation and influence towards bone healing is of utmost importance. We suggest the application of polytherapy for the treatment of large bone defects and advocate the use of the diamond concept as a guideline. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Calori, G. M.] Univ Milan, Reparat Orthopaed Surg Dept, Inst Orthopaed, COR, I-20122 Milan, Italy.
RP Calori, GM (reprint author), Univ Milan, Reparat Orthopaed Surg Dept, Inst Orthopaed, COR, Pza Cardinal Ferrari 1, I-20122 Milan, Italy.
EM gmc@studiocalori.it
CR An YH, 1999, MECH TESTING BONE BO
   Arts JJC, 2005, CLIN ORTHOP RELAT R, P239, DOI 10.1097/01.blo.0000169081.61398.58
   Bae HW, 2006, SPINE, V31, P1299, DOI 10.1097/01.brs.0000218581.92992.b7
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Beuerlein MJS, 2010, J ORTHOP TRAUMA, V24, pS46, DOI 10.1097/BOT.0b013e3181cec48e
   Bidula J, 2006, CLIN ORTHOP RELAT R, P252, DOI 10.1097/01.blo.0000183738.43245.c2
   Blokhuis TJ, 2000, J TRAUMA, V48, P179, DOI 10.1097/00005373-200001000-00037
   Blom AW, 2009, ACTA ORTHOP, V80, P150, DOI 10.3109/17453670902884767
   Blom AW, 2002, P I MECH ENG H, V216, P265, DOI 10.1243/09544110260138754
   Bohner M, 2001, EUR SPINE J, V10, pS114, DOI 10.1007/s005860100276
   Bolder SBT, 2002, BIOMATERIALS, V23, P659, DOI 10.1016/S0142-9612(01)00153-3
   Bolder SBT, 2003, J ARTHROPLASTY, V18, P1056, DOI 10.1016/S0883-5403(03)00408-X
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Calori GM, 2007, INJURY, V38, pS11, DOI 10.1016/S0020-1383(07)80004-0
   Calori GM, 2008, INJURY, V39, P1391, DOI 10.1016/j.injury.2008.08.011
   Calori GM, 2008, INJURY, V39, pS59, DOI 10.1016/S0020-1383(08)70016-0
   Calori GM, INJURY IN PRESS
   Calori GM, 2010, GIOT, V36, P183
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465
   Dimitriou R, 2005, INJURY, V36, pS51, DOI 10.1016/j.injury.2005.10.010
   Dinopoulos H, 2007, CURR ORTHOPAED, V21, P268, DOI 10.1016/j.cuor.2007.07.007
   Driskell T D, 1972, J Biomed Mater Res, V6, P345, DOI 10.1002/jbm.820060107
   Drosos GI, 2007, INJURY, V38, pS13, DOI 10.1016/S0020-1383(08)70005-6
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151
   Gheduzzi S, 2006, J MATER SCI-MATER M, V17, P421, DOI 10.1007/s10856-006-8469-6
   Giannoudis PV, 2008, INJURY, V39, pS5, DOI 10.1016/S0020-1383(08)70010-X
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Giannoudis PV, 2005, INJURY, V36, P47, DOI 10.1016/j.injury.2005.07.035
   Giannoudis PV, 2005, INJURY S, V36
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   GROSS AE, 1999, CLIN ORTHOP RELAT R, V369, P198
   Gupta AR, 2001, INT MED J, V8, P163
   Hamanishi C, 1994, CLIN ORTHOP RELAT R, V303, P250
   Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215
   Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455
   Hing KA, 1999, J MATER SCI-MATER M, V10, P663, DOI 10.1023/A:1008900127475
   Huang Z, 2010, CYTOKINE, V51, P305, DOI 10.1016/j.cyto.2010.06.002
   Huber FX, 2008, J MATER SCI-MATER M, V19, P33, DOI 10.1007/s10856-007-3039-0
   Jacobsen KA, 2008, J BONE MINER RES, V23, P596, DOI 10.1359/JBMR.080103
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Kanakaris NK, 2008, INJURY, V39, pS83, DOI 10.1016/S0020-1383(08)70019-6
   Kanakaris NK, 2007, INJURY, V38, pS65, DOI 10.1016/S0020-1383(07)80011-8
   Kanakaris NK, 2009, INJURY, pS54
   Keramaris NC, 2008, INJURY, V39, pS45, DOI 10.1016/S0020-1383(08)70015-9
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lewandrowski KU, 2000, BIOMATERIALS, V21, P757, DOI 10.1016/S0142-9612(99)00179-9
   Lindfors NC, 2010, BONE, V47, P212, DOI 10.1016/j.bone.2010.05.030
   McKee MD, 2005, J ORTHOP TRAUMA, V19, pS26, DOI 10.1097/00005131-200511101-00008
   McNamara I, 2010, J BONE JOINT SURG BR, V92B, P617, DOI 10.1302/0301-620X.92B5.23044
   Mistry S, 2011, AUST DENT J, V56, P68, DOI 10.1111/j.1834-7819.2010.01305.x
   Muschler GF, 1996, CLIN ORTHOP RELAT R, V328, P250
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Ornstein E, 2002, ACTA ORTHOP SCAND, V73, P3
   Papathanasopoulos A, 2008, INJURY, V39, pS21, DOI 10.1016/S0020-1383(08)70012-3
   Patka P, 1984, BONE REPLACEMENT CAL
   Peltola M, 2008, J ORAL MAXIL SURG, V66, P639, DOI 10.1016/j.joms.2007.11.019
   Peters CL, 2006, J BIOMED MATER RES A, V76A, P456, DOI 10.1002/jbm.a.30569
   Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016
   Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8
   Ronga M, 2006, INJURY, V37, pS51, DOI 10.1016/j.injury.2006.08.024
   Schnettler R, 2004, EUR J TRAUMA, V30, P219
   Schreurs BW, 2004, J BONE JOINT SURG BR, V86B, P492, DOI 10.1302/0301-620X.86B4.14769
   SCHREURS BW, 2001, CLIN ORTHOP RELAT R, V393, P202
   SHARMA S, 1992, ACTA ORTHOP SCAND, V63, P166, DOI 10.3109/17453679209154815
   Shen BJ, 2010, J CELL BIOCHEM, V109, P406, DOI 10.1002/jcb.22412
   SLOOFF TJJH, 1984, ACTA ORTHOP SCAND, V55, P593, DOI 10.3109/17453678408992402
   St John Thomas A, 2003, Am J Orthop (Belle Mead NJ), V32, P18
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006
   Tzioupis C, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(07)80003-9
   Urban RM, 2004, ORTHOPEDICS, V27, pS113
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Van der Stok J, 2011, ACTA BIOMATER, V7, P739, DOI 10.1016/j.actbio.2010.07.035
   van Haaren EH, 2005, J BONE JOINT SURG BR, V87B, P267, DOI 10.1302/0301-620X.87B2.14749
   Veillette CJH, 2007, INJURY, V38, pS38, DOI 10.1016/j.injury.2007.02.009
   WOLFF J, 1986, GESETZ TRANSFORMATIO
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   Yu BQ, 2009, INT ORTHOP, V33, P1127, DOI 10.1007/s00264-008-0611-2
NR 81
TC 152
Z9 159
U1 0
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-1383
EI 1879-0267
J9 INJURY
JI Injury-Int. J. Care Inj.
PD SEP
PY 2011
VL 42
SU 2
BP S56
EP S63
DI 10.1016/j.injury.2011.06.011
PG 8
WC Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery
SC General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery
GA 824PB
UT WOS:000295213300010
PM 21752369
DA 2018-10-20
ER

PT J
AU Akturk, O
   Tezcaner, A
   Bilgili, H
   Deveci, MS
   Gecit, MR
   Keskin, D
AF Akturk, Omer
   Tezcaner, Aysen
   Bilgili, Hasan
   Deveci, M. Salih
   Gecit, M. Rusen
   Keskin, Dilek
TI Evaluation of sericin/collagen membranes as prospective wound dressing
   biomaterial
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Sericin; Collagen; Wound dressing; Membrane; Biocompatibility
ID SILK SERICIN; IN-VITRO; SKIN SUBSTITUTES; CELL-ADHESION; BOMBYX-MORI;
   PROTEIN; COLLAGEN; MATRIX; ATTACHMENT; INTEGRINS
AB Sericin, a silk protein, has high potential for use in biomedical applications. In this study, wound dressing membranes of Sericin (S) and Collagen (C) were prepared by glutaraldehyde cross-linking at S/C; 2:1,1:1, 1:2, and 0:1 weight ratios. They were stable in water for 4 weeks. However, increasing the proportion of sericin had decreasing effect on the membrane stability. Water swelling property of membranes was enhanced with sericin. The highest water swelling was obtained in 1:1 group (9.06 g/g), but increasing collagen or sericin content in the membranes had a diminishing effect. Highest water vapor transmission rate was obtained with 1:2 group (1013.80 g/m(2)/day). Oxygen permeability results showed that 1:2 (7.67 mg/L) and 2:1 (7.85 mg/L) SIC groups were better than the other groups. While sericin decreased the tensile strength and elongation of membranes, it increased modulus. Sericin also increased brittleness of membranes, but their UTS range (24.93-44.92 MPa) was still suitable for a wound dressing. Membranes were not penetrable to microorganisms. Cytotoxicity studies showed that fibroblasts and keratinocytes attached and gained their characteristic morphologies. They also proliferated on membranes significantly. After 1 week of subcutaneous implantation, a fibrous capsule formed around all membranes with an acute inflammation. Sericin containing membranes showed signs of degradation (at 2nd week), while collagen only membranes remained largely intact. Eventually, sericin containing membranes degraded in 3 weeks with moderate inflammatory response. Overall results suggest that sericin/collagen membranes would be favorable as wound dressing material when sericin ratio is less than or equal to the collagen component. (C) 2011, The Society for Biotechnology, Japan. All rights reserved.
C1 [Akturk, Omer; Tezcaner, Aysen; Gecit, M. Rusen; Keskin, Dilek] Middle E Tech Univ, Dept Engn Sci, TR-06531 Ankara, Turkey.
   [Tezcaner, Aysen; Keskin, Dilek] Middle E Tech Univ, Grad Dept Biotechnol, TR-06531 Ankara, Turkey.
   [Bilgili, Hasan] Middle E Tech Univ, Fac Vet Med, Dept Surg, TR-06110 Ankara, Turkey.
   [Deveci, M. Salih] Gulhane Mil Med Acad, Fac Med, Dept Pathol, Ankara, Turkey.
RP Keskin, D (reprint author), Middle E Tech Univ, Dept Engn Sci, TR-06531 Ankara, Turkey.
EM dkeskin@metu.edu.tr
FU Scientific and Technological Research Council of Turkey, TUBITAK
   [106M062]
FX This investigation was financially supported by the Scientific and
   Technological Research Council of Turkey, TUBITAK (Project no: 106M062
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Aramwit P, 2007, BIOSCI BIOTECH BIOCH, V71, P2473, DOI 10.1271/bbb.70243
   Aramwit P, 2009, J BIOSCI BIOENG, V107, P556, DOI 10.1016/j.jbiosc.2008.12.012
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Chen JP, 2008, COLLOID SURFACE A, V313, P183, DOI 10.1016/j.colsurfa.2007.04.129
   De Jong WH, 2005, BIOMATERIALS, V26, P1781, DOI 10.1016/j.biomaterials.2004.06.026
   HAARER JC, 2006, INTRO BIOMATERIALS B, P122
   HOLLANDER DH, 1994, MED HYPOTHESES, V43, P155, DOI 10.1016/0306-9877(94)90142-2
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   Ki CS, 2007, INT J BIOL MACROMOL, V41, P346, DOI 10.1016/j.ijbiomac.2007.05.005
   Kokabi M, 2007, EUR POLYM J, V43, P773, DOI 10.1016/j.eurpolymj.2006.11.030
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kurioka A, 2004, BIOSCI BIOTECH BIOCH, V68, P774, DOI 10.1271/bbb.68.774
   Kweon H.Y., 2001, INT J IND ENTOMOL, V3, P1
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li ST, 2003, BIOMATERIALS PRINCIP
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MANDAL BB, 2007, ACTA BIOMATER, V5, P3007
   Meyers MA, 2008, PROG MATER SCI, V53, P1, DOI 10.1016/j.pmatsci.2007.05.002
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nagura Masanobu, 2001, Journal of Insect Biotechnology and Sericology, V70, P149
   Ovington LG, 2007, CLIN DERMATOL, V25, P33, DOI 10.1016/j.clindermatol.2006.09.003
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park JB, 1992, BIOMATERIALS INTRO, P216
   Park SN, 2004, BIOMATERIALS, V25, P3689, DOI 10.1016/j.biomaterials.2003.10.072
   Pei HN, 2008, J BIOMED MATER RES A, V85A, P566, DOI 10.1002/jbm.a.31223
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sai K P, 2000, BURNS, V26, P54
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4
   Silver F.H., 1994, BIOMATERIALS MED DEV, P46
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Tanodekaew S, 2004, BIOMATERIALS, V25, P1453, DOI 10.1016/j.biomaterials.2003.08.020
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2008, BIOSCI BIOTECH BIOCH, V72, P3189, DOI 10.1271/bbb.80375
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang CC, 2008, J BIOMED MATER RES A, V84A, P1006, DOI 10.1002/jbm.a.31482
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Wittaya-areekul S, 2006, INT J PHARM, V313, P123, DOI 10.1016/j.ijpharm.2006.01.027
   Yannas V., 1980, J BIOMED MATER RES, V14, P65
   YOSHIKAWA M, 2002, MATER SCI ENG C, V20, P135
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhaorigetu S, 2003, J PHOTOCH PHOTOBIO B, V71, P11, DOI 10.1016/S1011-1344(03)00092-7
NR 48
TC 69
Z9 71
U1 0
U2 53
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD SEP
PY 2011
VL 112
IS 3
BP 279
EP 288
DI 10.1016/j.jbiosc.2011.05.014
PG 10
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 832OI
UT WOS:000295813900013
PM 21697006
DA 2018-10-20
ER

PT J
AU Nguyen, TL
   Staiger, MP
   Dias, GJ
   Woodfield, TBF
AF Nguyen, Thanh L.
   Staiger, Mark P.
   Dias, George J.
   Woodfield, Timothy B. F.
TI A Novel Manufacturing Route for Fabrication of Topologically-Ordered
   Porous Magnesium Scaffolds
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID ANODIC-DISSOLUTION; BONE REGENERATION; IN-VITRO; DESIGN; CORROSION;
   BEHAVIOR; ALLOYS; BIOMATERIALS; IMPLANTS; POROSITY
AB The use of porous metal foams as biomaterial scaffolds has been widely adopted; however, many of these porous structures are manufactured with pore architectures that are inherently random. This makes structural optimization for a specific purpose challenging. Scaffolds containing ordered pore architectures can be fabricated to meet design criteria, such as porosity, stiffness, and volume fraction. Mg and its alloys offer potential as a new class of degradable metallic orthopedic biomaterials. In comparison with current metallic orthopedic implant materials, Mg offers advantages such as, closer-to-bone stiffness and biodegradability, thereby eliminating the need for a second surgery to remove hardware. Currently there are few methods described in literature to manufacture ordered porous Mg. The aim of this study was to determine the resolution of a novel indirect solid free-form fabrication (SFF) process for producing topologically ordered Mg (TOPM) structures. The multi-step method involved the printing of an SFF mould, NaCl infiltration, and liquid Mg casting techniques. Using a range of characterization methods, we demonstrated that the selected structures were manufactured with a high level of accuracy. Differences in dimensions from CAD models to Mg scaffolds ranged from 2.5% to a maximum of 8.33%. Similarly, there was a maximum of 6.1% reduction in porosity in Mg scaffolds compared with initial design. Meanwhile, with surface roughness of 10.17 +/- 1.75 mu m, there was an average of 70% increase in surface area. This study demonstrates a simple, reliable, and safe route to manufacture TOPM scaffolds for potential application in medical device design.
C1 [Nguyen, Thanh L.; Staiger, Mark P.; Woodfield, Timothy B. F.] Univ Canterbury, Dept Mech Engn, Biomat & Tissue Engn BioMATE Grp, Christchurch 1, New Zealand.
   [Woodfield, Timothy B. F.] Univ Otago, Dept Orthopaed Surg, Christchurch Regenerat Med & Tissue Engn CReATE G, Christchurch 8140, New Zealand.
   [Dias, George J.] Univ Otago, Dept Anat & Struct Biol, Dunedin, New Zealand.
RP Nguyen, TL (reprint author), Univ Canterbury, Dept Mech Engn, Biomat & Tissue Engn BioMATE Grp, Christchurch 1, New Zealand.
EM tim.woodfield@otago.ac.nz
RI Woodfield, Tim/A-2705-2009; Staiger, Mark/H-2102-2011
OI Woodfield, Tim/0000-0002-5428-7575; Staiger, Mark/0000-0002-1517-4404
FU New Zealand Foundation for Research Science & Technology (FRST);
   Wishbone Trust
FX The authors gratefully acknowledge funding from the New Zealand
   Foundation for Research Science & Technology (FRST) as well as the
   Wishbone Trust. We also acknowledge Mr. Joseph Bain for developing
   surface roughness measurement techniques and help from Mr. Kevin Stobbs,
   Mr. Mike Flaws, and Mr. Andrew McNaughton for technical assistance.
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790
   Bender S, 2007, MATER CORROS, V58, P977, DOI 10.1002/maco.200704091
   Gu XN, 2010, MATER LETT, V64, P1871, DOI 10.1016/j.matlet.2010.06.015
   Ho S., 2009, SCRIPTA MATER, V62, P21
   HOFMANN G O, 1992, Clinical Materials, V10, P75, DOI 10.1016/0267-6605(92)90088-B
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Krishna BV, 2007, ACTA BIOMATER, V3, P997, DOI 10.1016/j.actbio.2007.03.008
   Leong KF, 2008, J MECH BEHAV BIOMED, V1, P140, DOI 10.1016/j.jmbbm.2007.11.002
   Li JP, 2006, BIOMATERIALS, V27, P1223, DOI 10.1016/j.biomaterials.2005.08.033
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Miao X, 2007, MAT SCI ENG C-BIO S, V27, P257, DOI 10.1016/j.msec.2006.03.009
   Müller Wolf Dieter, 2007, Mat. Res., V10, P5, DOI 10.1590/S1516-14392007000100003
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Peroni L, 2008, INT J IMPACT ENG, V35, P644, DOI 10.1016/j.ijimpeng.2007.02.007
   Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032
   Song G, 1997, CORROS SCI, V39, P1981, DOI 10.1016/S0010-938X(97)00090-5
   Song GL, 2004, CORROS SCI, V46, P1381, DOI 10.1016/j.corsci.2003.10.008
   Staiger MP, 2010, MATER LETT, V64, P2572, DOI 10.1016/j.matlet.2010.08.049
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Staiger MP, 2010, MATER CHARACT, V61, P9
   Swiatowska J, 2010, CORROS SCI, V52, P2372, DOI 10.1016/j.corsci.2010.02.038
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Tan LL, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/1/015016
   Tomovich SJ, 2005, J PHYS CONF SER, V13, P426, DOI 10.1088/1742-6596/13/1/098
   TUNOLD R, 1977, CORROS SCI, V17, P353, DOI 10.1016/0010-938X(77)90059-2
   Wen CE, 2004, MATER LETT, V58, P357, DOI 10.1016/S0167-577X(03)004500-7
   Wennerberg A, 1996, MED ENG PHYS, V18, P548, DOI 10.1016/1350-4533(95)00005-4
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F., 2006, J BIOMED MATER RES A, P748
   Woodfield TBF, 2009, COMB CHEM HIGH T SCR, V12, P562, DOI 10.2174/138620709788681899
   Zhu HX, 2002, ACTA MATER, V50, P1041, DOI 10.1016/S1359-6454(01)00402-5
NR 33
TC 34
Z9 35
U1 1
U2 51
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD SEP
PY 2011
VL 13
IS 9
BP 872
EP 881
DI 10.1002/adem.201100029
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 824DV
UT WOS:000295183300011
DA 2018-10-20
ER

PT J
AU Pedimonte, J
   Travitzky, N
   Korn, M
   Kriegelstein, S
   Greil, P
AF Pedimonte, J.
   Travitzky, N.
   Korn, M.
   Kriegelstein, S.
   Greil, P.
TI Surface Modification of an Alumina-Based Bioceramic for Cement
   Application
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID ZIRCONIA-TOUGHENED ALUMINA; ACRYLIC BONE-CEMENT; ANODIC ALUMINA; POROUS
   ALUMINA; CRACK-GROWTH; CERAMICS; ARRAYS; FILMS; BIOACTIVATION; TOUGHNESS
AB Biograde zirconia toughened alumina (ZTA) has found wide application in load bearing endoprosthetic implants due to high strength, fracture toughness, and wear resistance. In order to enhance bonding to acrylic bone cement (BC) for implants, fixation modification of ZTA with a thin layer of porous anodic alumina (PAA) was investigated. An Al-layer of approximately 500 nm was sputtered on the ZTA substrate which subsequently was electrochemically oxidized by anodic polarization in H2C2O4 or H3PO4 solution. PAA layers with a total porosity ranging from 11 to 30%, mean pore spacing of 90-200 nm and pore diameters of 30-110 nm were prepared. Compared to unmodified ZTA/BC interface (approximate to 30 MPa), the PAA modified specimens (ZTA/PAA/BC) achieved a significantly higher interface bonding strength (approximate to 60 MPa) measured by four point bending on composite beam specimens. While crack propagation in the unmodified ZTA/BC specimen was found to proceed along the interface, fracture analysis on the ZTA/PAA/BC specimens showed a mixed mode fracture with part of the fracture propagation localized along the PAA/BC interface and part through BC. Thus, pore structure controlled mechanical interlocking is expected to offer a high potential for applying PAA surface modification to improve biomaterial to BC bonding.
C1 [Pedimonte, J.; Travitzky, N.; Greil, P.] Dept Mat Sci Glass & Ceram, D-91058 Erlangen, Germany.
   [Korn, M.] Gen Mat Properties, Dept Mat Sci, D-91058 Erlangen, Germany.
   [Kriegelstein, S.] Univ Hosp, Clin Trauma Surg, D-91054 Erlangen, Germany.
RP Pedimonte, J (reprint author), Dept Mat Sci Glass & Ceram, Martensstr 5, D-91058 Erlangen, Germany.
EM joana.pedimonte@ww.uni-erlangen.de
RI Travitzky, Nahum/B-9094-2018
OI Travitzky, Nahum/0000-0003-2112-9375
FU Bavarian Research Foundation (BFS)
FX Financial support from Bavarian Research Foundation (BFS) is gratefully
   acknowledged. The authors are thankful to experimental support from the
   Cluster of Excellence EAM and from the Chair of Electron Devices,
   University of Erlangen.
CR Affatato S, 2006, J BIOMED MATER RES B, V78B, P76, DOI 10.1002/jbm.b.30462
   BECHER PF, 1991, J AM CERAM SOC, V74, P255, DOI 10.1111/j.1151-2916.1991.tb06872.x
   Ben Amor S, 2000, APPL SURF SCI, V153, P172, DOI 10.1016/S0169-4332(99)00354-2
   Bohner M, 2003, BIOMATERIALS, V24, P2721, DOI 10.1016/S0142-9612(03)00086-3
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2009, BIOMATERIALS, V30, P5279, DOI 10.1016/j.biomaterials.2009.06.022
   De Aza AH, 2002, BIOMATERIALS, V23, P937, DOI 10.1016/S0142-9612(01)00206-X
   ERDOGAN F, 1974, J APPL MECH-T ASME, V41, P1007, DOI 10.1115/1.3423424
   Erli H. J., 2003, BIOMED ENG ONLINE, P2
   EVANS AG, 1990, J AM CERAM SOC, V73, P187, DOI 10.1111/j.1151-2916.1990.tb06493.x
   Fischer H, 2005, BIOMATERIALS, V26, P6151, DOI 10.1016/j.biomaterials.2005.04.038
   Gao HJ, 2005, MECH MATER, V37, P275, DOI 10.1016/j.mechmat.2004.03.008
   Garino J. P., 2002, P 7 INT BIOLOX S THI
   Grohens Y, 1997, INT J ADHES ADHES, V17, P163, DOI 10.1016/S0143-7496(96)00035-8
   Heimke G, 2002, BIOMATERIALS, V23, P1539, DOI 10.1016/S0142-9612(01)00262-9
   Jessensky O, 1998, APPL PHYS LETT, V72, P1173, DOI 10.1063/1.121004
   Kaltenborn N, 2007, J AM CERAM SOC, V90, P1644, DOI 10.1111/j.1551-2916.2007.01601.x
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   Khongwar JK, 2008, MATER RES BULL, V43, P418, DOI 10.1016/j.materresbull.2007.02.039
   Klein RW, 2004, BIOMATERIALS, V25, P943, DOI 10.1016/S0142-9612(03)00578-7
   Lamblet M, 2007, LANGMUIR, V23, P6966, DOI 10.1021/la063104h
   Launey ME, 2009, ACTA MATER, V57, P2919, DOI 10.1016/j.actamat.2009.03.003
   LEWIS BF, 1974, SURF SCI, V41, P142, DOI 10.1016/0039-6028(74)90301-X
   Lewis G, 1997, J BIOMED MATER RES, V38, P155, DOI 10.1002/(SICI)1097-4636(199722)38:2<155::AID-JBM10>3.0.CO;2-C
   Lewis G, 2002, BIO-MED MATER ENG, V12, P149
   Maccauro G, 2010, INT J IMMUNOPATH PH, V23, P841, DOI 10.1177/039463201002300319
   MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466
   Nielsch K, 2002, NANO LETT, V2, P677, DOI [10.1021/nl025537k, 10.1021/n1025537k]
   PARKHUTIK VP, 1992, J PHYS D APPL PHYS, V25, P1258, DOI 10.1088/0022-3727/25/8/017
   Paul A, 2003, APPL PHYS LETT, V82, P1905, DOI 10.1063/1.1563056
   Piconi C, 2003, J Appl Biomater Biomech, V1, P19
   Rabin O, 2003, ADV FUNCT MATER, V13, P631, DOI 10.1002/adfm.200304394
   Rice R., 1968, ADV TREATISE, V2
   Sulks G.D., 2008, NANOSTRUCTURED MAT E
   Szutkowska M, 2006, J MATER PROCESS TECH, V175, P416, DOI 10.1016/j.jmatprotec.2005.04.030
   Thompson GE, 1997, THIN SOLID FILMS, V297, P192, DOI 10.1016/S0040-6090(96)09440-0
   Vallo CI, 1997, POLYM INT, V43, P260, DOI 10.1002/(SICI)1097-0126(199707)43:3<260::AID-PI771>3.0.CO;2-Q
   Vrublevsky I, 2003, APPL SURF SCI, V220, P51, DOI 10.1016/S0169/4332(03)00747-5
   Xia Z, 2004, REV ADV MATER SCI, V6, P131
   XU Y, 1985, T I MET FINISH, V63, P98
NR 41
TC 2
Z9 2
U1 1
U2 16
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1438-1656
EI 1527-2648
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD SEP
PY 2011
VL 13
IS 9
BP B306
EP B312
DI 10.1002/adem.201180004
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 824DV
UT WOS:000295183300006
DA 2018-10-20
ER

PT J
AU Schmelzeisen, R
   Gutwald, R
   Oshima, T
   Nagursky, H
   Vogeler, M
   Sauerbier, S
AF Schmelzeisen, Rainer
   Gutwald, Ralf
   Oshima, Toshiyuki
   Nagursky, Heiner
   Vogeler, Michael
   Sauerbier, Sebastian
TI Making bone II: maxillary sinus augmentation with mononuclear cells-case
   report with a new clinical method
SO BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY
LA English
DT Article
DE Biomaterials; Bone substitutes; Clinical research; Implants; Sinus floor
   elevation; Mesenchymal stem cells; Mononuclear cells; Bone marrow
   aspirate
ID TISSUE-ENGINEERED BONE
AB We report a simplified method of using bone marrow aspirate concentrate (BMAC (TM)) to regenerate hard tissue.
   The results suggest that BMACTm combined with a suitable biomaterial can form sufficient bone within 3 months for further implants to be inserted, and at the same time minimise morbidity at the donor site. (C) 2010 British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
C1 [Schmelzeisen, Rainer; Gutwald, Ralf; Oshima, Toshiyuki; Nagursky, Heiner; Vogeler, Michael; Sauerbier, Sebastian] Univ Hosp Freiburg, Dept Oral & Craniomaxillofacial Surg, D-79106 Freiburg, Germany.
RP Sauerbier, S (reprint author), Univ Hosp Freiburg, Dept Oral & Craniomaxillofacial Surg, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM sebastian.sauerbier@uniklinik-freiburg.de
OI Schmelzeisen, Rainer/0000-0002-9686-6989; nagurski,
   heiner/0000-0002-5300-7076
FU Geistlich Biomaterials, Wolhusen, Switzerland
FX The study was funded by a grant from Geistlich Biomaterials, Wolhusen,
   Switzerland. Any surplus was given to the University of Freiburg, a
   non-profit-making organisation. Technical assistance was provided by
   Harvest Technologies, Munich, Germany.
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Gutwald R, 2010, BRIT J ORAL MAX SURG, V48, P285, DOI 10.1016/j.bjoms.2009.06.226
   HEALEY JH, 1990, CLIN ORTHOP RELAT R, P280
   Sauerbier S, 2010, TISSUE ENG PART C-ME, V16, P215, DOI [10.1089/ten.tec.2009.0269, 10.1089/ten.TEC.2009.0269]
   Schmelzeisen R, 2003, J CRANIO MAXILL SURG, V31, P34, DOI 10.1016/S1010-5182
   Voss P, 2010, BRIT J ORAL MAX SURG, V48, P121, DOI 10.1016/j.bjoms.2009.04.032
   Yildirim M, 2000, CLIN ORAL IMPLAN RES, V11, P217, DOI 10.1034/j.1600-0501.2000.011003217.x
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 9
TC 13
Z9 13
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0266-4356
J9 BRIT J ORAL MAX SURG
JI Br. J. Oral Maxillofac. Surg.
PD SEP
PY 2011
VL 49
IS 6
BP 480
EP 482
DI 10.1016/j.bjoms.2010.06.020
PG 3
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 825SS
UT WOS:000295303000014
PM 20678831
DA 2018-10-20
ER

PT J
AU Mundada, AS
   Avari, JG
AF Mundada, Atish S.
   Avari, Jasmine G.
TI In Vitro and In Vivo Characterization of Novel Biomaterial for
   Transdermal Application
SO CURRENT DRUG DELIVERY
LA English
DT Review
DE Verapamil hydrochloride; matrix system; in vitro release; in vitro
   permeation; transdermal drug delivery
ID DRUG-DELIVERY SYSTEMS; CIPROFLOXACIN HYDROCHLORIDE; CONTROLLED-RELEASE;
   POLYMERS; FILMS; SKIN; PERMEABILITY; DERIVATIVES; PERMEATION; INSERT
AB Polymers have become an indispensable part in the design of a conventional as well as novel drug delivery system. Gum Copal (GC), a novel biomaterial obtained from Agathis species, is evaluated in the present study for its potential application as a matrix former in transdermal drug delivery systems. GC was initially characterized for various physicochemical properties and then mechanical characterization of the Plasticized films of GC was investigated. Verapamil hydrochloride (VH), owing to its pharmacokinetic properties, was selected as the model drug for the present work. Matrix type transdermal films of VH with GC, alone and in combination with polyvinyl pyrrolidone (PVP K-30), were developed and evaluated for various physicochemical properties. In-vitro drug release study was carried out using paddle over disk method and in-vitro skin permeation study was performed using human cadaver skin. On the basis of physicochemical properties, in-vitro drug release study and permeation performance, formulation F5 containing GC: PVP K-30 (60: 40) was selected as an optimized formulation for in vivo study. Animal studies were carried out using Dawley rats and the data obtained from the plasma drug analysis showed that peak drug concentration of about 244.94 +/- 1.25 ng/mL was achieved in 6 h after the application of the patch and plasma drug concentration was maintained till 24 h. Skin irritancy test results proved the suitability of the biomaterial for transdermal application. The drug polymer interaction studies carried out using UV, FTIR and TLC analysis indicated that drug and polymer were compatible. Due to reasonably good mechanical properties, low water vapor transmission and sustained release capability, GC seems to be a promising film former for transdermal drug delivery.
C1 [Mundada, Atish S.] SSDJ Coll Pharm, Neminagar 423101, Chandwad, India.
   [Mundada, Atish S.; Avari, Jasmine G.] RTM Nagpur Univ, Div Pharmaceut, Dept Pharmaceut Sci, Nagpur 440033, Maharashtra, India.
RP Mundada, AS (reprint author), SSDJ Coll Pharm, Neminagar 423101, Chandwad, India.
EM atishmundada@rediffmail.com
CR Alonso-Sande M, 2009, EUR J PHARM BIOPHARM, V72, P453, DOI 10.1016/j.ejpb.2008.02.005
   Aqil M, 2002, EUR J PHARM BIOPHARM, V54, P161, DOI 10.1016/S0939-6411(02)00059-0
   BERNER B, 1989, J PHARM SCI, V78, P401
   BODMEIER R, 1990, J PHARM SCI, V79, P32, DOI 10.1002/jps.2600790109
   BOWEN MR, 1980, IUFRO S WORKSH GEN I
   BOWEN MR, 1980, 2 LOOK AGATHIS, P19
   Chamarthy SP, 2008, COLLOID SURFACE A, V331, P25, DOI 10.1016/j.colsurfa.2008.05.047
   Chaurasia M., 2006, AAPS PHARMSCITECH, V7, pE1
   Chien Y.W., 1987, TRANSDERMAL CONTROLL
   Chien Y.W., 1992, NOVEL DRUG DELIVERY, P1
   CHIEN YW, 1984, DRUG DEV IND PHARM, V10, P575, DOI 10.3109/03639048409041408
   Chivate AA, 2008, AAPS PHARMSCITECH, V9, P197, DOI 10.1208/s12249-008-9039-7
   CONELLY WT, 1985, ECON BOT, V39, P39, DOI 10.1007/BF02861172
   DEVI VK, 1999, DRUG DEV IND PHARM, V25, P695
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   *GOV IND MIN HLTH, 1996, PHARM IND, V2, pA50
   Guo JH, 1998, PHARM SCI TECHNOL TO, V1, P254, DOI 10.1016/S1461-5347(98)00072-8
   Jain GK, 1996, INT J PHARM, V130, P169, DOI 10.1016/0378-5173(95)04222-9
   Jain SK, 2003, DRUG DELIV, V10, P169, DOI 10.1080/10717540390215582
   KERINS DM, 2001, GOODMAN GILMANS PHAR, P856
   Lopez CR, 1996, DRUG DEV IND PHARM, V22, P1201
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mundada AS, 2008, CURR EYE RES, V33, P469, DOI 10.1080/02713680802023104
   Mundada AS, 2006, DRUG DEV IND PHARM, V32, P443, DOI 10.1080/03639040500534101
   MUNDADA AS, 2010, ACTA PHARM SCI, V52, P31
   Mutalik S, 2004, J PHARM SCI-US, V93, P1577, DOI 10.1002/jps.20058
   Nagarsenker MS, 1999, DRUG DEV IND PHARM, V25, P95, DOI 10.1081/DDC-100102147
   Pandey Rajesh, 2004, Current Drug Delivery, V1, P195, DOI 10.2174/1567201043334669
   Paranjothy K. L. K., 1997, Indian Journal of Pharmaceutical Sciences, V59, P49
   Paranjothy KLK, 1997, INDIAN J PHARM SCI, V59, P1
   PATEL M, 1964, J PHARM SCI, V53, P286, DOI 10.1002/jps.2600530308
   RANADE VV, 2004, DRUG DELIVERY SYSTEM
   Rao PR, 2003, EUR J PHARM BIOPHARM, V56, P81, DOI 10.1016/S0939-6411(03)00038-9
   RIYANTO TW, 1980, DUTA RIMBA, V6, P23
   ROWE RC, 1984, INT J PHARM, V22, P57, DOI 10.1016/0378-5173(84)90045-0
   Sangalli ME, 2001, J CONTROL RELEASE, V73, P103, DOI 10.1016/S0168-3659(01)00291-7
   SARPOTDAR PP, 1986, J PHARM SCI, V75, P26, DOI 10.1002/jps.2600750107
   Satturwar P. M., 2003, AAPS PHARMSCITECH, V4, P1
   SETH A K, 1985, Indian Drugs, V23, P45
   Shekher A., 1996, INDIAN DRUGS, V33, P259
   Shogren R, 1997, J ENVIRON POLYM DEGR, V5, P91, DOI 10.1007/BF02763592
   SPROCKEL OL, 1990, J PHARM PHARMACOL, V42, P152, DOI 10.1111/j.2042-7158.1990.tb05375.x
   Tiwari SB, 2003, AAPS PHARMSCITECH, V4, DOI DOI 10.1208/PT040331
   Ubaidulla U., 2007, AAPS PHARMSCITECH, V8, pE1
   UTSUMI I, 1961, J PHARM SCI, V50, P592, DOI 10.1002/jps.2600500714
   Varshosaz J, 2006, DRUG DELIV, V13, P113, DOI 10.1080/10717540500313356
NR 46
TC 1
Z9 1
U1 0
U2 17
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2018
J9 CURR DRUG DELIV
JI Curr. Drug Deliv.
PD SEP
PY 2011
VL 8
IS 5
BP 517
EP 525
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 827DG
UT WOS:000295406700005
PM 21696352
DA 2018-10-20
ER

PT J
AU Lendlein, A
   Wischke, C
AF Lendlein, Andreas
   Wischke, Christian
TI How to accelerate biomaterial development? Strategies to support the
   application of novel polymer-based biomaterials in implantable devices
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Editorial Material
DE biomaterial development; degradable polymers; implant material; medical
   devices; multifunctional materials; regenerative medicine
ID SHAPE-MEMORY POLYMERS; CONTROLLED DRUG-RELEASE; HYDROLYTIC DEGRADATION;
   BIOMEDICAL APPLICATIONS; MULTIBLOCK COPOLYMERS; NETWORKS;
   POLY(EPSILON-CAPROLACTONE); SCAFFOLDS; SEGMENTS; DESIGN
C1 [Lendlein, Andreas; Wischke, Christian] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, D-14513 Teltow, Germany.
   [Lendlein, Andreas; Wischke, Christian] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies BCRT, Polymer Res Inst, D-14513 Teltow, Germany.
RP Lendlein, A (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Polymer Res Inst, Kantstr 55, D-14513 Teltow, Germany.
EM andreas.lendlein@hzg.de
RI Wischke, Christian/K-9651-2013; Lendlein, Andreas/K-9553-2013
OI Wischke, Christian/0000-0001-5531-9033; Lendlein,
   Andreas/0000-0003-4126-4670
CR Behl M, 2010, ADV MATER, V22, P3388, DOI 10.1002/adma.200904447
   Bertmer M, 2005, MACROMOLECULES, V38, P3793, DOI 10.1021/ma0501489
   Bettinger CJ, 2011, MACROMOL BIOSCI, V11, P467, DOI 10.1002/mabi.201000397
   Groth T, 2004, ANGEW CHEM INT EDIT, V43, P926, DOI 10.1002/anie.200301708
   Han XX, 2011, ACTA BIOMATER, V7, P538, DOI 10.1016/j.actbio.2010.09.005
   Hiebl B, 2009, MATER RES SOC SYMP P, V1140, P143
   Hofmann D, 2009, ADV MATER, V21, P3237, DOI 10.1002/adma.200802213
   Jung F, 2010, MRS BULL, V35, P607, DOI 10.1557/mrs2010.529
   Kelch S, 2007, BIOMACROMOLECULES, V8, P1018, DOI 10.1021/bm0610370
   Kulkarni A, 2008, EUR J PHARM BIOPHARM, V68, P46, DOI 10.1016/j.ejpb.2007.05.021
   Kummerlowe G, 2007, J AM CHEM SOC, V129, P6080, DOI 10.1021/ja071248s
   Lendlein A, 1998, MACROMOL CHEM PHYSIC, V199, P2785, DOI 10.1002/macp.1998.021991222
   Lendlein A, 1999, CHEM UNSERER ZEIT, V33, P279, DOI 10.1002/ciuz.19990330505
   Lendlein A, 2001, MACROMOL CHEM PHYSIC, V202, P2702, DOI 10.1002/1521-3935(20010901)202:13<2702::AID-MACP2702>3.0.CO;2-I
   Lendlein A, 2011, INT J ARTIF ORGANS, V34, P71, DOI 10.5301/IJAO.2011.6422
   Lendlein A, 2010, EXPERT REV MED DEVIC, V7, P357, DOI 10.1586/ERD.10.8
   Luetzow K, 2007, J BIOMECH, V40, pS80, DOI 10.1016/j.jbiomech.2007.02.022
   Neffe AT, 2009, ADV MATER, V21, P3394, DOI 10.1002/adma.200802333
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Rickert D, 2007, CLIN HEMORHEOL MICRO, V36, P301
   Scharnagl N, 2010, J MATER CHEM, V20, P8789, DOI 10.1039/c0jm00997k
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Sobhi H, 2008, J THERM ANAL CALORIM, V93, P535, DOI 10.1007/s10973-008-9086-z
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Verreck G, 2007, J SUPERCRIT FLUID, V40, P153, DOI 10.1016/j.supflu.2006.05.005
   Weigel T, 2006, EXPERT REV MED DEVIC, V3, P835, DOI 10.1586/17434440.3.6.835
   Wischke C, 2010, MACROMOL BIOSCI, V10, P1063, DOI 10.1002/mabi.201000089
   Wischke C, 2010, EUR J PHARM SCI, V41, P136, DOI 10.1016/j.ejps.2010.06.003
   Wischke C, 2008, INT J PHARMACEUT, V364, P298, DOI 10.1016/j.ijpharm.2008.04.042
NR 30
TC 16
Z9 16
U1 2
U2 25
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD SEP
PY 2011
VL 8
IS 5
BP 533
EP 537
DI 10.1586/ERD.11.39
PG 5
WC Engineering, Biomedical
SC Engineering
GA 825IH
UT WOS:000295264900002
PM 22026618
DA 2018-10-20
ER

PT J
AU Maniar, S
   Kondareddy
   Topkara, VK
AF Maniar, Sanjay
   Kondareddy
   Topkara, Veli K.
TI Left ventricular assist device-related infections: past, present and
   future
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; device-related infections; driveline; heart failure; LVAD;
   pump-pocket
ID MECHANICAL CIRCULATORY SUPPORT; HEART-FAILURE PATIENTS; EXIT-SITE
   INFECTION; AXIAL-FLOW PUMP; POSTTRANSPLANT OUTCOMES; IMPLANTATION;
   TRANSPLANTATION; MANAGEMENT; COMPLICATIONS; EXPERIENCE
AB Over the last decade, left ventricular assist device (LVAD) implantation has emerged as an alternative treatment strategy in patients with advanced heart failure irrespective of their transplant eligibility. However, success and applicability of this therapy is largely limited by high complication rates associated with these devices. Although superior outcomes have been achieved with the second-generation continuous-flow LVADs, device-related infections continue to be a prevalent complication in this patient population and contribute significantly to the financial burden of this therapy due to an increased need for hospitalizations and surgical interventions. Patient selection, device design and LVAD-induced immune system dysfunction appear to be major risk factors for the development of device-related infections. Improvements in device design and better patient selection strategies, particularly with respect to identifying individuals with genetic susceptibility to device-related infections, may further reduce this prevalent complication and improve outcomes in patients with advanced heart failure.
C1 [Maniar, Sanjay; Kondareddy; Topkara, Veli K.] Washington Univ, Sch Med, Dept Internal Med, Cardiovasc Res Ctr,Div Cardiol, St Louis, MO 63110 USA.
   [Kondareddy] Robert Packer Hosp, Dept Internal Med, Sayre, PA 18840 USA.
RP Topkara, VK (reprint author), Washington Univ, Sch Med, Dept Internal Med, Cardiovasc Res Ctr,Div Cardiol, 660 S Euclid Ave,Campus POB 8066, St Louis, MO 63110 USA.
EM vtopkara@wustl.edu
FU NIH [T32HL007081]
FX This research has been supported by research funds from the NIH
   (T32HL007081). The authors have no other relevant affiliations or
   financial involvement with any organization or entity with a financial
   interest in or financial conflict with the subject matter or materials
   discussed in the manuscript apart from those disclosed.
CR AARONSON KD, 2010, CIRCULATION, V122, P2215
   Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8
   Ankersmit HJ, 2002, J THORAC CARDIOV SUR, V123, P557, DOI 10.1067/mtc.2002.120011
   Ankersmit HJ, 1999, CIRCULATION, V100, P211
   Baradarian S, 2006, ASAIO J, V52, P354, DOI 10.1097/01.mat.0000204760
   Butler J, 2005, J CARD FAIL, V11, P510, DOI 10.1016/j.cardfail.2005.05.003
   Butler J, 2005, ANN THORAC SURG, V79, P66, DOI 10.1016/j.athoracsur.2004.06.047
   Chinn R, 2005, ASAIO J, V51, P461, DOI 10.1097/01.mat.0000170620.65279.aa
   Dang NC, 2004, ASAIO J, V50, P148
   Dang Nicholas C, 2005, J Thorac Cardiovasc Surg, V130, pe3, DOI 10.1016/j.jtcvs.2005.07.038
   Garatti A, 2007, J HEART LUNG TRANSPL, V26, P956, DOI 10.1016/j.healun.2007.06.007
   Gordon SM, 2001, ANN THORAC SURG, V72, P725, DOI 10.1016/S0003-4975(01)02888-0
   Herrmann M, 1997, CIRCULATION, V95, P814
   Holdy K, 2005, J HEART LUNG TRANSPL, V24, P1690, DOI 10.1016/j.healun.2004.11.047
   Holman WL, 2010, J THORAC CARDIOV SUR, V139, P1632, DOI 10.1016/j.jtcvs.2010.01.014
   Holman WL, 2004, J HEART LUNG TRANSPL, V23, P1359, DOI 10.1016/j.healun.2003.09.025
   Holman WL, 2003, ANN THORAC SURG, V75, pS48, DOI 10.1016/S0003-4975(03)00479-X
   Huang R, 2006, TRANSPLANT P, V38, P1496, DOI 10.1016/j.transproceed.2006.02.115
   Hutchinson OZ, 2001, PLAST RECONSTR SURG, V107, P364, DOI 10.1097/00006534-200102000-00011
   Kimball P, 2006, TRANSPLANT P, V38, P3695, DOI 10.1016/j.transproceed.2006.10.153
   Kimball PM, 2008, ANN THORAC SURG, V85, P1656, DOI 10.1016/j.athoracsur.2008.01.050
   Litzler PY, 2010, J NUCL MED, V51, P1044, DOI 10.2967/jnumed.109.070664
   Martin SI, 2010, INTERACT CARDIOV TH, V11, P20, DOI 10.1510/icvts.2009.227801
   McKellar SH, 1999, ANN THORAC SURG, V67, P554, DOI 10.1016/S0003-4975(98)01243-0
   Milano CA, 2010, J HEART LUNG TRANSPL, V29, pS52, DOI 10.1016/j.healun.2009.11.150
   Miller LW, 2007, NEW ENGL J MED, V357, P885, DOI 10.1056/NEJMoa067758
   Monkowski DH, 2007, TRANSPL INFECT DIS, V9, P114, DOI 10.1111/j.1399-3062.2006.00185.x
   Morgan JA, 2004, J THORAC CARDIOV SUR, V127, P1193, DOI 10.1016/S0022-5223(03)00801-8
   Nurozler F, 2001, ANN THORAC SURG, V71, P614, DOI 10.1016/S0003-4975(00)01444-2
   Oz MC, 2003, ANN SURG, V238, P577, DOI 10.1097/01.sla.0000090447.73384.ad
   Pae WE, 2007, J HEART LUNG TRANSPL, V26, P219, DOI 10.1016/j.healun.2006.12.007
   Pagani FD, 2009, J AM COLL CARDIOL, V54, P312, DOI 10.1016/j.jacc.2009.03.055
   Raymond AL, 2010, ASAIO J, V56, P57, DOI 10.1097/MAT.0b013e3181c879b1
   Roger V.L., 2010, NY TIMES 1026, V123, pe18, DOI DOI 10.1161/CIR.0B013E3182009701
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   Sajjadian A, 2006, PLAST RECONSTR SURG, V118, P919, DOI 10.1097/01.prs.0000232419.74219.15
   Schaffer JM, 2011, J HEART LUNG TRANSPL, V30, P164, DOI 10.1016/j.healun.2010.08.003
   Schaffer JM, 2009, ANN THORAC SURG, V88, P1889, DOI 10.1016/j.athoracsur.2009.08.011
   Schulman AR, 2007, J THORAC CARDIOV SUR, V133, P841, DOI 10.1016/j.jtcvs.2006.09.083
   Schulman AR, 2009, J HEART LUNG TRANSPL, V28, P237, DOI 10.1016/j.healun.2008.12.007
   Schuster M, 2002, HUM IMMUNOL, V63, P211, DOI 10.1016/S0198-8859(01)00380-9
   Simon D, 2005, CLIN INFECT DIS, V40, P1108, DOI 10.1086/428728
   Sinha P, 2000, CIRCULATION, V102, P194
   Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938
   Stehlik J, 2010, J HEART LUNG TRANSPL, V29, P1089, DOI 10.1016/j.healun.2010.08.007
   Tjan TDT, 2000, ANN THORAC SURG, V70, P538, DOI 10.1016/S0003-4975(00)01348-5
   Topkara VK, 2010, ANN THORAC SURG, V90, P1270, DOI 10.1016/j.athoracsur.2010.04.093
   Topkara VK, 2005, J HEART LUNG TRANSPL, V24, P2048, DOI 10.1016/j.healun.2005.06.021
   Topkara VK, 2005, J THORAC CARDIOV SUR, V130, P881, DOI 10.1016/j.jtcvs.2005.03.009
   Uriel N, 2011, EUR J HEART FAIL, V13, P195, DOI 10.1093/eurjhf/hfq204
   Williams MR, 2001, ANN THORAC SURG, V71, pS86, DOI 10.1016/S0003-4975(00)02627-8
   Zierer A, 2007, ANN THORAC SURG, V84, P515, DOI 10.1016/j.athoracsur.2007.03.085
NR 52
TC 32
Z9 32
U1 0
U2 4
PU EXPERT REVIEWS
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD SEP
PY 2011
VL 8
IS 5
BP 627
EP 634
DI 10.1586/ERD.11.36
PG 8
WC Engineering, Biomedical
SC Engineering
GA 825IH
UT WOS:000295264900017
PM 22026627
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kim, JJ
   Won, JE
   Shin, US
   Kim, HW
AF Kim, Jung-Ju
   Won, Jong-Eun
   Shin, Ueon Sang
   Kim, Hae-Won
TI Improvement of Bioactive Glass Nanofiber by a Capillary-Driven
   Infiltration Coating with Degradable Polymers
SO JOURNAL OF THE AMERICAN CERAMIC SOCIETY
LA English
DT Article
ID TISSUE; HYDROXYAPATITE; BIOMATERIAL; GENERATION
AB Herein, we developed a bioactive nanofibrous membrane by coating the bioactive glass nanofiber with degradable biopolymers, such as poly(caprolactone) and poly(lactic acid). A thin layer of the biopolymers could be covered on the glass nanofiber through a capillary-driven infiltration of the polymer solution into the small-sized nanofibrous mesh. The biopolymer-coated glass nanofiber showed significantly enhanced mechanical properties while preserving the excellent bioactivity of the glass nanofiber. The produced nanofibrous membrane may be useful as a bioactive substrate for defect-filling and cell-culturing in bone regeneration area.
C1 [Kim, Jung-Ju; Won, Jong-Eun; Shin, Ueon Sang; Kim, Hae-Won] Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
   [Kim, Jung-Ju; Won, Jong-Eun; Shin, Ueon Sang; Kim, Hae-Won] Dankook Univ, WCU Res Ctr, Cheonan, South Korea.
   [Kim, Jung-Ju; Won, Jong-Eun; Shin, Ueon Sang; Kim, Hae-Won] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea.
   [Kim, Hae-Won] Dankook Univ, Dept Biomat Sci, Coll Dent, Cheonan, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Dept Nanobiomed Sci, Cheonan, South Korea.
EM kimhw@dku.edu
FU National Research Foundation of Korea (NRF) [2009-0093829, R31-10069];
   Ministry of Education, Science and Technology
FX This work was supported by the Priority Research Centers Program (grant
   No. 2009-0093829) and WCU Program (grant No. R31-10069) through the
   National Research Foundation of Korea (NRF) funded by the Ministry of
   Education, Science and Technology.
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   JANG JH, 2009, ADV DRUG DELIV REV, V6, P1065
   Kim HW, 2006, ADV FUNCT MATER, V16, P1529, DOI 10.1002/adfm.200500750
   Kim HW, 2006, J BIOMED MATER RES B, V77B, P323, DOI 10.1002/jbm.b.30376
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Stevens MM, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70086-5
   Wu YQ, 2004, J AM CERAM SOC, V87, P1988
NR 9
TC 2
Z9 2
U1 0
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0002-7820
J9 J AM CERAM SOC
JI J. Am. Ceram. Soc.
PD SEP
PY 2011
VL 94
IS 9
BP 2812
EP 2815
DI 10.1111/j.1551-2916.2011.04735.x
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 824QB
UT WOS:000295215900024
DA 2018-10-20
ER

PT J
AU Dettin, M
   Muncan, N
   Bugatti, A
   Grezzo, F
   Danesin, R
   Rusnati, M
AF Dettin, Monica
   Muncan, Natali
   Bugatti, Antonella
   Grezzo, Francesca
   Danesin, Roberta
   Rusnati, Marco
TI Chemoselective Surface Immobilization of Proteins through a Cleavable
   Peptide
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID BIOMIMETIC TRANSAMINATION REACTION; FACTOR-I
AB Surface immobilization of biomolecules is a fundamental step in several experimental techniques such as surface plasmon resonance analysis and microarrays. Oxime ligation allows reaching chemoselective protein immobilization with the retention of native-like conformation by proteins. Beside the need for chemoselective ligation of molecules to the immobilized molecules, even after a specific binding event. surface/particle, equally important is the controlled release of For this purpose, we have designed and assessed in an SPR experiment a peptide linker able to (i) anchor a given protein (enzymes, receptors, or antibodies) to a surface in a precise orientation and (ii) release the immobilized protein after selective enzymatic cleavage. These results open up the possibility to anchor to a surface a protein probe leaving bioactive sites free for interaction with substrates, ligands, antigens, or drugs and successively remove the probe ligand complex by enzymatic cleavage. This peptide linker can be considered both an improvement of SPR analysis for macromolecular interaction and a novel strategy for drug delivery and biomaterial developments.
C1 [Dettin, Monica; Muncan, Natali; Grezzo, Francesca; Danesin, Roberta] Univ Padua, Dept Chem & Proc Engn, I-35131 Padua, Italy.
   [Bugatti, Antonella; Rusnati, Marco] Univ Brescia, Dept Biomed Sci & Biotechnol, Brescia, Italy.
RP Dettin, M (reprint author), Univ Padua, Dept Chem & Proc Engn, Via Marzolo 9, I-35131 Padua, Italy.
EM monica.dettin@unipd.it
OI RUSNATI, Marco/0000-0001-9968-5908
FU MIUR; ISS; CARIPLO [2008-2198]; University of Padova [prot.STPD089KSC]
FX This work was supported by grants from MIUR, ISS (AIDS Project), and
   CARIPLO (grant 2008-2198) to M.R. The authors gratefully acknowledge
   support from the University of Padova through the PLATFORMS strategic
   project "PLAsmonic nano-Textured materials and architectures FOR
   enhanced Molecular Sensing" -prot.STPD089KSC.
CR Carrico IS, 2007, NAT CHEM BIOL, V3, P321, DOI 10.1038/nchembio878
   Chalker JM, 2010, CURR OPIN CHEM BIOL, V14, P781, DOI 10.1016/j.cbpa.2010.10.007
   Day JJ, 2010, CURR OPIN CHEM BIOL, V14, P803, DOI 10.1016/j.cbpa.2010.09.015
   Gilmore JM, 2006, ANGEW CHEM INT EDIT, V45, P5307, DOI 10.1002/anie.200600368
   Gullotti E, 2009, MOL PHARMACEUT, V6, P1041, DOI 10.1021/mp900090z
   Jason-Moller L., 2006, CURR PROTOC PROTEIN, DOI DOI 10.1002/0471140864
   Johnson JA, 2010, CURR OPIN CHEM BIOL, V14, P774, DOI 10.1016/j.cbpa.2010.09.013
   Kausaite-Minkstimiene A, 2010, ANAL CHEM, V82, P6401, DOI 10.1021/ac100468k
   Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015
   Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011
   Lempens EHM, 2009, CHEMBIOCHEM, V10, P658, DOI 10.1002/cbic.200900028
   McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200
   Ogi H, 2009, BIOSENS BIOELECTRON, V24, P3148, DOI 10.1016/j.bios.2009.03.035
   Rabuka D, 2010, CURR OPIN CHEM BIOL, V14, P790, DOI 10.1016/j.cbpa.2010.09.020
   Rich RL, 2010, J MOL RECOGNIT, V23, P1, DOI 10.1002/jmr.1004
   Scheck RA, 2008, J AM CHEM SOC, V130, P11762, DOI 10.1021/ja802495w
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Sharma PS, 2009, CURR PHARM DESIGN, V15, P758, DOI 10.2174/138161209787582219
   Spisak S, 2009, CURR MED CHEM, V16, P2806, DOI 10.2174/092986709788803141
   Wang M, 2010, PHARMACOL RES, V62, P90, DOI 10.1016/j.phrs.2010.03.005
NR 20
TC 16
Z9 16
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD SEP
PY 2011
VL 22
IS 9
BP 1753
EP 1757
DI 10.1021/bc200254u
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 822OW
UT WOS:000295059000002
PM 21819154
DA 2018-10-20
ER

PT J
AU Li, CY
   Yuan, W
   Jiang, H
   Li, JS
   Xu, FJ
   Yang, WT
   Ma, J
AF Li, C. Y.
   Yuan, W.
   Jiang, H.
   Li, J. S.
   Xu, F. J.
   Yang, W. T.
   Ma, J.
TI PCL Film Surfaces Conjugated with P(DMAEMA)/Gelatin Complexes for
   Improving Cell Immobilization and Gene Transfection
SO BIOCONJUGATE CHEMISTRY
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; CYTOCOMPATIBILITY; BRUSHES
AB Successful gene transfection on a tissue scaffold is of crucial importance in facilitating tissue repair and regeneration by enabling the localized production of therapeutic drugs. Polycaprolactone (PCL) has been widely adopted as a scaffold biomaterial, but its unfavorable cell-adhesion property needs to be improved. In this work, the PCL film surface was conjugated with poly((2-dimethyl amino)ethyl methacrylate) (P(DMAEMA))/gelatin complexes via surface-initiated atom transfer radical polymerization (ATRP) for improving cell immobilization and subsequent gene transfection. A simple aminolysis-based method was first used for the covalent immobilization of ATRP initiators on the PCL film. Well-defined P(DMAEMA) brushes were subsequently prepared via surface-initiated ATRP from the initiator-functionalized PCL surfaces. The P(DMAEMA) chains with a pK(a) of 7.0-7.3 were used for conjugating gelatin with a pI of 4.7 via electrostatic interaction. The amount of complexed gelatin increased as that of the grafted P(DMAEMA) layer. The cell-adhesion property on the functionalized PCL surface could be controlled by adjusting the ratio of P(DMAEMA)/gelatin. It was found that the gene transfection property on the immobilized cells was dependent on the density of the immobilized cells on the functionalized PCL film. With the good cell-adhesive nature of gelatin and the efficient gene transfection on the dense immobilized cells, the incorporating the suitable of P(DMAEMA)/gelatin complexes onto PCL surfaces could endow the PCL substrates new and interesting properties for potential tissue engineering applications.
C1 [Li, C. Y.; Jiang, H.; Xu, F. J.; Yang, W. T.] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Key Lab Carbon Fiber & Funct Polymers, Minist Educ,Coll Mat Sci & Engn, Beijing 100029, Peoples R China.
   [Yuan, W.; Ma, J.] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China.
   [Li, J. S.] Sichuan Univ, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
RP Xu, FJ (reprint author), Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Key Lab Carbon Fiber & Funct Polymers, Minist Educ,Coll Mat Sci & Engn, Beijing 100029, Peoples R China.
EM xufj@mail.buct.edu.cn; majie2004@yahoo.com.cn
RI Xu, Fu-Jian/U-8024-2017
OI Li, Jianshu/0000-0002-1522-7326
FU National Natural Science Foundation of China [50903007, 21074007]; Fok
   Ying Tung Education Foundation [121048]; Program for New Century
   Excellent Talents in University [NCET-10-0203]; National Novel Drug
   Development Foundation of China [2009ZX09303-008]; National Basic
   Research Program of China [2011CB911004]; Beijing Natural Science
   Foundation of China [7092086]
FX This work was supported in part by National Natural Science Foundation
   of China (grant numbers 50903007 and 21074007), Fok Ying Tung Education
   Foundation (Project no. 121048), Program for New Century Excellent
   Talents in University (NCET-10-0203), National Novel Drug Development
   Foundation of China (Grant no. 2009ZX09303-008), National Basic Research
   Program of China (Grant no. 2011CB911004), and Beijing Natural Science
   Foundation of China (Grant no. 7092086).
CR Blocker KM, 2011, LANGMUIR, V27, P2739, DOI 10.1021/la104313z
   Bratt-Leal AM, 2011, BIOMATERIALS, V32, P48, DOI 10.1016/j.biomaterials.2010.08.113
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Fu L, 2008, LANGMUIR, V24, P6100, DOI 10.1021/la703661z
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   Jiang T, 2010, BIOMACROMOLECULES, V11, P1254, DOI 10.1021/bm100050d
   KWEON HY, 2003, BIOMATERIALS, V801, P808
   Liu SY, 2001, J AM CHEM SOC, V123, P9910, DOI 10.1021/ja011206i
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Moulder J. F., 1992, XRAY PHOTOELECTRON S
   Oyane A, 2005, BIOMATERIALS, V26, P2407, DOI 10.1016/j.biomaterials.2004.07.048
   Teramura Y, 2008, BIOCONJUGATE CHEM, V19, P1389, DOI 10.1021/bc800064t
   Wang ZH, 2011, MACROMOLECULES, V44, P230, DOI 10.1021/ma102419e
   Xu FJ, 2011, MACROMOLECULES, V44, P2371, DOI 10.1021/ma200160h
   Xu FJ, 2010, BIOMATERIALS, V31, P3139, DOI 10.1016/j.biomaterials.2010.01.032
   Xu FJ, 2009, PROG POLYM SCI, V34, P719, DOI 10.1016/j.progpolymsci.2009.04.005
   Xu FJ, 2006, BIOMATERIALS, V27, P2787, DOI 10.1016/j.biomaterials.2006.01.003
   Xu FJ, 2005, BIOMACROMOLECULES, V6, P1759, DOI 10.1021/bm050071w
   Yin YJ, 2005, J MATER SCI, V40, P4649, DOI 10.1007/s10853-005-3929-9
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 24
TC 37
Z9 37
U1 0
U2 59
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1043-1802
J9 BIOCONJUGATE CHEM
JI Bioconjugate Chem.
PD SEP
PY 2011
VL 22
IS 9
BP 1842
EP 1851
DI 10.1021/bc200241m
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Multidisciplinary; Chemistry, Organic
SC Biochemistry & Molecular Biology; Chemistry
GA 822OW
UT WOS:000295059000013
PM 21848338
DA 2018-10-20
ER

PT J
AU Khoda, AKM
   Ozbolat, IT
   Koc, B
AF Khoda, A. K. M.
   Ozbolat, Ibrahim T.
   Koc, Bahattin
TI A functionally gradient variational porosity architecture for hollowed
   scaffolds fabrication
SO BIOFABRICATION
LA English
DT Article
ID TISSUE ENGINEERING SCAFFOLDS; FREE-FORM FABRICATION; SILK FIBROIN;
   DESIGN; BIOMATERIALS; MODELS
AB This paper presents a novel continuous tool-path planning methodology for hollowed scaffold fabrication in tissue engineering. A new functionally gradient porous architecture is proposed with a continuous material deposition planning scheme. A controllable variational pore size and hence the porosity have been achieved with a combination of two geometrically oriented consecutive layers. The desired porosity has been achieved with consecutive layers by geometrically partitioning each layer into sub-regions based on the area and the tissue scaffold design constraints. A continuous, interconnected and optimized tool-path for layers has been generated for a three-dimensional biomaterial deposition/printing process. A zigzag pattern tool-path has been proposed for an accumulated sub-region layer, and a concentric spiral-like optimal tool-path pattern has been generated for the successive layer to ensure continuity along the structure. Three-dimensional layers, formed by the proposed tool-path plan, vary the pore size and the porosity based on the biological and mechanical requirements. Several examples demonstrate the proposed methodology along with illustrative results. Also a comparative study between the proposed design and conventional Cartesian coordinate scaffolds has been performed. The results demonstrate a significant reduction in design error with the proposed method. Moreover, sample examples have been fabricated using a micro-nozzle biomaterial deposition system, and characterized for validation.
C1 [Khoda, A. K. M.] SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
   [Ozbolat, Ibrahim T.] Univ Iowa, Dept Mech & Ind Engn, Ctr Comp Aided Design, Iowa City, IA 52242 USA.
   [Koc, Bahattin] Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey.
RP Khoda, AKM (reprint author), SUNY Buffalo, Dept Ind Engn, Buffalo, NY 14260 USA.
EM bahattinkoc@sabanciuniv.edu
RI Koc, Bahattin/D-7277-2012
OI Koc, Bahattin/0000-0001-9073-8516
CR Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   GOMEZ C, 2007, THESIS DREXEL U
   Hollister SJ, 2007, COMPUT METHOD APPL M, V196, P2991, DOI 10.1016/j.cma.2006.09.023
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   *ITK SNAP, 2008, ITK SNAP VERS 1 6
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   KARANDE TS, 2007, BIOMEDICAL ENG
   Khoda AKMB, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4002933
   Koc B, 2002, J MANUF SYST, V21, P153, DOI 10.1016/S0278-6125(02)80159-5
   LEE JJ, 2007, CURR APPL PHYS, V7, pE37
   Li MZ, 2001, J APPL POLYM SCI, V79, P2192, DOI 10.1002/1097-4628(20010321)79:12<2192::AID-APP1027>3.0.CO;2-0
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Lv Q, 2006, J MATER SCI-MATER M, V17, P1349, DOI 10.1007/s10856-006-0610-z
   MADDEN LR, 2010, PROANGIOGENIC SCAFFO, P15211
   *MAT, 2008, MIM
   Metcalfe AD, 2005, BIOCHEM SOC T, V33, P413, DOI 10.1042/BST0330413
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ozbolat IT, 2011, COMPUT AIDED DESIGN, V43, P863, DOI 10.1016/j.cad.2011.04.002
   PAPENBURG B, 2009, THESIS U TWENTE NETH, P208
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Rajagopalan S, 2006, LECT NOTES COMPUT SC, V4191, P544
   Samanta K, 2005, COMPUT AIDED DESIGN, V37, P287, DOI 10.1016/j.cad.2004.03.005
   Sobral JM, 2011, ACTA BIOMATER, V7, P1009, DOI 10.1016/j.actbio.2010.11.003
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zhang JC, 2005, POLYMER, V46, P4979, DOI 10.1016/j.polymer.20058.02.120
NR 32
TC 15
Z9 15
U1 3
U2 30
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
J9 BIOFABRICATION
JI Biofabrication
PD SEP
PY 2011
VL 3
IS 3
SI SI
AR 034106
DI 10.1088/1758-5082/3/3/034106
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 821DO
UT WOS:000294955200008
PM 21725150
DA 2018-10-20
ER

PT J
AU Shim, JH
   Kim, JY
   Park, M
   Park, J
   Cho, DW
AF Shim, Jin-Hyung
   Kim, Jong Young
   Park, Min
   Park, Jaesung
   Cho, Dong-Woo
TI Development of a hybrid scaffold with synthetic biomaterials and
   hydrogel using solid freeform fabrication technology
SO BIOFABRICATION
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; CONTROLLED-PORE STRUCTURES; HEAD
   DEPOSITION SYSTEM; MESENCHYMAL STEM-CELLS; DRUG-DELIVERY; GROWTH-FACTOR;
   PLGA; BIOCOMPATIBILITY; PROLIFERATION; ENCAPSULATION
AB Natural biomaterials such as hyaluronic acid, gelatin and collagen provide excellent environments for tissue regeneration. Furthermore, gel-state natural biomaterials are advantageous for encapsulating cells and growth factors. In cell printing technology, hydrogel which contains cells was printed directly to form three-dimensional (3D) structures for tissue or organ regeneration using various types of printers. However, maintaining the 3D shape of the printed structure, which is made only of the hydrogel, is very difficult due to its weak mechanical properties. In this study, we developed a hybrid scaffold consisting of synthetic biomaterials and natural hydrogel using a multi-head deposition system, which is useful in solid freeform fabrication technology. The hydrogel was intentionally infused into the space between the lines of a synthetic biomaterial-based scaffold. The cellular efficacy of the hybrid scaffold was validated using rat primary hepatocytes and a mouse pre-osteoblast MC3T3-E1 cell line. In addition, the collagen hydrogel, which encapsulates cells, was dispensed and the viability of the cells observed. We demonstrated superior effects of the hybrid scaffold on cell adhesion and proliferation and showed the high viability of dispensed cells.
C1 [Kim, Jong Young] Andong Natl Univ, Dept Mech Engn, Angong, South Korea.
EM dwcho@postech.ac.kr
FU National Research Foundation of Korea (NRF); Korea government (MEST)
   [2010-0018294]; World Class University through the National Research
   Foundation of Korea; Ministry of Education, Science and Technology
   [R31-2008-000-10105-0]
FX Thisworkwas supported by the National Research Foundation of Korea (NRF)
   grant funded by the Korea government (MEST) (no 2010-0018294). This
   researchwas also supported by the World Class University program through
   the National Research Foundation of Korea funded by the Ministry of
   Education, Science and Technology (R31-2008-000-10105-0).
CR Ahn G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002429
   Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Chastain SR, 2006, J BIOMED MATER RES A, V78A, P73, DOI 10.1002/jbm.a.30686
   Cho KJ, 2009, INT J PRECIS ENG MAN, V10, P171, DOI 10.1007/s12541-009-0064-6
   Choi JW, 2011, J MATER PROCESS TECH, V211, P318, DOI 10.1016/j.jmatprotec.2010.10.003
   Choi SW, 2009, ADV MATER, V21, P2997, DOI 10.1002/adma.200803504
   Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Elisseeff J, 2008, NAT MATER, V7, P271, DOI 10.1038/nmat2147
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Hayashi C, 2009, J CELL PHYSIOL, V220, P1, DOI 10.1002/jcp.21760
   He XM, 2010, TISSUE ENG PART C-ME, V16, P329, DOI [10.1089/ten.tec.2008.0703, 10.1089/ten.TEC.2008.0703]
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x
   KANG SW, 2011, BONE, V48, P278
   Kawazoe N, 2010, BIOTECHNOL PROGR, V26, P819, DOI 10.1002/btpr.375
   Kim JY, 2010, TISSUE ENG PT A, V16, P2229, DOI [10.1089/ten.tea.2009.0644, 10.1089/ten.TEA.2009.0644]
   Kim JY, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/5/055027
   Kim JY, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015002
   Kim JY, 2009, MICROELECTRON ENG, V86, P1447, DOI 10.1016/j.mee.2008.11.026
   Kim J, 2007, BIOMATERIALS, V28, P1830, DOI 10.1016/j.biomaterials.2006.11.050
   Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619
   Lee JW, 2010, J MATER SCI-MATER M, V21, P3195, DOI 10.1007/s10856-010-4173-7
   Lee JW, 2011, BIOMATERIALS, V32, P744, DOI 10.1016/j.biomaterials.2010.09.035
   Lee KW, 2007, BIOMACROMOLECULES, V8, P1077, DOI 10.1021/bm060834v
   Lee KW, 2006, TISSUE ENG, V12, P2801, DOI 10.1089/ten.2006.12.2801
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   Mehlhorn AT, 2009, TISSUE ENG PT A, V15, P1159, DOI 10.1089/ten.tea.2008.0069
   Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822
   Nguyen TH, 2010, J MATER SCI-MATER M, V21, P1969, DOI 10.1007/s10856-010-4048-y
   Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332
   Parsa S, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/025003
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Portney NG, 2006, ANAL BIOANAL CHEM, V384, P620, DOI 10.1007/s00216-005-0247-7
   Reichert JC, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065001
   Shim JH, 2010, J BIOMAT SCI-POLYM E, V21, P1069, DOI 10.1163/092050609X12457428919034
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Wang HN, 2007, BIOMATERIALS, V28, P3338, DOI 10.1016/j.biomaterials.2007.04.014
   Warnke PH, 2010, J BIOMED MATER RES B, V93B, P212, DOI 10.1002/jbm.b.31577
   Wen YA, 2009, TOXICOL IN VITRO, V23, P744, DOI 10.1016/j.tiv.2009.02.009
   Wu DQ, 2008, LANGMUIR, V24, P10306, DOI 10.1021/la8006876
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
NR 44
TC 99
Z9 100
U1 5
U2 115
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
EI 1758-5090
J9 BIOFABRICATION
JI Biofabrication
PD SEP
PY 2011
VL 3
IS 3
SI SI
AR 034102
DI 10.1088/1758-5082/3/3/034102
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 821DO
UT WOS:000294955200004
PM 21725147
DA 2018-10-20
ER

PT J
AU Rocha, PM
   Santo, VE
   Gomes, ME
   Reis, RL
   Mano, JF
AF Rocha, Pedro M.
   Santo, Vitor E.
   Gomes, Manuela E.
   Reis, Rui L.
   Mano, Joao F.
TI Encapsulation of adipose-derived stem cells and transforming growth
   factor-beta 1 in carrageenan-based hydrogels for cartilage tissue
   engineering
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE Carrageenan; adipose derived stem cells; hydrogel; cartilage tissue
   engineering; Transforming Growth Factor; Controlled release
ID HUMAN ARTICULAR CHONDROCYTES; STROMAL CELLS; IN-VITRO; BIODEGRADABLE
   HYDROGELS; REGENERATIVE MEDICINE; CONTROLLED-RELEASE; DIFFERENTIATION;
   DELIVERY; SCAFFOLDS; SYSTEM
AB Tissue engineering (TE) is an emerging field for the regeneration of damaged tissues. The combination of hydrogels with stem cells and growth factors (GFs) has become a promising approach to promote cartilage regeneration. In this study, carrageenan-based hydrogels were used to encapsulate both cells and transforming growth factor-beta 1 (TGF-beta 1). The ATDC5 cell line was encapsulated to determine the cytotoxicity and the influence of polymer concentration on cell viability and proliferation. Human adipose-derived stem cells (hASCs) were encapsulated with TGF-beta 1 in the hydrogel networks to enhance the chondrogenic differentiation of hASCs. Specific cartilage extracellular matrix molecules expression by hASCs were observed after 14 days of cultures of the constructs under different conditions. The kappa-carrageenan was found to be a suitable biomaterial for cell and GF encapsulation. The incorporation of TGF-beta 1 within the carrageenan-based hydrogel enhanced the cartilage differentiation of hASCs. These findings indicate that this new system for cartilage TE is very promising for injectable thermoresponsive formulation applications.
C1 [Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI E. Santo, Vitor/B-3345-2013; Group, 3Bs/E-4374-2012; Espirito Santo,
   Vitor/K-7668-2015; Reis, Rui L./A-8938-2008; Mano, Joao/A-4418-2009;
   Gomes, Manuela/B-6282-2009
OI Group, 3Bs/0000-0002-5195-3456; Espirito Santo,
   Vitor/0000-0002-0854-0197; Reis, Rui L./0000-0002-4295-6129; Mano,
   Joao/0000-0002-2342-3765; Gomes, Manuela/0000-0002-2036-6291
FU European NoE EXPERTISSUES [NMP3-CT-2004-500283]; European FP7 Project
   Find and Bind [NMP4-SL-2009-229292]; Portuguese Foundation for Science
   and Technology (FCT) [PTDC/FIS/68517/2006, PTDC/QUI/69263/2006,
   BD/39486/2007]
FX This study was supported by the European NoE EXPERTISSUES
   (NMP3-CT-2004-500283), European FP7 Project Find and Bind
   (NMP4-SL-2009-229292), and by the Portuguese Foundation for Science and
   Technology (FCT) through the projects PTDC/FIS/68517/2006,
   PTDC/QUI/69263/2006, and through V. E. Santo's PhD grant
   (BD/39486/2007). They are also grateful to Hospital da Prelada for the
   lipoaspirates donations, especially to Doctor Paulo Costa.
CR Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Betre H, 2006, BIOMATERIALS, V27, P91, DOI 10.1016/j.biomaterials.2005.05.071
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Chaubey A, 2008, J BIOACT COMPAT POL, V23, P20, DOI 10.1177/0883911507085534
   Chiang HS, 2009, J FORMOS MED ASSOC, V108, P87, DOI 10.1016/S0929-6646(09)60039-5
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   DeFail AJ, 2006, BIOMATERIALS, V27, P1579, DOI 10.1016/j.biomaterials.2005.08.013
   DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306
   Elisseeff J, 2001, J ORTHOPAED RES, V19, P1098, DOI 10.1016/S0736-0266(01)00054-7
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Gomes ME, 2004, MACROMOL BIOSCI, V4, P737, DOI 10.1002/mabi.200400094
   Haider M, 2008, PHARM RES, V25, P692, DOI 10.1007/s11095-007-9282-8
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   Hardingham T., 2002, ARTHRITIS RES S3, V3z, P63
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Holland TA, 2003, J CONTROL RELEASE, V86, P1, DOI 10.1016/S0168-3659(02)00373-5
   Huang JI, 2004, PLAST RECONSTR SURG, V113, P585, DOI 10.1097/01.PRS.0000101063.27008.E1
   Hubbell J. A., 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036
   Jin R, 2009, BIOMATERIALS, V30, P2544, DOI 10.1016/j.biomaterials.2009.01.020
   Khademhosseini A, 2009, SCI AM, V300, P64, DOI 10.1038/scientificamerican0509-64
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LEV R, 1964, J HISTOCHEM CYTOCHEM, V12, P309, DOI 10.1177/12.4.309
   Li HD, 2009, J BIOACT COMPAT POL, V24, P83, DOI 10.1177/0883911508100655
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Marijnissen WJCM, 2000, BIOMATERIALS, V21, P571, DOI 10.1016/S0142-9612(99)00218-5
   Martin I, 2007, J BIOMECH, V40, P750, DOI 10.1016/j.jbiomech.2006.03.008
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Pereira RC, 2009, J TISSUE ENG REGEN M, V3, P97, DOI 10.1002/term.145
   Rada T, 2009, J TISSUE ENG REGEN M, V3, P158, DOI 10.1002/term.141
   Ren YJ, 2009, J BIOACT COMPAT POL, V24, P56, DOI 10.1177/0883911508099472
   Ringe J, 2002, NATURWISSENSCHAFTEN, V89, P338, DOI 10.1007/s00114-002-0344-9
   Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Santo VE, 2009, BIOMACROMOLECULES, V10, P1392, DOI 10.1021/bm8014973
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Wolf F, 2008, EUR CELLS MATER, V16, P92, DOI 10.22203/eCM.v016a10
   Xu MG, 2009, J BIOACT COMPAT POL, V24, P31, DOI 10.1177/0883911509102794
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 50
TC 36
Z9 37
U1 0
U2 26
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD SEP
PY 2011
VL 26
IS 5
BP 493
EP 507
DI 10.1177/0883911511420700
PG 15
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 819HN
UT WOS:000294816100005
DA 2018-10-20
ER

PT J
AU Opell, BD
   Karinshak, SE
   Sigler, MA
AF Opell, Brent D.
   Karinshak, Shannon E.
   Sigler, Mary A.
TI Humidity affects the extensibility of an orb-weaving spider's viscous
   thread droplets
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE Araneoidea; biomaterial; glycoprotein; hygroscopic; Larinioides cornutus
ID AMPULLATE SILK FIBERS; CAPTURE THREADS; MECHANICAL-PROPERTIES; SPUN;
   WEB; ADHESION; WATER
AB The prey-capture threads found in most spider orb webs rely on viscous droplets for their stickiness. Each droplet is formed of a central mass of viscoelastic glycoprotein glue surrounded by an aqueous covering, both of which incorporate hydrophilic components. We found that the extensibility of droplets on Larinioides cornutus threads increased as humidity increased. However, the deflection of the droplets' supporting axial lines did not change, indicating that atmospheric water uptake increases glycoprotein plasticity, but not glycoprotein adhesion. The extensibility of droplets, along with that of the thread's supporting axial fibers, is responsible for summing the adhesion of multiple thread droplets. Therefore, daily changes in humidity have the potential to significantly alter the performance of viscous threads and orb webs.
C1 [Opell, Brent D.; Karinshak, Shannon E.; Sigler, Mary A.] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
RP Opell, BD (reprint author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.
EM bopell@vt.edu
OI Speight, Shannon/0000-0002-2079-0973
CR Agnarsson I, 2009, J ZOOL, V278, P134, DOI 10.1111/j.1469-7998.2009.00558.x
   Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2006, ETHOLOGY, V112, P1194, DOI 10.1111/j.1439-0310.2006.01277.x
   Blackledge TA, 2006, J EXP BIOL, V209, P3131, DOI 10.1242/jeb.02327
   BONTHRONE KM, 1992, P ROY SOC B-BIOL SCI, V248, P141, DOI 10.1098/rspb.1992.0054
   Chacon P., 1980, Bulletin of the British Arachnological Society, V5, P29
   Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w
   CODDINGTON JA, 1989, J ARACHNOL, V17, P71
   EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055
   Gosline J. M., 1994, SILK POLYM MAT SCI B, P328
   Guinea GV, 2010, BIOMACROMOLECULES, V11, P1174, DOI 10.1021/bm901285c
   Opell BD, 2010, J EXP BIOL, V213, P339, DOI 10.1242/jeb.036947
   Opell BD, 2008, J EXP BIOL, V211, P2243, DOI 10.1242/jeb.016147
   Opell BD, 2007, J EXP BIOL, V210, P2352, DOI 10.1242/jeb.004952
   Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682
   Opell BD, 2011, J EXP BIOL, V214, P2237, DOI 10.1242/jeb.055707
   Opell BD, 2009, J EXP BIOL, V212, P3026, DOI 10.1242/jeb.030064
   Peters H. M., 1986, ECOPHYSIOLOGY SPIDER, P187
   PETERS HM, 1995, NATURWISSENSCHAFTEN, V82, P380, DOI 10.1007/BF01134566
   Platnick NI, 2011, WORLD SPIDER CATALOG, DOI [10.5531/db.iz.0001, DOI 10.5531/DB.IZ.0001]
   Sahni V, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1019
   Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225
   SENSENIG A, 2010, J EVOLUTION BIOL, V23, P1807
   Swanson BO, 2007, J EXP ZOOL PART A, V307A, P654, DOI 10.1002/jez.420
   TILLINGHAST EK, 1993, MATER RES SOC SYMP P, V292, P9
   TOWNLEY MA, 1991, J EXP ZOOL, V259, P154, DOI 10.1002/jez.1402590203
   VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0
   VOLLRATH F, 1991, NATURWISSENSCHAFTEN, V78, P557, DOI 10.1007/BF01134447
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0
   WORK RW, 1982, TEXT RES J, V52, P349, DOI 10.1177/004051758205200508
   WORK RW, 1981, J ARACHNOL, V9, P299
NR 32
TC 27
Z9 27
U1 1
U2 21
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
J9 J EXP BIOL
JI J. Exp. Biol.
PD SEP
PY 2011
VL 214
IS 17
BP 2988
EP 2993
DI 10.1242/jeb.055996
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 805NW
UT WOS:000293736200026
PM 21832141
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Tchemtchoua, VT
   Atanasova, G
   Aqil, A
   Filee, P
   Garbacki, N
   Vanhooteghem, O
   Deroanne, C
   Noel, A
   Jerome, C
   Nusgens, B
   Poumay, Y
   Colige, A
AF Tchemtchoua, Victor T.
   Atanasova, Ganka
   Aqil, Abdel
   Filee, Patrice
   Garbacki, Nancy
   Vanhooteghem, Olivier
   Deroanne, Chnstophe
   Noel, Agnes
   Jerome, Christine
   Nusgens, Betty
   Poumay, Yves
   Colige, Alain
TI Development of a Chitosan Nanofibrillar Scaffold for Skin Repair and
   Regeneration
SO BIOMACROMOLECULES
LA English
DT Article
ID EXTRACELLULAR-MATRIX; IN-VITRO; HUMAN KERATINOCYTES; GROWTH-FACTORS;
   WOUND REPAIR; TISSUE; BIOCOMPATIBILITY; FIBROBLASTS; MEMBRANE;
   PROLIFERATION
AB The final goal of the present study was the development of a 3-D chitosan dressing that would shorten the healing time of skin wounds by stimulating migration, invasion, and proliferation of the relevant cutaneous resident cells. Three-dimensional chitosan nanofibrillar scaffolds produced by electrospinning were compared with evaporated films and freeze-dried sponges for their, biological properties. The nanofibrillar, structure strongly improved cell adhesion and proliferation in vitro. When implanted in mice, the nanofibrillar scaffold was colonized mesenchymal cells and blood vessels. Accumulation of collagen fibrils was also observed. In contrast, sponges induced a foreign body granuloma. When used as a dressing covering full thickness skin wounds in mice, chitosan nanofibrils induced a faster regeneration of both the epidermis and dermis compartments. Altogether our data illustrate the critical importance of the nanofibrillar structure of chitosan devices for their full biocompatibility and demonstrate the significant beneficial effect of chitosan as a wound healing biomaterial
C1 [Tchemtchoua, Victor T.; Garbacki, Nancy; Deroanne, Chnstophe; Nusgens, Betty; Colige, Alain] Univ Liege, GIGA R, Lab Connect Tissues Biol, B-4000 Cointe Ougree, Belgium.
   [Noel, Agnes] Univ Liege, GIGA R, Lab Tumor & Dev Biol, B-4000 Cointe Ougree, Belgium.
   [Atanasova, Ganka; Poumay, Yves] Fac Univ Notre Dame Paix, Lab Cells & Tissues, B-5000 Namur, Belgium.
   [Aqil, Abdel; Jerome, Christine] Univ Liege, Ctr Educ & Res Macromol, B-4000 Cointe Ougree, Belgium.
   [Filee, Patrice] Univ Liege, Ctr Prot Engn, B-4000 Cointe Ougree, Belgium.
   [Vanhooteghem, Olivier] St Elizabeth Hosp, B-5000 Namur, Belgium.
RP Colige, A (reprint author), Univ Liege, GIGA R, Lab Connect Tissues Biol, 3 Ave Hop, B-4000 Cointe Ougree, Belgium.
EM acolige@ulg.ac.be
RI Poumay, Yves/G-4525-2016
OI Poumay, Yves/0000-0001-5200-3367; Noel, Agnes/0000-0002-7670-6179
FU Region wallonne [516025, 616262]
FX We thank the Region wallonne (DG06) for its support (GoCell project,
   grant nos. 516025 and 616262). The antichitosan antibody is a generous
   gift of Daniel Hartmann, Laboratoire des Biomateriaux et Remodelages
   Matriciels, EA 3090, Lyon, France.
CR Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210
   Cao H., 2009, J BIOMED MATER RES A, V93A, P1151
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chern PL, 2009, DERMATOL SURG, V35, P891, DOI 10.1111/j.1524-4725.2009.01153.x
   Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Davidson J M, 1998, J Hand Ther, V11, P80
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701
   Falanga V J, 2000, Adv Skin Wound Care, V13, P15
   Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Ignatova M, 2009, MACROMOL BIOSCI, V9, P102, DOI 10.1002/mabi.200800189
   Khan TA, 2003, J PHARM PHARM SCI, V6, P20
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Machado P, 2002, EUR J DERMATOL, V12, P449
   Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Minner F, 2010, METHODS MOL BIOL, V585, P71, DOI 10.1007/978-1-60761-380-0_6
   Neamnark A, 2008, EUR POLYM J, V44, P2060, DOI 10.1016/j.eurpolymj.2008.04.016
   Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4
   Pochanavanich P, 2002, LETT APPL MICROBIOL, V35, P17, DOI 10.1046/j.1472-765X.2002.01118.x
   Rippon M, 2008, J Wound Care, V17, P224
   Saino E, 2011, BIOMACROMOLECULES, V12, P1900, DOI 10.1021/bm200248h
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Schwartz MA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005066
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Shim IK, 2009, J BIOMED MATER RES A, V90A, P595, DOI 10.1002/jbm.a.32109
   Sorlier P, 2003, J BIOMED MATER RES A, V67A, P766, DOI 10.1002/jbm.a.10132
   Tchemtchoua VT, 2009, ANAL BIOCHEM, V393, P145, DOI 10.1016/j.ab.2009.06.013
   Theoret CL, 2005, VET CLIN N AM-EQUINE, V21, P1, DOI 10.1016/j.cveq.2004.11.001
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Vogt JC, 2008, J MATER SCI-MATER M, V19, P2629, DOI 10.1007/s10856-007-3353-6
   Widgerow AD, 2011, WOUND REPAIR REGEN, V19, P117, DOI 10.1111/j.1524-475X.2010.00662.x
   YANG Y, 2011, WILEY INTERDISCIP RE, V2, P478
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Zhong SP, 2010, WIRES NANOMED NANOBI, V2, P510, DOI 10.1002/wnan.100
   Zhou YS, 2008, BIOMACROMOLECULES, V9, P349, DOI 10.1021/bm7009015
NR 49
TC 82
Z9 87
U1 5
U2 64
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2011
VL 12
IS 9
BP 3194
EP 3204
DI 10.1021/bm200680q
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 817TH
UT WOS:000294699000011
PM 21761871
DA 2018-10-20
ER

PT J
AU Ghaffar, A
   Draaisma, GJJ
   Mihov, G
   Dias, AA
   Schoenmakers, PJ
   van der Wal, S
AF Ghaffar, A.
   Draaisma, G. J. J.
   Mihov, G.
   Dias, A. A.
   Schoenmakers, P. J.
   van der Wal, Sj
TI Monitoring the in Vitro Enzyme-Mediated Degradation of Degradable
   Poly(ester amide) for Controlled Drug Delivery by LC-ToF-MS
SO BIOMACROMOLECULES
LA English
DT Article
ID AMINO-ACID-RESIDUES; ALIPHATIC COPOLYESTERS; L-PHENYLALANINE;
   BIODEGRADATION; HYDROLYSIS; COPOLYMERS; SUCCINATE); PROTEINS; TYROSINE;
   WATER
AB To scrutinize materials for specific biomedical applications, we need sensitive and selective analytical methods that can give more insight into the process of their biodegradation. In the present study, the enzymatic degradation of multi-block poly(ester amide) based on natural amino acids, such as lysine and leucine, was performed with serine proteases (alpha-chymotrypsin (alpha-CT) and proteinase K (PK)) in phosphate-buffered saline solution at 37 degrees C for 4 weeks. Fully and partially degraded water-soluble products were analyzed by liquid chromatography hyphenated with time-of-flight mass spectrometry using an electrospray interface (LC-ESI-ToF-MS). Tracking the release of monomeric and oligomeric products into the enzyme media during the course of enzymatic degradation revealed the preferences of alpha-CT and PK toward ester and amide bonds: both alpha-CT and PK showed esterase and amidase activity. Although within the experimental time frame up to 30 and 15% weight loss was observed in case of alpha-CT and PK, respectively, analysis by size exclusion chromatography showed no change in the characteristic molecular-weight averages of the remaining polymer. This suggests that the enzymatic degradation occurs at the surface of this biomaterial. A sustained and linear degradation over a period of 4 weeks supports the potential of this class of poly(ester amide)s for drug delivery applications.
C1 [Ghaffar, A.; Schoenmakers, P. J.; van der Wal, Sj] Univ Amsterdam, Analyt Chem Grp, Vant Hoff Inst Mol Sci, NL-1098 XH Amsterdam, Netherlands.
   [Ghaffar, A.] Univ Engn & Technol Lahore, Dept Chem, Lahore, Pakistan.
   [Draaisma, G. J. J.; Mihov, G.; Dias, A. A.] DSM Ahead, NL-6160 MD Geleen, Netherlands.
   [Dias, A. A.] DSM Biomed, NL-6160 MD Geleen, Netherlands.
   [van der Wal, Sj] DSM Resolve, NL-6160 MD Geleen, Netherlands.
RP Ghaffar, A (reprint author), Univ Amsterdam, Analyt Chem Grp, Vant Hoff Inst Mol Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.
EM a.ghaffar@uva.nl
OI Schoenmakers, Peter/0000-0002-9167-7716
FU DSM Biomedical; HEC Pakistan; NUFFIC Netherlands
FX We gratefully acknowledge the support of DSM Biomedical and the
   financial support of HEC Pakistan and NUFFIC Netherlands. The useful
   discussions with Dr. Bas de Bruin (UvA) for NMR interpretation and the
   help of Dr. Claudia Cusan (DSM) and A.F. Hartog (UvA) for supplying
   enzymes and reagents for enzyme activity experiments are very much
   appreciated.
CR ABE H, 1995, MACROMOLECULES, V28, P7630, DOI 10.1021/ma00127a007
   Adamus G, 2009, BIOMACROMOLECULES, V10, P1540, DOI 10.1021/bm9001415
   BURKERSRODA F, 2002, BIOMATERIALS, V23, P4221, DOI DOI 10.1016/S0142-9612(02)00170-9
   Castro GR, 2000, ENZYME MICROB TECH, V27, P143, DOI 10.1016/S0141-0229(00)00197-6
   Chu C.-C., 2007, US Patent, Patent No. [7304122 B2, 7304122]
   DeFife KM, 2009, J BIOMAT SCI-POLYM E, V20, P1495, DOI 10.1163/092050609X12464344572881
   Fan YJ, 2002, J POLYM SCI POL CHEM, V40, P385, DOI 10.1002/pola.10126
   Fan YJ, 2001, J POLYM SCI POL CHEM, V39, P1318, DOI 10.1002/pola.1109
   Folin O, 1927, J BIOL CHEM, V73, P627
   Gan Z, 2001, BIOMACROMOLECULES, V2, P313, DOI 10.1021/bm0056557
   GRAHAM LD, 1993, BIOCHEMISTRY-US, V32, P6250, DOI 10.1021/bi00075a019
   Guo K, 2007, BIOMACROMOLECULES, V8, P2851, DOI 10.1021/bm070158c
   INTVELD PJA, 1993, J CLIN MAT, V13, P143
   Kitakuni E, 2001, ENVIRON TOXICOL CHEM, V20, P941, DOI 10.1897/1551-5028(2001)020<0941:BOPTSC>2.0.CO;2
   MIHOV G, 2010, 11 EUR S CONTR DRUG, P340
   Montaudo G, 2000, POLYM DEGRAD STABIL, V70, P305, DOI 10.1016/S0141-3910(00)00139-7
   Paredes N, 1998, J APPL POLYM SCI, V69, P1537, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1537::AID-APP8>3.0.CO;2-D
   Rizzarelli P, 2005, RAPID COMMUN MASS SP, V19, P2407, DOI 10.1002/rcm.2075
   Rizzarelli P, 2004, BIOMACROMOLECULES, V5, P433, DOI 10.1021/bm034230s
   Sarkar D, 2007, POLYM DEGRAD STABIL, V92, P1994, DOI 10.1016/j.polymdegradstab.2007.08.003
   Scandola M, 1997, MACROMOLECULES, V30, P2568, DOI 10.1021/ma961431y
   Scherer TM, 1999, POLYM DEGRAD STABIL, V64, P267, DOI 10.1016/S0141-3910(98)00201-8
   Wang N, 2010, J AM SOC MASS SPECTR, V21, P1573, DOI 10.1016/j.jasms.2010.04.014
NR 23
TC 24
Z9 24
U1 3
U2 23
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD SEP
PY 2011
VL 12
IS 9
BP 3243
EP 3251
DI 10.1021/bm200709r
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 817TH
UT WOS:000294699000016
PM 21786745
DA 2018-10-20
ER

PT J
AU Fujibayashi, S
   Takemoto, M
   Neo, M
   Matsushita, T
   Kokubo, T
   Doi, K
   Ito, T
   Shimizu, A
   Nakamura, T
AF Fujibayashi, Shunsuke
   Takemoto, Mitsuru
   Neo, Masashi
   Matsushita, Tomiharu
   Kokubo, Tadashi
   Doi, Kenji
   Ito, Tatsuya
   Shimizu, Akira
   Nakamura, Takashi
TI A novel synthetic material for spinal fusion: a prospective clinical
   trial of porous bioactive titanium metal for lumbar interbody fusion
SO EUROPEAN SPINE JOURNAL
LA English
DT Article
DE Porous titanium metal; Spinal fusion; Biomaterial; Clinical trial
ID TOTAL HIP-ARTHROPLASTY; SODIUM REMOVAL; HEAT-TREATMENT; BONE; RHBMP-2;
   OSTEOINDUCTION; COMPLICATIONS; CERAMICS; IMPLANTS; LAYER
AB The objective of this study was to establish the efficacy and safety of porous bioactive titanium metal for use in a spinal fusion device, based on a prospective human clinical trial. A high-strength spinal interbody fusion device was manufactured from porous titanium metal. A bioactive surface was produced by simple chemical and thermal treatment. Five patients with unstable lumbar spine disease were treated surgically using this device in a clinical trial approved by our Ethics Review Committee and the University Hospital Medical Information Network. Clinical and radiological results were reported at the minimum follow-up period of 1 year. The optimal mechanical strength and interconnected structure of the porous titanium metal were adjusted for the device. The whole surface of porous titanium metal was treated uniformly and its bioactive ability was confirmed before clinical use. Successful bony union was achieved in all cases within 6 months without the need for autologous iliac crest bone grafting. Two specific findings including an anchoring effect and gap filling were evident radiologically. All clinical parameters improved significantly after the operation and no adverse effects were encountered during the follow-up period. Although a larger and longer-term follow-up clinical study is mandatory to reach any firm conclusions, the study results show that this porous bioactive titanium metal is promising material for a spinal fusion device.
C1 [Fujibayashi, Shunsuke; Takemoto, Mitsuru; Neo, Masashi; Nakamura, Takashi] Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto 6068507, Japan.
   [Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 4878501, Japan.
   [Doi, Kenji] Osaka Yakin Kogyou Co Ltd, Miki, Kagawa 6730043, Japan.
   [Ito, Tatsuya; Shimizu, Akira] Kyoto Univ Hosp, Dept Expt Therapeut, Translat Res Ctr, Kyoto 6068507, Japan.
RP Fujibayashi, S (reprint author), Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto 6068507, Japan.
EM shfuji@kuhp.kyoto-u.ac.jp
OI Neo, Masashi/0000-0001-9208-6419
FU Japan Society for the Promotion of Science [19200039]
FX This study was supported by a Grant in Aid for Scientific Research from
   the Japan Society for the Promotion of Science (No. 19200039). No
   benefits in any form have been or will be received from a commercial
   party related directly or indirectly to the subject of this manuscript.
   This manuscript has not been previously published and is not under
   consideration for publication elsewhere. The first two authors
   contributed equally to this study and preparation of this manuscript.
CR BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   BLOEBAUM RD, 1994, CLIN ORTHOP RELAT R, P19
   Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   BRANTIGAN JW, 1993, SPINE, V18, P1213, DOI 10.1097/00007632-199307000-00015
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   Desogus N, 2005, J Neurosurg Sci, V49, P137
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Fujibayashi S, 2001, J SPINAL DISORD, V14, P214, DOI 10.1097/00002517-200106000-00005
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Fujibayashi S, 2010, J NEUROSURG-SPINE, V13, P500, DOI 10.3171/2010.4.SPINE09691
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Jost B, 1998, Eur Spine J, V7, P132, DOI 10.1007/s005860050043
   Kawanabe K, 2009, J BIOMED MATER RES B, V90B, P476, DOI 10.1002/jbm.b.31309
   Kim HM, 2000, J BIOMED MATER RES, V52, P553, DOI 10.1002/1097-4636(20001205)52:3<553::AID-JBM14>3.0.CO;2-X
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 1996, J AM CERAM SOC, V79, P1127, DOI 10.1111/j.1151-2916.1996.tb08561.x
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   McClellan JW, 2006, J SPINAL DISORD TECH, V19, P483, DOI 10.1097/01.bsd.0000211231.83716.4b
   MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678
   Morscher EW, 1998, J BONE JOINT SURG BR, V80B, P267, DOI 10.1302/0301-620X.80B2.8316
   NACHEMSON AL, 1981, SPINE, V6, P93, DOI 10.1097/00007632-198101000-00020
   Otsuki B, 2006, BIOMATERIALS, V27, P5892, DOI 10.1016/j.biomaterials.2006.08.013
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Takemoto M, 2007, J NEUROSURG-SPINE, V7, P435, DOI 10.3171/SPI-07/10/435
   Toth JM, 2009, SPINE, V34, P539, DOI 10.1097/BRS.0b013e3181952695
   Tullberg T, 1996, Eur Spine J, V5, P178, DOI 10.1007/BF00395510
   Tullberg T, 1998, SPINE, V23, P1804, DOI 10.1097/00007632-199808150-00016
   Vaccaro AR, 2008, SPINE, V33, P2850, DOI 10.1097/BRS.0b013e31818a314d
   Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 32
TC 26
Z9 26
U1 0
U2 13
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
J9 EUR SPINE J
JI Eur. Spine J.
PD SEP
PY 2011
VL 20
IS 9
BP 1486
EP 1495
DI 10.1007/s00586-011-1728-3
PG 10
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 817WG
UT WOS:000294706700011
PM 21369760
OA Green Published
DA 2018-10-20
ER

PT J
AU Unger, AS
   Duggan, JP
AF Unger, Anthony S.
   Duggan, John P.
TI Midterm Results of a Porous Tantalum Monoblock Tibia Component Clinical
   and Radiographic Results of 108 Knees
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE cementless knee arthroplasty; Trabecular Metal; tantalum; MIS knee
   arthroplasty; uncemented knee arthroplasty
ID MINI MIDVASTUS APPROACH; ARTHROPLASTY; BIOMATERIAL; EXPERIENCE; INGROWTH
AB The use of Trabecular Metal (TM), a biomaterial manufactured from elemental tantalum metal, has recently increased in orthopedics. One hundred eight consecutive TM monoblock tibias were implanted in 95 patients and followed for a minimum of 2 years. The average follow-up was 4.5 years. The average age was 65 years. The Knee Society score of 36 improved to 89. One hundred five of the knees were rated good/excellent, and 3 knees were rated poor. Two patellar revisions were performed for loose components and one for patellar misalignment. One patella fracture required open reduction and internal fixation. One femur was revised. There were no tibia revisions. There were no progressive radiographic lucencies. Midterm clinical and radiographic results of 108 consecutive TM tibia components have a high rate of success.
C1 [Unger, Anthony S.; Duggan, John P.] George Washington Univ, Dept Orthoped Surg, Washington, DC USA.
RP Unger, AS (reprint author), WOSM, 2021 K St,400, Washington, DC 20006 USA.
FU Zimmer Corporation
FX A research grant was received from Zimmer Corporation.
CR Bal BS, 2007, TECH KNEE SURG, V6, P60
   BENOIT B, J BONE JOINT SU B S1, V90, P94
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Boerger TO, 2005, CLIN ORTHOP RELAT R, P82, DOI 10.1097/01.blo.0000185755.09777.2d
   Bonutti PM, 2004, J BONE JOINT SURG AM, V86A, P26, DOI 10.2106/00004623-200412002-00005
   Dalury DF, 2005, CLIN ORTHOP RELAT R, P77, DOI 10.1097/01.blo.0000185757.17401.7b
   DODD CA, 1990, CLIN ORTHOP RELAT RE, V66
   DORR LD, 2002, J BONE JOINT SURG BR, V84, P172
   Dunbar MJ, 2009, J BONE JOINT SURG AM, V91A, P1578, DOI 10.2106/JBJS.H.00282
   EWALD FC, 1998, CLIN ORTHOP RELAT R, V351, P270
   GHALAYINI S, J BONE JOINT SU B S2, V87, P145
   Haas SB, 2004, CLIN ORTHOP RELAT R, P68, DOI 10.1097/01.blo.0000147649.82883.ca
   Haas SB, 2006, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000238820.33154.18
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   INSALL JN, 1989, CLIN ORTHOP RELAT R, P13
   LACHIEWICZ PF, 2001, CURR OPIN ORTHOP, V12, P33
   Laskin RS, 2005, CLIN ORTHOP RELAT R, P54, DOI 10.1097/01.blo.0000186562.08685.a2
   LASKIN RS, 2004, CLIN ORTHOP RELAT R, V428, P774
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   MASRI BA, 2007, TECH KNEE SURG, V6, P124
   MENEGHINI RM, 2009, EARLY FAILURE CEMENT
   Minoda Y, 2010, J BONE JOINT SURG AM, V92A, P700, DOI 10.2106/JBJS.H.01349
   Naudie DDR, 2007, J AM ACAD ORTHOP SUR, V15, P53, DOI 10.5435/00124635-200701000-00006
   Scuderi GR, 2004, CLIN ORTHOP RELAT R, P61, DOI 10.1097/01.blo.0000148574.79874.d0
   Tenholder M, 2005, CLIN ORTHOP RELAT R, P67, DOI 10.1097/01.blo.0000185450.89364.10
   Tria AJ, 2003, CLIN ORTHOP RELAT R, P185, DOI 10.1097/01.blo.0000093030.56370.d9
   Vail TP, 2004, CLIN ORTHOP RELAT R, P51, DOI 10.1097/01.blo.0000147706.53226.53
   Wood JEJ., 2007, CURR OPIN ORTHOP, V18, P61
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 30
TC 20
Z9 21
U1 1
U2 2
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD SEP
PY 2011
VL 26
IS 6
BP 855
EP 860
DI 10.1016/j.arth.2010.08.017
PG 6
WC Orthopedics
SC Orthopedics
GA 813TK
UT WOS:000294392900006
PM 21036009
DA 2018-10-20
ER

PT J
AU Liu, YF
   Zhu, FD
   Dong, XT
   Peng, W
AF Liu, Yun-feng
   Zhu, Fu-dong
   Dong, Xing-tao
   Peng, Wei
TI Digital design of scaffold for mandibular defect repair based on tissue
   engineering
SO JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B
LA English
DT Article
DE Digital design; Mandibular defect; Scaffold; Tissue engineering
ID POLYCAPROLACTONE SCAFFOLDS; BONE; REGENERATION; CELLS
AB Mandibular defect occurs more frequently in recent years, and clinical repair operations via bone transplantation are difficult to be further improved due to some intrinsic flaws. Tissue engineering, which is a hot research field of biomedical engineering, provides a new direction for mandibular defect repair. As the basis and key part of tissue engineering, scaffolds have been widely and deeply studied in regards to the basic theory, as well as the principle of biomaterial, structure, design, and fabrication method. However, little research is targeted at tissue regeneration for clinic repair operations. Since mandibular bone has a special structure, rather than uniform and regular structure in existing studies, a methodology based on tissue engineering is proposed for mandibular defect repair in this paper. Key steps regarding scaffold digital design, such as external shape design and internal microstructure design directly based on triangular meshes are discussed in detail. By analyzing the theoretical model and the measured data from the test parts fabricated by rapid prototyping, the feasibility and effectiveness of the proposed methodology are properly verified. More works about mechanical and biological improvements need to be done to promote its clinical application in future.
C1 [Liu, Yun-feng; Dong, Xing-tao; Peng, Wei] Zhejiang Univ Technol, Minist Educ & Zhejiang Prov, Key Lab E&M, Hangzhou 310032, Zhejiang, Peoples R China.
   [Zhu, Fu-dong] Zhejiang Univ, Sch Med, Affiliated Stomatol Hosp, Hangzhou 310006, Zhejiang, Peoples R China.
RP Liu, YF (reprint author), Zhejiang Univ Technol, Minist Educ & Zhejiang Prov, Key Lab E&M, Hangzhou 310032, Zhejiang, Peoples R China.
EM liuyf76@126.com
RI Peng, Wei/H-2307-2011
FU National Natural Science Foundation of China [50905164]; Zhejiang
   Provincial Natural Science Foundation of China [Y2090835]
FX Project supported by the National Natural Science Foundation of China
   (No. 50905164), and the Zhejiang Provincial Natural Science Foundation
   of China (No. Y2090835)
CR Abu-Serriah M, 2006, J CRANIO MAXILL SURG, V34, P162, DOI 10.1016/j.jcms.2005.12.001
   Abu-Serriah MM, 2004, BRIT J ORAL MAX SURG, V42, P410, DOI 10.1016/j.bjoms.2004.05.005
   Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Armillotta A, 2008, INT J ADV MANUF TECH, V39, P501, DOI 10.1007/s00170-007-1247-x
   Ciocca L, 2009, COMPUT MED IMAG GRAP, V33, P58, DOI 10.1016/j.compmedimag.2008.10.005
   d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07
   Drosse I, 2008, INJURY, V39, pS9, DOI 10.1016/S0020-1383(08)70011-1
   Estelles JM, 2008, J MATER SCI-MATER M, V19, P189, DOI 10.1007/s10856-006-0101-2
   Fang Z, 2005, COMPUT AIDED DESIGN, V37, P65, DOI 10.1016/j.cad.2004.04.002
   Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039
   Hollister SJ, 2007, COMPUT METHOD APPL M, V196, P2991, DOI 10.1016/j.cma.2006.09.023
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sun W, 2002, COMPUT METH PROG BIO, V67, P85, DOI 10.1016/S0169-2607(01)00116-X
   Sun W, 2005, COMPUT AIDED DESIGN, V37, P1097, DOI 10.1016/j.cad.2005.02.002
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
   Zhao J, 2009, BONE, V45, P517, DOI 10.1016/j.bone.2009.05.026
NR 19
TC 8
Z9 8
U1 1
U2 13
PU ZHEJIANG UNIV
PI HANGZHOU
PA EDITORIAL BOARD, 20 YUGU RD, HANGZHOU, 310027, PEOPLES R CHINA
SN 1673-1581
EI 1862-1783
J9 J ZHEJIANG UNIV-SC B
JI J. Zhejiang Univ.-SCI. B
PD SEP
PY 2011
VL 12
IS 9
BP 769
EP 779
DI 10.1631/jzus.B1000323
PG 11
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Research & Experimental Medicine
GA 815XO
UT WOS:000294563500011
PM 21887853
OA Green Published
DA 2018-10-20
ER

PT J
AU Paulino, AT
   Fajardo, AR
   Junior, AP
   Muniz, EC
   Tambourgi, EB
AF Paulino, Alexandre T.
   Fajardo, Andre R.
   Junior, Andrea P.
   Muniz, Edvani C.
   Tambourgi, Elias B.
TI Two-step synthesis and properties of amagnetic-field-sensitive modified
   maltodextrin-based hydrogel
SO POLYMER INTERNATIONAL
LA English
DT Article
DE maltodextrin; ferrogel; polysaccharide; magnetic biomaterial; hydrogel
ID GLYCIDYL METHACRYLATE; MAGNETIC BIOMATERIAL; POTENTIAL DEVICE; DRUG
   TRANSPORT; CHITOSAN; POLYSACCHARIDE; MECHANISMS; KINETICS; DEXTRAN
AB A magnetic-field-sensitive modified maltodextrin-based hydrogel (ferrogel) was synthesized. Fourier transform infrared and C-13-CP/MAS NMR spectral analyses confirmed the efficiency of the gelling process. X-ray diffraction analysis revealed the appearance of new crystalline planes in the hydrogel diffractograms after embedding of magnetite nanoparticles. Magnetization curves and Mossbauer analysis revealed that the magnetic hydrogel has a high lattice strain due to bonded iron atom covalence. Moreover, some magnetite molecules embedded in the hydrogel ensure a degree of paramagnetism and iron atoms exhibiting oxidation states alternating between 2 and 3 in the final material. Scanning electron microscopy and energy-dispersive X-ray analysis revealed that no phase separation occurred between the magnetite nanoparticles and crosslinked hydrogel, indicating excellent dispersion throughout the hydrogel. Moreover, the average pore sizes decreased on increasing the amount of magnetite inside the polymer network. The results of compression stress versus strain revealed that the elasticity of the magnetic hydrogel was increased on increasing the amount of magnetite nanoparticles. Finally, kinetic studies revealed that the diffusion mechanism of water in the hydrogel is driven by anomalous release with a tendency towards the occurrence of macromolecular relaxation. (C) 2011 Society of Chemical Industry
C1 [Paulino, Alexandre T.; Tambourgi, Elias B.] Univ Estadual Campinas, Sch Chem Engn, Dept Chem Syst Engn, Separat Proc Lab, BR-13083852 Campinas, SP, Brazil.
   [Fajardo, Andre R.; Muniz, Edvani C.] Univ Estadual Maringa, Dept Chem, Polymer Mat & Composite Lab, Maringa, Parana, Brazil.
   [Junior, Andrea P.] Univ Estadual Maringa, Dept Phys, Maringa, Parana, Brazil.
RP Paulino, AT (reprint author), Univ Estadual Campinas, Sch Chem Engn, Dept Chem Syst Engn, Separat Proc Lab, Av Albert Einstein 500,Bloco A, BR-13083852 Campinas, SP, Brazil.
EM atpaulino10@gmail.com
RI Fajardo, Andre/H-1783-2012; Tambourgi, Elias/E-1863-2012; Inomat,
   Inct/H-9989-2013; Paulino, Alexandre/B-8075-2013
OI Fajardo, Andre/0000-0001-5362-6478; Tambourgi,
   Elias/0000-0002-4734-9723; Paulino, Alexandre/0000-0001-7076-2797;
   Muniz, Edvani/0000-0001-6685-1519
FU State of Sao Paulo Research Foundation (FAPESP, Brazil) [2008/00285-7]
FX AT Paulino and EB Tambourgi thank the State of Sao Paulo Research
   Foundation (FAPESP, Brazil) for post-doctoral fellowships (process no.
   2008/00285-7).
CR Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   Brazel CS, 1999, POLYMER, V40, P3383, DOI 10.1016/S0032-3861(98)00546-1
   Buchholz F., 1998, MODERN SUPERABSORBEN
   Dumitrius S., 1996, POLYSACCHARIDES MED, P125
   Guilherme MR, 2009, BIOMACROMOLECULES, V10, P190, DOI 10.1021/bm801250p
   Huang SH, 2003, BIOTECHNOL PROGR, V19, P1095, DOI 10.1021/bp025587v
   Kato N, 1997, J INTEL MAT SYST STR, V8, P588, DOI 10.1177/1045389X9700800703
   Lau KT, 2009, SMART MATER STRUCT, V18, DOI 10.1088/0964-1726/18/7/070201
   Li H, 2009, INT J SOLIDS STRUCT, V46, P1326, DOI 10.1016/j.ijsolstr.2008.11.001
   Liu XQ, 2007, IEEE T MAGN, V43, P2462, DOI 10.1109/TMAG.2007.894004
   Massart R., 1982, [No title captured], Patent No. [4.329 241, 4329241, 4 329 241]
   Mi FL, 2003, POLYMER, V44, P6521, DOI 10.1016/S0032-3861(03)00620-7
   Morozov K, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.040801
   Paneva D, 2004, E-POLYMERS
   Patterson AL, 1939, PHYS REV, V56, P978, DOI 10.1103/PhysRev.56.978
   Paulino AT, 2006, J COLLOID INTERF SCI, V301, P55, DOI 10.1016/j.jcis.2006.04.036
   Paulino AT, 2010, MACROMOL CHEM PHYS, V211, P1196, DOI 10.1002/macp.200900657
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Rubira AF, 2009, POLIMEROS, V19, P105, DOI 10.1590/S0104-14282009000200006
   Serra L, 2006, BIOMATERIALS, V27, P5440, DOI 10.1016/j.biomaterials.2006.06.011
   Sorescu M, 1997, MATER LETT, V30, P235, DOI 10.1016/S0167-577X(96)00202-9
   Tharanathan RN, 2002, CRIT REV BIOTECHNOL, V22, P65, DOI 10.1080/07388550290789469
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P3411, DOI 10.1021/ma961764v
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   Winkleman A, 2007, CHEM MATER, V19, P1362, DOI 10.1021/cm062626f
   Zhang J, 2009, POLYMER, V50, P2516, DOI 10.1016/j.polymer.2009.03.044
   Zhang YX, 2005, POLYMER, V46, P7695, DOI 10.1016/j.polymer.2005.05.121
NR 28
TC 15
Z9 15
U1 1
U2 44
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD SEP
PY 2011
VL 60
IS 9
BP 1324
EP 1333
DI 10.1002/pi.3084
PG 10
WC Polymer Science
SC Polymer Science
GA 818TJ
UT WOS:000294778200007
DA 2018-10-20
ER

PT J
AU Wang, XF
   He, F
   Tan, YH
   Tian, WD
   Qiu, SB
AF Wang, Xuefei
   He, Fei
   Tan, Yinghui
   Tian, Weidong
   Qiu, Songbo
TI Inhibition of Delta1 promotes differentiation of odontoblasts and
   inhibits proliferation of human dental pulp stem cell in vitro
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE Human dental pulp stem cells (DPSCs); Notch signalling; Odontogenic
   differentiation; Tissue engineering
ID BONE MORPHOGENETIC PROTEIN-2; HUMAN OSTEOGENIC PROTEIN-1; HARD-TISSUE
   FORMATION; GROWTH-FACTOR; GENE-EXPRESSION; NOTCH LIGANDS; ACTIVATION;
   PATHWAY; VIVO; INDUCTION
AB Objective: Dental pulp stem cells (DPSCs) have been receiving more attentions recently as an important biomaterial for tissue engineering. Notch signalling plays a key role in regulating self-renewal and differentiation of a variety of cells. The objective of this study is to investigate the effects of Notch-Delta1 RNA interference (RNAi) on the proliferation and differentiation of human dental pulp stem cells in vitro.
   Design: In the present study, we performed gene knockdown of Notch ligand Delta1 in DPSCs using lentivirus-mediated Delta1-RNAi. Changes of proliferation in DPSCs/Delta1-RNAi were examined by cell cycle analysis, Cell viability assay (CCK-8) and Western blot analysis of proliferating cell nuclear antigen (PCNA). Cells were cultured in odontoblast differentiation-inducing medium, and the differentiation of cells was detected with Alkaline phosphatase ALP activity assay, Alizarin red S staining, calcium concentration measurement, and Western blot analysis of Dentine sialophosphoprotein (DSPP).
   Results: Lentivirus-mediated Delta1-RNAi stably knocked-down the expression of Delta1 and Notch signalling, and some of DPSCs/Delta1-RNAi displayed changes in morphology or DSPP expression. The growth rate of Delta1-deficient DPSCs was significantly suppressed as compared with wild type DPSCs and control lentivirus vector transfected DPSCs. Furthermore, the differentiating capability of DPSCs/Delta1-RNAi into odontoblasts is much higher than the two control groups.
   Conclusions: Notch signalling plays a crucial role in regulating self-renewal and differentiation in DPSCs. The deficient Notch signalling inhibits the self-renewal capacity of DPSCs and tends to induce DPSCs differentiation under odontoblast differentiation-inducing conditions. These findings suggested that DPSCs/Delta1-RNAi might be applicable to stem cell therapies and tooth tissue engineering. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Tan, Yinghui] Third Mil Med Univ, Xinqiao Hosp, Dept Oral & Maxillofacial Surg, Chongqing 400037, Peoples R China.
   [Wang, Xuefei; He, Fei; Qiu, Songbo] Third Mil Med Univ, Xinqiao Hosp, Dept Stomatol, Chongqing 400037, Peoples R China.
   [Tian, Weidong] Sichuan Univ, Western China Stomatol Hosp, Dept Oral & Maxillofacial Surg, Chengdu 610041, Peoples R China.
RP Tan, YH (reprint author), Third Mil Med Univ, Xinqiao Hosp, Dept Oral & Maxillofacial Surg, Xinqiao St, Chongqing 400037, Peoples R China.
EM tanyhoms@yahoo.cn
RI Yu, Mei/G-4994-2015
OI Yu, Mei/0000-0003-0306-6817
FU CQ CSTC [2007BB5016]; The National Basic Research Program of China (973
   Program) [2010CB9444800]
FX This research was supported by The Natural Science Foundation Project of
   CQ CSTC (2007BB5016) and The National Basic Research Program of China
   (973 Program 2010CB9444800).
CR Batouli S, 2003, J DENT RES, V82, P976, DOI 10.1177/154405910308201208
   Berendsen AD, 2007, BIOMATERIALS, V28, P3530, DOI 10.1016/j.biomaterials.2007.04.031
   Canalis E, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.117pe17
   Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014
   Chen S, 2008, J BIOL CHEM, V283, P19359, DOI 10.1074/jbc.M709492200
   Feng JQ, 1998, J BIOL CHEM, V273, P9457, DOI 10.1074/jbc.273.16.9457
   Goldberg Michel, 2006, Dent Clin North Am, V50, P277, DOI 10.1016/j.cden.2005.11.008
   Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Han W, 2000, BLOOD, V95, P1616
   He F, 2009, ARCH ORAL BIOL, V54, P216, DOI 10.1016/j.archoralbio.2008.10.003
   Iejima D, 2007, ARCH ORAL BIOL, V52, P924, DOI 10.1016/j.archoralbio.2007.04.004
   Jepsen S, 1997, J ENDODONT, V23, P378, DOI 10.1016/S0099-2399(97)80187-2
   Jiang HB, 2008, CELL BIOL INT, V32, P671, DOI 10.1016/j.cellbi.2008.01.293
   Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786
   Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960
   Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365
   Kiraly M, 2009, NEUROCHEM INT, V55, P323, DOI 10.1016/j.neuint.2009.03.017
   Kojika S, 2001, EXP HEMATOL, V29, P1041, DOI 10.1016/S0301-472X(01)00676-2
   Le Borgne R, 2003, DEV CELL, V5, P139, DOI 10.1016/S1534-5807(03)00187-4
   Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X
   Lovschall H, 2005, EUR J ORAL SCI, V113, P312, DOI 10.1111/j.1600-0722.2005.00221.x
   Mangano C, 2010, BIOMATERIALS, V31, P3543, DOI 10.1016/j.biomaterials.2010.01.056
   Miele L, 1999, J CELL PHYSIOL, V181, P393, DOI 10.1002/(SICI)1097-4652(199912)181:3<393::AID-JCP3>3.0.CO;2-6
   Mitsiadis TA, 1999, EXP CELL RES, V246, P312, DOI 10.1006/excr.1998.4285
   MIYACHI K, 1978, J IMMUNOL, V121, P2228
   NAKASHIMA M, 1994, DEV BIOL, V162, P18, DOI 10.1006/dbio.1994.1063
   NAKASHIMA M, 1994, J DENT RES, V73, P1515, DOI 10.1177/00220345940730090601
   Ohishi K, 2002, INT J HEMATOL, V75, P449, DOI 10.1007/BF02982106
   RUTHERFORD RB, 1994, ARCH ORAL BIOL, V39, P833, DOI 10.1016/0003-9969(94)90014-0
   Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Stallwood Y, 2006, J IMMUNOL, V177, P885, DOI 10.4049/jimmunol.177.2.885
   Tada H, 2010, BIOCHEM BIOPH RES CO, V394, P1093, DOI 10.1016/j.bbrc.2010.03.135
   Tohda S, 2005, EXP HEMATOL, V33, P558, DOI 10.1016/j.exphem.2005.01.010
   Wang J, 2010, ACTA BIOMATER, V6, P3856, DOI 10.1016/j.actbio.2010.04.009
   Yang XC, 2009, TISSUE ENG PT A, V15, P367, DOI 10.1089/ten.tea.2008.0133
   Zhang C, 2008, J DENT RES, V87, P250, DOI 10.1177/154405910808700312
   Zhang W, 2005, TISSUE ENG, V11, P357, DOI 10.1089/ten.2005.11.357
   Zhang W, 2008, TISSUE ENG PT A, V14, P285, DOI 10.1089/tea.2007.0146
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
NR 42
TC 7
Z9 8
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD SEP
PY 2011
VL 56
IS 9
BP 837
EP 845
DI 10.1016/j.archoralbio.2011.02.006
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 815IK
UT WOS:000294519100002
PM 21392732
DA 2018-10-20
ER

PT J
AU Reyes-Carmona, JF
   Santos, ARS
   Figueiredo, CP
   Felippe, MS
   Felippe, WT
   Cordeiro, MM
AF Reyes-Carmona, Jessie F.
   Santos, Adair R. S.
   Figueiredo, Claudia P.
   Felippe, Mara S.
   Felippe, Wilson T.
   Cordeiro, Mabel M.
TI In Vivo Host Interactions with Mineral Trioxide Aggregate and Calcium
   Hydroxide: Inflammatory Molecular Signaling Assessment
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Bioactivity; calcium hydroxide; cyclooxygenase-2; inducible nitric oxide
   synthase enzymes; inflammation
ID FACTOR-KAPPA-B; RAT CONNECTIVE-TISSUE; DENTAL-PULP CELLS; BIOMATERIAL
   INTERACTION; MESSENGER-RNA; CYCLOOXYGENASE-2; EXPRESSION; MECHANISM;
   RESPONSES; MTA
AB Introduction: Mineral trioxide aggregate (MTA) and calcium hydroxide [Ca(OH)(2)] are promising biomaterials for stimulating dentinogenesis and cementogenesis. This research was undertaken to understand how MTA and CA(OH)(2) participate in the inflammatory, healing, and biomineralization processes. In this part of the study, we evaluated inflammatory signaling molecules promoted by in vivo host interaction with MTA and Ca(OH)(2). Methods: Human dentin tubes were filled with Pro Root MTA (Dentsply Tulsa Dental, Tulsa, OK), Ca(OH)(2), or kept empty. After 12 hours and 1, 3, 7, 15, 30, and 60 days of implantation in subcutaneous tissues in the backs of mice, the tubes and surrounding tissues were retrieved for cytokine level quantification and histological and immunohistochemical analysis. Results: MTA and Ca(OH)(2) induced proinflammatory cytokine up-regulation for up to 3 days. Moreover, interleukin-10 overexpression was noted on the tissue in contact with the biomaterials during the acute phase of the inflammatory reaction. Immunohistochemical analyses showed an increased expression of myeloperoxidase, nuclear factor kappa B (NF-kappa B), cyclooxygenase-2, inducible nitric oxide synthase enzymes, and vascular endothelial growth factor on day 1 for all groups. Conclusions: MTA and Ca(OH)(2) increased the activation of the NF-kappa B signaling system on day 1 for all groups. This finding can be associated with a proinflammatory and pro-wound healing environment, which was promoted earlier by MTA. (J Endod 2011;37:1225-1235)
C1 [Reyes-Carmona, Jessie F.] Univ Costa Rica, Dept Restorat Sci, San Jose, Costa Rica.
   [Reyes-Carmona, Jessie F.; Felippe, Mara S.; Felippe, Wilson T.] Univ Fed Santa Catarina, Postgrad Dent Program, Florianopolis, SC, Brazil.
   [Santos, Adair R. S.; Figueiredo, Claudia P.] Univ Fed Santa Catarina, Dept Physiol Sci, Florianopolis, SC, Brazil.
   [Cordeiro, Mabel M.] Univ Fed Santa Catarina, Dept Morphol Sci, Florianopolis, SC, Brazil.
RP Reyes-Carmona, JF (reprint author), Univ Costa Rica, Dept Restorat Sci, San Jose, Costa Rica.
EM jessreyesc@hotmail.com
RI Santos, Adair/C-5565-2013; Reyes-Carmona, Jessie/B-4828-2013
OI Santos, Adair/0000-0002-6435-4698; Reyes-Carmona,
   Jessie/0000-0003-2872-6623
FU University of Costa Rica; Federal University of Santa Catarina
FX Supported in part by Grants in Aid for Scientific Research from the
   University of Costa Rica and Federal University of Santa Catarina.
CR Aeinehchi M, 2003, INT ENDOD J, V36, P225, DOI 10.1046/j.1365-2591.2003.00652.x
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Silva MJB, 2008, ORAL SURG ORAL MED O, V105, pE70, DOI 10.1016/j.tripleo.2008.01.025
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   CARMONA JR, 2009, J ENDODONT, V35, P731
   Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009
   Pita AD, 2009, J ENDODONT, V35, P529, DOI 10.1016/j.joen.2009.01.004
   Dominguez MS, 2003, J ENDODONT, V29, P324, DOI 10.1097/00004770-200305000-00003
   Faraco IM, 2001, DENT TRAUMATOL, V17, P163, DOI 10.1034/j.1600-9657.2001.170405.x
   Ferracane JL, 2010, ODONTOLOGY, V98, P2, DOI 10.1007/s10266-009-0116-5
   Ford TRP, 1996, J AM DENT ASSOC, V127, P1491, DOI 10.14219/jada.archive.1996.0058
   Fridland M, 2005, J ENDODONT, V31, P376, DOI 10.1097/01.DON.0000140566.97319.3e
   Gomes AC, 2008, ORAL SURG ORAL MED O, V106, P450, DOI 10.1016/j.tripleo.2008.03.022
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Holland R, 2002, J ENDODONT, V28, P173, DOI 10.1097/00004770-200203000-00007
   Holland R, 1999, J ENDODONT, V25, P161, DOI 10.1016/S0099-2399(99)80134-4
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Huang TH, 2005, J BIOMED MATER RES B, V73B, P123, DOI 10.1002/jbm.b.30182
   Iniguez MA, 2003, TRENDS MOL MED, V9, P73, DOI 10.1016/S1471-4914(02)00011-4
   Koh ET, 1998, J ENDODONT, V24, P543, DOI 10.1016/S0099-2399(98)80074-5
   Lee YY, 2007, J ENDODONT, V33, P1177, DOI 10.1016/j.joen.2007.05.011
   LOWENSTEIN CJ, 1992, P NATL ACAD SCI USA, V89, P6711, DOI 10.1073/pnas.89.15.6711
   Majima M, 2000, BRIT J PHARMACOL, V130, P641, DOI 10.1038/sj.bjp.0703327
   Minamikawa H, 2009, J ENDODONT, V35, P843, DOI 10.1016/j.joen.2009.03.008
   Okabe T, 2006, J ENDODONT, V32, P198, DOI 10.1016/j.joen.2005.10.041
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Rashid F, 2003, J ENDODONT, V29, P104, DOI 10.1097/00004770-200302000-00004
   Reyes-Carmona JF, 2010, J ENDODONT, V36, P1347, DOI 10.1016/j.joen.2010.04.029
   Reyes-Carmona JF, 2010, J ENDODONT, V36, P286, DOI 10.1016/j.joen.2009.10.009
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Tay FR, 2007, J ENDODONT, V33, P1347, DOI 10.1016/j.joen.2007.07.008
   Costa MMTD, 2008, ORAL SURG ORAL MED O, V105, P814, DOI 10.1016/j.tripleo.2007.12.013
   THOMSON PL, 2007, J DENT, V35, P636
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
NR 34
TC 6
Z9 6
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD SEP
PY 2011
VL 37
IS 9
BP 1225
EP 1235
DI 10.1016/j.joen.2011.05.031
PG 11
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 813TR
UT WOS:000294393600008
PM 21846538
DA 2018-10-20
ER

PT J
AU Lee, H
   Yu, A
   Johnson, CC
   Lilly, EA
   Noverr, MC
   Fidel, PL
AF Lee, H.
   Yu, A.
   Johnson, C. C.
   Lilly, E. A.
   Noverr, M. C.
   Fidel, P. L., Jr.
TI Fabrication of a multi-applicable removable intraoral denture system for
   rodent research
SO JOURNAL OF ORAL REHABILITATION
LA English
DT Article
DE denture; oral biofilm; animal models; denture stomatitis; Candida
   albicans
ID CONTINUOUS PRESSURE; SUPPORTING TISSUES; STOMATITIS; BIOFILMS; CANDIDA;
   RATS
AB The objective was to engineer an inexpensive intraoral removable denture system for rodents that can be utilised in numerous oral health research applications. At the forefront is biofilm research related to Candida-associated denture stomatitis. Previously described intraoral devices are primitive and inadequate. The denture system was engineered consisting of a fixed part that is anchored to the posterior palate by orthodontic wires and acrylic resin and a removable part fitted to the anterior palate that is retained by magnets embedded in the fixed part. Both parts are custom fitted to the rodent palate by impression making and cast fabrication. Rats fitted with the intraoral denture system maintained body weight and normal activity with the device maintaining integrity and durability for upwards of 8 weeks. The denture system was used successfully to establish a working model of denture stomatitis. This newly engineered inexpensive intraoral removable denture system for rodents can be utilised in numerous oral health research applications, including denture-associated infections, biofilms and a variety of biomaterial applications. The removable portion is advantageous for longitudinal analyses and charging/discharging of biomaterials.
C1 [Lee, H.; Yu, A.] Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Dept Prosthodont, New Orleans, LA 70119 USA.
   [Johnson, C. C.] Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70119 USA.
   [Lilly, E. A.; Noverr, M. C.; Fidel, P. L., Jr.] Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Dept Oral & Craniofacial Biol, New Orleans, LA 70119 USA.
RP Fidel, PL (reprint author), Louisiana State Univ, Hlth Sci Ctr, Sch Dent, Dept Prosthodont, New Orleans, LA 70119 USA.
EM pfidel@lsithsc.edu
FU NIH NCRR [P20RR20160-SI]; South Louisiana Institute for Infectious
   Disease Research; Louisiana Vaccine Center; Louisiana Board of Regents
FX This work was supported by NIH NCRR CoBRE grant ARRA supplement
   (P20RR20160-SI) and in part by the South Louisiana Institute for
   Infectious Disease Research and the Louisiana Vaccine Center sponsored
   by the Louisiana Board of Regents.
CR Barclay SC, 1997, J DENT, V25, P71, DOI 10.1016/0300-5712(95)00115-8
   Barclay SC, 1997, J DENT, V25, P251, DOI 10.1016/S0300-5712(96)00005-X
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Fejerskov O, 2004, CARIES RES, V38, P182, DOI 10.1159/000077753
   Imai Y, 2002, J ORAL REHABIL, V29, P72, DOI 10.1046/j.1365-2842.2002.00799.x
   Mori S, 1997, J ORAL REHABIL, V24, P37, DOI 10.1046/j.1365-2842.1997.00443.x
   Newton A. V., 1962, BRIT DENT J, V112, P357
   Pires FR, 2002, J ORAL REHABIL, V29, P1115, DOI 10.1046/j.1365-2842.2002.00947.x
   Ramage G, 2004, ORAL SURG ORAL MED O, V98, P53, DOI 10.1016/j.tripleo.2003.04.002
   Schaudinn C, 2009, J AM DENT ASSOC, V140, P978, DOI 10.14219/jada.archive.2009.0307
   Shulman JD, 2005, J ORAL PATHOL MED, V34, P340, DOI 10.1111/j.1600-0714.2005.00287.x
   Tsuruoka M, 2008, J ORAL REHABIL, V35, P889, DOI 10.1111/j.1365-2842.2008.01883.x
   Zissis A, 2006, INT J PROSTHODONT, V19, P621
NR 14
TC 10
Z9 10
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0305-182X
J9 J ORAL REHABIL
JI J. Oral Rehabil.
PD SEP
PY 2011
VL 38
IS 9
BP 686
EP 690
DI 10.1111/j.1365-2842.2011.02206.x
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 815KL
UT WOS:000294524400009
PM 21323935
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Carty, FL
   Cashman, JP
   Parvizi, J
   Zoga, AC
   Morrison, WB
AF Carty, Fiona L.
   Cashman, James P.
   Parvizi, Javad
   Zoga, Adam C.
   Morrison, William B.
TI Imaging of the Postoperative Hip
SO SEMINARS IN MUSCULOSKELETAL RADIOLOGY
LA English
DT Article
DE Imaging; surgery; postoperative; hip; arthroplasty; complications
ID POROUS TANTALUM BIOMATERIAL; LOW-FRICTION ARTHROPLASTY; FEMORAL-NECK
   FRACTURES; ON-METAL BEARINGS; 50 YEARS OLD; CORE DECOMPRESSION;
   AVASCULAR NECROSIS; FOLLOW-UP; RADIOGRAPHIC EVALUATION; ACETABULAR
   COMPONENT
AB A basic understanding of the surgical approach, technique, and potential complications in addition to the types of hardware used is essential in interpreting postoperative imaging of the hip. This article reviews the various surgical approaches to the hip and hardware components in total hip arthroplasty and hip preservation surgery and the potential complications that may arise. The various surgical treatments in the management of acetabular dysplasia and avascular necrosis and the imaging appearances of these on different imaging modalities are also discussed.
C1 [Carty, Fiona L.; Zoga, Adam C.; Morrison, William B.] Thomas Jefferson Univ Hosp, Dept Radiol, Philadelphia, PA 19107 USA.
   [Cashman, James P.; Parvizi, Javad] Thomas Jefferson Univ Hosp, Dept Orthoped, Rothman Inst, Philadelphia, PA 19107 USA.
RP Carty, FL (reprint author), Thomas Jefferson Univ Hosp, Dept Radiol, 132 S 10th St, Philadelphia, PA 19107 USA.
EM fcarty@gmail.com
CR AGINS HJ, 1988, J BONE JOINT SURG AM, V70A, P347, DOI 10.2106/00004623-198870030-00005
   ANTHONY PP, 1990, J BONE JOINT SURG BR, V72, P971
   BARRACK RL, 1992, J BONE JOINT SURG BR, V74, P385
   Berend KR, 2003, J BONE JOINT SURG AM, V85A, P987, DOI 10.2106/00004623-200306000-00001
   Berger RA, 1997, CLIN ORTHOP RELAT R, P216
   Berry DJ, 1999, ORTHOP CLIN N AM, V30, P183, DOI 10.1016/S0030-5898(05)70073-0
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Breusch SJ, 2000, J ARTHROPLASTY, V15, P921, DOI 10.1054/arth.2000.8098
   BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629
   Callaghan JJ, 1998, J BONE JOINT SURG AM, V80A, P704, DOI 10.2106/00004623-199805000-00011
   Charnley J, 2005, CLIN ORTHOP RELAT R, P12
   Charnley John, 2005, Clin Orthop Relat Res, P3
   Clohisy John C, 2005, Iowa Orthop J, V25, P164
   COLWELL CW, 1989, ARTHRITIS RHEUM, V32, P797, DOI 10.1002/anr.1780320622
   CROWNINSHIELD RD, 1980, CLIN ORTHOP RELAT R, P71
   Cyteval C, 2002, RADIOLOGY, V224, P477, DOI 10.1148/radiol.2242010989
   DELEE JG, 1976, CLIN ORTHOP RELAT R, P20
   Dumbleton JH, 2002, J ARTHROPLASTY, V17, P649, DOI 10.1054/arth.2002.33664
   Fang CSJ, 2008, SKELETAL RADIOL, V37, P715, DOI 10.1007/s00256-008-0492-x
   FITZGERALD RH, 1988, CLIN ORTHOP RELAT R, P61
   Gambera Dario, 2002, Acta Biomed, V73, P85
   Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964
   Ganz R, 2004, CLIN ORTHOP RELAT R, P3
   Garcia-Cimbrelo E, 2000, J BONE JOINT SURG BR, V82B, P108, DOI 10.1302/0301-620X.82B1.9796
   GarciaCimbrelo E, 1997, J BONE JOINT SURG AM, V79A, P1373, DOI 10.2106/00004623-199709000-00012
   Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426
   Goodwin R A, 1968, Am J Orthop Surg, V10, P40
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17
   Hallab NJ, 2004, J ARTHROPLASTY, V19, P88, DOI 10.1016/j.arth.2004.09.012
   HARDINGE K, 1982, J BONE JOINT SURG BR, V64, P17
   Harris W H, 1993, Orthop Rev, V22, P531
   HARRIS WH, 1967, J BONE JOINT SURG AM, VA 49, P891, DOI 10.2106/00004623-196749050-00005
   Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P738, DOI 10.1302/0301-620X.91B6.21682
   Heffernan EJ, 2008, SKELETAL RADIOL, V37, P59, DOI 10.1007/s00256-007-0362-y
   Hing CB, 2007, J BONE JOINT SURG BR, V89B, P1431, DOI 10.1302/0301-620X.89B11.19336
   Huo MH, 2009, J BONE JOINT SURG AM, V91A, P2522, DOI 10.2106/JBJS.I.00801
   JASTY M, 1991, J BONE JOINT SURG BR, V73, P551
   Johnston C, 2007, SKELETAL RADIOL, V36, P955, DOI 10.1007/s00256-007-0349-8
   JOHNSTON RC, 1990, J BONE JOINT SURG AM, V72A, P161, DOI 10.2106/00004623-199072020-00002
   Koulouris George, 2005, Magn Reson Imaging Clin N Am, V13, P743, DOI 10.1016/j.mric.2005.09.001
   KRISTENSEN KD, 1991, ACTA ORTHOP SCAND, V62, P113, DOI 10.3109/17453679108999235
   Kwon YM, 2011, J ARTHROPLASTY, V26, P511, DOI 10.1016/j.arth.2010.05.030
   Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770
   Laude F, 2009, CLIN ORTHOP RELAT R, V467, P747, DOI 10.1007/s11999-008-0656-y
   LINDHOLM RV, 1976, ACTA ORTHOP SCAND, V47, P70, DOI 10.3109/17453677608998976
   Manaster BJ, 1996, RADIOGRAPHICS, V16, P645, DOI 10.1148/radiographics.16.3.8897629
   McCormack BAO, 1996, CLIN BIOMECH, V11, P214, DOI 10.1016/0268-0033(95)00076-3
   McGrory BJ, 2007, J BONE JOINT SURG AM, V89A, P1194, DOI 10.2106/JBJS.F.00302
   Miki H, 2006, ARCH ORTHOP TRAUM SU, V126, P192, DOI 10.1007/s00402-006-0112-y
   MULLER ME, 1970, CLIN ORTHOP RELAT R, P46
   NEUHOLD A, 1992, J COMPUT ASSIST TOMO, V16, P951, DOI 10.1097/00004728-199211000-00023
   Ng VY, 2010, MED HYPOTHESES, V74, P725, DOI 10.1016/j.mehy.2009.10.039
   Pluot E, 2009, CLIN RADIOL, V64, P961, DOI 10.1016/j.crad.2009.05.002
   Pohler OEM, 2000, INJURY, V31, pS7
   Potter HG, 2004, J BONE JOINT SURG AM, V86A, P1947, DOI 10.2106/00004623-200409000-00013
   Puri L, 2002, J BONE JOINT SURG AM, V84A, P609, DOI 10.2106/00004623-200204000-00016
   QUALE JL, 1992, RADIOLOGY, V182, P855, DOI 10.1148/radiology.182.3.1535907
   Rahbek O, 2005, INT ORTHOP, V29, P368, DOI 10.1007/s00264-005-0008-4
   Reinus WR, 1996, AM J ROENTGENOL, V166, P1439, DOI 10.2214/ajr.166.6.8633459
   Reuter N, 2009, J RHEUMATOL, V36, P385, DOI 10.3899/jrheum.080363
   Sanchis-Alfonso V, 2007, KNEE SURG SPORT TR A, V15, P361, DOI 10.1007/s00167-006-0207-6
   SCHULTE KR, 1993, J BONE JOINT SURG AM, V75A, P961, DOI 10.2106/00004623-199307000-00002
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   Sharkey PF, 1999, J ARTHROPLASTY, V14, P426, DOI 10.1016/S0883-5403(99)90097-9
   SHELLEY P, 1988, J BONE JOINT SURG BR, V70, P358
   Shimmin AJ, 2005, J BONE JOINT SURG BR, V87B, P463, DOI 10.1302/0301-620X.87B4
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   SMITHPETERSEN MN, 1949, J BONE JOINT SURG AM, V31-A, P40, DOI 10.2106/00004623-194931010-00003
   Sofka Carolyn M, 2002, Semin Musculoskelet Radiol, V6, P79, DOI 10.1055/s-2002-23166
   Spencer S, 2008, J ARTHROPLASTY, V23, P1105, DOI 10.1016/j.arth.2007.10.014
   Steffen RT, 2009, J ARTHROPLASTY, V24, P614, DOI 10.1016/j.arth.2008.04.008
   Sugimoto H, 2003, RADIOLOGY, V229, P718, DOI 10.1148/radiol.2293021061
   TIGGES S, 1994, AM J ROENTGENOL, V163, P377, DOI 10.2214/ajr.163.2.8037035
   Vaughn ZD, 2010, SPORTS MED ARTHROSC, V18, P90, DOI 10.1097/JSA.0b013e3181dfce63
   WARNER JJP, 1987, CLIN ORTHOP RELAT R, P104
   WATANABE S, 1976, JPN CIRC J, V40, P603, DOI 10.1253/jcj.40.603
   White LM, 2000, RADIOLOGY, V215, P254, DOI 10.1148/radiology.215.1.r00ap11254
   WILLERT HG, 1990, CLIN ORTHOP RELAT R, P95
   Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp
   Wirtz DC, 1998, Z ORTHOP GRENZGEB, V136, P138, DOI 10.1055/s-2008-1051296
   Witzleb WC, 2007, ACTA ORTHOP, V78, P211, DOI 10.1080/17453670710013708
   Yoo MC, 2008, CLIN ORTHOP RELAT R, V466, P1133, DOI 10.1007/s11999-008-0204-9
NR 83
TC 3
Z9 4
U1 0
U2 0
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 1089-7860
EI 1098-898X
J9 SEMIN MUSCULOSKEL R
JI Semin. Musculoskelet. Radiol.
PD SEP
PY 2011
VL 15
IS 4
BP 357
EP 371
DI 10.1055/s-0031-1286016
PG 15
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 817DC
UT WOS:000294650200005
PM 21928159
DA 2018-10-20
ER

PT J
AU Brunelli, G
   Sollazzo, V
   Carinci, F
   Palmieri, A
   Girardi, A
   Monguzzi, R
AF Brunelli, G.
   Sollazzo, V.
   Carinci, F.
   Palmieri, A.
   Girardi, A.
   Monguzzi, R.
TI OSTEOBIOL (R) INFLUENCES OSTEOGENIC DIFFERENTIATION OF ADIPOSE DERIVED
   STEM CELLS
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Stem cells; adipose tissue; Osteoplant; bone; gene expression
AB OsteoBiol(R) is a cortical collagenated porcine bone largely employed as substitute for bone grafting. In animal model porcine bone showed good biocompatibility and osteoconductive properties. To study how cortical porcine bone can induce osteoblast differentiation and proliferation in mesenchymal stem cells, the expression levels of bone related genes (RUNX2, SP7, ALPL, SPP1, COL1A1, COL3A1 and FOSL1) and mesenchymal stem cells marker (ENG) were measured in Adipose Derived stem cells (ADSCs) and Human Osteoblasts (HOb) cultivated with OsteoBiol(R). OsteoBiol(R) induces up-regulation of SPP1 and ALPL during the first 15 days of treatment both in treated ADSCs than in treated HOb. In particular the up-regulation of SPP1 demonstrated that this biomaterial is actively resorbed by human osteoclasts.
C1 [Brunelli, G.] Don Orione Inst, Dept Dent & Maxillofacial Surg, Bergamo, Italy.
   [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
   [Carinci, F.; Palmieri, A.; Monguzzi, R.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   [Girardi, A.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & PlasticSurg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
FU FAR from the University of Ferrara, Ferrara, Italy; Regione Emilia
   Romagna, Programma di Ricerca Regione Universita [14]; Don Orione
   Service s.r.l., Bergamo, Italy
FX This work was supported by FAR from the University of Ferrara (FC),
   Ferrara, Italy, and from Regione Emilia Romagna, Programma di Ricerca
   Regione Universita, 2007-2009, Area 1B: Patologia osteoarticolare:
   ricerca pre-clinica e applicazioni cliniche della medicina rigenerativa,
   Unita Operativa n. 14. This work was partially supported by Don Orione
   Service s.r.l., Bergamo, Italy.
CR Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   MCKEE MD, 1993, J BONE MINER RES, V8, P485
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Sollazzo Vincenzo, 2011, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V9, P1, DOI 10.4028/www.scientific.net/JBBTE.9.1
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 12
TC 0
Z9 0
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD SEP-DEC
PY 2011
VL 9
IS 3
SU S
BP 103
EP 107
PG 5
WC Immunology
SC Immunology
GA V37BK
UT WOS:000209251100019
DA 2018-10-20
ER

PT J
AU Jantzen, AE
   Lane, WO
   Gage, SM
   Haseltine, JM
   Galinat, LJ
   Jamiolkowski, RM
   Lin, FH
   Truskey, GA
   Achneck, HE
AF Jantzen, Alexandra E.
   Lane, Whitney O.
   Gage, Shawn M.
   Haseltine, Justin M.
   Galinat, Lauren J.
   Jamiolkowski, Ryan M.
   Lin, Fu-Hsiung
   Truskey, George A.
   Achneck, Hardean E.
TI Autologous Endothelial Progenitor Cell-Seeding Technology and
   Biocompatibility Testing For Cardiovascular Devices in Large Animal
   Model
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 55; Stent; Titanium; Thrombosis; Endothelial
   Progenitor Cell; Endothelium; Biomaterial; Biocompatibility;
   Bioengineering; Translational Medicine; Vascular Surgery; Porcine
AB Implantable cardiovascular devices are manufactured from artificial materials (e.g. titanium (Ti), expanded polytetrafluoroethylene), which pose the risk of thromboemboli formation(1,2,3). We have developed a method to line the inside surface of Ti tubes with autologous blood-derived human or porcine endothelial progenitor cells (EPCs)(4). By implanting Ti tubes containing a confluent layer of porcine EPCs in the inferior vena cava (IVC) of pigs, we tested the improved biocompatibility of the cell-seeded surface in the prothrombotic environment of a large animal model and compared it to unmodified bare metal surfaces(5,6,7) (Figure 1). This method can be used to endothelialize devices within minutes of implantation and test their antithrombotic function in vivo.
   Peripheral blood was obtained from 50 kg Yorkshire swine and its mononuclear cell fraction cultured to isolate EPCs4,8. Ti tubes (9.4 mm ID) were pre-cut into three 4.5 cm longitudinal sections and reassembled with heat-shrink tubing. A seeding device was built, which allows for slow rotation of the Ti tubes.
   We performed a laparotomy on the pigs and externalized the intestine and urinary bladder. Sharp and blunt dissection was used to skeletonize the IVC from its bifurcation distal to the right renal artery proximal. The Ti tubes were then filled with fluorescently-labeled autologous EPC suspension and rotated at 10 RPH x 30 min to achieve uniform cell-coating(9). After administration of 100 USP/kg heparin, both ends of the IVC and a lumbar vein were clamped. A 4 cm veinotomy was performed and the device inserted and filled with phosphate-buffered saline. As the veinotomy was closed with a 4-0 Prolene running suture, one clamp was removed to de-air the IVC. At the end of the procedure, the fascia was approximated with 0-PDS (polydioxanone suture), the subcutaneous space closed with 2-0 Vicryl and the skin stapled closed.
   After 3 - 21 days, pigs were euthanized, the device explanted en-block and fixed. The Ti tubes were disassembled and the inner surfaces imaged with a fluorescent microscope.
   We found that the bare metal Ti tubes fully occluded whereas the EPC-seeded tubes remained patent. Further, we were able to demonstrate a confluent layer of EPCs on the inside blood-contacting surface.
   Concluding, our technology can be used to endothelialize Ti tubes within minutes of implantation with autologous EPCs to prevent thrombosis of the device. Our surgical method allows for testing the improved biocompatibility of such modified devices with minimal blood loss and EPC-seeded surface disruption.
C1 [Jantzen, Alexandra E.; Haseltine, Justin M.; Galinat, Lauren J.; Truskey, George A.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.
   [Lane, Whitney O.] Duke Univ, Sch Med, Durham, NC 27706 USA.
   [Gage, Shawn M.; Lin, Fu-Hsiung; Achneck, Hardean E.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27706 USA.
   [Jamiolkowski, Ryan M.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA.
RP Achneck, HE (reprint author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27706 USA.
EM hardean.achneck@duke.edu
OI Truskey, George/0000-0002-6885-4489
FU NIH [RC1HL099863-01]; National Science Foundation
FX The authors would like to thank Leica Microsystems for their valuable
   advice on imaging titanium sections and Gemini Bio-Products for
   providing the porcine serum used in this study. We also like to thank
   the NIH for their support through Grant "Autologous EPC lining to
   improve biocompatibility of circulatory assist devices", RC1HL099863-01.
   Further, we are grateful for the National Science Foundation Graduate
   Research Fellowship's support of Alexandra Jantzen. We also like to
   thank George Quick, Mike Lowe and Ianthia Parker for assisting with many
   aspects of the surgical procedure and handling of our research animals.
   Steven Owen has been invaluable in machining many parts of our seeding
   device and cutting titanium tubes.
CR Achneck H.E., 2010, AM HEART ASS SCI SES
   Achneck HE, 2008, VASCULAR, V16, pS6, DOI 10.2310/6670.2008.00028
   Achneck HE, 2010, CIRCULATION, V122, P2068, DOI 10.1161/CIRCULATIONAHA.110.936773
   Achneck HE, 2011, BIOMATERIALS, V32, P10, DOI 10.1016/j.biomaterials.2010.08.073
   Achneck HE, 2010, MICROSC RES TECHNIQ, V73, P71, DOI 10.1002/jemt.20757
   Arvidsson S, 2007, BIOMATERIALS, V28, P1346, DOI 10.1016/j.biomaterials.2006.11.005
   Ford JW, 1996, J SURG RES, V62, P23, DOI 10.1006/jsre.1996.0167
   Kang C, 2003, THROMB HAEMOSTASIS, V89, P256
   Ueberrueck T, 2005, J SURG RES, V124, P305, DOI 10.1016/j.jss.2004.10.021
   Velik-Salchner C, 2006, THROMB RES, V117, P597, DOI 10.1016/j.thromres.2005.05.015
   Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471
NR 11
TC 1
Z9 1
U1 0
U2 1
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD SEP
PY 2011
IS 55
AR UNSP e3197
DI 10.3791/3197
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36OY
UT WOS:000209222100035
PM 21931293
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Musson, DS
   Matthews, BG
   Terreni, V
   Callon, KE
   Naot, D
   Cornish, J
AF Musson, D. S.
   Matthews, B. G.
   Terreni, V.
   Callon, K. E.
   Naot, D.
   Cornish, J.
TI BIOMATERIAL SCAFFOLDS FOR MUSCULOSKELETAL REGENERATIVE MEDICINE: AN IN
   VITRO ANALYSIS
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Meeting Abstract
CT IOF Regionals 2nd Asia-Pacific Osteoporosis and Bone Meeting / ANZBMS
   Annual Scientific Meeting held with the JSBMR
CY SEP 04-08, 2011
CL Gold Coast, AUSTRALIA
SP ANZBMS, JSBMR, IOF Reg
C1 [Musson, D. S.; Matthews, B. G.; Callon, K. E.; Naot, D.; Cornish, J.] Univ Auckland, Dept Med, Auckland, New Zealand.
   [Terreni, V.] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD SEP
PY 2011
VL 22
SU 4
MA 66
BP S542
EP S543
PG 2
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 012SZ
UT WOS:000309258200085
DA 2018-10-20
ER

PT J
AU Yang, YM
   Yuan, XL
   Ding, F
   Yao, DB
   Gu, Y
   Liu, J
   Gu, XS
AF Yang, Yumin
   Yuan, Xinlu
   Ding, Fei
   Yao, Dengbing
   Gu, Yun
   Liu, Jie
   Gu, Xiaosong
TI Repair of Rat Sciatic Nerve Gap by a Silk Fibroin-Based Scaffold Added
   with Bone Marrow Mesenchymal Stem Cells
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID IMPROVE FUNCTIONAL RECOVERY; INJURED SPINAL-CORD; STROMAL CELLS;
   PERIPHERAL-NERVE; IN-VITRO; SCHWANN-CELLS; ADULT-RAT; REGENERATION;
   DIFFERENTIATE; PHENOTYPES
AB Tissue-engineered nerve grafts (TENGs), typically consisting of a neural scaffold included with support cells and/or growth factors, represent a promising alternative to autologous nerve grafts for surgical repair of large peripheral nerve gaps. Here, we developed a new design of TENGs by introducing bone marrow mesenchymal stem cells (MSCs) of rats, as support cells, into a silk fibroin (SF)-based scaffold, which was composed of an SF nerve guidance conduit and oriented SF filaments as the conduit lumen filler. The biomaterial SF had been tested to possess good biocompatibility and noncytoxicity with MSCs before the TENG was implanted to bridge a 10-mm-long gap in rat sciatic nerve. Functional and histological assessments showed that at 12 weeks after nerve grafting, TENGs yielded an improved outcome of nerve regeneration and functional recovery, which was better than that achieved by SF scaffolds and close to that by autologous nerve grafts. During 1-4 weeks after nerve grafting, MSCs contained in the TENG significantly accelerated axonal growth, displaying a positive reaction to S-100 (a Schwann cell marker). During 1-3 weeks after nerve grafting, MSCs contained in the TENG led to gene expression upregulation of S100 and several growth factors (brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor). These results suggest that the cell behaviors and neurotrophic functions of MSCs might be responsible for their promoting effects on peripheral nerve regeneration.
C1 [Yang, Yumin; Yuan, Xinlu; Ding, Fei; Yao, Dengbing; Gu, Yun; Liu, Jie; Gu, Xiaosong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong 226001, Jiangsu, Peoples R China.
RP Gu, XS (reprint author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.
EM neurongu@public.nt.js.cn
FU Hi-Tech Research and Development Program of China (863 Program)
   [2006AA02A128]; National Natural Science Foundation of China [30670667,
   30770585]; Priority Academic Program Development of Jiangsu Higher
   Education Institutions; Natural Science Foundation of Jiangsu Province
   [BK2008010, 07KJA31025]
FX The financial supports from Hi-Tech Research and Development Program of
   China (863 Program, Grant No. 2006AA02A128), National Natural Science
   Foundation of China (Grant No. 30670667 and 30770585), a project funded
   by the Priority Academic Program Development of Jiangsu Higher Education
   Institutions, and Natural Science Foundation of Jiangsu Province (Grant
   No. BK2008010 and 07KJA31025) are gratefully acknowledged.
CR Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D
   Chen X, 2006, MICROSURG, V26, P111, DOI 10.1002/micr.20184
   Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6
   Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fan HB, 2008, BIOMATERIALS, V29, P3324, DOI 10.1016/j.biomaterials.2008.04.012
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gobin AS, 2006, TISSUE ENG, V12, P3383, DOI 10.1089/ten.2006.12.3383
   Heath CA, 1998, TRENDS BIOTECHNOL, V16, P163, DOI 10.1016/S0167-7799(97)01165-7
   Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   JOHNSON A, 1986, BLOOD, V68, P1348
   Kocsis JD, 2002, J REHABIL RES DEV, V39, P287
   Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711
   Krekoski CA, 2001, J NEUROSCI, V21, P6206
   Li QF, 2006, MICROSURG, V26, P116, DOI 10.1002/micr.20192
   Lin WW, 2008, IN VITRO CELL DEV-AN, V44, P31, DOI 10.1007/s11626-007-9064-y
   Liu CH, 2005, CYTOKINE, V32, P270, DOI 10.1016/j.cyto.2005.11.003
   Liu M, 2007, MUSCLE NERVE, V35, P649, DOI 10.1002/mus.20749
   Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053
   Lu L, 2008, STEM CELLS, V26, P580, DOI 10.1634/stemcells.2007-0106
   Lundborg G, 2004, HANDCHIR MIKROCHIR P, V36, P1
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Mazzitellia S., 2008, J CONTROL RELEASE, V132, P58
   Meechaisue C, 2007, BIOMED MATER, V2, P181, DOI 10.1088/1748-6041/2/3/003
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Mosahebi A, 2003, TISSUE ENG, V9, P209, DOI 10.1089/107632703764664684
   Munoz-Elias G, 2003, STEM CELLS, V21, P437, DOI 10.1634/stemcells.21-4-437
   Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055
   Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105
   Oliveira JT, 2010, NEUROSCIENCE, V170, P1295, DOI 10.1016/j.neuroscience.2010.08.042
   Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637
   POSTLETHWAIT RW, 1970, ANN SURG, V171, P892, DOI 10.1097/00000658-197006010-00010
   Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Suzuki H, 2004, BIOCHEM BIOPH RES CO, V322, P918, DOI 10.1016/j.bbrc.2004.07.201
   Toba T, 2002, INT J ARTIF ORGANS, V25, P230
   Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Valero-Cabre A, 2001, J NEUROSCI RES, V63, P214, DOI 10.1002/1097-4547(20010115)63:2<214::AID-JNR1014>3.0.CO;2-D
   Wang D, 2008, BRAIN RES, V1188, P44, DOI 10.1016/j.brainres.2007.09.098
   Wang J, 2009, BRAIN RES, V1262, P7, DOI 10.1016/j.brainres.2009.01.056
   Wang SM, 2005, INVEST OPHTH VIS SCI, V46, P2552, DOI 10.1167/iovs.05-0279
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C
   Wurm FM, 2003, NAT BIOTECHNOL, V21, P34, DOI 10.1038/nbt0103-34
   Yang Y, 2007, BIOMATERIALS, V28, P5526, DOI 10.1016/j.biomaterials.2007.09.001
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Yu KM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002470
   Zhong C, 2003, NEUROSCI LETT, V342, P93, DOI 10.1016/S0304-3940(03)00255-6
   Zhou C, 2009, BRAIN RES, V1269, P23, DOI 10.1016/j.brainres.2009.02.049
NR 63
TC 64
Z9 73
U1 2
U2 24
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2011
VL 17
IS 17-18
BP 2231
EP 2244
DI 10.1089/ten.tea.2010.0633
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 812OV
UT WOS:000294303700011
PM 21542668
DA 2018-10-20
ER

PT J
AU Boukhechba, F
   Balaguer, T
   Bouvet-Gerbettaz, S
   Michiels, JF
   Bouler, JM
   Carle, GF
   Scimeca, JC
   Rochet, N
AF Boukhechba, Florian
   Balaguer, Thierry
   Bouvet-Gerbettaz, Sebastien
   Michiels, Jean-Francois
   Bouler, Jean-Michel
   Carle, Georges F.
   Scimeca, Jean-Claude
   Rochet, Nathalie
TI Fate of Bone Marrow Stromal Cells in a Syngenic Model of Bone Formation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERED BONE; IN-VIVO; OSTEOGENIC
   DIFFERENTIATION; TELOMERASE EXPRESSION; DEFECTS; PHOSPHATE; REPAIR;
   TRANSPLANTATION; MICE
AB Bone marrow stromal cells (BMSCs) have been demonstrated to induce bone formation when associated to osteoconductive biomaterials and implanted in vivo. Nevertheless, their role in bone reconstruction is not fully understood and rare studies have been conducted to follow their destiny after implantation in syngenic models. The aim of the present work was to use sensitive and quantitative methods to track donor and recipient cells after implantation of BMSCs in a syngenic model of ectopic bone formation. Using polymerase chain reaction (PCR) amplification of the Sex determining Region Y (Sry) gene and in situ hybridization of the Y chromosome in parallel to histological analysis, we have quantified within the implants the survival of the donor cells and the colonization by the recipient cells. The putative migration of the BMSCs in peripheral organs was also analyzed. We show here that grafted cells do not survive more than 3 weeks after implantation and might migrate in peripheral lymphoid organs. These cells are responsible for the attraction of host cells within the implants, leading to the centripetal colonization of the biomaterial by new bone.
C1 [Boukhechba, Florian; Balaguer, Thierry; Bouvet-Gerbettaz, Sebastien; Carle, Georges F.; Scimeca, Jean-Claude; Rochet, Nathalie] Univ Nice Sophia Antipolis, CNRS, UFR Med, GEPITOS, 28 Ave Valombrose, F-06100 Nice, France.
   [Balaguer, Thierry] Ctr Hosp Univ Nice, Hop St Roch, Serv Chirurg Plast Reparatrice & Esthet Chirurg M, Nice, France.
   [Michiels, Jean-Francois] Ctr Hosp Univ Nice, Hop Pasteur, Serv Anatomopathol, Nice, France.
   [Bouler, Jean-Michel] Univ Nantes, INSERM, LIOAD, UMR 791,UFR Odontol Nantes, Nantes, France.
RP Rochet, N (reprint author), Univ Nice Sophia Antipolis, CNRS, UFR Med, GEPITOS, 28 Ave Valombrose, F-06100 Nice, France.
EM nathalie.rochet@unice.fr
RI ROCHET, Nathalie/N-1819-2018
OI ROCHET, Nathalie/0000-0002-9995-6699; Scimeca,
   Jean-Claude/0000-0003-3773-6110; BOULER, Jean-Michel/0000-0001-9784-5584
FU CDD CNRS; P.R.A. fellowship; Centre National de la Recherche
   Scientifique (CNRS)
FX The authors are very grateful to Dr. Diane S. Krause for the gift of the
   Y probe and to GRAFTYS SA for supplying BCP particles. The authors thank
   all the staff of the Anatomy-Pathology Department for excellent
   technical assistance. This work was supported by a CDD CNRS for F.B., a
   P.R.A. fellowship for T. B. (Accord cadre CNRS/CHU de Nice), and by
   grants from the Centre National de la Recherche Scientifique (CNRS).
CR Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Cao F, 2007, J TISSUE ENG REGEN M, V1, P465, DOI 10.1002/term.55
   Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886
   Cooper LF, 2001, J DENT RES, V80, P314, DOI 10.1177/00220345010800010401
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   Eghbali-Fatourechi GZ, 2005, NEW ENGL J MED, V352, P1959, DOI 10.1056/NEJMoa044264
   Eyckmans J, 2006, TISSUE ENG, V12, P2203, DOI 10.1089/ten.2006.12.2203
   Fang DJ, 2007, STEM CELLS, V25, P1021, DOI 10.1634/stemcells.2006-0576
   Fellah BH, 2007, J MATER SCI-MATER M, V18, P287, DOI 10.1007/s10856-006-0691-8
   Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253
   Gan YK, 2008, BIOMATERIALS, V29, P3973, DOI 10.1016/j.biomaterials.2008.06.026
   Gauthier O, 1999, J PERIODONTOL, V70, P375, DOI 10.1902/jop.1999.70.4.375
   Geuze RE, 2010, TISSUE ENG PT A, V16, P3343, DOI [10.1089/ten.tea.2009.0774, 10.1089/ten.TEA.2009.0774]
   Giannoni P, 2008, J TISSUE ENG REGEN M, V2, P253, DOI 10.1002/term.90
   Giannoni P, 2010, TISSUE ENG PT A, V16, P489, DOI [10.1089/ten.tea.2009.0041, 10.1089/ten.TEA.2009.0041]
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hannouche D, 2007, J HISTOCHEM CYTOCHEM, V55, P255, DOI 10.1369/jhc.6A7063.2006
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   Jager M, 2007, J BONE MINER RES, V22, P1224, DOI 10.1359/JBMR.070414
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Krebsbach PH, 1998, TRANSPLANTATION, V66, P1272, DOI 10.1097/00007890-199811270-00002
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Lavrovsky Y, 1998, TRANSGENIC RES, V7, P319, DOI 10.1023/A:1008838616203
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x
   Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055
   OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019
   Seybold D, 2010, LANGENBECK ARCH SURG, V395, P719, DOI 10.1007/s00423-009-0588-3
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Tasso R, 2009, TISSUE ENG PT A, V15, P2203, DOI 10.1089/ten.tea.2008.0269
   Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135
   Theise ND, 2002, EXP HEMATOL, V30, P1333, DOI 10.1016/S0301-472X(02)00931-1
   Tortelli F, 2010, BIOMATERIALS, V31, P242, DOI 10.1016/j.biomaterials.2009.09.038
   Trojani C, 2006, BIOMATERIALS, V27, P3256, DOI 10.1016/j.biomaterials.2006.01.057
   Vacanti CA, 2001, NEW ENGL J MED, V344, P1511, DOI 10.1056/NEJM200105173442004
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018
   Zhang ZY, 2010, BIOMATERIALS, V31, P608, DOI 10.1016/j.biomaterials.2009.09.078
NR 47
TC 23
Z9 23
U1 1
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD SEP
PY 2011
VL 17
IS 17-18
BP 2267
EP 2278
DI 10.1089/ten.tea.2010.0461
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 812OV
UT WOS:000294303700014
PM 21539494
DA 2018-10-20
ER

PT J
AU Kew, SJ
   Gwynne, JH
   Enea, D
   Abu-Rub, M
   Pandit, A
   Zeugolis, D
   Brooks, RA
   Rushton, N
   Best, SM
   Cameron, RE
AF Kew, S. J.
   Gwynne, J. H.
   Enea, D.
   Abu-Rub, M.
   Pandit, A.
   Zeugolis, D.
   Brooks, R. A.
   Rushton, N.
   Best, S. M.
   Cameron, R. E.
TI Regeneration and repair of tendon and ligament tissue using collagen
   fibre biomaterials
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Collagen fibre; Tendon; Ligament; Regenerative medicine; Review
ID ANTERIOR CRUCIATE-LIGAMENT; MESENCHYMAL STEM-CELLS; POLARIZED-LIGHT
   MICROSCOPY; RABBIT ACHILLES-TENDON; ROTATOR CUFF REPAIRS; PATELLAR
   TENDON; MECHANICAL-PROPERTIES; IN-VITRO; EXTRACELLULAR-MATRIX;
   CROSS-LINKING
AB Collagen fibres are ubiquitous macromelecular assemblies in nature, providing the structures that support tensile mechanical loads within the human body. Aligned type I collagen fibres are the primary structural motif for tendon and ligament, and therefore biomaterials based on these structures are considered promising candidates for mediating regeneration of these tissues. However, despite considerable investigation, there remains no collagen-fibre-based biomaterial that has undergone clinical evaluation for this application. Recent research in this area has significantly enhanced our understanding of these complex and challenging biomaterials, and is reinvigorating interest in the development of such structures to recapitulate mechanical function. In this review we describe the progress to date towards a ligament or tendon regeneration template based on collagen fibre scaffolds. We highlight reports of particular relevance to the development of the underlying biomaterials science in this area. In addition, the potential for tailoring and manipulating the interactions between collagen fibres and biological systems, as hybrid biomaterial-biological ensembles, is discussed in the context of developing novel tissue engineering strategies for tendon and ligament. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kew, S. J.] Tigenix Ltd, Cambridge CB4 0WZ, England.
   [Gwynne, J. H.; Best, S. M.; Cameron, R. E.] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB2 3QZ, England.
   [Enea, D.; Brooks, R. A.; Rushton, N.] Univ Cambridge, Addenbrookes Hosp, Orthopaed Res Unit, Cambridge CB2 2QQ, England.
   [Abu-Rub, M.; Pandit, A.; Zeugolis, D.] Natl Univ Ireland Galway, Network Excellence Funct Biomat NFB, Galway, Ireland.
RP Kew, SJ (reprint author), Tigenix Ltd, Byron House,Cambridge Business Pk,Milton Rd, Cambridge CB4 0WZ, England.
EM sjkew@hotmail.com
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933; Cameron, Ruth/0000-0003-1573-4923;
   zeugolis, dimitrios/0000-0002-7599-5191
FU Technology Strategy Board [TP/8/BIO/6/I/Q0052K]; Science Foundation
   Ireland [07/SRC/B1163, 09/RFP/ENM2483]; Engineering and Physical
   Sciences Research Council, UK; Faculty Research Committee of the Faculty
   of Engineering, NUS, Singapore; Irish Research Council for Science
   Engineering and Technology, Ireland; Engineering and Physical Sciences
   Research Council [DT/F006977/1]
FX S.J.K., J.H.G., D.E., R.B., N.R., S.M.B. and R.E.C. would like to thank
   the Technology Strategy Board for support under Grant No.
   TP/8/BIO/6/I/Q0052K. A.P., D.Z. and M.A. would like to thank Science
   Foundation Ireland for support under Grant Nos. 07/SRC/B1163 and
   09/RFP/ENM2483; the Engineering and Physical Sciences Research Council,
   UK; the Faculty Research Committee of the Faculty of Engineering, NUS,
   Singapore; and the Irish Research Council for Science Engineering and
   Technology, Ireland.
CR AMIEL D, 1986, J ORTHOPAED RES, V4, P162, DOI 10.1002/jor.1100040204
   ARNOCZKY SP, 1982, J BONE JOINT SURG AM, V64, P217, DOI 10.2106/00004623-198264020-00011
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Bach BR, 2005, AM J SPORT MED, V33, P284, DOI 10.1177/0363546504267347
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Baker BM, 2007, BIOMATERIALS, V28, P1967, DOI 10.1016/j.biomaterials.2007.01.004
   Barrett GR, 2002, ARTHROSCOPY, V18, P46, DOI 10.1053/jars.2002.25974
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   Beynnon BD, 2002, J BONE JOINT SURG AM, V84A, P1503, DOI 10.2106/00004623-200209000-00001
   BIRK DE, 1990, J CELL SCI, V95, P649
   BOSCH U, 1992, AM J SPORT MED, V20, P558, DOI 10.1177/036354659202000513
   Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   CAO Y, 2002, PLAST RECONSTR SURG, V110
   Carey JL, 2009, J BONE JOINT SURG AM, V91A, P2242, DOI 10.2106/JBJS.I.00610
   Caruso AB, 2005, J BIOMED MATER RES A, V73A, P388, DOI 10.1002/jbm.a.30233
   CAVALLARO JF, 1994, BIOTECHNOL BIOENG, V43, P781, DOI 10.1002/bit.260430813
   Caves JM, 2010, J BIOMED MATER RES B, V93B, P24, DOI 10.1002/jbm.b.31555
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Cheema U, 2007, BIOTECHNOL BIOPROC E, V12, P9, DOI 10.1007/BF02931797
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   Cheng XG, 2008, BIOMATERIALS, V29, P3278, DOI 10.1016/j.biomaterials.2008.04.028
   CHVAPIL M, 1993, J BIOMED MATER RES, V27, P313, DOI 10.1002/jbm.820270305
   Cornwell KG, 2004, J BIOMED MATER RES A, V71A, P55, DOI 10.1002/jbm.a.30132
   Costa MA, 2006, TISSUE ENG, V12, P1937, DOI 10.1089/ten.2006.12.1937
   Dunn MG, 1997, J APPL POLYM SCI, V63, P1423, DOI 10.1002/(SICI)1097-4628(19970314)63:11<1423::AID-APP4>3.0.CO;2-O
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   DUNN MG, 1994, J ORTHOPAED RES, V12, P128, DOI 10.1002/jor.1100120116
   Dustmann M, 2008, KNEE SURG SPORT TR A, V16, P360, DOI 10.1007/s00167-007-0471-0
   Funakoshi T, 2005, J BIOMED MATER RES A, V74A, P338, DOI 10.1002/jbm.a.30237
   Gentleman E, 2006, ANN BIOMED ENG, V34, P726, DOI 10.1007/s10439-005-9058-4
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014
   Gigante A, 2009, J ORTHOP RES, V27, P826, DOI 10.1002/jor.20812
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   GOLDSTEIN JD, 1989, J BONE JOINT SURG AM, V71A, P1183, DOI 10.2106/00004623-198971080-00010
   GRISET EJ, 1964, Patent No. 3114593
   GROSS J, 1958, J BIOL CHEM, V233, P355
   JACKSON DW, 1993, AM J SPORT MED, V21, P176, DOI 10.1177/036354659302100203
   JANSSEN R, 2011, KNEE SURG SPORT TR A, P1
   JENKINS DHR, 1977, J BONE JOINT SURG BR, V59, P53
   JONES KG, 1970, J BONE JOINT SURG AM, VA 52, P838
   Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369
   KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283
   KATO YP, 1989, BIOMATERIALS, V10, P38, DOI 10.1016/0142-9612(89)90007-0
   KATO YP, 1990, BIOMATERIALS, V11, P169, DOI 10.1016/0142-9612(90)90150-O
   KATO YP, 1991, J BONE JOINT SURG AM, V73A, P561, DOI 10.2106/00004623-199173040-00013
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KLEINER JB, 1986, J ORTHOPAED RES, V4, P466, DOI 10.1002/jor.1100040410
   Koob TJ, 2002, BIOMATERIALS, V23, P203, DOI 10.1016/S0142-9612(01)00096-5
   Krych AJ, 2008, ARTHROSCOPY, V24, P292, DOI 10.1016/j.arthro.2007.08.029
   Kustos T, 2004, INT ORTHOP, V28, P290, DOI 10.1007/s00264-004-0568-8
   Liu W, 2006, TISSUE ENG, V12, P775, DOI 10.1089/ten.2006.12.775
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Marshall GD, 1928, J BONE JOINT SURG, V10, P816
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MCPHERSON GK, 1985, CLIN ORTHOP RELAT R, V196, P186
   Menetrey J, 2008, KNEE SURG SPORT TR A, V16, P224, DOI 10.1007/s00167-007-0474-x
   MODY BS, 1993, J BONE JOINT SURG BR, V75, P818
   Moffat KL, 2009, CLIN SPORT MED, V28, P157, DOI 10.1016/j.csm.2008.08.006
   MUNETA T, 1994, J ORTHOPAED RES, V12, P138, DOI 10.1002/jor.1100120117
   Murray MM, 2007, J ORTHOP RES, V25, P1007, DOI 10.1002/jor.20367
   NICHOLLS SP, 1984, ANN RHEUM DIS, V43, P477, DOI 10.1136/ard.43.3.477
   NOYES FR, 1976, J BONE JOINT SURG AM, V58, P1074, DOI 10.2106/00004623-197658080-00006
   Ohan MP, 2002, J BIOMED MATER RES, V60, P384, DOI 10.1002/jbm.10111
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Pinczewski LA, 2007, AM J SPORT MED, V35, P564, DOI 10.1177/0363546506296042
   Pins GD, 1995, MAT SCI ENG C-BIOMIM, V3, P101, DOI 10.1016/0928-4931(95)00109-3
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Prodromos C, 2007, KNEE SURG SPORT TR A, V15, P851, DOI 10.1007/s00167-007-0328-6
   Raspanti M, 2005, MATRIX BIOL, V24, P503, DOI 10.1016/j.matbio.2005.07.006
   Reddy GK, 1999, WOUND REPAIR REGEN, V7, P518, DOI 10.1046/j.1524-475X.1999.00518.x
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   SACHS RA, 1989, AM J SPORT MED, V17, P760, DOI 10.1177/036354658901700606
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Scheffler SU, 2008, KNEE SURG SPORT TR A, V16, P834, DOI 10.1007/s00167-008-0560-8
   Scheffler SU, 2008, ARTHROSCOPY, V24, P448, DOI 10.1016/j.arthro.2007.10.011
   Screen HRC, 2004, STRAIN, V40, P157, DOI 10.1111/j.1475-1305.2004.00164.x
   SHINO K, 1995, AM J SPORT MED, V23, P203, DOI 10.1177/036354659502300213
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   SILVER FH, 1980, J BIOL CHEM, V255, P9427
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   VANSTEENSEL CJ, 1987, J BONE JOINT SURG AM, V69A, P860, DOI 10.2106/00004623-198769060-00010
   Vidal BD, 2003, MICRON, V34, P423, DOI 10.1016/S0968-4328(03)00039-8
   Virchenko O, 2005, SCAND J MED SCI SPOR, V15, P260, DOI 10.1111/j.1600-0838.2005.00462.x
   Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   WANG MC, 1994, BIOMATERIALS, V15, P507
   Wang XT, 2005, J HAND SURG-AM, V30A, P222, DOI 10.1016/j.jhsa.2004.09.002
   Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M
   WOLMAN M, 1986, HISTOCHEMISTRY, V85, P41, DOI 10.1007/BF00508652
   WOO SLY, 1991, AM J SPORT MED, V19, P217, DOI 10.1177/036354659101900303
   YAHIA L'Ho-cine, 1997, LIGAMENTS LIGAMENTOP
   Yahyouche A, 2011, ACTA BIOMATER, V7, P278, DOI 10.1016/j.actbio.2010.08.005
   Yaltirik M, 2003, ORAL DIS, V9, P284, DOI 10.1034/j.1601-0825.2003.00954.x
   Yang L, 2008, BIOMATERIALS, V29, P955, DOI 10.1016/j.biomaterials.2007.10.058
   YUKO A, 2005, CLIN BIOMECH, V20, P959
   Zeugois DI, 2010, J BIOMED MATER RES A, V92A, P1310, DOI 10.1002/jbm.a.32383
   Zeugolis DI, 2008, J BIOMED MATER RES B, V85B, P343, DOI 10.1002/jbm.b.30952
   Zeugolis DI, 2008, J APPL POLYM SCI, V108, P2886, DOI 10.1002/app.27208
   Zeugolis DI, 2010, MAT SCI ENG C-MATER, V30, P190, DOI 10.1016/j.msec.2009.09.017
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031
   Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
NR 112
TC 76
Z9 80
U1 4
U2 109
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2011
VL 7
IS 9
BP 3237
EP 3247
DI 10.1016/j.actbio.2011.06.002
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 809GX
UT WOS:000294040900001
PM 21689792
DA 2018-10-20
ER

PT J
AU Baino, F
AF Baino, Francesco
TI Biomaterials and implants for orbital floor repair
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Orbital floor surgery; Biocompatibility; Autograft; Alloplastic; Tissue
   regeneration
ID BLOW-OUT FRACTURE; DRUG-RELEASE PROPERTY; RESORBABLE MESH PLATE;
   IN-VITRO BIOACTIVITY; CRANIAL BONE-GRAFTS; SMOOTH NYLON FOIL; TITANIUM
   MESH; HYDROXYAPATITE CEMENT; CRANIOFACIAL RECONSTRUCTION;
   POLY(L-LACTIDE) IMPLANTS
AB Treatment of orbital floor fractures and defects is often a complex issue. Repair of these injuries essentially aims to restore the continuity of the orbital floor and to provide an adequate support to the orbital content. Several materials and implants have been proposed over the years for orbital floor reconstruction, in the hope of achieving the best clinical outcome for the patient. Autografts have been traditionally considered as the "gold standard" choice due to the absence of an adverse immunological response, but they are available in limited amounts and carry the need for extra surgery. In order to overcome the drawbacks related to autografts, researchers' and surgeons' attention has been progressively attracted by alloplastic materials, which can be commercially produced and easily tailored to fit a wide range of specific clinical needs. In this review the advantages and limitations of the various biomaterials proposed and tested for orbital floor repair are critically examined and discussed. Criteria and guidelines for optimal material/implant choice, as well as future research directions, are also presented, in an attempt to understand whether an ideal biomaterial already exists or a truly functional implant will eventually materialise in the next few years. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Politecn Torino, Mat Sci & Chem Engn Dept, I-10129 Turin, Italy.
RP Baino, F (reprint author), Politecn Torino, Mat Sci & Chem Engn Dept, Corso Duca Abruzzi 24, I-10129 Turin, Italy.
EM francesco.baino@polito.it
OI Baino, Francesco/0000-0001-8860-0497
CR Adya N., 2005, J INDIAN PROSTHODONT, V5, P126, DOI DOI 10.4103/0972-4052.17104
   Agrawal CM, 1997, MATER SCI FORUM, V250, P115, DOI 10.4028/www.scientific.net/MSF.250.115
   Aho AJ, 1998, ACTA ORTHOP SCAND, V69, P559, DOI 10.3109/17453679808999255
   Aitasalo K, 2001, J ORAL MAXIL SURG, V59, P1390, DOI 10.1053/joms.2001.27524
   Al-Sukhun J, 2006, J ORAL MAXIL SURG, V64, P1038, DOI 10.1016/j.joms.2006.03.010
   Andreiotelli M, 2009, CLIN ORAL IMPLAN RES, V20, P32, DOI 10.1111/j.1600-0501.2009.01785.x
   Asamura S, 2010, J CRANIO MAXILL SURG, V38, P197, DOI 10.1016/j.jcms.2009.06.011
   Asamura S, 2010, ANN PLAS SURG, V64, P496, DOI 10.1097/SAP.0b013e31819b6c52
   Baino F, 2011, J BIOMED MATER RES A, V97A, P514, DOI 10.1002/jbm.a.33072
   Baino F, 2010, MED ENG PHYS, V32, P945, DOI 10.1016/j.medengphy.2010.07.007
   Balogh C, 2001, Rev Stomatol Chir Maxillofac, V102, P109
   Banovetz JM, 1996, J ORTHOP TRAUMA, V10, P389, DOI 10.1097/00005131-199608000-00005
   Bansagi ZC, 2000, OPHTHALMOLOGY, V107, P829, DOI 10.1016/S0161-6420(00)00015-4
   Baumann A, 2002, INT J ORAL MAX SURG, V31, P367, DOI 10.1054/ijom.2001.0219
   Bayat M, 2010, BRIT J ORAL MAX SURG, V48, P617, DOI 10.1016/j.bjoms.2009.10.019
   Becker ST, 2010, J CRANIOFAC SURG, V21, P1066, DOI 10.1097/SCS.0b013e3181e62c5f
   Bergmann C, 2010, J EUR CERAM SOC, V30, P2563, DOI 10.1016/j.jeurceramsoc.2010.04.037
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   BERGSMA JE, 1994, CELL MATER, V4, P31
   Betz MW, 2010, TISSUE ENG PART B-RE, V16, P541, DOI 10.1089/ten.teb.2009.0393
   Betz MW, 2009, J BIOMED MATER RES A, V90A, P819, DOI 10.1002/jbm.a.32131
   BEVIVINO JR, 1994, ANN PLAS SURG, V33, P32, DOI 10.1097/00000637-199407000-00007
   BOUSH GA, 1994, OPHTHALMIC PLAST REC, V10, P271, DOI 10.1097/00002341-199412000-00010
   Breton P, 1990, Rev Stomatol Chir Maxillofac, V91 Suppl 1, P52
   BROWN AE, 1993, BRIT J ORAL MAX SURG, V31, P154, DOI 10.1016/0266-4356(93)90114-C
   Buchel P, 2005, J ORAL MAXIL SURG, V63, P646, DOI 10.1016/j.joms.2004.11.013
   Burnstine MA, 2002, OPHTHALMOLOGY, V109, P1207, DOI 10.1016/S0161-6420(02)01057-6
   BURRES SA, 1981, LARYNGOSCOPE, V91, P1881
   Campbell DG, 1999, AUST NZ J SURG, V69, P517, DOI 10.1046/j.1440-1622.1999.01615.x
   Carroll SC, 2010, BRIT J OPHTHALMOL, V94, P736, DOI 10.1136/bjo.2008.155143
   Celikoz B, 1997, J ORAL MAXIL SURG, V55, P240
   Chang Edward W, 2005, Facial Plast Surg, V21, P207, DOI 10.1055/s-2005-922861
   CHEN JM, 1992, J ORAL MAXIL SURG, V50, P935, DOI 10.1016/0278-2391(92)90049-6
   Cheung D, 2004, OPHTHAL PLAST RECONS, V20, P257, DOI 10.1097/01.IOP.0000129019.24879.C2
   Chiono V, 2010, BIOMACROMOLECULES, V11, P309, DOI 10.1021/bm901169v
   Chowdhury K, 1998, ARCH OTOLARYNGOL, V124, P1398, DOI 10.1001/archotol.124.12.1398
   Chrobok Viktor, 2008, Acta Medica (Hradec Kralove), V51, P229
   Cieslik T, 2009, J CRANIOFAC SURG, V20, P512, DOI 10.1097/SCS.0b013e31818436a5
   Cole P, 2007, PLAST RECONSTR SURG, V120, p57S, DOI 10.1097/01.prs.0000260752.20481.b4
   *COMM EUR UN, 2004, DIR EU PARL COUNC SE
   CONSTANTIAN MB, 1982, PLAST RECONSTR SURG, V69, P951, DOI 10.1097/00006534-198206000-00006
   Cordewener FW, 1996, J ORAL MAXIL SURG, V54, P9, DOI 10.1016/S0278-2391(96)90292-X
   COSTA JMC, 2005, ARQ INT OTORRINOLARI, V9, P181
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   COSTANTINO PD, 1992, PLAST RECONSTR SURG, V90, P174, DOI 10.1097/00006534-199290020-00003
   Courtney DJ, 2000, BRIT J ORAL MAX SURG, V38, P496, DOI 10.1054/bjom.2000.0500
   CUTRIGHT DE, 1972, ORAL SURG ORAL MED O, V33, P28, DOI 10.1016/0030-4220(72)90204-6
   de Roche R, 2001, Mund Kiefer Gesichtschir, V5, P49, DOI 10.1007/s100060000254
   de Roche R, 1998, MUND KIEFER GESIC S1, V2, P117
   DOBBS HS, 1983, J MATER SCI, V18, P391, DOI 10.1007/BF00560627
   Dost P, 1996, LARYNGO RHINO OTOL, V75, P57, DOI 10.1055/s-2007-997533
   Dougherty W R, 1994, J Craniofac Surg, V5, P26, DOI 10.1097/00001665-199402000-00007
   Downes RN, 1991, BIOCERAMICS, V4, P239
   Ducic Y, 2009, OTOLARYNG HEAD NECK, V140, P849, DOI 10.1016/j.otohns.2009.03.004
   Edwards RC, 2001, J ORAL MAXIL SURG, V59, P19, DOI 10.1053/joms.2001.19267
   Ellis E, 2003, J ORAL MAXIL SURG, V61, P442, DOI 10.1053/joms.2003.50085
   Elmazar H, 2003, EUR J PLAST SURG, V25, P362
   Enislidis G, 1997, J CRANIO MAXILL SURG, V25, P316, DOI 10.1016/S1010-5182(97)80033-9
   Eppley BL, 2004, PLAST RECONSTR SURG, V114, P850, DOI 10.1097/01.FRS.0000132856.69391.43
   Farwell DG, 2007, OTOLARYNG CLIN N AM, V40, P319, DOI 10.1016/j.otc.2006.11.007
   Ferraris S, 2011, J MATER SCI-MATER M, V22, P533, DOI 10.1007/s10856-011-4246-2
   Fialkov JA, 2001, J CRANIOFAC SURG, V12, P362, DOI 10.1097/00001665-200107000-00009
   FRANCEL TJ, 1992, PLAST RECONSTR SURG, V90, P568, DOI 10.1097/00006534-199210000-00004
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   FRIEDMAN CD, 1991, ARCH OTOLARYNGOL, V117, P385
   Gear AJL, 2002, ANN PLAS SURG, V48, P1, DOI 10.1097/00000637-200201000-00001
   Gerhardt LC, 2010, MATERIALS, V3, P3867, DOI 10.3390/ma3073867
   GLASSMAN RD, 1990, PLAST RECONSTR SURG, V86, P1103, DOI 10.1097/00006534-199012000-00009
   Gosau M, 2011, CLIN ORAL INVEST, V15, P305, DOI 10.1007/s00784-010-0385-y
   GUOL L, 2002, ANN PLAST SURG, V63, P624
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hammer B, 1995, ORBITAL FRACTURES DI
   HANSON LJ, 1994, J ORAL MAXIL SURG, V52, P1050, DOI 10.1016/0278-2391(94)90175-9
   Hartstein M E, 2000, Facial Plast Surg, V16, P95
   Hatton P. V., 1994, Clinical Materials, V17, P71, DOI 10.1016/0267-6605(94)90014-0
   HAWES MJ, 1983, OPHTHALMOLOGY, V90, P1066
   HENCH L L, 1972, Journal of Biomedical Materials Research Biomedical Materials Symposium, V2, P117
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Hench LL, 2009, J EUR CERAM SOC, V29, P1257, DOI 10.1016/j.jeurceramsoc.2008.08.002
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hollier LH, 2001, J CRANIOFAC SURG, V12, P242, DOI 10.1097/00001665-200105000-00009
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   HOLT GR, 1988, OTOLARYNG CLIN N AM, V21, P35
   Hughes CW, 2003, BRIT J ORAL MAX SURG, V41, P50, DOI 10.1016/S0266-4356(02)00249-8
   Hwang K, 2002, J CRANIOFAC SURG, V13, P510, DOI 10.1097/00001665-200207000-00006
   ILANKOVAN V, 1992, BRIT J ORAL MAX SURG, V30, P92, DOI 10.1016/0266-4356(92)90077-V
   Jank S, 2003, ORAL SURG ORAL MED O, V95, P16, DOI 10.1067/moe.2003.11
   Johnson PE, 1999, PLAST RECONSTR SURG, V103, P1709, DOI 10.1097/00006534-199905060-00023
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Jones JR, 2007, ELEMENTS, V3, P393, DOI 10.2113/GSELEMENTS.3.6.393
   Jones JR, 2009, J EUR CERAM SOC, V29, P1275, DOI 10.1016/j.jeurceramsoc.2008.08.003
   Jordan DR, 1998, OPHTHALMIC PLAST REC, V14, P379, DOI 10.1097/00002341-199811000-00001
   Kakibuchi M, 2003, PLAST RECONSTR SURG, V111, P961, DOI 10.1097/00006534-200302000-00099
   Kellman RM, 1998, ARCH OTOLARYNGOL, V124, P1402
   Kinnunen I, 2000, J CRANIO MAXILL SURG, V28, P229, DOI 10.1054/jcms.2000.0140
   KLINE RM, 1995, PLAST RECONSTR SURG, V95, P5, DOI 10.1097/00006534-199501000-00002
   Klisovic Dino D, 2002, Orbit, V21, P149, DOI 10.1076/orbi.21.2.149.7190
   Kontakis GM, 2007, ACTA ORTHOP BELG, V73, P159
   Kontio R, 2001, INT J ORAL MAX SURG, V30, P278, DOI 10.1054/ijom.2001.0067
   Kozakiewicz M, 2009, J CRANIO MAXILL SURG, V37, P229, DOI 10.1016/j.jcms.2008.11.009
   Kraus M, 2002, INT J PEDIATR OTORHI, V64, P187, DOI 10.1016/S0165-5876(02)00013-7
   KRAUS M, 2001, J ORAL MAXILLOFAC SU, V59, P1307
   Kwon JH, 2008, ARCH FACIAL PLAST S, V10, P21, DOI 10.1001/archfacial.2007.9
   Lai A, 1998, LARYNGOSCOPE, V108, P645, DOI 10.1097/00005537-199805000-00004
   LATROU I, 2001, ORAL SURG ORAL MED O, V91, P281
   Laxenaire A., 1997, Revue de Stomatologie et de Chirurgie Maxillo-Faciale, V98, P96
   LAXENAIRE A, 1996, ANN CHIR PLAST ESTH, V4, P631
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Lemke BN, 1999, OPHTHALMIC PLAST REC, V15, P161, DOI 10.1097/00002341-199905000-00004
   Levy RA, 1997, AM J NEURORADIOL, V18, P1522
   Lieger O, 2010, ARCH FACIAL PLAST S, V12, P399, DOI 10.1001/archfacial.2010.91
   Lieger O, 2010, ARCH FACIAL PLAST S, V12, P186, DOI 10.1001/archfacial.2010.26
   LIN KY, 1990, PLAST RECONSTR SURG, V86, P449, DOI 10.1097/00006534-199009000-00010
   LIPSHUTZ H, 1963, J Trauma, V3, P563, DOI 10.1097/00005373-196311000-00006
   Liu D, 1999, AM J OPHTHALMOL, V128, P122
   Lupi E, 2004, INVEST OPHTH VIS SCI, V45, pE4700
   Lyu SP, 2009, INT J MOL SCI, V10, P4033, DOI 10.3390/ijms10094033
   Mackenzie D J, 1999, J Craniomaxillofac Trauma, V5, P9
   Majmundar MV, 2007, ARCH FACIAL PLAST S, V9, P64, DOI 10.1001/archfaci.9.1.64
   Manolidis S, 2002, J CRANIOFAC SURG, V13, P726, DOI 10.1097/01.SCS
   Mathog RH, 1998, ARCH OTOLARYNGOL, V124, P1402, DOI 10.1001/archotol.124.12.1402
   Mathur Kevin K, 2003, Arch Facial Plast Surg, V5, P379, DOI 10.1001/archfaci.5.5.379
   MCVICAR I, 1995, BRIT J ORAL MAX SURG, V33, P220, DOI 10.1016/0266-4356(95)90003-9
   Meijer AGW, 2002, ORL J OTO-RHINO-LARY, V64, P173, DOI 10.1159/000058021
   MERBS SL, 2005, INVEST OPHTH VIS S S, V46, pNI821
   Mermer R W, 1995, J Craniomaxillofac Trauma, V1, P30
   Merten H A, 1994, Fortschr Kiefer Gesichtschir, V39, P186
   Mintz SM, 1998, J ORAL MAXIL SURG, V56, P1140, DOI 10.1016/S0278-2391(98)90755-8
   Miyasaka Muneo, 2008, Tokai J Exp Clin Med, V33, P35
   Mok David, 2004, Can J Plast Surg, V12, P134
   Morax S, 1993, Ann Chir Plast Esthet, V38, P445
   MORRISON AD, 1995, J ORAL MAXIL SURG, V53, P412, DOI 10.1016/0278-2391(95)90714-9
   Munoz Guerra M F, 2001, J Oral Maxillofac Surg, V59, P595
   MUNOZGUERRA MF, 2000, J ORAL MAXILLOFAC SU, V58, P361
   Nakamura Y, 1999, NEUROLOGY, V53, P218, DOI 10.1212/WNL.53.1.218
   Nam SB, 2006, ANN PLAS SURG, V56, P263, DOI 10.1097/01.sap.0000199173.73610.bc
   Neigel JM, 1996, OPHTHAL PLAST RECONS, V12, P108, DOI 10.1097/00002341-199606000-00005
   Ng P, 1996, Australas Radiol, V40, P264, DOI 10.1111/j.1440-1673.1996.tb00400.x
   Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9
   Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4
   Nishiike S, 2005, ARCH OTOLARYNGOL, V131, P911, DOI 10.1001/archotol.131.10.911
   Nunery WR, 2008, OPHTHAL PLAST RECONS, V24, P271, DOI 10.1097/IOP.0b013e3181788de8
   ONO I, 1994, SCAND J PLAST RECONS, V28, P193, DOI 10.3109/02844319409015980
   Ozaki W, 1998, PLAST RECONSTR SURG, V102, P291, DOI 10.1097/00006534-199808000-00001
   Park DJJ, 2008, OPHTHAL PLAST RECONS, V24, P266, DOI 10.1097/IOP.0b013e31817e0fe0
   Park HS, 2001, J CRANIOFAC SURG, V12, P555, DOI 10.1097/00001665-200111000-00010
   Patel B C, 1998, Facial Plast Surg, V14, P83, DOI 10.1055/s-0028-1085305
   Patel M, 2010, TISSUE ENG PT A, V16, P55, DOI [10.1089/ten.tea.2009.0027, 10.1089/ten.TEA.2009.0027]
   Patel PJ, 2003, ARCH OPHTHALMOL-CHIC, V121, P400
   Peltola M, 2008, J ORAL MAXIL SURG, V66, P639, DOI 10.1016/j.joms.2007.11.019
   PHILLIPS JH, 1990, PLAST RECONSTR SURG, V85, P891, DOI 10.1097/00006534-199006000-00009
   PILLAI CKS, 2011, J BIOMATER APPL, P291
   Piotrowski WP, 1999, J ORAL MAXIL SURG, V57, P1301, DOI 10.1016/S0278-2391(99)90865-0
   Potter JK, 2004, J ORAL MAXIL SURG, V62, P1280, DOI 10.1016/j.joms.2004.04.018
   Prowse SJB, 2010, J PLAST RECONSTR AES, V63, P1105, DOI 10.1016/j.bjps.2009.05.057
   Quadrani P, 2005, MED BIOL ENG COMPUT, V43, P196, DOI 10.1007/BF02345954
   Rahaman MN, 2011, ACTA BIOMATER, V7, P2355, DOI 10.1016/j.actbio.2011.03.016
   Ram H, 2010, J MAXILLOFAC ORAL SU, V9, P134, DOI 10.1007/s12663-010-0047-2
   Reyes JP, 2005, ADV TECHNOL MAT MAT, V7, P1
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   Romano J J, 1993, J Craniofac Surg, V4, P142, DOI 10.1097/00001665-199307000-00007
   ROZEMA FR, 1990, J ORAL MAXIL SURG, V48, P1305, DOI 10.1016/0278-2391(90)90487-M
   Sachs ME, 1981, ADV OPTHALMOL PLAST, V6, P387
   Sakakibara S, 2009, J ORAL MAXIL SURG, V67, P957, DOI 10.1016/j.joms.2008.08.014
   Sallam MM, 2010, J APPL SCI RES, V6, P653
   Saluja H, 2009, J MAXILLOFAC ORAL SU, V8, P141, DOI 10.1007/s12663-009-0035-6
   SARGENT LA, 1991, PLAST RECONSTR SURG, V88, P31, DOI 10.1097/00006534-199107000-00006
   Schlickewei W, 2007, MACROMOL SYMP, V253, P10, DOI 10.1002/masy.200750702
   Schmidt BL, 1998, J CRANIOFAC SURG, V9, P452, DOI 10.1097/00001665-199809000-00012
   Schon R, 2006, INT J ORAL MAX SURG, V35, P990, DOI 10.1016/j.ijom.2006.06.018
   Schubert W, 2002, PLAST RECONSTR SURG, V110, P1022, DOI 10.1097/01.PRS.0000021307.23118.E7
   Sevin K, 2000, BRIT J ORAL MAX SURG, V38, P44, DOI 10.1054/bjom.1998.0038
   Shetty P, 2009, J MAXILLOFAC ORAL SU, V8, P137, DOI 10.1007/s12663-009-0034-7
   Sires BS, 1998, ARCH OPHTHALMOL-CHIC, V116, P955
   SMITH B, 1957, AM J OPHTHALMOL, V44, P734
   Strong EB, 2004, OTOLARYNG HEAD NECK, V131, P683, DOI 10.1016/j.otohns.2004.05.017
   SULLIVAN PK, 1993, PLAST RECONSTR SURG, V91, P769, DOI 10.1097/00006534-199304001-00002
   SULLIVAN PK, 1994, PLAST RECONSTR SURG, V94, P589, DOI 10.1097/00006534-199410000-00004
   Tabrizi R, 2010, J CRANIOFAC SURG, V21, P1142, DOI 10.1097/SCS.0b013e3181e57241
   Tanner KE, 2010, J R SOC INTERFACE, V7, pS541, DOI 10.1098/rsif.2010.0229.focus
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   TENZEL RR, 1971, AM J OPHTHALMOL, V71, P1141, DOI 10.1016/0002-9394(71)90592-7
   Tuncer S, 2007, J CRANIOFAC SURG, V18, P598, DOI 10.1097/01.scs.0000246735.92095.ef
   Uygur S, 2009, J CRANIOFAC SURG, V20, P71, DOI 10.1097/SCS.0b013e318190dee0
   Villarreal PM, 2002, PLAST RECONSTR SURG, V109, P877, DOI 10.1097/00006534-200203000-00007
   Wachler BSB, 1998, OPHTHALMIC PLAST REC, V14, P17
   WAITE PD, 1988, J ORAL MAXIL SURG, V46, P727, DOI 10.1016/0278-2391(88)90180-2
   WALTER WL, 1972, SOUTHERN MED J, V65, P1229, DOI 10.1097/00007611-197210000-00014
   Wang ST, 2008, ORAL SURG ORAL MED O, V106, P324, DOI 10.1016/j.tripleo.2007.12.022
   WEBSTER K, 1988, ORAL SURG ORAL MED O, V65, P161, DOI 10.1016/0030-4220(88)90158-2
   WILKINS RB, 1982, OPHTHALMOLOGY, V89, P464
   WILLIAMS DF, 1982, J MATER SCI, V17, P1233, DOI 10.1007/BF00752233
   Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002
   Xia W, 2008, J NON-CRYST SOLIDS, V354, P1338, DOI 10.1016/j.jnoncrysol.2006.10.084
   YOUNG VL, 1990, PLAST RECONSTR SURG, V86, P763, DOI 10.1097/00006534-199010000-00029
   Zhang Y, 2007, J BIOMED MATER RES A, V81A, P409, DOI 10.1002/jbm.a.31078
   Zhu YF, 2009, MICROPOR MESOPOR MAT, V118, P176, DOI 10.1016/j.micromeso.2008.08.046
   ZINS JE, 1983, PLAST RECONSTR SURG, V72, P778, DOI 10.1097/00006534-198312000-00005
   Zoumaras J., 2009, AUST NZ J SURG, V79, pA55
NR 203
TC 59
Z9 61
U1 2
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2011
VL 7
IS 9
BP 3248
EP 3266
DI 10.1016/j.actbio.2011.05.016
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 809GX
UT WOS:000294040900002
PM 21651997
OA Green Published
DA 2018-10-20
ER

PT J
AU Greulich, C
   Diendorf, J
   Gessmann, J
   Simon, T
   Habijan, T
   Eggeler, G
   Schildhauer, TA
   Epple, M
   Koller, M
AF Greulich, C.
   Diendorf, J.
   Gessmann, J.
   Simon, T.
   Habijan, T.
   Eggeler, G.
   Schildhauer, T. A.
   Epple, M.
   Koeller, M.
TI Cell type-specific responses of peripheral blood mononuclear cells to
   silver nanoparticles
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silver nanoparticles; Peripheral blood mononuclear cells; Cellular
   uptake; Cellular response; Focused ion beam
ID MESENCHYMAL STEM-CELLS; NANO-SILVER; NANOSILVER; RELEASE; MECHANISM;
   TOXICITY; IONS; CYTOTOXICITY; EXPRESSION; GRADIENTS
AB Silver nanoparticles (Ag-NP) are increasingly used in biomedical applications because of their remarkable antimicrobial activity. In biomedicine, Ag-NP are coated onto or embedded in wound dressings, surgical instruments and bone substitute biomaterials, such as silver-containing calcium phosphate cements. Free Ag-NP and silver ions are released from these coatings or after the degradation of a biomaterial, and may come into close contact with blood cells. Despite the widespread use of Ag-NP as an antimicrobial agent, there is a serious lack of information on the biological effects of Ag-NP on human blood cells. In this study, the uptake of Ag-NP by peripheral monocytes and lymphocytes (T-cells) was analyzed, and the influence of nanosilver on cell biological functions (proliferation, the expression of adhesion molecules, cytokine release and the generation of reactive oxygen species) was studied. After cell culture in the presence of monodispersed Ag-NP (5-30 mu g ml(-1) silver concentration), agglomerates of nanoparticles were detected within monocytes (CD14+) but not in T-cells (CD3+) by light microscopy, flow cytometry and combined focused ion beam/scanning electron microscopy. The uptake rate of nanoparticles was concentration dependent, and the silver agglomerates were typically found in the cytoplasm. Furthermore, a concentration-dependent activation (e.g. an increased expression of adhesion molecule CD54) of monocytes at Ag-NP concentrations of 10-15 mu g ml(-1) was observed, and cytotoxicity of Ag-NP-treated monocytes was observed at Ag-NP levels of 25 mu g ml(-1) and higher. However, no modulation of T-cell proliferation was observed in the presence of Ag-NP. Taken together, our results provide the first evidence for a cell-type-specific uptake of Ag-NP by peripheral blood mononuclear cells (PBMC) and the resultant cellular responses after exposure. (C) 2011 Acta materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Greulich, C.; Gessmann, J.; Habijan, T.; Schildhauer, T. A.; Koeller, M.] Ruhr Univ Bochum, Bergmannsheil Univ Hosp Surg Res, D-44789 Bochum, Germany.
   [Diendorf, J.; Epple, M.] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CeNIDE, D-45117 Essen, Germany.
   [Simon, T.; Eggeler, G.] Ruhr Univ Bochum, Inst Mat, Fac Mech Engn, D-44789 Bochum, Germany.
RP Greulich, C (reprint author), Ruhr Univ Bochum, Bergmannsheil Univ Hosp Surg Res, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.
EM christina.greulich@rub.de
RI Eggeler, Gunther/R-9833-2016
OI Eggeler, Gunther/0000-0002-6671-4618; Schildhauer,
   Thomas/0000-0002-3232-9869
FU Deutsche Forschungsgemeinschaft (DFG) [SPP1313]
FX We thank the Deutsche Forschungsgemeinschaft (DFG) for financial support
   of this project within the Priority Program Nano-BioResponses (SPP1313).
CR Alberts B, 2002, MOL BIOL CELL
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Asokan A, 2002, J PHARM SCI, V91, P903, DOI 10.1002/jps.10095
   Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m
   Cartiera MS, 2009, BIOMATERIALS, V30, P2790, DOI 10.1016/j.biomaterials.2009.01.057
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Dausend J, 2008, MACROMOL BIOSCI, V8, P1135, DOI 10.1002/mabi.200800123
   ENGLISH D, 1974, J IMMUNOL METHODS, V5, P249, DOI 10.1016/0022-1759(74)90109-4
   Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Foldbjerg R, 2011, ARCH TOXICOL, V85, P743, DOI 10.1007/s00204-010-0545-5
   Furno F, 2004, J ANTIMICROB CHEMOTH, V54, P1019, DOI 10.1093/jac/dkh478
   Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423
   Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Greulich C, 2011, ACTA BIOMATER, V7, P347, DOI 10.1016/j.actbio.2010.08.003
   Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1
   Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135
   Heymann JAW, 2009, J STRUCT BIOL, V166, P1, DOI 10.1016/j.jsb.2008.11.005
   Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015
   Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074
   Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482
   Kittler S, 2010, CHEM MATER, V22, P4548, DOI 10.1021/cm100023p
   Kittler S, 2010, J MATER CHEM, V20, P512, DOI 10.1039/b914875b
   KLEIN CL, 1994, J MATER SCI-MATER M, V5, P789
   Liang AH, 2008, SCI CHINA SER B, V51, P226, DOI 10.1007/s11426-008-0005-8
   Liochev SI, 1999, MET IONS BIOL SYST, V36, P1
   Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n
   Liu JY, 2010, ENVIRON SCI TECHNOL, V44, P2169, DOI 10.1021/es9035557
   Lovestam G., 2010, CONSIDERATIONS DEFIN
   Matsumura Y, 2003, APPL ENVIRON MICROB, V69, P4278, DOI 10.1128/AEM.69.7.4278-4281.2003
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Rigano R, 1999, CLIN EXP IMMUNOL, V118, P95
   Roe D, 2008, J ANTIMICROB CHEMOTH, V61, P869, DOI 10.1093/jac/dkn034
   Schmal H, 2007, CYTOTHERAPY, V9, P69, DOI 10.1080/14653240601011557
   Schmalz G, 2000, EUR J ORAL SCI, V108, P442, DOI 10.1034/j.1600-0722.2000.108005442.x
   Shin SH, 2007, INT IMMUNOPHARMACOL, V7, P1813, DOI 10.1016/j.intimp.2007.08.025
   Slawson R M, 1990, Biol Met, V3, P151, DOI 10.1007/BF01140573
   Stevens KNJ, 2009, BIOMATERIALS, V30, P3682, DOI 10.1016/j.biomaterials.2009.03.054
   Suzuki H, 2007, ENVIRON SCI TECHNOL, V41, P3018, DOI 10.1021/es0625632
   Tang JL, 2009, J NANOSCI NANOTECHNO, V9, P4924, DOI 10.1166/jnn.2009.1269
   Vaidyanathan R, 2009, BIOTECHNOL ADV, V27, P924, DOI 10.1016/j.biotechadv.2009.08.001
   Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Wang HS, 2005, COLLOID SURFACE A, V256, P111, DOI 10.1016/j.colsurfa.2004.12.058
   Wijnhoven S.W. P., EXPOSURE NANOMATERIA
   Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914
   Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126
   ZHANG IW, 2009, TOXICOL SCI, V110, P138
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
NR 51
TC 87
Z9 93
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2011
VL 7
IS 9
BP 3505
EP 3514
DI 10.1016/j.actbio.2011.05.030
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 809GX
UT WOS:000294040900029
PM 21651999
DA 2018-10-20
ER

PT J
AU Irvine, SM
   Cayzer, J
   Todd, EM
   Lun, S
   Floden, EW
   Negron, L
   Fisher, JN
   Dempsey, SG
   Alexander, A
   Hill, MC
   O'Rouke, A
   Gunningham, SP
   Knight, C
   Davis, PF
   Ward, BR
   May, BCH
AF Irvine, Sharleen M.
   Cayzer, Juliet
   Todd, Elise M.
   Lun, Stan
   Floden, Evan W.
   Negron, Leonardo
   Fisher, James N.
   Dempsey, Sandi G.
   Alexander, Alan
   Hill, Michael C.
   O'Rouke, Annalee
   Gunningham, Sarah P.
   Knight, Cameron
   Davis, Paul F.
   Ward, Brian R.
   May, Barnaby C. H.
TI Quantification of in vitro and in vivo angiogenesis stimulated by ovine
   forestomach matrix biomaterial
SO BIOMATERIALS
LA English
DT Article
DE Angiogenesis; Animal model; Bioactivity; ECM (extracellular matrix);
   Scaffold; Growth factors
ID SMALL-INTESTINAL SUBMUCOSA; ENDOTHELIAL GROWTH-FACTOR;
   EXTRACELLULAR-MATRIX; SCAFFOLD MATERIAL; PROGENITOR CELLS; HERNIA
   REPAIR; RABBIT MODEL; HUMAN SKIN; IDENTIFICATION; RECRUITMENT
AB Ovine forestomach matrix (OFM) biomaterial acts as a biomimetic of native extracellular matrix (ECM) by providing structural and functional cues to orchestrate cell activity during tissue regeneration. The ordered collagen matrix of the biomaterial is supplemented with secondary ECM-associated macro-molecules that function in cell adhesion, migration and communication. As angiogenesis and vasculo-genesis are critical processes during tissue regeneration we sought to quantify the angiogenic properties of the OFM biomaterial. In vitro studies demonstrated that soluble OFM components stimulated human umbilical vein endothelial cell (HUVEC) migration and increased vascular sprouting from an aorta. Blood vessel density and branch points increased in response to OFM in an ex ovo chicken chorioallantoic membrane (CAM) assay. The OFM biomaterial was shown to undergo remodeling in a porcine full-thickness excisional model and gave rise to significantly more blood vessels than wounds treated with small intestinal submucosa decellularized ECM or untreated wounds. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Irvine, Sharleen M.; Todd, Elise M.; Lun, Stan; Floden, Evan W.; Negron, Leonardo; Fisher, James N.; Dempsey, Sandi G.; Ward, Brian R.; May, Barnaby C. H.] Mesynthes Ltd, Lower Hutt 5040, New Zealand.
   [Irvine, Sharleen M.; Davis, Paul F.] Univ Otago, Dept Med, Wellington 6242, Wellington S, New Zealand.
   [Cayzer, Juliet; Alexander, Alan] Estendart Ltd, Palmerston North 4442, New Zealand.
   [Gunningham, Sarah P.] Univ Otago, Christchurch Angiogenesis & Canc Res Grp, Christchurch 8011, New Zealand.
   [Hill, Michael C.] Waikato Dist Hlth Board, Hamilton 3240, New Zealand.
   [O'Rouke, Annalee; Davis, Paul F.] Trinity Bioact Ltd, Wellington 6243, New Zealand.
   [Knight, Cameron] Inst Vet Anim & Biomed Sci, Palmerston North 4442, New Zealand.
RP May, BCH (reprint author), Mesynthes Ltd, POB 31311, Lower Hutt 5040, New Zealand.
EM barnaby.may@mesynthes.com
RI Floden, Evan/H-2115-2015
OI Floden, Evan/0000-0002-5431-190X; Fisher, James
   Neil/0000-0002-1876-088X; Negron, Leonardo/0000-0003-3852-3002
FU Foundation for Research Science and Technology (New Zealand) [MSMA0701]
FX We would like to acknowledge the Foundation for Research Science and
   Technology (New Zealand) (MSMA0701) for funding this project. Additional
   technical assistance was provided by Gribbles Pathology (Hamilton, New
   Zealand), Dr. Jacqui Harper (Malaghan Institute - Wellington, New
   Zealand), Carl Bigley (Carl and Wenfang Bigley Poultry - Wellington, New
   Zealand) and Lee Bates (Olympus. New Zealand).
CR Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Beattie AJ, 2009, TISSUE ENG PT A, V15, P1119, DOI 10.1089/ten.tea.2008.0162
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   DANGELO G, 1995, P NATL ACAD SCI USA, V92, P6374, DOI 10.1073/pnas.92.14.6374
   Floden E. W., 2010, J BIOMED MATER RES B, V96, P67
   Franchitto A, 1998, MUTAGENESIS, V13, P499, DOI 10.1093/mutage/13.5.499
   Franklin ME, 2008, SURG ENDOSC, V22, P1941, DOI 10.1007/s00464-008-0005-y
   Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002
   Hodde J P, 2005, J Wound Care, V14, P23
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodde JP, 2001, WOUNDS, V13, P195
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Lun S, 2010, BIOMATERIALS, V31, P4517, DOI 10.1016/j.biomaterials.2010.02.025
   McDevitt CA, 2003, J BIOMED MATER RES A, V67A, P637, DOI 10.1002/jbm.a.10144
   Menon NG, 2003, ANN PLAS SURG, V50, P523, DOI 10.1097/01.SAP.0000044252.76804.6B
   Meyer W, 2007, ANN ANAT, V189, P143, DOI 10.1016/j.aanat.2006.09.004
   Milburn ML, 2008, SURG INFECT, V9, P433, DOI 10.1089/sur.2007.044
   NICOSIA RF, 1990, LAB INVEST, V63, P115
   NICOSIA RF, 1995, LAB INVEST, V73, P658
   Petter-Puchner AH, 2008, J SURG RES, V145, P105, DOI 10.1016/j.jss.2007.03.090
   PREVEL CD, 1995, ANN PLAS SURG, V35, P381, DOI 10.1097/00000637-199510000-00009
   PROPHET EB, 1994, LAB METHODS HISTOTEC
   Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425
   Shepherd BR, 2006, FASEB J, V20, P1739, DOI 10.1096/fj.05-5682fje
   Slevin M, 2004, INT J CANCER, V109, P793, DOI 10.1002/ijc.20059
   Slevin M, 2004, INT J CANCER, V109, P793
   Suh W, 2005, STEM CELLS, V23, P1571, DOI 10.1634/stemcells.2004-0340
   Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   Yang B, 2010, J BIOMED MATER RES A, V93A, P1100, DOI 10.1002/jbm.a.32534
   YEN A, 1976, J INVEST DERMATOL, V66, P131, DOI 10.1111/1523-1747.ep12481678
NR 40
TC 25
Z9 25
U1 2
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2011
VL 32
IS 27
BP 6351
EP 6361
DI 10.1016/j.biomaterials.2011.05.040
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 801HR
UT WOS:000293429700001
PM 21665268
DA 2018-10-20
ER

PT J
AU Hancock, MJ
   Piraino, F
   Camci-Unal, G
   Rasponi, M
   Khademhosseini, A
AF Hancock, Matthew J.
   Piraino, Francesco
   Camci-Unal, Gulden
   Rasponi, Marco
   Khademhosseini, Ali
TI Anisotropic material synthesis by capillary flow in a fluid stripe
SO BIOMATERIALS
LA English
DT Article
DE Anisotropic materials; Composite materials; Microfluidics; Gradients;
   Cell encapsulation
ID DIRECTED CELL-MIGRATION; POLY(ETHYLENE GLYCOL); MICROFLUIDIC PLATFORM;
   GRADIENT HYDROGELS; TISSUE INTERFACES; SCAFFOLDS; GELATIN; CULTURE;
   FABRICATION; DIFFUSION
AB We present a simple bench-top technique to produce centimeter long concentration gradients in biomaterials incorporating soluble, material, and particle gradients. By patterning hydrophilic regions on a substrate, a stripe of prepolymer solution is held in place on a glass slide by a hydrophobic boundary. Adding a droplet to one end of this "pre-wet" stripe causes a rapid capillary flow that spreads the droplet along the stripe to generate a gradient in the relative concentrations of the droplet and pre-wet solutions. The gradient length and shape are controlled by the pre-wet and droplet volumes, stripe thickness, fluid viscosity and surface tension. Gradient biomaterials are produced by crosslinking gradients of prepolymer solutions. Demonstrated examples include a concentration gradient of cells encapsulated in three dimensions (3D) within a homogeneous biopolymer and a constant concentration of cells encapsulated in 3D within a biomaterial gradient exhibiting a gradient in cell spreading. The technique employs coated glass slides that may be purchased or custom made from tape and hydrophobic spray. The approach is accessible to virtually any researcher or student and should dramatically reduce the time required to synthesize a wide range of gradient biomaterials. Moreover, since the technique employs passive mechanisms it is ideal for remote or resource poor settings. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Hancock, Matthew J.; Piraino, Francesco; Camci-Unal, Gulden; Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Cambridge, MA 02139 USA.
   [Hancock, Matthew J.; Piraino, Francesco; Camci-Unal, Gulden; Khademhosseini, Ali] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Piraino, Francesco; Rasponi, Marco] Politecn Milan, Dept Bioengn, I-20133 Milan, Italy.
   [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.
RP Khademhosseini, A (reprint author), Partners Res Bldg,Room 252,65 Landsdowne St, Cambridge, MA 02139 USA.
EM alik@rics.bwh.harvard.edu
RI Khademhosseini, Ali/A-9435-2010; Piraino, Francesco/E-9194-2011;
   Rasponi, Marco/C-5010-2011; Hancock, Matthew/G-3859-2010
OI Khademhosseini, Ali/0000-0002-2692-1524; Rasponi,
   Marco/0000-0002-2904-8652; Hancock, Matthew/0000-0001-9820-3620;
   Khademhosseini, Ali/0000-0001-6322-8852; /0000-0003-4692-0550
FU NIH [HL092836, DE019024, EB012597, AR057837, DE021468, HL099073,
   EB008392]; Office of Naval Research; US Army Corps of Engineers;
   National Science Foundation; Progetto Rocca Visiting PhD Student
   Fellowship; Cariplo Foundation [2008-2531]
FX This research was funded by the NIH (HL092836, DE019024, EB012597,
   AR057837, DE021468, HL099073, EB008392), the Office of Naval Research,
   the US Army Corps of Engineers, and the National Science Foundation
   CAREER award (AK). FP was supported by a Progetto Rocca Visiting PhD
   Student Fellowship and a Cariplo Foundation Grant (2008-2531). We thank
   Dr. Shilpa Sant and Dr. Fumiki Yanagawa for technical help and Dr. Ian
   Wheeldon for useful comments.
CR Atencia J, 2005, NATURE, V437, P648, DOI 10.1038/nature04163
   Barbetta A, 2005, LANGMUIR, V21, P12333, DOI 10.1021/la0520233
   Berthier J, 2006, ARTECH HSE MICROEL S, P1
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   Califano JP, 2010, J BIOMECH, V43, P79, DOI 10.1016/j.jbiomech.2009.09.012
   Chen RR, 2007, FASEB J, V21, P3896, DOI 10.1096/fj.06-7873com
   Chin CD, 2007, LAB CHIP, V7, P41, DOI 10.1039/b611455e
   Chung S, 2010, ANN BIOMED ENG, V38, P1164, DOI 10.1007/s10439-010-9899-3
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Cosson S, 2009, ADV FUNCT MATER, V19, P3411, DOI 10.1002/adfm.200900968
   DAVIS SH, 1980, J FLUID MECH, V98, P225, DOI 10.1017/S0022112080000110
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Du YN, 2010, BIOMATERIALS, V31, P2686, DOI 10.1016/j.biomaterials.2009.12.012
   Du Y, 2009, LAB CHIP, V9, P761, DOI 10.1039/b815990d
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Hale NA, 2010, ACS APPL MATER INTER, V2, P2317, DOI 10.1021/am100346k
   Hancock MJ, 2011, SMALL, V7, P892, DOI 10.1002/smll.201002088
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   He JK, 2011, BIOTECHNOL BIOENG, V108, P175, DOI 10.1002/bit.22901
   He JK, 2010, ADV FUNCT MATER, V20, P131, DOI 10.1002/adfm.200901311
   Hori Y, 2009, ACTA BIOMATER, V5, P969, DOI 10.1016/j.actbio.2008.11.019
   Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712
   Johnson PM, 2005, POLYMER, V46, P3300, DOI 10.1016/j.polymer.2005.02.085
   Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b
   Kim S, 2010, INTEGR BIOL-UK, V2, P584, DOI 10.1039/c0ib00055h
   Kloxin AM, 2010, NAT PROTOC, V5, P1867, DOI 10.1038/nprot.2010.139
   Lam P, 2002, LANGMUIR, V18, P948, DOI 10.1021/l010589v
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee WG, 2010, ADV DRUG DELIVER REV, V62, P449, DOI 10.1016/j.addr.2009.11.016
   Lee W, 2010, P NATL ACAD SCI USA, V107, P20709, DOI 10.1073/pnas.1005211107
   Liu YX, 2009, BIOMATERIALS, V30, P196, DOI 10.1016/j.biomaterials.2008.09.041
   Lo CT, 2008, LAB CHIP, V8, P1273, DOI 10.1039/b804485f
   Lutolf MP, 2009, NAT MATER, V8, P451, DOI 10.1038/nmat2458
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   MUHR AH, 1982, POLYMER, V23, P1012, DOI 10.1016/0032-3861(82)90402-5
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Nilasaroya A, 2008, BIOMATERIALS, V29, P4658, DOI 10.1016/j.biomaterials.2008.08.011
   Oh C. S., 1999, US Patent, Patent No. [5,904,824, 5904824]
   Oliveira NM, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.085205
   Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804
   Pedron S, 2011, J BIOMED MATER RES A, V96A, P196, DOI 10.1002/jbm.a.32974
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Periasamy N, 1998, BIOPHYS J, V75, P557, DOI 10.1016/S0006-3495(98)77545-9
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Sant S, 2010, CAN J CHEM ENG, V88, P899, DOI 10.1002/cjce.20411
   Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e
   Simon CG, 2009, COMB CHEM HIGH T SCR, V12, P544, DOI 10.2174/138620709788681961
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106
   Speth RL, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/7/075024
   Stachowiak AN, 2008, J BIOMED MATER RES A, V85A, P815, DOI 10.1002/jbm.a.31661
   Sundararaghavan HG, 2011, BIOMACROMOLECULES, V12, P2344, DOI 10.1021/bm200415g
   Tripathi A, 2009, J BIOMED MATER RES A, V90A, P680, DOI 10.1002/jbm.a.32127
   Vickerman V, 2008, LAB CHIP, V8, P1468, DOI 10.1039/b802395f
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Wu MH, 2010, LAB CHIP, V10, P939, DOI 10.1039/b921695b
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zhao B, 2001, SCIENCE, V291, P1023, DOI 10.1126/science.291.5506.1023
   Zhao XJ, 2005, BIOMATERIALS, V26, P5048, DOI 10.1016/j.biomaterials.2004.12.003
NR 69
TC 25
Z9 25
U1 0
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2011
VL 32
IS 27
BP 6493
EP 6504
DI 10.1016/j.biomaterials.2011.05.057
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 801HR
UT WOS:000293429700015
PM 21684595
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kiehntopf, M
   Krawczak, M
AF Kiehntopf, Michael
   Krawczak, Michael
TI Biobanking and international interoperability: samples
SO HUMAN GENETICS
LA English
DT Article
ID MOLECULAR MARKERS; HUMAN SERUM; BIOMARKER; PLASMA; COLLECTION;
   STABILITY; BANKING; CONSENT; STORAGE; DEGRADATION
AB In terms of sample exchange, international collaborations between biobanks, or between biobanks and their research partners, have two important aspects. First, the donors' consent usually implies that the scope and purpose of any sample transfer to third parties is subject to major constraints. Since the legal, ethical and political framework of biobanking may differ substantially, even between countries of comparable jurisdictional systems, general rules for the international sharing of biomaterial are difficult, if not impossible, to define. Issues of uncertainty include the right to transfer the material, the scope of research allowed, and intellectual property rights. Since suitable means of international law enforcement may not be available in the context of biobanking, collaborators are advised to clarify any residual uncertainty by means of bilateral contracts, for example, in the form of material transfer agreements. Second, biobank partners may rightly expect that the biomaterial they receive for further analysis attains a certain level of quality. This implies that a biobank has to implement stringent quality control measures covering, in addition to the material transfer itself, the whole process of material acquisition, transport, pre-analytical handling and storage. Again, it may be advisable for biobank partners to claim contractual warranties for the type and quality of the biomaterial they wish to acquire.
C1 [Kiehntopf, Michael] Jena Univ Hosp, Inst Clin Chem, D-07740 Jena, Germany.
   [Kiehntopf, Michael] Jena Univ Hosp, Diagnost Lab, D-07740 Jena, Germany.
   [Kiehntopf, Michael; Krawczak, Michael] TMF Technol Methods & Infrastruct Networked Med R, Berlin, Germany.
   [Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany.
RP Kiehntopf, M (reprint author), Jena Univ Hosp, Inst Clin Chem, D-07740 Jena, Germany.
EM michael.kiehntopf@med.uni-jena.de
RI Krawczak, Michael/A-8964-2010
OI Krawczak, Michael/0000-0003-2603-1502
CR Ahmad S, 2009, ANAL BIOCHEM, V394, P237, DOI 10.1016/j.ab.2009.07.029
   Asslaber Martin, 2007, Briefings in Functional Genomics & Proteomics, V6, P193, DOI 10.1093/bfgp/elm023
   Banks RE, 2005, CLIN CHEM, V51, P1637, DOI 10.1373/clinchem.2005.051417
   Banks RE, 2008, CLIN CHEM, V54, P6, DOI 10.1373/clinchem.2007.097667
   Betsou F, 2010, CANCER EPIDEM BIOMAR, V19, P1004, DOI 10.1158/1055-9965.EPI-09-1268
   Betsou F, 2009, THROMB HAEMOSTASIS, V101, P1172, DOI 10.1160/TH08-10-0679
   Caboux E, 2007, COMMON MINIMUM TECHN
   Chalmers D, 2008, J LAW MED, V15, P538
   Christians U, 2011, CURR PHARM BIOTECHNO, V12, P1053, DOI 10.2174/138920111795909078
   Denery JR, 2011, ANAL CHEM, V83, P1040, DOI 10.1021/ac102806p
   Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740
   Gasser U., 2007, BREAKING DIGITAL BAR, V2007-8
   Goebel JW, 2010, EUR J HUM GENET, V18, P522, DOI 10.1038/ejhg.2009.214
   Hannisdal R, 2010, J NUTR, V140, P522, DOI 10.3945/jn.109.116418
   Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0
   HARRIS JR, 2008, REP REC NETW M EU FU
   Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8
   Hsieh SY, 2006, PROTEOMICS, V6, P3189, DOI 10.1002/pmic.200500535
   Karsan A, 2005, CLIN CHEM, V51, P1525, DOI 10.1373/clinchem.2005.050708
   Lengelle J, 2008, CYTOKINE, V44, P275, DOI 10.1016/j.cyto.2008.08.010
   *MED RES COUNC, 2001, MRC ETH SER
   *NAT CANC I, 2007, NAT CANC I BEST PRAC
   *OECD TASK FORC BI, 2007, OECD BEST PRACT GUID
   Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245
   Ransohoff DF, 2007, J CLIN EPIDEMIOL, V60, P1205, DOI 10.1016/j.jclinepi.2007.04.020
   Ransohoff DF, 2010, J CLIN ONCOL, V28, P698, DOI 10.1200/JCO.2009.25.6065
   Riegman PH, 2006, ADV EXP MED BIOL, V587, P65
   Salvaterra E, 2008, EMBO REP, V9, P307, DOI 10.1038/embor.2008.41
   Stankovic AK, 2006, CLIN CHEM, V52, P1627, DOI 10.1373/clinchem.2006.069997
   Timms JF, 2007, CLIN CHEM, V53, P645, DOI 10.1373/clinchem.2006.080101
   Vysekantsev IP, 2005, CRYOLETTERS, V26, P401
   Woodhams B, 2001, BLOOD COAGUL FIBRIN, V12, P229, DOI 10.1097/00001721-200106000-00002
   Yi JZ, 2011, METHODS MOL BIOL, V728, P161, DOI 10.1007/978-1-61779-068-3_10
   Yuille M, 2008, BRIEF BIOINFORM, V9, P14, DOI 10.1093/bib/bbm050
   Yuille M, 2010, CELL TISSUE BANK, V11, P241, DOI 10.1007/s10561-009-9150-3
   Zika E, 2010, BIOBANKS EUROPE PROS
NR 36
TC 20
Z9 22
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-6717
J9 HUM GENET
JI Hum. Genet.
PD SEP
PY 2011
VL 130
IS 3
SI SI
BP 369
EP 376
DI 10.1007/s00439-011-1068-8
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 807OD
UT WOS:000293908000005
PM 21761135
DA 2018-10-20
ER

PT J
AU Underwood, RA
   Usui, ML
   Zhao, G
   Hauch, KD
   Takeno, MM
   Ratner, BD
   Marshall, AJ
   Shi, XF
   Olerud, JE
   Fleckman, P
AF Underwood, Robert A.
   Usui, Marcia L.
   Zhao, Ge
   Hauch, Kip D.
   Takeno, Marc M.
   Ratner, Buddy D.
   Marshall, Andrew J.
   Shi, Xuefeng
   Olerud, John E.
   Fleckman, Philip
TI Quantifying the effect of pore size and surface treatment on epidermal
   incorporation into percutaneously implanted sphere-templated porous
   biomaterials in mice
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE quantification; epidermal migration; porous biomaterial; percutaneous
   implant; mouse model
ID IN-VITRO; SKIN; MODEL; INTERFACE; MIGRATION; DEVICES; REGENERATION;
   REPAIR
AB The sinus between skin and a percutaneous medical device is often a portal for infection. Epidermal integration into an optimized porous biomaterial could seal this sinus. In this study, we measured epithelial ingrowth into rods of sphere-templated porous poly(2-hydroxyethyl methacrylate) implanted percutaneously in mice. The rods contained spherical 20-, 40-, or 60-mu m pores with and without surface modification. Epithelial migration was measured 3, 7, and 14 days post-implantation utilizing immunohistochemistry for pankeratins and image analysis. Our global results showed average keratinocyte migration distances of 81 6 16.85 mu m (SD). Migration was shorter through 20-mu m pores (69.32 +/- 21.73) compared with 40 and 60 mu m (87.04 +/- 13.38 mu m and 86.63 +/- 8.31 mu m, respectively). Migration was unaffected by 1,1' carbonyldiimidazole surface modification without considering factors of pore size and healing duration. Epithelial integration occurred quickly showing an average migration distance of 74.13 +/- 12.54 mu m after 3 days without significant progression over time. These data show that the epidermis closes the sinus within 3 days, migrates into the biomaterial (an average of 11% of total rod diameter), and stops. This process forms an integrated epithelial collar without evidence of marsupialization or permigration. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 499-508, 2011.
C1 [Underwood, Robert A.; Usui, Marcia L.; Zhao, Ge; Olerud, John E.; Fleckman, Philip] Univ Washington, Div Dermatol, Dept Med, Seattle, WA 98195 USA.
   [Hauch, Kip D.; Takeno, Marc M.; Ratner, Buddy D.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   [Ratner, Buddy D.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
   [Marshall, Andrew J.] Healionics Inc, Seattle, WA USA.
RP Underwood, RA (reprint author), Univ Washington, Div Dermatol, Dept Med, Seattle, WA 98195 USA.
EM underwoo@u.washington.edu
FU NIH [EB 004422]; George F. Odland Endowed Research Fund; Marvin and Judy
   Young Research Fund
FX Contract grant sponsor: NIH; contract grant number: EB 004422; Contract
   grant sponsors: the George F. Odland Endowed Research Fund and the
   Marvin and Judy Young Research Fund
CR BRIGGAMAN RA, 1984, J EXP MED, V160, P1027, DOI 10.1084/jem.160.4.1027
   Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720
   Fitton JH, 1998, J BIOMED MATER RES, V42, P245
   Fleckman P, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034006
   Fukano Y, 2010, J BIOMED MATER RES A, V94A, P1172, DOI 10.1002/jbm.a.32798
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Isenhath SN, 2007, J BIOMED MATER RES A, V83A, P915, DOI 10.1002/jbm.a.31391
   Knowles NG, 2005, J BIOMED MATER RES A, V74A, P482, DOI 10.1002/jbm.a.30384
   Marshall AJ, 2005, AICHE J, V51, P1221, DOI 10.1002/aic.10390
   MARSHALL AJ, 2002, POROUS HYDOGEL SCAFF
   MARSHALL AJ, 2004, POLYM PREPRINTS, V45, P100
   MARSHALL AJ, 2001, T SOC BIOMATERIALS 2
   MARSHALL AJ, 2004, THESIS U WASHINGTON
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   ODLAND G, 1968, J CELL BIOL, V39, P135, DOI 10.1083/jcb.39.1.135
   OLERUD JE, 1988, J INVEST DERMATOL, V90, P845, DOI 10.1111/1523-1747.ep12462083
   Safdar N, 2002, MEDICINE, V81, P466, DOI 10.1097/00005792-200211000-00007
   Santoro MM, 2003, DEV CELL, V5, P257, DOI 10.1016/S1534-5807(03)00201-6
   Tavakkol Z, 2010, J AM ASSOC LAB ANIM, V49, P588
   Underwood RA, 2009, J HISTOCHEM CYTOCHEM, V57, P123, DOI 10.1369/jhc.2008.952176
   Usui ML, 2005, WOUND REPAIR REGEN, V13, P468, DOI 10.1111/j.1067-1927.2005.00067.x
   Vernon RB, 1999, MICROVASC RES, V57, P118, DOI 10.1006/mvre.1998.2122
   Vernon RB, 2002, MATRIX BIOL, V21, P661, DOI 10.1016/S0945-053X(02)00091-4
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   VONRECUM AF, 1981, CRC CR REV BIOM ENG, V5, P37
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 27
TC 28
Z9 28
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2011
VL 98A
IS 4
BP 499
EP 508
DI 10.1002/jbm.a.33125
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 806XJ
UT WOS:000293850500003
PM 21681942
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Broda, CR
   Lee, JY
   Sirivisoot, S
   Schmidt, CE
   Harrison, BS
AF Broda, Christopher R.
   Lee, Jae Y.
   Sirivisoot, Sirinrath
   Schmidt, Christine E.
   Harrison, Benjamin S.
TI A chemically polymerized electrically conducting composite of
   polypyrrole nanoparticles and polyurethane for tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE tissue engineering; polyurethane; polypyrrole; myoblast; electrical
   conduction
ID MYOCARDIAL REPAIR; IN-VITRO; SCAFFOLDS; NERVE; FIELD; VIVO; STIMULATION;
   PYRROLE; CELLS; BONE
AB A variety of cell types respond to electrical stimuli; accordingly, many conducting polymers (CPs) have been used as tissue engineering (TE) scaffolds, and one such CP is polypyrrole (PPy). PPy is a well-studied biomaterial with potential TE applications because of its electrical conductivity and many other beneficial properties. Combining its characteristics with an elastomeric material, such as polyurethane (PU), may yield a hybrid scaffold with electrical activity and significant mechanical resilience. Pyrrole was in situ polymerized within a PU emulsion mixture in weight ratios of 1:100, 1:20, 1:10, and 1:5, respectively. Morphology, electrical conductivity, mechanical properties, and cytocompatibility with C2C12 myoblast cells were characterized. The polymerization resulted in a composite with a principle base of PU interspersed with an electrically percolating network of PPy nanoparticles. As the mass ratio of PPy to PU increased so did electrical conductivity of the composites. In addition, as the mass ratio of PPy to PU increased, stiffness of the composite increased while maximum elongation length decreased. Ultimate tensile strength was reduced by similar to 47% across all samples with the addition of PPy to the PU base. Cytocompatibility assay data indicated no significant cytotoxic effect from the composites. Static cellular seeding of C2C12 cells and subsequent differentiation showed myotube formation on the composite materials. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 509-516, 2011.
C1 [Broda, Christopher R.] Wake Forest Univ, Sch Med, Wake Forest Baptist Med Ctr, Winston Salem, NC 27157 USA.
   [Lee, Jae Y.; Schmidt, Christine E.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.
   [Sirivisoot, Sirinrath; Harrison, Benjamin S.] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Schmidt, Christine E.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
RP Broda, CR (reprint author), Wake Forest Univ, Sch Med, Wake Forest Baptist Med Ctr, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM chbroda@wfubmc.edu
RI Schmidt, Christine/P-1613-2016
FU NIH [R01EB003416]; Wake Forest Institute for Regenerative Medicine
FX Contract grant sponsor: NIH; contract grant number: R01EB003416;
   Contract grant sponsor: Wake Forest Institute for Regenerative
   Medicine's Medical Student Research Scholarship
CR Ateh DD, 2006, J R SOC INTERFACE, V3, P741, DOI 10.1098/rsif.2006.0141
   BASSETT CA, 1964, NATURE, V204, P652, DOI 10.1038/204652a0
   BASSETT CAL, 1981, J BONE JOINT SURG AM, V63, P511, DOI 10.2106/00004623-198163040-00001
   BI XT, 1987, SYNTHETIC MET, V22, P145, DOI 10.1016/0379-6779(87)90532-7
   Bonzani IC, 2007, BIOMATERIALS, V28, P423, DOI 10.1016/j.biomaterials.2006.08.026
   Carlberg B., 2009, BIOMED MATER, V4, P1
   Chen SJ, 2000, J MATER SCI LETT, V19, P2157, DOI 10.1023/A:1026799415199
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Deligoz H, 2006, MACROMOL MATER ENG, V291, P793, DOI 10.1002/mame.200600126
   GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761
   Gilmore KJ, 2009, BIOMATERIALS, V30, P5292, DOI 10.1016/j.biomaterials.2009.06.059
   Gogolewski S., 1996, DESK REFERENCE FUNCT, P657
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012
   Guimard NKE, 2009, MACROMOLECULES, V42, P502, DOI 10.1021/ma8019859
   JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114
   Kang HC, 2000, POLYMER, V41, P6931, DOI 10.1016/S0032-3861(00)00116-6
   Keohan F, 2007, J BIOMAT SCI-POLYM E, V18, P1057, DOI 10.1163/156856207781494395
   KERNS JM, 1987, J NEUROSCI METH, V19, P217, DOI 10.1016/S0165-0270(87)80005-5
   Kidane AG, 2009, J BIOMED MATER RES B, V88B, P290, DOI 10.1002/jbm.b.31151
   Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042
   Lelah M. D., 1986, POLYURETHANES MED
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   PEDROTTY DM, 2005, AM J PHYSIOL-HEART C, V288, P1620
   Robila G, 2000, J APPL POLYM SCI, V75, P1385, DOI 10.1002/(SICI)1097-4628(20000314)75:11<1385::AID-APP10>3.0.CO;2-Q
   Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shi GX, 2004, BIOMATERIALS, V25, P2477, DOI 10.1016/j.biomaterials.2003.09.032
   Siepe M, 2007, ARTIF ORGANS, V31, P425, DOI 10.1111/j.1525-1594.2007.00385.x
   SMITS FM, 1958, AT&T TECH J, V37, P711, DOI 10.1002/j.1538-7305.1958.tb03883.x
   UHLIR A, 1955, AT&T TECH J, V34, P105, DOI 10.1002/j.1538-7305.1955.tb03765.x
   Wan Y, 2004, MACROMOL BIOSCI, V4, P882, DOI 10.1002/mabi.200400044
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Wang Y, 2008, CHEM MATER, V20, P2574, DOI 10.1021/cm800005r
   Wang ZX, 2003, J BIOMED MATER RES A, V66A, P738, DOI 10.1002/jbm.a.10037
   WILLIAMS RL, 1994, J MATER SCI-MATER M, V5, P429, DOI 10.1007/BF00058978
   WONG JY, 1994, P NATL ACAD SCI USA, V91, P3201, DOI 10.1073/pnas.91.8.3201
NR 40
TC 34
Z9 34
U1 1
U2 64
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2011
VL 98A
IS 4
BP 509
EP 516
DI 10.1002/jbm.a.33128
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 806XJ
UT WOS:000293850500004
PM 21681943
OA Green Accepted
DA 2018-10-20
ER

PT J
AU van Putten, SM
   Wubben, M
   Plantinga, JA
   Hennink, WE
   van Luyn, MJA
   Harmsen, MC
AF van Putten, Sander M.
   Wubben, Maike
   Plantinga, Josee A.
   Hennink, Wim E.
   van Luyn, Marja J. A.
   Harmsen, Martin C.
TI Endotoxin contamination delays the foreign body reaction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE endotoxin; LPS; foreign body reaction; biocompatibility; tissue
   engineering
ID CYTOKINE PRODUCTION; ADHERENT ENDOTOXIN; CELLS; MACROPHAGES; MODULATION;
   ACTIVATION; PARTICLES; MONOCYTES; RESPONSES; SURVIVAL
AB Biomaterials are at continuous risk of bacterial contamination during production and application. In vivo, bacterial contamination of biomaterials delays the foreign body reaction (FBR). Endotoxins such as lipopolysaccharides (LPS), major constituents of the bacterial cell wall, are potent stimulators of the immune system in vitro and in vivo. In vitro, biomaterials contaminated with LPS induce the production of proinflammatory cytokines by adherent macrophages. This suggests that the presence of endotoxins on biomaterials will intensify the FBR. The effects of LPS on the course of the FBR have never been studied in vivo. In this study, the influence of LPS contamination on the FBR to subcutaneously implanted Puramatrix-loaded hexamethylenediisocyanate-crosslinked dermal sheep collagen (HDSC) disks was studied in rats. During the onset phase of the FBR, a massive influx of granulocytes was detected in LPS-contaminated disks, while their presence was prolonged. IL-10 production inside LPS-contaminated disks was increased at days 10 and 21. Macrophage densities were not affected by the presence of LPS. However, macrophage functionality was altered: giant cell formation and biomaterial degradation were delayed by LPS-contamination up to 21 days. On the basis of these results, we conclude that LPS delays the FBR. This finding indicates that endotoxin contamination has significant implications for the in vivo function of biomaterials and medical devices and emphasizes the importance of endotoxin testing. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 527-534, 2011.
C1 [van Putten, Sander M.; Wubben, Maike; Plantinga, Josee A.; van Luyn, Marja J. A.; Harmsen, Martin C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands.
   [Hennink, Wim E.] Univ Utrecht, Dept Pharmaceut, UIPS, NL-3508 TB Utrecht, Netherlands.
RP Harmsen, MC (reprint author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.
EM M.C.Harmsen@med.umcg.nl
FU Dutch Platform for Tissue Engineering (DPTE) [6731]
FX Contract grant sponsor: Dutch Platform for Tissue Engineering (DPTE);
   contract grant number: 6731
CR Akisue T, 2002, J BIOMED MATER RES, V59, P507, DOI 10.1002/jbm.1264
   Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393
   Bi YM, 2001, J BONE MINER RES, V16, P2082, DOI 10.1359/jbmr.2001.16.11.2082
   Bi YM, 2002, J ORTHOPAED RES, V20, P696, DOI 10.1016/S0736-0266(01)00176-0
   Byrne A, 2002, J IMMUNOL, V168, P1968, DOI 10.4049/jimmunol.168.4.1968
   CASEY LC, 1993, ANN INTERN MED, V119, P771, DOI 10.7326/0003-4819-119-8-199310150-00001
   Cho DR, 2002, J ORTHOPAED RES, V20, P704, DOI 10.1016/S0736-0266(01)00179-6
   COLOTTA F, 1992, BLOOD, V80, P2012
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112
   Gorbet MB, 2005, BIOMATERIALS, V26, P6811, DOI 10.1016/j.biomaterials.2005.04.063
   HOENDERS CSM, 2008, MICROORGANISMS INFLA
   HONGJIE G, 2008, CURR TOP MED CHEM, V8, P141
   Luttikhuizen DT, 2007, J BIOMED MATER RES A, V83A, P879, DOI 10.1002/jbm.a.31420
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957
   van Putten SM, 2009, BIOMATERIALS, V30, P730, DOI 10.1016/j.biomaterials.2008.10.043
   VANGOOR H, 1991, LAB INVEST, V64, P754
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   WACHEM PB, 1996, J MATER SCI-MATER M, V7, P415
   Williams David, 2003, Med Device Technol, V14, P8
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
NR 24
TC 12
Z9 13
U1 1
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2011
VL 98A
IS 4
BP 527
EP 534
DI 10.1002/jbm.a.33144
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 806XJ
UT WOS:000293850500006
PM 21681945
DA 2018-10-20
ER

PT J
AU Pinto, S
   Alves, P
   Santos, AC
   Matos, CM
   Oliveiros, B
   Goncalves, S
   Gudina, E
   Rodrigues, LR
   Teixeira, JA
   Gil, MH
AF Pinto, S.
   Alves, P.
   Santos, A. C.
   Matos, C. M.
   Oliveiros, B.
   Goncalves, S.
   Gudina, E.
   Rodrigues, L. R.
   Teixeira, J. A.
   Gil, M. H.
TI Poly(dimethyl siloxane) surface modification with biosurfactants
   isolated from probiotic strains
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE poly(dimethyl siloxane); biosurfactants; plasma; surface modification
ID POTENTIAL APPLICATIONS; ADHESION; PLASMA; HEMOCOMPATIBILITY;
   MACROPHAGES; BIOADHESIVE; ADSORPTION; POLYMERS; BACTERIA; RUBBER
AB Depending on the final application envisaged for a given biomaterial, many surfaces must be modified before use. The material performance in a biological environment is mainly mediated by its surface properties that can be improved using suitable modification methods. The aim of this work was to coat poly(dimethyl siloxane) (PDMS) surfaces with biosurfactants (BSs) and to evaluate how these compounds affect the PDMS surface properties. BSs isolated from four probiotic strains (Lactococcus lactis, Lactobacillus paracasei, Streptococcus thermophilus A, and Streptococcus thermophilus B) were used. Bare PDMS and PDMS coated with BSs were characterized by contact angle measurements, infrared spectroscopy (ATR-FTIR), X-ray photoelectron spectroscopy (XPS), and atomic force microscopy (AFM). The influence of the surface modifications on the materials blood compatibility was studied through thrombosis and hemolysis assays. The cytotoxicity of these materials was tested against rat peritoneal macrophages. AFM results demonstrated the successful coating of the surfaces. Also, by contact angle measurements, an increase of the coated surfaces hydrophilicity was seen. Furthermore, XPS analysis indicated a decrease of the silicon content at the surface, and ATR-FTIR results showed the presence of BS characteristic groups as a consequence of the modification. All the studied materials revealed no toxicity and were found to be nonhemolytic. The proposed approach for the modification of PDMS surfaces was found to be effective and opens new possibilities for the application of these surfaces in the biomedical field. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 535-543, 2011.
C1 [Pinto, S.; Alves, P.; Gil, M. H.] Univ Coimbra, Dept Chem Engn, P-3030790 Coimbra, Portugal.
   [Santos, A. C.; Matos, C. M.; Oliveiros, B.] Univ Coimbra, Fac Med, Biomed Inst Res Light & Image IBILI, Inst Biophys Biomath, P-3030790 Coimbra, Portugal.
   [Goncalves, S.; Gudina, E.; Rodrigues, L. R.; Teixeira, J. A.] Univ Minho, Ctr Biol Engn, IBB, P-4710057 Braga, Portugal.
RP Pinto, S (reprint author), Univ Coimbra, Dept Chem Engn, P-3030790 Coimbra, Portugal.
EM susanacspinto@gmail.com
RI Teixeira, Jose Antonio/A-6268-2012; Gudina, Eduardo/F-4898-2011;
   Rodrigues, Ligia/C-3151-2009; Alves, Patricia/I-1004-2013; Goncalves,
   Sara/F-5048-2010
OI Teixeira, Jose Antonio/0000-0002-4918-3704; Gudina,
   Eduardo/0000-0002-3156-7363; Rodrigues, Ligia/0000-0001-9265-0630;
   Alves, Patricia/0000-0002-8943-8329; Goncalves,
   Sara/0000-0002-7117-2198; Oliveiros, Barbara/0000-0001-7836-8161; Pinto,
   Susana/0000-0003-2658-1045; Gil, Maria Helena/0000-0003-0657-7751
FU Portuguese Science and Technology Foundation (Fundacao para a Ciencia e
   Tecnologia-FCT) [BIOSURFA-PTDC/SAU-BEB/73498/2006]
FX Contract grant sponsors: Portuguese Science and Technology Foundation
   (Fundacao para a Ciencia e Tecnologia-FCT;
   BIOSURFA-PTDC/SAU-BEB/73498/2006 project)
CR ABOK K, 1984, VIRCHOWS ARCH B, V46, P307, DOI 10.1007/BF02890319
   American Society for Testing of Materials, 2000, F75600 ASTM
   Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Besteiro MC, 2010, J BIOMED MATER RES A, V93A, P954, DOI 10.1002/jbm.a.32594
   Bland M, 2000, INTRO MED STAT
   BODAS D, 2006, MICROELECTRON ENG, V83, P1227
   Bodas D, 2007, SENSOR ACTUAT B-CHEM, V123, P368, DOI 10.1016/j.snb.2006.08.037
   BUSSCHER HJ, 1984, APPL MICROBIOL BIOT, V41, P4
   Chen H, 2004, BIOMATERIALS, V25, P2273, DOI 10.1016/j.biomaterials.2003.09.023
   Chibowski E, 2003, ADV COLLOID INTERFAC, V103, P149, DOI 10.1016/S0001-8686(02)00093-3
   *DAT PHYS INSTR GM, 2002, DATAPHYSICS INT CHEM
   Ferreira P, 2007, INT J BIOL MACROMOL, V40, P144, DOI 10.1016/j.ijbiomac.2006.06.023
   Gudina EJ, 2010, LETT APPL MICROBIOL, V50, P419, DOI 10.1111/j.1472-765X.2010.02818.x
   Gudina EJ, 2010, COLLOID SURFACE B, V76, P298, DOI 10.1016/j.colsurfb.2009.11.008
   ISO, 2002, 109934 ISO
   Lee S, 2005, LANGMUIR, V21, P11957, DOI 10.1021/la051932p
   LIU DY, 1984, CELL IMMUNOL, V88, P350, DOI 10.1016/0008-8749(84)90168-0
   Makamba H, 2003, ELECTROPHORESIS, V24, P3607, DOI 10.1002/elps.200305627
   Masters KS, 2007, BIOMATERIALS, V29, P150
   Meylheuc T, 2006, COLLOID SURFACE B, V52, P128, DOI 10.1016/j.colsurfb.2006.04.016
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024
   Rodrigues L, 2004, APPL MICROBIOL BIOT, V66, P306, DOI 10.1007/s00253-004-1674-7
   Rodrigues L. R., 2006, COLLOID SURFACE B, V49, P78
   Rodrigues LR, 2006, COLLOID SURFACE B, V53, P105, DOI 10.1016/j.colsurfb.2006.08.009
   Santos A.C., 2008, EXP PATHOL HLTH SCI, V2, P33
   SILVA CL, 1989, BRAZ J MED BIOL RES, V22, P327
   Singh P, 2004, TRENDS BIOTECHNOL, V22, P142, DOI 10.1016/j.tibtech.2004.01.010
   SMETANA K, 1993, J MATER SCI-MATER M, V4, P526, DOI 10.1007/BF00120134
   STAHL PD, 1978, P NATL ACAD SCI USA, V75, P1399, DOI 10.1073/pnas.75.3.1399
   STROBEL M, 1996, PLASMA MODIFICATION, V39
   Tan HML, 2007, THIN SOLID FILMS, V515, P5172, DOI 10.1016/j.tsf.2006.10.026
   Vijayanand K., 2005, TRENDS BIOMATER ARTI, V18, P73
   Wang P, 2000, EUR POLYM J, V36, P1323, DOI 10.1016/S0014-3057(99)00193-7
   WEIR DM, 1973, HDB EXPT IMMUNOLOGY, V2
   Wenzhong Shen, 2008, Recent Patents on Chemical Engineering, V1, P27
   Wu MH, 2009, SURF INTERFACE ANAL, V41, P11, DOI 10.1002/sia.2964
   Zeraik AE, 2010, CURR MICROBIOL, V61, P554, DOI 10.1007/s00284-010-9652-z
   Zhang XJ, 2009, POLYMER, V50, P5414, DOI 10.1016/j.polymer.2009.01.047
NR 40
TC 10
Z9 11
U1 2
U2 20
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2011
VL 98A
IS 4
BP 535
EP 543
DI 10.1002/jbm.a.33146
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 806XJ
UT WOS:000293850500007
PM 21681946
DA 2018-10-20
ER

PT J
AU Saul, JM
   Ellenburg, MD
   de Guzman, RC
   Van Dyke, M
AF Saul, Justin M.
   Ellenburg, Mary D.
   de Guzman, Roche C.
   Van Dyke, Mark
TI Keratin hydrogels support the sustained release of bioactive
   ciprofloxacin
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE keratin; biomaterial; antibiotic; drug delivery; tissue engineering;
   regenerative medicine
ID SPONGE SCAFFOLDS; RABBIT MODEL; HUMAN HAIR; OSTEOMYELITIS; BIOMATERIAL;
   CULTIVATION; FRACTURES; THERAPY; BINDING; WOUNDS
AB Keratins are naturally derived proteins that can be fabricated into several biomaterial forms including hydrogels. These materials are a potential polymeric system for several tissue engineering and regenerative medicine applications due to their ability to support cell attachment, proliferation, and migration. However, little is known regarding their ability to support sustained release of therapeutic agents. This report describes the use of keratin hydrogels for sustained release of the antibiotic ciprofloxacin, which may prove useful to traumatic injury applications that would benefit from materials promoting tissue regeneration while also preventing acute infection. Hydrogels were formed from keratins obtained by oxidative extraction and known as keratose. We found that keratose hydrogels released similar to 60% of loaded ciprofloxacin over the first 10 days and that continued release was detectable over the course of 3 weeks. Released ciprofloxacin was bioactive, inhibiting growth of Staphylococcus aureus for 23 days in vitro and for 2 weeks in a mouse subcutaneous model. The rate of ciprofloxacin release was highly correlated with degradation of the keratin hydrogel and not consistent with simple diffusion. Further experiments indicated that ciprofloxacin binds to keratose through electrostatic interactions. These studies demonstrate the specific use of keratose hydrogels for the release of antibiotic and the potential for the more general use of this material in tissue engineering and regenerative medicine applications. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 544-553, 2011.
C1 [Saul, Justin M.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Dept Biomed Engn, Winston Salem, NC 27157 USA.
   [Saul, Justin M.; Ellenburg, Mary D.; de Guzman, Roche C.; Van Dyke, Mark] Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Saul, JM (reprint author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Dept Biomed Engn, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM jsaul@wfubmc.edu
RI de Guzman, Roche/K-8832-2015; Saul, Justin/I-1765-2016
OI de Guzman, Roche/0000-0001-6051-4765; 
FU KeraNetics, LLC
FX Contract grant sponsor: KeraNetics, LLC
CR Aboushwareb T, 2009, J BIOMED MATER RES B, V90B, P45, DOI 10.1002/jbm.b.31251
   Ambrose CG, 2004, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000126303.41711.a2
   BELCARZ A, 2008, J BIOMED MATER RES B, V89, P102
   Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116
   Brandelli A, 2010, APPL MICROBIOL BIOT, V85, P1735, DOI 10.1007/s00253-009-2398-5
   CREWTHER W. G. R. D. B. FRASER, 1965, ADVANCE PROTEIN CHEM, V20, P191, DOI 10.1016/S0065-3233(08)60390-3
   Dias GJ, 2010, J BIOMED MATER RES A, V92A, P513, DOI 10.1002/jbm.a.32394
   Feng K, 2010, J CONTROL RELEASE, V146, P363, DOI 10.1016/j.jconrel.2010.05.035
   Fraimow Henry S, 2009, Semin Plast Surg, V23, P90, DOI 10.1055/s-0029-1214161
   GILLESPIE JM, 1983, STRUCTURAL PROTEINS
   Granick M, 2006, WOUND REPAIR REGEN, V14, pS1, DOI 10.1111/j.1743-6109.2005.00096.x
   Granick MS, 2007, OSTOMY WOUND MANAG, V53, P64
   Granick MS, 2007, OSTOMY WOUND MANAG, V53, P68
   Granick MS, 2007, OSTOMY WOUND MANAG, V53, P72
   Hill P, 2010, BIOMATERIALS, V31, P585, DOI 10.1016/j.biomaterials.2009.09.076
   Ikkai F, 2002, BIOMACROMOLECULES, V3, P482, DOI 10.1021/bm010160i
   Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006
   Jhunjhunwala S, 2009, J CONTROL RELEASE, V133, P191, DOI 10.1016/j.jconrel.2008.10.011
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Katoh K, 2004, BIOMATERIALS, V25, P2265, DOI 10.1016/j.biomaterials.2003.09.021
   Kaye KS, 2004, INFECT DIS CLIN N AM, V18, P467, DOI 10.1016/j.idc.2004.04.003
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Klein LK, 1996, J VET DIAGN INVEST, V8, P494, DOI 10.1177/104063879600800418
   Krasko MY, 2007, J CONTROL RELEASE, V117, P90, DOI 10.1016/j.jconrel.2006.10.010
   Lal S, 1999, J GEN APPL MICROBIOL, V45, P283, DOI 10.2323/jgam.45.283
   Li B, 2010, J CONTROL RELEASE, V145, P221, DOI 10.1016/j.jconrel.2010.04.002
   Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6
   PETRI WA, 2001, PHARMACOL BASIS THER, P1171
   Prokuski Laura, 2006, J Am Acad Orthop Surg, V14, pS101
   Reichl S, 2009, BIOMATERIALS, V30, P6854, DOI 10.1016/j.biomaterials.2009.08.051
   Ristiniemi J, 2007, ACTA ORTHOP, V78, P520, DOI 10.1080/17453670710014176
   Rouse JG, 2010, MATERIALS, V3, P999, DOI 10.3390/ma3020999
   Sando L, 2010, J BIOMED MATER RES A, V95A, P901, DOI 10.1002/jbm.a.32913
   SCHAEFFER AJ, 2002, AM J MED S1A, V113, P45
   Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161
   Segev S, 1999, CLIN INFECT DIS, V28, P299, DOI 10.1086/515132
   Sharma R, 2010, BIOTECHNOL LETT, V32, P1863, DOI 10.1007/s10529-010-0361-2
   Shi M, 2010, BIOMATERIALS, V31, P4146, DOI 10.1016/j.biomaterials.2010.01.112
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Sripriya R, 2007, J BIOMAT SCI-POLYM E, V18, P335, DOI 10.1163/156856207779996913
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   Tachibana A, 2006, J BIOSCI BIOENG, V102, P425, DOI 10.1263/jbb.102.425
   Verma V, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025007
   Vilfan ID, 2003, BBA-GENE STRUCT EXPR, V1628, P111, DOI 10.1016/S0167-4781(03)00135-0
   Wenke JC, 2006, J BONE JOINT SURG BR, V88B, P1102, DOI 10.1302/0301-620X.88B8.17368
   Yamauchi K, 1998, J BIOMAT SCI-POLYM E, V9, P259, DOI 10.1163/156856298X00640
   Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d
   Zilberman M, 2008, J CONTROL RELEASE, V130, P202, DOI 10.1016/j.jconrel.2008.05.020
NR 48
TC 52
Z9 53
U1 2
U2 51
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2011
VL 98A
IS 4
BP 544
EP 553
DI 10.1002/jbm.a.33147
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 806XJ
UT WOS:000293850500008
PM 21681948
DA 2018-10-20
ER

PT J
AU Nirmala, R
   Lee, JH
   Navamathavan, R
   Yang, JH
   Kim, HY
AF Nirmala, R.
   Lee, Ji-Hui
   Navamathavan, R.
   Yang, Jae Heon
   Kim, Hak Yong
TI Preparation of the crosslinked poly(vinyl alcohol)/blocked isocyanate
   prepolymers nanofibers with hydrolyzed products of Scutellariae Radix
SO MATERIALS LETTERS
LA English
DT Article
DE Polymeric composites; Biomaterial; Crosslinking; Scutellariae Radix;
   Nanofibers; Electrospinning
ID ELECTROSPUN NANOFIBERS; CONTROLLED-RELEASE; BAICALEIN; COMPONENTS;
   WOGONIN; MATS; CELL
AB We report on the preparation and characterizations of Scutellariae Radix (SR) blended poly(vinyl alcohol) (PVA)/blocked isocyanate prepolymer (BIP) composite nanofibers via electrospinning process. In order to improve the biocompatibility properties, SR biological macromolecules were blended in PVA/BIP composite nanofibers. SEM images revealed that the composite nanofibers were well-oriented and had good incorporation of SR. Ultraviolet (UV) absorbance spectra revealed that the maximum measured absorbance intensities were linearly increased with increasing SR in the composite nanofibers. TEM images revealed a peculiar morphology by the additive SR. This additive SR possesses a lower molecular component which was exhibited at the outside of the nanofibers structure due to strong applied electric field during electrospinning process. These results indicated that the PVA/BIP blended SR composite nanofibers might be utilized for many biomedical applications including control release and wound dressing. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Lee, Ji-Hui; Yang, Jae Heon; Kim, Hak Yong] Chonbuk Natl Univ, Ctr Healthcare Technol & Dev, Jeonju 561756, South Korea.
   [Lee, Ji-Hui; Kim, Hak Yong] Chonbuk Natl Univ, Dept Text Engn, Jeonju 561756, South Korea.
   [Navamathavan, R.] Chonbuk Natl Univ, Sch Adv Mat Engn, Jeonju 561756, South Korea.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Ctr Healthcare Technol & Dev, Jeonju 561756, South Korea.
EM khy@jbnu.ac.kr
RI Kim, Hak Yong/G-3826-2013
OI Kim, Hak Yong/0000-0002-4133-124X
FU Korean Ministry of Education, Science and Technology
FX This work was supported by the grant of the Korean Ministry of
   Education, Science and Technology (The Regional Core Research
   Program/Center for Healthcare Technology & Development, Chonbuk National
   University, Jeonju 561-756 Republic of Korea).
CR Cao YY, 2008, INT J ANTIMICROB AG, V32, P73, DOI 10.1016/j.ijantimicag.2008.01.026
   CHUNG HL, 2007, WORLD J GASTROENTERO, V14, P5605
   HUANG HC, 1994, EUR J PHARMACOL, V251, P91, DOI 10.1016/0014-2999(94)90447-2
   Ikemoto S, 2000, UROLOGY, V55, P951, DOI 10.1016/S0090-4295(00)00467-2
   Kenawy ER, 2007, MAT SCI ENG A-STRUCT, V459, P390, DOI 10.1016/j.msea.2007.01.039
   Kim CK, 2007, MACROMOLECULES, V40, P4823, DOI 10.1021/ma070056e
   KUBO M, 1981, PLANTA MED, V43, P194, DOI 10.1055/s-2007-971499
   Lee JH, 2010, POLYM INT, V59, P1683, DOI 10.1002/pi.2905
   Lin CC, 1996, AM J CHINESE MED, V24, P31, DOI 10.1142/S0192415X96000050
   Shao CL, 2003, MATER LETT, V57, P1579, DOI 10.1016/S0167-577X(02)01036-4
   Vargas EAT, 2010, ACTA BIOMATER, V6, P1069, DOI 10.1016/j.actbio.2009.09.018
   Wu JA, 2001, AM J CHINESE MED, V29, P69, DOI 10.1142/S0192415X01000083
   Yang DZ, 2007, CARBOHYD POLYM, V69, P538, DOI 10.1016/j.carbpol.2007.01.008
   Zheng H, 2001, J APPL POLYM SCI, V80, P2558, DOI 10.1002/app.1365
NR 14
TC 4
Z9 5
U1 1
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD SEP
PY 2011
VL 65
IS 17-18
BP 2772
EP 2775
DI 10.1016/j.matlet.2011.05.100
PG 4
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 807UY
UT WOS:000293929300066
DA 2018-10-20
ER

PT J
AU Yan, HD
   Black, D
   Jones, NI
   McCraw, J
   Chen, H
   Arnold, P
   Zhang, F
AF Yan, Hede
   Black, David
   Jones, Nicholas I.
   McCraw, John
   Chen, Henan
   Arnold, Peter
   Zhang, Feng
TI Integra Acellular Collagen as a Vascular Carrier for Skin Flap
   Prefabrication in Rats
SO ANNALS OF PLASTIC SURGERY
LA English
DT Article
DE flap prefabrication; Integra acelluar collagen; vascular carrier
ID PEDICLE FLAPS; RECONSTRUCTION; TISSUE; TRANSPLANTATION; GRAFTS; VEIN
AB In this study, the feasibility of Integra acellular collagen used as a vascular carrier in skin flap prefabrication was examined. In all, 20 Sprague-Dawley rats were randomly divided into 3 groups. The saphenous vascular bundle was used as the vascular carrier. In group 1 (n = 8), an arteriovenous fistula was made by anastomosis of distal saphenous artery and vein. An Integra patch (2 x 3 cm(2)) was placed underneath the vascular bundle. In group 2 (n = 6), an Integra patch was placed on the top of the saphenous vessels, which remained intact. In group 3 (n = 6), an arteriovenous fistula was made without Integra implant. Two weeks after the initial management, a skin flap (2 x 3 cm(2) in size) was raised and replaced in each group. The survival of the flaps and histology were evaluated at 7 days after flap replacement. The results showed that the average survival area in group 1 was 98% +/- 2%. No flap survival was observed in group 2. The mean survival area in group 3 was 29% +/- 6%. The differences among all 3 groups were significant (P < 0.05). Although the mean survival area in group 3 was significantly lower than that in group 1 (P < 0.001), it was significantly higher than that in group 2. Histology showed that the Integra patch was incorporated into the adjacent connective tissue, and increased amounts of neovascularization were seen between the collagenous sheets and dermis in group 1. In conclusion, this study demonstrated that Integra acellular collagen can incorporate into the adjacent tissue as a vascular carrier and induce angiogenesis in flap prefabrication. This biomaterial can provide a scaffold for supporting and enhancing the survival of a vascular prefabricated skin flap. The results indicate that this material is an ideal biomaterial for flap prefabrication and may be used for this clinical purpose in the future.
C1 [Yan, Hede; Black, David; Jones, Nicholas I.; McCraw, John; Chen, Henan; Arnold, Peter; Zhang, Feng] Univ Mississippi, Med Ctr, Div Plast Surg, Jackson, MS 39216 USA.
   [Yan, Hede] Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthoped Surg, Div Plast & Hand Surg, Wenzhou, Peoples R China.
RP Zhang, F (reprint author), Univ Mississippi, Med Ctr, Div Plast Surg, 2500 N State St, Jackson, MS 39216 USA.
EM fzhang@surgery.umsmed.edu
CR de Figueiredo JCA, 2010, J PLAST RECONSTR AES, V63, pE525, DOI 10.1016/j.bjps.2010.01.033
   Chen HC, 1999, ANN THORAC SURG, V67, P911, DOI 10.1016/S0003-4975(99)00152-6
   Diller J G, 1965, Surg Forum, V16, P471
   Druecke D, 2004, WOUND REPAIR REGEN, V12, P518, DOI 10.1111/j.1067-1927.2004.012504.x
   EROL OO, 1980, PLAST RECONSTR SURG, V65, P277, DOI 10.1097/00006534-198003000-00002
   EROL OO, 1976, PLAST RECONSTR SURG, V58, P470
   EROL OO, 1980, PLAST RECONSTR SURG, V65, P405, DOI 10.1097/00006534-198004000-00003
   Friedstat JS, 2009, CLIN PLAST SURG, V36, P653, DOI 10.1016/j.cps.2009.05.004
   Govila A, 1993, Acta Chir Plast, V35, P125
   GUTHRIE RH, 1975, ARCH OTOLARYNGOL, V101, P89
   Hoang NT, 2005, BRIT J PLAST SURG, V58, P632, DOI 10.1016/j.bjps.2005.01.007
   Kashiwa K, 2009, ANN PLAS SURG, V62, P633, DOI 10.1097/SAP.0b013e31817f023e
   KHOURI RK, 1992, CLIN PLAST SURG, V19, P763
   KHOURI RK, 1991, PLAST RECONSTR SURG, V87, P108, DOI 10.1097/00006534-199101000-00017
   Kimura N, 2001, PLAST RECONSTR SURG, V108, P1972, DOI 10.1097/00006534-200112000-00020
   MUTAF M, 1994, ANN PLAS SURG, V33, P392, DOI 10.1097/00000637-199410000-00006
   Nasir S, 2008, J PLAST RECONSTR AES, V61, P799, DOI 10.1016/j.bjps.2007.08.021
   Nguyen DQA, 2010, BURNS, V36, P23, DOI 10.1016/j.burns.2009.07.011
   Nguyen TH, 2009, ANN PLAS SURG, V63, P209, DOI 10.1097/SAP.0b013e31818a6629
   Okuda T, 2010, ANN PLAS SURG, V64, P98, DOI 10.1097/SAP.0b013e3181999ec1
   Orringer JS, 1999, PLAST RECONSTR SURG, V104, P793, DOI 10.1097/00006534-199909030-00028
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P315, DOI 10.1097/00006534-199202000-00020
   Shaterian A, 2009, BURNS, V35, P811, DOI 10.1016/j.burns.2008.12.012
   SHINTOMI Y, 1982, PLAST RECONSTR SURG, V70, P725, DOI 10.1097/00006534-198212000-00012
   TAKATO T, 1991, BRIT J PLAST SURG, V44, P593, DOI 10.1016/0007-1226(91)90096-3
   Tan BK, 2004, ANN ACAD MED SINGAP, V33, P662
   TARK KC, 1991, ANN PLAS SURG, V26, P149, DOI 10.1097/00000637-199102000-00007
   Tark KC, 1996, ANN PLAS SURG, V37, P298, DOI 10.1097/00000637-199609000-00011
   WASHIO H, 1971, PLAST RECONSTR SURG, V48, P48, DOI 10.1097/00006534-197107000-00010
   YAO ST, 1982, PLAST RECONSTR SURG, V69, P568, DOI 10.1097/00006534-198203000-00051
   Zhang F, 2003, ANN PLAS SURG, V51, P488, DOI 10.1097/01.SAP.0000070648.65942.E6
NR 31
TC 7
Z9 8
U1 0
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-7043
J9 ANN PLAS SURG
JI Ann. Plast. Surg.
PD SEP
PY 2011
VL 67
IS 3
BP 299
EP 302
DI 10.1097/SAP.0b013e3181fabc32
PG 4
WC Surgery
SC Surgery
GA 806QW
UT WOS:000293826100021
PM 21407060
DA 2018-10-20
ER

PT J
AU Kretlow, JD
   Mikos, AG
AF Kretlow, James D.
   Mikos, Antonios G.
TI Founder's Award to Antonios G. Mikos, Ph.D., 2011 Society for
   Biomaterials Annual Meeting and Exposition, Orlando, Florida, April
   13-16, 2011
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterials; tissue engineering; polymer scaffolds; hydrogels;
   biomimetics; bioreactors
ID CO-ETHYLENE GLYCOL); MARROW STROMAL OSTEOBLASTS; BIODEGRADABLE POLYMER
   MICROPARTICLES; OSTEOGENIC CELL-POPULATIONS; CALCIUM-PHOSPHATE CEMENT;
   GROWTH-FACTOR DELIVERY; IN-VITRO CYTOTOXICITY; SIZE DEFECT MODEL;
   POLY(DL-LACTIC-CO-GLYCOLIC ACID) FOAMS; POLY(PROPYLENE FUMARATE)
   SCAFFOLDS
AB For biomaterials scientists focusing on tissue engineering applications, the gold standard material is healthy, autologous tissue. Ideal material properties and construct design parameters are thus both obvious and often times unachievable; additional considerations such as construct delivery and the underlying pathology necessitating new tissue yield additional design challenges with solutions that are not evident in nature. For the past nearly two decades, our laboratory and collaborators have aimed to develop both new biomaterials and a better understanding of the complex interplay between material and host tissue to facilitate bone and cartilage regeneration. Various approaches have ranged from mimicking native tissue material properties and architecture to developing systems for bioactive molecule delivery as soluble factors or bound directly to the biomaterial substrate. Such technologies have allowed others and us to design synthetic biomaterials incorporating increasing levels of complexity found in native tissues with promising advances made toward translational success. Recent work focuses on translation of these technologies in specific clinical situations through the use of adjunctive biomaterials designed to address existing pathologies or guide host-material integration. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 323-331, 2011.
C1 [Kretlow, James D.; Mikos, Antonios G.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Mikos, AG (reprint author), Rice Univ, Dept Bioengn, POB 1892,MS 142, Houston, TX 77251 USA.
EM mikos@rice.edu
FU NIDCR NIH HHS [R01 DE017441, R01 DE017441-04]; NIAMS NIH HHS [R01
   AR057083-03, R01 AR048756-07, R01 AR048756, R01 AR057083]
CR Atala A, 2008, REGEN MED, V3, P463, DOI 10.2217/17460751.3.4.463
   Badylak SF, 2010, ANNU REV BIOMED ENG, V13, DOI [10.1146/annurev-bioeng-071910-124743, DOI 10.1146/ANNUREV-BIOENG-071910-124743]
   Bancroft GN, 2003, TISSUE ENG, V9, P549, DOI 10.1089/107632703322066723
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Baylis Francoise, 2002, Health Law Rev, V11, P44
   Behravesh E, 2003, J BIOMED MATER RES A, V66A, P698, DOI 10.1002/jbm.a.10003
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Behravesh E, 2002, BIOMACROMOLECULES, V3, P374, DOI 10.1021/bm010158r
   Carpenter MK, 2010, REGEN MED, V5, P569, DOI 10.2217/RME.10.55
   Chew SA, 2009, BIOMACROMOLECULES, V10, P2436, DOI 10.1021/bm9003783
   Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057
   Datta N, 2006, P NATL ACAD SCI USA, V103, P2488, DOI 10.1073/pnas.0505661103
   Datta N, 2005, BIOMATERIALS, V26, P971, DOI 10.1016/j.biomaterials.2004.04.001
   Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1327, DOI 10.1021/bm030028d
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Fisher JP, 2001, J BIOMAT SCI-POLYM E, V12, P673
   Ginty PJ, 2010, REGEN MED, V5, P463, DOI 10.2217/RME.10.13
   Guo X, 2010, ACTA BIOMATER, V6, P39, DOI 10.1016/j.actbio.2009.07.041
   Habraken WJEM, 2008, J BIOMED MATER RES A, V87A, P643, DOI 10.1002/jbm.a.31703
   Habraken WJEM, 2006, J BIOMAT SCI-POLYM E, V17, P1057, DOI 10.1163/156856206778366004
   Habraken WJEM, 2008, BIOMATERIALS, V29, P2464, DOI 10.1016/j.biomaterials.2008.02.012
   Hacker MC, 2008, BIOMACROMOLECULES, V9, P1558, DOI 10.1021/bm8000414
   He S, 2001, POLYMER, V42, P1251, DOI 10.1016/S0032-3861(00)00479-1
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Hedberg EL, 2005, J BIOMED MATER RES A, V72A, P343, DOI 10.1002/jbm.a.30265
   Hedberg EL, 2002, J CONTROL RELEASE, V84, P137, DOI 10.1016/S0168-3659(02)00261-4
   Hellman K B, 1995, Tissue Eng, V1, P203, DOI 10.1089/ten.1995.1.203
   Holden C, 2008, SCIENCE, V320, P437, DOI 10.1126/science.320.5875.437a
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Holland TA, 2004, J CONTROL RELEASE, V94, P101, DOI 10.1016/j.jconrel.2003.09.007
   Holland TA, 2003, J CONTROL RELEASE, V91, P299, DOI 10.1016/S0168-3659(03)00258-X
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hollister SJ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/012001
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Jo S, 2001, BIOMACROMOLECULES, V2, P255, DOI 10.1021/bm000107e
   Jo S, 2001, MACROMOLECULES, V34, P2839, DOI 10.1021/ma001563y
   Klouda L, 2009, BIOMATERIALS, V30, P4558, DOI 10.1016/j.biomaterials.2009.05.029
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Kretlow JD, 2010, TISSUE ENG PT A, V16, P3555, DOI 10.1089/ten.TEA.2010.0471
   Kretlow JD, 2010, TISSUE ENG PART C-ME, V16, P1427, DOI 10.1089/ten.tec.2010.0046
   Kretlow JD, 2009, ADV MATER, V21, P3368, DOI 10.1002/adma.200802009
   Lee MH, 2010, TISSUE ENG PART B-RE, V16, P41, DOI [10.1089/ten.teb.2009.0449, 10.1089/ten.TEB.2009.0449]
   Liras A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-131
   Liu GZ, 2001, J CELL BIOCHEM, V83, P129, DOI 10.1002/jcb.1208
   Lu L, 2000, J BIOMED MATER RES, V50, P440, DOI 10.1002/(SICI)1097-4636(20000605)50:3<440::AID-JBM19>3.0.CO;2-G
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu LC, 2001, J BONE JOINT SURG AM, V83A, pS82
   Lu LC, 1998, J BIOMAT SCI-POLYM E, V9, P1187
   Lu LC, 2000, BIOMATERIALS, V21, P1595, DOI 10.1016/S0142-9612(00)00048-X
   Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6
   Mason C, 2010, REGEN MED, V5, P307, DOI [10.2217/rme.10.37, 10.2217/RME.10.37]
   MIKOS AG, 1994, BIOMATERIALS, V15, P55, DOI 10.1016/0142-9612(94)90197-X
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mistry AS, 2007, J BIOMED MATER RES A, V83A, P940, DOI 10.1002/jbm.a.31280
   Mistry AS, 2009, J BIOMED MATER RES A, V89A, P68, DOI 10.1002/jbm.a.32010
   Nguyen C, 2011, J ORAL MAXIL SURG, V69, P11, DOI 10.1016/j.joms.2010.02.026
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Park H, 2007, BIOMATERIALS, V28, P3217, DOI 10.1016/j.biomaterials.2007.03.030
   Park H, 2009, J BIOMED MATER RES A, V88A, P889, DOI 10.1002/jbm.a.31948
   Patel ZS, 2008, BONE, V43, P931, DOI 10.1016/j.bone.2008.06.019
   Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002
   Patel ZS, 2008, PHARM RES-DORDR, V25, P2370, DOI 10.1007/s11095-008-9685-1
   Payne RG, 2002, BIOMATERIALS, V23, P4381, DOI 10.1016/S0142-9612(02)00186-2
   Payne RG, 2002, BIOMATERIALS, V23, P4359, DOI 10.1016/S0142-9612(02)00184-9
   Payne RG, 2002, BIOMATERIALS, V23, P4373, DOI 10.1016/S0142-9612(02)00185-0
   PENA SDJ, 1978, CELL BIOL INT REP, V2, P339, DOI 10.1016/0309-1651(78)90019-X
   Peter SJ, 2000, J BIOMED MATER RES, V50, P452, DOI 10.1002/(SICI)1097-4636(20000605)50:3<452::AID-JBM20>3.3.CO;2-S
   Peter SJ, 1999, J BIOMED MATER RES, V44, P314
   Peter SJ, 1999, J BIOMAT SCI-POLYM E, V10, P363, DOI 10.1163/156856299X00423
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   Pham QP, 2009, J BIOMED MATER RES A, V88A, P295, DOI 10.1002/jbm.a.31875
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Shi M, J CONTROL R IN PRESS
   Shi M, 2010, BIOMATERIALS, V31, P4146, DOI 10.1016/j.biomaterials.2010.01.112
   Shi X., 2005, NANOTECHNOLOGY, V16, P531
   Shi XF, 2008, J BIOMED MATER RES A, V86A, P813, DOI 10.1002/jbm.a.31671
   Shi XF, 2007, BIOMATERIALS, V28, P4078, DOI 10.1016/j.biomaterials.2007.05.033
   Shi XF, 2006, BIOMACROMOLECULES, V7, P2237, DOI 10.1021/bm060391v
   Shin H, 2005, BIOMATERIALS, V26, P3645, DOI 10.1016/j.biomaterials.2004.09.050
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2004, BIOMATERIALS, V25, P895, DOI 10.1016/S0142-9612(03)00602-1
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Shung AK, 2002, J BIOMAT SCI-POLYM E, V13, P95, DOI 10.1163/156856202753525963
   Sikavitsas VI, 2005, ANN BIOMED ENG, V33, P63, DOI 10.1007/s10439-005-8963-x
   Sikavitsas VI, 2003, J BIOMED MATER RES A, V67A, P944, DOI 10.1002/jbm.a.10126
   Suggs LJ, 1998, J BIOMAT SCI-POLYM E, V9, P653, DOI 10.1163/156856298X00073
   Suggs LJ, 1999, J BIOMED MATER RES, V46, P22, DOI 10.1002/(SICI)1097-4636(199907)46:1<22::AID-JBM3>3.0.CO;2-R
   Suggs LJ, 1998, J BIOMED MATER RES, V42, P312, DOI 10.1002/(SICI)1097-4636(199811)42:2<312::AID-JBM17>3.0.CO;2-K
   Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402
   Tanahashi K, 2003, J BIOMED MATER RES A, V67A, P1148, DOI 10.1002/jbm.a.10147
   Tanahashi K, 2003, J BIOMED MATER RES A, V67A, P448, DOI 10.1002/jbm.a.10077
   Temenoff JS, 2003, BIOMACROMOLECULES, V4, P1605, DOI 10.1021/bm030056w
   Temenoff JS, 2003, J BIOMAT SCI-POLYM E, V14, P989, DOI 10.1163/156856203322381465
   Temenoff JS, 2002, J BIOMED MATER RES, V59, P429, DOI 10.1002/jbm.1259
   THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805
   Thomson RC, 1996, BIOMATERIALS, V17, P321, DOI 10.1016/0142-9612(96)85570-0
   Timmer MD, 2003, J BIOMAT SCI-POLYM E, V14, P369, DOI 10.1163/156856203321478874
   Timmer MD, 2002, MACROMOLECULES, V35, P4373, DOI 10.1021/ma020028q
   Vaheri A, 1978, Ann N Y Acad Sci, V312, P343, DOI 10.1111/j.1749-6632.1978.tb16812.x
   VONRECUM HA, 1995, BIOMATERIALS, V16, P441, DOI 10.1016/0142-9612(95)98816-W
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Yang PJ, 2009, TISSUE ENG PART B-RE, V15, P127, DOI 10.1089/ten.teb.2008.0371
   Yaszemski M J, 1995, Tissue Eng, V1, P41, DOI 10.1089/ten.1995.1.41
   Young S, 2009, TISSUE ENG PT A, V15, P2347, DOI 10.1089/ten.tea.2008.0510
NR 120
TC 3
Z9 3
U1 0
U2 9
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP
PY 2011
VL 98A
IS 3
BP 323
EP 331
DI 10.1002/jbm.a.33154
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 805AZ
UT WOS:000293699800001
PM 21714068
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Genuneit, J
   Buchele, G
   Waser, M
   Kovacs, K
   Debinska, A
   Boznanski, A
   Strunz-Lehner, C
   Horak, E
   Cullinan, P
   Heederik, D
   Braun-Fahrlander, C
   von Mutius, E
AF Genuneit, Jon
   Buechele, Gisela
   Waser, Marco
   Kovacs, Katalin
   Debinska, Anna
   Boznanski, Andrzej
   Strunz-Lehner, Christine
   Horak, Elisabeth
   Cullinan, Paul
   Heederik, Dick
   Braun-Fahrlaender, Charlotte
   von Mutius, Erika
CA GABRIELA Study Grp
TI The GABRIEL Advanced Surveys: study design, participation and evaluation
   of bias
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article
DE GABRIEL Advanced Surveys; study design; asthma; atopy
ID RESPIRATORY ALLERGIES; CHILDHOOD ASTHMA; CHILDREN; EXPOSURE; DUST;
   SENSITIZATION; ASSOCIATION; ENDOTOXIN; COLLECTOR; PARSIFAL
AB Exposure to farming environments has been shown to protect substantially against asthma and atopic disease across Europe and in other parts of the world. The GABRIEL Advanced Surveys (GABRIELA) were conducted to determine factors in farming environments which are fundamental to protecting against asthma and atopic disease.
   The GABRIEL Advanced Surveys have a multi-phase stratified design. In a first-screening phase, a comprehensive population-based survey was conducted to assess the prevalence of exposure to farming environments and of asthma and atopic diseases (n = 103 219). The second phase was designed to ascertain detailed exposure to farming environments and to collect biomaterial and environmental samples in a stratified random sample of phase 1 participants (n = 15 255). A third phase was carried out in a further stratified sample only in Bavaria, southern Germany, aiming at in-depth respiratory disease and exposure assessment including extensive environmental sampling (n = 895).
   Participation rates in phase 1 were around 60% but only about half of the participating study population consented to further study modules in phase 2. We found that consenting behaviour was related to familial allergies, high parental education, wheeze, doctor diagnosed asthma and rhinoconjunctivitis, and to a lesser extent to exposure to farming environments. The association of exposure to farm environments with asthma or rhinoconjunctivitis was not biased by participation or consenting behaviour.
   The GABRIEL Advanced Surveys are one of the largest studies to shed light on the protective 'farm effect' on asthma and atopic disease. Bias with regard to the main study question was able to be ruled out by representativeness and high participation rates in phases 2 and 3. The GABRIEL Advanced Surveys have created extensive collections of questionnaire data, biomaterial and environmental samples promising new insights into this area of research.
C1 [Genuneit, Jon; Buechele, Gisela] Univ Ulm, Inst Epidemiol & Med Biometry, D-89081 Ulm, Germany.
   [Strunz-Lehner, Christine; von Mutius, Erika] Univ Childrens Hosp, LMU Munich, Munich, Germany.
   [Buechele, Gisela; Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Basel, Switzerland.
   [Waser, Marco; Braun-Fahrlaender, Charlotte] Univ Basel, Basel, Switzerland.
   [Kovacs, Katalin; Horak, Elisabeth] Innsbruck Med Univ, Div Cardiol & Pulmonol, Dept Pediat & Adolescents, Innsbruck, Austria.
   [Debinska, Anna; Boznanski, Andrzej] Wroclaw Med Univ, Dept Paediat Allergol & Cardiol 1, Wroclaw, Poland.
   [Cullinan, Paul] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.
   [Heederik, Dick] Univ Utrecht, Div Environm Epidemiol, IRAS, Utrecht, Netherlands.
RP Genuneit, J (reprint author), Univ Ulm, Inst Epidemiol & Med Biometry, Helmholtzstr 22, D-89081 Ulm, Germany.
EM jon.genuneit@uni-ulm.de
RI Genuneit, Jon/I-9323-2012; Loss, Georg/F-1557-2013
OI Genuneit, Jon/0000-0001-5764-1528; Ege, Markus/0000-0001-6643-3923;
   Latzin, Philipp/0000-0002-5239-1571; von Mutius,
   Erika/0000-0002-8893-4515; Normand, Anne-Cecile/0000-0002-9589-4603
FU European Commission [018996, LSH-2004-1.2.5-1]
FX This work was supported by the European Commission as part of GABRIEL,
   contract number 018996 under the Integrated Program LSH-2004-1.2.5-1.
CR Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x
   [Anonymous], 2005, AM J RESP CRIT CARE, V171, P912, DOI DOI 10.1164/RCCM.200406-710ST
   ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483
   Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST
   Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28
   Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302
   Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041
   Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037
   EHRENSTEIN OS, 2000, CLIN EXP ALLERGY, V30, P187
   Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312
   MUTIUS E, 2006, ALLERGY, V4, P407
   Mutius E, 2010, NATURE REV IMMUNOLOG, V10, P861, DOI [10.1038/nri2871, DOI 10.1038/NRI2871]
   NORMAND AC, 2011, OCCUPATIONAL ENV MED, DOI DOI 10.1136/OEM.2010.061879
   Noss I, 2008, APPL ENVIRON MICROB, V74, P5621, DOI 10.1128/AEM.00619-08
   Noss I, 2010, ANN OCCUP HYG, V54, P651, DOI 10.1093/annhyg/meq026
   Radon K, 2006, ALLERGY, V61, P443, DOI 10.1111/j.1398-9995.2006.00995.x
   Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3
   Schram-Bijkerk D, 2005, CLIN EXP ALLERGY, V35, P1272, DOI 10.1111/j.1365-2222.2005.02339.x
   Sozanska B, 2007, ALLERGY, V62, P394, DOI 10.1111/j.1398-9995.2007.01346.x
   Tse K, 2008, SEMIN IMMUNOPATHOL, V30, P53, DOI 10.1007/s00281-007-0098-8
   van der Pal S, 2011, PUBLIC HEALTH GENOM, V14, P271, DOI 10.1159/000294173
NR 21
TC 32
Z9 32
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0269-5022
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD SEP
PY 2011
VL 25
IS 5
BP 436
EP 447
DI 10.1111/j.1365-3016.2011.01223.x
PG 12
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA 804MV
UT WOS:000293658800004
PM 21819425
DA 2018-10-20
ER

PT J
AU Cameron, AR
   Frith, JE
   Cooper-White, JJ
AF Cameron, Andrew R.
   Frith, Jessica E.
   Cooper-White, Justin J.
TI The influence of substrate creep on mesenchymal stem cell behaviour and
   phenotype
SO BIOMATERIALS
LA English
DT Article
DE Mesenchymal stem cell; Mechanical properties; Creep; Viscoelasticity;
   Tension
ID FOCAL ADHESIONS; VISCOELASTIC BEHAVIOR; CYTOSKELETAL TENSION;
   MECHANICAL-BEHAVIOR; POLYMER GELS; MATRIX; DIFFERENTIATION; FIBROBLASTS;
   TISSUE; FORCE
AB Human mesenchymal stem cells (hMSCs) are capable of probing and responding to the mechanical properties of their substrate. Although most biological and synthetic matrices are viscoelastic materials, previous studies have primarily focused upon substrate compressive modulus (rigidity), neglecting the relative contributions that the storage (elastic) and loss (viscous) moduli make to the summed compressive modulus. In this study we aimed to isolate and identify the effects of the viscous component of a substrate on hMSC behaviour. Using a polyacrlyamide gel system with constant compressive modulus and varying loss modulus we determined that changes to substrate loss modulus substantially affected hMSC morphology, proliferation and differentiation potential. In addition, we showed that the effect of substrate loss modulus on hMSC behaviour is due to a reduction in both passive and actively generated isometric cytoskeletal tension caused by the inherent creep of substrates with a high loss modulus. These findings highlight substrate creep, or more explicitly substrate loss modulus, as an important mechanical property of a biomaterial system that can be tailored to encourage the growth and differentiation of specific cell types. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
C1 [Cameron, Andrew R.; Frith, Jessica E.; Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Brisbane, Qld 4072, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.
RP Cooper-White, JJ (reprint author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Tissue Engn & Microfluid Lab, Bldg 75,Cnr Coll & Cooper Rd, Brisbane, Qld 4072, Australia.
EM j.cooperwhite@uq.edu.au
RI Frith, Jessica/J-6873-2017
OI Frith, Jessica/0000-0002-6558-5412; Cameron, Andrew/0000-0002-6341-0379;
   Cooper-White, Justin/0000-0002-1920-8229
FU Cooperative Research Centre for Polymers; School of Chemical
   Engineering; Australian Institute of Bioengineering and Nanotechnology
   at The University of Queensland
FX We gratefully acknowledge Dr Erik Miller for discussions on
   polyacrylamide mechanical testing and Dr Gary Brooke from the Mater
   Medical Research Institute for providing hMSCs. This study was
   financially supported by the Cooperative Research Centre for Polymers as
   well as the School of Chemical Engineering and the Australian Institute
   of Bioengineering and Nanotechnology at The University of Queensland.
CR Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293
   Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273
   Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015
   Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881
   Boudou T, 2006, BIORHEOLOGY, V43, P721
   Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806
   Calvet D, 2004, MACROMOLECULES, V37, P7762, DOI 10.1021/ma049072r
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   du Roure O, 2005, P NATL ACAD SCI USA, V102, P2390, DOI 10.1073/pnas.0408482102
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Evans ND, 2009, EUR CELLS MATER, V18, P1
   Frith JE, 2009, TISSUE ENG PART C-ME, V16, P735
   Galbraith CG, 1997, P NATL ACAD SCI USA, V94, P9114, DOI 10.1073/pnas.94.17.9114
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Geerligs M, 2008, BIORHEOLOGY, V45, P677, DOI 10.3233/BIR-2008-0517
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   GEISSLER E, 1980, MACROMOLECULES, V13, P1276, DOI 10.1021/ma60077a047
   Grattoni CA, 2001, J COLLOID INTERF SCI, V240, P601, DOI 10.1006/jcis.2001.7633
   Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hrapko M, 2006, BIORHEOLOGY, V43, P623
   Hudson JE, 2011, STEM CELLS DEV, V20
   Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024
   INGBER DE, 1993, J CELL SCI, V104, P613
   Ingber DE, 2003, J CELL SCI, V116, P1157, DOI 10.1242/jcs.00359
   Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281
   Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X
   Kawada N, 1999, BIOCHEM BIOPH RES CO, V266, P296, DOI 10.1006/bbrc.1999.1823
   Klein EA, 2009, CURR BIOL, V19, P1511, DOI 10.1016/j.cub.2009.07.069
   Liu Z, 2000, BIORHEOLOGY, V37, P191
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lozito TP, 2009, J CELL BIOCHEM, V107, P714, DOI 10.1002/jcb.22167
   Lozito TP, 2009, J CELL BIOCHEM, V107, P706, DOI 10.1002/jcb.22166
   Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880
   Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Miano JM, 1996, J BIOL CHEM, V271, P7095, DOI 10.1074/jbc.271.12.7095
   Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Petroll WM, 2004, INVEST OPHTH VIS SCI, V45, P3466, DOI 10.1167/iovs.04-0361
   Peyton SR, 2007, CELL BIOCHEM BIOPHYS, V47, P300, DOI 10.1007/s12013-007-0004-y
   Rowlands A. S., 2008, AM J PHYSIOL-CELL PH, V295, P1037
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salhia B, 2005, CANCER RES, V65, P8792, DOI 10.1158/0008-5472.CAN-05-0160
   Scaife RM, 2003, MOL BIOL CELL, V14, P4605, DOI 10.1091/mbc.E02-11-0739
   SCHWARTZ MA, 2002, NAT CELL BIOL, V4, P65
   Simper D, 2002, CIRCULATION, V106, P1199, DOI 10.1161/01.CIR.0000031525.61826.A8
   Sinha S., 2004, AM J PHYSIOL-CELL PH, V287, P1560
   Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X
   Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   van Dam EA, 2008, BIOMECH MODEL MECHAN, V7, P127, DOI 10.1007/s10237-007-0080-3
   Wakatsuki T, 2003, J CELL SCI, V116, P1617, DOI 10.1242/jcs.00340
   Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang Yu-Li, 1998, V298, P489
   Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
NR 65
TC 117
Z9 118
U1 3
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2011
VL 32
IS 26
BP 5979
EP 5993
DI 10.1016/j.biomaterials.2011.04.003
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 794NH
UT WOS:000292904100004
PM 21621838
DA 2018-10-20
ER

PT J
AU McBane, JE
   Sharifpoor, S
   Cai, KH
   Labow, RS
   Santerre, JP
AF McBane, Joanne E.
   Sharifpoor, Soroor
   Cai, Kuihua
   Labow, Rosalind S.
   Santerre, J. Paul
TI Biodegradation and in vivo biocompatibility of a degradable,
   polar/hydrophobic/ionic polyurethane for tissue engineering applications
SO BIOMATERIALS
LA English
DT Article
DE Polyurethane; Polylactic glycolic acid; Biodegradation;
   Biocompatibility; Rat subcutaneous implant; Porous scaffold
ID ENZYME-INDUCED BIODEGRADATION; POLY(DL-LACTIC-CO-GLYCOLIC ACID) FOAMS;
   TYROSINE-DERIVED POLYCARBONATES; CHOLESTEROL ESTERASE; HYDROLYTIC
   DEGRADATION; POLY(CARBONATE URETHANE); POLY(ETHER URETHANE);
   ARTICULAR-CARTILAGE; VITRO; SCAFFOLDS
AB A degradable, polar/hydrophobic/ionic polyurethane (D-PHI) scaffold was optimized in in vitro studies to yield mechanical properties appropriate to replicate vascular graft tissue while eliciting a more wound-healing phenotype macrophage when compared to established materials. The objectives of this study were to characterize the biodegradation (in vitro and in vivo) and assess the in vivo biocompatibility of D-PHI, comparing it to a well-established, commercially-available scaffold biomaterial, polylactic glycolic acid (PLGA), recognized as being degradable, non-cytotoxic, and showing good biocompatibility. PLGA and D-PHI were formed into 6 mm diameter disk-shaped scaffolds (2 mm thick) of similar porosity (similar to 82%) and implanted subcutaneously in rats. Both PLGA and D-PHI scaffolds were well-tolerated at the 7 d time point in vivo. In vitro D-PHI scaffolds degraded slowly (only 12 wt% in PBS in vitro after 120 d at 37 degrees C). In vivo, D-PHI scaffolds degraded at a more controlled rate (7 wt% loss over the acute 7 d implant phase and subsequently a linear profile of degradation leading to a 21 wt% mass loss by 100 d (chronic period)) than PLGA scaffolds which showed an initial more rapid degradation (14 wt% over 7 d), followed by minimal change between 7 and 30 d, and then a very rapid breakdown of the scaffold over the next 60 d. Histological examination of D-PHI scaffolds showed tissue ingrowth into the pores increased with time whereas PLGA scaffolds excluded cells/tissue from its porous structure as it degraded. The results of this study suggest that D-PHI has promising qualities for use as an elastomeric scaffold material for soft TE applications yielding well integrated tissue within the scaffold and a controlled rate of degradation stabilizing the form and shape of the implant. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Santerre, J. Paul] Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Inst Biomat & Biomed Engn, Toronto, ON M5S 1G6, Canada.
   [McBane, Joanne E.; Labow, Rosalind S.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Labow, Rosalind S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1Y 4W7, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Inst Biomat & Biomed Engn, 124 Edward St,Room 460, Toronto, ON M5S 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
FU CIHR/NSERC [CHRP 337246/83459]; Heart and Stroke Foundation; CIHR
FX Thanks to Michel Araujo (Bone Interface Group, IBBME, University of
   Toronto) for performing the MicroCT analysis. Thanks to Feryal Sarraf
   (Faculty of Dentistry, University of Toronto) for preparation and
   staining of the histology slides. Thanks to Jiang Wang and Nancy
   Valiquette (Faculty of Dentistry, University of Toronto) for assistance
   with SEM sample preparation. Funding for this project was obtained from
   a CIHR/NSERC collaborative grant CHRP 337246/83459 (RSL/JPS). JEM was
   funded in part by a Heart and Stroke Foundation - Focus on Stroke VII
   post-doctoral fellowship scholarship. SS was funded in part by a CIHR
   strategic training program: Cell signaling in mucosal inflammation and
   pain.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Araujo JC, 2003, J ELECTRON MICROSC, V52, P429, DOI 10.1093/jmicro/52.4.429
   Araujo MVF, 2010, CLIN ORAL IMPLAN RES, V21, P632, DOI 10.1111/j.1600-0501.2009.01864.x
   BATTISTON KG, 2011, 36 ANN M SOC BIOM OR
   Bertoldi S, 2010, J MATER SCI-MATER M, V21, P1005, DOI 10.1007/s10856-009-3953-4
   CAI K, 2007, 26 ANN M CAN BIOM SO
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Christenson EM, 2006, BIOMATERIALS, V27, P3920, DOI 10.1016/j.biomaterials.2006.03.012
   Christenson EM, 2004, J BIOMED MATER RES A, V70A, P245, DOI 10.1002/jbm.a.30067
   Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184
   DUGUAY DG, 1995, POLYM DEGRAD STABIL, V47, P229, DOI 10.1016/0141-3910(94)00114-N
   Emin N, 2008, ARTIF CELL BLOOD SUB, V36, P123, DOI 10.1080/10731190801932116
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Guelcher SA, 2008, TISSUE ENG PT B-REV, V14, P3, DOI 10.1089/teb.2007.0133
   Holy CE, 1999, BIOMATERIALS, V20, P1177, DOI 10.1016/S0142-9612(98)00256-7
   Hong Y, 2008, BIOMACROMOLECULES, V9, P1200, DOI 10.1021/bm701201w
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Huang YY, 2006, T NONFERR METAL SOC, V16, pS293, DOI 10.1016/S1003-6326(06)60194-5
   Ibim SM, 1998, BIOMATERIALS, V19, P941, DOI 10.1016/S0142-9612(98)00019-2
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Jahangir R, 2003, BIOMATERIALS, V24, P121, DOI 10.1016/S0142-9612(02)00269-7
   Labow RS, 2002, BIOMATERIALS, V23, P3969, DOI 10.1016/S0142-9612(02)00137-0
   Labow RS, 2002, J BIOMAT SCI-POLYM E, V13, P651, DOI 10.1163/156856202320269148
   Labow RS, 1999, J BIOMATER APPL, V13, P187, DOI 10.1177/088532829901300302
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   McBane JE, 2011, BIOMATERIALS, V32, P3584, DOI 10.1016/j.biomaterials.2011.01.069
   McBane JE, 2011, ACTA BIOMATER, V7, P115, DOI 10.1016/j.actbio.2010.08.014
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   Moore MJ, 2004, J BIOMED MATER RES A, V71A, P258, DOI 10.1002/jbm.a.30138
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   Pamula E, 2008, J MATER SCI-MATER M, V19, P2063, DOI 10.1007/s10856-007-3292-2
   Pan H, 2008, BIOMATERIALS, V29, P1583, DOI 10.1016/j.biomaterials.2007.12.005
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Rowlands AS, 2007, BIOMATERIALS, V28, P2109, DOI 10.1016/j.biomaterials.2006.12.032
   SALTZMAN WM, 1989, BIOPHYS J, V55, P163, DOI 10.1016/S0006-3495(89)82788-2
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Schwach G, 1999, INT J BIOL MACROMOL, V25, P283, DOI 10.1016/S0141-8130(99)00043-4
   Sharifpoor S, 2010, ACTA BIOMATER, V6, P4218, DOI 10.1016/j.actbio.2010.06.018
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   STOKES K, 1995, J BIOMATER APPL, V9, P321, DOI 10.1177/088532829500900402
   Tang YW, 2003, BIOMATERIALS, V24, P2003, DOI 10.1016/S0142-9612(02)00563-X
   Tang YW, 2001, J BIOMED MATER RES, V57, P597, DOI 10.1002/1097-4636(20011215)57:4<597::AID-JBM1207>3.0.CO;2-T
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2371, DOI 10.1016/S0142-9612(00)00104-6
   Tangpasuthadol V, 2000, BIOMATERIALS, V21, P2379, DOI 10.1016/S0142-9612(00)00105-8
   Tanzi MC, 1997, J BIOMED MATER RES, V36, P550, DOI 10.1002/(SICI)1097-4636(19970915)36:4<550::AID-JBM14>3.0.CO;2-E
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
   Yoshioka T, 2008, BIOMATERIALS, V29, P3438, DOI 10.1016/j.biomaterials.2008.04.011
   Zhang L, 2008, BIOTECHNOL BIOENG, V99, P1007, DOI 10.1002/bit.21629
NR 57
TC 71
Z9 74
U1 4
U2 82
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2011
VL 32
IS 26
BP 6034
EP 6044
DI 10.1016/j.biomaterials.2011.04.048
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 794NH
UT WOS:000292904100009
PM 21641638
DA 2018-10-20
ER

PT J
AU Chiu, YC
   Cheng, MH
   Engel, H
   Kao, SW
   Larson, JC
   Gupta, S
   Brey, EM
AF Chiu, Yu-Chieh
   Cheng, Ming-Huei
   Engel, Holger
   Kao, Shu-Wei
   Larson, Jeffery C.
   Gupta, Shreya
   Brey, Eric M.
TI The role of pore size on vascularization and tissue remodeling in PEG
   hydrogels
SO BIOMATERIALS
LA English
DT Article
DE Porous; Poly (ethylene glycol); Vascularization; Hydrogels
ID POLY(ETHYLENE GLYCOL) HYDROGELS; NEOVASCULARIZATION; SCAFFOLDS;
   ANGIOGENESIS; DEGRADATION; MEMBRANE; MATRICES; RELEASE; MODEL; VEGF
AB Vascularization is influenced by the physical architecture of a biomaterial. The relationship between pore size and vascularization has been examined for hydrophobic polymer foams, but there has been little research on tissue response in porous hydrogels. The goal of this study was to examine the role of pore size on vessel invasion in porous poly(ethylene glycol) (PEG) hydrogels. Vascularized tissue ingrowth was examined using three-dimensional cell culture and rodent models. In culture, all porous gels supported vascular invasion with the rate increasing with pore size. Following subfascia implantation, porous gels rapidly absorbed wound fluid, which promoted tissue ingrowth even in the absence of exogenous growth factors. Pore size influenced neovascularization, within the scaffolds and also the overall tissue response. Cell and vessel invasion into gels with pores 25-50 mu m in size was limited to the external surface, while gels with pores larger pores (50-100 and 100-150 mu m) permitted mature vascularized tissue formation throughout the entire material volume. A thin layer of inflammatory tissue was present at all PEG-tissue interfaces, effectively reducing the area available for tissue growth. These results show that porous PEG hydrogels can support extensive vascularized tissue formation, but the nature of the response depends on the pore size. Published by Elsevier Ltd.
C1 [Chiu, Yu-Chieh; Larson, Jeffery C.; Gupta, Shreya; Brey, Eric M.] IIT, Dept Biomed Engn, Chicago, IL 60616 USA.
   [Cheng, Ming-Huei; Kao, Shu-Wei] Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Div Reconstruct Microsurg, Tao Yuan, Taiwan.
   [Engel, Holger] Heidelberg Univ, Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Burn Ctr,BG, D-6900 Heidelberg, Germany.
   [Brey, Eric M.] Edward Hines Jr VA Hosp, Res Serv, Hines, IL 60141 USA.
RP Brey, EM (reprint author), IIT, Dept Biomed Engn, 3255 S Dearborn St,Wishnick Hall,Room 223, Chicago, IL 60616 USA.
EM brey@iit.edu
FU Veterans Administration; National Science Foundation [0852048, 0731201];
   Taiwan National Science Council [98-2314-B-182-015-MY3]
FX This research was supported by funding from Veterans Administration, the
   National Science Foundation (Grants 0852048,0731201) and the Taiwan
   National Science Council (98-2314-B-182-015-MY3). We thank Sarah Lopez
   for assistance with analysis of collagen content in the hydrogels.
CR Aimetti AA, 2009, BIOMATERIALS, V30, P6048, DOI 10.1016/j.biomaterials.2009.07.043
   Bai F, 2010, TISSUE ENG PT A, V16, P3791, DOI 10.1089/ten.TEA.2010.0148
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Brey EM, 2005, TISSUE ENG, V11, P567, DOI 10.1089/ten.2005.11.567
   Brey EM, 2002, MICROVASC RES, V63, P279, DOI 10.1006/mvre.2002.2395
   Brey EM, 2010, TISSUE ENG PART C-ME, V16, P1597, DOI 10.1089/ten.tec.2010.0150
   CANAL T, 1989, J BIOMED MATER RES, V23, P1183, DOI 10.1002/jbm.820231007
   Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220
   Chen CW, 2010, TISSUE ENG PART C-ME, V17, P101
   Chiu YC, 2010, TISSUE ENG PART C-ME, V16, P905, DOI [10.1089/ten.tec.2009.0646, 10.1089/ten.TEC.2009.0646]
   Chiu YC, 2011, J TISSUE VIABILITY, V20, P37, DOI 10.1016/j.jtv.2009.11.005
   Chiu YC, 2009, CHEM MATER, V21, P1677, DOI 10.1021/cm803520j
   Francis ME, 2008, TISSUE ENG PART B-RE, V14, P19, DOI 10.1089/teb.2007.0115
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Kim JK, 2008, BIOMACROMOLECULES, V9, P149, DOI 10.1021/bm700924n
   Lim TC, 2008, VIRTUAL PHYS PROTOTY, V3, P25, DOI 10.1080/17452750701799303
   Lin CC, 2009, ADV FUNCT MATER, V19, P2325, DOI 10.1002/adfm.200900107
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   McIntire LV, 2002, ANN NY ACAD SCI, V961, P246, DOI 10.1111/j.1749-6632.2002.tb03092.x
   Moon JJ, 2007, BIOMACROMOLECULES, V8, P42, DOI 10.1021/bm060452p
   Moya ML, 2010, BIOMATERIALS, V31, P2816, DOI 10.1016/j.biomaterials.2009.12.053
   Papavasiliou G, 2010, J INVEST MED, V58, P838, DOI 10.231/JIM.0b013e3181f18e38
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sontjens SHM, 2006, BIOMACROMOLECULES, V7, P310, DOI 10.1021/bm050663e
   van de Wetering P, 2005, J CONTROL RELEASE, V102, P619, DOI 10.1016/j.jconrel.2004.10.029
   White JA, 2002, BIOPHYS J, V82, P2081, DOI 10.1016/S0006-3495(02)75555-0
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 29
TC 94
Z9 97
U1 3
U2 69
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2011
VL 32
IS 26
BP 6045
EP 6051
DI 10.1016/j.biomaterials.2011.04.066
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 794NH
UT WOS:000292904100010
PM 21663958
DA 2018-10-20
ER

PT J
AU Blit, PH
   McClung, WG
   Brash, JL
   Woodhouse, KA
   Santerre, JP
AF Blit, Patrick H.
   McClung, W. Glenn
   Brash, John L.
   Woodhouse, Kimberly A.
   Santerre, J. Paul
TI Platelet inhibition and endothelial cell adhesion on elastin-like
   polypeptide surface modified materials
SO BIOMATERIALS
LA English
DT Article
DE Elastin; Platelet activation; Endothelial cell; Polyurethane; Surface
   modification
ID LYSINE-DERIVATIZED POLYURETHANE; EXPRESSED HUMAN ELASTIN; REDUCED
   THROMBOGENICITY; FIBRINOGEN ADSORPTION; VASCULAR-TONE; SMOOTH-MUSCLE;
   IN-VITRO; PROTEIN; PEPTIDES; PLASMA
AB Platelet adhesion and activation are important early markers of biomaterial blood compatibility, while surfaces that promote enhanced endothelial cell adhesion and eNOS expression are strategic targets for long term vascular graft applications. Materials surface modified with fluorinated surface modifiers, containing peptides inspired from elastin cross-linking domains, have been used for the cross-linking of elastin-like polypeptide 4 (ELP4) macromolecules onto polyurethane surfaces. In the present study, ELP4 modified polyurethanes were evaluated in vitro to assess platelet adhesion, microparticle formation and bulk platelet activation following blood-material interactions. Reduced platelet adhesion and bulk platelet activation were observed following contact between reconstituted human blood and the ELP4 materials, relative to the uncoated base polyurethane controls. ELP4 modified materials also promoted endothelial cell adhesion and retention over a period of one week and showed that the endothelial cells exhibited an organized actin cytoskeleton and enhanced endothelial nitric oxide synthase (eNOS) expression relative to the control surfaces. These results indicate that polyurethane elastomers modified with ELP4 covalently bound to fluorinated surface modifiers provide a promising approach for endowing synthetic elastomers with both reduced blood platelet activation properties and enhanced endothelial cell adhesion for potential use in vascular graft applications. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Santerre, J. Paul] Univ Toronto, Fac Dent, Dept Biomat, Inst Biomat & Biomed Engn, Toronto, ON M5G 1G6, Canada.
   [Blit, Patrick H.; Woodhouse, Kimberly A.; Santerre, J. Paul] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5G 1G6, Canada.
   [McClung, W. Glenn; Brash, John L.] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   [McClung, W. Glenn; Brash, John L.] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada.
   [Woodhouse, Kimberly A.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada.
   [Santerre, J. Paul] Univ Toronto, Fac Dent, Dept Biol & Diagnost Sci, Toronto, ON M5G 1G6, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Dept Biomat, Inst Biomat & Biomed Engn, 124 Edward St,Room 464D, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
FU Canadian Institutes of Health Research (CIHR) [82388]; Natural Sciences
   and Engineering Research Council
FX The authors would like to thank Dr. Jian Wang and Mrs. Nancy Valiquette
   at the Faculty of Dentistry (University of Toronto) who assisted with
   scanning electron microscopy. Funding was provided by the Canadian
   Institutes of Health Research (CIHR, grant #82388). P.H. Blit was funded
   by a Natural Sciences and Engineering Research Council Postgraduate
   Scholarship and by a CIHR - Strategic Training Fellowship in Cell
   Signaling in Mucosal Inflammation & Pain.
CR Amaral IF, 2009, BIOMATERIALS, V30, P5465, DOI 10.1016/j.biomaterials.2009.06.056
   Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X
   Berrocal MJ, 2001, ANAL CHEM, V73, P5328, DOI 10.1021/ac010375i
   Blit PH, 2011, J BIOMED MATER RES A, V96A, P648, DOI 10.1002/jbm.a.33022
   Brash JL, 2000, J BIOMAT SCI-POLYM E, V11, P1135, DOI 10.1163/156856200744237
   BUDD JS, 1990, J VASC SURG, V12, P126, DOI 10.1067/mva.1990.21400
   CERRAI P, 1994, J MATER SCI-MATER M, V5, P33, DOI 10.1007/BF00121151
   Chen KY, 2002, J MATER SCI-MATER M, V13, P37, DOI 10.1023/A:1013678301050
   CHINN JA, 1991, THROMB HAEMOSTASIS, V65, P608
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   DAVIS EC, 1993, CELL TISSUE RES, V272, P211, DOI 10.1007/BF00302726
   Doi K, 1996, ASAIO J, V42, pM394, DOI 10.1097/00002480-199609000-00018
   Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200
   Dutoya S, 2000, BIOMATERIALS, V21, P1521, DOI 10.1016/S0142-9612(99)00274-4
   Ernsting MJ, 2007, J BIOMED MATER RES A, V83A, P759, DOI 10.1002/jbm.a.31370
   Ernsting MJ, 2005, BIOMATERIALS, V26, P6536, DOI 10.1016/j.biomaterials.2005.04.047
   FAURY G, 1995, J VASC RES, V32, P112, DOI 10.1159/000159084
   Faury G, 1998, CIRC RES, V82, P328, DOI 10.1161/01.RES.82.3.328
   Gemmell CH, 2001, J BIOMAT SCI-POLYM E, V12, P933, DOI 10.1163/156856201753113114
   GOTT VL, 1963, SCIENCE, V142, P1297, DOI 10.1126/science.142.3597.1297
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   HERGENROTHER RW, 1994, BIOMATERIALS, V15, P635, DOI 10.1016/0142-9612(94)90215-1
   Hylton DM, 2005, J BIOMED MATER RES A, V73A, P349, DOI 10.1002/jbm.a.30295
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   JAFFE EA, 1985, ANN NY ACAD SCI, V454, P279, DOI 10.1111/j.1749-6632.1985.tb11868.x
   Jahangir AR, 2002, J BIOMED MATER RES, V60, P135, DOI 10.1002/jbm.10033
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   Jun HW, 2004, J BIOMAT SCI-POLYM E, V15, P73, DOI 10.1163/156856204322752246
   KASHIWAGI T, 1993, J BIOMAT SCI-POLYM E, V5, P157
   Kawabata K, 2002, NEPHRON, V90, P391, DOI 10.1159/000054726
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   KINLOUGHRATHBONE RL, 1977, THROMB HAEMOSTASIS, V37, P291
   KISHIDA A, 1995, ASAIO J, V41, pM369, DOI 10.1097/00002480-199507000-00033
   LONG MM, 1989, J CELL PHYSIOL, V140, P512, DOI 10.1002/jcp.1041400316
   Massa TM, 2007, J BIOMED MATER RES A, V81A, P178, DOI 10.1002/jbm.a.30936
   Massa TM, 2005, BIOMATERIALS, V26, P7367, DOI 10.1016/j.biomaterials.2005.05.063
   McClung WG, 2001, BIOMATERIALS, V22, P1919, DOI 10.1016/S0142-9612(00)00378-1
   MECHAM RP, 1989, BIOCHEMISTRY-US, V28, P3716, DOI 10.1021/bi00435a014
   MERRILL EW, 1982, T AM SOC ART INT ORG, V28, P482
   Michelson AD, 1996, BLOOD, V87, P4925
   Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200
   MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x
   Nakao A, 1987, J Biomater Appl, V2, P219, DOI 10.1177/088532828700200203
   Nakazawa G, 2010, JACC-CARDIOVASC INTE, V3, P68, DOI 10.1016/j.jcin.2009.09.015
   Parang P, 2009, CAN J CARDIOL, V25, pE57, DOI 10.1016/S0828-282X(09)70486-6
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Privitera S, 1998, J BIOL CHEM, V273, P6319, DOI 10.1074/jbc.273.11.6319
   Rhodes NP, 1998, J MATER SCI-MATER M, V9, P767, DOI 10.1023/A:1008971406590
   Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613
   Sahoo SK, 2005, BIOMACROMOLECULES, V6, P1132, DOI 10.1021/bm0492632
   SDOUGOS HP, 1984, J FLUID MECH, V138, P379, DOI 10.1017/S0022112084000161
   Sefton MV, 2001, J BIOMED MATER RES, V55, P447, DOI 10.1002/1097-4636(20010615)55:4<447::AID-JBM1036>3.0.CO;2-5
   Sivaraman B, 2010, BIOMATERIALS, V31, P832, DOI 10.1016/j.biomaterials.2009.10.008
   Skarja GA, 1997, J BIOMED MATER RES, V34, P427, DOI 10.1002/(SICI)1097-4636(19970315)34:4<427::AID-JBM4>3.3.CO;2-R
   Tang YW, 2001, J BIOMED MATER RES, V56, P516, DOI 10.1002/1097-4636(20010915)56:4<516::AID-JBM1123>3.0.CO;2-B
   UNIYAL S, 1982, THROMB HAEMOSTASIS, V47, P285
   WAROCQUIERCLEROUT R, 1990, CYTOTECHNOLOGY, V3, P259, DOI 10.1007/BF00365490
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   WOODHOUSE KA, 1992, BIOMATERIALS, V13, P1103, DOI 10.1016/0142-9612(92)90143-C
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Ye SH, 2009, J BIOMED MATER RES A, V91A, P18, DOI 10.1002/jbm.a.32184
   Yeh HY, 2009, J BIOMAT SCI-POLYM E, V20, P807, DOI 10.1163/156856209X426952
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
NR 65
TC 37
Z9 39
U1 1
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2011
VL 32
IS 25
BP 5790
EP 5800
DI 10.1016/j.biomaterials.2011.04.067
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 792BE
UT WOS:000292714700006
PM 21601275
DA 2018-10-20
ER

PT J
AU Zhao, HX
   Dong, WJ
   Zheng, YY
   Liu, AP
   Yao, JM
   Li, CR
   Tang, WH
   Chen, BY
   Wang, G
   Shi, Z
AF Zhao, Haixin
   Dong, Wenjun
   Zheng, Yingying
   Liu, Aiping
   Yao, Juming
   Li, Chaorong
   Tang, Weihua
   Chen, Benyong
   Wang, Ge
   Shi, Zhan
TI The structural and biological properties of hydroxyapatite-modified
   titanate nanowire scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Scaffold; Hydroxyapatite; Titanate nanowire; Biomaterial
ID CALCIUM PHOSPHATES; TITANIUM SUBSTRATE; DRUG-DELIVERY; COATINGS;
   BIOMATERIALS; ELECTRODEPOSITION; COMPOSITE; APATITE; PRECIPITATION;
   LUMINESCENT
AB Hydroxyapatite-modified titanate nanowire scaffolds as alternative materials for tissue engineering have been developed via a titanate nanowire matrix assisted electrochemical deposition method. The macroporous titanate nanowire matrix on Ti metal was fabricated by a hydrothermal method, and then followed by an electrochemical synthesis of hydroxyapatite nanoparticles on titanate nanowire. The incorporation of titanate nanowire matrix with high oriented hydroxyapatite nanoparticles generates hierarchical scaffolds with highly osteogenic, structural integrity and excellent mechanical performance. As-prepared porous three dimensional interconnected hydroxyapatite-modified titanate nanowire scaffolds, mimicking the nature's extracellular matrix, could provide a suitable microenvironment for tissue cell ingrowth and differentiation. The ceramic titanate nanowire core with HA nanoparticle sheath structure displays superhydrophilicity, which facilitates the cell attachment and proliferation, and induces the in vitro tissue-engineered bone. Human osteoblast-like MG63 cells were cultured on the hydroxyapatite-modified titanate nanowire scaffolds, and the results showed that the scaffolds highly promote the bioactivity, osteoconductivity and osteoblast differentiation. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zhao, Haixin; Dong, Wenjun; Zheng, Yingying; Liu, Aiping; Yao, Juming; Li, Chaorong; Tang, Weihua; Chen, Benyong] Zhejiang Sci Tech Univ, Ctr Optoelect Mat & Devices, Key Lab Adv Text Mat & Mfg Technol,Minist Educ, Ctr Nanosci & Noanotechnol,Engn Res Ctr Eco Dying, Hangzhou 310018, Zhejiang, Peoples R China.
   [Dong, Wenjun; Wang, Ge] Univ Sci & Technol Beijing, Sch Mat Sci & Engn, Beijing 100083, Peoples R China.
   [Shi, Zhan] Jilin Univ, Coll Chem, State Key Lab Inorgan Synth & Preparat Chem, Changchun 130012, Peoples R China.
RP Dong, WJ (reprint author), Zhejiang Sci Tech Univ, Ctr Optoelect Mat & Devices, Key Lab Adv Text Mat & Mfg Technol,Minist Educ, Ctr Nanosci & Noanotechnol,Engn Res Ctr Eco Dying, Hangzhou 310018, Zhejiang, Peoples R China.
EM wenjundong@zstu.edu.cn; yaoj@zstu.edu.cn
RI Tang, Weihua/O-1998-2013; Tang, Weihua/B-5984-2011; Liiu,
   Aiping/H-3591-2014; Yao, Juming/N-7886-2014
OI Tang, Weihua/0000-0002-8771-3120; 
FU National Natural Science Foundation of China [50972130, 20701033,
   50772100, 10874153]; Qianjiang Talent Program of Zhejiang Province
   [QJD1002001]; China Postdoctoral Science Foundation [201003048,
   20090450292]; State Key Laboratory of Inorganic Synthesis and
   Preparative Chemistry, Jilin University
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 50972130, 20701033, 50772100, 10874153); Qianjiang Talent
   Program of Zhejiang Province (QJD1002001); China Postdoctoral Science
   Foundation (No. 201003048, 20090450292). Open Project Program of State
   Key Laboratory of Inorganic Synthesis and Preparative Chemistry, Jilin
   University.
CR Bakos D, 1999, BIOMATERIALS, V20, P191, DOI 10.1016/S0142-9612(98)00163-X
   Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001
   Barrere F, 2002, BIOMATERIALS, V23, P2211, DOI 10.1016/S0142-9612(01)00354-4
   Bhumiratana S, 2011, BIOMATERIALS, V32, P2812, DOI 10.1016/j.biomaterials.2010.12.058
   Bigi A, 2005, BIOMATERIALS, V26, P4085, DOI 10.1016/j.biomaterials.2004.10.034
   Brandt J, 2010, J MATER SCI-MATER M, V21, P283, DOI 10.1007/s10856-009-3859-1
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Dong W, 2007, CHEM MATER, V19, P4454, DOI 10.1021/cm070845a
   Fujii S, 2009, LANGMUIR, V25, P9759, DOI 10.1021/la901100z
   FUREDIMILHOFER H, 1976, FARADAY DISCUSS, V61, P184, DOI 10.1039/dc9766100184
   Gao HJ, 2003, P NATL ACAD SCI USA, V100, P5597, DOI 10.1073/pnas.0631609100
   Gomez-Vega JM, 2000, ADV MATER, V12, P894, DOI 10.1002/1521-4095(200006)12:12<894::AID-ADMA894>3.0.CO;2-4
   Habibovic P, 2006, J ORTHOP RES, V24, P867, DOI 10.1002/jor.20115
   Han Y, 2001, J BIOMED MATER RES, V54, P96, DOI 10.1002/1097-4636(200101)54:1<96::AID-JBM11>3.0.CO;2-U
   Hanzu I, 2009, J PHYS CHEM C, V113, P20568, DOI 10.1021/jp906070v
   Hou CH, 2009, BIOMATERIALS, V30, P3956, DOI 10.1016/j.biomaterials.2009.04.020
   Hu R, 2007, J BIOMED MATER RES A, V80A, P687, DOI 10.1002/jbm.a.30891
   Kawai N, 1997, J BIOMED MATER RES, V37, P1
   Kothapalli CR, 2005, ACTA BIOMATER, V1, P653, DOI 10.1016/j.actbio.2005.06.005
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Leyva AG, 2001, ENVIRON SCI TECHNOL, V35, P3669, DOI 10.1021/es0009929
   Liao SS, 2004, J BIOMED MATER RES B, V69B, P158, DOI 10.1002/jbm.b.20035
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Ma GB, 2009, CRYST GROWTH DES, V9, P2991, DOI 10.1021/cg900156w
   Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2
   Moreau JE, 2007, CANCER RES, V67, P10304, DOI 10.1158/0008-5472.CAN-07-2483
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Naldoni A, 2011, J MATER CHEM, V21, P400, DOI 10.1039/c0jm02446e
   Natarajan C, 1996, J ELECTROCHEM SOC, V143, P1547, DOI 10.1149/1.1836677
   Nie X, 2001, J BIOMED MATER RES, V57, P612, DOI 10.1002/1097-4636(20011215)57:4<612::AID-JBM1208>3.0.CO;2-H
   Padmanabhan SK, 2009, PARTICUOLOGY, V7, P466, DOI 10.1016/j.partic.2009.06.008
   Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361
   Rabiee SM, 2010, J MOL STRUCT, V969, P172, DOI 10.1016/j.molstruc.2010.01.068
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Reichert JC, 2010, BIOMATERIALS, V31, P7928, DOI 10.1016/j.biomaterials.2010.06.055
   SHORS EC, 1993, POROUS HYDROXYAPATIT, P181
   SOBALLE K, 1993, ACTA ORTHOP SCAND, V64, pR1
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wei M, 1999, J MATER SCI-MATER M, V10, P401, DOI 10.1023/A:1008923029945
   Wilson RM, 2004, BIOMATERIALS, V25, P2205, DOI 10.1016/j.biomaterials.2003.08.057
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
   Yen SK, 2003, MATER CHEM PHYS, V77, P70, DOI 10.1016/S0254-0584(01)00562-4
   Yuan QH, 2009, THIN SOLID FILMS, V518, P55, DOI 10.1016/j.tsf.2009.06.029
   Zhang CM, 2010, BIOMATERIALS, V31, P3374, DOI 10.1016/j.biomaterials.2010.01.044
   Zhang HQ, 2002, ADV ENG MATER, V4, P916, DOI 10.1002/adem.200290003
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
NR 51
TC 55
Z9 57
U1 5
U2 92
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2011
VL 32
IS 25
BP 5837
EP 5846
DI 10.1016/j.biomaterials.2011.04.083
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 792BE
UT WOS:000292714700011
PM 21605896
DA 2018-10-20
ER

PT J
AU Khorasaninejad, M
   Clarke, N
   Anantram, MP
   Saini, SS
AF Khorasaninejad, Mohammadreza
   Clarke, Nigel
   Anantram, M. P.
   Saini, Simarjeet Singh
TI Optical bio-chemical sensors on SNOW ring resonators
SO OPTICS EXPRESS
LA English
DT Article
ID WAVE-GUIDE SNOW; PHOTONIC CRYSTAL; SILICON; BIOSENSOR
AB In this paper, we propose and analyze novel ring resonator based bio-chemical sensors on silicon nanowire optical waveguide (SNOW) and show that the sensitivity of the sensors can be increased by an order of magnitude as compared to silicon-on-insulator based ring resonators while maintaining high index contrast and compact devices. The core of the waveguide is hollow and allows for introduction of biomaterial in the center of the mode, thereby increasing the sensitivity of detection. A sensitivity of 243 nm/refractive index unit (RIU) is achieved for a change in bulk refractive index. For surface attachment, the sensor is able to detect monolayer attachments as small as 1 angstrom on the surface of the silicon nanowires. (C) 2011 Optical Society of America
C1 [Khorasaninejad, Mohammadreza; Saini, Simarjeet Singh] Univ Waterloo, Dept Elect & Comp Engn, Waterloo, ON N2L 3G1, Canada.
   [Anantram, M. P.] Univ Washington, Dept Elect & Comp Engn, Seattle, WA 98195 USA.
RP Khorasaninejad, M (reprint author), Univ Waterloo, Dept Elect & Comp Engn, 200 Univ Ave W, Waterloo, ON N2L 3G1, Canada.
EM sssaini@uwaterloo.ca
FU Canadian National Science and Engineering Research Council (NSERC);
   Ontario Centres of Excellence (OCE); DALSA Corp.
FX This work was supported by the Canadian National Science and Engineering
   Research Council (NSERC), Ontario Centres of Excellence (OCE) and DALSA
   Corp.
CR Armani AM, 2006, OPT LETT, V31, P1896, DOI 10.1364/OL.31.001896
   Balslev S, 2006, LAB CHIP, V6, P213, DOI 10.1039/b512546d
   Bienstman P., 2007, OPT EXPRESS, V15, P7610
   Bock PJ, 2010, OPT EXPRESS, V18, P16146, DOI 10.1364/OE.18.016146
   Claes T, 2009, IEEE PHOTONICS J, V1, P197, DOI 10.1109/JPHOT.2009.2031596
   Cloutier SG, 2005, NAT MATER, V4, P887, DOI 10.1038/nmat1530
   Cox WG, 2004, BIOTECHNIQUES, V36, P114, DOI 10.2144/04361RR02
   Fan XD, 2008, ANAL CHIM ACTA, V620, P8, DOI 10.1016/j.aca.2008.05.022
   HENRY MD, 2009, NANOTECHNOLOGY, V20, P1
   Hopman WCL, 2005, IEEE J SEL TOP QUANT, V11, P11, DOI 10.1109/JSTQE.2004.841693
   Hosseini ES, 2009, OPT EXPRESS, V17, P14543, DOI 10.1364/OE.17.014543
   Hung YJ, 2010, OPT EXPRESS, V18, P6841, DOI 10.1364/OE.18.006841
   Khorasaninejad M, 2011, IEEE PHOTONICS J, V3, P696, DOI 10.1109/JPHOT.2011.2160527
   Khorasaninejad M, 2010, OPT EXPRESS, V18, P23442, DOI 10.1364/OE.18.023442
   Larsen E. S., 2006, INT TABLES CRYSTALLO, VC, P160
   Luff BJ, 1996, OPT LETT, V21, P618, DOI 10.1364/OL.21.000618
   Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104
   Prieto F, 2003, NANOTECHNOLOGY, V14, P907, DOI 10.1088/0957-4484/14/8/312
   Rindorf L, 2006, OPT EXPRESS, V14, P8224, DOI 10.1364/OE.14.008224
   Saini SS, 2007, IEEE PHOTONIC TECH L, V19, P1341, DOI 10.1109/LPT.2007.902345
NR 20
TC 12
Z9 12
U1 0
U2 14
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD AUG 29
PY 2011
VL 19
IS 18
BP 17575
EP 17584
DI 10.1364/OE.19.017575
PG 10
WC Optics
SC Optics
GA 814XE
UT WOS:000294489700091
PM 21935124
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Servantez, TG
   Johnson, PA
AF Servantez, Thomas G.
   Johnson, Patrick A.
TI Electrospun recombinant silk protein fibers for use as a biomaterial
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 242nd National Meeting of the American-Chemical-Society (ACS)
CY AUG 28-SEP 01, 2011
CL Denver, CO
SP Amer Chem Soc (ACS)
C1 [Servantez, Thomas G.; Johnson, Patrick A.] Univ Wyoming, Dept Chem & Petr Engn, Laramie, WY 82071 USA.
EM tservan@uwyo.edu
NR 0
TC 0
Z9 0
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 28
PY 2011
VL 242
MA 526-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 880BE
UT WOS:000299378307229
DA 2018-10-20
ER

PT J
AU Chang, CT
   Lin, H
   Ho, TY
   Li, CC
   Lo, HY
   Wu, SL
   Huang, YF
   Liang, JA
   Hsiang, CY
AF Chang, Chung-Ta
   Lin, Ho
   Ho, Tin-Yun
   Li, Chia-Cheng
   Lo, Hsin-Yi
   Wu, Shih-Lu
   Huang, Yi-Fang
   Liang, Ji-An
   Hsiang, Chien-Yun
TI Comprehensive Assessment of Host Responses to Ionizing Radiation by
   Nuclear Factor-kappa B Bioluminescence Imaging-Guided Transcriptomic
   Analysis
SO PLOS ONE
LA English
DT Article
ID IN-VIVO; GENE-EXPRESSION; NORMAL TISSUE; BIOMATERIAL INTERACTION;
   ABDOMINAL IRRADIATION; INTESTINAL UPTAKE; INDUCED DAMAGE; MICE;
   ACTIVATION; PROTEINS
AB The aim of this study was to analyze the host responses to ionizing radiation by nuclear factor-kappa B (NF-kappa B) bioluminescence imaging-guided transcriptomic tool. Transgenic mice carrying the NF-kappa B-driven luciferase gene were exposed to a single dose of 8.5 Gy total-body irradiation. In vivo imaging showed that a maximal NF-kappa B-dependent bioluminescent intensity was observed at 3 h after irradiation and ex vivo imaging showed that liver, intestine, and brain displayed strong NF-kappa B activations. Microarray analysis of these organs showed that irradiation altered gene expression signatures in an organ-specific manner and several pathways associated with metabolism and immune system were significantly altered. Additionally, the upregulation of fatty acid binding protein 4, serum amyloid A2, and serum amyloid A3 genes, which participate in both inflammation and lipid metabolism, suggested that irradiation might affect the cross pathways of metabolism and inflammation. Moreover, the alteration of chemokine (CC-motif) ligand 5, chemokine (CC-motif) ligand 20, and Jagged 1 genes, which are involved in the inflammation and enterocyte proliferation, suggested that these genes might be involved in the radiation enteropathy. In conclusion, this report describes the comprehensive evaluation of host responses to ionizing radiation. Our findings provide the fundamental information about the in vivo NF-kappa B activity and transcriptomic pattern after irradiation. Moreover, novel targets involved in radiation injury are also suggested.
C1 [Chang, Chung-Ta] Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan.
   [Chang, Chung-Ta; Lin, Ho] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.
   [Ho, Tin-Yun; Li, Chia-Cheng; Lo, Hsin-Yi] China Med Univ, Grad Inst Chinese Med, Taichung, Taiwan.
   [Ho, Tin-Yun] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.
   [Wu, Shih-Lu] China Med Univ, Dept Biochem, Taichung, Taiwan.
   [Huang, Yi-Fang] Chang Gung Mem Hosp, Dept Prosthodont, Dent Sect, Tao Yuan, Taiwan.
   [Liang, Ji-An] China Med Univ Hosp, Dept Radiat Therapy & Oncol, Taichung, Taiwan.
   [Hsiang, Chien-Yun] China Med Univ, Dept Microbiol, Taichung, Taiwan.
RP Chang, CT (reprint author), Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan.
EM cyhsiang@mail.cmu.edu.tw
RI Ho, Tin-Yun/O-3889-2015; Hsiang, Chien-Yun/O-3853-2015
OI Chang, Chung-Ta/0000-0002-9211-1407
FU National Science Council [NSC97-2320-B-039-012-MY3,
   NSC98-2320-B-039-030-MY2, NSC98-2324-B-039-004]; Committee on Chinese
   Medicine and Pharmacy at Department of Health [CCMP97-RD-201]; China
   Medical University [CMU99-S-06, CMU99-S-31]
FX This work was supported by National Science Council
   (NSC97-2320-B-039-012-MY3, NSC98-2320-B-039-030-MY2, and
   NSC98-2324-B-039-004), Committee on Chinese Medicine and Pharmacy at
   Department of Health (CCMP97-RD-201), and China Medical University
   (CMU99-S-06 and CMU99-S-31). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Acharya MM, 2010, FREE RADICAL BIO MED, V49, P1846, DOI 10.1016/j.freeradbiomed.2010.08.021
   Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649
   Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Chen CH, 2008, J NUTR, V138, P674
   Cheng WY, 2009, BRIT J PHARMACOL, V157, P746, DOI 10.1111/j.1476-5381.2009.00223.x
   Chu PG, 2001, APPL IMMUNOHISTO M M, V9, P97, DOI 10.1097/00022744-200106000-00001
   Coleman C N, 1996, Oncology (Williston Park), V10, P399
   de la Coste A, 2006, IMMUNOL LETT, V102, P1, DOI 10.1016/j.imlet.2005.06.014
   Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589
   Guilmeau S, 2010, ONCOGENE, V29, P992, DOI 10.1038/onc.2009.393
   Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175
   Hill RP, 2001, INT J RADIAT ONCOL, V49, P353, DOI 10.1016/S0360-3016(00)01484-X
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Inukai T, 2009, SPINE, V34, P2848, DOI 10.1097/BRS.0b013e3181b0d078
   Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7
   Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621
   Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853
   Lee WH, 2010, INT J RADIAT BIOL, V86, P132, DOI 10.3109/09553000903419346
   Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200
   Mahmoud-Ahmed AS, 2006, RADIAT RES, V165, P142, DOI 10.1667/RR3485.1
   Osterreicher CH, 2011, P NATL ACAD SCI USA, V108, P308, DOI 10.1073/pnas.1017547108
   OVERGAARD J, 1990, RADIOTHER ONCOL, V18, P71, DOI 10.1016/0167-8140(90)90024-Q
   Packey CD, 2010, CURR OPIN GASTROEN, V26, P88, DOI 10.1097/MOG.0b013e3283361927
   Pawlik A, 2009, INT J RADIAT BIOL, V85, P656, DOI 10.1080/09553000903020024
   Plews M, 2010, FREE RADICAL BIO MED, V49, P1417, DOI 10.1016/j.freeradbiomed.2010.07.025
   Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313
   Rodilla V, 2009, P NATL ACAD SCI USA, V106, P6315, DOI 10.1073/pnas.0813221106
   Roudkenar MH, 2008, J RADIAT RES, V49, P29, DOI 10.1269/jrr.07078
   Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233
   Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Smyth G. K., 2005, BIOINFORMATICS COMPU, P397, DOI [10.1007/0-387-29362-0_23, DOI 10.1007/0-387-29362-0_23]
   Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941
   Stone HB, 2003, LANCET ONCOL, V4, P529, DOI 10.1016/S1470-2045(03)01191-4
   TEE PG, 1995, CANCER RES, V55, P298
   Teran LM, 2000, IMMUNOL TODAY, V21, P235, DOI 10.1016/S0167-5699(00)01634-0
   Thompson JS, 2010, FREE RADICAL RES, V44, P529, DOI 10.3109/10715761003649578
   THOMSON ABR, 1984, INT J RADIAT ONCOL, V10, P671, DOI 10.1016/0360-3016(84)90299-2
   THOMSON ABR, 1983, J LAB CLIN MED, V102, P813
   Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x
   Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591
   Zhang B, 2005, NUCLEIC ACIDS RES, V33, P741
   Zhao WL, 2006, CLIN CANCER RES, V12, P3823, DOI 10.1158/1078-0432.CCR-05-2418
   Zhou DH, 1999, RADIAT RES, V151, P703, DOI 10.2307/3580209
NR 46
TC 15
Z9 15
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD AUG 24
PY 2011
VL 6
IS 8
AR e23682
DI 10.1371/journal.pone.0023682
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 832TW
UT WOS:000295832000046
PM 21887294
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Singh, AV
   Nath, LK
   Guha, M
AF Singh, Akhilesh V.
   Nath, Lila K.
   Guha, Manisha
TI Microwave assisted synthesis and characterization of Phaseolus
   aconitifolius starch-g-acrylamide
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Moth bean starch; SEM; Grafting; XRD; FT-IR
ID POLYMER SYNTHESIS; POLYACRYLAMIDE
AB Moth bean starch was modified through microwave assisted synthesis using a very low concentration of free radical initiator. Grafted copolymer was characterized by Fourier transform infrared spectroscopy (FT-IR), scanning electron microscopy (SEM), X-ray diffraction (XRD), and thermogravimetric analysis (TGA). Swelling study was also performed at various temperatures to access its suitability in diverse industrial application. Starch-grafted-acrylamide could be efficiently synthesized using a small concentration of ceric ammonium nitrate (CAN) in aqueous medium under microwave irradiation. The FT-IR Spectral analysis confirms group attachment on starch backbone. XRD and SEM studies confirmed more crystalline structure, while TGA confirmed high thermal stability as compared to native starch. Starch-g acrylamide was successfully grafted and this novel biomaterial could be used in various industrial applications like food, textile paper, petroleum and pharmaceutical. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Singh, Akhilesh V.; Nath, Lila K.] Dibrugarh Univ, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India.
   [Guha, Manisha] Cent Food Technol Res Inst, Mysore 570020, Karnataka, India.
RP Singh, AV (reprint author), Dibrugarh Univ, Dept Pharmaceut Sci, Dibrugarh 786004, Assam, India.
EM akhileshvikram@gmail.com
OI Singh, Akhilesh Vikram/0000-0003-0838-0207
CR Bhattacharya A, 2004, PROG POLYM SCI, V29, P767, DOI 10.1016/j.progpolymsci.2004.05.002
   Cheng ZP, 2003, POLYMER, V44, P2243, DOI 10.1016/S0032-3861(03)00111-3
   Hoogenboom R, 2007, MACROMOL RAPID COMM, V28, P368, DOI 10.1002/marc.200600749
   KEVATE BN, 2010, AFRICAN J FOOD SCI T, V1, P68
   Liu HJ, 1999, STARCH-STARKE, V51, P249, DOI 10.1002/(SICI)1521-379X(199907)51:7<249::AID-STAR249>3.3.CO;2-F
   Misra S., 2010, INT J BIOL MACROMOL, V48, P106
   Roper H., 1996, CARBOHYDR EUR, V15, P4
   Sen G, 2010, J APPL POLYM SCI, V115, P63, DOI 10.1002/app.30596
   Singh V, 2006, POLYMER, V47, P254, DOI 10.1016/j.polymer.2005.10.101
   Singh V, 2004, CARBOHYD POLYM, V58, P1, DOI 10.1016/j.carbpol.2004.04.010
   Singh V, 2006, STARCH-STARKE, V58, P536, DOI 10.1002/star.200600520
   Tester RF, 2004, J CEREAL SCI, V39, P151, DOI 10.1016/j.jcs.2003.12.001
   WANKHEDE DB, 1982, STARKE, V34, P189, DOI 10.1002/star.19820340604
   Wiesbrock F, 2004, MACROMOL RAPID COMM, V25, P1739, DOI 10.1002/marc.200400313
NR 14
TC 14
Z9 14
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD AUG 15
PY 2011
VL 86
IS 2
BP 872
EP 876
DI 10.1016/j.carbpol.2011.05.029
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 811EW
UT WOS:000294187400064
DA 2018-10-20
ER

PT J
AU Paluszkiewicz, C
   Stodolak, E
   Hasik, M
   Blazewicz, M
AF Paluszkiewicz, C.
   Stodolak, E.
   Hasik, M.
   Blazewicz, M.
TI FT-IR study of montmorillonite-chitosan nanocomposite materials
SO SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY
LA English
DT Article
DE FT-IR spectroscopy; Nanocomposites; Biomaterials; Chitosan;
   montmorillonite
ID ELECTRICAL-CONDUCTIVITY; SILICATE NANOCOMPOSITES; CLAY NANOCOMPOSITES;
   THERMAL-PROPERTIES; SPECTROSCOPY; BEHAVIOR; MORPHOLOGY; DISPERSION;
   CHITIN; FILMS
AB Bone defect is one of the most frequent problems in bone tissue reconstruction in which application of a biomaterial filling is necessary. It creates a still rising demand of biomaterials for bone surgery. Polymer-ceramic nanocomposites (e.g. based on chitosan matrix) is a group of novel materials whose properties such as strength, Young's modulus, bioactivity and controlled degradation time make them suitable materials for filling bone defects. Investigations of nanocomposite foils which consisted of biopolymer-chitosan (CS) matrix and montmorillonite (MMT) as a nano-filler was the subject of the work. The nanocomposite materials were produced by a two-step dispersion of the nanoparticles in the biopolymer matrix. The first stage involved mechanical stirring and the second one - ultrasonic agitation. Mechanical tests were performed on the nanocomposites and their Young's modulus was estimated. Significant improvement of mechanical properties of the nanocomposites in comparison with the pure polymer (CS) was observed. The nanocomposite foils (CS/MMT) were subjected to FT-IR spectroscopy investigations whose objective was to explain the reason of the change in mechanical characteristics of the nanocomposites. Transmission and AIR techniques operating in MIR range were used to study the nanocomposites. The FT-IR techniques were used to determine interactions at nanoparticle-biopolymer matrix interface. A pure unmodified CS foil was used as a reference material for FT-IR studies. It was proven that application of FT-IR techniques allows not only to identify phases, but also to explain structural changes in the systems studied. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Stodolak, E.; Blazewicz, M.] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biomat, PL-30059 Krakow, Poland.
   [Paluszkiewicz, C.; Hasik, M.] AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Silicates Chem, PL-30059 Krakow, Poland.
RP Stodolak, E (reprint author), AGH Univ Sci & Technol, Fac Mat Sci & Ceram, Dept Biomat, Al Mickiewicza 30, PL-30059 Krakow, Poland.
EM stodolak@agh.edu.pl
OI Stodolak-Zych, Ewa/0000-0002-8935-4811
CR BAOCHUN G, 2004, EUR POLYM J, V40, P1743
   Crini G, 2008, PROG POLYM SCI, V33, P399, DOI 10.1016/j.progpolymsci.2007.11.001
   DEVENDRA V, 2008, MAT SCI ENG C, V28, P399
   Du ZF, 2009, MAT SCI ENG C-MATER, V29, P1794, DOI 10.1016/j.msec.2009.02.003
   Duarte ML, 2002, INT J BIOL MACROMOL, V31, P1, DOI 10.1016/S0141-8130(02)00039-9
   Garcia-Lopez D, 2003, EUR POLYM J, V39, P945, DOI 10.1016/S0014-3057(02)00333-6
   Garcia-Serrano G, 2004, SOL ENERG MAT SOL C, V82, P291, DOI 10.1016/j.solmat.2004.01.026
   Gesti S, 2009, EUR POLYM J, V45, P398, DOI 10.1016/j.eurpolymj.2008.10.037
   Jeon K, 2007, POLYMER, V48, P4751, DOI 10.1016/j.polymer.2007.05.078
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   LAUNER PJ, 1987, REPRINTED SILICONE C, P211
   Lingaiah S, 2008, COMPOS PART B-ENG, V39, P196, DOI 10.1016/j.compositesb.2007.02.027
   Liu D, 2006, POLYMER, V47, P2918, DOI 10.1016/j.polymer.2006.02.010
   Lu HD, 2006, COMPOS SCI TECHNOL, V66, P3035, DOI 10.1016/j.compscitech.2006.01.018
   Madejova J, 1999, SPECTROCHIM ACTA A, V55, P2467, DOI 10.1016/S1386-1425(99)00039-6
   Mano JF, 2003, J MATER SCI-MATER M, V14, P127, DOI 10.1023/A:1022015712170
   Marchessault RH, 2006, POLYSACCHARIDES DRUG
   Monticelli O, 2007, MATER LETT, V61, P3446, DOI 10.1016/j.matlet.2006.11.086
   Nunthanid J, 2001, DRUG DEV IND PHARM, V27, P143, DOI 10.1081/DDC-100000481
   Paluszkiewicz C, 2008, J MOL STRUCT, V880, P109, DOI 10.1016/j.molstruc.2008.01.028
   Patel HA, 2007, APPL CLAY SCI, V35, P194, DOI 10.1016/j.clay.2006.09.012
   Ray SS, 2003, MACROMOLECULES, V36, P2355, DOI 10.1021/ma021728y
   Samyn F, 2008, EUR POLYM J, V44, P1642, DOI 10.1016/j.eurpolymj.2008.03.021
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Sonawane SH, 2009, ULTRASON SONOCHEM, V16, P351, DOI 10.1016/j.ultsonch.2008.10.008
   Sundararajan V. M., 1999, BIOMATERIALS, V20, P1133
   Tang CY, 2009, POLYM DEGRAD STABIL, V94, P124, DOI 10.1016/j.polymdegradstab.2008.09.008
   Thakur AK, 2006, J POWER SOURCES, V159, P272, DOI 10.1016/j.jpowsour.2006.04.096
   Tyagi B, 2006, SPECTROCHIM ACTA A, V64, P273, DOI 10.1016/j.saa.2005.07.018
   Uragami T, 2002, DESALINATION, V147, P449, DOI 10.1016/S0011-9164(02)00642-2
   Wang JQ, 2002, POLYM DEGRAD STABIL, V77, P249, DOI 10.1016/S0141-3910(02)00055-1
   Wang SF, 2005, POLYM DEGRAD STABIL, V90, P123, DOI 10.1016/j.polymdegradstab.2005.03.001
   Wang XY, 2007, CARBOHYD POLYM, V69, P41, DOI 10.1016/j.carbpol.2006.08.025
   Wang XY, 2006, POLYMER, V47, P6738, DOI 10.1016/j.polymer.2006.07.026
   Xu YX, 2005, IND CROP PROD, V21, P185, DOI 10.1016/j.indcrop.2004.03.002
   Yeh MH, 2007, APPL SURF SCI, V253, P4777, DOI 10.1016/j.apsusc.2006.10.064
   Yeh MK, 2008, MAT SCI ENG A-STRUCT, V483-84, P289, DOI 10.1016/j.msea.2006.09.138
   Yu L., 2004, RADIAT PHYS CHEM, V69, P467
   Zhang W, 2007, SCRIPTA MATER, V57, P949, DOI 10.1016/j.scriptamat.2007.07.030
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zulfiqar S, 2008, SCRIPTA MATER, V59, P436, DOI 10.1016/j.scriptamat.2008.04.021
NR 41
TC 105
Z9 110
U1 1
U2 65
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1386-1425
J9 SPECTROCHIM ACTA A
JI Spectroc. Acta Pt. A-Molec. Biomolec. Spectr.
PD AUG 15
PY 2011
VL 79
IS 4
SI SI
BP 784
EP 788
DI 10.1016/j.saa.2010.08.053
PG 5
WC Spectroscopy
SC Spectroscopy
GA 791OW
UT WOS:000292675500016
PM 20864391
DA 2018-10-20
ER

PT J
AU Ionita, D
   Grecu, M
   Ungureanu, C
   Demetrescu, I
AF Ionita, Daniela
   Grecu, Mihaela
   Ungureanu, Camelia
   Demetrescu, Ioana
TI Modifying the TiAlZr biomaterial surface with coating, for a better
   anticorrosive and antibacterial performance
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Antimicrobial effect; Anticorrosive properties; TiAlZr; Silver
   nanoparticles
ID TIO2 THIN-FILMS; SILVER NANOPARTICLES; TITANIUM; DEPOSITION; IMPLANTS;
   TI-6AL-4V; CORROSION; ALLOYS
AB The paper investigates the increase of anticorrosive and antimicrobial properties of a composite elaborated by coating TiAlZr with Ag nanoparticles. Silver nanoparticles (AgNPs) were synthesized by reducing silver salts using NaBH(4), and were characterized using dynamic light scattering instrument to determine the size distribution. The morphological and elemental analysis of Ag nanoparticles on the TiAlZr surface were performed with scanning electron microscopy (SEM) and energy disperse spectroscopy (EDS). Antibacterial activity was evaluated on the basis of the inhibition of the growth of Escherichia coli bacteria, and of the electrochemical parameters from dynamic polarization tests performed in Ringers bioliquid.
   An empirical model of antibacterial effect of silver nanoparticles at biointerface in the presence of TiAlZr implant was discussed. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Ionita, Daniela; Grecu, Mihaela; Ungureanu, Camelia; Demetrescu, Ioana] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
RP Demetrescu, I (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, 1-7 Polizu Str, Bucharest 011061, Romania.
EM i_demetrescu@chim.upb.ro
FU CNCSIS - UEFISCSU [PNII - IDEI PCCE 248/2010]
FX This work was supported by CNCSIS - UEFISCSU, project number PNII - IDEI
   PCCE 248/2010.
CR AILLON KL, 2009, ADV DRUG DELIVERY RE, V21, P457
   Aparicio C, 2011, MAT SCI ENG C-MATER, V31, P320, DOI 10.1016/j.msec.2010.09.018
   Berbecaru C, 2009, APPL SURF SCI, V255, P5476, DOI 10.1016/j.apsusc.2008.08.020
   Cabrini M, 1997, BIOMATERIALS, V18, P783, DOI 10.1016/S0142-9612(96)00205-0
   Cheng QL, 2006, APPL SURF SCI, V252, P4154, DOI 10.1016/j.apsusc.2005.06.022
   Cimenoglu H, 2011, MATER CHARACT, V62, P304, DOI 10.1016/j.matchar.2011.01.002
   Demetrescu I, 2010, BIOELECTROCHEMISTRY, V79, P122, DOI 10.1016/j.bioelechem.2010.02.001
   Demetrescu I., 2008, MOL CRYST LIQ CRYST, V486, P110
   Edwards C, 2008, J BONE JOINT SURG BR, V90B, P770, DOI 10.1302/0301-620X.90B6.20194
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Hoonacker AV, 2006, CURR NANOSCI, V2, P359
   Jaiswal S, 2010, INT J ANTIMICROB AG, V36, P280, DOI 10.1016/j.ijantimicag.2010.05.006
   *JAP IND STAND IMP, 2000, T0304 JIS
   KEES G, 2009, MATER CHEM PHYS, V118, P99
   KEES G, 2005, ANN FR ANESTH, V24, P653
   Landolt D, 2003, ELECTROCHIM ACTA, V48, P3185, DOI 10.1016/S0013-4686(03)00368-2
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Luo J, 2010, INT J ANTIMICROB AG, V36, P549, DOI 10.1016/j.ijantimicag.2010.08.015
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Maury F, 2009, KEY ENG MAT, V415, P1
   Narayan RJ, 2009, JOM-US, V61, P12, DOI 10.1007/s11837-009-0081-z
   Narayanan R, 2008, CORROS SCI, V50, P1521, DOI 10.1016/j.corsci.2008.02.023
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Papp T, 2008, NANOTOXICOLOGY, V2, P9, DOI 10.1080/17435390701847935
   Prodana M, 2011, DIG J NANOMATER BIOS, V6, P549
   Saha S, 2010, DIG J NANOMATER BIOS, V5, P887
   Sharma K.V., 2009, ADV COLLOID INTERFAC, V145, P83
   Shi ZL, 2008, INT J ARTIF ORGANS, V31, P777
   Silva TM, 1998, ELECTROCHIM ACTA, V43, P203, DOI 10.1016/S0013-4686(97)00226-0
   Walenkamp GHIM, 1983, THESIS U NIJMEGEN NE
   Watari F, 2009, J R SOC INTERFACE, V6, pS371, DOI 10.1098/rsif.2008.0488.focus
   Zuo J, 2010, APPL SURF SCI, V256, P7096, DOI 10.1016/j.apsusc.2010.05.034
NR 33
TC 24
Z9 24
U1 1
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD AUG 15
PY 2011
VL 257
IS 21
BP 9164
EP 9168
DI 10.1016/j.apsusc.2011.05.125
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 789TR
UT WOS:000292539700064
DA 2018-10-20
ER

PT J
AU Pavlukhina, S
   Sukhishvili, S
AF Pavlukhina, Svetlana
   Sukhishvili, Svetlana
TI Polymer assemblies for controlled delivery of bioactive molecules from
   surfaces
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Layer-by-layer; Surface; Controlled delivery of biomolecules; Polymers;
   Polymer nanoparticles; Block copolymer micelles
ID POLYELECTROLYTE MULTILAYER FILMS; BLOCK-COPOLYMER MICELLES; BY-LAYER
   DEPOSITION; HYDROGEN-BONDED MULTILAYERS; MICROGEL THIN-FILMS;
   CONTROLLED-RELEASE; DRUG-DELIVERY; DIBLOCK COPOLYMER; PLASMID DNA;
   2-IMINOBIOTIN-LABELED POLY(ETHYLENEIMINE)
AB Localized delivery of bioactive compounds from surfaces of biomedical devices affords significant therapeutic benefits, and often relies on the capability of surface coatings to provide spatial and temporal control over release rate. The layer-by-layer technique presents a unique means to construct surface coatings that can conform to a variety of biomaterial surfaces and serve as matrices enabling controlled delivery of bioactive molecules from surfaces. The versatility of layer-by-layer assembly enables construction of surface coatings of diverse chemistry and internal architecture with controlled release properties. This review focuses on recent developments in constructing such layered matrices using linear polymers, polymer nanoparticles and block copolymer micelles, including micelles with stimuli-responsive cores, as film building blocks and in controlling release rate of therapeutics from these matrices via degradation, application of pH, ionic strength, temperature, light, electric field and chemical or biological stimuli. Challenges and opportunities associated with fabrication of stratified multilayer films capable of multi-stage delivery of multiple drugs are also discussed. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Pavlukhina, Svetlana; Sukhishvili, Svetlana] Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.
RP Sukhishvili, S (reprint author), Stevens Inst Technol, Dept Chem Chem Biol & Biomed Engn, Hoboken, NJ 07030 USA.
EM ssukhish@stevens.edu
FU National Science Foundation [DMR-0906474, CBET-0708379]
FX This work was supported in part by the National Science Foundation under
   Awards DMR-0906474 and CBET-0708379.
CR Addison T, 2008, LANGMUIR, V24, P13328, DOI 10.1021/la802396g
   Ainalem ML, 2010, LANGMUIR, V26, P8625, DOI 10.1021/la9047177
   Andre X, 2005, MACROMOL RAPID COMM, V26, P558, DOI 10.1002/marc.200400510
   Angelatos AS, 2005, J PHYS CHEM B, V109, P3071, DOI 10.1021/jp045070x
   Berg MC, 2006, BIOMACROMOLECULES, V7, P357, DOI 10.1021/bm050174e
   Bieker P, 2010, MACROMOLECULES, V43, P5052, DOI 10.1021/ma1007489
   Biggs S, 2007, ADV MATER, V19, P247, DOI 10.1002/adma.200601553
   Blacklock J, 2007, BIOMATERIALS, V28, P117, DOI 10.1016/j.biomaterials.2006.08.035
   Blacklock J, 2009, BIOMATERIALS, V30, P939, DOI 10.1016/j.biomaterials.2008.10.012
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Burke SE, 2004, MACROMOLECULES, V37, P5375, DOI 10.1021/ma049445o
   Butun V, 2001, MACROMOLECULES, V34, P1503, DOI 10.1021/ma0018392
   Cao Y, 2010, BIOMACROMOLECULES, V11, P1298, DOI 10.1021/bm100095t
   CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0
   CHEN L, 2007, SMALL, V3, P636
   Cho J, 2006, J AM CHEM SOC, V128, P9935, DOI 10.1021/ja062437y
   Connal LA, 2009, CHEM MATER, V21, P576, DOI 10.1021/cm803011w
   Crespilho FN, 2006, INT J ELECTROCHEM SC, V1, P194
   De P, 2008, BIOMACROMOLECULES, V9, P1064, DOI 10.1021/bm701255v
   Dierich A, 2007, ADV MATER, V19, P693, DOI 10.1002/adma.200601271
   DIMITROVA M, 2008, P NATL ACAD SCI USA, V205, P16320
   Dvoracek CM, 2009, LANGMUIR, V25, P10322, DOI 10.1021/la901161z
   Erel-Unal I, 2008, MACROMOLECULES, V41, P8737, DOI 10.1021/ma8013564
   Erel-Unal I, 2008, MACROMOLECULES, V41, P3962, DOI 10.1021/ma800186q
   Garza JM, 2004, LANGMUIR, V20, P7298, DOI 10.1021/la049106o
   Gaucher G, 2010, EUR J PHARM BIOPHARM, V76, P147, DOI 10.1016/j.ejpb.2010.06.007
   Gillies ER, 2005, BIOCONJUGATE CHEM, V16, P361, DOI 10.1021/bc049851c
   Gopinadhan M, 2005, MACROMOLECULES, V38, P5228, DOI 10.1021/ma047552c
   Guan Y, 2009, SOFT MATTER, V5, P842, DOI 10.1039/b815913k
   Hiller J, 2003, MACROMOLECULES, V36, P4078, DOI 10.1021/ma025837o
   Hu XF, 2010, LANGMUIR, V26, P2624, DOI 10.1021/la902719k
   Inoue H, 2005, LANGMUIR, V21, P8354, DOI 10.1021/la0508341
   Inoue H, 2005, BIOMACROMOLECULES, V6, P27, DOI 10.1021/bm0495856
   Jaber JA, 2005, MACROMOLECULES, V38, P1300, DOI 10.1021/ma0485235
   Jessel N, 2006, P NATL ACAD SCI USA, V103, P8618, DOI 10.1073/pnas.0508246103
   Jewell CM, 2008, ADV DRUG DELIVER REV, V60, P979, DOI 10.1016/j.addr.2008.02.010
   Jiao Q, 2008, POLYMER, V49, P1520, DOI 10.1016/j.polymer.2008.01.064
   Jiao YH, 2010, LANGMUIR, V26, P8270, DOI 10.1021/la101123y
   Jierry L, 2010, MACROMOLECULES, V43, P3994, DOI 10.1021/ma100402v
   Jomaa HW, 2005, MACROMOLECULES, V38, P8473, DOI 10.1021/ma050072g
   Jourdainne L, 2007, MACROMOLECULES, V40, P316, DOI 10.1021/ma062201e
   Karlsson AJ, 2010, BIOMACROMOLECULES, V11, P2321, DOI 10.1021/bm100424s
   Kharlampieva E, 2004, LANGMUIR, V20, P9677, DOI 10.1021/la048763d
   Kharlampieva E, 2005, MACROMOLECULES, V38, P10523, DOI 10.1021/ma0516891
   Kharlampieva E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.128303
   Kharlampieva E, 2008, LANGMUIR, V24, P11346, DOI 10.1021/la802502c
   Kharlampieva E, 2007, MACROMOLECULES, V40, P3663, DOI 10.1021/ma062811e
   Kharlampieva E, 2007, LANGMUIR, V23, P175, DOI 10.1021/la061652p
   Kharlampieva E, 2006, POLYM REV, V46, P377, DOI 10.1080/15583720600945386
   Kharlampieva E, 2009, LANGMUIR, V25, P14017, DOI 10.1021/la9014042
   Kharlampieva E, 2009, ADV MATER, V21, P3053, DOI 10.1002/adma.200803653
   Khopade AJ, 2005, BIOMACROMOLECULES, V6, P229, DOI 10.1021//bm049554a
   Khutoryanskaya OV, 2007, MACROMOLECULES, V40, P7707, DOI 10.1021/ma071644v
   Kim BS, 2009, CHEM COMMUN, V28, P4194
   Kim BS, 2008, ACS NANO, V2, P386, DOI 10.1021/nn700408z
   Kim BS, 2009, LANGMUIR, V25, P14086, DOI 10.1021/la9017618
   Kim BS, 2009, MACROMOLECULES, V42, P368, DOI 10.1021/ma801812v
   Kim J, 2007, BIOMACROMOLECULES, V8, P3682, DOI 10.1021/bm700756z
   Kittitheeranun P, 2010, LANGMUIR, V26, P6869, DOI 10.1021/la1003676
   Kozlovskaya V, 2008, SOFT MATTER, V4, P1499, DOI 10.1039/b719952j
   Kozlovskaya V, 2009, SOFT MATTER, V5, P4077, DOI 10.1039/b912168d
   Laurent D, 1997, LANGMUIR, V13, P1552, DOI 10.1021/la960959t
   Lee HI, 2008, CHEM COMMUN, P3726, DOI 10.1039/b807561a
   Lee HI, 2007, ANGEW CHEM INT EDIT, V46, P2453, DOI 10.1002/anie.200604278
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Lynn DM, 2007, ADV MATER, V19, P4118, DOI 10.1002/adma.200701748
   Ma N, 2006, LANGMUIR, V22, P3906, DOI 10.1021/la053441a
   Ma N, 2007, LANGMUIR, V23, P2874, DOI 10.1021/la0632068
   Ma YJ, 2006, NAT MATER, V5, P724, DOI 10.1038/nmat1716
   Macdonald M, 2008, J CONTROL RELEASE, V131, P228, DOI 10.1016/j.jconrel.2008.07.032
   Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w
   Manna U, 2010, ACS APPL MATER INTER, V2, P1521, DOI 10.1021/am100139j
   Manna U, 2009, LANGMUIR, V25, P10515, DOI 10.1021/la901243m
   Manna U, 2009, BIOMACROMOLECULES, V10, P2632, DOI 10.1021/bm9005535
   Mansouri S, 2009, LANGMUIR, V25, P14071, DOI 10.1021/la9016799
   Matyjaszewski K, 2001, CHEM REV, V101, P2921, DOI 10.1021/cr940534g
   Mendelsohn JD, 2000, LANGMUIR, V16, P5017, DOI 10.1021/la000075g
   Na K, 2007, J AM CHEM SOC, V129, P5788, DOI 10.1021/ja067707r
   Nadiri A, 2007, SMALL, V3, P1577, DOI 10.1002/smll.200700115
   Nguyen PM, 2007, CHEM MATER, V19, P5524, DOI 10.1021/cm070981f
   Nolan CM, 2004, BIOMACROMOLECULES, V5, P1940, DOI 10.1021/bm049750h
   Ono Y, 2006, J AM CHEM SOC, V128, P10030, DOI 10.1021/ja063990i
   Pavlukhina S, 2010, BIOMACROMOLECULES, V11, P3448, DOI 10.1021/bm100975w
   Picart C, 2002, P NATL ACAD SCI USA, V99, P12531, DOI 10.1073/pnas.202486099
   Podsiadlo P, 2009, LANGMUIR, V25, P14093, DOI 10.1021/la9021323
   Qi B, 2006, MACROMOLECULES, V39, P5714, DOI 10.1021/ma0605393
   Quinn JF, 2005, MACROMOLECULES, V38, P3414, DOI 10.1021/ma047414n
   Quinn JF, 2004, LANGMUIR, V20, P20, DOI 10.1021/la0360310
   Recksiedler CL, 2006, LANGMUIR, V22, P2811, DOI 10.1021/la053031m
   Ren KF, 2006, BIOMATERIALS, V27, P1152, DOI 10.1016/j.biomaterials.2005.07.021
   Rijcken CJF, 2007, J CONTROL RELEASE, V120, P131, DOI 10.1016/j.jconrel.2007.03.023
   Rodriguez-Hernandez J, 2005, J AM CHEM SOC, V127, P2026, DOI 10.1021/ja043920g
   Sakai K, 2008, LANGMUIR, V24, P116, DOI 10.1021/la7021006
   Schilli CM, 2004, MACROMOLECULES, V37, P7861, DOI 10.1021/ma035838w
   SCHNEIDER CF, 2009, NANO LETT, V9, P636
   Serizawa T, 2003, ANGEW CHEM INT EDIT, V42, P1115, DOI 10.1002/anie.200390293
   Serizawa T, 2004, MACROMOLECULES, V37, P6531, DOI 10.1021/ma049154f
   Serpe MJ, 2005, BIOMACROMOLECULES, V6, P408, DOI 10.1021/bm049455x
   Serpe MJ, 2003, LANGMUIR, V19, P8759, DOI 10.1021/la034391h
   Shimazaki Y, 1997, LANGMUIR, V13, P1385, DOI 10.1021/la9609579
   Skirtach AG, 2004, LANGMUIR, V20, P6988, DOI 10.1021/la048873k
   Smith EG, 2007, J PHYS CHEM B, V111, P5536, DOI 10.1021/jp072231z
   Smith RC, 2009, ANGEW CHEM INT EDIT, V48, P8974, DOI 10.1002/anie.200902782
   Smith RC, 2009, CHEM MATER, V21, P1108, DOI 10.1021/cm802972d
   Soike T, 2010, ADV MATER, V22, P1392, DOI 10.1002/adma.200903069
   Soltwedel O, 2010, MACROMOLECULES, V43, P7288, DOI 10.1021/ma101279q
   Such GK, 2006, J AM CHEM SOC, V128, P9318, DOI 10.1021/ja063043+
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sukhishvili SA, 2005, CURR OPIN COLLOID IN, V10, P37, DOI 10.1016/j.cocis.2005.05.001
   Swiston AJ, 2010, BIOMACROMOLECULES, V11, P1826, DOI 10.1021/bm100305h
   Szarpak A, 2008, LANGMUIR, V24, P9767, DOI 10.1021/la801274z
   Tan WS, 2010, MACROMOLECULES, V43, P1950, DOI 10.1021/ma902459a
   Tang ZY, 2006, ADV MATER, V18, P3203, DOI 10.1002/adma.200600113
   Thierry B, 2005, J AM CHEM SOC, V127, P1626, DOI 10.1021/ja045077s
   Tong WJ, 2005, CHEM MATER, V17, P4610, DOI 10.1021/cm0507516
   Torchilin VP, 2007, PHARM RES-DORDR, V24, P1, DOI 10.1007/s11095-006-9132-0
   Vasconcellos FC, 2010, BIOMACROMOLECULES, V11, P2407, DOI 10.1021/bm100570r
   Vazquez E, 2002, J AM CHEM SOC, V124, P13992, DOI 10.1021/ja026405w
   Volodkin DV, 2009, LANGMUIR, V25, P14037, DOI 10.1021/la9015433
   Wang F, 2007, LANGMUIR, V23, P9540, DOI 10.1021/1a701969q
   Wang L, 2009, LANGMUIR, V25, P7990, DOI 10.1021/la9004664
   Wang X, 2010, LANGMUIR, V26, P8187, DOI 10.1021/la904558h
   Wang XF, 2009, LANGMUIR, V25, P11664, DOI 10.1021/la9013575
   Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813
   Wood KC, 2006, P NATL ACAD SCI USA, V103, P10207, DOI 10.1073/pnas.0602884103
   Wood KC, 2008, P NATL ACAD SCI USA, V105, P2280, DOI 10.1073/pnas.0706994105
   Yang SY, 2002, J AM CHEM SOC, V124, P2100, DOI 10.1021/ja017681y
   Yoo PJ, 2006, NAT MATER, V5, P234, DOI 10.1038/nmat1596
   Zacharia NS, 2007, MACROMOLECULES, V40, P9523, DOI 10.1021/ma071828+
   Zelikin AN, 2008, CHEM MATER, V20, P2655, DOI 10.1021/cm703403p
   Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r
   Zhang JT, 2007, ADV MATER, V19, P4218, DOI 10.1002/adma.200701028
   Zhang JT, 2006, LANGMUIR, V22, P239, DOI 10.1021/052360b
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zhang YJ, 2005, BIOMACROMOLECULES, V6, P2365, DOI 10.1021/bm050058b
   Zhao QH, 2006, J BIOMAT SCI-POLYM E, V17, P997, DOI 10.1163/156856206778366031
   Zhi ZL, 2010, BIOMACROMOLECULES, V11, P610, DOI 10.1021/bm901152k
   Zhong Y, 2007, CHEM COMMUN, P1415, DOI 10.1039/b615699a
   Zhu ZC, 2009, ACS NANO, V3, P3595, DOI 10.1021/nn900655z
NR 139
TC 135
Z9 136
U1 7
U2 228
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD AUG 14
PY 2011
VL 63
IS 9
BP 822
EP 836
DI 10.1016/j.addr.2011.03.017
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 802AS
UT WOS:000293482300010
PM 21684313
DA 2018-10-20
ER

PT J
AU Kitaoka, T
   Yokota, S
   Opietnik, M
   Rosenau, T
AF Kitaoka, Takuya
   Yokota, Shingo
   Opietnik, Martina
   Rosenau, Thomas
TI Synthesis and bio-applications of carbohydrate-gold nanoconjugates with
   nanoparticle and nanolayer forms
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Carbohydrate; Gold; Nanoconjugate; N-Methylmorpholine N-oxide;
   Self-assembly; Biomaterial
ID NEUTRON FIBER DIFFRACTION; HYDROGEN-BONDING SYSTEM; SELF-ASSEMBLED
   MONOLAYERS; SYNCHROTRON X-RAY; CELL-ADHESION; CRYSTAL-STRUCTURE;
   CELLULOSE; SURFACE; METHYLCELLULOSE; CHEMISTRY
AB Carbohydrate-conjugated gold nanoparticles (GNPs) and gold nanolayers (GNLs), which have recently attracted increasing attention as innovative nano-biomaterials, were successfully synthesized using carbohydrate thiosemicarbazones in an aqueous N-methylmorpholine N-oxide (NMMO) system. This system can dissolve various types of carbohydrates including structural polysaccharides, e.g., cellulose. We observed that oxidative NMMO solvent unexpectedly promoted the immediate reduction of [(AuCl4)-Cl-III](-) species to nanosized metallic Au-0, that is GNP. One possible mechanism is that the chloride ligand was oxidized to chlorate via the formation of a hypochlorite intermediate. Site-selective S-labeling of sugar reducing ends with thiosemicarbazide may have enabled regulated self-assembly immobilization to the surfaces of GNPs and GNLs. The carbohydrate-gold nanoconjugates possess unique nanoarchitectures and biofunctions for carbohydrate-cell interactions. Novel and simple approaches for the structural design of carbohydrate-decorated GNPs and GNLs in the NMMO system have potential to inspire a new phase in glyco-biomaterials engineering. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Kitaoka, Takuya] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, Fukuoka 8128581, Japan.
   [Yokota, Shingo] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.
   [Opietnik, Martina; Rosenau, Thomas] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria.
RP Kitaoka, T (reprint author), Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.
EM tkitaoka@agr.kyushu-u.ac.jp
OI Kitaoka, Takuya/0000-0003-1691-9946; Rosenau, Thomas/0000-0002-6636-9260
FU Japan Society for the Promotion of Science; Ministry of Education,
   Culture, Sports, Science and Technology of Japan [S: 21678002]; Austrian
   Christian Doppler Society
FX The studies in this review article were supported by a Research
   Fellowship for Young Scientists from the Japan Society for the Promotion
   of Science (S.Y.), by a Grant-in-Aid for Young Scientists (S: 21678002)
   from the Ministry of Education, Culture, Sports, Science and Technology
   of Japan (T.K.), and by the Austrian Christian Doppler Society (T.R.).
CR Ackerson CJ, 2010, BIOCONJUGATE CHEM, V21, P214, DOI 10.1021/bc900135d
   Alkilany AM, 2009, LANGMUIR, V25, P13874, DOI 10.1021/la901270x
   Bertozzi CR, 2001, SCIENCE, V291, P2357, DOI 10.1126/science.1059820
   Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q
   Boisselier E, 2010, J AM CHEM SOC, V132, P2729, DOI 10.1021/ja909133f
   Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g
   Chen CH, 2006, BIOMACROMOLECULES, V7, P736, DOI 10.1021/bm0506400
   Chevillard C, 1997, COLLOID POLYM SCI, V275, P537, DOI 10.1007/s003960050116
   Corma A, 2008, CHEM SOC REV, V37, P2096, DOI 10.1039/b707314n
   Couet F, 2007, MACROMOL BIOSCI, V7, P701, DOI 10.1002/mabi.200700002
   Czaja WK, 2007, BIOMACROMOLECULES, V8, P1, DOI 10.1021/bm060620d
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Faraday M., 1857, PHILOS T ROY SOC LON, V147, P145, DOI DOI 10.1098/RSTL.1857.0011
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Hoenich N, 2006, BIORESOURCES, V1, P270
   ISHIHARA K, 1990, J BIOMED MATER RES, V24, P1069, DOI 10.1002/jbm.820240809
   Jang H., 2010, CHEM COMMUN, P583
   Jarvis M, 2003, NATURE, V426, P611, DOI 10.1038/426611a
   Jiang XZ, 2010, BIOCONJUGATE CHEM, V21, P521, DOI 10.1021/bc900431p
   Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   KOLPAK FJ, 1976, MACROMOLECULES, V9, P273, DOI 10.1021/ma60050a019
   Kontturi E, 2006, CHEM SOC REV, V35, P1287, DOI 10.1039/b601872f
   Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020
   Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i
   Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002
   Langan P, 1999, J AM CHEM SOC, V121, P9940, DOI 10.1021/ja9916254
   Lee CU, 2010, POLYMER, V51, P1244, DOI 10.1016/j.polymer.2010.01.033
   Lee MH, 2008, BIOMACROMOLECULES, V9, P2315, DOI 10.1021/bm8002094
   Lemieux GA, 1998, TRENDS BIOTECHNOL, V16, P506, DOI 10.1016/S0167-7799(98)01230-X
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Lim JY, 2004, J BIOMED MATER RES A, V68A, P504, DOI 10.1002/jbm.a.20087
   Lyu YK, 2008, CHEM COMMUN, P4771, DOI 10.1039/b807438k
   Matsuda N, 2007, ADV MATER, V19, P3089, DOI 10.1002/adma.200701978
   Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u
   Nakanishi J, 2006, ANAL CHIM ACTA, V578, P100, DOI 10.1016/j.aca.2006.04.059
   Ning YG, 1996, SURF INTERFACE ANAL, V24, P667
   Nishiyama Y, 2002, J AM CHEM SOC, V124, P9074, DOI 10.1021/ja0257319
   Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w
   Oezyuerek Z, 2009, BIOMATERIALS, V30, P1026, DOI 10.1016/j.biomaterials.2008.11.005
   Onodera T, 2006, BIOMACROMOLECULES, V7, P2949, DOI 10.1021/bm060027w
   Opietnik M, 2010, J LABELLED COMPD RAD, V53, P78, DOI 10.1002/jlcr.1708
   Quintanilla A, 2010, CHEM MATER, V22, P1656, DOI 10.1021/cm903712y
   Raynor JE, 2009, BIOMACROMOLECULES, V10, P748, DOI 10.1021/bm8011924
   Rosenau T, 2001, PROG POLYM SCI, V26, P1763, DOI 10.1016/S0079-6700(01)00023-5
   SCHRODER M, 1980, CHEM REV, V80, P187, DOI 10.1021/cr60324a003
   SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tanaka N, 2010, CARBOHYD POLYM, V82, P100, DOI 10.1016/j.carbpol.2010.04.028
   Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816
   Wang X, 2009, J MATER CHEM, V19, P8944, DOI 10.1039/b917900c
   Xu Y, 2009, BIOMATERIALS, V30, P4930, DOI 10.1016/j.biomaterials.2009.06.005
   Yokota S, 2008, CARBOHYD POLYM, V74, P666, DOI 10.1016/j.carbpol.2008.04.027
   Yokota S, 2007, ADV MATER, V19, P3368, DOI 10.1002/adma.200602761
   Yokota S, 2007, APPL SURF SCI, V253, P5149, DOI 10.1016/j.apsusc.2006.11.029
   Yokota S, 2008, ANGEW CHEM INT EDIT, V47, P9866, DOI 10.1002/anie.200803922
   Yoshiike Y, 2010, CARBOHYD POLYM, V82, P21, DOI 10.1016/j.carbpol.2010.04.015
   Zhao J, 2008, ACCOUNTS CHEM RES, V41, P1710, DOI 10.1021/ar800028j
   Zhao W.T., 2010, CHEM COMMUN, P1314
   Zhu JM, 2006, BIOMACROMOLECULES, V7, P1036, DOI 10.1021/bm050611p
NR 61
TC 8
Z9 8
U1 0
U2 39
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD AUG 12
PY 2011
VL 31
IS 6
SI SI
BP 1221
EP 1229
DI 10.1016/j.msec.2010.10.009
PG 9
WC Materials Science, Biomaterials
SC Materials Science
GA 789AU
UT WOS:000292486500011
DA 2018-10-20
ER

PT J
AU Wang, Y
   Zhao, Z
   Zhao, B
   Qi, HX
   Peng, J
   Zhang, L
   Xu, WJ
   Hu, P
   Lu, SB
AF Wang Yu
   Zhao Zhe
   Zhao Bin
   Qi Hong-xu
   Peng Jiang
   Zhang Li
   Xu Wen-jing
   Hu Ping
   Lu Shi-bi
TI Biocompatibility evaluation of electrospun aligned poly(propylene
   carbonate) nanofibrous scaffolds with peripheral nerve tissues and cells
   in vitro
SO CHINESE MEDICAL JOURNAL
LA English
DT Article
DE dorsal root ganglia; electrospinning; nerve tissue engineering;
   poly(propylene carbonate); Schwann cell
ID MESENCHYMAL STEM-CELLS; PROPYLENE-OXIDE; SCHWANN-CELLS; REGENERATION;
   GRAFTS; COPOLYMERIZATION; ALIGNMENT; DIOXIDE; GROWTH; ARRAYS
AB Background Peripheral nerve regeneration across large gaps is clinically challenging. Scaffold design plays a pivotal role in nerve tissue engineering. Recently, nanofibrous scaffolds have proven a suitable environment for cell attachment and proliferation due to similarities of their physical properties to natural extracellular matrix. Poly(propylene carbonate) (PPC) nanofibrous scaffolds have been investigated for vascular tissue engineering. However, no reports exist of PPC nanofibrous scaffolds for nerve tissue engineering. This study aimed to evaluate the potential role of aligned and random PPC nanofibrous scaffolds as substrates for peripheral nerve tissue and cells in nerve tissue engineering.
   Methods Aligned and random PPC nanofibrous scaffolds were fabricated by electrospinning and their chemical characterization were carried out using scanning electron microscopy (SEM). Dorsal root ganglia (DRG) from Sprague-Dawley rats were cultured on the nanofibrous substrates for 7 days. Neurite outgrowth and Schwann-cell migration from DRG were observed and quantified using immunocytochemistry and SEM. Schwann cells derived from rat sciatic nerves were cultured in electrospun PPC scaffold-extract fluid for 24, 48, 72 hours and 7 days. The viability of Schwann cells was evaluated by 3-[4,5-dimethyl(thiazol-2-yl)-2,5-diphenyl] tetrazolium bromide (MTT) assay.
   Results The diameter of aligned and random fibers ranged between 800 nm and 1200 nm, and the thickness of the films was approximately 10-20 mu m. Quantification of aligned fiber films revealed approximately 90% alignment of all fibers along the longitudinal axis. However, with random fiber films, the alignment of fibers was random through all angle bins. Rat DRG explants were grown on PPC nanofiber films for up to 1 week. On the aligned fiber films, the majority of neurite outgrowth and Schwann cell migration from the DRG extended unidirectionally, parallel to the aligned fibers. However, on the random fiber films, neurite outgrowth and Schwann cell migration were randomly distributed. A comparison of cumulative neurite lengths from cultured DRGs indicated that neurites grew faster on aligned PPC films ((2537.6 +/- 987.3) mu m) than randomly-distributed fibers ((493.5 +/- 50.6) mu m). The average distance of Schwann cell migration on aligned PPC nanofibrous films ((2803.5 +/- 943.6) mu m) were significantly greater than those on random fibers ((625.3 +/- 47.8) mu m). The viability of Schwann cells cultured in aligned PPC scaffold extract fluid was not significantly different from that in the plain DMEM/F12 medium at all time points after seeding.
   Conclusions The aligned PPC nanofibrous film, but not the randomly-oriented fibers, significantly enhanced peripheral nerve regeneration in vitro, indicating the substantial role of topographical cues in stimulating endogenous nerve repair mechanisms. Aligned PPC nanofibrous scaffolds may be a promising biomaterial for nerve regeneration. Chin Med J 2011;124(15): 2361-2366
C1 [Wang Yu; Zhao Zhe; Zhao Bin; Peng Jiang; Zhang Li; Xu Wen-jing; Lu Shi-bi] Chinese People Liberat Army Gen Hosp, Orthoped Res Inst Chinese Peoples Liberat Army, Beijing 100853, Peoples R China.
   [Qi Hong-xu; Hu Ping] Tsinghua Univ, Inst Polymer Sci & Technol, Beijing 100084, Peoples R China.
RP Peng, J (reprint author), Chinese People Liberat Army Gen Hosp, Orthoped Res Inst Chinese Peoples Liberat Army, Beijing 100853, Peoples R China.
EM pengjiang301@126.com
RI QI, Hongxu/B-1025-2012
FU Hi-Tech Research and Development Program of China ("863" Program)
   [2009AA03Z312]; Beijing Natural Science Foundation (The oriented
   micro-structure, double-aligned nerve-derived extracellular matrix
   scaffolds promote peripheral nerve long defects regeneration)
FX This study was supported by grants from the Hi-Tech Research and
   Development Program of China ("863" Program, No. 2009AA03Z312), Beijing
   Natural Science Foundation (The oriented micro-structure, double-aligned
   nerve-derived extracellular matrix scaffolds promote peripheral nerve
   long defects regeneration).
CR Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Chisholm MH, 2002, MACROMOLECULES, V35, P6494, DOI 10.1021/ma020348+
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Jin YQ, 2008, J NEUROSCI METH, V170, P140, DOI 10.1016/j.jneumeth.2008.01.003
   Kandenwein JA, 2005, J NEUROSURG, V103, P614, DOI 10.3171/jns.2005.103.4.0614
   Kim G, 2008, MACROMOL RES, V16, P473, DOI 10.1007/BF03218547
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Lackie JM, 2007, DICT CELL MOL BIOL
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li D, 2004, ADV MATER, V16, P361, DOI 10.1002/adma.200306226
   Lietz M, 2006, BIOMATERIALS, V27, P1425, DOI 10.1016/j.biomaterials.2005.08.007
   Miller C, 2001, BIOMATERIALS, V22, P1263, DOI 10.1016/S0142-9612(00)00278-7
   NI SL, 2005, CMINS, V10, P404
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Phillips JB, 2005, TISSUE ENG, V11, P1611, DOI 10.1089/ten.2005.11.1611
   Prabhakaran MP, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/45/455102
   Rutkowski GE, 2004, J NEURAL ENG, V1, P151, DOI 10.1088/1741-2560/1/3/004
   Schmalenberg KE, 2005, BIOMATERIALS, V26, P1423, DOI 10.1016/j.biomaterials.2004.04.046
   Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253
   Stang F, 2005, BIOMATERIALS, V26, P3083, DOI 10.1016/j.biomaterials.2004.07.060
   Taras John S, 2005, J Hand Ther, V18, P191, DOI 10.1197/j.jht.2005.02.012
   Venugopal J, 2008, J BIOMED MATER RES A, V85A, P408, DOI 10.1002/jbm.a.31538
   Welle A, 2007, BIOMATERIALS, V28, P2211, DOI 10.1016/j.biomaterials.2007.01.024
   Wislet-Gendebien S, 2005, STEM CELLS, V23, P392, DOI 10.1634/stemcells.2004-0149
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang YM, 2007, BIOMATERIALS, V28, P1643, DOI 10.1016/j.biomaterials.2006.12.004
   Zhang J, 2006, ARTIF ORGANS, V30, P898, DOI 10.1111/j.1525-1594.2006.00322.x
   Zhang M, 2005, ADV BIOCHEM ENG BIOT, V94, P67, DOI 10.1007/b100000
NR 31
TC 21
Z9 21
U1 1
U2 50
PU CHINESE MEDICAL ASSOC
PI BEIJING
PA 42 DONGSI XIDAJIE, BEIJING 100710, PEOPLES R CHINA
SN 0366-6999
J9 CHINESE MED J-PEKING
JI Chin. Med. J.
PD AUG 5
PY 2011
VL 124
IS 15
BP 2361
EP 2366
DI 10.3760/cma.j.issn.0366-6999.2011.15.020
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 816FM
UT WOS:000294584100020
PM 21933569
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Lee, JY
   Choi, YS
   Lee, SJ
   Chung, CP
   Park, YJ
AF Lee, Jue-Yeon
   Choi, Young-Suk
   Lee, Seung-Jin
   Chung, Chong-Pyoung
   Park, Yoon-Jeong
TI Bioactive Peptide-modified Biomaterials for Bone Regeneration
SO CURRENT PHARMACEUTICAL DESIGN
LA English
DT Review
DE Bioactive peptide; biomaterials; ECM (extracellular matrix); bone
   regeneration; tissue engineering
ID HEPARIN-BINDING DOMAIN; OSTEOBLAST-LIKE CELLS; SITE-DIRECTED
   MUTAGENESIS; MESENCHYMAL STEM-CELLS; OSTEOGENESIS IN-VITRO; MARROW
   STROMAL CELLS; SYNTHETIC PEPTIDE; AMPHIPHILE NANOFIBERS; HYDROXYAPATITE
   CRYSTALS; EXTRACELLULAR-MATRIX
AB Bioactive biomaterials are desirable as tissue engineering scaffolds by virtue of their capability to mimic the natural environment of the extracellular matrix. Bioactive biomaterials have been achieved by incorporating synthetic short peptide sequences into suitable materials either by surface modification or by bulk incorporation. The goal is to enhance cell attachment and other basic functions. Bioactive peptides can be obtained from biological or chemically synthesized sources, increasing their specific cellular responses for tissue growth and development. Compared to using an entire growth factor in regenerative therapy, these peptides demonstrate potential advantages such as overcoming possible immunogenicity, being less susceptible to degradation, and producing fewer tumor-related side effects. Biomaterial scaffolds modified with peptides can provide biological ligands for cell-scaffold interactions that promote cell attachment, proliferation, and differentiation. Peptide-based biomaterial scaffolds can be fabricated to form two-and three-dimensional structures. This review discusses cell-binding, biominerailization inducing peptides, and receptor-binding peptides for bone regeneration. This review also addresses issues related to peptide immobilization as well as potential complications that may develop as a result of using these versatile bioactive peptides. The development of self-assembled peptide amphiphiles with the goal of generating new three-dimensional scaffolds for tissue engineering is also summarized.
C1 [Park, Yoon-Jeong] Seoul Natl Univ, Dept Craniomaxillofacial Reconstruct Sci, Sch Dent, Seoul 110749, South Korea.
   [Choi, Young-Suk; Park, Yoon-Jeong] Seoul Natl Univ, Dept Dent Regenerat Biotechnol, Dent Res Inst, Seoul 110749, South Korea.
   [Lee, Jue-Yeon; Chung, Chong-Pyoung; Park, Yoon-Jeong] Seoul Natl Univ, Res Ctr, NIBEC, Coll Dent, Seoul 110749, South Korea.
   [Lee, Seung-Jin] Ewha Womans Univ, Dept Pharm, Coll Pharm, Seoul 120750, South Korea.
RP Park, YJ (reprint author), Seoul Natl Univ, Dept Craniomaxillofacial Reconstruct Sci, Sch Dent, 28-22 Yongon Dong, Seoul 110749, South Korea.
EM parkyj@snu.ac.kr
FU Korea Science and Technology Foundation (KOSEF) [2011-0007744]; Ministry
   of Health, Welfare and Family Affairs, Republic of Korea [A085056]
FX This study was supported by the Korea Science and Technology Foundation
   (KOSEF) Nanobiotechnology Development Program entitled Regenomics
   (#2011-0007744) and supported by the Ministry of Health, Welfare and
   Family Affairs (#A085056), Republic of Korea.
CR AOTA S, 1991, J BIOL CHEM, V266, P15938
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854
   Boskey AL, 1996, CONNECT TISSUE RES, V35, P357, DOI 10.3109/03008209609029212
   BOSKEY AL, 1995, ANN NY ACAD SCI, V760, P249, DOI 10.1111/j.1749-6632.1995.tb44635.x
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Choi YJ, 2010, BIOMATERIALS, V31, P7226, DOI 10.1016/j.biomaterials.2010.05.022
   Croteau S, 1999, ORTHOPEDICS, V22, P686
   Dahl T, 1998, J STRUCT BIOL, V123, P162, DOI 10.1006/jsbi.1998.4025
   Dahl T, 2003, CONNECT TISSUE RES, V44, P206, DOI 10.1080/03008200390181672
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1996, BIOMATERIALS, V17, P209, DOI 10.1016/0142-9612(96)85765-6
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   DENHARDT DT, 1993, FASEB J, V7, P1475
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   Devescovi Valentina, 2008, Chir Organi Mov, V92, P161, DOI 10.1007/s12306-008-0064-1
   Egusa H, 2009, BIOMATERIALS, V30, P4676, DOI 10.1016/j.biomaterials.2009.05.032
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   FISHER LW, 1983, J BIOL CHEM, V258, P2723
   FUJISAWA R, 1995, CALCIFIED TISSUE INT, V56, P140, DOI 10.1007/BF00296346
   FUJISAWA R, 1992, CALCIFIED TISSUE INT, V51, P438
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   FUJISAWA R, 1991, BIOCHIM BIOPHYS ACTA, V1075, P56
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   GORSKI JP, 1992, CALCIFIED TISSUE INT, V50, P391, DOI 10.1007/BF00296767
   GREEN J, 1995, AM J PHYSIOL-CELL PH, V268, pC1090
   Hamada Y, 2007, DENT MATER J, V26, P487, DOI 10.4012/dmj.26.487
   HARAKAS NK, 1984, CLIN ORTHOP RELAT R, P239
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   He G, 2003, NAT MATER, V2, P552, DOI 10.1038/nmat945
   He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200
   Hennessy KM, 2009, BIOMATERIALS, V30, P1898, DOI 10.1016/j.biomaterials.2008.12.053
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Huebsch JB, 1996, J BIOMED MATER RES, V31, P555, DOI 10.1002/(SICI)1097-4636(199608)31:4<555::AID-JBM16>3.0.CO;2-F
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   JOHNSSON M, 1993, CRIT REV ORAL BIOL M, V4, P371, DOI 10.1177/10454411930040031601
   Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08
   Kirkham J, 2007, J DENT RES, V86, P426, DOI 10.1177/154405910708600507
   Kirsch T, 2000, NAT STRUCT BIOL, V7, P492
   KOIVUNEN E, 1994, METHOD ENZYMOL, V245, P346
   Lai CF, 2006, CIRC RES, V98, P1479, DOI 10.1161/01.RES.0000227550.00426.60
   Lee JY, 2008, J BIOMED MATER RES A, V87A, P688, DOI 10.1002/jbm.a.31721
   Lee JY, 2007, J BIOMED MATER RES A, V83A, P970, DOI 10.1002/jbm.a.31351
   Lee JY, 2007, BIOMATERIALS, V28, P4257, DOI 10.1016/j.biomaterials.2007.05.040
   Lee JY, 2007, BIOCHEM BIOPH RES CO, V357, P68, DOI 10.1016/j.bbrc.2007.03.106
   Lee JY, 2009, BIOMATERIALS, V30, P3532, DOI 10.1016/j.biomaterials.2009.03.018
   Lee JY, 2009, BIOTECHNOL APPL BIOC, V52, P69, DOI 10.1042/BA20070169
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   McCann TJ, 1997, MATRIX BIOL, V16, P273, DOI 10.1016/S0945-053X(97)90015-9
   MCCARTHY JB, 1990, J CELL BIOL, V110, P777, DOI 10.1083/jcb.110.3.777
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   Mertz Patricia M., 1996, Journal of Burn Care and Rehabilitation, V17, P199, DOI 10.1097/00004630-199605000-00004
   Misawa H, 2006, CELL TRANSPLANT, V15, P903, DOI 10.3727/000000006783981369
   Murphy MB, 2007, BIOMACROMOLECULES, V8, P2237, DOI 10.1021/bm070121s
   Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x
   Nelson M, 2006, INT J NANOMED, V1, P339
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Nickel J, 2001, J BONE JOINT SURG AM, V83A, pS7
   Nimni ME, 1997, BIOMATERIALS, V18, P1201, DOI 10.1016/S0142-9612(97)00050-1
   OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6
   Park JB, 2007, J PERIODONTOL, V78, P157, DOI 10.1902/jop.2007.060200
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 1997, J BIOMED MATER RES, V37, P9, DOI 10.1002/(SICI)1097-4636(199710)37:1<9::AID-JBM2>3.0.CO;2-W
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   ROBEY PG, 1989, J CELL BIOL, V108, P719, DOI 10.1083/jcb.108.2.719
   Rocha LB, 2006, J BIOMED MATER RES A, V79A, P237, DOI 10.1002/jbm.a.30782
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   Saito A, 2004, J BIOMED MATER RES A, V70A, P115, DOI 10.1002/jbm.a.30071
   Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X
   Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012
   Schieker M, 2006, UNFALLCHIRURG, V109, P715, DOI 10.1007/s00113-006-1152-z
   Segvich SJ, 2009, BIOMATERIALS, V30, P1287, DOI 10.1016/j.biomaterials.2008.11.008
   Sekiya I, 2005, CELL TISSUE RES, V320, P269, DOI 10.1007/s00441-004-1075-3
   Seol YJ, 2006, J BIOMED MATER RES A, V77A, P599, DOI 10.1002/jbm.a.30639
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sreejalekshmi KG, 2010, J BIOMED MAT RES A
   STAATZ WD, 1991, J BIOL CHEM, V266, P7363
   Tamai N, 2005, OSTEOARTHR CARTILAGE, V13, P405, DOI 10.1016/j.joca.2004.12.014
   TANAHASHI M, 1995, J BIOMED MATER RES, V29, P349, DOI 10.1002/jbm.820290310
   Thorwarth M, 2005, BIOCHEM BIOPH RES CO, V329, P789, DOI 10.1016/j.bbrc.2005.01.157
   TRAUB W, 1989, P NATL ACAD SCI USA, V86, P9822, DOI 10.1073/pnas.86.24.9822
   Tye CE, 2003, J BIOL CHEM, V278, P7949, DOI 10.1074/jbc.M211915200
   VACANTI JP, 1999, LANCET S1, V354, pS132
   VUKICEVIC S, 1990, CELL, V63, P437, DOI 10.1016/0092-8674(90)90176-F
   Wiesmann HP, 2004, INT J ORAL MAX SURG, V33, P523, DOI 10.1016/j.ijom.2004.04.005
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 107
TC 19
Z9 20
U1 3
U2 65
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1381-6128
EI 1873-4286
J9 CURR PHARM DESIGN
JI Curr. Pharm. Design
PD AUG
PY 2011
VL 17
IS 25
BP 2663
EP 2676
DI 10.2174/138161211797416011
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 883JJ
UT WOS:000299629900008
PM 21728982
DA 2018-10-20
ER

PT J
AU Bonilla, CEP
   Perilla, JE
AF Plazas Bonilla, Clara Eugenia
   Ernesto Perilla, Jairo
TI The past, present and near future of materials for use in biodegradable
   orthopaedic implants
SO INGENIERIA E INVESTIGACION
LA English
DT Article
DE biomaterial; orthopaedic implant; biodegradability; bone regeneration
ID SCIENCE-AND-TECHNOLOGY; COMPOSITE COATINGS; BIOMATERIALS; SCAFFOLDS;
   POLYMERS; BIOCOMPATIBILITY; MICROSPHERES; DEGRADATION; SURFACES; SURGERY
AB The aim of bone replacement or fracture treatment methodologies is to induce tissue regeneration respecting anatomy and try to recover functionality. This goal was initially achieved in the 17th century by using animal or human grafts and several medical devices made of natural and synthetic materials are currently used having a whole range of chemical and physical properties. Research in this field continues to seek a solution to the disadvantages usually found when using grafts: immunological reactions, the risk of microbiological contamination, the absence of donors, the need for several surgical interventions and the risk of disease transmission. Basic and applied research must thus be carried out not only in the development of biology and studies about embryonic stem cells but also in the field of new material development. This tendency may be clearly detected by looking at the vast numbers of studies related to using metallic, polymer and ceramic materials and, at present, compound or hybrid materials having potential use in orthopaedic implants. Most of them fulfil conditions regarding biocompatibility and non-toxicity and could be considered when designing biodegradable materials thereby making it feasible to identify a range of research subjects on biomaterials. This paper starts by identifying material development periods and then establishes the advantages and disadvantages of groups which have been considered for bone regeneration and identifies some guidelines which should be taken into account in the field of biodegradable materials in the near future. There is still a long way to go in this subject, especially regarding the field of materials science and technology.
C1 [Plazas Bonilla, Clara Eugenia; Ernesto Perilla, Jairo] Univ Nacl Colombia, Bogota, Colombia.
EM ceplazasb@unal.edu.co; jeperi-llap@unal.edu.co
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   Akkouch A., 2008, THESIS U LAVAL OPTAR
   Alcaide M, 2009, BIOMATERIALS, V30, P45, DOI 10.1016/j.biomaterials.2008.09.012
   Ambard D., 2005, ITBM RBM, V26, P117
   Ambrose CG, 2004, ANN BIOMED ENG, V32, P171, DOI 10.1023/B:ABME.0000007802.59936.fc
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   [Anonymous], 2000, REP 2009
   [Anonymous], 2008, ACTA BIOMATERIALIO, V4, P1637
   [Anonymous], 2009, MET BIOIND EV
   Armelin E., 2002, THESIS U POLITECNICA
   Baino F., 2011, J BIOMEDICAL MAT R A, V97A
   Barcellos IO, 1998, BIOMATERIALS, V19, P2075, DOI 10.1016/S0142-9612(98)00119-7
   Bordenave L., 2004, Medecine Nucleaire, V28, P623
   Bordes P, 2009, PROG POLYM SCI, V34, P125, DOI 10.1016/j.progpolymsci.2008.10.002
   Carvajal M., 2007, REV MED COSTA RICA C, VLXIV, P199
   Chai CS, 1999, J MATER SCI-MATER M, V10, P465, DOI 10.1023/A:1008992807888
   Chen S, 2010, J MATER CHEM, V20, P7337, DOI 10.1039/c0jm01546f
   Davies JE, 2007, BIOMATERIALS, V28, P5058, DOI 10.1016/j.biomaterials.2007.07.049
   Fatimi A, 2009, IRBM, V30, P139, DOI 10.1016/j.irbm.2008.11.001
   Fernandez E., 2005, THESIS U POLITECNICA
   Fundacion OPTI.  Ministerio de Industrie Turismo y Comercio Gobierno de Espana Observatorio de Prospective Tecnologica Industrial, 2008, APL IND NAN ESP HOR
   Gaona M., 2007, THESIS U BARCELONA O
   Goto T., 2005, CONTROL INT C SERIES, V1284, P248
   Gupta R., 2008, BIOMED MATER, V3, P1
   Jacota S., 2008, THESIS U TOULOUSE OP
   Kong L, 2007, J BIOMATER APPL, V22, P223, DOI 10.1177/0885328206073706
   Laquerriere P., 2005, REV EUROPEENNE TECHN, V26, P200
   LI H, 2008, J COMPUT AID MOL DES, P1
   Likibi F, 2005, ANN CHIR, V130, P235, DOI 10.1016/j.anchir.2004.12.006
   Lu X, 2007, MATER LETT, V61, P3970, DOI 10.1016/j.matlet.2006.12.089
   Maia JL, 2004, BRAZ J CHEM ENG, V21, P1, DOI 10.1590/S0104-66322004000100002
   Mano JF, 2008, MAT SCI ENG C-BIO S, V28, P1356, DOI 10.1016/j.msec.2008.03.005
   Martínez-Valencia A.B., 2008, Superf. vacío, V21, P18
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Navarro M, 2005, THESIS U POLITECNICA
   Pan P, 2009, PROG POLYM SCI, V34, P605, DOI 10.1016/j.progpolymsci.2009.01.003
   Pariente J., 2006, ITBM RBM, V27, P150
   Pashkuleva I., 2007, MACROMOL BIOSCI, V8, P210
   Pavithra D., 2008, BIOMED MATER, V3, P1
   Pena J, 2006, POLYM DEGRAD STABIL, V91, P1424, DOI 10.1016/j.polymdegradstab.2005.10.016
   Pereda O., 2005, REV CUBANA ORTOP TRA, V19, P35
   Rojas-Cortes MG, 2008, INGENIERIA INVESTIGA, V28, P57
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Santos AR, 2009, MATER RES-IBERO-AM J, V12, P257, DOI 10.1590/S1516-14392009000300002
   Schottner G, 2001, CHEM MATER, V13, P3422, DOI 10.1021/cm011060m
   Shum AWT, 2005, POLYM DEGRAD STABIL, V87, P487, DOI 10.1016/j.polymdegradstab.2004.10.005
   Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P71, DOI 10.1016/S0924-2244(02)00280-7
   Thombre SM, 2005, J MACROMOL SCI PURE, VA42, P1299, DOI 10.1080/10601320500189604
   Uhlmann DR, 1997, J SOL-GEL SCI TECHN, V8, P1083, DOI 10.1023/A:1018315231532
   United Nations Department of Economic and Social Affairs World Population Prospects, 2004, WORLD POP PROSP REV
   Valliant EM, 2011, SOFT MATTER, V7, P5083, DOI 10.1039/c0sm01348j
   Vaz CM, 2003, POLYM DEGRAD STABIL, V81, P65, DOI 10.1016/S0141-3910(03)00063-6
   VERDIER C, 2003, J THEOR MED, V5, P67, DOI DOI 10.1080/10273360410001678083
   Wu J, 2009, POLYM REV, V49, P25, DOI 10.1080/15583720802656237
   Yoshida M, 2006, POLYM REV, V46, P347, DOI 10.1080/15583720600945394
   Zarate-Kalfopulos Baron, 2006, Cir Cir, V74, P217
   Zarzycki J, 1997, J SOL-GEL SCI TECHN, V8, P17, DOI 10.1023/A:1026480424495
NR 57
TC 1
Z9 2
U1 1
U2 10
PU UNIV NAC COLOMBIA, FAC INGENIERIA
PI BOGOTA
PA CALLE 44, NO 45-67, UNIDAD CAMILO TORRES, BLOQUE B5, OFICINA 401,
   BOGOTA, 00000, COLOMBIA
SN 0120-5609
J9 ING INVEST
JI Ing. Invest.
PD AUG
PY 2011
VL 31
IS 2
BP 124
EP 133
PG 10
WC Engineering, Multidisciplinary
SC Engineering
GA 872SG
UT WOS:000298829100014
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Neffe, AT
   Zaupa, A
   Lendlein, A
AF Neffe, A. T.
   Zaupa, A.
   Lendlein, A.
TI PHYSICAL CROSSLINKING OF GELATIN: A SUPRAMOLECULAR APPROACH TO
   BIOMATERIAL
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Meeting Abstract
C1 [Neffe, A. T.; Zaupa, A.; Lendlein, A.] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev & Berlin Brandenburg, Ctr Regenerat Therapies BCRT, Ctr Bio Mat Dev, Teltow, Germany.
   [Neffe, A. T.; Zaupa, A.; Lendlein, A.] Univ Potsdam, Inst Chem, Potsdam, Germany.
RI Neffe, Axel/H-6997-2013; Lendlein, Andreas/K-9553-2013
OI Neffe, Axel/0000-0002-5056-3990; Lendlein, Andreas/0000-0003-4126-4670
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD AUG
PY 2011
VL 34
IS 8
SI SI
BP 656
EP 656
PG 1
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 875GH
UT WOS:000299017900200
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Luo, DM
   Hu, WY
   Li, YC
   Hodgson, P
   Wen, C
AF Zhou, Ying-Long
   Luo, Dong-Mei
   Hu, Wang-Yu
   Li, Yuncang
   Hodgson, Peter
   Wen, Cuie
TI Microstructural Characterization and Mechanical Properties of Mg-Zr-Ca
   Alloys Prepared by Hot-Extrusion for Biomedical Applications
SO ADVANCED SCIENCE LETTERS
LA English
DT Article
DE Hot-Extrusion; Mg-Zr-Ca Alloy; Microstructure; Mechanical Property;
   Biomaterial
ID MAGNESIUM ALLOYS; CORROSION; BONE; BIOMATERIALS; TITANIUM
AB This paper investigated the microstructural characterization and mechanical properties of Mg-Zr-Ca alloys prepared by hot-extrusion for potential use in biomedical applications. Mg-Zr-Ca alloys were fabricated by commercial pure Mg (99.9%), Ca (99.9%), and master Mg-33% Zr alloy (mass%). The microstructural characterization of the hot-extruded Mg-Zr-Ca alloys was examined by X-ray diffraction analysis and optical microscopy, and the mechanical properties were determined from tensile tests. The experimental results indicate that the hot-extruded Mg-Zr-Ca alloys with 1 mass% Ca are composed atone single a phase and those alloys with 2 mass% Ca consist of both Mg,Ca and a phase. The hot-extruded Mg-Zr-Ca alloys exhibit equiaxed granular microstructures and the hot-extrusion process can effectively increase both the tensile strength and ductility of Mg-Zr-Ca alloys. The hot-extruded Mg-1Zr-1Ca alloy (mass%) exhibits the highest strength and best ductility among all the alloys, and has much higher strength than the human bone, suggesting that it has a great potential to be a good candidate for biomedical application.
C1 [Zhou, Ying-Long] Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
   [Luo, Dong-Mei] Foshan Univ, Dept Civil Engn, Foshan 528000, Peoples R China.
   [Hu, Wang-Yu] Hunan Univ, Dept Appl Phys, Changsha 410082, Hunan, Peoples R China.
   [Li, Yuncang; Hodgson, Peter] Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
   [Wen, Cuie] Swinburne Univ Technol, Fac Engn & Ind Sci, IRIS, Hawthorn, Vic 3122, Australia.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, Foshan 528000, Peoples R China.
RI Wen, Cuie/I-2872-2012; Li, Yuncang/I-5832-2012; Hu, Wangyu/B-5762-2009
OI Wen, Cuie/0000-0001-8008-3536; Li, Yuncang/0000-0003-4290-4772; Hu,
   Wangyu/0000-0001-7416-3994
FU Guangdong Province, PR China [2008B010600003]; Australia
   [AISRF-BF030031]
FX This work was supported by the Key Scientific and Technological Projects
   of Guangdong Province, PR China (Project No. 2008B010600003) and
   AISRF-BF030031, Australia. And the special gratitude was expressed to
   Professor Lei Wang from Northeastern University, PR China for his kind
   help during the hot-extrusion process.
CR [艾延龄 AI Yanling], 2005, [机械工程材料, Materials for Mechanical Engineering], V29, P3
   ASM International, 1992, ASM HDB, V3
   ASTM International, 2006, STAND TEST METH TENS
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Hartwig A, 2001, MUTAT RES-FUND MOL M, V475, P113, DOI 10.1016/S0027-5107(01)00074-4
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Nayab SN, 2007, BIOMATERIALS, V28, P38, DOI 10.1016/j.biomaterials.2006.08.032
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Wan YZ, 2008, MATER DESIGN, V29, P2034, DOI 10.1016/j.matdes.2008.04.017
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Xu H, 2007, MAGNESIUM ALLOYS FAB
   Zhang J., 2004, MAGNESIUM ALLOYS THE
NR 15
TC 9
Z9 9
U1 0
U2 12
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1936-6612
J9 ADV SCI LETT
JI Adv. Sci. Lett.
PD AUG-OCT
PY 2011
VL 4
IS 8-10
BP 2860
EP 2863
DI 10.1166/asl.2011.1741
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 822OJ
UT WOS:000295057700052
DA 2018-10-20
ER

PT J
AU Jaatinen, JJP
   Korhonen, RK
   Pelttari, A
   Helminen, HJ
   Korhonen, H
   Lappalainen, R
   Kroger, H
AF Jaatinen, Jarkko J. P.
   Korhonen, Rami K.
   Pelttari, Alpo
   Helminen, Heikki J.
   Korhonen, Hannu
   Lappalainen, Reijo
   Kroger, Heikki
TI Early bone growth on the surface of titanium implants in rat femur is
   enhanced by an amorphous diamond coating
SO ACTA ORTHOPAEDICA
LA English
DT Article
ID TOTAL HIP-ARTHROPLASTY; FOLLOW-UP; IN-VIVO; REPLACEMENT;
   OSSEOINTEGRATION; PROSTHESES; ABSORPTIOMETRY
AB Background and purpose Amorphous diamond (AD) is a durable and compatible biomaterial for joint prostheses. Knowledge regarding bone growth on AD-coated implants and their early-stage osseointegration is poor. We investigated bone growth on AD-coated cementless intramedullary implants implanted in rats. Titanium was chosen as a reference due to its well-known performance.
   Materials and methods We placed AD-coated and non-coated titanium implants (R(a) approximate to 0.2 mu m) into the femoral bone marrow of 25 rats. The animals were divided in 2 groups according to implant coating and they were killed after 4 or 12 weeks. The osseointegration of the implants was examined from hard tissue specimens by measuring the new bone formation on their surface.
   Results 4 weeks after the operation, the thickness of new bone in the AD-coated group was greater than that in the non-coated group (15.3 (SD 7.1) mu m vs. 7.6 (SD 6.0) mu m). 12 weeks after the operation, the thickness of new bone was similar in the non-coated group and in the AD-coated group.
   Interpretation We conclude that AD coating of femoral implants can enhance bone ongrowth in rats in the acute, early stage after the operation and might be an improvement over earlier coatings.
C1 [Korhonen, Rami K.; Korhonen, Hannu; Lappalainen, Reijo] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.
   [Jaatinen, Jarkko J. P.; Kroger, Heikki] Kuopio Univ Hosp, Dept Orthoped, Bone & Cartilage Res Ctr, SF-70210 Kuopio, Finland.
   [Pelttari, Alpo; Lappalainen, Reijo] Univ Eastern Finland, BioMater Ctr, Kuopio, Finland.
   [Helminen, Heikki J.] Univ Eastern Finland, Inst Biomed, Dept Anat, Kuopio, Finland.
RP Korhonen, RK (reprint author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.
EM rami.korhonen@uef.fi
OI Korhonen, Rami/0000-0002-3486-7855
FU Academy of Finland
FX We thank the Academy of Finland for financial support.
CR Aamodt A, 2004, ACTA ORTHOP SCAND, V75, P663, DOI 10.1080/00016470410004021
   Bhadang KA, 2004, BIOMATERIALS, V25, P4935, DOI 10.1016/j.biomaterials.2004.02.043
   Branemark R, 1997, BIOMATERIALS, V18, P969, DOI 10.1016/S0142-9612(97)00018-5
   Ellison Brad, 2009, J Orthop Surg Res, V4, P42, DOI 10.1186/1749-799X-4-42
   Emerson RH, 2002, J ARTHROPLASTY, V17, P584, DOI 10.1054/arth.2002.32696
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   Hooper GJ, 2009, J BONE JOINT SURG BR, V91B, P451, DOI 10.1302/0301-620X.91B4.21363
   Lan J, 2007, INT J ORAL MAX SURG, V36, P345, DOI 10.1016/j.ijom.2006.10.019
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   Lappalainen R, 2003, J BIOMED MATER RES B, V66B, P410, DOI 10.1002/jbm.b.10026
   Lappalainen R, 2008, WOODHEAD PUBL MATER, P176, DOI 10.1533/9781845694807.2.176
   Miettinen SSA, 2009, J ORTHOP SCI, V14, P431, DOI 10.1007/s00776-009-1352-9
   Moreland JR, 2001, CLIN ORTHOP RELAT R, P194
   Santavirta SS, 1999, CLIN ORTHOP RELAT R, P92
   Santori FS, 2001, ORTHOPEDICS, V24, P1147
   Schopper C, 2005, CLIN ORAL IMPLAN RES, V16, P357, DOI 10.1111/j.1600-0501.2004.01080.x
   Sorrells RB, 2004, J BONE JOINT SURG AM, V86A, P2156, DOI 10.2106/00004623-200410000-00005
   Toyras J, 2005, J BIOMED MATER RES B, V73B, P15, DOI 10.1002/jbm.b.30173
   Venesmaa P, 2000, J Orthop Sci, V5, P380, DOI 10.1007/s007760070047
   Venesmaa PK, 2003, ACTA ORTHOP SCAND, V74, P31, DOI 10.1080/00016470310013617
   Venesmaa PK, 2001, J BONE MINER RES, V16, P1056, DOI 10.1359/jbmr.2001.16.6.1056
   Xiao J, 2011, OSTEOPOROSIS INT, V22, P1907, DOI 10.1007/s00198-010-1413-0
   Yamada H, 2009, J ORTHOP SCI, V14, P228, DOI 10.1007/s00776-008-1317-4
   Yamaguchi K, 2000, J BONE JOINT SURG AM, V82A, P1426, DOI 10.2106/00004623-200010000-00009
NR 25
TC 12
Z9 12
U1 1
U2 8
PU INFORMA HEALTHCARE
PI NEW YORK
PA 52 VANDERBILT AVE, NEW YORK, NY 10017 USA
SN 1745-3674
J9 ACTA ORTHOP
JI Acta Orthop.
PD AUG
PY 2011
VL 82
IS 4
BP 499
EP 503
DI 10.3109/17453674.2011.579522
PG 5
WC Orthopedics
SC Orthopedics
GA 819ST
UT WOS:000294851100019
PM 21504369
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Kim, WJ
   Lee, KA
   Kim, KT
   Chung, MS
   Cho, S
   Paik, HD
AF Kim, Won Ju
   Lee, Kyoung Ah
   Kim, Kee-Tae
   Chung, Myong-Soo
   Cho, SangWoo
   Paik, Hyun-Dong
TI Antimicrobial Effects of Onion (Allium cepa L.) Peel Extracts Produced
   via Subcritical Water Extraction against Bacillus cereus Strains as
   Compared with Ethanolic and Hot Water Extraction
SO FOOD SCIENCE AND BIOTECHNOLOGY
LA English
DT Article
DE antimicrobial effect; onion; subcritical water extraction; Bacillus
   cereus; SEM
ID PRESSURIZED LIQUID EXTRACTION; LOW-POLARITY WATER; PHENOLIC-COMPOUNDS;
   PASTEURIZED MILK; GARLIC EXTRACT; GROWTH; INGREDIENTS; CATECHINS;
   BACTERIA; PLANTS
AB In this study, the antimicrobial effects of an onion peel extract prepared using subcritical water extraction (SWE) were assessed for possible development into new bio-functional materials. The extraction temperatures were controlled to 110 and 160 degrees C. At 0.15, 0.3, 0.6, and 1.2 mg extract/mL of broth, the growth inhibition and bactericidal activity of SWE extracts against Bacillus cereus KCCM 40935 and KCCM 11341 were compared with those of ethanol and hot-water extracts. In the case of B. cereus KCCM 40935, it appeared that over 0.6 mg/mL of SWE (110 degrees C) extract exerted a bactericidal effect, and 1.2 mg/mL of SWE (160 degrees C) extract exerted a bacteriostatic effect during culturing, and also that B. cereus KCCM 11341 was more resistant than B. cereus KCCM 40935. Furthermore, our results demonstrated that the death time of 10(7) CFU/mL of B. cereus KCCM 40935 treated with SWE (110 degrees C) extract at 1.2 mg/mL was 60 min at maximum in 0.8% NaCl. Additionally, the cells damaged by SWE extract were observed with a SEM. It was suggested that an extract of onion peels prepared via SWE (110 degrees C) could be used as a functional biomaterial for the food or pharmaceutical industries.
C1 [Kim, Won Ju; Lee, Kyoung Ah; Paik, Hyun-Dong] Konkuk Univ, Div Anim Life Sci, Seoul 143701, South Korea.
   [Kim, Kee-Tae; Paik, Hyun-Dong] Konkuk Univ, Biomol Informat Ctr, Seoul 143701, South Korea.
   [Chung, Myong-Soo] Ewha Womans Univ, Div Food Sci & Engn, Seoul 120750, South Korea.
   [Cho, SangWoo] Pulmuone Co Ltd, Seoul 135885, South Korea.
RP Paik, HD (reprint author), Konkuk Univ, Div Anim Life Sci, Seoul 143701, South Korea.
EM hdpaik@konkuk.ac.kr
CR AHMED AAH, 1983, J FOOD PROTECT, V46, P126, DOI 10.4315/0362-028X-46.2.126
   Bakri IM, 2005, ARCH ORAL BIOL, V50, P645, DOI 10.1016/j.archoralbio.2004.12.002
   Cacace JE, 2006, J FOOD ENG, V77, P1087, DOI 10.1016/j.jfoodeng.2005.08.039
   Choi MPK, 2003, J CHROMATOGR A, V983, P153, DOI 10.1016/S0021-9673(02)01649-7
   COGHILL D, 1979, AUST J DAIRY TECHNOL, V34, P150
   Garcia-Marino M, 2006, ANAL CHIM ACTA, V563, P44, DOI 10.1016/j.aca.2005.10.054
   Griffiths G, 2002, PHYTOTHER RES, V16, P603, DOI 10.1002/ptr.1222
   Gupta N, 2001, J NUTR, V131, P1662
   HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U
   Ibanez E, 2003, J AGR FOOD CHEM, V51, P375, DOI 10.1021/jf025878j
   JOHNSTON DW, 1982, J APPL BACTERIOL, V52, P333, DOI 10.1111/j.1365-2672.1982.tb05061.x
   Ju Z. Y., 2005, J FOOD SCI, V70, P270
   Kim JW, 2006, J AGR FOOD CHEM, V54, P7575, DOI 10.1021/jf0608221
   Lamm LJ, 2003, ANAL CHEM, V75, P2237, DOI 10.1021/ac020724o
   Lanzotti V, 2006, J CHROMATOGR A, V1112, P3, DOI 10.1016/j.chroma.2005.12.016
   Larsen HD, 1999, INT J FOOD MICROBIOL, V46, P173, DOI 10.1016/S0168-1605(98)00188-3
   Morris CE, 1997, APPL ENVIRON MICROB, V63, P1570
   Pineiro Z, 2004, J CHROMATOGR A, V1026, P19, DOI 10.1016/j.chroma.2003.10.096
   Pszczola DE, 2002, FOOD TECHNOL-CHICAGO, V56, P56
   Puupponen-Pimia R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x
   Ramos FA, 2006, J AGR FOOD CHEM, V54, P3551, DOI 10.1021/jf060251c
   Ramos L, 2002, J CHROMATOGR A, V975, P3, DOI 10.1016/S0021-9673(02)01336-5
   Rose P, 2005, NAT PROD REP, V22, P351, DOI 10.1039/b417639c
   Shotipruk A, 2004, BIOTECHNOL PROGR, V20, P1872, DOI 10.1021/bp049779x
   Smith RM, 2002, J CHROMATOGR A, V975, P31, DOI 10.1016/S0021-9673(02)01225-6
   TANSEY MR, 1975, MYCOLOGIA, V67, P409, DOI 10.2307/3758431
   Taran M, 2006, IRAN J PUBLIC HEALTH, V35, P92
   Te Giffel M. C., 1997, International Journal of Food Microbiology, V34, P307, DOI 10.1016/S0168-1605(96)01204-4
   Viljoen A, 2003, J ETHNOPHARMACOL, V88, P137, DOI 10.1016/S0378-8741(03)00191-0
   WONG HC, 1988, APPL ENVIRON MICROB, V54, P699
NR 30
TC 5
Z9 6
U1 2
U2 19
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1226-7708
J9 FOOD SCI BIOTECHNOL
JI Food Sci. Biotechnol.
PD AUG
PY 2011
VL 20
IS 4
BP 1101
EP 1106
DI 10.1007/s10068-011-0149-8
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA 815RV
UT WOS:000294546400029
DA 2018-10-20
ER

PT J
AU Terada, M
   Marques, RA
   Simoes, AM
   Padilha, AF
   Costa, I
AF Terada, M.
   Albuquerque Marques, R.
   Simoes, A. M.
   Fernando Padilha, A.
   Costa, I.
TI Use of SECM to compare corrosion resistance of DIN W. Nr. 1.4460 high N
   and AISI 316L austenitic stainless steels in physiological solutions
SO CORROSION ENGINEERING SCIENCE AND TECHNOLOGY
LA English
DT Review
DE Corrosion; Biomaterials; DIN W. Nr. 1.4460 high N; AISI 316L; Scanning
   electrochemical microscopy
ID IN-VITRO; BIOMATERIAL APPLICATIONS; PRECIPITATION BEHAVIOR; CREVICE
   CORROSION; NITROGEN; IRON; IMPEDANCE
AB The pitting corrosion resistance of DIN W. Nr. 1.4460 stainless steel (SS) with high amounts of nitrogen (0.87%) was evaluated to be used for medical implants. The SS pitting corrosion resistance was tested in a minimum essential medium at 37 degrees C by electrochemical impedance spectroscopy and potentiodynamic polarisation curves and in a 0.1 mol L(-1) NaCl solution at 25 degrees C, by scanning electrochemical microscopy. This last technique measures the concentration of chemical species released by corrosion processes. The potential of an ultramicroelectrode was set to amperometrically detect the Fe(2+) ions released at the anodic areas and also the depletion of oxygen due to the cathodic reactions in the vicinity of the cathodic areas. The AISI 316L stainless steel was also tested for comparison reasons. The results showed that the DIN W. Nr. 1.4460 with 0.87% nitrogen presents higher pitting corrosion resistance than the AISI 316L SS, being a potential candidate for biomaterial applications.
C1 [Terada, M.; Fernando Padilha, A.] Univ Sao Paulo, Dept Engn Met & Mat, Escola Politecn, BR-05508030 Sao Paulo, Brazil.
   [Albuquerque Marques, R.; Costa, I.] CCTM, IPEN CNEN SP, BR-05508000 Sao Paulo, Brazil.
   [Simoes, A. M.] Inst Super Tecn, Dept Engn Quim, Lisbon, Portugal.
RP Terada, M (reprint author), Univ Sao Paulo, Dept Engn Met & Mat, Escola Politecn, Av Prof Mello de Morais 2463, BR-05508030 Sao Paulo, Brazil.
EM maysaterada@uol.com.br
RI Terada, Maysa/D-3277-2012; Costa, Isolda/E-8506-2012; Padilha, Angelo
   Fernando/D-9595-2016
OI Terada, Maysa/0000-0002-2011-5759; Costa, Isolda/0000-0002-4987-3334;
   Padilha, Angelo Fernando/0000-0002-5494-9137; Simoes,
   Alda/0000-0002-7652-4930
FU CAPES [3702/06-5]; FAPESP [08/54836-4]
FX The authors acknowledge CAPES (grant no. 3702/06-5) and FAPESP (grant
   no. 08/54836-4) for financial support to Dr Maysa Terada.
CR ASSIS SL, 2006, THESIS I PESQUISAS E
   AZUMI K, 1986, T JPN I MET, V27, P382, DOI 10.2320/matertrans1960.27.382
   Baba H, 2006, CORROS SCI, V48, P2510, DOI 10.1016/j.corsci.2005.09.010
   Bastos AC, 2004, ELECTROCHEM COMMUN, V6, P1212, DOI 10.1016/j.elecom.2004.09.022
   BONNEFOIS B, 1989, HNS88 HIGH NITROGEN, P81
   CASTRO EB, 1993, ELECTROCHIM ACTA, V38, P1567, DOI 10.1016/0013-4686(93)80291-7
   Fini M, 2003, BIOMATERIALS, V24, P4929, DOI 10.1016/S0142-9612(03)00416-2
   Ge HH, 2003, APPL SURF SCI, V211, P321, DOI 10.1016/S0169-4332(03)00355-6
   Grabke HJ, 1996, ISIJ INT, V36, P777, DOI 10.2355/isijinternational.36.777
   Hanninen H, 2001, J MATER PROCESS TECH, V117, P424, DOI 10.1016/S0924-0136(01)00804-4
   HITCHMAN ML, 1978, MEASUREMENT DISSOLVE, V22
   Kimura T, 2007, ENVIRON TOXICOL, V22, P176, DOI 10.1002/tox.20243
   Lide D. R., 2003, HDB CHEM PHYS
   Lister TE, 2003, ELECTROCHIM ACTA, V48, P2371, DOI 10.1016/S0013-4686(03)00228-7
   Machado IF, 1996, STEEL RES, V67, P285, DOI 10.1002/srin.199605492
   Machado IF, 1998, STEEL RES, V69, P381, DOI 10.1002/srin.199805568
   Machado IF, 2000, ISIJ INT, V40, P719, DOI 10.2355/isijinternational.40.719
   MACHADO IF, 1999, THESIS U SAO PAULO S
   Montanaro L, 2006, J MATER SCI-MATER M, V17, P267, DOI 10.1007/s10856-006-7313-3
   Mori G, 2004, MATER CORROS, V55, P164, DOI 10.1002/maco.200303746
   Nielsen K., 1987, British Corrosion Journal, V22, P272
   Padilha AF, 2002, ISIJ INT, V42, P325, DOI 10.2355/isijinternational.42.325
   Pan J, 2000, J ELECTROCHEM SOC, V147, P1021, DOI 10.1149/1.1393307
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Sieurin H, 2006, METALL MATER TRANS A, V37A, P2975, DOI 10.1007/s11661-006-0179-7
   Simoes AM, 2007, CORROS SCI, V49, P726, DOI 10.1016/j.corsci.2006.04.021
   SIVAKUMAR M, 1993, J MATER SCI, V28, P6081, DOI 10.1007/BF00365025
   STEINBECK G, 1994, NICHTROSTENDE STAHL, P1
   Sumita M, 2004, MAT SCI ENG C-BIO S, V24, P753, DOI 10.1016/j.msec.2004.08.030
   Terada M, 2007, MATER CORROS, V58, P762, DOI 10.1002/maco.200704070
   TERADA M, 2008, THESIS U SAO PAULO S
   Turnbull A, 2002, CORROSION, V58, P1039, DOI 10.5006/1.3280793
   Uggowitzer PJ, 1996, ISIJ INT, V36, P901, DOI 10.2355/isijinternational.36.901
   WILLIAMS DF, 1987, J MATER SCI, V22, P3421, DOI 10.1007/BF01161439
   WIPF DO, 1994, PHYSICOCHEM ENG ASPE, V93, P251
   WOODS TO, 2002, P ASTM S LAS VEG NV, P82
NR 36
TC 2
Z9 2
U1 1
U2 20
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 1478-422X
J9 CORROS ENG SCI TECHN
JI Corros. Eng. Sci. Technol.
PD AUG
PY 2011
VL 46
IS 5
BP 599
EP 604
DI 10.1179/147842210X12722706885922
PG 6
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 814BU
UT WOS:000294421100002
DA 2018-10-20
ER

PT J
AU Prasad, TNVKV
   Kambala, VSR
   Naidu, R
AF Prasad, T. N. V. K. V.
   Kambala, Venkata Subba Rao
   Naidu, Ravi
TI A Critical Review on Biogenic Silver Nanoparticles and their
   Antimicrobial Activity
SO CURRENT NANOSCIENCE
LA English
DT Review
DE Silver; Nanoparticles; Biosynthesis; Antimicrobial agents;
   Nanobiotechnology
ID FUNGUS-MEDIATED SYNTHESIS; GREEN SYNTHESIS; ESCHERICHIA-COLI;
   EXTRACELLULAR BIOSYNTHESIS; ANTIBACTERIAL ACTIVITY;
   STAPHYLOCOCCUS-AUREUS; GOLD NANOPARTICLES; BACILLUS-LICHENIFORMIS;
   CULTURE SUPERNATANT; BIOLOGICAL APPROACH
AB The new bio-branch of nanotechnology is considered to be one of the fastest emerging fields often called as Nanobiotechnology. Recent studies on exploitation of the nature's secrets for the synthesis of inorganic materials are relatively new and exciting area of research with considerable potential for development. Among the inorganic materials, noble metals research is been always interesting, silver in particular. Nanoscale silver has been proved to be one of the potential antibacterial, antifungal and anti-inflammatory agents. Biologically synthesized silver nanoparticles can be more effective in the medicinal applications due to their diversified surface coatings (biomaterial). The present review gives an idea about the importance of biogenic metallic silver nanoparticles, their characterization and potential antimicrobial properties.
C1 [Prasad, T. N. V. K. V.; Kambala, Venkata Subba Rao; Naidu, Ravi] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes 5095, Australia.
   [Prasad, T. N. V. K. V.] ANG Ranga Univ, Reg Agr Res Stn, Dept Nanotechnol, Tirupati 517502, Andhra Pradesh, India.
   [Kambala, Venkata Subba Rao; Naidu, Ravi] Univ S Australia, CRC Contaminat Assessment & Remediat Environm, Mawson Lakes 5095, Australia.
RP Prasad, TNVKV (reprint author), Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes 5095, Australia.
EM tnvkvprasad@gmail.com
RI Naidu, Ravi/F-5927-2012
FU Department of Education, Employment and Workplace relations (DEEWR),
   Australia
FX The first author TNVKVP is thankful to Department of Education,
   Employment and Workplace relations (DEEWR), Australia for Endeavour
   research fellowship. The authors are thankful to Centre for
   Environmental Risk Assessment and Remediation (CERAR), University of
   South Australia and CRC for Contamination Assessment and Remediation of
   Environment (CARE) for infrastructure and research facilities.
CR Abu Bakar NHH, 2007, MATER CHEM PHYS, V104, P276, DOI 10.1016/j.matchemphys.2007.03.015
   Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Ankamwar B, 2005, J NANOSCI NANOTECHNO, V5, P1665, DOI 10.1166/jnn.2005.184
   Ankamwar B, 2005, SYNTH REACT INORG ME, V35, P19, DOI 10.1081/SIM-200047527
   Ankanna S, 2010, DIG J NANOMATER BIOS, V5, P369
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Balaji S., 2009, COLLOID SURFACE B, V68, P88
   Bankar A, 2010, MATER LETT, V64, P1951, DOI 10.1016/j.matlet.2010.06.021
   Bar H, 2009, COLLOID SURFACE A, V339, P134, DOI 10.1016/j.colsurfa.2009.02.008
   BARND HS, 2008, MAT SCI ENG C, V28, P515
   Basavaraja S, 2008, MATER RES BULL, V43, P1164, DOI 10.1016/j.materresbull.2007.06.020
   Batarseh KI, 2004, J ANTIMICROB CHEMOTH, V54, P546, DOI 10.1093/jac/dkh349
   BEGUM AN, 2009, COLLOID SURFACE B, V71, P113
   Beveridge TJ, 1997, ADV MICROB PHYSIOL, V38, P177
   Bhainsa CK, 2006, COLLOID SURFACE B, V47, P160
   Bhushan B., 2004, SPRINGER HDB NANOTEC
   Binupriya AR, 2010, COLLOID SURFACE B, V79, P531, DOI 10.1016/j.colsurfb.2010.05.021
   Birla SS, 2009, LETT APPL MICROBIOL, V48, P173, DOI 10.1111/j.1472-765X.2008.02510.x
   Boulch F, 2001, IMAGE ANAL STEREOL, V20, P157
   Brooks R., 1992, NOBLE METALS BIOL SY
   Castellano Joseph J, 2007, Int Wound J, V4, P114, DOI 10.1111/j.1742-481X.2007.00316.x
   Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423
   Chen JC, 2003, LETT APPL MICROBIOL, V37, P105, DOI 10.1046/j.1472-765X.2003.01348.x
   Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h
   Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006
   Chung YC, 2004, ACTA PHARMACOL SIN, V25, P932
   Dickson DPE, 1999, J MAGN MAGN MATER, V203, P46, DOI 10.1016/S0304-8853(99)00178-X
   DREXLER KE, 1986, ENGINES CREATION COM
   Du WL, 2009, CARBOHYD POLYM, V75, P385, DOI 10.1016/j.carbpol.2008.07.039
   Dubey M, 2009, DIG J NANOMATER BIOS, V4, P537
   Duran Nelson, 2005, J Nanobiotechnology, V3, P8, DOI 10.1186/1477-3155-3-8
   Elumalai E. K., 2010, J PHARM SCI RES, V2, P549
   Farooqui MA, 2010, DIG J NANOMATER BIOS, V5, P43
   Fayaz AM, 2009, COLLOID SURFACE B, V74, P123, DOI 10.1016/j.colsurfb.2009.07.002
   Fendler J. H., 1998, NANOPARTICLES NANOST
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Feynman R, 1959, LECT CALIFORNIA I TE
   Fu MX, 2006, CHINESE J CHEM ENG, V14, P114, DOI 10.1016/S1004-9541(06)60046-3
   Gade A.K., 2008, J BIOBASED MATER BIO, V2, P1, DOI DOI 10.1166/JBMB.2008.204
   Gajbhiye M, 2009, NANOMED-NANOTECHNOL, V5, P382, DOI 10.1016/j.nano.2009.06.005
   GARDEATORRESDAY LJ, 2003, LANGMUIR, V19, P1357
   GAUTHERET R. J., 1935, REV GEN BOT, V47, P401
   Gemmell CG, 2006, J ANTIMICROB CHEMOTH, V57, P589, DOI 10.1093/jac/dkl017
   Ghosh S, 2010, CARBOHYD RES, V345, P2220, DOI 10.1016/j.carres.2010.08.001
   Govindaraju K., 2010, Journal of Biopesticides, V3, P394
   Gurunathan S, 2009, BIOMATERIALS, V30, P6341, DOI 10.1016/j.biomaterials.2009.08.008
   Huang JL, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105104
   Ingle A., 2008, J NANOPART RES, V11, P2079
   Ingle A, 2008, CURR NANOSCI, V4, P141, DOI 10.2174/157341308784340804
   Jain D, 2009, DIG J NANOMATER BIOS, V4, P557
   Janaki B, 2000, FOOD CHEM TOXICOL, V38, P523, DOI 10.1016/S0278-6915(00)00037-5
   Jha AK, 2010, INT J GREEN NANOTECH, V1, pP110, DOI DOI 10.1080/19430871003684572
   Jha AK, 2009, BIOTECHNOL PROGR, V25, P1476, DOI 10.1002/btpr.233
   Jha AK, 2009, COLLOID SURFACE B, V73, P219, DOI 10.1016/j.colsurfb.2009.05.018
   Jiang ZL, 2001, ACTA CHIM SINICA, V59, P438
   Jyothi Koraa Aruna, 2010, CARBOHYD POLYM, V82, P670
   Kalimuthu K, 2008, COLLOID SURFACE B, V65, P150, DOI 10.1016/j.colsurfb.2008.02.018
   Kalishwaralal K, 2008, MATER LETT, V62, P4411, DOI 10.1016/j.matlet.2008.06.051
   Kannan B. N., 2010, ADV COLLOID INTERFAC, V156, P1
   Karbasian M., 2008, American Journal of Agricultural and Biological Sciences, V3, P433
   Kasthuri J, 2009, COLLOID SURFACE B, V68, P55, DOI 10.1016/j.colsurfb.2008.09.021
   Klasen HJ, 2000, BURNS, V30, P1
   Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611
   Klaus-Joerger T, 2001, TRENDS BIOTECHNOL, V19, P15, DOI 10.1016/S0167-7799(00)01514-6
   Kowshik M, 2003, NANOTECHNOLOGY, V14, P95, DOI 10.1088/0957-4484/14/1/321
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Landsdown ABG, 2002, J WOUND CARE, V11, P125
   Lengke MF, 2006, LANGMUIR, V22, P2780, DOI 10.1021/la052652c
   Li LS, 2001, NANO LETT, V1, P349, DOI 10.1021/nl015559r
   Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079
   Lovely D R, 1987, NATURE, V330, P252
   Maliszewska I., 2009, J PHYS, V146, P1
   Maneerung T, 2008, CARBOHYD POLYM, V72, P43, DOI 10.1016/j.carbpol.2007.07.025
   Milligan AJ, 2002, SCIENCE, V297, P1848, DOI 10.1126/science.1074958
   MINAEIAN S, 2008, J SCI IA, V66, P1
   Mohammadian A, 2007, SCI IRAN, V14, P323
   Mohan YM, 2007, J APPL POLYM SCI, V106, P3375, DOI 10.1002/app.26979
   Mokhtari M., 2009, MAT RES B, V44, P1415
   Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059
   MOYER CA, 1965, ARCH SURG-CHICAGO, V90, P812
   Mukherjee P, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/7/075103
   Mukherjee P, 2001, NANO LETT, V1, P515, DOI 10.1021/nl0155274
   Nabikhan A, 2010, COLLOID SURFACE B, V79, P488, DOI 10.1016/j.colsurfb.2010.05.018
   Naidu VGM, 2009, CARBOHYD POLYM, V76, P464, DOI 10.1016/j.carbpol.2008.11.010
   Nair B, 2002, CRYST GROWTH DES, V2, P293, DOI 10.1021/cg0255164
   Nithya R, 2009, DIG J NANOMATER BIOS, V4, P623
   Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06
   Parikh RY, 2008, CHEMBIOCHEM, V9, P1415, DOI 10.1002/cbic.200700592
   Philip D, 2010, SPECTROCHIM ACTA A, V75, P1078, DOI 10.1016/j.saa.2009.12.058
   Philip D, 2009, SPECTROCHIM ACTA A, V73, P374, DOI 10.1016/j.saa.2009.02.037
   Prabhu N, 2010, DIG J NANOMATER BIOS, V5, P185
   Pum D, 1999, TRENDS BIOTECHNOL, V17, P8, DOI 10.1016/S0167-7799(98)01221-9
   Raimondi F, 2005, ANGEW CHEM INT EDIT, V44, P2190, DOI 10.1002/anie.200460466
   RAJINI P, P AM I PHY IN PRESS
   Raut R.W., 2009, CURR NANOSCI, V5, P117, DOI DOI 10.2174/157341309787314674
   REDDY PR, 2010, J NANOPART RES, V12, P1711
   Richard III J. W., 2002, J BURNS SURG WOUND C, V1, P11
   Sadhasivam S, 2010, COLLOID SURFACE B, V81, P358, DOI 10.1016/j.colsurfb.2010.07.036
   Sadowski Z, 2008, MATER SCI-POLAND, V26, P419
   Sadowski Z, 2008, POL J CHEM, V82, P377
   Saifuddin N, 2009, E-J CHEM, V6, P61, DOI 10.1155/2009/734264
   Sanghi R, 2009, BIORESOURCE TECHNOL, V100, P501, DOI 10.1016/j.biortech.2008.05.048
   Saravanana M, 2010, COLLOID SURFACE B, V77, P214, DOI 10.1016/j.colsurfb.2010.01.026
   Sarkar R, 2010, DIG J NANOMATER BIOS, V5, P491
   Sastry M, 2003, CURR SCI INDIA, V85, P162
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Sathishkumar M, 2010, BIORESOURCE TECHNOL, V101, P7958, DOI 10.1016/j.biortech.2010.05.051
   Senapati S, 2004, INDIAN J PHYS PT-A, V78A, P101
   Shahverdi R., 2007, P BIOCH, V42, P919
   Shaligram S. N., 2009, PROCESS BIOCHEM, V44, P939
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Sharma NC, 2007, ENVIRON SCI TECHNOL, V41, P5137, DOI 10.1021/es062929a
   Shirley AD, 2010, DIG J NANOMATER BIOS, V5, P447
   Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0
   Singh A, 2010, DIG J NANOMATER BIOS, V5, P483
   SLAWSON RM, 1994, BIOMETALS, V7, P30
   SONG JY, 2008, J CHEM ENG, V2, P5808
   Taiz L., 2006, PLANT PHYSL
   Taniguchi N., 1974, P INT C PROD ENG T 2
   Valodkar M, 2010, CARBOHYD RES, V345, P1767, DOI 10.1016/j.carres.2010.05.005
   Vigneshwaran N, 2006, CARBOHYD RES, V341, P2012, DOI 10.1016/j.carres.2006.04.042
   VIGNESWARAN N, 2007, MATER LETT, V66, P1413
   Vilchis-Nestor AR, 2008, MATER LETT, V62, P3103, DOI 10.1016/j.matlet.2008.01.138
   Xu XY, 2006, EUR POLYM J, V42, P2081, DOI 10.1016/j.eurpolymj.2006.03.032
   Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005
   Zahra R.N., 2010, IRAN J BIOTECHNOL, V8, P56
   Zhang HR, 2005, J CHEM TECHNOL BIOT, V80, P285, DOI 10.1002/jctb.1191
NR 128
TC 30
Z9 30
U1 5
U2 71
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
J9 CURR NANOSCI
JI Curr. Nanosci.
PD AUG
PY 2011
VL 7
IS 4
BP 531
EP 544
PG 14
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 814AD
UT WOS:000294412500005
DA 2018-10-20
ER

PT J
AU Ricci, JL
   Terracio, L
AF Ricci, John L.
   Terracio, Louis
TI Where is dentistry in regenerative medicine?
SO INTERNATIONAL DENTAL JOURNAL
LA English
DT Article
DE Regenerative dentistry; regenerative medicine; implants; restorations
ID DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE RESPONSES; CRESTAL BONE
   LEVELS; STEM-CELLS; DENTAL IMPLANTS; SCAFFOLDS; GROWTH; FIBROBLASTS;
   ATTACHMENT; PULP
AB Where does dentistry fit into the field of regenerative medicine? Based on the fact that the goal of regenerative medicine is to restore function to damaged organs and tissues, it is apparent that dentistry, which has long embraced the concept of restoring function of damaged teeth, has embraced this goal from the very beginning. In this brief review we present the opinion that if you take as the primary criterion the restoration of tissue and organ function, dentistry has not only been at the forefront of restorative medicine but actually predates it in practice. We illustrate the depth and breadth of dental regenerative medicine using examples of therapies or potential therapies from our laboratories. These begin with an example from a historical area of strength, dental implant design and fabrication, progress to a more high tech bone scaffold fabrication project, and finish with a stem cell-based soft tissue engineering project. In the final analysis we believe that the restorative nature of dentistry will keep it at the forefront of regenerative medicine.
C1 [Terracio, Louis] NYU, Coll Dent, Adm Off, Res Off, New York, NY 10010 USA.
   [Ricci, John L.] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA.
RP Terracio, L (reprint author), NYU, Coll Dent, Adm Off, Res Off, Rm 1036W,345 E 24th St, New York, NY 10010 USA.
EM louis.terracio@nyu.edu
FU NYSTEM, New York State Department of Health [CO24253]
FX Work supported in part by Grant CO24253 from NYSTEM, New York State
   Department of Health to LT.
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Ahn S, 2010, TISSUE ENG PART C-ME, V16, P813, DOI 10.1089/ten.tec.2009.0511
   Bluteau G, 2008, EUR CELLS MATER, V16, P1
   Collier Mark, 2006, Nurs Stand, V21, ppassim
   Cook S D, 1987, Int J Oral Maxillofac Implants, V2, P15
   Cronin KJ, 2007, J BIOMED MATER RES B, V82B, P122, DOI 10.1002/jbm.b.30713
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   Frenkel SR, 2002, J BIOMED MATER RES, V63, P706, DOI 10.1002/jbm.10408
   Fung Y., 2001, 865023 UCSD CTR ENG
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45
   Ikeda H, 2011, ANN BIOMED ENG, V39, P26, DOI 10.1007/s10439-010-0115-2
   Kaiser L R, 1992, Top Health Care Financ, V18, P32
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Nevins M, 2008, INT J PERIODONT REST, V28, P111
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Propst JT, 2009, J INVEST SURG, V22, P35, DOI 10.1080/08941930802566748
   Ricci J, 2000, BONE ENG, P282
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Shapoff CA, 2010, INT J PERIODONT REST, V30, P129
   Simon JL, 2007, J BIOMED MATER RES A, V83A, P747, DOI 10.1002/jbm.a.31329
   Smay JE, 2002, LANGMUIR, V18, P5429, DOI 10.1021/la0257135
   Snead ML, 2008, J DENT EDUC, V72, P903
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Weiner S, 2008, IMPLANT DENT, V17, P217, DOI 10.1097/ID.0b013e3181779016
   Yan W, 2007, TISSUE ENG, V13, P2781, DOI 10.1089/ten.2006.0408
   Young HE, 2004, ANAT REC PART A, V276A, P75, DOI 10.1002/ar.a.10134
NR 29
TC 3
Z9 3
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-6539
J9 INT DENT J
JI Int. Dent. J.
PD AUG
PY 2011
VL 61
SU 1
SI SI
BP 2
EP 10
DI 10.1111/j.1875-595X.2011.00024.x
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 815VX
UT WOS:000294559200002
PM 21726220
OA Bronze
DA 2018-10-20
ER

PT J
AU Meng, DC
   Francis, L
   Roy, I
   Boccaccini, AR
AF Meng, Decheng
   Francis, Lydia
   Roy, Ipsita
   Boccaccini, Aldo R.
TI Using electrophoretic deposition to identify protein charge in
   biological medium
SO JOURNAL OF APPLIED ELECTROCHEMISTRY
LA English
DT Article
DE Electrophoretic deposition; Proteins; Coatings
ID IN-VITRO; ADSORPTION; CERAMICS; BACTERIA; SURFACE
AB Protein adsorption is the first step involved in establishing a suitable integration between a biomaterial and host tissue. It is therefore of highest interest to know the electric charge of proteins present in the relevant medium to be able to predict the behaviour of cells on given surfaces. In this study, electrophoretic deposition (EPD) was used as a simple method to identify the charge of proteins present in biological medium. In the model experiment carried out here, EPD was conducted using a biological medium containing 10% fetal calf serum (FCS) and the charge of the protein was determined by examining the migration of the protein in the EPD cell under a certain applied voltage. In addition, the suitability of EPD of proteins to deliver tailored surfaces for enhanced bioactivity or for controlled deposition of protein films on metallic surfaces was explored.
C1 [Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
   [Meng, Decheng; Boccaccini, Aldo R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England.
   [Francis, Lydia; Roy, Ipsita] Univ Westminster, Dept Mol & Appl Biosci, London W1W 6UW, England.
RP Boccaccini, AR (reprint author), Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
EM aldo.boccaccini@ww.uni-erlangen.de
RI Boccaccini, Aldo/C-7905-2013
CR Alkan S, 2001, SYNTHETIC MET, V123, P95, DOI 10.1016/S0379-6779(00)00580-4
   Ammam M, 2009, BIOSENS BIOELECTRON, V25, P191, DOI 10.1016/j.bios.2009.06.036
   BOCCACCINI AR, 2010, J R SOC INTERFACE, V6, pS581
   DAVIES JE, 1986, BIOMATERIALS, V7, P231
   ELGHANNAM A, 1996, P 5 WORLD BIOM C J B
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P825, DOI 10.1002/1097-4636(20001215)52:4<825::AID-JBM28>3.0.CO;2-M
   Krajewski A, 1998, BIOMATERIALS, V19, P637, DOI 10.1016/S0142-9612(97)00153-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Ma R, 2011, SURF ENG, V27, P51, DOI 10.1179/026708410X12506870724271
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Neirinck B, 2009, ELECTROCHEM COMMUN, V11, P1842, DOI 10.1016/j.elecom.2009.07.033
   Novak S, 2009, COLLOID SURFACE A, V340, P155, DOI 10.1016/j.colsurfa.2009.03.023
   Nuffer JH, 2010, TISSUE ENG PT A, V16, P423, DOI [10.1089/ten.tea.2009.0294, 10.1089/ten.TEA.2009.0294]
   OPITZ HG, 1977, J EXP MED, V145, P1029, DOI 10.1084/jem.145.4.1029
   Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029
   Poortinga AT, 2000, BIOTECHNOL BIOENG, V67, P117, DOI 10.1002/(SICI)1097-0290(20000105)67:1<117::AID-BIT14>3.0.CO;2-6
   Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015
   Simchi A, 2009, MATER LETT, V63, P2253, DOI 10.1016/j.matlet.2009.07.046
NR 18
TC 2
Z9 2
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0021-891X
J9 J APPL ELECTROCHEM
JI J. Appl. Electrochem.
PD AUG
PY 2011
VL 41
IS 8
BP 919
EP 923
DI 10.1007/s10800-011-0317-9
PG 5
WC Electrochemistry
SC Electrochemistry
GA 814SS
UT WOS:000294478100005
DA 2018-10-20
ER

PT J
AU Zhang, BB
   Wang, BL
   Li, L
   Zheng, YF
AF Zhang, B. B.
   Wang, B. L.
   Li, L.
   Zheng, Y. F.
TI Corrosion behavior of newly developed Ti-Ag-Fe dental alloys in neutral
   saline solution
SO MATERIALS AND CORROSION-WERKSTOFFE UND KORROSION
LA English
DT Article
ID ELECTROCHEMICAL-BEHAVIOR; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS;
   BODY-FLUID; CU ALLOYS; GRINDABILITY; TI-6AL-4V; BIOMATERIAL
AB The corrosion behavior of Ti-5Ag-xFe alloys (x = 1, 2.5, 5wt%) in neutral saline solution was investigated by the open-circuit potential (OCP), potentiodynamic polarization, electrochemical impedance spectroscopy (EIS), and potentiostatic tests. The microstructural observation indicated that beta-Ti phase was retained by the addition of Fe into Ti-Ag alloys. Compared with commercially pure (CP) Ti, Ti-5Ag-xFe alloys exhibited higher corrosion potentials, lower current densities, and larger impedance, these suggested that Ti-5Ag-xFe alloys have nobler electrochemical corrosion behavior when compared with CP Ti in neutral saline solution.
C1 [Zhang, B. B.; Wang, B. L.; Li, L.; Zheng, Y. F.] Harbin Engn Univ, Ctr Biomed Mat & Engn, Harbin 150001, Peoples R China.
   [Zheng, Y. F.] Peking Univ, Dept Adv Mat & Nanotechnol, Coll Engn, Beijing 100871, Peoples R China.
RP Zheng, YF (reprint author), Harbin Engn Univ, Ctr Biomed Mat & Engn, Harbin 150001, Peoples R China.
EM yfzheng@pku.edu.cn
RI Zheng, Yufeng/A-4146-2010
OI Zheng, Yufeng/0000-0002-7402-9979
CR ALMAYOUF AM, 2004, MATER CORROS, V7, P55
   Bordji K, 1996, BIOMATERIALS, V17, P929, DOI 10.1016/0142-9612(96)83289-3
   Brunette D. M., 2001, TITANIUM MED
   de Assis SL, 2006, ELECTROCHIM ACTA, V51, P1815, DOI 10.1016/j.electacta.2005.02.121
   Figueira N, 2009, ELECTROCHIM ACTA, V54, P921, DOI 10.1016/j.electacta.2008.08.001
   Gordin DM, 2005, MATER LETT, V59, P2959, DOI 10.1016/j.matlet.2004.09.064
   Ho WF, 2009, MAT SCI ENG C-BIO S, V29, P36, DOI 10.1016/j.msec.2008.05.004
   Hong SB, 2001, CORROS SCI, V43, P1781, DOI 10.1016/S0010-938X(00)00181-5
   Hsu HC, 2009, J ALLOY COMPD, V474, P578, DOI 10.1016/j.jallcom.2008.07.003
   Kikuchi M, 2003, DENT MATER J, V22, P191, DOI 10.4012/dmj.22.191
   Koike M, 2005, MAT SCI ENG C-BIO S, V25, P349, DOI 10.1016/j.msec.2005.04.002
   Liu L, 2006, J ALLOY COMPD, V425, P268, DOI 10.1016/j.jallcom.2006.01.048
   Nag S, 2005, J MATER SCI-MATER M, V16, P679, DOI 10.1007/s10856-005-2540-6
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Pimenova NV, 2006, ELECTROCHIM ACTA, V51, P2042, DOI 10.1016/j.electacta.2005.07.024
   Shim HM, 2005, J BIOMED MATER RES B, V73B, P252, DOI 10.1002/jbm.b.30206
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   Souza MEP, 2007, SURF COAT TECH, V201, P7775, DOI 10.1016/j.surfcoat.2007.03.005
   Takahashi M, 2002, DENT MATER J, V21, P270, DOI 10.4012/dmj.21.270
   Tamilselvi S, 2007, MATER CORROS, V58, P113, DOI 10.1002/maco.200603979
   Tamilselvi S, 2006, ELECTROCHIM ACTA, V52, P839, DOI 10.1016/j.electacta.2006.06.018
   Wang BL, 2009, MATER CORROS, V60, P788, DOI 10.1002/maco.200805173
   Wang BL, 2009, MATER CORROS, V60, P330, DOI 10.1002/maco.200805120
NR 24
TC 10
Z9 10
U1 0
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0947-5117
J9 MATER CORROS
JI Mater. Corros.
PD AUG
PY 2011
VL 62
IS 8
BP 766
EP 770
DI 10.1002/maco.200905561
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 812WR
UT WOS:000294324400005
DA 2018-10-20
ER

PT J
AU Nazari, AG
   Tahari, A
   Moztarzadeh, F
   Mozafari, M
   Bahrololoom, ME
AF Nazari, A. Ghafari
   Tahari, A.
   Moztarzadeh, F.
   Mozafari, M.
   Bahrololoom, M. E.
TI Ion exchange behaviour of silver-doped apatite micro- and nanoparticles
   as antibacterial biomaterial
SO MICRO & NANO LETTERS
LA English
DT Article
ID POORLY CRYSTALLINE APATITES; LOADED BONE-CEMENT; ESCHERICHIA-COLI;
   CALCIUM PHOSPHATES; IN-VITRO; HYDROXYAPATITE; NANOCOMPOSITES;
   DISINFECTION; OPTIMIZATION; MATURATION
AB Hydroxyapatite (HAp) micro- and nanoparticles have been widely used as highly promising bioactive materials in different ways because of their bone growth induction. As microbial infection of HAp might be frequently occurred, silver (Ag) can be doped in the HAp lattice to enhance the antimicrobial properties. Herein, Ag-doped HAp was successfully synthesised through an ion exchange reaction. This study describes experiments on the preparation and testing of Ag-loaded HAp as an antibacterial biomaterial. The effects of synthesis conditions such as maturation state and silver ion exchange were investigated on the samples by the Taguchi method. Also, chemical analysis was conducted by atomic absorption spectrophotometers, and the antibacterial activity of the prepared samples against bacterium of Escherichia coli was tested. The effectiveness of the material depends upon the synthesis conditions that were assessed statistically. In addition, the material was examined by scanning electron microscopy and its antibacterial action given a physical basis. Finally, the obtained results indicated that maturation caused an increase in the homogeneity of particles, with a decrease in silver absorption ability and antibacterial activity.
C1 [Nazari, A. Ghafari] Islamic Azad Univ, Dept Mat Engn, So Branch, Tehran, Iran.
   [Tahari, A.; Bahrololoom, M. E.] Shiraz Univ, Dept Mat Sci & Engn, Shiraz, Iran.
   [Moztarzadeh, F.; Mozafari, M.] Amir Kabir Univ Technol, Biomat Grp, Fac Biomed Engn, Ctr Excellence, Tehran, Iran.
RP Nazari, AG (reprint author), Islamic Azad Univ, Dept Mat Engn, So Branch, Tehran, Iran.
EM alighafarinazari@yahoo.de
RI Mozafari, Masoud/I-3061-2013; ghafarinazari, ali/F-5334-2015
OI Mozafari, Masoud/0000-0002-0232-352X; ghafarinazari,
   ali/0000-0001-6287-0640; Moztarzadeh, Fathollah/0000-0001-9109-0264
CR Bale C, 2002, CALPHAD, V26, P189, DOI 10.1016/S0364-5916(02)00035-4
   Basar B, 2010, CERAM INT, V36, P1633, DOI 10.1016/j.ceramint.2010.02.033
   Cazalbou S, 2005, J MATER SCI-MATER M, V16, P405, DOI 10.1007/s10856-005-6979-2
   Cazalbou S, 2004, J BONE MINER METAB, V22, P310, DOI 10.1007/s00774-004-0488-0
   Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004
   Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017
   Corami A, 2008, J COLLOID INTERF SCI, V317, P402, DOI 10.1016/j.jcis.2007.09.075
   Dellino G, 2010, INT J PROD ECON, V125, P52, DOI 10.1016/j.ijpe.2009.12.003
   Fong N, 2010, ACTA BIOMATER, V6, P2554, DOI 10.1016/j.actbio.2010.01.005
   GHAFARINAZARI A, 2011, ADV POWDER IN PRESS
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   Kokura S, 2010, NANOMED-NANOTECHNOL, V6, P570, DOI 10.1016/j.nano.2009.12.002
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015
   Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5
   Li YB, 2008, INT J APPL CERAM TEC, V5, P442, DOI 10.1111/j.1744-7402.2008.02210.x
   MA QY, 1994, ENVIRON SCI TECHNOL, V28, P1219, DOI 10.1021/es00056a007
   Moojen DJF, 2009, J ORTHOP RES, V27, P1002, DOI 10.1002/jor.20854
   Mori R, 2011, CLIN ORTHOP RELAT R, V469, P600, DOI 10.1007/s11999-010-1626-8
   Nath S, 2010, J MATER SCI-MATER M, V21, P1273, DOI 10.1007/s10856-009-3939-2
   Pang ML, 2010, J AM CHEM SOC, V132, P10771, DOI 10.1021/ja102105q
   Pitto RP, 2004, INT ORTHOP, V28, P129, DOI 10.1007/s00264-004-0545-2
   Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015
   Rey C, 2009, OSTEOPOROSIS INT, V20, P1013, DOI 10.1007/s00198-009-0860-y
   Rey C, 1995, CELL MATER, V5, P345
   REY C, 2008, MAT SCI ENG C, V28, P1544
   REY C, 2009, NANOCRYSTALLINE APAT
   REY C, 2003, J CRYST GROWTH, V144, P304
   Roy R. K., 1990, PRIMER TAGUCHI METHO
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Sokmen M, 2001, J PHOTOCH PHOTOBIO A, V143, P241, DOI 10.1016/S1010-6030(01)00497-X
   Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012
   Tan O, 2005, TUNN UNDERGR SP TECH, V20, P167, DOI 10.1016/j.tust.2004.08.004
   Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068
   Torres N, 2010, ACTA BIOMATER, V6, P3242, DOI 10.1016/j.actbio.2010.02.032
   Wei QS, 2007, SCI CHINA SER B, V50, P418, DOI 10.1007/s11426-007-0028-6
   ZOLFAGHARI G, 2011, J HAZARD MAT IN PRES
NR 37
TC 16
Z9 16
U1 1
U2 27
PU INST ENGINEERING TECHNOLOGY-IET
PI HERTFORD
PA MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND
SN 1750-0443
J9 MICRO NANO LETT
JI Micro Nano Lett.
PD AUG
PY 2011
VL 6
IS 8
BP 713
EP 717
DI 10.1049/mnl.2011.0381
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 814PX
UT WOS:000294470400034
DA 2018-10-20
ER

PT J
AU Cranford, SW
   Buehler, MJ
AF Cranford, Steven W.
   Buehler, Markus J.
TI Shaky foundations of hierarchical biological materials
SO NANO TODAY
LA English
DT Article
DE Hierarchical materials; Tissue engineering; Regenerative medicine;
   Mechanical properties; Structure; Scaffolding; Materiomics
ID BIOMIMETIC MATERIALS; POLYMER BRUSHES; TISSUE; SCAFFOLDS; HYDROGELS;
   CELLS; ARCHITECTURE; GRADIENTS; MEMBRANES; SURFACE
AB It is popular stance that successful growth be it structural, economic or biological requires a stable foundation. The hierarchical structure of native biological materials and tissues introduces variations in form and function across a multitude of scales. Yet, many synthetic scaffolds and substrates in which such materials are assembled, the foundation, are designed at a single scale. The result is an uncertain or shaky foundation for material assembly and tissue growth, where changes in the scaffold properties and architecture result in unpredictable behaviors in tissue development, and proven, reliable scaffolds for one tissue type may be completely unsuitable for another. This is in contrast to the behavior of foundations for civil engineering structures, which provide a decoupling of the foundation from the building design since different foundations can support equivalent functional structures. Current advancements in the design of biologically active foundations shed light on proven scaffolds and substrates, but cannot be used to design and predict success from the bottom-up. This is because while the phenomenological coupling between materials and substrates has been well investigated and has yielded methodologies for biomaterial synthesis, the underlying mechanisms of self-assembly and growth are not fully understood. A potential solution lies in the utilization of hierarchical material foundations, with molecular, fibrillar and other interactions designed across all length- and time-scales with engineered, predictive, and repeatable outcomes. The potential to realize such hierarchical multiscale scaffolds can be found in the exploitation of responsive, or mutable, polymer systems that exhibit precise control and variegated chemical functionalities for applications in diverse areas such as regenerative medicine, cancer treatment or drug delivery. (C) 2011 Published by Elsevier Ltd.
C1 [Cranford, Steven W.; Buehler, Markus J.] MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.
   [Cranford, Steven W.; Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA.
RP Buehler, MJ (reprint author), MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, 77 Massachusetts Ave,Room 1-235A&B, Cambridge, MA 02139 USA.
EM mbuehler@MIT.EDU
RI Buehler, Markus/C-4580-2008; Cranford, Steven/H-4260-2012
OI Buehler, Markus/0000-0002-4173-9659; 
FU NSF
FX This work was supported by the NSF-MRSEC program and NSF-CAREER.
   Additional support provided by DOD-PECASE and ONR.
CR Alarcon CDH, 2005, J MATER CHEM, V15, P2089, DOI 10.1039/b419142k
   Alexander C, 2006, ADV MATER, V18, P3321, DOI 10.1002/adma.200502640
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Brammer KS, 2011, ACTA BIOMATER, V7, P683, DOI 10.1016/j.actbio.2010.09.022
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Buehler MJ, 2008, PROG MATER SCI, V53, P1101, DOI 10.1016/j.pmatsci.2008.06.002
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chia KK, 2009, LANGMUIR, V25, P14044, DOI 10.1021/la9015959
   Cranford SW, 2010, SOFT MATTER, V6, P4175, DOI 10.1039/c0sm00095g
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fernandes H, 2009, J MATER CHEM, V19, P5474, DOI 10.1039/b822177d
   Fisher JP, 2002, BIOMATERIALS, V23, P4333, DOI 10.1016/S0142-9612(02)00178-3
   Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001
   Hayashi G, 2007, J AM CHEM SOC, V129, P8678, DOI 10.1021/ja071298x
   Ionov L, 2009, BIOINTERPHASES, V4, pFA45, DOI 10.1116/1.3119722
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016
   Knowles TPJ, 2010, NAT NANOTECHNOL, V5, P204, DOI [10.1038/nnano.2010.26, 10.1038/NNANO.2010.26]
   Liu XH, 2011, NAT MATER, V10, P398, DOI [10.1038/NMAT2999, 10.1038/nmat2999]
   Liu ZS, 2000, ADV MATER, V12, P288, DOI 10.1002/(SICI)1521-4095(200002)12:4<288::AID-ADMA288>3.0.CO;2-1
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Luzinov I, 2008, SOFT MATTER, V4, P714, DOI 10.1039/b718999k
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Melchels FPW, 2010, ACTA BIOMATER, V6, P4208, DOI 10.1016/j.actbio.2010.06.012
   Mendes PM, 2008, CHEM SOC REV, V37, P2512, DOI 10.1039/b714635n
   Motornov M, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/43/434006
   Nandakumar A, 2010, LANGMUIR, V26, P7380, DOI 10.1021/la904406b
   Pugno NM, 2008, SMALL, V4, P1044, DOI 10.1002/smll.200800062
   Pugno NM, 2006, NANOTECHNOLOGY, V17, P5480, DOI 10.1088/0957-4484/17/21/031
   Pugno NM, 2010, MATER TODAY, V13, P40, DOI 10.1016/S1369-7021(10)70032-8
   Ren CL, 2008, J PHYS CHEM B, V112, P16238, DOI 10.1021/jp8080904
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   Stuart MAC, 2010, NAT MATER, V9, P101, DOI [10.1038/NMAT2614, 10.1038/nmat2614]
   Tagliazucchi M, 2008, LANGMUIR, V24, P2869, DOI 10.1021/la702734n
   Tokarev I, 2006, ADV MATER, V18, P2458, DOI 10.1002/adma.200601288
   Tokarev I, 2009, ADV MATER, V21, P241, DOI 10.1002/adma.200801408
   Zhao XH, 2011, P NATL ACAD SCI USA, V108, P67, DOI 10.1073/pnas.1007862108
NR 44
TC 7
Z9 7
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1748-0132
EI 1878-044X
J9 NANO TODAY
JI Nano Today
PD AUG
PY 2011
VL 6
IS 4
BP 332
EP 338
DI 10.1016/j.nantod.2011.07.001
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 815KE
UT WOS:000294523700005
DA 2018-10-20
ER

PT J
AU Khadka, DB
   Cross, MC
   Haynie, DT
AF Khadka, Dhan B.
   Cross, Michael C.
   Haynie, Donald T.
TI A Synthetic Polypeptide Electrospun Biomaterial
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE biocompatibility; cross-linking; electrospinning; fiber scaffold;
   functionalization; polypeptide
ID DRUG-DELIVERY; CROSS-LINKING; NANOSTRUCTURED MATERIALS; POLYMER
   NANOFIBERS; CARBODIIMIDE; SCAFFOLDS; FIBERS
AB Fiber mats of a synthetic anionic copolypeptide of L-glutamic acid and L-tyrosine (PLEY) have been produced by electrospinning, and physical, chemical, and biological properties of the fibers have been characterized in vitro. Fibers were obtained from polymer dissolved in water at concentrations of 20-60% (w/v) but not below this range. Applied voltage and spinneret-collector distance were also found to influence polymer spinnability. Oriented fibers were obtained by changing the geometry of the collector. Fiber diameter was measured by scanning electron microscopy (SEM). A common chemical reagent was used to cross-link polymers postspinning. Fiber solubility in aqueous solution varied as a function of cross-linking time. Cationic polypeptides labeled with a fluorescent dye became noncovalently associated with cross-linked fibers, enabling visualization by fluorescence microscopy. Spectroscopy provided information on polymer chain conformation in solution and in fibers. Degradation of cross-linked fibers by different proteases has been demonstrated. Fibroblasts were cultured on cross-linked fiber mats to test basic cytocompatibility. Synthetic polypeptide fiber mats may be useful in applications in medicine, biotechnology, and other areas.
C1 [Haynie, Donald T.] Univ S Florida, Dept Phys, Ctr Integrated Funct Mat, Tampa, FL 33620 USA.
   [Khadka, Dhan B.; Cross, Michael C.] Univ S Florida, Nanomed & Nanobiotechnol Lab, Tampa, FL 33620 USA.
RP Haynie, DT (reprint author), Univ S Florida, Dept Phys, Ctr Integrated Funct Mat, 4202 E Fowler Ave, Tampa, FL 33620 USA.
EM dhaynie@usf.edu
FU National Science Foundation; Faculty Research and Development
FX M.C.C. is the recipient of a fellowship from the Louis Stokes Alliance
   for Minority Participation-Bridge to the Doctorate program, which is
   supported by the National Science Foundation. The project was supported
   by Faculty Research and Development grant to D.T.H.
CR Agarwal S, 2010, MACROMOL RAPID COMM, V31, P1317, DOI 10.1002/marc.201000021
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   Berg J. M., 2010, BIOCHEMISTRY
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Creighton T. E., 1993, PROTEINS STRUCTURES
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Dawson R. M. C., 1989, DATA BIOCH RES
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   HARIS PI, 1995, BIOPOLYMERS, V37, P251, DOI 10.1002/bip.360370404
   Haynie DT, 2004, LANGMUIR, V20, P4540, DOI 10.1021/la036330p
   Huang L, 2000, MACROMOLECULES, V33, P2989, DOI 10.1021/ma991858f
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Khadka DB, 2010, ACS APPL MATER INTER, V2, P2728, DOI 10.1021/am1006657
   Kim J, 2009, CHEM SOC REV, V38, P372, DOI 10.1039/b709883a
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Kumbar Sangamesh Q., 2008, Recent Patents on Biomedical Engineering, V1, P68
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   MaHam A, 2009, SMALL, V5, P1706, DOI 10.1002/smll.200801602
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McCullen SD, 2009, WIRES NANOMED NANOBI, V1, P369, DOI 10.1002/wnan.039
   Minato KI, 2006, MACROMOL BIOSCI, V6, P487, DOI 10.1002/mabi.200600066
   Ner Y, 2009, POLYMER, V50, P5828, DOI 10.1016/j.polymer.2009.09.017
   Nivison-Smith L, 2010, ACTA BIOMATER, V6, P354, DOI 10.1016/j.actbio.2009.08.011
   Park KE, 2006, INT J BIOL MACROMOL, V38, P165, DOI 10.1016/j.ijbiomac.2006.03.003
   PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0
   Reneker DH, 2008, POLYMER, V49, P2387, DOI 10.1016/j.polymer.2008.02.002
   Rihova B, 1996, ADV DRUG DELIVER REV, V21, P157
   Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182
   Sell SA, 2010, POLYMERS-BASEL, V2, P522, DOI 10.3390/polym2040522
   Shang SH, 2010, EUR CELLS MATER, V19, P180, DOI 10.22203/eCM.v019a18
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Sung HW, 2003, J BIOMED MATER RES A, V64A, P427, DOI 10.1002/jbm.a.10346
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Verreck G, 2003, PHARMACEUT RES, V20, P810, DOI 10.1023/A:1023450006281
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang YZ, 2006, POLYMER, V47, P2911, DOI 10.1016/j.polymer.2006.02.046
   Zhi ZL, 2004, MACROMOLECULES, V37, P8668, DOI 10.1021/ma049136y
NR 43
TC 12
Z9 13
U1 1
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD AUG
PY 2011
VL 3
IS 8
BP 2994
EP 3001
DI 10.1021/am200498r
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 810SH
UT WOS:000294146900026
PM 21761826
DA 2018-10-20
ER

PT J
AU Shin, YM
   Park, H
   Shin, H
AF Shin, Young Min
   Park, Hansoo
   Shin, Heungsoo
TI Enhancement of Cardiac Myoblast Responses onto Electrospun PLCL Fibrous
   Matrices Coated with Polydopamine for Gelatin Immobilization
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE surface modification; polydopamine; electrospinning; gelatin
ID MESENCHYMAL STEM-CELLS; SURFACE MODIFICATION; MYOCARDIAL TISSUE; WOUNDED
   HEART; ACRYLIC-ACID; REGENERATION; SCAFFOLDS; RADIATION; ADHESION;
   DIFFERENTIATION
AB A variety of surface modification techniques have been proposed to improve the cell-biomaterial interactions. On the other hand, these processes may cleave long-chained polymers, and compromise their mechanical properties. In this study, dopamine was used as a bridge molecule to immobilize gelatin on the poly(L-lactide-co-epsilon-caprolactone) (PLCL) fibrous matrices, which may then be used as a cell delivery carrier. The PLCL fibrous matrices coated with polydopamine by dipping (D-PLCL) can subsequently immobilize gelatin (GD-PLCL). The D-PLCL matrices showed minimal changes in the mechanical properties with a tensile strain of 251.0 +/- 33.4% and 247.8 +/- 32.1% before and after the coating process, respectively. The cellular activities on the fibrous matrices increased in the order of PLCL<G-PLCL<D-PLCL<GD-PLCL; the H9c2 myoblasts on the GD-PLCL matrices showed approximately two-times higher adhesion and spreading than those on the PLCL matrices, and the proliferation was significantly greater on the GD-PLCL matrices than on the other matrices. Therefore, polydopamine can effectively immobilize the bioactive functional groups on the surface of electrospun fibrous matrices for the development of a tissue specific cell delivery carrier.
C1 [Park, Hansoo] Chung Ang Univ, Dept Biomed Engn, Seoul 156756, South Korea.
   [Shin, Young Min; Shin, Heungsoo] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
   [Shin, Heungsoo] Hanyang Univ, Inst Bioengn & Biopharmaceut Res, Seoul 133791, South Korea.
   [Shin, Heungsoo] Hanyang Univ, Inst Aging Soc, Seoul 133791, South Korea.
RP Park, H (reprint author), Chung Ang Univ, Dept Biomed Engn, Seoul 156756, South Korea.
EM heyshoo@cau.ac.kr; hshin@hanyang.ac.kr
FU Ministry of Education, Science and Technology, Korea [R332009000100360]
FX This work was supported by the WCU program funded by the Ministry of
   Education, Science and Technology, Korea (R332009000100360).
CR Arafat MT, 2011, ACTA BIOMATER, V7, P809, DOI 10.1016/j.actbio.2010.09.010
   Bernsmann F, 2009, J PHYS CHEM C, V113, P8234, DOI 10.1021/jp901188h
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   Cheng ZY, 2004, BIOMATERIALS, V25, P1991, DOI 10.1016/j.biomaterials.2003.08.038
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Cui YL, 2003, J BIOMED MATER RES A, V66A, P770, DOI 10.1002/jbm.a.10071
   De Bartolo L, 2005, BIOMATERIALS, V26, P4432, DOI 10.1016/j.biomaterials.2004.11.009
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Fuchs JR, 2006, SURGERY, V140, P100, DOI 10.1016/j.surg.2006.01.016
   Gaudette GR, 2006, CIRCULATION, V114, P2575, DOI 10.1161/CIRCULATIONAHA.106.668707
   Gorna K, 2003, POLYM DEGRAD STABIL, V79, P465, DOI 10.1016/S0141-3910(02)00362-2
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   Gupta B, 2001, J APPL POLYM SCI, V82, P2629, DOI 10.1002/app.2115
   Hagege AA, 2001, HYPERTENSION, V38, P1413, DOI 10.1161/hy1201.099618
   He T, 2009, BIOMATERIALS, V30, P317, DOI 10.1016/j.biomaterials.2008.09.049
   Hwang CM, 2008, LANGMUIR, V24, P6845, DOI 10.1021/la800253b
   Jeong SI, 2004, BIOMATERIALS, V25, P5939, DOI 10.1016/j.biomaterials.2004.01.057
   Jeong SI, 2008, J BIOMAT SCI-POLYM E, V19, P339, DOI 10.1163/156856208783721029
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103
   Lee HS, 2009, APPL RADIAT ISOTOPES, V67, P1513, DOI 10.1016/j.apradiso.2009.02.053
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   Repoli MF, 2009, J CARDIOVASC MED, V10, P624, DOI 10.2459/JCM.0b013e328329ac77
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Shin YM, 2008, BIOMACROMOLECULES, V9, P1772, DOI 10.1021/bm701410g
   Shin YM, 2010, MACROMOL RES, V18, P472, DOI 10.1007/s13233-010-0507-z
   Sivagnanam V, 2008, MICROELECTRON ENG, V85, P1355, DOI 10.1016/j.mee.2007.12.043
   Urbanek K, 2005, P NATL ACAD SCI USA, V102, P8692, DOI 10.1073/pnas.0500169102
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   Zhu YB, 2002, BIOMACROMOLECULES, V3, P1312, DOI 10.1021/bm020074y
   Zimmermann WH, 2002, CIRCULATION, V106, pI151, DOI 10.1161/01.cir.0000032876.55215.10
NR 39
TC 12
Z9 12
U1 0
U2 45
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD AUG
PY 2011
VL 19
IS 8
BP 835
EP 842
DI 10.1007/s13233-011-0815-y
PG 8
WC Polymer Science
SC Polymer Science
GA 808FL
UT WOS:000293962500012
DA 2018-10-20
ER

PT J
AU Schaub, NJ
   Gilbert, RJ
AF Schaub, Nicholas J.
   Gilbert, Ryan J.
TI Controlled release of 6-aminonicotinamide from aligned, electrospun
   fibers alters astrocyte metabolism and dorsal root ganglia neurite
   outgrowth
SO JOURNAL OF NEURAL ENGINEERING
LA English
DT Article; Proceedings Paper
CT 39th Neural Interfaces Conference (NIC2010)
CY JUN, 2010
CL Long Beach, CA
ID FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD; IN-VITRO; POLYMER; GROWTH;
   CELLS; REGENERATION; NANOFIBERS; RAT; COMBINATION
AB Following central nervous system (CNS) injury, activated astrocytes form a glial scar that inhibits the migration of axons ultimately leading to regeneration failure. Biomaterials developed for CNS repair can provide local delivery of therapeutics and/or guidance mechanisms to encourage cell migration into damaged regions of the brain or spinal cord. Electrospun fibers are a promising type of biomaterial for CNS injury since these fibers can direct cellular and axonal migration while slowly delivering therapy to the injury site. In this study, it was hypothesized that inclusion of an anti-metabolite, 6-aminonicotinamide (6AN), within poly-L-lactic acid electrospun fibers could attenuate astrocyte metabolic activity while still directing axonal outgrowth. Electrospinning parameters were varied to produce highly aligned electrospun fibers that contained 10% or 20% (w/w) 6AN. 6AN release from the fiber substrates occurred continuously over 2 weeks. Astrocytes placed onto drug-releasing fibers were less active than those cultured on scaffolds without 6AN. Dorsal root ganglia placed onto control and drug-releasing scaffolds were able to direct neurites along the aligned fibers. However, neurite outgrowth was stunted by fibers that contained 20% 6AN. These results show that 6AN release from aligned, electrospun fibers can decrease astrocyte activity while still directing axonal outgrowth.
C1 [Schaub, Nicholas J.; Gilbert, Ryan J.] Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA.
   [Gilbert, Ryan J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
RP Gilbert, RJ (reprint author), Michigan Technol Univ, Dept Biomed Engn, Houghton, MI 49931 USA.
EM gilber2@rpi.edu
FU NINDS NIH HHS [R21NS62392, R21 NS062392]; NICHD NIH HHS [R15HD61096, R15
   HD061096]
CR Avola R, 2004, CLIN EXP HYPERTENS, V26, P323, DOI 10.1081/CEH-120034137
   BLAKEMORE WF, 1975, J NEUROCYTOL, V4, P745, DOI 10.1007/BF01181634
   Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720
   Chew SY, 2007, ADV FUNCT MATER, V17, P1288, DOI 10.1002/adfm.200600441
   Chow WN, 2007, NEURON GLIA BIOL, V3, P119, DOI 10.1017/S1740925X07000580
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Delgado-Rivera R, 2009, MATRIX BIOL, V28, P137, DOI 10.1016/j.matbio.2009.02.001
   FRIEDE RL, 1978, J NEUROL SCI, V35, P341, DOI 10.1016/0022-510X(78)90014-X
   Gertz CC, 2010, DEV NEUROBIOL, V70, P589, DOI 10.1002/dneu.20792
   Haghighat N, 1997, METAB BRAIN DIS, V12, P29, DOI 10.1007/BF02676352
   He LM, 2010, ACTA BIOMATER, V6, P2960, DOI 10.1016/j.actbio.2010.02.039
   Hothersall JS, 1998, FEBS LETT, V434, P97, DOI 10.1016/S0014-5793(98)00959-4
   HUNTING D, 1985, BIOCHEM PHARMACOL, V34, P3999, DOI 10.1016/0006-2952(85)90379-X
   KAUR C, 1993, HISTOL HISTOPATHOL, V8, P699
   Kim K, 2004, J CONTROL RELEASE, V98, P47, DOI 10.1016/j.jconrel.2004.04.009
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Moon LDF, 2001, EUR J NEUROSCI, V14, P1667, DOI 10.1046/j.0953-816x.2001.01795.x
   Natu MV, 2010, INT J PHARMACEUT, V397, P50, DOI 10.1016/j.ijpharm.2010.06.045
   POLITIS MJ, 1989, J NEUROL SCI, V92, P71, DOI 10.1016/0022-510X(89)90176-7
   Rasband WS, 1997, IMAGEJ
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Seggio AM, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046001
   Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326
   Smith GM, 2005, GLIA, V52, P209, DOI 10.1002/glia.20236
   Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002
   Sotelo C, 1967, Prog Brain Res, V25, P226
   Taylor AR, 2007, NAT PROTOC, V2, P1499, DOI 10.1038/nprot.2007.208
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004
   Xie JW, 2009, ACS NANO, V3, P1151, DOI 10.1021/nn900070z
   YARIN AL, 2000, J APPL PHYS, V87, P4531
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zeng Jing, 2003, Journal of Controlled Release, V92, P227, DOI 10.1016/S0168-3659(03)00372-9
NR 37
TC 19
Z9 20
U1 1
U2 17
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1741-2560
J9 J NEURAL ENG
JI J. Neural Eng.
PD AUG
PY 2011
VL 8
IS 4
SI SI
AR 046026
DI 10.1088/1741-2560/8/4/046026
PG 10
WC Engineering, Biomedical; Neurosciences
SC Engineering; Neurosciences & Neurology
GA 795GR
UT WOS:000292962800037
PM 21730749
DA 2018-10-20
ER

PT J
AU Tkachenko, MV
   Ol'khovik, LP
   Kamzin, AS
AF Tkachenko, M. V.
   Ol'khovik, L. P.
   Kamzin, A. S.
TI Magnetic ceramics based on hydroxyapatite modified by particles of
   M-type hexagonal ferrite for medical applications
SO PHYSICS OF THE SOLID STATE
LA English
DT Article
ID HYPERTHERMIC TREATMENT; BONE
AB Magnetic bioceramics based on hydroxyapatite Ca-5(PO4)(3)OH and particles of the M-type hexagonal (barium or calcium) ferrite with a high bioactivity and magnetic characteristics providing hyperthermal treatment of oncology diseases has been developed and studied. The phase composition, microstructure, and magnetic properties of the synthesized bioceramics have been determined. It has been shown that the synthesized biomaterial consists of the biocompatible matrix with the apatite structure into which particles of hexagonal ferrite are incorporated. The magnetic parameters of the synthesized ceramics are substantially higher than those of the bioglass ceramics modified by iron oxides that have been used in medicine, which suggests good potential and effectiveness of application of the created ceramics for medical purposes. Thus, a new class of magnetic bioceramics combining hydroxyapatite Ca-5(PO4)(3)OH, which exhibits good properties in biocompatibility and bioactivity, with particles of the M-type hexagonal ferrite, which possess high magnetic characteristics, has been created.
C1 [Tkachenko, M. V.; Ol'khovik, L. P.] Kharkov Natl Univ, UA-61077 Kharkov, Ukraine.
   [Kamzin, A. S.] Russian Acad Sci, Ioffe Phys Tech Inst, St Petersburg 194021, Russia.
RP Tkachenko, MV (reprint author), Kharkov Natl Univ, Maidan Svobody 4, UA-61077 Kharkov, Ukraine.
EM kamzin@mail.ioffe.ru
OI Tkachenko, Mykola/0000-0003-3174-0290
FU International Russian-Ukrainian project; Foundation for Basic Research
   of the Ministry of Education and Science of Ukraine [F 28/248-09];
   Russian Foundation for Basic Research [09-02-90447]
FX This study was carried out under the auspices of the International
   Russian-Ukrainian project (2009-2010) and supported by the Foundation
   for Basic Research of the Ministry of Education and Science of Ukraine
   (contract F 28/248-09) and the Russian Foundation for Basic Research
   (project no. 09-02-90447).
CR Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Hergt R, 1998, IEEE T MAGN, V34, P3745, DOI 10.1109/20.718537
   Kamzin AS, 1997, J EXP THEOR PHYS+, V84, P788, DOI 10.1134/1.558212
   Kawashita M, 2005, BIOMATERIALS, V26, P2231, DOI 10.1016/j.biomaterials.2004.07.014
   Leventouri T, 2005, BIOMATERIALS, V26, P4924, DOI 10.1016/j.biomaterials.2005.01.017
   Ol'khovik L. P., 2011, Bulletin of the Russian Academy of Sciences. Physics, V75, P281, DOI 10.3103/S1062873810031025
   Ol'khovik LP, 2010, TECH PHYS LETT+, V36, P756, DOI 10.1134/S1063785010080237
   Ol'khovik LP, 2010, LOW TEMP PHYS+, V36, P226, DOI 10.1063/1.3331495
   Ol'khovik L.P., 2010, UA Patent, Patent No. 54514
   Ol'khovik L.P., 2010, UA Patent, Patent No. [48 345, 48345]
   Roca AG, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224002
   Ruiz-Hernandez E, 2006, J BIOMED MATER RES A, V79A, P533, DOI 10.1002/jbm.a.30889
   Rusakov VS, 1999, IZV AKAD NAUK FIZ+, V63, P1389
   Singh RK, 2011, J MAGN MAGN MATER, V323, P330, DOI 10.1016/j.jmmm.2010.09.029
   Singh RK, 2010, CERAM INT, V36, P283, DOI 10.1016/j.ceramint.2009.07.028
   Thorek DLJ, 2006, ANN BIOMED ENG, V34, P23, DOI 10.1007/s10439-005-9002-7
   Zyman Z, 2001, J BIOMED MATER RES, V54, P256, DOI 10.1002/1097-4636(200102)54:2<256::AID-JBM13>3.3.CO;2-2
   Zyman Z, 2004, J MATER SCI-MATER M, V15, P551, DOI 10.1023/B:JMSM.0000026099.74563.db
   Zyman Z.Z., 2007, P INT C FUNCT MAT PA, P503
NR 20
TC 1
Z9 1
U1 2
U2 14
PU MAIK NAUKA/INTERPERIODICA/SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013-1578 USA
SN 1063-7834
EI 1090-6460
J9 PHYS SOLID STATE+
JI Phys. Solid State
PD AUG
PY 2011
VL 53
IS 8
BP 1588
EP 1593
DI 10.1134/S1063783411080294
PG 6
WC Physics, Condensed Matter
SC Physics
GA 804FR
UT WOS:000293640200009
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Jang, JH
   Schaffer, DV
   Shea, LD
AF Jang, Jae-Hyung
   Schaffer, David V.
   Shea, Lonnie D.
TI Engineering Biomaterial Systems to Enhance Viral Vector Gene Delivery
SO MOLECULAR THERAPY
LA English
DT Review
ID POLYETHYLENE-GLYCOL MODIFICATION; ANTIBODY-TETHERED ADENOVIRUS;
   POLYMER-COATED ADENOVIRUS; HUMORAL IMMUNE-RESPONSES; PHASE-I TRIAL;
   RECOMBINANT ADENOVIRUS; ADENOASSOCIATED VIRUS; PEGYLATED ADENOVIRUS;
   BONE REGENERATION; NEURITE EXTENSION
AB Integrating viral gene delivery with engineered biomaterials is a promising strategy to overcome a number of challenges associated with virus-mediated gene delivery, including inefficient delivery to specific cell types, limited tropism, spread of vectors to distant sites, and immune responses. Viral vectors can be combined with biomaterials either through encapsulation within the material or immobilization onto a material surface. Subsequent biomaterial-based delivery can increase the vector's residence time within the target site, thereby potentially providing localized delivery, enhancing transduction, and extending the duration of gene expression. Alternatively, physical or chemical modification of viral vectors with biomaterials can be employed to modulate the tropism of viruses or reduce inflammatory and immune responses, both of which may benefit transduction. This review describes strategies to promote viral gene delivery technologies using biomaterials, potentially providing opportunities for numerous applications of gene therapy to inherited or acquired disorders, infectious disease, and regenerative medicine.
C1 [Jang, Jae-Hyung] Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
   [Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.
   [Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.
   [Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.
RP Jang, JH (reprint author), Yonsei Univ, Dept Chem & Biomol Engn, Seoul 120749, South Korea.
EM j-jang@yonsei.ac.kr
RI Shea, Lonnie/B-7615-2009; Jang, Jae-Hyung/G-8030-2012
FU Korea government (MEST) through the Active Polymer Center for Pattern
   Integration [R11-2007-050-00000-0]; Seoul RBD Program [10816]; NIH
   [R01HL081527, RO1EB005678]
FX We acknowledge support from the National Research Foundation (NRF) grant
   funded by the Korea government (MEST) through the Active Polymer Center
   for Pattern Integration (No. R11-2007-050-00000-0) and the Seoul R&BD
   Program (10816). We also acknowledge funding from NIH (R01HL081527,
   RO1EB005678).
CR Abrahams JM, 2002, STROKE, V33, P1376, DOI 10.1161/01.STR.0000014327.03964.C0
   Alemany R, 2000, J GEN VIROL, V81, P2605, DOI 10.1099/0022-1317-81-11-2605
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Beer SJ, 1998, GENE THER, V5, P740, DOI 10.1038/sj.gt.3300647
   Bengali Z, 2005, BIOTECHNOL BIOENG, V90, P290, DOI 10.1002/bit.20393
   Breen A, 2006, J BIOMED MATER RES A, V78A, P702, DOI 10.1002/jbm.a.30735
   Breen AM, 2008, BIOMATERIALS, V29, P3143, DOI 10.1016/j.biomaterials.2008.04.020
   Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Champion JA, 2008, PHARM RES-DORDR, V25, P1815, DOI 10.1007/s11095-008-9562-y
   Chandler LA, 2000, WOUND REPAIR REGEN, V8, P473, DOI 10.1046/j.1524-475x.2000.00473.x
   Cheng X, 2003, PHARMACEUT RES, V20, P1444, DOI 10.1023/A:1025714412337
   CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075
   Cresce AV, 2008, MOL PHARMACEUT, V5, P891, DOI 10.1021/mp800054w
   Croyle MA, 2005, GENE THER, V12, P579, DOI 10.1038/sj.gt.3302441
   Croyle MA, 2001, J VIROL, V75, P4792, DOI 10.1128/JVI.75.10.4792-4801.2001
   Croyle MA, 2000, HUM GENE THER, V11, P1713, DOI 10.1089/10430340050111368
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   DAI YF, 1995, P NATL ACAD SCI USA, V92, P1401, DOI 10.1073/pnas.92.5.1401
   De Geest B, 2005, HUM GENE THER, V16, P1439
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   De Laporte L, 2010, ACTA BIOMATER, V6, P2889, DOI 10.1016/j.actbio.2010.02.018
   del Barrio GG, 2004, J CONTROL RELEASE, V94, P229, DOI 10.1016/j.conrel.2003.10.011
   DELGADO C, 1992, CRIT REV THER DRUG, V9, P249
   Diebold SS, 1999, J BIOL CHEM, V274, P19087, DOI 10.1074/jbc.274.27.19087
   Dong JY, 1996, HUM GENE THER, V7, P319, DOI 10.1089/hum.1996.7.3-319
   Doukas J, 2002, MOL THER, V5, P517, DOI 10.1006/mthe.2002.0579
   Doukas J, 2001, HUM GENE THER, V12, P783, DOI 10.1089/104303401750148720
   Drake DM, 2010, PHARM RES-DORDR, V27, P2457, DOI 10.1007/s11095-010-0238-z
   Edwards CK, 2003, ADV DRUG DELIVER REV, V55, P1315, DOI 10.1016/S0169-409X(03)00112-1
   Espenlaub S, 2008, J GENE MED, V10, P1303, DOI 10.1002/jgm.1262
   Eto Y, 2005, J GENE MED, V7, P604, DOI 10.1002/jgm.699
   Feng XD, 1999, J INVEST DERMATOL, V113, P913, DOI 10.1046/j.1523-1747.1999.00786.x
   Fisher KD, 2001, GENE THER, V8, P341, DOI 10.1038/sj.gt.3301389
   Gersbach CA, 2007, BIOMATERIALS, V28, P5121, DOI 10.1016/j.biomaterials.2007.07.047
   Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513
   Gonin P, 2004, GENE THER, V11, pS98, DOI 10.1038/sj.gt.3302378
   Green NK, 2008, J GENE MED, V10, P280, DOI 10.1002/jgm.1121
   Greish K, 2009, BIOMACROMOLECULES, V10, P2183, DOI 10.1021/bm900356j
   Gu DL, 2004, MOL THER, V9, P699, DOI 10.1016/j.ymthe.2004.02.018
   Gustafson J, 2009, J CONTROL RELEASE, V140, P256, DOI 10.1016/j.jconrel.2009.05.022
   Gustafson JA, 2010, MOL PHARMACEUT, V7, P1050, DOI 10.1021/mp100161u
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Hatefi A, 2007, PHARM RES, V24, P773, DOI 10.1007/s11095-006-9200-5
   Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107
   Hobson DA, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-4
   Hofherr SE, 2007, HUM GENE THER, V18, P837, DOI 10.1089/hum.2007.0051
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Houchin-Ray T, 2007, MOL THER, V15, P705, DOI 10.1038/mt.sj.6300106
   Houchin-Ray T, 2009, J NEUROSCI RES, V87, P844, DOI 10.1002/jnr.21908
   Hu WW, 2007, GENE THER, V14, P891, DOI 10.1038/sj.gt.3302940
   Ito H, 2005, NAT MED, V11, P291, DOI 10.1038/nm1190
   Jang JH, 2010, GENE THER, V17, P1384, DOI 10.1038/gt.2010.81
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9
   Kasman LM, 2009, MOL PHARMACEUT, V6, P1612, DOI 10.1021/mp9000958
   Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464
   Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8
   Kim PH, 2010, BIOMATERIALS, V31, P1865, DOI 10.1016/j.biomaterials.2009.11.043
   Kim TI, 2009, BIOMATERIALS, V30, P658, DOI 10.1016/j.biomaterials.2008.10.009
   Klugherz BD, 2002, HUM GENE THER, V13, P443, DOI 10.1089/10430340252792576
   Koerber JT, 2007, HUM GENE THER, V18, P367, DOI 10.1089/hum.2006.139
   Kreppel F, 2008, MOL THER, V16, P16, DOI 10.1038/sj.mt.6300321
   Lameiro MH, 2006, J BIOTECHNOL, V126, P152, DOI 10.1016/j.jbiotec.2006.04.030
   LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Le HT, 2005, J CONTROL RELEASE, V108, P161, DOI 10.1016/j.jconrel.2005.07.019
   Lee GK, 2005, BIOTECHNOL BIOENG, V92, P24, DOI 10.1002/bit.20562
   Levy RJ, 2001, GENE THER, V8, P659, DOI 10.1038/sj.gt.3301452
   Liao IC, 2009, J CONTROL RELEASE, V139, P48, DOI 10.1016/j.jconrel.2009.06.007
   Luo D, 2000, NAT BIOTECHNOL, V18, P893, DOI 10.1038/78523
   Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315
   Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5
   Marshall E, 2000, SCIENCE, V288, P242
   Matthews CB, 1999, GENE THER, V6, P1558, DOI 10.1038/sj.gt.3300978
   McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a
   McNeer NA, 2011, MOL THER, V19, P172, DOI 10.1038/mt.2010.200
   Mei L, 2006, J GENE MED, V8, P690, DOI 10.1002/jgm.912
   Mellott MB, 2001, BIOMATERIALS, V22, P929, DOI 10.1016/S0142-9612(00)00258-1
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Mingozzi F, 2007, BLOOD, V110, P2334, DOI 10.1182/blood-2007-03-080093
   Mittal SK, 2000, VACCINE, V19, P253, DOI 10.1016/S0264-410X(00)00170-5
   Moffatt S, 2000, VIROLOGY, V272, P159, DOI 10.1006/viro.2000.0350
   Mok H, 2005, MOL THER, V11, P66, DOI 10.1016/j.ymthe.2004.09.015
   Mok H, 2007, PHARM RES, V24, P2263, DOI 10.1007/s11095-007-9441-y
   Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135
   Nguyen EH, 2011, MACROMOL BIOSCI, V11, P483, DOI 10.1002/mabi.201000448
   Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109
   O'Riordan CR, 1999, HUM GENE THER, V10, P1349, DOI 10.1089/10430349950018021
   Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766
   Oh IK, 2006, BIOCONJUGATE CHEM, V17, P721, DOI 10.1021/bc060030c
   Pandori MW, 2002, VIROLOGY, V299, P204, DOI 10.1006/viro.2002.1510
   Pelled G, 2010, TISSUE ENG PART B-RE, V16, P13, DOI 10.1089/ten.teb.2009.0156
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Periwal SB, 1997, J VIROL, V71, P2844
   Phillips JE, 2008, P NATL ACAD SCI USA, V105, P12170, DOI [10.1073/pnas.0801988105, 10.1073/pnas.0B019BB105]
   Pirone DM, 2008, BIOMED MICRODEVICES, V10, P561, DOI 10.1007/s10544-008-9166-7
   Ramsey JD, 2010, J CONTROL RELEASE, V144, P39, DOI 10.1016/j.jconrel.2010.01.031
   Ranaldi G, 2002, J NUTR BIOCHEM, V13, P157, DOI 10.1016/S0955-2863(01)00208-X
   Raut SD, 2010, J CONTROL RELEASE, V144, P213, DOI 10.1016/j.jconrel.2010.02.009
   Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253
   Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7
   Sailaja G, 2002, GENE THER, V9, P1722, DOI 10.1038/sj.gt.3301858
   Sakai S, 2008, J TISSUE ENG REGEN M, V2, P164, DOI 10.1002/term.72
   Schek RM, 2004, MOL THER, V9, P130, DOI 10.1016/j.ymthe.2003.10.002
   Selkirk SM, 2004, POSTGRAD MED J, V80, P560, DOI 10.1136/pgmj.2003.017764
   Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X
   Sharif F, 2008, MOL THER, V16, P1674, DOI 10.1038/mt.2008.165
   Sharif F, 2006, HUM GENE THER, V17, P741, DOI 10.1089/hum.2006.17.741
   Shepard JA, 2010, J CONTROL RELEASE, V146, P128, DOI 10.1016/j.jconrel.2010.04.032
   Shin S, 2010, J BIOMED MATER RES A, V93A, P1252, DOI 10.1002/jbm.a.32619
   Shin SJ, 2010, BIOMATERIALS, V31, P4353, DOI 10.1016/j.biomaterials.2010.02.013
   Siemens DR, 2000, J NATL CANCER I, V92, P403, DOI 10.1093/jnci/92.5.403
   Singh R, 2008, ACS NANO, V2, P1040, DOI 10.1021/nn8000565
   Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166
   Stachelek SJ, 2004, GENE THER, V11, P15, DOI 10.1038/sj.gt.3302129
   Stankunas K, 2010, DEV BIOL, V347, P325, DOI 10.1016/j.ydbio.2010.08.030
   Stevenson M, 2007, CANCER GENE THER, V14, P335, DOI 10.1038/sj.cgt.7701022
   Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179
   Tayalia P, 2011, BIOMATERIALS, V32, P2634, DOI 10.1016/j.biomaterials.2010.12.019
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Turner P, 2007, BIOTECHNOL PROGR, V23, P423, DOI 10.1021/bp0600177
   Van den Bossche J, 2011, BIOMATERIALS, V32, P3085, DOI 10.1016/j.biomaterials.2010.12.043
   Waehler R, 2007, NAT REV GENET, V8, P573, DOI 10.1038/nrg2141
   Walter J, 1996, P NATL ACAD SCI USA, V93, P3056, DOI 10.1073/pnas.93.7.3056
   Wang D, 2007, J PHARM PHARM SCI, V10, P217
   YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
   Zhang YF, 2009, J CONTROL RELEASE, V136, P172, DOI 10.1016/j.jconrel.2009.02.016
NR 130
TC 63
Z9 64
U1 0
U2 41
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1525-0016
J9 MOL THER
JI Mol. Ther.
PD AUG
PY 2011
VL 19
IS 8
BP 1407
EP 1415
DI 10.1038/mt.2011.111
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA 800QL
UT WOS:000293378500004
PM 21629221
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Khan, OF
   Sefton, MV
AF Khan, Omar F.
   Sefton, Michael V.
TI Endothelialized biomaterials for tissue engineering applications in vivo
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID SMOOTH-MUSCLE-CELLS; VASCULAR GRAFTS; EXTRACELLULAR-MATRIX;
   SHEAR-STRESS; PHENOTYPIC HETEROGENEITY; ADHESION MOLECULES; HOST
   VASCULATURE; SCAFFOLDS; VITRO; ANGIOGENESIS
AB Rebuilding tissues involves the creation of a vasculature to supply nutrients and this in turn means that the endothelial cells (ECs) of the resulting endothelium must be a quiescent non-thrombogenic blood contacting surface. Such ECs are deployed on biomaterials that are composed of natural materials such as extracellular matrix proteins or synthetic polymers in the form of vascular grafts or tissue-engineered constructs. Because EC function is influenced by their origin, biomaterial surface chemistry and hemodynamics, these issues must be considered to optimize implant performance. In this review, we examine the recent in vivo use of endothelialized biomaterials and discuss the fundamental issues that must be considered when engineering functional vasculature.
C1 [Khan, Omar F.; Sefton, Michael V.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada.
   [Khan, Omar F.; Sefton, Michael V.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada.
   [Khan, Omar F.; Sefton, Michael V.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Sefton, MV (reprint author), Univ Toronto, Dept Chem Engn & Appl Chem, 200 Coll St, Toronto, ON M5S 3E5, Canada.
EM michael.sefton@utoronto.ca
RI Khan, Omar/G-6952-2014
OI Khan, Omar/0000-0003-3811-2369
FU Natural Sciences and Engineering Research Council; Canadian Institutes
   of Health Research; US National Institutes of Health [EB006903]; Ontario
   Graduate Scholarship Program
FX The authors acknowledge the financial support of the Natural Sciences
   and Engineering Research Council, the Canadian Institutes of Health
   Research and the US National Institutes of Health (EB006903). O.F.K.
   acknowledges scholarship support from the Ontario Graduate Scholarship
   Program.
CR Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a
   Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae
   ALBELDA SM, 1990, FASEB J, V4, P2868
   Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437
   Cenni E, 1997, BIOMATERIALS, V18, P489, DOI 10.1016/S0142-9612(96)00160-3
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chen XF, 2009, TISSUE ENG PT A, V15, P1363, DOI 10.1089/ten.tea.2008.0314
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a
   Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815
   Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643
   Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215
   Derham C, 2008, TISSUE ENG PT A, V14, P1871, DOI 10.1089/ten.tea.2007.0103
   Draget KI, 2011, FOOD HYDROCOLLOID, V25, P251, DOI 10.1016/j.foodhyd.2009.10.007
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Dye JF, 2004, ENDOTHELIUM-J ENDOTH, V11, P151, DOI 10.1080/10623320490512093
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Golden AP, 2007, LAB CHIP, V7, P720, DOI 10.1039/b618409j
   GRAHAM LM, 1980, ARCH SURG-CHICAGO, V115, P929
   Granchi D, 1998, BIOMATERIALS, V19, P93, DOI 10.1016/S0142-9612(97)00161-0
   Gupta R, 2009, TISSUE ENG PT A, V15, P2875, DOI [10.1089/ten.tea.2008.0494, 10.1089/ten.TEA.2008.0494]
   Hamada Y, 2007, DENT MATER J, V26, P487, DOI 10.4012/dmj.26.487
   Hordijk PL, 1999, J CELL SCI, V112, P1915
   Jacob MP, 2001, PATHOL BIOL, V49, P326, DOI 10.1016/S0369-8114(01)00151-1
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kang J, 2010, BLOOD, V116, P140, DOI 10.1182/blood-2009-11-252270
   Khan OF, 2011, J BIOMAT SCI-POLYM E, V22, P2499, DOI 10.1163/092050610X540693
   Khan OF, 2010, BIOMATERIALS, V31, P8254, DOI 10.1016/j.biomaterials.2010.07.041
   Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005
   Kyriakidou K, 2008, J BIOACT COMPAT POL, V23, P227, DOI 10.1177/0883911508091905
   L'Heureux N, 2007, NAT CLIN PRACT CARD, V4, P389, DOI 10.1038/ncpcardio0930
   LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203
   Landman KA, 2007, B MATH BIOL, V69, P2405, DOI 10.1007/s11538-007-9225-x
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Lee EJ, 2009, CELL TRANSPLANT, V18, P731, DOI 10.3727/096368909X470919
   Leung BM, 2007, ANN BIOMED ENG, V35, P2039, DOI 10.1007/s10439-007-9380-0
   Leung BM, 2010, TISSUE ENG PT A, V16, P3207, DOI [10.1089/ten.tea.2009.0746, 10.1089/ten.TEA.2009.0746]
   Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030
   Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107
   Maidhof R, 2010, BIOTECHNOL PROGR, V26, P565, DOI 10.1002/btpr.337
   Malda J, 2007, TISSUE ENG, V13, P2153, DOI 10.1089/ten.2006.0417
   MARGIOTTA MS, 1992, ANN SURG, V216, P600, DOI 10.1097/00000658-199211000-00013
   McGuigan AP, 2008, BIOMATERIALS, V29, P2453, DOI 10.1016/j.biomaterials.2008.02.010
   McGuigan AP, 2006, P NATL ACAD SCI USA, V103, P11461, DOI 10.1073/pnas.0602740103
   Miyagi Y, 2011, BIOMATERIALS, V32, P1280, DOI 10.1016/j.biomaterials.2010.10.007
   MIZUNO T, 2007, THROMB RES, V121, P855
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Noria S, 1999, CIRC RES, V85, P504, DOI 10.1161/01.RES.85.6.504
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Pober JS, 1999, IMMUNOL RES, V19, P225, DOI 10.1007/BF02786490
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   Serrano MC, 2009, ACTA BIOMATER, V5, P2045, DOI 10.1016/j.actbio.2009.02.034
   Shaikh FM, 2008, CELLS TISSUES ORGANS, V188, P333, DOI 10.1159/000139772
   Sieminski AL, 2008, J BIOMED MATER RES A, V87A, P494, DOI 10.1002/jbm.a.31785
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5
   Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9
   Sundstrom J, 2006, CURR OPIN LIPIDOL, V17, P45, DOI 10.1097/01.mol.0000203891.34890.b5
   Tang ZCW, 2011, BIOMATERIALS, V32, P75, DOI 10.1016/j.biomaterials.2010.08.085
   Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
   van der Zijpp YJT, 2003, J BIOMED MATER RES A, V65A, P51, DOI 10.1002/jbm.a.10327
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wieghaus KA, 2008, BIOMATERIALS, V29, P4698, DOI 10.1016/j.biomaterials.2008.08.029
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yao C, 2008, BIOMATERIALS, V29, P66, DOI 10.1016/j.biomaterials.2007.08.049
   Yu J, 2009, BIOMATERIALS, V30, P751, DOI 10.1016/j.biomaterials.2008.09.059
   Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107
   Zavan B, 2008, FASEB J, V22, P2853, DOI 10.1096/fj.08-107284
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhao YL, 2010, BIOMATERIALS, V31, P296, DOI 10.1016/j.biomaterials.2009.09.049
   ZILLA P, 1993, J CARDIAC SURG, V8, P32, DOI 10.1111/j.1540-8191.1993.tb00574.x
NR 82
TC 44
Z9 44
U1 2
U2 39
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD AUG
PY 2011
VL 29
IS 8
BP 379
EP 387
DI 10.1016/j.tibtech.2011.03.004
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 802BW
UT WOS:000293485300003
PM 21549438
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Mieszawska, AJ
   Llamas, JG
   Vaiana, CA
   Kadakia, MP
   Naik, RR
   Kaplan, DL
AF Mieszawska, Aneta J.
   Llamas, Jabier Gallego
   Vaiana, Christopher A.
   Kadakia, Madhavi P.
   Naik, Rajesh R.
   Kaplan, David L.
TI Clay enriched silk biomaterials for bone formation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk; Clay; Montmorillonite; Stem cells; Osteogenesis
ID LAYERED SILICATE NANOCOMPOSITES; DRUG-RELEASE; MODIFIED MONTMORILLONITE;
   MECHANICAL-PROPERTIES; AMINO-ACIDS; NANOCLAYS; GENOTOXICITY;
   OSTEOBLASTS; HYDROGELS; DELIVERY
AB The formation of silk protein/clay composite biomaterials for bone tissue formation is described. Silk fibroin serves as an organic scaffolding material offering mechanical stability suitable for bone-specific uses. Clay montmorillonite (Cloisite (R) Na+) and sodium silicate are sources of osteoinductive silica-rich inorganic species, analogous to bioactive bioglass-like bone repair biomaterial systems. Different clay particle-silk composite biomaterial films were compared with silk films doped with sodium silicate as controls for the support of human bone marrow derived mesenchymal stem cells in osteogenic culture. The cells adhered to and proliferated on the silk/clay composites over 2 weeks. Quantitative real time polymerase chain reaction analysis revealed increased transcript levels for alkaline phosphatase, bone sialoprotein, and collagen type 1 osteogenic markers in the cells cultured on the silk/clay films in comparison with the controls. Early evidence of bone formation based on collagen deposition at the cell-biomaterial interface was also found, with more collagen observed for the silk films with higher contents of clay particles. The data suggest that silk/clay composite systems may be useful for further study for bone regenerative needs. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Mieszawska, Aneta J.; Llamas, Jabier Gallego; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Vaiana, Christopher A.; Naik, Rajesh R.] USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA.
   [Vaiana, Christopher A.; Kadakia, Madhavi P.; Naik, Rajesh R.] Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
FU National Science Foundation [ECS-0335765]; NIH [DE017207, EB003210,
   EB002520]
FX This work was performed in part at the Center for Nanoscale Systems, a
   member of the National Nanotechnology Infrastructure Network at Harvard
   University, which is supported by the National Science Foundation under
   NSF Award No. ECS-0335765. The authors thank the NIH (DE017207,
   EB003210, EB002520) for support of the research. The authors also thank
   to Professor Carole C. Perry at Nottingham Trent University for
   performing ICP analysis.
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   Atai M, 2009, DENT MATER, V25, P339, DOI 10.1016/j.dental.2008.08.005
   Bombonato-Prado KF, 2009, J BIOMED MATER RES A, V88A, P401, DOI 10.1002/jbm.a.31701
   Campbell K, 2008, INT J PHARMACEUT, V363, P126, DOI 10.1016/j.ijpharm.2008.06.027
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Christodoulou L, 2006, J BIOMED MATER RES B, V77B, P431, DOI 10.1002/jbm.b.30455
   Depan D, 2009, ACTA BIOMATER, V5, P93, DOI 10.1016/j.aetbio.2008.08.007
   Drummy LF, 2007, SOFT MATTER, V3, P877, DOI 10.1039/b701220a
   Eglin D, 2005, BIO-MED MATER ENG, V15, P43
   Eglin D, 2006, J MATER CHEM, V16, P4220, DOI 10.1039/b606270a
   Giannelis EP, 1998, APPL ORGANOMET CHEM, V12, P675, DOI 10.1002/(SICI)1099-0739(199810/11)12:10/11<675::AID-AOC779>3.0.CO;2-V
   Haroun AA, 2009, J MATER SCI-MATER M, V20, P2527, DOI 10.1007/s10856-009-3818-x
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Katti DR, 2005, BIOMACROMOLECULES, V6, P3276, DOI 10.1021/bm0503219
   Katti K.S., 2008, BIOMED MATER, V3, P1, DOI DOI 10.1088/1748-6041/3/3/034122
   Katti KS, 2010, PHILOS T R SOC A, V368, P1963, DOI 10.1098/rsta.2010.0008
   Katti KS, 2006, LANGMUIR, V22, P532, DOI 10.1021/la051533u
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   LeBaron PC, 1999, APPL CLAY SCI, V15, P11, DOI 10.1016/S0169-1317(99)00017-4
   Lewkowitz-Shpuntoff HM, 2009, BIOMATERIALS, V30, P8, DOI 10.1016/j.biomaterials.2008.09.015
   Lin FH, 2006, BIOMATERIALS, V27, P3333, DOI 10.1016/j.biomaterials.2005.12.029
   Lin KF, 2005, J APPL POLYM SCI, V98, P2042, DOI 10.1002/app.22401
   Liu KH, 2008, ACTA BIOMATER, V4, P1038, DOI 10.1016/j.actbio.2008.01.012
   Lordan S, 2011, J APPL TOXICOL, V31, P27, DOI 10.1002/jat.1564
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Mieszawska AJ, 2010, BIOMATERIALS, V31, P8902, DOI 10.1016/j.biomaterials.2010.07.109
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Park JK, 2008, INT J PHARM, V359, P198, DOI 10.1016/j.ijpharm.2008.04.012
   Patel HA, 2006, B MATER SCI, V29, P133, DOI 10.1007/BF02704606
   de Abreu DAP, 2007, EUR POLYM J, V43, P2229, DOI 10.1016/j.eurpolymj.2007.01.021
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Say R, 2008, J HAZARD MATER, V150, P560, DOI 10.1016/j.jhazmat.2007.03.089
   Schins RPF, 2007, INHAL TOXICOL, V19, P189, DOI 10.1080/08958370701496202
   Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05
   Sharma AK, 2010, MUTAT RES-GEN TOX EN, V700, P18, DOI 10.1016/j.mrgentox.2010.04.021
   Sikdar D, 2006, POLYMER, V47, P5196, DOI 10.1016/j.polymer.2006.05.026
   Styan KE, 2008, J BIOMED MATER RES A, V86A, P571, DOI 10.1002/jbm.a.31667
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Ter Brugge PJ, 2002, TISSUE ENG, V8, P321, DOI 10.1089/107632702753725076
   Varanasi VG, 2009, ACTA BIOMATER, V5, P3536, DOI 10.1016/j.actbio.2009.05.035
   Wiles MC, 2005, CHEMOSPHERE, V59, P1455, DOI 10.1016/j.chemosphere.2004.12.022
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Wu ZG, 2002, J APPL POLYM SCI, V83, P2403, DOI 10.1002/app.10198
   Zhuang H, 2007, J MATER SCI-MATER M, V18, P951, DOI 10.1007/s10856-006-0093-y
NR 48
TC 37
Z9 37
U1 4
U2 69
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2011
VL 7
IS 8
BP 3036
EP 3041
DI 10.1016/j.actbio.2011.04.016
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 799BW
UT WOS:000293259500003
PM 21549864
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Schlichting, KE
   Copeland-Johnson, TM
   Goodman, M
   Lipert, RJ
   Prozorov, T
   Liu, XP
   McKinley, TO
   Lin, ZQ
   Martin, JA
   Mallapragada, SK
AF Schlichting, Kathryn E.
   Copeland-Johnson, Trishelle M.
   Goodman, Matthew
   Lipert, Robert J.
   Prozorov, Tanya
   Liu, Xunpei
   McKinley, Todd O.
   Lin, Zhiqun
   Martin, James A.
   Mallapragada, Surya K.
TI Synthesis of a novel photopolymerized nanocomposite hydrogel for
   treatment of acute mechanical damage to cartilage
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Nanocomposite; Hydrogel; Biomaterials; Injectable; Cartilage
ID CALCIUM-PHOSPHATE NANOCOMPOSITES; ARTICULAR-CARTILAGE; CHONDROCYTE
   DEATH; CELL-DEATH; DEGENERATIVE ARTHRITIS; PLATEAU FRACTURES; TIBIAL
   PLAFOND; IMPACT INJURY; MATRIX DAMAGE; SINGLE IMPACT
AB Intra-articular fractures initiate a cascade of pathobiological and pathomechanical events that culminate in post-traumatic osteoarthritis (PTOA). Hallmark features of PTOA include destruction of the cartilage matrix in combination with loss of chondrocytes and acute mechanical damage (AMD). Currently, treatment of intra-articular fractures essentially focuses completely on restoration of the macroanatomy of the joint. However, current treatment ignores AMD sustained by cartilage at the time of injury. We are exploring aggressive biomaterial-based interventions designed to treat the primary pathological components of AMD. This study describes the development of a novel injectable co-polymer solution that forms a gel at physiological temperatures that can be photocrosslinked, and can form a nanocomposite gel in situ through mineralization. The injectable co-polymer solution will allow the material to fill cracks in the cartilage after trauma. The mechanical properties of the nanocomposite are similar to those of native cartilage, as measured by compressive and shear testing. It thereby has the potential to mechanically stabilize and restore local structural integrity to acutely injured cartilage. Additionally, in situ mineralization ensures good adhesion between the biomaterial and cartilage at the interface, as measured through tensile and shear testing. Thus we have successfully developed a new injectable co-polymer which forms a nanocomposite in situ with mechanical properties similar to those of native cartilage, and which can bond well to native cartilage. This material has the potential to stabilize injured cartilage and prevent PTOA. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Liu, Xunpei; Mallapragada, Surya K.] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
   [Schlichting, Kathryn E.; Goodman, Matthew; Lin, Zhiqun; Mallapragada, Surya K.] Iowa State Univ, Dept Mat Sci & Engn, Ames, IA USA.
   [Copeland-Johnson, Trishelle M.] Univ S Florida, Dept Chem Engn, Tampa, FL 33620 USA.
   [Lipert, Robert J.] Iowa State Univ, Inst Combinatorial Discovery, Ames, IA USA.
   [McKinley, Todd O.; Martin, James A.] Univ Iowa, Dept Orthopaed Surg & Rehabil, Ames, IA 50011 USA.
   [Prozorov, Tanya; Mallapragada, Surya K.] Ames Lab, Div Mat Sci & Engn, Ames, IA USA.
RP Mallapragada, SK (reprint author), Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA.
EM suryakm@iastate.edu
RI Lin, Zhiqun/G-6136-2011; Mallapragada, Surya/F-9375-2012
FU NSF [EEC 0851519]; Department of Energy; University of Iowa Vice
   Provost's office; NIH
FX We would like to acknowledge Colin Paul who assisted with a lot of the
   initial work on this project through NSF-REU Grant EEC 0851519. We would
   like to acknowledge financial support from the Department of Energy's
   Science Undergraduate Laboratory Internship (DOE-SULI) program that
   supported Trishelle Cope-land-Johnson. Support from the University of
   Iowa Vice Provost's office and NIH CORT grant on Post-Traumatic
   Osteo-Arthritis is gratefully acknowledged.
CR Baars DC, 2006, BIOMECH MODEL MECHAN, V5, P133, DOI 10.1007/s10237-006-0024-3
   Bali D, 2003, AUST J CHEM, V56, P293, DOI 10.1071/CH02142
   Barei DP, 2006, J BONE JOINT SURG AM, V88A, P1713, DOI 10.2106/JBJS.E.00907
   Borrelli J, 2009, J ORTHOP RES, V27, P347, DOI 10.1002/jor.20760
   Bush PG, 2005, OSTEOARTHR CARTILAGE, V13, P54, DOI 10.1016/j.joca.2004.10.007
   Chen CT, 1999, J ORTHOP RES, V17, P870, DOI 10.1002/jor.1100170612
   Chen CT, 2001, J ORTHOPAED RES, V19, P703, DOI 10.1016/S0736-0266(00)00066-8
   Clements KM, 2004, OSTEOARTHR CARTILAGE, V12, P577, DOI 10.1016/j.joca.2004.04.006
   D'Lima DD, 2001, OSTEOARTHR CARTILAGE, V9, P712, DOI 10.1053/joca.2001.0468
   Duda GN, 2001, CLIN ORTHOP RELAT R, P302
   Enlow D, 2007, J MATER CHEM, V17, P1570, DOI 10.1039/b613760a
   Garrido CP, 2009, OSTEOARTHR CARTILAGE, V17, P1244, DOI 10.1016/j.joca.2009.03.007
   Green DM, 2006, ARTHRITIS RHEUM, V54, P1509, DOI 10.1002/art.21812
   Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162
   Hettrich CM, 2008, SPORTS MED ARTHROSC, V16, P230, DOI 10.1097/JSA.0b013e31818cdc98
   HONKONEN SE, 1995, J ORTHOP TRAUMA, V9, P273, DOI 10.1097/00005131-199509040-00001
   Hurtig M, 2009, J ORTHOP RES, V27, P602, DOI 10.1002/jor.20787
   Jeffrey JE, 2006, P I MECH ENG H, V220, P677, DOI 10.1243/09544119JEIM31
   Kanapathipillai M, 2008, CHEM MATER, V20, P5922, DOI 10.1021/cm703441n
   Krueger JA, 2003, J BIOMECH ENG-T ASME, V125, P114, DOI 10.1115/1.1536654
   Lewis JL, 2003, J ORTHOP RES, V21, P881, DOI 10.1016/S0736-0266(03)00039-1
   MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406
   Marsh JL, 2003, J BONE JOINT SURG AM, V85A, P287, DOI 10.2106/00004623-200302000-00016
   Martin JA, 2009, J BONE JOINT SURG AM, V91A, P1890, DOI 10.2106/JBJS.H.00545
   Matta JM, 1996, J BONE JOINT SURG AM, V78A, P1632, DOI 10.2106/00004623-199611000-00002
   Milentijevic D, 2003, J BIOMECH ENG-T ASME, V125, P594, DOI 10.1115/1.1610021
   Morel V, 2004, BIORHEOLOGY, V41, P509
   Narmoneva DA, 1999, J BIOMECH, V32, P401, DOI 10.1016/S0021-9290(98)00184-5
   OLSON SA, 1995, J BONE JOINT SURG AM, V77A, P1184, DOI 10.2106/00004623-199508000-00007
   OVADIA DN, 1986, J BONE JOINT SURG AM, V68A, P543, DOI 10.2106/00004623-198668040-00010
   VOLPIN G, 1990, J BONE JOINT SURG BR, V72, P634
   Yusufoglu Y, 2008, J MATER RES, V23, P3196, DOI 10.1557/JMR.2008.0388
   Zeng FQ, 2006, BIOCONJUGATE CHEM, V17, P399, DOI 10.1021/bc050350g
NR 33
TC 13
Z9 14
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD AUG
PY 2011
VL 7
IS 8
BP 3094
EP 3100
DI 10.1016/j.actbio.2011.04.010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 799BW
UT WOS:000293259500010
PM 21530694
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Morita, M
   Eckert, CE
   Matsuzaki, K
   Noma, M
   Ryan, LP
   Burdick, JA
   Jackson, BM
   Gorman, JH
   Sacks, MS
   Gorman, RC
AF Morita, Masato
   Eckert, Chad E.
   Matsuzaki, Kanji
   Noma, Mio
   Ryan, Liam P.
   Burdick, Jason A.
   Jackson, Benjamin M.
   Gorman, Joseph H., III
   Sacks, Michael S.
   Gorman, Robert C.
TI Modification of Infarct Material Properties Limits Adverse Ventricular
   Remodeling
SO ANNALS OF THORACIC SURGERY
LA English
DT Article
ID UNDERLYING MECHANICAL DYSFUNCTION; FINITE-ELEMENT MODEL;
   MYOCARDIAL-INFARCTION; TISSUE RESPONSES; BORDER ZONE; OVINE MODEL;
   EXPANSION; RESTRAINT; ANEURYSM; EXTENSION
AB Background. Infarct expansion after myocardial infarction (MI) is an important phenomenon that initiates and sustains adverse left ventricular (LV) remodeling. We tested the hypothesis that infarct modification by material-induced infarct stiffening and thickening limits infarct expansion and LV remodeling.
   Methods. Anteroapical infarction was induced in 21 sheep. Sheep were randomized to injection of saline (2.6 mL) or tissue filler material (2.6 mL) into the infarct within 3 hours of MI. Animals were monitored for 8 weeks with echocardiography to assess infarct expansion and global LV remodeling. Morphometric measurements were performed of excised hearts to quantify infarct thickness. Regional blood flow was assessed with colored microspheres. Infarct material properties were measured using biaxial tensile testing.
   Results. Compared with controls at 8 weeks, treatment animals had less infarct expansion, reduced LV dilatation (LV systolic volumes: 60.8 +/- 4.3 vs 80.3 +/- 6.9 mL; p < 0.05), greater ejection fraction (0.310 +/- 0.026 vs 0.276 +/- 0.013; p < 0.05), thicker infarcts (5.5 +/- 0.2 vs 2.2 +/- 0.3 mm; p < 0.05), and greater infarct blood flow (0.22 +/- 0.04 vs 0.11 +/- 0.03 mL/min/g; p < 0.05). The longitudinal peak strain in the treatment group was less (0.05014 +/- 0.0141) than the control group (0.1024 +/- 0.0101), indicating increased stiffness of the treated infarcts.
   Conclusions. Durable infarct thickening and stiffening can be achieved by infarct biomaterial injection, resulting in the amelioration of infarct expansion and global LV remodeling. Further material optimization will allow for clinical translation of this novel treatment paradigm. (Ann Thorac Surg 2011;92:617-25) (C) 2011 by The Society of Thoracic Surgeons ADULT CARDIAC
C1 Univ Penn, Dept Surg, Gorman Cardiovasc Res Grp, Philadelphia, PA 19104 USA.
   Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   Univ Pittsburgh, Sch Med, Engineered Tissue Mech & Mechanobiol Lab, Dept Bioengn,Swanson Sch Engn,McGowan Inst, Pittsburgh, PA USA.
RP Gorman, RC (reprint author), Univ Penn, Glenolden Res Lab, Gorman Cardiovasc Res Grp, 500 S Ridgeway Ave, Glenolden, PA 19036 USA.
EM gormanr@uphs.upenn.edu
RI Sacks, Michael/F-3703-2011
FU National Heart, Lung and Blood Institute of the National Institutes of
   Health, Bethesda, Maryland [HL63954, HL73021]; American Heart
   Association, Dallas, Texas
FX This research project was supported by grants from the National Heart,
   Lung and Blood Institute of the National Institutes of Health (HL63954
   and HL73021), Bethesda, Maryland. R. Gorman and J. Gorman are supported
   by individual Established Investigator Awards from the American Heart
   Association, Dallas, Texas.
CR Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   Blom AS, 2007, ANN THORAC SURG, V84, P2004, DOI 10.1016/j.athoracsur.2007.06.062
   Blom AS, 2005, CIRCULATION, V112, P1274, DOI 10.1161/CIRCULATIONAHA.104.499202
   BOGEN DK, 1980, CIRC RES, V47, P728, DOI 10.1161/01.RES.47.5.728
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   DROBECK HP, 1984, J ORAL MAXIL SURG, V42, P143, DOI 10.1016/S0278-2391(84)80024-5
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   ERLEBACHER JA, 1984, J AM COLL CARDIOL, V4, P201, DOI 10.1016/S0735-1097(84)80203-X
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Gorman RC, 2001, ANN THORAC SURG, V71, P662, DOI 10.1016/S0003-4975(00)02572-8
   Guccione JM, 2001, ANN THORAC SURG, V71, P654, DOI 10.1016/S0003-4975(00)02338-9
   GUPTA KB, 1994, CIRCULATION, V89, P2315, DOI 10.1161/01.CIR.89.5.2315
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jackson BM, 2002, J AM COLL CARDIOL, V40, P1160, DOI 10.1016/S0735-1097(02)02121-6
   Kanchwala SK, 2005, ANN PLAS SURG, V55, P30, DOI 10.1097/01.sap.0000168292.69753.73
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   KRAMER CM, 1993, CIRCULATION, V88, P1279, DOI 10.1161/01.CIR.88.3.1279
   Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li W, 2005, AM J PHYSIOL-HEART C, V288, pH408, DOI 10.1152/ajpheart.00176.2004
   MARKOVITZ LJ, 1989, ANN THORAC SURG, V48, P838, DOI 10.1016/0003-4975(89)90682-6
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   Morita M, 2011, ANN THORAC SURG, V92, P617, DOI 10.1016/j.athoracsur.2011.04.051
   Narula N, 2005, ANN THORAC SURG, V79, P1333, DOI 10.1016/j.athoracsur.2004.09.061
   Pilla JJ, 2009, ANN THORAC SURG, V87, P803, DOI 10.1016/j.athoracsur.2008.11.044
   Pilla JJ, 2005, ANN THORAC SURG, V80, P2257, DOI 10.1016/j.athoracsur.2005.05.089
   Pilla JJ, 2002, CIRCULATION, V106, pI207, DOI 10.1161/01.cir.0000032871.55215.de
   Ratcliffe MB, 2002, J AM COLL CARDIOL, V40, P1168, DOI 10.1016/S0735-1097(02)02113-7
   Ryan LP, 2009, ANN THORAC SURG, V87, P148, DOI 10.1016/j.athoracsur.2008.09.028
   Sacks MS, 2006, ANN THORAC SURG, V82, P1369, DOI 10.1016/j.athoracsur.2006.03.117
   SHIMIZU S, 1988, BIOMED RES-TOKYO, V9, P95
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Tzikas Thomas L, 2004, Arch Facial Plast Surg, V6, P234, DOI 10.1001/archfaci.6.4.234
   WEISMAN HF, 1987, PROG CARDIOVASC DIS, V30, P73, DOI 10.1016/0033-0620(87)90004-1
   Wilson EM, 2003, CIRCULATION, V107, P2857, DOI 10.1161/01.CIR.0000068375.40887.FA
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
NR 38
TC 35
Z9 36
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0003-4975
EI 1552-6259
J9 ANN THORAC SURG
JI Ann. Thorac. Surg.
PD AUG
PY 2011
VL 92
IS 2
BP 617
EP 625
DI 10.1016/j.athoracsur.2011.04.051
PG 9
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 798OX
UT WOS:000293221000039
PM 21801916
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zheng, ML
   Han, BQ
   Yang, Y
   Liu, WS
AF Zheng, Meiling
   Han, Baoqin
   Yang, Yan
   Liu, Wanshun
TI Synthesis, characterization and biological safety of O-carboxymethyl
   chitosan used to treat Sarcoma 180 tumor
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Carboxymethyl chitosan; Sarcoma 180; Tumor; Biological safety;
   Biomaterial
ID IN-VITRO EVALUATION; SKIN FIBROBLASTS; DRUG-DELIVERY; CHITIN;
   DERIVATIVES; CELLS; PROLIFERATION; SURFACTANTS; IRRITATION; COMPOSITE
AB Carboxymethyl chitosan (CM-chitosan) was prepared and characterized by FTIR and NMR spectroscopy, and its biological safety in tumor application was investigated both in vitro and in vivo. Cytotoxicity studies by MTT assay indicated that CM-chitosan was safe both on normal cell L02 and three tumor cell lines: Bel-7402, SGC-7901 and Hela in vitro. CM-chitosan also improved the TGF-alpha secretion of L02 cell (P < 0.05), whereas decreased levels of TGF-alpha and VEGF secreted by Bel-7402 cell (P < 0.05), which are compatible with the observations at cell levels. In vivo, transplant tumor model of sarcoma 180 was established in mice and CM-chitosan was administered through intraperitoneal injection. Experimental data indicated that CM-chitosan was safe in vivo and slightly inhibited growth of sarcoma 180 and enhanced body immunity via elevation of serum IL-2 and TNF-alpha levels in treated mice (P < 0.05). These results suggest that CM-chitosan is safe in tumor application as biomedical material. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zheng, Meiling; Han, Baoqin; Yang, Yan; Liu, Wanshun] Ocean Univ China, Coll Marine Life Sci, Qingdao 266003, Peoples R China.
RP Han, BQ (reprint author), Room 220,Sci Bldg,5 Yushan Rd, Qingdao, Peoples R China.
EM baoqinh@ouc.edu.cn
FU Ocean University of China; National High Technology Research and
   Development Program of China [2007AA091603]
FX This work was supported by Ocean University of China and by a grant from
   the National High Technology Research and Development Program of China
   (no. 2007AA091603).
CR Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   ANITHA A, 2010, CARBOHYDRATE POLYM
   Bidgoli H, 2010, CARBOHYD RES, V345, P2683, DOI 10.1016/j.carres.2010.09.024
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Chen XG, 2003, CARBOHYD POLYM, V53, P355, DOI 10.1016/S0144-8617(03)00051-1
   Chen XG, 2002, BIOMATERIALS, V23, P4609, DOI 10.1016/S0142-9612(02)00207-7
   Dong W, 2010, BIOMACROMOLECULES, V11, P1527, DOI 10.1021/bm100158p
   El Shafei A, 2011, CARBOHYD POLYM, V83, P920, DOI 10.1016/j.carbpol.2010.08.083
   El-Sherbiny IM, 2009, EUR POLYM J, V45, P199, DOI 10.1016/j.eurpolymj.2008.10.042
   Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55
   HENNEY CS, 1981, NATURE, V291, P335, DOI 10.1038/291335a0
   Jolles P., 1999, CHITIN CHITINASES
   Kubota N, 1997, POLYM J, V29, P123, DOI 10.1295/polymj.29.123
   Lanigan Rebecca S, 2002, Int J Toxicol, V21 Suppl 2, P95
   Lee JK, 2000, TOXICOL IN VITRO, V14, P345, DOI 10.1016/S0887-2333(00)00028-X
   Mathew ME, 2010, CARBOHYD POLYM, V80, P442, DOI 10.1016/j.carbpol.2009.11.047
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Muzzarelli RAA, 1998, CARBOHYD POLYM, V36, P267, DOI 10.1016/S0144-8617(98)00008-3
   MUZZARELLI RAA, 1982, CARBOHYD RES, V107, P199, DOI 10.1016/S0008-6215(00)80539-X
   MUZZARELLI RAA, 1984, CARBOHYD RES, V126, P225, DOI 10.1016/0008-6215(84)85380-X
   Muzzarelli RAA, 2010, MAR DRUGS, V8, P292, DOI 10.3390/md8020292
   Muzzarelli RAA, 2009, CARBOHYD POLYM, V76, P167, DOI 10.1016/j.carbpol.2008.11.002
   Paolino D, 2007, BIOMED MICRODEVICES, V9, P421, DOI 10.1007/s10544-007-9046-6
   Rasad MSBA, 2010, CARBOHYD POLYM, V79, P1094, DOI 10.1016/j.carbpol.2009.10.048
   Sanchez L, 2004, PHARM RES-DORDR, V21, P1637, DOI 10.1023/B:PHAM.0000041459.63362.6f
   SASHIWA H, 1990, INT J BIOL MACROMOL, V12, P295, DOI 10.1016/0141-8130(90)90016-4
   Shigemasa Y, 1996, INT J BIOL MACROMOL, V18, P237, DOI 10.1016/0141-8130(95)01079-3
   Shigemasa Y, 1996, BIOTECHNOL GENET ENG, V13, P383, DOI 10.1080/02648725.1996.10647935
   Sun LP, 2006, POLYMER, V47, P1796, DOI 10.1016/j.polymer.2006.01.073
   TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G
   WALDMANN TA, 1984, J EXP MED, V160, P1450, DOI 10.1084/jem.160.5.1450
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wang LC, 2007, J MATER SCI-MATER M, V18, P1125, DOI 10.1007/s10856-007-0159-5
   Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195
   Xia JL, 2005, J CENT SOUTH UNIV T, V12, P526, DOI 10.1007/s11771-005-0116-8
   Xu S., 1991, PHARM EXPT METHOD, P1424
   Zamani A, 2010, CARBOHYD POLYM, V80, P1091, DOI 10.1016/j.carbpol.2010.01.029
   Zhang LN, 2000, J APPL POLYM SCI, V77, P610, DOI 10.1002/(SICI)1097-4628(20000718)77:3<610::AID-APP16>3.0.CO;2-B
   Zhao X, 2001, INT J ADHES ADHES, V21, P227, DOI 10.1016/S0143-7496(01)00003-3
   Zhao ZP, 2002, DESALINATION, V144, P35, DOI 10.1016/S0011-9164(02)00285-0
   Zhu AP, 2005, BIOMACROMOLECULES, V6, P2607, DOI 10.1021/bm050328q
NR 41
TC 48
Z9 51
U1 5
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD AUG 1
PY 2011
VL 86
IS 1
BP 231
EP 238
DI 10.1016/j.carbpol.2011.04.038
PG 8
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 797HK
UT WOS:000293114900031
DA 2018-10-20
ER

PT J
AU Zhang, YL
   Yu, WQ
   Jiang, XQ
   Lv, KG
   Sun, SJ
   Zhang, FQ
AF Zhang, Yilin
   Yu, Weiqiang
   Jiang, Xinquan
   Lv, Kaige
   Sun, Shengjun
   Zhang, Fuqiang
TI Analysis of the cytotoxicity of differentially sized titanium dioxide
   nanoparticles in murine MC3T3-E1 preosteoblasts
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID IN-VITRO; TIO2 NANOPARTICLES; OXIDATIVE STRESS; EPITHELIAL-CELLS;
   SURFACE-AREA; OXIDE NANOPARTICLES; MAMMALIAN-CELLS; WEAR DEBRIS;
   PARTICLES; TOXICITY
AB There is an increased use of nanophase titanium dioxide (TiO2) in bone implants and scaffolds. However, nano-debris is generated at the bone-biomaterial interface. Therefore, TiO2 nanoparticles (NPs) of many sizes were investigated for cytotoxic effects on murine MC3T3-E1 preosteoblasts. These TiO2 NPs induced a time- and dose-dependent decrease in cell viability. There was a significant increase in lactate dehydrogenase (LDH) release, apoptosis and mitochondrial membrane permeability following short-term exposure of the cells to TiO2 NPs. These NPs also increased granulocyte-macrophage colony stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) gene expression. Compared with the 32 nm TiO2 NPs, 5 nm TiO2 NPs were more toxic, induced more apoptosis, increased mitochondrial membrane permeability and stimulated more GM-CSF expression at a high concentration (a parts per thousand yen100 mu g/ml). The results implied that the differential toxicity was associated with variations in size, so more attention should be given to the toxicity of small NPs for the design of future materials for implantation.
C1 [Zhang, Yilin; Yu, Weiqiang; Jiang, Xinquan; Lv, Kaige; Sun, Shengjun; Zhang, Fuqiang] Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China.
   [Jiang, Xinquan] Shanghai Jiao Tong Univ, Shanghai Res Inst Stomatol, Shanghai Key Lab Stomatol,Peoples Hosp 9, Oral Bioengn Lab,Sch Med, Shanghai 200011, Peoples R China.
RP Zhang, FQ (reprint author), Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Shanghai Key Lab Stomatol,Peoples Hosp 9, Shanghai 200030, Peoples R China.
EM fqzhang@vip.163.com
FU Shanghai Leading Academic Discipline Project [S30206, T0202]; Science
   and Technology Committee of Shanghai [08DZ2271100]
FX This work was supported by grants from the Shanghai Leading Academic
   Discipline Project (No. S30206, T0202) and the Science and Technology
   Committee of Shanghai (No. 08DZ2271100). The authors would like to thank
   Xiuli Zhang and Dongxia Ye (Oral Bioengineering Lab, Ninth People's
   Hospital, Shanghai Jiao Tong University School of Medicine) for their
   helpful assistance with the experiments.
CR Atkins GJ, 2009, BIOMATERIALS, V30, P3672, DOI 10.1016/j.biomaterials.2009.03.035
   Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242
   Bermudez E, 2004, TOXICOL SCI, V77, P347, DOI 10.1093/toxsci/kfh019
   Bhattacharya K, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-17
   Cheng YY, 2003, ULTRASTRUCT PATHOL, V27, P385, DOI 10.1080/01913120390248629
   Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y
   Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
   DARZYNKIEWICZ Z, 1992, CYTOMETRY, V13, P795, DOI 10.1002/cyto.990130802
   Di Virgilio AL, 2010, J HAZARD MATER, V177, P711, DOI 10.1016/j.jhazmat.2009.12.089
   Di Virgilio AL, 2010, J BIOMED MATER RES A, V92A, P80, DOI 10.1002/jbm.a.32339
   Engel E, 2008, TRENDS BIOTECHNOL, V26, P39, DOI 10.1016/j.tibtech.2007.10.005
   Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001
   Fritz EA, 2006, J BIOMED MATER RES A, V77A, P192, DOI 10.1002/jbm.a.30609
   Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102
   Gerhardt LC, 2007, J MATER SCI-MATER M, V18, P1287, DOI 10.1007/s10856-006-0062-5
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   Hashiguchi T, 1999, ARCH ORTHOP TRAUM SU, V119, P30, DOI 10.1007/s004020050350
   Hashimoto M, 2007, J MATER SCI-MATER M, V18, P661, DOI 10.1007/s10856-007-2317-1
   Hussain S, 2009, TOXICOLOGY, V260, P142, DOI 10.1016/j.tox.2009.04.001
   Hussain SM, 2005, TOXICOL IN VITRO, V19, P975, DOI 10.1016/j.tiv.2005.06.034
   Jeng HA, 2006, J ENVIRON SCI HEAL A, V41, P2699, DOI 10.1080/10934520600966177
   Jin CY, 2008, CHEM RES TOXICOL, V21, P1871, DOI 10.1021/tx800179f
   Karlsson HL, 2009, TOXICOL LETT, V188, P112, DOI 10.1016/j.toxlet.2009.03.014
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33
   Kong SJ, 2008, ENVIRON MOL MUTAGEN, V49, P399, DOI 10.1002/em.20399
   Liang GY, 2009, J TOXICOL ENV HEAL A, V72, P740, DOI 10.1080/15287390902841516
   Limbach LK, 2005, ENVIRON SCI TECHNOL, V39, P9370, DOI 10.1021/es051043o
   Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x
   Long TC, 2007, ENVIRON HEALTH PERSP, V115, P1631, DOI 10.1289/ehp.10216
   MacNee W, 2003, EUR RESPIR J, V21, p47S, DOI 10.1183/09031936.03.00403203
   Masoud A, 2009, CELL MOL NEUROBIOL, V29, P1245, DOI 10.1007/s10571-009-9420-4
   Monteiller C, 2007, OCCUP ENVIRON MED, V64, P609, DOI 10.1136/oem.2005.024802
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Oparaugo PC, 2001, ACTA ORTHOP SCAND, V72, P22, DOI 10.1080/000164701753606644
   Oropesa M, 2011, APOPTOSIS, V16, P404, DOI 10.1007/s10495-011-0577-1
   Palomaki J, 2010, TOXICOLOGY, V267, P125, DOI 10.1016/j.tox.2009.10.034
   Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park S, 2007, INHAL TOXICOL, V19, P59, DOI 10.1080/08958370701493282
   Phenrat T, 2007, ENVIRON SCI TECHNOL, V41, P284, DOI 10.1021/es0614349a
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Rahman Q, 2002, ENVIRON HEALTH PERSP, V110, P797, DOI 10.1289/ehp.02110797
   Renwick LC, 2004, OCCUP ENVIRON MED, V61, P442, DOI 10.1136/oem.2003.008227
   Rodrigo A, 2006, J ORTHOP RES, V24, P46, DOI 10.1002/jor.20007
   Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009
   Singh S, 2007, TOXICOL APPL PHARM, V222, P141, DOI 10.1016/j.taap.2007.05.001
   SLATER TF, 1963, BIOCHIM BIOPHYS ACTA, V77, P383, DOI 10.1016/0006-3002(63)90513-4
   Sterner T, 2004, BIOMED TECH, V49, P340, DOI 10.1515/BMT.2004.063
   Streicher RM, 2007, NANOMEDICINE-UK, V2, P861, DOI 10.2217/17435889.2.6.861
   Sun J, 2009, J BIOMED MATER RES A, V88A, P673, DOI 10.1002/jbm.a.31892
   Thevenot P, 2008, NANOMED-NANOTECHNOL, V4, P226, DOI 10.1016/j.nano.2008.04.001
   Thrall L, 2006, ENVIRON SCI TECHNOL, V40, P4327
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   Valles G, 2006, BIOMATERIALS, V27, P5199, DOI 10.1016/j.biomaterials.2006.05.045
   Wang JX, 2009, BIOMATERIALS, V30, P4590, DOI 10.1016/j.biomaterials.2009.05.008
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Wu JM, 2004, J AM CERAM SOC, V87, P1635, DOI 10.1111/j.1551-2916.2004.01635.x
   Xin X, 2011, HUM EXP TOXICOL, V30, P1062, DOI 10.1177/0960327110386815
   Yu WQ, 2010, J BIOMED MATER RES A, V94A, P1012, DOI 10.1002/jbm.a.32687
   Zhang F, 1998, J BIOMED MATER RES, V42, P128, DOI 10.1002/(SICI)1097-4636(199810)42:1<128::AID-JBM16>3.0.CO;2-H
   Zhao JS, 2009, J TOXICOL ENV HEAL A, V72, P1141, DOI 10.1080/15287390903091764
NR 64
TC 23
Z9 25
U1 1
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2011
VL 22
IS 8
BP 1933
EP 1945
DI 10.1007/s10856-011-4375-7
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 799PP
UT WOS:000293298900016
PM 21681655
DA 2018-10-20
ER

PT J
AU Muschin, T
   Han, SQ
   Kanamoto, T
   Nakashima, H
   Yoshida, T
AF Muschin, Tegshi
   Han, Shuqin
   Kanamoto, Taisei
   Nakashima, Hideki
   Yoshida, Takashi
TI Synthesis and Specific Influenza A Virus-Adsorptive Functionality of
   Alkyl Curdlan Sulfate-Coated Membrane Filter
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE adsorptive functionality; biological applications of polymers; curdlan
   sulfate; influenza A virus; membrane filter; polysaccharides; synthesis
ID HIV; POLYSACCHARIDES; INFECTION; ADSORBERS; SEQUENCE; CAPTURE; DRUG; NMR
AB To develop a biomaterial with an influenza virus-adsorptive functionality, an alkyl curdlan sulfate was prepared by ionic interaction between a positively charged didodecyldimethyl ammonium bromide and a negatively charged sulfate group of curdlan sulfate, which has potent anti-HIV activity, and then it was coated on a membrane filter with a 1-mu m pore size by hydrophobic interaction with the long alkyl groups in the curdlan sulfate. The alkyl curdlan sulfate with the degree of alkylation (DOA) of 0.03 (one didodecyldimethyl group/12 sugar residues with 36 hydroxyl or sulfate groups) showed potent anti-HIV activity in a 50% effective concentration (EC(50)) as low as 0.87 mu g/mL (standard curdlan sulfate EC(50) 0.3 mu g/mL), and the activity decreased with increasing DOA. A DOA higher than 0.1 (one didodecyldimethyl group/three sugar residues with nine hydroxyl or sulfate groups) gave no anti-HIV activity. Although both curdlan sulfate and alkyl curdlan sulfates did not inhibited infection of Madin-Darby canine kidney cells by influenza viruses, the alkyl curdlan sulfate-coated membrane filter was found to have a specific adsorptive functionality for influenza A virus in vitro. When 1.6 mg of the alkyl curdlan sulfate with the DOA of 0.03 was coated on a membrane filter (phi 13 mm; pore size, 1 mu m), three stacked alkyl curdlan sulfate-coated membrane filters dramatically decreased hemagglutination to 1/4-1/32. However, the membrane filter did not effectively remove on influenza B viruses, and thus a membrane filter without alkyl curdlan sulfate was not effective against influenza viruses. These results can therefore be presumed to demonstrate that the alkyl curdlan sulfate-coated membrane filter removed influenza A viruses by adsorption between the negatively charged sulfate groups and the positively charged envelope protein of the virus. (C) 2011 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 49: 3241-3247, 2011
C1 [Muschin, Tegshi; Yoshida, Takashi] Kitami Inst Technol, Dept Bio & Environm Chem, Kitami, Hokkaido 0908507, Japan.
   [Han, Shuqin] Inner Mongolia Univ, Coll Chem & Chem Engn, Hohhot 010021, Peoples R China.
   [Kanamoto, Taisei; Nakashima, Hideki] St Marianna Univ, Sch Med, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan.
RP Yoshida, T (reprint author), Kitami Inst Technol, Dept Bio & Environm Chem, 165 Koen Cho, Kitami, Hokkaido 0908507, Japan.
EM yoshida@chem.kitami-it.ac.jp
FU Japan Society for the Promotion of Science [21550199]; Kitami Institute
   of Technology
FX This research was partly supported by a Grant-in-Aid for Scientific
   Research (C) from Japan Society for the Promotion of Science 2009-2011
   (no. 21550199) and SVBL research program found of Kitami Institute of
   Technology 2009-2011.
CR GERBER P, 1958, P SOC EXP BIOL MED, V99, P590
   Gordon M, 1997, J MED, V28, P108
   Jagodzinski PP, 1996, VIROLOGY, V226, P217, DOI 10.1006/viro.1996.0649
   Jeon KJ, 2000, J AM CHEM SOC, V122, P12536, DOI 10.1021/ja001577j
   Jeon KJ, 1997, MACROMOLECULES, V30, P1997, DOI 10.1021/ma961392q
   KALBFUSS B, 2007, BIOTECHNOL BIOENG, V96, P932
   Kalbfuss B, 2007, J MEMBRANE SCI, V299, P251, DOI 10.1016/j.memsci.2007.04.048
   Kovensky J, 2009, CURR MED CHEM, V16, P2338, DOI 10.2174/092986709788453096
   LINDAHL U, 1983, J BIOL CHEM, V258, P9826
   Opitz L, 2009, BIOTECHNOL BIOENG, V103, P1144, DOI 10.1002/bit.22345
   Paulsen B. S., 2000, BIOACTIVE CARBOHYDRA
   PAUWELS R, 1988, J VIROL METHODS, V20, P309, DOI 10.1016/0166-0934(88)90134-6
   RAMALHOSANTOS J, 2001, BIOSCIENCE REP, V21, P294
   Sasaki K, 2003, BIOORG MED CHEM LETT, V13, P2821, DOI 10.1016/S0960-894X(03)00611-5
   SUZUKI Y, 2002, Patent No. 200258730
   WHO, 2002, WHO MAN AN INFL DIAG
   YOSHIDA O, 1988, BIOCHEM PHARMACOL, V37, P2887, DOI 10.1016/0006-2952(88)90272-9
   YOSHIDA T, 1990, MACROMOLECULES, V23, P3717, DOI 10.1021/ma00218a001
   Yoshida T, 2001, PROG POLYM SCI, V26, P379, DOI 10.1016/S0079-6700(00)00045-9
   Yoshida T., 2005, POLYSACCHARIDES STRU
   INFLUENZA RES DATABA
NR 21
TC 5
Z9 5
U1 0
U2 14
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD AUG 1
PY 2011
VL 49
IS 15
BP 3241
EP 3247
DI 10.1002/pola.24738
PG 7
WC Polymer Science
SC Polymer Science
GA 799IE
UT WOS:000293279500001
DA 2018-10-20
ER

PT J
AU Liu, XY
   Zhang, CC
   Xu, WL
   Liu, HT
   Ouyang, CX
AF Liu, Xiuying
   Zhang, Chaocan
   Xu, Weilin
   Liu, Hongtao
   Ouyang, Chenxi
TI Blend films of silk fibroin and water-insoluble polyurethane prepared
   from an ionic liquid
SO MATERIALS LETTERS
LA English
DT Article
DE Silk fibroin; Ionic liquid; Polyurethane; Biomaterials; Polymers;
   Composite materials
ID PHYSICAL-PROPERTIES; BIOMATERIAL; CELLULOSE; ACID
AB In order to blend the water-insoluble and biocompatible polyurethane (PU) with silk fibroin (SF) to prepare water-insoluble films as a biomaterial, the ionic liquid, 1-butyl-3-methylimidazolium chloride (BMIMCI), was used to prepare a SF/BMIMCI solution, which was directly blended with PU solution in N, N-dimethylformamide (DMF). Infrared spectroscopy indicated that the solution blending led to chemical bonding between the two polymers and a beta-sheet structure was the main conformation of SF in the films. The hydrophilicity of the films increased with the content of SF, based on contact angle measurements. The composite showed good blood compatibility in coagulation time tests and has potential biomaterial applications. (C) 2011 Published by Elsevier B.V.
C1 [Liu, Xiuying; Zhang, Chaocan] Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China.
   [Liu, Xiuying] Wuhan Text Univ, Coll Chem Engn, Wuhan 430073, Peoples R China.
   [Xu, Weilin; Liu, Hongtao] Wuhan Text Univ, Key Lab Green Proc & Funct Text New Text Mat, Minist Educ, Wuhan 430073, Peoples R China.
   [Ouyang, Chenxi] Huazhong Univ Sci & Technol, Union Hosp, Dept Vasc Surg, Tongji Med Coll, Wuhan 430022, Peoples R China.
RP Zhang, CC (reprint author), Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China.
EM polymers@whut.edu.cn; weilin_xu@wtu.edu.cn
FU National Natural Science Foundation of China [50873079]; Major State
   Basic Research Development Program of China (973 Program)
   [2009CB526402]; Wuhan Textile University [093921]
FX This work was supported by the National Natural Science Foundation of
   China (No. 50873079), the Major State Basic Research Development Program
   of China (973 Program) (No. 2009CB526402) and Wuhan Textile University
   (No. 093921).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   Hameed N, 2010, CELLULOSE, V17, P803, DOI 10.1007/s10570-010-9411-0
   Iizuka Eisaku, 1998, Journal of Sericultural Science of Japan, V67, P217
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Kuzmina OG, 2009, FIBRES TEXT EAST EUR, V17, P36
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   Liu XY, 2009, MATER LETT, V63, P263, DOI 10.1016/j.matlet.2008.10.006
   Moraes MA, 2010, POLYMERS, V2, P719, DOI DOI 10.3390/P0LYM2040719
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Sun XQ, 2009, AICHE J, V55, P2062, DOI 10.1002/aic.11797
   Tanaka T, 1998, POLYM INT, V45, P175, DOI 10.1002/(SICI)1097-0126(199802)45:2<175::AID-PI883>3.0.CO;2-K
   Tao YZ, 2010, ACTA POLYM SIN, P27
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P961, DOI 10.1002/polb.1994.090320519
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   VENYAMINOV SY, 1990, BIOPOLYMERS, V30, P1243, DOI 10.1002/bip.360301309
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K
   Wu RL, 2009, IND ENG CHEM RES, V48, P7132, DOI 10.1021/ie9001052
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
NR 23
TC 14
Z9 16
U1 5
U2 45
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD AUG
PY 2011
VL 65
IS 15-16
BP 2489
EP 2491
DI 10.1016/j.matlet.2011.05.017
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 797IP
UT WOS:000293118000053
DA 2018-10-20
ER

PT J
AU Zhang, YF
   Fan, W
   Nothdurft, L
   Wu, CT
   Zhou, YH
   Crawford, R
   Xiao, Y
AF Zhang, Yufeng
   Fan, Wei
   Nothdurft, Luke
   Wu, Chengtie
   Zhou, Yinghong
   Crawford, Ross
   Xiao, Yin
TI In Vitro and In Vivo Evaluation of Adenovirus Combined Silk Fibroin
   Scaffolds for Bone Morphogenetic Protein-7 Gene Delivery
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID MARROW STROMAL CELLS; TISSUE; DIFFERENTIATION; REGENERATION; EXPRESSION;
   DEFECTS; OSTEOBLASTS; IMPLANTS; BMP-2
AB Introduction and Aims: For a scaffold material to be considered effective and efficient for tissue engineering, it should be biocompatible and bioinductive. Silk fiber is a natural biocompatible material suitable for scaffold fabrication; however, silk is tissue conductive and lacks tissue-inductive properties. One proposed method to make the scaffold tissue inductive is to introduce plasmids or viruses encoding a specific growth factor into the scaffold. In this study, we constructed adenoviruses encoding bone morphogenetic protein-7 (BMP-7) and incorporated these into silk scaffolds. The osteoinductive and new bone formation properties of these constructs were assessed in vivo in a critical-sized skull defect animal model.
   Materials and Methods: Silk fibroin scaffolds containing adenovirus particles coding BMP-7 were prepared. The release of the adenovirus particles from the scaffolds was quantified by tissue-culture infective dose (TCID50), and the bioactivity of the released viruses was evaluated on human bone marrow mesenchymal stromal cells (BMSCs). To demonstrate the in vivo bone forming ability of the virus-carrying silk fibroin scaffold, the scaffold constructs were implanted into calvarial defects in SCID mice.
   Results: In vitro studies demonstrated that the virus-carrying silk fibroin scaffold released virus particles over a 3-week period while preserving their bioactivity. In vivo test of the scaffold constructs in critical-sized skull defect areas revealed that silk scaffolds were capable of delivering the adenovirus encoding BMP-7, resulting in significantly enhanced new bone formation.
   Conclusions: Silk scaffolds carrying BMP-7 encoding adenoviruses can effectively transfect cells and enhance both in vitro and in vivo osteogenesis. The findings of this study indicate that silk fibroin is a promising biomaterial for gene delivery to repair critical-sized bone defects.
C1 [Zhang, Yufeng; Fan, Wei; Wu, Chengtie; Zhou, Yinghong; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Zhang, Yufeng] Wuhan Univ, Sch Stomatol, Key Lab Oral Biomed Engn, Minist Educ, Wuhan 430072, Peoples R China.
RP Xiao, Y (reprint author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
EM yin.xiao@qut.edu.au
RI Nothdurft, Luke/B-4299-2011
OI Nothdurft, Luke/0000-0001-9646-9070; Crawford, Ross/0000-0001-6079-1316;
   Zhou, Yinghong/0000-0001-9757-7735; Xiao, Yin/0000-0003-1785-3491
FU National Health and Medical Research Council
FX Dr. Yufeng Zhang is funded by an Australian-China Exchange Postdoctoral
   Fellowship Scheme from National Health and Medical Research Council. The
   author would like to thank Mr. Thor Friis for his assistance in
   preparing this manuscript.
CR Bernhardt A, 2011, CLIN ORAL IMPLAN RES, V22, P651, DOI 10.1111/j.1600-0501.2010.02015.x
   Carpenter RS, 2010, J ORTHOP RES, V28, P1330, DOI 10.1002/jor.21126
   Deng XY, 2008, INT J CANCER, V122, P209, DOI 10.1002/ijc.23053
   Fowler JM, 2007, ANAL CHEM, V79, P350, DOI 10.1021/ac061175f
   Hassan KS, 2009, ORAL SURG ORAL MED O, V108, pE19, DOI 10.1016/j.tripleo.2009.07.023
   Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229
   Keogh MB, 2010, CELL TISSUE RES, V340, P169, DOI 10.1007/s00441-010-0939-y
   Koleganova VA, 2006, J BIOMED MATER RES A, V77A, P572, DOI 10.1002/jbm.a.30561
   Kutzler MA, 2003, THERIOGENOLOGY, V60, P299, DOI 10.1016/S0093-691X(02)01366-3
   Lecanda F, 1997, J CELL BIOCHEM, V67, P386, DOI 10.1002/(SICI)1097-4644(19971201)67:3<386::AID-JCB10>3.0.CO;2-B
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lian Z, 2010, J ORTHOP RES, V28, P412, DOI 10.1002/jor.20973
   Lin ZM, 2007, J ENDODONT, V33, P930, DOI 10.1016/j.joen.2007.03.010
   Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Nie H, 2009, BIOMATERIALS, V30, P892, DOI 10.1016/j.biomaterials.2008.10.029
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Renghini C, 2009, ACTA BIOMATER, V5, P1328, DOI 10.1016/j.actbio.2008.10.017
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Ugai H, 2005, BIOCHEM BIOPH RES CO, V331, P1053, DOI 10.1016/j.bbrc.2005.03.227
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Xiao Y, 2004, CELL TRANSPLANT, V13, P15, DOI 10.3727/000000004772664851
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Zhang YF, 2006, BIOCHEM BIOPH RES CO, V344, P362, DOI 10.1016/j.bbrc.2006.03.106
   Zhang YF, 2007, BIOMATERIALS, V28, P4635, DOI 10.1016/j.biomaterials.2007.07.009
NR 25
TC 34
Z9 37
U1 1
U2 20
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD AUG
PY 2011
VL 17
IS 8
BP 789
EP 797
DI 10.1089/ten.tec.2010.0453
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 799HW
UT WOS:000293278600001
PM 21506685
DA 2018-10-20
ER

PT J
AU Umemura, E
   Yamada, Y
   Nakamura, S
   Ito, K
   Hara, K
   Ueda, M
AF Umemura, Eri
   Yamada, Yoichi
   Nakamura, Sayaka
   Ito, Kenji
   Hara, Kenji
   Ueda, Minoru
TI Viable Cryopreserving Tissue-Engineered Cell-Biomaterial for Cell
   Banking Therapy in an Effective Cryoprotectant
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID PULP STEM-CELLS; VITRIFICATION PROPERTIES; ETHYLENE-GLYCOL;
   TECHNOLOGIES; SCAFFOLDS; EMBRYOS; BONE
AB The application of cell-biomaterial systems in tissue engineering and regenerative medicine is an important challenge in biomedicine, which preserves not only cells, but also tissue-engineered constructs. In this study, the constructs and cryoprotectant parameters were optimized, and it was evaluated whether the characteristics of dental pulp stem cells (DPSCs), which have high proliferation ability as stem cells, were maintained during encapsulation and cryopreservation. The optimal cell-biomaterial gel constructs with the gelation rate of 2% alginate: 100mM CaCO3: 200mM glucono-delta-lactone (GDL) = 4: 1: 1 and suitable cryoprotectants (CPAs) used for cryopreservation were Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% ethylene glycol (EG), 1.0M sucrose and 0.00075M polyvinylpyrrolidone (PVP). Optimality was confirmed by cell viability (trypan blue, live/dead analysis), the proliferation of DPSCs, and the microstructure using scanning electron microscopy (SEM) in the constructs, and surface epitope by flow cytometric analysis before and after cryopreservation. There were no visible differences in the structure. In conclusion, this study indicates that the optimal cell-biomaterial gel constructs and the cryoprotectant are promising biomaterials. The defined encapsulation/thawing system offers an excellent option for cell-banking therapy to be developed with ready-to-use viable biomaterials and patient-specific products as drug delivery systems.
C1 [Yamada, Yoichi] Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Showa Ku, Nagoya, Aichi 4668550, Japan.
   [Ito, Kenji; Hara, Kenji] Hamamatsu Kita Hosp, Shizuoka, Japan.
RP Yamada, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.
EM yyamada@med.nagoya-u.ac.jp
RI HARA, KENJI/B-1857-2016
FU Japan Society for the Promotion of Science [20659297, 21390507,
   21791848]
FX The authors are grateful to the members of the Department of Oral and
   Maxillofacial Surgery, Nagoya University Graduate School of Medicine,
   for discussions. This work was partly supported by Grants-in-Aid for
   Scientific Research (Nos. 20659297, 21390507, 21791848) from the Japan
   Society for the Promotion of Science.
CR Baust JM, 2002, CRYOBIOLOGY, V45, P97, DOI 10.1016/S0011-2240(02)00100-1
   Bhakta G, 2009, BIOMATERIALS, V30, P336, DOI 10.1016/j.biomaterials.2008.09.030
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4
   Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0
   Hunt NC, 2009, BIOMATERIALS, V30, P6435, DOI 10.1016/j.biomaterials.2009.08.014
   Keros V, 2009, HUM REPROD, V24, P1670, DOI 10.1093/humrep/dep079
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Kuleshova LL, 2007, BIOMATERIALS, V28, P1585, DOI 10.1016/j.biomaterials.2006.11.047
   Kuleshova LL, 1999, CRYOBIOLOGY, V38, P119, DOI 10.1006/cryo.1999.2153
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Matsumoto Y, 2001, JSME INT J C-MECH SY, V44, P937, DOI 10.1299/jsmec.44.937
   Mukaida T, 1998, HUM REPROD, V13, P2874, DOI 10.1093/humrep/13.10.2874
   Nakamura S, 2009, J ENDODONT, V35, P1536, DOI 10.1016/j.joen.2009.07.024
   Shaw JM, 1997, CRYOBIOLOGY, V35, P219, DOI 10.1006/cryo.1997.2043
   Sugiyama N, 2002, J SURG RES, V103, P236, DOI 10.1006/jsre.2002.6367
   Vanhoutte L, 2004, BIOL REPROD, V70, P1041, DOI 10.1095/biolreprod.103.020933
   Yamada Y, 2006, BIOMATERIALS, V27, P3766, DOI 10.1016/j.biomaterials.2006.02.009
   Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284
   Yamada Y, 2010, TISSUE ENG PT A, V16, P1891, DOI 10.1089/ten.TEA.2009.0732
   Zimmermann H, 2007, APPL PHYS A-MATER, V89, P909, DOI 10.1007/s00339-007-4270-8
NR 25
TC 14
Z9 15
U1 1
U2 16
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD AUG
PY 2011
VL 17
IS 8
BP 799
EP 807
DI 10.1089/ten.tec.2011.0003
PG 9
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 799HW
UT WOS:000293278600002
PM 21517691
DA 2018-10-20
ER

PT J
AU Mundada, AS
   Avari, JG
AF Mundada, A. S.
   Avari, J. G.
TI Novel biomaterial for transdermal application: in vitro and in vivo
   characterization
SO DRUG DELIVERY
LA English
DT Article
DE Damar Batu; Diltiazem hydrochloride; in vitro release; in vitro skin
   permeation; transdermal drug delivery system; pharmacokinetic study
ID DRUG-DELIVERY SYSTEMS; SKIN PERMEATION; CONTROLLED-RELEASE; POLYMERIC
   FILMS; DAMAR BATU; HYDROCHLORIDE; PINACIDIL; MODEL
AB The objective of the present study was to evaluate a novel film forming biomaterial for its potential application in the preparation of unilaminate transdermal adhesive matrix systems. The biomaterial, Damar Batu (DB), was tried alone and in combination with Eudragit RL100 as a matrixing agent in the preparation of transdermal patches. Developed transdermal patches of Diltiazem hydrochloride (DH) were evaluated for thickness uniformity, weight uniformity, folding endurance and drug content. USP dissolution apparatus V was used for in vitro drug release studies. Modified Franz diffusion cell used for permeation study using excised human cadaver skin. Total 6 formulations were developed and on the basis of in vitro drug release and in vitro skin permeation profile F5 composed of DB:Eudragit RL100 (60:40) and carrying 20 % w/w DH was selected as an optimized formulation for in vivo study. The in vivo study results showed that F5 achieved the Cmax of about 269.76 +/- 1.52 ng/mL in 6 h and sustained the release of the drug till 24 h. The skin irritation study results proved that the novel biomaterial is non-sensitizing and non-irritating. Drug-polymer interaction study carried out to check the compatibility of drug and polymer showed the intactness of the drug in the formulation proving the compatibility of the polymer. It can be proposed from the outcome of the present study that by applying suitable adhesive layer and backing membrane, DB:Eudragit RL100 (60:40) transdermal patches can be of potential therapeutic use.
C1 [Mundada, A. S.] SSDJ Coll Pharm, Neminagar 423101, Chandwad, India.
   [Mundada, A. S.; Avari, J. G.] RTM Nagpur Univ, Dept Pharmaceut Sci, Div Pharmaceut, Nagpur 440033, Maharashtra, India.
RP Mundada, AS (reprint author), SSDJ Coll Pharm, Neminagar 423101, Chandwad, India.
EM atishmundada@rediffmail.com
CR ANDRIEUSOLER C, 2005, MOLECULAR VISION, V11, pRD1
   Aqil M, 2004, PHARMAZIE, V59, P631
   Aqil M, 2002, EUR J PHARM BIOPHARM, V54, P161, DOI 10.1016/S0939-6411(02)00059-0
   Aqil Mohamed, 2003, Acta Pharmaceutica (Zagreb), V53, P119
   Ayalasomayajula SP, 2005, EUR J PHARMACOL, V511, P191, DOI 10.1016/j.ejphar.2005.02.019
   BERNER B, 1989, J PHARM SCI, V78, P402, DOI 10.1002/jps.2600780512
   BODMEIER R, 1990, J PHARM SCI, V79, P32, DOI 10.1002/jps.2600790109
   BONINA FP, 1993, INT J PHARM, V100, P41, DOI 10.1016/0378-5173(93)90073-O
   Chaurasia M, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070374
   Chien Y.W., 1992, NOVEL DRUG DELIVERY, P1
   CHIEN YW, 1984, DRUG DEV IND PHARM, V10, P575, DOI 10.3109/03639048409041408
   Chivate AA, 2008, AAPS PHARMSCITECH, V9, P197, DOI 10.1208/s12249-008-9039-7
   de Faria TJ, 2005, MACROMOL SYMP, V229, P228, DOI 10.1002/masy.200551128
   Draize JH, 1944, J PHARMACOL EXP THER, V82, P377
   Fialho SL, 2005, DRUG DELIV, V12, P109, DOI 10.1080/10717540590921432
   Guo JH, 1998, PHARM SCI TECHNOL TO, V1, P254, DOI 10.1016/S1461-5347(98)00072-8
   Huang SF, 2005, J OCUL PHARMACOL TH, V21, P445, DOI 10.1089/jop.2005.21.445
   Jain SK, 2003, DRUG DELIV, V10, P169, DOI 10.1080/10717540390215582
   Malafaya PB, 2007, ADV DRUG DELIVER REV, V59, P207, DOI 10.1016/j.addr.2007.03.012
   Mundada AS, 2009, DRUG DEV IND PHARM, V35, P1147, DOI 10.1080/03639040902882249
   Mundada AS, 2006, DRUG DEV IND PHARM, V32, P443, DOI 10.1080/03639040500534101
   Mundada AS, 2009, CHEM IND CHEM ENG Q, V15, P83, DOI 10.2298/CICEQ0902083M
   Mutalik S, 2004, J PHARM SCI-US, V93, P1577, DOI 10.1002/jps.20058
   Perepelkin KE, 2005, FIBRE CHEM+, V37, P417, DOI 10.1007/s10692-006-0014-3
   Rao PR, 2003, EUR J PHARM BIOPHARM, V56, P81, DOI 10.1016/S0939-6411(03)00038-9
   Rowe RC, 2006, HDB PHARM EXCIPIENTS, P553
   SARPOTDAR PP, 1986, J PHARM SCI, V75, P26, DOI 10.1002/jps.2600750107
   Satturwar P. M., 2003, AAPS PHARMSCITECH, V4, P1
   *US PHARM CONV, 1995, US PHARM, V23, P1796
   Varshosaz J, 2006, DRUG DELIV, V13, P113, DOI 10.1080/10717540500313356
NR 30
TC 4
Z9 4
U1 0
U2 13
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1071-7544
EI 1521-0464
J9 DRUG DELIV
JI Drug Deliv.
PD AUG
PY 2011
VL 18
IS 6
BP 424
EP 431
DI 10.3109/10717544.2011.577107
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 794EP
UT WOS:000292878600005
PM 21554152
OA Bronze
DA 2018-10-20
ER

PT J
AU Murali, R
   Anumary, A
   Ashokkumar, M
   Thanikaivelan, P
   Chandrasekaran, B
AF Murali, R.
   Anumary, A.
   Ashokkumar, M.
   Thanikaivelan, P.
   Chandrasekaran, B.
TI Hybrid Biodegradable Films from Collagenous Wastes and Natural Polymers
   for Biomedical Applications
SO WASTE AND BIOMASS VALORIZATION
LA English
DT Article
DE Tissue engineering; Hybrid biomaterial; SEM; Starch; Soy protein
AB Biopolymeric films have been the focus of research for the past few decades because they offer favorable advantages compared to synthetic polymeric films in the field of biomedical engineering. In this study, collagen (C) was extracted from skin waste using acetic acid and blended with starch (ST)/soy protein (SP) to prepare C/ST/SP hybrid films. The prepared hybrid films were examined for biocompatibility, physical and chemical properties. The results demonstrated that the strength properties of hybrid films increase as the composition of starch increases while elongation increases as the composition of soy protein increases. Thermogravimetric analysis of select hybrid films showed that the thermal stability of the hybrid films improved moderately. The infrared spectroscopy of hybrid films show functional groups associated with C, ST and SP. Scanning electron microscopy reveals that the hybrid films becomes smoother as the starch concentration increases while increasing soy protein concentration lead to roughness in the hybrid films. The equilibrium swelling, in vitro biodegradation and in vitro cytotoxicity studies show good biostability and biocompatibility for the hybrid films. Therefore, it is envisaged that the promising mechanical, thermal, swelling, biostability and biocompatibility properties of the developed hybrid films suggest a beneficial role for the biomedical applications.
C1 [Murali, R.; Anumary, A.; Ashokkumar, M.; Thanikaivelan, P.; Chandrasekaran, B.] CSIR, Cent Leather Res Inst, Ctr Leather Apparel & Accessories Dev, Adv Mat Lab, Madras 600020, Tamil Nadu, India.
RP Thanikaivelan, P (reprint author), CSIR, Cent Leather Res Inst, Ctr Leather Apparel & Accessories Dev, Adv Mat Lab, Madras 600020, Tamil Nadu, India.
EM thanik8@yahoo.com; cladclri@yahoo.com
RI Ashokkumar, Muthupandian/B-1739-2013
OI Ashokkumar, Muthupandian/0000-0002-8442-1499; Meiyazhagan,
   AshokKumar/0000-0002-9765-4347
FU Council of Scientific and Industrial Research (CSIR), India
FX The authors gratefully thank Council of Scientific and Industrial
   Research (CSIR), India for their financial support under Young Scientist
   Award project. The authors also wish to thank Dr. A.B. Mandal, Director,
   Central Leather Research Institute, India for his constant
   encouragement.
CR Anumary A., SOFT MAT IN PRESS
   Auger FA, 1998, MED BIOL ENG COMPUT, V36, P801, DOI 10.1007/BF02518887
   Barbani N., 1996, J BIOMAT SCI-POLYM E, V7, P461
   BERGSMA EJ, 1993, J ORAL MAXIL SURG, V51, P666, DOI 10.1016/S0278-2391(10)80267-8
   Bergsma EJ, 1995, BIOMATERIALS, V16, P25
   Boesel LF, 2004, J MATER SCI-MATER M, V15, P73, DOI 10.1023/B:JMSM.0000010100.07715.eb
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   BOYCE ST, 1988, J BIOMED MATER RES, V22, P939, DOI 10.1002/jbm.820221008
   BRADLEY WG, 1977, BIOMATER ARTIF CELL, V5, P159, DOI 10.3109/10731197709118671
   Brand KE, 1987, U.S. Patent, Patent No. [4,704,289, 4704289]
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Chiellini E, 2001, BIOMACROMOLECULES, V2, P806, DOI 10.1021/bm015519h
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Elvira C, 2002, BIOMATERIALS, V23, P1955, DOI 10.1016/S0142-9612(01)00322-2
   Espigares I, 2002, BIOMATERIALS, V23, P1883, DOI 10.1016/S0142-9612(01)00315-5
   Fang M., 2002, CARBOHYD POLYM, V47, P245
   Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Gomes ME, 2002, MAT SCI ENG C-BIO S, V20, P19, DOI 10.1016/S0928-4931(02)00008-5
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   HARDY PM, 1976, J CHEM SOC PERK T 1, P958, DOI 10.1039/p19760000958
   HARDY PM, 1979, J CHEM SOC PERK T 1, P2282, DOI 10.1039/p19790002282
   Hua YF, 2003, FOOD HYDROCOLLOID, V17, P889, DOI 10.1016/S0268-005X(03)00110-3
   Huang LLH, 1998, J BIOMED MATER RES, V39, P630, DOI 10.1002/(SICI)1097-4636(19980315)39:4<630::AID-JBM18>3.3.CO;2-U
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lee KY, 1998, J CONTROL RELEASE, V51, P213, DOI 10.1016/S0168-3659(97)00173-9
   LEE LLH, 1990, J BIOMED MAT, V24, P1185
   Leonor IB, 2002, J MATER SCI-MATER M, V13, P939, DOI 10.1023/A:1019800411229
   LEVY RJ, 1986, AM J PATHOL, V122, P71
   Li GY, 2004, J SOC LEATH TECH CH, V88, P66
   Luyn M.J.A.V., 1992, BIOMATERIALS, V13, P1017
   LUYN MJA, 1992, J BIOMED MATER RES, V26, P1091
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Maeda M, 2001, J CONTROL RELEASE, V77, P261, DOI 10.1016/S0168-3659(01)00512-0
   Malafaya PB, 2001, J BIOMAT SCI-POLYM E, V12, P1227, DOI 10.1163/156856201753395761
   Marques AP, 2005, MACROMOL BIOSCI, V5, P775, DOI 10.1002/mabi.200500010
   Mo XQ, 2001, IND CROP PROD, V14, P1, DOI 10.1016/S0926-6690(00)00083-2
   Mohd Nasir N. F., 2006, AM J BIOCH BIOTECHNO, V2, P175
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   Pereira CS, 1998, J MATER SCI-MATER M, V9, P825, DOI 10.1023/A:1008944127971
   Reddi AH, 2000, TISSUE ENG, V6, P351, DOI 10.1089/107632700418074
   REHM KE, 1994, BIODEGRADABLE IMPLAN, P54
   Reis R.L., 1998, BIOCERAMICS, P169
   Reis R. L., 1997, MED PLAST BIOMATER, V4, P46
   Reis R.L., 2000, J APPL MED POLYM, V4, P1
   Rhim JW, 1998, IND CROP PROD, V8, P195, DOI 10.1016/S0926-6690(98)00003-X
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Schmidt V, 2005, POLYM DEGRAD STABIL, V87, P25, DOI 10.1016/j.polymdegradstab.2004.07.003
   Shanmugasundaram N, 2001, BIOMATERIALS, V22, P1943, DOI 10.1016/S0142-9612(00)00220-9
   SHANTHA KL, 1995, BIOMATERIALS, V16, P1313, DOI 10.1016/0142-9612(95)91046-2
   Silva SS, 2007, CARBOHYD POLYM, V70, P25, DOI 10.1016/j.carbpol.2007.02.023
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Sousa RA, 2000, J APPL POLYM SCI, V77, P1303, DOI 10.1002/1097-4628(20000808)77:6<1303::AID-APP15>3.0.CO;2-1
   SOUSA RA, 2000, BIOCERAMICS, V192, P669
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Sripriya R, 2011, REACT FUNCT POLYM, V71, P62, DOI 10.1016/j.reactfunctpolym.2010.11.005
   Thanikaivelan P, 2002, ENVIRON SCI TECHNOL, V36, P4187, DOI 10.1021/es025618i
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   Tonkova E.V., 2007, CURR MICROBIOL, V54, P54
   Vaz CM, 2003, J BIOMED MATER RES A, V65A, P60, DOI 10.1002/jbm.a.10416
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Were L, 1999, J FOOD SCI, V64, P514, DOI 10.1111/j.1365-2621.1999.tb15074.x
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 73
TC 17
Z9 17
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1877-2641
EI 1877-265X
J9 WASTE BIOMASS VALORI
JI Waste Biomass Valorization
PD AUG
PY 2011
VL 2
IS 3
BP 323
EP 335
DI 10.1007/s12649-011-9072-8
PG 13
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA V36ET
UT WOS:000209196700009
DA 2018-10-20
ER

PT J
AU Roccuzzo, M
   Bonino, F
   Bonino, L
   Dalmasso, P
AF Roccuzzo, Mario
   Bonino, Francesca
   Bonino, Luca
   Dalmasso, Paola
TI Surgical therapy of peri-implantitis lesions by means of a
   bovine-derived xenograft: comparative results of a prospective study on
   two different implant surfaces
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE biomaterial; bone substitute; defect fill; peri-implantitis; surgical
   treatment
ID 3-YEAR CLINICAL-TRIAL; SHAPED ORAL IMPLANTS; ACID-ETCHED SURFACE;
   RE-OSSEOINTEGRATION; FOLLOW-UP; BONE LOSS; REGENERATIVE TREATMENT;
   NONSURGICAL TREATMENT; BIO-OSS(R) COLLAGEN; PROSPECTIVE COHORT
AB Objectives: The aim of this prospective study was to evaluate a regenerative surgical treatment modality for peri-implantitis lesions on two different implant surfaces.
   Materials and Methods: Twenty-six patients with one crater-like defect, around either TPS (Control) or SLA (Test) dental implants, with a probing depth (PD) >= 6 mm and no implant mobility, were included. The implant surface was mechanically debrided and treated using a 24% EDTA gel and a 1% chlorhexidine gel. The bone defect was filled with a bovine-derived xenograft (BDX) and the flap was sutured around the non-submerged implant.
   Results: One-year follow-up demonstrated clinical and radiographic improvements. PDs were significantly reduced by 2.1 +/- 1.2 mm in the Control implants and by 3.4 +/- 1.7 mm in the Test implants. Complete defect fill was never found around Controls, while it occurred in three out of 12 Test implants. Bleeding on probing decreased from 91.1 +/- 12.4% (Control) and 75.0 +/- 30.2% (Test) to 57.1 +/- 38.5% (p = 0.004) and 14.6 +/- 16.7% (p = 0.003), respectively. Several deep pockets (>= 6 mm) were still present after surgical therapy around Controls.
   Conclusions: Surface characteristics may have an impact on the clinical outcome following surgical debridement, disinfection of the contaminated surfaces and grafting with BDX. Complete fill of the bony defect seems not to be a predictable result.
C1 [Roccuzzo, Mario; Bonino, Francesca; Bonino, Luca] Private Practice, Turin, Italy.
   [Roccuzzo, Mario] Univ Turin, Dept Maxillofacial Surg, Turin, Italy.
   [Dalmasso, Paola] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy.
RP Roccuzzo, M (reprint author), Corso Tassoni 14, I-10143 Turin, Italy.
EM mroccuzzo@iol.it
RI Dalmasso, Paola/F-8555-2013
OI Dalmasso, Paola/0000-0001-6081-6966
FU Institut Straumann AG; Geistlich Pharma AG
FX Mario Roccuzzo received grants and travel funds from Institut Straumann
   AG and Geistlich Pharma AG.
CR Albouy JP, 2011, J CLIN PERIODONTOL, V38, P58, DOI 10.1111/j.1600-051X.2010.01631.x
   Araujo MG, 2011, CLIN ORAL IMPLAN RES, V22, P1, DOI 10.1111/j.1600-0501.2010.01920.x
   Araujo MG, 2009, CLIN ORAL IMPLAN RES, V20, P433, DOI 10.1111/j.1600-0501.2009.01705.x
   Behneke A, 2000, INT J ORAL MAX IMPL, V15, P125
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Bornstein MM, 2005, CLIN ORAL IMPLAN RES, V16, P631, DOI 10.1111/j.1600-0501.2005.01209.x
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   Claffey N, 2008, J CLIN PERIODONTOL, V35, P316, DOI 10.1111/j.1600-051X.2008.01277.x
   Esposito M., 2010, COCHRANE DB SYST REV, V6
   Fiorellini J P, 1994, Periodontol 2000, V4, P98, DOI 10.1111/j.1600-0757.1994.tb00010.x
   Fransson C, 2009, J CLIN PERIODONTOL, V36, P357, DOI 10.1111/j.1600-051X.2009.01375.x
   Gosau M, 2010, CLIN ORAL IMPLAN RES, V21, P866, DOI 10.1111/j.1600-0501.2009.01908.x
   Khoury F, 2001, J PERIODONTOL, V72, P1498, DOI 10.1902/jop.2001.72.11.1498
   Koldsland OC, 2010, J PERIODONTOL, V81, P231, DOI 10.1902/jop.2009.090269
   Kotsovilis S, 2008, J CLIN PERIODONTOL, V35, P621, DOI 10.1111/j.1600-051X.2008.01240.x
   Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x
   LANG NP, 1990, J CLIN PERIODONTOL, V17, P714, DOI 10.1111/j.1600-051X.1990.tb01059.x
   Leonhardt A, 2003, J PERIODONTOL, V74, P1415, DOI 10.1902/jop.2003.74.10.1415
   Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x
   Mombelli A, 1998, PERIODONTOL 2000, V17, P63, DOI 10.1111/j.1600-0757.1998.tb00124.x
   Parlar A, 2009, CLIN ORAL IMPLAN RES, V20, P391, DOI 10.1111/j.1600-0501.2008.01655.x
   Persson LG, 2001, CLIN ORAL IMPLAN RES, V12, P595, DOI 10.1034/j.1600-0501.2001.120607.x
   Renvert S, 2008, J CLIN PERIODONTOL, V35, P305, DOI 10.1111/j.1600-051X.2008.01276.x
   Renvert S, 2011, J CLIN PERIODONTOL, V38, P214, DOI 10.1111/j.1600-051X.2010.01661.x
   Renvert S, 2009, CLIN ORAL IMPLAN RES, V20, P216, DOI 10.1111/j.1600-0501.2009.01786.x
   Roccuzzo M, 2001, CLIN ORAL IMPLAN RES, V12, P572, DOI 10.1034/j.1600-0501.2001.120604.x
   Roccuzzo M, 2008, CLIN ORAL IMPLAN RES, V19, P148, DOI 10.1111/j.1600-0501.2007.01426.x
   Roccuzzo M, 2010, CLIN ORAL IMPLAN RES, V21, P490, DOI 10.1111/j.1600-0501.2009.01886.x
   Romeo E, 2005, CLIN ORAL IMPLAN RES, V16, P9, DOI 10.1111/j.1600-0501.2004.01084.x
   Romeo E, 2007, CLIN ORAL IMPLAN RES, V18, P179, DOI 10.1111/j.1600-0501.2006.01318.x
   Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600.051X.2006.00906.x
   Roos-Jansaker AM, 2007, J CLIN PERIODONTOL, V34, P723, DOI 10.1111/j.1600-051X.2007.01098.x
   Roos-Jansaker AM, 2007, J CLIN PERIODONTOL, V34, P625, DOI 10.1111/j.1600-051X.2007.01102.x
   Sahrmann P, 2011, CLIN IMPLANT DENT R, V13, P46, DOI 10.1111/j.1708-8208.2009.00183.x
   Schou S, 2003, CLIN ORAL IMPLAN RES, V14, P412, DOI 10.1034/j.1600-0501.2003.00912.x
   Schwarz F, 2006, CLIN ORAL INVEST, V10, P279, DOI 10.1007/s00784-006-0070-3
   Schwarz F, 2011, J CLIN PERIODONTOL, V38, P276, DOI 10.1111/j.1600-051X.2010.01690.x
   Schwarz F, 2010, J CLIN PERIODONTOL, V37, P449, DOI 10.1111/j.1600-051X.2010.01540.x
   Schwarz F, 2009, J CLIN PERIODONTOL, V36, P807, DOI 10.1111/j.1600-051X.2009.01443.x
   SERINO G, 2011, CLIN ORAL IMPLAN RES, DOI DOI 10.1111/J.1600-0501.2010.02098.X
   Wiltfang J, 2010, CLIN IMPLANTS DENT R, DOI [10.1111/j.17088208.2009.00264.x, DOI 10.1111/J.1708-8208.2009.00264.X]
   Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x
NR 42
TC 39
Z9 41
U1 0
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD AUG
PY 2011
VL 38
IS 8
BP 738
EP 745
DI 10.1111/j.1600-051X.2011.01742.x
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 791UV
UT WOS:000292693000008
PM 21635278
DA 2018-10-20
ER

PT J
AU Coutinho, E
   Cardoso, MV
   Fernandes, CP
   Neves, AA
   Gouvea, CVD
   Van Landuyt, KL
   De Munck, J
   Van Meerbeek, B
AF Coutinho, E.
   Cardoso, M. V.
   Fernandes, C. P.
   Neves, A. A.
   Gouvea, C. V. D.
   Van Landuyt, K. L.
   De Munck, J.
   Van Meerbeek, B.
TI Nanoleakage Distribution at Adhesive-Dentin Interfaces in 3D
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE 3D; FIB tomography; electron tomography; dental bonding; dentin
ID SCANNING-ELECTRON-MICROSCOPY; PHASE-SEPARATION; 2 MODES; EXPRESSION
AB In spite of its role in the degradation of tooth-biomaterial interfaces, reports on nanoleakage are largely inconsistent. The aim of this work was to assess nanoleakage patterns qualitatively and quantitatively in 3D, to determine the influence of direction, position, and inclination of the field-of-view. Therefore, we applied a gold-standard 3-step etch-and-rinse adhesive to bur-cut dentin surfaces, after which interface samples were sectioned, infiltrated with an ammoniacal silver-nitrate solution, and embedded by common TEM procedures. High-resolution 3D models of interfaces were then generated by FIB and electron tomography, following strict conditions determined by Monte Carlo simulations. Inverted images in FIB tomography disclosed morphological characteristics analogous to those revealed by TEM. Quantitative analysis revealed large variations in silver-nitrate uptake between 2D image projections in different directions. Furthermore, silver-nitrate fractions in individual 2D image projections were seldom related to the total 3D volumetric fraction. Electron tomography showed that inclination also affected the morphology of silver-nitrate patterns. In conclusion, conventional nanoleakage evaluation is heavily influenced by direction, position, and inclination of the field-of-view, and thus may contain artifacts.
C1 [Coutinho, E.; Cardoso, M. V.; Neves, A. A.; Van Landuyt, K. L.; De Munck, J.; Van Meerbeek, B.] Catholic Univ Louvain, Leuven BIOMAT Res Cluster, Dept Conservat Dent, Sch Dent Oral Pathol & Maxillofacial Surg, B-3000 Louvain, Belgium.
   [Coutinho, E.; Fernandes, C. P.; Gouvea, C. V. D.] Univ Fed Fluminense, Dept Prosthodont, Sch Dent, Rio De Janeiro, Brazil.
RP Van Meerbeek, B (reprint author), Catholic Univ Louvain, Leuven BIOMAT Res Cluster, Dept Conservat Dent, Sch Dent Oral Pathol & Maxillofacial Surg, Kapucijnenvoer 7, B-3000 Louvain, Belgium.
EM bart.vanmeerbeek@med.kuleuven.be
RI Neves, Aline/A-2593-2009; Coutinho, Eduardo/E-6765-2013; Van Landuyt,
   Kirsten/K-5850-2015
OI Neves, Aline/0000-0002-6049-0588; Van Landuyt,
   Kirsten/0000-0002-4932-3148
FU K.U. Leuven Research Grant [OT/06/55]
FX This study was supported by K.U. Leuven Research Grant OT/06/55. Dr. K.
   Van Landuyt is an appointed Post-doctoral Research Fellow of
   FWO-Flanders. The authors have no commercial interests in the products
   herein investigated.
CR Bernhardt R, 2004, Eur Cell Mater, V7, P42
   Breschi L, 2010, DENT MATER, V26, P320, DOI 10.1016/j.dental.2009.11.153
   Coutinho E, 2009, DENT MATER, V25, P1325, DOI 10.1016/j.dental.2009.06.002
   De Munck J, 2009, J DENT RES, V88, P1101, DOI 10.1177/0022034509346952
   Drouin D, 2007, SCANNING, V29, P92, DOI 10.1002/sca.20000
   Frank J., 2006, ELECT TOMOGRAPHY MET
   Frank RM, 1999, ARCH ORAL BIOL, V44, P979, DOI 10.1016/S0003-9969(99)00109-0
   Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008
   Misra A, 2004, J BIOMED MATER RES B, V70B, P56, DOI 10.1002/jbm.b.30012
   Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x
   Okuda M, 2001, OPER DENT, V26, P482
   Pashley DH, 2004, J DENT RES, V83, P216, DOI 10.1177/154405910408300306
   Peumans M, 2005, DENT MATER, V21, P864, DOI 10.1016/j.dental.2005.02.003
   Peumans M, 2011, CLIN ORAL I IN PRESS
   Pioch T, 2001, AM J DENT, V14, P252
   Reis AF, 2007, DENT MATER, V23, P1164, DOI 10.1016/j.dental.2006.10.006
   Sano H, 2006, J DENT RES, V85, P11, DOI 10.1177/154405910608500102
   SANO H, 1995, OPER DENT, V20, P18
   Scherrer SS, 2010, DENT MATER, V26, pE78, DOI 10.1016/j.dental.2009.12.002
   Spencer P, 2002, J BIOMED MATER RES, V62, P447, DOI 10.1002/jbm.10364
   Spencer P, 2010, ANN BIOMED ENG, V38, P1989, DOI 10.1007/s10439-010-9969-6
   Tay FR, 2009, J DENT RES, V88, P719, DOI 10.1177/0022034509341826
   Tay FR, 2002, J DENT RES, V81, P472, DOI 10.1177/154405910208100708
   Tay FR, 2003, J DENT RES, V82, P537, DOI 10.1177/154405910308200710
   Tezvergil-Mutluay A, 2010, ACTA BIOMATER, V6, P4136, DOI 10.1016/j.actbio.2010.05.017
   Van Landuyt KL, 2005, J DENT RES, V84, P183, DOI 10.1177/154405910508400214
   Van Meerbeek B, 2003, OPER DENT, V28, P215
   Van Meerbeek B, 2010, DENT MATER, V26, pE100, DOI 10.1016/j.dental.2009.11.148
   Van Meerbeek B, 2007, J ADHES DENT, V9, P491
   Yuan Y, 2007, DENT MATER, V23, P561, DOI 10.1016/j.dental.2006.03.015
NR 30
TC 8
Z9 8
U1 1
U2 6
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD AUG
PY 2011
VL 90
IS 8
BP 1019
EP 1025
DI 10.1177/0022034511408430
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 791AM
UT WOS:000292632200013
PM 21586664
DA 2018-10-20
ER

PT J
AU Bachmann, F
   Erdmann, R
   Hartmann, V
   Becker-Wegerich, P
   Wiest, L
   Rzany, B
AF Bachmann, F.
   Erdmann, R.
   Hartmann, V.
   Becker-Wegerich, P.
   Wiest, L.
   Rzany, B.
TI Adverse reactions caused by consecutive injections of different fillers
   in the same facial region: risk assessment based on the results from the
   Injectable Filler Safety study
SO JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
LA English
DT Article
DE combination; combined; complications; fillers; injectable; reactions
ID SOFT-TISSUE FILLERS; PERMANENT FILLERS; HYALURONIC-ACID; SURFACE-CHARGE;
   DERMAL FILLERS; GEL FILLERS; PHAGOCYTOSIS; BIOMATERIAL; SIZE;
   MICROSPHERES
AB Background The combination of different injectable fillers in one area is considered to increase the risk of adverse reactions.
   Objectives To characterize adverse reactions in patients who received more than one filler in the same facial region.
   Methods Data (up to July 2009) of the Injectable Filler Safety Study, a German-based registry for adverse filler reactions, was analysed descriptively. All cases were discussed individually.
   Results In 22 of the 161 patients (13.7%), two or more different fillers were injected consecutively into the same facial region. All patients were female with an average age of 50.6 (SD 13.6) years. In 12 of the 22 patients (54.5%), a specific filler could be attributed to the adverse reactions whereas in the other 10 patients (45.5%), the filler was not clearly attributable to one filler substance causing the adverse reactions.
   Conclusions With the continuous changes in the filler market, the combination of different fillers in one area becomes more likely. Based on our data, there is not a lot of evidence that the combination of different injectable fillers, specifically biodegradable fillers, in the same region increases the risk of adverse reactions.
C1 [Bachmann, F.; Erdmann, R.; Hartmann, V.; Rzany, B.] Charite, Dept Dermatol, Div Evidence Based Med, D-13353 Berlin, Germany.
   [Becker-Wegerich, P.] Aesthet & Laserzentrum Zurichsee, Meilen, Switzerland.
RP Bachmann, F (reprint author), Charite, Dept Dermatol, Div Evidence Based Med, Charitepl 1, D-13353 Berlin, Germany.
EM frank.bachmann@charite.de
CR Alijotas-Reig J, 2009, DERMATOL SURG, V35, P360, DOI 10.1111/j.1524-4725.2008.01041.x
   *ASAPS, 2007, ASAPS 2007 DAT INJ A
   Bachmann F, 2009, DERMATOL SURG, V35, P1629, DOI 10.1111/j.1524-4725.2009.01341.x
   Beer K, 2009, DERMATOL CLIN, V27, P427, DOI 10.1016/j.det.2009.08.011
   Bentkover SH, 2009, FACIAL PLAST SURG, V25, P73, DOI 10.1055/s-0029-1220646
   Broder KW, 2006, PLAST RECONSTR SURG, V118, p7S, DOI 10.1097/01.prs.0000234900.26676.0b
   Christensen L, 2005, AESTHET PLAST SURG, V29, P34, DOI 10.1007/s00266-004-0113-6
   Christensen L, 2007, DERMATOL SURG, V33, pS168, DOI 10.1111/j.1524-4725.2007.33357.x
   Christensen LH, 2009, DERMATOL SURG, V35, P1612, DOI 10.1111/j.1524-4725.2009.01338.x
   DEMAIO M, 2006, INJECTABLE FILLERS A
   ELSHAFEY I, 2007, AESTHET PLAST SURG, V32, P162
   Eppley BL, 2006, PLAST RECONSTR SURG, V118, p98E, DOI 10.1097/01.prs.0000232436.91409.30
   EPPLEY BL, 1994, AESTHET PLAST SURG, V18, P413, DOI 10.1007/BF00451350
   EPPLEY BL, 1995, AESTHET PLAST SURG, V19, P445, DOI 10.1007/BF00453878
   FREITAS RA, 2003, ALUMINA SAPPHIRE PAR
   *GACD, 2008, NEUE STAT SCHONH GES
   GELB H, 1994, J ORTHOP RES, V12, P83, DOI 10.1002/jor.1100120111
   Laeschke K, 2004, SEMIN CUTAN MED SURG, V23, P214, DOI 10.1016/j.sder.2004.09.005
   Lemperle G, 2004, PLAST RECONSTR SURG, V113, P1380, DOI 10.1097/01.PRS.0000112764.22839.7A
   MUSTOE TA, 1992, PLAST RECONSTR SURG, V89, P891, DOI 10.1097/00006534-199205000-00018
   MUSTOE TA, 1992, PLAST RECONSTR SURG, V89, P898
   NAGURA H, 1977, CELL STRUCT FUNCT, V2, P21, DOI 10.1247/csf.2.21
   Narins RS, 2008, DERMATOL SURG, V34, pS2, DOI 10.1111/j.1524-4725.2008.34236.x
   Narins RS, 2008, DERMATOL SURG S1, V34, pS8
   Nicolau PJ, 2007, PLAST RECONSTR SURG, V119, P2271, DOI 10.1097/01.prs.0000260710.30934.a1
   Okada Y, 1999, J BIOMED MATER RES, V45, P277, DOI 10.1002/(SICI)1097-4636(19990615)45:4<277::AID-JBM1>3.0.CO;2-0
   PONSGUIRAUD A, 2003, NOUV DERMATOL, V22, P202
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   ROSSNER F, 2006, KOSMETISCHE MED, V27, P4
   Rossner F, 2009, J COSMET DERMATOL-US, V8, P14, DOI 10.1111/j.1473-2165.2009.00417.x
   Rossner M, 2009, DERMATOL SURG, V35, P367, DOI 10.1111/j.1524-4725.2008.01062.x
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P931, DOI 10.1097/00006534-199205000-00025
   SANGER JR, 1992, PLAST RECONSTR SURG, V89, P941
   TABATA Y, 1988, BIOMATERIALS, V9, P356, DOI 10.1016/0142-9612(88)90033-6
   Tomazic-Jezic VJ, 2001, J BIOMED MATER RES, V55, P523, DOI 10.1002/1097-4636(20010615)55:4<523::AID-JBM1045>3.0.CO;2-G
   Wiest LG, 2007, HAUTARZT, V58, P224, DOI 10.1007/s00105-007-1303-3
   Wiest LG, 2009, DERMATOL SURG, V35, P1681, DOI 10.1111/j.1524-4725.2009.01347.x
   Zielke H, 2008, DERMATOL SURG, V34, P326, DOI 10.1111/j.1524-4725.2007.34066.x
NR 38
TC 13
Z9 13
U1 0
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0926-9959
J9 J EUR ACAD DERMATOL
JI J. Eur. Acad. Dermatol. Venereol.
PD AUG
PY 2011
VL 25
IS 8
BP 902
EP 912
DI 10.1111/j.1468-3083.2010.03878.x
PG 11
WC Dermatology
SC Dermatology
GA 790SA
UT WOS:000292608300004
PM 21054567
DA 2018-10-20
ER

PT J
AU Lim, JT
   Hastie, IAG
   Hiscock, RJ
   Shedda, SM
AF Lim, James T.
   Hastie, Ian A. G.
   Hiscock, Richard J.
   Shedda, Susan M.
TI Sacral Nerve Stimulation for Fecal Incontinence: Long-term Outcomes
SO DISEASES OF THE COLON & RECTUM
LA English
DT Article
DE Sacral nerve stimulation; Neuromodulation; Fecal incontinence
ID INTACT ANAL-SPHINCTER
AB BACKGROUND: Numerous studies advocate the short-term benefits of sacral nerve stimulation for fecal incontinence, but there has been a paucity of studies on longer-term outcomes.
   OBJECTIVE: The objective of this study was to report the long-term outcome of sacral nerve stimulation performed for fecal incontinence at a single institution.
   PATIENTS AND DESIGN: Between January 2004 and May 2007, 53 patients underwent definitive sacral nerve stimulation for fecal incontinence at our institution. Prospectively recorded baseline information, including Wexner incontinence scores and standard short-form (SF-12) health survey scores, were compared with scores at follow-up.
   RESULTS: Forty-one patients were available for long-term follow-up with a mean duration of 51 months. The median Wexner score decreased from a baseline of 11.5 (range, 3.0-18.0) to 8.0 (range, 0.0-18.0) at follow-up. The mean difference in Wexner score was 2.7 (P < .001). There was no statistically significant change in SF-12 physical scores, but a small but highly significant change occurred in SF-12 mental scores. The median SF-12 mental domain score was 49.5 (range, 15.0-62.1) at baseline, and 57.0 (range, 20.0-64.0) at follow-up, with a mean difference of 4.5 (P = .006). Subgroup analysis performed comparing patients with or without prior intersphincteric silicon biomaterial implants demonstrated a mean difference in Wexner score of -3.5 (no implant) vs 0.0 (previous implant), with P < .09 (not statistically significant).
   CONCLUSIONS: Sacral nerve stimulation results in a statistically significant improvement in fecal incontinence scores in the long term.
C1 [Lim, James T.; Hastie, Ian A. G.; Shedda, Susan M.] Royal Melbourne Hosp, Colorectal Surg Unit, Melbourne, Vic, Australia.
   [Hiscock, Richard J.] Mercy Hosp Women, Melbourne, Vic, Australia.
RP Lim, JT (reprint author), POB 5139, Brandon Pk, Vic 3150, Australia.
EM drjamestlim@gmail.com
FU Medtronic
FX Dr Lim is a Colorectal Research Fellow at the Royal Melbourne Hospital
   and receives partial funding from Medtronic. Medtronic has had no
   influence on the study design, analysis or reporting. The authors
   declare no competing interests.
CR Altomare DF, 2009, DIS COLON RECTUM, V52, P11, DOI 10.1007/DCR.0b013e3181974444
   Baxter NN, 2003, DIS COLON RECTUM, V46, P1591, DOI 10.1097/013DCR.0000098906.61097.1C
   Boyle DJ, 2009, DIS COLON RECTUM, V52, P1234, DOI 10.1007/DCR.0b013e31819f7400
   Chan MKY, 2008, DIS COLON RECTUM, V51, P1015, DOI 10.1007/s10350-008-9326-0
   Deutekom M, 2005, DIS COLON RECTUM, V48, P2294, DOI 10.1007/s10350-005-0162-1
   FRASER C, SYSTEMATIC REV EFFIC
   Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x
   MAROSSZEKY N, 2005, INSTRUMENT REV SF 12
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Melenhorst J, 2008, COLORECTAL DIS, V10, P257, DOI 10.1111/j.1463-1318.2007.01375.x
   Michelsen HB, 2010, DIS COLON RECTUM, V53, P414, DOI 10.1007/DCR.0b013e3181ca7dc2
   Sanderson K, 2002, AUST NZ J PUBL HEAL, V26, P343, DOI 10.1111/j.1467-842X.2002.tb00182.x
   Tjandra JJ, 2008, DIS COLON RECTUM, V51, P494, DOI 10.1007/s10350-007-9103-5
   *UR LTD, 2008, PTQ IMPL SAF SIMPL R
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   Wexner SD, 2010, ANN SURG, V251, P441, DOI 10.1097/SLA.0b013e3181cf8ed0
NR 16
TC 14
Z9 14
U1 2
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0012-3706
J9 DIS COLON RECTUM
JI Dis. Colon Rectum
PD AUG
PY 2011
VL 54
IS 8
BP 969
EP 974
DI 10.1097/DCR.0b013e31821e57c2
PG 6
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 788LQ
UT WOS:000292446800011
PM 21730785
DA 2018-10-20
ER

PT J
AU Pinheiro, ALB
   Soares, LGP
   Aciole, GTS
   Correia, NA
   Barbosa, AFS
   Ramalho, LMP
   dos Santos, JN
AF Pinheiro, Antonio L. B.
   Soares, Luiz G. P.
   Aciole, Gilberth T. S.
   Correia, Neandder A.
   Barbosa, Artur F. S.
   Ramalho, Luciana M. P.
   dos Santos, Jean N.
TI Light microscopic description of the effects of laser phototherapy on
   bone defects grafted with mineral trioxide aggregate, bone morphogenetic
   proteins, and guided bone regeneration in a rodent model
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biomaterial; LLLT; mineral trioxide aggregate
ID END FILLING MATERIALS; IN-VIVO; TISSUE REGENERATION; PERIAPICAL LESIONS;
   RAMAN-SPECTROSCOPY; DENTAL IMPLANTS; BOVINE BONE; GUINEA-PIGS; REPAIR;
   CELLS
AB We carried out a histological analysis on bone defects grafted with mineral trioxide aggregate (MTA) treated or not with laser, bone morphogenetic protein (BMP), and guided bone regeneration (GBR). Benefits of the use of MTA, laser, BMPs, and GBR on bone repair are well known, but there is no report on their association with laser light. Ninety rats were divided into 10 groups each subdivided into 3. Defects on G II and I were filled with the blood clot. G II was further irradiated with LED. G III and IV were filled with MTA; G IV was further irradiated with laser. G V and VI, the defects filled with MTA and covered with a membrane (GBR). G VI was further irradiated with laser. G VII and VIII, BMPs were added to the MTA and group VIII further irradiated with laser. G IX and X, the MTA + BMP graft was covered with a membrane (GBR). G X was further irradiated with laser. Laser light (lambda = 850 nm, 150 mW, 4 J/cm(2)) was applied over the defect at 48-h intervals and repeated for 15 days. Specimens were processed, cut and stained with H&E and Sirius red and underwent histological analysis. Subjects on group X were irradiated. The results showed different tissue response on all groups during the experimental time. Major changes were seen on irradiated subjects and included marked deposition of new bone in advanced maturation. It is concluded that near infrared laser phototherapy improved the results of the use of the MTA on bone defects. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 212-221, 2011.
C1 [Pinheiro, Antonio L. B.; Soares, Luiz G. P.; Aciole, Gilberth T. S.; Correia, Neandder A.; Barbosa, Artur F. S.; Ramalho, Luciana M. P.] Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
   [Pinheiro, Antonio L. B.] Univ Camilo Castelo Branco, Inst Biomed Engn, BR-12245230 Sao Jose Dos Campos, SP, Brazil.
   [Pinheiro, Antonio L. B.; Ramalho, Luciana M. P.; dos Santos, Jean N.] Univ Sao Carlos, Natl Inst Opt & Photon, Inst Phys, Sao Carlos, SP, Brazil.
   [dos Santos, Jean N.] Univ Fed Bahia, Lab Surg Pathol, Sch Dent, BR-40110150 Salvador, BA, Brazil.
RP Pinheiro, ALB (reprint author), Univ Fed Bahia, Ctr Biophoton, Sch Dent, BR-40110150 Salvador, BA, Brazil.
EM albp@ufba.br
RI Sao Carlos Institute of Physics, IFSC/USP/M-2664-2016; Pinheiro, Antonio
   Luiz/A-1962-2008; Optica e fotonica, Inct/I-2419-2013; Barbosa,
   Artur/G-3839-2012
OI Pinheiro, Antonio Luiz/0000-0002-5805-0321; 
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
FX Contract grant sponsors: Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)
CR Al-Rabeah E, 2006, J ENDODONT, V32, P872, DOI 10.1016/j.joen.2006.03.019
   BYSTROM A, 1985, Endodontics and Dental Traumatology, V1, P170
   Camilleri J, 2006, INT ENDOD J, V39, P747, DOI 10.1111/j.1365-2591.2006.01135.x
   CONEGLIAN PZA, 2007, THESIS SAO PAULO U B
   CORTELLINI P, 1993, J PERIODONTOL, V64, P387, DOI 10.1902/jop.1993.64.5.387
   De Moor RJG, 2002, INT ENDOD J, V35, P946, DOI 10.1046/j.1365-2591.2002.00597.x
   De Rossi A, 2005, ORAL SURG ORAL MED O, V99, P628, DOI 10.1016/j.tripleo.2004.07.018
   Domon T, 2001, ANN ANAT, V183, P103, DOI 10.1016/S0940-9602(01)80027-3
   Ebina H, 2009, ORAL DIS, V15, P273, DOI 10.1111/j.1601-0825.2009.01522.x
   Economides N, 2003, INT ENDOD J, V36, P44, DOI 10.1046/j.0143-2885.2003.00611.x
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gerbi MEM, 2008, PHOTOMED LASER SURG, V26, P55, DOI 10.1089/pho.2007.2026
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Gerbi MMEM, 2008, LASER MED SCI, V23, P313
   GOTTLOW J, 1984, J CLIN PERIODONTOL, V11, P494, DOI 10.1111/j.1600-051X.1984.tb00901.x
   Holland R, 1999, J ENDODONT, V25, P728, DOI 10.1016/S0099-2399(99)80118-6
   Lee YL, 2004, BIOMATERIALS, V25, P787, DOI 10.1016/S0142-9612(03)00591-X
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   Lopes CB, 2007, J PHOTOCH PHOTOBIO B, V89, P125, DOI 10.1016/j.jphotobiol.2007.09.011
   Lopes CB, 2005, PHOTOMED LASER SURG, V23, P27, DOI 10.1089/pho.2005.23.27
   Lopes CB, 2007, PHOTOMED LASER SURG, V25, P96, DOI 10.1089/pho.2006.2030
   Matsuda C, 2005, CYTOTECHNOLOGY, V47, P11, DOI 10.1007/s10616-005-3751-x
   Mitchell PJC, 1999, BIOMATERIALS, V20, P167, DOI 10.1016/S0142-9612(98)00157-4
   Mooney MP, 2005, BONE TISSUE ENGINEERING, P217
   Moretton TR, 2000, J BIOMED MATER RES, V52, P528, DOI 10.1002/1097-4636(20001205)52:3<528::AID-JBM11>3.0.CO;2-9
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   OLIVEIRA EA, 2008, BRAZ J ORAL SCI, V27, P1657
   Oliveira M. A. M., 2001, REV FOUFBA, V22, P12
   Oviir T, 2006, J ENDODONT, V32, P210, DOI 10.1016/j.joen.2006.10.036
   Palumbo C., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P327
   Park YJ, 2000, J BIOMED MATER RES, V51, P391, DOI 10.1002/1097-4636(20000905)51:3<391::AID-JBM13>3.0.CO;2-9
   PASTORI CM, 1996, REV BRAS CIENC ESTOM, V1, P51
   Perez AL, 2003, INT ENDOD J, V36, P564, DOI 10.1046/j.1365-2591.2003.00691.x
   Perinpanayagam H, 2009, J CAN DENT ASSOC, V75, P369
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Pinheiro ALB, 2003, J CLIN LASER MED SUR, V21, P383
   Pinheiro ALB, 2010, J BIOMED MATER RES A, V95A, P1041, DOI 10.1002/jbm.a.32930
   Pinheiro ALB, 2008, PHOTOMED LASER SURG, V26, P167, DOI [10.1089/pho.2007.2027, 10.1089/pho.2007.7027]
   Pinheiro ALB, 2009, LASER MED SCI, V24, P234, DOI 10.1007/s10103-008-0556-0
   Pinheiro Antonio Luiz Barbosa, 2003, Braz. Dent. J., V14, P177, DOI 10.1590/S0103-64402003000300007
   Reddi AH, 1998, CLIN ORTHOP RELAT R, pS66
   Regan JD, 2002, INT ENDOD J, V35, P840, DOI 10.1046/j.1365-2591.2002.00582.x
   RESTREPO LL, AVALIACAO IMPLANTES
   Romano PR, 1997, J PERIODONTAL RES, V32, P143, DOI 10.1111/j.1600-0765.1997.tb01396.x
   Saidon J, 2003, ORAL SURG ORAL MED O, V95, P483, DOI 10.1067/moe.2003.20
   Schwartz RS, 1999, J AM DENT ASSOC, V130, P967, DOI 10.14219/jada.archive.1999.0337
   Segundo T., 2000, RGO, V48, P217
   Silva Junior N, 2002, J CLIN LASER MED SUR, V20, P83
   STAHL SS, 1990, J CLIN PERIODONTOL, V17, P191, DOI 10.1111/j.1600-051X.1990.tb01085.x
   TAGA EM, BIOMATERIALS USO CLI
   Torabinejad M, 1998, J ENDODONT, V24, P468, DOI 10.1016/S0099-2399(98)80048-4
   TORABINEJAD M, 1995, J ENDODONT, V21, P489, DOI 10.1016/S0099-2399(06)80518-2
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   TORABINEJAD M, 1995, J ENDODONT, V21, P569, DOI 10.1016/S0099-2399(06)80987-8
   TORABINEJAD M, 1995, J ENDODONT, V21, P349, DOI 10.1016/S0099-2399(06)80967-2
   Torabinejad M, 1999, J ENDODONT, V25, P197, DOI 10.1016/S0099-2399(99)80142-3
   Torres CS, 2008, PHOTOMED LASER SURG, V26, P371, DOI 10.1089/pho.2007.2172
   Tronstad L, 1981, J Endod, V7, P17, DOI 10.1016/S0099-2399(81)80262-2
   TRONSTAD L, 1988, ENDOD DENT TRAUMATOL, V4, P241
   Weber JBB, 2006, PHOTOMED LASER SURG, V24, P38, DOI 10.1089/pho.2006.24.38
   Young S, 2008, TISSUE ENG PT B-REV, V14, P295, DOI 10.1089/ten.teb.2008.0153
   Zhu Q, 2000, J ENDODONT, V26, P404, DOI 10.1097/00004770-200007000-00006
NR 62
TC 27
Z9 28
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2011
VL 98A
IS 2
BP 212
EP 221
DI 10.1002/jbm.a.33107
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 788TD
UT WOS:000292466400007
PM 21548072
DA 2018-10-20
ER

PT J
AU Wang, H
   Shi, ZM
AF Wang, Hao
   Shi, Zhiming
TI In vitro biodegradation behavior of magnesium and magnesium alloy
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE magnesium and magnesium alloy; biodegradation; biodegradable materials;
   biodegradable implant; biocorrosion
ID PSEUDO-PHYSIOLOGICAL CONDITIONS; BIO-CORROSION; VIVO CORROSION;
   PERFORMANCE
AB Magnesium has the potential to be used as degradable metallic biomaterial. For magnesium and its alloys to be used as biodegradable implant materials, their degradation rates should be consistent with the rate of healing of the affected tissue, and the release of the degradation products should be within the body's acceptable absorption levels. Conventional magnesium degrades rapidly, which is undesirable. In this study, biodegradation behaviors of high purity magnesium and commercial purity magnesium alloy AZ31 in both static and dynamic Hank's solution are systematically investigated. The in vitro test results show that magnesium purification and selective alloying are effective approaches to reduce the degradation rate of magnesium. In the static condition, the corrosion products accumulate on the materials surface as a protective layer, which results in a lower degradation rate than the dynamic condition. Anodized coating can significantly further reduce the degradation rate of magnesium. This study strongly indicates that magnesium can be used as degradable implant material as long as the degradation is controlled at a low rate. Magnesium purification, selective alloying, and anodized coating are three effective approaches to reduce the rate of degradation. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 98B: 203-209, 2011.
C1 [Wang, Hao] Univ So Queensland, Fac Engn & Surveying, Toowoomba, Qld 4350, Australia.
   [Shi, Zhiming] Univ Queensland, ARC Ctr Excellence Design Light Met, Div Mat Engn, Sch Mech & Min Engn, Brisbane, Qld 4072, Australia.
RP Wang, H (reprint author), Univ So Queensland, Fac Engn & Surveying, Toowoomba, Qld 4350, Australia.
EM wangh@usq.edu.au
RI Wang, Hao/A-7340-2016
OI Wang, Hao/0000-0001-8869-9669
CR AVEDESIN M, 1999, ASM SPECIALTY HDB
   BARTON T, 1998, ANODIZATION MAGNESIU
   ELIEZER A, 2007, P 7 INT C MAGN ALL T, P822
   Kaesel V., 2003, P 6 INT C MAGN ALL T, P534
   Kontani M, 2005, INTERNAL MED, V44, P448, DOI 10.2169/internalmedicine.44.448
   Levesque J, 2003, MATER SCI FORUM, V426-4, P521, DOI 10.4028/www.scientific.net/MSF.426-432.521
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Ren YB, 2005, ACTA METALL SIN, V41, P1228
   Shi ZM, 2006, CORROS SCI, V48, P3531, DOI 10.1016/j.corsci.2006.02.008
   Song GL, 2003, ADV ENG MATER, V5, P837, DOI 10.1002/adem.200310405
   Song GL, 2007, ADV ENG MATER, V9, P298, DOI 10.1002/adem.200600252
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   STERN M, 1957, J ELECTROCHEM SOC, V104, P56, DOI 10.1149/1.2428496
   Tamai H, 2000, CIRCULATION, V102, P399
   Wang H, 2008, MATER LETT, V62, P2476, DOI 10.1016/j.matlet.2007.12.052
   Wang H, 2006, TISSUE ENG, V12, P1067
   Wang H, 2007, ADV ENG MATER, V9, P967, DOI 10.1002/adem.200700200
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
NR 19
TC 32
Z9 35
U1 2
U2 37
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2011
VL 98B
IS 2
BP 203
EP 209
DI 10.1002/jbm.b.31769
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 789NN
UT WOS:000292522300001
PM 21732527
OA Green Published
DA 2018-10-20
ER

PT J
AU Sawada, Y
   Hokugo, A
   Yang, YW
   Kamitani, M
   Matsuda, S
   Mao, TQ
   Lei, DL
   Chen, FL
   Iseki, T
   Morita, S
AF Sawada, Yasunori
   Hokugo, Akishige
   Yang, Yaowu
   Kamitani, Masayuki
   Matsuda, Sakiko
   Mao, Tianqiu
   Lei, Delin
   Chen, Fulin
   Iseki, Tomio
   Morita, Shosuke
TI A novel hydroxyapatite ceramic bone substitute transformed by ostrich
   cancellous bone: Characterization and evaluations of bone regeneration
   activity
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bone regeneration; bone substitute; ostrich
ID BETA-TRICALCIUM PHOSPHATE; GRAFT SUBSTITUTES; BOVINE BONE; EGGSHELL;
   ELEVATION; CALVARIA; RABBITS
AB Various biomaterials have been used for bone repair and reconstruction of bone defects. Inorganic xenogenic bone substitutes have been intensively studied because they possesses favorable regenerative properties. The purpose of this study was to evaluate the properties of a novel inorganic xenogenic bone substitute, sintered ostrich cancellous bone (SOCB). Bone regeneration capability was also comparing to that of other bone substitutes in rabbit calvarial defects. Biochemical and biomechanical properties of the SOCB ceramic closely resembled those of human bone. Bone regeneration was evaluated by radiograph, histology, and histomorphometry. Bone regeneration was significantly enhanced in defects treated with SOCB when compared with other bone substitutes. The biochemical and biomechanical properties of SOCB are favorable for bone regeneration. SOCB might be a promising biomaterial for the repair of bone defects. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 98B: 217-222, 2011.
C1 [Sawada, Yasunori; Hokugo, Akishige; Kamitani, Masayuki; Matsuda, Sakiko; Iseki, Tomio; Morita, Shosuke] Osaka Dent Univ, Dept Oral & Maxillofacial Surg 1, Grad Sch Dent, Osaka, Japan.
   [Yang, Yaowu; Mao, Tianqiu; Lei, Delin; Chen, Fulin] Fourth Mil Med Univ, Dept Oral & Maxillofacial Surg, Sch Stomatol, Xian 710032, Peoples R China.
RP Morita, S (reprint author), Osaka Dent Univ, Dept Oral & Maxillofacial Surg 1, Grad Sch Dent, Osaka, Japan.
EM morita-s@cc.osaka-dent.ac.jp
FU Osaka Dental University
FX Contract grant sponsor: Osaka Dental University (International
   Collaboration Grant)
CR Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Dupoirieux L, 1999, BRIT J ORAL MAX SURG, V37, P467, DOI 10.1054/bjom.1999.0041
   Durmus E, 2008, J BIOMED MATER RES B, V86B, P82, DOI 10.1002/jbm.b.30990
   El-Ghannam A, 2005, EXPERT REV MED DEVIC, V2, P87, DOI 10.1586/17434440.2.1-87
   Fountos G, 1999, APPL RADIAT ISOTOPES, V51, P273, DOI 10.1016/S0969-8043(99)00056-1
   Handschel Jorg, 2009, Head Face Med, V5, P12, DOI 10.1186/1746-160X-5-12
   Hertz A, 2007, NANOMEDICINE-UK, V2, P899, DOI 10.2217/17435889.2.6.899
   Hokugo A, 2007, ORAL SURG ORAL MED O, V104, P44, DOI 10.1016/j.tripleo.2006.11.032
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Jalila A, 2004, Med J Malaysia, V59 Suppl B, P125
   KAPLAN SJ, 1994, ORTHOPAEDIC BASIC SC, P128
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Maiorana C, 2006, INT J ORAL MAX IMPL, V21, P426
   Park JW, 2008, J BIOMED MATER RES A, V87A, P203, DOI 10.1002/jbm.a.31768
   Park JW, 2009, CLIN ORAL IMPLAN RES, V20, P372, DOI 10.1111/j.1600-0501.2008.01602.x
   Rawashdeh MA, 2008, BRIT J ORAL MAX SURG, V46, P665, DOI 10.1016/j.bjoms.2008.07.184
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Ripamonti U, 2000, J BONE MINER RES, V15, P1798, DOI 10.1359/jbmr.2000.15.9.1798
   Schlegel AK, 1998, J LONG-TERM EFF MED, V8, P201
   Szabo G, 2001, INT J ORAL MAX IMPL, V16, P681
   Tadjoedin ES, 2003, J CLIN PERIODONTOL, V30, P261, DOI 10.1034/j.1600-051X.2003.01099.x
   UCHIDA A, 1985, J ORTHOP RES, V3, P65, DOI 10.1002/jor.1100030108
NR 23
TC 6
Z9 7
U1 0
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2011
VL 98B
IS 2
BP 217
EP 222
DI 10.1002/jbm.b.31783
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 789NN
UT WOS:000292522300003
PM 21681951
DA 2018-10-20
ER

PT J
AU Lee, H
   Fisher, S
   Kallos, MS
   Hunter, CJ
AF Lee, Haeyeon
   Fisher, Stephanie
   Kallos, Michael S.
   Hunter, Christopher J.
TI Optimizing gelling parameters of gellan gum for fibrocartilage tissue
   engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE gellan gum; tissue engineering; fibrocartilage; hydrogel; gelling
   parameters
ID MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; CONFINED COMPRESSION;
   INTERVERTEBRAL DISC; CARTILAGE; HYDROGELS; CHONDROGENESIS; EQUILIBRIUM;
   CULTIVATION; SCAFFOLDS
AB Gellan gum is an attractive biomaterial for fibrocartilage tissue engineering applications because it is cell compatible, can be injected into a defect, and gels at body temperature. However, the gelling parameters of gellan gum have not yet been fully optimized. The aim of this study was to investigate the mechanics, degradation, gelling temperature, and viscosity of low acyl and low/high acyl gellan gum blends. Dynamic mechanical analysis showed that increased concentrations of low acyl gellan gum resulted in increased stiffness and the addition of high acyl gellan gum resulted in greatly decreased stiffness. Degradation studies showed that low acyl gellan gum was more stable than low/high acyl gellan gum blends. Gelling temperature studies showed that increased concentrations of low acyl gellan gum and CaCl2 increased gelling temperature and low acyl gellan gum concentrations below 2% (w/v) would be most suitable for cell encapsulation. Gellan gum blends were generally found to have a higher gelling temperature than low acyl gellan gum. Viscosity studies showed that increased concentrations of low acyl gellan gum increased viscosity. Our results suggest that 2% (w/v) low acyl gellan gum would have the most appropriate mechanics, degradation, and gelling temperature for use in fibrocartilage tissue engineering applications. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 98B: 238-245, 2011.
C1 [Lee, Haeyeon; Fisher, Stephanie; Kallos, Michael S.; Hunter, Christopher J.] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 1N4, Canada.
   [Fisher, Stephanie; Kallos, Michael S.] Univ Calgary, PPRF, Dept Chem & Petr Engn, Schulich Sch Engn, Calgary, AB T2N 1N4, Canada.
   [Hunter, Christopher J.] Univ Calgary, Dept Mech & Mfg Engn, Schulich Sch Engn, Calgary, AB T2N 1N4, Canada.
RP Hunter, CJ (reprint author), Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 1N4, Canada.
EM topherhunter@gmail.com
OI Kallos, Michael/0000-0002-1480-8022
FU Natural Sciences and Engineering Research Council (NSERC); Canadian
   Institutes of Health Research (CIHR), Canada; Queen Elizabeth II
   Scholarship, Government of Alberta, Alberta, Canada; Alberta Innovates -
   Health Solutions
FX Contract grant sponsor: Collaborative Health Research Project grant from
   the Natural Sciences and Engineering Research Council (NSERC); Contract
   grant sponsor: The Canadian Institutes of Health Research (CIHR),
   Canada; Contract grant sponsor: Queen Elizabeth II Scholarship,
   Government of Alberta, Alberta, Canada; Contract grant sponsor: Alberta
   Innovates - Health Solutions (formerly Alberta Heritage Foundation for
   Medical Research (AHFMR))
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   [Anonymous], 2008, BURDEN MUSCULOSKELET
   BEST BA, 1994, SPINE, V19, P212, DOI 10.1097/00007632-199401001-00017
   Bi L, 2011, J MATER SCI-MATER M, V22, P51, DOI 10.1007/s10856-010-4177-3
   Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Bursac P, 2009, BIORHEOLOGY, V46, P227, DOI 10.3233/BIR-2009-0537
   Chang SCN, 2001, J BIOMED MATER RES, V55, P503, DOI 10.1002/1097-4636(20010615)55:4<503::AID-JBM1043>3.0.CO;2-S
   Chen WC, 2011, CYTOTECHNOLOGY, V63, P13, DOI 10.1007/s10616-010-9314-9
   Chia HN, 2008, J ORTHOP RES, V26, P951, DOI 10.1002/jor.20573
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Froimson MI, 1997, OSTEOARTHR CARTILAGE, V5, P377, DOI 10.1016/S1063-4584(97)80042-8
   Funami T, 2008, J AGR FOOD CHEM, V56, P8609, DOI 10.1021/jf8007713
   Gong YH, 2009, J MATER CHEM, V19, P1968, DOI 10.1039/b818090c
   GRASDALEN H, 1987, CARBOHYD POLYM, V7, P371, DOI 10.1016/0144-8617(87)90004-X
   Huang YQ, 2004, CARBOHYD POLYM, V56, P27, DOI 10.1016/j.carbpol.2003.11.014
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Johannessen W, 2004, ANN BIOMED ENG, V32, P70, DOI 10.1023/B:ABME.0000007792.19071.8c
   Jurvelin J S, 2003, Proc Inst Mech Eng H, V217, P215, DOI 10.1243/095441103765212712
   KLOMPMAKER J, 1991, BIOMATERIALS, V12, P810, DOI 10.1016/0142-9612(91)90066-J
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   Mao R, 2000, CARBOHYD POLYM, V41, P331, DOI 10.1016/S0144-8617(99)00108-3
   Miyoshi E, 1996, CARBOHYD POLYM, V30, P109, DOI 10.1016/S0144-8617(96)00093-8
   MOORHOUSE R, 1981, ACS S SERIES, V150
   Morris ER, 1996, CARBOHYD POLYM, V30, P165, DOI 10.1016/S0144-8617(96)00059-8
   Oliveira JT, 2010, J BIOMED MATER RES A, V93A, P852, DOI 10.1002/jbm.a.32574
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   OLIVEIRA JT, J ORTHOP RES, V28, P1193
   Perie D, 2005, J BIOMECH, V38, P2164, DOI 10.1016/j.jbiomech.2004.10.002
   Quinn F. X., 1993, Polymer Gels and Networks, V1, P93, DOI 10.1016/0966-7822(93)90014-9
   Ragetly GR, 2010, ACTA BIOMATER, V6, P1430, DOI 10.1016/j.actbio.2009.10.040
   Sanderson G. R., 1988, GUMS STABILISERS FOO, V4, P219
   SEBASTINE IM, 2007, C P IEEE ENG MED BIO, P6401
   SILVACORREIA J, J TISSUE EN IN PRESS
   Smith AM, 2007, J BIOMATER APPL, V22, P241, DOI 10.1177/0885328207076522
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Umehara S, 1996, SPINE, V21, P811, DOI 10.1097/00007632-199604010-00007
   UMEHARA S, 1996, SPINE, V21, P820
   Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   2007, KELCOGEL GELLAN GUM
NR 43
TC 21
Z9 21
U1 4
U2 27
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2011
VL 98B
IS 2
BP 238
EP 245
DI 10.1002/jbm.b.31845
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 789NN
UT WOS:000292522300006
PM 21604364
DA 2018-10-20
ER

PT J
AU Chen, YH
   Zhou, SW
   Li, Q
AF Chen, Yuhang
   Zhou, Shiwei
   Li, Qing
TI Microstructure design of biodegradable scaffold and its effect on tissue
   regeneration
SO BIOMATERIALS
LA English
DT Article
DE Biodegradation; Tissue ingrowth; Mechanobiology; Homogenization;
   Topology optimization; poly(lactic-co-glycolic acid) (PLGA)
ID COMPUTER-AIDED-DESIGN; BONE REGENERATION; BIOMATERIAL SCAFFOLDS; BULK
   EROSION; DRUG-RELEASE; DIFFERENTIATION; POROSITY; PERMEABILITY;
   DEGRADATION; FABRICATION
AB Biodegradable scaffolds play a critical role in therapeutic tissue engineering, in which the matrix degradation and tissue ingrowth are of particular importance for determining the ongoing performance of tissue-scaffold system during regenerative process. This paper aims to explore the mechanobiological process within biodegradable scaffolds, where the representative volume element (RVE) is extracted from periodic scaffold micro-architectures as a base-cell design model. The degradation of scaffold matrix is modeled in terms of a stochastic hydrolysis process enhanced by diffusion-controlled autocatalysis; and the tissue ingrowth is modeled through the mechano-regulatory theory. By using the finite element based homogenization technique and topology optimization approach, the effective properties of various periodic scaffold structures are obtained. To explore the effect of scaffold design on the mechanobiological evolutions of tissue-scaffold systems, different scaffold architectures are considered for polymer degradation and tissue regeneration. It is found that the different tissues can grow into the degraded voids inside the polymer matrix. It is demonstrated that the design of scaffold architecture has a considerable impact on the tissue regeneration outcome, which exhibits the importance of implementing different criteria in scaffold micro-structural design, before being fabricated via rapid prototyping technique, e.g. solid free-form fabrication (SFF). This study models such an interactive process of scaffold degradation and tissue growth, thereby providing some new insights into design of biodegradable scaffold micro-architecture for tissue engineering. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Chen, Yuhang; Zhou, Shiwei; Li, Qing] Univ Sydney, Sch Aerosp Mech & Mechtron Engn, Sydney, NSW 2006, Australia.
RP Li, Q (reprint author), Univ Sydney, Sch Aerosp Mech & Mechtron Engn, Sydney, NSW 2006, Australia.
EM Qing.Li@Sydney.edu.au
RI Chen, Yuhang/B-3532-2010; Chen, Yuhang/C-8602-2014; Li, Qing/B-3422-2009
OI Li, Qing/0000-0002-7930-2145
FU Australian Research Council (ARC); University of Sydney
FX The support from the Australian Research Council (ARC) is greatly
   acknowledged. The first author is grateful for the Faculty scholarship
   at the University of Sydney.
CR Adachi T, 2006, BIOMATERIALS, V27, P3964, DOI 10.1016/j.biomaterials.2006.02.039
   Bawolin NK, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002551
   Bendsoe M. P., 2003, TOPOLOGY OPTIMIZATIO
   Boccaccio A, 2008, MED BIOL ENG COMPUT, V46, P283, DOI 10.1007/s11517-007-0247-1
   Byrne DP, 2007, BIOMATERIALS, V28, P5544, DOI 10.1016/j.biomaterials.2007.09.003
   CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517
   Checa S, 2009, ANN BIOMED ENG, V37, P129, DOI 10.1007/s10439-008-9594-9
   Chen YH, 2011, ACTA BIOMATER, V7, P1140, DOI 10.1016/j.actbio.2010.09.038
   Chen YH, 2010, COMPUT STRUCT, V88, P806, DOI 10.1016/j.compstruc.2009.10.003
   Chen YH, 2009, INT J MOD PHYS B, V23, P1345, DOI 10.1142/S0217979209060920
   Cordell JM, 2009, J MECH BEHAV BIOMED, V2, P560, DOI 10.1016/j.jmbbm.2009.01.009
   de Kruijf N, 2007, INT J SOLIDS STRUCT, V44, P7092, DOI 10.1016/j.ijsolstr.2007.03.028
   GIBSON LJ, 1985, J BIOMECH, V18, P317, DOI 10.1016/0021-9290(85)90287-8
   Gopferich A, 1997, MACROMOLECULES, V30, P2598, DOI 10.1021/ma961627y
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   GRIZZI I, 1995, BIOMATERIALS, V16, P305, DOI 10.1016/0142-9612(95)93258-F
   Guest JK, 2006, INT J SOLIDS STRUCT, V43, P7028, DOI 10.1016/j.ijsolstr.2006.03.001
   Guest JK, 2007, COMPUT METHOD APPL M, V196, P1006, DOI 10.1016/j.cma.2006.08.006
   Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huiskes R, 1997, J MATER SCI-MATER M, V8, P785, DOI 10.1023/A:1018520914512
   Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Hutmacher DW, 2004, TRENDS BIOTECHNOL, V22, P354, DOI 10.1016/j.tibtech.2004.05.006
   Isaksson H, 2008, J THEOR BIOL, V252, P230, DOI 10.1016/j.jtbi.2008.01.030
   Jacobs CR, 2010, ANNU REV BIOMED ENG, V12, P369, DOI 10.1146/annurev-bioeng-070909-105302
   Kang H, 2010, STRUCT MULTIDISCIP O, V42, P633, DOI 10.1007/s00158-010-0508-8
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kelly DJ, 2010, BIRTH DEFECTS RES C, V90, P75, DOI 10.1002/bdrc.20173
   Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026
   Klose D, 2006, INT J PHARMACEUT, V314, P198, DOI 10.1016/j.ijpharm.2005.07.031
   Lacroix D, 2009, PHILOS T R SOC A, V367, P1993, DOI 10.1098/rsta.2009.0024
   LAM CXF, 2008, BIOMED MAT, V3
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   McIntosh L, 2009, ACTA BIOMATER, V5, P680, DOI 10.1016/j.actbio.2008.09.010
   Neogi P., 1996, DIFFUSION POLYM
   Papoulis A., 1991, PROBABILITY RANDOM V
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Sanz-Herrera JA, 2009, ACTA BIOMATER, V5, P219, DOI 10.1016/j.actbio.2008.06.021
   Siepmann J, 2005, BIOMACROMOLECULES, V6, P2312, DOI 10.1021/bm050228k
   Stops AJF, 2010, J BIOMECH, V43, P618, DOI 10.1016/j.jbiomech.2009.10.037
   Sturm S, 2010, J BIOMECH, V43, P1738, DOI 10.1016/j.jbiomech.2010.02.020
   Sun W, 2004, BIOTECHNOL APPL BIOC, V39, P29, DOI 10.1042/BA20030108
   THOMBRE AG, 1985, AICHE J, V31, P759, DOI 10.1002/aic.690310509
   Tracy MA, 1999, BIOMATERIALS, V20, P1057, DOI 10.1016/S0142-9612(99)00002-2
   Tsubota K, 2009, J BIOMECH, V42, P1088, DOI 10.1016/j.jbiomech.2009.02.030
   van der Meulen MCH, 2002, J BIOMECH, V35, P401, DOI 10.1016/S0021-9290(01)00184-1
   Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231
   von Burkersroda F, 2002, BIOMATERIALS, V23, P4221, DOI 10.1016/S0142-9612(02)00170-9
NR 53
TC 63
Z9 63
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2011
VL 32
IS 22
BP 5003
EP 5014
DI 10.1016/j.biomaterials.2011.03.064
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 780ZP
UT WOS:000291900700003
PM 21529933
DA 2018-10-20
ER

PT J
AU Furlani, EP
   Biswas, R
   Cartwright, AN
   Litchinitser, NM
AF Furlani, Edward P.
   Biswas, Roshni
   Cartwright, Alexander N.
   Litchinitser, Natalia M.
TI Antiresonant guiding optofluidic biosensor
SO OPTICS COMMUNICATIONS
LA English
DT Article
DE Optofluidic biosensor; Photonic bandgap biosensor; Microstructure
   optical fiber; ARROW waveguide biosensor
ID OPTICAL WAVE-GUIDES; PROTEIN-DETECTION; SENSORS
AB We propose a novel optofluidic biosensor in which detection is based on a shift in the transmission spectrum due to the contrast in refractive index between the carrier fluid and the target biomaterial. The sensor can function using focused illumination without the need for fiber or waveguide coupled input/output signals. We study the spectral response of the sensor using 20 full-wave time-harmonic field analysis and perform parametric analysis of detection sensitivity as a function of material and device parameters. Our analysis demonstrates that detectible shifts in the transmission spectrum can be achieved with nanoscale accumulation of biomaterial within the sensor. We show that the transmission minima and detection sensitivity can be estimated using analytical expressions based on a 1D antiresonant waveguide model. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Furlani, Edward P.; Biswas, Roshni; Cartwright, Alexander N.; Litchinitser, Natalia M.] SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.
   [Furlani, Edward P.; Cartwright, Alexander N.] SUNY Buffalo, Inst Lasers Photon & Biophoton, Buffalo, NY 14260 USA.
   [Furlani, Edward P.] SUNY Buffalo, Chem & Biol Engn Dept, Buffalo, NY 14260 USA.
RP Furlani, EP (reprint author), SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.
EM efurlani@buffalo.edu
RI Cartwright, Alexander/C-4380-2008
OI Cartwright, Alexander/0000-0002-0921-8036
FU US Air Force Office of Scientific Research [FA95501010216]
FX This work was partially supported by the US Air Force Office of
   Scientific Research, Award # FA95501010216.
CR ARCHAMBAULT JL, 1993, J LIGHTWAVE TECHNOL, V11, P416, DOI 10.1109/50.219574
   Armani AM, 2007, SCIENCE, V317, P783, DOI 10.1126/science.1145002
   BABA T, 1992, IEEE J QUANTUM ELECT, V28, P1689, DOI 10.1109/3.142556
   DUGUAY MA, 1986, APPL PHYS LETT, V49, P13, DOI 10.1063/1.97085
   Fang XY, 2006, IEEE SENS J, V6, P661, DOI 10.1109/JSEN.2006.874021
   Furlani EP, 2009, J MOD OPTIC, V56, P523, DOI 10.1080/09500340802582706
   Furlani EP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026607
   Hu JJ, 2009, J OPT SOC AM B, V26, P1032, DOI 10.1364/JOSAB.26.001032
   Lee M, 2007, OPT EXPRESS, V15, P4530, DOI 10.1364/OE.15.004530
   Litchinitser NM, 2005, APPL PHYS B-LASERS O, V81, P347, DOI 10.1007/s00340-005-1880-0
   Litchinitser NM, 2004, OPT EXPRESS, V12, P1540, DOI 10.1364/OPEX.12.001540
   Litchinitser NM, 2002, OPT LETT, V27, P1592, DOI 10.1364/OL.27.001592
   LUA B, 1996, ANALYST, V121, pR29
   Monat C, 2007, NAT PHOTONICS, V1, P106, DOI 10.1038/nphoton.2006.96
   Psaltis D, 2006, NATURE, V442, P381, DOI 10.1038/nature05060
   Schmidt H, 2008, MICROFLUID NANOFLUID, V4, P3, DOI 10.1007/s10404-007-0199-7
   Svedendahl M, 2009, NANO LETT, V9, P4428, DOI 10.1021/nl902721z
   Vollmer F, 2002, APPL PHYS LETT, V80, P4057, DOI 10.1063/1.1482797
   White IM, 2008, OPT EXPRESS, V16, P1020, DOI 10.1364/OE.16.001020
   Yalcin A, 2006, IEEE J SEL TOP QUANT, V12, P148, DOI 10.1109/JSTQE.2005.863003
   Zheltikov AM, 2008, APPL OPTICS, V47, P474, DOI 10.1364/AO.47.000474
NR 21
TC 7
Z9 8
U1 1
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0030-4018
J9 OPT COMMUN
JI Opt. Commun.
PD AUG 1
PY 2011
VL 284
IS 16-17
BP 4094
EP 4098
DI 10.1016/j.optcom.2011.04.014
PG 5
WC Optics
SC Optics
GA 781HA
UT WOS:000291920000049
DA 2018-10-20
ER

PT J
AU Boerckel, JD
   Kolambkar, YM
   Dupont, KM
   Uhrig, BA
   Phelps, EA
   Stevens, HY
   Garcia, AJ
   Guldberg, RE
AF Boerckel, Joel D.
   Kolambkar, Yash M.
   Dupont, Kenneth M.
   Uhrig, Brent A.
   Phelps, Edward A.
   Stevens, Hazel Y.
   Garcia, Andres J.
   Guldberg, Robert E.
TI Effects of protein dose and delivery system on BMP-mediated bone
   regeneration
SO BIOMATERIALS
LA English
DT Article
DE BMP (bone morphogenetic protein); Drug release; Alginate; Hydrogel;
   Collagen; Bone tissue engineering
ID GROWTH-FACTOR DELIVERY; CONTROLLED SCAFFOLD DEGRADATION; MARROW STROMAL
   CELLS; MORPHOGENETIC PROTEIN-2; IN-VIVO; EXTRACELLULAR-MATRIX;
   SPINAL-FUSION; LUMBAR FUSION; CLINICAL-APPLICATIONS; BIOLOGICAL-ACTIVITY
AB Delivery of recombinant proteins is a proven therapeutic strategy to promote endogenous repair mechanisms and tissue regeneration. Bone morphogenetic protein-2 (rhBMP-2) has been used to promote spinal fusion and repair of challenging bone defects; however, the current clinically-used carrier, absorbable collagen sponge, requires high doses and has been associated with adverse complications. We evaluated the hypothesis that the relationship between protein dose and regenerative efficacy depends on delivery system. First, we determined the dose-response relationship for rhBMP-2 delivered to 8-mm rat bone defects in a hybrid nanofiber mesh/alginate delivery system at six doses ranging from 0 to 5 mu g. Next, we directly compared the hybrid delivery system to the collagen sponge at 0.1 and 1.0 mu g. Finally, we compared the in vivo protein release properties of the two delivery methods. In the hybrid delivery system, bone volume, connectivity and mechanical properties increased in a dose-dependent manner to rhBMP-2. Consistent bridging of the defect was observed for doses of 1.0 mu g and greater. Compared to collagen sponge delivery at the same 1.0 mu g dose, the hybrid system yielded greater connectivity by week 4 and 2.5-fold greater bone volume by week 12. These differences may be explained by the significantly greater protein retention in the hybrid system compared to collagen sponge. This study demonstrates a clear dose-dependent effect of rhBMP-2 delivered using a hybrid nanofiber mesh/alginate delivery system. Furthermore, the effective dose was found to vary with delivery system, demonstrating the importance of biomaterial carrier properties in the delivery of recombinant proteins. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Boerckel, Joel D.; Kolambkar, Yash M.; Dupont, Kenneth M.; Uhrig, Brent A.; Phelps, Edward A.; Stevens, Hazel Y.; Garcia, Andres J.; Guldberg, Robert E.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   [Boerckel, Joel D.; Dupont, Kenneth M.; Uhrig, Brent A.; Phelps, Edward A.; Stevens, Hazel Y.; Garcia, Andres J.; Guldberg, Robert E.] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   [Kolambkar, Yash M.; Guldberg, Robert E.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
RP Guldberg, RE (reprint author), Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, 315 Ferst Dr NW, Atlanta, GA 30332 USA.
EM joel.boerckel@gatech.edu; yashk@gatech.edu; kennethmdupont@yahoo.com;
   brent.uhrig@gatech.edu; eaphelps@gatech.edu;
   hazel.stevens@me.gatech.edu; andres.garcia@me.gatech.edu;
   robert.guldberg@me.gatech.edu
RI Phelps, Edward/Q-1302-2016; Boerckel, Joel/A-7223-2015
OI Phelps, Edward/0000-0001-8666-805X; 
FU NIH [R01 AR051336]; AFIRM; DoD
FX This work was supported by grants from the NIH (R01 AR051336), AFIRM,
   and DoD. The authors would like to thank the following individuals: Dr.
   David Mooney, for providing the RGD-alginate and Dr. Laura O'Farrell,
   for assistance with animal studies. We gratefully acknowledge Angela
   Lin, Dr. Tamim Diab, Dr. Mela Johnson, Christopher Dosier, Jessica
   O'Neal, Jason Wang, Tanushree Thote, Alice Li, and Ashley Allen for
   their assistance in surgeries.
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Benglis D, 2008, NEUROSURGERY, V62, P423, DOI 10.1227/01.neu.0000326030.24220.d8
   BERREY BH, 1990, J BONE JOINT SURG AM, V72A, P825, DOI 10.2106/00004623-199072060-00005
   Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P81, DOI 10.1002/term.74
   Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005
   Boerckel JD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3148472
   Brown KV, 2011, TISSUE ENG A
   Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956
   Dahabreh Z, 2009, INT ORTHOP, V33, P1407, DOI 10.1007/s00264-008-0709-6
   Delgado JJ, 2006, J CONTROL RELEASE, V114, P223, DOI 10.1016/j.jconrel.2006.05.026
   Ebara S, 2002, SPINE, V27, pS10, DOI 10.1097/01.BRS.0000020727.98493.20
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Friess W, 1999, INT J PHARM, V185, P51, DOI 10.1016/S0378-5173(99)00128-3
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, P1
   Garrison KR, 2007, HEALTH TECHNOL ASSES, V11, piii
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Guldberg RE, 2009, J BONE MINER RES, V24, P1507, DOI [10.1359/JBMR.090801, 10.1359/jbmr.090801]
   Haidar ZS, 2010, BIOMATERIALS, V31, P2746, DOI 10.1016/j.biomaterials.2009.12.034
   Johnsson R, 2002, SPINE, V27, P2654, DOI 10.1097/00007632-200212010-00004
   Jones AL, 2006, J BONE JOINT SURG AM, V88A, P1431, DOI 10.2106/JBJS.E.00381
   Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21
   Kempen DHR, 2008, J CONTROL RELEASE, V130, P15, DOI 10.1016/j.jconrel.2008.05.004
   Kempen DHR, 2009, J CONTROL RELEASE, V134, P169, DOI 10.1016/j.jconrel.2008.11.023
   Koefoed M, 2005, MOL THER, V12, P212, DOI 10.1016/j.ymthe.2005.02.026
   Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Li B, 2009, BIOMATERIALS, V30, P6768, DOI 10.1016/j.biomaterials.2009.08.038
   LI M, 1996, BONE, V18, P53
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   McKay B, 2002, SPINE, V27, pS66, DOI 10.1097/01.BRS.0000020738.16636.B3
   Mehta G, 2010, BIOMATERIALS, V31, P4657, DOI 10.1016/j.biomaterials.2010.01.138
   Minear S, 2010, J BONE MINER RES, V25, P1196, DOI 10.1002/jbmr.29
   Oest ME, 2007, J ORTHOP RES, V25, P941, DOI 10.1002/jor.20372
   Orthopaedic and Rehabilitation Devices Advisory Panel, 2010, USFADA EX SUMM P0500
   Paramore CG, 1999, NEUROSURGERY, V44, P1151, DOI 10.1097/00006123-199905000-00134
   PARAMORE CG, 1999, NEUROSURGERY, V44, P1155
   PATTERSON, 2010, BIOMATERIALS, V31, P6772
   Peters MC, 1998, J BIOMAT SCI-POLYM E, V9, P1267, DOI 10.1163/156856298X00389
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Platt MO, 2009, J CELL PHYSIOL, V221, P306, DOI 10.1002/jcp.21854
   PUTNAM C, 2010, PROTEIN CALCULATOR V
   Rihn JA, 2010, SPINE, V35, P1629, DOI 10.1097/BRS.0b013e3181d25803
   Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006
   ROSENBERG L, 1971, J BONE JOINT SURG AM, VA 53, P69, DOI 10.2106/00004623-197153010-00007
   Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z
   Ruhe PQ, 2005, J CONTROL RELEASE, V106, P162, DOI 10.1016/j.jconrel.2005.04.018
   Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x
   SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109
   SAMPATH TK, 1981, P NATL ACAD SCI-BIOL, V78, P7599, DOI 10.1073/pnas.78.12.7599
   SAMPATH TK, 1983, P NATL ACAD SCI-BIOL, V80, P6591, DOI 10.1073/pnas.80.21.6591
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Seeherman H, 2002, SPINE, V27, pS16, DOI 10.1097/01.BRS.0000020728.34131.03
   Silva EA, 2007, J THROMB HAEMOST, V5, P590, DOI 10.1111/j.1538-7836.2007.02386.x
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   Swiontkowski MF, 2006, J BONE JOINT SURG AM, V88A, P1258, DOI 10.2106/JBJS.E.00499
   Uludag H, 2001, J BONE JOINT SURG AM, V83A, pS128
   URIST MR, 1971, J DENT RES, V50, P1392, DOI 10.1177/00220345710500060601
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   URIST MR, 1979, P NATL ACAD SCI USA, V76, P1828, DOI 10.1073/pnas.76.4.1828
   Vaccaro AR, 2004, SPINE, V29, P1885, DOI 10.1097/01.brs.0000137062.79201.98
   Visser R, 2009, BIOMATERIALS, V30, P2032, DOI 10.1016/j.biomaterials.2008.12.046
   Wang Y, 2010, J BIOMED MATER RES A, V92A, P693, DOI 10.1002/jbm.a.32190
   Wei GB, 2007, BIOMATERIALS, V28, P2087, DOI 10.1016/j.biomaterials.2006.12.028
   Winn SR, 1999, CLIN ORTHOP RELAT R, pS95
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   You JO, 2001, J MICROENCAPSUL, V18, P521
   Zhang XP, 2008, CLIN ORTHOP RELAT R, V466, P1777, DOI 10.1007/s11999-008-0312-6
NR 71
TC 154
Z9 157
U1 3
U2 55
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2011
VL 32
IS 22
BP 5241
EP 5251
DI 10.1016/j.biomaterials.2011.03.063
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 780ZP
UT WOS:000291900700027
PM 21507479
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Williams, RJ
   Hall, TE
   Glattauer, V
   White, J
   Pasic, PJ
   Sorensen, AB
   Waddington, L
   McLean, KM
   Currie, PD
   Hartley, PG
AF Williams, Richard J.
   Hall, Thomas E.
   Glattauer, Veronica
   White, Jacinta
   Pasic, Paul J.
   Sorensen, Anders B.
   Waddington, Lynne
   McLean, Keith M.
   Currie, Peter D.
   Hartley, Patrick G.
TI The in vivo performance of an enzyme-assisted self-assembled
   peptide/protein hydrogel
SO BIOMATERIALS
LA English
DT Article
DE Self assembly; Peptide; Animal model; Hydrogel; ECM (extracellular
   matrix); Laminin
ID CONGENITAL MUSCULAR-DYSTROPHY; EXTRACELLULAR-MATRIX; BIOMATERIALS;
   NANOFIBERS; ZEBRAFISH; SCAFFOLDS; CHEMISTRY; COATINGS; CELLS; GENE
AB We demonstrate the distribution of the important extracellular matrix protein laminin in a novel biomaterial consisting of a hydrogel underpinned by nanofibrillar networks. These are formed by the immobilised enzyme mediated self-assembly of fmoc-L(3) (9-fluorenylmethoxycarbonyl-tri-leucine). The peptide assembly yields nanofibrils formed of beta-sheets that are locked together via pi-stacking interactions. This ordering allows the localisation of the peptide sidechains on the surface, creating a hydrophobic environment. This induces the formation of bundles of these nanofibrils producing a clear hydrogel. This mechanism enables the three dimensional distribution of laminin throughout the network via supramolecular interactions. These forces favour the formation and improve the order of the network itself, as observed by spectroscopic and mechanical testing. In order to test the stability and suitability of this class of material for in vivo applications, we utilise microinjection to deliver the biomaterial under fine spatial control into a dystrophic zebrafish model organism, which lacks laminin as a result of a genetic mutation. Using confocal and transmission electron microscopy, we confirm that the biomaterial remains stable structurally, and is confined spatially to the site of injection. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
C1 [Williams, Richard J.; Glattauer, Veronica; White, Jacinta; Pasic, Paul J.; Sorensen, Anders B.; Waddington, Lynne; McLean, Keith M.; Hartley, Patrick G.] CSIRO Mat Sci & Engn, Ian Wark Labs, Clayton, Vic 3169, Australia.
   [Hall, Thomas E.; Currie, Peter D.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.
RP Williams, RJ (reprint author), CSIRO Mat Sci & Engn, Ian Wark Labs, Bag 10, Clayton, Vic 3169, Australia.
EM Richard.Williams@CSIRO.au
RI Waddington, Lynne/H-3500-2013; Sorensen, Anders/D-5209-2013; Hall,
   Thomas/J-2125-2014; Hartley, Patrick/C-1862-2015; White,
   Jacinta/D-6961-2013; McLean, Keith/H-1568-2011; Glattauer,
   veronica/A-9435-2018
OI Hall, Thomas/0000-0002-7718-7614; Hartley, Patrick/0000-0002-2692-2682;
   White, Jacinta/0000-0002-4855-0170; Currie, Peter/0000-0001-8874-8862
FU NHMRC [573709]
FX The authors would like to thank S. Littler for assistance with HPLC, Dr.
   F. Burgmann for assistance with the AFM and Drs. K. Styan and N. Cooley
   for manuscript review. Prof PD Currie and Dr TE Hall were funded via
   NHMRC Project Grant number 573709.
CR Branco MC, 2010, BIOMATERIALS, V31, P9527, DOI 10.1016/j.biomaterials.2010.08.047
   Cheng G, 2010, LANGMUIR, V26, P4990, DOI 10.1021/la903678e
   Corbett PT, 2006, CHEM REV, V106, P3652, DOI 10.1021/cr020452p
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Guilbaud JB, 2010, LANGMUIR, V26, P11297, DOI 10.1021/la100623y
   Hall TE, 2007, P NATL ACAD SCI USA, V104, P7092, DOI 10.1073/pnas.0700942104
   HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216
   Hirst AR, 2010, NAT CHEM, V2, P1089, DOI 10.1038/NCHEM.861
   IGOUCHEVA K, 2008, J INVEST DERMATOL, V128, P1476
   Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Kobe B, 1996, NAT STRUCT BIOL, V3, P977, DOI 10.1038/nsb1296-977
   KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6
   Kopecek J, 2007, BIOMATERIALS, V28, P5185, DOI 10.1016/j.biomaterials.2007.07.044
   Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343
   Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241
   Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Mahmoud ZN, 2010, BIOMATERIALS, V31, P7468, DOI 10.1016/j.biomaterials.2010.06.041
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Rieger Sandra, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4772
   Robbins PB, 2001, HUM GENE THER, V12, P1443, DOI 10.1089/104303401750298599
   Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith AM, 2008, ADV MATER, V20, P37, DOI 10.1002/adma.200701221
   Snatzke G., 1967, OPTICAL ROTATORY DIS
   Tang C, 2009, LANGMUIR, V25, P9447, DOI 10.1021/la900653q
   Toledano S, 2006, J AM CHEM SOC, V128, P1070, DOI 10.1021/ja056549l
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Westerfield M., 2000, ZEBRAFISH BOOK GUIDE
   Williams RJ, 2010, BIOPOLYMERS, V94, P107, DOI 10.1002/bip.21346
   Williams RJ, 2009, NAT NANOTECHNOL, V4, P19, DOI [10.1038/nnano.2008.378, 10.1038/NNANO.2008.378]
   Xu HX, 2010, NANOSCALE, V2, P960, DOI 10.1039/b9nr00233b
   Yan CQ, 2010, SOFT MATTER, V6, P5143, DOI 10.1039/c0sm00642d
   Zelzer M, 2010, CHEM SOC REV, V39, P3351, DOI 10.1039/c0cs00035c
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang Y, 2003, J AM CHEM SOC, V125, P13680, DOI 10.1021/ja036817k
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
NR 39
TC 44
Z9 45
U1 0
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2011
VL 32
IS 22
BP 5304
EP 5310
DI 10.1016/j.biomaterials.2011.03.078
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 780ZP
UT WOS:000291900700033
PM 21531457
DA 2018-10-20
ER

PT J
AU Caliari, SR
   Harley, BAC
AF Caliari, Steven R.
   Harley, Brendan A. C.
TI The effect of anisotropic collagen-GAG scaffolds and growth factor
   supplementation on tendon cell recruitment, alignment, and metabolic
   activity
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Scaffold; Tendon; Growth factors; Porosity
ID MESENCHYMAL STEM-CELLS; BONE INSERTION SITE; IN-VITRO; BIODEGRADABLE
   SCAFFOLDS; NANOFIBER SCAFFOLDS; CROSS-LINKING; FLEXOR TENDON; PORE-SIZE;
   PROLIFERATION; REGENERATION
AB Current surgical and tissue engineering approaches for treating tendon injuries have shown limited success, suggesting the need for new biomaterial strategies. Here we describe the development of an anisotropic collagen-glycosaminoglycan (CG) scaffold and use of growth factor supplementation strategies to create a 3D platform for tendon tissue engineering. We fabricated cylindrical CG scaffolds with aligned tracks of ellipsoidal pores that mimic the native physiology of tendon by incorporating a directional solidification step into a conventional lyophilization strategy. By modifying the freezing temperature, we created a homologous series of aligned CG scaffolds with constant relative density and degree of anisotropy but a range of pore sizes (55-243 mu m). Equine tendon cells showed greater levels of attachment, metabolic activity, and alignment as well as less cell-mediated scaffold contraction, when cultured in anisotropic scaffolds compared to an isotropic CG scaffold control. The anisotropic CG scaffolds also provided critical contact guidance cues for cell alignment. While tendon cells were randomly oriented in the isotropic control scaffold and the transverse (unaligned) plane of the anisotropic scaffolds, significant cell alignment was observed in the direction of the contact guidance cues in the longitudinal plane of the anisotropic scaffolds. Scaffold pore size was found to significantly influence tendon cell viability, proliferation, penetration into the scaffold, and metabolic activity in a manner predicted by cellular solids arguments. Finally, the addition of the growth factors PDGF-BB and IGF-1 to aligned CG scaffolds was found to enhance tendon cell motility, viability, and metabolic activity in dose-dependent manners. This work suggests a composite strategy for developing bioactive, 3D material systems for tendon tissue engineering. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Harley, Brendan A. C.] Univ Illinois, Dept Chem & Biomol Engn, Inst Genom Biol, Roger Adams Lab 110, Urbana, IL 61801 USA.
RP Harley, BAC (reprint author), Univ Illinois, Dept Chem & Biomol Engn, Inst Genom Biol, Roger Adams Lab 110, 600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X; Caliari, Steven/0000-0002-7506-3079
FU NIH NIGMS [T32GM070421]; Chemical and Biomolecular Engineering Dept.;
   Institute for Genomic Biology at the University of Illinois at
   Urbana-Champaign; U.S. Department of Energy [DE-FG02-07ER46453,
   DE-FG02-07ER46471]
FX The authors would like to acknowledge Dr. Allison Stewart and Dr.
   Matthew Stewart (Veterinary Sciences, UIUC) for providing equine tendon
   cells, Karen Doty (Veterinary Sciences, UIUC) for sectioning of GMA
   embedded samples, Donna Epps for sectioning and staining of paraffin
   embedded samples, and Dr. Charles Schroeder (ChBE, UIUC) for the use of
   his fluorescence spectrophotometer. We are grateful for the funding for
   this study provided by the Chemistry-Biology Interface Training Program
   NIH NIGMS T32GM070421 (SRC), the Chemical and Biomolecular Engineering
   Dept. (BAH), and the Institute for Genomic Biology (BAH) at the
   University of Illinois at Urbana-Champaign. This research was carried
   out in part in the Frederick Seitz Materials Research Laboratory Central
   Facilities, University of Illinois, which are partially supported by the
   U.S. Department of Energy under grants DE-FG02-07ER46453 and
   DE-FG02-07ER46471.
CR ABRAHAMSSON SO, 1991, J ORTHOPAED RES, V9, P495, DOI 10.1002/jor.1100090405
   Agrawal CM, 2000, BIOMATERIALS, V21, P2443, DOI 10.1016/S0142-9612(00)00112-5
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Cole DW, 2005, ARTHROSCOPY, V21, P786, DOI 10.1016/j.arthro.2005.04.102
   Costa MA, 2006, TISSUE ENG, V12, P1937, DOI 10.1089/ten.2006.12.1937
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Dines JS, 2007, J SHOULDER ELB SURG, V16, p204S, DOI 10.1016/j.jse.2007.03.004
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Fonck E, 2009, STROKE, V40, P2552, DOI 10.1161/STROKEAHA.108.528091
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Gibson L. J, 1997, CELLULAR SOLIDS STRU
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Haugh JM, 2006, BIOPHYS J, V90, P2297, DOI 10.1529/biophysj.105.077610
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Kapoor A, 2010, ACTA BIOMATER, V6, P2580, DOI 10.1016/j.actbio.2009.12.047
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   Li XR, 2009, NANO LETT, V9, P2763, DOI 10.1021/nl901582f
   Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049
   Liu Y, 2008, TRENDS BIOTECHNOL, V26, P201, DOI 10.1016/j.tibtech.2008.01.003
   Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054
   LOREE HM, 1989, P 15 ANN NE BIOENG C, P53
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Martin TA, 2011, BIOMATERIALS, V32, P3949, DOI 10.1016/j.biomaterials.2011.02.018
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Ozaki Y, 2007, STEM CELLS DEV, V16, P119, DOI 10.1089/scd.2006.0032
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770
   Soo C, 2003, AM J PATHOL, V163, P2459, DOI 10.1016/S0002-9440(10)63601-2
   Spilker MH, 2001, BIOMATERIALS, V22, P1085, DOI 10.1016/S0142-9612(00)00345-8
   Steinert AF, 2007, TISSUE ENG, V13, P2227, DOI 10.1089/ten.2006.0270
   Thomopoulos S, 2005, J HAND SURG-AM, V30A, P441, DOI 10.1016/j.jhsa.2004.12.006
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Xie JW, 2010, NANOSCALE, V2, P923, DOI 10.1039/c0nr00192a
   Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4
   Yannas I., 2001, TISSUE ORGAN REGENER
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Yoshikawa Y, 2001, ACTA ORTHOP SCAND, V72, P287, DOI 10.1080/00016470152846646
   Zhu J, 2010, BIOMATERIALS, V31, P6952, DOI 10.1016/j.biomaterials.2010.05.058
NR 56
TC 94
Z9 96
U1 3
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2011
VL 32
IS 23
BP 5330
EP 5340
DI 10.1016/j.biomaterials.2011.04.021
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 780ZR
UT WOS:000291900900003
PM 21550653
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zheng, Y
   Henderson, PW
   Choi, NW
   Bonassar, LJ
   Spector, JA
   Stroock, AD
AF Zheng, Ying
   Henderson, Peter W.
   Choi, Nak Won
   Bonassar, Lawrence J.
   Spector, Jason A.
   Stroock, Abraham D.
TI Microstructured templates for directed growth and vascularization of
   soft tissue in vivo
SO BIOMATERIALS
LA English
DT Article
DE Vascularization; Tissue template; Microfabrication; Directed invasion
ID EXTRACELLULAR-MATRIX; FACTOR DELIVERY; SCAFFOLDS; SKIN; FIBROBLAST;
   RELEASE; OPPORTUNITIES; REGENERATION; ARCHITECTURE; BIOMATERIAL
AB Tissue templates for reconstruction and regeneration in vivo have achieved clinical successes for homogeneous tissues in well vascularized regions. Outstanding challenges exist for applications in poorly vascularized regions and for spatially differentiated tissues. Here, we present a strategy to control the spatial patterns of cell and vascular ingrowth throughout the volume of a bioremodelable and resorbable matrix via well-defined micropores and networks of microchannels. Our presentation of this approach includes: a description of a lithographic technique to form deterministic microstructures within a matrix of native collagen; elucidation of multistep process by which microstructures drive rapid invasion and vascularization; and demonstration of long range guidance of invasion through the full thickness of patterned templates. Experiments were performed in a murine wound model. These microstructured tissue templates (MITs) could improve outcomes in reconstructive surgery and open paths to directed regeneration of spatially heterogeneous tissues or organs. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Zheng, Ying; Choi, Nak Won; Stroock, Abraham D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
   [Henderson, Peter W.; Spector, Jason A.] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA.
   [Bonassar, Lawrence J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Dept Biomed Engn, Ithaca, NY 14853 USA.
   [Stroock, Abraham D.] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA.
RP Stroock, AD (reprint author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
EM jas2037@med.cornell.edu; ads10@cornell.edu
RI Choi, Nakwon/K-8915-2013; Henderson, Peter/O-1053-2017; Bonassar,
   Lawrence/C-2103-2016
OI Choi, Nakwon/0000-0003-2993-9233; Henderson, Peter/0000-0002-8392-7180;
   Bonassar, Lawrence/0000-0003-1094-6433; Zheng, Ying/0000-0003-2723-9022
FU Morgan Fund for Tissue Engineering; NYSTAR; Arnold and Mabel Beckman
   Foundation; Human Frontiers in Science Programme; Empire Clinical
   Research Investigator Program; Cornell Nanobiotechnology Center; Cornell
   Center for Nanoscale Science the Cornell Nanobiotechnology Center; STC
   of the National Science Foundation [ECS-9876771]
FX We acknowledge the technical assistance of G. Swan and J.J. Ballyns. We
   acknowledge the helpful discussions with A. Diaz-Santana, V.L. Cross and
   A. Reiffel. We acknowledge the financial support of the Morgan Fund for
   Tissue Engineering, NYSTAR, the Arnold and Mabel Beckman Foundation
   Young Investigator Award, the Human Frontiers in Science Programme, the
   Empire Clinical Research Investigator Program, the Cornell
   Nanobiotechnology Center and the Cornell Center for Nanoscale Science
   the Cornell Nanobiotechnology Center (supported by the STC Program of
   the National Science Foundation under Agreement No. ECS-9876771).
CR Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Barry RA, 2009, ADV MATER, V21, P2407, DOI 10.1002/adma.200803702
   Baum CL, 2005, DERMATOL SURG, V31, P674
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   BLOTNICK S, 1994, P NATL ACAD SCI USA, V91, P2890, DOI 10.1073/pnas.91.8.2890
   Brem H, 2000, ARCH SURG-CHICAGO, V135, P627, DOI 10.1001/archsurg.135.6.627
   Cabodi M, 2005, J AM CHEM SOC, V127, P13788, DOI 10.1021/ja054820t
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chen RR, 2007, PHARM RES, V24, P258, DOI 10.1007/s11095-006-9173-4
   Chin CD, 2008, BIOMED MICRODEVICES, V10, P459, DOI 10.1007/s10544-007-9155-2
   Cho CH, 2007, BIOTECHNOL BIOENG, V97, P188, DOI 10.1002/bit.21225
   Choi NW, 2007, NAT MATER, V6, P908, DOI 10.1038/nmat2022
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   Cross VL, 2010, BIOMATERIALS, V31, P8596, DOI 10.1016/j.biomaterials.2010.07.072
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2000, NATURE, V408, P998
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   Ott HC, 2010, NAT MED, V16, P927, DOI 10.1038/nm.2193
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   ROSS R, 1968, BIOL REV, V43, P51, DOI 10.1111/j.1469-185X.1968.tb01109.x
   Sanders JE, 2002, J BIOMED MATER RES, V60, P36, DOI 10.1002/jbm.1279
   Saxena V, 2004, PLAST RECONSTR SURG, V114, P1086, DOI 10.1097/01.prs.0000135330.51408.97
   Semenza GL, 2000, J APPL PHYSIOL, V88, P1474
   Seo YK, 2007, ARTIF ORGANS, V31, P509, DOI 10.1111/j.1525-1594.2007.00417.x
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Tang MD, 2004, ADV MATER, V16, P1345, DOI 10.1002/adma.200400766
   Timoshenko S. P., 1970, THEORY ELASTICITY
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
NR 45
TC 31
Z9 31
U1 0
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2011
VL 32
IS 23
BP 5391
EP 5401
DI 10.1016/j.biomaterials.2011.04.001
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 780ZR
UT WOS:000291900900009
PM 21549426
DA 2018-10-20
ER

PT J
AU Du, J
   Che, PL
   Wang, ZY
   Aich, U
   Yarema, KJ
AF Du, Jian
   Che, Pao-Lin
   Wang, Zhi-Yun
   Aich, Udayanath
   Yarema, Kevin J.
TI Designing a binding interface for control of cancer cell adhesion via 3D
   topography and metabolic oligosaccharide engineering
SO BIOMATERIALS
LA English
DT Article
DE Cell morphology; Cell spreading; Gold; Leukocyte; Surface modification;
   Surface nanotopography
ID SIALIC-ACID; MANNAC ANALOGS; EXPRESSION; BIOSYNTHESIS; SCAFFOLDS;
   CULTURE; SURFACE; BIOLOGY; THIOLS
AB This study combines metabolic oligosaccharide engineering (MOE), a technology where the glycocalyx of living cells is endowed with chemical features not normally found in sugars, with custom-designed three-dimensional biomaterial substrates to enhance the adhesion of cancer cells and control their morphology and gene expression. Specifically, Ac(5)ManNTGc, a thiol-bearing analog of N-acetyl-D-mannosamine (ManNAc) was used to introduce thiolated sialic acids into the glycocalyx of human Jurkat T-lymphoma derived cells. In parallel 2D films and 3D electrospun nanofibrous scaffolds were prepared from polyethersulfone (PES) and (as controls) left unmodified or aminated. Alternately, the materials were malemided or gold-coated to provide bio-orthogonal binding partners for the thiol groups newly expressed on the cell surface. Cell attachment was modulated by both the topography of the substrate surface and by the chemical compatibility of the binding interface between the cell and the substrate: a substantial increase in binding for normally non-adhesive Jurkat line for 3D scaffold compared to 2D surfaces with an added degree of adhesion resulting from chemoselective binding to malemidede-derivatived or gold-coated surfaces. In addition, the morphology of the cells attached to the 3D scaffolds via MOE-mediated adhesion was dramatically altered and the expression of genes involved in cell adhesion changed in a time-dependent manner. This study showed that cell adhesion could be enhanced, gene expression modulated, and cell fate controlled by introducing the 3D topograhical cues into the growth substrate and by creating a glycoengineered binding interface where the chemistry of both the cell surface and biomaterials scaffold was controlled to facilitate a new mode of carbohydrate-mediated adhesion. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Yarema, Kevin J.] Johns Hopkins Univ, Translat Tissue Engn Ctr, Dept Biomed Engn, Baltimore, MD 21218 USA.
RP Yarema, KJ (reprint author), Johns Hopkins Univ, Translat Tissue Engn Ctr, Dept Biomed Engn, 5029 Robert & Clarice Smith Bldg,400 N Broadway, Baltimore, MD 21218 USA.
EM kyarema1@jhu.edu
OI DU, JIAN/0000-0001-7154-8987
FU National Institute for Biomedical Imaging and Bioengineering [EB
   005692-04]; National Cancer Institute [CA112314-05]
FX Funding for this study was primarily provided by the National Institute
   for Biomedical Imaging and Bioengineering (EB 005692-04) except for
   ManNAc analog synthesis, which was supported by the National Cancer
   Institute (CA112314-05).
CR Campbell CT, 2007, MOL BIOSYST, V3, P187, DOI 10.1039/b614939c
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017
   Dhiman HK, 2005, BIOMATERIALS, V26, P979, DOI 10.1016/j.biomaterials.2004.04.012
   DU J, 2010, ADV DRUG DELIV REV, V62, P271
   Du J, 2009, GLYCOBIOLOGY, V19, P1382, DOI 10.1093/glycob/cwp115
   Eda S, 2004, J BIOL CHEM, V279, P5967, DOI 10.1074/jbc.M310805200
   Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085
   HUTMACHER OW, 2009, J CELL MOL MED, V13, P1417
   Isaev RN, 2003, J ANAL CHEM+, V58, P435, DOI 10.1023/A:1024017928535
   Jones MB, 2004, BIOTECHNOL BIOENG, V85, P394, DOI 10.1002/bit.10901
   KAKABAKOS SE, 1994, BIOMATERIALS, V15, P289, DOI 10.1016/0142-9612(94)90054-X
   KAYSER H, 1992, J BIOL CHEM, V267, P16934
   Kim EJ, 2004, BIOTECHNOL PROGR, V20, P1674, DOI 10.1021/bp049841q
   Kim EJ, 2004, J BIOL CHEM, V279, P18342, DOI 10.1074/jbc.M400205200
   Kim YJ, 2009, INT J BIOL MACROMOL, V45, P65, DOI 10.1016/j.ijbiomac.2009.04.003
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lemieux GA, 1998, TRENDS BIOTECHNOL, V16, P506, DOI 10.1016/S0167-7799(98)01230-X
   Lim SH, 2010, BIOMATERIALS, V31, P9031, DOI 10.1016/j.biomaterials.2010.08.021
   Lin K, 2007, POLYMER, V48, P6384, DOI 10.1016/j.polymer.2007.08.056
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125
   Pham QP, 2006, BIOMACROMOLECULES, V7, P2796, DOI 10.1021/bm060680j
   Sampathkumar SG, 2006, NAT CHEM BIOL, V2, P149, DOI 10.1038/nchembio770
   Sampathkumar SG, 2006, NAT PROTOC, V1, P1840, DOI 10.1038/nprot.2006.252
   Sampathkumar SG, 2006, NAT PROTOC, V1, P2377, DOI 10.1038/nprot.2006.319
   Sampathkumar SG, 2006, CHEM BIOL, V13, P1265, DOI 10.1016/j.chembiol.2006.09.016
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
   Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200
   Whitesides George M, 2005, Sci Prog, V88, P17, DOI 10.3184/003685005783238462
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
NR 34
TC 17
Z9 17
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2011
VL 32
IS 23
BP 5427
EP 5437
DI 10.1016/j.biomaterials.2011.04.005
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 780ZR
UT WOS:000291900900013
PM 21549424
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Camilleri, J
AF Camilleri, J.
TI Characterization and hydration kinetics of tricalcium silicate cement
   for use as a dental biomaterial
SO DENTAL MATERIALS
LA English
DT Article
DE Hydration kinetics; Leaching; Mineral trioxide aggregate; Portland
   cement; pH; Rietveld X-ray diffraction analysis; Scanning electron
   microscopy; Tricalcium silicate
ID MINERAL TRIOXIDE AGGREGATE; IN-VITRO BIOACTIVITY; SELF-SETTING
   PROPERTIES; WHITE PORTLAND-CEMENT; COMPOSITE BONE-CEMENT; MTA;
   CONSTITUTION; GRAY
AB Objectives. Investigation and characterization of the replacement of the Portland cement component in mineral trioxide aggregate (MTA) with tricalcium silicate cement which is manufactured using the sol-gel method from pure raw materials.
   Methods. Tricalcium silicate and Portland cement were characterized by viewing under the scanning electron microscope (SEM) and surface imaging and elemental analysis with X-ray energy dispersive analysis (EDX), and by X-ray diffraction analysis with Rietveld refinement. In addition the hydration products of the material after 28 days of curing were evaluated by plotting atomic ratio plots from the EDX data. The cement leachate was evaluated for pH and chemical composition by inductively coupled plasma.
   Results. Portland cement was composed of 68% tricalcium silicate. The tricalcium silicate cement was 99% pure. On hydration both cements produced calcium silicate hydrate and calcium hydroxide. The calcium hydroxide was leached in solution with higher leaching in HBSS. The leaching of calcium hydroxide in solution resulted in an alkaline pH. The reaction of calcium with the phosphorus present in HBSS resulting in the deposition of calcium phosphate on the cement surface.
   Significance. Tricalcium silicate could prospectively replace the Portland cement component in MTA. (C) 2011 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 Univ Malta, Dept Dent Surg, Fac Dent Surg, Msida 2080, Msd, Malta.
RP Camilleri, J (reprint author), Univ Malta, Dept Dent Surg, Fac Dent Surg, Msida 2080, Msd, Malta.
EM josette.camilleri@um.edu.mt
RI Camilleri, Josette/N-9409-2015
OI Camilleri, Josette/0000-0003-3556-6365
CR Achternbosch M., 2003, HEAVY METALS CEMENT
   Asgary Saeed, 2004, Aust Endod J, V30, P89
   Bramante CM, 2008, ORAL SURG ORAL MED O, V106, P909, DOI 10.1016/j.tripleo.2008.07.018
   Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x
   Camilleri J, 2007, INT ENDOD J, V40, P462, DOI 10.1111/j.1365-2591.2007.01248.x
   Camilleri J, 2005, DENT MATER, V21, P297, DOI 10.1016/j.dental.2004.05.010
   Camilleri J, 2005, INT ENDOD J, V38, P834, DOI 10.1111/j.1365-2591.2005.01028.x
   Camilleri J, 2011, J ENDODONT, V37, P239, DOI 10.1016/j.joen.2010.11.012
   Chang SW, 2010, ORAL SURG ORAL MED O, V109, P642, DOI 10.1016/j.tripleo.2009.12.017
   Chen CC, 2009, J ENDODONT, V35, P1554, DOI 10.1016/j.joen.2009.08.006
   Chen CC, 2009, J ENDODONT, V35, P1288, DOI 10.1016/j.joen.2009.05.036
   Coleman NJ, 2007, CEMENT CONCRETE RES, V37, P1518, DOI 10.1016/j.cemconres.2007.08.008
   De-Deus G, 2009, J ENDODONT, V35, P887, DOI 10.1016/j.joen.2009.03.003
   Ding SJ, 2009, J MATER CHEM, V19, P1183, DOI 10.1039/b819033j
   Duarte MAH, 2005, ORAL SURG ORAL MED O, V99, P648, DOI 10.1016/j.tripleo.2004.09.015
   Estrela C, 2000, Braz Dent J, V11, P3
   Forbes WF, 1998, EXP GERONTOL, V33, P141, DOI 10.1016/S0531-5565(97)00061-2
   Funteas U R, 2003, Aust Endod J, V29, P43
   Gonçalves Jorge Luis, 2010, Braz. oral res., V24, P277, DOI 10.1590/S1806-83242010000300004
   Huan ZG, 2008, J MATER SCI-MATER M, V19, P2913, DOI 10.1007/s10856-008-3423-4
   Huan ZG, 2007, J BIOMED MATER RES B, V82B, P352, DOI 10.1002/jbm.b.30740
   *ISO EN, 2007, 99171 ISO EN
   Laurent P, 2008, DENT MATER, V24, P1486, DOI 10.1016/j.dental.2008.02.020
   Matsunaga T, 2010, J ENDODONT, V36, P1988, DOI 10.1016/j.joen.2010.08.045
   Neville A. M, 1981, PROPERTIES CONCRETE
   Oliveira Marília Gerhardt de, 2007, Braz. Dent. J., V18, P3, DOI 10.1590/S0103-64402007000100002
   Primus CM, 2006, ORAL SURG ORAL MED O, V101, P416, DOI 10.1016/j.tripleo.2005.09.023
   Reyes-Carmona JF, 2009, J ENDODONT, V35, P731, DOI 10.1016/j.joen.2009.02.011
   Ridi F, 2005, J PHYS CHEM B, V109, P14727, DOI 10.1021/jp050237n
   Sarkar NK, 2005, J ENDODONT, V31, P97, DOI 10.1097/01.DON.0000133155.04468.41
   Schembri M, 2010, J ENDODONT, V36, P1210, DOI 10.1016/j.joen.2010.02.011
   Scrivener KL, 1993, ADV CEM RES, V5, P139
   Taylor HF, 1997, CEMENT CHEM
   Torabinejad M, 1997, J ENDODONT, V23, P225, DOI 10.1016/S0099-2399(97)80051-9
   TORABINEJAD M, 1995, J ENDODONT, V21, P603, DOI 10.1016/S0099-2399(06)81112-X
   Torabinejad M., 1995, US Patent, Patent No. [5769638, 5,769,638]
   Wang XH, 2008, DENT MATER, V24, P74, DOI 10.1016/j.dental.2007.02.006
   Zhao WY, 2008, J BIOMED MATER RES A, V85A, P336, DOI 10.1002/jbm.a.31523
   Zhao WY, 2005, BIOMATERIALS, V26, P6113, DOI 10.1016/j.biomaterials.2005.04.025
NR 39
TC 55
Z9 55
U1 2
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
EI 1879-0097
J9 DENT MATER
JI Dent. Mater.
PD AUG
PY 2011
VL 27
IS 8
BP 836
EP 844
DI 10.1016/j.dental.2011.04.010
PG 9
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 782UH
UT WOS:000292037200015
PM 21600643
DA 2018-10-20
ER

PT J
AU Sarig, U
   Machluf, M
AF Sarig, Udi
   Machluf, Marcelle
TI Engineering cell platforms for myocardial regeneration
SO EXPERT OPINION ON BIOLOGICAL THERAPY
LA English
DT Review
DE cardiomyocyte cell sources; cell therapy; extracellular matrix (ECM);
   injection- and patch-based cell platforms; myocardial infarction;
   myocardial tissue engineering; scaffolds
ID MESENCHYMAL STEM-CELLS; CARDIAC PROGENITOR CELLS; INFARCTED RAT HEARTS;
   CHRONIC ISCHEMIC CARDIOMYOPATHY; ARTIFICIAL EXTRACELLULAR-MATRIX;
   RESPONSIVE CHITOSAN HYDROGEL; LEFT-VENTRICULAR FUNCTION; MARROW
   MONONUCLEAR-CELLS; COLLAGEN-BASED MATRICES; SMALL ANIMAL-MODEL
AB Introduction: Various engineered 'cell-platforms' have been reported in recent years for the possible treatment of myocardial infarction (MI) and end-stage heart failure. These engineered platforms rely on two key factors: cells and/or biomaterial scaffolds for the regeneration of the infarcted heart tissue.
   Areas covered: Two major cell-platform approaches are described and broadly categorized as ''injectable cell platforms'' and ''patch-based cell platforms''. The recent advancements in these cell-platforms in terms of their relative successes in-vivo as well as their clinical feasibility are summarized. Natural as well as synthetic scaffolds, with or without the cellular component, are compared with cell based therapy alone. This review focuses on achievements, as well as the gaps that are presently checking any progress towards producing clinically relevant panacea for myocardial regeneration.
   Expert opinion: Cardiac and induced pluripotent stem cells will probably be the focus of future research. The combined cell-biomaterial scaffold therapy is superior to cell therapy alone. Nevertheless, encouraging pre-clinical successes have limited translation into clinical practice due to limited cell survival post transplantation, inadequate construct thicknesses for human-sized hearts and the traditional use of ''flat (2D) tissue culture'' techniques. The development of complementary dynamic 3D cultivation platforms will probably lead to improved outcomes and enable fast screening of various therapeutic approaches.
C1 [Sarig, Udi; Machluf, Marcelle] Technion Israel Inst Technol, Canc Lab, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.
RP Machluf, M (reprint author), Technion Israel Inst Technol, Canc Lab, Fac Biotechnol & Food Engn, IL-32000 Haifa, Israel.
EM machlufm@tx.technion.ac.il
OI Sarig, Udi/0000-0001-5260-4023
CR Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Akhyari P, 2002, CIRCULATION, V106, pI137, DOI 10.1161/01.cir.0000032893.55215.fc
   Amir G, 2009, CELL TRANSPLANT, V18, P275, DOI 10.3727/096368909788534898
   Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72
   Arbel G, 2010, METHODS MOL BIOL, V660, P85, DOI 10.1007/978-1-60761-705-1_6
   Arminan A, 2010, J CARDIOVASC TRANSL, V3, P61, DOI 10.1007/s12265-009-9144-3
   Arminan A, 2009, STEM CELLS DEV, V18, P907, DOI 10.1089/scd.2008.0292
   Atar D, 2007, CARDIOLOGY, V108, P117, DOI 10.1159/000095982
   Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Banito A, 2010, EMBO REP, V11, P353, DOI 10.1038/embor.2010.47
   Barash Y, 2010, TISSUE ENG PART C-ME, V16, P1417, DOI [10.1089/ten.tec.2010.0068, 10.1089/ten.TEC.2010.0068]
   Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916
   Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303
   Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218
   Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120
   Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32
   Bolli P, 2010, ANN NY ACAD SCI, V1211, P113, DOI 10.1111/j.1749-6632.2010.05814.x
   Bonaros N, 2008, TRANSPLANTATION, V86, P1151, DOI 10.1097/TP.0b013e3181880f9e
   Callegari A, 2007, BIOMATERIALS, V28, P5449, DOI 10.1016/j.biomaterials.2007.07.022
   Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff
   *CED SIN MED CTR, CARD DERV UT STEM CE
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   Chacko SM, 2011, AM J PHYSIOL-CELL PH, V299, pC1562
   Chang Y, 2002, BIOMATERIALS, V23, P2447, DOI 10.1016/S0142-9612(01)00379-9
   Chekanov V, 2003, PACE, V26, P496, DOI 10.1046/j.1460-9592.2003.00080.x
   Chen CH, 2008, CARDIOVASC RES, V80, P88, DOI 10.1093/cvr/cvn149
   Chen QZ, 2010, BIOMATERIALS, V31, P3885, DOI 10.1016/j.biomaterials.2010.01.108
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Christoforou N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011536
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Cortes-Morichetti M, 2007, TISSUE ENG, V13, P2681, DOI 10.1089/ten.2006.0447
   Covas DT, 2003, BRAZ J MED BIOL RES, V36, P1179, DOI 10.1590/S0100-879X2003000900006
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019
   Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dobner S, 2009, J CARD FAIL, V15, P629, DOI 10.1016/j.cardfail.2009.03.003
   Dvir T, 2006, TISSUE ENG, V12, P2843, DOI 10.1089/ten.2006.12.2843
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Eschenhagen T, 1997, FASEB J, V11, P683
   Fernandes S, 2010, J MOL CELL CARDIOL, V49, P941, DOI 10.1016/j.yjmcc.2010.09.008
   Fujimoto KL, 2009, BIOMATERIALS, V30, P4357, DOI 10.1016/j.biomaterials.2009.04.055
   Fukuhara S, 2005, CIRC J, V69, P850, DOI 10.1253/circj.69.850
   Genovese JA, 2009, FRONT BIOSCI-LANDMRK, V14, P2996, DOI 10.2741/3429
   Gepstein L, 2010, STEM CELLS, V28, P2151, DOI 10.1002/stem.545
   Gerecht-Nir S, 2006, INT J DEV BIOL, V50, P233, DOI 10.1387/ijdb.052041sg
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   Giraud MN, 2008, ARTIF ORGANS, V32, P692, DOI 10.1111/j.1525-1594.2008.00595.x
   Giraud MN, 2010, ARTIF ORGANS, V34, pE184, DOI 10.1111/j.1525-1594.2009.00979.x
   Graham HK, 2008, ACTA PHYSIOL, V194, P3, DOI 10.1111/j.1748-1716.2008.01881.x
   Grayson WL, 2009, SEMIN CELL DEV BIOL, V20, P665, DOI 10.1016/j.semcdb.2008.12.008
   Hamdi H, 2009, ANN THORAC SURG, V87, P1196, DOI 10.1016/j.athoracsur.2008.12.074
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   He XQ, 2010, MOL CELL BIOCHEM, V339, P89, DOI 10.1007/s11010-009-0372-2
   Henning RJ, 2007, CELL TRANSPLANT, V16, P907, DOI 10.3727/096368907783338299
   Hess PG, 2009, ACCOUNT RES, V16, P175, DOI 10.1080/08989620903065145
   Hodgson DM, 2004, AM J PHYSIOL-HEART C, V287, pH471, DOI 10.1152/ajpheart.01247.2003
   Hu XH, 2008, J APPL POLYM SCI, V110, P1059, DOI 10.1002/app.28704
   Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971
   Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002
   Ikaria Holdings Inc, IK 5001 PREV REM VEN
   Il Cho Y, 2009, EUR J PHARM BIOPHARM, V73, P59, DOI 10.1016/j.ejpb.2009.04.010
   Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Jiang WH, 2006, TRANSPLANT INT, V19, P570, DOI 10.1111/j.1432-2277.2006.00307.x
   Jiang XJ, 2009, J BIOMED MATER RES A, V90A, P472, DOI 10.1002/jbm.a.32118
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Kanwal S, 2009, ARTIF ORGANS, V33, P87, DOI [10.1111/j.1525-1594.2008.00680.x, 10.1111/j.1525-1594.2008.00681.x]
   Kehat I, 2004, NAT BIOTECHNOL, V22, P1282, DOI 10.1038/nbt1014
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI200112131
   Kelly DJ, 2009, TISSUE ENG PT A, V15, P2189, DOI 10.1089/ten.tea.2008.0430
   Khademhosseini A, 2007, BIOMED MICRODEVICES, V9, P149, DOI 10.1007/s10544-006-9013-7
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim S, 2005, J BIOMED MATER RES A, V75A, P73, DOI 10.1002/jbm.a.30375
   Kochupura PV, 2005, CIRCULATION, V112, pI144, DOI 10.1161/CIRCULATIONAHA.104.524355
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2005, CIRCULATION, V112, pI173, DOI 10.1161/CIRCULATIONAHA.104.526178
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Kutschka I, 2007, J HEART LUNG TRANSPL, V26, P273, DOI 10.1016/j.healun.2006.11.604
   Kutschka I, 2006, CIRCULATION, V114, pI167, DOI 10.1161/CIRCULATIONAHA.105.001297
   Labovsky V, 2010, DIFFERENTIATION, V79, P93, DOI 10.1016/j.diff.2009.10.001
   Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   Lee BH, 2005, MACROMOL BIOSCI, V5, P629, DOI 10.1002/mabi.200500029
   Lee BH, 2005, POLYM INT, V54, P418, DOI 10.1002/pi.1709
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Li RK, 1999, CIRCULATION S, V100, pII63
   Li XY, 2010, CARDIOLOGY, V115, P194, DOI 10.1159/000281840
   Lin QX, 2010, EUR J HEART FAIL, V12, P1179, DOI 10.1093/eurjhf/hfq144
   Lu WN, 2009, TISSUE ENG PT A, V15, P1437, DOI 10.1089/ten.tea.2008.0143
   Lu SH, 2010, TISSUE ENG PT A, V16, P1303, DOI 10.1089/ten.TEA.2009.0434
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Martin-Rendon E, 2008, VOX SANG, V95, P137, DOI 10.1111/j.1423-0410.2008.01076.x
   Mastitskaya S, 2009, J NEGAT RESULTS BIOM, V8, DOI 10.1186/1477-5751-8-11
   Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795
   MAYOR S, 2010, BRIT MED J, V341, pR5724
   McCurdy S, 2010, J MOL CELL CARDIOL, V48, P544, DOI 10.1016/j.yjmcc.2009.06.018
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Miyagi Y, 2010, BIOMATERIALS, V31, P7684, DOI 10.1016/j.biomaterials.2010.06.048
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   MOLINA EJ, 2008, J THORAC CARDIOVASC, V135
   Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003
   Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374
   Nakanishi C, 2008, BIOCHEM BIOPH RES CO, V374, P11, DOI 10.1016/j.bbrc.2008.06.074
   Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154
   Ng KM, 2010, J MOL CELL CARDIOL, V48, P1129, DOI 10.1016/j.yjmcc.2010.01.015
   Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com
   Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100
   Ohya S, 2005, J BIOMAT SCI-POLYM E, V16, P809, DOI 10.1163/1568562054255736
   Ohya S, 2001, BIOMACROMOLECULES, V2, P856, DOI 10.1021/bm010040a
   Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270
   Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Ozawa T, 2002, CIRCULATION, V106, pI176, DOI 10.1161/01.cir.0000032901.55215.cc
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pereira WC, 2008, J TISSUE ENG REGEN M, V2, P394, DOI 10.1002/term.107
   Piepoli Massimo F., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P127
   Poncelet AJ, 2010, EUR J CARDIO-THORAC, V38, P781, DOI 10.1016/j.ejcts.2010.03.035
   Pozzobon M, 2010, CELL TRANSPLANT, V19, P1247, DOI 10.3727/096368910X505864
   Prat-Vidal C, 2007, TRANSPL P, V39, P2434, DOI 10.1016/j.transproceed.2007.06.016
   Quevedo HC, 2009, P NATL ACAD SCI USA, V106, P14022, DOI 10.1073/pnas.0903201106
   Radisic M, 2007, PHILOS T R SOC B, V362, P1357, DOI 10.1098/rstb.2007.2121
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Satin J, 2004, J PHYSIOL-LONDON, V559, P479, DOI 10.1113/jphysiol.2004.068213
   Schuleri KH, 2009, EUR HEART J, V30, P2722, DOI 10.1093/eurheartj/ehp265
   Sekine H, 2008, CIRCULATION, V118, pS145, DOI 10.1161/CIRCULATIONAHA.107.757286
   Serena E, 2009, EXP CELL RES, V315, P3611, DOI 10.1016/j.yexcr.2009.08.015
   Shachar M, 2003, HEART FAIL REV, V8, P271, DOI 10.1023/A:1024729919743
   Shafy A, 2009, J THORAC CARDIOV SUR, V138, P994, DOI 10.1016/j.jtcvs.2009.02.025
   Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833
   Siepe M, 2006, J THORAC CARDIOV SUR, V132, P124, DOI 10.1016/j.jtcvs.2006.01.052
   Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Singelyn JM, 2009, BIOMATERIALS, V30, P5409, DOI 10.1016/j.biomaterials.2009.06.045
   Smith JD, 2007, BIOCONJUGATE CHEM, V18, P695, DOI 10.1021/bc060265o
   Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209
   Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106
   Stevens KR, 2009, TISSUE ENG PT A, V15, P1211, DOI 10.1089/ten.tea.2008.0151
   Suuronen EJ, 2006, CIRCULATION, V114, pI138, DOI 10.1161/CIRCULATIONAHA.105.001081
   Takehara N, 2008, J AM COLL CARDIOL, V52, P1858, DOI 10.1016/j.jacc.2008.06.052
   Tandon N, 2009, NAT PROTOC, V4, P155, DOI 10.1038/nprot.2008.183
   Taylor DA, 2008, DIABETES OBES METAB, V10, P5, DOI 10.1111/j.1463-1326.2008.00937.x
   Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442
   Tomita S, 1999, CIRCULATION, V100, P247
   Tsur-Gang O, 2009, BIOMATERIALS, V30, P189, DOI 10.1016/j.biomaterials.2008.09.018
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   Vandervelde S, 2005, J MOL CELL CARDIOL, V39, P363, DOI 10.1016/j.yjmcc.2005.05.012
   Wainwright JM, 2010, TISSUE ENG PART C-ME, V16, P525, DOI [10.1089/ten.tec.2009.0392, 10.1089/ten.TEC.2009.0392]
   Wang B, 2010, J BIOMED MATER RES A, V94A, P1100, DOI 10.1002/jbm.a.32781
   Wang F, 2010, ADV DRUG DELIVER REV, V62, P784, DOI 10.1016/j.addr.2010.03.001
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x
   Wang JA, 2009, INT J CARDIOL, V133, P410, DOI 10.1016/j.ijcard.2007.11.096
   Wang SN, 2010, STEM CELL RES, V4, P117, DOI 10.1016/j.scr.2009.12.002
   Wang T, 2009, EUR J HEART FAIL, V11, P14, DOI 10.1093/eurjhf/hfn009
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wei HJ, 2008, BIOMATERIALS, V29, P3547, DOI 10.1016/j.biomaterials.2008.05.009
   Wu DQ, 2009, ACS APPL MATER INTER, V1, P319, DOI 10.1021/am8000456
   Xi JY, 2010, FASEB J, V24, P2739, DOI 10.1096/fj.09-145177
   Yildirim Y, 2007, CIRCULATION, V116, pI16, DOI 10.1161/CIRCULATIONAHA.106.679688
   Yoon SJ, 2009, J BIOMED MATER RES B, V91B, P163, DOI 10.1002/jbm.b.31386
   Yu JS, 2009, J THORAC CARDIOV SUR, V137, P180, DOI 10.1016/j.jtcvs.2008.08.036
   Zhang G, 2008, TISSUE ENG PT A, V14, P1025, DOI 10.1089/ten.tea.2007.0289
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
   Zhang Y, 2008, CIRC-CARDIOVASC IMAG, V1, P197, DOI 10.1161/CIRCIMAGING.108.781120
   Zhao ZQ, 2010, J AM COLL CARDIOL, V55, P1250, DOI 10.1016/j.jacc.2009.10.049
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   Zwi L, 2009, CIRCULATION, V120, P1513, DOI 10.1161/CIRCULATIONAHA.109.868885
   Zwi-Dantsis L, 2011, TISSUE ENG PT A, V17, P1027, DOI [10.1089/ten.tea.2010.0235, 10.1089/ten.TEA.2010.0235]
NR 199
TC 38
Z9 38
U1 0
U2 33
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1471-2598
EI 1744-7682
J9 EXPERT OPIN BIOL TH
JI Expert Opin. Biol. Ther.
PD AUG
PY 2011
VL 11
IS 8
BP 1055
EP 1077
DI 10.1517/14712598.2011.578574
PG 23
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 785CG
UT WOS:000292204400007
PM 21542780
DA 2018-10-20
ER

PT J
AU Huang, YC
   Hsiao, PC
   Chai, HJ
AF Huang, Yi-Cheng
   Hsiao, Pei-Chi
   Chai, Huey-Jine
TI Hydroxyapatite extracted from fish scale: Effects on MG63
   osteoblast-like cells
SO CERAMICS INTERNATIONAL
LA English
DT Article
DE Sintering; Hydroxyapatite; Fish scale; Bio-waste; Enzymatic hydrolysis
ID DIFFERENTIATION; SCAFFOLDS; ROUGHNESS; ADHESION; POWDERS; PLASMA; NANO
AB In recent years, environmental and economic conditions have raised concerns about the treatment and use of bio-waste. This study analyzed hydroxyapatite extracted from fish scale (FHAP) by enzymatic hydrolysis. The structures of FHAP were characterized by Fourier transform infrared spectroscopy, particle size analyzer, scanning electron microscopy, X-ray diffraction, and energy dispersive spectrometry. The analytical results indicated that FHAP consisted of nano-sized particles with Ca/P ratio of 1.76. After FHAP particles were sintered at 800 degrees C for 4 h, the particles showed increased porosity and surface roughness. The influence of FHAP particles on the proliferation and osteogenic differentiation of MG63 cells was also investigated. Compared with hydroxyapatite from Sigma (SHAP), FHAP significantly increased MG63 growth, whether hydroxyapatite powders were sintered or not. Under osteogenic-inductive culture condition, FHAP particles promoted osteogenic differentiation and mineralization of MG63 cells, which was confirmed by alkaline phosphate assay and von Kossa staining. This study confirms that FHAP extracted by enzymatic hydrolysis is a promising biomaterial for artificial bone fabrication. (C) 2011 Elsevier Ltd and Techna Group S.r.l. All rights reserved.
C1 [Huang, Yi-Cheng; Hsiao, Pei-Chi] Natl Taiwan Ocean Univ, Dept Food Sci, Coll Life Sci, Keelung 20224, Taiwan.
   [Chai, Huey-Jine] Council Agr, Fisheries Res Inst, Seafood Technol Div, Keelung 20246, Taiwan.
RP Huang, YC (reprint author), Natl Taiwan Ocean Univ, Dept Food Sci, Coll Life Sci, 2 Pei Ning Rd, Keelung 20224, Taiwan.
EM ychuang@mail.ntou.edu.tw
FU National Science Council of the Republic of China, Taiwan
   [NSC98-2320-B-019-001-MY3]
FX The authors would like to thank the National Science Council of the
   Republic of China, Taiwan for financially supporting
   (NSC98-2320-B-019-001-MY3). Ted Knoy is appreciated for his editorial
   assistance.
CR Aubin JE, 1998, J CELL BIOCHEM, P73, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<73::AID-JCB11>3.0.CO;2-L
   Barakat NAM, 2009, J MATER PROCESS TECH, V209, P3408, DOI 10.1016/j.jmatprotec.2008.07.040
   Chai HJ, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/757301
   CHEN S, 2010, ACTA BIOMATER
   Cui WU, 2007, J BIOMED MATER RES A, V82A, P831, DOI 10.1002/jbm.a.31187
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Elvevoll Edel O, 2003, Forum Nutr, V56, P337
   Elvevoll Edel O., 2001, Nutrition and Health (Bicester), V15, P155
   Fratzl-Zelman N, 1998, BONE, V23, P511, DOI 10.1016/S8756-3282(98)00139-2
   Hola M, 2011, APPL SURF SCI, V257, P1932, DOI 10.1016/j.apsusc.2010.09.029
   Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.0.CO;2-9
   JACOBS MB, 1951, J AM PHARM ASSOC SCI, V40, P151, DOI 10.1002/jps.3030400309
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LEE M, 1992, SKELETAL RADIOL, V21, P161
   Lin CC, 2010, EUR CELLS MATER, V19, P50, DOI 10.22203/eCM.v019a06
   Miyajima K, 1990, Nihon Kyosei Shika Gakkai Zasshi, V49, P226
   Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   Nair MB, 2009, ACTA BIOMATER, V5, P1742, DOI 10.1016/j.actbio.2009.01.009
   Okuda M, 2009, MICRON, V40, P665, DOI 10.1016/j.micron.2009.04.001
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Pati F, 2010, BIORESOURCE TECHNOL, V101, P3737, DOI 10.1016/j.biortech.2009.12.133
   Pezzatini S, 2006, J BIOMED MATER RES A, V76A, P656, DOI 10.1002/jbm.a.30524
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Sanosh KP, 2009, MATER LETT, V63, P2100, DOI 10.1016/j.matlet.2009.06.062
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   Scheel J, 2009, TOXICOL IN VITRO, V23, P531, DOI 10.1016/j.tiv.2009.01.007
   SOLOMONS C, 1955, S Afr J Med Sci, V20, P27
   Trommershauser J, 2009, TRENDS NEUROSCI, V32, P583, DOI 10.1016/j.tins.2009.07.004
   Xu JL, 2004, MAT SCI ENG A-STRUCT, V374, P101, DOI 10.1016/j.msea.2003.12.040
   Yuan Y, 2010, BIOMATERIALS, V31, P730, DOI 10.1016/j.biomaterials.2009.09.088
NR 31
TC 46
Z9 52
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0272-8842
J9 CERAM INT
JI Ceram. Int.
PD AUG
PY 2011
VL 37
IS 6
BP 1825
EP 1831
DI 10.1016/j.ceramint.2011.01.018
PG 7
WC Materials Science, Ceramics
SC Materials Science
GA 780HE
UT WOS:000291844300016
DA 2018-10-20
ER

PT J
AU Ring, A
   Tilkorn, DJ
   Goertz, O
   Langer, S
   Schaffran, A
   Awakowicz, P
   Hauser, J
AF Ring, Andrej
   Tilkorn, Daniel J.
   Goertz, Ole
   Langer, Stefan
   Schaffran, Angela
   Awakowicz, Peter
   Hauser, Joerg
TI Surface Modification by Glow Discharge Gasplasma Treatment Improves
   Vascularization of Allogenic Bone Implants
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE bone substitute; vascularization; plasma treatment; biomaterial surface;
   tissue engineering
ID MESENCHYMAL STEM-CELLS; OSTEOCUTANEOUS FLAP PREFABRICATION; DORSAL
   SKINFOLD CHAMBER; TOTAL HIP-ARTHROPLASTY; INTRAVITAL MICROSCOPY; PLASMA
   TREATMENT; OSTEOGENIC DIFFERENTIATION; CANCELLOUS ALLOGRAFT;
   ANGIOGENESIS; REVISION
AB Sufficient induction of blood vessel ingrowth decisively influence transplant functionality. In this study, microvascular response to transplants of surface modified bone substitutes were assessed in vivo. The surface modification of allogenic bone substitutes (dehydrated human femoral head) was achieved in a double-conductive low-pressure gasplasma reactor (Ar(2)/O(2), 13.65 MHz, 1,000 W, 5 Pa). The modified bone substitutes (n = 10) as well as untreated bone substitutes serving as controls (n = 10) were placed into the dorsal skinfold chamber of female balb/c mice (n = 10). Dynamic assessment of microcirculatory parameters was performed using intravital fluorescence microscopy during an implantation period of 10 days. The angiogenic response was found markedly accelerated in gasplasma-treated bone. Compared to untreated implants, the gasplasma-activated bone substitutes showed significantly higher microvascular density on days 5 and 10. The quantification of the microvascular diameters, red blood cell velocity, and microvascular permeability displayed stable perfusion and vascular integrity of the newly developed blood vessels throughout the 10-day observation period. The surface activation via cold low-pressure glow discharge gasplasma supports the vascular integration of allogenic bone by earlier induction of the angiogenesis. (C) 2011 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29: 1237-1244, 2011
C1 [Ring, Andrej; Tilkorn, Daniel J.; Goertz, Ole; Langer, Stefan; Schaffran, Angela; Hauser, Joerg] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, D-44789 Bochum, Germany.
   [Awakowicz, Peter] Ruhr Univ Bochum, Inst Plasma Technol, D-44789 Bochum, Germany.
RP Ring, A (reprint author), Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Plast Surg, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.
EM andrej.ring@ruhr-uni-bochum.de
CR Abshagen K., 2008, J BIOMED MATER RES A, V91A, P557
   Adamson R, 2009, J Wound Care, V18, P349
   Alves CM, 2008, J BIOMED MATER RES B, V87B, P59, DOI 10.1002/jbm.b.31068
   Charalambides C, 2005, ACTA ORTHOP, V76, P544, DOI 10.1080/17453670510041547
   Dattani R, 2007, ACTA ORTHOP BELG, V73, P558
   Fan W, 2010, BIOMATERIALS, V31, P3580, DOI 10.1016/j.biomaterials.2010.01.083
   Giannini Sandro, 2008, Chir Organi Mov, V91, P171, DOI 10.1007/s12306-007-0029-9
   Gierse H, 1999, ARCH ORTHOP TRAUM SU, V119, P349, DOI 10.1007/s004020050426
   Goldberg VM, 2000, CLIN ORTHOP RELAT R, P68
   Gonzalez E, 2008, LANGMUIR, V24, P12636, DOI 10.1021/la802296c
   Guo LK, 2008, J BIOMED MATER RES A, V87A, P903, DOI 10.1002/jbm.a.31834
   Guo X, 2006, BIOMED MATER, V1, P93, DOI 10.1088/1748-6041/1/3/001
   Hauser J, 2009, J MATER SCI-MATER M, V20, P2541, DOI 10.1007/s10856-009-3826-x
   Hoffmann JN, 1999, SHOCK, V12, P355, DOI 10.1097/00024382-199911000-00005
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Klyscz T, 1997, BIOMED TECH, V42, P168, DOI 10.1515/bmte.1997.42.6.168
   Leopold SS, 2000, CLIN ORTHOP RELAT R, P86
   Leunig M, 1999, ACTA ORTHOP SCAND, V70, P374, DOI 10.3109/17453679908997827
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Matsushima A, 2009, ARTIF ORGANS, V33, P474, DOI 10.1111/j.1525-1594.2009.00749.x
   Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893
   Meyer S, 2008, ARCH ORTHOP TRAUM SU, V128, P539, DOI 10.1007/s00402-007-0402-z
   Mwale F, 2006, BIOMATERIALS, V27, P2258, DOI 10.1016/j.biomaterials.2005.11.006
   Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521
   Nolte D, 1995, INT J MICROCIRC, V15, P244, DOI 10.1159/000179025
   Pelzer M, 2010, J RECONSTR MICROSURG, V26, P291, DOI 10.1055/s-0030-1248239
   Rajan GP, 2006, J TRAUMA, V60, P1322, DOI 10.1097/01.ta.0000195977.18035.40
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Ring A, 2007, EUR SURG RES, V39, P75, DOI 10.1159/000099146
   Roetman B, 2010, LANGENBECK ARCH SURG, V395, P1147, DOI 10.1007/s00423-010-0608-3
   Safak T, 2000, PLAST RECONSTR SURG, V105, P1304
   Schmidmaier G, 2007, INJURY, V38, P35
   Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x
   Sckell Axel, 2009, V467, P305, DOI 10.1007/978-1-59745-241-0_19
   Seebach C, 2010, INJURY, V41, P731, DOI 10.1016/j.injury.2010.02.017
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015
   Tachi M, 2010, J RECONSTR MICROSURG, V26, P417, DOI 10.1055/s-0030-1251560
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560
   Top H, 2004, PLAST RECONSTR SURG, V113, P574, DOI 10.1097/01.PRS.0000101062.00227.4F
   Xie C, 2007, TISSUE ENG, V13, P435, DOI 10.1089/ten.2006.0182
   ZEINTL H, 1989, INT J MICROCIRC, V8, P293
NR 43
TC 10
Z9 11
U1 0
U2 4
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD AUG
PY 2011
VL 29
IS 8
BP 1237
EP 1244
DI 10.1002/jor.21358
PG 8
WC Orthopedics
SC Orthopedics
GA 777KQ
UT WOS:000291614800014
PM 21381095
OA Bronze
DA 2018-10-20
ER

PT J
AU Magallanes-Perdomo, M
   Luklinska, ZB
   De Aza, AH
   Carrodeguas, RG
   De Aza, S
   Pena, P
AF Magallanes-Perdomo, M.
   Luklinska, Z. B.
   De Aza, A. H.
   Carrodeguas, R. G.
   De Aza, S.
   Pena, P.
TI Bone-like forming ability of apatite-wollastonite glass ceramic
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article
DE Simulated body fluid; Glass ceramics; Apatite; Wollastonite-2M;
   Biomedical applications
ID IN-VITRO BIOACTIVITY; SIMULATED BODY-FLUID; TRICALCIUM PHOSPHATE;
   CRYSTAL STRUCTURE; HYDROXYAPATITE; SILICON; BIOCERAMICS; MATRIX; CELLS;
   SI
AB This research describes the preparation, characterisation and in vitro behavior of a bioactive glass ceramic containing 44.8 wt% apatite, 28.0 wt% wollastonite-2 M and 27.2 wt% of amorphous phase. The biomaterial was obtained by a specific thermal cycle process that caused the devitrification of the Ca-3(PO4)(2)-CaSiO3 binary system's stoichiometric eutectic composition. Overall, the material combines the properties of a resorbable Si-Ca-rich glass, in addition to bioactive properties of wollastonite and apatite phases. The bioactivity of this material was studied by soaking the samples in a simulated body fluid (SFB) for 3, 7, 14 and 21 days at 36.5 degrees C. During the soaking, the amorphous phase and also wollastonite-2 M phase underwent steady dissolution by releasing Si and Ca ions into the SBF medium. After 7 days, a porous hydroxy-carbonate apatite (HCA) layer was formed at the SBF-glass ceramic interface. The micro-nanostructured apatite-wollastonite-2 M glass ceramics with improved mechanical properties, in comparison with the parent glass, could serve as a promising platform for hard tissue regeneration. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Magallanes-Perdomo, M.; De Aza, A. H.; Carrodeguas, R. G.; De Aza, S.; Pena, P.] ICV CSIC, Madrid 28049, Spain.
   [Luklinska, Z. B.] Queen Mary Univ London, Dept Mat, London E1 4NS, England.
RP De Aza, AH (reprint author), ICV CSIC, C Kelsen 5, Madrid 28049, Spain.
EM aaza@icv.csic.es
RI Garcia Carrodeguas, Raul/E-5087-2012; de Aza, Antonio/G-4626-2015
OI Garcia Carrodeguas, Raul/0000-0002-4379-4598; de Aza,
   Antonio/0000-0002-1655-3932; PILAR, PENA/0000-0001-6312-7373
FU Science and Technology Inter-Ministry Commission of Spain
   [MAT2006-12749-C02-01-02, MAT2010-17753]; Ministry of Science and
   Innovation of Spain [AP 2005 - 5181]
FX This work was supported by Science and Technology Inter-Ministry
   Commission of Spain under projects CICYT MAT2006-12749-C02-01-02 &
   MAT2010-17753. M. Magallanes-Perdomo wishes to acknowledge financial
   support (AP 2005 - 5181) from the Ministry of Science and Innovation of
   Spain.
CR Aguiar H, 2008, J NON-CRYST SOLIDS, V354, P4075, DOI [10.1016/j.jnoncrysol.2008.05.031, 10.1016/j.jnoncryso1.2008.05.031]
   Aguiar H, 2008, J NON-CRYST SOLIDS, V354, P5004, DOI 10.1016/j.jnoncrysol.2008.07.033
   Best SM, 2008, J EUR CERAM SOC, V28, P1319, DOI 10.1016/j.jeurceramsoc.2007.12.001
   Cao WP, 1996, CERAM INT, V22, P493, DOI 10.1016/0272-8842(95)00126-3
   CARLISLE EM, 1980, J NUTR, V110, P352
   CARLISLE EM, 1980, J NUTR, V110, P1046
   Chevalier J, 2009, J EUR CERAM SOC, V29, P1245, DOI 10.1016/j.jeurceramsoc.2008.08.025
   De Aza PN, 2004, BIOMATERIALS, V25, P1983, DOI 10.1016/j.biomaterials.2003.08.036
   De La Torre AG, 2001, J APPL CRYSTALLOGR, V34, P196, DOI 10.1107/S0021889801002485
   DEAZA PN, 1995, J AM CERAM SOC, V78, P1653
   DEER WA, 2001, ROCK FORMING MINER, V2, P547
   Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050
   ElGhannam A, 1997, J BIOMED MATER RES, V36, P167, DOI 10.1002/(SICI)1097-4636(199708)36:2<167::AID-JBM5>3.0.CO;2-I
   ElGhannam A, 1997, BIOMATERIALS, V18, P295, DOI 10.1016/S0142-9612(96)00059-2
   Iimori Y, 2005, J MATER SCI-MATER M, V16, P73, DOI 10.1007/s10856-005-6449-x
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Kaysinger KK, 1998, J CELL BIOCHEM, V68, P83, DOI 10.1002/(SICI)1097-4644(19980101)68:1<83::AID-JCB8>3.0.CO;2-S
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kokubo T., 1982, Bulletin of the Institute for Chemical Research, Kyoto University, V60, P260
   Larson A.C., 1994, LAUR86748 LOS AL NAT
   LIU DM, 1994, J MATER SCI-MATER M, V5, P7, DOI 10.1007/BF00121146
   Liu XY, 2008, BIOMED PHARMACOTHER, V62, P526, DOI 10.1016/j.biopha.2008.07.051
   Magallanes-Perdomo M, 2010, ACTA BIOMATER, V6, P2254, DOI 10.1016/j.actbio.2009.12.027
   Magallanes-Perdomo M, 2009, ACTA BIOMATER, V5, P3057, DOI 10.1016/j.actbio.2009.04.026
   Magallanes-Perdomo M, 2009, KEY ENG MATER, V396-398, P127, DOI 10.4028/www.scientific.net/KEM.396-398.127
   NAVARRO JF, 2003, VIDRIO, P270
   Ni SY, 2006, J BIOMED MATER RES A, V76A, P196, DOI 10.1002/jbm.a.30525
   *OUT RES INF SERV, HSC CHEM WIND
   Pietak AM, 2007, BIOMATERIALS, V28, P4023, DOI 10.1016/j.biomaterials.2007.05.003
   Porter AE, 2006, MICRON, V37, P681, DOI 10.1016/j.micron.2006.03.006
   RAMP WK, 1994, BONE MINER, V24, P59, DOI 10.1016/S0169-6009(08)80131-6
   Sainz MA, 2010, ACTA BIOMATER, V6, P2797, DOI 10.1016/j.actbio.2010.01.003
   Salinas AJ, 2000, BIOMATERIALS, V21, P251, DOI 10.1016/S0142-9612(99)00150-7
   SERGEY V, 2008, J MATER SCI, V43, P3028
   Tian T, 2008, MAT SCI ENG C-BIO S, V28, P57, DOI 10.1016/j.msec.2007.10.049
   TROJER FJ, 1968, Z KRISTALLOGR KRIST, V127, P291, DOI 10.1524/zkri.1968.127.1-4.291
   TROJER FJ, CASIO3 WOLLASTONITE
   Varshneya A. K., 2006, FUNDAMENTALS INORGAN, P682
   VOGEL W, 1985, CHEM GLASS, P325
   Wilson RM, 2005, BIOMATERIALS, V26, P1317, DOI 10.1016/j.biomaterials.2004.04.038
   WILSON RM, CA9 303 PO4 6 OH 0 6
   YOUNG RA, 1993, RIETVELD METHOD, P336
NR 45
TC 40
Z9 40
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PD AUG
PY 2011
VL 31
IS 9
BP 1549
EP 1561
DI 10.1016/j.jeurceramsoc.2011.03.007
PG 13
WC Materials Science, Ceramics
SC Materials Science
GA 771FU
UT WOS:000291143400004
DA 2018-10-20
ER

PT J
AU Cilurzo, F
   Gennari, CGM
   Selmin, F
   Marotta, LA
   Minghetti, P
   Montanari, L
AF Cilurzo, Francesco
   Gennari, Chiara G. M.
   Selmin, Francesca
   Marotta, Laura A.
   Minghetti, Paola
   Montanari, Luisa
TI An investigation into silk fibroin conformation in composite materials
   intended for drug delivery
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Silk fibroin; Spray-drying; Casting; ATR-FTIR spectroscopy
ID CONTROLLED-RELEASE; BIOMATERIAL; MICROSPHERES
AB Regenerated silk fibroin (SF) is a promising biomaterial to design drug delivery systems. To guarantee satisfactory prolonged release of loaded drugs, the native beta-sheet conformation of SF is generally induced by a final curing which can determine instability of the loaded drug. This work aimed to investigate the influence on SF conformation of the addition of hydrophilic polymers, namely poloxamer 188 (PEO), a range of poly(ethylenglycol) (PEG)and poly(vinyl pyrrolidone) (PVP) and drying conditions, namely spray-drying or evaporation at 60 degrees C. DSC data on spray-dried products indicated that SF in composite materials was in the random coil conformation. ATR-FTIR spectroscopy with Fourier self-deconvolution of the amide I band revealed that SF in spray dried products was partially organized in the beta-sheet structure only in presence of PEG4000.
   Both DSC and ATR-FTIR spectra registered on composite materials obtained by the slowest evaporation method indicated that all hydrophilic polymers favoured the beta-sheet conformation. This feature was attributed to the formation of H-bonds with the tyrosine residues of the semicrystalline region in SF. In conclusion, this approach to prepare of SF/hydrophilic polymer composites at slow evaporation rate leads to water insoluble materials which could be used in the development of drug delivery systems. (C) 2011 Published by Elsevier B.V.
C1 [Cilurzo, Francesco; Gennari, Chiara G. M.; Selmin, Francesca; Marotta, Laura A.; Minghetti, Paola; Montanari, Luisa] Univ Milan, Dept Pharmaceut Sci Pietro Pratesi, I-20133 Milan, Italy.
RP Cilurzo, F (reprint author), Univ Milan, Dept Pharmaceut Sci Pietro Pratesi, Via G Colombo 71, I-20133 Milan, Italy.
EM francesco.cilurzo@unimi.it
RI Cilurzo, Francesco/F-6663-2012
OI Cilurzo, Francesco/0000-0003-3560-291X; Minghetti,
   Paola/0000-0001-7723-441X; Selmin, Francesca/0000-0002-3680-6124;
   MONTANARI, LUISA/0000-0003-2576-9871; Gennari,
   Chiara/0000-0001-8814-1673
CR BOUDETAUDET M, 2008, APP SPECTROSC, V62, P956
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Kaplan DL, 1997, PROTEIN BASED MAT, P103
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Li MZ, 2001, J APPL POLYM SCI, V79, P2185, DOI 10.1002/1097-4628(20010321)79:12<2185::AID-APP1026>3.0.CO;2-3
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Savitzky A., 1964, ANAL CHEM, V36, P1628
   Taddei P, 2005, BIOPOLYMERS, V78, P249, DOI 10.1002/bip.20275
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang S, 2003, CHINESE J POLYM SCI, V21, P87
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 19
TC 20
Z9 21
U1 2
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD JUL 29
PY 2011
VL 414
IS 1-2
BP 218
EP 224
DI 10.1016/j.ijpharm.2011.05.023
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 793BN
UT WOS:000292795500028
PM 21601621
DA 2018-10-20
ER

PT J
AU Rai, RK
   Sinha, N
AF Rai, Ratan Kumar
   Sinha, Neeraj
TI Dehydration-Induced Structural Changes in the Collagen-Hydroxyapatite
   Interface in Bone by High-Resolution Solid-State NMR Spectroscopy
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID NUCLEAR-MAGNETIC-RESONANCE; CORTICAL BONE; MECHANICAL-PROPERTIES;
   MINERAL INTERFACE; ROTATIONAL-ECHO; STATHERIN; WATER; CRYSTALS;
   STRENGTH; RECOGNITION
AB Study of interactions among different components of amorphous biomaterial such as bone is important to understand the mechanism of its formation and biomineralization process and for its unique mechanical properties. In this article, we present dehydration-induced structural changes at the interface of the collagen protein and hydroxyapatite interface in intact mammalian bones by high-resolution solid-state NMR (SSNMR) spectroscopy. With recent advances in SSNMR methodologies, this is the only spectroscopic technique which can provide atomic piercing structural details on amorphous systems such as bone. We performed three SSNMR experiments on bone samples with different degrees of hydration level to probe comparative structural changes. One of the SSNMR experiments is a (13)C{(31)P} Rotational Echo Double Resonance (RED OR) SSNMR experiment which gives an estimate of distances between collagen protein side chain residues and the hydroxyapatite surface in bone. Other SSNMR experiments such as relaxation measurement (T(2) measurement) of (13)C resonances of collagen protein along with (1)H chemical shift measurement give structural changes in the bone matrix due to dehydration. These experiments were performed on bone samples with different degree of water content and also on bone samples in which water was exchanged with D(2)O, thereby reducing the strength of the hydrogen bonding network: We find that when water molecules from the bone matrix are removed the distance of collagen with the hydroxyapatite surface decreases significantly. The present study explains the role of water in stabilizing the structural properties of amorphous biomaterial like bone and will help in synthesizing bone implant materials with desired properties.
C1 [Rai, Ratan Kumar; Sinha, Neeraj] Ctr Biomed Magnet Resonance, Lucknow 226014, Uttar Pradesh, India.
RP Sinha, N (reprint author), Ctr Biomed Magnet Resonance, SGPGIMS Campus,Raibarelly Rd, Lucknow 226014, Uttar Pradesh, India.
EM neeraj.sinha@cbmr.res.in
RI Rai, Ratan/N-6344-2018
OI Rai, Ratan/0000-0001-6015-5539
FU Department of Biotechnology, India [BT/PR12700/BRB/10/719/2009]
FX Financial support from the Department of Biotechnology, India (Grant
   number BT/PR12700/BRB/10/719/2009), is gratefully acknowledged.
CR Aliev AE, 2005, BIOPOLYMERS, V77, P230, DOI 10.1002/bip.20217
   Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   Best SM, 2008, MAGN RESON CHEM, V46, P323, DOI 10.1002/mrc.2168
   Blank RD, 2003, CONNECT TISSUE RES, V44, P134, DOI 10.1080/03008200390223918
   CHUNG H, 1993, P NATL ACAD SCI USA, V90, P10250, DOI 10.1073/pnas.90.21.10250
   Drobny GP, 2003, ANNU REV PHYS CHEM, V54, P531, DOI 10.1146/annurev.physchem.54.011002.103903
   Fernandez-Seara MA, 2004, J BONE MINER RES, V19, P289, DOI 10.1359/JBMR.0301227
   Fernandez-Seara MA, 2002, BIOPHYS J, V82, P522, DOI 10.1016/S0006-3495(02)75417-9
   Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896
   Gibson JM, 2006, J AM CHEM SOC, V128, P5364, DOI 10.1021/ja056731m
   Gibson JM, 2005, J AM CHEM SOC, V127, P9350, DOI 10.1021/ja050910m
   Goobes G, 2006, SOLID STATE NUCL MAG, V29, P242, DOI 10.1016/j.ssnmr.2005.09.016
   Goobes G, 2006, P NATL ACAD SCI USA, V103, P16083, DOI 10.1073/pnas.0607193103
   Goobes R, 2007, BIOCHEMISTRY-US, V46, P4725, DOI 10.1021/bi602345a
   GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1
   GULLION T, 1991, J MAGN RESON, V92, P439, DOI 10.1016/0022-2364(91)90286-3
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Hu YY, 2010, P NATL ACAD SCI USA, V107, P22425, DOI 10.1073/pnas.1009219107
   Jaeger C, 2005, CHEM MATER, V17, P3059, DOI 10.1021/cm050492k
   Knott L, 1997, BIOCHEM J, V322, P535, DOI 10.1042/bj3220535
   LEVITT MH, 1993, SOLID STATE NUCL MAG, V2, P151, DOI 10.1016/0926-2040(93)90021-E
   Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c
   Long JR, 1998, P NATL ACAD SCI USA, V95, P12083, DOI 10.1073/pnas.95.21.12083
   NAITO A, 1994, EUR J BIOCHEM, V224, P729, DOI 10.1111/j.1432-1033.1994.00729.x
   Ndao M, 2009, LANGMUIR, V25, P12136, DOI 10.1021/la901647n
   Nyman JS, 2008, BONE, V42, P193, DOI 10.1016/j.bone.2007.09.049
   Nyman JS, 2006, J BIOMECH, V39, P931, DOI 10.1016/j.jbiomech.2005.01.012
   PRINCE CW, 1987, J BIOL CHEM, V262, P2900
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Raghunathan V, 2006, J PHYS CHEM B, V110, P9324, DOI 10.1021/jp056644g
   Ramamoorthy A, 2004, ANN R NMR S, V52, P1, DOI 10.1016/S0066-4103(04)52001-X
   ROBINSON RA, 1975, CLIN ORTHOP RELAT R, P263
   Robson MD, 2003, J COMPUT ASSIST TOMO, V27, P825, DOI 10.1097/00004728-200311000-00001
   SAITO H, 1984, BIOPOLYMERS, V23, P2279, DOI 10.1002/bip.360231111
   SAITO H, 1992, J BIOCHEM-TOKYO, V111, P376, DOI 10.1093/oxfordjournals.jbchem.a123765
   SANTOS RA, 1994, J MAGN RESON SER B, V105, P183, DOI 10.1006/jmrb.1994.1120
   Schmidt-Rohr K, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2429069
   SEIBEL MJ, 2006, DYNAMICS BONE CARTIL, pR13
   Shaw WJ, 2000, J AM CHEM SOC, V122, P7118, DOI 10.1021/ja000878q
   Stayton PS, 2003, CRIT REV ORAL BIOL M, V14, P370, DOI 10.1177/154411130301400507
   Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666
   vanRossum BJ, 1997, J MAGN RESON, V124, P516, DOI 10.1006/jmre.1996.1089
   Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9
   Wang XD, 2002, SCAND J METALL, V31, P1, DOI 10.1034/j.1600-0692.2002.310101.x
   Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Wilson EE, 2006, BIOPHYS J, V90, P3722, DOI 10.1529/biophysj.105.070243
   Wilson EE, 2005, J BONE MINER RES, V20, P625, DOI 10.1359/JBMR.041217
   Wise ER, 2007, CHEM MATER, V19, P5055, DOI 10.1021/cm702054c
   Wu YT, 1999, P NATL ACAD SCI USA, V96, P1574, DOI 10.1073/pnas.96.4.1574
   Xu JD, 2010, J AM CHEM SOC, V132, P11504, DOI 10.1021/ja101961x
   Zhu PZ, 2009, J AM CHEM SOC, V131, P17064, DOI 10.1021/ja9081028
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 54
TC 34
Z9 34
U1 1
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD JUL 28
PY 2011
VL 115
IS 29
BP 14219
EP 14227
DI 10.1021/jp2025768
PG 9
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 794JP
UT WOS:000292892500033
DA 2018-10-20
ER

PT J
AU Boutry, C
   Rezac, M
   Blackledge, TA
AF Boutry, Cecilia
   Rezac, Milan
   Blackledge, Todd Alan
TI Plasticity in Major Ampullate Silk Production in Relation to Spider
   Phylogeny and Ecology
SO PLOS ONE
LA English
DT Article
ID CLAVIPES DRAGLINE SILK; BLACK-WIDOW SPIDER; MECHANICAL-PROPERTIES;
   NEPHILA-CLAVIPES; LATRODECTUS-HESPERUS; TENSILE PROPERTIES; WEAVING
   SPIDERS; FORCED SILKING; PREY VARIATION; FIBERS SPUN
AB Spider major ampullate silk is a high-performance biomaterial that has received much attention. However, most studies ignore plasticity in silk properties. A better understanding of silk plasticity could clarify the relative importance of chemical composition versus processing of silk dope for silk properties. It could also provide insight into how control of silk properties relates to spider ecology and silk uses. We compared silk plasticity (defined as variation in the properties of silk spun by a spider under different conditions) between three spider clades in relation to their anatomy and silk biochemistry. We found that silk plasticity exists in RTA clade and orbicularian spiders, two clades that differ in their silk biochemistry. Orbiculariae seem less dependent on external spinning conditions. They probably use a valve in their spinning duct to control friction forces and speed during spinning. Our results suggest that plasticity results from different processing of the silk dope in the spinning duct. Orbicularian spiders seem to display better control of silk properties, perhaps in relation to their more complex spinning duct valve.
C1 [Boutry, Cecilia; Rezac, Milan; Blackledge, Todd Alan] Univ Akron, Dept Biol, Akron, OH 44325 USA.
   [Boutry, Cecilia; Rezac, Milan; Blackledge, Todd Alan] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA.
   [Rezac, Milan] Crop Res Inst, Dept Entomol, Prague 6, Ruzyne, Czech Republic.
RP Boutry, C (reprint author), Univ Akron, Dept Biol, Akron, OH 44325 USA.
EM cb54@zips.uakron.edu
FU National Science Foundation [DEB-0516038, IOS-0745379, DBI-0521261];
   Czech Ministry of Agriculture [MZE0002700604]; University of Akron
FX This research was supported by awards DEB-0516038, IOS-0745379 and
   DBI-0521261 from the National Science Foundation to TAB, grant
   #MZE0002700604 from the Czech Ministry of Agriculture to MR, and a
   University of Akron Integrated Bioscience award to CB. The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275
   Blackledge TA, 2005, J EXP BIOL, V208, P1937, DOI 10.1242/jeb.01597
   Blackledge TA, 2005, INVERTEBR BIOL, V124, P165, DOI 10.1111/j.1744-7410.2005.00016.x
   Blackledge TA, 2009, P NATL ACAD SCI USA, V106, P5229, DOI 10.1073/pnas.0901377106
   Blamires SJ, 2010, J EXP BIOL, V213, P3906, DOI 10.1242/jeb.046730
   Boutry C, 2008, J EXP ZOOL PART A, V309A, P542, DOI 10.1002/jez.487
   Boutry C, 2009, ZOOLOGY, V112, P451, DOI 10.1016/j.zool.2009.03.003
   CAPELLO J, 1994, ACS SYM SER, P311
   Chen X, 2006, SOFT MATTER, V2, P448, DOI 10.1039/b601286h
   CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x
   CRAIG CL, 2003, SPIDERWEBS SILK TRAC
   Dicko C, 2004, BIOMACROMOLECULES, V5, P704, DOI 10.1021/bm034307c
   Eadie L, 2011, J R SOC INTERFACE, V8, P761, DOI 10.1098/rsif.2010.0487
   Eles PT, 2004, BIOMACROMOLECULES, V5, P661, DOI 10.1021/bm0342685
   Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121
   Garrido MA, 2002, POLYMER, V43, P1537, DOI 10.1016/S0032-3861(01)00713-3
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Guinea GV, 2006, BIOMACROMOLECULES, V7, P2173, DOI 10.1021/bm060138v
   Guinea GV, 2005, J EXP ZOOL PART A, V303A, P37, DOI 10.1002/jez.a.111
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   KOVOOR J, 1977, Annee Biologique, V16, P97
   Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i
   Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Liivak O, 1997, MACROMOLECULES, V30, P7127, DOI 10.1021/ma970834a
   Liu Y, 2008, BIOMACROMOLECULES, V9, P116, DOI 10.1021/bm700877g
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Madsen B, 2000, NATURWISSENSCHAFTEN, V87, P148, DOI 10.1007/s001140050694
   OPELL BD, 1994, FUNCT ECOL, V8, P85, DOI 10.2307/2390115
   Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x
   Perez-Rigueiro J, 2005, J EXP BIOL, V208, P2633, DOI 10.1242/jeb.01701
   Perez-Riguero J, 2001, J APPL POLYM SCI, V82, P2245, DOI 10.1002/app.2072
   Pollard S.D., 1987, P133
   Pouchkina-Stantcheva NN, 2004, COMP BIOCHEM PHYS B, V138, P371, DOI 10.1016/j.cbpc.2004.04.020
   Read J, 2006, AM J BOT, V93, P1546, DOI 10.3732/ajb.93.10.1546
   Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Sensenig A, 2010, J EVOLUTION BIOL, V23, P1839, DOI 10.1111/j.1420-9101.2010.02048.x
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Swanson BO, 2006, APPL PHYS A-MATER, V82, P213, DOI 10.1007/s00339-005-3427-6
   Tian MZ, 2004, BIOMACROMOLECULES, V5, P657, DOI 10.1021/bm034391w
   TIETJEN WJ, 1983, SPIDER COMMUNICATION, P249
   Tso IM, 2007, ETHOLOGY, V113, P324, DOI 10.1111/j.1439-0310.2007.01318.x
   Tso IM, 2005, J EXP BIOL, V208, P1053, DOI 10.1242/jeb.01437
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vincent JFV, 2002, COMPOS PART A-APPL S, V33, P1311, DOI 10.1016/S1359-835X(02)00167-7
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Vollrath F., 2000, REV MOL BIOTECHNOL, V74, P67, DOI DOI 10.1016/S1389-0352(00)00006-4)
   WILSON RS, 1962, Q J MICROSC SCI, V103, P549
   WILSON RS, 1969, AM ZOOL, V9, P103
   Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Zax DB, 2004, BIOMACROMOLECULES, V5, P732, DOI 10.1021/bm034309x
NR 64
TC 12
Z9 12
U1 2
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 27
PY 2011
VL 6
IS 7
AR e22467
DI 10.1371/journal.pone.0022467
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 799JJ
UT WOS:000293282700033
PM 21818328
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Hillel, AT
   Unterman, S
   Nahas, Z
   Reid, B
   Coburn, JM
   Axelman, J
   Chae, JJ
   Guo, QY
   Trow, R
   Thomas, A
   Hou, ZP
   Lichtsteiner, S
   Sutton, D
   Matheson, C
   Walker, P
   David, N
   Mori, S
   Taube, JM
   Elisseeff, JH
AF Hillel, Alexander T.
   Unterman, Shimon
   Nahas, Zayna
   Reid, Branden
   Coburn, Jeannine M.
   Axelman, Joyce
   Chae, Jemin J.
   Guo, Qiongyu
   Trow, Robert
   Thomas, Andrew
   Hou, Zhipeng
   Lichtsteiner, Serge
   Sutton, Damon
   Matheson, Christine
   Walker, Patricia
   David, Nathaniel
   Mori, Susumu
   Taube, Janis M.
   Elisseeff, Jennifer H.
TI Photoactivated Composite Biomaterial for Soft Tissue Restoration in
   Rodents and in Humans
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID HYALURONIC-ACID GEL; IN-VIVO; DERMAL FILLERS; ADIPOSE-TISSUE;
   STEM-CELLS; VITRO; HYDROGELS; SKIN; PHOTOPOLYMERIZATION; DIFFERENTIATION
AB Soft tissue reconstruction often requires multiple surgical procedures that can result in scars and disfiguration. Facial soft tissue reconstruction represents a clinical challenge because even subtle deformities can severely affect an individual's social and psychological function. We therefore developed a biosynthetic soft tissue replacement composed of poly(ethylene glycol) (PEG) and hyaluronic acid (HA) that can be injected and photocrosslinked in situ with transdermal light exposure. Modulating the ratio of synthetic to biological polymer allowed us to tune implant elasticity and volume persistence. In a small-animal model, implanted photocrosslinked PEG-HA showed a dose-dependent relationship between increasing PEG concentration and enhanced implant volume persistence. In direct comparison with commercial HA injections, the PEG-HA implants maintained significantly greater average volumes and heights. Reversibility of the implant volume was achieved with hyaluronidase injection. Pilot clinical testing in human patients confirmed the feasibility of the transdermal photocrosslinking approach for implantation in abdomen soft tissue, although an inflammatory response was observed surrounding some of the materials.
C1 [Unterman, Shimon; Reid, Branden; Axelman, Joyce; Chae, Jemin J.; Guo, Qiongyu; Elisseeff, Jennifer H.] Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA.
   [Hillel, Alexander T.] Johns Hopkins Univ, Dept Otolaryngol, Baltimore, MD 21287 USA.
   [Unterman, Shimon; Reid, Branden; Axelman, Joyce; Chae, Jemin J.; Guo, Qiongyu; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21287 USA.
   [Nahas, Zayna] Stanford Univ, Dept Ophthalmol, Palo Alto, CA 94305 USA.
   [Coburn, Jeannine M.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.
   [Trow, Robert; Thomas, Andrew] Energist N Amer, Nyack, NY 10960 USA.
   [Hou, Zhipeng; Mori, Susumu] Johns Hopkins Univ, Dept Radiol, Baltimore, MD 21287 USA.
   [Lichtsteiner, Serge; Sutton, Damon; Matheson, Christine; Walker, Patricia; David, Nathaniel] Kythera Biopharmaceut, Calabasas, CA 91301 USA.
   [Taube, Janis M.] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD 21287 USA.
RP Elisseeff, JH (reprint author), Johns Hopkins Univ, Wilmer Eye Inst, Translat Tissue Engn Ctr, Baltimore, MD 21287 USA.
EM jhe@jhu.edu
RI Guo, Qiongyu/J-3118-2014
OI Guo, Qiongyu/0000-0002-1916-9100; Coburn, Jeannine
   M./0000-0001-6354-5436
FU Kythera Biopharmaceuticals
FX The research was supported by a grant from Kythera Biopharmaceuticals.
CR Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Cosgrove GR, 2007, J NEUROSURG, V106, P52, DOI 10.3171/jns.2007.106.1.52
   Duranti F, 1998, DERMATOL SURG, V24, P1317, DOI 10.1111/j.1524-4725.1998.tb00007.x
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Falcone SJ, 2008, J BIOMED MATER RES A, V87A, P264, DOI 10.1002/jbm.a.31675
   FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869
   Ghislanzoni M, 2006, BRIT J DERMATOL, V154, P755, DOI 10.1111/j.1365-2133.2005.07074.x
   Halbleib M, 2003, BIOMATERIALS, V24, P3125, DOI 10.1016/S0142-9612(03)00156-X
   HANKE CW, 1991, J AM ACAD DERMATOL, V25, P319, DOI 10.1016/0190-9622(91)70200-L
   Hillel AT, 2009, TISSUE ENG PT A, V15, P479, DOI 10.1089/ten.tea.2007.0352
   HILLWEST JL, 1994, P NATL ACAD SCI USA, V91, P5967, DOI 10.1073/pnas.91.13.5967
   HIRSCH BC, 1984, INT J DERMATOL, V23, P531, DOI 10.1111/j.1365-4362.1984.tb04204.x
   Homicz Mark R, 2004, Facial Plast Surg, V20, P21, DOI 10.1055/s-2004-822955
   Ishida T, 2007, J CONTROL RELEASE, V122, P349, DOI 10.1016/j.jconrel.2007.05.015
   Kablik J, 2009, DERMATOL SURG, V35, P302, DOI 10.1111/j.1524-4725.2008.01046.x
   Laschke MW, 2010, ACTA BIOMATER, V6, P2020, DOI 10.1016/j.actbio.2009.12.004
   Laszig R, 2002, J LARYNGOL OTOL, V116, P371
   Lee JC, 2010, ANN PLAS SURG, V64, P164, DOI 10.1097/SAP.0b013e3181a20ab0
   Lowe NJ, 2001, J AM ACAD DERMATOL, V45, P930, DOI 10.1067/mjd.2001.117381
   Lynn AD, 2010, J BIOMED MATER RES A, V93A, P941, DOI 10.1002/jbm.a.32595
   Matarasso Seth L, 2004, Aesthet Surg J, V24, P361, DOI 10.1016/j.asj.2004.04.009
   Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922
   Narins RS, 2009, DERMATOL SURG, V35, P1667, DOI 10.1111/j.1524-4725.2009.01335.x
   Patel PN, 2005, J BIOMED MATER RES A, V73A, P313, DOI 10.1002/jbm.a.30291
   PEPPAS NA, 1976, J POLYM SCI POL CHEM, V14, P441, DOI 10.1002/pol.1976.170140215
   Raso DS, 1996, J AM ACAD DERMATOL, V35, P32, DOI 10.1016/S0190-9622(96)90492-2
   Robinson E, 1996, BRIT J PLAST SURG, V49, P281, DOI 10.1016/S0007-1226(96)90156-3
   Ross AS, 2004, CLIN TRANSPLANT, V18, P166, DOI 10.1046/j.1399-0012.2003.00145.x
   Salles AG, 2008, PLAST RECONSTR SURG, V121, P1811, DOI 10.1097/PRS.0b013e31816b1385
   Schor SL, 2006, CELL MOTIL CYTOSKEL, V63, P287, DOI 10.1002/cm.20123
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   SHAH M, 1995, J CELL SCI, V108, P985
   Storr-Paulsen A, 2007, ACTA OPHTHALMOL SCAN, V85, P183, DOI 10.1111/j.1600-0420.2006.00784.x
   Tagami T, 2011, J CONTROL RELEASE, V151, P149, DOI 10.1016/j.jconrel.2010.12.013
   Varghese S, 2010, STEM CELLS, V28, P765, DOI 10.1002/stem.325
   Wain JC, 2001, ANN THORAC SURG, V71, P1623, DOI 10.1016/S0003-4975(01)02537-1
   Wang F, 2007, ARCH DERMATOL, V143, P155, DOI 10.1001/archderm.143.2.155
   Wang W, 2010, BIOMATERIALS, V31, P5953, DOI 10.1016/j.biomaterials.2010.04.029
   Wong VW, 2011, TISSUE ENG PT A, V17, P631, DOI [10.1089/ten.tea.2010.0298, 10.1089/ten.TEA.2010.0298]
   Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x
NR 41
TC 38
Z9 38
U1 2
U2 40
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JUL 27
PY 2011
VL 3
IS 93
AR 93ra67
DI 10.1126/scitranslmed.3002331
PG 12
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 797ZV
UT WOS:000293170300003
PM 21795587
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Wendt, H
   Hillmer, A
   Reimers, K
   Kuhbier, JW
   Schafer-Nolte, F
   Allmeling, C
   Kasper, C
   Vogt, PM
AF Wendt, Hanna
   Hillmer, Anja
   Reimers, Kerstin
   Kuhbier, Joern W.
   Schaefer-Nolte, Franziska
   Allmeling, Christina
   Kasper, Cornelia
   Vogt, Peter M.
TI Artificial Skin - Culturing of Different Skin Cell Lines for Generating
   an Artificial Skin Substitute on Cross-Weaved Spider Silk Fibres
SO PLOS ONE
LA English
DT Article
ID NEPHILA-CLAVIPES ARANEAE; DRAGLINE SILK; ESCHERICHIA-COLI; BOMBYX-MORI;
   IN-VIVO; BIOMATERIALS; SCAFFOLDS; PROTEIN; WEB; DEGRADATION
AB Background: In the field of Plastic Reconstructive Surgery the development of new innovative matrices for skin repair is in urgent need. The ideal biomaterial should promote attachment, proliferation and growth of cells. Additionally, it should degrade in an appropriate time period without releasing harmful substances, but not exert a pathological immune response. Spider dragline silk from Nephila spp meets these demands to a large extent.
   Methodology/Principal Findings: Native spider dragline silk, harvested directly out of Nephila spp spiders, was woven on steel frames. Constructs were sterilized and seeded with fibroblasts. After two weeks of cultivating single fibroblasts, keratinocytes were added to generate a bilayered skin model, consisting of dermis and epidermis equivalents. For the next three weeks, constructs in co-culture were lifted on an originally designed setup for air/liquid interface cultivation. After the culturing period, constructs were embedded in paraffin with an especially developed program for spidersilk to avoid supercontraction. Paraffin cross-sections were stained in Haematoxylin & Eosin (H&E) for microscopic analyses.
   Conclusion/Significance: Native spider dragline silk woven on steel frames provides a suitable matrix for 3 dimensional skin cell culturing. Both fibroblasts and keratinocytes cell lines adhere to the spider silk fibres and proliferate. Guided by the spider silk fibres, they sprout into the meshes and reach confluence in at most one week. A well-balanced, bilayered cocultivation in two continuously separated strata can be achieved by serum reduction, changing the medium conditions and the cultivation period at the air/liquid interphase. Therefore spider silk appears to be a promising biomaterial for the enhancement of skin regeneration.
C1 [Wendt, Hanna; Hillmer, Anja; Reimers, Kerstin; Kuhbier, Joern W.; Schaefer-Nolte, Franziska; Allmeling, Christina; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.
   [Kasper, Cornelia] Leibniz Univ Hannover, Inst Tech Chem, D-3000 Hannover, Germany.
RP Wendt, H (reprint author), Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany.
EM HannaFW@web.de
FU StrucMed of Hannover Medical School
FX The study was funded in part by the student support program StrucMed of
   Hannover Medical School. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. No additional external funding received for this study.
CR Agapov II, 2009, DOKL BIOCHEM BIOPHYS, V426, P127, DOI 10.1134/S1607672909030016
   Agnarsson I, 2008, J EXP ZOOL PART A, V309A, P494, DOI 10.1002/jez.480
   Agnarsson I, 2009, ZOOLOGY, V112, P325, DOI 10.1016/j.zool.2008.11.003
   Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x
   Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.2755/jcmm010.003.18
   Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944
   Bogush VG, 2009, J NEUROIMMUNE PHARM, V4, P17, DOI 10.1007/s11481-008-9129-z
   Cao Y, 2009, INT J MOL SCI, V10, P1514, DOI 10.3390/ijms10041514
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   Curran MP, 2002, BIODRUGS, V16, P439, DOI 10.2165/00063030-200216060-00005
   Dai DY, 2007, STROKE, V38, P170, DOI 10.1161/01.STR.0000252128.83405.71
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   FANGMANN J, 1992, J EXP MED, V175, P1521, DOI 10.1084/jem.175.6.1521
   Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6
   Gentzkow GD, 1996, DIABETES CARE, V19, P350, DOI 10.2337/diacare.19.4.350
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hakimi O, 2010, J BIOMED MATER RES A, V92A, P1366, DOI 10.1002/jbm.a.32462
   Hardy JG, 2009, BIOCHEM SOC T, V37, P677, DOI 10.1042/BST0370677
   Higgins L, 2006, J ARACHNOL, V34, P374, DOI 10.1636/T04-53.1
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu SS, 2006, WOUND REPAIR REGEN, V14, P427, DOI 10.1111/j.1743-6109.2006.00148.x
   Ko FK, 2004, BIOMACROMOLECULES, V5, P780, DOI 10.1021/bm0345099
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032
   LOMBARDI SJ, 1990, J ARACHNOL, V18, P297
   Lou RB, 2009, HAND CLIN, V25, P497, DOI 10.1016/j.hcl.2009.06.002
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x
   MANGOLDT VF, 1895, DEUT MED WOCHENSCHR, P789
   Mann R, 1996, WESTERN J MED, V165, P215
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Monstrey S, 1999, ANN PLAS SURG, V43, P268, DOI 10.1097/00000637-199909000-00008
   NEWMAN J, 1995, INT J DERMATOL, V34, P290, DOI 10.1111/j.1365-4362.1995.tb01600.x
   Nova A, 2010, NANO LETT, V10, P2626, DOI 10.1021/nl101341w
   OSANAI M, 1984, EXP GERONTOL, V19, P37, DOI 10.1016/0531-5565(84)90030-5
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   PHILLIPS TJ, 1994, J INVEST DERMATOL S, V102, P38
   Rios CN, 2009, TISSUE ENG PT A, V15, P2717, DOI 10.1089/ten.TEA.2008.0360
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781
   Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x
   Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998
   Supp DM, 2005, CLIN DERMATOL, V23, P403, DOI 10.1016/j.clindermatol.2004.07.023
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   Vollrath F, 2002, IN VIVO, V16, P229
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wen HX, 2010, MOL BIOL REP, V37, P1815, DOI 10.1007/s11033-009-9615-2
   WORK RW, 1982, J ARACHNOL, V10, P1
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   XIAO J, 1992, BURNS, V18, P401, DOI 10.1016/0305-4179(92)90040-2
   Zhou SB, 2008, J PHYS CHEM B, V112, P11209, DOI 10.1021/jp800913k
NR 55
TC 47
Z9 50
U1 0
U2 39
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUL 26
PY 2011
VL 6
IS 7
AR e21833
DI 10.1371/journal.pone.0021833
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 798BE
UT WOS:000293175100010
PM 21814557
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Pereda, MD
   Alonso, C
   Gamero, M
   del Valle, JA
   de Mele, MFL
AF Pereda, M. D.
   Alonso, C.
   Gamero, M.
   del Valle, J. A.
   Fernandez Lorenzo de Mele, M.
TI Comparative study of fluoride conversion coatings formed on
   biodegradable powder metallurgy Mg: The effect of chlorides at
   physiological level
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Magnesium; Fluoride conversion coating; Chloride; Biodegradable; Powder
   metallurgy; Biomaterial
ID SCANNING ELECTROCHEMICAL MICROSCOPY; SIMULATED BODY-FLUIDS; IN-VITRO
   CORROSION; RARE-EARTH ALLOY; MAGNESIUM ALLOYS; TREATED MAGNESIUM;
   AQUEOUS-SOLUTIONS; VIVO CORROSION; PURE MAGNESIUM; BEHAVIOR
AB The development of a biodegradable metallic implant demands a precisely defined degradation profile and adequate mechanical properties. Mg has been proposed for this purpose but it has an excessively high corrosion rate and insufficient yield strength. In the present work pure Mg mechanically reinforced by a powder metallurgy (Mg(PM)) route and treated with KF was used. The effect of chlorides, at the physiological level, on four fluoride conversion coatings (F-CC) formed on Mg(PM) was evaluated comparatively. The behavior of Mg(PM) during fluoride treatments (0.01 M-0.3 M fluoride-containing solutions) before and after the addition of chlorides (8 g L-1 NaCl) was investigated by conventional corrosion techniques and by scanning electrochemical microscopy (SECM) complemented with SEM observations and EDX analysis. Results showed that the composition and the microstructural characteristics of the F-CCs as well as their corrosion behavior change with KF concentration and immersion time. Treatments in the 0.01 M-0.1 M KF range prove to be effective to protect Mg(PM) against corrosion in the absence of chlorides while higher KF solution concentration (0.3 M) adversely affects the corrosion resistance of this metal. In the presence of chloride ions the F-CCs progressively lose their fluoride content and their corrosion resistance at a rate that depends on the treatment conditions. Such temporary corrosion protection is appropriate for biodegradable implants. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Pereda, M. D.; Fernandez Lorenzo de Mele, M.] Univ Nacl La Plata, Fac Ciencias Exactas, INIFTA, CCT La Plata,CONICET, RA-1900 La Plata, Argentina.
   [Pereda, M. D.; Fernandez Lorenzo de Mele, M.] Univ Nacl La Plata, Fac Ingn, RA-1900 La Plata, Argentina.
   [Alonso, C.; Gamero, M.] Univ Autonoma Madrid, Dept Quim Fis Aplicada, E-28049 Madrid, Spain.
   [del Valle, J. A.] CSIC, CENIM, E-28040 Madrid, Spain.
RP de Mele, MFL (reprint author), Univ Nacl La Plata, Fac Ciencias Exactas, INIFTA, CCT La Plata,CONICET, Casilla Correo 16,Sucursal 4, RA-1900 La Plata, Argentina.
EM mmele@inifta.unlp.edu.ar
RI Gamero, Miriam/E-8340-2012; Fernandez Lorenzo de Mele,
   Monica/I-1388-2015
OI Fernandez Lorenzo de Mele, Monica/0000-0002-8093-7551
FU Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
   [PIP 6075]; Agenda Nacional de Promocion Cientifica y Tecnica [PICT
   0533225]; Universidad Nacional de La Plata (UNLP) [11-l129]; Ministerio
   de Educacion y Ciencia, Spain [CTQ2005-087-C02-01, CTQ2008-05775/BQU,
   MAT 2009-14452]; AVANSENS [S2009/PPQ-1642]; SEM service of LIMF,
   Facultad de Ingenieria, UNLP
FX This work was financially supported by the Consejo Nacional de
   Investigaciones Cientificas y Tecnicas (CONICET) (PIP 6075), the Agenda
   Nacional de Promocion Cientifica y Tecnica (PICT 0533225), the
   Universidad Nacional de La Plata (UNLP) (grant no: 11-I129), and by the
   grants CTQ2005-087-C02-01, CTQ2008-05775/BQU and MAT 2009-14452
   (Ministerio de Educacion y Ciencia, Spain), by the grant AVANSENS
   S2009/PPQ-1642 (CAM) and by the SEM service of LIMF, Facultad de
   Ingenieria, UNLP.
CR BARD AJ, 1991, SCIENCE, V254, P68, DOI 10.1126/science.254.5028.68
   BARD AJ, 2003, ENCY ELECTROCHEMISTR, V3, P444
   Barker AL, 1999, ANAL CHIM ACTA, V385, P223, DOI 10.1016/S0003-2670(98)00588-1
   Bastos AC, 2004, ELECTROCHEM COMMUN, V6, P1212, DOI 10.1016/j.elecom.2004.09.022
   BRAGATO C, 2002, ANN CHIM, V92, P3312
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   COWAN KG, 1979, ELECTROCHIM ACTA, V24, P301, DOI 10.1016/0013-4686(79)85049-5
   Gabrielli C, 2006, J ELECTROCHEM SOC, V153, pB68, DOI 10.1149/1.2161574
   Gonzalez-Garcia Y, 2004, ELECTROCHEM COMMUN, V6, P637, DOI 10.1016/j.elecom.2004.04.018
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gruhl S, 2009, J ANAL ATOM SPECTROM, V24, P181, DOI 10.1039/b813734j
   Gu XN, 2010, MAT SCI ENG C-MATER, V30, P827, DOI 10.1016/j.msec.2010.03.016
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Heakal FET, 2009, ELECTROCHIM ACTA, V54, P1545, DOI 10.1016/j.electacta.2008.09.055
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Inoue H, 2002, CORROS SCI, V44, P603, DOI 10.1016/S0010-938X(01)00092-0
   Lamaka SV, 2008, ELECTROCHEM COMMUN, V10, P259, DOI 10.1016/j.elecom.2007.12.003
   Lamolle SF, 2009, BIOMATERIALS, V30, P736, DOI 10.1016/j.biomaterials.2008.10.052
   Lei T, 2010, CORROS SCI, V52, P3504, DOI 10.1016/j.corsci.2010.06.028
   Li JZ, 2009, T NONFERR METAL SOC, V19, P50, DOI 10.1016/S1003-6326(08)60227-7
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liu XL, 2009, CORROS SCI, V51, P1772, DOI 10.1016/j.corsci.2009.05.002
   Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042
   MGUTMANAS EY, 1991, PROGR MAT SCI, V34, P261
   Mueller WD, 2009, J BIOMED MATER RES A, V90A, P487, DOI 10.1002/jbm.a.32106
   Pereda MD, 2010, ACTA BIOMATER, V6, P1772, DOI 10.1016/j.actbio.2009.11.004
   Perez P, 2007, J MATER SCI, V42, P3969, DOI 10.1007/s10853-006-1301-3
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rettig R, 2009, J BIOMED MATER RES A, V88A, P359, DOI 10.1002/jbm.a.31887
   Seegmiller JC, 2003, J ELECTROCHEM SOC, V150, pB413, DOI 10.1149/1.1593041
   Simoes AM, 2007, CORROS SCI, V49, P3838, DOI 10.1016/j.corsci.2007.03.045
   Song GL, 1999, CORROS SCI, V41, P249
   Song GL, 1998, CORROS SCI, V40, P1769, DOI 10.1016/S0010-938X(98)00078-X
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Verdier S, 2004, APPL SURF SCI, V235, P513, DOI 10.1016/j.apsusc.2004.03.250
   WIPF DO, 1994, COLLOID SURFACE A, V93, P251, DOI 10.1016/0927-7757(94)02872-9
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Wu CS, 2007, APPL SURF SCI, V253, P3893, DOI 10.1016/j.apsusc.2006.08.020
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Yamamoto A, 2008, MATER TRANS, V49, P1042, DOI 10.2320/matertrans.MC200704
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
   Zheng YF, 2010, ACTA BIOMATER, V6, P1783, DOI 10.1016/j.actbio.2009.10.009
NR 46
TC 21
Z9 22
U1 0
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 20
PY 2011
VL 31
IS 5
BP 858
EP 865
DI 10.1016/j.msec.2011.01.010
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 779LJ
UT WOS:000291778800007
DA 2018-10-20
ER

PT J
AU Nogueira, GM
   de Moraes, MA
   Rodas, ACD
   Higa, OZ
   Beppu, MM
AF Nogueira, Grinia Michelle
   de Moraes, Mariana Agostini
   Dorion Rodas, Andrea Cecilia
   Higa, Olga Zazuco
   Beppu, Marisa Masumi
TI Hydrogels from silk fibroin metastable solution: Formation and
   characterization from a biomaterial perspective
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Biomaterials; Biopolymers; Silk fibroin; Hydrogels
ID IN-VITRO; BOMBYX-MORI; SCAFFOLDS; TRANSITIONS; VIVO; GEL
AB Silk fibroin (SF) hydrogels were obtained from the dialysis of a SF metastable solution. Temperature and calcium concentration in SF solution/hydrogel were measured, as critical variables for SF gelation phenomenon. Gelation time of SF solution was increased by decreasing the dialysis temperature, whereas the residual calcium concentration was higher when higher dialysis temperatures were applied. Hydrogels obtained at 20 degrees C were characterized after freeze-drying. SEM micrographs showed porous structures, of ca. 20 mu m (in cross-sectional area) and 5 mu m (on surface). XRD indicated the presence of a beta-sheet structure that is formed during SF gelation. In hydrogel formation, SF molecules in solution are dehydrated and interact by intra and intermolecular hydrogen bonds, forming a stable hydrogel. DSC measurements showed the decomposition peak for SF at 290 degrees C, characteristic of SF beta-sheet structure, which is in accordance with the XRD results and demonstrate its high thermal resistance. SF hydrogels were found not to be toxic to cells using in vitro cytotoxicity tests. Results indicate that silk fibroin hydrogels hold promise for use in the biomaterial field. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Nogueira, Grinia Michelle; de Moraes, Mariana Agostini; Beppu, Marisa Masumi] Univ Estadual Campinas, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
   [Dorion Rodas, Andrea Cecilia; Higa, Olga Zazuco] IPEN, Ctr Biotechnol, Energy & Nucl Res Inst, Sao Paulo, Brazil.
RP Beppu, MM (reprint author), Univ Estadual Campinas, Sch Chem Engn, BR-13083852 Campinas, SP, Brazil.
EM beppu@feq.unicamp.br
RI Agostini de Moraes, Mariana/C-4595-2013; Biofabris, Inct/I-2418-2013;
   Rodas, Andrea/E-1130-2012; BEPPU, MARISA/E-1057-2012
OI Agostini de Moraes, Mariana/0000-0002-2586-6834; 
FU CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior);
   CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)
FX The authors thank CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior) and CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for financial support.
CR Acharya C, 2008, J MATER SCI-MATER M, V19, P2827, DOI 10.1007/s10856-008-3408-3
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Fang Jia-You, 2006, Chem Pharm Bull (Tokyo), V54, P156, DOI 10.1248/cpb.54.156
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Freddi G, 1999, INT J BIOL MACROMOL, V24, P251, DOI 10.1016/S0141-8130(98)00087-7
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Li MZ, 2002, INT J BIOL MACROMOL, V30, P89, DOI 10.1016/S0141-8130(02)00007-7
   MacIntosh AC, 2008, J TISSUE ENG REGEN M, V2, P71, DOI 10.1002/term.68
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nogueira GM, 2008, KEY ENG MATER, V361-363, P503, DOI 10.4028/www.scientific.net/KEM.361-363.503
   Sashina ES, 2006, RUSS J APPL CHEM+, V79, P869, DOI 10.1134/S1070427206060012
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang H, 2005, INT J BIOL MACROMOL, V36, P66, DOI 10.1016/j.ijbiomac.2005.03.011
   Wang L, 2004, J EUR CERAM SOC, V24, P2707, DOI 10.1016/j.jeurceramsoc.2003.09.006
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 24
TC 16
Z9 17
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD JUL 20
PY 2011
VL 31
IS 5
BP 997
EP 1001
DI 10.1016/j.msec.2011.02.019
PG 5
WC Materials Science, Biomaterials
SC Materials Science
GA 779LJ
UT WOS:000291778800027
DA 2018-10-20
ER

PT J
AU Paulino, AT
   Belfiore, LA
   Kubota, LT
   Muniz, EC
   Almeida, VC
   Tambourgi, EB
AF Paulino, Alexandre T.
   Belfiore, Laurence A.
   Kubota, Lauro T.
   Muniz, Edvani C.
   Almeida, Vitor C.
   Tambourgi, Elias B.
TI Effect of magnetite on the adsorption behavior of Pb(II), Cd(II), and
   Cu(II) in chitosan-based hydrogels
SO DESALINATION
LA English
DT Article
DE Chitosan; Adsorption isotherms; Wastewater; Hydrogel; Magnetite
ID HEAVY-METAL IONS; WASTE-WATER; SILKWORM CHRYSALIDES; POTENTIAL DEVICE;
   REMOVAL; ISOTHERMS; POLYSACCHARIDE; BIOMATERIAL; POLYMERS; SORPTION
AB In the present investigation, a chitosan-based hydrogel, graft-copolymerized with methylenebisacrylamide and poly(acrylic acid), (i.e., CS-co-MMB-co-PAA), was employed in studies on the adsorption kinetics of Pb (II), Cd(II), and Cu(II) ions in aqueous solution. Swelling studies performed using the Fickian diffusion model inferred that the mass transfer mechanism of water in hydrogels was governed by diffusion and macromolecular structural relaxation, modified by the presence of magnetite. The best parameters for the removal of metals were pH between 4.5 and 5.5, initial metal concentration of 300 mg dm(-3) and 100 mg of dried hydrogel mass. Isotherm models of Langmuir, Freundlich and Redlich-Peterson suggest that there may be variation in the physicochemical phenomena involving metal adsorption. These isotherms reveal that the adsorption efficiency decreased in the presence of magnetite. Hydrogels with magnetite and the metal ions adsorbed on them may be recovered after the application of an external magnetic field, as opposed to the hydrogels without magnetite, which are frequently recovered using a chemical solvent. The recovery of adsorbents by applying external ac or dc magnetic fields in the absence of solvent is an environmentally clean alternative, with no production of a secondary waste. (C) 2011 Elsevier By. All rights reserved.
C1 [Paulino, Alexandre T.; Tambourgi, Elias B.] Univ Estadual Campinas, Sch Chem Engn, Dept Chem Syst Engn, Separat Proc Lab, BR-13083852 Campinas, SP, Brazil.
   [Paulino, Alexandre T.; Belfiore, Laurence A.] Colorado State Univ, Dept Chem & Biol Engn, Polymer Phys & Engn Lab, Ft Collins, CO 80523 USA.
   [Kubota, Lauro T.] Univ Estadual Campinas, Inst Chem, Dept Analyt Chem, Lab Electrochem Electroanalyt & Dev Sensors, BR-13083970 Campinas, SP, Brazil.
   [Muniz, Edvani C.; Almeida, Vitor C.] Univ Estadual Maringa, Dept Chem, BR-87050900 Maringa, Parana, Brazil.
RP Paulino, AT (reprint author), Univ Estadual Campinas, Sch Chem Engn, Dept Chem Syst Engn, Separat Proc Lab, Av Albert Einstein 500,Bloco A, BR-13083852 Campinas, SP, Brazil.
EM atpaulino10@gmail.com
RI Paulino, Alexandre/B-8075-2013; Tambourgi, Elias/E-1863-2012; Kubota,
   Lauro/C-1459-2012; Inomat, Inct/H-9989-2013
OI Paulino, Alexandre/0000-0001-7076-2797; Tambourgi,
   Elias/0000-0002-4734-9723; Kubota, Lauro/0000-0001-8189-2618; Muniz,
   Edvani/0000-0001-6685-1519
FU State of Sao Paulo Research Foundation (FAPESP, Brazil) [2008/00285-7];
   Coordination of Improvement of Higher Education Personnel (CAPES,
   Brazil) [5267/09-9]
FX A.T. Paulino and E.B. Tambourgi thank the State of Sao Paulo Research
   Foundation (FAPESP, Brazil) for the post-doctorate fellowship (Process
   No 2008/00285-7) and A.T. Paulino and LA. Belfiore thank the
   Coordination of Improvement of Higher Education Personnel (CAPES,
   Brazil) for the post-doctorate fellowship abroad (Process No 5267/09-9).
CR Chadlia A, 2009, J HAZARD MATER, V30, P1579
   Chakraborty P, 2008, WATER AIR SOIL POLL, V195, P63, DOI 10.1007/s11270-008-9727-7
   Chan AW, 2009, BIOMATERIALS, V30, P6119, DOI 10.1016/j.biomaterials.2009.07.034
   Crini G, 2005, PROG POLYM SCI, V30, P38, DOI 10.1016/j.progpolymsci.2004.11.002
   Dorkoosh FA, 2002, INT J PHARM, V247, P47, DOI 10.1016/S0378-5173(02)00361-7
   Dorkoosh FA, 2002, EUR J PHARM SCI, V15, P433, DOI 10.1016/S0928-0987(02)00028-3
   Freundlich H, 1906, Z PHYS CHEM-STOCH VE, V57, P385
   Hallinan DT, 2010, MACROMOLECULES, V43, P4667, DOI 10.1021/ma100047z
   Ho YS, 2006, POL J ENVIRON STUD, V15, P81
   Jiang GQ, 2010, J MACROMOL SCI A, V47, P663, DOI 10.1080/10601325.2010.483360
   Ju XJ, 2009, J HAZARD MATER, V167, P114, DOI 10.1016/j.jhazmat.2008.12.089
   Kasgoz H, 2003, POLYMER, V44, P1785, DOI 10.1016/S0032-3861(03)00033-8
   Kasgoz H, 2008, POLYM ADVAN TECHNOL, V19, P213, DOI 10.1002/pat.999
   Kavakh PA, 2007, SEPAR SCI TECHNOL, V42, P1245, DOI 10.1080/01496390601120490
   Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004
   May DB, 2009, WATER ENVIRON J, V23, P247, DOI 10.1111/j.1747-6593.2008.00138.x
   Ozay O, 2010, DESALINATION, V260, P57, DOI 10.1016/j.desal.2010.04.067
   Ozay O, 2009, WATER RES, V43, P4403, DOI 10.1016/j.watres.2009.06.058
   Paulino AT, 2006, J COLLOID INTERF SCI, V301, P55, DOI 10.1016/j.jcis.2006.04.036
   Paulino AT, 2010, MACROMOL CHEM PHYS, V211, P1196, DOI 10.1002/macp.200900657
   Paulino AT, 2009, J MAGN MAGN MATER, V321, P2636, DOI 10.1016/j.jmmm.2009.03.078
   Paulino AT, 2008, REACT FUNCT POLYM, V68, P634, DOI 10.1016/j.reactfunctpolym.2007.10.028
   Paulino AT, 2006, CARBOHYD POLYM, V64, P98, DOI 10.1016/j.carbpol.2005.10.032
   Perez N, 2007, LAT AM APPL RES, V37, P157
   REDLICH O, 1959, J PHYS CHEM-US, V63, P1024, DOI 10.1021/j150576a611
   Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036
   Thys RCS, 2010, J FOOD ENG, V100, P468, DOI 10.1016/j.jfoodeng.2010.04.033
   Simionato JI, 2006, POLYM INT, V55, P1243, DOI 10.1002/pi.2070
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Tang QW, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/1/015002
   WONG E, 1995, INORG CHEM, V34, P3057, DOI 10.1021/ic00115a036
   Zhao L, 2008, J APPL POLYM SCI, V110, P1388, DOI 10.1002/app.28718
NR 32
TC 71
Z9 76
U1 1
U2 94
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
J9 DESALINATION
JI Desalination
PD JUL 15
PY 2011
VL 275
IS 1-3
BP 187
EP 196
DI 10.1016/j.desal.2011.02.056
PG 10
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 790JS
UT WOS:000292584900025
DA 2018-10-20
ER

PT J
AU Ma, Z
   Chen, F
   Zhu, YJ
   Cui, T
   Liu, XY
AF Ma, Zhao
   Chen, Feng
   Zhu, Ying-Jie
   Cui, Ting
   Liu, Xuan-Yong
TI Amorphous calcium phosphate/poly(D,L-lactic acid) composite nanofibers:
   Electrospinning preparation and biomineralization
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Calcium phosphate; Poly(D,L-lactic acid); Electrospinning;
   Biomineralization; Nanofiber; Nanocomposite
ID BONE TISSUE; PHOSPHATE; HYDROXYAPATITE; TRANSFORMATION; SCAFFOLDS;
   FIBERS; BIOMATERIALS; REGENERATION; MICROBELTS; COATINGS
AB Amorphous calcium phosphate (ACP) has been recognized as an attractive biomaterial due to its bioactivity and biocompatibility. Electrospinning is a simple and low-cost way to fabricate polymer fibers. In this study, ACP nanoparticles with diameters ranging from 20 to 80 nm were synthesized using a simple precipitation method. ACP nanoparticles were hybridized with poly(D,L-lactic acid) (PDLLA) to form ACP/PDLLA composite nanofibers by electrospinning, and different architectures including the nanofibrous mesh and tube consisting of ACP/PDLLA composite nanofibers were obtained and characterized. The biomineralization and cytocompatibility of as-prepared ACP/PDLLA composite nanofibers were evaluated in vitro. Osteoblast-like MG63 cells were seeded on the ACP/PDLLA composite nanofiber meshes to perform the cytocompatibility evaluation. The ACP/PDLLA composite nanofibers exhibited a fast mineralization behavior in the simulated body fluid. The attachment of MG63 cells and cytotoxicity of ACP/PDLLA composite nanofibers were also evaluated, and the experiments indicated good biocompatibility and bioactivity of ACP/PDLLA composite nanofibers. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Ma, Zhao; Chen, Feng; Zhu, Ying-Jie; Cui, Ting; Liu, Xuan-Yong] Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
RP Zhu, YJ (reprint author), Chinese Acad Sci, Shanghai Inst Ceram, State Key Lab High Performance Ceram & Superfine, Shanghai 200050, Peoples R China.
EM y.j.zhu@mail.sic.ac.cn
RI CHEN, Feng/E-4310-2016; Liu, Xuanyong/J-2609-2018; Xu,
   Qingguo/C-1962-2014; Chen, Feng/D-6406-2012
OI CHEN, Feng/0000-0002-1162-1684; Xu, Qingguo/0000-0003-3191-0771; Chen,
   Feng/0000-0002-1162-1684
FU Science and Technology Commission of Shanghai [1052nm06200]; National
   Natural Science Foundation of China [50821004]; Shanghai-Unilever
   Research and Development Fund [09520715200]
FX This work was funded by the Science and Technology Commission of
   Shanghai (1052nm06200), the National Natural Science Foundation of China
   (50821004), and Shanghai-Unilever Research and Development Fund
   (09520715200).
CR Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Asran AS, 2010, POLYMER, V51, P868, DOI 10.1016/j.polymer.2009.12.046
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   BOSKEY AL, 1973, J PHYS CHEM-US, V77, P2313, DOI 10.1021/j100638a011
   BRES EF, 1993, J CRYST GROWTH, V129, P149, DOI 10.1016/0022-0248(93)90444-2
   Chen F, 2010, ACTA BIOMATER, V6, P3013, DOI 10.1016/j.actbio.2010.02.015
   Cleries L, 2000, J BIOMED MATER RES, V49, P43, DOI 10.1002/(SICI)1097-4636(200001)49:1<43::AID-JBM6>3.0.CO;2-G
   Combes C, 2010, ACTA BIOMATER, V6, P3362, DOI 10.1016/j.actbio.2010.02.017
   Cui WU, 2007, J BIOMED MATER RES A, V82A, P831, DOI 10.1002/jbm.a.31187
   Cui WG, 2010, POLYMER, V51, P2320, DOI 10.1016/j.polymer.2010.03.037
   Deng XL, 2007, J BIOMAT SCI-POLYM E, V18, P117, DOI 10.1163/156856207779146123
   Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P4457, DOI 10.1016/j.actbio.2010.06.031
   EANES ED, 1970, CALC TISS RES, V5, P133, DOI 10.1007/BF02017543
   EANES ED, 1977, CALC TISS RES, V23, P259, DOI 10.1007/BF02012795
   EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730
   Feng C, 2010, J APPL POLYM SCI, V115, P756, DOI 10.1002/app.31059
   Habibovic P, 2004, J MATER SCI-MATER M, V15, P373, DOI 10.1023/B:JMSM.0000021104.42685.9f
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HOLMES JM, 1971, CALC TISS RES, V7, P163, DOI 10.1007/BF02062604
   Hou ZY, 2008, CHEM MATER, V20, P6686, DOI 10.1021/cm801538t
   Hou ZY, 2010, CHEM-EUR J, V16, P14513, DOI 10.1002/chem.201000900
   Hou ZY, 2009, CHEM-EUR J, V15, P6973, DOI 10.1002/chem.200900269
   Im JS, 2010, BIOMATERIALS, V31, P1414, DOI 10.1016/j.biomaterials.2009.11.004
   Im JS, 2010, ACTA BIOMATER, V6, P102, DOI 10.1016/j.actbio.2009.06.017
   Jin Y, 2010, LANGMUIR, V26, P1186, DOI 10.1021/la902313t
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   KLEIN CPAT, 1983, J BIOMED MATER RES, V17, P769, DOI 10.1002/jbm.820170505
   Li XR, 2008, LANGMUIR, V24, P14145, DOI 10.1021/la802984a
   Liu SQ, 2009, J MATER SCI-MATER M, V20, P359, DOI 10.1007/s10856-008-3584-1
   MCGANN TCA, 1983, BIOCHIM BIOPHYS ACTA, V760, P415, DOI 10.1016/0304-4165(83)90383-5
   Ofir PBY, 2004, CRYST GROWTH DES, V4, P177, DOI 10.1021/cg034148g
   POSNER AS, 1975, ACCOUNTS CHEM RES, V8, P273, DOI 10.1021/ar50092a003
   Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007
   SEDLAK JM, 1974, J COLLOID INTERF SCI, V47, P483, DOI 10.1016/0021-9797(74)90280-X
   Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Toyama T, 2002, J CERAM SOC JPN, V110, P716, DOI 10.2109/jcersj.110.716
   Van den Vreken NMF, 2010, ACTA BIOMATER, V6, P617, DOI 10.1016/j.actbio.2009.07.038
   Wang CG, 2009, CRYST GROWTH DES, V9, P2620, DOI 10.1021/cg801069t
   Wang GC, 2009, ACTA BIOMATER, V5, P2270, DOI 10.1016/j.actbio.2009.01.023
   Yang DZ, 2008, MACROMOL BIOSCI, V8, P239, DOI 10.1002/mabi.200700221
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709
NR 46
TC 38
Z9 40
U1 5
U2 68
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
EI 1095-7103
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 15
PY 2011
VL 359
IS 2
BP 371
EP 379
DI 10.1016/j.jcis.2011.04.023
PG 9
WC Chemistry, Physical
SC Chemistry
GA 768XU
UT WOS:000290973800006
PM 21536302
DA 2018-10-20
ER

PT J
AU Tilocca, A
   Cormack, AN
AF Tilocca, Antonio
   Cormack, Alastair N.
TI The initial stages of bioglass dissolution: a Car-Parrinello
   molecular-dynamics study of the glass-water interface
SO PROCEEDINGS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING
   SCIENCES
LA English
DT Article
DE bioglass; molecular-dynamics simulations; dissolution
ID ANATASE TIO2(101); BIOACTIVE GLASSES; AMORPHOUS SILICA; SIMULATIONS;
   ADSORPTION; REACTIVITY; SURFACES; LAYERS
AB The initial dissolution stages following implantation of a biomaterial in a physiological environment are critical for its bioactive properties. Car-Parrinello molecular-dynamics (CPMD) simulations of the interface between the 45S5 bioglass surface and liquid water have been carried out to investigate these processes. The analysis of a 40 ps CPMD trajectory has highlighted the potential mechanism of Na(+)/H(+) exchange, leading to formation of surface silanols through water dissociation. Moreover, by comparing the properties of water layers arranged at different distances from the glass surface, we discuss the way in which the particular structure and composition of the bioglass surface affects the hydrogen-bond network and orientation of water in its close proximity.
C1 [Tilocca, Antonio] UCL, Dept Chem, London WC1H 0AJ, England.
   [Tilocca, Antonio] UCL, Thomas Young Ctr Theory & Simulat Mat, London WC1H 0AJ, England.
   [Cormack, Alastair N.] Alfred Univ, New York State Coll Ceram, Alfred, NY 14802 USA.
RP Tilocca, A (reprint author), UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England.
EM a.tilocca@ucl.ac.uk
RI Tilocca, Antonio/B-6460-2008
OI Tilocca, Antonio/0000-0002-8689-7044
FU UK's Royal Society; EPSRC [EP/D504872, EP/F067496]; Engineering and
   Physical Sciences Research Council [EP/F067496/1]
FX A.T. thanks the UK's Royal Society for support (RS-URF). Computer
   resources on the HPCx and HECToR national supercomputing services were
   provided via the UK's HPC Materials Chemistry Consortium, funded by
   EPSRC (grants EP/D504872 and EP/F067496).
CR Adeagbo WA, 2008, CHEMPHYSCHEM, V9, P994, DOI 10.1002/cphc.200700819
   Bolis V, 2008, J PHYS CHEM C, V112, P16879, DOI 10.1021/jp805206z
   CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471
   CLARK AE, 1976, J AM CERAM SOC, V59, P37, DOI 10.1111/j.1151-2916.1976.tb09382.x
   Giannozzi P, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/39/395502
   He YB, 2009, NAT MATER, V8, P585, DOI [10.1038/NMAT2466, 10.1038/nmat2466]
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Jallot E, 2001, LANGMUIR, V17, P4467, DOI 10.1021/la001669m
   Knowles JC, 2003, J MATER CHEM, V13, P2395, DOI 10.1039/b307119g
   Marx D., 2000, NIC SERIES, V1, P301
   Mischler C, 2005, J PHYS-CONDENS MAT, V17, P4005, DOI 10.1088/0953-8984/17/26/001
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Sahai N, 2005, BIOMATERIALS, V26, P5763, DOI 10.1016/j.biomaterials.2005.02.037
   Sit PHL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1908913
   Tilocca A, 2004, LANGMUIR, V20, P8379, DOI 10.1021/la048937r
   Tilocca A, 2004, J PHYS CHEM B, V108, P4743, DOI 10.1021/jp037685k
   Tilocca A, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.224202
   Tilocca A, 2008, J PHYS CHEM C, V112, P11936, DOI 10.1021/jp803541j
   Tilocca A, 2007, J PHYS CHEM B, V111, P14256, DOI 10.1021/jp075677o
   Tilocca A, 2010, J MATER CHEM, V20, P6848, DOI 10.1039/c0jm01081b
   Tilocca A, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3456712
   Tilocca A, 2009, ACS APPL MATER INTER, V1, P1324, DOI 10.1021/am900198t
   Tilocca A, 2009, P ROY SOC A-MATH PHY, V465, P1003, DOI 10.1098/rspa.2008.0462
   Todorova T, 2006, J PHYS CHEM B, V110, P3685, DOI [10.1021/jp055127v, 10.1021/jp0551527v]
   VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 27
TC 21
Z9 21
U1 1
U2 27
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1364-5021
J9 P ROY SOC A-MATH PHY
JI Proc. R. Soc. A-Math. Phys. Eng. Sci.
PD JUL 8
PY 2011
VL 467
IS 2131
BP 2102
EP 2111
DI 10.1098/rspa.2010.0519
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 769NA
UT WOS:000291020800019
OA Other Gold
DA 2018-10-20
ER

PT J
AU Wang, W
   Lin, JH
   Tsai, CC
   Chuang, HC
   Ho, CY
   Yao, CH
   Chen, YS
AF Wang, Walter
   Lin, Jia-Horng
   Tsai, Chin-Chuan
   Chuang, Hao-Che
   Ho, Chien-Yi
   Yao, Chun-Hsu
   Chen, Yueh-Sheng
TI Biodegradable Glutaraldehyde-crosslinked Casein Conduit Promotes
   Regeneration after Peripheral Nerve Injury in Adult Rats
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biocompatibility; biodegradable; crosslinking; strength
ID HOST-BIOMATERIAL INTERACTION; GENE-RELATED PEPTIDE; IN-VIVO EVALUATION;
   SCIATIC-NERVE; ELECTRICAL-STIMULATION; SCHWANN-CELLS; GUIDE CONDUIT;
   GROWTH-FACTOR; PHYSICOCHEMICAL CHARACTERIZATION; NANOFIBROUS SCAFFOLDS
AB In this study, GCC protein was used for the first time to construct a biodegradable conduit for peripheral nerve repair. The GCC was highly stable with a sufficiently high level of mechanical properties and it was non-toxic and non-apoptotic which could maintain the survival and outgrowth of Schwann cells. Noninvasive bioluminescence imaging accompanied with histochemical assessment showed the GCC was highly biocompatible after subcutaneous implantation in transgenic mice. Electrophysiology, labeling of calcitonin gene-related peptide in the lumbar spinal cord and histology analysis also showed a rapid morphological and functional recovery for disrupted rat sciatic nerves repaired with the GCC conduits. Therefore, we conclude that the GCC can offer great nerve regeneration characteristics and can be a promising material for the successful repair of peripheral nerve defects.
C1 [Wang, Walter; Yao, Chun-Hsu; Chen, Yueh-Sheng] China Med Univ, Lab Biomat, Sch Chinese Med, Taichung, Taiwan.
   [Lin, Jia-Horng] Feng Chia Univ, Grad Inst Text Engn, Lab Fiber Applicat & Mfg, Taichung 40724, Taiwan.
   [Tsai, Chin-Chuan] I Shou Univ, Sch Chinese Med Postbaccalaureate, Kaohsiung, Taiwan.
   [Tsai, Chin-Chuan] E DA Hosp, Chinese Med Dept, Kaohsiung, Taiwan.
   [Chuang, Hao-Che] China Med Univ, China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan.
   [Ho, Chien-Yi] China Med Univ, China Med Univ Hosp, Dept Family Med, Taichung, Taiwan.
   [Yao, Chun-Hsu] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.
RP Chen, YS (reprint author), China Med Univ, Lab Biomat, Sch Chinese Med, Taichung, Taiwan.
EM yuehsc@mail.cmu.edu.tw
FU China Medical University and Hospital [CMU99-EW-03, DMR99-075]; Taiwan
   Department of Health Clinical Trial and Research Center of Excellence
   [DOH100-TD-B-111-004]
FX This research is supported in part by China Medical University and
   Hospital (CMU99-EW-03; DMR99-075) and Taiwan Department of Health
   Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004).
   We also would like to thank Dr. Tin-Yun Ho for the experimental help.
CR Adeghate E, 2006, ANN NY ACAD SCI, V1084, P296, DOI 10.1196/annals.1372.030
   AIMUTIS WR, 1982, J DAIRY SCI, V65, P1874, DOI 10.3168/jds.S0022-0302(82)82432-6
   [Anonymous], 1992, ISO109935
   Belyantseva IA, 1999, EUR J NEUROSCI, V11, P457, DOI 10.1046/j.1460-9568.1999.00458.x
   Bentley E, 2010, CORNEA, V29, P910, DOI 10.1097/ICO.0b013e3181c846aa
   BIRCH R, 1979, HAND, V11, P211, DOI 10.1016/S0072-968X(79)80036-4
   Blesch A, 2001, J COMP NEUROL, V436, P399, DOI 10.1002/cne.1076
   Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5
   Chang CJ, 2009, J BIOMED MATER RES A, V91A, P586, DOI 10.1002/jbm.a.32252
   Chang JY, 2009, ARTIF ORGANS, V33, P1075, DOI 10.1111/j.1525-1594.2009.00818.x
   Chen LJ, 2010, J CLIN NEUROSCI, V17, P87, DOI 10.1016/j.jocn.2009.03.042
   Chen MH, 2006, J BIOMED MATER RES B, V77B, P89, DOI 10.1002/jbm.b.30402
   Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Chi GF, 2010, EXP NEUROL, V222, P304, DOI 10.1016/j.expneurol.2010.01.008
   Chiang HY, 2005, J NEUROPATH EXP NEUR, V64, P576, DOI 10.1097/01.jnen.0000171654.24836.bd
   Dainiak MB, 2010, BIOMATERIALS, V31, P67, DOI 10.1016/j.biomaterials.2009.09.029
   di Summa PG, 2010, J PLAST RECONSTR AES, V63, P1544, DOI 10.1016/j.bjps.2009.09.012
   EIGEL WN, 1979, P NATL ACAD SCI USA, V76, P2244, DOI 10.1073/pnas.76.5.2244
   Ghasemi-Mobarakeh L, 2008, BIOMATERIALS, V29, P4532, DOI 10.1016/j.biomaterials.2008.08.007
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Ho TY, 2007, BIOMATERIALS, V28, P4370, DOI 10.1016/j.biomaterials.2007.07.005
   Hsiang CY, 2009, BIOMATERIALS, V30, P3042, DOI 10.1016/j.biomaterials.2009.02.016
   Huang C, 2011, COLLOID SURFACE B, V82, P307, DOI 10.1016/j.colsurfb.2010.09.002
   Ishiguro M, 2010, J ORTHOP SCI, V15, P233, DOI 10.1007/s00776-009-1438-4
   Keogh MB, 2010, ACTA BIOMATER, V6, P4305, DOI 10.1016/j.actbio.2010.06.001
   Klimczak Aleksandra, 2007, Semin Plast Surg, V21, P226, DOI 10.1055/s-2007-991192
   Lago N, 2007, J NEUROSCI RES, V85, P2800, DOI 10.1002/jnr.21286
   Latha MS, 2000, CONTRACEPTION, V61, P329, DOI 10.1016/S0010-7824(00)00113-X
   Li XQ, 2004, J NEUROPATH EXP NEUR, V63, P1092, DOI 10.1093/jnen/63.10.1092
   Liu BS, 2008, J BIOMED MATER RES A, V87A, P1092, DOI 10.1002/jbm.a.31916
   Liu HQ, 2010, J NEUROPATH EXP NEUR, V69, P386, DOI 10.1097/NEN.0b013e3181d68d12
   Loesch A, 2010, ANGIOLOGY, V61, P651, DOI 10.1177/0003319709360030
   Lu MC, 2008, NEUROREHAB NEURAL RE, V22, P367, DOI 10.1177/1545968307313507
   Lu MC, 2010, J TRAUMA, V68, P434, DOI 10.1097/TA.0b013e31819adb38
   Lu MC, 2009, J TRAUMA, V67, P1066, DOI 10.1097/TA.0b013e318182351a
   Madduri S, 2010, BIOMATERIALS, V31, P8402, DOI 10.1016/j.biomaterials.2010.07.052
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   Meek MF, 2004, J BIOMED MATER RES A, V68A, P43, DOI 10.1002/jbm.a.10157
   MERLE M, 1989, MICROSURG, V10, P130, DOI 10.1002/micr.1920100213
   Pan J, 2009, J BIOMED MATER RES A, V89A, P160, DOI 10.1002/jbm.a.31965
   Plikk P, 2009, BIOMACROMOLECULES, V10, P1259, DOI 10.1021/bm900093r
   Prabhakaran MP, 2009, BIOMATERIALS, V30, P4996, DOI 10.1016/j.biomaterials.2009.05.057
   Rivlin M, 2010, HAND CLIN, V26, P435, DOI 10.1016/j.hcl.2010.04.010
   Santinho AJP, 2002, J MICROENCAPSUL, V19, P549, DOI 10.1080/02652040110105391
   Sionkowska A, 2010, INT J BIOL MACROMOL, V47, P570, DOI 10.1016/j.ijbiomac.2010.08.004
   Sun MZ, 2009, J MATER SCI-MATER M, V20, P1181, DOI 10.1007/s10856-008-3671-3
   Thomsen L, 2010, CHIR MAIN, V29, P255, DOI 10.1016/j.main.2010.07.004
   Valmikinathan CM, 2009, BIOMACROMOLECULES, V10, P1084, DOI 10.1021/bm8012499
   Waitayawinyu T, 2007, J HAND SURG-AM, V32A, P1521, DOI 10.1016/j.jhsa.2007.07.015
   Wang G, 2010, BIOTECHNOL LETT, V32, P59, DOI 10.1007/s10529-009-0123-1
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wang J, 2010, ARTIF CELL BLOOD SUB, V38, P24, DOI 10.3109/10731190903495736
   Wang W, 2008, J BIOMED MATER RES A, V84A, P557, DOI 10.1002/jbm.a.31536
   Wang XL, 2011, COLLOID SURFACE B, V82, P233, DOI 10.1016/j.colsurfb.2010.08.047
   Werdin F, 2009, J NEUROSCI METH, V182, P71, DOI 10.1016/j.jneumeth.2009.05.017
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   Wood MD, 2010, J BIOMAT SCI-POLYM E, V21, P771, DOI 10.1163/156856209X445285
   Xie F, 2008, MICROSURG, V28, P471, DOI 10.1002/micr.20514
   Yang YC, 2010, J BIOMED MATER RES B, V95B, P207, DOI 10.1002/jbm.b.31705
   Yannas IV, 2004, BIOMATERIALS, V25, P1593, DOI 10.1016/S0142-9612(03)00505-2
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yeh CC, 2010, NEUROREHAB NEURAL RE, V24, P730, DOI 10.1177/1545968310376758
   Zheng LF, 2008, BRAIN RES, V1187, P20, DOI 10.1016/j.brainres.2007.10.044
NR 63
TC 9
Z9 10
U1 2
U2 30
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD JUL 7
PY 2011
VL 11
IS 7
BP 914
EP 926
DI 10.1002/mabi.201000498
PG 13
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 789UD
UT WOS:000292540900007
PM 21500350
DA 2018-10-20
ER

PT J
AU Luk, JZ
   Rondeau, E
   Trau, M
   Cooper-White, J
   Grondahl, L
AF Luk, Jing Zhong
   Rondeau, Elisabeth
   Trau, Matt
   Cooper-White, Justin
   Grondahl, Lisbeth
TI Characterisation of amine functionalised
   poly(3-hydroxybuturate-co-3-hydroxyvalerate) surfaces
SO POLYMER
LA English
DT Article
DE Surface modification; PHBV; AEMA
ID INDUCED GRAFT-COPOLYMERIZATION; GOLD NANOPARTICLES;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE) SURFACE; POLY
   3-HYDROXYBUTYRATE; MECHANICAL-PROPERTIES; MEDICAL APPLICATIONS;
   METHACRYLIC-ACID; MOLECULAR-WEIGHT; GAMMA-RADIATION; POLYMERIZATION
AB There is an increasing acceptance of the importance of tailoring biomaterial surface properties. This study aimed to introduce and characterise amine functionalities onto the hydrophobic bacterial polymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV). Gamma irradiation induced simultaneous grafting of 2-aminoethyl methacrylate (AEMA) onto PHBV films was carried out using various concentrations of AEMA (2.5 or 4.5 w/v%) in either water or methanol and at two irradiation doses (4.5 or 9 kGy). Successful grafting was verified from XPS analysis, water contact angle and ATR-FTIR spectroscopy. Characterisation using DSC indicated that grafting had occurred predominantly in the amorphous region of the PHBV substrate. H-1 NMR of the grafting solution post grafting showed that monomer conversion is incomplete in methanol. The use of gold nano-particles (AuNPs) as a simple tool to probe the presence of these functional groups was evaluated using a suspension of citrate functionalized AuNPs prepared by reduction of Au(III) with citric acid. These particles were found to be polydisperse (0.8-2 nm and 7-70 nm) and negatively charged (zeta potential of -33 +/- 9 mV) and capable of interacting electrostatically with the amine groups on the PHBV surface and imaged using SEM. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Luk, Jing Zhong; Grondahl, Lisbeth] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.
   [Rondeau, Elisabeth; Trau, Matt; Cooper-White, Justin] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
RP Grondahl, L (reprint author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.
EM l.grondahl@uq.edu.au
RI Trau, Matt/E-3944-2015
OI Trau, Matt/0000-0001-5516-1280; Grondahl, Lisbeth/0000-0001-6012-9808;
   Cooper-White, Justin/0000-0002-1920-8229
CR Alidedeoglu AH, 2009, J POLYM SCI POL CHEM, V47, P5405, DOI 10.1002/pola.23590
   Avella M, 2000, J MATER SCI, V35, P829, DOI 10.1023/A:1004773603516
   Bahari K, 1997, ANGEW MAKROMOL CHEM, V250, P31, DOI 10.1002/apmc.1997.052500103
   Barton A. F. M., 1990, HDB POLYM LIQUID INT
   Bayari S, 1998, BIOM HLTH R, V16, P58
   Briggs B. G., 1992, HIGH RESOLUTION XPS
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   CARSWELLPOMERAN.T, 1996, IRRADIATION POLYM FU, V620, P11
   Chambers R, 2001, J MATER SCI, V36, P3785, DOI 10.1023/A:1017938203630
   Chandler-Temple AF, 2010, LANGMUIR, V26, P15409, DOI 10.1021/la1010677
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Choi JS, 2004, POLYM TEST, V23, P455, DOI 10.1016/j.polymertesting.2003.09.005
   Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+
   Desmet T, 2010, MACROMOL BIOSCI, V10, P1484, DOI 10.1002/mabi.201000147
   Dobrovolskaia MA, 2009, NANOMED-NANOTECHNOL, V5, P106, DOI 10.1016/j.nano.2008.08.001
   EINESR EM, 1997, J APPL POLYM SCI, V63, P377
   FUKADA E, 1986, INT J BIOL MACROMOL, V8, P361, DOI 10.1016/0141-8130(86)90056-5
   Gengenbach TR, 1996, SURF INTERFACE ANAL, V24, P611, DOI 10.1002/(SICI)1096-9918(19960916)24:9<611::AID-SIA169>3.0.CO;2-7
   Geurts JM, 2001, J APPL POLYM SCI, V80, P1401, DOI 10.1002/app.1230
   Giannuzzi L, 1996, FOOD SCI TECHNOL-LEB, V29, P278
   Gonzalez M, 2009, INT J POLYM ANAL CH, V14, P231, DOI 10.1080/10236660802663480
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   He LH, 2007, MACROMOLECULES, V40, P4429, DOI 10.1021/ma070670q
   Huo Q, 2007, J NANOPART RES, V9, P1013, DOI 10.1007/s11051-006-9170-x
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Jana NR, 2008, ADV MATER, V20, P430, DOI 10.1002/adma.200701348
   Keen I, 2006, BIOMACROMOLECULES, V7, P427, DOI 10.1021/bm050497a
   Keen I, 2007, J BIOMAT SCI-POLYM E, V18, P1101, DOI 10.1163/156856207781554046
   Kose GT, 2003, J MATER SCI-MATER M, V14, P121
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Kumarasuriyar A, 2005, TISSUE ENG, V11, P1281, DOI 10.1089/ten.2005.11.1281
   Kuyper AC, 1933, J AM CHEM SOC, V55, P1722, DOI 10.1021/ja01331a071
   Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6
   Lawrie G, 2006, LANGMUIR, V22, P497, DOI 10.1021/la051833b
   Lee HS, 1997, POLYMER, V38, P4505, DOI 10.1016/S0032-3861(96)01050-6
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   Liu SP, 2007, ANAL CHIM ACTA, V598, P304, DOI 10.1016/j.aca.2007.06.054
   Liu SP, 2006, ANAL BIOCHEM, V353, P108, DOI 10.1016/j.ab.2006.03.012
   Luo S, 1999, J APPL POLYM SCI, V73, P1059, DOI 10.1002/(SICI)1097-4628(19990808)73:6<1059::AID-APP25>3.3.CO;2-H
   MITOMO H, 1995, J MACROMOL SCI PURE, VA32, P429, DOI 10.1080/10601329508013674
   MUKHERJEE AK, 1985, J APPL POLYM SCI, V30, P2655, DOI 10.1002/app.1985.070300628
   ORGAN SJ, 1993, POLYMER, V34, P2175, DOI 10.1016/0032-3861(93)90747-X
   SANO S, 1993, BIOMATERIALS, V14, P817, DOI 10.1016/0142-9612(93)90003-K
   Sarathy KV, 1997, CHEM COMMUN, P537
   Sauzedde F, 1997, J APPL POLYM SCI, V65, P2331, DOI 10.1002/(SICI)1097-4628(19970919)65:12<2331::AID-APP7>3.0.CO;2-A
   Schulz-Dobrick M, 2005, J AM CHEM SOC, V127, P12816, DOI 10.1021/ja054734t
   Shan J, 2007, CHEM COMMUN, P4580, DOI 10.1039/b707740h
   Slow KS, 2006, PLASMA PROCESS POLYM, V3, P392
   Stine R, 2010, APPL SURF SCI, V256, P4171, DOI 10.1016/j.apsusc.2010.01.120
   Suwantong O, 2007, INT J BIOL MACROMOL, V40, P217, DOI 10.1016/j.ijbiomac.2006.07.006
   Tesema Y, 2005, J APPL POLYM SCI, V98, P1916, DOI 10.1002/app.22352
   UCHIDA E, 1993, LANGMUIR, V9, P1121, DOI 10.1021/la00028a040
   Verma A, 2005, CHEM COMMUN, P303, DOI 10.1039/b410889b
   Verma A, 2004, LANGMUIR, V20, P4178, DOI 10.1021/la036183v
   Wu ACK, 2006, BIOMATERIALS, V27, P4715, DOI 10.1016/j.biomaterials.2006.05.010
   Wu CKA, 2009, J BIOMED MATER RES A, V91A, P845, DOI 10.1002/jbm.a.32238
   You CC, 2007, NANO TODAY, V2, P34, DOI 10.1016/S1748-0132(07)70085-3
   Yu HY, 2007, J MEMBRANE SCI, V302, P235, DOI 10.1016/j.memsci.2007.06.061
NR 59
TC 13
Z9 13
U1 1
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0032-3861
EI 1873-2291
J9 POLYMER
JI Polymer
PD JUL 7
PY 2011
VL 52
IS 15
BP 3251
EP 3258
DI 10.1016/j.polymer.2011.05.048
PG 8
WC Polymer Science
SC Polymer Science
GA 789RF
UT WOS:000292533300001
DA 2018-10-20
ER

PT J
AU Ye, RR
   Wang, ZY
   Luo, SH
   Yang, LT
   Xiao, X
AF Ye, Ruirong
   Wang, Zhaoyang
   Luo, Shihe
   Yang, Liting
   Xiao, Xin
TI Synthesis and Characterization of the Biomaterial Poly(lactic
   acid-co-N-epsilon-carbobenzoyloxy-L-lysine) via Direct Melt
   Copolymerization
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE biodegradable; copolymerization; drug delivery systems; melt;
   polycondensation
ID BIODEGRADABLE POLYMER MATERIALS; DRUG-DELIVERY APPLICATION; RGD PEPTIDE
   MODIFICATION; CO-GLYCOLIC ACID); LACTIC ACID; POLY(D,L-LACTIC ACID);
   PHYSICAL-PROPERTIES; TRIBLOCK COPOLYMER; DIBLOCK COPOLYMER; L-LYSINE
AB With D, L-lactic acid and N-epsilon-carbobenzoyloxy-L-lysine [Lys(Z)] as the starting monomer material and tin dichloride as the catalyst, the drug carrier material poly(lactic acid-co-N-epsilon-carbobenzoyloxy-L-lysine) was synthesized via direct melt polycondensation. The copolymer was systematically characterized with intrinsic viscosity testing, Fourier transform infrared spectroscopy, H-1-NMR, gel permeation chromatography, differential scanning calorimetry, and X-ray diffraction. The influences of different feed molar ratios were examined. With increasing molar feed content of Lys(Z), the intrinsic viscosity, weight-average molecular weight, and polydispersity index (weight-average molecular weight/number-average molecular weight) gradually decreased. Because of the introduction of Lys(Z) with a big aromatic ring into the copolymer, the glass-transition temperature gradually increased with increasing feed charge of Lys(Z), and all of the copolymers were amorphous. The copolymers, with weight-average molecular weights from 10,500 to 6900 Da, were obtained and could reach the molecular weight level of poly(lactic acid) modified by Lys(Z) via the ring-opening polymerization of the cyclic intermediates, such as lactide and morpholine-2,5-dione. However, a few terminal carboxyl groups might have been deprotected during the polymerization reaction under high temperatures. (c) 2011 Wiley Periodicals, Inc. J Appl Polym Sci 121: 420-426, 2011
C1 [Ye, Ruirong; Wang, Zhaoyang; Luo, Shihe; Yang, Liting; Xiao, Xin] S China Normal Univ, Sch Chem & Environm, Guangzhou 510006, Guangdong, Peoples R China.
RP Wang, ZY (reprint author), S China Normal Univ, Sch Chem & Environm, Guangzhou 510006, Guangdong, Peoples R China.
EM wangwangzhaoyang@tom.com; yanglt63@yahoo.com.cn
OI Luo, Shihe/0000-0002-2419-6103
FU Guangdong Provincial Natural Science Foundation of China [5300082];
   National Natural Science Foundation of China [20772035]
FX Contract grant sponsor: Guangdong Provincial Natural Science Foundation
   of China; contract grant number: 5300082.; Contract grant sponsor:
   National Natural Science Foundation of China; contract grant number:
   20772035.
CR Abe H, 2005, POLYM PREPR JPN, V54, P5243
   BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   Boxberg Y, 2006, J POLYM SCI POL PHYS, V44, P656, DOI 10.1002/polb.20723
   Chen GX, 2006, EUR POLYM J, V42, P468, DOI 10.1016/j.eurpolymj.2005.07.022
   Deng C, 2006, BIOMACROMOLECULES, V7, P590, DOI 10.1021/bm050678c
   Deng C, 2007, POLYMER, V48, P139, DOI 10.1016/j.polymer.2006.10.046
   Duan JF, 2007, J APPL POLYM SCI, V103, P2654, DOI 10.1002/app.25415
   Duan JF, 2007, J APPL POLYM SCI, V103, P3585, DOI 10.1002/app.25122
   Fan YJ, 2005, BIOMACROMOLECULES, V6, P3051, DOI 10.1021/bm050368u
   Feng YK, 2009, INT J MOL SCI, V10, P589, DOI 10.3390/ijms10020589
   Fini M, 2001, BIOMED PHARMACOTHER, V55, P213, DOI 10.1016/S0753-3322(01)00054-3
   GRICAR M, 2008, ACTA CHIM SLOV, V53, P575
   Kricheldorf HR, 2001, CHEMOSPHERE, V43, P49, DOI 10.1016/S0045-6535(00)00323-4
   Li Y, 2007, BIOMACROMOLECULES, V8, P1409, DOI 10.1021/bm0701806
   Lim LT, 2008, PROG POLYM SCI, V33, P820, DOI 10.1016/j.progpolymsci.2008.05.004
   Liu Y, 2003, EUR POLYM J, V39, P977, DOI 10.1016/S0014-3057(02)00354-3
   Liu Y, 2009, SPECTROSC SPECT ANAL, V29, P661, DOI 10.3964/j.issn.1000-0593(2009)03-0661-04
   Lu DD, 2008, J APPL POLYM SCI, V107, P3638, DOI 10.1002/app.27549
   Luo YF, 2007, EUR POLYM J, V43, P3856, DOI 10.1016/j.eurpolymj.2007.06.022
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Peng H, 2009, BIOMACROMOLECULES, V10, P95, DOI 10.1021/bm800937g
   Singh BB, 2005, ALTERN MED REV, V10, P123
   Sun J, 2008, LANGMUIR, V24, P10099, DOI 10.1021/la8013877
   Tetsuka H, 2006, MACROMOLECULES, V39, P2875, DOI 10.1021/ma052566j
   Tetsuka H, 2006, MACROMOLECULES, V39, P9071, DOI 10.1021/ma061979x
   Wang N, 1997, J BIOMAT SCI-POLYM E, V9, P75
   Wang N, 1997, J BIOMAT SCI-POLYM E, V8, P905
   Wang ZY, 2006, J APPL POLYM SCI, V102, P577, DOI 10.1002/app.24321
   Wang ZY, 2008, IRAN POLYM J, V17, P791
   Wang ZY, 2006, J APPL POLYM SCI, V99, P244, DOI 10.1002/app.22468
   Yu H, 2008, J MATER SCI-MATER M, V19, P1275, DOI 10.1007/s10856-007-3237-9
   Zhang GD, 2008, BIOMACROMOLECULES, V9, P36, DOI 10.1021/bm700713p
   Zhao YM, 2005, J APPL POLYM SCI, V97, P195, DOI 10.1002/app.21746
   Zhao YM, 2004, J APPL POLYM SCI, V91, P2143, DOI 10.1002/app.13354
   Zhou SB, 2004, J APPL POLYM SCI, V91, P1848, DOI 10.1002/app.13385
NR 36
TC 3
Z9 4
U1 3
U2 22
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 5
PY 2011
VL 121
IS 1
BP 420
EP 426
DI 10.1002/app.33621
PG 7
WC Polymer Science
SC Polymer Science
GA 747XD
UT WOS:000289353700051
DA 2018-10-20
ER

PT J
AU Wirsching, K
   Lehle, K
   Jacob, P
   Gleich, O
   Strutz, J
   Kwok, P
AF Wirsching, Kornelia
   Lehle, Karla
   Jacob, Peter
   Gleich, Otto
   Strutz, Juergen
   Kwok, Pingling
TI Influence of Surface Processing on the Biocompatibility of Titanium
SO MATERIALS
LA English
DT Article
DE biocompatibility; Titanium surface processing; Titanium ossicular
   implant; Kurz
ID OSSICULAR REPLACEMENT PROSTHESES; MIDDLE-EAR; IMPLANTS; RECONSTRUCTION;
   CHAIN
AB Surface conditioning of titanium middle ear implants results in an improved biocompatibility, which can be characterized by the properties of fibroblasts cultured on conditioned surfaces. Titanium has been established as a favorable biomaterial in ossicular chain reconstruction. The epithelization of the surface of the implants is important for their integration and stable positioning in the middle ear. Mouse fibroblast cells were cultured on platelets made from pure Grade 2 titanium. Platelets that had been etched along their production process were compared to unetched platelets. The DNA in the cell nuclei was stained with DAPI and the actin filaments of the cytoskeleton were stained with FITC-conjugated phalloidin in order to analyze the cells grown on etched and unetched platelets by fluorescence microscopy. SEM (scanning electron microscopic) images were used to compare the surface structure of etched and unetched titanium platelets. There was a statistically significant increase of the area covered by the cytoplasm and increased actin expression by fibroblasts grown on the etched titanium platelets. In addition, the area of the platelets covered by nuclei on the etched platelets exceeded on average the one on unetched platelets, although this difference was not significant. The SEM pictures comparing unetched and etched titanium platelets showed a clear difference in surface structure. Surface conditioning of titanium implants improved the epithelization by fibroblasts and consequently etched titanium should be the preferred biomaterial for reconstructive middle ear surgery.
C1 [Wirsching, Kornelia; Gleich, Otto; Strutz, Juergen; Kwok, Pingling] Univ Regensburg, Ear Nose & Throat Dept, D-93042 Regensburg, Germany.
   [Lehle, Karla] Univ Regensburg, Dept Cardiothorac Surg, D-93042 Regensburg, Germany.
   [Jacob, Peter] Sorlandet Sykehus, Ear Nose & Throat Dept, N-4600 Kristiansand, Norway.
RP Wirsching, K (reprint author), Univ Regensburg, Ear Nose & Throat Dept, D-93042 Regensburg, Germany.
EM wirsching.kornelia@gmx.de
FU German Research Foundation (DFG)
FX We are grateful to KURZ Medicals for providing the titanium platelets
   and thank Sara Bergmann for performing the cell cultures. This
   publication was funded by the German Research Foundation (DFG) in the
   funding programme Open Acess Publishing.
CR ALBREKTSSON T, 1981, ACTA ORTHOP SCAND, V52, P155, DOI 10.3109/17453678108991776
   Begall K, 2000, LARYNGO RHINO OTOL, V79, P139
   Coffey CS, 2008, LARYNGOSCOPE, V118, P1650, DOI 10.1097/MLG.0b013e31817bd807
   Dalchow CV, 2001, OTOLARYNG HEAD NECK, V125, P628, DOI 10.1067/mhn.2001.120397
   Geyer G, 1999, HNO, V47, P77, DOI 10.1007/s001060050363
   Ho SY, 2003, OTOL NEUROTOL, V24, P149, DOI 10.1097/00129492-200303000-00005
   Martin AD, 2004, LARYNGOSCOPE, V114, P61, DOI 10.1097/00005537-200401000-00010
   Neudert M, 2010, JARO-J ASSOC RES OTO, V11, P161, DOI 10.1007/s10162-009-0202-y
   Schmerber S, 2006, EUR ARCH OTO-RHINO-L, V263, P347, DOI 10.1007/s00405-005-1002-6
   Schwager K, 2002, LARYNGO RHINO OTOL, V81, P178, DOI 10.1055/s-2002-25037
   Schwager K, 2000, LARYNGO RHINO OTOL, V79, P762
   Schwager K, 1998, EUR ARCH OTO-RHINO-L, V255, P396, DOI 10.1007/s004050050086
   Stupp CH, 1999, LARYNGO RHINO OTOL, V78, P299, DOI 10.1055/s-2007-996875
   Thull R, 2002, BIOMOL ENG, V19, P43, DOI 10.1016/S1389-0344(02)00009-6
   Wang XJ, 1999, OTOLARYNG HEAD NECK, V121, P606, DOI 10.1016/S0194-5998(99)70066-5
NR 15
TC 1
Z9 1
U1 0
U2 8
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1996-1944
J9 MATERIALS
JI Materials
PD JUL
PY 2011
VL 4
IS 7
BP 1238
EP 1248
DI 10.3390/ma4071238
PG 11
WC Materials Science, Multidisciplinary
SC Materials Science
GA 864MY
UT WOS:000298245500004
PM 28824139
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Ficai, A
   Ficai, D
   Andronescu, E
   Maganu, M
   Voicu, G
   Sonmez, M
AF Ficai, A.
   Ficai, D.
   Andronescu, E.
   Maganu, M.
   Voicu, G.
   Sonmez, M.
TI BIOMIMETIC MINERALIZATION OF THE HUMAN NASAL SEPTUM CARTILAGE
SO DIGEST JOURNAL OF NANOMATERIALS AND BIOSTRUCTURES
LA English
DT Article
DE human nasal septum cartilage; hybrid composites; mineralization; SBF
   immersion; characterization
ID MECHANICAL-PROPERTIES; COMPOSITE-MATERIALS; COLLAGEN; BONE;
   CALCIFICATION; BIOACTIVITY; ENVIRONMENT; DEPOSITION; SCAFFOLDS; SBF
AB Simulated body fluid (SBF) immersion technique is an attractive method for biomaterial synthesis due to the conditions similar to the in vivo synthesis ones. The collagen/hydroxyapatite (COLL/HA) composite biomaterials obtained by immersing the collagen matrices in SBF are usually well mimicking the bone, especially the mineral phase synthesis and properties. Starting from these hypotheses, we have achieved the mineralization of human nasal septum cartilage by SBF immersion technique. For this, nasal septum cartilages were collected from a 33 years old woman and used as obtained. The mineralization was conducted by immersion for 168 hours at similar to 37 degrees C and pH=7.4. The cartilage mineralization process by SBF immersion can be compared with the endochondral ossification occurring naturally. When compared with other related materials, the obtained materials have shown better characteristics because the organic phase had been synthesized by the human body and, the mineral phase was deposited by a biomimetic method. Summarizing, the proposed method can be considered an advanced biomimetic method and the obtained materials can be expected to exhibit improved properties.
C1 [Ficai, A.; Ficai, D.; Andronescu, E.; Voicu, G.; Sonmez, M.] Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, Bucharest 011061, Romania.
   [Maganu, M.] Acad Romana, Ctr Organ Chem Costin D Nenitescu, Bucharest 050461, Romania.
RP Ficai, A (reprint author), Univ Politehn Bucuresti, Fac Appl Chem & Mat Sci, 1-5 Polizu Str, Bucharest 011061, Romania.
EM anton_ficai81@yahoo.com
OI FICAI, Anton/0000-0002-1777-0525; Ecaterina,
   Andronescu/0000-0002-7325-9115; Voicu, Georgeta/0000-0001-7155-7138;
   Ficai, Denisa/0000-0003-1243-6904
FU European Social Fund [POSDRU/89/1.5/S/54785]
FX Authors recognise financial support from the European Social Fund
   through POSDRU/89/1.5/S/54785 project: "Postdoctoral Program for
   Advanced Research in the field of nanomaterials.
CR Al-Munajjed AA, 2009, J BIOMED MATER RES B, V90B, P584, DOI 10.1002/jbm.b.31320
   Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   Brancaccio D, 2005, CONTRIB NEPHROL, V149, P279
   Chen KH, 2006, GRAEF ARCH CLIN EXP, V244, P407, DOI 10.1007/s00417-005-1191-0
   CHEN XF, 2007, BIOCERAMICS, V19, P939
   CHEN XF, 2007, BIOCERAMICS, V19, P330
   Fathi M.H., 2008, DENT RES J, V5, P81
   Ficai A, 2010, UNIV POLITEH BUCHAR, V72, P47
   Ficai A, 2010, MATER PLAST, V47, P205
   Ficai A, 2009, MATER PLAST, V46, P11
   Forsgren J, 2007, ACTA BIOMATER, V3, P980, DOI 10.1016/j.actbio.2007.03.006
   Freeman J, 2004, CONNECT TISSUE RES, V45, P131, DOI 10.1080/03008200490471859
   Goff AK, 2006, J FORENSIC SCI, V51, P493, DOI 10.1111/j.1556-4029.2006.00109.x
   Hengsberger S, 2002, JSME INT J C-MECH SY, V45, P936, DOI 10.1299/jsmec.45.936
   Kowalski S. J, 2003, THERMOMECHANICS DRYI
   Maroudas A, 1979, PHYSICOCHEMICAL PROP
   Meyer U., 2006, BONE CARTILAGE ENG
   MOWVC, 1984, J BIOMECH, V17, P377
   Muller L, 2006, ACTA BIOMATER, V2, P181, DOI 10.1016/j.actbio.2005.11.001
   Prabahar MR, 2006, DIALYSIS TRANSPLANT, V35, P772, DOI 10.1002/dat.20072
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   Taddei P, 2006, INT J ARTIF ORGANS, V29, P719
   Tsai SW, 2008, ACTA BIOMATER, V4, P1332, DOI 10.1016/j.actbio.2008.03.015
   WANG J, 2008, BIOMEDICAL MAT, V3
   Yoo JJ, 2004, J BIOMED MATER RES A, V68A, P401, DOI 10.1002/jbm.a.20038
   YUEHUEI HA, 2003, HDB HISTOLOGY METHOD
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
   Zhao HG, 2008, POLYM ADVAN TECHNOL, V19, P1590, DOI 10.1002/pat.1174
   2007, NATURE COMPOSITION I
NR 29
TC 0
Z9 0
U1 0
U2 4
PU INST MATERIALS PHYSICS
PI BUCHAREST
PA NATL INST R&D MATERIALS PHYSICS, ATOMISTILOR STR, 105 BIS, BUCHAREST,
   077125, ROMANIA
SN 1842-3582
J9 DIG J NANOMATER BIOS
JI Dig. J. Nanomater. Biostruct.
PD JUL-SEP
PY 2011
VL 6
IS 3
BP 1377
EP 1383
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 860YX
UT WOS:000297986100056
DA 2018-10-20
ER

PT J
AU Li, DC
   Zhang, LN
   Zhu, Y
   Li, MQ
AF Li Dechao
   Zhang Lina
   Zhu Yang
   Li Muqin
TI Preparation of Titanium Substrate Biomaterials Using Microarc Oxidation
   and Measurement of Blood Compatibility
SO RARE METAL MATERIALS AND ENGINEERING
LA English
DT Article
DE microarc oxidation; blood compatibility; hemolytic ratio
ID IN-VITRO; ANTIBACTERIAL; COATINGS
AB Microarc oxidation (MAO) is a break-through anodizing technology for forming oxide films on valve metal. Use of this technology allows thick, porous oxide layers to be formed on the surface of titanium alloy. Few biocompatibility reports using this treatment have been found. The blood compatibility of a novel surface modified titanium substrate biomaterial using MAO was investigated. Fresh whole blood was collected from rabbit and then mixed with the liquids in the four groups respectively after anticoagulation. In addition, UV-Visible Spectrophotometer was used to evaluate the hemolytic ratio. The hemolytic ratio of the test group was 0.50% and 0.30%. The results indicate that this new material have no haemolysis effect. The material does not resolve red blood cells and is coincident with the international and governmental standard.
C1 [Li Dechao; Zhang Lina; Zhu Yang; Li Muqin] Jiamusi Univ, Jiamusi 154004, Peoples R China.
RP Li, DC (reprint author), Jiamusi Univ, Jiamusi Dent Hosp Clin Dent Res, Jiamusi 154004, Peoples R China.
EM dechaoli2004@yahoo.com.cn
FU Health Office Scientific Research Topics of Helongjiang Provincial
   [2009-366]; Jiamusi University [Sz 2009-001]
FX Foundation item: Health Office Scientific Research Topics of Helongjiang
   Provincial (2009-366); Jiamusi University Key Research Projects of
   Science and Technology (Sz 2009-001)
CR *ASTM, 1983, F174882S ASTM
   Balamurugan A, 2008, DENT MATER, V24, P1343, DOI 10.1016/j.dental.2008.02.015
   Chung RJ, 2006, J BIOMED MATER RES B, V76B, P169, DOI 10.1002/jbm.b.30365
   *GB, 2003, 168864S GBT
   [龚巍巍 Gong Weiwei], 2005, [材料热处理学报, Transactions of materials and heat treatment], V26, P77
   HARMAND MF, 1995, J BIOMAT SCI-POLYM E, V6, P809, DOI 10.1163/156856295X00193
   HE HM, 2000, CHINESE J CONSERVATI, V10, P48
   *ISO, 1989, 9966S ISOTR
   *ISO, 2002, ISO109934S
   Katz J., 1996, BIOMATERIALS SCI INT, P335
   Kawashita M, 2000, BIOMATERIALS, V21, P393, DOI 10.1016/S0142-9612(99)00201-X
   Lemons J. E., 1996, BIOMATERIALS SCI INT, P308
   LI BG, 2005, CHINESE J BIOMEDICAL, V22, P452
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Mezzour H, 2006, ANN BIOL CLIN-PARIS, V64, P319
   RAMANATHAN V, 2009, BIOTECHNOLOGY ADV, V7, P924
   Ruan Hongjiang, 2009, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V23, P226
   SHI HC, 2003, CHINESE J BIOMEDICAL, V20, P608
   Spoerke ED, 2005, BIOMATERIALS, V26, P5120, DOI 10.1016/j.biomaterials.2005.01.039
   Wang YQ, 2004, BIOMATERIALS, V25, P4777, DOI 10.1016/j.biomaterials.2003.11.051
   Xue WB, 2003, RARE METALS, V22, P42
NR 21
TC 0
Z9 0
U1 0
U2 6
PU NORTHWEST INST NONFERROUS METAL RESEARCH
PI SHAANXI
PA C/O RARE METAL MATERIAL ENGINEERING PRESS, PO BOX 51, XIAN, SHAANXI
   710016, PEOPLES R CHINA
SN 1002-185X
J9 RARE METAL MAT ENG
JI Rare Metal Mat. Eng.
PD JUL
PY 2011
VL 40
SU 2
BP 87
EP 90
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 846UD
UT WOS:000296927800019
DA 2018-10-20
ER

PT J
AU Patel, S
   Das, D
   Goyal, A
AF Patel, Seema
   Das, D.
   Goyal, A.
TI Structural characterization of the exopolysaccharide produced by a new
   strain of Pediococcus pentosaceus (SPO) isolated from soil of Orissa
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES INDIA SECTION
   B-BIOLOGICAL SCIENCES
LA English
DT Article
DE lactic acid bacteria; exopolysaccharide; FT-IR; NMR; SEM; rheometry
ID DEXTRAN; GLUCAN
AB An exopolysaccharide (EPS) producing strain of Pediococcus pentosaceus (SPO) belonging to lactic acid bacteria was isolated from the soil sample of sugarcane field of Orissa. The purified EPS synthesizing enzyme of the isolate was used for production of EPS. The crude EPS was purified by ethanol precipitation. The lyophilised EPS was characterized through a battery of physico-chemical analyses such as optical rotation, FT-IR, NMR, SEM and rheometry studies. Polarimetric results demonstrated the D-rotation of the EPS. FT-IR spectrum showed the abundance of -OH group revealing the cause of its hydrophilicity. (1)HNMR, (13)C NMR and 2D NMR studies showed the mixed alpha and beta glycosidic linkages and branched nature of the EPS. Scanning electron microscopy revealed the highly porous surface, very crucial for food additive and biomaterial applications. Rheological study showed the typical polymeric Non-Newtonian pseudoplastic nature of EPS from the isolate Pediococcus pentosaceus opening a slew of industrial prospects.
C1 [Patel, Seema; Das, D.; Goyal, A.] Indian Inst Technol, Dept Biotechnol, Gauhati 781039, Assam, India.
RP Patel, S (reprint author), Indian Inst Technol, Dept Biotechnol, Gauhati 781039, Assam, India.
EM arungoyl@iitg.ernet.in
OI Das, Deeplina/0000-0002-7889-3780
FU CSIR, New Delhi, India; Ministry of Human Resource Development,
   Government of India
FX The research work and DD was financially supported by a grant from CSIR,
   New Delhi, India to AG. The authors thank Indian Institute of Technology
   Guwahati, Guwahati, India, for providing the research facilities and
   Ministry of Human Resource Development, Government of India, for
   providing doctoral fellowship to SP.
CR Adolfsson O, 2004, AM J CLIN NUTR, V80, P245
   Ahmed NH, 2005, LWT-FOOD SCI TECHNOL, V38, P843, DOI 10.1016/j.lwt.2004.10.001
   Asker MMS, 2009, CARBOHYD POLYM, V77, P563, DOI 10.1016/j.carbpol.2009.01.037
   Chandra K, 2007, CARBOHYD RES, V342, P2484, DOI 10.1016/j.carres.2007.07.013
   DEBASHIS B, 2009, INT J FOOD SCI TECH, V44, P24
   Dlamini A. M., 2007, African Journal of Biotechnology, V6, P2603
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   FOX JD, 1991, ANAL BIOCHEM, V19, P593
   Goyal A, 1996, J GEN APPL MICROBIOL, V42, P81, DOI 10.2323/jgam.42.81
   Koocheki A, 2009, J FOOD ENG, V91, P490, DOI 10.1016/j.jfoodeng.2008.09.028
   Liu CH, 2007, CARBOHYD POLYM, V67, P313, DOI 10.1016/j.carbpol.2006.05.024
   Liu JR, 2006, J SCI FOOD AGR, V86, P2527, DOI 10.1002/jsfa.2649
   Majumder A, 2009, FOOD RES INT, V42, P525, DOI 10.1016/j.foodres.2009.01.003
   Maragkoudakis PA, 2006, INT DAIRY J, V16, P189, DOI 10.1016/j.idairyj.2005.02.009
   Morris V., 1995, BACTERIAL POLYSACCHA, P341
   Patel S, 2012, INDIAN J MICROBIOL, V52, P3, DOI 10.1007/s12088-011-0148-8
   Purama RK, 2009, CARBOHYD POLYM, V76, P30, DOI 10.1016/j.carbpol.2008.09.018
   Salva A, 2003, BBA-PROTEINS PROTEOM, V1647, P83, DOI 10.1016/S1570-9639(03)00061-X
   Schiffrin EJ, 2001, CURR OPIN BIOTECH, V12, P499, DOI 10.1016/S0958-1669(00)00253-6
   SEYMOUR FR, 1979, CARBOHYD RES, V7, P231
   Shingel KI, 2002, CARBOHYD RES, V337, P1445, DOI 10.1016/S0008-6215(02)00209-4
   TSUCHIYA HM, 1955, J AM CHEM SOC, V77, P2412, DOI 10.1021/ja01614a016
   Williams P. A., 2000, Handbook of hydrocolloids, P1
   1990, FOOD ADDITIVES PERMI
NR 24
TC 0
Z9 0
U1 0
U2 4
PU NATL ACAD SCIENCES INDIA
PI ALLAHABAD
PA 5 LAJPATRAI RD, ALLAHABAD 211002, INDIA
SN 0369-8211
J9 P NATL A SCI INDIA B
JI Proc. Nat. Acad. Sci. India Sect. B-Biol. Sci.
PD JUL-SEP
PY 2011
VL 81
BP 291
EP 298
PN 3
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 836JY
UT WOS:000296109200007
DA 2018-10-20
ER

PT J
AU Kuraitis, D
   Zhang, P
   Zhang, Y
   Padavan, DT
   McEwan, K
   Sofrenovic, T
   Mckee, D
   Zhang, J
   Griffith, M
   Cao, X
   Musaro, A
   Ruel, M
   Suuronen, J
AF Kuraitis, D.
   Zhang, P.
   Zhang, Y.
   Padavan, D. T.
   McEwan, K.
   Sofrenovic, T.
   McKee, D.
   Zhang, J.
   Griffith, M.
   Cao, X.
   Musaro, A.
   Ruel, M.
   Suuronen, J.
TI A STROMAL CELL-DERIVED FACTOR-1 RELEASING MATRIX ENHANCES THE PROGENITOR
   CELL RESPONSE AND BLOOD VESSEL GROWTH IN ISCHAEMIC SKELETAL MUSCLE
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Cytokines; hydrogels; injectables; neovascularisation; regenerative
   medicine; vascular biology
ID PERIPHERAL ARTERIAL-DISEASE; ACUTE MYOCARDIAL-INFARCTION; HINDLIMB
   ISCHEMIA; BONE-MARROW; ENDOTHELIAL DYSFUNCTION; ALGINATE BIOMATERIAL;
   TISSUE REGENERATION; CXCR4 EXPRESSION; STEM-CELLS; ANGIOGENESIS
AB Although many regenerative cell therapies are being developed to replace or regenerate ischaemic muscle, the lack of vasculature and poor persistence of the therapeutic cells represent major limiting factors to successful tissue restoration. In response to ischaemia, stromal cell-derived factor-1 (SDF-1) is up-regulated by the affected tissue to stimulate stem cell-mediated regenerative responses. Therefore, we encapsulated SDF-1 into alginate microspheres and further incorporated these into an injectable collagen-based matrix in order to improve local delivery. Microsphere-matrix impregnation reduced the time for matrix thermogelation, and also increased the viscosity reached. This double-incorporation prolonged the release of SDF-1, which maintained adhesive and migratory bioactivity, attributed to chemotaxis in response to SDF-1. In vivo, treatment of ischaemic hindlimb muscle with microsphere-matrix led to increased mobilisation of bone marrow-derived progenitor cells, and also improved recruitment of angiogenic cells expressing the SDF-1 receptor (CXCR4) from bone marrow and local tissues. Both matrix and SDF-1-releasing matrix were successful at restoring perfusion, but SDF-1 treatment appeared to play an earlier role, as evidenced by arterioles that are phenotypically older and by increased angiogenic cytokine production, stimulating the generation of a qualitative microenvironment for a rapid and therefore more efficient regeneration. These results support the release of implanted SDF-1 as a promising method for enhancing progenitor cell responses and restoring perfusion to ischaemic tissues via neovascularisation.
C1 [Kuraitis, D.; Zhang, P.; Zhang, Y.; Padavan, D. T.; McEwan, K.; Sofrenovic, T.; McKee, D.; Ruel, M.; Suuronen, J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Kuraitis, D.; Zhang, Y.; Sofrenovic, T.; Griffith, M.; Ruel, M.; Suuronen, J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4W7, Canada.
   [Kuraitis, D.; Musaro, A.] Univ Roma La Sapienza, IIM, DAHFMO Unit Histol & Med Embryol, Rome, Italy.
   [McEwan, K.; Cao, X.] Univ Ottawa, Fac Engn, Ottawa, ON K1Y 4W7, Canada.
   [Zhang, J.] Univ Western Ontario, Dept Chem & Biochem Engn, London, ON N6A 5B9, Canada.
   [Griffith, M.] Linkoping Univ, Integrat Regenerat Med Ctr, Linkoping, Sweden.
RP Suuronen, J (reprint author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.
EM esuuronen@ottawaheart.ca
RI Musaro, Antonio/K-9598-2016
OI Musaro, Antonio/0000-0002-2944-9739; Griffith, May/0000-0003-1222-6720;
   RUEL, MARC/0000-0002-0487-1319
FU Canadian Institutes of Health Research [MOP-77536]; Lawrence Soloway
   Research Fellowship Award; Heart & Stroke Foundation of Ontario [T6793];
   University of Ottawa; Ontario Graduate Scholarship; Natural Sciences and
   Engineering Research Council of Canada; Canadian Stem Cell Network;
   Fondazione Roma; 7FP-Myoage
FX DK was supported by a Canadian Institutes of Health Research Canadian
   Graduate Scholarship; PZ is a recipient of the Lawrence Soloway Research
   Fellowship Award; YZ was supported by a Heart & Stroke Foundation of
   Ontario Doctoral Research Award; DTP was supported by a University of
   Ottawa Cardiology Research Endowment Fellowship; KM was supported by an
   Ontario Graduate Scholarship; DK and TS were supported by Heart & Stroke
   Foundation of Ontario Master's Studentships; JZ was supported by a
   Natural Sciences and Engineering Research Council of Canada postdoctoral
   fellowship. The authors would like to thank Suzanne Crowe for her flow
   cytometry expertise and Ann Fook Yang for assistance with SEM.; This
   work was supported by grant-in-aid T6793 from the Heart and Stroke
   Foundation of Ontario (to EJS), by grant MOP-77536 from the Canadian
   Institutes of Health Research (to MR and EJS), by a Natural Sciences and
   Engineering Research Council of Canada Research Tool and Instruments
   Grant (to XC), by a Canadian Stem Cell Network grant (to MG), and by
   Fondazione Roma and 7FP-Myoage (to AM). Funding sources did not have a
   role in experimental design, data management, or manuscript preparation.
CR Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Balciunas M, 2009, MED LITH, V45, P434
   Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884
   Bourne David W. A., 2002, VVolume 121, P67
   Cadee JA, 2002, J CONTROL RELEASE, V78, P1, DOI 10.1016/S0168-3659(01)00483-7
   Cho HJ, 2007, J EXP MED, V204, P3257, DOI 10.1084/jem.20070166
   De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423
   Deng C, 2010, TISSUE ENG PT A, V16, P3099, DOI 10.1089/ten.tea.2009.0504
   Fassbender M, 2011, EUR CELLS MATER, V22, P1
   Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019
   Formigli L, 2007, J CELL MOL MED, V11, P1087, DOI 10.1111/j.1582-4934.2007.00111.x
   FUJIO M, 2011, BONE IN PRESS
   Giannoudis PV, 2008, INJURY, V39, P5
   Hadjiioannou T., 1993, QUANTITATIVE CALCULA, P345
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Hixson AW, 1931, IND ENG CHEM, V23, P923, DOI 10.1021/ie50260a018
   Ho TK, 2010, J VASC SURG, V51, P689, DOI 10.1016/j.jvs.2009.10.044
   Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P5836, DOI 10.1016/j.biomaterials.2006.08.003
   Kaully T, 2009, TISSUE ENG PART B-RE, V15, P159, DOI 10.1089/ten.teb.2008.0193
   Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031
   Kim HK, 2006, BLOOD, V108, P812, DOI 10.1182/blood-10-4162
   Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070
   Kimura Y, 2010, J BIOMAT SCI-POLYM E, V21, P37, DOI 10.1163/156856209X410193
   Ko HCH, 2007, EUR CELLS MATER, V14, P1
   KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9
   Li Q, 1997, J CLIN INVEST, V100, P1991, DOI 10.1172/JCI119730
   Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185
   Liu WG, 2008, J MATER SCI-MATER M, V19, P3365, DOI 10.1007/s10856-008-3486-2
   Misiak-Tloczek A, 2009, APMIS, V117, P558, DOI 10.1111/j.1600-0463.2009.02518.x
   Mitra T, 2011, INT J BIOL MACROMOL, V48, P276, DOI 10.1016/j.ijbiomac.2010.11.011
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Park S, 2004, PLAST RECONSTR SURG, V113, P284, DOI 10.1097/01.PRS.0000091169.51035.A5
   Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690comd
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   REDDY K, 2008, INT J CANCER, V15, P831
   Ruel M, 2005, J THORAC CARDIOV SUR, V130, P633, DOI 10.1016/j.jtcvs.2005.01.013
   Ruvinov E, 2011, BIOMATERIALS, V32, P565, DOI 10.1016/j.biomaterials.2010.08.097
   Ruvinov E, 2010, BIOMATERIALS, V31, P4573, DOI 10.1016/j.biomaterials.2010.02.026
   Sandstedt J, 2010, BASIC RES CARDIOL, V105, P545, DOI 10.1007/s00395-010-0088-1
   Seeger FH, 2009, ARTERIOSCL THROM VAS, V29, P1802, DOI 10.1161/ATVBAHA.109.194688
   Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718
   Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0
   Shamoun Fadi, 2008, Expert Rev Cardiovasc Ther, V6, P539, DOI 10.1586/14779072.6.4.539
   Su EJ, 2003, AM J PHYSIOL-HEART C, V284, pH1429, DOI 10.1152/ajpheart.00885.2002
   SUNDARARAMAN S, 2011, GENE THER IN PRESS
   Suuronen EJ, 2007, J THORAC CARDIOV SUR, V134, P1249, DOI 10.1016/j.jtcvs.2007.07.028
   Suuronen EJ, 2010, J THORAC CARDIOV SUR, V139, P209, DOI 10.1016/j.jtcvs.2009.04.055
   Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054
   Takagi Y, 2009, AM J PHYSIOL-LUNG C, V297, pL420, DOI 10.1152/ajplung.90477.2008
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   TURAN RG, STEM CELLS IN PRESS
   VANWEEL V, 2007, ARTERIOSCLER THROMB, V27, P2050
   Whitman SC, 2004, ARTERIOSCL THROM VAS, V24, P1049, DOI 10.1161/01.ATV.0000124923.95545.2c
   Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02
   Yang J, 2010, J APPL POLYM SCI, V117, P178, DOI 10.1002/app.31943
   Zhang G, 2007, TISSUE ENG, V13, P2063, DOI 10.1089/ten.2006.0013
NR 57
TC 40
Z9 42
U1 0
U2 7
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2011
VL 22
BP 109
EP 123
DI 10.22203/eCM.v022a09
PG 15
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 833HR
UT WOS:000295874600009
PM 21892805
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Laschke, MW
   Vollmar, B
   Menger, MD
AF Laschke, M. W.
   Vollmar, B.
   Menger, M. D.
TI THE DORSAL SKINFOLD CHAMBER: WINDOW INTO THE DYNAMIC INTERACTION OF
   BIOMATERIALS WITH THEIR SURROUNDING HOST TISSUE
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE Dorsal skinfold chamber; biomaterials; inflammation; angiogenesis;
   intravital fluorescence microscopy; in vivo; implantation; tissue
   engineering
ID COMPARATIVE IN-VIVO; POROUS POLYETHYLENE IMPLANTS; NANOCRYSTALLINE
   HYDROXYAPATITE PASTE; INTRAVITAL FLUORESCENCE MICROSCOPY;
   STRIATED-MUSCLE MICROCIRCULATION; ISCHEMIA-REPERFUSION INJURY;
   ENDOTHELIAL GROWTH-FACTOR; FOREIGN-BODY RESPONSE; MICROVASCULAR
   RESPONSE; STAPHYLOCOCCUS-AUREUS
AB The implantation of biomaterials into the human body has become an indispensable part of almost all fields of modern medicine. Accordingly, there is an increasing need for appropriate approaches, which can be used to evaluate the suitability of different biomaterials for distinct clinical indications. The dorsal skinfold chamber is a sophisticated experimental model, which has been proven to be extremely valuable for the systematic in vivo analysis of the dynamic interaction of small biomaterial implants with the surrounding host tissue in rats, hamsters and mice. By means of intravital fluorescence microscopy, this chronic model allows for repeated analyses of various cellular, molecular and microvascular mechanisms, which are involved in the early inflammatory and angiogenic host tissue response to biomaterials during the initial 2-3 weeks after implantation. Therefore, the dorsal skinfold chamber has been broadly used during the last two decades to assess the in vivo performance of prosthetic vascular grafts, metallic implants, surgical meshes, bone substitutes, scaffolds for tissue engineering, as well as for locally or systemically applied drug delivery systems. These studies have contributed to identify basic material properties determining the biocompatibility of the implants and vascular ingrowth into their surface or internal structures. Thus, the dorsal skinfold chamber model does not only provide deep insights into the complex interactions of biomaterials with the surrounding soft tissues of the host but also represents an important tool for the future development of novel biomaterials aiming at an optimisation of their biofunctionality in clinical practice.
C1 [Laschke, M. W.; Vollmar, B.; Menger, M. D.] Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   [Laschke, M. W.; Menger, M. D.] Univ Saarland, Collaborat Res Ctr, AO Fdn, D-66421 Homburg, Germany.
   [Vollmar, B.] Univ Rostock, Inst Expt Surg, Rostock, Germany.
RP Laschke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uks.eu
CR Abshagen K, 2009, J BIOMED MATER RES A, V91A, P557, DOI 10.1002/jbm.a.32237
   Al-Jamal KT, 2010, P NATL ACAD SCI USA, V107, P3966, DOI 10.1073/pnas.0908401107
   Albrektsson T, 1989, Int J Oral Maxillofac Implants, V4, P45
   Algire GH, 1943, J NATL CANCER I, V4, P1
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   ARFORS K E, 1970, Microvascular Research, V2, P516, DOI 10.1016/0026-2862(70)90045-2
   BAATZ H, 1995, INT J MICROCIRC, V15, P85, DOI 10.1159/000178955
   BECKER M, 1994, AM J PHYSIOL, V267, pH925
   Berghaus A, 2010, ADV OTO-RHINO-LARYNG, V68, P53, DOI 10.1159/000314562
   Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   Bonhomme S, 2010, ACTA CHIR BELG, V110, P445, DOI 10.1080/00015458.2010.11680653
   BORRERO E, 1988, J CARDIOVASC SURG, V29, P46
   BROWN RM, 1976, P NATL ACAD SCI USA, V73, P4565, DOI 10.1073/pnas.73.12.4565
   Burger JWA, 2004, ANN SURG, V240, P578
   Busenlechner D, 2008, BIOMATERIALS, V29, P3195, DOI 10.1016/j.biomaterials.2008.04.021
   CARDON S Z, 1970, Microvascular Research, V2, P67, DOI 10.1016/0026-2862(70)90052-X
   Carletti E, 2011, METHODS MOL BIOL, V695, P17, DOI 10.1007/978-1-60761-984-0_2
   Chiesa R, 2002, ACTA CHIR BELG, V102, P238
   Contaldo C, 2007, AM J PHYSIOL-HEART C, V293, pH274, DOI 10.1152/ajpheart.01031.2006
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   Ehrmantraut S, 2010, EUR CELLS MATER, V19, P107, DOI 10.22203/eCM.v019a11
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   Erten A, 2010, NANOMED-NANOTECHNOL, V6, P797, DOI 10.1016/j.nano.2010.06.005
   Esguerra M, 2010, J BIOMED MATER RES A, V93A, P140, DOI 10.1002/jbm.a.32516
   Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351
   Gaber MH, 1996, INT J RADIAT ONCOL, V36, P1177, DOI 10.1016/S0360-3016(96)00389-6
   Garcia P, 2008, J SURG RES, V147, P84, DOI 10.1016/j.jss.2007.09.013
   Gaustad JV, 2008, NEOPLASIA, V10, P354, DOI 10.1593/neo.08162
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Glaeser JD, 2010, TISSUE ENG PT A, V16, P3139, DOI [10.1089/ten.tea.2009.0508, 10.1089/ten.TEA.2009.0508]
   Gloria A, 2010, J APPL BIOMATER BIOM, V8, P57
   Gotz W, 2008, CLIN ORAL IMPLAN RES, V19, P1016, DOI 10.1111/j.1600-0501.2008.01569.x
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hak S, 2010, ANGIOGENESIS, V13, P113, DOI 10.1007/s10456-010-9176-y
   Harder Y, 2005, ANN SURG, V242, P869, DOI 10.1097/01.sla.0000189671.06782.56
   Harder Y, 2005, ANN SURG, V242, P878
   Harris AG, 1997, AM J PHYSIOL-HEART C, V273, pH989
   Hauser J, 2009, EUR SURG RES, V43, P262, DOI 10.1159/000229026
   Herscu G, 2009, SURG CLIN N AM, V89, P391, DOI 10.1016/j.suc.2008.09.007
   Huber FX, 2008, J MATER SCI-MATER M, V19, P33, DOI 10.1007/s10856-007-3039-0
   Ichioka S, 2005, BRIT J PLAST SURG, V58, P1124, DOI 10.1016/j.bjps.2005.04.054
   Isaka N, 2004, CANCER RES, V64, P4400, DOI 10.1158/0008-5472.CAN-04-0752
   Ishii T., 2011, ANN RHEUM DIS S1, V70, pi113
   Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015
   Jezupors A, 2006, WORLD J SURG, V30, P2270, DOI 10.1007/s00268-006-0130-5
   Jiang G, 2009, INT J PHARM, V369, P155, DOI 10.1016/j.ijpharm.2008.10.022
   Kahn J, 2007, CLIN TRANSPLANT, V21, P423, DOI 10.1111/j.1399-0012.2007.00666.x
   Kara CO, 1999, PLAST RECONSTR SURG, V104, P2213, DOI 10.1097/00006534-199912000-00041
   Kargi E, 2003, ANN PLAS SURG, V51, P570, DOI 10.1097/01.sap.0000095652.35806.c5
   Kasper G, 2007, STEM CELLS, V25, P903, DOI 10.1634/stemcells.2006-0432
   Kawai M, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2330
   KELLEY SF, 1990, P SOC EXP BIOL MED, V194, P320
   Kerdudou S, 2006, THROMB HAEMOSTASIS, V96, P183, DOI 10.1160/TH-06-02-0116
   Kerger H, 1996, AM J PHYSIOL-HEART C, V270, pH827
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kim K, 2010, TISSUE ENG PART B-RE, V16, P523, DOI [10.1089/ten.teb.2010.0171, 10.1089/ten.TEB.2010.0171]
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Kraft CN, 2005, J BIOMED MATER RES A, V75A, P31, DOI 10.1002/jbm.a.30407
   Kraft CN, 2002, Z ORTHOP GRENZGEB, V140, P672, DOI 10.1055/s-2002-36035
   Kraft CN, 2003, J BONE JOINT SURG BR, V85B, P133, DOI 10.1302/0301-620X.85B1.12749
   Kraft CN, 2001, J MATER SCI-MATER M, V12, P1057, DOI 10.1023/A:1012854325474
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   KRAISS LW, 1995, SURG CLIN N AM, V75, P761, DOI 10.1016/S0039-6109(16)46697-1
   Krasnici S, 2003, INT J CANCER, V105, P561, DOI 10.1002/ijc.11108
   Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503
   Laschke MW, 2010, EUR CELLS MATER, V20, P356
   Laschke MW, 2010, ACTA BIOMATER, V6, P2020, DOI 10.1016/j.actbio.2009.12.004
   Laschke MW, 2009, ACTA BIOMATER, V5, P1991, DOI 10.1016/j.actbio.2009.02.006
   Laschke MW, 2007, J BIOMED MATER RES B, V82B, P494, DOI 10.1002/jbm.b.30755
   Laschke MW, 2006, TISSUE ENG, V12, P2093, DOI 10.1089/ten.2006.12.2093
   Laschke MW, 2011, TISSUE ENG PT A, V17, P841, DOI [10.1089/ten.tea.2010.0329, 10.1089/ten.TEA.2010.0329]
   Laschke MW, 2009, TISSUE ENG PART B-RE, V15, P455, DOI 10.1089/ten.TEB.2009.0252
   Laschke MW, 2009, J BIOMED MATER RES B, V91B, P497, DOI 10.1002/jbm.b.31423
   Laschke MW, 2009, TRANSPL INT, V22, P654, DOI 10.1111/j.1432-2277.2009.00841.x
   Laschke MW, 2008, ANN SURG, V248, P939, DOI 10.1097/SLA.0b013e31818fa52f
   Laschke MW, 2002, J ENDOCRINOL, V172, P535, DOI 10.1677/joe.0.1720535
   Laschke MW, 2005, FERTIL STERIL, V84, P1199, DOI 10.1016/j.fertnstert.2005.05.010
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   Laschke MW, 2005, J INFECT DIS, V191, P435, DOI 10.1086/427193
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   LEUNIG M, 1992, CANCER RES, V52, P6553
   Lindhorst D, 2010, J BIOMED MATER RES A, V95A, P783, DOI 10.1002/jbm.a.32902
   Liu Ping, 2004, Conf Proc IEEE Eng Med Biol Soc, V4, P2662
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Makale M, 2007, METHOD ENZYMOL, V426, P375, DOI 10.1016/S0076-6879(07)26016-1
   MENGER MD, 1990, EUR J CARDIO-THORAC, V4, P191, DOI 10.1016/1010-7940(90)90003-I
   MENGER MD, 1992, PLAST RECONSTR SURG, V89, P1104, DOI 10.1097/00006534-199206000-00017
   Menger MD, 2003, LANGENBECK ARCH SURG, V388, P281, DOI 10.1007/s00423-003-0426-y
   Menger MD, 2002, EUR SURG RES, V34, P83, DOI 10.1159/000048893
   MENGER MD, 1992, AM J PHYSIOL, V263, pH1901
   MENGER MD, 1990, THORAC CARDIOV SURG, V38, P139, DOI 10.1055/s-2007-1014008
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   Monsky WL, 1999, CANCER RES, V59, P4129
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Moosmann S, 2005, CELLS TISSUES ORGANS, V179, P91, DOI 10.1159/000085000
   Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3
   Naik MN, 2007, OPHTHAL PLAST RECONS, V23, P463, DOI 10.1097/IOP.0b013e318158ec8e
   Nickerson MM, 2009, J BIOMED MATER RES A, V91A, P317, DOI 10.1002/jbm.a.32209
   Orr AW, 2003, J CELL SCI, V116, P2917, DOI 10.1242/jcs.00600
   PAPENFUSS HD, 1979, MICROVASC RES, V18, P311, DOI 10.1016/0026-2862(79)90039-6
   Pennekamp PH, 2007, J MATER SCI-MATER M, V18, P2053, DOI 10.1007/s10856-007-3116-4
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   RAHLF G, 1986, THORAC CARDIOV SURG, V34, P43, DOI 10.1055/s-2007-1020371
   Ring A, 2007, EUR SURG RES, V39, P75, DOI 10.1159/000099146
   Ring A, 2006, BURNS, V32, P35, DOI 10.1016/j.burns.2005.07.009
   Ring A, 2006, EUR J MED RES, V11, P471
   Ring A, 2010, EPLASTY, V10
   Ring A, 2011, INT WOUND J, V8, P112, DOI 10.1111/j.1742-481X.2010.00742.x
   Ring A, 2011, J ORTHOP RES, V29, P1237, DOI 10.1002/jor.21358
   Ring A, 2010, INT J ARTIF ORGANS, V33, P877
   Ring A, 2010, BURNS, V36, P1222, DOI 10.1016/j.burns.2010.03.002
   Ring A, 2008, INT WOUND J, V5, P464, DOI 10.1111/j.1742-481X.2007.00403.x
   Robinson TN, 2005, SURG ENDOSC, V19, P1556, DOI 10.1007/s00464-005-0120-y
   Roetman B, 2010, LANGENBECK ARCH SURG, V395, P1147, DOI 10.1007/s00423-010-0608-3
   Roll Stephanie, 2008, BMC Surg, V8, P22, DOI 10.1186/1471-2482-8-22
   Roller J, 2008, LANGENBECK ARCH SURG, V393, P349, DOI 10.1007/s00423-008-0295-5
   Rucker M, 2008, J BIOMED MATER RES A, V86A, P1002, DOI 10.1002/jbm.a.31722
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Rutkow IM, 2003, SURG CLIN N AM, V83, P1045, DOI 10.1016/S0039-6109(03)00132-4
   Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002
   Sandino C, 2010, BIOMATERIALS, V31, P2446, DOI 10.1016/j.biomaterials.2009.11.063
   Sandison JC, 1928, AM J ANAT, V41, P447, DOI 10.1002/aja.1000410303
   Schacht V, 2004, ARCH DERMATOL RES, V295, P542, DOI 10.1007/s00403-004-0453-8
   Schaffer M, 2007, LANGENBECK ARCH SURG, V392, P297, DOI 10.1007/s00423-007-0174-5
   Schafer SC, 2005, AM J PHYSIOL-HEART C, V289, pH330, DOI 10.1152/ajpheart.00674.2004
   Schumann P, 2009, MICROVASC RES, V78, P180, DOI 10.1016/j.mvr.2009.06.003
   Sclafani AP, 1997, ARCH OTOLARYNGOL, V123, P328
   Sefcik LS, 2008, BIOMATERIALS, V29, P2869, DOI 10.1016/j.biomaterials.2008.03.017
   Sefcik LS, 2011, TISSUE ENG PT A, V17, P617, DOI [10.1089/ten.tea.2010.0404, 10.1089/ten.TEA.2010.0404]
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Shankaran V, 2011, ANN SURG, V253, P16, DOI 10.1097/SLA.0b013e3181f9b6e6
   Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91
   Strieth S, 2008, INT J CANCER, V122, P452, DOI 10.1002/ijc.23088
   Strieth S, 2010, J BIOMED MATER RES A, V93A, P1566, DOI 10.1002/jbm.a.32670
   Svirskis D, 2010, J CONTROL RELEASE, V146, P6, DOI 10.1016/j.jconrel.2010.03.023
   Tada H, 2007, CANCER RES, V67, P1138, DOI 10.1158/0008-5472.CAN-06-1185
   Tavassol F, 2010, TISSUE ENG PT A, V16, P2265, DOI [10.1089/ten.tea.2008.0457, 10.1089/ten.TEA.2008.0457]
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Thorlacius H, 1998, J TRAUMA, V45, P715, DOI 10.1097/00005373-199810000-00016
   Ushiyama A, 2004, MICROVASC RES, V68, P147, DOI 10.1016/j.mvr.2004.05.004
   Vajkoczy P, 2000, INT J CANCER, V87, P261, DOI 10.1002/1097-0215(20000715)87:2<261::AID-IJC18>3.0.CO;2-6
   Velard F, 2010, BIOMATERIALS, V31, P2001, DOI 10.1016/j.biomaterials.2009.11.066
   Vermonden T, 2010, MACROMOLECULES, V43, P782, DOI 10.1021/ma902186e
   Vollmar B, 2001, AM J PATHOL, V159, P1661, DOI 10.1016/S0002-9440(10)63013-1
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   Westermann S, 1999, SURGERY, V126, P881, DOI 10.1016/S0039-6060(99)70029-2
   Wieghaus KA, 2008, BIOMATERIALS, V29, P4698, DOI 10.1016/j.biomaterials.2008.08.029
   WINET H, 1988, J ORTHOPAED RES, V6, P531, DOI 10.1002/jor.1100060409
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Xu JJ, 2009, J CRANIOFAC SURG, V20, P918, DOI 10.1097/SCS.0b013e3181a2d728
   ZAREM HA, 1969, SURGERY, V66, P392
   Zetrenne Eleonore, 2007, Yale J Biol Med, V80, P113
NR 155
TC 70
Z9 71
U1 1
U2 5
PU AO RESEARCH INSTITUTE DAVOS-ARI
PI DAVOS
PA CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2011
VL 22
BP 147
EP 167
DI 10.22203/eCM.v022a12
PG 21
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 833HR
UT WOS:000295874600012
PM 21932192
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Sollazzo, V
   Pezzetti, F
   Massari, L
   Palmieri, A
   Brunelli, G
   Zollino, I
   Lucchese, A
   Caruso, G
   Carinci, F
AF Sollazzo, Vincenzo
   Pezzetti, Furio
   Massari, Leo
   Palmieri, Annalisa
   Brunelli, Giorgio
   Zollino, Ilaria
   Lucchese, Alessandra
   Caruso, Gaetano
   Carinci, Francesco
TI Evaluation of Gene Expression in MG63 Human Osteoblastlike Cells Exposed
   to Tantalum Powder by Microarray Technology
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID POROUS TANTALUM; COMPOSITE COATINGS; CANINE MODEL; TITANIUM; IMPLANTS;
   ZIRCONIA; BONE; OSSEOINTEGRATION; INGROWTH; METAL
AB Conventional orthopedic implants are composed from titanium. To improve some characteristics (ie, volumetric porosity, modulus of elasticity, frictional modulus), a new porous tantalum biomaterial has been developed and its biocompatibility reported. By using DNA microarrays containing 20,000 genes, several genes whose expression were significantly up-or down-regulated were identified in an osteoblastlike cell line (MG63) cultured with tantalum powder (TP). The differentially expressed genes cover a broad range of functional activities: signaling transduction; transcription; cell cycle regulation, proliferation, and apoptosis; and cytoskeleton formation. To the authors' knowledge, the data reported represent the first genetic portrait of TP. (Int J Periodontics Restorative Dent 2011;31:e17-e28.)
C1 [Carinci, Francesco] Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, Orthoped Clin, I-44100 Ferrara, Italy.
   [Pezzetti, Furio] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Palmieri, Annalisa; Brunelli, Giorgio; Zollino, Ilaria; Lucchese, Alessandra; Carinci, Francesco] Univ Ferrara, Dept Med Surg Sci Commun & Behav, Sect Maxillofacial Surg, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, Orthoped Clin, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
RI Caruso, Gaetano/L-4828-2016
OI Caruso, Gaetano/0000-0002-6665-5283
FU University of Ferrara, Italy; Fondazione CARISBO
FX This work was supported by grants from the University of Ferrara, Italy,
   and Fondazione CARISBO.
CR Alcivar A, 2003, ONCOGENE, V22, P291, DOI 10.1038/sj.onc.1206099
   Bermudez MD, 2005, WEAR, V258, P693, DOI 10.1016/j.wear.2004.09.023
   Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1987, CLIN ORTHOP RELAT R, P303
   Carinci F, 2004, J BIOMED MATER RES B, V71B, P260, DOI 10.1002/jbm.b.30133
   Carinci F, 2004, CLIN ORAL IMPLAN RES, V15, P180, DOI 10.1111/j.1600-0501.2004.00997.x
   Carinci F, 2004, J PERIODONTOL, V75, P66, DOI 10.1902/jop.2004.75.1.66
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Carinci F, 2003, J BIOMED MATER RES B, V66B, P341, DOI 10.1002/jbm.b.10021
   COLLIER JP, 1988, CLIN ORTHOP RELAT R, P173
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   Fisher MC, 2007, DEV GROWTH DIFFER, V49, P503, DOI 10.1111/j.1440-169x.2007.00941.x
   Frosch KH, 2003, J ORTHOPAED RES, V21, P213, DOI 10.1016/S0736-0266(02)00143-2
   Gu YW, 2004, BIOMATERIALS, V25, P3177, DOI 10.1016/j.biomaterials.2003.09.101
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Huang X, 2006, GENE EXPRESSION, V13, P141, DOI 10.3727/000000006783991836
   Karabatsos B, 2001, CLIN ORTHOP RELAT R, P442
   Kim HW, 2004, BIOMATERIALS, V25, P4203, DOI 10.1016/j.biomaterials.2003.10.094
   LANDON GC, 1999, J BONE JOINT SURG BR, V81, P907
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   Lee TM, 2004, J BIOMED MATER RES A, V71A, P652, DOI 10.1002/jbm.a.30190
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Liu Y, 2007, MOL ENDOCRINOL, V21, P376, DOI 10.1210/me.2006-0342
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Yang YZ, 2003, BIOMATERIALS, V24, P619, DOI 10.1016/S0142-9612(02)00376-9
NR 27
TC 12
Z9 13
U1 0
U2 4
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD JUL-AUG
PY 2011
VL 31
IS 4
BP E17
EP E28
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 820LN
UT WOS:000294907300003
PM 21837296
DA 2018-10-20
ER

PT J
AU Fangel, R
   Bossini, PS
   Renno, AC
   Ribeiro, DA
   Wang, CC
   Toma, RL
   Nonaka, KO
   Driusso, P
   Parizotto, NA
   Oishi, J
AF Fangel, Renan
   Bossini, Paulo Sergio
   Renno, Ana Claudia
   Ribeiro, Daniel Araki
   Wang, Charles Chenwei
   Toma, Renata Luri
   Nonaka, Keico Okino
   Driusso, Patricia
   Parizotto, Nivaldo Antonio
   Oishi, Jorge
TI Low-level laser therapy, at 60 J/cm(2) associated with a Biosilicate (R)
   increase in bone deposition and indentation biomechanical properties of
   callus in osteopenic rats
SO JOURNAL OF BIOMEDICAL OPTICS
LA English
DT Article
DE low-level lasertherapy; biomaterials; osteoporosis; bone healing;
   biomechanical properties
ID FRACTURE; REPAIR; EXPRESSION
AB We investigate the effects of a novel bioactive material (Biosilicate (R)) and low-level laser therapy (LLLT), at 60 J/cm(2), on bone-fracture consolidation in osteoporotic rats. Forty female Wistar rats are submitted to the ovariectomy, to induce osteopenia. Eight weeks after the ovariectomy, the animals are randomly divided into four groups, with 10 animals each: bone defect control group; bone defect filled with Biosilicate group; bone defect irradiated with laser at 60 J/cm(2) group; bone defect filled with Biosilicate and irradiated with LLLT, at 60 J/cm(2) group. Laser irradiation is initiated immediately after surgery and performed every 48 h for 14 days. Histopathological analysis points out that bone defects are predominantly filled with the biomaterial in specimens treated with Biosilicate. In the 60-J/cm(2) laser plus Biosilicate group, the biomaterial fills all bone defects, which also contained woven bone and granulation tissue. Also, the biomechanical properties are increased in the animals treated with Biosilicate associated to lasertherapy. Our results indicate that laser therapy improves bone repair process in contact with Biosilicate as a result of increasing bone formation as well as indentation biomechanical properties. (C) 2011 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.3598847]
C1 [Fangel, Renan; Bossini, Paulo Sergio; Driusso, Patricia; Parizotto, Nivaldo Antonio] Univ Fed Sao Carlos, Dept Physiotherapy, BR-13600970 Sao Paulo, Brazil.
   [Renno, Ana Claudia; Ribeiro, Daniel Araki] Univ Fed Sao Paulo, Dept Biosci, BR-11050240 Sao Paulo, Brazil.
   [Wang, Charles Chenwei; Nonaka, Keico Okino] Univ Fed Sao Carlos, Dept Biol, BR-13600970 Sao Paulo, Brazil.
   [Toma, Renata Luri] Univ Fed Sao Paulo, Dept Physiotherapy, BR-11050240 Sao Paulo, Brazil.
   [Oishi, Jorge] Univ Fed Sao Carlos, Dept Stat, BR-13565208 Sao Paulo, Brazil.
RP Fangel, R (reprint author), Univ Fed Sao Carlos, Dept Physiotherapy, Rod Washington Luiz,Km 235, BR-13600970 Sao Paulo, Brazil.
EM renanfangel@yahoo.com.br
RI Parizotto, Nivaldo/D-5347-2014; Nonaka, Keico Okino/E-3679-2012;
   Bossini, Paulo/G-2333-2014; Driusso, Patricia/D-8592-2012; Renno, Ana
   Claudia/C-1266-2015
OI Parizotto, Nivaldo/0000-0003-1774-9053; Driusso,
   Patricia/0000-0001-8067-9786; 
CR Christiansen C, 1991, Nord Med, V106, P145
   COMELEKOGLU S, 2007, CLIN RHEUMATOL, V26, P380
   DINIZ R, 2009, LASER MED SCI, V24, P347
   Gerbi MEM, 2005, PHOTOMED LASER SURG, V23, P382, DOI 10.1089/pho.2005.23.382
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   GREENSPAN D, 1995, BIOCERAMICS, P89
   Hollinger JO, 2008, J ORTHOP RES, V26, P83, DOI 10.1002/jor.20453
   Kalu DN, 1991, BONE MINER, V15, P171
   Liu XC, 2007, PHOTOMED LASER SURG, V25, P487, DOI 10.1089/pho.2006.2075
   Matsumoto MA, 2009, LASER MED SCI, V24, P195, DOI 10.1007/s10103-008-0544-4
   MOURA LN, 2007, J BIOMED MATER RES A, V82, P545
   Muniz Renno AC, 2006, LASER MED SCI, V21, P202
   Renno ACM, 2010, PHOTOMED LASER SURG, V28, P131, DOI 10.1089/pho.2009.2487
   Obradovic R, 2007, J ORAL LASER APPL, V7, P161
   Oliveira P, 2010, J MATER SCI-MATER M, V21, P1379, DOI 10.1007/s10856-009-3945-4
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Pinheiro ALB, 2006, PHOTOMED LASER SURG, V24, P169, DOI 10.1089/pho.2006.24.169
   Renno ACM, 2006, PHOTOMED LASER SURG, V24, P202, DOI 10.1089/pho.2006.24.202
   STEIN D, 2005, PHOTOMED LASER SURG, V23, P161
   Vogel M, 2001, BIOMATERIALS, V22, P357, DOI 10.1016/S0142-9612(00)00191-5
   Wang ML, 2007, SPINE J, V7, P466, DOI 10.1016/j.spinee.2006.06.400
   Wheeler DL, 1998, J BIOMED MATER RES, V41, P527, DOI 10.1002/(SICI)1097-4636(19980915)41:4<527::AID-JBM3>3.0.CO;2-E
   Yaoita H, 2000, J BONE MINER METAB, V18, P63, DOI 10.1007/s007740050013
   ZANOTTO ED, 2004, PROCESS COMPOSITIONS
NR 24
TC 8
Z9 8
U1 0
U2 5
PU SPIE-SOC PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA
SN 1083-3668
J9 J BIOMED OPT
JI J. Biomed. Opt.
PD JUL
PY 2011
VL 16
IS 7
AR 078001
DI 10.1117/1.3598847
PG 5
WC Biochemical Research Methods; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
SC Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine &
   Medical Imaging
GA 814LF
UT WOS:000294453800051
PM 21806293
DA 2018-10-20
ER

PT J
AU Tirella, A
   Vozzi, F
   De Maria, C
   Vozzi, G
   Sandri, T
   Sassano, D
   Cognolato, L
   Ahluwalia, A
AF Tirella, Annalisa
   Vozzi, Federico
   De Maria, Carmelo
   Vozzi, Giovanni
   Sandri, Tazio
   Sassano, Duccio
   Cognolato, Livio
   Ahluwalia, Arti
TI Substrate stiffness influences high resolution printing of living cells
   with an ink-jet system
SO JOURNAL OF BIOSCIENCE AND BIOENGINEERING
LA English
DT Article
DE Inkjet printing; Cell viability; Finite element methods; Fibroblasts;
   Scaffold stiffness
ID SHEAR-STRESS; DROP; FABRICATION; TENSEGRITY; MECHANISMS; PRESSURE;
   TRAUMA; INJURY; MODEL; FLOW
AB The adaptation of inkjet printing technology for the realisation of controlled micro- and nano-scaled biological structures is of great potential in tissue and biomaterial engineering. In this paper we present the Olivetti BioJet system and its applications in tissue engineering and cell printing. BioJet, which employs a thermal inkjet cartridge, was used to print biomolecules and living cells. It is well known that high stresses and forces are developed during the inkjet printing process. When printing living particles (i.e., cell suspensions) the mechanical loading profile can dramatically damage the processed cells. Therefore computational models were developed to predict the velocity profile and the mechanical load acting on a droplet during the printing process. The model was used to investigate the role of the stiffness of the deposition substrate during droplet impact and compared with experimental investigations on cell viability after printing on different materials. The computational model and the experimental results confirm that impact forces are highly dependent on the deposition substrate and that soft and viscous surfaces can reduce the forces acting on the droplet, preventing cell damage. These results have high relevance for cell bioprinting; substrates should be designed to have a good compromise between substrate stiffness to conserve spatial patterning without droplet coalescence but soft enough to absorb the kinetic energy of droplets in order to maintain cell viability. (C) 2011, The Society for Biotechnology, Japan. All rights reserved.
C1 [Tirella, Annalisa; De Maria, Carmelo; Vozzi, Giovanni; Ahluwalia, Arti] Univ Pisa, Fac Engn, Interdept Res Ctr E Piaggio, I-56124 Pisa, Italy.
   [Vozzi, Federico; Ahluwalia, Arti] CNR, Inst Clin Physiol, Lab Biomimet Mat & Tissue Engn, I-56126 Pisa, Italy.
   [Sandri, Tazio; Sassano, Duccio; Cognolato, Livio] R&D Olivetti I Jet, I-10015 Ivrea, TO, Italy.
RP Tirella, A (reprint author), Univ Pisa, Fac Engn, Interdept Res Ctr E Piaggio, Via Diotisalvi 2, I-56124 Pisa, Italy.
EM tirella@gmail.com
RI Vozzi, Federico/C-9706-2014; Vozzi, Giovanni/F-9787-2014
OI Vozzi, Federico/0000-0001-5457-2328; Vozzi,
   Giovanni/0000-0002-9414-9994; Ahluwalia, Arti/0000-0001-5370-6750;
   Tirella, Annalisa/0000-0002-3743-3593; De Maria,
   Carmelo/0000-0002-1368-3571
CR Barbee KA, 2005, ANN NY ACAD SCI, V1066, P67, DOI 10.1196/annals.1363.006
   BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163
   Boland T, 2007, MAT SCI ENG C-BIO S, V27, P372, DOI 10.1016/j.msec.2006.05.047
   Boland Thomas, 2006, Biotechnology Journal, V1, P910, DOI 10.1002/biot.200600081
   BORN C, 1992, BIOTECHNOL BIOENG, V40, P1004, DOI 10.1002/bit.260400903
   Cai KY, 2009, COLLOID SURFACE B, V72, P230, DOI 10.1016/j.colsurfb.2009.04.008
   Chang R, 2008, TISSUE ENG PT A, V14, P41, DOI 10.1089/ten.a.2007.0004
   de Gans BJ, 2004, LANGMUIR, V20, P7789, DOI 10.1021/la049469o
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   INGBER DE, 1993, J CELL SCI, V104, P613
   IVES CL, 1986, IN VITRO CELL DEV B, V22, P500
   Meinhart CD, 2000, J MICROELECTROMECH S, V9, P67, DOI 10.1109/84.825779
   Merrin J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000663
   Mironov V, 2008, REGEN MED, V3, P93, DOI 10.2217/17460751.3.1.93
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Okamoto T, 2000, NAT BIOTECHNOL, V18, P438
   REIN M, 1993, FLUID DYN RES, V12, P61, DOI 10.1016/0169-5983(93)90106-K
   Ringeisen Bradley R., 2006, Biotechnology Journal, V1, P930, DOI 10.1002/biot.200600058
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Sanjana NE, 2004, J NEUROSCI METH, V136, P151, DOI 10.1016/j.jneumeth.2004.01.011
   Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomatei-ials.2007.09.032
   Serbest G, 2006, FASEB J, V20, P308, DOI 10.1096/fj.05-4024fje
   Stamenovic D, 2000, J BIOMECH ENG-T ASME, V122, P39, DOI 10.1115/1.429631
   Sumerel Jan, 2006, Biotechnology Journal, V1, P976, DOI 10.1002/biot.200600123
   Tirella A, 2011, TISSUE ENG PART C-ME, V17, P229, DOI [10.1089/ten.tec.2010.0195, 10.1089/ten.TEC.2010.0195]
   Wang W, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896118
   Watanabe K, 2003, ZOOL SCI, V20, P429, DOI 10.2108/zsj.20.429
   Zhou C, 2008, INT J MULTIPHAS FLOW, V34, P102, DOI 10.1016/j.ijmultiphaseflow.2007.09.002
NR 30
TC 22
Z9 23
U1 1
U2 46
PU SOC BIOSCIENCE BIOENGINEERING JAPAN
PI OSAKA
PA OSAKA UNIV, FACULTY ENGINEERING, 2-1 YAMADAOKA, SUITA, OSAKA, 565-0871,
   JAPAN
SN 1389-1723
J9 J BIOSCI BIOENG
JI J. Biosci. Bioeng.
PD JUL
PY 2011
VL 112
IS 1
BP 79
EP 85
DI 10.1016/j.jbiosc.2011.03.019
PG 7
WC Biotechnology & Applied Microbiology; Food Science & Technology
SC Biotechnology & Applied Microbiology; Food Science & Technology
GA 815EK
UT WOS:000294508700016
PM 21497548
DA 2018-10-20
ER

PT J
AU Dong, CX
   Zhu, SJ
   Mizuno, M
   Hashimoto, M
AF Dong, C. X.
   Zhu, S. J.
   Mizuno, Mineo
   Hashimoto, Masami
TI Fatigue Behavior of HDPE Composite Reinforced with Silane Modified TiO2
SO JOURNAL OF MATERIALS SCIENCE & TECHNOLOGY
LA English
DT Article
DE Fatigue; Composites; Polymers; Fracture; Interfaces
ID TOTAL HIP-ARTHROPLASTY; MECHANICAL-PROPERTIES; TIO2/HIGH-DENSITY
   POLYETHYLENE; CORTICAL BONE; CRACK-GROWTH; BIOACTIVITY; RESISTANCE;
   TITANIUM; BIOMATERIALS; REPLACEMENT
AB The composite of high density polyethylene reinforced with silane-modified TiO2 particles (silane-TiO2/HDPE) is a potential bone substitute biomaterial. The structure, bioactivity, and mechanical properties of silaneTiO(2)/HDPE are analogous to those of natural bone, correspondingly. In order to investigate the effect of silane connection and saline solution on fatigue behaviors, flexural fatigue tests with this composite were carried out in both air and saline solution. Saline solution was found to have different effect on fatigue life. In saline solution, the fatigue life could be improved at stress levels lower than 30 MPa, while the fatigue life could be reduced at stress levels higher than 30 MPa. After analyzing the fracture morphologies, different failure mechanisms were proposed, and the important role of silane connection in the composite during the fatigue process was discussed. Silane connection cannot only support the loading stress but also hinder the failure process under loading effectively. For dry specimens, no interfacial failure between the filler and matrix was found. For wet specimens, it is inferred that the synergetic effect of saline solution and high. concentrated stress at high stress level could easily destroy the silane connection, which accelerated the fracture process, whereas the synergetic effect of saline solution and silane connection at low stress level could promote the formation of more microcracks on sample surface, which hindered the final fracture.
C1 [Dong, C. X.; Zhu, S. J.] Fukuoka Inst Technol, Dept Intelligent Mech Engn, Fukuoka 8110295, Japan.
   [Dong, C. X.] Beihua Univ, Nanomat Lab, Jililn City 132013, Jilin, Peoples R China.
   [Mizuno, Mineo; Hashimoto, Masami] Japan Fine Ceram Ctr, Nagoya, Aichi 4568587, Japan.
RP Zhu, SJ (reprint author), Fukuoka Inst Technol, Dept Intelligent Mech Engn, Fukuoka 8110295, Japan.
EM zhu@fit.ac.jp
RI Hashimoto, Masami/J-7205-2013
FU Japan's Official Development Assistance (ODA) to China
FX C.X. Doug is grateful to Personnel Training Project for her study in
   Japan, financed by Japan's Official Development Assistance (ODA) to
   China.
CR Ascenzi MG, 2007, J BIOMECH, V40, P2619, DOI 10.1016/j.jbiomech.2007.01.014
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   BONFIELD W, 1981, BIOMATERIALS, V2, P185, DOI 10.1016/0142-9612(81)90050-8
   Bonfield W., 1997, 1997 CSE INT LECT, P5
   Chen YK, 2007, SURF COAT TECH, V202, P494, DOI 10.1016/j.surfcoat.2007.06.015
   Dong CX, 2010, J MATER SCI, V45, P3506, DOI 10.1007/s10853-010-4387-6
   Dong CX, 2010, J MATER SCI, V45, P1796, DOI 10.1007/s10853-009-4161-9
   Drozdov AD, 2007, EUR POLYM J, V43, P10, DOI 10.1016/j.eurpolymj.2006.09.013
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Guild FJ, 1998, J MATER SCI-MATER M, V9, P497, DOI 10.1023/A:1008831720198
   Hashimoto M, 2006, MATER RES BULL, V41, P515, DOI 10.1016/j.materresbull.2005.09.014
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Kultural SE, 2007, MATER DESIGN, V28, P816, DOI 10.1016/j.matdes.2005.11.009
   Liu Y, 2006, MAT SCI ENG C-BIO S, V26, P1390, DOI 10.1016/j.msec.2005.08.017
   Merah N, 2005, ENG FRACT MECH, V72, P1691, DOI 10.1016/j.engfracmech.2004.12.002
   Nalla RK, 2005, BIOMATERIALS, V26, P2183, DOI 10.1016/j.biomaterials.2004.05.024
   Sobelman OS, 2004, J BIOMECH, V37, P1295, DOI 10.1016/j.jbiomech.2003.12.034
   Takadama H, 2004, KEY ENG MAT, V254-2, P569, DOI 10.4028/www.scientific.net/KEM.254-256.569
   Tee DI, 2007, COMPOS SCI TECHNOL, V67, P2584, DOI 10.1016/j.compscitech.2006.12.007
   Teoh SH, 2000, INT J FATIGUE, V22, P825, DOI 10.1016/S0142-1123(00)00052-9
   That PTT, 2000, J BIOMED MATER RES, V51, P453
   Wang ZD, 2008, COMPOS PART A-APPL S, V39, P439, DOI 10.1016/j.compositesa.2007.08.030
   Yamamoto E, 2006, J BIOMECH, V39, P1812, DOI 10.1016/j.jbiomech.2005.05.017
   YAMAMURO T, 1990, J BONE JOINT SURG BR, V72, P889
   Zawrah MF, 2007, MATER CHEM PHYS, V106, P330, DOI 10.1016/j.matchemphys.2007.06.010
   Zhang SM, 2005, CURR APPL PHYS, V5, P516, DOI 10.1016/j.cap.2005.01.023
NR 26
TC 10
Z9 10
U1 0
U2 14
PU JOURNAL MATER SCI TECHNOL
PI SHENYANG
PA 72 WENHUA RD, SHENYANG 110015, PEOPLES R CHINA
SN 1005-0302
J9 J MATER SCI TECHNOL
JI J. Mater. Sci. Technol.
PD JUL
PY 2011
VL 27
IS 7
BP 659
EP 667
DI 10.1016/S1005-0302(11)60122-9
PG 9
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 808PP
UT WOS:000293991200012
DA 2018-10-20
ER

PT J
AU Toh, WS
   Spector, M
   Lee, EH
   Cao, T
AF Toh, Wei Seong
   Spector, Myron
   Lee, Eng Hin
   Cao, Tong
TI Biomaterial-Mediated Delivery of Microenvironmental Cues for Repair and
   Regeneration of Articular Cartilage
SO MOLECULAR PHARMACEUTICS
LA English
DT Review
DE biomaterials; delivery systems; cartilage; microenvironment; repair;
   regenerative medicine; tissue engineering
ID MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION;
   COLLAGEN-GAG SCAFFOLDS; AGE-RELATED-CHANGES; IN-VIVO; BONE-MARROW;
   TISSUE-REPAIR; ENGINEERING CARTILAGE; EXTRACELLULAR-MATRIX; PROGENITOR
   CELLS
AB Articular cartilage injuries are one of the most challenging problems in musculoskeletal medicine due to the poor intrinsic regenerative capacity of this tissue. The lack of efficient treatment modalities motivates research into tissue engineering: combining cells, biomaterials mimicking extracellular matrix (scaffolds) and microenvironmental signaling cues. The, aim of this review is to focus on the use of biomaterials as delivery systems for microenvironmental cues in relation to their applications for treatment of cartilage defects. The latest advances in cartilage tissue engineering and regeneration are critically reviewed to demonstrate an outline of challenges toward biomaterial-based approaches of cartilage regeneration.
C1 [Toh, Wei Seong; Spector, Myron] VA Boston Healthcare Syst, Tissue Engn Labs, Boston, MA 02130 USA.
   [Toh, Wei Seong; Spector, Myron] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA.
   [Lee, Eng Hin] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Orthopaed Surg, Singapore 117510, Singapore.
   [Cao, Tong] Natl Univ Singapore, Fac Dent, Singapore 119083, Singapore.
RP Toh, WS (reprint author), VA Boston Healthcare Syst, Tissue Engn Labs, Mail Stop 151 Res,150 S Huntington Ave, Boston, MA 02130 USA.
EM wtoh@partners.org
RI CAO, Tong/B-1008-2008; Toh, Wei Seong/K-7720-2013
OI CAO, Tong/0000-0002-7994-9627; Toh, Wei Seong/0000-0001-9147-6423;
   Spector, Myron/0000-0003-3328-4858
FU Agency for Science, Technology and Research (A*STAR) Singapore;
   Department of Veterans Affairs
FX W.S.T. is presently supported by A*STAR International Fellowship, Agency
   for Science, Technology and Research (A*STAR) Singapore. M.S. is
   supported by a Research Career Scientist Award from the Department of
   Veterans Affairs.
CR Abe Tomoyuki, 2003, J Orthop Sci, V8, P92, DOI 10.1007/s007760300016
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Amin AK, 2009, J BONE JOINT SURG BR, V91B, P691, DOI 10.1302/0301-620X.91B5.21544
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Breinan HA, 2000, J ORTHOPAED RES, V18, P781, DOI 10.1002/jor.1100180516
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 2010, AM J SPORT MED, V38, P1259, DOI 10.1177/0363546509346395
   Buckwalter JA, 2002, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000026073.30435.dc
   Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006
   CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9
   Casper ME, 2010, OSTEOARTHR CARTILAGE, V18, P981, DOI 10.1016/j.joca.2010.04.009
   Chung C, 2008, ADV DRUG DELIVER REV, V60, P243, DOI 10.1016/j.addr.2007.08.027
   Clair Benjamin L, 2009, Foot Ankle Spec, V2, P179, DOI 10.1177/1938640009342272
   Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005
   De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Emans PJ, 2010, P NATL ACAD SCI USA, V107, P3418, DOI 10.1073/pnas.0907774107
   Endres M, 2007, J ORTHOP RES, V25, P1299, DOI 10.1002/jor.20394
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   GRANDE DA, 1987, ANAT REC, V218, P142, DOI 10.1002/ar.1092180208
   GRANDE DA, 1989, J ORTHOP RES, V7, P208, DOI 10.1002/jor.1100070208
   Ho STB, 2010, TISSUE ENG PT A, V16, P1123, DOI 10.1089/ten.TEA.2009.0471
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Holland TA, 2007, OSTEOARTHR CARTILAGE, V15, P187, DOI 10.1016/j.joca.2006.07.006
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Jeng L, 2010, TISSUE ENG PT A, V16, P3011, DOI 10.1089/ten.tea.2009.0771
   Jiang Y. Z., 2010, CELL TRANSPLANT, DOI [10.3727/096368910X332738, DOI 10.3727/096368910X332738]
   Keung AJ, 2010, ANNU REV CELL DEV BI, V26, P533, DOI 10.1146/annurev-cellbio-100109-104042
   Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Klein TJ, 2009, TISSUE ENG PART B-RE, V15, P143, DOI [10.1089/ten.teb.2008.0563, 10.1089/ten.TEB.2008.0563]
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176
   Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X
   Lee CR, 2003, J ORTHOPAED RES, V21, P272, DOI 10.1016/S0736-0266(02)00153-5
   Lee EH, 2006, J BONE JOINT SURG BR, V88B, P841, DOI 10.1302/0301-620X.88B7.17305
   Lee HJ, 2008, TISSUE ENG PT A, V14, P1843, DOI 10.1089/ten.tea.2007.0204
   Liu SQ, 2010, BIOMATERIALS, V31, P7298, DOI 10.1016/j.biomaterials.2010.06.001
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marlovits S, 2006, EUR J RADIOL, V57, P24, DOI 10.1016/j.ejrad.2005.08.009
   Matsumoto T, 2009, ARTHRITIS RHEUM, V60, P1390, DOI 10.1002/art.24443
   Mierisch CM, 2003, J BONE JOINT SURG AM, V85A, P1757, DOI 10.2106/00004623-200309000-00015
   Mishima Y, 2008, J ORTHOP RES, V26, P1407, DOI 10.1002/jor.20668
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005
   Nehrer S, 2008, CLIN ORTHOP RELAT R, V466, P1849, DOI 10.1007/s11999-008-0322-4
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Ochi M, 2002, J BONE JOINT SURG BR, V84B, P571, DOI 10.1302/0301-620X.84B4.11947
   Ostrander RV, 2001, CLIN ORTHOP RELAT R, P228
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Payne KA, 2010, OSTEOARTHR CARTILAGE, V18, P705, DOI 10.1016/j.joca.2010.01.011
   Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136
   Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004
   Pufe T, 2004, MATRIX BIOL, V23, P267, DOI 10.1016/j.matbio.2004.06.003
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Re'em T, 2010, BIOMATERIALS, V31, P6746, DOI 10.1016/j.biomaterials.2010.05.025
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Robbins JR, 2000, ARTHRITIS RHEUM, V43, P2189, DOI 10.1002/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S
   Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004
   Shah RN, 2010, P NATL ACAD SCI USA, V107, P3293, DOI 10.1073/pnas.0906501107
   SHAPIRO F, 1993, J BONE JOINT SURG AM, V75A, P532, DOI 10.2106/00004623-199304000-00009
   Shastri VP, 2009, ADV MATER, V21, P3246, DOI [10.1002/adma.200900608, 10.1002/adma.200990155]
   Spector M, 2006, SWISS MED WKLY, V136, P293
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Stoddart MJ, 2009, REGEN MED, V4, P81, DOI 10.2217/17460751.4.1.81
   Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002
   Sun XD, 2009, BIOMATERIALS, V30, P1222, DOI 10.1016/j.biomaterials.2008.10.020
   Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228
   Tessmar JK, 2007, ADV DRUG DELIVER REV, V59, P274, DOI 10.1016/j.addr.2007.03.020
   Toh WS, 2011, STEM CELL REV REP, V7, P544, DOI 10.1007/s12015-010-9222-6
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Veilleux N, 2005, OSTEOARTHR CARTILAGE, V13, P278, DOI 10.1016/j.joca.2004.12.013
   Vickers SM, 2006, TISSUE ENG, V12, P1345, DOI 10.1089/ten.2006.12.1345
   Vickers SM, 2010, J ORTHOP RES, V28, P1184, DOI 10.1002/jor.21113
   Wang CM, 2010, ADV DRUG DELIVER REV, V62, P699, DOI 10.1016/j.addr.2010.02.001
   Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI 10.1016/j.cger.2010.03.001
NR 92
TC 34
Z9 36
U1 2
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD JUL-AUG
PY 2011
VL 8
IS 4
SI SI
BP 994
EP 1001
DI 10.1021/mp100437a
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 799SW
UT WOS:000293307400002
PM 21500855
DA 2018-10-20
ER

PT J
AU Mahor, S
   Collin, E
   Dash, BC
   Pandit, A
AF Mahor, Sunil
   Collin, Estelle
   Dash, Biraja C.
   Pandit, Abhay
TI Controlled Release of Plasmid DNA from Hyaluronan Nanoparticles
SO CURRENT DRUG DELIVERY
LA English
DT Review
DE Extracellular matrix; hyaluronan; nanoparticles; plasmid DNA; controlled
   release
ID GENE DELIVERY; IN-VITRO; DRUG-DELIVERY; CELLS; CD44; TRANSFECTION;
   CARRIERS; SYSTEMS; MICROSPHERES; RECEPTOR
AB Encapsulation of plasmid DNA (pDNA) in nanoparticulate gene delivery systems offers the possibility of control in dosing, enhanced pDNA uptake, increased resistance to nuclease degradation and sustained release of functionally active pDNA over time. Extracellular matrix based biomaterial i.e. hyaluronan (HA) was used to encapsulate pDNA (pCMV-GLuc, Gaussia Luciferase reporter plasmid DNA having CMV promoter) in submicron size particulate system. Nano size range (similar to 400-600 nm) pDNA loaded hyaluronan nanoparticles were formulated by ionic gelation followed by the cross-linking method with high encapsulation efficiency (similar to 75-85%). The particle preparation process was further optimized for molecular weight, cross-linking method, cross-linking time and plasmid/polymer ratio. The entrapped plasmid maintained its structural and functional integrity as revealed by agarose gel electrophoresis. The pDNA was released from the hyaluronan nanoparticles in a controlled manner over a period of one month. In vitro transfection by one-week released pDNA from nanoparticles with transfecting agent branched polyethyleneimine (bPEI) resulted in significantly higher expression levels than those in pDNA alone which demonstrated the functional bioactivity of released pDNA. For cellular localization studies, the hyaluronan nanoparticles encapsulated with FITC-dextran were incubated with adipose derived stem cells (ADSCs) and localization in the cellular environment was investigated. The results of this study illustrate that hyaluronan nanoparticles were rapidly internalized by the cells through nonspecific endocytosis and remained intact in the cytosol for up to 24 h.
C1 [Mahor, Sunil; Collin, Estelle; Dash, Biraja C.; Pandit, Abhay] Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
RP Pandit, A (reprint author), Natl Univ Ireland, Network Excellence Funct Biomat, Galway, Ireland.
EM abhay.pandit@nuigalway.ie
RI Pandit, Abhay/B-6187-2008
OI Pandit, Abhay/0000-0002-6292-4933
FU Science Foundation Ireland [07/SRC/B1163, 07/RFP/ENMF482]
FX The authors are thankful to Anthony Sloan for his assistance in editing
   this manuscript. The authors would also like to acknowledge Science
   Foundation Ireland for their support under the research grant no.
   07/SRC/B1163 and 07/RFP/ENMF482.
CR Al-Ghananeem AM, 2009, AAPS PHARMSCITECH, V10, P410, DOI 10.1208/s12249-009-9222-5
   Ando S, 1999, J PHARM SCI, V88, P126, DOI 10.1021/js9801687
   Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007
   Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO;2-4
   Chen JL, 2007, INT J PHARM, V343, P255, DOI 10.1016/j.ijpharm.2007.05.045
   Csaba N, 2005, BIOMACROMOLECULES, V6, P271, DOI 10.1021/bm049577p
   Diez S, 2006, EUR J PHARM BIOPHARM, V63, P188, DOI 10.1016/j.ejpb.2006.03.007
   Ditto AJ, 2009, EXPERT OPIN DRUG DEL, V6, P1149, DOI 10.1517/17425240903241796
   Gargouri M, 2009, TECHNOL CANCER RES T, V8, P433, DOI 10.1177/153303460900800605
   Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2
   Keeney M, 2010, BIOMATERIALS, V31, P2893, DOI 10.1016/j.biomaterials.2009.12.041
   Kim HR, 2004, CANCER RES, V64, P4569, DOI 10.1158/0008-5472.CAN-04-0202
   Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z
   Kumar MNVR, 2004, BIOMATERIALS, V25, P1771, DOI 10.1016/j.biomaterials.2003.08.069
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   Lee PW, 2010, BIOMATERIALS, V31, P2425, DOI 10.1016/j.biomaterials.2009.11.100
   Liao YH, 2005, DRUG DELIV, V12, P327, DOI 10.1080/10717540590952555
   Luo D, 1999, PHARMACEUT RES, V16, P1300, DOI 10.1023/A:1014870102295
   Luo D, 2000, NAT BIOTECHNOL, V18, P33
   MAHOR S, 2010, P TISS ENG REG MED I
   Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4
   Park TG, 2006, ADV DRUG DELIVER REV, V58, P467, DOI 10.1016/j.addr.2006.03.007
   Rafat M, 2010, BIOMATERIALS, V31, P3414, DOI 10.1016/j.biomaterials.2010.01.031
   Rimann M, 2008, BIOCONJUGATE CHEM, V19, P548, DOI 10.1021/bc7003439
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   UNDERHILL C, 1992, J CELL SCI, V103, P293
   Vasir JK, 2006, EXPERT OPIN DRUG DEL, V3, P325, DOI 10.1517/17425247.3.3.325
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Verissimo LM, 2010, J DRUG TARGET, V18, P333, DOI 10.3109/10611860903434019
   Verkoelen CF, 2006, J AM SOC NEPHROL, V17, P1673, DOI 10.1681/ASN.2006010088
   Yang F, 2009, GENE THER, V16, P533, DOI 10.1038/gt.2008.182
NR 32
TC 14
Z9 15
U1 2
U2 41
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1567-2018
J9 CURR DRUG DELIV
JI Curr. Drug Deliv.
PD JUL
PY 2011
VL 8
IS 4
BP 354
EP 362
DI 10.2174/156720111795768031
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 797NP
UT WOS:000293134900003
PM 21453262
DA 2018-10-20
ER

PT J
AU Rojas, S
   Gispert, JD
   Martin, R
   Abad, S
   Menchon, C
   Pareto, D
   Victor, VM
   Alvaro, M
   Garcia, H
   Herance, JR
AF Rojas, Santiago
   Gispert, Juan D.
   Martin, Roberto
   Abad, Sergio
   Menchon, Cristina
   Pareto, Deborah
   Victor, Victor M.
   Alvaro, Mercedes
   Garcia, Hermenegildo
   Raul Herance, J.
TI Biodistribution of Amino-Functionalized Diamond Nanoparticles. In Vivo
   Studies Based on F-18 Radionuclide Emission
SO ACS NANO
LA English
DT Article
DE nanodiamonds; PET; pharmacokinetics; in vivo evaluation; rodent;
   surfactant; filtration.
ID QUANTUM DOTS; NANOMATERIALS; CIRCULATION; DELIVERY; POLYMER; JEWELS;
   GOLD; RATS; MICE
AB Nanoparticles have been proposed for several biomedical applications; however, in vivo biodistribution studies to confirm their potential are scarce. Nanodiamonds are carbon nanoparticles that have been recently proposed as a promising biomaterial. In this study, we labeled nanodiamonds with F-18 to study their in vivo biodistribution by positron emission tomography. Moreover, the impact on the biodistribution of their kinetic particle size and of the surfactant agents has been evaluated. Radiolabeled diamond nanoparticles accumulated mainly in the lung, spleen, and liver and were excreted into the urinary tract. The addition of surfactant agents did not lead to significant changes in this pattern, with the exception of a slight reduction in the urinary excretion rate. On the other hand; after filtration of the radiolabeled diamond nanoparticles to remove those with a larger kinetic, size, the uptake In the lung and spleen was completely inhibited and significantly reduced in the liver.
C1 [Rojas, Santiago; Gispert, Juan D.; Pareto, Deborah; Raul Herance, J.] CRC Corp Sanitaria, Inst Alta Tecnol Parc Recerca Biomed Barcelona, Barcelona 08003, Spain.
   [Gispert, Juan D.; Pareto, Deborah] Ctr Invest Biomed Red Bioingn Biomat & Nanomed CI, Zaragoza 50018, Spain.
   [Martin, Roberto; Alvaro, Mercedes; Garcia, Hermenegildo] Univ Politecn Valencia, Inst Univ Tecnol Quim CSIC UPV, Valencia 46022, Spain.
   [Abad, Sergio; Menchon, Cristina] CRC Corp Sanitaria, CRC Ctr Imatge Mol, Barcelona 08003, Spain.
   [Victor, Victor M.] CIBERehd, Valencia 46017, Spain.
   [Victor, Victor M.] Univ Hosp Doctor Peset Fdn, Valencia 46017, Spain.
   [Victor, Victor M.] Univ Valencia, Dept Physiol, Valencia 46010, Spain.
RP Herance, JR (reprint author), CRC Corp Sanitaria, Inst Alta Tecnol Parc Recerca Biomed Barcelona, Barcelona 08003, Spain.
EM rherance@crccorp.es
RI Gispert, Juan Domingo/C-6355-2008; Pareto, Deborah/E-5965-2018; Garcia,
   Hermenegildo/E-3296-2010; VICTOR, VICTOR/I-3270-2015
OI Gispert, Juan Domingo/0000-0002-6155-0642; Pareto,
   Deborah/0000-0001-7356-3769; Garcia, Hermenegildo/0000-0002-9664-493X;
   VICTOR, VICTOR/0000-0002-3027-3945; Herance, Jose
   Raul/0000-0001-7178-3290; Alvaro, Mercedes/0000-0001-5070-4207
FU Spanish MICINN [CTQ-2009-11586]; Fondo de Investigacion Sanitaria (FIS)
   of the Instituto de Salud Carlos III [PS09/02620, PI10/1195,
   PS09/02217]; La Marato TO Foundation [090530]; CDTI; Spanish Ministry of
   Science and Innovation; Fond de Investigacion Sanitaria (FIS)
   [CES10/030]
FX The present work was supported by Spanish MICINN (Grant CTQ-2009-11586);
   the Fondo de Investigacion Sanitaria (FIS) of the Instituto de Salud
   Carlos III (Grants PS09/02620, PI10/1195, and PS09/02217), La Marato TO
   Foundation (Grant 090530), and CDTI under the CENIT Programme (AMIT
   Project) and supported by the Spanish Ministry of Science and
   Innovation. R.M. thanks the Spanish Ministry for a postgraduate
   scholarship. V.M.V. is a recipient of Fond de Investigacion Sanitaria
   (FIS) and Generalitat Valenciana contract (CES10/030)
CR Ambruosi A, 2005, J DRUG TARGET, V13, P535, DOI 10.1080/10611860500411043
   Balasubramanian SK, 2010, BIOMATERIALS, V31, P2034, DOI 10.1016/j.biomaterials.2009.11.079
   Chrastina A, 2010, INT J NANOMED, V5, P653, DOI 10.2147/IJN.S11677
   He XX, 2008, ANAL CHEM, V80, P9597, DOI 10.1021/ac801882g
   Kim BYS, 2010, NEW ENGL J MED, V363, P2434, DOI 10.1056/NEJMra0912273
   Krueger A, 2008, ADV MATER, V20, P2445, DOI 10.1002/adma.200701856
   Lam R, 2009, EXPERT OPIN DRUG DEL, V6, P883, DOI 10.1517/17425240903156382
   Liang XJ, 2008, CURR DRUG METAB, V9, P697, DOI 10.2174/138920008786049230
   Liu Z, 2008, P NATL ACAD SCI USA, V105, P1410, DOI 10.1073/pnas.0707654105
   Mading P, 2005, APPL RADIAT ISOTOPES, V63, P329, DOI 10.1016/j.apradiso.2005.03.005
   Martin R, 2010, ACS NANO, V4, P6957, DOI 10.1021/nn1019412
   Martin R, 2010, ACS NANO, V4, P65, DOI 10.1021/nn901616c
   Martin R, 2009, CHEM MATER, V21, P4505, DOI 10.1021/cm9012602
   Milane L., 2010, NANOMEDICIN IN PRESS
   Prencipe G, 2009, J AM CHEM SOC, V131, P4783, DOI 10.1021/ja809086q
   Rossin R, 2008, J NUCL MED, V49, P103, DOI 10.2967/jnumed.107.045302
   Schipper ML, 2009, SMALL, V5, P126, DOI 10.1002/smll.200800003
   Shokeen M, 2008, Q J NUCL MED MOL IM, V52, P267
   Texier I, 2009, METHODS MOL BIOL, V544, P393, DOI 10.1007/978-1-59745-483-4_26
   Yang H, 2010, PHARM RES-DORDR, V27, P1759, DOI 10.1007/s11095-010-0141-7
   Zhu ZP, 2003, MOD PHYS LETT B, V17, P1477, DOI 10.1142/S0217984903006554
NR 21
TC 76
Z9 78
U1 3
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUL
PY 2011
VL 5
IS 7
BP 5552
EP 5559
DI 10.1021/nn200986z
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 796ES
UT WOS:000293035200032
PM 21657210
DA 2018-10-20
ER

PT J
AU Luna, SM
   Silva, SS
   Gomes, ME
   Mano, JF
   Reis, RL
AF Luna, Sandra M.
   Silva, Simone S.
   Gomes, Manuela E.
   Mano, Joao F.
   Reis, Rui L.
TI Cell Adhesion and Proliferation onto Chitosan-based Membranes Treated by
   Plasma Surface Modification
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE chitosan membrane; plasma treatment; cell behavior; surface properties;
   biomaterial
ID STARCH-BASED SCAFFOLDS; IN-VITRO; POLYMERS; BIOMATERIALS; DERIVATIVES;
   CHEMISTRY; TISSUE; PHASE
AB Surface properties play a vital role in the functioning of a biomaterial. Cellular adherence and growth onto biomaterials can be enhanced in biomaterial modifications of their surface. In this work, the cell behavior on chitosan membranes modified by argon and nitrogen-plasma treatments was investigated. Characterization of the membranes was performed using atomic force microscopy, contact angle measurements, and X-ray photoelectron spectroscopy. Cytotoxicity assessment and direct contact assay were carried out for untreated and treated chitosan membranes using L929 fibroblast-like cells. Cell morphology and cell viability were assessed to evaluate the cell attachment and proliferation. Changes in terms of roughness, surface chemistry, and hydrophilicity/hydrophobic balance of chitosan-modified membranes were observed. Regarding cell studies, the findings revealed that the extracts of all membranes do not induce cytotoxic effects. Moreover, the in vitro assays evidenced an improvement of the L929 adhesion and attachment when compared to untreated chitosan membranes. Overall, the data obtained clearly demonstrated that plasma treatments constitute an effective way of improving the biocompatibility of chitosan membranes towards to their use in biomedical applications.
C1 [Silva, Simone S.] Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   IBB, PT Govt Associated Lab, Guimaraes, Portugal.
RP Silva, SS (reprint author), Univ Minho, Headquarters European Inst Excellence Tissue Engn, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM simonesilva@dep.uminho.pt
RI Reis, Rui L./A-8938-2008; Gomes, Manuela/B-6282-2009; Mano,
   Joao/A-4418-2009; Silva, Simone/F-9757-2011; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Gomes, Manuela/0000-0002-2036-6291;
   Mano, Joao/0000-0002-2342-3765; Silva, Simone/0000-0003-4268-9419;
   Group, 3Bs/0000-0002-5195-3456
FU European Union [E04M041362CO]; Portuguese Foundation for Science and
   Technology [SFRH/BPD/45307/2008]; European Union-funded - STREP
   [NMP3-CT-2003-505758]
FX S. M. Luna acknowledges the support of the Programme Alssan - The
   European Union Programme of High Level Scholarships for Latin America
   (scholarship No E04M041362CO) and Silva SS acknowledge the support of
   the Portuguese Foundation for Science and Technology,
   (SFRH/BPD/45307/2008). This work was also partially supported by the
   European Union-funded - STREP project HIPPOCRATES (NMP3-CT-2003-505758)
   and was carried out under the scope of European NoE EXPERTISSUES
   (NMP3-CT-2004-500283).
CR [Anonymous], 109935 ISOEN
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Gerenser LJ, 2000, SURF INTERFACE ANAL, V29, P12, DOI 10.1002/(SICI)1096-9918(200001)29:1<12::AID-SIA687>3.3.CO;2-Z
   Gomes ME, 2001, BIOMATERIALS, V22, P1911, DOI 10.1016/S0142-9612(00)00377-X
   Gumpenberger T, 2003, BIOMATERIALS, V24, P5139, DOI 10.1016/S0142-9612(03)00460-5
   KIRKPATRICK CJ, 1992, BIOMATERIALS TISSUE
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   Pashkuleva I, 2005, J MATER SCI-MATER M, V16, P81, DOI 10.1007/s10856-005-6450-4
   PEREZ PML, 2007, J MATER CHEM, V17, P4064
   RATNER BD, 1995, BIOSENS BIOELECTRON, V10, P797, DOI 10.1016/0956-5663(95)99218-A
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Salgado AJ, 2002, MAT SCI ENG C-BIO S, V20, P27, DOI 10.1016/S0928-4931(02)00009-7
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013
   Silva SS, 2008, MACROMOL BIOSCI, V8, P568, DOI 10.1002/mabi.200700264
   Silva SS, 2005, J MATER SCI-MATER M, V16, P575, DOI 10.1007/s10856-005-0534-z
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   Ueno H, 1999, BIOMATERIALS, V20, P1407, DOI 10.1016/S0142-9612(99)00046-0
   Yang F, 2002, J BIOMATER APPL, V16, P215, DOI 10.1106/088532802021176
   Zhu X, 2005, J BIOMED MATER RES A, V73A, P264, DOI 10.1002/jbm.a.30211
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 30
TC 38
Z9 39
U1 0
U2 27
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2011
VL 26
IS 1
BP 101
EP 116
DI 10.1177/0885328210362924
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 794RB
UT WOS:000292917800003
PM 20511386
DA 2018-10-20
ER

PT J
AU Du, LQ
   Wu, XY
AF Du, Liqun
   Wu, Xinyi
TI Development and Characterization of a Full-Thickness Acellular Porcine
   Cornea Matrix for Tissue Engineering
SO ARTIFICIAL ORGANS
LA English
DT Article
DE Cornea; Decellularize; Porcine; Tissue engineering
ID EXTRACELLULAR-MATRIX; BIOMECHANICAL CHARACTERIZATION; CELL-INTERACTIONS;
   HEART-VALVES; COLLAGEN; TRANSPLANTATION; SCAFFOLDS; KERATOPROSTHESIS;
   BIOMATERIALS; REGENERATION
AB Our aim was to produce a natural, acellular matrix from porcine cornea for use as a scaffold in developing a tissue-engineered cornea replacement. Full-thickness, intact porcine corneas were decellularized by immersion in 0.5% (wt/vol) sodium dodecyl sulfate. The resulting acellular matrices were then characterized and examined specifically for completeness of the decellularization process. Histological analyses of decellularized corneal stromas showed that complete cell and alpha-Gal removal was achieved, while the major structural proteins including collagen type I and IV, laminin, and fibronectin were retained. DAPI staining did not detect any residual DNA within the matrix, and the DNA contents, which reflect the presence of cellular materials, were significantly diminished in the decellularized cornea. The collagen content of the decellularized cornea was well maintained compared with native tissues. Uniaxial tensile testing indicated that decellularization did not significantly compromise the ultimate tensile strength of the tissue (P > 0.05). In vitro cytotoxicity assays using rabbit corneal fibroblast cultures excluded the presence of soluble toxins in the biomaterial. In vivo implantation to rabbit interlamellar stromal pockets showed good biocompability. In summary, a full-thickness natural acellular matrix retaining the major structural components and strength of the cornea has been successfully developed. The matrix is biocompatible with cornea-derived cells and has potential for use in corneal transplantation and tissue-engineering applications.
C1 [Du, Liqun; Wu, Xinyi] Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan, Shandong, Peoples R China.
RP Wu, XY (reprint author), Shandong Univ, Qilu Hosp, Dept Ophthalmol, Jinan, Shandong, Peoples R China.
EM xywu8868@163.com
CR Atkinson JJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-1
   Banerjee D, 2008, J PHYS CHEM B, V112, P1016, DOI 10.1021/jp077090f
   BARBER JC, 1988, INT OPHTHALMOL CLIN, V28, P103, DOI 10.1097/00004397-198802820-00002
   Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Brown AL, 2005, BIOMATERIALS, V26, P529, DOI 10.1016/j.biomaterials.2004.02.055
   Conconi MT, 2005, BIOMATERIALS, V26, P2567, DOI 10.1016/j.biomaterials.2004.07.035
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Feng XS, 2006, BURNS, V32, P293, DOI 10.1016/j.burns.2005.10.006
   Ghosh K, 2006, TISSUE ENG, V12, P601, DOI 10.1089/ten.2006.12.601
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Griffith M, 2002, CORNEA, V21, pS54, DOI 10.1097/01.ICO.0000028326.06702.9C
   *INT ORG STAND, 109932 ISO
   Khan BF, 2007, ARCH OPHTHALMOL-CHIC, V125, P745, DOI 10.1001/archopht.125.6.745
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Koizumi Noriko, 2007, Nippon Ganka Gakkai Zasshi, V111, P493
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Lichtenberg A, 2006, J HEART VALVE DIS, V15, P287
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Liu L, 2007, BIOMATERIALS, V28, P3807, DOI 10.1016/j.biomaterials.2007.04.025
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Oh JY, 2009, TISSUE ENG PART C-ME, V15, P635, DOI 10.1089/ten.TEC.2009.0022
   Orwin E, 2007, ACTA BIOMATER, V3, P1041, DOI 10.1016/j.actbio.2007.04.008
   Oswal D, 2007, J HEART VALVE DIS, V16, P165
   Braga-Vilela AS, 2008, J MEMBRANE BIOL, V221, P15, DOI 10.1007/s00232-007-9081-5
   Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Tudorache I, 2007, J HEART VALVE DIS, V16, P567
   Vrana E, 2008, J BIOMED MATER RES A, V84A, P454, DOI 10.1002/jbm.a.31442
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Zerbe BL, 2006, OPHTHALMOLOGY, V113, P1779, DOI 10.1016/j.ophtha.2006.05.015
NR 37
TC 38
Z9 42
U1 1
U2 24
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD JUL
PY 2011
VL 35
IS 7
BP 691
EP 705
DI 10.1111/j.1525-1594.2010.01174.x
PG 15
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 791FU
UT WOS:000292651100011
PM 21501189
DA 2018-10-20
ER

PT J
AU Bowerman, CJ
   Liyanage, W
   Federation, AJ
   Nilsson, BL
AF Bowerman, Charles J.
   Liyanage, Wathsala
   Federation, Alexander J.
   Nilsson, Bradley L.
TI Tuning beta-Sheet Peptide Self-Assembly and Hydrogelation Behavior by
   Modification of Sequence Hydrophobicity and Aromaticity
SO BIOMACROMOLECULES
LA English
DT Article
ID AMYLOID FIBRIL FORMATION; AMINO-ACID-SEQUENCE; SOLID-STATE NMR;
   AGGREGATION-PRONE; POLYPEPTIDE IAPP; FORMING PEPTIDES; TWISTED RIBBONS;
   HELICAL RIBBONS; PROTEINS; STABILITY
AB Peptide self-assembly leading to cross-beta amyloid structures is a widely studied phenomenon because of its role in amyloid pathology and the exploitation of amyloid as a functional biomaterial. The self-assembly process is governed by hydrogen bonding, hydrophobic, aromatic pi-pi, and electrostatic Coulombic interactions. A role for aromatic pi-pi interactions in peptide self-assembly leading to amyloid has been proposed, but the relative contributions of pi-pi versus general hydrophobic interactions in these processes are poorly understood. The Ac-(XKXK)(2)-NH(2) peptide was used to study the contributions of aromatic and hydrophobic interactions to peptide self-assembly. Position X was globally replaced by valine (Val), isoleucine (Ile), phenylalanine (Phe), pentafluorophenylalanine (F(5)-Phe), and cyclohexylalanine (Cha). At low pH, these peptides remain monomeric because of repulsion of charged lysine (Lys) residues. Increasing the solvent ionic strength to shield repulsive charge-charge interactions between protonated Lys residues facilitated cross-beta fibril formation. It was generally found that as peptide hydrophobicity increased, the required ionic strength to induce self-assembly decreased. At [NaCl] ranging from 0 to 1000 mM, the Val sequence failed to assemble. Assembly of the Phe sequence commenced at 700 mM NaCl and at 300 mM NaCl for the less hydrophobic Ile variant, even though it displayed a mixture of random coil and beta-sheet secondary structures over all NaCl concentrations. beta-Sheet formation for F(5)-Phe and Cha sequences was observed at only 20 and 60 mM NaCl, respectively. Whereas self-assembly propensity generally correlated to peptide hydrophobicity and not aromatic character the presence of aromatic, amino acids imparted unique properties to fibrils derived from these peptides. Nonaromatic peptides formed fibrils of 3-15 nm in diameter, whereas aromatic peptides formed nanotape or nanoribbon architectures of 3-7 rim widths. In addition, all peptides formed fibrillar hydrogels at sufficient peptide concentrations, but nonaromatic peptides formed weak gels, whereas aromatic peptides formed rigid gels. These findings clarify the influence of aromatic amino acids on peptide self-assembly processes and illuminate design principles for the inclusion of aromatic amino acids in amyloid-derived biomaterials.
C1 [Bowerman, Charles J.; Liyanage, Wathsala; Federation, Alexander J.; Nilsson, Bradley L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA.
RP Nilsson, BL (reprint author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.
EM nilsson@chem.rochester.edu
RI Nilsson, Bradley/P-3718-2016
OI Nilsson, Bradley/0000-0003-1193-3693
FU DuPont Young Professor Award; Alzheimer's Association [NIRG-08-90797];
   ACS PRF [48922-DNI1]; Creative and Novel Ideas in HIV Research Program
   (CNIHR); U.S. National Science Foundation [CHE-0840410]
FX We acknowledge Dr. Scott Kennedy, Dr. Sandip Sur, and Karen Bentley
   (URMC Electron Microscope Research Core) for assistance with CD, NMR,
   and TEM experiments. We thank Chris Willoughby and TA Instruments for
   the use of an AR-G2 rheometer. This work was supported by a DuPont Young
   Professor Award to B.L.N., the Alzheimer's Association (NIRG-08-90797),
   ACS PRF (48922-DNI1), and the Creative and Novel Ideas in HIV Research
   Program (CNIHR). Mass spectroscopy instrumentation was supported in part
   by a grant from the U.S. National Science Foundation (CHE-0840410).
CR ABEDINI A, 2008, WILEY ENCY CHEM BIOL, P1
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Armstrong AH, 2011, BIOCHEMISTRY-US, V50, P4058, DOI 10.1021/bi200268w
   Aulisa L, 2009, BIOMACROMOLECULES, V10, P2694, DOI 10.1021/bm900634x
   Azriel R, 2001, J BIOL CHEM, V276, P34156, DOI 10.1074/jbc.M102883200
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P1651, DOI 10.1021/bm200035r
   Bakota EL, 2011, BIOMACROMOLECULES, V12, P82, DOI 10.1021/bm1010195
   Bellotti V, 2009, OPEN BIOL J, V2, P228
   Bemporad F, 2006, PROTEIN SCI, V15, P862, DOI 10.1110/ps.051915806
   Bemporad F, 2006, ACCOUNTS CHEM RES, V39, P620, DOI 10.1021/ar050067x
   Biancalana M, 2008, J MOL BIOL, V383, P205, DOI 10.1016/j.jmb.2008.08.031
   Bowerman CJ, 2010, J AM CHEM SOC, V132, P9526, DOI 10.1021/ja1025535
   Bowerman CJ, 2009, MOL BIOSYST, V5, P1058, DOI 10.1039/b904439f
   Branco MC, 2009, ACTA BIOMATER, V5, P817, DOI 10.1016/j.actbio.2008.09.018
   Caplan MR, 2000, BIOMACROMOLECULES, V1, P627, DOI 10.1021/bm005586w
   Caplan MR, 2002, BIOMATERIALS, V23, P219, DOI 10.1016/S0142-9612(01)00099-0
   Carrick LM, 2007, TETRAHEDRON, V63, P7457, DOI 10.1016/j.tet.2007.05.036
   Castelletto V, 2009, ANGEW CHEM INT EDIT, V48, P2317, DOI 10.1002/anie.200805500
   Chen J, 2008, J AM CHEM SOC, V130, P16496, DOI 10.1021/ja807651a
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131
   Chiu HP, 2009, J AM CHEM SOC, V131, P13192, DOI 10.1021/ja903631h
   Choudhury N, 2009, J CHEM ENG DATA, V54, P542, DOI 10.1021/je8004886
   Collier JH, 2010, CHEM SOC REV, V39, P3413, DOI 10.1039/b914337h
   Constantini S., 2006, BIOCHEM BIOPH RES CO, V342, P441
   Cui H, 2009, NANO LETT, V9, P945, DOI 10.1021/nl802813f
   Dobson C. M., 2003, NATURE, V426, P884
   DOBSON MC, 2004, SEMIN CELL DEV BIOIL, V15, P3
   Dong H, 2007, J AM CHEM SOC, V129, P12468, DOI 10.1021/ja072536r
   Easterhoff D, 2011, BIOPHYS J, V100, P1325, DOI 10.1016/j.bpj.2011.01.037
   Escuder B, 2006, J ORG CHEM, V71, P7747, DOI 10.1021/jo0612731
   FAUCHERE JL, 1988, INT J PEPT PROT RES, V32, P269
   Fishwick CWG, 2003, NANO LETT, V3, P1475, DOI 10.1021/nl034095p
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp
   Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107
   Hamley IW, 2007, ANGEW CHEM INT EDIT, V46, P8128, DOI 10.1002/anie.200700861
   Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701
   Heise H, 2008, CHEMBIOCHEM, V9, P179, DOI 10.1002/cbic.200700630
   Hwang WM, 2003, J CHEM PHYS, V118, P389, DOI 10.1063/1.1524618
   Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j
   Jelesarov I, 1998, BIOCHEMISTRY-US, V37, P7539, DOI 10.1021/bi972977v
   Jung JP, 2010, BIOPOLYMERS, V94, P49, DOI 10.1002/bip.21326
   Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007
   Kumada Y, 2010, SOFT MATTER, V6, P5073, DOI 10.1039/c0sm00333f
   Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002
   Larsen TH, 2009, MACROMOLECULES, V42, P8443, DOI 10.1021/ma901423n
   Liang Y, 2008, BIOCHEMISTRY-US, V47, P10018, DOI 10.1021/bi801081c
   Lowik DWPM, 2010, CHEM SOC REV, V39, P3394, DOI 10.1039/b914342b
   MAJI KS, 2009, SCIENCE, V325, P328
   Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102
   MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0
   Marek P, 2007, BIOCHEMISTRY-US, V46, P3255, DOI 10.1021/bi0621967
   Marini DM, 2002, NANO LETT, V2, P295, DOI 10.1021/nl015697g
   Marshall KE, 2011, BIOCHEMISTRY-US, V50, P2061, DOI 10.1021/bi101936c
   Marshall KE, 2009, OPEN BIOL J, V2, P185, DOI DOI 10.2174/1874196700902020185
   Measey TJ, 2010, MACROMOLECULES, V43, P7800, DOI 10.1021/ma101450b
   Menger FM, 2000, J AM CHEM SOC, V122, P11679, DOI 10.1021/ja0016811
   MISSEL PJ, 1980, J PHYS CHEM-US, V84, P1044, DOI 10.1021/j100446a021
   Nagarkar RP, 2008, J AM CHEM SOC, V130, P4466, DOI 10.1021/ja710295t
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   Nerelius C, 2010, BIOCHEM BIOPH RES CO, V396, P2, DOI 10.1016/j.bbrc.2010.02.105
   Nyrkova IA, 2000, EUR PHYS J B, V17, P481, DOI 10.1007/s100510070127
   O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7
   Otzen D, 2010, PRION, V4, P256, DOI 10.4161/pri.4.4.13676
   Ozbas B, 2004, MACROMOLECULES, V37, P7331, DOI 10.1021/ma0491762
   Pashuck ET, 2010, J AM CHEM SOC, V132, P8819, DOI 10.1021/ja100613w
   Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092
   Rajagopal K, 2004, CURR OPIN STRUC BIOL, V14, P480, DOI 10.1016/j.sbi.2004.06.006
   Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200
   Saiani A, 2009, SOFT MATTER, V5, P193, DOI 10.1039/b811288f
   Savin T, 2007, SOFT MATTER, V3, P1194, DOI 10.1039/b700434f
   SELKOE DJ, 2008, MOL GENETIC BASIS NE, P317
   Senguen FT, 2011, MOL BIOSYST, V7, P497, DOI 10.1039/c0mb00210k
   Senguen FT, 2011, MOL BIOSYST, V7, P486, DOI 10.1039/c0mb00080a
   Shamovsky IL, 2000, J PHYS CHEM B, V104, P11296, DOI 10.1021/jp002590t
   Smith AM, 2010, MACROMOL CHEM PHYS, V211, P127, DOI 10.1002/macp.200900420
   Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013
   Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422
   Tracz SM, 2004, BIOCHEMISTRY-US, V43, P15901, DOI 10.1021/bi0488121
   Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539
   Wang K, 2005, INT J BIOL MACROMOL, V36, P232, DOI 10.1016/j.ijbiomac.2005.06.006
   Waters ML, 2002, CURR OPIN CHEM BIOL, V6, P736, DOI 10.1016/S1367-5931(02)00359-9
   Woll MG, 2006, J AM CHEM SOC, V128, P15932, DOI 10.1021/ja0634573
   Wu M, 2011, MOL BIOSYST, V7, P2040, DOI 10.1039/c0mb00271b
   Yan CQ, 2010, CHEM SOC REV, V39, P3528, DOI 10.1039/b919449p
   Yerbury J. J., 2010, CURR CHEM BIOL, V4, P89
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   Zheng J, 2006, PHYS BIOL, V3, pP1, DOI 10.1088/1478-3975/3/3/P01
   Zou D., 2009, BIOPOLYMERS, V93, P318
NR 92
TC 79
Z9 80
U1 11
U2 80
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUL
PY 2011
VL 12
IS 7
BP 2735
EP 2745
DI 10.1021/bm200510k
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 790VG
UT WOS:000292617700037
PM 21568346
DA 2018-10-20
ER

PT J
AU Anselme, K
   Bigerelle, M
AF Anselme, K.
   Bigerelle, M.
TI Role of materials surface topography on mammalian cell response
SO INTERNATIONAL MATERIALS REVIEWS
LA English
DT Review
DE Surface topography; Cell adhesion; Roughness parameters; Cell
   proliferation; Cell differentiation; Contact guidance; Review
ID OSTEOBLAST-LIKE CELLS; TITANIUM IMPLANT SURFACES; SMOOTH-MUSCLE-CELL;
   PROTEIN-KINASE-A; POLYMER-DEMIXED NANOTOPOGRAPHY; DEFINED BIOMATERIAL
   SURFACES; CONNECTIVE-TISSUE RESPONSES; CORNEAL EPITHELIAL-CELLS;
   ATOMIC-FORCE MICROSCOPY; MESENCHYMAL STEM-CELLS
AB Many approaches are used to modify the surface topography of implant materials. Some produce unordered surfaces using, for example, classical implant surface treatments, whereas others produce ordered surfaces by micro- and nanopatterning techniques. Surface topographies can be characterised by several methods that can acquire two-dimensional profiles or three-dimensional measurements and calculate different roughness parameters. The importance of using systematically several roughness parameters for correlation with biological response, and of consider these parameters at different scales will be demonstrated. Furthermore, it will be described, from a general point of view, how cells are able to identify and respond to surface topography. The role of membrane receptors, cytoskeleton, filopods and intracellular signal transduction in the response to topography will be considered and discussed. A critical review of more than 300 papers provides the basis for illustrating how mammalian cells respond to surface topography and how their rugophilia, the increased cell response to rougher surfaces, is a function of cell phenotype. For the first time, the rugophilia of cells from different tissue origins is compared in a synthetic table.
C1 [Anselme, K.] Univ Haute Alsace, Inst Sci Mat Mulhouse, LRC CNRS 7228, Mulhouse, France.
   [Bigerelle, M.] Univ Technol Compiegne, UMR CNRS 6253, Lab Roberval, F-60206 Compiegne, France.
RP Anselme, K (reprint author), Univ Haute Alsace, Inst Sci Mat Mulhouse, LRC CNRS 7228, Mulhouse, France.
EM K.Anselme@uha.fr
RI Luong-Van, Emma/A-8685-2012
OI Maxence, Bigerelle/0000-0002-4144-245X; Anselme,
   Karine/0000-0002-6669-205X
CR ABERCROMBIE M, 1979, NATURE, V281, P259, DOI 10.1038/281259a0
   ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7
   ALBERTS B, 2002, MOL BIOL CELL, V17
   ALENGHAT FJ, 2002, SCI STKE, V119, pE6
   Altomare L, 2010, ACTA BIOMATER, V6, P1948, DOI 10.1016/j.actbio.2009.12.040
   Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   Andrews KD, 2008, J MATER SCI-MATER M, V19, P1601, DOI 10.1007/s10856-008-3377-6
   Anselme K, 2006, SURF COAT TECH, V200, P6325, DOI 10.1016/j.surfcoat.2005.11.001
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Anselme K, 2010, P I MECH ENG H, V224, P1487, DOI 10.1243/09544119JEIM901
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Anselme K, 2010, J ADHES SCI TECHNOL, V24, P831, DOI 10.1163/016942409X12598231568186
   Aparicio C, 2002, J MATER SCI-MATER M, V13, P1105, DOI 10.1023/A:1021173500990
   Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001
   Bagno A, 2004, BIOMATERIALS, V25, P2437, DOI 10.1016/j.biomaterials.2003.09.018
   Bagno A, 2007, BONE, V41, P704, DOI 10.1016/j.bone.2007.06.008
   Berry CC, 2005, BIOMATERIALS, V26, P4985, DOI 10.1016/j.biomaterials.2005.01.046
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Biela SA, 2009, ACTA BIOMATER, V5, P2460, DOI 10.1016/j.actbio.2009.04.003
   Bigerelle M, 2007, P I MECH ENG B-J ENG, V221, P1485, DOI 10.1243/09544054JEM777
   Bigerelle M, 2007, TRIBOL INT, V40, P1319, DOI 10.1016/j.triboint.2006.12.007
   Bigerelle M, 2005, ACTA BIOMATER, V1, P499, DOI 10.1016/j.actbio.2005.06.001
   Bigerelle M, 2005, WEAR, V258, P232, DOI 10.1016/j.wear.2004.09.025
   Bigerelle M, 2005, J BIOMED MATER RES A, V75A, P530, DOI 10.1002/jbm.a.30473
   Bigerelle M, 2003, J MATER SCI, V38, P2525, DOI 10.1023/A:1023929807546
   Bigerelle M, 2009, J MATER PROCESS TECH, V209, P6103, DOI 10.1016/j.jmatprotec.2009.04.013
   Bigerelle M, 2002, BIOMATERIALS, V23, P1563, DOI 10.1016/S0142-9612(01)00271-X
   Bigerelle M, 2009, INT J ARTIF ORGANS, V32, P461
   Bigerelle M, 2008, POLYM ENG SCI, V48, P1725, DOI 10.1002/pen.21131
   Bigerelle M, 2008, TRIBOL INT, V41, P992, DOI 10.1016/j.triboint.2008.03.015
   Bigerelle M, 2007, SENSOR ACTUAT B-CHEM, V126, P126, DOI 10.1016/j.snb.2006.11.006
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Biggs MJP, 2009, J BIOMED MATER RES A, V91A, P195, DOI 10.1002/jbm.a.32196
   Biggs MJP, 2009, BIOMATERIALS, V30, P5094, DOI 10.1016/j.biomaterials.2009.05.049
   Borsari V, 2005, BIOMATERIALS, V26, P4948, DOI 10.1016/j.biomaterials.2005.01.010
   Bowers K T, 1992, Int J Oral Maxillofac Implants, V7, P302
   Boyan B. D., 2003, European Cells & Materials, V6, P22
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Boyan BD, 2001, ANN REV MATER RES, V31, P357, DOI 10.1146/annurev.matsci.31.1.357
   Boyan BD, 1999, BIOMATERIALS, V20, P2305, DOI 10.1016/S0142-9612(99)00159-3
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Brunette DM, 1999, J BIOMECH ENG-T ASME, V121, P49, DOI 10.1115/1.2798042
   Buttiglieri S, 2003, BIOMATERIALS, V24, P2731, DOI 10.1016/S0142-9612(03)00088-7
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Cao Y, 2009, MAT SCI ENG C-BIO S, V29, P119, DOI 10.1016/j.msec.2008.05.015
   Carbone R, 2006, BIOMATERIALS, V27, P3221, DOI 10.1016/j.biomaterials.2006.01.056
   Carinci F, 2004, CLIN ORAL IMPLAN RES, V15, P180, DOI 10.1111/j.1600-0501.2004.00997.x
   Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546
   Castellani R, 1999, CLIN ORAL IMPLAN RES, V10, P369, DOI 10.1034/j.1600-0501.1999.100504.x
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   CHEHROUDI B, 1989, J BIOMED MATER RES, V23, P1067, DOI 10.1002/jbm.820230907
   CHEHROUDI B, 1991, J BIOMED MATER RES, V25, P387, DOI 10.1002/jbm.820250310
   Chen J, 2007, J BIOMED MATER RES B, V82B, P360, DOI 10.1002/jbm.b.30741
   Chen L, 2009, J AM CHEM SOC, V131, P10467, DOI 10.1021/ja9019935
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   Chien CC, 2008, DENT MATER, V24, P986, DOI 10.1016/j.dental.2007.11.020
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Chollet C, 2009, BIOMATERIALS, V30, P711, DOI 10.1016/j.biomaterials.2008.10.033
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   Citeau A, 2005, BIOMATERIALS, V26, P157, DOI 10.1016/j.biomaterials.2004.02.033
   Comelles J, 2010, NANOMED-NANOTECHNOL, V6, P44, DOI 10.1016/j.nano.2009.05.006
   Cyster LA, 2004, BIOMATERIALS, V25, P97, DOI 10.1016/S0142-9612(03)00480-0
   Dalby M J, 2005, Eur Cell Mater, V9, P1
   Dalby M J, 2004, IEE Proc Nanobiotechnol, V151, P53, DOI 10.1049/ip-nbt:20040534
   Dalby MJ, 2007, J CELL BIOCHEM, V102, P1234, DOI 10.1002/jcb.21354
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, IEEE T NANOBIOSCI, V1, P18, DOI 10.1109/TNB.2002.806933
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Dalby MJ, 2004, EXP CELL RES, V295, P387, DOI 10.1016/j.yexcr.2004.02.004
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Dalton BA, 1999, J BIOMED MATER RES, V45, P384, DOI 10.1002/(SICI)1097-4636(19990615)45:4<384::AID-JBM14>3.0.CO;2-O
   Dalton BA, 2001, J BIOMED MATER RES, V56, P83, DOI 10.1002/1097-4636(200107)56:1<83::AID-JBM1071>3.0.CO;2-H
   DAVIDSON P, 2010, J MATER SCI-MATER M, V31, P939
   Davidson PM, 2009, ADV MATER, V21, P3586, DOI 10.1002/adma.200900582
   Degasne I, 1999, CALCIFIED TISSUE INT, V64, P499, DOI 10.1007/s002239900640
   Degirmenbasi N, 2009, J BIOMED MATER RES A, V88A, P94, DOI 10.1002/jbm.a.31874
   Delgado-Rivera R, 2009, MATRIX BIOL, V28, P137, DOI 10.1016/j.matbio.2009.02.001
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   den Braber ET, 1998, J BIOMED MATER RES, V40, P425, DOI 10.1002/(SICI)1097-4636(19980605)40:3<425::AID-JBM13>3.0.CO;2-I
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Di Palma F, 2005, BIOMATERIALS, V26, P4249, DOI 10.1016/j.biomaterials.2004.10.041
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Dulgar-Tulloch AJ, 2009, J BIOMED MATER RES A, V90A, P586, DOI 10.1002/jbm.a.32116
   Duncan AC, 2007, COLLOID SURFACE B, V54, P150, DOI 10.1016/j.colsurfb.2006.09.013
   DUNN GA, 1986, J CELL SCI, V83, P313
   DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5
   Eaton P., 2010, ATOMIC FORCE MICROSC
   Eisenbarth E, 1996, BIOMATERIALS, V17, P1399, DOI 10.1016/0142-9612(96)87281-4
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Evans MDM, 2003, J BIOMED MATER RES A, V64A, P357, DOI 10.1002/jbm.a.10341
   Fedel M, 2009, J BIOMED MATER RES B, V90B, P338, DOI 10.1002/jbm.b.31291
   Feng B, 2003, BIOMATERIALS, V24, P4663, DOI 10.1016/S0142-9612(03)00366-1
   Ferrari A, 2010, BIOMATERIALS, V31, P2565, DOI 10.1016/j.biomaterials.2009.12.010
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   Fraser SA, 2008, J BIOMED MATER RES A, V86A, P725, DOI 10.1002/jbm.a.31519
   Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526
   Fu G, 2009, MAT SCI ENG C-BIO S, V29, P1293, DOI 10.1016/j.msec.2008.10.026
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Gautier A, 2007, MATER TECHNOL-FR, V95, P37, DOI 10.1051/mattech:2007029
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Giljean S., 2006, Mecanique & Industries, V7, P13, DOI 10.1051/meca:2006014
   Giljean S, 2008, SURF ENG, V24, P8, DOI 10.1179/174329408X271426
   GILJEAN S, 2007, THESIS U HAUTE ALSAC
   Goodman SL, 1996, BIOMATERIALS, V17, P2087, DOI 10.1016/0142-9612(96)00016-6
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Guell I, 2009, ACTA BIOMATER, V5, P288, DOI 10.1016/j.actbio.2008.07.029
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Hamilton DW, 2007, BIOMATERIALS, V28, P2281, DOI 10.1016/j.biomaterials.2007.01.026
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Hennebelle F, 2006, PROG ORG COAT, V56, P81, DOI 10.1016/j.porgcoat.2006.02.005
   Hillberg AL, 2009, BIOMATERIALS, V30, P4463, DOI 10.1016/j.biomaterials.2009.05.026
   HORMIA M, 1991, J PERIODONTAL RES, V26, P491, DOI 10.1111/j.1600-0765.1991.tb01800.x
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Huang Y, 2006, BIOTECHNOL BIOENG, V93, P64, DOI 10.1002/bit.20703
   Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   Isenberg BC, 2008, BIOMATERIALS, V29, P2565, DOI 10.1016/j.biomaterials.2008.02.023
   Iwanaga S, 2005, BIOMATERIALS, V26, P5395, DOI 10.1016/j.biomaterials.2005.01.021
   JIN CY, 2007, J MATER SCI-MATER M, V19, P2215
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Jouini N, 2009, INT J SURF SCI ENG, V3, P310, DOI 10.1504/IJSURFSE.2009.027418
   Jungbauer S, 2004, CHEMPHYSCHEM, V5, P85, DOI 10.1002/cphc.200300868
   Kantawong F, 2009, ACTA BIOMATER, V5, P1137, DOI 10.1016/j.actbio.2008.11.001
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KELLER JC, 1994, J BIOMED MATER RES, V28, P939, DOI 10.1002/jbm.820280813
   Khan SP, 2005, NANOMED-NANOTECHNOL, V1, P125, DOI 10.1016/j.nano.2005.03.007
   Khang D, 2008, BIOMATERIALS, V29, P970, DOI 10.1016/j.biomaterials.2007.11.009
   Khor HL, 2007, BIOMACROMOLECULES, V8, P1530, DOI 10.1021/bm0611533
   Kieswetter K, 1996, J BIOMED MATER RES, V32, P55, DOI 10.1002/(SICI)1097-4636(199609)32:1<55::AID-JBM7>3.0.CO;2-O
   Kikuchi L, 2005, BIOMATERIALS, V26, P5285, DOI 10.1016/j.biomaterials.2005.01.009
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   Kim HJ, 2005, J BIOMED MATER RES A, V74A, P366, DOI 10.1002/jbm.a.30327
   Kim MH, 2007, J BIOSCI BIOENG, V103, P192, DOI 10.1263/jbb.103.192
   Kim MJ, 2006, J BIOMED MATER RES A, V79A, P1023, DOI 10.1002/jbm.a.31040
   Kim MJ, 2006, BIOMATERIALS, V27, P5502, DOI 10.1016/j.biomaterials.2006.06.023
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003
   Kommireddy DS, 2006, BIOMATERIALS, V27, P4296, DOI 10.1016/j.biomaterials.2006.03.042
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Kubo K, 2009, BIOMATERIALS, V30, P5319, DOI 10.1016/j.biomaterials.2009.06.021
   Kunzler TP, 2007, BIOMATERIALS, V28, P2175, DOI 10.1016/j.biomaterials.2007.01.019
   Kwon KW, 2007, LAB CHIP, V7, P1461, DOI 10.1039/b710054j
   Lam MT, 2008, BIOMATERIALS, V29, P1705, DOI 10.1016/j.biomaterials.2007.12.010
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Le Guehennec L, 2008, ACTA BIOMATER, V4, P535, DOI 10.1016/j.actbio.2007.12.002
   Lee JY, 2008, BIOMATERIALS, V29, P3743, DOI 10.1016/j.biomaterials.2008.05.029
   Lee JW, 2004, BIOMATERIALS, V25, P1901, DOI 10.1016/j.biomaterials.2003.08.037
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee SJ, 2004, BIOMATERIALS, V25, P4699, DOI 10.1016/j.biomaterials.2003.11.034
   LEE WK, 2010, J IND ENG CHEM, V15, P677
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Lin NJ, 2009, BIOMATERIALS, V30, P4480, DOI 10.1016/j.biomaterials.2009.05.019
   Links J, 1998, BIOMATERIALS, V19, P2219
   Lipski AM, 2008, BIOMATERIALS, V29, P3836, DOI 10.1016/j.biomaterials.2008.06.002
   LOCKWOOD DJ, 2007, LIGHT SCATTERING NAN
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Lohmann CH, 2000, J BONE MINER RES, V15, P1169, DOI 10.1359/jbmr.2000.15.6.1169
   Lohmann CH, 1999, J BIOMED MATER RES, V47, P139, DOI 10.1002/(SICI)1097-4636(199911)47:2<139::AID-JBM4>3.0.CO;2-2
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Lu X, 2003, J BIOMED MATER RES A, V66A, P677, DOI 10.1002/jbm.a.10022
   Marchisio M, 2005, J BIOMED MATER RES B, V75B, P251, DOI 10.1002/jbm.b.30287
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Mata A, 2009, BIOMATERIALS, V30, P4610, DOI 10.1016/j.biomaterials.2009.05.023
   Matsunaga T, 1999, J BIOMED MATER RES, V48, P417
   Mendonca G, 2009, BIOMATERIALS, V30, P4053, DOI 10.1016/j.biomaterials.2009.04.010
   Meredith DO, 2005, J BIOMED MATER RES A, V75A, P541, DOI 10.1002/jbm.a.30457
   MEYLE J, 1993, J BIOMED MATER RES, V27, P1553, DOI 10.1002/jbm.820271212
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Miller DC, 2004, EXPERT REV MED DEVIC, V1, P259, DOI 10.1586/17434440.1.2.259
   Miller DC, 2007, J BIOMED MATER RES A, V81A, P678, DOI 10.1002/jbm.a.31093
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Minelli C., 2008, J NANOBIOTECHNOL, V6, P1
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   Morra M, 1998, J BIOMED MATER RES, V42, P473, DOI 10.1002/(SICI)1097-4636(19981205)42:3<473::AID-JBM18>3.0.CO;2-H
   Morra M, 2006, J BIOMED MATER RES A, V79A, P752, DOI 10.1002/jbm.a.31044
   Motlagh D, 2003, J BIOMED MATER RES A, V67A, P148, DOI 10.1002/jbm.a.10083
   MURRAY DW, 1989, J BONE JOINT SURG BR, V71, P632
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Najjar D, 2006, TRIBOL INT, V39, P1527, DOI 10.1016/j.triboint.2006.01.018
   Najjar D, 2006, SURF COAT TECH, V200, P6088, DOI 10.1016/j.surfcoat.2005.09.025
   Najjar D, 2003, WEAR, V254, P450, DOI 10.1016/S0043-1648(03)00140-6
   Najjar D, 2005, WEAR, V258, P240, DOI 10.1016/j.wear.2004.09.035
   Nebe JGB, 2007, MACROMOL BIOSCI, V7, P567, DOI 10.1002/mabi.200600293
   Nematollahi M, 2009, J BIOMED MATER RES A, V91A, P149, DOI 10.1002/jbm.a.32202
   Nguyen KT, 2007, J NANOSCI NANOTECHNO, V7, P2823, DOI 10.1166/jnn.2007.610
   Nishimura N, 1998, J MATER SCI-MATER M, V9, P99, DOI 10.1023/A:1008851115846
   OAKLEY C, 1993, J CELL SCI, V106, P343
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Panseri S, 2008, BMC BIOTECHNOL, V8, P1
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Patel S, 2007, NANO LETT, V7, P2122, DOI 10.1021/nl071182z
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Pegueroles M., 2009, ACTA BIOMATER, V6, P291
   Perizzolo D, 2001, J BIOMED MATER RES, V56, P494, DOI 10.1002/1097-4636(20010915)56:4<494::AID-JBM1121>3.0.CO;2-X
   Polonchuk L, 2000, BIOMATERIALS, V21, P539, DOI 10.1016/S0142-9612(99)00189-1
   Ponche A, 2010, P I MECH ENG H, V224, P1471, DOI 10.1243/09544119JEIM900
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Poon CY, 1995, WEAR, V190, P76, DOI 10.1016/0043-1648(95)06697-7
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Postiglione L, 2004, EUR J HISTOCHEM, V48, P213
   Postiglione L, 2003, J DENT RES, V82, P692, DOI 10.1177/154405910308200907
   Prasad BR, 2010, COLLOID SURFACE B, V78, P237, DOI 10.1016/j.colsurfb.2010.03.006
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Prichard HL, 2007, BIOMATERIALS, V28, P936, DOI 10.1016/j.biomaterials.2006.09.012
   Prina Mello A., 2003, Annals of Biomedical Engineering, V31, P1106, DOI 10.1114/1.1603261
   Puckett SD, 2010, ACTA BIOMATER, V6, P2352, DOI 10.1016/j.actbio.2009.12.016
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015
   REBOLLAR R, 2008, BIOMATERIALS, V29, P1796
   Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Richert L, 2008, ADV MATER, V20, P1488, DOI 10.1002/adma.200701428
   Rosa AL, 2003, CLIN ORAL IMPLAN RES, V14, P43, DOI 10.1034/j.1600-0501.2003.140106.x
   Rosales-Leal JI, 2010, COLLOID SURFACE A, V365, P222, DOI 10.1016/j.colsurfa.2009.12.017
   Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023
   Rossi A, 2009, TISSUE ENG PT A, V15, P525, DOI 10.1089/ten.tea.2007.0421
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   Rowat AC, 2008, BIOESSAYS, V30, P226, DOI 10.1002/bies.20720
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Schmidt C, 2002, J BIOMED MATER RES, V63, P252, DOI 10.1002/jbm.10185
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Schwartz Z, 2001, BIOMATERIALS, V22, P731, DOI 10.1016/S0142-9612(00)00241-6
   Sjostrom T, 2009, ACTA BIOMATER, V5, P1433, DOI 10.1016/j.actbio.2009.01.007
   Sommer B, 2005, J BIOMED MATER RES A, V72A, P67, DOI 10.1002/jbm.a.30202
   Sorensen A, 2007, BIOMATERIALS, V28, P5498, DOI 10.1016/j.biomaterials.2007.08.034
   Sreerekha PR, 2006, ARTIF ORGANS, V30, P242, DOI 10.1111/j.1525-1594.2006.00211.x
   Steele JG, 2000, J BIOMED MATER RES, V50, P475, DOI 10.1002/(SICI)1097-4636(20000615)50:4<475::AID-JBM2>3.0.CO;2-G
   Steinberg T, 2007, NANO LETT, V7, P287, DOI 10.1021/nl06227z
   Stout K. J, 2000, DEV METHODS CHARACTE
   Su WT, 2006, MICRON, V37, P699, DOI 10.1016/j.micron.2006.03.007
   Sutherland J, 2005, J ANAT, V206, P581, DOI 10.1111/j.1469-7580.2005.00415.x
   Swan EEL, 2005, J BIOMED MATER RES A, V72A, P288, DOI 10.1002/jbm.a.30223
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Tan KS, 2006, BIOMATERIALS, V27, P5170, DOI 10.1016/j.biomaterials.2006.05.002
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thapa A, 2003, BIOMATERIALS, V24, P2915, DOI 10.1016/S0142-9612(03)00123-6
   Tocce EJ, 2010, BIOMATERIALS, V31, P4064, DOI 10.1016/j.biomaterials.2010.01.101
   Tzvetkova-Chevolleau T, 2008, BIOMATERIALS, V29, P1541, DOI 10.1016/j.biomaterials.2007.12.016
   van den Dolder J, 2003, BIOMATERIALS, V24, P1853, DOI 10.1016/S0142-9612(02)00571-9
   Van Gorp A, 2007, MAT SCI ENG C-BIO S, V27, P1434, DOI 10.1016/j.msec.2006.09.041
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Walboomers XF, 2000, J BIOMED MATER RES, V51, P529, DOI 10.1002/1097-4636(20000905)51:3<529::AID-JBM30>3.0.CO;2-R
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wan LS, 2009, J BIOMED MATER RES A, V89A, P168, DOI 10.1002/jbm.a.31907
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang L, 2009, BIOMATERIALS, V30, P6825, DOI 10.1016/j.biomaterials.2009.08.046
   Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594
   Wang XF, 2008, BIOMATERIALS, V29, P2049, DOI 10.1016/j.biomaterials.2007.12.047
   Wang Y.-Q., 2007, CURR APPL PHYS, V7, pe108
   Washburn NR, 2004, BIOMATERIALS, V25, P1215, DOI 10.1016/j.biomaterials.2003.08.043
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2005, BIOMATERIALS, V26, P953, DOI 10.1016/j.biomaterials.0204.03.040
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WEBSTER TJ, 2004, BIOMATERIALS, V25, P4730
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Whitehouse D.J., 1994, HDB SURFACE METROLOG
   WHITEHOUSE DJ, 1982, WEAR, V83, P75, DOI 10.1016/0043-1648(82)90341-6
   Wieland M, 2002, J BIOMED MATER RES, V60, P434, DOI 10.1002/jbm.10059
   Williamson MR, 2006, BIOMATERIALS, V27, P1019, DOI 10.1016/j.biomaterials.2005.06.018
   Wirth C, 2005, MAT SCI ENG C-BIO S, V25, P51, DOI 10.1016/j.msec.2004.06.001
   WojciakStothard B, 1996, EXP CELL RES, V223, P426, DOI 10.1006/excr.1996.0098
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   XU CY, 2004, TISSUE ENG, V10, P1150
   Yamamoto S, 2007, LANGMUIR, V23, P8114, DOI 10.1021/1a7003326
   Yang JY, 2009, J BIOMED MATER RES A, V90A, P629, DOI 10.1002/jbm.a.32130
   Yang L, 2009, BIOMATERIALS, V30, P3458, DOI 10.1016/j.biomaterials.2009.03.014
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Young T, 1804, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zan QF, 2008, APPL SURF SCI, V255, P401, DOI 10.1016/j.apsusc.2008.06.074
   Zaveri TD, 2010, BIOMATERIALS, V31, P2999, DOI 10.1016/j.biomaterials.2009.12.055
   Zhu BS, 2004, J BIOMED MATER RES B, V70B, P43, DOI 10.1002/jbm.b.30011
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
   Zinger O, 2005, BIOMATERIALS, V26, P1837, DOI 10.1016/j.biomaterials.2004.06.035
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 318
TC 74
Z9 74
U1 7
U2 149
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0950-6608
J9 INT MATER REV
JI Int. Mater. Rev.
PD JUL
PY 2011
VL 56
IS 4
BP 243
EP 266
DI 10.1179/1743280411Y.0000000001
PG 24
WC Materials Science, Multidisciplinary
SC Materials Science
GA 790NK
UT WOS:000292595000003
DA 2018-10-20
ER

PT J
AU Hole, BB
   Keller, DS
   Burry, WM
   Schwarz, JA
AF Hole, Bhushan B.
   Keller, D. Steven
   Burry, William M.
   Schwarz, James A.
TI Surface energetics of bone mineral and synthetic hydroxyapatite using
   inverse gas chromatography
SO JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES
LA English
DT Article
DE Inverse gas chromatography; Hydroxyapatite coating; Biomaterial; Surface
   energy; Bone; Biological scaffolds
ID ADSORPTION; ALKANES; IONS
AB Surface energy is one of the important factors that govern protein adhesion and cell attachment on biomaterial surfaces. Inverse gas chromatography (IGC) provides an excellent method to measure the surface energetics of rough and porous biosurfaces. In this study IGC was used to characterize and compare the surface energetics of synthetic and biological hydroxyapatites (natural bone mineral). IGC experiments were performed on three samples: synthetic hydroxyapatites with two levels of purity (99% and 90%) and natural biological hydroxyapatite obtained from bovine trabecular bone. The Lifshitz-Van der Waals component of the surface free energy (gamma(LW)(S)) and specific interaction parameter (epsilon(pi)) were determined by using homologous series of n-alkanes and alkenes as IGC probe molecules. respectively. The synthetic hydroxyapatite had values of gamma(LW)(S) of 33.4 mJ m(-2) at 99% purity and 53.3 mJ m(-2) at 90% purity. Biological hydroxyapatite had a value of gamma(LW)(S) of 45.7 mJ m(-2). For the synthetic hydroxyapatite, the values of pi-bond specific interaction parameters. epsilon(pi), were 0.95 mJ (99%) and 3.01 mJ (90%). The biological hydroxyapatite sample had a value of 2.44 mJ for epsilon(pi). The results suggest that, as compared to the synthetic compounds, the biological apatite has considerable surface heterogeneity, either chemical (impurities) or structural suggesting a scaffold surface that is more conducive of protein adhesion and cell attachment. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Keller, D. Steven] Miami Univ, Dept Chem & Paper Engn, Oxford, OH 45056 USA.
   [Hole, Bhushan B.; Schwarz, James A.] Syracuse Univ, Dept Chem Engn & Mat Sci, Syracuse, NY 13244 USA.
   [Keller, D. Steven; Burry, William M.] SUNY Coll Environm Sci & Forestry, Dept Paper & Bioproc Engn, Syracuse, NY 13210 USA.
RP Keller, DS (reprint author), Miami Univ, Dept Chem & Paper Engn, Oxford, OH 45056 USA.
EM kellerds@muohio.edu
CR AMRAHBOUALI S, 1994, BIOMATERIALS, V15, P269, DOI 10.1016/0142-9612(94)90050-7
   Cho GY, 2003, SCIENCE, V300, P1123, DOI 10.1126/science.1078470
   CONTESCU C, 1991, J CATAL, V131, P433, DOI 10.1016/0021-9517(91)90277-B
   DORRIS GM, 1980, J COLLOID INTERF SCI, V77, P353, DOI 10.1016/0021-9797(80)90304-5
   GAMAL MS, 2001, J COLLOID INTERF SCI, V238, P160
   Goller G, 2003, CERAM INT, V29, P721, DOI 10.1016/S0272-8842(02)00223-7
   Guo LH, 2004, SURF COAT TECH, V185, P268, DOI 10.1016/j.surfcoat.2004.01.013
   Harding PH, 1998, J MATER SCI LETT, V17, P841, DOI 10.1023/A:1006602909509
   Kalfas IH, 2001, NEUROSURG FOCUS, V10, P1, DOI DOI 10.3171/FOC.2001.10.4.2
   Keller DS, 2000, COLLOID SURFACE A, V161, P401
   KELLER DS, 1997, T 11 FUND RES S CAMB
   Linger G., 1989, J COLLOID INTERF SCI, V133, P200
   LLOYD DR, 1989, ACS S SERIES, V391
   Milonjic SK, 1999, COLLOID SURFACE A, V149, P461, DOI 10.1016/S0927-7757(98)00563-9
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   REY C, 1995, BONE, V16, P583, DOI 10.1016/8756-3282(95)00101-I
   Smiciklas ID, 2000, J MATER SCI, V35, P2825, DOI 10.1023/A:1004795019433
   Smith DA, 2003, ANAL CHIM ACTA, V479, P39, DOI 10.1016/S0003-2670(02)01374-0
   WILLIAMS JB, 1954, SCIENCE, V11, P771
NR 19
TC 8
Z9 8
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-0232
J9 J CHROMATOGR B
JI J. Chromatogr. B
PD JUL 1
PY 2011
VL 879
IS 21
BP 1847
EP 1850
DI 10.1016/j.jchromb.2011.04.035
PG 4
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 791LB
UT WOS:000292665600001
PM 21622033
DA 2018-10-20
ER

PT J
AU Brady, MA
   Sivananthan, S
   Mudera, V
   Liu, Q
   Wiltfang, J
   Warnke, PH
AF Brady, Mariea A.
   Sivananthan, Sureshan
   Mudera, Vivek
   Liu, Qin
   Wiltfang, Joerg
   Warnke, Patrick H.
TI The primordium of a biological joint replacement: Coupling of two stem
   cell pathways in biphasic ultrarapid compressed gel niches
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE Osteochondral; Tissue engineering; MSCs; Osteogenic; Chondrogenic;
   Differentiation; Biphasic construct; Ultrarapid plastic compression;
   Joint; Endocultivation
ID BONE; CARTILAGE; COLLAGEN; GROWTH; DIFFERENTIATION; CHONDROCYTE;
   EXPRESSION; SCAFFOLDS
AB The impaired temporomandibular joint might be the first to benefit from applied tissue engineering techniques because it is small and tissue growth in larger amounts is challenging. Bone and cartilage require different competing environmental conditions to be cultivated in vitro. But coupling both the osteogenic and cartilaginous pathways of mesenchyrnal stem cell differentiation in homeostasis will be a key essential to grow osteochondral constructs or even the first biological joint replacement in the future.
   The aim of this study was to test a single source biomaterial and a single source cell type to engineer a biphasic osteochondral construct in vitro for future in vivo implantation. Ultrarapid tissue engineering techniques were used to create the biphasic matrix and primary human mesenchymal stem cells (MSCs) preconditioned in osteogenic and chondrogenic media were then seeded in opposite portions of the hyper-hydrated collagen gel in order to further substantiate the respective bone-like and cartilage-like layers thus potentially customising the collagen scaffold according to patient needs in regards to future biological joint replacements. After incubation for 7 days to allow cell growth and differentiation, mineralization of the bone-like layer was demonstrated using von Kossa staining and biochemical bone markers. The cartilage-like layer was demonstrated using alcian blue staining and biochemical cartilage markers. Integration of the bone-like and cartilage-like layers to simulate a tidemark layer was achieved through partial setting of the gels. Cell tracking was used to further confirm the establishment of distinct cartilage-like and bone-like areas within the single construct.
   This is the first report of one homogeneous human MSC population differentiating into dissimilar "bone-like" and "cartilage-like" zones hosted in a biphasic ultrarapid compressed gel phase niche and mimicking a primordial joint-like structure. (C) 2010 European Association for Cranio-Maxillo-Facial Surgery.
C1 [Warnke, Patrick H.] Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld 4229, Australia.
   [Brady, Mariea A.; Sivananthan, Sureshan; Liu, Qin; Wiltfang, Joerg; Warnke, Patrick H.] Univ Kiel, Dept Oral & Maxillofacial Surg, D-24105 Kiel, Germany.
   [Sivananthan, Sureshan] Univ London, St Georges Hosp NHS Trust, London SW17 QT, England.
   [Mudera, Vivek] Univ Coll London, Inst Orthopaed, Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England.
RP Warnke, PH (reprint author), Bond Univ, Fac Hlth Sci & Med, Gold Coast, Qld 4229, Australia.
EM mbrady@myjoint.org; suresh@myjoint.org; v.mudera@ucl.ac.uk;
   qliu@myjoint.org; pwarnke@bond.edu.au
RI Wiltfang, Jorg/B-1767-2010
FU European Union [FP6-NEST-028861]; Medical Research Council [G0700729B]
FX We acknowledge the inspiring comments by Dr. Eugene Sherry, Orthopaedic
   Surgery, Sydney Private Hospital, to create a biological joint. This
   work is part of the MyJoint project funded by the European Union inside
   the 6th framework program (FP6-NEST-028861) (www.myjoint.org).
CR Bitar M, 2008, BIOMACROMOLECULES, V9, P129, DOI 10.1021/bm701112w
   Brown RA, 2005, ADV FUNCT MATER, V15, P1762, DOI 10.1002/adfm.200500042
   Ciancaglini P, 2006, BRAZ J MED BIOL RES, V39, P603, DOI 10.1590/S0100-879X2006000500006
   Devine SM, 2001, CANCER J, V7, pS76
   DJOUAD F, 2009, FUNDAMENTALS TISSUE, P167
   Douglas T, 2009, J MATER SCI-MATER M, V20, P1909, DOI 10.1007/s10856-009-3756-7
   Eastwood M, 1998, CELL MOTIL CYTOSKEL, V40, P13, DOI 10.1002/(SICI)1097-0169(1998)40:1<13::AID-CM2>3.0.CO;2-G
   Getgood A, 2009, J BONE JOINT SURG BR, V91B, P565, DOI 10.1302/0301-620X.91B5.21832
   Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P230, DOI 10.1002/term.157
   HELLEM S, 1988, J CRANIO MAXILL SURG, V16, P173, DOI 10.1016/S1010-5182(88)80043-X
   Horan F, 1999, J BONE JOINT SURG BR, V81B, P377
   KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473
   Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3
   Lee EH, 2006, J BONE JOINT SURG BR, V88B, P841, DOI 10.1302/0301-620X.88B7.17305
   Lefebvre V, 1998, MATRIX BIOL, V16, P529
   Malpeli M, 2004, TISSUE ENG, V10, P145, DOI 10.1089/107632704322791790
   Pountos I, 2006, J BONE JOINT SURG BR, V88B, P421, DOI 10.1302/0301-620x.88B4.17060
   Seibel MJ, 2005, NAT CLIN PRACT ONCOL, V2, P504, DOI 10.1038/ncponc0320
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   SVENSSON B, 1998, J CRANIOMAXILLOFAC S, V26, P1275
   TEIXEIRA S, 2009, J BIOMED MATER RES A, V93, P567
   Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991
   Ueki K, 2003, J CRANIO MAXILL SURG, V31, P107, DOI 10.1016/S1010-5182(02)00187-7
   Warnke PH, 2010, LANCET, V376, P394, DOI 10.1016/S0140-6736(10)60931-2
   Warnke PH, 2006, BIOMATERIALS, V27, P3163, DOI 10.1016/j.biomaterials.2006.01.050
   Warnke PH, 2006, BIOMATERIALS, V27, P1081, DOI 10.1016/j.biomaterials.2005.07.042
   Warnke PH, 2004, LANCET, V364, P766, DOI 10.1016/S0140-6736(04)16935-3
   Williams Riley J, 2008, Instr Course Lect, V57, P563
NR 28
TC 13
Z9 16
U1 0
U2 9
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD JUL
PY 2011
VL 39
IS 5
BP 380
EP 386
DI 10.1016/j.jcms.2010.07.002
PG 7
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 792YN
UT WOS:000292786400014
PM 20810288
DA 2018-10-20
ER

PT J
AU Ramirez-Fernandez, MP
   Calvo-Guirado, JL
   Delgado-Ruiz, RA
   del Val, JEMS
   Gomez-Moreno, G
   Guardia, J
AF Piedad Ramirez-Fernandez, Ma
   Luis Calvo-Guirado, Jose
   Arcesio Delgado-Ruiz, Rafael
   Eduardo Mate-Sanchez del Val, Jose
   Gomez-Moreno, Gerardo
   Guardia, Javier
TI RETRACTED: Experimental model of bone response to xenografts of bovine
   origin (Endobon (R)): a radiological and histomorphometric study
   (Retracted article. See vol. 29, pg. 665, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE biomaterial; bone graft; bovine graft; xenografts
ID MAXILLARY SINUS AUGMENTATION; POROUS HYDROXYAPATITE; SPONGIFORM
   ENCEPHALOPATHY; IMPLANT PLACEMENT; DENTAL IMPLANTS; GRAFTS;
   RECONSTRUCTION; REGENERATION; BIOMATERIAL; SUBSTITUTE
AB Objective: To carry out a radiological and histomorphometric evaluation of bone response to bovine bone implants inserted in rabbits' tibiae.
   Materials and methods: Twenty New Zealand rabbits weighing 3900-4500 g were used. Twenty bovine bone implants (Endobon (R)) in granulated form of 500-1000 mu m granulometry were inserted in the proximal metaphyseal area of the animals' right tibia and 20 control areas were located in the proximal metaphyseal area. Following implantation, the animals were sacrificed in four groups of five, after 1 month, 2 months, 3 months and 4 months, respectively. Anteroposterior and lateral radiographs were taken. Samples were sectioned at 5 mu m and stained using Hematoxylin Eosin and Masson's trichromic.
   Results: After 4 months, radiological images showed complete repair of the bone defects. No healed or residual bone alterations attributable to the presence of the implant were observed. Histomorphometric analysis at 4 months showed the presence of a higher density of newly formed bone with mean values for new bone, residual graft material and non-mineralized connective tissue of 22.8 +/- 1.5%, 39.4 +/- 2.3% and 37.7 +/- 2.5%. There were no statistically significant differences in the length of cortical formation with bovine bone, 98.8 +/- 1.1%, compared with the control group, 99.1 +/- 0.7%, at the end of the study period.
   Conclusions: The biomaterial used in the study was shown to be biocompatible, osteoconductive and non-resorbable and as such a possible bone substitute that does not interfere with normal reparative bone processes.
C1 [Piedad Ramirez-Fernandez, Ma; Luis Calvo-Guirado, Jose] Univ Murcia, Fac Med & Dent, Dept Implant Dent, Murcia 30007, Spain.
   [Arcesio Delgado-Ruiz, Rafael; Eduardo Mate-Sanchez del Val, Jose] Univ Murcia, Fac Med & Dent, Dept Restorat Dent, Murcia 30007, Spain.
   [Gomez-Moreno, Gerardo; Guardia, Javier] Univ Granada, Sch Dent, Dept Pharmacol Interact, Granada, Spain.
RP Ramirez-Fernandez, MP (reprint author), Univ Murcia, Hosp Morales Meseguer, Fac Med & Dent, Dept Gen Dent, 2 Floor,Calle Marques de los Velez, Murcia 30007, Spain.
EM mpramirezfern@hotmail.com
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018; Gomez-Moreno,
   Gerardo/L-8123-2014
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; Gomez-Moreno,
   Gerardo/0000-0001-9094-4985; RAMIREZ FERNANDEZ, MARIA
   PIEDAD/0000-0003-1913-9902
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Arcuri C, 2005, Minerva Stomatol, V54, P351
   Baer W, 2002, J HAND SURG-BRIT EUR, V27B, P101, DOI 10.1054/jhsb.2001.0686
   Bareille R, 2000, BIOMATERIALS, V21, P1345, DOI 10.1016/S0142-9612(00)00015-6
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   Briem D, 2002, UNFALLCHIRURG, V105, P128, DOI 10.1007/s001130100303
   Cricchio Giovanni, 2003, Clin Implant Dent Relat Res, V5, P161, DOI 10.1111/j.1708-8208.2003.tb00198.x
   Cutter C Suzanne, 2006, J Long Term Eff Med Implants, V16, P249
   Di Stefano DA, 2009, CLIN IMPLANT DENT R, V11, P90, DOI 10.1111/j.1708-8208.2008.00104.x
   Ersanli S, 2004, J PERIODONTOL, V75, P750, DOI 10.1902/jop.2004.75.5.750
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Esposito M, 2010, EUR J ORAL IMPLANTOL, V3, P7
   Gierse H, 1999, ARCH ORTHOP TRAUM SU, V119, P349, DOI 10.1007/s004020050426
   Grimm J, 2001, ARCH ORTHOP TRAUM SU, V121, P158, DOI 10.1007/s004020000194
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hing KA, 1997, J MATER SCI-MATER M, V8, P731, DOI 10.1023/A:1018500309969
   Hising P, 2001, INT J ORAL MAX IMPL, V16, P90
   Jensen S S, 1996, Int J Oral Maxillofac Implants, V11, P55
   Johansson LA, 2010, J ORAL MAXIL SURG, V68, P837, DOI 10.1016/j.joms.2009.07.093
   Kehr P, 2000, EUR J ORTHOP SURG TR, V10, P217
   Khodadadyan-Klostermann C, 2002, Acta Chir Orthop Traumatol Cech, V69, P16
   Lang NP, 2000, PLAST RECONSTR SURG, V105, P2273, DOI 10.1097/00006534-200005000-00074
   Liebendorfer A, 1997, Unfallchirurgie, V23, P60, DOI 10.1007/BF02628151
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   McAllister BS, 2007, J PERIODONTOL, V78, P377, DOI 10.1902/jop.2007.060048
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Schnettler R, 1998, ORTHOPADE, V27, P80
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   van Steenberghe D, 2000, CLIN ORAL IMPLAN RES, V11, P210, DOI 10.1034/j.1600-0501.2000.011003210.x
   Wenz B, 2001, BIOMATERIALS, V22, P1599, DOI 10.1016/S0142-9612(00)00312-4
   Werber KD, 2000, J HAND SURG-AM, V25A, P833, DOI 10.1053/jhsu.2000.16354
   Wiltfang J, 1996, J CRANIO MAXILL SURG, V24, P300, DOI 10.1016/S1010-5182(96)80063-1
   Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x
   Yamamichi N, 2008, INT J PERIODONT REST, V28, P163
NR 44
TC 8
Z9 9
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2011
VL 22
IS 7
BP 727
EP 734
DI 10.1111/j.1600-0501.2010.02052.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 788ID
UT WOS:000292437700009
PM 21198892
DA 2018-10-20
ER

PT J
AU Ramirez-Fernandez, MP
   Calvo-Guirado, JL
   Delgado-Ruiz, RA
   del Val, JEMS
   Vicente-Ortega, V
   Meseguer-Olmos, L
AF Piedad Ramirez-Fernandez, Ma
   Luis Calvo-Guirado, Jose
   Arcesio Delgado-Ruiz, Rafael
   Eduardo Mate-Sanchez del Val, Jose
   Vicente-Ortega, Vicente
   Meseguer-Olmos, Luis
TI RETRACTED: Bone response to hydroxyapatites with open porosity of animal
   origin (porcine [OsteoBiol (R) mp3] and bovine [Endobon (R)]): a
   radiological and histomorphometric study (Retracted article. See vol.
   29, pg. 666, 2018)
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Retracted Publication
DE biomaterial; bone graft; bovine graft; bovine xenograft; porcine graft;
   porcine xenograft; xenografts
ID ALVEOLAR RIDGE; AUGMENTATION; BIOMATERIAL; IMPLANTS; EFFICACY; INGROWTH;
   DEFECTS; GRAFTS
AB Purpose: To carry out a radiological and histomorphometric evaluation of bone response to two xenografts of animal origin, one porcine, and the other bovine, inserted in rabbits' tibiae.
   Material and methods: Twenty New Zealand rabbits weighing 3900-4500 g were used. Twenty bovine bone grafts (Endobon (R)) in granulated form of 500-1000 mu m granulometry were inserted in the proximal metaphyseal area of the animals' right tibia, and 20 porcine bone grafts (OsteoBiol (R) Mp3) in granulated form of 600-1000 mu m granulometry were inserted in the proximal metaphyseal area of the animals' left tibia. Following graft insertion, the animals were sacrificed in four groups of five, after 1, 2, 3 and 4 months, respectively. Anteroposterior and lateral radiographs were taken. Samples were processed for observation under light microscopy. Histomorphometric measurements were presented as mean values +/- standard deviations.
   Results: At 4 months after treatment, the bone defects displayed radiological images that showed complete repair of osseous defects. Histomorphometric evaluation showed that for the porcine xenograft, the study averages for newly formed bone represented 22.8 +/- 1.8%, for residual graft material 23.6 +/- 3% and for connective tissue 53.5 +/- 2.5%, while for the bovine xenograft newly formed bone represented 23.1 +/- 1.8%, residual graft material 39.4 +/- 3% and non-mineralized connective tissue 37.5 +/- 2.5%.
   Conclusions: The biomaterials assessed in the study were shown to be biocompatible and osteoconductive. Collagenized porcine xenografts proved more resorbable than bovine xenografts. Both can be used as possible bone substitutes without interfering with normal reparative bone processes.
C1 [Piedad Ramirez-Fernandez, Ma; Luis Calvo-Guirado, Jose] Univ Murcia, Dept Implant Dent, Fac Med & Dent, Murcia 30007, Spain.
   [Arcesio Delgado-Ruiz, Rafael; Eduardo Mate-Sanchez del Val, Jose] Univ Murcia, Dept Restorat Dent, Fac Med & Dent, Murcia 30007, Spain.
   [Vicente-Ortega, Vicente] Univ Murcia, Fac Med, Dept Pathol, Inst Aging, Murcia 30007, Spain.
   [Meseguer-Olmos, Luis] Univ Murcia, Fac Med, Univ Hosp Virgen de la Arrixaca, Dept Traumatol, Murcia 30007, Spain.
RP Ramirez-Fernandez, MP (reprint author), Univ Murcia, Hosp Morales Meseguer, Fac Med & Dent, Dept Gen Dent, 2 Floor,Calle Marques de los Velez S-N, Murcia 30007, Spain.
EM mpramirezfern@hotmail.com
RI Mate Sanchez de Va, Jose Eduardo/R-9750-2018
OI Mate Sanchez de Va, Jose Eduardo/0000-0002-4216-421X; Meseguer-Olmo,
   Luis/0000-0003-3858-8148; RAMIREZ FERNANDEZ, MARIA
   PIEDAD/0000-0003-1913-9902
CR Aghaloo TL, 2007, INT J ORAL MAX IMPL, V22, P49
   Arcuri C, 2005, Minerva Stomatol, V54, P351
   Barone A, 2007, J ORAL MAXIL SURG, V65, P2039, DOI 10.1016/j.joms.2007.05.017
   Briem D, 2002, UNFALLCHIRURG, V105, P128, DOI 10.1007/s001130100303
   Cardaropoli D, 2008, INT J PERIODONT REST, V28, P469
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Kehr P, 2000, EUR J ORTHOP SURG TR, V10, P217
   Kim SH, 2004, J BIOMED MATER RES B, V68B, P69, DOI 10.1002/jbm.b.10084
   Liebendorfer A, 1997, Unfallchirurgie, V23, P60, DOI 10.1007/BF02628151
   Liljensten Elisabeth, 2003, Clin Implant Dent Relat Res, V5, P95, DOI 10.1111/j.1708-8208.2003.tb00190.x
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nannmark U, 2008, CLIN IMPLANT DENT R, V10, P264, DOI 10.1111/j.1708-8208.2007.00080.x
   Nkenke E, 2002, CLIN ORAL IMPLAN RES, V13, P514, DOI 10.1034/j.1600-0501.2002.130511.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Orsini G, 2006, J PERIODONTOL, V77, P1984, DOI 10.1902/jop.2006.060181
   Santos FA, 2010, CLIN IMPLANT DENT R, V12, P18, DOI 10.1111/j.1708-8208.2008.00126.x
   Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83
   Scarano A, 2011, CLIN IMPLANT DENT R, V13, P13, DOI 10.1111/j.1708-8208.2009.00176.x
   Tadic D, 2004, BIOMATERIALS, V25, P987, DOI 10.1016/S0142-9612(03)00621-5
   Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
   Wang W, 2009, ACTA BIOMATER, V5, P3132, DOI 10.1016/j.actbio.2009.04.036
   Werber KD, 2000, J HAND SURG-AM, V25A, P833, DOI 10.1053/jhsu.2000.16354
   Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x
   Yamada Y, 2008, CLIN ORAL IMPLAN RES, V19, P1003, DOI 10.1111/j.1600-0501.2008.01554.x
NR 26
TC 23
Z9 24
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0905-7161
EI 1600-0501
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD JUL
PY 2011
VL 22
IS 7
BP 767
EP 773
DI 10.1111/j.1600-0501.2010.02058.x
PG 7
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 788ID
UT WOS:000292437700014
PM 21244497
DA 2018-10-20
ER

PT J
AU Li, JJ
   Sun, H
   Sun, D
   Yao, YL
   Yao, FL
   Yao, KD
AF Li, Junjie
   Sun, Hong
   Sun, Da
   Yao, Yuli
   Yao, Fanglian
   Yao, Kangde
TI Biomimetic multicomponent polysaccharide/nano-hydroxyapatite composites
   for bone tissue engineering
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Polysaccharide; Multicomponent; Nano-hydroxyapatite; Scaffold; Bone
   tissue engineering
ID IN-VITRO; BIOMEDICAL APPLICATIONS; CHITOSAN SCAFFOLDS; GELATIN; CELLS;
   DIFFERENTIATION; REGENERATION; OSTEOBLASTS; MEMBRANES; CARTILAGE
AB Nano-hydroxyapatite/chitosan-pectin (nHCP) composite was prepared via mineralization of a chitosan-pectin network. Then nHCP/chitosan-gelatin (nHCP/CG) scaffolds were prepared via the blending of nHCP and chitosan-gelatin solution. Results suggested that nHCP/CG scaffolds have appropriate porosity, water absorption ability and degradation behaviors. nHCP can be fused into the pore wall of nHCP/CG scaffold via chemical crosslinking interactions, which avoids the agglomeration and migration of nHA particles. Moreover, the compressive strength of nHCP/CG scaffold ranges from 10.4 +/- 1.64 to 13.5 +/- 3.85 MPa. nHCP/CG scaffolds have stable physical and chemical structures, which can provide appropriate microenvironments for cells to attach and proliferate for MC 3T3-E1 cells. Therefore, nHCG/CG is a potential biomaterial in bone tissue engineering. (C) 2011 Published by Elsevier Ltd.
C1 [Li, Junjie; Sun, Da; Yao, Fanglian] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Dept Polymer Sci, Tianjin 300072, Peoples R China.
   [Li, Junjie; Sun, Da; Yao, Fanglian] Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.
   [Sun, Hong; Yao, Yuli] N China Coal Med Coll, Dept Basic Med Sci, Tangshan 063000, Peoples R China.
   [Li, Junjie; Yao, Kangde] Tianjin Univ, Res Inst Polymer Mat, Tianjin 300072, Peoples R China.
RP Yao, FL (reprint author), Tianjin Univ, Sch Chem Engn & Technol, Minist Educ, Dept Polymer Sci, Tianjin 300072, Peoples R China.
EM yaofanglian@tju.edu.cn
RI Li, Junjie/B-7068-2012
OI Li, Junjie/0000-0003-2152-6952
FU National Nature Science Foundation of China [51073119, 50773050]; Hebei
   Provincial Office of Public Health Foundation [20090549]; Programme of
   Introducing Talents of Discipline to Universities [B060006]
FX This work has been supported in part by National Nature Science
   Foundation of China 51073119 and 50773050; Hebei Provincial Office of
   Public Health Foundation Key Project (20090549). The Programme of
   Introducing Talents of Discipline to Universities, no. B060006.
CR Cai X, 2009, ACTA BIOMATER, V5, P2693, DOI 10.1016/j.actbio.2009.03.005
   Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Cui FZ, 2007, MAT SCI ENG R, V57, P1, DOI 10.1016/j.mser.2007.04.001
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Hamilton V, 2006, J MATER SCI-MATER M, V17, P1373, DOI 10.1007/s10856-006-0613-9
   Haroun AA, 2009, J MATER SCI-MATER M, V20, P2527, DOI 10.1007/s10856-009-3818-x
   Kerin AJ, 1998, P I MECH ENG H, V212, P273, DOI 10.1243/0954411981534051
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   Kokkonen H, 2008, BIOMACROMOLECULES, V9, P2369, DOI 10.1021/bm800356b
   Li JJ, 2007, BIOMATERIALS, V28, P781, DOI 10.1016/j.biomaterials.2006.09.042
   Li JJ, 2010, MAT SCI ENG C-MATER, V30, P795, DOI 10.1016/j.msec.2010.03.011
   Li JJ, 2009, MAT SCI ENG C-BIO S, V29, P1207, DOI 10.1016/j.msec.2008.09.038
   Li LH, 2010, ACTA BIOMATER, V6, P2525, DOI 10.1016/j.actbio.2009.03.028
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Liu LS, 2004, BIOMATERIALS, V25, P3201, DOI 10.1016/j.biomaterials.2003.10.036
   Liu LS, 2003, BIOMATERIALS, V24, P3333, DOI 10.1016/S0142-9612(03)00213-8
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Manjubala I, 2008, J BIOMED MATER RES B, V84B, P7, DOI 10.1002/jbm.b.30838
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Nejati E, 2009, MAT SCI ENG C-BIO S, V29, P942, DOI 10.1016/j.msec.2008.07.038
   O'Shea TM, 2008, TISSUE ENG PART B-RE, V14, P447, DOI 10.1089/ten.teb.2008.0327
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   Rohanizadeh R, 2008, J MATER SCI-MATER M, V19, P1173, DOI 10.1007/s10856-007-3154-y
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Teng SH, 2009, J BIOMED MATER RES A, V88A, P569, DOI 10.1002/jbm.a.31897
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Wang XJ, 2010, J MATER SCI-MATER M, V21, P183, DOI 10.1007/s10856-009-3855-5
   Ye CP, 2000, BONE, V27, P21, DOI 10.1016/S8756-3282(00)00288-X
   Yin YJ, 2004, MACROMOL BIOSCI, V4, P971, DOI 10.1002/mabi.200400063
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 34
TC 49
Z9 50
U1 4
U2 92
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JUL 1
PY 2011
VL 85
IS 4
BP 885
EP 894
DI 10.1016/j.carbpol.2011.04.015
PG 10
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 780FC
UT WOS:000291838900024
DA 2018-10-20
ER

PT J
AU Mitra, T
   Sailakshmi, G
   Gnanamani, A
   Mandal, AB
AF Mitra, Tapas
   Sailakshmi, G.
   Gnanamani, A.
   Mandal, A. B.
TI Di-carboxylic acid cross-linking interactions improves thermal stability
   and mechanical strength of reconstituted type I collagen
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article
DE Type I collagen; Oxalic acid; Cross-linker; Thermal stability; Circular
   dichroism
ID RAT TAIL TENDON; BIODEGRADABLE FILMS; PEPTIDES; FIBERS
AB This study emphasizes, cross-linking potential of a simple di-carboxylic acid, namely, oxalic acid with type I collagen for the preparation of collagen based biomaterial for clinical applications. Further the study discusses the characteristics features of the cross-linked material in comparison with the standard cross-linker. In addition, the study also demonstrates the role of ionic interactions in providing the thermal stability and tensile strength to the cross-linked biopolymer material. Type I collagen from rat tail tendon treated with oxalic acid at optimized concentrations provided a biopolymer material without changing the triple helical pattern of collagen (CD spectrum) and also with 6-7 fold increase in tensile strength than native collagen. FTIR spectral details demonstrate the ionic interactions between collagen and oxalic acid. Thermal stability analyses of oxalic acid cross-linked biopolymer revealed, high thermal stability compared to materials of glutaraldehyde cross-linked. The results of the study suggest oxalic acid as a suitable cross-linker for collagen and it cross-link with collagen through ionic interactions.
C1 [Mitra, Tapas; Sailakshmi, G.; Gnanamani, A.] Cent Leather Res Inst, CSIR, Div Microbiol, Madras 600020, Tamil Nadu, India.
   [Mandal, A. B.] Cent Leather Res Inst, CSIR, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Gnanamani, A (reprint author), Cent Leather Res Inst, CSIR, Div Microbiol, Madras 600020, Tamil Nadu, India.
EM gnanamani3@gmail.com
RI Mandal, Asit Baran/B-9977-2009
OI Mitra, Tapas/0000-0003-0813-7389
FU Department of Biotechnology, Ministry of Science and Technology, New
   Delhi [BT/PR10179/AAQ/03/385/2007]
FX All authors thank Department of Biotechnology, Ministry of Science and
   Technology, New Delhi, for the financial assistance provided in the form
   of project in vide sanction no. BT/PR10179/AAQ/03/385/2007.
CR CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   DAMINK LHHO, 1995, J BIOMED MATER RES, V29, P149, DOI 10.1002/jbm.820290203
   Ghaffari A, 2007, EUR J PHARM BIOPHARM, V67, P175, DOI 10.1016/j.ejpb.2007.01.013
   Jaklenec A, 2008, BIOMATERIALS, V29, P185, DOI 10.1016/j.biomaterials.2007.09.017
   Langmaier F, 2010, J THERM ANAL CALORIM, V102, P37, DOI 10.1007/s10973-009-0525-2
   Lin YK, 2006, FOOD CHEM, V99, P244, DOI 10.1016/j.foodchem.2005.06.053
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   MELINA H, 2006, RHEOL ACTA, V45, P659
   Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001
   Mitra T, 2011, INT J BIOL MACROMOL, V48, P276, DOI 10.1016/j.ijbiomac.2010.11.011
   Nam K, 2008, MACROMOL BIOSCI, V8, P32, DOI 10.1002/mabi.200700206
   Nunes PS, 2010, J THERM ANAL CALORIM, V99, P1011, DOI 10.1007/s10973-009-0661-8
   Pavia D..L.G., 2001, INTRO SPECTROSCOPY
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   PUETT D, 1967, BIOPOLYMERS, V5, P327, DOI 10.1002/bip.1967.360050311
   Sacca B, 2002, J MOL BIOL, V324, P309, DOI 10.1016/S0022-2836(02)01065-3
   Saito H, 2008, J MATER SCI-MATER M, V19, P1297, DOI 10.1007/s10856-007-3239-7
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   Skotak M, 2008, BIOMACROMOLECULES, V9, P1902, DOI 10.1021/bm800158c
   Tharanathan RN, 2003, TRENDS FOOD SCI TECH, V14, P71, DOI 10.1016/S0924-2244(02)00280-7
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   WEADOCK KS, 1995, J BIOMED MATER RES, V29, P1373, DOI 10.1002/jbm.820291108
   Weber CJ, 2002, FOOD ADDIT CONTAM, V19, P172, DOI 10.1080/02652030110087483
   Wei XL, 2006, INT J PHARM, V318, P132, DOI 10.1016/j.ijpharm.2006.03.024
NR 25
TC 13
Z9 13
U1 1
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD JUL
PY 2011
VL 105
IS 1
BP 325
EP 330
DI 10.1007/s10973-011-1472-2
PG 6
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 778ZE
UT WOS:000291747100039
DA 2018-10-20
ER

PT J
AU Zhou, H
   Lee, J
AF Zhou, Hongjian
   Lee, Jaebeom
TI Nanoscale hydroxyapatite particles for bone tissue engineering
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Biomaterials; Bioceramics; Nanoscale particles; Hydroxyapatite; Bone
   tissue engineering
ID CALCIUM-PHOSPHATE CEMENTS; SILICON-SUBSTITUTED HYDROXYAPATITE; WALLED
   CARBON NANOTUBES; OSTEOBLAST-LIKE CELLS; NANO-HYDROXYAPATITE; SOL-GEL;
   MECHANICAL-PROPERTIES; ARTIFICIAL BONE; DRUG-DELIVERY; IN-VITRO
AB Hydroxyapatite (HAp) exhibits excellent biocompatibility with soft tissues such as skin, muscle and gums, making it an ideal candidate for orthopedic and dental implants or components of implants. Synthetic HAp has been widely used in repair of hard tissues, and common uses include bone repair, bone augmentation, as well as coating of implants or acting as fillers in bone or teeth. However, the low mechanical strength of normal HAp ceramics generally restricts its use to low load-bearing applications. Recent advancements in nanoscience and nanotechnology have reignited investigation of nanoscale HAP formation in order to clearly define the small-scale properties of HAp. It has been suggested that nano-HAp may be an ideal biomaterial due to its good biocompatibility and bone integration ability. HAp biomedical material development has benefited significantly from advancements in nanotechnology. This feature article looks afresh at nano-HAp particles, highlighting the importance of size, crystal morphology control, and composites with other inorganic particles for biomedical material development. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Zhou, Hongjian; Lee, Jaebeom] Pusan Natl Univ, Dept Nanomed Engn, Coll Nanosci & Nanotechnol, Miryang 627706, South Korea.
RP Lee, J (reprint author), Pusan Natl Univ, Dept Nanomed Engn, Coll Nanosci & Nanotechnol, Miryang 627706, South Korea.
EM jaebeom@pusan.ac.kr
RI Zhou, Hongjian/F-8519-2014
OI Zhou, Hongjian/0000-0002-2428-0559; Lee, Jaebeom/0000-0002-8414-7290
FU Ministry of Education. Science and Technology (MEST) of Korea; National
   Fisheries Research and Development Institute [K20091003000, FY2009,
   20100434961-00]
FX This research was supported by the International Research and
   Development Program of the National Research Foundation of Korea (NRF)
   funded by the Ministry of Education. Science and Technology (MEST) of
   Korea, and National Fisheries Research and Development Institute (Grant
   Nos. K20091003000, FY2009, 20100434961-00).
CR Ajeesh M, 2010, J MATER SCI-MATER M, V21, P1427, DOI 10.1007/s10856-010-4005-9
   Alivisatos AP, 2000, SCIENCE, V289, P736, DOI 10.1126/science.289.5480.736
   [Anonymous], 2009, MATER LETT, V63, P2123
   Appleford MR, 2009, J BIOMED MATER RES A, V89A, P1019, DOI 10.1002/jbm.a.32049
   Arcos D, 2004, CHEM MATER, V16, P2300, DOI 10.1021/cm035337
   Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9
   BALANI A, 2007, BIOMATERIALS, V28, P618
   Balani K, 2008, ACTA MATER, V56, P571, DOI 10.1016/j.actamat.2007.10.038
   Balani K, 2007, ACTA BIOMATER, V3, P944, DOI 10.1016/j.actbio.2007.06.001
   Balani K, 2009, JOM-US, V61, P63, DOI 10.1007/s11837-009-0136-1
   Banfield JF, 2000, SCIENCE, V289, P751, DOI 10.1126/science.289.5480.751
   Bauer IW, 2008, J MATER SCI-MATER M, V19, P1091, DOI 10.1007/s10856-007-3124-4
   BAUER TW, 1991, J BONE JOINT SURG AM, V73A, P1439, DOI 10.2106/00004623-199173100-00001
   Bernard L, 1999, POWDER TECHNOL, V103, P19, DOI 10.1016/S0032-5910(99)00009-1
   Bhowmik R, 2009, INT J NANOTECHNOL, V6, P511, DOI 10.1504/IJNT.2009.024642
   Boanini E, 2006, EUR J INORG CHEM, P4821, DOI 10.1002/ejic.200600423
   Boduch-Lee KA, 2004, MACROMOLECULES, V37, P8959, DOI 10.1021/ma0493630
   Bohner M, 2000, INJURY, V31, pS37
   Bohner M, 2010, EUR CELLS MATER, V20, P1
   Borum L, 2003, BIOMATERIALS, V24, P3681, DOI 10.1016/S0142-9612(03)00240-0
   Borum-Nicholas L, 2003, BIOMATERIALS, V24, P3671, DOI 10.1016/S0142-9612(03)00239-4
   Bose S, 2003, J AM CERAM SOC, V86, P1055, DOI 10.1111/j.1151-2916.2003.tb03423.x
   Boskey AL, 2003, OSTEOPOROS INT S5, V14, P16
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   Busch S, 2004, ANGEW CHEM INT EDIT, V43, P1428, DOI 10.1002/anie.200352183
   Cai YR, 2008, J MATER CHEM, V18, P3775, DOI 10.1039/b805407j
   Cai YR, 2007, J MATER CHEM, V17, P3780, DOI 10.1039/b705129h
   Cao MH, 2004, LANGMUIR, V20, P4784, DOI 10.1021/la0498197
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Chen DZ, 2007, COMPOS SCI TECHNOL, V67, P1617, DOI 10.1016/j.compscitech.2006.07.034
   Chen HF, 2004, LANGMUIR, V20, P4168, DOI 10.1021/la0303005
   Chen Y, 2007, CARBON, V45, P998, DOI 10.1016/j.carbon.2006.12.021
   Chen Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1951054
   Cho JS, 2008, J ALLOY COMPD, V464, P282, DOI 10.1016/j.jallcom.2007.09.092
   Donners JJJM, 2003, ADV MATER, V15, P313, DOI 10.1002/adma.200390076
   Dorozhkin S. V., 2010, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V5, P57, DOI 10.4028/www.scientific.net/JBBTE.5.57
   Dorozhkin SV, 2008, J MATER SCI, V43, P3028, DOI 10.1007/s10853-008-2527-z
   Dorozhkin SV, 2009, MATERIALS, V2, P1975, DOI 10.3390/ma2041975
   Dorozhkin SV, 2010, ACTA BIOMATER, V6, P715, DOI 10.1016/j.actbio.2009.10.031
   Dorozhkin SV, 2009, MATERIALS, V2, P399, DOI 10.3390/ma2020399
   Dorozhkin SV, 2009, J MATER SCI, V44, P2343, DOI 10.1007/s10853-008-3124-x
   Ergun C, 2002, J BIOMED MATER RES, V59, P305, DOI 10.1002/jbm.1246
   Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g
   Furuichi K, 2006, SCI TECHNOL ADV MAT, V7, P219, DOI 10.1016/j.stam.2005.10.008
   Garcia C, 2004, J NON-CRYST SOLIDS, V348, P218, DOI 10.1016/j.jnoncrysol.2004.08.172
   Gergely G, 2010, CENT EUR J CHEM, V8, P375, DOI 10.2478/s11532-010-0004-4
   Gibson IR, 1999, J BIOMED MATER RES, V44, P422, DOI 10.1002/(SICI)1097-4636(19990315)44:4<422::AID-JBM8>3.0.CO;2-#
   Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007
   Ginebra MP, 2010, ACTA BIOMATER, V6, P2863, DOI 10.1016/j.actbio.2010.01.036
   Ginebra MP, 2006, BIOMATERIALS, V27, P2171, DOI 10.1016/j.biomaterials.2005.11.023
   Gonzalez-McQuire R, 2004, J MATER CHEM, V14, P2277, DOI 10.1039/b400317a
   Gopi D, 2008, SPECTROCHIM ACTA A, V70, P1243, DOI 10.1016/j.saa.2008.02.015
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   Habraken WJEM, 2007, ADV DRUG DELIVER REV, V59, P234, DOI 10.1016/j.addr.2007.03.011
   Hahn BD, 2009, ACTA BIOMATER, V5, P3205, DOI 10.1016/j.actbio.2009.05.005
   Hellmich C, 2003, BIOMECH MODEL MECHAN, V2, P21, DOI 10.1007/S10237-002-0025-9
   Hench LL, 2004, KEY ENG MAT, V254-2, P3, DOI 10.4028/www.scientific.net/KEM.254-256.3
   HEYWOOD BR, 1992, ADV MATER, V4, P278, DOI 10.1002/adma.19920040407
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hsieh MF, 2002, MATER CHEM PHYS, V74, P245, DOI 10.1016/S0254-0584(01)00474-6
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Imai H, 2003, CHEM COMMUN, P1952, DOI 10.1039/b304367c
   Jiang DL, 2009, CURR APPL PHYS, V9, pS252, DOI 10.1016/j.cap.2009.01.029
   Jiang H, 2009, J NANOSCI NANOTECHNO, V9, P6844, DOI 10.1166/jnn.2009.1481
   Johnson AJW, 2011, ACTA BIOMATER, V7, P16, DOI 10.1016/j.actbio.2010.07.012
   Joshy MIA, 2010, CRYST RES TECHNOL, V45, P551, DOI 10.1002/crat.200900734
   Kalita SJ, 2010, MAT SCI ENG C-MATER, V30, P295, DOI 10.1016/j.msec.2009.11.007
   Kaneko T, 2004, CHEM MATER, V16, P5596, DOI 10.1021/cm0490975
   Kaya C, 2008, ADV ENG MATER, V10, P131, DOI 10.1002/adem.200700241
   Kealley C, 2006, PHYSICA B, V385, P496, DOI 10.1016/j.physb.2006.05.254
   Kim W, 2000, J MATER SCI, V35, P5401, DOI 10.1023/A:1004859231795
   Kim YG, 2008, J PHYS CHEM SOLIDS, V69, P1556, DOI 10.1016/j.jpcs.2007.10.102
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Koumoulidis GC, 2003, J COLLOID INTERF SCI, V259, P254, DOI 10.1016/S0021-9797(02)00233-3
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Lahiri D, 2010, CARBON, V48, P3103, DOI 10.1016/j.carbon.2010.04.047
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee SJ, 2007, J NANOSCI NANOTECHNO, V7, P4061, DOI 10.1166/jnn.2007.067
   Lee SH, 2007, ADV DRUG DELIVER REV, V59, P339, DOI 10.1016/j.addr.2007.03.016
   Legeros Racquel Z., 1993, Clinical Materials, V14, P65, DOI 10.1016/0267-6605(93)90049-D
   Li AM, 2007, MATER LETT, V61, P1839, DOI 10.1016/j.matlet.2006.07.159
   Li B, 2008, APPL SURF SCI, V255, P357, DOI 10.1016/j.apsusc.2008.06.114
   Li B, 2009, ACTA BIOMATER, V5, P134, DOI 10.1016/j.actbio.2008.07.035
   Li CF, 2009, POWDER TECHNOL, V192, P1, DOI 10.1016/j.powtec.2008.11.001
   Li HP, 2008, COMPOS PART A-APPL S, V39, P1128, DOI 10.1016/j.compositesa.2008.04.007
   Li W, 2003, BIOMATERIALS, V24, P937, DOI 10.1016/S0142-9612(02)00428-3
   Liang JH, 2005, INORG CHEM, V44, P9405, DOI 10.1021/ic048237+
   Liao S, 2007, ACTA BIOMATER, V3, P669, DOI [10.1016/j.actbio.2007.03.007, 10.1016/j.aetbio.2007.03.007]
   Lim BK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025017
   Lim GK, 1999, LANGMUIR, V15, P7472, DOI 10.1021/la981659+
   Lim GK, 1997, BIOMATERIALS, V18, P1433, DOI 10.1016/S0142-9612(97)00081-1
   Lim GK, 1999, J MATER CHEM, V9, P1635, DOI 10.1039/a809644i
   Liu HS, 1997, CERAM INT, V23, P19, DOI 10.1016/0272-8842(95)00135-2
   Liu JB, 2005, NANOTECHNOLOGY, V16, P82, DOI 10.1088/0957-4484/16/1/017
   Liu L, 2007, J BIOMED MATER RES A, V82A, P618, DOI 10.1002/bjm.a.31177
   Liu TY, 2005, J CONTROL RELEASE, V107, P112, DOI 10.1016/j.jconrel.2005.05.025
   Lopez-Macipe A, 1998, ADV MATER, V10, P49, DOI 10.1002/(SICI)1521-4095(199801)10:1<49::AID-ADMA49>3.0.CO;2-R
   LU HB, 1995, J CRYST GROWTH, V155, P120, DOI 10.1016/0022-0248(95)00229-4
   Ma RZ, 1998, J MATER SCI, V33, P5243, DOI 10.1023/A:1004492106337
   Malkaj P, 2005, J MATER SCI-MATER M, V16, P733, DOI 10.1007/s10856-005-2610-9
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Mao YB, 2006, J AM CHEM SOC, V128, P8217, DOI 10.1021/ja0607483
   Mao Y, 2007, SMALL, V3, P1122, DOI 10.1002/smll.200700048
   Martins MA, 2008, J COLLOID INTERF SCI, V318, P210, DOI 10.1016/j.jcis.2007.10.008
   Matsumoto T, 2002, BIOMATERIALS, V23, P2241, DOI 10.1016/S0142-9612(01)00358-1
   Mavis B, 2000, J AM CERAM SOC, V83, P989
   Mochales C, 2004, BIOMATERIALS, V25, P1151, DOI 10.1016/j.biomaterials.2003.08.002
   Mollazadeh S, 2007, CERAM INT, V33, P1579, DOI 10.1016/j.ceramint.2006.06.006
   Moseke C, 2010, ACTA BIOMATER, V6, P3815, DOI 10.1016/j.actbio.2010.04.020
   Mostaghaci B, 2009, INT J NANOTECHNOL, V6, P1015, DOI 10.1504/IJNT.2009.027564
   Murphy WL, 2002, J AM CHEM SOC, V124, P1910, DOI 10.1021/ja012433n
   Murugan R, 2002, TRENDS BIOMATER ARTI, V16, P43
   Muthutantri AI, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025009
   Natarajan UV, 2008, J CRYST GROWTH, V310, P4601, DOI 10.1016/j.jcrysgro.2008.07.118
   NESA ET, 2009, BIOINORG CHEM APPL
   Oaki Y, 2006, SMALL, V2, P66, DOI 10.1002/smll.200500246
   Omori M, 2004, KEY ENG MATER, V254-2, P395, DOI 10.4028/www.scientific.net/KEM.254-256.395
   Ong HT, 2008, J NANOPART RES, V10, P141, DOI 10.1007/s11051-007-9239-1
   Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Poinern GE, 2009, ULTRASON SONOCHEM, V16, P469, DOI 10.1016/j.ultsonch.2009.01.007
   Prakash KH, 2006, LANGMUIR, V22, P11002, DOI 10.1021/la0621665
   Qiu Y, 2010, J NANOSCI NANOTECHNO, V10, P2213, DOI 10.1166/jnn.2010.2142
   Randolph A. D., 1971, THEORY PARTICULATE P
   Rivera EM, 1999, MATER LETT, V41, P128, DOI 10.1016/S0167-577X(99)00118-4
   Rocha JHG, 2005, BONE, V37, P850, DOI 10.1016/j.bone.2005.06.018
   Rodriguez-Clemente R, 1998, J EUR CERAM SOC, V18, P1351, DOI 10.1016/S0955-2219(98)00064-8
   Rogel MR, 2008, J MATER CHEM, V18, P4233, DOI 10.1039/b804692a
   Ryu SC, 2009, B KOREAN CHEM SOC, V30, P887
   Sanosh KP, 2009, MATER LETT, V63, P2100, DOI 10.1016/j.matlet.2009.06.062
   Sarig S, 2002, J CRYST GROWTH, V237, P55, DOI 10.1016/S0022-0248(01)01850-4
   Sarkar SK, 2007, MATER SCI FORUM, V534-536, P893, DOI 10.4028/www.scientific.net/MSF.534-536.893
   Shi ZL, 2010, J BIOMATER APPL, V25, P19, DOI 10.1177/0885328209339396
   Shih WJ, 2004, J CRYST GROWTH, V270, P211, DOI 10.1016/j.jcrysgro.2004.06.023
   Siegel RW, 2001, SCRIPTA MATER, V44, P2061, DOI 10.1016/S1359-6462(01)00892-2
   Singh I, 2006, J MATER SCI, V41, P8144, DOI 10.1007/s10853-006-0170-0
   Sinha A, 2008, J MATER SCI-MATER M, V19, P2009, DOI 10.1007/s10856-007-3286-0
   Solla EL, 2007, APPL SURF SCI, V254, P1189, DOI 10.1016/j.apsusc.2007.09.041
   Song J, 2005, J AM CHEM SOC, V127, P3366, DOI 10.1021/ja043776z
   Song J, 2003, J AM CHEM SOC, V125, P1236, DOI 10.1021/ja028559h
   Song RQ, 2007, J AM CHEM SOC, V129, P4152, DOI 10.1021/ja070536l
   Sopyan I, 2007, SCI TECHNOL ADV MAT, V8, P116, DOI 10.1016/j.stam.2006.11.017
   STUPP SI, 1992, J BIOMED MATER RES, V26, P169, DOI 10.1002/jbm.820260204
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Suchanek WL, 1998, J AM CERAM SOC, V81, P765
   Suchanek WL, 2002, BIOMATERIALS, V23, P699, DOI 10.1016/S0142-9612(01)00158-2
   Tan QG, 2009, APPL SURF SCI, V255, P7036, DOI 10.1016/j.apsusc.2009.03.036
   Tercero JE, 2009, MAT SCI ENG C-MATER, V29, P2195, DOI 10.1016/j.msec.2009.05.001
   Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23
   Tung MS, 1996, COLLOID SURFACE A, V110, P191, DOI 10.1016/0927-7757(95)03450-1
   Vallet-Regi M, 2005, J MATER CHEM, V15, P1509, DOI 10.1039/b414143a
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Victor SP, 2008, J BIOMED NANOTECHNOL, V4, P203, DOI 10.1166/jbn.2008.019
   Wahl DA, 2006, EUR CELLS MATER, V11, P43, DOI 10.22203/eCM.v011a06
   WALSH D, 1993, J CRYST GROWTH, V133, P1, DOI 10.1016/0022-0248(93)90097-G
   WANG D, 2007, ZHONGGUO ZUZHI GONGC, V11, P9641
   Wang LY, 2006, NANO LETT, V6, P1645, DOI 10.1021/nl060684u
   Wang W, 2009, ACTA BIOMATER, V5, P3132, DOI 10.1016/j.actbio.2009.04.036
   Wang XJ, 2002, BIOMATERIALS, V23, P4787, DOI 10.1016/S0142-9612(02)00229-6
   Weiner S, 1998, ANNU REV MATER SCI, V28, P271, DOI 10.1146/annurev.matsci.28.1.271
   Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j
   Wilson OC, 2008, MAT SCI ENG C-BIO S, V28, P434, DOI 10.1016/j.msec.2007.04.005
   WOODS AH, 1970, SCIENCE, V167, P179, DOI 10.1126/science.167.3915.179
   Xiao Y, 2010, BIOMATERIALS, V31, P5182, DOI 10.1016/j.biomaterials.2010.03.012
   Xu HHK, 2006, BIOMATERIALS, V27, P4279, DOI 10.1016/j.biomaterials.2006.03.001
   Xu JL, 2009, MAT SCI ENG C-BIO S, V29, P44, DOI 10.1016/j.msec.2008.05.009
   Yao X, 2010, J MATER SCI, V45, P1930, DOI 10.1007/s10853-009-4182-4
   YOUNG RA, 1982, CALCIFIED TISSUE INT, V34, pS17
   Yuasa T, 2004, BIOMATERIALS, V25, P1159, DOI 10.1016/j.biomaterials.2003.08.003
   Zhan GD, 2003, NAT MATER, V2, P38, DOI 10.1038/nmat793
   Zhang CM, 2009, CRYST GROWTH DES, V9, P2725, DOI 10.1021/cg801353n
   Zhang JX, 2008, MICROPOR MESOPOR MAT, V111, P411, DOI 10.1016/j.micromeso.2007.08.029
   Zhang J, 2008, MATER LETT, V62, P1162, DOI 10.1016/j.matlet.2007.07.067
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhou H, 2007, CHEM MATER, V19, P5238, DOI 10.1021/cm671456j
   Zhu W, 2010, MICRO NANO LETT, V5, P19, DOI 10.1049/mnl.2009.0049
NR 177
TC 516
Z9 528
U1 73
U2 722
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2011
VL 7
IS 7
BP 2769
EP 2781
DI 10.1016/j.actbio.2011.03.019
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 785JT
UT WOS:000292226000001
PM 21440094
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Oyane, A
   Ootsuka, T
   Hayama, K
   Sogo, Y
   Ito, A
AF Oyane, Ayako
   Ootsuka, Teruhisa
   Hayama, Kazumi
   Sogo, Yu
   Ito, Atsuo
TI Enhanced immobilization of acidic proteins in the apatite layer via
   electrostatic interactions in a supersaturated calcium phosphate
   solution
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Apatite; Protein; Composite; Calcium phosphate solution; Immobilization
ID SIMPLE SURFACE MODIFICATION; FIBROBLAST GROWTH FACTOR-2; VINYL ALCOHOL
   COPOLYMER; SIMULATED BODY-FLUID; COMPOSITE LAYER; BIOMIMETIC PROCESS;
   ALPHA-LACTALBUMIN; HIGHLY EFFICIENT; TITANIUM METAL; GENE-TRANSFER
AB Artificial materials coated with a protein-apatite composite layer have great potential in clinical applications as a third generation biomaterial. Such composite materials can be prepared by immersing a surface modified substrate into a supersaturated calcium phosphate solution (CP solution: 142 mM NaCl. 3.75 mM CaCl2, 1.5 mM K2HPO4 center dot 3H(2)O, buffered at pH 7.4 at 25 degrees C with tris(hydroxymethyl)aminomethane and HCl) supplemented with a protein. In the present study proteins of various molecular weights (MW) and isoelectric points (pI) were used to form a protein-apatite composite layer on a polymeric material to determine how the molecular properties of the protein affect the efficiency of protein immobilization (i.e. the amount of immobilized protein in the apatite layer as a percentage of the total amount of protein in solution). The results indicated that the efficiency of protein immobilization did not correlate with the MW of the protein. In contrast, the efficiency of protein immobilization was strongly related to the pI of the protein. As the pI decreased the efficiency of protein immobilization increased due to the high adsorption affinity of negatively charged acidic proteins for positively charged apatite crystals and/or apatite precursors in the CP solution. Thus, the use of acidic rather than basic proteins improves the immobilization efficiency in the present coating process. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Oyane, Ayako] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058562, Japan.
   [Ootsuka, Teruhisa; Hayama, Kazumi] Natl Inst Adv Ind Sci & Technol, Nanodevice Innovat Res Ctr, Tsukuba, Ibaraki 3058568, Japan.
   [Sogo, Yu; Ito, Atsuo] Human Technol Res Inst, Tsukuba, Ibaraki 3058566, Japan.
RP Oyane, A (reprint author), Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.
EM a-oyane@aist.go.jp
RI Ito, Atsuo/M-6785-2018; Sogo, Yu/L-8045-2018
OI Ito, Atsuo/0000-0003-3318-040X; Sogo, Yu/0000-0003-1228-4648
FU New Energy and Industrial Technology Development Organization of Japan;
   IBEC Innovation Platform, AIST, Japan
FX We acknowledge the technical support of Mr. Kozo Tanabe of the
   Nanosystem Research Institute, National Institute of Advanced Industrial
   Science and Technology (AIST), Japan. This work was supported by an
   Industrial Technology Research Grant Program (2005) from the New Energy
   and Industrial Technology Development Organization of Japan. A part of
   this work was conducted at the Nano-Processing Facility, supported by
   the IBEC Innovation Platform, AIST, Japan.
CR Aoki H., 1991, SCI MED APPL HYDROXY, P193
   Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z
   Elliot J.C., 1994, STRUCTURE CHEM APATI, P305
   Fasman G. D., 1976, HDB BIOCH MOL BIOL, V1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Ito A, 2002, CRYSTAL GROWTH TECHN, P525
   JARCHO M, 1977, J BIOENG, V1, P79
   JOHNSSON MSA, 1992, CRIT REV ORAL BIOL M, V3, P61, DOI 10.1177/10454411920030010601
   Kataoka M, 1997, PROTEIN SCI, V6, P422
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Kim HM, 2005, BIOMATERIALS, V26, P4366, DOI 10.1016/j.biomaterials.2004.11.022
   Midy V, 1998, J BIOMED MATER RES, V41, P405, DOI 10.1002/(SICI)1097-4636(19980905)41:3<405::AID-JBM10>3.0.CO;2-H
   Mutsuzaki H, 2008, J BIOMED MATER RES B, V86B, P365, DOI [10.1002/jbm.b.31029, 10.1002/jmb.b.31029]
   Onuma K, 2004, MACROMOL BIOSCI, V4, P39, DOI 10.1002/mabi.200350037
   Oyane A, 2006, BIOMATERIALS, V27, P3295, DOI 10.1016/j.biomaterials.2006.01.029
   Oyane A, 2006, BIOMATERIALS, V27, P167, DOI 10.1016/j.biomaterials.2005.06.001
   Oyane A, 2005, KEY ENG MAT, V284-286, P227, DOI 10.4028/www.scientific.net/KEM.284-286.227
   Oyane A, 2005, J BIOMED MATER RES A, V75A, P138, DOI 10.1002/jbm.a.30397
   Oyane A, 2005, BIOMATERIALS, V26, P2407, DOI 10.1016/j.biomaterials.2004.07.048
   Oyane A, 2005, J BIOMED MATER RES A, V72A, P168, DOI 10.1002/jbm.a.30205
   Oyane A, 2010, J GENE MED, V12, P194, DOI 10.1002/jgm.1425
   Oyane A, 2010, J BIOMED MATER RES A, V92A, P1038, DOI 10.1002/jbm.a.32449
   Park JB, 1992, BIOMATERIALS, P194
   Permyakov EA, 2000, FEBS LETT, V473, P269, DOI 10.1016/S0014-5793(00)01546-5
   Quizat S, 1999, MATER RES BULL, V34, P2279
   Rohanizadeh R, 1998, J BIOMED MATER RES, V42, P530, DOI 10.1002/(SICI)1097-4636(19981215)42:4<530::AID-JBM8>3.3.CO;2-Y
   Sasaki K, 2010, BIOMED MATER, V5
   Sogo Y, 2005, CURR APPL PHYS, V5, P526, DOI 10.1016/j.cap.2005.01.025
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   Tsuji T, 2008, P NATL ACAD SCI USA, V105, P16866, DOI 10.1073/pnas.0804277105
   Tsurushima H, 2010, ACTA BIOMATER, V6, P2751, DOI 10.1016/j.actbio.2009.12.045
   Uchida M, 2005, BIOMATERIALS, V26, P6924, DOI 10.1016/j.biomaterials.2005.04.066
   Uchida M, 2004, ADV MATER, V16, P1071, DOI 10.1002/adma.200400152
   Yokoyama Y, 2008, J BIOMED MATER RES B, V86B, P341, DOI 10.1002/jbm.b.31025
NR 35
TC 15
Z9 16
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2011
VL 7
IS 7
BP 2969
EP 2976
DI 10.1016/j.actbio.2011.04.012
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 785JT
UT WOS:000292226000023
PM 21536155
DA 2018-10-20
ER

PT J
AU Chevalier, J
   Loh, J
   Gremillard, L
   Meille, S
   Adolfson, E
AF Chevalier, Jerome
   Loh, Joel
   Gremillard, Laurent
   Meille, Sylvain
   Adolfson, Erik
TI Low-temperature degradation in zirconia with a porous surface
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Zirconia; Dental; Degradation; Porosity; Porous coating
ID TRANSFORMATION; CERAMICS; IMPLANTS; BIOMATERIAL; STRESSES; FUTURE
AB Today there is growing interest in zirconia in the dental field, but its use is still recent. Dental zirconia is mainly found in the form of yttria-stabilized zirconia crowns, bridges and abutments, and several companies are developing zirconia implants as an alternative to the standard biomedical grade titanium. In order to favor bone in-growth and osseointegration of zirconia implants, several strategies are now being explored to process rough and/or porous surfaces. The aim of this paper was to evaluate the resistance to environmental degradation of yttria-stabilized zirconia coated with a porous layer. We show that specific conditions of processing to generate the porous layer at the surface can lead to an accelerated tetragonal-monoclinic transformation of the porous layer in the presence of water. The impact of the transformation was evaluated in terms of structural integrity. Bending strength was not affected but the cohesion of the porous coating and its adhesion with the dense part deteriorated. We show that other processing conditions insure much better stability. Low-temperature degradation resistance of such porous surfaces should therefore be carefully followed and controlled in order to avoid critical problems in the future. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Chevalier, Jerome; Loh, Joel; Gremillard, Laurent; Meille, Sylvain] Univ Lyon, INSA Lyon, CNRS, UMR 5510, F-69621 Villeurbanne, France.
   [Adolfson, Erik] Swerea IVF, SE-43122 Molndal, Sweden.
RP Chevalier, J (reprint author), Univ Lyon, INSA Lyon, CNRS, UMR 5510, 20 Ave Albert Einstein, F-69621 Villeurbanne, France.
EM jerome.chevalier@insa-lyon.fr
OI Meille, Sylvain/0000-0002-4553-1206; Gremillard,
   Laurent/0000-0001-7258-6483
CR Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Chevalier J, 2007, ANNU REV MATER RES, V37, P1, DOI 10.1146/annurev.matsci.37.052506.084250
   Chevalier J, 2009, J AM CERAM SOC, V92, P1901, DOI 10.1111/j.1551-2916.2009.03278.x
   CHRISTEL PS, 1989, B HOSP JOINT DIS ORT, V49, P170
   Christian J. W., 1965, THEORY TRANSFORMATIO
   Clarke IC, 2003, J BONE JOINT SURG AM, V85A, P73, DOI 10.2106/00004623-200300004-00009
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30
   Deville S, 2006, BIOMATERIALS, V27, P2186, DOI 10.1016/j.biomaterials.2005.11.021
   GARVIE RC, 1972, J AM CERAM SOC, V55, P303, DOI 10.1111/j.1151-2916.1972.tb11290.x
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Gremillard L, 2004, J EUR CERAM SOC, V24, P3483, DOI 10.1016/j.jeurceramsoc.2003.11.025
   Haraguchi K, 2001, J BONE JOINT SURG BR, V83B, P996, DOI 10.1302/0301-620X.83B7.12122
   Kohal RJ, 2004, J PERIODONTOL, V75, P1262, DOI 10.1902/jop.2004.75.9.1262
   LUGHI V, 2010, DENT MATER, V26, P922
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   Matsui K, 2003, J AM CERAM SOC, V86, P1401, DOI 10.1111/j.1151-2916.2003.tb03483.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   SCHMAUDER S, 1986, J AM CERAM SOC, V69, P534, DOI 10.1111/j.1151-2916.1986.tb04789.x
   Sennerby L, 2005, CLIN IMPLANT DENT R, V7, P13
   Studart AR, 2007, DENT MATER, V23, P106, DOI 10.1016/j.dental.2005.12.008
   Toraya H., 1984, J AM CERAM SOC, V67, P119
   TSUBAKINO H, 1993, J MATER SCI LETT, V12, P196, DOI 10.1007/BF00819957
NR 24
TC 34
Z9 37
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2011
VL 7
IS 7
BP 2986
EP 2993
DI 10.1016/j.actbio.2011.03.006
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 785JT
UT WOS:000292226000025
PM 21414426
DA 2018-10-20
ER

PT J
AU Hodgkinson, T
   Bayat, A
AF Hodgkinson, T.
   Bayat, A.
TI Dermal substitute-assisted healing: enhancing stem cell therapy with
   novel biomaterial design
SO ARCHIVES OF DERMATOLOGICAL RESEARCH
LA English
DT Review
DE Dermal substitutes; Stem cells; 3D microenvironment; Bioprinting;
   Electrospinning
ID RANDOMIZED CLINICAL-TRIAL; TISSUE-ENGINEERED SKIN; HUMAN ADIPOSE-TISSUE;
   HUMAN BONE-MARROW; GROWTH-FACTOR; IN-VITRO; GENE-THERAPY; CUTANEOUS
   WOUNDS; STROMAL CELLS; BURN WOUNDS
AB The use of dermal substitutes is increasingly widespread but the outcomes of substitute-assisted healing remain functionally deficient. Presently, the most successful scaffolds are acellular polymer matrices, prepared through lyophilization and phase separation techniques, designed to mimic the dermal extracellular matrix. The application of scaffolds containing viable cells has proven to be problematic due to short shelf-life, high cost and death of transplanted cells as a result of immune rejection and apoptosis. Recent advances in biomaterial science have made new techniques available capable of increasing scaffold complexity, allowing the creation of 3D microenvironments that actively control cell behaviour. Importantly, it may be possible through these sophisticated novel techniques, including bio-printing and electrospinning, to accurately direct stem cell behaviour. This complex proposal involves the incorporation of cell-matrix, cell-cell, mechanical cues and soluble factors delivered in a spatially and temporally pertinent manner. This requires accurate modelling of three-dimensional stem cell interactions within niche environments to identify key signalling molecules and mechanisms. The application of stem cells within substitutes containing such environments may result in greatly improved transplanted cell viability. Ultimately this may increase cellular organization and complexity of skin substitutes. This review discusses progress made in improving the efficacy of cellular dermal substitutes for the treatment of cutaneous defects and the potential of evolving new technology to improve current results.
C1 [Hodgkinson, T.; Bayat, A.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England.
   [Bayat, A.] S Manchester Univ Hosp Fdn Trust, Wythenshawe Hosp, Dept Plast & Reconstruct Surg, Manchester, Lancs, England.
RP Bayat, A (reprint author), Univ Manchester, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.
EM ardeshir.bayat@manchester.ac.uk
RI Hodgkinson, Tom/E-5767-2016
OI Hodgkinson, Tom/0000-0002-3242-1593; BAYAT, ARDESHIR/0000-0002-4116-6491
CR Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559
   Ahmed TAE, 2008, TISSUE ENG PT B-REV, V14, P199, DOI 10.1089/ten.teb.2007.0435
   Altman AM, 2008, BIOMATERIALS, V29, P1431, DOI 10.1016/j.biomaterials.2007.11.026
   Amoh Y, 2005, P NATL ACAD SCI USA, V102, P17734, DOI 10.1073/pnas.0508440102
   Amos PJ, 2010, TISSUE ENG PT A, V16, P1595, DOI [10.1089/ten.tea.2009.0616, 10.1089/ten.TEA.2009.0616]
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592
   Asai J, 2006, CIRCULATION, V113, P2413, DOI 10.1161/CIRCULATIONAHA.105.603167
   ASHTON BA, 1984, CALCIFIED TISSUE INT, V36, P83, DOI 10.1007/BF02405298
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Ayres CE, 2010, WIRES NANOMED NANOBI, V2, P20, DOI 10.1002/wnan.55
   BACH FH, 1968, LANCET, V2, P1364
   Badiavas EV, 2003, ARCH DERMATOL, V139, P510, DOI 10.1001/archderm.139.4.510
   Badillo AT, 2008, J PEDIATR SURG, V43, P1128, DOI 10.1016/j.jpedsurg.2008.02.043
   Badillo AT, 2007, J SURG RES, V143, P35, DOI 10.1016/j.jss.2007.04.051
   Baumann LS, 2007, DERMATOL SURG, V33, pS128, DOI 10.1111/j.1524-4725.2007.33352.x
   Beattie AJ, 2008, TISSUE ENG PART A, V15, P1119
   BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Bellon G, 2004, CRIT REV ONCOL HEMAT, V49, P203, DOI 10.1016/j.critrevonc.2003.10.004
   BEUMER GJ, 1993, BIOMATERIALS, V14, P598, DOI 10.1016/0142-9612(93)90178-5
   Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Brusselaers N, 2010, J TRAUMA, V68, P490, DOI 10.1097/TA.0b013e3181c9c074
   Caravaggi C, 2003, DIABETES CARE, V26, P2853, DOI 10.2337/diacare.26.10.2853
   Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606
   Casasco M, 2004, J MOL HISTOL, V35, P421
   Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669
   Chen GP, 2005, BIOMATERIALS, V26, P2559, DOI 10.1016/j.biomaterials.2004.07.034
   Chen RN, 2004, BIOMATERIALS, V25, P2679, DOI 10.1016/j.biomaterials.2003.09.070
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Dahl SLM, 2003, CELL TRANSPLANT, V12, P659, DOI 10.3727/000000003108747136
   de Vries H J, 1994, Wound Repair Regen, V2, P37, DOI 10.1046/j.1524-475X.1994.20107.x
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Drossopoulou G, 2000, DEVELOPMENT, V127, P1337
   Duocastella M, 2008, APPL PHYS A-MATER, V93, P453, DOI 10.1007/s00339-008-4781-y
   Ehrbar M, 2004, CIRC RES, V94, P1124, DOI 10.1161/01.RES.0000126411.29641.08
   El Ghalbzouri A, 2004, BIOMATERIALS, V25, P2987, DOI 10.1016/j.biomaterials.2003.09.098
   Elcin YM, 2001, ARTIF ORGANS, V25, P558, DOI 10.1046/j.1525-1594.2001.025007558.x
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Falanga V, 2007, TISSUE ENG, V13, P1299, DOI 10.1089/ten.2006.0278
   Fan VH, 2007, STEM CELLS, V25, P1241, DOI 10.1634/stemcells.2006-0320
   Fisher OZ, 2010, ACCOUNTS CHEM RES, V43, P419, DOI 10.1021/ar900226q
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Fox A, 2008, BRIT J SURG, V95, P244, DOI 10.1002/bjs.5913
   Fu XB, 2006, WOUND REPAIR REGEN, V14, P325, DOI 10.1111/j.1743-6109.2006.00128.x
   FU XB, 2004, ZHONGHUA YI XUE ZA Z, V84, P9204
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026
   Goetz AK, 2006, P NATL ACAD SCI USA, V103, P11063, DOI 10.1073/pnas.0510926103
   Goissis G, 2000, ARTIF ORGANS, V24, P217, DOI 10.1046/j.1525-1594.2000.06537.x
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463
   Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Gupta A, 2007, J BIOACT COMPAT POL, V22, P265, DOI 10.1177/0883911507078268
   Hanson SE, 2010, PLAST RECONSTR SURG, V125, P510, DOI 10.1097/PRS.0b013e3181c722bb
   Haslik W, 2007, BURNS, V33, P364, DOI 10.1016/j.burns.2006.07.021
   He WL, 2007, INT J PHARMACEUT, V334, P173, DOI 10.1016/j.ijpharm.2006.10.025
   Hodgkinson T, 2009, EXPERT REV MED DEVIC, V6, P621, DOI 10.1586/ERD.09.48
   Hoffman LM, 2005, NAT BIOTECHNOL, V23, P699, DOI 10.1038/nbt1102
   Hopp B, 2005, TISSUE ENG, V11, P1817, DOI 10.1089/ten.2005.11.1817
   Huang S, 1998, MOL BIOL CELL, V9, P3179, DOI 10.1091/mbc.9.11.3179
   Huang S, 2009, TISSUE ENG PT A, V15, P2617, DOI [10.1089/ten.tea.2008.0505, 10.1089/ten.TEA.2008.0505]
   Huang S, 2010, BIOMATERIALS, V31, P5520, DOI 10.1016/j.biomaterials.2010.03.060
   Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346
   Jahoda CAB, 2003, J INVEST DERMATOL, V121, pIX, DOI 10.1111/j.1523-1747.2003.12585.x
   Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x
   Jayasinghe SN, 2007, NANOMEDICINE-UK, V2, P555, DOI 10.2217/17435889.2.4.555
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K
   Kang XH, 2007, BIOMATERIALS, V28, P450, DOI 10.1016/j.biomaterials.2006.08.052
   Kastrinaki MC, 2008, ANN RHEUM DIS, V67, P741, DOI 10.1136/ard.2007.076174
   Kearney JN, 2001, BURNS, V27, P545, DOI 10.1016/S0305-4179(01)00020-1
   Kemp P, 2006, REGEN MED, V1, P653, DOI 10.2217/17460751.1.5.653
   Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005
   Kim MS, 2010, TISSUE ENG PT A, V16, P2999, DOI [10.1089/ten.tea.2009.0828, 10.1089/ten.TEA.2009.0828]
   Kim WS, 2009, ARCH DERMATOL RES, V301, P329, DOI 10.1007/s00403-009-0951-9
   Knoepfler PS, 2009, STEM CELLS, V27, P1050, DOI 10.1002/stem.37
   Kolokol'chikova EG, 2001, B EXP BIOL MED+, V131, P89, DOI 10.1023/A:1017503301550
   Kotton DN, 2003, CYTOTHERAPY, V5, P169, DOI 10.1080/14653240310001073
   KUMAR RK, 1991, EXP CELL RES, V193, P398, DOI 10.1016/0014-4827(91)90112-8
   Kusano KF, 2005, NAT MED, V11, P1197, DOI 10.1038/nm1313
   LAJTHA LG, 1979, DIFFERENTIATION, V14, P23, DOI 10.1111/j.1432-0436.1979.tb01007.x
   Lattari Vincent, 1997, Journal of Burn Care and Rehabilitation, V18, P147, DOI 10.1097/00004630-199703000-00010
   Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014
   Liu P, 2008, ARTIF ORGANS, V32, P925, DOI 10.1111/j.1525-1594.2008.00654.x
   Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2
   Lund AW, 2009, TISSUE ENG PART B-RE, V15, P371, DOI [10.1089/ten.teb.2009.0270, 10.1089/ten.TEB.2009.0270]
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014
   Mansbridge J, 1998, TISSUE ENG, V4, P403, DOI 10.1089/ten.1998.4.403
   Mansilla E, 2005, TRANSPL P, V37, P292, DOI 10.1016/j.transproceed.2005.01.070
   Mei Y, 2009, ADV MATER, V21, P2781, DOI 10.1002/adma.200803184
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mironov V, 2006, TISSUE ENG, V12, P631, DOI 10.1089/ten.2006.12.631
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mironov V, 2008, REGEN MED, V3, P93, DOI 10.2217/17460751.3.1.93
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027
   Mizuno H, 2010, J PLAST RECONSTR AES, V63, P1875, DOI 10.1016/j.bjps.2009.11.037
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   MORIYAMA K, 1991, MATRIX, V11, P190, DOI 10.1016/S0934-8832(11)80158-7
   Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Muller LUW, 2009, MOL THER, V17, P947, DOI 10.1038/mt.2009.72
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Nakagawa H, 2005, BRIT J DERMATOL, V153, P29, DOI 10.1111/j.1365-2133.2005.06554.x
   Nakajima M, 2007, BIOMATERIALS, V28, P1048, DOI 10.1016/j.biomaterials.2006.10.004
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Nambu M, 2009, ANN PLAS SURG, V62, P317, DOI 10.1097/SAP.0b013e31817f01b6
   Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022
   Ng Kee Woei, 2001, Tissue Engineering, V7, P441, DOI 10.1089/10763270152436490
   Nie CL, 2009, MED HYPOTHESES, V72, P679, DOI 10.1016/j.mehy.2008.10.033
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.3.CO;2-6
   Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Pessina A, 2006, CURR MED RES OPIN, V22, P2287, DOI 10.1185/030079906X148517
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Price RD, 2004, PLAST RECONSTR SURG, V113, P1719, DOI 10.1097/01.PRS.0000117367.86893.CE
   Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Rabbany SY, 2010, CELL TRANSPLANT, V19, P399, DOI 10.3727/096368909X481782
   Rasulov MF, 2005, B EXP BIOL MED+, V139, P141, DOI 10.1007/s10517-005-0232-3
   Ravanti L, 1999, J BIOL CHEM, V274, P2446, DOI 10.1074/jbc.274.4.2446
   Richardson GD, 2005, J INVEST DERM SYMP P, V10, P180, DOI 10.1111/j.1087-0024.2005.10101.x
   Romanelli Marco, 2007, Int Wound J, V4, P3, DOI 10.1111/j.1742-481X.2007.00300.x
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Salvolini E, 2010, ARCH DERMATOL RES, V302, P367, DOI 10.1007/s00403-009-1018-7
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581
   Schluter H, 2009, LANCET, V374, P1725, DOI 10.1016/S0140-6736(09)61707-4
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584
   SHIGEHIKO S, 2000, BR J PLAST SURG, V53, P659
   Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304
   Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100
   STOFF A, 2008, EXP DERMATOL, V18, P362
   Strande LF, 1997, TRANSPLANT P, V29, P2118, DOI 10.1016/S0041-1345(97)00256-X
   Tabata Y., 2003, TISSUE ENG, V9, P5
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Togel F, 2007, DEV DYNAM, V236, P3321, DOI 10.1002/dvdy.21258
   Tran KT, 2005, J DERMATOL SCI, V40, P11, DOI 10.1016/j.jdermsci.2005.05.001
   Uzunismail A, 2008, EUR J PLAST SURG, V31, P179, DOI 10.1007/s00238-008-0222-6
   van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145
   Vats A, 2003, CLIN OTOLARYNGOL, V28, P165, DOI 10.1046/j.1365-2273.2003.00686.x
   Wainwright David, 1996, Journal of Burn Care and Rehabilitation, V17, P124, DOI 10.1097/00004630-199603000-00006
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
   WATANABE S, 1995, J GASTROEN HEPATOL, V10, P627, DOI 10.1111/j.1440-1746.1995.tb01361.x
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
   WISEMAN DM, 1988, BIOCHEM BIOPH RES CO, V157, P793, DOI 10.1016/S0006-291X(88)80319-X
   Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
   Yan YN, 2005, BIOMATERIALS, V26, P5864, DOI 10.1016/j.biomaterials.2005.02.027
   Yang J, 2002, J BIOMED MATER RES, V62, P438, DOI 10.1002/jbm.10318
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yang XC, 2009, TISSUE ENG PT A, V15, P945, DOI 10.1089/ten.tea.2007.0280
   Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103
   Yoshikawa T, 2008, PLAST RECONSTR SURG, V121, P860, DOI 10.1097/01.prs.0000299922.96006.24
   Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005
   Zhu XL, 2008, BIOMACROMOLECULES, V9, P1795, DOI 10.1021/bm800476u
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
NR 181
TC 26
Z9 29
U1 3
U2 88
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0340-3696
J9 ARCH DERMATOL RES
JI Arch. Dermatol. Res.
PD JUL
PY 2011
VL 303
IS 5
BP 301
EP 315
DI 10.1007/s00403-011-1131-2
PG 15
WC Dermatology
SC Dermatology
GA 780SU
UT WOS:000291880100001
PM 21365208
DA 2018-10-20
ER

PT J
AU Muller, WEG
   Wang, XH
   Wiens, M
   Schlossmacher, U
   Jochum, KP
   Schroder, HC
AF Mueller, Werner E. G.
   Wang, Xiaohong
   Wiens, Matthias
   Schlossmacher, Ute
   Jochum, Klaus Peter
   Schroeder, Heinz C.
TI Hardening of bio-silica in sponge spicules involves an aging process
   after its enzymatic polycondensation: Evidence for an aquaporin-mediated
   water absorption
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Sponges; Spicules; Bio-silica; Hardening; Suberites domuncula;
   Primmorphs
ID DEMOSPONGE SUBERITES-DOMUNCULA; GENE-EXPRESSION; IN-VITRO;
   MONORHAPHIS-CHUNI; MANGANESE; BIOSILICA; PROTEIN; CHANNEL; ALPHA; GLASS
AB Background: Spicules, the siliceous skeletal elements of the siliceous sponges, are synthesized enzymatically via silicatein. The product formed, bio-silica, constitutes their inorganic matrix. It remained unexplored which reactions are involved in molding of the amorphous bio-silica and formation of a solid and rigid biomaterial.
   Methods: Cell and molecular biological techniques have been applied to analyze processes resulting in the hardening of the enzymatically synthesized bio-silica. The demosponge Suberites domuncula has been used for the studies.
   Results: Cell aggregates (primmorphs) from the sponges. domuncula, grown in the presence of Mn-sulfate, form spicules that comprise, instead of a smooth, a rough and porous surface which is decorated with irregular bio-silica deposits. During this process, the expression of the aquaporin-8 gene becomes down-regulated. Further in vitro studies showed that aquaporin is required for dehydration, and hardening of bio-silica following its enzymatic formation. The data show that in cell aggregates grown in the presence of Mn-sulfate, aquaporin-8 is down-regulated. We conclude that in cell aggregates grown in the presence of Mn-sulfate, the removal of reaction water, produced during the bio-silica polycondensation reaction, is inhibited.
   General significance: This study highlights that besides the silicatein-driven polycondensation reaction, the spicule formation also requires a phase of syneresis that results in a hardening of the material. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Mueller, Werner E. G.; Wang, Xiaohong; Wiens, Matthias; Schlossmacher, Ute; Schroeder, Heinz C.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, ERC Adv Grant Res Grp, D-55128 Mainz, Germany.
   [Wang, Xiaohong] Natl Res Ctr Geoanal, Beijing 100037, Peoples R China.
   [Jochum, Klaus Peter] Max Planck Inst Chem, D-55020 Mainz, Germany.
RP Muller, WEG (reprint author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Physiol Chem, Duesbergweg 6, D-55099 Mainz, Germany.
EM wmueller@uni-mainz.de
FU ERC [268476 BIOSILICA]; German Bundesministerium fur Bildung und
   Forschung; Deutsche Forschungsgemeinschaft [Schr 277/10-1]; European
   Commission/EUREKA (EUROSTARS) [4289 SILIBACTS]; European Commission
   [244967]; Ministry of Land and Resources of the People's Republic of
   China [201011005-06]; International S & T Cooperation Program of China
   [2008DFA00980]
FX W.E.G. M. is a holder of an ERC Advanced Investigator Grant (no. 268476
   BIOSILICA). This work was supported by grants from the German
   Bundesministerium fur Bildung und Forschung (project "Center of
   Excellence BIOTECmarin"), the Deutsche Forschungsgemeinschaft (Schr
   277/10-1), the European Commission/EUREKA (EUROSTARS, no. 4289
   SILIBACTS), the International Human Frontier Science Program, the
   European Commission (project no. 244967 - Mem-S Project), the Public
   Welfare Project of the Ministry of Land and Resources of the People's
   Republic of China (grant no. 201011005-06) and the International S & T
   Cooperation Program of China (grant no. 2008DFA00980).
CR ALEXANDER A, 2004, NORDIC NUTR RECOMMEN
   ARNDT W, 1935, PORIFERA TIERWELT A, V3, P1
   Baek SY, 2004, IND HEALTH, V42, P315, DOI 10.2486/indhealth.42.315
   Cai Y, 2007, J AM CERAM SOC, V90, P1304, DOI 10.1111/j.1551-2916.2007.01612.x
   Calamita G, 2001, EUR J CELL BIOL, V80, P711, DOI 10.1078/0171-9335-00210
   Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361
   Chen CJ, 2006, NEUROCHEM INT, V49, P62, DOI 10.1016/j.neuint.2005.12.020
   Coligan JE, 2000, CURRENT PROTOCOLS PR, P201
   Crisan M, 2006, J OPTOELECTRON ADV M, V8, P815
   Echevarria M, 1998, J PHYSIOL BIOCHEM, V54, P107
   Eckert C, 2006, J HISTOCHEM CYTOCHEM, V54, P1031, DOI 10.1369/jhc.5A6903.2006
   Ehrlich H., 2010, BIOL MAT MARINE ORIG
   FELSENSTEIN J, 1993, PHYLIP VER 3 5
   Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200
   Hench L. L., 1998, SOL GEL SILICA PROPE
   Hoque ATMS, 2002, J CELL PHYSIOL, V191, P336, DOI 10.1002/jcp.10106
   Huang PB, 2001, P NATL ACAD SCI USA, V98, P14120, DOI 10.1073/pnas.241318498
   IMSIECKE G, 1995, IN VITRO CELL DEV-AN, V31, P528
   King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6
   Krasko A, 2002, DNA CELL BIOL, V21, P67, DOI 10.1089/10445490252810320
   Krasko A, 2000, EUR J BIOCHEM, V267, P4878, DOI 10.1046/j.1432-1327.2000.01547.x
   LEACH RM, 1962, J NUTR, V78, P51, DOI 10.1093/jn/78.1.51
   Li XD, 2002, MATER CHARACT, V48, P11
   Liu K, 2006, BIOL CELL, V98, P153, DOI 10.1042/BC20050026
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Losic D, 2007, LANGMUIR, V23, P5014, DOI 10.1021/la062666y
   Mayer G, 2005, SCIENCE, V310, P1144, DOI 10.1126/science.1116994
   Mertz W, 1988, TRACE ELEMENTS HUMAN
   Miserez A, 2008, ADV FUNCT MATER, V18, P1241, DOI 10.1002/adfm.200701135
   Morse DE, 1999, TRENDS BIOTECHNOL, V17, P230, DOI 10.1016/S0167-7799(99)01309-8
   Muller WEG, 2008, CHEM MATER, V20, P4703, DOI 10.1021/cm800734q
   Muller WEG, 2008, BIOMATERIALS, V29, P771, DOI 10.1016/j.biomaterials.2007.10.038
   Muller WEG, 2008, FEBS J, V275, P362, DOI 10.1111/j.1742-4658.2007.06206.x
   Muller WEG, 2007, BIOMATERIALS, V28, P4501, DOI 10.1016/j.biomaterials.2007.06.030
   Muller WEG, 2007, GENE, V395, P62, DOI 10.1016/j.gene.2007.02.014
   Muller WEG, 2010, FEBS J, V277, P1182, DOI 10.1111/j.1742-4658.2009.07552.x
   Muller WEG, 2009, J STRUCT BIOL, V168, P548, DOI 10.1016/j.jsb.2009.08.003
   Muller WEG, 2009, APPL MICROBIOL BIOT, V83, P397, DOI 10.1007/s00253-009-2014-8
   Muller WEG, 2006, MICRON, V37, P107, DOI 10.1016/j.micron.2005.09.003
   Muller WEG, 2005, FEBS J, V272, P3838, DOI 10.1111/j.1742-4658.2005.04795.x
   Muller WEG, 2005, CELL TISSUE RES, V321, P285, DOI 10.1007/s00441-005-1141-5
   Muller WEG, 1999, MAR ECOL PROG SER, V178, P205, DOI 10.3354/meps178205
   Muller WEG, 2002, IMMUNOGENETICS, V54, P48, DOI 10.1007/s00251-002-0441-0
   Muller WEG, 1997, TRENDS GLYCOSCI GLYC, V9, P123
   Murr MM, 2005, P NATL ACAD SCI USA, V102, P11657, DOI 10.1073/pnas.0503968102
   Natalio F, 2010, CELL TISSUE RES, V339, P429, DOI 10.1007/s00441-009-0903-x
   Pei LH, 2005, J COLLOID INTERF SCI, V284, P222, DOI 10.1016/j.jcis.2004.09.075
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V92, P2002, DOI DOI 10.1093/NAR/29.9.E45
   Prokopowicz M, 2010, J NON-CRYST SOLIDS, V356, P1711, DOI 10.1016/j.jnoncrysol.2010.06.024
   Reaney SH, 2002, CHEM RES TOXICOL, V15, P1119, DOI 10.1021/tx025525e
   Rico H, 2000, EUR J OBSTET GYN R B, V90, P97, DOI 10.1016/S0301-2115(99)00223-7
   SACHS L, 1984, ANGEW STAT
   Schladt TD, 2010, ANGEW CHEM INT EDIT, V49, P3976, DOI 10.1002/anie.200906689
   Schroder HC, 2006, J BIOL CHEM, V281, P12001, DOI 10.1074/jbc.M512677200
   Schroder HC, 2008, NAT PROD REP, V25, P455, DOI 10.1039/b612515h
   Schroder HC, 2007, J STRUCT BIOL, V159, P325, DOI 10.1016/j.jsb.2007.01.007
   Schroder HC, 2012, SILICON-NETH, V4, P33, DOI 10.1007/s12633-010-9057-4
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   SIMPSON TL, 1984, CELL BIOL SPONGES
   Smirniotis PG, 2006, IND ENG CHEM RES, V45, P6436, DOI 10.1021/ie060484t
   STEVENSON RA, 1966, LIMNOL OCEANOGR, V11, P11, DOI 10.4319/lo.1966.11.1.0011
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tong X, 2002, J APPL POLYM SCI, V86, P3532, DOI [10.1002/app.11152, 10.1002/aap.11152]
   Towbin H, 2001, ELECTROPHORESIS, V22, P1887, DOI 10.1002/1522-2683(200106)22:10<1887::AID-ELPS1887>3.0.CO;2-Q
   Turekian K. K., 1968, OCEANS
   Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849
   Velarde E, 2009, J BIOL RHYTHM, V24, P104, DOI 10.1177/0748730408329901
   Vinogradov A.P., 1953, ELEMENTARY CHEM COMP
   WANG XH, 2010, MAR DRUGS, V9, P1
   Wang XH, 2010, ADV ENG MATER, V12, pB422, DOI 10.1002/adem.200980042
   Wang XH, 2009, INT REV CEL MOL BIO, V273, P69, DOI 10.1016/S1937-6448(08)01803-0
   Wiens M, 2003, J EXP BIOL, V206, P3261, DOI 10.1242/jeb.00541
   Wiens M, 2010, J CELL BIOCHEM, V111, P1377, DOI 10.1002/jcb.22866
   Wiens M, 2009, BIOMATERIALS, V30, P1648, DOI 10.1016/j.biomaterials.2008.12.021
   Zaki MI, 1999, NEW J CHEM, V23, P1197, DOI 10.1039/a907468f
NR 75
TC 22
Z9 22
U1 2
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-4165
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD JUL
PY 2011
VL 1810
IS 7
BP 713
EP 726
DI 10.1016/j.bbagen.2011.04.009
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 787EE
UT WOS:000292358600008
PM 21565255
DA 2018-10-20
ER

PT J
AU Roth, CC
   Mondalek, FG
   Kibar, Y
   Ashley, RA
   Bell, CH
   Califano, JA
   Madihally, SV
   Frimberger, D
   Lin, HK
   Kropp, BP
AF Roth, Christopher C.
   Mondalek, Fadee G.
   Kibar, Yusuf
   Ashley, Richard A.
   Bell, Cardin H.
   Califano, John A.
   Madihally, Sundar V.
   Frimberger, Dominic
   Lin, Hsueh-Kung
   Kropp, Bradley P.
TI Bladder regeneration in a canine model using hyaluronic
   acid-poly(lactic-co-glycolic-acid) nanoparticle modified porcine small
   intestinal submucosa
SO BJU INTERNATIONAL
LA English
DT Article
DE extracellular matrix; nanotechnology; small intestinal submucosa; tissue
   engineering
ID ACID; SCAFFOLDS; TISSUE; DOG
AB OBJECTIVE
   To determine if hyaluronic acid (HA) can be incorporated into porcine small intestinal submucosa (SIS) through poly (lactide-co-glycolide-acid) (PLGA) nanoparticles to improve the consistency of the naturally derived biomaterial and promote bladder tissue regeneration.
   METHODS
   Beagle dogs were subjected to 40% partial cystectomy followed by bladder augmentation with commercial SIS or HA-PLGA-modified SIS.
   Urodynamic testing was performed before and after augmentation to assess bladder volume.
   A scoring system was created to evaluate gross and histological presentations of regenerative bladders.
   RESULTS
   All dogs showed full-thickness bladder regeneration.
   Histological assessment showed improved smooth muscle regeneration in the HA-PLGA-modified SIS group.
   For both groups of dogs, urodynamics and graft measurements showed an approximate 40% reduction in bladder capacity and graft size from pre-augmentation to post-regeneration measurements.
   Application of the scoring system and statistical analysis failed to show a significant difference between the groups.
   CONCLUSIONS
   SIS can be modified through the addition of HA-PLGA nanoparticles. The modified grafts showed evidence of improved smooth muscle regeneration on histological assessment, although this difference was not evident on a novel grading scale.
   The volume loss and graft shrinkage experienced are consistent with previous models of SIS bladder regeneration at the 10-week time point.
   Additional research into the delivery of HA and the long-term benefits of HA on bladder regeneration is needed to determine the full benefit of HA-PLGA-modified SIS. In addition, a more objective biochemical characterization will be needed to evaluate the quality of regeneration.
C1 [Roth, Christopher C.; Mondalek, Fadee G.; Ashley, Richard A.; Bell, Cardin H.; Califano, John A.; Frimberger, Dominic; Lin, Hsueh-Kung; Kropp, Bradley P.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK USA.
   [Madihally, Sundar V.] Oklahoma State Univ, Sch Chem Engn, Stillwater, OK 74078 USA.
   [Kibar, Yusuf] Gulhane Mil Med Acad, Dept Urol, Ankara, Turkey.
RP Roth, CC (reprint author), 200 Henry Clay Ave, New Orleans, LA 70118 USA.
EM croth@lsuhsc.edu
RI Madihally, Sundararajan/D-9285-2012
OI Madihally, Sundararajan/0000-0001-7498-5760
FU Cook Biotech, Inc.
FX This project was supported in part by Cook Biotech, Inc.
CR ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Brown AL, 2006, MACROMOL BIOSCI, V6, P648, DOI 10.1002/mabi.200600052
   Bullard KM, 2003, WORLD J SURG, V27, P54, DOI 10.1007/s00268-002-6737-2
   Croce MA, 2001, TISSUE CELL, V33, P326, DOI 10.1054/tice.2001.0180
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Ibrahim S, 2008, J TISSUE ENG REGEN M, V2, P22, DOI 10.1002/term.61
   Iocono Joseph A., 1998, Wound Repair and Regeneration, V6, P442, DOI 10.1046/j.1524-475X.1998.60506.x
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 2004, J UROLOGY, V172, P1710, DOI 10.1097/01.ju.0000139952.64753.27
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Mast Bruce A., 1995, Wound Repair and Regeneration, V3, P66, DOI 10.1046/j.1524-475X.1995.30112.x
   Mondalek FG, 2008, BIOMATERIALS, V29, P1159, DOI 10.1016/j.biomaterials.2007.11.020
   Mondalek FG, 2010, J BIOMED MATER RES A, V94A, P712, DOI 10.1002/jbm.a.32748
   Nesti LJ, 2008, TISSUE ENG PT A, V14, P1527, DOI 10.1089/ten.tea.2008.0215
   Pope JC, 1997, J UROLOGY, V158, P1105, DOI 10.1016/S0022-5347(01)64398-2
   Price RD, 2005, AM J CLIN DERMATOL, V6, P393, DOI 10.2165/00128071-200506060-00006
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Safran MR, 2008, J AM ACAD ORTHOP SUR, V16, P306, DOI 10.5435/00124635-200806000-00002
   Toole B. P., 1989, CIBA F SYMP, V143, P281
   TOOLE BP, 1989, CIBA F SYMP, V143, P138
   TOOLE BP, 1989, CIBA F SYMP, V143, P145
   Zhang YY, 2006, BJU INT, V98, P1100, DOI 10.1111/j.1464-410X.2006.06447.x
NR 24
TC 27
Z9 32
U1 0
U2 19
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD JUL
PY 2011
VL 108
IS 1
BP 148
EP 155
DI 10.1111/j.1464-410X.2010.09757.x
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 781JW
UT WOS:000291928500029
PM 20942834
OA Bronze
DA 2018-10-20
ER

PT J
AU Kraft, JJ
   Jeong, C
   Novotny, JE
   Seacrist, T
   Chan, G
   Domzalski, M
   Turka, CM
   Richardson, DW
   Dodge, GR
AF Kraft, Jeffrey J.
   Jeong, Changhoon
   Novotny, John E.
   Seacrist, Thomas
   Chan, Gilbert
   Domzalski, Marcin
   Turka, Christina M.
   Richardson, Dean W.
   Dodge, George R.
TI Effects of Hydrostatic Loading on a Self-Aggregating, Suspension
   Culture-Derived Cartilage Tissue Analog
SO CARTILAGE
LA English
DT Article
DE bioengineering; cartilage tissue engineering; hydrostatic loading;
   cartilage repair
AB Objective: Many approaches are being taken to generate cartilage replacement materials. The goal of this study was to use a self-aggregating suspension culture model of chondrocytes with mechanical preconditioning. Design: Our model differs from others in that it is based on a scaffold-less, self-aggregating culture model that produces a cartilage tissue analog that has been shown to share many similarities with the natural cartilage phenotype. Owing to the known loaded environment under which chondrocytes function in vivo, we hypothesized that applying force to the suspension culture-derived chondrocyte biomass would improve its cartilage-like characteristics and provide a new model for engineering cartilage tissue analogs. Results: In this study, we used a specialized hydrostatic pressure bioreactor system to apply mechanical forces during the growth phase to improve biochemical and biophysical properties of the biomaterial formed. We demonstrated that using this high-density suspension culture, a biomaterial more consistent with the hyaline cartilage phenotype was produced without any foreign material added. Unpassaged chondrocytes responded to a physiologically relevant hydrostatic load by significantly increasing gene expression of critical cartilage molecule collagen and aggrecan along with other cartilage relevant genes, CD44, perlecan, decorin, COMP, and iNOS. Conclusions: This study describes a self-aggregating bioreactor model without foreign material or scaffold in which chondrocytes form a cartilage tissue analog with many features similar to native cartilage. This study represents a promising scaffold-less, methodological advancement in cartilage tissue engineering with potential translational applications to cartilage repair.
C1 [Kraft, Jeffrey J.; Dodge, George R.] Univ Delaware, Dept Biol Sci, Newark, DE USA.
   [Jeong, Changhoon; Seacrist, Thomas; Chan, Gilbert; Domzalski, Marcin] Alfred I duPont Hosp Children, Wilmington, DE USA.
   [Novotny, John E.; Turka, Christina M.] Univ Delaware, Dept Mech Engn, Newark, DE 19716 USA.
   [Richardson, Dean W.] Univ Penn, New Bolton Ctr, Sch Vet Med, Kennett Sq, PA 19348 USA.
RP Dodge, GR (reprint author), Univ Penn, McKay Orthopaed Res Lab, Dept Orthopaed Surg, 424 Stemmler Hall,36th St & Hamilton Walk, Philadelphia, PA 19104 USA.
EM gdodge@upenn.edu
RI Domzalski, Marcin/M-3523-2016
FU National Institutes of Health (NIH) [AR045242, P20RR016458,
   P20RR020173]; Nemours
FX The authors thank Theresa Michel and Christopher Saeui for exceptional
   editorial assistance, and Minwook Kim, Aaron Littleton, and Chuanzhao Li
   for expert technical assistance. The study was sponsored in part by
   National Institutes of Health (NIH) grant #AR045242, NIH grant
   #P20RR016458, and NIH grant #P20RR020173 and Nemours.
CR Bonassar LJ, 2001, J ORTHOPAED RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   CARTER DR, 1988, J ORTHOPAED RES, V6, P804, DOI 10.1002/jor.1100060604
   Das P, 1997, J ORTHOPAED RES, V15, P87, DOI 10.1002/jor.1100150113
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Elder BD, 2009, TISSUE ENG PART B-RE, V15, P43, DOI 10.1089/ten.teb.2008.0435
   Elder BD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002341
   Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086
   Estrada LE, 2001, OSTEOARTHR CARTILAGE, V9, P169, DOI 10.1053/joca.2000.0373
   Evans CH, 1995, CLIN ORTHOP RELAT R, V312, P275
   Haisch A, 2004, EUR ARCH OTO-RHINO-L, V261, P216, DOI 10.1007/s00405-003-0646-3
   Hall AC, 1996, EXP PHYSIOL, V81, P535, DOI 10.1113/expphysiol.1996.sp003956
   HALL AC, 1991, J ORTHOPAED RES, V9, P1, DOI 10.1002/jor.1100090102
   Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969
   Hunziker EB, 2001, CLIN ORTHOP RELAT R, pS171
   Ikenoue T, 2003, J ORTHOPAED RES, V21, P110, DOI 10.1016/S0736-0266(02)00091-8
   Jin M, 2001, ARCH BIOCHEM BIOPHYS, V395, P41, DOI 10.1006/abbi.2001.2543
   KAWABE N, 1991, CLIN ORTHOP RELAT R, P279
   Kisiday JD, 2004, J BIOMECH, V37, P595, DOI 10.1016/j.jbiomech.2003.10.005
   Kues WA, 2004, TRENDS BIOTECHNOL, V22, P286, DOI 10.1016/j.tibtech.2004.04.003
   Larson CM, 2002, MATRIX BIOL, V21, P349, DOI 10.1016/S0945-053X(02)00026-4
   Lee GM, 1997, OSTEOARTHR CARTILAGE, V5, P261, DOI 10.1016/S1063-4584(97)80022-2
   Lee MS, 2002, J ORTHOP RES, V20, P556, DOI 10.1016/S0736-0266(01)00149-8
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mizuno S, 2002, J CELL PHYSIOL, V193, P319, DOI 10.1002/jcp.10180
   Murrell GAC, 1996, J BONE JOINT SURG AM, V78A, P265, DOI 10.2106/00004623-199602000-00014
   Natoli RM, 2009, TISSUE ENG PT A, V15, P3119, DOI [10.1089/ten.tea.2008.0478, 10.1089/ten.TEA.2008.0478]
   Nottle MB, 2002, XENOTRANSPLANTATION, V9, P305, DOI 10.1034/j.1399-3089.2002.t01-1-02036.x
   Novotny JE, 2006, TISSUE ENG, V12, P2755, DOI 10.1089/ten.2006.12.2755
   Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795
   PARKKINEN JJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P458, DOI 10.1006/abbi.1993.1062
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   SAKURAI H, 1995, J CLIN INVEST, V96, P2357, DOI 10.1172/JCI118292
   Sironen R, 2000, BIORHEOLOGY, V37, P85
   STOCKWELL RA, 1971, J ANAT, V109, P411
   Toyoda T, 2003, BIORHEOLOGY, V40, P79
   Waldman SD, 2003, J ORTHOPAED RES, V21, P590, DOI 10.1016/S0736-0266(03)00009-3
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   WONG M, 1990, BONE, V11, P127, DOI 10.1016/8756-3282(90)90060-C
   WONG M, 1988, J BONE JOINT SURG AM, V70A, P992, DOI 10.2106/00004623-198870070-00006
NR 41
TC 14
Z9 15
U1 2
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1947-6035
EI 1947-6043
J9 CARTILAGE
JI Cartilage
PD JUL
PY 2011
VL 2
IS 3
BP 254
EP 264
DI 10.1177/1947603510383686
PG 11
WC Orthopedics
SC Orthopedics
GA V36NC
UT WOS:000209217500005
PM 26069584
OA Green Published
DA 2018-10-20
ER

PT J
AU Salahshoor, M
   Guo, YB
AF Salahshoor, M.
   Guo, Y. B.
TI Cutting mechanics in high speed dry machining of biomedical
   magnesium-calcium alloy using internal state variable plasticity model
SO INTERNATIONAL JOURNAL OF MACHINE TOOLS & MANUFACTURE
LA English
DT Article
DE High speed dry cutting; Biomaterial; Magnesium alloy; Mechanical
   behavior; FEA
ID SURFACE
AB Magnesium-Calcium (MgCa) alloys become attractive orthopedic biomaterials due to their biodegradability, biocompatibility, and congruent mechanical properties with bone tissues. However, process mechanics of cutting biomedical MgCa alloys is poorly understood. Mechanical properties of the biomedical magnesium alloy at high strain rates and large strains are determined using the split-Hopkinson pressure bar testing method. Internal state variable (ISV) plasticity model is implemented to model the material behavior under cutting regimes. A finite element analysis (FEA) model has been developed to study the chip formation during high speed dry cutting of MgCa0.8 (wt%) alloy. Continuous chip formation predicted by finite element simulation is verified by high speed dry face milling of MgCa0.8 using polycrystalline diamond (PCD) inserts. Chip ignition as the most hazardous aspect in machining Mg alloys does not occur in high-speed dry cutting with sharp PCD tools. The predicted temperature distribution well explains the reason for the absence of chip ignition in high speed dry cutting of MgCa0.8 alloy. In addition, sporadic surface deterioration and void marks on the back face of chips are explained. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Salahshoor, M.; Guo, Y. B.] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
RP Guo, YB (reprint author), Univ Alabama, Dept Mech Engn, Tuscaloosa, AL 35487 USA.
EM yguo@eng.ua.edu
FU National Science Foundation [CMMI-1000706]
FX This research is based upon the work supported by the National Science
   Foundation under Grant no. CMMI-1000706.
CR Bammann D. J., 1996, THEORETICAL APPL MEC, P359
   BLACK JT, 2000, ASM HDB MACHINING, V16, P5
   Byrne G, 2003, CIRP ANN-MANUF TECHN, V52, P483, DOI 10.1016/S0007-8506(07)60200-5
   Danilenko B.D., 2009, RUSS ENG RES, V29, P316
   DAVIES EDH, 1963, J MECH PHYS SOLIDS, V11, P155, DOI 10.1016/0022-5096(63)90050-4
   Denkena B, 2007, CIRP ANN-MANUF TECHN, V56, P113, DOI 10.1016/j.cirp.2007.05.029
   Denkena B, 2007, P 7 INT C MG ALL THE, P895
   Denkena B, 2005, P 5 EUSP INT C MONTP
   Fang FZ, 2005, J MATER PROCESS TECH, V167, P119, DOI 10.1016/j.jmatprotec.2004.10.002
   Friemuth T, 1999, ADV ENG MATER, V1, P183, DOI 10.1002/(SICI)1527-2648(199912)1:3/4<183::AID-ADEM183>3.3.CO;2-M
   Gama B, 2004, APPL MECH REV, V57, P223, DOI DOI 10.1115/1.1704626
   Gefen A, 2002, MED BIOL ENG COMPUT, V40, P311, DOI 10.1007/BF02344213
   Gray GT, 2000, MECH TESTING EVALUAT, V8, P462, DOI DOI 10.1361/ASMHBA0003296
   Guo YB, 2010, CIRP ANN-MANUF TECHN, V59, P151, DOI 10.1016/j.cirp.2010.03.051
   Guo YB, 2005, INT J MECH SCI, V47, P1423, DOI 10.1016/j.ijmecsci.2005.04.015
   Guo YB, 2002, J MANUF SCI E-T ASME, V124, P189, DOI 10.1115/1.1430678
   Hallum D, 1995, AM MACH, V139, P48
   KALPAKJIAN S, 2001, MANUFACTURING ENG TE, P537
   Lathrop J. F., 1996, SAND978218 SANDIA LA
   Massalski T. B., 1990, BINARY ALLOY PHASE D, p[927, 2528]
   Merchant M.E., 1945, Journal of Applied Physics, V16, P267, DOI 10.1063/1.1707586
   Pedersen W, 2006, J MATER PROCESS TECH, V172, P417, DOI 10.1016/j.jmatprotec.2005.07.016
   Salahshoor M, 2009, INT J MACH TOOL MANU, V49, P1136, DOI 10.1016/j.ijmachtools.2009.07.016
   Salahshoor M., 2010, P ASME INT MAN SCI E
   Salahshoor M, 2009, P ASM MPMD MAT PROC
   Sanz C, 2007, P 7 INT C MG ALL THE, P916
   Schmidt J., 1998, ALUMINIUM, V74, P412
   Schwerin R, 2007, P 7 INT C MG ALL THE, P922
   Shaw M.C., 1984, METAL CUTTING PRINCI, P18
   Tomac N., 1991, ANN CIRP, V40, P79
   Tonshoff HK, 1997, SURF COAT TECH, V94-5, P610, DOI 10.1016/S0257-8972(97)00505-7
   Tonshoff HK, 1999, MATERIALWISS WERKST, V30, P401
   TONSHOFF HK, 1999, MG ALLOYS APPL, P406
   TRENT EM, 2000, METAL CUTTING, P12
   Videm M, 1994, SAE T, V103, P213
   Von Der Hoh N, 2009, ADV ENG MATER, V11, pB47, DOI 10.1002/adem.200800273
NR 36
TC 14
Z9 15
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0890-6955
J9 INT J MACH TOOL MANU
JI Int. J. Mach. Tools Manuf.
PD JUL-AUG
PY 2011
VL 51
IS 7-8
BP 579
EP 590
DI 10.1016/j.ijmachtools.2011.04.004
PG 12
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 787EY
UT WOS:000292360600002
DA 2018-10-20
ER

PT J
AU Mukherjee, S
   Gualandi, C
   Focarete, ML
   Ravichandran, R
   Venugopal, JR
   Raghunath, M
   Ramakrishna, S
AF Mukherjee, Shayanti
   Gualandi, Chiara
   Focarete, Maria Letizia
   Ravichandran, Rajeswari
   Venugopal, Jayarama Reddy
   Raghunath, Michael
   Ramakrishna, Seeram
TI Elastomeric electrospun scaffolds of poly(l-lactide-co-trimethylene
   carbonate) for myocardial tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CARDIAC STEM-CELLS; HEART-TISSUE; 1,3-TRIMETHYLENE CARBONATE; IN-VITRO;
   POLY(1,3-TRIMETHYLENE CARBONATE); POLYURETHANE SCAFFOLDS;
   VENTRICULAR-FUNCTION; CARDIOMYOCYTES; D,L-LACTIDE; EXPRESSION
AB In myocardial tissue engineering the use of synthetically bioengineered flexible patches implanted in the infarcted area is considered one of the promising strategy for cardiac repair. In this work the potentialities of a biomimetic electrospun scaffold made of a commercial copolymer of (l)-lactic acid with trimethylene carbonate (P(l)LA-co-TMC) are investigated in comparison to electrospun poly(l)lactic acid. The P(l)LA-co-TMC scaffold used in this work is a glassy rigid material at room temperature while it is a rubbery soft material at 37A degrees C. Mechanical characterization results (tensile stress-strain and creep-recovery measurements) show that at 37A degrees C electrospun P(l)LA-co-TMC displays an elastic modulus of around 20 MPa and the ability to completely recover up to 10% of deformation. Cell culture experiments show that P(l)LA-co-TMC scaffold promotes cardiomyocyte proliferation and efficiently preserve cell morphology, without hampering expression of sarcomeric alpha actinin marker, thus demonstrating its potentialities as synthetic biomaterial for myocardial tissue engineering.
C1 [Gualandi, Chiara; Focarete, Maria Letizia] Univ Bologna, Dept Chem G Ciamician, Bologna, Italy.
   [Gualandi, Chiara; Focarete, Maria Letizia] Univ Bologna, Natl Consortium Mat Sci & Technol INSTM Bologna R, Bologna, Italy.
   [Mukherjee, Shayanti; Raghunath, Michael] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.
   [Mukherjee, Shayanti; Ravichandran, Rajeswari; Venugopal, Jayarama Reddy; Ramakrishna, Seeram] Natl Univ Singapore, Nanosci & Nanotechnol Initiat, HEM Lab, Singapore 117548, Singapore.
   [Ravichandran, Rajeswari; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
   [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.
RP Focarete, ML (reprint author), Univ Bologna, Dept Chem G Ciamician, Bologna, Italy.
EM marialetizia.focarete@unibo.it
RI Focarete, Maria Letizia/B-2369-2009; gualandi, chiara/A-5935-2015;
   Ravichandran, Rajeswari/C-9313-2012; Raghunath, Michael/E-6483-2010
OI Focarete, Maria Letizia/0000-0002-0458-7836; gualandi,
   chiara/0000-0002-2020-1892; Raghunath, Michael/0000-0002-2138-6614;
   Jayarama Reddy, Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-063-592]; Division of Bioengineering,
   Nanoscience and Nanotechnology Initiative (National University of
   Singapore); Italian Ministry of University and Research; Spinner
   Consortium of Regione Emilia Romagna (Italy)
FX The authors gratefully acknowledge the NRF-Technion (Grant No.:
   R-398-001-063-592), Division of Bioengineering, Nanoscience and
   Nanotechnology Initiative (National University of Singapore) and Italian
   Ministry of University and Research for the financial support. C.G. is
   the recipient of a fellowship awarded from the Spinner Consortium of
   Regione Emilia Romagna (Italy).
CR AKHYARI P, 2002, CIRCULATION S1, V106, P137
   Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Amir G, 2009, CELL TRANSPLANT, V18, P275, DOI 10.3727/096368909788534898
   ANDRONOVA N, 2006, BIOMACROMOLECULES, V7, P1495
   Ayelet D., 2002, BIOTECHNOL BIOENG, V80, P305
   Bat E, 2011, ACTA BIOMATER, V7, P1939, DOI 10.1016/j.actbio.2011.01.010
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   Bruggeman JP, 2008, BIOMATERIALS, V29, P4726, DOI 10.1016/j.biomaterials.2008.08.037
   BUCHHOLZ B, 1993, J MATER SCI-MATER M, V4, P381, DOI 10.1007/BF00122196
   Bursac N., 1999, AM J PHYSIOL, V277, P433
   Cabello N, 2007, J BIOL CHEM, V282, P12143, DOI 10.1074/jbc.M608880200
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chiu LLY, 2010, MACROMOL BIOSCI, V10, P1286, DOI 10.1002/mabi.201000202
   Du AP, 2003, DEV BIOL, V257, P382, DOI 10.1016/S0012-1606(03)00104-0
   ESCHENHAGEN T, 2002, BASIC RES CARDIOL S1, V97, P146, DOI DOI 10.1007/S003950200043
   Focarete ML, 2009, NANOTECHNOL SCI TECH, P19
   Giraud MN, 2010, ARTIF ORGANS, V34, pE184, DOI 10.1111/j.1525-1594.2009.00979.x
   Gupta B, 2007, PROG POLYM SCI, V32, P455, DOI 10.1016/j.progpolymsci.2007.01.005
   Hosseinkhani H, 2010, J BIOMED MATER RES A, V94A, P1, DOI 10.1002/jbm.a.32676
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Kao Race L, 2009, Asian Cardiovasc Thorac Ann, V17, P89, DOI 10.1177/0218492309104144
   Ke Qingen, 2005, Shengli Xuebao, V57, P673
   Kellar RS, 2001, CIRCULATION, V104, P2063, DOI 10.1161/hc4201.097192
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kong HJ, 2004, BIOMACROMOLECULES, V5, P1720, DOI 10.1021/bm049879r
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Leor J, 2000, CIRCULATION, V102, P56
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Lu JW, 2008, MACROMOLECULES, V41, P3762, DOI 10.1021/ma702881k
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Martinez Eliana C, 2009, Expert Rev Cardiovasc Ther, V7, P921, DOI 10.1586/erc.09.81
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Mukherjee S, 2010, J MATER CHEM, V20, P8819, DOI 10.1039/c0jm00805b
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Ozawa T., 2002, CIRCULATION S1, V106, P1176
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2003, J CONTROL RELEASE, V87, P69, DOI 10.1016/S0168-3659(02)00351-6
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Pego AP, 2003, J MATER SCI-MATER M, V14, P767, DOI 10.1023/A:1025084304766
   PETER P, 2009, BIOMACROMOLECULES, V10, P1259
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008
   Serrano MC, 2010, ADV FUNCT MATER, V20, P192, DOI 10.1002/adfm.200901040
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Siepe M, 2007, ARTIF ORGANS, V31, P425, DOI 10.1111/j.1525-1594.2007.00385.x
   Song Y, 2010, ACTA BIOMATER, V6, P1269, DOI 10.1016/j.actbio.2009.10.002
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Tyson T, 2009, BIOMACROMOLECULES, V10, P149, DOI 10.1021/bm801052m
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wei X, 2009, INT J EXP COMP BIOME, V1, P45, DOI DOI 10.1504/IJECB.2009.022858
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   You ZW, 2010, BIOMATERIALS, V31, P3129, DOI 10.1016/j.biomaterials.2010.01.023
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
   Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 60
TC 27
Z9 28
U1 0
U2 40
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2011
VL 22
IS 7
BP 1689
EP 1699
DI 10.1007/s10856-011-4351-2
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 786GA
UT WOS:000292290200009
PM 21617996
DA 2018-10-20
ER

PT J
AU Struillou, X
   Boutigny, H
   Badran, Z
   Fellah, BH
   Gauthier, O
   Sourice, S
   Pilet, P
   Rouillon, T
   Layrolle, P
   Weiss, P
   Soueidan, A
AF Struillou, Xavier
   Boutigny, Herve
   Badran, Zahi
   Fellah, Borhane H.
   Gauthier, Olivier
   Sourice, Sophie
   Pilet, Paul
   Rouillon, Thierry
   Layrolle, Pierre
   Weiss, Pierre
   Soueidan, Assem
TI Treatment of periodontal defects in dogs using an injectable composite
   hydrogel/biphasic calcium phosphate
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID GUIDED TISSUE REGENERATION; BETA-TRICALCIUM PHOSPHATE;
   ENAMEL-MATRIX-PROTEINS; BONE-MARROW GRAFT; HYDROXYPROPYL
   METHYLCELLULOSE; GENERAL-PROPERTIES; CLINICAL-TRIAL; SUBSTITUTE;
   RECONSTRUCTION; SCAFFOLD
AB An injectable composite silanized hydroxypropyl methyl cellulose/biphasic calcium phosphate (Si-HPMC/BCP) has been investigated in humans with promising results. The aim of this study was to evaluate his efficacy for treating periodontal defects (canine fenestration and premolar furcation) in dog models. At 3 months, we observed that bone formation around BCP particles in furcation model is more discernible but not statistically significant in defects filled with Si-HPMC/BCP compared to healing in control. We suggest that BCP particles sustain the bone healing process by osteoconduction, while the Si-HPMC hydrogel enhances intergranular cohesion and acts as an exclusion barrier. Furthermore, bone ingrowth is not so distinctive in superficial defects where the biomaterial appears unstable. These results with Si-HPMC/BCP are encouraging. In addition, this biomaterial is easy to use and simplifies the process of filling periodontal lesions. However, more researches are needed to improve the viscosity and hardness to adjust the material to the specificities of periodontal defects.
C1 [Struillou, Xavier; Badran, Zahi; Sourice, Sophie; Pilet, Paul; Rouillon, Thierry; Weiss, Pierre; Soueidan, Assem] Univ Nantes, Fac Dent Surg, Lab Osteoarticular & Dent Tissue Engn LIOAD, INSERM,U791, F-44042 Nantes, France.
   [Boutigny, Herve; Badran, Zahi; Soueidan, Assem] Univ Nantes, Fac Dent Surg, Dept Periodontol, F-44042 Nantes, France.
   [Fellah, Borhane H.; Gauthier, Olivier] Natl Vet Sch Nantes, F-44307 Nantes, France.
   [Soueidan, Assem] Univ Nantes, ERT 2004, F-44042 Nantes, France.
   [Layrolle, Pierre] Univ Nantes, Fac Med, LPRO, INSERM,U957, F-44042 Nantes, France.
RP Weiss, P (reprint author), Univ Nantes, Fac Dent Surg, Lab Osteoarticular & Dent Tissue Engn LIOAD, INSERM,U791, 1 Pl Alexis Ricordeau,BP 84215, F-44042 Nantes, France.
EM pierre.weiss@univ-nantes.fr
RI FELLAH, Borhane/L-6266-2015; Paul, Pilet/A-3755-2015; Rouillon,
   Thierry/P-1587-2014; struillou, xavier/P-2800-2014; Badran,
   Zahi/A-4307-2015; Gauthier, Olivier/A-4639-2015; Layrolle,
   Pierre/K-9257-2015; Soueidan, Assem/P-1781-2014; Weiss,
   Pierre/P-1372-2014
OI Badran, Zahi/0000-0003-2592-4333; Layrolle, Pierre/0000-0001-9800-5210;
   Weiss, Pierre/0000-0002-6159-8590
CR AlGhamdi Ali Saad, 2010, J Int Acad Periodontol, V12, P39
   AlGhamdi Ali Saad, 2010, J Int Acad Periodontol, V12, P34
   Bodde EWH, 2007, J BIOMED MATER RES A, V82A, P711, DOI 10.1002/bjm.a.30990
   Boix D, 2006, J MATER SCI-MATER M, V17, P1145, DOI 10.1007/s10856-006-0542-7
   Bourges X, 2002, BIOPOLYMERS, V63, P232, DOI 10.1002/bip.10053
   Bourges X, 2002, ADV COLLOID INTERFAC, V99, P215, DOI 10.1016/S0001-8686(02)00035-0
   Bourges X, 2001, J BIOMAT SCI-POLYM E, V12, P573, DOI 10.1163/156856201316883412
   Cordaro L, 2008, CLIN ORAL IMPLAN RES, V19, P796, DOI 10.1111/j.1600-0501.2008.01565.x
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   Daculsi G, 2010, J MATER SCI-MATER M, V21, P855, DOI 10.1007/s10856-009-3914-y
   Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051
   Fatimi A, 2008, BIOMATERIALS, V29, P533, DOI 10.1016/j.biomaterials.2007.10.032
   Fellah BH, 2006, J ORTHOP RES, V24, P628, DOI 10.1002/jor.20125
   Friedmann A, 2009, CLIN ORAL IMPLAN RES, V20, P708, DOI 10.1111/j.1600-0501.2009.01708.x
   Froum SJ, 2008, INT J PERIODONT REST, V28, P273
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P669, DOI 10.1111/j.1600-051X.1997.tb00248.x
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x
   HASHIMOTOUOSHIMA M, 1995, INT J PERIODONT REST, V15, P205
   Jegoux F, 2010, ARCH OTOLARYNGOL, V136, P971, DOI 10.1001/archoto.2010.173
   Kawase T, 2010, J PERIODONTOL, V81, P420, DOI 10.1902/jop.2009.090523
   LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g
   Lerouxel E, 2006, BIOMATERIALS, V27, P4566, DOI 10.1016/j.biomaterials.2006.04.027
   Malard O, 2005, BONE, V36, P323, DOI 10.1016/j.bone.2004.07.018
   Miranda LA, 2006, ACTA ODONTOL SCAND, V64, P37, DOI 10.1080/00016350500367520
   Nasr HF, 1999, PERIODONTOL 2000, V19, P74, DOI 10.1111/j.1600-0757.1999.tb00148.x
   NERY EB, 1992, J PERIODONTOL, V63, P729, DOI 10.1902/jop.1992.63.9.729
   Pandit Nymphea, 2010, J Contemp Dent Pract, V11, P025
   Schmitt M, 2002, BIOMATERIALS, V23, P2789, DOI 10.1016/S0142-9612(02)00015-7
   Sculean A, 2000, Clin Oral Investig, V4, P50, DOI 10.1007/s007840050113
   Sculean A, 2000, J CLIN PERIODONTOL, V27, P466, DOI 10.1034/j.1600-051x.2000.027007466.x
   Sculean A, 2008, J PERIODONTOL, V79, P1991, DOI 10.1902/jop.2008.080009 
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   SOUCACOS PN, 2008, INJURY S2, V39, pS1, DOI DOI 10.1016/S0020-1383(08)70009-3
   Struillou X, 2010, OPEN DENT J, V4, P37, DOI 10.2174/1874210601004010037
   Tatakis DN, 1999, PERIODONTOL 2000, V19, P59, DOI 10.1111/j.1600-0757.1999.tb00147.x
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   Turczyn R, 2000, J BIOMAT SCI-POLYM E, V11, P217, DOI 10.1163/156856200743661
   Vinatier C, 2006, BIO-MED MATER ENG, V16, pS107
   Vinatier C, 2005, BIOMATERIALS, V26, P6643, DOI 10.1016/j.biomaterials.2005.04.057
   Weiss P, 2007, BIOMATERIALS, V28, P3295, DOI 10.1016/j.biomaterials.2007.04.006
   Wikesjo UME, 1999, PERIODONTOL 2000, V19, P21, DOI 10.1111/j.1600-0757.1999.tb00145.x
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
NR 42
TC 18
Z9 19
U1 1
U2 31
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2011
VL 22
IS 7
BP 1707
EP 1717
DI 10.1007/s10856-011-4344-1
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 786GA
UT WOS:000292290200011
PM 21611794
DA 2018-10-20
ER

PT J
AU Numata, K
   Doi, Y
AF Numata, Keiji
   Doi, Yoshiharu
TI Dual biosyntheses of poly[(R)-3-hydroxybutyric acid] and silk protein
   for the fabrication of biofunctional bioplastic
SO POLYMER JOURNAL
LA English
DT Article
DE biomaterial; poly[(R)-3-hydroxybutyric acid]; silk protein
ID PHA GRANULE FORMATION; BETA-SHEET CRYSTALS; ENZYMATIC DEGRADATION;
   DRAGLINE SILK; FIBROIN; CLONING; GENE; EXPRESSION
AB This is the first report on dual synthesis of poly[(R)-3-hydroxybutyric acid] (PHB) and protein polymer by recombinant microorganisms for use in the fabrication of a biofunctional PHB-based material hybridized with functional proteins. PHB and recombinant silk protein, a model protein developed in this study, were synthesized by a recombinant Escherichia coli system, and then films of PHB hybridized with the silk protein (PHB/Silk) were prepared. The presence of the silk protein in the amorphous phase of the PHB/Silk film was demonstrated based on wide-angle X-ray diffraction and differential scanning calorimetry measurements, which also revealed the enhanced tensile strength and elongation at break of the PHB/Silk film. The cell adhesion of human mesenchymal stem cells (hMSCs) for the PHB/Silk film increased because of the addition of silk molecules to the film. This might have been because the silk molecules existed in the amorphous phase at the surface of the PHB/Silk films, and were exposed to hMSCs. The overall results illustrate the potential of this dual synthesis system as a versatile and useful platform method for preparation of biofunctional PHB-based materials, especially for biomedical applications. Polymer Journal (2011) 43, 642-647; doi:10.1038/pj.2011.27; published online 27 April 2011
C1 [Numata, Keiji] RIKEN, Biomass Engn Program, Enzyme Res Team, Wako, Saitama 3510198, Japan.
   [Doi, Yoshiharu] RIKEN, RIKEN Res Cluster Innovat, Saitama, Japan.
RP Numata, K (reprint author), RIKEN, Biomass Engn Program, Enzyme Res Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.
EM keiji.numata@riken.jp
RI Numata, Keiji/H-9751-2012
OI Numata, Keiji/0000-0003-2199-7420
FU RIKEN
FX This work was supported by a grant for the RIKEN Biomass Engineering
   Program.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2009, CHEM SOC REV, V38, P2434, DOI 10.1039/b812677c
   DOI Y, 2001, POLYESTERS 1 2, V3
   Doi Y., 1990, MICROBIAL POLYESTERS
   Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Jurasek L, 2004, APPL MICROBIOL BIOT, V64, P611, DOI 10.1007/s00253-003-1551-9
   Kaplan DL, 2002, ADV DRUG DELIV REV, V54, P1131, DOI DOI 10.1016/S0169-409X(02)00061-3
   Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/NMAT2704, 10.1038/nmat2704]
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Koyama N, 1997, MACROMOLECULES, V30, P826, DOI 10.1021/ma961195r
   Lenz RW, 2005, BIOMACROMOLECULES, V6, P1, DOI 10.1021/bm049700c
   Martin D. P., 1999, US Patent Appl, Patent No. 359086
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   MITA K, 1994, J MOL EVOL, V38, P583
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Numata K, 2011, MACROMOL BIOSCI, V11, P60, DOI 10.1002/mabi.201000250
   Numata K, 2010, BIOMACROMOLECULES, V11, P3189, DOI 10.1021/bm101055m
   Numata K, 2010, J CONTROL RELEASE, V146, P136, DOI 10.1016/j.jconrel.2010.05.006
   Numata K, 2010, BIOCHEMISTRY-US, V49, P3254, DOI 10.1021/bi902134p
   Numata K, 2010, BIOMATERIALS, V31, P2926, DOI 10.1016/j.biomaterials.2009.12.026
   Numata K, 2009, BIOMATERIALS, V30, P5775, DOI 10.1016/j.biomaterials.2009.06.028
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Peters V, 2005, FEMS MICROBIOL LETT, V248, P93, DOI 10.1016/j.femsle.2005.05.027
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Taguchi S, 2001, FEMS MICROBIOL LETT, V198, P65, DOI 10.1111/j.1574-6968.2001.tb10620.x
   VONK CG, 1973, J APPL CRYSTALLOGR, V6, P148, DOI 10.1107/S0021889873008332
   Williams S. F., 2000, US Patent Appl, Patent No. 661948
NR 34
TC 5
Z9 5
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0032-3896
J9 POLYM J
JI Polym. J.
PD JUL
PY 2011
VL 43
IS 7
BP 642
EP 647
DI 10.1038/pj.2011.27
PG 6
WC Polymer Science
SC Polymer Science
GA 787LK
UT WOS:000292377500009
OA Bronze
DA 2018-10-20
ER

PT J
AU Rathna, GVN
   Jog, JP
   Gaikwad, AB
AF Rathna, Gundloori Venkata Naga
   Jog, Jyoti Prakash
   Gaikwad, Anil Bhikaji
TI Development of non-woven nanofibers of egg albumen-poly (vinyl alcohol)
   blends: influence of solution properties on morphology of nanofibers
SO POLYMER JOURNAL
LA English
DT Article
DE biocompatibility; biodegradable; blends; nanotechnology; proteins
ID POLYVINYL-ALCOHOL; POLY(VINYL ALCOHOL); FIBER FORMATION; GOOD SOLVENT;
   FORMIC-ACID; PROTEIN; FILMS; COMPOSITE; MEMBRANES; WHITE
AB Egg albumen (EA), a highly functional globular protein with desirable properties, is the least-explored material for biomaterial applications, although it is available in abundance. In our studies, we explored the viability of EA and various blends with biocompatible and non-toxic poly (vinyl alcohol) (PVA) to produce nanofibers for biomedical applications. EA and PVA blends were prepared in various compositions. Electrospinning was used to fabricate non-woven nanofibers. Solution properties, such as viscosity and electrical conductivity, were evaluated for various prepared solutions. Solution viscosity increased with increasing polymer concentration. Solutions with higher contents of EA recorded increased conductivity, which decreased with increasing PVA content. The influence of solution properties on the morphological appearance of as-spun products was studied using scanning electron microscopy. Instead of nanofibers, nanoparticles and microparticles of EA were produced at even higher contents. In contrast, a gradual increase in the addition of PVA content to 8% EA solution resulted in the transformation of particles from large agglomerates to very fine fibers (approximate to 100nm in diameter) because of the influence of polymer content, viscosity and conductivity. The polymer-polymer interactions in the prepared materials have been validated by Fourier transform infrared spectroscopy, differential scanning calorimetry, X-ray diffraction and gel electrophoresis. Polymer Journal (2011) 43, 654-661; doi:10.1038/pj.2011.34; published online 18 May 2011
C1 [Rathna, Gundloori Venkata Naga; Gaikwad, Anil Bhikaji] Natl Chem Lab, Ctr Mat Characterizat, Pune 411008, Maharashtra, India.
RP Rathna, GVN (reprint author), Natl Chem Lab, Ctr Mat Characterizat, Homi Bhabha Rd, Pune 411008, Maharashtra, India.
EM rv.gundloori@ncl.res.in
CR ADITYA MK, 2008, MOL PHARM, V5, P937
   Bongnitzki M., 2001, ADV MATER, V13, P70
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Caner C, 1998, J FOOD SCI, V63, P1049, DOI 10.1111/j.1365-2621.1998.tb15852.x
   CHANDRA MV, 2009, BIOMACROMOLECULES, V10, P1084
   Chen HC, 2009, POLYM ADVAN TECHNOL, V20, P98, DOI 10.1002/pat.1244
   DeMerlis CC, 2003, FOOD CHEM TOXICOL, V41, P319, DOI 10.1016/S0278-6915(02)00258-2
   Dong J, 2010, POLYMER, V51, P3164, DOI 10.1016/j.polymer.2010.04.058
   George L, 2004, SPECTROCHIM ACTA A, V60, P3225, DOI 10.1016/j.saa.2004.03.004
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Hong KH, 2006, J POLYM SCI POL PHYS, V44, P2468, DOI 10.1002/polb.20913
   Hong YL, 2006, J MEMBRANE SCI, V276, P1, DOI 10.1016/j.memsci.2005.09.024
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   HUANG L, 2000, MACROMOLECULES, V13, P70
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Jiang QR, 2010, ACTA BIOMATER, V6, P4042, DOI 10.1016/j.actbio.2010.04.024
   Ki CS, 2005, POLYMER, V46, P5094, DOI 10.1016/j.polymer.2005.04.040
   Kim SE, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044106
   KINSELLA JE, 1985, RELATIONSHIP STRUCTU, P51
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Lu GH, 1999, J FOOD ENG, V42, P147, DOI 10.1016/S0260-8774(99)00112-0
   MARTIN DC, 1997, PROTEIN BASED MAT
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mishra S, 2008, MICROSYST TECHNOL, V14, P193, DOI 10.1007/s00542-007-0427-9
   Naebe M, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/30/305702
   NAUANCHAN C, 2007, POLYM J, V39, P622
   Pal K, 2007, AAPS PHARMSCITECH, V8
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Rathna GVN, 2004, POLYM INT, V53, P1994, DOI 10.1002/pi.1611
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   Safi S, 2007, J APPL POLYM SCI, V104, P3245, DOI 10.1002/app.25696
   Shao CL, 2003, MATER LETT, V57, P1579, DOI 10.1016/S0167-577X(02)01036-4
   Shenoy SL, 2005, POLYMER, V46, P3372, DOI 10.1016/j.polymer.2005.03.011
   SONA WK, 2004, POLYMER, V45, P2959
   Sudhamani SR, 2003, FOOD HYDROCOLLOID, V17, P245, DOI 10.1016/S0268-005X(02)00057-7
   Vega-Lugo AC, 2008, J BIOBASED MATER BIO, V2, P223, DOI 10.1166/jbmb.2008.408
   Woerdeman DL, 2005, BIOMACROMOLECULES, V6, P707, DOI 10.1021/bm0494545
   Wongsasulak S, 2007, POLYMER, V48, P448, DOI 10.1016/j.polymer.2006.11.025
   YOUNG JL, 2007, J APPL POLYM SCI, V106, P1337
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
   Zoccola M, 2008, BIOMACROMOLECULES, V9, P2819, DOI 10.1021/bm800579a
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 43
TC 13
Z9 13
U1 2
U2 26
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0032-3896
EI 1349-0540
J9 POLYM J
JI Polym. J.
PD JUL
PY 2011
VL 43
IS 7
BP 654
EP 661
DI 10.1038/pj.2011.34
PG 8
WC Polymer Science
SC Polymer Science
GA 787LK
UT WOS:000292377500011
OA Bronze
DA 2018-10-20
ER

PT J
AU Monteiro, GA
   Fernandes, AV
   Sundararaghavan, HG
   Shreiber, DI
AF Monteiro, Gary A.
   Fernandes, Anthony V.
   Sundararaghavan, Harini G.
   Shreiber, David I.
TI Positively and Negatively Modulating Cell Adhesion to Type I Collagen
   Via Peptide Grafting
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID SMOOTH-MUSCLE-CELLS; ARG-GLY-ASP; EXTRACELLULAR-MATRIX; GROWTH-FACTOR;
   MECHANICAL-PROPERTIES; INTEGRIN EXPRESSION; SIGNAL-TRANSDUCTION;
   MIGRATION SPEED; FIBROBLASTS; MOTILITY
AB The biophysical interactions between cells and type I collagen are controlled by the level of cell adhesion, which is dictated primarily by the density of ligands on collagen and the density of integrin receptors on cells. The native adhesivity of collagen was modulated by covalently grafting glycine-arginine-glycine-aspartic acid-serine (GRGDS), which includes the bioactive RGD sequence, or glycine-arginine-aspartic acid-glycine-serine (GRDGS), which includes the scrambled RDG sequence, to collagen with the hetero-bifunctional coupling agent 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide. The peptide-grafted collagen self-assembled into a fibrillar gel with negligible changes in gel structure and rheology. Rat dermal fibroblasts (RDFs) and human smooth muscle cells demonstrated increased levels of adhesion on gels prepared from RGD-grafted collagen, and decreased levels of adhesion on RDG-grafted collagen. Both cell types demonstrated an increased ability to compact free-floating RGD-grafted collagen gels, and an impaired ability to compact RDG-grafted gels. RDF migration on and within collagen was increased with RDG-grafted collagen and decreased with RGD-grafted collagen, and dose-response experiments indicated a biphasic response of RDF migration to adhesion. Smooth muscle cells demonstrated similar, though not statistically significant, trends. The ability to both positively and negatively modulate cell adhesion to collagen increases the versatility of this natural biomaterial for regenerative therapies.
C1 [Monteiro, Gary A.; Sundararaghavan, Harini G.; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Fernandes, Anthony V.] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ 08854 USA.
RP Shreiber, DI (reprint author), Rutgers State Univ, Dept Biomed Engn, 599 Taylor Rd, Piscataway, NJ 08854 USA.
EM shreiber@rci.rutgers.edu
OI Shreiber, David/0000-0001-8248-419X
FU New Jersey Commission on Spinal Cord Research [03-3028-SCR-E-0,
   05-2907-SCR-E-0]; Paralyzed Veterans of America Research Foundation
   [2401]; Charles and Johanna Busch Biomedical Research Foundation; NIH
   [1R21EB009245-01A1]; NSF (DGE IGERT) [0801620, 0333196]
FX The preliminary efforts of Minjung Song, Kathryn Uhrich, and Vikram
   Munikoti are greatly appreciated. This research was supported by grants
   from the New Jersey Commission on Spinal Cord Research (03-3028-SCR-E-0
   and 05-2907-SCR-E-0), the Paralyzed Veterans of America Research
   Foundation (#2401), the Charles and Johanna Busch Biomedical Research
   Foundation, the NIH (1R21EB009245-01A1), and the NSF (DGE IGERT 0801620
   (Stem Cell Science and Engineering) and 0333196 (Biointerfaces), PI: P.
   Moghe).
CR Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   BELL E, 1984, SCAN ELECTRON MICROS, P1957
   Beningo KA, 2004, P NATL ACAD SCI USA, V101, P18024, DOI 10.1073/pnas.0405747102
   Bet MR, 2003, BIOMATERIALS, V24, P131, DOI 10.1016/S0142-9612(02)00270-3
   Burgess BT, 2000, ANN BIOMED ENG, V28, P110, DOI 10.1114/1.259
   CARLSSON J, 1978, BIOCHEM J, V173, P723, DOI 10.1042/bj1730723
   Chen R, 2007, J MATER CHEM, V17, P3974, DOI 10.1039/b706765h
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726
   DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   DIMILLA PA, 1991, BIOPHYS J, V60, P15, DOI 10.1016/S0006-3495(91)82027-6
   DONALDSON DJ, 1988, J CELL SCI, V90, P325
   DUNN GA, 1987, J CELL SCI, P81
   Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   Fujimura T, 2007, J DERMATOL SCI, V45, P45, DOI 10.1016/j.jdermsci.2006.09.012
   Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313
   GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D
   Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029
   Hazgui S, 2005, AM J PHYSIOL-CELL PH, V289, pC1547, DOI 10.1152/ajpcell.00319.2005
   Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hsu SH, 2006, ARTIF ORGANS, V30, P42, DOI 10.1111/j.1525-1594.2006.00179.x
   HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637
   Iglesia DDS, 2000, J HISTOCHEM CYTOCHEM, V48, P363, DOI 10.1177/002215540004800306
   Jarvelainen H, 2004, ARTERIOSCL THROM VAS, V24, P67, DOI 10.1161/01.ATV.0000107026.98626.3b
   Kilarski WW, 2005, LAB INVEST, V85, P643, DOI 10.1038/labinvest.3700255
   Knapp DM, 1999, AICHE J, V45, P2628, DOI 10.1002/aic.690451219
   Knapp DM, 1999, EXP CELL RES, V247, P543, DOI 10.1006/excr.1998.4364
   Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35
   Kuntz RM, 1997, BIOPHYS J, V72, P1472, DOI 10.1016/S0006-3495(97)78793-9
   Lafrenie RM, 1996, J CELL BIOCHEM, V61, P543, DOI 10.1002/(SICI)1097-4644(19960616)61:4<543::AID-JCB7>3.0.CO;2-O
   Li XW, 2001, J CELL SCI, V114, P2665
   Li XW, 1998, INVAS METAST, V18, P1, DOI 10.1159/000024494
   Liu GZ, 2001, J CELL BIOCHEM, V83, P129, DOI 10.1002/jcb.1208
   Ljubimov AV, 2001, J HISTOCHEM CYTOCHEM, V49, P1341, DOI 10.1177/002215540104901102
   Mineur P, 2005, BBA-MOL CELL RES, V1746, P28, DOI 10.1016/j.bbamcr.2005.07.004
   Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X
   Myles JL, 2000, J BIOMAT SCI-POLYM E, V11, P69, DOI 10.1163/156856200743508
   Ogle BM, 1999, TISSUE ENG, V5, P387, DOI 10.1089/ten.1999.5.387
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Park KH, 2005, BIOTECHNOL LETT, V27, P227, DOI 10.1007/s10529-004-8297-z
   Reyes CD, 2008, J CELL PHYSIOL, V217, P450, DOI 10.1002/jcp.21512
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schor SL, 1999, J CELL SCI, V112, P3879
   Shreiber DI, 2001, EXP CELL RES, V266, P155, DOI 10.1006/excr.2001.5208
   Shreiber DI, 2003, BIOPHYS J, V84, P4102, DOI 10.1016/S0006-3495(03)75135-2
   Simova O, 2006, ANN NEUROL, V60, P430, DOI 10.1002/ana.20948
   Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   TAYLOR WR, 1993, EXP CELL RES, V204, P295, DOI 10.1006/excr.1993.1036
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662
   Wang R, 1998, J HISTOCHEM CYTOCHEM, V46, P119, DOI 10.1177/002215549804600115
   Wells A, 1999, CELL MOTIL CYTOSKEL, V44, P227, DOI 10.1002/(SICI)1097-0169(199912)44:4<227::AID-CM1>3.0.CO;2-B
   WU P, 1994, ANN BIOMED ENG, V22, P144, DOI 10.1007/BF02390372
   YAMADA KM, 1985, J CELL BIOCHEM, V28, P79, DOI 10.1002/jcb.240280202
   Yu XJ, 1999, TISSUE ENG, V5, P291, DOI 10.1089/ten.1999.5.291
   Zaman MH, 2005, BIOPHYS J, V89, P1389, DOI 10.1529/biophysj.105.060723
   Zaman MH, 2007, BIOPHYS J, V92, pL17, DOI 10.1529/biophysj.106.097519
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 63
TC 12
Z9 12
U1 1
U2 10
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUL
PY 2011
VL 17
IS 13-14
BP 1663
EP 1673
DI 10.1089/ten.tea.2008.0346
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 782PT
UT WOS:000292022300001
PM 19196133
OA Green Accepted, Green Published
DA 2018-10-20
ER

PT J
AU Correia, CR
   Moreira-Teixeira, LS
   Moroni, L
   Reis, RL
   van Blitterswijk, CA
   Karperien, M
   Mano, JF
AF Correia, Clara R.
   Moreira-Teixeira, Liliana S.
   Moroni, Lorenzo
   Reis, Rui L.
   van Blitterswijk, Clemens A.
   Karperien, Marcel
   Mano, Joao F.
TI Chitosan Scaffolds Containing Hyaluronic Acid for Cartilage Tissue
   Engineering
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID ARTICULAR-CARTILAGE; IN-VITRO; MECHANICAL-PROPERTIES; BIOMATERIAL;
   DEGRADATION; DERIVATIVES; HYDROGELS; LYSOZYME; DESIGN; MICROSPHERES
AB Scaffolds derived from natural polysaccharides are very promising in tissue engineering applications and regenerative medicine, as they resemble glycosaminoglycans in the extracellular matrix (ECM). In this study, we have prepared freeze-dried composite scaffolds of chitosan (CHT) and hyaluronic acid (HA) in different weight ratios containing either no HA (control) or 1%, 5%, or 10% of HA. We hypothesized that HA could enhance structural and biological properties of CHT scaffolds. To test this hypothesis, physicochemical and biological properties of CHT/HA scaffolds were evaluated. Scanning electron microscopy micrographs, mechanical properties, swelling tests, enzymatic degradation, and Fourier transform infrared (FTIR) chemical maps were performed. To test the ability of the CHT/HA scaffolds to support chondrocyte adhesion and proliferation, live-dead and MTT assays were performed. Results showed that CHT/HA composite scaffolds are noncytotoxic and promote cell adhesion. ECM formation was further evaluated with safranin-O and alcian blue staining methods, and glycosaminoglycan and DNA quantifications were performed. The incorporation of HA enhanced cartilage ECM production. CHT/5HA had a better pore network configuration and exhibited enhanced ECM cartilage formation. On the basis of our results, we believe that CHT/HA composite matrixes have potential use in cartilage repair.
C1 [Correia, Clara R.; Reis, Rui L.; Mano, Joao F.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 S Claudio Do Barco, Guimaraes, Portugal.
   [Correia, Clara R.; Reis, Rui L.; Mano, Joao F.] IBB, PT Associated Lab, Guimaraes, Portugal.
   [Moreira-Teixeira, Liliana S.; Moroni, Lorenzo; van Blitterswijk, Clemens A.; Karperien, Marcel] Univ Twente, Dept Tissue Regenerat, MIRA Inst Biomed Technol & Tech Med, NL-7500 AE Enschede, Netherlands.
RP Mano, JF (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 S Claudio Do Barco, Guimaraes, Portugal.
EM jmano@dep.uminho.pt
RI Moroni, Lorenzo/D-2826-2014; Correia, Clara/A-8824-2017; Group,
   3Bs/E-4374-2012; Reis, Rui L./A-8938-2008; Moreira Teixeira,
   Liliana/G-6293-2011; Mano, Joao/A-4418-2009
OI Moroni, Lorenzo/0000-0003-1298-6025; Correia, Clara/0000-0002-1559-6295;
   Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Mano,
   Joao/0000-0002-2342-3765; van Blitterswijk, Clemens/0000-0003-2371-4615;
   Moreira Teixeira, Liliana/0000-0001-5039-8369
CR Antunes JC, 2010, J BIOMED MATER RES A, V94A, P856, DOI 10.1002/jbm.a.32753
   Barry JJA, 2004, BIOMATERIALS, V25, P3559, DOI 10.1016/j.biomaterials.2003.10.023
   Bobic V, 2000, J BONE JOINT SURG BR, V82B, P165, DOI 10.1302/0301-620X.82B2 .10707
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen JP, 2009, POLYMER, V50, P107, DOI 10.1016/j.polymer.2008.10.045
   Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4
   Fan JY, 2010, J MATER SCI-MATER M, V21, P319, DOI 10.1007/s10856-009-3833-y
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.32549
   Gobbi A, 2005, KNEE SURG SPORT TR A, V13, P213, DOI 10.1007/s00167-004-0499-3
   Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652
   Graziano A, 2008, J CELL PHYSIOL, V214, P166, DOI 10.1002/jcp.21175
   GREENWAL.RA, 1972, J CLIN INVEST, V51, P2264, DOI 10.1172/JCI107035
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Jin R, 2010, ACTA BIOMATER, V6, P1968, DOI 10.1016/j.actbio.2009.12.024
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kim SE, 2003, J CONTROL RELEASE, V91, P365, DOI 10.1016/S0168-3659(03)00274-8
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Lee J, 2009, TISSUE ENG REGEN MED, V6, P229
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Lin YC, 2009, ACTA BIOMATER, V5, P2591, DOI 10.1016/j.actbio.2009.03.038
   Mano JF, 2007, J TISSUE ENG REGEN M, V1, P261, DOI 10.1002/term.37
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Nge TT, 2010, CELLULOSE, V17, P349, DOI 10.1007/s10570-009-9394-x
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Oyarzun-Ampuero FA, 2009, INT J PHARMACEUT, V381, P122, DOI 10.1016/j.ijpharm.2009.04.009
   PANGBURN SH, 1982, BIOMATERIALS, V3, P105, DOI 10.1016/0142-9612(82)90043-6
   Ren YJ, 2009, INT J BIOL MACROMOL, V44, P372, DOI 10.1016/j.ijbiomac.2009.02.004
   Shen H, 2004, NAT MATER, V3, P569, DOI 10.1038/nmat1179
   Tan HP, 2009, ACTA BIOMATER, V5, P328, DOI 10.1016/j.actbio.2008.07.030
   Tan HP, 2009, BIOMATERIALS, V30, P2499, DOI 10.1016/j.biomaterials.2008.12.080
   TELMEL A, 1991, ANN OPHTHALMOL, V23, P191
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Woodfield TBF, 2006, BIOMATERIALS, V27, P1043, DOI 10.1016/j.biomaterials.2005.07.032
   Wu SC, 2010, BIOMATERIALS, V31, P631, DOI 10.1016/j.biomaterials.2009.09.089
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   YAMANE S, 2006, J BIOMED MATER RES A, V81, P587
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
NR 52
TC 82
Z9 85
U1 2
U2 49
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUL
PY 2011
VL 17
IS 7
BP 717
EP 730
DI 10.1089/ten.tec.2010.0467
PG 14
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 784VG
UT WOS:000292185800002
PM 21517692
DA 2018-10-20
ER

PT J
AU Rainer, A
   Spadaccio, C
   Sedati, P
   De Marco, F
   Carotti, S
   Lusini, M
   Vadala, G
   Di Martino, A
   Morini, S
   Chello, M
   Covino, E
   Denaro, V
   Trombetta, M
AF Rainer, Alberto
   Spadaccio, Cristiano
   Sedati, Pietro
   De Marco, Federico
   Carotti, Simone
   Lusini, Mario
   Vadala, Gianluca
   Di Martino, Alberto
   Morini, Sergio
   Chello, Massimo
   Covino, Elvio
   Denaro, Vincenzo
   Trombetta, Marcella
TI Electrospun Hydroxyapatite-Functionalized PLLA Scaffold: Potential
   Applications in Sternal Bone Healing
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Acellular scaffold; Poly(L-lactide); Hydroxyapatite; Electrospinning;
   Median sternotomy; Bone healing
ID TISSUE ENGINEERING SCAFFOLDS; BETA-TRICALCIUM PHOSPHATE; POLY(L-LACTIC
   ACID); POSTOPERATIVE MEDIASTINITIS; WOUND COMPLICATIONS; HEART-SURGERY;
   RISK-FACTORS; CELLS; REGENERATION; COMPOSITE
AB Sternal synthesis after median sternotomy, a conventional access practice in thoracic and cardiac surgery, is at the basis of severe complications, often impairing the clinical outcome of surgical interventions. In this work, we propose the use of an acellular biomaterial scaffold, to be interposed across the fracture rime during closure operations, directly exposing the biomaterial to bone marrow, in order to expedite healing process. A rabbit model of median sternotomy was performed and an electrospun scaffold composed of a hydroxyapatite-loaded absorbable biopolymer (poly-l-lactide), shaped into a fibrillar structure, was used. CT follow-up confirmed a complete healing in the scaffold-treated group 1 week before the control. Histological evaluation demonstrated presence of newly formed bone trabeculae among scaffold fibers showing a higher degree of maturity with respect to the control untreated group. The proposed approach is able to both guide a more rapid healing and modulate inflammatory response across the wound site, resulting in improved healing and tissue remodeling with respect to conventional closure technique.
C1 [Rainer, Alberto; Trombetta, Marcella] Univ Campus Bio Med Rome, Ctr Integrated Res, Tissue Engn Lab, I-00128 Rome, Italy.
   [Spadaccio, Cristiano; Lusini, Mario; Chello, Massimo; Covino, Elvio] Univ Campus Bio Med Rome, Ctr Integrated Res, Area Cardiovasc Surg, I-00128 Rome, Italy.
   [Sedati, Pietro] Univ Campus Bio Med Rome, Ctr Integrated Res, Area Image Diagnost, I-00128 Rome, Italy.
   [De Marco, Federico] Italian Natl Canc Inst Regina Elena, Virol Lab, Rome, Italy.
   [Carotti, Simone; Morini, Sergio] Univ Campus Bio Med Rome, Ctr Integrated Res, Lab Anat & Ultrastruct Microscopy, I-00128 Rome, Italy.
   [Vadala, Gianluca; Di Martino, Alberto; Denaro, Vincenzo] Univ Campus Bio Med Rome, Ctr Integrated Res, Area Orthopaed & Trauma Surg, I-00128 Rome, Italy.
RP Rainer, A (reprint author), Univ Campus Bio Med Rome, Ctr Integrated Res, Tissue Engn Lab, Via Alvaro Portillo 21, I-00128 Rome, Italy.
EM a.rainer@unicampus.it
RI Rainer, Alberto/G-8588-2011; Vadala, Gianluca/B-1538-2014; Carotti,
   Simone/G-7822-2012; Denaro, Vincenzo/K-9567-2016
OI Rainer, Alberto/0000-0001-8971-551X; Vadala,
   Gianluca/0000-0001-7142-1660; Carotti, Simone/0000-0002-3164-1500;
   Denaro, Vincenzo/0000-0003-4739-9795; Di Martino,
   Alberto/0000-0002-0716-4951; De Marco, Federico/0000-0002-1173-2843;
   Covino, Elvio/0000-0002-6671-4626; Morini, Sergio/0000-0001-6137-2404;
   chello, massimo/0000-0001-8178-7068; Trombetta,
   Marcella/0000-0002-1357-4885
CR Alkadhi H, 2004, J COMPUT ASSIST TOMO, V28, P378, DOI 10.1097/00004728-200405000-00013
   Auclair-Daigle C, 2005, J BIOMED MATER RES A, V73A, P398, DOI 10.1002/jbm.a.30284
   Azevedo HS, 2005, BIODEGRADABLE SYSTEM, P178
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bonzani IC, 2006, CURR OPIN CHEM BIOL, V10, P568, DOI 10.1016/j.cbpa.2006.09.009
   Borger MA, 1998, ANN THORAC SURG, V65, P1050, DOI 10.1016/S0003-4975(98)00063-0
   Bottio T, 2003, J THORAC CARDIOV SUR, V126, P1352, DOI 10.1016/S0022-5223(03)00945-0
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Donati D, 2008, CLIN ORTHOP RELAT R, V466, P459, DOI 10.1007/s11999-007-0055-9
   EHRENKRANZ NJ, 1991, REV INFECT DIS, V13, P803
   Engum SA, 2008, SEMIN PEDIAT SURG, V17, P154, DOI 10.1053/j.sempedsurg.2008.03.004
   Flohr TG, 2005, MED PHYS, V32, P2536, DOI 10.1118/1.1949787
   Gardlund B, 2002, EUR J CARDIO-THORAC, V21, P825, DOI 10.1016/S1010-7940(02)00084-2
   Gomez-Vega JM, 2000, BIOMATERIALS, V21, P105, DOI 10.1016/S0142-9612(99)00131-3
   He W, 2006, TISSUE ENG, V12, P2457, DOI 10.1089/ten.2006.12.2457
   HOOLE PF, 1971, MED LAB TECHNOL, V28, P201
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   Imren Y, 2006, HEART SURG FORUM, V9, pE871, DOI 10.1532/HSF98.20061109
   JULIAN OC, 1957, SURGERY, V42, P753
   Karra R, 2006, J THORAC CARDIOV SUR, V132, P537, DOI 10.1016/j.jtcvs.2006.04.037
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Lee TM, 2004, J BIOMED MATER RES A, V71A, P652, DOI 10.1002/jbm.a.30190
   LI S, 2003, DEGRADABLE POLYM PRI, P71
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liu Y, 2008, J NANOSCI NANOTECHNO, V8, P1528, DOI 10.1166/jnn.2008.043
   LOOP FD, 1990, ANN THORAC SURG, V49, P179, DOI 10.1016/0003-4975(90)90136-T
   Losanoff JE, 2004, ANN THORAC SURG, V77, P203, DOI 10.1016/S0003-4975(03)01468-1
   Luong-Van E, 2006, BIOMATERIALS, V27, P2042, DOI 10.1016/j.biomaterials.2005.10.028
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Mazurkiewicz Tomasz, 2005, Ortop Traumatol Rehabil, V7, P465
   Montjovent MO, 2005, TISSUE ENG, V11, P1640, DOI 10.1089/ten.2005.11.1640
   Nair LS, 2004, EXPERT OPIN BIOL TH, V4, P659, DOI 10.1517/14712598.4.5.659
   Noh HK, 2006, BIOMATERIALS, V27, P3934, DOI 10.1016/j.biomaterials.2006.03.016
   Oh T, 2006, J VET SCI, V7, P73, DOI 10.4142/jvs.2006.7.1.73
   Ramer JC, 1999, COMP CONT EDUC PRACT, V21, P116
   Samir Khaled, 2003, Interact Cardiovasc Thorac Surg, V2, P611, DOI 10.1016/S1569-9293(03)00144-0
   Schimmer C, 2008, EUR J CARDIO-THORAC, V34, P132, DOI 10.1016/j.ejcts.2008.04.006
   Shamberger RC, 1996, CURR PROB SURG, V33, P474
   Simon CG, 2005, BIOMATERIALS, V26, P6906, DOI 10.1016/j.biomaterials.2005.04.050
   Sohier J, 2008, EXPERT OPIN DRUG DEL, V5, P543, DOI [10.1517/17425247.5.5.543 , 10.1517/17425240802088033]
   Song DH, 2004, EUR J CARDIO-THORAC, V26, P367, DOI 10.1016/j.ejcts.2004.04.38
   Spadaccio C, 2009, ANN BIOMED ENG, V37, P1376, DOI 10.1007/s10439-009-9704-3
   Steigman SA, 2009, J PEDIATR SURG, V44, P1120, DOI 10.1016/j.jpedsurg.2009.02.038
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Su SH, 2005, J BIOMAT SCI-POLYM E, V16, P353, DOI 10.1163/1568562053654077
   Tsuji H, 2006, BIOMACROMOLECULES, V7, P380, DOI 10.1021/bm0507453
   Venugopal J, 2010, PHILOS T R SOC A, V368, P2065, DOI 10.1098/rsta.2010.0012
   Viljanen J, 2001, J Orthop Sci, V6, P160, DOI 10.1007/s007760100065
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
NR 51
TC 22
Z9 22
U1 0
U2 23
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD JUL
PY 2011
VL 39
IS 7
BP 1882
EP 1890
DI 10.1007/s10439-011-0289-2
PG 9
WC Engineering, Biomedical
SC Engineering
GA 775RA
UT WOS:000291479600004
PM 21404125
DA 2018-10-20
ER

PT J
AU Matl, FD
   Obermeier, A
   Zlotnyk, J
   Friess, W
   Stemberger, A
   Burgkart, R
AF Matl, F. D.
   Obermeier, A.
   Zlotnyk, J.
   Friess, W.
   Stemberger, A.
   Burgkart, R.
TI Augmentation of Antibiotic Activity by Low-Frequency Electric and
   Electromagnetic Fields Examining Staphylococcus aureus in Broth Media
SO BIOELECTROMAGNETICS
LA English
DT Article
DE sinusoidal; PEMF; bacteria; gentamicin; implant infection
ID HIGH MAGNETIC-FIELD; CURRENT-INDUCED DETACHMENT; SURGICAL
   STAINLESS-STEEL; ESCHERICHIA-COLI DEATH; DOUBLE-BLIND TRIAL; EPIDERMIDIS
   BIOFILMS; ORTHOPEDIC IMPLANTS; BACTERIAL BIOFILMS; EXPOSURE; EFFICACY
AB Systemic treatment of biomaterial-associated bacterial infections with high doses of antibiotics is an established therapeutic concept. The purpose of this in vitro study was to determine the influence of magnetic, electromagnetic, and electric fields on gentamicin-based, antibiotic therapy. It has been previously reported that these fields are successful in the treatment of bone healing and reducing osteitis in infected tibia-pseudarthroses. Four separate experimental setups were used to expose bacterial cultures of Staphylococcus aureus both in Mueller-Hinton broth (MHB) and on Mueller-Hinton agar (MHA), in the presence of gentamicin, to (1) a low-frequency magnetic field (MF) 20 Hz, 5 mT; (2) a low-frequency MF combined with an additional alternating electric field (MF + EF) 20 Hz, 5 mT, 470 mV/cm; (3) a sinusoidal alternating electric field (EF AC) 20 Hz, 470 mV/cm; and (4) a direct current electric field (EF DC) 588 mV/cm. No significant difference between samples and controls was detected on MHA. However, in MHB each of the four fields applied showed a significant growth reduction of planktonically grown Staphylococcus aureus in the presence of gentamicin between 32% and 91% within 24 h of the experiment. The best results were obtained by a direct current EF, decreasing colony-forming units (CFU)/ml more than 91%. The application of electromagnetic fields in the area of implant and bone infections could offer new perspectives in antibiotic treatment and antimicrobial chemotherapy. Bioelectromagnetics 32:367-377, 2011. (C) 2011 Wiley-Liss, Inc.
C1 [Matl, F. D.; Obermeier, A.; Stemberger, A.; Burgkart, R.] Tech Univ Munich, Klin Orthopad & Unfallchirurg, Klinikum Rd Isar, D-81675 Munich, Germany.
   [Friess, W.] Univ Munich, Dept Pharm Pharmaceut Technol, Munich, Germany.
   [Zlotnyk, J.] Tech Univ Munich, Inst Med Engn, D-81675 Munich, Germany.
RP Matl, FD (reprint author), Tech Univ Munich, Klin Orthopad & Unfallchirurg, Klinikum Rd Isar, Ismaninger Str 22, D-81675 Munich, Germany.
EM matl@termeer.de
RI Obermeier, Andreas Karl-Werner/B-3020-2016
OI Obermeier, Andreas Karl-Werner/0000-0002-1774-5194
FU Bayerische Forschungsstiftung (Bavarian Research Foundation)
FX Grant sponsor: Bayerische Forschungsstiftung (Bavarian Research
   Foundation).
CR Andersson DI, 2003, CURR OPIN MICROBIOL, V6, P452, DOI 10.1016/j.mib.2003.09.001
   Ascherl R, 1985, Reconstr Surg Traumatol, V19, P106
   BASSEN H, 1992, BIOELECTROMAGNETICS, V13, P183, DOI 10.1002/bem.2250130303
   Benson DE, 1994, ASAIO J, V40, P371
   Caubet R, 2004, ANTIMICROB AGENTS CH, V48, P4662, DOI 10.1128/AAC.48.12.4662-4664.2004
   Cohen J, 1988, STAT POWER ANAL BEHA
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   *CSLI, 2005, M100S15 CLSI, V25
   Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Geipel U, 2005, UNFALLCHIRURG, V108, P961, DOI 10.1007/s00113-005-1027-8
   Griffin XL, 2008, INJURY, V39, P419, DOI 10.1016/j.injury.2007.12.014
   Griffiths D. J., 1999, INTRO ELECTRODYNAMIC
   Grosman Zdenek, 1992, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V134, P7
   Horiuchi S, 2002, BIOELECTROCHEMISTRY, V57, P139, DOI 10.1016/S1567-5394(02)00111-1
   Ishizaki Y, 2001, BIOELECTROCHEMISTRY, V54, P101, DOI 10.1016/S1567-5394(01)00108-6
   KRAUS W, 1992, BIOELECTROCH BIOENER, V27, P321, DOI 10.1016/0302-4598(92)87007-H
   Kraus W, 1972, Munch Med Wochenschr, V114, P1814
   LECHNER F, 1979, FORTSCHR MED, V97, P943
   LECHNER F, 1981, CLIN ORTHOP RELAT R, P71
   Linovitz RJ, 2002, SPINE, V27, P1383, DOI 10.1097/00007632-200207010-00002
   McLeod BR, 1999, METHOD ENZYMOL, V310, P656
   McLeod BR, 2010, BIOELECTROMAGNETICS, V31, P56, DOI 10.1002/bem.20529
   Obermeier A, 2009, BIOELECTROMAGNETICS, V30, P270, DOI 10.1002/bem.20479
   Pickering SAW, 2003, J BONE JOINT SURG BR, V85B, P588, DOI 10.1302/0301-620X.85B4.12644
   Rabinovitch C, 2006, APPL ENVIRON MICROB, V72, P6364, DOI 10.1128/AEM.00442-06
   SHARRARD WJW, 1990, J BONE JOINT SURG BR, V72, P347
   Simonis RB, 2003, INJURY, V34, P357, DOI 10.1016/S0020-1383(02)00209-7
   Stansell MJ, 2001, BIOELECTROMAGNETICS, V22, P129, DOI 10.1002/1521-186X(200102)22:2<129::AID-BEM1016>3.0.CO;2-L
   Trampuz A, 2006, DRUGS, V66, P1089, DOI 10.2165/00003495-200666080-00005
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Tsuchiya K, 1999, BIOELECTROCH BIOENER, V48, P383, DOI 10.1016/S0302-4598(99)00023-9
   van der Borden AJ, 2005, BIOMATERIALS, V26, P6731, DOI 10.1016/j.biomaterials.2004.04.052
   van der Borden AJ, 2004, APPL ENVIRON MICROB, V70, P6871, DOI 10.1128/AEM.70.11.6871-6874.2004
   van der Borden AJ, 2007, BIOMATERIALS, V28, P2122, DOI 10.1016/j.biomaterials.2007.01.001
NR 35
TC 15
Z9 15
U1 1
U2 19
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0197-8462
J9 BIOELECTROMAGNETICS
JI Bioelectromagnetics
PD JUL
PY 2011
VL 32
IS 5
BP 367
EP 377
DI 10.1002/bem.20667
PG 11
WC Biology; Biophysics
SC Life Sciences & Biomedicine - Other Topics; Biophysics
GA 775GU
UT WOS:000291447600006
PM 21437921
DA 2018-10-20
ER

PT J
AU Kempf, M
   Miyamura, Y
   Liu, PY
   Chen, ACH
   Nakamura, H
   Shimizu, H
   Tabata, Y
   Kimble, RM
   McMillan, JR
AF Kempf, Margit
   Miyamura, Yuki
   Liu, Pei-Yun
   Chen, Alice C. -H.
   Nakamura, Hideki
   Shimizu, Hiroshi
   Tabata, Yasuhiko
   Kimble, Roy M.
   McMillan, James R.
TI A denatured collagen microfiber scaffold seeded with human fibroblasts
   and keratinocytes for skin grafting
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Dermis; Scaffold; Keratinocyte; Fibroblast; Surface graft
ID CELL SUPPORT MEMBRANES; ELECTROSPUN COLLAGEN; CROSS-LINKING;
   MECHANICAL-PROPERTIES; ENGINEERED SKIN; IN-VITRO; TISSUE; SUBSTITUTES;
   REGENERATION; MODEL
AB Biomaterial scaffolds are categorized into artificial or natural polymers, or combinations of the two. Artificial polymers often undergo serum protein adsorption, elicit foreign body and encapsulation immune responses post-implantation. Large pore bovine electrospun collagen I was therefore screened as a candidate for human keratinocyte and fibroblast cell scaffolds. Human HaCaT keratinocyte and dermal fibroblasts were seeded on electrospun denatured collagen I microfiber (DCM) scaffolds and after 72 h Livedead (R) assays performed to determine adhesive cell, survival and scaffold penetration. Both keratinocytes and fibroblasts attached to and survived on DCM scaffolds, however only fibroblasts migrated over and into this biomaterial. HaCaT keratinocytes remained largely stationary on the scaffold surface in discrete islands of monolayered cells. For this reason, normal human epidermal keratinocyte (NHEK) scaffold interactions were assessed using scanning and transmission electron microscopy (EM) that demonstrated DCM scaffolds comprised networks of interlocking and protruding collagen fibers with a mean diameter of 2-5 mu m, with a mean inter-fiber pore size of 6.7 mu m (range 3-10 mu m) and scaffold thickness 50-70 mu m. After 72 h the keratinocytes and fibroblasts on DCM scaffolds had attached, flattened and spread over the entire scaffold with assembly of lamellapodia and focal adhesion (FA)-like junctions. Using transmission EM, NHEKs and HaCaT keratinocytes assembled desmosomes, lamellapodia and FA junctions, however, neither hemidesmosomes nor basal lamina were present. In long term (21 day) co-culture fibroblasts migrated throughout the scaffold and primary keratinocytes (and to a lesser extend HaCaTs) stratified on the scaffold surface forming a human skin equivalent (HSE). In vivo testing of these HSEs on immunocompetent (BalbC) and immunodeficient (SCID) excisionally wounded model mice demonstrated scaffold wound biocompatibility and ability to deliver human cells after scaffold biodegradation. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kempf, Margit; Liu, Pei-Yun; Chen, Alice C. -H.; Kimble, Roy M.; McMillan, James R.] Univ Queensland, Queensland Childrens Med Res Inst QCMRI, Ctr Childrens Burns & Trauma Res CCBTR, Brisbane, Qld, Australia.
   [Miyamura, Yuki; Nakamura, Hideki; Shimizu, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan.
   [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Kyoto 6068501, Japan.
RP McMillan, JR (reprint author), Univ Queensland, Queensland Childrens Med Res Inst QCMRI, Ctr Childrens Burns & Trauma Res CCBTR, Royal Childrens Hosp, L-4 RCH Fdn Bldg, Brisbane, Qld, Australia.
EM j.mcmillan@uq.edu.au
OI Kimble, Roy/0000-0002-2449-7707
FU University of Queensland; Health and Labor Sciences Research Grant
   (Japan) [H17-Saisei-12]; Brisbane Royal Children's Hospital Foundation
   (Queensland Children's Medical Research Institute, QCMRI)
FX This work was funded by a New Staff Start-Up Grant from The University
   of Queensland (JRM), by a grant-in-aid from the Health and Labor
   Sciences Research Grant (research into specific diseases) H17-Saisei-12
   (Japan) and by support from the Brisbane Royal Children's Hospital
   Foundation (Queensland Children's Medical Research Institute, QCMRI).
   Author Disclosure Statement: The authors state that no completing
   financial interests exist.
CR Barnes CP, 2007, TISSUE ENG, V13, P1593, DOI 10.1089/ten.2006.0292
   Berthod F, 2001, MATRIX BIOL, V20, P463, DOI 10.1016/S0945-053X(01)00162-7
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Boyce ST, 2006, J TRAUMA, V60, P821, DOI 10.1097/01.ta.0000196802.91829.cc
   Butler CE, 1998, PLAST RECONSTR SURG, V101, P1572, DOI 10.1097/00006534-199805000-00021
   Dai NT, 2005, BIOCHEM BIOPH RES CO, V329, P905, DOI 10.1016/j.bbrc.2005.02.059
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   FEI X, 1991, Annals Academy of Medicine Singapore, V20, P493
   Gawronska-Kozak B, 2006, WOUND REPAIR REGEN, V14, P265, DOI 10.1111/j.1743-6109.2006.00121.x
   GEISLER HP, 1996, BIOMATERIALS, V17
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Klingenberg JM, 2010, J INVEST DERMATOL, V130, P587, DOI 10.1038/jid.2009.295
   Lee SB, 2005, BIOMATERIALS, V26, P1961, DOI 10.1016/j.biomaterials.2004.06.032
   LIU PY, 2009, J ELECTRON MICROSC, V59, P87
   MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Matthews JA, 2003, J BIOACT COMPAT POL, V18, P125, DOI 10.1177/088391103033856
   McMillan JR, 2007, TISSUE ENG, V13, P789, DOI 10.1089/ten.2006.0321
   Metcalfe AD, 2007, BIOMATERIALS, V28, P5100, DOI 10.1016/j.biomaterials.2007.07.031
   Metcalfe AD, 2007, J R SOC INTERFACE, V4, P413, DOI 10.1098/rsif.2006.0179
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Powell HM, 2008, J BIOMED MATER RES A, V84A, P1078, DOI 10.1002/jbm.a.31498
   Powell HM, 2008, BIOMATERIALS, V29, P834, DOI 10.1016/j.biomaterials.2007.10.036
   Powell HM, 2009, TISSUE ENG PT A, V15, P2177, DOI 10.1089/ten.tea.2008.0473
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Rho KS, 2006, BIOMATERIALS, V27, P1452, DOI 10.1016/j.biomaterials.2005.08.004
   RICHARDSON KC, 1960, STAIN TECHNOL, V35, P313, DOI 10.3109/10520296009114754
   Shields KJ, 2004, TISSUE ENG, V10, P1510, DOI 10.1089/1076327042500373
   Swope VB, 2001, J INVEST DERMATOL, V116, P650, DOI 10.1046/j.1523-1747.2001.01325.x
   TANNER J C Jr, 1964, Plast Reconstr Surg, V34, P287
   Usha R, 2004, THERMOCHIM ACTA, V409, P201, DOI 10.1016/S0040-6031(03)00335-6
   Vacanti JP, 2000, PRINCIPLES TISSUE EN
   Wang XQ, 2009, BURNS, V35, P264, DOI 10.1016/j.burns.2008.05.030
   WARDEN GD, 1982, J TRAUMA, V22, P98, DOI 10.1097/00005373-198202000-00004
   YANNAS IV, 1982, SCIENCE, V215, P174, DOI 10.1126/science.7031899
   Zhao YN, 2005, AM J PATHOL, V167, P1519, DOI 10.1016/S0002-9440(10)61238-2
NR 37
TC 48
Z9 53
U1 0
U2 52
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2011
VL 32
IS 21
BP 4782
EP 4792
DI 10.1016/j.biomaterials.2011.03.023
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 776WT
UT WOS:000291571400011
PM 21477857
DA 2018-10-20
ER

PT J
AU Stoll, C
   John, T
   Conrad, C
   Lohan, A
   Hondke, S
   Ertel, W
   Kaps, C
   Endres, M
   Sittinger, M
   Ringe, J
   Schulze-Tanzil, G
AF Stoll, Christiane
   John, Thilo
   Conrad, Claudia
   Lohan, Anke
   Hondke, Sylvia
   Ertel, Wolfgang
   Kaps, Christian
   Endres, Michaela
   Sittinger, Michael
   Ringe, Jochen
   Schulze-Tanzil, G.
TI Healing parameters in a rabbit partial tendon defect following
   tenocyte/biomaterial implantation
SO BIOMATERIALS
LA English
DT Article
DE Tendon; Polyglycolic-acid; Fibrin; Implantation
ID MESENCHYMAL STEM-CELLS; ACHILLES-TENDON; REPAIR; TENOCYTES;
   TENDINOPATHY; EXPRESSION; INJURIES; MATRIX; MODEL
AB Although rabbits are commonly used as tendon repair model, interpretative tools are divergent and comprehensive scoring systems are lacking. Hence, the aim was to develop a multifaceted scoring system to characterize healing in a partial Achilles tendon defect model. A 3 mm diameter defect was created in the midsubstance of the medial M. gastrocnemius tendon, which remained untreated or was filled with a polyglycolic-acid (PGA) scaffold + fibrin and either left cell-free or seeded with Achilles tenocytes. After 6 and 12 weeks, tendon repair was assessed macroscopically and histologically using self-constructed scores. Macroscopical scoring revealed superior results in the tenocyte seeded PGA + fibrin group compared with the controls at both time points. Histology of all operated tendons after 6 weeks proved extracellular matrix (ECM) disorganization, hypercellularity and occurrence of irregular running elastic fibres with no significance between the groups. Some inflammation was associated with PGA implantation and increased sulphated proteoglycan deposition predominantly with the empty defects. After 12 weeks defect areas became hard to recognize and differences between groups, except for the increased sulphated proteoglycans content in the empty defects, were almost nullified. We describe a partial Achilles tendon defect model and versatile scoring tools applicable for characterizing biomaterial-supported tendon healing. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Stoll, Christiane; John, Thilo; Conrad, Claudia; Lohan, Anke; Hondke, Sylvia; Ertel, Wolfgang; Schulze-Tanzil, G.] Charite, Dep Traumat & Reconstruct Surg, FEM, Campus Benjamin Franklin, D-14195 Berlin, Germany.
   [Stoll, Christiane; Sittinger, Michael; Ringe, Jochen] Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany.
   [Kaps, Christian; Endres, Michaela] TransTissue Technol GmbH, Res & Dev, Berlin, Germany.
   [Sittinger, Michael; Ringe, Jochen] Tissue Engn Lab, Berlin, Germany.
   [Sittinger, Michael; Ringe, Jochen] Charite, Dept Rheumatol, D-14195 Berlin, Germany.
RP Schulze-Tanzil, G (reprint author), Charite, Dep Traumat & Reconstruct Surg, FEM, Campus Benjamin Franklin, Campus Benjamin Franklin,Garystr 5, D-14195 Berlin, Germany.
EM gundula.schulze-tanzil@charite.de
OI Hondke, Sylvia/0000-0001-7742-5128
FU Berlin-Brandenburg Centre for Regenerative Therapies (BCRT); Sonnenfeld
   foundation
FX Financial support was provided by the Berlin-Brandenburg Centre for
   Regenerative Therapies (BCRT) and the Sonnenfeld foundation. The authors
   also thank Hannah Gough for proof reading of the manuscript, Ulrike
   Marzahn for brilliant histological advice and Benjamin Kohl for
   excellent technical assistance.
CR Aspenberg P, 2007, INT ORTHOP, V31, P783, DOI 10.1007/s00264-007-0398-6
   Cao DJ, 2006, TISSUE ENG, V12, P1369, DOI 10.1089/ten.2006.12.1369
   Clayton RAE, 2008, INJURY, V39, P1338, DOI 10.1016/j.injury.2008.06.021
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   Doherty GP, 2006, COMPARATIVE MED, V56, P68
   Jarvinen TAH, 2001, CURR OPIN RHEUMATOL, V13, P150
   JOHN T, 2009, J ORTHOP RES, V28, P1071
   Khan RJK, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003674.pub4
   Kryger GS, 2007, J HAND SURG-AM, V32A, P597, DOI 10.1016/j.jhsa.2007.02.018
   LANDVATER SJ, 1992, CLIN SPORT MED, V11, P741
   Leppilahti J, 1998, SPORTS MED, V25, P79, DOI 10.2165/00007256-199825020-00002
   Lui PPY, 2010, RHEUMATOLOGY, V49, P231, DOI 10.1093/rheumatology/kep384
   Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9
   Movin T, 1997, ACTA ORTHOP SCAND, V68, P170, DOI 10.3109/17453679709004002
   Nagasawa K, 2008, CLIN BIOMECH, V23, P832, DOI 10.1016/j.clinbiomech.2008.02.002
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Pihlajamaki H, 2008, J ORTHOP RES, V26, P264, DOI 10.1002/jor.20504
   Qi J, 2006, TISSUE ENG, V12, P2913, DOI 10.1089/ten.2006.12.2913
   SCHULZETANZIL G, 2011, SCAND J MED SCI SPOR
   SCOTT SH, 1990, MED SCI SPORT EXER, V22, P357
   Shalabi A, 2002, ACTA RADIOL, V43, P198, DOI 10.1080/028418502127347781
   Sharma P, 2005, SURG-J R COLL SURG E, V3, P309, DOI 10.1016/S1479-666X(05)80109-X
   Stoll C, 2010, J ORTHOP RES, V28, P1170, DOI 10.1002/jor.21109
   Suckow MA, 2007, J MATER SCI-MATER M, V18, P1105, DOI 10.1007/s10856-007-0158-6
   Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Wang B, 2008, BIOMATERIALS, V29, P2954, DOI 10.1016/j.biomaterials.2008.03.038
   Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342
   Xia Z, 2006, BIOMED MATER, V1, pR1, DOI 10.1088/1748-6041/1/1/R01
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
NR 30
TC 31
Z9 32
U1 1
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2011
VL 32
IS 21
BP 4806
EP 4815
DI 10.1016/j.biomaterials.2011.03.026
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 776WT
UT WOS:000291571400013
PM 21474176
DA 2018-10-20
ER

PT J
AU Scott, JB
   Afshari, M
   Kotek, R
   Saul, JM
AF Scott, John B.
   Afshari, Mehdi
   Kotek, Richard
   Saul, Justin M.
TI The promotion of axon extension in vitro using polymer-templated fibrin
   scaffolds
SO BIOMATERIALS
LA English
DT Article
DE Fibrin; Micropatterning; Nerve guide; Nerve tissue engineering; Scaffold
ID PERIPHERAL-NERVE REGENERATION; DORSAL-ROOT GANGLIA; GROWTH-FACTOR;
   NEURITE OUTGROWTH; AGAROSE SCAFFOLDS; SILICONE CHAMBER; HYALURONIC-ACID;
   CELL BEHAVIOR; SPINAL-CORD; REPAIR
AB Biomaterial nerve cuffs are a clinical alternative to autografts and allografts as a means to repair segmental peripheral nerve defects. However, existing clinical biomaterial constructs lack true incorporation of physical guidance cues into their design. In both two- and three-dimensional systems, it is known that substrate geometry directly affects rates of axon migration. However, the ability to incorporate these cues into biomaterial scaffolds of sufficient porosity to promote robust nerve regeneration in three-dimensional systems is a challenge. We have developed fibrin constructs fabricated by a sacrificial templating approach, yielding scaffolds with multiple 10-250 mu m diameter conduits depending on the diameter of the template fibers. The resulting scaffolds contained numerous, highly aligned conduits, had porosity of similar to 80%, and showed mechanical properties comparable to native nerve (150-300 kPa Young's modulus). We studied the effects of the conduit diameters on the rate of axon migration through the scaffold to investigate if manipulation of this geometry could be used to ultimately promote more rapid bridging of the scaffold. All diameters studied led to axon migration, but in contrast to effects of fiber diameters in other systems, the rate of axon migration was independent of conduit diameter in these templated scaffolds. However, aligned conduits did support more rapid axon migration than non-aligned, tortuous controls. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Scott, John B.; Saul, Justin M.] Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Winston Salem, NC 27157 USA.
   [Scott, John B.; Saul, Justin M.] Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Afshari, Mehdi; Kotek, Richard] N Carolina State Univ, Coll Text, Raleigh, NC 27695 USA.
   [Afshari, Mehdi] Fiberweb Inc, Old Hickory, TN 37138 USA.
RP Saul, JM (reprint author), Wake Forest Univ, Virginia Tech, Sch Biomed Engn & Sci, Med Ctr Blvd,2nd Floor,MRI Bldg, Winston Salem, NC 27157 USA.
EM jsaul@wfubmc.edu
RI Saul, Justin/I-1765-2016
FU Wake Forest University; Department of Biomedical Engineering; Wake
   Forest Institute for Regenerative Medicine
FX This work was funded by the Wake Forest University Health Sciences
   Venture Fund, the Department of Biomedical Engineering, and the Wake
   Forest Institute for Regenerative Medicine. The authors gratefully
   acknowledge the laboratory of Dr. Carolanne Milligan, Wake Forest
   University Health Sciences Department of Neurobiology and Anatomy, for
   assistance with isolation and culture of embryonic chicken DRG.
CR Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   Borschel GH, 2003, J SURG RES, V114, P133, DOI 10.1016/S0022-4804(03)00255-5
   Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   Champney TH, 2011, ANAT SCI EDUC, V4, P49, DOI 10.1002/ase.199
   Clements IP, 2009, BIOMATERIALS, V30, P3834, DOI 10.1016/j.biomaterials.2009.04.022
   Deister C, 2007, J BIOMAT SCI-POLYM E, V18, P983, DOI 10.1163/156856207781494377
   Dodla MC, 2008, BIOMATERIALS, V29, P33, DOI 10.1016/j.biomaterials.2007.08.045
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   Flynn L, 2003, BIOMATERIALS, V24, P4265, DOI 10.1016/S0142-9612(03)00334-X
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641
   Hudson TW, 2004, TISSUE ENG, V10, P1346, DOI 10.1089/ten.2004.10.1346
   Hurtado A, 2006, BIOMATERIALS, V27, P430, DOI 10.1016/j.biomaterials.2005.07.014
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Kalbermatten DF, 2008, J PLAST RECONSTR AES, V61, P669, DOI 10.1016/j.bjps.2007.12.015
   Kalbermatten DF, 2009, J RECONSTR MICROSURG, V25, P27, DOI 10.1055/s-0028-1090619
   Kim Y., 2008, BIOMATERIALS
   Labrador RO, 1998, EXP NEUROL, V149, P243, DOI 10.1006/exnr.1997.6650
   Lacour SP, 2009, IEEE T NEUR SYS REH, V17, P454, DOI 10.1109/TNSRE.2009.2031241
   Larsen M, 2007, J NEUROSURG, V106, P924, DOI 10.3171/jns.2007.106.5.924
   Lee S K, 2000, J Am Acad Orthop Surg, V8, P243
   Lee W, 2010, BIOTECHNOL BIOENG, V105, P1178, DOI 10.1002/bit.22613
   LEON A, 1984, J NEUROSCI RES, V12, P277, DOI 10.1002/jnr.490120215
   Linnes MP, 2007, BIOMATERIALS, V28, P5298, DOI 10.1016/j.biomaterials.2007.08.020
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   Midha R, 2003, J NEUROSURG, V99, P555, DOI 10.3171/jns.2003.99.3.0555
   Mieszawska AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-59
   Nakayama K, 2007, J NANOSCI NANOTECHNO, V7, P730, DOI 10.1166/jnn.2007.519
   Nakayama K, 2007, ARTIF ORGANS, V31, P500, DOI 10.1111/j.1525-1594.2007.00418.x
   Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Noble J, 1998, J TRAUMA, V45, P116, DOI 10.1097/00005373-199807000-00025
   Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030
   Siemionow M, 2010, MICROSURG, V30, P574, DOI 10.1002/micr.20799
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777
   Suri S, 2010, TISSUE ENG PT A, V16, P1703, DOI 10.1089/ten.tea.2009.0381
   Taras John S, 2005, J Hand Ther, V18, P191, DOI 10.1197/j.jht.2005.02.012
   Wang DY, 2008, J BIOMED MATER RES A, V85A, P434, DOI 10.1002/jbm.a.31568
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   WEBB PA, 2001, MICROMETRICS INSTRUM, P1
   Wei GB, 2006, J BIOMED MATER RES A, V78A, P306, DOI 10.1002/jbm.a.30704
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220
   WILLIAMS LR, 1987, NEUROCHEM RES, V12, P851, DOI 10.1007/BF00966306
   WILLIAMS LR, 1987, J COMP NEUROL, V264, P284, DOI 10.1002/cne.902640211
   Wood MD, 2009, ACTA BIOMATER, V5, P959, DOI 10.1016/j.actbio.2008.11.008
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
NR 50
TC 27
Z9 29
U1 0
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2011
VL 32
IS 21
BP 4830
EP 4839
DI 10.1016/j.biomaterials.2011.03.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 776WT
UT WOS:000291571400015
PM 21492932
DA 2018-10-20
ER

PT J
AU Chandler, EM
   Berglund, CM
   Lee, JS
   Polacheck, WJ
   Gleghorn, JP
   Kirby, BJ
   Fischbach, C
AF Chandler, Emily M.
   Berglund, Caroline M.
   Lee, Jason S.
   Polacheck, William J.
   Gleghorn, Jason P.
   Kirby, Brian J.
   Fischbach, Claudia
TI Stiffness of Photocrosslinked RGD-Alginate Gels Regulates Adipose
   Progenitor Cell Behavior
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE alginate; mechanical stiffness; adipose progenitor cells; adipose tissue
   engineering; angiogenesis
ID STEM-CELLS; IN-VITRO; CYTOSKELETAL TENSION; 3T3-L1 PREADIPOCYTES; MATRIX
   STIFFNESS; ENDOCRINE ORGAN; TISSUE; PROLIFERATION; ANGIOGENESIS;
   HYDROGELS
AB Adipose progenitor cells (APCs) are widely investigated for soft tissue reconstruction following tumor resection; however, the long-term success of current approaches is still limited. In order to develop clinically relevant therapies, a better understanding of the role of cell-microenvironment interactions in adipose tissue regeneration is essential. In particular, the effect of extracellular matrix (ECM) mechanics on the regenerative capability of APCs remains to be clarified. We have used artificial ECMs based on photocrosslinkable RGD-alginate to investigate the adipogenic and pro-angiogenic potential of 3T3-L1 preadipocytes as a function of matrix stiffness. These hydrogels allowed us to decouple matrix stiffness from changes in adhesion peptide density or extracellular Ca2+ concentration and provided a physiologically relevant 3D culture context. Our findings suggest that increased matrix rigidity promotes APC self-renewal and angiogenic capacity, whereas, it inhibits adipose differentiation. Collectively, this study advances our understanding of the role of ECM mechanics in adipose tissue formation and vascularization and will aid in the design of efficacious biomaterial scaffolds for adipose tissue engineering applications. Biotechnol. Bioeng. 2011; 108: 1683-1692. (C) 2011 Wiley Periodicals, Inc.
C1 [Chandler, Emily M.; Lee, Jason S.; Fischbach, Claudia] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.
   [Berglund, Caroline M.; Polacheck, William J.; Gleghorn, Jason P.; Kirby, Brian J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA.
RP Fischbach, C (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.
EM cf99@cornell.edu
RI Fischbach, Claudia/C-8550-2009; Kirby, Brian/D-4139-2012
OI Fischbach, Claudia/0000-0002-9368-0150; Kirby,
   Brian/0000-0002-7479-9738; Polacheck, William/0000-0003-2728-0746
FU New York State Center for Advanced Technology; Morgan Tissue Engineering
   Fund; Cornell Center for Materials Research; National Science Foundation
   [DMR 0520404]; Graduate Research Fellowship for Emily Chandler
FX Contract grant sponsor: New York State Center for Advanced Technology;
   Contract grant sponsor: Morgan Tissue Engineering Fund; Contract grant
   sponsor: Cornell Center for Materials Research; Contract grant sponsor:
   National Science Foundation; Contract grant number: DMR 0520404;
   Contract grant sponsor: Graduate Research Fellowship for Emily Chandler
CR Boontheekul T, 2008, FARADAY DISCUSS, V139, P105
   Boontheekul T, 2008, FARADAY DISCUSS, V139, P419
   Boontheekul T, 2008, FARADAY DISCUSS, V139, P53, DOI 10.1039/b719928g
   BOYNTON AL, 1974, IN VITRO CELL DEV B, V10, P12, DOI 10.1007/BF02615333
   Chou AI, 2009, J BIOMED MATER RES A, V91A, P187, DOI 10.1002/jbm.a.32191
   Corr DT, 2009, WOUND REPAIR REGEN, V17, P250, DOI 10.1111/j.1524-475X.2009.00463.x
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Fischbach C, 2004, EXP CELL RES, V300, P54, DOI 10.1016/j.yexcr.2004.05.036
   Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09
   Gimeno RE, 2005, CURR OPIN PHARMACOL, V5, P122, DOI 10.1016/j.coph.2005.01.006
   Jensen B, 2004, EXP CELL RES, V301, P280, DOI 10.1016/j.yexcr.2004.08.030
   Jeon O, 2010, TISSUE ENG PT A, V16, P2915, DOI [10.1089/ten.tea.2010.0096, 10.1089/ten.TEA.2010.0096]
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Kang JH, 2009, TISSUE ENG PT A, V15, P2227, DOI 10.1089/ten.tea.2008.0469
   Karamichos D, 2007, J BIOMED MATER RES A, V83A, P887, DOI 10.1002/jbm.a.31423
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Lai N, 2009, TISSUE ENG PT A, V15, P1053, DOI 10.1089/ten.tea.2008.0101
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Li Q, 2004, J BIOMED MATER RES A, V68A, P28, DOI 10.1002/jbm.a.20007
   Lin CC, 2008, BIOMACROMOLECULES, V9, P75, DOI 10.1021/bm700782c
   Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765
   Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4
   Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018
   Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339
   NTAMBI JM, 2000, J NUTR, V130, P3122
   Ono K, 2000, J BIOMED MATER RES, V49, P289
   Parker AM, 2006, EXPERT OPIN BIOL TH, V6, P567, DOI 10.1517/14712598.6.6.567
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Pirone DM, 2006, J CELL BIOL, V174, P277, DOI 10.1083/jcb.200510062
   Rouillard AD, 2011, TISSUE ENG PART C-ME, V17, P173, DOI [10.1089/ten.tec.2009.0582, 10.1089/ten.TEC.2009.0582]
   Rouillard AD, 2010, BIOMACROMOLECULES, V11, P2184, DOI 10.1021/bm1001312
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359
   Samani A, 2003, PHYS MED BIOL, V48, P2183, DOI 10.1088/0031-9155/48/14/310
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Stacey DH, 2009, TISSUE ENG PT A, V15, P3389, DOI [10.1089/ten.tea.2008.0293, 10.1089/ten.TEA.2008.0293]
   Subramanian A, 2005, J BIOMED MATER RES A, V75A, P742, DOI 10.1002/jbm.a.30489
   TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765
   Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859
   Underhill GH, 2007, BIOMATERIALS, V28, P256, DOI 10.1016/j.biomaterials.2006.08.043
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388
   Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 53
TC 55
Z9 56
U1 1
U2 43
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD JUL
PY 2011
VL 108
IS 7
BP 1683
EP 1692
DI 10.1002/bit.23079
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 775NV
UT WOS:000291467600020
PM 21328324
DA 2018-10-20
ER

PT J
AU Dubey, AK
   Gupta, SD
   Basu, B
AF Dubey, Ashutosh Kumar
   Gupta, Shourya Dutta
   Basu, Bikramjit
TI Optimization of electrical stimulation parameters for enhanced cell
   proliferation on biomaterial surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE pulsed electric field; calcium phosphate(s); cell-material interactions;
   BaTiO3
ID PROTEIN ADSORPTION; FIELD; ADHESION; BONE; HYDROXYAPATITE; FIBROBLASTS;
   OSTEOBLASTS; FREQUENCY; MOTILITY
AB From the point of view of biocompatibility of bone analog materials, cell-material interaction is of fundamental importance. In this article, we report the effect of pulse electric field stimulation on cell-material interaction by analyzing cellular functionality and viability. An in-house fabricated pulse electric field setup was used for the application of electric field during cell culture experiments. To optimize voltage/electric field, the first set of exploratory experiments was conducted with varying field strength at fixed frequency, and subsequently, the frequency of the electrical stimulation was varied to study its influence on the proliferation of L929 mouse fibroblast cells on gelatin-coated control disc. Subsequently, L929 cells were cultured on hydroxyapatite (HA) and HA-40 wt % BaTiO3 composite. Cell-cultured samples were analyzed qualitatively as well as quantitatively using fluorescence microscope and scanning electron microscope. It has been demonstrated that due to the application of electric field during the cell culture experiment, the cell proliferation and the cell spreading on the surface of the biomaterials were enhanced within a narrow window of voltage/frequency of electrical stimulation. At lower field intensities, the energy density is quite low and increases parabolically with field strength. There is no significant increase in the temperature (Delta T similar to 10(-5) K) of the medium due to the application of short duration pulse electric field. This led us to believe that electric field with appropriate strength and duration can enhance the cell-material interaction. (c) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 98B: 18-29, 2011.
C1 [Dubey, Ashutosh Kumar; Gupta, Shourya Dutta; Basu, Bikramjit] Indian Inst Technol, Lab Biomat, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
RP Basu, B (reprint author), Indian Inst Technol, Lab Biomat, Dept Mat Sci & Engn, Kanpur 208016, Uttar Pradesh, India.
EM bikram@iitk.ac.in
RI BASU, BIKRAMJIT/A-9967-2013
FU Department of Science and Technology, India; Department of
   Biotechnology, India
FX Contract grant sponsor: Department of Science and Technology, India;
   Department of Biotechnology, India
CR Alberts B, 2002, MOL BIOL CELL
   BOURGUIGNON GJ, 1987, FASEB J, V1, P398
   COOPER MS, 1984, P NATL ACAD SCI-BIOL, V81, P160, DOI 10.1073/pnas.81.1.160
   Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Dubey AK, 2010, J BIOMED MATER RES B, V95B, P320, DOI 10.1002/jbm.b.31716
   Ercan B, 2008, INT J NANOMED, V3, P477
   ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296
   FERRIER J, 1986, J CELL PHYSIOL, V129, P283, DOI 10.1002/jcp.1041290303
   Finkelstein E, 2004, J CELL SCI, V117, P1533, DOI 10.1242/jcs.00986
   FUJITA T, 1983, CALCIFIED TISSUE INT, V35, P153, DOI 10.1007/BF02405023
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   GRINNELL F, 1980, CELL, V19, P517, DOI 10.1016/0092-8674(80)90526-7
   Hair PS, 2003, BIOELECTROCHEMISTRY, V61, P65, DOI 10.1016/S1567-5394(03)00076-8
   He HW, 2008, APPL SURF SCI, V255, P565, DOI 10.1016/j.apsusc.2008.06.102
   Joshi RP, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011913
   Kolb JF, 2006, BIOELECTROMAGNETICS, V27, P172, DOI 10.1002/bem.20185
   Kotwal A, 2001, BIOMATERIALS, V22, P1055, DOI 10.1016/S0142-9612(00)00344-6
   Lynch I, 2007, PHYSICA A, V373, P511, DOI 10.1016/j.physa.2006.06.008
   MAROUDAS NG, 1975, J THEOR BIOL, V49, P417, DOI 10.1016/0022-5193(75)90182-4
   Panagopoulos DJ, 2000, BIOCHEM BIOPH RES CO, V272, P634, DOI 10.1006/bbrc.2000.2746
   SCHIMMELPFENG J, 1993, BIOELECTROCH BIOENER, V30, P143, DOI 10.1016/0302-4598(93)80072-3
   Schoenbach KH, 1997, IEEE T PLASMA SCI, V25, P284, DOI 10.1109/27.602501
   Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220
   SINGH VR, 1989, J BIOMED ENG, V11, P457, DOI 10.1016/0141-5425(89)90039-3
   SU S, 2005, J MATH MODELL ALGORI, V4, P99
   TIMOSHKIN IV, 2006, C EL INS DIEL PHEN I, P676
   VODOVNIK L, 1992, MED BIOL ENG COMPUT, V30, pCE21, DOI 10.1007/BF02446174
   YANG WP, 1984, EXP CELL RES, V155, P92, DOI 10.1016/0014-4827(84)90770-5
NR 28
TC 39
Z9 39
U1 0
U2 34
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2011
VL 98B
IS 1
BP 18
EP 29
DI 10.1002/jbm.b.31827
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 777EP
UT WOS:000291598900003
PM 21432997
DA 2018-10-20
ER

PT J
AU Piascik, JR
   Wolter, SD
   Stoner, BR
AF Piascik, Jeffrey R.
   Wolter, Scott D.
   Stoner, Brian R.
TI Enhanced bonding between YSZ surfaces using a gas-phase fluorination
   pretreatment
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE adhesion; zirconia; surface modification; surface characterization;
   ceramic
ID ZIRCONIA-BASED MATERIALS; RESIN CEMENT; CERAMICS; STRENGTH; BIOMATERIAL
AB The present investigation focuses on the surface modification, via gas-phase fluorination process, of yttria-stabilized zirconia (YSZ) to increase its wettability and chemical bonding directly to acrylate-based resin cements. YSZ plates and cylinders, as-received and roughened, were pretreated in a fluorine containing plasma and bonded with a commercially available resin cement for simple shear bond adhesion testing. No organo-silane coupling agent was used to enhance bonding between the two substrates. Shear bond tests revealed that bond strength increased with fluorination time. Furthermore, the pretreated, as received (nonroughened) specimen group displayed relatively high bond strengths suggesting surface reactivity and direct chemical bonding with the resin cement. X-ray photoelectron spectroscopy analysis revealed the surface conversion layer to be a mixture of phases; zirconium oxyfluoride, zirconium fluoride, and yttrium fluoride. It is hypothesized that these fluoride and oxyfluoride phases have the potential to increase surface hydroxylation, enabling direct covalent bonding between YSZ and resin cement. It is believed that this surface treatment has broad reaching impact when using high-strength ceramics in a multitude of bioapplications. (c) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 98B: 114-119, 2011.
C1 [Piascik, Jeffrey R.; Stoner, Brian R.] RTI Int, Ctr Mat & Elect Technol, Res Triangle Pk, NC USA.
   [Wolter, Scott D.; Stoner, Brian R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC USA.
RP Piascik, JR (reprint author), RTI Int, Ctr Mat & Elect Technol, Res Triangle Pk, NC USA.
EM jpiascik@rti.org
RI Stoner, Brian/D-9747-2011
FU RTI
FX Contract grant sponsors: RTI International Research and Development Fund
CR Aboushelib MN, 2008, DENT MATER, V24, P1268, DOI 10.1016/j.dental.2008.02.010
   Aboushelib MN, 2010, J PROSTHODONT, V19, P340, DOI 10.1111/j.1532-849X.2010.00575.x
   Aboushelib MN, 2009, DENT MATER, V25, P989, DOI 10.1016/j.dental.2009.02.011
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   Al-Amleh B, 2010, J ORAL REHABIL, V37, P641, DOI 10.1111/j.1365-2842.2010.02094.x
   Chakrapani V, 2007, SCIENCE, V318, P1424, DOI 10.1126/science.1148841
   Della Bona A, 2008, J AM DENT ASSOC, V139, p8S
   Denry IL, 1996, CRIT REV ORAL BIOL M, V7, P134, DOI 10.1177/10454411960070020201
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Derand T, 2005, DENT MATER, V21, P1158, DOI 10.1016/j.dental.2005.02.005
   Valandro LF, 2006, J ADHES DENT, V8, P175
   Guess PC, 2010, J DENT RES, V89, P592, DOI 10.1177/0022034510363253
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Lawn BR, 2002, J DENT RES, V81, P433, DOI 10.1177/154405910208100615
   Lohbauer U, 2008, J BIOMED MATER RES B, V87B, P461, DOI 10.1002/jbm.b.31126
   Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005
   Matinlinna JP, 2006, DENT MATER, V22, P824, DOI 10.1016/j.dental.2005.11.035
   PANTANO CG, 1988, J AM CERAM SOC, V71, P577, DOI 10.1111/j.1151-2916.1988.tb05922.x
   Piascik JR, 2009, DENT MATER, V25, P1116, DOI 10.1016/j.dental.2009.03.008
   PIASCIK JR, 2011, DENT MATER, pE1
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Yoshida K, 2006, J BIOMED MATER RES B, V77B, P28, DOI 10.1002/jbm.b.30424
NR 23
TC 13
Z9 14
U1 0
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2011
VL 98B
IS 1
BP 114
EP 119
DI 10.1002/jbm.b.31840
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 777EP
UT WOS:000291598900013
PM 21504059
DA 2018-10-20
ER

PT J
AU Yamada, Y
   Katagiri, F
   Hozumi, K
   Kikkawa, Y
   Nomizu, M
AF Yamada, Yuji
   Katagiri, Fumihiko
   Hozumi, Kentaro
   Kikkawa, Yamato
   Nomizu, Motoyoshi
TI Cell behavior on protein matrices containing laminin alpha 1 peptide
   AG73
SO BIOMATERIALS
LA English
DT Article
DE Peptide; Collagen; Integrin; ECM (extra cellular matrix); Laminin;
   Fibroconectin
ID HEPARAN-SULFATE CHAINS; EXTRACELLULAR-MATRIX; SYNTHETIC PEPTIDES;
   NEURITE OUTGROWTH; G-DOMAIN; BIOLOGICAL-ACTIVITIES; CHITOSAN MEMBRANES;
   BINDING SEQUENCES; GLOBULAR DOMAIN; PC12 CELLS
AB Collagen has been widely used for tissue engineering. Here, we applied bioactive laminin-derived peptides as an additive for collagen, laminin-111, and fibronectin matrices resulting in peptide/collagen, peptide/laminin-111, and peptide/fibronectin matrices. Several syndecan-binding peptides, including AG73 (RKRLQVQLSIRT), enhanced the cell attachment activity of collagen matrices. AG73 synergistically enhanced not only cell attachment but also cell spreading on collagen matrices. AG73 also enhanced integrin-binding to the collagen matrices, including organization of actin stress fibers and promotion of Tyr397-focal adhesion kinase (FAK) phosphorylation. Additionally, AG73 enhanced neurite outgrowth on collagen matrices. These results suggest that the integrin-mediated biological activity of collagen matrices is synergistically enhanced by the syndecan-mediated cellular function of AG73. Further, cell attachment and spreading activity of laminin-111 and fibronectin matrices was also synergistically enhanced by AG73. The syndecan-binding peptides are useful to enhance the integrin-mediated biological activities of extracellular matrix (ECM) proteins, such as collagen, laminin-111, and fibronectin. The peptide/matrix mixed method is a new concept for biomaterial fabrication and has the potential for wide use in cell and tissue engineering. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Yamada, Yuji; Katagiri, Fumihiko; Hozumi, Kentaro; Kikkawa, Yamato; Nomizu, Motoyoshi] Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, Tokyo 1920392, Japan.
RP Nomizu, M (reprint author), Tokyo Univ Pharm & Life Sci, Lab Clin Biochem, Sch Pharm, Tokyo 1920392, Japan.
EM nomizu@toyaku.ac.jp
RI Kikkawa, Yamato/D-1503-2010
FU Ministry of Education, Cultures, Sports, Science and Technology of Japan
   [22390017]
FX This work was supported by Grants-in-Aid for Scientific Research from
   the Ministry of Education, Cultures, Sports, Science and Technology of
   Japan (22390017).
CR Arnaout MA, 2007, CURR OPIN CELL BIOL, V19, P495, DOI 10.1016/j.ceb.2007.08.002
   Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3
   Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4
   Cen L, 2008, PEDIATR RES, V63, P492, DOI 10.1203/PDR.0b013e31816c5bc3
   Couchman JR, 2001, INT REV CYTOL, V207, P113
   ELENIUS K, 1990, J BIOL CHEM, V265, P17837
   Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820
   Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871
   Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633
   Hoffman MP, 2001, J BIOL CHEM, V276, P22077, DOI 10.1074/jbc.M100774200
   Hozumi K, 2006, J BIOL CHEM, V281, P32929, DOI 10.1074/jbc.M605708200
   Hozumi K, 2010, FEBS LETT, V584, P3381, DOI 10.1016/j.febslet.2010.06.032
   Hozumi K, 2009, BIOMATERIALS, V30, P1596, DOI 10.1016/j.biomaterials.2008.12.011
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ikemoto S, 2006, J BIOMED MATER RES A, V79A, P716, DOI 10.1002/jbm.a.30804
   Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200
   Kasai S, 2007, BIOCHEMISTRY-US, V46, P3966, DOI 10.1021/bi062097t
   Kruegel J, 2010, CELL MOL LIFE SCI, V67, P2879, DOI 10.1007/s00018-010-0367-x
   Kusano Y, 2000, EXP CELL RES, V256, P434, DOI 10.1006/excr.2000.4802
   Lopes CC, 2006, BRAZ J MED BIOL RES, V39, P157, DOI 10.1590/S0100-879X2006000200001
   McLean SM, 2005, BRIT J OPHTHALMOL, V89, P1506, DOI 10.1136/bjo.2005.071886
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Mochizuki M, 2003, FASEB J, V17, P875, DOI 10.1096/fj.02-0564fje
   Mochizuki M, 2007, ARCH BIOCHEM BIOPHYS, V459, P249, DOI 10.1016/j.abb.2006.12.026
   Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289
   Nomizu M, 1997, J BIOL CHEM, V272, P32198, DOI 10.1074/jbc.272.51.32198
   Nomizu M, 1998, J BIOL CHEM, V273, P32491, DOI 10.1074/jbc.273.49.32491
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Nomizu M, 2000, ARCH BIOCHEM BIOPHYS, V378, P311, DOI 10.1006/abbi.2000.1828
   Rapraeger AC, 2000, J CELL BIOL, V149, P995, DOI 10.1083/jcb.149.5.995
   Richard BL, 1996, EXP CELL RES, V228, P98, DOI 10.1006/excr.1996.0304
   Sroka IC, 2010, J CELL PHYSIOL, V224, P283, DOI 10.1002/jcp.22149
   Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948
   Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527
   Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s
   Suzuki N, 2003, J BIOL CHEM, V278, P45697, DOI 10.1074/jbc.M304667200
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   TOMASELLI KJ, 1990, NEURON, V5, P651, DOI 10.1016/0896-6273(90)90219-6
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005
   Weeks BS, 1998, EXP CELL RES, V243, P375, DOI 10.1006/excr.1998.4157
   Whelan MC, 2003, J BIOL CHEM, V278, P327, DOI 10.1074/jbc.M207554200
   Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002
   Woods A, 2001, CURR OPIN CELL BIOL, V13, P578, DOI 10.1016/S0955-0674(00)00254-4
   Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   ZHANG ZY, 1993, J BIOL CHEM, V268, P5557
NR 48
TC 7
Z9 8
U1 1
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2011
VL 32
IS 19
BP 4327
EP 4335
DI 10.1016/j.biomaterials.2011.02.052
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771OX
UT WOS:000291171700002
PM 21420730
DA 2018-10-20
ER

PT J
AU Roberts, SJ
   Geris, L
   Kerckhofs, G
   Desmet, E
   Schrooten, J
   Luyten, FP
AF Roberts, Scott J.
   Geris, Liesbet
   Kerckhofs, Greet
   Desmet, Eline
   Schrooten, Jan
   Luyten, Frank P.
TI The combined bone forming capacity of human periosteal derived cells and
   calcium phosphates
SO BIOMATERIALS
LA English
DT Article
DE Progenitor cell; Bone regeneration; Osteogenesis; Calcium phosphate;
   Scaffold
ID MESENCHYMAL STEM-CELLS; IN-VITRO; PROGENITOR CELLS; DENTAL-PULP; REPAIR;
   TISSUE; REGENERATION; MULTIPOTENT; SCAFFOLDS; MARROW
AB Current knowledge suggests that the periosteum, a fibrous tissue which covers the surface of all bones, contains a population of progenitor cells which mediate the repair of bone defects. In an effort to optimise the utilisation of this source of cells for bone engineering, herein we describe the rational selection of calcium phosphate (CaP) containing materials, based on biomaterial properties, and evaluation of their combined bone forming capacity. Five different commercially available orthopaedic 3D matrices composed of CaP particles in an open collagen network (NuOss (TM), CopiOs (TM), Bio-Oss (R), Collagraft (TM) and Vitoss (R)) were evaluated in vitro and in vivo with human periosteal derived cells (hPDCs). It was found that the cell-material combinations behaved quite differently in vivo, despite apparent in vitro similarities in gene expression profiles. Bone formation was highest within the NuOss (TM)/hPDC implant at 13.03%, which also contained the highest incidence of bone marrow formation. The bone formed in this implant was chimeric with approximately 65% originating from implanted cells. Upon analysis of human specific gene expression, although it was found that predominantly osteogenic differentiation was observed within NuOss (TM)/hPDC implants, a lesser induction of chondrogenic genes was also observed. The formation of a cartilage intermediate was confirmed by histology. Additionally the NuOss (TM)/hPDC implant integrated into the mouse environment with apparent active scaffold resorption. This study demonstrates the importance of matching a cell support/biological matrix with a cell type and subsequently has outlined parameters which can be used for the rational selection of biomaterials for bone engineering. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Roberts, Scott J.; Desmet, Eline; Luyten, Frank P.] Katholieke Univ Leuven, Lab Skeletal Dev & Joint Disorders, B-3000 Louvain, Belgium.
   [Roberts, Scott J.; Geris, Liesbet; Kerckhofs, Greet; Desmet, Eline; Schrooten, Jan; Luyten, Frank P.] Katholieke Univ Leuven, Prometheus Div Skeletal Tissue Engn, B-3000 Louvain, Belgium.
   [Geris, Liesbet] Univ Liege, Biomech Res Unit, B-4000 Liege, Belgium.
   [Geris, Liesbet] Katholieke Univ Leuven, Div Biomech & Engn Design, B-3001 Heverlee, Belgium.
   [Kerckhofs, Greet; Schrooten, Jan] Katholieke Univ Leuven, Dept Met & Mat Engn, B-3001 Heverlee, Belgium.
RP Luyten, FP (reprint author), Katholieke Univ Leuven, Lab Skeletal Dev & Joint Disorders, Onderwijs Navorsing 8th Floor,Bus 813,O&N 1,Heres, B-3000 Louvain, Belgium.
EM Frank.Luyten@uz.kuleuven.be
RI Kerckhofs, Greet/J-5006-2016
OI Kerckhofs, Greet/0000-0002-1750-8324; geris, liesbet/0000-0002-8180-1445
FU K.U. Leuven - IOF Knowledge Platform 'Prometheus' [IOFKP/07/004]; IWT
   (Institute for the Promotion of Innovation through Science and
   Technology - Vlaanderen) [IWT/OZM/090655]
FX The authors are grateful to Carla Geeroms, Isabelle de Wit, Kathleen
   Bosmans and Ward Puttemans for excellent technical assistance. We would
   also like to thank Prof. Maurilio Sampaolesi & Dr. Stefania Crippa for
   the generous gift of hMES, Prof. Rik Lories & Dr. Kristel Van Landuyt
   for the generous gift of hSDC, Sebastian De Boodt for developing the
   MatLab image analysis tool and An Kempeneers for assistance with ICP
   measurements. We would also like to thank all collaborators of
   Laboratory for Skeletal Development and Joint Disorders for useful
   comments and discussions. Funding for this research was obtained from
   the K.U. Leuven - IOF Knowledge Platform 'Prometheus' IOFKP/07/004 and
   the IWT (Institute for the Promotion of Innovation through Science and
   Technology - Vlaanderen) - IWT/OZM/090655. This work is part of
   Prometheus, the Leuven Research & Development Division of Skeletal
   Tissue Engineering of the Katholieke Universiteit Leuven:
   www.kuleuven.be/prometheus.
CR Adams CS, 2001, J BIOL CHEM, V276, P20316, DOI 10.1074/jbc.M006492200
   Bakken GA, 2000, J MED CHEM, V43, P4534, DOI 10.1021/jm000244u
   BHASKAR SN, 1953, J DENT RES, V32, P398, DOI 10.1177/00220345530320031401
   Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200
   Colnot C, 2009, J BONE MINER RES, V24, P274, DOI 10.1359/JBMR.081003
   d'Aquino R, 2008, STEM CELL REV, V4, P21, DOI 10.1007/s12015-008-9013-5
   De Bari C, 2006, ARTHRITIS RHEUM, V54, P1209, DOI 10.1002/art.21753
   De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064
   De Bari C, 2008, ARTHRITIS RHEUM, V58, P240, DOI 10.1002/art.23143
   de Girolamo L, 2009, CYTOTHERAPY, V11, P793, DOI 10.3109/14653240903079393
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Duhamel HL, 1742, HIST MEMOIRES ACADEM, V2, P481
   Eyckmans J, 2010, J CELL MOL MED, V14, P1845, DOI 10.1111/j.1582-4934.2009.00807.x
   Eyckmans J, 2006, TISSUE ENG, V12, P2203, DOI 10.1089/ten.2006.12.2203
   Fell HB, 1932, J ANAT, V66, P157
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Giannoudis R V., 2005, INJURY S3, V3, pS20
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Guilak F, 2010, CLIN ORTHOP RELAT R, V468, P2530, DOI 10.1007/s11999-010-1410-9
   Habibovic P, 2006, J BIOMED MATER RES A, V77A, P747, DOI 10.1002/jbm.a.30712
   Hatano H, 1998, J PATHOL, V185, P204
   Kanatani M, 2002, J CELL PHYSIOL, V190, P306, DOI 10.1002/jcp.10067
   Lenas P, 2009, TISSUE ENG PART B-RE, V15, P395, DOI [10.1089/ten.teb.2009.0461, 10.1089/ten.TEB.2009.0461]
   Lenas P, 2009, TISSUE ENG PART B-RE, V15, P381, DOI [10.1089/ten.teb.2008.0575, 10.1089/ten.TEB.2008.0575]
   Liu YK, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/2/025004
   Lorensen WE, 1988, ACM SIGGRAPH COMPUTE, V21, P163, DOI DOI 10.1145/37402.37422
   Martin I, 2002, TISSUE ENG, V8, P847, DOI 10.1089/10763270260424204
   Matsumoto T, 2008, BONE, V43, P434, DOI 10.1016/j.bone.2008.05.001
   McCullen SD, 2010, TISSUE ENG PT A, V16, P1971, DOI [10.1089/ten.tea.2009.0691, 10.1089/ten.TEA.2009.0691]
   Melnick M, 2005, CELLS TISSUES ORGANS, V179, P146, DOI 10.1159/000085950
   Minasi MG, 2002, DEVELOPMENT, V129, P2773
   Nah HD, 2000, J BONE MINER RES, V15, P522, DOI 10.1359/jbmr.2000.15.3.522
   Nayab SN, 2007, J BIOMED MATER RES A, V83A, P296, DOI 10.1002/jbm.a.31218
   Ozaki A, 2000, J Orthop Sci, V5, P64, DOI 10.1007/s007760050010
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   QUARTO R, 1995, CALCIFIED TISSUE INT, V56, P123, DOI 10.1007/BF00296343
   Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Sen MK, 2007, INJURY, V38, pS75, DOI 10.1016/j.injury.2007.02.012
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Shibata S, 2006, J ANAT, V208, P169, DOI 10.1111/j.1469-7580.2006.00525.x
   Sun JS, 2005, BIOMATERIALS, V26, P3953, DOI 10.1016/j.biomaterials.2004.10.016
   Taguchi K, 2005, BIOCHEM BIOPH RES CO, V331, P31, DOI 10.1016/j.bbrc.2006.03.119
   Waese EYL, 2008, SKELETAL RADIOL, V37, P601, DOI 10.1007/s00256-007-0438-8
   WANG Q, 2010, AM J PATHOL
   Yuan HP, 2006, TISSUE ENG, V12, P1607, DOI 10.1089/ten.2006.12.1607
   Zhao L, 2010, BIOMATERIALS, V31, P3848, DOI 10.1016/j.biomaterials.2010.01.093
NR 47
TC 61
Z9 60
U1 1
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2011
VL 32
IS 19
BP 4393
EP 4405
DI 10.1016/j.biomaterials.2011.02.047
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771OX
UT WOS:000291171700009
PM 21421268
DA 2018-10-20
ER

PT J
AU Andersen, TE
   Palarasah, Y
   Skjodt, MO
   Ogaki, R
   Benter, M
   Alei, M
   Kolmos, HJ
   Koch, C
   Kingshott, P
AF Andersen, Thomas E.
   Palarasah, Yaseelan
   Skjodt, Mikkel-Ole
   Ogaki, Ryosuke
   Benter, Maike
   Alei, Mojagan
   Kolmos, Hans J.
   Koch, Claus
   Kingshott, Peter
TI Decreased material-activation of the complement system using low-energy
   plasma polymerized poly(vinyl pyrrolidone) coatings
SO BIOMATERIALS
LA English
DT Article
DE Silicone; Complement activation; Protein adsorption; Plasma
   polymerization; Vinyl pyrrolidone
ID MODIFIED POLYSTYRENE SURFACES; MODEL BIOMATERIAL SURFACE; IN-VITRO;
   PROTEIN ADSORPTION; ARTIFICIAL SURFACES; BLOOD COMPATIBILITY;
   PLATELET-ADHESION; 2 PARTS; PEO; HEMODIALYSIS
AB In the current study we investigate the activation of blood complement on medical device silicone rubber and present a plasma polymerized vinyl pyrrolidone (ppVP) coating which strongly decreases surface-activation of the blood complement system. We show that uncoated silicone and polystyrene are both potent activators of the complement system, measured both as activated, deposited C3b and quantifying fluid-phase release of the cleavage fragment C3c. The ppVP coated silicone exhibits approximately 90% reduced complement activation compared to untreated silicone. Quartz crystal microbalance with dissipation (QCM-D) measurements show relatively strong adsorption of blood proteins including native C3 to the ppVP surface, indicating that reduction of complement activation on ppVP is neither a result of low protein adsorption nor lower direct C3-binding, and is therefore possibly a consequence of differences in the adsorbed protein layer composition. The alternative and classical complement pathways are barely detectable on ppVP while the lectin pathway through MBL/ficolin-2 deposition remains active on ppVP suggesting this pathway is responsible for the remaining subtle activation on the ppVP coated surface. The ppVP surface is furthermore characterized physically and chemically using scanning electron microscopy (SEM), x-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FTIR), which indicates preservation of chemical functionality by the applied plasma process. Overall, the ppVP coating shows a potential for increasing complement compatibility of blood-contacting devices. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Andersen, Thomas E.; Kolmos, Hans J.] Univ So Denmark, Res Unit Clin Microbiol, Inst Clin Res, DK-5000 Odense C, Denmark.
   [Palarasah, Yaseelan; Skjodt, Mikkel-Ole; Koch, Claus] Univ So Denmark, Dept Canc & Inflammat, Inst Mol Med, DK-5000 Odense C, Denmark.
   [Andersen, Thomas E.; Benter, Maike; Alei, Mojagan] Nanon AS, DK-2605 Brondby, Denmark.
   [Andersen, Thomas E.; Ogaki, Ryosuke; Kingshott, Peter] Aarhus Univ, Interdisciplinary Nanosci Ctr, Fac Sci, DK-8000 Aarhus C, Denmark.
RP Kingshott, P (reprint author), Swinburne Univ Technol, IRIS, Fac Engn & Ind Sci, Hawthorn, Vic 3122, Australia.
EM pkingshott@groupwise.swin.edu.au
OI Skjodt, Mikkel-Ole/0000-0003-1306-6482; Kingshott,
   Peter/0000-0001-5882-5804; Andersen, Thomas Emil/0000-0001-9453-1141
FU Danish Agency for Science Technology and Innovation
FX We wish to thank the Danish Agency for Science Technology and Innovation
   for financial support.
CR Ademovic Z, 2006, J MATER SCI-MATER M, V17, P203, DOI 10.1007/s10856-006-7306-2
   Ademovic Z, 2005, PLASMA PROCESS POLYM, V2, P53, DOI 10.1002/ppap.200400038
   ALTEMEIER WA, 1954, AMA ARCH SURG, V69, P309, DOI 10.1001/archsurg.1954.01270030037004
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   [Anonymous], 1099342002 ISO
   Beamson G., 1998, XPS POLYM DATABASE
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Bremmell KE, 2006, LANGMUIR, V22, P313, DOI 10.1021/la052143a
   Cenni E, 1997, J MATER SCI-MATER M, V8, P771, DOI 10.1023/A:1018564629533
   CHENOWETH DE, 1984, ARTIF ORGANS, V8, P281, DOI 10.1111/j.1525-1594.1984.tb04291.x
   COLAS A, 2004, BIOMATERIALS SCI INT, P80
   CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Gemmell CH, 1997, J BIOMED MATER RES, V37, P474
   GOLANDER CG, 1992, J BIOMAT SCI-POLYM E, V4, P25
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   GRAINGER DW, 1989, J BIOMED MATER RES, V23, P979, DOI 10.1002/jbm.820230903
   HAUSER AC, 1990, CLIN SCI, V79, P471, DOI 10.1042/cs0790471
   Hayama M, 2004, J MEMBRANE SCI, V234, P41, DOI 10.1016/j.memsci.2004.01.020
   Kidane A, 1999, J BIOMED MATER RES, V48, P640, DOI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O
   Langer R, 1995, CHEM ENG SCI, V50, P4109, DOI 10.1016/0009-2509(95)00226-X
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   Marosok R, 1996, J BIOMED MATER RES, V30, P245
   Michanetzis GPA, 2002, J MATER SCI-MATER M, V13, P757, DOI 10.1023/A:1016166807299
   Mollnes TE, 1997, EXP CLIN IMMUNOGENET, V14, P24
   Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   NOJIRI C, 1990, J BIOMED MATER RES, V24, P1151, DOI 10.1002/jbm.820240903
   Ortega-Vinuesa JL, 1998, J COLLOID INTERF SCI, V207, P228, DOI 10.1006/jcis.1998.5624
   Palarasah Y, 2010, J IMMUNOL METHODS, V362, P142, DOI 10.1016/j.jim.2010.09.024
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   RATNER BD, 1993, J BIOMED MATER RES, V27, P837, DOI 10.1002/jbm.820270702
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Sperling C, 2006, J BIOMED MATER RES A, V76A, P681, DOI 10.1002/jbm.a.30519
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   TACK BF, 1981, METHOD ENZYMOL, V80, P64
   Te Velthuis Henk, 1997, Journal of Thoracic and Cardiovascular Surgery, V114, P117, DOI 10.1016/S0022-5223(97)70124-7
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Vienken J, 2002, INT J ARTIF ORGANS, V25, P470
   Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406
   Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Xu XL, 2009, BLOOD PURIFICAT, V27, P321, DOI 10.1159/000207199
NR 49
TC 19
Z9 20
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2011
VL 32
IS 20
BP 4481
EP 4488
DI 10.1016/j.biomaterials.2011.03.002
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771XJ
UT WOS:000291193700001
PM 21453967
DA 2018-10-20
ER

PT J
AU Li, R
   Guo, WH
   Yang, B
   Guo, LJ
   Sheng, L
   Chen, G
   Li, Y
   Zou, Q
   Xie, D
   An, XX
   Chen, Y
   Tian, WD
AF Li, Rui
   Guo, Weihua
   Yang, Bo
   Guo, Lijuan
   Sheng, Lei
   Chen, Gang
   Li, Ye
   Zou, Qing
   Xie, Dan
   An, Xiaoxue
   Chen, Yali
   Tian, Weidong
TI Human treated dentin matrix as a natural scaffold for complete human
   dentin tissue regeneration
SO BIOMATERIALS
LA English
DT Article
DE Dentin matrix; Stem cells; Microenvironment; Natural scaffold; Tooth;
   Regeneration
ID GROWTH-FACTOR-BETA; STEM-CELLS; SMEAR LAYER; TOOTH REGENERATION;
   ENGINEERED TOOTH; EDTA SOLUTION; BUD CELLS; TGF-BETA; DECORIN; PULP
AB An essential aspect of tooth tissue engineering is the identification of suitable scaffolding materials to support cell growth and tissue regeneration. Treated dentin matrix (TDM) from a rat has recently been shown to be a suitable scaffold for rat dentin regeneration. However, due to species-specific differences, it remains unclear whether a similar fabrication method can be extended to human TDM and human dentin regeneration. Therefore, this present study explored the biological response to a human TDM (hTDM) created using a modified dentin treatment method. Various biological characteristics, including cell proliferation, cell migration, cell viability, and cytotoxity were investigated. To assess the inductive capacity of hTDM, dental follicle cells (DFCs) were combined with hTDM and were implanted in vivo for 8 weeks in a mouse model. The resulting grafts were studied histologically. The results showed hTDM released dentinogenic factors, indicating that hTDM could play a sustained role in odontogenesis. DFC attachment, growth, viability, and cytotoxicity on the surface of hTDM showed a notable improvement over those on calcium phosphate controls. Most importantly, in vivo hTDM induced and supported regeneration of complete dentin tissues, which expressed dentin markers DSP and DMP-1. As cells in and around the regenerated dentin were positive for human mitochondria, implanted DFCs and hTDM were responsible for the regenerated dentin tissues. In conclusion, hTDM is indicated as an ideal biomaterial for human dentin regeneration. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Li, Rui; Yang, Bo; Guo, Lijuan; Sheng, Lei; Chen, Gang; Tian, Weidong] Sichuan Univ, Dept Oral & Maxillofacial Surg, W China Coll Stomatol, Chengdu 610041, Peoples R China.
   [Li, Rui; Guo, Weihua; Yang, Bo; Guo, Lijuan; Sheng, Lei; Chen, Gang; Li, Ye; Zou, Qing; Xie, Dan; An, Xiaoxue; Chen, Yali; Tian, Weidong] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610041, Peoples R China.
RP Tian, WD (reprint author), Sichuan Univ, Dept Oral & Maxillofacial Surg, W China Coll Stomatol, 14 3rd Sect,Renmin S Rd, Chengdu 610041, Peoples R China.
EM drtwd@sina.com
RI Yu, Mei/G-4994-2015; jingjing, cai/M-2687-2013
OI Yu, Mei/0000-0003-0306-6817; 
FU Nature Science Foundation of China [2010CB944800, 30973348]; the Key
   Technology R&D Program of Sichuan Province [10ZC1618]
FX This study was supported by grants from the Nature Science Foundation of
   China (project nos. 2010CB944800 and 30973348) and the Key Technology
   R&D Program of Sichuan Province (project nos. 10ZC1618).
CR Abukawa H, 2009, J ORAL MAXIL SURG, V67, P335, DOI 10.1016/j.joms.2008.09.002
   Ando Y, 2009, NAGOYA J MED SCI, V71, P51
   Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035
   Aung FM, 2011, AM J CLIN PATHOL, V135, P90, DOI 10.1309/AJCP98JNYHGCGMHK
   Chun SY, 2011, TISSUE ENG PT A, V17, P181, DOI [10.1089/ten.tea.2010.0121, 10.1089/ten.TEA.2010.0121]
   Di Lenarda R, 2000, INT ENDOD J, V33, P46, DOI 10.1046/j.1365-2591.2000.00273.x
   Duailibi MT, 2004, J DENT RES, V83, P523, DOI 10.1177/154405910408300703
   Duailibi SE, 2008, J DENT RES, V87, P745, DOI 10.1177/154405910808700811
   Ferdous Z, 2007, J BIOL CHEM, V282, P35887, DOI 10.1074/jbc.M705180200
   FUKAZAWA E, 1994, J PERIODONTOL, V65, P168, DOI 10.1902/jop.1994.65.2.168
   Goldberg M, 2005, CALCIFIED TISSUE INT, V77, P297, DOI 10.1007/s00223-005-0026-7
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Guo WH, 2009, BIOMATERIALS, V30, P6708, DOI 10.1016/j.biomaterials.2009.08.034
   Honda MJ, 2007, BIOMATERIALS, V28, P680, DOI 10.1016/j.biomaterials.2006.09.039
   Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001
   Huang GTJ, 2009, REGEN MED, V4, P697, DOI 10.2217/RME.09.45
   Hulsmann M, 2003, INT ENDOD J, V36, P810, DOI 10.1111/j.1365-2591.2003.00754.x
   Jo YY, 2007, TISSUE ENG, V13, P767, DOI 10.1089/ten.2006.0192
   Kuah HG, 2009, J ENDODONT, V35, P393, DOI 10.1016/j.joen.2008.12.007
   Kuo TF, 2008, J BIOMED MATER RES A, V86A, P1062, DOI 10.1002/jbm.a.31.746
   Liu J, 2007, IN VITRO CELL DEV-AN, V43, P120, DOI 10.1007/s11626-007-9022-8
   Lluch AV, 2009, J BIOMED MATER RES B, V90B, P182, DOI 10.1002/jbm.b.31272
   Lottanti S, 2009, INT ENDOD J, V42, P335, DOI 10.1111/j.1365-2591.2008.01514.x
   Marshall GW, 1997, J DENT, V25, P441, DOI 10.1016/S0300-5712(96)00065-6
   Morsczeck C, 2005, MATRIX BIOL, V24, P155, DOI 10.1016/j.matbio.2004.12.004
   Nakashima K, 2005, J ENDODONT, V31, P47, DOI 10.1097/01.DON.0000134205.05404.8E
   Nakashima M, 2005, J ENDODONT, V31, P711, DOI 10.1097/01.don.0000164138.49923.e5
   Okabayashi K, 2004, BONE, V34, P124, DOI 10.1016/j.bone.2003.08.010
   Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4
   Park ES, 2009, J PROTEOME RES, V8, P1338, DOI 10.1021/pr801065s
   Peng L, 2009, INT J ORAL SCI, V1, P6, DOI 10.4248/ijos.08032
   Perez F, 2005, ORAL SURG ORAL MED O, V99, P383, DOI 10.1016/j.tripleo.2004.07.007
   Piattelli A, 2004, INT ENDOD J, V37, P114, DOI 10.1111/j.0143-2885.2004.00758.x
   Reed CC, 2003, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444
   Scheller EL, 2009, J ORAL REHABIL, V36, P368, DOI 10.1111/j.1365-2842.2009.01939.x
   Schonherr E, 1998, ARCH BIOCHEM BIOPHYS, V355, P241, DOI 10.1006/abbi.1998.0720
   Sen BH, 2009, ORAL SURG ORAL MED O, V108, P622, DOI 10.1016/j.tripleo.2009.04.042
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069
   Thesleff I, 1992, Proc Finn Dent Soc, V88 Suppl 1, P357
   Vigano L, 2008, CHEMOSPHERE, V73, P1078, DOI 10.1016/j.chemosphere.2008.07.057
   Yalvac ME, 2009, NEUROCHEM RES, V34, P1272, DOI 10.1007/s11064-008-9905-4
   YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0
   Yao S, 2008, J DENT RES, V87, P767, DOI 10.1177/154405910808700801
   Young CS, 2005, TISSUE ENG, V11, P1599, DOI 10.1089/ten.2005.11.1599
   Zaman KU, 2000, J PERIODONTOL, V71, P1094, DOI 10.1902/jop.2000.71.7.1094
NR 46
TC 69
Z9 77
U1 2
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2011
VL 32
IS 20
BP 4525
EP 4538
DI 10.1016/j.biomaterials.2011.03.008
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771XJ
UT WOS:000291193700006
PM 21458067
DA 2018-10-20
ER

PT J
AU Hsu, CW
   Olabisi, RM
   Olmsted-Davis, EA
   Davis, AR
   West, JL
AF Hsu, Chih-Wei
   Olabisi, Ronke M.
   Olmsted-Davis, Elizabeth A.
   Davis, Alan R.
   West, Jennifer L.
TI Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in
   response to bone resorption
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE hydrogel; biodegradation; bone remodeling; osteoclast
ID GRAFTS; CELLS; RECONSTRUCTION
AB We propose a new strategy of biomaterial design to achieve selective cellular degradation by the incorporation of cathepsin K-degradable peptide sequences into a scaffold structure so that scaffold biodegradation can be induced at the end of the bone formation process. Poly(ethylene glycol) diacrylate (PEGDA) hydrogels were used as a model biomaterial system in this study. A cathepsin K-sensitive peptide, GGGMGPSGPWGGK (GPSG), was synthesized and modified with acryloyl-PEG-succinimidyl carbonate to produce a cross-linkable cathepsin K-sensitive polymer that can be used to form a hydrogel. Specificity of degradation of the GPSG hydrogels was tested with cathepsin K and proteinase K as a positive control, with both resulting in significant degradation compared to incubation with nonspecific collagenases over a 24-h time period. No degradation was observed when the hydrogels were incubated with plasmin or control buffers. Cell-induced degradation was evaluated by seeding differentiated MC3T3-E1 osteoblasts and RAW264.7 osteoclasts on GPSG hydrogels that were also modified with the cell adhesion peptide RGDS. Resulting surface features and resorption pits were analyzed by differential interference contrast (DIC) and fluorescent images obtained with confocal microscopy. Results from both analyses demonstrated that GPSG hydrogels can be degraded specifically in response to osteoclast attachment but not in response to osteoblasts. In summary, we have demonstrated that by incorporating a cathepsin K-sensitive peptide into a synthetic polymer structure, we can generate biomaterials that specifically respond to cues from the natural process of bone remodeling. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 98A: 53-62, 2011.
C1 [Hsu, Chih-Wei; Olabisi, Ronke M.; West, Jennifer L.] Rice Univ, Dept Bioengn, Houston, TX 77005 USA.
   [Olmsted-Davis, Elizabeth A.; Davis, Alan R.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.
RP West, JL (reprint author), Rice Univ, Dept Bioengn, 6100 Main St, Houston, TX 77005 USA.
EM jwest@rice.edu
RI West, Jennifer/A-4582-2008
OI West, Jennifer/0000-0001-8550-2875; Olabisi, Ronke/0000-0003-3738-5250
FU Department of Defense [W82XWH-04-1-0068]
FX Contract grant sponsor: Department of Defense; contract grant number:
   W82XWH-04-1-0068
CR Bikram M, 2007, ANN BIOMED ENG, V35, P796, DOI 10.1007/s10439-007-9263-4
   Bouzide A, 2002, ORG LETT, V4, P2329, DOI 10.1021/ol020071y
   Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153
   Cornell Charles N, 2004, Bull Hosp Jt Dis, V62, P13
   Cruise GM, 1999, CELL TRANSPLANT, V8, P293, DOI 10.1177/096368979900800310
   EBELING W, 1974, EUR J BIOCHEM, V47, P91, DOI 10.1111/j.1432-1033.1974.tb03671.x
   Goldberg VM, 2000, CLIN ORTHOP RELAT R, P68
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hill P A, 1998, Br J Orthod, V25, P101
   Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448
   Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011
   Li WY, 2003, WOUND REPAIR REGEN, V11, P239, DOI 10.1046/j.1524-475X.2003.11402.x
   Malizos KN, 2004, J AM ACAD ORTHOP SUR, V12, P360, DOI 10.5435/00124635-200409000-00010
   Miller JS, 2010, BIOMATERIALS, V31, P3736, DOI 10.1016/j.biomaterials.2010.01.058
   Nishida J, 2008, MED SCI MONITOR, V14, pRA107
   Nosaka AY, 1999, BIOORGAN MED CHEM, V7, P375, DOI 10.1016/S0968-0896(98)00227-2
   Price CT, 2003, SPINE, V28, P793, DOI 10.1097/00007632-200304150-00012
   Redey SA, 1999, J BIOMED MATER RES, V45, P140, DOI 10.1002/(SICI)1097-4636(199905)45:2<140::AID-JBM9>3.3.CO;2-9
   Vaananen HK, 2000, J CELL SCI, V113, P377
NR 19
TC 25
Z9 25
U1 0
U2 19
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2011
VL 98A
IS 1
BP 53
EP 62
DI 10.1002/jbm.a.33076
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 770SC
UT WOS:000291107800006
PM 21523904
DA 2018-10-20
ER

PT J
AU Gonzalez, M
   Gil, FJ
   Manero, JM
   Pena, J
AF Gonzalez, M.
   Gil, F. J.
   Manero, J. M.
   Pena, J.
TI Characterization of Two Ti-Nb-Hf-Zr Alloys Under Different Cold Rolling
   Conditions
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
CY 2010
CL Pacific Grove, CA
SP Int Org Shape Memory & Superelastic Technolog
DE cold rolling; low elastic modulus; nanoindentation; Ni-free Ti alloys;
   shape memory effect
ID INDENTATION
AB The objective of this study is to obtain a new biomaterial to use in the load transfer medical implants field. The influence of cold work in the thermoelastic martensitic transformation and elastic modulus was investigated for a previously developed Ti-24.8Nb-16.2Hf-1Zr alloy (A1) and a new Ti-35Nb-9Hf-1Zr alloy (A2). The nanoindentation tests with spherical tip showed a decrease of the elastic modulus when increasing the cold work percentage. The lowest value (46 GPa) was achieved after the 95% reduction in thickness for A1. By contrast, the A2 alloy exhibits its lowest elastic modulus in the uncold-worked condition (58 GPa) and did not present evidences of thermoelastic martensitic transformation.
C1 [Gonzalez, M.; Gil, F. J.; Manero, J. M.; Pena, J.] Univ Politecn Cataluna, Dept Mat Sci & Met, E-08028 Barcelona, Spain.
   [Pena, J.] Elisava Escola Super Disseny, Barcelona 08002, Spain.
RP Gonzalez, M (reprint author), Univ Politecn Cataluna, Dept Mat Sci & Met, Avda Diagonal 647, E-08028 Barcelona, Spain.
EM Marta.Gonzalez.Colominas@upc.edu; Francesc.Xavier.Gil@upc.edu;
   Jose.Maria.Manero@upc.edu; jpenya@elisava.es
RI Manero, Jose Maria/B-4169-2015
OI Manero, Jose Maria/0000-0002-1673-4389
CR Arciniegas M, 2008, PHILOS MAG, V88, P2529, DOI 10.1080/14786430802375667
   BOYER R, 1998, MAT PROPERTIES HDB T, P5
   Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1
   Fischer-Cripps AC, 2000, VACUUM, V58, P569, DOI 10.1016/S0042-207X(00)00377-8
   Gonzalez M, 2009, J MATER ENG PERFORM, V18, P506, DOI 10.1007/s11665-009-9393-y
   Gonzalez M, 2009, J MATER ENG PERFORM, V18, P490, DOI 10.1007/s11665-009-9381-2
   Hao Y.L., 2007, Titanium alloy with extra-low modulus and superelasticity and its producing method and processing thereof, Patent No. [US 2007/0137742 al, 20070137742]
   Michiardi A, 2007, BIOMATERIALS, V28, P586, DOI 10.1016/j.biomaterials.2006.09.040
   Niinomi M., 2003, Science and Technology of Advanced Materials, V4, P445, DOI 10.1016/j.stam.2003.09.002
   Pharr GM, 1998, MAT SCI ENG A-STRUCT, V253, P151, DOI 10.1016/S0921-5093(98)00724-2
   Saito T, 2003, SCIENCE, V300, P464, DOI 10.1126/science.1081957
   Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328
NR 12
TC 7
Z9 7
U1 1
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JUL
PY 2011
VL 20
IS 4-5
SI SI
BP 653
EP 657
DI 10.1007/s11665-011-9917-0
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 772HQ
UT WOS:000291225400029
DA 2018-10-20
ER

PT J
AU Xu, SG
   Zhang, P
   Zhu, GM
   Jiang, YM
AF Xu, Shuo-Gui
   Zhang, Peng
   Zhu, Guang-Ming
   Jiang, Ying-Ming
TI Effect of Biodegradable Shape-Memory Polymers on Proliferation of 3T3
   Cells
SO JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE
LA English
DT Article; Proceedings Paper
CT International Conference on Shape Memory and Superelastic Technologies
CY 2010
CL Pacific Grove, CA
SP Int Org Shape Memory & Superelastic Technolog
DE 3T3-Swiss albino GNM 9; biocompatibility; biodegradable shape-memory
   polymers; biomaterial
AB This article evaluates the in vitro biocompatibility for biodegradable shape-memory polymers (BSMP) invented by the authors. 3T3 cells (3T3-Swiss albino GNM 9) of primary and passaged cultures were inoculated into two kinds of carriers: the BSMP carrier and the control group carrier. Viability, proliferation, and DNA synthesis (the major biocompatibility parameters), were measured and evaluated for both the BSMP and naked carrier via cell growth curve analysis, MTT colorimetry and addition of H-3-TdR to culture media. The results showed that there was no difference between the BSMP carrier and the control dish in terms of viability, proliferation, and metabolism of the 3T3 cells. Overall, the BSMP carrier provides good biocompatibility and low toxicity to cells in vitro, and could indicate future potential for this medium as a biological material for implants in vivo.
C1 [Xu, Shuo-Gui] Second Mil Med Univ, Changhai Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China.
   [Zhang, Peng] Shandong Prov Hosp, Dept Orthoped, Jinan, Peoples R China.
   [Zhu, Guang-Ming] Northwestern Polytech Univ, Dept Appl Chem, Xian 710072, Peoples R China.
   [Jiang, Ying-Ming] Second Mil Med Univ, Teaching & Res Div Immunol, Shanghai 200433, Peoples R China.
RP Xu, SG (reprint author), Second Mil Med Univ, Changhai Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China.
EM bonexu@yahoo.cn
CR JOHNSON HJ, 1983, J BIOMED MATER RES, V17, P571, DOI 10.1002/jbm.820170403
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Tormala P, 1998, P I MECH ENG H, V212, P101, DOI 10.1243/0954411981533872
   Tsuchiya T, 1994, J Biomater Appl, V9, P138
   XU SG, 2006, Patent No. 200610023175
NR 5
TC 4
Z9 4
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1059-9495
EI 1544-1024
J9 J MATER ENG PERFORM
JI J. Mater. Eng. Perform.
PD JUL
PY 2011
VL 20
IS 4-5
SI SI
BP 807
EP 811
DI 10.1007/s11665-011-9880-9
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 772HQ
UT WOS:000291225400055
DA 2018-10-20
ER

PT J
AU Joshy, MIA
   Elayaraja, K
   Suganthi, RV
   Veerla, SC
   Kalkura, SN
AF Joshy, M. I. Ahymah
   Elayaraja, K.
   Suganthi, R. V.
   Veerla, Sarath Chandra
   Kalkura, S. Narayana
TI In vitro sustained release of amoxicillin from lanthanum hydroxyapatite
   nano rods
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE Hydroxyapatite; Sol-gel technique; Drug release; Biomaterial
ID HYDROTHERMAL SYNTHESIS; APATITE FORMATION; TEMPERATURE; BIOACTIVITY;
   POWDERS; IONS; GEL; NANOPARTICLES; CALCINATION; BEHAVIOR
AB Nano rods (similar to 100 nm) of pure hydroxyapatite [Ca(10)(PO(4))(6)(OH)(2))-HAp] and lanthanum doped HAp was synthesized by sol-gel route using calcium nitrate and diammonium hydrogen phosphate as precursors. The samples were without La(2)O(3) or beta-TCP phases, which were present in samples prepared by solid state and co-precipitation technique. Increase in the concentration of lanthanum lead to the enhancement of crystallinity and crystallite size. In addition, increase in specific surface area (31%) and hardness (14%) was observed in doped samples. The studies using PBS revealed a decrease in the dissolution of the samples as the dopant concentration increased. Further, the doping extended the amoxicillin release from the samples. Bactericidal effect against Gram positive and Gram negative bacteria indicated high antimicrobial resistant activity of these samples. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Joshy, M. I. Ahymah; Elayaraja, K.; Suganthi, R. V.; Veerla, Sarath Chandra; Kalkura, S. Narayana] Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
RP Kalkura, SN (reprint author), Anna Univ, Ctr Crystal Growth, Madras 600025, Tamil Nadu, India.
EM kalkura@annauniv.edu
RI Kolanthai, Elayaraja/D-3041-2015
OI Kolanthai, Elayaraja/0000-0003-2615-6866
FU AICTE, India [8023/BOR/RID/RPS-63/2008]; National Doctoral Fellowship;
   DST, New Delhi [SR/SO/HS-05/2005]
FX This work was supported by a grant from AICTE, India through project No.
   8023/BOR/RID/RPS-63/2008 and a National Doctoral Fellowship award to one
   of the authors (M.I.A.J). The study was funded by a grant from DST, New
   Delhi through research project No. SR/SO/HS-05/2005. The authors wish to
   thank Prof. M. Palanichamy, Department of Chemistry, Anna University,
   Chennai for useful discussions and Cryotem facility available in Tata
   Institute of Fundamental Research for characterizing the sample by TEM.
CR Adamopoulos O, 2007, J MATER SCI-MATER M, V18, P1587, DOI 10.1007/s10856-007-3041-6
   Cao LY, 2005, CERAM INT, V31, P1041, DOI 10.1016/j.ceramint.2004.11.002
   Chaudhry AA, 2006, CHEM COMMUN, P2286, DOI 10.1039/b518102j
   Cho SB, 1998, J MATER SCI-MATER M, V9, P279, DOI 10.1023/A:1008808828567
   Cortes D, 2005, J MATER SCI, V40, P3509, DOI 10.1007/s10853-005-2856-0
   DESGRENIERS S, 1994, J APPL CRYSTALLOGR, V27, P432, DOI 10.1107/S0021889893012610
   Doat A, 2003, BIOMATERIALS, V24, P3365, DOI 10.1016/S0142-9612(03)00169-8
   Earl JS, 2006, J PHYS CONF SER, V26, P268, DOI 10.1088/1742-6596/26/1/064
   FRICKER P. SIMON, 2006, CHEM SOC REV, V35, P524
   Girija EK, 2008, J CERAM SOC JPN, V116, P320, DOI 10.2109/jcersj2.116.320
   Guo DG, 2009, ACTA BIOMATER, V5, P3512, DOI 10.1016/j.actbio.2009.05.026
   Han JK, 2006, MATER CHEM PHYS, V99, P235, DOI 10.1016/j.matchemphys.2005.10.017
   KLUG HP, 1947, XRAY DIFFRACTION PRO
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Komath M, 2000, B MATER SCI, V23, P135, DOI 10.1007/BF02706555
   Kuriakose TA, 2004, J CRYST GROWTH, V263, P517, DOI 10.1016/j.jcrysgro.2003.11.057
   Landi E, 2000, J EUR CERAM SOC, V20, P2377, DOI 10.1016/S0955-2219(00)00154-0
   LEBUGLE A, 2006, CHEM COMMUN, P608
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Mayer I, 1999, J INORG BIOCHEM, V73, P221, DOI 10.1016/S0162-0134(99)00019-7
   Melville AJ, 2008, J MATER SCI-MATER M, V19, P1187, DOI 10.1007/s10856-007-3185-4
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Pang YX, 2003, J EUR CERAM SOC, V23, P1697, DOI 10.1016/S0955-2219(02)00413-2
   Parhi P, 2006, J MATER SCI, V41, P1455, DOI 10.1007/s10853-006-7460-4
   SCHAAD P, 1994, J CHEM SOC FARADAY T, V90, P3405, DOI 10.1039/ft9949003405
   Vallet-Regi M, 2004, SOLID STATE IONICS, V172, P435, DOI 10.1016/j.ssi.2004.04.036
   VALLETREGI M, 2004, PROG SOLID STATE CHE, V32, pE31
   Velayudhan S, 2000, MATER LETT, V46, P142, DOI 10.1016/S0167-577X(00)00157-9
   Wakamura M, 2000, COLLOID SURFACE A, V164, P297, DOI 10.1016/S0927-7757(99)00384-2
   Webster J. T., 2004, BIOMATERIALS, V25, P2111
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
   Yang H, 2008, J MATER PROCESS TECH, V207, P276, DOI 10.1016/j.jmatprotec.2007.12.079
   Yang PP, 2008, BIOMATERIALS, V29, P4341, DOI 10.1016/j.biomaterials.2008.07.042
NR 33
TC 29
Z9 29
U1 2
U2 41
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD JUL
PY 2011
VL 11
IS 4
BP 1100
EP 1106
DI 10.1016/j.cap.2011.02.003
PG 7
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 769HX
UT WOS:000291004600027
DA 2018-10-20
ER

PT J
AU Pennisi, CP
   Dolatshahi-Pirouz, A
   Foss, M
   Chevallier, J
   Fink, T
   Zachar, V
   Besenbacher, F
   Yoshida, K
AF Pennisi, Cristian Pablo
   Dolatshahi-Pirouz, Alireza
   Foss, Morten
   Chevallier, Jacques
   Fink, Trine
   Zachar, Vladimir
   Besenbacher, Flemming
   Yoshida, Ken
TI Nanoscale topography reduces fibroblast growth, focal adhesion size and
   migration-related gene expression on platinum surfaces
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Surface nanotopography; Platinum; Cytoskeleton; Cell adhesion; Focal
   adhesions; Glancing angle deposition (GLAD)
ID EXTRACELLULAR-MATRIX DEPOSITION; CELL-ADHESION; NANOTOPOGRAPHY;
   ADSORPTION; PROLIFERATION; FILMS; SHAPE; BIOCOMPATIBILITY; LITHOGRAPHY;
   ELECTRODES
AB Controlling cellular responses on biomaterial surfaces is crucial in biomedical applications such as tissue engineering and implantable prosthetics. Since cells encounter various nanoscale topographic features in their natural environment, it has been postulated that surface nanotopography may be an alternative route to fabricate biomaterials with a desirable cellular response. In this framework, we investigated the responses of primary human fibroblasts to platinum substrates with different levels of surface roughness at the nanoscale. The nanorough surfaces were fabricated by using the glancing angle deposition technique (GLAD). We found that levels of cellular responses depended on the surface roughness and the size of the nanoscale features. We showed that in response to nanotopography cells spread less and have an elongated morphology, displaying signs of actin cytoskeleton impairment and reduced formation of focal adhesion complexes. Although cell growth and adhesion were impaired on the nanorough substrates, cell viability was not affected by topography. To a minor extent our results also indicate that cell migration might be reduced on the nanorough surfaces, since a significantly lower gene expression of migration related genes were found on the roughest surfaces as compared to the flat reference. The results presented here demonstrate that surface nanotopography influences fibroblasts responses on platinum, which may be used to reduce cellular adhesion on platinum implant surfaces such as implantable neural electrodes. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Pennisi, Cristian Pablo; Fink, Trine; Zachar, Vladimir] Univ Aalborg, Dept Hlth Sci & Technol, Lab Stem Cell Res, DK-9220 Aalborg, Denmark.
   [Dolatshahi-Pirouz, Alireza; Foss, Morten; Chevallier, Jacques; Besenbacher, Flemming] Aarhus Univ, Interdisciplinary Nanasci Ctr iNANO, Aarhus, Denmark.
   [Chevallier, Jacques; Besenbacher, Flemming] Aarhus Univ, Dept Phys & Astron, Aarhus, Denmark.
   [Yoshida, Ken] Univ Aalborg, Ctr Sensory Motor Interact SMI, DK-9220 Aalborg, Denmark.
   [Yoshida, Ken] Indiana Univ Purdue Univ, Dept Biomed Engn, Indianapolis, IN 46202 USA.
RP Pennisi, CP (reprint author), Univ Aalborg, Dept Hlth Sci & Technol, Lab Stem Cell Res, Frederik Bajers Vej 3B, DK-9220 Aalborg, Denmark.
EM cpennisi@hst.aau.dk
RI Pennisi, Cristian/B-6878-2008; Dolatshahi-Pirouz, Alireza/P-8179-2014;
   Fink, Trine/H-4434-2012
OI Pennisi, Cristian/0000-0002-7716-1182; Dolatshahi-Pirouz,
   Alireza/0000-0001-6326-0836; Fink, Trine/0000-0001-7578-1137; Yoshida,
   Ken/0000-0003-4566-580X
FU Danish Research Council
FX We gratefully acknowledge the financial support from the Danish Research
   Council to the Centre for NeuroEngineering (CNE) and Interdisciplinary
   Nanoscience Center (iNANO). The authors would also like to thank Helle
   Skjodt for her valuable support during PCR procedures in this work.
CR Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Bajaj P, 2007, BIOMED MICRODEVICES, V9, P787, DOI 10.1007/s10544-007-9090-2
   BERNABEU P, 1990, BIOMATERIALS, V11, P258, DOI 10.1016/0142-9612(90)90007-D
   Berry CC, 2005, BIOMATERIALS, V26, P4985, DOI 10.1016/j.biomaterials.2005.01.046
   BEWIG KW, 1965, J PHYS CHEM-US, V69, P4238, DOI 10.1021/j100782a029
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Choi CH, 2007, BIOMATERIALS, V28, P1672, DOI 10.1016/j.biomaterials.2006.11.031
   Craighead HG, 2001, CURR OPIN SOLID ST M, V5, P177, DOI 10.1016/S1359-0286(01)00005-5
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2008, J BIOMED MATER RES A, V84A, P973, DOI 10.1002/jbm.a.31409
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Davis J. R., 2003, HDB MAT MED DEVICES
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   Dolatshahi-Pirouz A, 2010, ACS NANO, V4, P2874, DOI 10.1021/nn9017872
   Dolatshahi-Pirouz A, 2009, J PHYS CHEM C, V113, P4406, DOI 10.1021/jp808488f
   Dolatshahi-Pirouz A, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/9/095101
   DOLATSHAHIPIROU.A, 2008, PHYS REV B, V77
   EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Geddes LA, 2003, ANN BIOMED ENG, V31, P879, DOI 10.1114/1.1581292
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   GRAY JW, 1987, TECHNIQUES CELL CYCL
   HALL CL, 1994, J CELL BIOL, V126, P575, DOI 10.1083/jcb.126.2.575
   Heldin P, 2008, CONNECT TISSUE RES, V49, P215, DOI 10.1080/03008200802143323
   Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085
   Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100
   Kennedy L, 2008, MATRIX BIOL, V27, P274, DOI 10.1016/j.matbio.2008.01.004
   Kriparamanan R, 2006, J NANOSCI NANOTECHNO, V6, P1905, DOI 10.1166/jnn.2006.330
   Lago N, 2007, IEEE T BIO-MED ENG, V54, P281, DOI 10.1109/TBME.2006.886617
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lee J, 2009, BIOMATERIALS, V30, P4488, DOI 10.1016/j.biomaterials.2009.05.028
   Linfante I, 2007, STROKE, V38, P1411, DOI 10.1161/01.STR.0000259824.10732.bb
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Pan HA, 2009, NANOSCALE RES LETT, V4, P903, DOI 10.1007/s11671-009-9333-7
   Pennisi CP, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385103
   RECHENDORFF K, 2005, APPL PHYS LETT, V87, P1
   Reich U, 2008, J BIOMED MATER RES B, V87B, P146, DOI 10.1002/jbm.b.31084
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Selvakumaran J., 2002, P 2 ANN INT IEEE EMB, P261
   Selvakumaran J, 2008, J MATER SCI-MATER M, V19, P143, DOI 10.1007/s10856-007-3110-x
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tanimoto K, 2008, ARCH ORAL BIOL, V53, P330, DOI 10.1016/j.archoralbio.2007.11.007
   Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799
   Turner N, 2004, CELL BIOL INT, V28, P541, DOI 10.1016/j.cellbi.2004.04.009
   VIM EKF, 2010, BIOMATERIALS, V31, P1299
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5
   Ye DX, 2002, NANOTECHNOLOGY, V13, P615, DOI 10.1088/0957-4484/13/5/314
NR 61
TC 48
Z9 48
U1 1
U2 42
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2011
VL 85
IS 2
BP 189
EP 197
DI 10.1016/j.colsurfb.2011.02.028
PG 9
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 767FZ
UT WOS:000290842000012
PM 21435850
DA 2018-10-20
ER

PT J
AU Xiang, Y
   Wang, YL
   Luo, YF
   Zhang, BB
   Xin, J
   Zheng, DF
AF Xiang, Yan
   Wang, Yuanliang
   Luo, Yanfeng
   Zhang, Bingbing
   Xin, Juan
   Zheng, Danfang
TI Molecular biocompatibility evaluation of poly(D,L-lactic acid)-modified
   biomaterials based on long serial analysis of gene expression
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Serial analysis of gene expression; Polylactic acid; Molecular
   biocompatibility; Surface modification
ID SELF-ASSEMBLED MONOLAYERS; II HISTONE DEACETYLASES; SURFACE-CHEMISTRY;
   CELL-ADHESION; POLY(DL-LACTIC ACID); MALEIC-ANHYDRIDE; INTEGRIN BINDING;
   DIFFERENTIATION; OSTEOBLASTS; GENOME
AB In this work, long serial analysis of gene expression (LongSAGE) technology was used to investigate the molecular mechanism of the interaction between cells and poly(D,L-lactic acid)-modified biomaterials. After mouse osteoblast-like MC3T3-E1 cells were cultured on poly(D,L-lactic acid) (PDLLA) and a novel maleic anhydride-modified poly(D,L-lactic acid) (MPLA) films, the morphology, proliferation activity and alkaline phosphatase (ALP) activity of MC3T3-E1 cells were assessed by laser confocal microscope, cell counting assay and ALP assay, and the gene expression profiles of the cells were detected and compared at the transcript levels, respectively. 202 tags were found differentially expressed (p < 0.05, and fold change > 2) between PDLLA and MPLA LongSAGE libraries. Gene ontology functional analysis of the differentially expressed genes indicates that surface modification of MPLA biomaterial has an extensive influence on cells by regulating expression of genes related to cell proliferation, cell cycle, cytoskeleton organization, ossification, bone remodeling, metabolism, and eventually induces osteoblast proliferation and differentiation. The approach presented here provides a new insight in the molecular biocompatibility evaluation of biomaterials, contributing to the development of biomaterials in tissue engineering field. Crown Copyright (C) 2011 Published by Elsevier B.V. All rights reserved.
C1 [Xiang, Yan; Wang, Yuanliang; Luo, Yanfeng; Zhang, Bingbing; Xin, Juan; Zheng, Danfang] Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Chongqing 400044, Peoples R China.
RP Wang, YL (reprint author), Chongqing Univ, Coll Bioengn, Res Ctr Bioinspired Mat Sci & Engn, Chongqing 400044, Peoples R China.
EM wyl@cqu.edu.cn
FU National Natural Science Foundation of China [30470474, 30870609]
FX This work was financially supported by National Natural Science
   Foundation of China (Nos. 30470474 and 30870609).
CR Abarrategi A, 2009, ACTA BIOMATER, V5, P2633, DOI 10.1016/j.actbio.2009.02.031
   Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Carinci F, 2003, J BIOMED MATER RES B, V66B, P341, DOI 10.1002/jbm.b.10021
   Chang SF, 2009, MOL ENDOCRINOL, V23, P1827, DOI 10.1210/me.2009-0143
   Chen JJ, 2002, P NATL ACAD SCI USA, V99, P12257, DOI 10.1073/pnas.192436499
   CHOU L, 1995, J DENT RES, V74, P190
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Drissi H, 1999, CANCER RES, V59, P3705
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Ferreira R, 2001, EMBO REP, V2, P794, DOI 10.1093/embo-reports/kve173
   Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   HARPER JW, 1993, CELL, V75, P805
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Higuchi C, 2009, J BONE MINER METAB, V27, P158, DOI 10.1007/s00774-009-0037-y
   Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Kamioka H, 2004, J BONE MINER RES, V19, P471, DOI 10.1359/JBMR.040128
   KANG IK, 1993, BIOMATERIALS, V14, P787, DOI 10.1016/0142-9612(93)90045-4
   Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim YC, 2006, FEBS LETT, V580, P6721, DOI 10.1016/j.febslet.2006.11.013
   Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025
   Kricheldorf HR, 1996, MACROMOL SYMP, V103, P85
   Ku CH, 2002, BIOMATERIALS, V23, P4193, DOI 10.1016/S0142-9612(02)00161-8
   Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050
   Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051
   Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lee S, 2005, RNA, V11, P939, DOI 10.1261/rna.7239605
   Lee S, 2002, GENOMICS, V79, P598, DOI 10.1006/geno.2002.6730
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832
   Lien CY, 2007, STEM CELLS, V25, P1462, DOI 10.1634/stemcells.2006-0391
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lu XY, 2010, BIOMATERIALS, V31, P1965, DOI 10.1016/j.biomaterials.2009.12.044
   Lu XY, 2009, BIOMATERIALS, V30, P141, DOI 10.1016/j.biomaterials.2008.09.011
   Luo YF, 2007, EUR POLYM J, V43, P3856, DOI 10.1016/j.eurpolymj.2007.06.022
   Luo YF, 2004, CHINESE CHEM LETT, V15, P521
   Ma ZW, 2003, BIOMATERIALS, V24, P3725, DOI 10.1016/S0142-9612(03)00247-3
   Mehta R, 2005, J MACROMOL SCI-POL R, VC45, P325, DOI 10.1080/15321790500304148
   NIU XF, 2005, J MATER SCI TECHNOL, V20, P571
   Onishi T, 1997, ENDOCRINOLOGY, V138, P1995, DOI 10.1210/en.138.5.1995
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pan J, 2005, J BIOMED MATER RES B, V74B, P476, DOI 10.1002/jbm.b.30208
   Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X
   Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Tanahashi M, 1997, J BIOMED MATER RES, V34, P305
   Vartanian KB, 2008, BIOCHEM BIOPH RES CO, V371, P787, DOI 10.1016/j.bbrc.2008.04.167
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   VERT M, 1995, J MACROMOL SCI PURE, VA32, P787, DOI 10.1080/10601329508010289
   Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359
   Wang SM, 2007, TRENDS GENET, V23, P42, DOI 10.1016/j.tig.2006.11.001
   Wang YX, 2004, PHARM RES, V21, P1362, DOI 10.1023/B:PHAM.0000036909.41843.18
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wolffe AP, 1996, SCIENCE, V272, P371, DOI 10.1126/science.272.5260.371
   XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Zhong Sheng, 2004, Appl Bioinformatics, V3, P261, DOI 10.2165/00822942-200403040-00009
   Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06
   Zupkovitz G, 2010, MOL CELL BIOL, V30, P1171, DOI 10.1128/MCB.01500-09
NR 66
TC 9
Z9 9
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2011
VL 85
IS 2
BP 248
EP 261
DI 10.1016/j.colsurfb.2011.02.036
PG 14
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 767FZ
UT WOS:000290842000020
PM 21435849
DA 2018-10-20
ER

PT J
AU Chen, SG
   Chen, SJ
   Jiang, S
   Mo, YM
   Luo, JX
   Tang, JN
   Ge, ZC
AF Chen, Shiguo
   Chen, Shaojun
   Jiang, Song
   Mo, Yangmiao
   Luo, Junxuan
   Tang, Jiaoning
   Ge, Zaochuan
TI Study of zwitterionic sulfopropylbetaine containing reactive siloxanes
   for application in antibacterial materials
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Betaine; Siloxane; Antibacterial; Quaternary ammonium; Zwitterionic
ID QUATERNARY AMMONIUM-COMPOUNDS; ANTIMICROBIAL ACTIVITY; POLYMERIC
   BETAINES; SURFACES; TEXTILES; NANOPARTICLES; ACRYLAMIDE; COPOLYMER;
   CELLULOSE; PROPERTY
AB Antibacterial agents receive a great deal of attention around the world due to the interesting academic problems of how to combat bacteria and of the beneficial health, social and economic effects of successful agents. Scientists are actively developing new antibacterial agents for biomaterial applications. This paper reports the novel antibacterial agent siloxane sulfopropylbetaine (SSPB), which contains reactive alkoxysilane groups. The structure and properties of SSPB were systematically investigated, with the results showing that SSPB contains both quaternary ammonium compounds and reactive siloxane groups. SSPB has good antibacterial activity against both Escherichia coli (E. coli, 8099) and Staphylococcus aureus (S. aureus, ATCC 6538). The minimal inhibition concentration is 70 mu mol/ml SSPB against both E. coli and S. aureus. In addition, the SSPB antibacterial agent can be used in both weak acid and weak alkaline environments, functioning within the wide pH range of 4.0-9.0. The SSPB-modified glass surface killed 99.96% of both S. aureus and E. colt organisms within 24 h. No significant decrease was observed in this antibacterial activity after 20 washes. Moreover, SSPB does not induce a skin reaction and is nontoxic to animals. Thus, SSPB is an ideal candidate for future applications as a safe, environmentally friendly antibacterial agent. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Chen, Shiguo; Chen, Shaojun; Jiang, Song; Mo, Yangmiao; Luo, Junxuan; Tang, Jiaoning; Ge, Zaochuan] Shenzhen Univ, Shenzhen Key Lab Special Funct Mat, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China.
RP Chen, SG (reprint author), Shenzhen Univ, Shenzhen Key Lab Special Funct Mat, Coll Mat Sci & Engn, Shenzhen 518060, Peoples R China.
EM csg@szu.edu.cn
RI chen, shiguo/J-3076-2014
OI chen, shiguo/0000-0002-5338-690X
FU Natural Science Foundation of China [50803037]; Natural Science
   Foundation of Guangdong [2008211]; Science and Technology Planning
   Project of Guangdong province [2008A010500001]; Science and Technology
   Planning Project of Shenzhen city [ZYC200903250180A]
FX The authors gratefully acknowledge financial support from the Natural
   Science Foundation of China (no. 50803037)), the Natural Science
   Foundation of Guangdong (no. 2008211), the Science and Technology
   Planning Project of Guangdong province (grant no. 2008A010500001) and
   the Science and Technology Planning Project of Shenzhen city (no.
   ZYC200903250180A).
CR [Anonymous], 2002, TECHN STAND DIS
   Beyth N, 2006, BIOMATERIALS, V27, P3995, DOI 10.1016/j.biomaterials.2006.03.003
   Carson RT, 2008, J ANTIMICROB CHEMOTH, V62, P1160, DOI 10.1093/jac/dkn332
   Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   CLARKSON N, 1993, BIOFOULING, V7, P187
   Gao BJ, 2006, J APPL POLYM SCI, V100, P1531, DOI 10.1002/app.23130
   Gao Y, 2008, TEXT RES J, V78, P60, DOI 10.1177/0040517507082332
   Gui ZL, 2009, EUR POLYM J, V45, P1403, DOI 10.1016/j.eurpolymj.2009.02.010
   Jampala SN, 2008, LANGMUIR, V24, P8583, DOI 10.1021/la800405x
   Kangwansupamonkon W, 2009, NANOMED-NANOTECHNOL, V5, P240, DOI 10.1016/j.nano.2008.09.004
   Kenawy ER, 2007, BIOMACROMOLECULES, V8, P1359, DOI 10.1021/bm061150q
   Kim YS, 2007, INT J BIOL MACROMOL, V41, P36, DOI 10.1016/j.ijbiomac.2006.12.004
   Kudaibergenov S, 2006, ADV POLYM SCI, V201, P157, DOI 10.1007/12_078
   Lee H, 2008, ADV MATER, V20, P1619, DOI 10.1002/adma.200702378
   Lim SH, 2003, J MACROMOL SCI-POL R, VC43, P223, DOI 10.1081/MC-120020161
   Liong M, 2009, ADV MATER, V21, P1684, DOI 10.1002/adma.200802646
   Liu H, 2004, CARBOHYD POLYM, V55, P291, DOI 10.1016/j.carbpol.2003.10.001
   Lu GQ, 2007, REACT FUNCT POLYM, V67, P355, DOI 10.1016/j.reactfunctpolym.2007.01.008
   Ramstedt M, 2007, LANGMUIR, V23, P3314, DOI 10.1021/la062670+
   Rankin DA, 2008, MACROMOLECULES, V41, P614, DOI 10.1021/ma701952c
   Saif MJ, 2009, LANGMUIR, V25, P377, DOI 10.1021/la802878p
   Shi Q, 2008, J MEMBRANE SCI, V319, P271, DOI 10.1016/j.memsci.2008.03.047
   Simoncic B, 2010, TEXT RES J, V80, P1721, DOI 10.1177/0040517510363193
   Song YB, 2008, BIOMACROMOLECULES, V9, P2259, DOI 10.1021/bm800429a
   Su YL, 2008, REACT FUNCT POLYM, V68, P161, DOI 10.1016/j.reactfunctpolym.2007.10.001
   Tada S, 2009, MACROMOL BIOSCI, V9, P63, DOI 10.1002/mabi.200800150
   Ward M, 2006, J APPL POLYM SCI, V101, P1036, DOI 10.1002/app.23269
   Yuan JA, 2004, COLLOID SURFACE B, V36, P27, DOI [10.1016/j.colsurfc.2004.03.017, 10.1016/j.colsurfb.2004.03.017]
   Zhang W, 2006, POLYMER, V47, P7441, DOI 10.1016/j.polymer.2006.08.057
   Zhang Z, 2008, BIOMATERIALS, V29, P4719, DOI 10.1016/j.biomaterials.2008.08.030
   ZOU H, 1989, Patent No. 89104903
NR 31
TC 36
Z9 37
U1 3
U2 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2011
VL 85
IS 2
BP 323
EP 329
DI 10.1016/j.colsurfb.2011.03.004
PG 7
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 767FZ
UT WOS:000290842000029
PM 21450443
DA 2018-10-20
ER

PT J
AU Kaihara, S
   Suzuki, Y
   Fujimoto, K
AF Kaihara, Sachiko
   Suzuki, Yoichi
   Fujimoto, Keiji
TI In situ synthesis of polysaccharide nanoparticles via polyion complex of
   carboxymethyl cellulose and chitosan
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Polyion complex; Magnetite; Polysaccharide; Semi-IPN network; In situ
   synthesis
ID POLYMER NETWORK MICROSPHERES; CONTROLLED-RELEASE; HYPERTHERMIA;
   MECHANISMS; PARTICLES; THERAPY; GENIPIN
AB Biocompatible polymer-magnetite hybrid nanoparticles were prepared by means of in situ synthesis of magnetite within polysaccharide hydrogel nanoparticles. Hydrogel nanoparticles were first fabricated by blending high-molecular-weight carboxymethyl cellulose as an anionic polymer, and low-molecular-weight chitosan as a cationic polymer to form polyion complexes (CC particles). These polyion complexes were then chemically crosslinked using genipin, a bio-based cross-linker, to form stable nanoparticles having a semi-IPN structure (CCG particles). Magnetite was lastly synthesized within CCG particles by the coprecipitation method to obtain polymer-magnetite hybrid nanoparticles (CCGM particles). The formations of CC, CCG and CCGM particles were mainly observed by transmittance, absorbance of genipin and TEM, respectively, and their hydrodynamic diameters and zeta-potentials were analyzed. It was confirmed that the hydrodynamic diameters and the zeta-potentials of these particles were significantly influenced by pH of the suspension, which was attributed to the charges of polymers. The diameters of CCGM particles were smaller than 200 nm at any pH conditions, suggesting the possibility to apply them as drug delivery carriers. CCGM particles exhibited the responsiveness to a magnetic field in addition to their high dispersion stability, indicating their potential to be utilized as a biomaterial for hyperthermia. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kaihara, Sachiko; Suzuki, Yoichi; Fujimoto, Keiji] Keio Univ, Ctr Chem Biol, Sch Fundamental Sci & Technol, Grad Sch Sci & Technol,Kohoku Ku, Yokohama, Kanagawa 2238522, Japan.
RP Fujimoto, K (reprint author), Keio Univ, Ctr Chem Biol, Sch Fundamental Sci & Technol, Grad Sch Sci & Technol,Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.
EM fujimoto@applc.keio.ac.jp
RI Fujimoto, Keiji/D-6583-2014
FU MEXT
FX This work was supported by High-Tech Research Center Project for Private
   Universities: matching fund subsidy from MEXT.
CR ALLEN MT, 2004, SCIENCE, V19, P1818
   Butler MF, 2003, J POLYM SCI POL CHEM, V41, P3941, DOI 10.1002/pola.10960
   Coviello T, 2007, J CONTROL RELEASE, V119, P5, DOI 10.1016/j.jconrel.2007.01.004
   Cui ZR, 2001, J CONTROL RELEASE, V75, P409, DOI 10.1016/S0168-3659(01)00407-2
   Daniel-da-Silva AL, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/35/355602
   FUKUDA H, 1980, B CHEM SOC JPN, V53, P837, DOI 10.1246/bcsj.53.837
   Ichikawa S, 2005, BIOSCI BIOTECH BIOCH, V69, P1637, DOI 10.1271/bbb.69.1637
   Kofuji K, 2005, EUR POLYM J, V41, P2784, DOI 10.1016/j.eurpolymj.2005.04.041
   KONDO A, 1994, APPL MICROBIOL BIOT, V41, P99
   Li BQ, 2006, J MAGN MAGN MATER, V306, P223, DOI 10.1016/j.jmmm.2006.01.250
   Li N, 2005, SEP PURIF TECHNOL, V42, P237, DOI 10.1016/j.seppur.2004.08.002
   Matsuda T, 2002, BIOMACROMOLECULES, V3, P942, DOI 10.1021/bm0200229
   Moyer HR, 2008, INT J HYPERTHER, V24, P251, DOI 10.1080/02656730701772480
   Muller S, 2009, NANOMED-NANOTECHNOL, V5, P387, DOI 10.1016/j.nano.2009.01.011
   Oh JK, 2009, PROG POLYM SCI, V34, P1261, DOI 10.1016/j.progpolymsci.2009.08.001
   Pankhurst QA, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/224001
   Remunan-Lopez C, 1998, EUR J PHARM BIOPHARM, V45, P49, DOI 10.1016/S0939-6411(97)00122-7
   Rokhade AP, 2007, CARBOHYD POLYM, V67, P605, DOI 10.1016/j.carbpol.2006.07.001
   Rokhade AP, 2006, CARBOHYD POLYM, V65, P243, DOI 10.1016/j.carbpol.2006.01.013
   Saitoh T, 2009, REACT FUNCT POLYM, V69, P792, DOI 10.1016/j.reactfunctpolym.2009.06.01
   SHIOYA CKR, 1989, TRANSMEMBRANE PERMEA
   SPERLING LH, 1994, ADV CHEM SER, V239, P3
   Suzuki D, 2006, COLLOID POLYM SCI, V284, P1443, DOI 10.1007/s00396-006-1523-6
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571
   Wang YL, 2009, NANOSCALE RES LETT, V4, P1041, DOI 10.1007/s11671-009-9355-1
   Watanabe J, 2005, COLLOID SURFACE B, V42, P141, DOI 10.1016/j.colsurfb.2005.02.005
   XIA JH, 2007, SCI CHINA SER B, V50, P754
   YOSHIOKA T, 1990, BIOTECHNOL BIOENG, V35, P66, DOI 10.1002/bit.260350110
   Zhang SL, 2010, INT J PHARMACEUT, V397, P211, DOI 10.1016/j.ijpharm.2010.07.007
   Zhou HY, 2006, BIOCHEM ENG J, V31, P228, DOI 10.1016/j.bej.2006.08.007
NR 30
TC 28
Z9 28
U1 4
U2 72
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD JUL 1
PY 2011
VL 85
IS 2
BP 343
EP 348
DI 10.1016/j.colsurfb.2011.03.008
PG 6
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 767FZ
UT WOS:000290842000032
PM 21458962
DA 2018-10-20
ER

PT J
AU Mukherjee, S
   Venugopal, JR
   Ravichandran, R
   Ramakrishna, S
   Raghunath, M
AF Mukherjee, Shayanti
   Venugopal, Jayarama Reddy
   Ravichandran, Rajeswari
   Ramakrishna, Seeram
   Raghunath, Michael
TI Evaluation of the Biocompatibility of PLACL/Collagen Nanostructured
   Matrices with Cardiomyocytes as a Model for the Regeneration of
   Infarcted Myocardium
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID CARDIAC STEM-CELLS; HEART-FAILURE; TISSUE; EXPRESSION; SCAFFOLDS
AB Pioneering research suggests various modes of cellular therapeutics and biomaterial strategies for myocardial tissue engineering. Despite several advantages, such as safety and improved function, the dynamic myocardial microenvironment prevents peripherally or locally administered therapeutic cells from homing and integrating of biomaterial constructs with the infarcted heart. The myocardial microenvironment is highly sensitive due to the nanoscale cues that it exerts to control bioactivities, such as cell migration, proliferation, differentiation, and angiogenesis. Nanoscale control of cardiac function has not been extensively analyzed in the field of myocardial tissue engineering. Inspired by microscopic analysis of the ventricular organization in native tissue, a scalable in-vitro model of nanoscale poly(L-lactic acid)-co-poly(epsilon-caprolactone)/collagen biocomposite scaffold is fabricated, with nanofibers in the order of 594 +/- 56 nm to mimic the native myocardial environment for freshly isolated cardiomyocytes from rabbit heart, and the specifically underlying extracellular matrix architecture: this is done to address the specificity of the underlying matrix in overcoming challenges faced by cellular therapeutics. Guided by nanoscale mechanical cues provided by the underlying random nanofibrous scaffold, the tissue constructs display anisotropic rearrangement of cells, characteristic of the native cardiac tissue. Surprisingly, cell morphology, growth, and expression of an interactive healthy cardiac cell population are exquisitely sensitive to differences in the composition of nanoscale scaffolds. It is shown that suitable cell-material interactions on the nanoscale can stipulate organization on the tissue level and yield novel insights into cell therapeutic science, while providing materials for tissue regeneration.
C1 [Mukherjee, Shayanti; Raghunath, Michael] Natl Univ Singapore, Div Bioengn, Singapore 117548, Singapore.
   [Mukherjee, Shayanti; Venugopal, Jayarama Reddy; Ramakrishna, Seeram] Natl Univ Singapore, Fac Engn, HEM Lab Nanosci & Nanotechnol Initiat, Singapore 117548, Singapore.
   [Ravichandran, Rajeswari; Ramakrishna, Seeram] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.
   [Ramakrishna, Seeram] ASTAR, Inst Mat Res & Engn, Singapore, Singapore.
   [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore.
RP Mukherjee, S (reprint author), Natl Univ Singapore, Div Bioengn, 9 Engn Dr 1,Block EA 03-12, Singapore 117548, Singapore.
EM nnijrv@nus.edu.sg
RI Ravichandran, Rajeswari/C-9313-2012; Raghunath, Michael/E-6483-2010
OI Raghunath, Michael/0000-0002-2138-6614; Jayarama Reddy,
   Venugopal/0000-0001-5867-8007
FU NRF-Technion [R-398-001-063-592]; Division of Bioengineering,
   Nanoscience and Nanotechnology Initiative, National University of
   Singapore
FX The authors gratefully acknowledge the NRF-Technion (Grant No.:
   R-398-001-063-592), Division of Bioengineering, Nanoscience and
   Nanotechnology Initiative, National University of Singapore for
   financial support.
CR Baig MK, 1999, HEART LUNG, V28, P87, DOI 10.1053/hl.1999.v28.a97762
   Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104
   BISHOP JE, 1995, EUR HEART J, V16, P38, DOI 10.1093/eurheartj/16.suppl_C.38
   Cabello N, 2007, J BIOL CHEM, V282, P12143, DOI 10.1074/jbc.M608880200
   Costa KD, 2003, TISSUE ENG, V9, P567, DOI 10.1089/107632703768247278
   Du AP, 2003, DEV BIOL, V257, P382, DOI 10.1016/S0012-1606(03)00104-0
   EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Fomovsky GM, 2010, J MOL CELL CARDIOL, V48, P490, DOI 10.1016/j.yjmcc.2009.08.003
   Goldsmith EC, 2004, DEV DYNAM, V230, P787, DOI 10.1002/dvdy.20095
   Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055
   He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996
   Hitchcock-DeGregori SE, 2007, ADV EXP MED BIOL, V592, P87
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Kai D, 2010, NANO BIOMED, V2, P1
   Kao Race L, 2009, Asian Cardiovasc Thorac Ann, V17, P89, DOI 10.1177/0218492309104144
   Kofidis Theo, 2007, V140, P273
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Lu JW, 2008, MACROMOLECULES, V41, P3762, DOI 10.1021/ma702881k
   Martinez Eliana C, 2009, Expert Rev Cardiovasc Ther, V7, P921, DOI 10.1586/erc.09.81
   Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51
   Miller LW, 2008, J CARDIOVASC TRANSL, V1, P185, DOI 10.1007/s12265-008-9042-0
   Mitcheson JS, 1998, CARDIOVASC RES, V39, P280, DOI 10.1016/S0008-6363(98)00128-X
   Mukherjee S, 2010, J MATER CHEM, V20, P8819, DOI 10.1039/c0jm00805b
   Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078
   Nagueh SF, 2004, CIRCULATION, V110, P155, DOI 10.1161/01.CIR.0000135591.37759.AF
   Omens JH, 1998, PROG BIOPHYS MOL BIO, V69, P559, DOI 10.1016/S0079-6107(98)00025-X
   Packer M, 2002, J CARD FAIL, V8, P193, DOI 10.1054/jcaf.2002.128001
   Schulz R, 2004, CARDIOVASC RES, V62, P335, DOI 10.1016/j.cardiores.2003.12.017
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505
   Wagner M, 2007, EXP BIOL MED, V232, P852
   Wei X, 2009, INT J EXP COMP BIOME, V1, P45, DOI DOI 10.1504/IJECB.2009.022858
   YAMAUCHITAKIHARA K, 1989, P NATL ACAD SCI USA, V86, P3504, DOI 10.1073/pnas.86.10.3504
NR 35
TC 31
Z9 31
U1 1
U2 25
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUN 21
PY 2011
VL 21
IS 12
BP 2291
EP 2300
DI 10.1002/adfm.201002434
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 778RQ
UT WOS:000291723300014
DA 2018-10-20
ER

PT J
AU Han, I
   Vagaska, B
   Park, BJ
   Lee, MH
   Lee, SJ
   Park, JC
AF Han, Inho
   Vagaska, Barbora
   Park, Bong Joo
   Lee, Mi Hee
   Lee, Seung Jin
   Park, Jong-Chul
TI Selective fibronectin adsorption against albumin and enhanced stem cell
   attachment on helium atmospheric pressure glow discharge treated
   titanium
SO JOURNAL OF APPLIED PHYSICS
LA English
DT Article
ID PLASMA TREATMENT; OSTEOBLAST ADHESION; SURFACE MODIFICATION; PROTEIN
   ADSORPTION; INTEGRINS; BIOMATERIALS; PLATES; MECHANISM
AB Successful tissue integration of implanted medical devices depends on appropriate initial cellular response. In this study, the effect of helium atmospheric pressure glow discharge (He-APGD) treatment of titanium on selective protein adsorption and the initial attachment processes and focal adhesion formation of osteoprogenitor cells and stem cells were examined. Titanium disks were treated in a self-designed He-APGD system. Initial attachment of MC3T3-E1 mouse preosteoblasts and human mesenchymal stem cells (MSCs) was evaluated by MTT assay and plasma membrane staining followed by morphometric analysis. Fibronectin adsorption was investigated by Enzyme-Linked ImmunoSorbant Assay. MSCs cell attachment to treated and non-treated titanium disks coated with different proteins was verified also in serum-free culture. Organization of actin cytoskeleton and focal adhesions was evaluated microscopically. He-APGD treatment effectively modified the titanium surfaces by creating a super-hydrophilic surface, which promoted selectively higher adsorption of fibronectin, a protein of critical importance for cell/biomaterial interaction. In two different types of cells, the He-APGD treatment enhanced the number of attaching cells as well as their attachment area. Moreover, cells had higher organization of actin cytoskeleton and focal adhesions. Faster acceptance of the material by the progenitor cells in the early phases of tissue integration after the implantation may significantly reduce the overall healing time; therefore, titanium treatment with He-APGD seems to be an effective method of surface modification of titanium for improving its tissue inductive properties. VC 2011 American Institute of Physics. [doi:10.1063/1.3599885]
C1 [Han, Inho; Vagaska, Barbora; Park, Bong Joo; Lee, Mi Hee; Park, Jong-Chul] Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, Seoul 102752, South Korea.
   [Vagaska, Barbora; Lee, Mi Hee; Park, Jong-Chul] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 102752, South Korea.
   [Lee, Seung Jin] Ewha Womans Univ, Coll Pharm, Dept Ind Pharm, Seoul 120750, South Korea.
RP Park, JC (reprint author), Yonsei Univ, Coll Med, Dept Med Engn, Cellbiocontrol Lab, Seoul 102752, South Korea.
EM parkjc@yuhs.ac
OI Vagaska, Barbora/0000-0001-7511-6428
FU Korean Government (MEST) [2010-0002089]; Ministry for Health & Welfare,
   Republic of Korea [A100834]
FX This work was supported by a National Research Foundation (NRF) of Korea
   Grant funded by the Korean Government (MEST) (Grant number 2010-0002089)
   and was supported by a grant of the Korea Healthcare technology R&D
   Project, Ministry for Health & Welfare, Republic of Korea (A100834).
   This article is dedicated to I. Han's lovely wife (Jeehae Choi) and
   pretty children (Jisu Han and Sangyoon Han).
CR Albrektsson T., 2001, EUR SPINE J, V10, P96
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aronsson BO, 1997, J BIOMED MATER RES, V35, P49
   Briem D, 2005, J MATER SCI-MATER M, V16, P671, DOI 10.1007/s10856-005-2539-z
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   Danen EHJ, 2003, J PATHOL, V200, P471, DOI 10.1002/path.1416
   Davies John E, 2003, J Dent Educ, V67, P932
   GARCIA JA, 2005, BIOMATERIALS, V26, P7525
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Globus RK, 1998, J CELL SCI, V111, P1385
   Guehennec L., 2007, DENT MATER, V23, P844, DOI DOI 10.1016/J.DENTAL.2006.06.025
   GUPTA A, 2009, INTERNET J DENT SCI, V7, P1
   HAN I, MACROMOL RE IN PRESS
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Horbett T., 2004, BIOMATERIALS SCI INT
   Horbett T. A., 1999, BMES BULL, V13, P5
   Hori N, 2009, J DENT RES, V88, P663, DOI 10.1177/0022034509339567
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Iwasa F, 2010, BIOMATERIALS, V31, P2717, DOI 10.1016/j.biomaterials.2009.12.024
   KASEMO B, 1994, ENVIRON HEALTH PERSP, V102, P41, DOI 10.2307/3432057
   Khang G, 1999, BIO-MED MATER ENG, V9, P179
   Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013
   Lim YW, 2009, CLIN ORTHOP RELAT R, V467, P2251, DOI 10.1007/s11999-009-0879-6
   Lin CC, 2005, JPN J APPL PHYS 1, V44, P8590, DOI 10.1143/JJAP.44.8590
   Owen G Rh, 2005, Eur Cell Mater, V9, P85
   Poncin-Epaillard F, 2003, J BIOMAT SCI-POLYM E, V14, P1005, DOI 10.1163/156856203769231538
   Shibata Y, 2002, INT J ORAL MAX IMPL, V17, P771
   Sousa SR, 2008, J BIOMED MATER RES A, V84A, P281, DOI 10.1002/jbm.a.31201
   Tang S, 2008, J PHYS CHEM C, V112, P4712, DOI 10.1021/jp711238k
   Teraoka F, 2006, DENT MATER J, V25, P560, DOI 10.4012/dmj.25.560
   Thomas CH, 1997, J BIOMED MATER RES, V37, P81, DOI 10.1002/(SICI)1097-4636(199710)37:1<81::AID-JBM10>3.0.CO;2-T
   Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200
   Yamamoto H, 2005, J DENT RES, V84, P668, DOI 10.1177/154405910508400717
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
NR 34
TC 7
Z9 8
U1 0
U2 8
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0021-8979
J9 J APPL PHYS
JI J. Appl. Phys.
PD JUN 15
PY 2011
VL 109
IS 12
AR 124701
DI 10.1063/1.3599885
PG 6
WC Physics, Applied
SC Physics
GA 786TQ
UT WOS:000292331200145
DA 2018-10-20
ER

PT J
AU Pham, VH
   Yook, SW
   Li, Y
   Jeon, G
   Lee, JJ
   Kim, HE
   Koh, YH
AF Pham, Vuong-Hung
   Yook, Se-Won
   Li, Yuanlong
   Jeon, Gyuran
   Lee, Jung-Joong
   Kim, Hyoun-Ee
   Koh, Young-Hag
TI Improving hardness of biomedical Co-Cr by deposition of dense and
   uniform TiN films using negative substrate bias during reactive
   sputtering
SO MATERIALS LETTERS
LA English
DT Article
DE Biomaterial; TiN coating; Hardness
ID THIN-FILMS; ELECTROCHEMICAL CORROSION; MECHANICAL-PROPERTIES; NITRIDE
   FILM; COATINGS; PROSTHESIS; STEEL
AB This paper reports the deposition of a fully dense and uniform TiN film to improve the surface hardness of Co-Cr, particularly, by applying a negative substrate bias during reactive direct current (DC) sputtering. As the TiN film was deposited with a negative substrate bias voltage of 150 V. the microstructure of the films was shifted from a columnar to non-columnar one that was observed to have a dense, uniform and smooth surface. In addition, the preferred orientation was the (111) plane when the films were deposited with a negative substrate bias; however, the (200) plane when they were deposited without a substrate bias. The deposition of the dense and uniform TiN film resulted in a significant increase of the hardness of the Co-Cr. The TiN-deposited Co-Cr with a negative substrate bias showed a very high hardness of 44.7 +/- 1.7 GPa, which was much higher than those of the bare Co-Cr (4.2 +/- 0.3 GPa) and TiN-deposited Co-Cr without a negative substrate bias (23.6 +/- 2.8 GPa). (C) 2011 Elsevier B.V. All rights reserved.
C1 [Pham, Vuong-Hung; Yook, Se-Won; Li, Yuanlong; Jeon, Gyuran; Lee, Jung-Joong; Kim, Hyoun-Ee] Seoul Natl Univ, Dept Mat Sci & Engn, WCU Hybrid Mat Program, Seoul 151747, South Korea.
   [Koh, Young-Hag] Korea Univ, Dept Dent Lab Sci & Engn, Seoul 136703, South Korea.
RP Kim, HE (reprint author), Seoul Natl Univ, Dept Mat Sci & Engn, WCU Hybrid Mat Program, Seoul 151747, South Korea.
EM kimhe@snu.ac.kr
RI Lee, Jung-Joong/F-6183-2013
FU Ministry of Knowledge Economy; Ministry of Education, Science and
   Technology, Republic of Korea [R31-2008-000-10075-0]
FX This research was supported by grants from the Fundamental R&D Program
   for Core Technology of Materials funded by the Ministry of Knowledge
   Economy and WCU (World Class University) program through National
   Research Foundation of Korea funded by the Ministry of Education,
   Science and Technology (R31-2008-000-10075-0), Republic of Korea.
CR Carpenter S, 2009, SURF COAT TECH, V204, P923, DOI 10.1016/j.surfcoat.2009.07.003
   Chawla V, 2008, MATER CHARACT, V59, P1015, DOI 10.1016/j.matchar.2007.08.017
   Chen CT, 1998, J MATER ENG PERFORM, V7, P324, DOI 10.1361/105994998770347756
   Chien CC, 2008, DENT MATER, V24, P986, DOI 10.1016/j.dental.2007.11.020
   Chou WJ, 2002, SURF COAT TECH, V149, P7, DOI 10.1016/S0257-8972(01)01382-2
   Chou WJ, 2001, SURF COAT TECH, V140, P206, DOI 10.1016/S0257-8972(01)01120-3
   Groessner-Schreiber B, 2003, J BIOMED MATER RES A, V64A, P591, DOI 10.1002/jbm.a.10417
   HULTMAN L, 1994, J CRYST GROWTH, V135, P309, DOI 10.1016/0022-0248(94)90757-9
   Hyslop O.J.S., 2010, ACTA MAT, V58, P3124
   Ishii J, 2009, WEAR, V267, P2173, DOI 10.1016/j.wear.2009.04.007
   Ljungcrantz H, 1996, J APPL PHYS, V80, P6725, DOI 10.1063/1.363799
   Mori J. C., 1999, Applied Physics A (Materials Science Processing), P699, DOI 10.1007/s003390051509
   Nose M, 1999, SURF COAT TECH, V116, P296, DOI 10.1016/S0257-8972(99)00131-0
   Reclaru L, 2005, BIOMATERIALS, V26, P4747, DOI 10.1016/j.biomaterials.2005.01.004
   Roy ME, 2010, ACTA BIOMATER, V6, P1619, DOI 10.1016/j.actbio.2009.10.037
   Staia MH, 1995, SURF COAT TECH, V76, P231
   Subramanian B, 2008, MATER LETT, V62, P1727, DOI 10.1016/j.matlet.2007.09.072
   Tentardini EK, 2001, NUCL INSTRUM METH B, V175, P626, DOI 10.1016/S0168-583X(00)00652-2
   WOKULSKI Z, 1990, PHYS STATUS SOLIDI A, V120, P175, DOI 10.1002/pssa.2211200116
   WOODMAN J L, 1984, Journal of Orthopaedic Research, V1, P421
   Yen SK, 2001, BIOMATERIALS, V22, P125, DOI 10.1016/S0142-9612(00)00133-2
NR 21
TC 12
Z9 12
U1 0
U2 9
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-577X
J9 MATER LETT
JI Mater. Lett.
PD JUN 15
PY 2011
VL 65
IS 11
BP 1707
EP 1709
DI 10.1016/j.matlet.2011.03.020
PG 3
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 773FY
UT WOS:000291293600057
DA 2018-10-20
ER

PT J
AU Cho, KC
   Lien, CH
   Lin, CY
   Chang, CY
   Huang, LLH
   Campagnola, PJ
   Dong, CY
   Chen, SJ
AF Cho, Keng-Chi
   Lien, Chi-Hsiang
   Lin, Chun-Yu
   Chang, Chia-Yuan
   Huang, Lynn L. H.
   Campagnola, Paul J.
   Dong, Chen Yuan
   Chen, Shean-Jen
TI Enhanced two-photon excited fluorescence in three-dimensionally
   crosslinked bovine serum albumin microstructures
SO OPTICS EXPRESS
LA English
DT Article
ID WAVE-GUIDES; LASER; FABRICATION; POLYMERIZATION; MICROMACHINES;
   LITHOGRAPHY; EMISSION; COMPLEX; LIGHT; DNA
AB In this study, the intensity of two-photon excited fluorescence (TPEF) of xanthene dye, Rose Bengal (RB), was significantly enhanced via bovine serum albumin (BSA) microstructures fabricated by the two-photon crosslinking (TPC) technique. The RB was utilized as the photoactivator in the TPC processing and the enhanced TPEF intensity correlates with the concentration of fabricated crosslinked BSA microstructures via the power control and pulse selection of the employed femtosecond laser. As a result, fabrication of three-dimensional BSA microstructures can be simultaneously monitored by the use of TPEF intensity. The crosslinked BSA microstructures synthesized may be used as an ordered biomaterial for fluorescence enhancement. (C) 2011 Optical Society of America
C1 [Cho, Keng-Chi; Chang, Chia-Yuan] Natl Cheng Kung Univ, Inst Electroopt Sci & Engn, Tainan 701, Taiwan.
   [Lien, Chi-Hsiang; Lin, Chun-Yu; Chen, Shean-Jen] Natl Cheng Kung Univ, Dept Engn Sci, Tainan 701, Taiwan.
   [Huang, Lynn L. H.] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 701, Taiwan.
   [Campagnola, Paul J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.
   [Dong, Chen Yuan] Natl Taiwan Univ, Dept Phys, Taipei 106, Taiwan.
   [Chen, Shean-Jen] Natl Cheng Kung Univ, Adv Optoelect Technol Ctr, Tainan 701, Taiwan.
RP Cho, KC (reprint author), Natl Cheng Kung Univ, Inst Electroopt Sci & Engn, Tainan 701, Taiwan.
EM sheanjen@mail.ncku.edu.tw
RI Huang, Lynn/J-9237-2016
OI Huang, Lynn/0000-0002-6602-7578
FU National Science Council (NSC) of Taiwan [NSC 97-3112-B-006-013, NSC
   97-3111-B-006-004]; Advanced Optoelectronic Technology Center in
   National Cheng Kung University
FX This work was supported by the National Research Program for Genomic
   Medicine (NRPGM) of the National Science Council (NSC) of Taiwan (NSC
   97-3112-B-006-013), (NSC 97-3111-B-006-004), and by the Advanced
   Optoelectronic Technology Center in National Cheng Kung University.
CR Campagnola PJ, 2000, MACROMOLECULES, V33, P1511, DOI 10.1021/ma991042e
   DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027
   Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258
   Hagen JA, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2197973
   Hagen JA, 2007, NANO LETT, V7, P133, DOI 10.1021/nl062342u
   Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130
   Kuo WS, 2010, OPT EXPRESS, V18, P27550, DOI 10.1364/OE.18.027550
   Lambert CR, 1999, J PHYS CHEM B, V103, P3737, DOI 10.1021/jp983812e
   Miwa M, 2001, APPL PHYS A-MATER, V73, P561, DOI 10.1007/s003390100934
   Mysliwiec J, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3377912
   NECKERS DC, 1989, J PHOTOCH PHOTOBIO A, V47, P1, DOI 10.1016/1010-6030(89)85002-6
   Ner Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3262944
   Otomo A, 2000, APPL PHYS LETT, V77, P3881, DOI 10.1063/1.1331092
   Pitts JD, 2000, MACROMOLECULES, V33, P1514, DOI 10.1021/ma9910437
   Steckl AJ, 2007, NAT PHOTONICS, V1, P3, DOI 10.1038/nphoton.2006.56
   Sun ZB, 2008, ADV MATER, V20, P914, DOI 10.1002/adma.200702035
   Tanaka T, 2002, APPL PHYS LETT, V80, P312, DOI 10.1063/1.1432450
   Watanabe T, 2002, ADV FUNCT MATER, V12, P611, DOI 10.1002/1616-3028(20020916)12:9<611::AID-ADFM611>3.0.CO;2-3
   Yang PD, 2000, SCIENCE, V287, P465, DOI 10.1126/science.287.5452.465
   ZHANG ZG, 1993, APPL PHYS LETT, V63, P2993, DOI 10.1063/1.110262
NR 20
TC 14
Z9 14
U1 0
U2 27
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD JUN 6
PY 2011
VL 19
IS 12
BP 11732
EP 11739
DI 10.1364/OE.19.011732
PG 8
WC Optics
SC Optics
GA 794AI
UT WOS:000292865500075
PM 21716404
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Dai, L
   Chen, DF
   Liu, YL
   Zhao, Y
   Yang, F
   Yang, JS
   Yang, WJ
AF Dai, Li
   Chen, Dian-Fu
   Liu, Yu-Lei
   Zhao, Yang
   Yang, Fan
   Yang, Jin-Shu
   Yang, Wei-Jun
TI Extracellular Matrix Peptides of Artemia Cyst Shell Participate in
   Protecting Encysted Embryos from Extreme Environments
SO PLOS ONE
LA English
DT Article
ID SHOCK/ALPHA-CRYSTALLIN PROTEIN; BRINE SHRIMP; TERTIARY ENVELOPE;
   BIOMINERALIZATION; ANOSTRACA; FRANCISCANA; MEMBRANES; DIAPAUSE; STRAINS;
   PCR
AB Background: Many species of the brine shrimp Artemia are found in various severe environments in many parts of the world where extreme salinity, high UV radiation levels, high pH, anoxia, large temperature fluctuations, and intermittent dry conditions are often recorded. To withstand adverse environments, Artemia undergoes an oviparous developmental pathway to release cysts whereas, under favorable conditions, swimming nauplius larvae are formed directly via an ovoviviparous pathway. In the former case these cysts have an extraordinary ability to keep the embryos protected from the harsh environment for long periods. This is achieved through the protection by a complex out-wrapping cyst shell. However, the formation and function of the cyst shell is complex; the details remain largely unclear.
   Principal Finding: A shell gland-specific gene (SGEG2) was cloned and identified from a suppression subtractive hybridization library. Western blot analysis showed that SGEG2 presumably requires post-translational proteolysis in order to be processed into two mature peptides (SGEG2a and 2b). The three matrix peptides (SGEG1 reported previously, 2a, and 2b) were found to distribute throughout the cyst shell. The results of gene knockdown by RNAi and subsequent resistance to environmental stresses assays indicated that these matrix peptides are required for cyst shell formation and are involved in protecting the encysted embryos from environmental stress.
   Conclusions/Significance: This study revealed that extracellular matrix peptides participate in protecting embryos from extreme salinity, UV radiation, large temperature fluctuations and dry environments, thereby facilitating their survival. The cyst shell provides an excellent opportunity to link the ecological setting of an organism to the underlying physiological and biochemical processes enabling its survival. The cyst shell material has also a high potential to become an excellent new biomaterial with a high number of prospective uses due, specifically, to such biological characteristics.
C1 [Dai, Li; Chen, Dian-Fu; Liu, Yu-Lei; Zhao, Yang; Yang, Fan; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310003, Zhejiang, Peoples R China.
   [Yang, Wei-Jun] Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou, Zhejiang, Peoples R China.
RP Dai, L (reprint author), Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Zijingang Campus, Hangzhou 310003, Zhejiang, Peoples R China.
EM w_jyang@cls.zju.edu.cn
FU National Natural Sciences Foundation of China [40730212]; National Basic
   Research Program of China (973 Program) [2010CB833803]
FX Funding: This work was supported by the National Natural Sciences
   Foundation of China (40730212) and National Basic Research Program of
   China (973 Program, 2010CB833803). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR ANDERSON E, 1970, J ULTRA MOL STRUCT R, V32, P497, DOI 10.1016/S0022-5320(70)80025-9
   Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x
   Clegg J.S., 1986, P169
   Clegg James S., 2002, P129
   Clegg JS, 1999, AM ZOOL, V39, P836
   Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715
   CROWE JH, 1998, ISOPOW, V6, P440
   Dai JQ, 2008, J BIOL CHEM, V283, P1705, DOI 10.1074/jbc.M707853200
   Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2
   Drinkwater L.E., 1991, P93
   Gaubin Y, 1996, ADV SPACE RES, V18, P221, DOI 10.1016/0273-1177(96)00043-9
   HOFMANN GE, 1990, J EXP ZOOL, V253, P287, DOI 10.1002/jez.1402530308
   Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242
   Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6
   Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899
   LAVENS P, 1986, MAR ECOL-PROG SER, V31, P179
   LEE KW, 1994, PROC ANN MEET MSA, P362
   Lenz P.H., 1991, P237
   Liu YL, 2009, J BIOL CHEM, V284, P16931, DOI 10.1074/jbc.M109.004051
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   MORRIS JE, 1967, J ULTRA MOL STRUCT R, V20, P244, DOI 10.1016/S0022-5320(67)90285-7
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sollner C, 2003, SCIENCE, V302, P282, DOI 10.1126/science.1088443
   STAPPEN GV, 2002, ARTEMIA BASIC APPL B, P171
   Sugumar V, 2006, MICROSC RES TECHNIQ, V69, P957, DOI 10.1002/jemt.20371
   Suzuki M, 2009, SCIENCE, V325, P1388, DOI 10.1126/science.1173793
   Tajik H, 2008, MOLECULES, V13, P1263, DOI 10.3390/molecules13061263
   Tanguay JA, 2004, J BIOSCIENCES, V29, P489, DOI 10.1007/BF02712121
   Triantaphyllidis GV, 1998, J BIOGEOGR, V25, P213, DOI 10.1046/j.1365-2699.1998.252190.x
   Wang SF, 2007, MICROSC RES TECHNIQ, V70, P663, DOI 10.1002/jemt.20451
   Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022
   WILLIAMS WD, 1981, HYDROBIOLOGIA, V81-2, P1, DOI 10.1007/BF00048701
   Yodmuang S, 2006, BIOCHEM BIOPH RES CO, V341, P351, DOI [10.1016/j.bbrc.2005.12.186, 10.1016/j.bbrc.2005.2.186]
NR 33
TC 18
Z9 18
U1 0
U2 27
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 6
PY 2011
VL 6
IS 6
AR e20187
DI 10.1371/journal.pone.0020187
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 774BN
UT WOS:000291356400002
PM 21673998
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Lee, HS
   Lee, HJ
   Yu, HJ
   Ju, DW
   Kim, Y
   Kim, CT
   Kim, CJ
   Cho, YJ
   Kim, N
   Choi, SY
   Suh, HJ
AF Lee, Hyun-Sun
   Lee, Hyun Jung
   Yu, Hyung Jo
   Ju, Do Weon
   Kim, Yoonsook
   Kim, Chong-Tai
   Kim, Chul-Jin
   Cho, Yong-Jin
   Kim, Namsoo
   Choi, Sin-Yang
   Suh, Hyung Joo
TI A comparison between high hydrostatic pressure extraction and heat
   extraction of ginsenosides from ginseng (Panax ginseng CA Meyer)
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article
DE ginseng; heat extraction; high hydrostatic pressure extraction;
   ginsenoside metabolite
ID SUPERCRITICAL-FLUID EXTRACTION; LIQUID-CHROMATOGRAPHY; ROOTS
AB BACKGROUND: To determine biomaterial components, the components must first be transferred into solution; thus extraction is the first step in biomaterial analysis. High hydrostatic pressure technology was used for ginsenoside extraction from ginseng roots. In the extraction of fresh and red ginseng, high hydrostatic pressure extraction (HHPE) was found to be more effective than heat extraction (HE).
   RESULTS: In fresh ginseng extraction under HHPE, total ginsenosides (1602.2 mu g mL(-1)) and ginsenoside metabolite (132.6 mu g mL(-1)) levels were slightly higher than those under HE (1259.0 and 78.7 mu g mL(-1)), respectively. In red ginseng, similar results indicated total ginsenoside and ginsenoside metabolite amounts according to the extraction methods. Most volatile compounds by HHPE were higher than by HE treatment. HHPE of red ginseng was conducted under four pressures: 0.1 MPa (1 atm), 30, 50, and 80 MPa. Total sugar, uronic acid, and polyphenol amounts increased until 30 MPa of pressure and then showed decreasing tendencies. Total ginsenoside and ginsenoside metabolite contents linearly increased with increasing pressure, and a maximum was reached at 80 MPa for the metabolites.
   CONCLUSION: HHPE used for red ginseng processing contributes to enhanced extraction efficiencies of functional materials such as ginsenosides through cell structure modification. (C) 2011 Society of Chemical Industry
C1 [Lee, Hyun-Sun; Lee, Hyun Jung; Suh, Hyung Joo] Korea Univ, Dept Food & Nutr, Seoul 136703, South Korea.
   [Lee, Hyun-Sun] Korea Univ, Inst Hlth Sci, Seoul 136703, South Korea.
   [Yu, Hyung Jo; Ju, Do Weon] ITC21, Songnam 462120, Gyeonggi, South Korea.
   [Kim, Yoonsook; Kim, Chong-Tai; Kim, Chul-Jin; Cho, Yong-Jin; Kim, Namsoo; Choi, Sin-Yang] Korea Food Res Inst, Songnam 463746, Gyeonggi, South Korea.
RP Suh, HJ (reprint author), Korea Univ, Dept Food & Nutr, Seoul 136703, South Korea.
EM Suh1960@korea.ac.kr
FU Ministry of Knowledge Economy, Republic of Korea
FX This study was supported by the Food High Pressure Technology
   Development Project (2010), Ministry of Knowledge Economy, Republic of
   Korea.
CR Barbosa-Canovas UR, 1998, NONTHERMAL PRESERVAT, P9
   Belogortseva NI, 2000, PLANTA MED, V66, P217, DOI 10.1055/s-2000-8658
   BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1
   Butz P., 1994, Lebensmittel-Wissenschaft and Technologie, V27, P463, DOI 10.1006/fstl.1994.1093
   Chang Yuan S, 2003, Integr Cancer Ther, V2, P13, DOI 10.1177/1534735403251167
   Cho JY, 2002, PLANTA MED, V68, P497, DOI 10.1055/s-2002-32556
   DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0
   Gillis CN, 1997, BIOCHEM PHARMACOL, V54, P1, DOI 10.1016/S0006-2952(97)00193-7
   Goto M, 1998, J CHEM ENG JPN, V31, P171, DOI 10.1252/jcej.31.171
   HAN BH, 1982, PLANTA MED, V44, P146, DOI 10.1055/s-2007-971425
   Hayashi R, 2002, TRENDS HIGH PRESSURE, P365
   IWABUCHI H, 1990, CHEM PHARM BULL, V38, P1405
   Jovanovski E, 2010, AM J HYPERTENS, V23, P469, DOI 10.1038/ajh.2010.5
   Kiefer D, 2003, AM FAM PHYSICIAN, V68, P1539
   Kim SJ, 2007, SEP PURIF TECHNOL, V56, P401, DOI 10.1016/j.seppur.2007.06.014
   Lee HJ, 2009, J FOOD SCI NUTR, V14, P201
   Lee J, 2009, CURR MED CHEM, V16, P2475
   Li WK, 2002, J LIQ CHROMATOGR R T, V25, P2485, DOI 10.1081/JLC-120014269
   Lou DW, 2005, CHROMATOGRAPHIA, V62, P349, DOI 10.1365/s10337-005-0640-6
   Park J.D., 1996, KOREAN J GINSENG SCI, V20, P389
   Park JH, 2004, FOOD IND NUTR, V9, P23
   Quan C, 2004, J SUPERCRIT FLUID, V31, P149, DOI 10.1016/j.supflu.2003.11.003
   Reynolds L. B., 1998, Journal of Herbs, Spices & Medicinal Plants, V6, P9, DOI 10.1300/J044v06n02_02
   SADUS RJ, 1993, FLUID PHASE EQUILIBR, V83, P101, DOI 10.1016/0378-3812(93)87012-P
   Sahena F, 2009, J FOOD ENG, V95, P240, DOI 10.1016/j.jfoodeng.2009.06.026
   Shin KS, 1998, CARBOHYD RES, V307, P97, DOI 10.1016/S0008-6215(98)00016-0
   Singleton VL, 1999, METHOD ENZYMOL, V299, P152
   SOHN HJ, 2000, J GINSENG RES, V24, P148
   SOHN HJ, 1997, KOREAN J GINSENG SCI, V21, P196
   Song HY, 2002, INT IMMUNOPHARMACOL, V2, P857
   Suh HJ, 2009, Korea Patent, Patent No. [10-0970455, 100970455]
   VANBREEMEN RB, 1995, ANAL CHEM, V67, P3985, DOI 10.1021/ac00117a026
   Xi J, 2009, INT J PHARMACEUT, V382, P139, DOI 10.1016/j.ijpharm.2009.08.023
   Xie JT, 2002, PHYTOMEDICINE, V9, P254, DOI 10.1078/0944-7113-00106
   Yen GC, 1999, J AGR FOOD CHEM, V47, P2082, DOI 10.1021/jf9810057
   Zhang SQ, 2004, INT J PHARM, V278, P471, DOI 10.1016/j.ijpharm.2004.02.029
NR 36
TC 27
Z9 30
U1 3
U2 27
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-5142
EI 1097-0010
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD JUN
PY 2011
VL 91
IS 8
BP 1466
EP 1473
DI 10.1002/jsfa.4334
PG 8
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 767MK
UT WOS:000290860500016
PM 21384379
DA 2018-10-20
ER

PT J
AU Kumar, GVP
AF Kumar, G. V. Pavan
TI Gold nanoparticle-coated biomaterial as SERS micro-probes
SO BULLETIN OF MATERIALS SCIENCE
LA English
DT Article
DE Surface enhanced Raman scattering; micro-probes; biomaterial; plasmonics
ID PLASMON RESONANCE SPECTROSCOPY; ENHANCED RAMAN-SCATTERING; NANOSPHERE
   LITHOGRAPHY; SILVER NANOPARTICLES; SURFACE; SUBSTRATE; MOLECULES; OPTICS
AB We report for the first time, on the utility of plant-based biomaterial as enhanced-Raman scattering probes. The bio-substrate used in this study are commonly found in plant extracts, and are cost-effective, mechanically robust, flexible and easily transportable. The probe was fabricated by coating the plant extract with gold nanoparticles and characterized. By employing a 'single-touch contact' method, we reveal the ability of these probes to detect routinely used Raman markers such as 2-napthalenethiol and rhodamine B, at nano-molar concentrations, in dry and liquid forms, respectively. Reproducibility of the signals with variation <5%, and the ability to detect biomolecules are demonstrated herein. We envision these bio-probes as potential candidates for enhanced Raman sensing in chemical, environmental, and archaeological applications. By further engineering the shape, morphology, and surface chemistry of these micro-probes, we foresee their utility as miniaturized, natural SERS substrates.
C1 Indian Inst Sci Educ & Res IISER, Div Phys & Chem, Pune 411021, Maharashtra, India.
RP Kumar, GVP (reprint author), Indian Inst Sci Educ & Res IISER, Div Phys & Chem, Pune 411021, Maharashtra, India.
EM pavan@iiserpune.ac.in
FU DST
FX The author thanks Prof. J Irudayaraj and Prof. D Szymanski for their
   feedback and plant facilities during the initial stage of the project.
   The author is also thankful to IISER, Pune and IIT, Bombay for
   experimental facilities. DST, India is acknowledged for DST Nanoscience
   project at IISER, Pune and a DST Ramanujan fellowship to the author.
CR Aroca R., 2006, SURFACE ENHANCED VIB
   Bhuvana T, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/4/045504
   CLARO F, 1993, J PHYS-CONDENS MAT, V5, pA187, DOI 10.1088/0953-8984/5/33A/054
   Cui B, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/14/145302
   D'Andrea C, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/24/245606
   De Angelis F, 2008, NANO LETT, V8, P2321, DOI 10.1021/nl801112e
   Garrett NL, 2009, J BIOPHOTONICS, V2, P157, DOI 10.1002/jbio.200810057
   Haes AJ, 2002, J AM CHEM SOC, V124, P10596, DOI 10.1021/ja020393x
   Haynes CL, 2001, J PHYS CHEM B, V105, P5599, DOI 10.1021/jp010657m
   Jackson JB, 2004, P NATL ACAD SCI USA, V101, P17930, DOI 10.1073/pnas.0408319102
   Jensen TR, 2000, J PHYS CHEM B, V104, P10549, DOI 10.1021/jp002435e
   Kneipp K., 2006, SURFACE ENHANCED RAM
   Lal S, 2007, NAT PHOTONICS, V1, P641, DOI 10.1038/nphoton.2007.223
   Le F, 2008, ACS NANO, V2, P707, DOI 10.1021/nn800047e
   LEE DW, 2009, BIOMIMETICS BIOINSPI
   LeRu EC, 2009, PRINCIPLES OF SURFACE-ENHANCED RAMAN SPECTROSCOPY: AND RELATED PLASMONIC EFFECTS, P1
   Linn NC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/22/225303
   Liu YJ, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2369644
   MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783
   Smith LG, 2005, ANNU REV CELL DEV BI, V21, P271, DOI 10.1146/annurev.cellbio.21.122303.114901
   Szymanski DB, 1998, DEVELOPMENT, V125, P1161
   West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723
   Whitney AV, 2007, J PHYS CHEM C, V111, P16827, DOI 10.1021/jp04462b
   Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607
NR 24
TC 4
Z9 4
U1 2
U2 20
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0250-4707
EI 0973-7669
J9 B MATER SCI
JI Bull. Mat. Sci.
PD JUN
PY 2011
VL 34
IS 3
BP 417
EP 422
DI 10.1007/s12034-011-0121-5
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 822CI
UT WOS:000295020900001
DA 2018-10-20
ER

PT J
AU Moura, ES
   Cunha, AS
   Heneine, LGD
   Faraco, AAG
AF Moura, Edson S.
   Cunha Junior, Armando S.
   Heneine, Luiz G. D.
   Faraco, Andre A. G.
TI Characterization and Basic Guidelines for the Quality Control of
   Chitosan for Drug Delivery in Pharmaceutical Applications
SO LATIN AMERICAN JOURNAL OF PHARMACY
LA English
DT Article
DE Biomaterial; Biopolymer; Characterization; Chitosan
ID DEACETYLATION; ACETYLATION; CHITIN; MOLECULES; TITRATION; FILMS
AB Chitosan is increasingly used as an alternative to synthetic polymers due to its water solubility, biodegradability, and biological activity. In this work, chitosan samples from three suppliers were evaluated and characterized by physicochemical methods in an attempt to analyze pharmaceutical applications. The degree of deacetylation (DD) was determined by H-1 NMR, IR spectra, potentiometric titration, and UV spectrophotometry. The analysis was supplemented by the techniques of DSC, TG, loss on drying, pH of the suspension, heavy metals, sulphated ash, and triple detector size exclusion chromatography (TriSEC). The use of UV, IR, and H-1 NMR techniques to determine the degree of deacetylation, limit testing for heavy metals and sulphated ash to analyze, inorganic waste, and TriSEC to analyze molecular weights and molecular distribution are recommended as basic requirements for pharmaceutical applications.
C1 [Moura, Edson S.; Cunha Junior, Armando S.; Faraco, Andre A. G.] Univ Fed Minas Gerais, Dept Pharmaceut Prod, BR-31270901 Belo Horizonte, MG, Brazil.
   [Heneine, Luiz G. D.] Ezequiel Dias Fdn FUNED, BR-30510010 Belo Horizonte, MG, Brazil.
RP Moura, ES (reprint author), Univ Fed Minas Gerais, Dept Pharmaceut Prod, Av Presidente Antonio Carlos 6627,Campus Pampulha, BR-31270901 Belo Horizonte, MG, Brazil.
EM moura_edson@yahoo.com.br
RI Cunha, Armando/G-1157-2012
OI Cunha, Armando/0000-0002-1161-8936
CR Argin-Soysal S, 2009, FOOD HYDROCOLLOID, V23, P202, DOI 10.1016/j.foodhyd.2007.12.011
   Augsten C, 2008, INT J PHARM, V351, P23, DOI 10.1016/j.ijpharm.2007.09.013
   Balazs N, 2007, CARBOHYD RES, V342, P124, DOI 10.1016/j.carres.2006.11.016
   Brugnerotto J, 2001, MACROMOL SYMP, V168, P1, DOI 10.1002/1521-3900(200103)168:1<1::AID-MASY1>3.0.CO;2-W
   Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   Canella KMND, 2001, QUIM NOVA, V24, P13
   CANEVAROLO SV, 2004, TECNICAS CARACTERIZA, P117
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   *COUNC EUR, 2004, EUR PHARM, V2, P1248
   GALLO JM, 1988, PHARMACEUT RES, V5, P300, DOI 10.1023/A:1015978704810
   Guinesi LS, 2006, THERMOCHIM ACTA, V444, P128, DOI 10.1016/j.tca.2006.03.003
   IANG ZX, 2003, CARBOHYD POLYM, V54, P457
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820
   KASSAI M.R., 2010, CARBOHYD POLYM, V79, P801
   Kean T, 2010, ADV DRUG DELIVER REV, V62, P3, DOI 10.1016/j.addr.2009.09.004
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Liu DS, 2006, CARBOHYD RES, V341, P782, DOI 10.1016/j.carres.2006.01.008
   Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Quijada-Garrido I, 2007, CARBOHYD POLYM, V68, P173, DOI 10.1016/j.carbpol.2006.07.025
   RAYMOND L, 1993, CARBOHYD RES, V246, P331, DOI 10.1016/0008-6215(93)84044-7
   ROSSLER B, 1995, J MICROENCAPSUL, V12, P49, DOI 10.3109/02652049509051126
   Santos José E. dos, 2003, Polímeros, V13, P242, DOI 10.1590/S0104-14282003000400009
   SAWAYANAGI Y, 1982, CHEM PHARM BULL, V30, P4454
   Singh B, 2009, J POLYM ENG, V29, P249, DOI 10.1515/POLYENG.2009.29.5.249
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Torres Marco A., 2005, Polímeros, V15, P306, DOI 10.1590/S0104-14282005000400016
   Ulubayram K, 2002, J BIOMATER APPL, V16, P227, DOI 10.1106/088532802021178
   Varum K. M., 2005, POLYSACCHARIDES STRU, P625
   WAN Y, 2009, THERMOCHIM ACTA, V487, P3338
   Wu T, 2008, J AGR FOOD CHEM, V56, P5112, DOI 10.1021/jf073136q
   Zohuriaan MJ, 2004, POLYM TEST, V23, P575, DOI 10.1016/j.polymertesting.2003.11.001
NR 34
TC 0
Z9 0
U1 0
U2 6
PU COLEGIO FARMACEUTICOS PROVINCIA DE BUENOS AIRES
PI LA PLATA
PA DEPT CIENTIFICO, CALLE 5 NO 966, LA PLATA, 00000, ARGENTINA
SN 0326-2383
J9 LAT AM J PHARM
JI Lat. Am. J. Pharm.
PD JUN
PY 2011
VL 30
IS 5
BP 937
EP 944
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 822QF
UT WOS:000295064000016
DA 2018-10-20
ER

PT J
AU Engelhardt, S
   Hoch, E
   Borchers, K
   Meyer, W
   Kruger, H
   Tovar, GEM
   Gillner, A
AF Engelhardt, Sascha
   Hoch, Eva
   Borchers, Kirsten
   Meyer, Wolfdietrich
   Krueger, Hartmut
   Tovar, Guenter E. M.
   Gillner, Arnold
TI Fabrication of 2D protein microstructures and 3D polymer-protein hybrid
   microstructures by two-photon polymerization
SO BIOFABRICATION
LA English
DT Article
ID NANO-STRUCTURED SURFACES; FREE-FORM FABRICATION; 3-DIMENSIONAL
   MICROFABRICATION; VISIBLE RANGE; CELL BEHAVIOR; LASER; MATRICES; MICRO;
   SCAFFOLDS; LITHOGRAPHY
AB Two-photon polymerization (TPP) offers the possibility of creating artificial cell scaffolds composed of micro-and nanostructures with spatial resolutions of less than 1 mu m. For use in tissue engineering, the identification of a TPP-processable polymer that provides biocompatibility, biofunctionality and appropriate mechanical properties is a difficult task. ECM proteins such as collagen or fibronectin, which could mimic native tissues best, often lack the mechanical stability. Hence, by generating polymer-protein hybrid structures, the beneficial properties of proteins can be combined with the advantageous characteristics of polymers, such as sufficient mechanical stability. This study describes three steps toward facilitated application of TPP for biomaterial generation. (1) The efficiency of a low-cost ps-laser source is compared to a fs-laser source by testing several materials. A novel photoinitiator for polymerization with a ps-laser source is synthesized and proved to enable increased fabrication throughput. (2) The fabrication of 3D-microstructures with both systems and the fabrication of polymer-protein hybrid structures are demonstrated. (3) The tissue engineering capabilities of TPP are demonstrated by creating cross-linked gelatin microstructures, which clearly forced porcine chondrocytes to adapt their cell morphology.
C1 [Engelhardt, Sascha] Rhein Westfal TH Aachen, Lehrstuhl Lasertech, D-5100 Aachen, Germany.
   [Hoch, Eva; Tovar, Guenter E. M.] Univ Stuttgart, Inst Grenzflachenverfahrenstech, Stuttgart, Germany.
   [Borchers, Kirsten; Tovar, Guenter E. M.] Fraunhofer Inst Grenzflachen & Bioverfahrenstech, D-7000 Stuttgart, Germany.
   [Meyer, Wolfdietrich; Krueger, Hartmut] Fraunhofer Inst Angew Polymerforsch, Potsdam, Germany.
   [Gillner, Arnold] Fraunhofer Inst Lasertech, D-5100 Aachen, Germany.
RP Engelhardt, S (reprint author), Rhein Westfal TH Aachen, Lehrstuhl Lasertech, Steinbachstr 15, D-5100 Aachen, Germany.
EM sascha.engelhardt@ilt.fraunhofer.de
RI Engelhardt, Sascha/F-7749-2014
OI Meyer, Wolfdietrich/0000-0003-1330-2887
FU Fraunhofer-Gesellschaft
FX The authors thank Dominik Riester, Nadine Seiler, Elke
   Bremus-Kobberling, Daniela Pufky-Heinrich and Christian Schuh for
   fruitful discussions, Yanlei Hu for the performance of most of the voxel
   experiments and Aaron Elliot for LabVIEW programming (all
   Fraunhofer-Gesellschaft). They gratefully acknowledge financial support
   of the Fraunhofer-Gesellschaft for the project 'BioRap'.
CR Alberts B., 2008, MOL BIOL CELL
   Allen R, 2005, ANAL CHEM, V77, P5089, DOI 10.1021/ac0507892
   Anemian R, 2003, J MATER CHEM, V13, P2157, DOI 10.1039/b304619b
   Basu S, 2004, J BIOMED MATER RES A, V71A, P359, DOI 10.1002/jbm.a.30175
   Berry CC, 2004, BIOMATERIALS, V25, P5781, DOI 10.1016/j.biomaterials.2004.01.029
   Claeyssens F, 2009, LANGMUIR, V25, P3219, DOI 10.1021/la803803m
   Coenjarts CA, 2004, CHEM MATER, V16, P5556, DOI 10.1021/cm048717z
   Cunningham LP, 2006, OPT EXPRESS, V14, P8613, DOI 10.1364/OE.14.008613
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dinca V, 2008, NANO LETT, V8, P538, DOI 10.1021/nl072798r
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Drakakis TS, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2359533
   Engelhardt S, 2011, J LASER MICRO NANOEN, V6, P54, DOI 10.2961/jlmn.2011.01.0012
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Hsieh TM, 2010, BIOMATERIALS, V31, P7648, DOI 10.1016/j.biomaterials.2010.06.029
   Hutmacher DW, 2007, J CELL MOL MED, V11, P654, DOI 10.1111/j.1582-4934.2007.00078.x
   Iosin M, 2007, J OPTOELECTRON ADV M, V9, P716
   Juodkazis S, 2005, NANOTECHNOLOGY, V16, P846, DOI 10.1088/0957-4484/16/6/039
   Kaehr B, 2006, ANAL CHEM, V78, P3198, DOI 10.1021/ac052267s
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee KS, 2008, PROG POLYM SCI, V33, P631, DOI 10.1016/j.progpolymsci.2008.01.001
   Liska R, 2007, J COAT TECHNOL RES, V4, P505, DOI 10.1007/s11998-007-9059-3
   Martineau C, 2002, CHEM PHYS LETT, V362, P291, DOI 10.1016/S0009-2614(02)01073-4
   Martinez E, 2009, ANN ANAT, V191, P126, DOI 10.1016/j.aanat.2008.05.006
   Melchels FPW, 2010, BIOMATERIALS, V31, P6121, DOI 10.1016/j.biomaterials.2010.04.050
   Ovsianikov A, 2011, ACTA BIOMATER, V7, P967, DOI 10.1016/j.actbio.2010.10.023
   Ovsianikov A, 2011, BIOMACROMOLECULES, V12, P851, DOI 10.1021/bm1015305
   Ovsianikov A, 2011, MATERIALS, V4, P288, DOI 10.3390/ma4010288
   Pins GD, 2006, J BIOMED MATER RES A, V78A, P194, DOI 10.1002/jbm.a.30680
   Pitts JD, 2000, MACROMOLECULES, V33, P1514, DOI 10.1021/ma9910437
   Ritschdorff ET, 2010, ANAL CHEM, V82, P8733, DOI 10.1021/ac101274u
   Rouwkema J, 2008, TRENDS BIOTECHNOL, V26, P434, DOI 10.1016/j.tibtech.2008.04.009
   Schade R, 2010, INT J ARTIF ORGANS, V33, P219
   Schafer KJ, 2004, J PHOTOCH PHOTOBIO A, V162, P497, DOI 10.1016/S1010-6030(03)00394-0
   Schlie S, 2007, J BIOMATER APPL, V22, P275, DOI 10.1177/0885328207077590
   Serbin J, 2003, OPT LETT, V28, P301, DOI 10.1364/OL.28.000301
   Sun HB, 2002, APPL PHYS LETT, V80, P3673, DOI 10.1063/1.1478128
   Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Wang I, 2002, OPT LETT, V27, P1348, DOI 10.1364/OL.27.001348
   Weiss T, 2009, ENG LIFE SCI, V9, P384, DOI 10.1002/elsc.200900002
NR 41
TC 49
Z9 53
U1 5
U2 77
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1758-5082
J9 BIOFABRICATION
JI Biofabrication
PD JUN
PY 2011
VL 3
IS 2
AR 025003
DI 10.1088/1758-5082/3/2/025003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 821DH
UT WOS:000294954500005
PM 21562366
DA 2018-10-20
ER

PT J
AU Kim, HR
   Liu, K
   Roberts, TJ
   Hai, CM
AF Kim, Hak Rim
   Liu, Katrina
   Roberts, Thomas J.
   Hai, Chi-Ming
TI Length-Dependent Modulation of Cytoskeletal Remodeling and Mechanical
   Energetics in Airway Smooth Muscle
SO AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
LA English
DT Article
DE airway smooth muscle; asthma; bronchoconstriction; cytoskeleton;
   mechanics
ID FORCED OSCILLATION TECHNIQUE; FOCAL ADHESION KINASE;
   PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MECHANOSENSITIVE MODULATION;
   CHOLINERGIC-RECEPTOR; INTEGRIN-BINDING; META-VINCULIN; C ISOFORMS;
   F-ACTIN; DYNAMICS
AB Actin cytoskeletal remodeling is an important mechanism of airway smooth muscle (ASM) contraction. We tested the hypothesis that mechanical strain modulates the cholinergic receptor-mediated cytoskeletal recruitment of actin-binding and integrin-binding proteins in intact airway smooth muscle, thereby regulating the mechanical energetics of airway smooth muscle. We found that the carbachol-stimulated cytoskeletal recruitment of actin-related protein-3 (Arp3), metavinculin, and talin were up-regulated at short muscle lengths and down-regulated at long muscle lengths, suggesting that the actin cytoskeleton-integrin complex becomes enriched in cross-linked and branched actin filaments in shortened ASM. The mechanical energy output/input ratio during sinusoidal length oscillation was dependent on muscle length, oscillatory amplitude, and cholinergic activation. The enhancing effect of cholinergic stimulation on mechanical energy output/input ratio at short and long muscle lengths may be explained by the length-dependent modulation of cytoskeletal recruitment and crossbridge cycling, respectively. We postulate that ASM functions as a hybrid biomaterial, capable of switching between operating as a cytoskeleton-based mechanical energy store at short muscle lengths to operating as an actomyosin-powered mechanical energy generator at long muscle lengths. This postulate predicts that targeting the signaling molecules involved in cytoskeletal recruitment may provide a novel approach to dilating collapsed airways in obstructive airway disease.
C1 [Kim, Hak Rim; Liu, Katrina; Hai, Chi-Ming] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
   [Roberts, Thomas J.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.
   [Kim, Hak Rim] Dankook Univ, Coll Med, Dept Pharmacol, Cheonan Si, Chungnam, South Korea.
RP Hai, CM (reprint author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Box G-B3,171 Meeting St, Providence, RI 02912 USA.
EM Chi-Ming_Hai@brown.edu
FU National Heart, Lung, and Blood Institute [HL-52714]; National
   Institutes of Health
FX This study was supported by National Heart, Lung, and Blood Institute
   grant HL-52714.; T.J.R. received a sponsored grant from the National
   Institutes of Health for more than $ 100,001. H. R. K. does not have a
   financial relationship with a commercial entity that has an interest in
   the subject of this manuscript. K. L. does not have a financial
   relationship with a commercial entity that has an interest in the
   subject of this manuscript. C.-M.H. does not have a financial
   relationship with a commercial entity that has an interest in the
   subject of this manuscript.
CR An SS, 1999, AM J PHYSIOL-LUNG C, V277, pL968, DOI 10.1152/ajplung.1999.277.5.L968
   An SS, 2000, AM J PHYSIOL-CELL PH, V279, pC1375
   Bates JHT, 2005, AM J PHYSIOL-LUNG C, V289, pL849, DOI 10.1152/ajplung.00129.2005
   BELKIN AM, 1988, J BIOL CHEM, V263, P6631
   BLAKE JT, 1982, J DAIRY SCI, V65, P1544, DOI 10.3168/jds.S0022-0302(82)82380-1
   Brown N, 2007, AM J RESP CRIT CARE, V176, P129, DOI 10.1164/rccm.200609-1317OC
   BYRNE BJ, 1992, J BIOL CHEM, V267, P12845
   CHILVERS ER, 1991, BIOCHEM J, V275, P373, DOI 10.1042/bj2750373
   Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044
   Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185
   DUY Y, 2007, J BIOMECH, V40, P3207
   Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911
   Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562
   Fredberg JJ, 1997, AM J RESP CRIT CARE, V156, P1752, DOI 10.1164/ajrccm.156.6.9611016
   Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0
   GIMONA M, 1988, EMBO J, V7, P2329, DOI 10.1002/j.1460-2075.1988.tb03076.x
   Goldberg M, 1997, J CLIN INVEST, V99, P55, DOI 10.1172/JCI119133
   Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026
   Gu ZZ, 2007, EXP CELL RES, V313, P849, DOI 10.1016/j.yexcr.2006.12.005
   Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008
   Hai CM, 2000, ARCH PHARM RES, V23, P535, DOI 10.1007/BF02975237
   Harrington EO, 2003, AM J RESP CELL MOL, V28, P626, DOI 10.1165/rcmb.2002-0085OC
   Josephson RK, 2000, J EXP BIOL, V203, P2713
   Kanefsky J, 2006, AM J RESP CELL MOL, V34, P417, DOI 10.1165/rcmb.2005-0326OC
   Katoh K, 1998, MOL BIOL CELL, V9, P1919, DOI 10.1091/mbc.9.7.1919
   Kawai M, 2007, J MUSCLE RES CELL M, V28, P371, DOI 10.1007/s10974-008-9131-3
   Kim HR, 2004, AM J PHYSIOL-CELL PH, V287, pC1375, DOI 10.1152/ajpcell.00100.2004
   Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200
   Mehta D, 1996, AM J PHYSIOL-CELL PH, V270, pC243
   Mijailovich SM, 2000, BIOPHYS J, V79, P2667, DOI 10.1016/S0006-3495(00)76505-2
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403
   Roberts Gordon C K, 2009, Biophys Rev, V1, P61, DOI 10.1007/s12551-009-0009-4
   Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299
   Tang D, 1999, AM J PHYSIOL-CELL PH, V276, pC250, DOI 10.1152/ajpcell.1999.276.1.C250
   TRANQUI L, 1995, EXP CELL RES, V217, P149, DOI 10.1006/excr.1995.1074
   TRELOAR LRG, 2009, PHYS RUBBER ELASTICI, P15
   Tseng S, 1997, AM J PHYSIOL-CELL PH, V272, pC1960
   Tsutsumi T, 2000, J BIOL CHEM, V275, P9157, DOI 10.1074/jbc.275.13.9157
   WALSH MP, 1990, PROG CLIN BIOL RES, V245, P127
   Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094
   Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517
   Youn T, 1998, AM J PHYSIOL-CELL PH, V274, pC1601, DOI 10.1152/ajpcell.1998.274.6.C1601
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 44
TC 3
Z9 3
U1 0
U2 3
PU AMER THORACIC SOC
PI NEW YORK
PA 61 BROADWAY, FL 4, NEW YORK, NY 10006 USA
SN 1044-1549
J9 AM J RESP CELL MOL
JI Am. J. Respir. Cell Mol. Biol.
PD JUN
PY 2011
VL 44
IS 6
BP 888
EP 897
DI 10.1165/rcmb.2010-0144OC
PG 10
WC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
SC Biochemistry & Molecular Biology; Cell Biology; Respiratory System
GA 808AZ
UT WOS:000293946800019
PM 20705939
OA Green Published
DA 2018-10-20
ER

PT J
AU Saraydin, SU
   Develioglu, H
AF Saraydin, Serpil Unver
   Develioglu, Hakan
TI Evaluation of the Bone Repair Capacity and the Cytotoxic Properties of a
   Particular Xenograft: An Experimental Study in Rats
SO TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
LA English
DT Article
DE Bone and bones; cytotoxicity tests, immunologic; dental prosthesis
   repair; osteogenesis
ID CALVARIAL DEFECT MODEL; MANDIBULAR DEFECTS; XENOGENEIC BONE;
   GIANT-CELLS; REGENERATION; BIO-OSS(R); HUMANS; GROWTH; CORAL
AB Objective: Bone grafts have been widely used in osseous defects in medicine and dentistry (e.g. periodontology, implantology). This study aims to assess bone and tissue response to a xenograft (Unilab Surgibone) after the first and third month of implantation and its cytotoxicity in vitro. Material and Methods: Fifteen rats, each of which having a 5 mm critical-size, symmetrical, circular defects in the corpus of the mandible were recruited. The experimental defects were filled with the biomaterial whereas defects on the opposite side were used as controls (sham-operated group). After histological follow-up, serial sections were prepared for evaluation under light microscope. The cytotoxicity of xenograft was examined in vitro. Result: Xenografts did not show any cytotoxicity for the cells. There was no callus formation in the implantation site at the first and third months, and Unilab Surgibone material was surrounded with fibrous tissue. Dense collagenous tissue was observed in the control site at the first and third months. Conclusion: Although there was no evidence of bone building, the biomaterial seems biocompatible and can be considered as a space filler for such applications in dentistry.
C1 [Saraydin, Serpil Unver] Cumhuriyet Univ, Fac Med, Dept Histol & Embryol, Sivas, Turkey.
   [Develioglu, Hakan] Cumhuriyet Univ, Fac Dent, Dept Periodontol, Sivas, Turkey.
RP Saraydin, SU (reprint author), Cumhuriyet Univ, Fac Med, Dept Histol & Embryol, Sivas, Turkey.
EM usaraydin@cumhuriyet.edu.tr
CR Allen T.C., 1992, LAB METHODS HISTOTEC, P53
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   Arosarena OA, 2003, ARCH OTOLARYNGOL, V129, P1125, DOI 10.1001/archotol.129.10.1125
   Balakrishnan M, 2000, Med J Armed Forces India, V56, P21, DOI 10.1016/S0377-1237(17)30083-7
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Develioglu H, 2006, J BIOMED MATER RES A, V77A, P627, DOI 10.1002/jbm.a.30692
   Develioglu H, 2007, J BIOMED MATER RES A, V80A, P505, DOI 10.1002/jbm.a.31121
   Develioglu H, 2009, DENT MATER J, V28, P396, DOI 10.4012/dmj.28.396
   DOHERTY MJ, 1994, BIOMATERIALS, V15, P601, DOI 10.1016/0142-9612(94)90210-0
   Donos N, 2005, CLIN ORAL IMPLAN RES, V16, P140, DOI 10.1111/j.1600-0501.2004.01088.x
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   Higuchi T, 1999, J PERIODONTOL, V70, P1026, DOI 10.1902/jop.1999.70.9.1026
   Hollinger J O, 1990, J Craniofac Surg, V1, P60, DOI 10.1097/00001665-199001000-00011
   MALLORY FB, 1968, PATHOLOGICAL TECHNIQ, P169
   MATHESON MA, 2004, J CELL PHYSL, V199, P8
   MURCH AR, 1982, J PATHOL, V137, P177, DOI 10.1002/path.1711370302
   PAPADIMITRIOU JM, 1979, CRC CRIT R TOXICOL, V6, P212
   PIETRZAK WS, 2008, MUSCULOSKELETAL TISS, P121
   PROLO DJ, 1985, CLIN ORTHOP RELAT R, V200, P322
   SALAMA R, 1983, CLIN ORTHOP RELAT R, P113
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   Sculean A, 2002, INT J PERIODONT REST, V22, P259
   Srouji S, 2005, J CRANIO MAXILL SURG, V33, P79, DOI 10.1016/j.jcms.2004.09.003
   Yilmaz S, 1996, Periodontal Clin Investig, V18, P13
   Yukna RA, 1998, J CLIN PERIODONTOL, V25, P1036, DOI 10.1111/j.1600-051X.1998.tb02410.x
   Zellin G, 1997, J BIOMED MATER RES, V35, P181
   Zhao YF, 1999, INT J ORAL MAX IMPL, V14, P889
NR 32
TC 2
Z9 2
U1 0
U2 4
PU ORTADOGU AD PRES & PUBL CO
PI ANKARA
PA TURKOCAGI CAD NO 30, BALGAT, ANKARA, 06520, TURKEY
SN 1300-0292
J9 TURK KLIN TIP BILIM
JI Turk. Klin. Tip Bilim. Derg.
PD JUN
PY 2011
VL 31
IS 3
BP 541
EP 547
DI 10.5336/medsci.2009-16581
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 797FC
UT WOS:000293108900005
OA Other Gold
DA 2018-10-20
ER

PT J
AU Karaoglu, MH
   Ugurlu, M
AF Karaoglu, M. Hamdi
   Ugurlu, Mehmet
TI Adsorption and Recovery of Methylene Blue from Aqueous Solution by
   NaOH-Treated of Prina
SO ASIAN JOURNAL OF CHEMISTRY
LA English
DT Article
DE Methylene blue; Biosorbent; Kinetics; Thermodynamic parameters;
   Desorption
ID LEAF POWDER; REMOVAL; KINETICS; DYE; EQUILIBRIUM; THERMODYNAMICS;
   BIOSORPTION; BIOSORBENT; SHELLS; WASTE
AB In the present work, we have investigated the sorption efficiency of base activated prina towards methylene blue removal from their respective aqueous solutions. Base activated prina material was prepared by treatment of olive stones and aqueous solution at room temperature. The resulting material has been thoroughly characterized by FTIR. The sorption study of 0.1 M NaOH base activated prina at the solid-liquid interface was investigated using adsorbent dosage, initial pH, initial dye concentration, temperature and ionic strength. The application of the Langmuir and Freundlich models showed a better fitting of experimental data to the first model. Base activated prina exhibited the highest methylene blue uptake of 12.90 mg/g at natural pH. The methylene blue adsorbed could be desorbed by ultrapure water, ethyl alcohol and hydrochloric acid. In the kinetic of the adsorbent process, the adsorption data followed the second-order, kinetic model better than first order kinetic model and particle diffusion models. In addition, the diffusion coefficient values was found in the range from 0.62 x 10(-7)-31.79 x 10(-7) cm(2)/s. Isotherms have also been used to obtain the thermodynamic parameters such as free energy, enthalpy and entropy of adsorption. The positive value of the enthalpy change (68.122 kJ mol(-1)) indicated that the adsorption is endothermic process. The results indicate that base activated prina could be fruitfully employed as effective biomaterial and as low-cost sorbents for the removal of methylene blue from effluents.
C1 [Karaoglu, M. Hamdi; Ugurlu, Mehmet] Mugla Univ, Fac Sci & Arts, Dept Chem, TR-48000 Mugla, Turkey.
RP Karaoglu, MH (reprint author), Mugla Univ, Fac Sci & Arts, Dept Chem, TR-48000 Mugla, Turkey.
EM fahamdi1972@hotmail.com
CR Alkan M, 2008, CHEM ENG J, V139, P213, DOI 10.1016/j.cej.2007.07.080
   Arami M, 2008, CHEM ENG J, V139, P2, DOI 10.1016/j.cej.2007.07.060
   Batzias FA, 2004, J HAZARD MATER, V114, P167, DOI 10.1016/j.jhazmat.2004.08.014
   Bhattacharyya KG, 2005, DYES PIGMENTS, V65, P51, DOI 10.1016/j.dyepig.2004.06.016
   Blazquez G, 2009, CHEM ENG J, V148, P473, DOI 10.1016/j.cej.2008.09.026
   Bulut Y, 2006, DESALINATION, V194, P259, DOI 10.1016/j.desal.2005.10.032
   Cengiz S, 2008, BIORESOURCE TECHNOL, V99, P2357, DOI 10.1016/j.biortech.2007.05.011
   Chen JP, 2002, J CHEM TECHNOL BIOT, V77, P657, DOI 10.1002/jctb.627
   Brito SMD, 2010, J HAZARD MATER, V174, P84, DOI 10.1016/j.jhazmat.2009.09.020
   Dogan M, 2008, WATER AIR SOIL POLL, V192, P141, DOI 10.1007/s11270-008-9641-z
   Dogan M, 2009, J HAZARD MATER, V165, P1142, DOI 10.1016/j.jhazmat.2008.10.101
   Dogan M, 2009, J HAZARD MATER, V164, P172, DOI 10.1016/j.jhazmat.2008.07.155
   Gibert O, 2005, WATER RES, V39, P2827, DOI 10.1016/j.watres.2005.04.056
   Hameed BH, 2009, DESALINATION, V247, P551, DOI 10.1016/j.desal.2008.08.005
   Ho YS, 2005, PROCESS BIOCHEM, V40, P119, DOI 10.1016/j.procbio.2003.11.035
   Karaoglu MH, 2010, DESALINATION, V256, P154, DOI 10.1016/j.desal.2010.01.021
   Karaoglu MH, 2009, MICROPOR MESOPOR MAT, V122, P20, DOI 10.1016/j.micromeso.2009.02.013
   Kavitha D, 2007, BIORESOURCE TECHNOL, V98, P14, DOI 10.1016/j.biortech.2005.12.008
   Kumar KV, 2006, J HAZARD MATER, V138, P633, DOI 10.1016/j.jhazmat.2006.06.078
   Laidler K. J., 1999, PHYS CHEM, P852
   Martinez M, 2006, J HAZARD MATER, V133, P203, DOI 10.1016/j.jhazmat.2005.10.030
   Maurya NS, 2006, BIORESOURCE TECHNOL, V97, P512, DOI 10.1016/j.biortech.2005.02.045
   Nacera Y, 2006, CHEM ENG J, V119, P121, DOI 10.1016/j.cej.2006.01.018
   Pekkuz H, 2008, BIORESOURCE TECHNOL, V99, P2009, DOI 10.1016/j.biortech.2007.03.014
   Ugurlu M, 2007, COLOR TECHNOL, V123, P106, DOI 10.1111/j.1478-4408.2007.00072.x
   Weber J.W., 1963, J SANIT ENG DIV ASCE, V89, P31
   Weng CH, 2009, J HAZARD MATER, V170, P417, DOI 10.1016/j.jhazmat.2009.04.080
NR 27
TC 1
Z9 1
U1 0
U2 4
PU ASIAN JOURNAL OF CHEMISTRY
PI SAHIBABAD
PA 11/100 RAJENDRA NAGAR, SECTOR 3,, SAHIBABAD 201 005, GHAZIABAD, INDIA
SN 0970-7077
J9 ASIAN J CHEM
JI Asian J. Chem.
PD JUN
PY 2011
VL 23
IS 6
BP 2577
EP 2583
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 798HI
UT WOS:000293193000047
DA 2018-10-20
ER

PT J
AU Fioretti, F
   Mendoza-Palomares, C
   Avoaka-Boni, MC
   Ramaroson, J
   Bahi, S
   Richert, L
   Granier, F
   Benkirane-Jessel, N
   Haikel, Y
AF Fioretti, F.
   Mendoza-Palomares, C.
   Avoaka-Boni, M. C.
   Ramaroson, J.
   Bahi, S.
   Richert, L.
   Granier, F.
   Benkirane-Jessel, N.
   Haikel, Y.
TI Nano-Odontology: Nanostructured Assemblies for Endodontic Regeneration
SO JOURNAL OF BIOMEDICAL NANOTECHNOLOGY
LA English
DT Article
DE Endodontic Regeneration; Pulp Fibroblast; Inflammation; Drug Delivery;
   Multilayered Films; Melanocortin; Dendri Graft Poly-L-Lysine;
   Nano-Odontology; Nanomedicine
ID PEPTIDES; STRATEGY
AB The vitality of the pulp is so fundamental to the functional life of the tooth that new strategies are required to avoid the removal of the whole pulp following irreversible pulpitis and to regenerate the lost endodontic tissues. Nano-odontology would provide suitable solutions for pulp tissue conservative and regenerative approaches. In our group, we have shown that when covalently coupled to Poly-Glutamic Acid (PGA) the incorporation of an anti-inflammatory hormone (melanocortin, alpha-MSH) into the multilayered films Poly-L-Lysine (PLL)/PGA increases the anti-inflammatory reaction of pulp fibroblasts and macrophages stimulated by LPS (Lipo-Polysaccharides). Recently, usual linear PLL polymers have been chemically grafted for making new Dendrigraft polymers (DGL(G4)) whose higher branching ratios can give useful properties. The objective is to use nanostructured assemblies containing DGL(G4) and PGA-alpha-MSH to design a new nanomaterial. These nanostructured assemblies (DGL(G4)-PGA-alpha-MSH)(n) constitute a thick reservoir of the anti-inflammatory peptide and promote adhesion and proliferation of pulp fibroblast on the biomaterial surface. These nanostructured films could be adapted for an endodontic regeneration application to target pulp connective tissue regeneration. Firstly, the crucial reduction of inflammation could be helpful by using PGA-alpha-MSH and secondly the initiation of the regeneration of the connective tissue will be promoted by the whole nanostructured film of which allows pulp cells colonisation.
C1 [Fioretti, F.; Mendoza-Palomares, C.; Avoaka-Boni, M. C.; Ramaroson, J.; Bahi, S.; Haikel, Y.] UdS, Fac Chirurg Dent, F-67000 Strasbourg, France.
   [Fioretti, F.; Mendoza-Palomares, C.; Avoaka-Boni, M. C.; Benkirane-Jessel, N.; Haikel, Y.] INSERM, UMR 977, F-67000 Strasbourg, France.
   [Richert, L.] CNRS, UMR 7213, F-67400 Illkirch Graffenstaden, France.
   [Granier, F.] COLCOM, F-34000 Montpellier, France.
RP Fioretti, F (reprint author), UdS, Fac Chirurg Dent, 1 Pl Hop, F-67000 Strasbourg, France.
RI Richert, Ludovic/B-5006-2008; Benkirane-Jessel, Nadia/H-6438-2016
OI Richert, Ludovic/0000-0003-4479-5418; Fioretti,
   Florence/0000-0002-2433-5070; Mendoza, Carlos/0000-0002-7431-1296;
   Benkirane-Jessel, Nadia/0000-0003-3059-3559
FU "Ligue contre le Cancer" (Region Alsace)
FX This work was supported by the "Ligue contre le Cancer" (Region Alsace).
CR Balooch G, 2004, J BIOMECH, V37, P1223, DOI 10.1016/j.jbiomech.2003.12.012
   BAYNES CS, 2005, J DENT EDUC, V69, P571
   Catania A, 2004, PHARMACOL REV, V56, P1, DOI 10.1124/pr.56.1.1.
   Chaussain-Miller C, 2006, J DENT RES, V85, P22, DOI 10.1177/154405910608500104
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   Collet H, 1996, TETRAHEDRON LETT, V37, P9043, DOI 10.1016/S0040-4039(96)01974-0
   Collet H, 2010, CHEM-EUR J, V16, P2309, DOI 10.1002/chem.200901734
   Commeyras A, 2002, POLYM INT, V51, P661, DOI 10.1002/pi.10207
   DENKEWATLTER RG, 1985, CHEM ABSTR, V102, P79324
   FIORETTI F, 2011, NANOMED DRU IN PRESS
   FIORETTI F, 2010, INFO DENT, V22, P33
   Fioretti F, 2010, ACS NANO, V4, P3277, DOI 10.1021/nn100713m
   Huang Z, 2008, J BONE MINER RES, V23, P1995, DOI 10.1359/JBMR.080705
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Kokot A, 2009, ARTHRITIS RHEUM, V60, P592, DOI 10.1002/art.24228
   Lam Connie W., 2004, Current Drug Targets - Inflammation and Allergy, V3, P311, DOI 10.2174/1568010043343606
   Mitra SB, 2003, J AM DENT ASSOC, V134, P1382, DOI 10.14219/jada.archive.2003.0054
   MURRAY PE, 2007, J ENDODONT, V33, P77
   Schultz P, 2005, BIOMATERIALS, V26, P2621, DOI 10.1016/j.biomaterials.2004.06.049
   Tang MX, 1996, BIOCONJUGATE CHEM, V7, P703, DOI 10.1021/bc9600630
   Wan ACA, 2010, ADV DRUG DELIVER REV, V62, P731, DOI 10.1016/j.addr.2010.02.002
   WEBBER J, 2009, J INTERN MED, V267, P71
   Zhang X, 2010, BIOMATERIALS, V31, P6013, DOI 10.1016/j.biomaterials.2010.04.024
NR 24
TC 10
Z9 10
U1 1
U2 13
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1550-7033
J9 J BIOMED NANOTECHNOL
JI J. Biomed. Nanotechnol.
PD JUN
PY 2011
VL 7
IS 3
BP 471
EP 475
DI 10.1166/jbn.2011.1312
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Biomaterials
SC Science & Technology - Other Topics; Materials Science
GA 793YD
UT WOS:000292858900021
PM 21830492
DA 2018-10-20
ER

PT J
AU Clements, LR
   Wang, PY
   Harding, F
   Tsai, WB
   Thissen, H
   Voelcker, NH
AF Clements, Lauren R.
   Wang, Peng-Yuan
   Harding, Frances
   Tsai, Wei-Bor
   Thissen, Helmut
   Voelcker, Nicolas H.
TI Mesenchymal stem cell attachment to peptide density gradients on porous
   silicon generated by electrografting
SO PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE
LA English
DT Article
DE biomaterial; electrochemistry; gradient surfaces; porous silicon;
   surface chemistry
ID SURFACE INTERACTIONS; CHEMICAL GRADIENTS; RGD PEPTIDES; DIFFERENTIATION;
   TOPOGRAPHY; BIOSENSOR; POLYMERS; ADHESION
AB Chemical gradients of ethyl-6-bromohexanoate (EBH) were generated over porous silicon (pSi) substrates via electrochemical attachment. Immobilised ester moieties were hydrolysed and activated to produce a gradient of functional carboxylic acid groups. After subsequent immobilisation of cyclic RGD (cRGD), the surfaces were used to screen the extent of rat mesenchymal stem cell (MSC) attachment. Mapping of surface chemistry was carried out by means of infrared microscopy and X-ray photoelectron spectroscopy (XPS). MSC culture studies showed that short-term cell attachment responded to the cRGD density present on the gradient surface. (C) 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
C1 [Clements, Lauren R.; Harding, Frances; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem & Phys Sci, Bedford Pk, SA 5042, Australia.
   [Clements, Lauren R.; Thissen, Helmut] CSIRO Mol & Hlth Technol, Melbourne, Vic 3168, Australia.
   [Wang, Peng-Yuan; Tsai, Wei-Bor] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
RP Voelcker, NH (reprint author), Flinders Univ S Australia, Sch Chem & Phys Sci, GPO Box 2100, Bedford Pk, SA 5042, Australia.
EM nico.voelcker@flinders.edu.au
RI Tsai, Wei-Bor/B-7953-2011; Thissen, Helmut/D-3835-2011; wang,
   peng-yuan/F-5589-2015; Harding, Frances/F-3585-2013; Voelcker,
   Nicolas/D-6199-2012
OI wang, peng-yuan/0000-0001-7965-2914; Harding,
   Frances/0000-0002-9080-5413; Voelcker, Nicolas/0000-0002-1536-7804;
   Tsai, Wei-Bor/0000-0002-2316-5751
FU CSIRO; Australian Synchrotron; Australian Research Council
FX The authors thank the CSIRO, the Australian Synchrotron and the
   Australian Research Council for funding.
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Baac HW, 2004, MAT SCI ENG C-BIO S, V24, P209, DOI 10.1016/j.msec.2003.09.009
   Cavalcanti-Adam EA, 2002, J BONE MINER RES, V17, P2130, DOI 10.1359/jbmr.2002.17.12.2130
   Charest JL, 2006, BIOMATERIALS, V27, P2487, DOI 10.1016/j.biomaterials.2005.11.022
   Choee JH, 2004, J APPL POLYM SCI, V92, P599, DOI 10.1002/app.20048
   CLEMENTS L, 2008, P SOC PHOTO-OPT INS, V7267, P1
   Clements L. R., 2007, P SOC PHOTO-OPT INS, V6799, P1
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Cole MA, 2009, BIOMATERIALS, V30, P1827, DOI 10.1016/j.biomaterials.2008.12.026
   Collins BE, 2002, ADV FUNCT MATER, V12, P187, DOI 10.1002/1616-3028(200203)12:3<187::AID-ADFM187>3.0.CO;2-E
   GALLAGHER JO, 2002, NANOBIOSCIENCE, V1, P24
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   Genzer J, 2008, LANGMUIR, V24, P2294, DOI 10.1021/la7033164
   Hook AL, 2006, TRENDS BIOTECHNOL, V24, P471, DOI 10.1016/j.tibtech.2006.08.001
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   Khung YL, 2006, BIOTECHNOL PROGR, V22, P1388, DOI 10.1021/bp060115s
   Kilian KA, 2009, CHEM COMMUN, P630, DOI 10.1039/b815449j
   Lees IN, 2003, LANGMUIR, V19, P9812, DOI 10.1021/la035197y
   Li X, 2000, BIOMED MICRODEVICES, V2, P265, DOI 10.1023/A:1009951121205
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Mathew FP, 2005, BIOSENS BIOELECTRON, V20, P1656, DOI 10.1016/j.bios.2004.08.006
   McInnes SJP, 2009, J COLLOID INTERF SCI, V332, P336, DOI 10.1016/j.jcis.2008.12.073
   Morgenthaler S, 2008, SOFT MATTER, V4, P419, DOI 10.1039/b715466f
   Pek YS, 2010, BIOMATERIALS, V31, P385, DOI 10.1016/j.biomaterials.2009.09.057
   Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   SHIRATO I, 1991, CELL TISSUE RES, V266, P1, DOI 10.1007/BF00678705
   Thapa A, 2003, J BIOMED MATER RES A, V67A, P1374, DOI 10.1002/jbm.a.20037
   Thompson CM, 2010, LANGMUIR, V26, P7598, DOI 10.1021/la904408h
   Wang PY, 2010, BIOTECHNOL BIOENG, V106, P285, DOI 10.1002/bit.22697
   Whittle JD, 2003, CHEM COMMUN, P1766, DOI 10.1039/b305445b
   Yoshinari M, 2004, J ORAL TISSUE ENG, V1, P69
   Zelzer M, 2008, BIOMATERIALS, V29, P172, DOI 10.1016/j.biomaterials.2007.09.026
NR 35
TC 19
Z9 19
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1862-6300
J9 PHYS STATUS SOLIDI A
JI Phys. Status Solidi A-Appl. Mat.
PD JUN
PY 2011
VL 208
IS 6
BP 1440
EP 1445
DI 10.1002/pssa.201000320
PG 6
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA 795BF
UT WOS:000292945800040
DA 2018-10-20
ER

PT J
AU Cao, LH
   Yu, BQ
   Wu, GS
   Su, JC
AF Cao Lie-Hui
   Yu Bao-Qing
   Wu Guo-Sheng
   Su Jia-Can
TI Study on Adulterate Sodium Silica Apatite Cement Porous Scaffolds for
   Bone Defect Repair
SO JOURNAL OF INORGANIC MATERIALS
LA English
DT Article
DE sodium silicon apatite; cement porous scaffold; biocompatibility;
   degradation; osteogenesis
ID CALCIUM SILICATE; WOLLASTONITE; HYDROXYAPATITE; BIOCERAMICS; BIOACTIVITY
AB Adulterate sodium silicon apatite cement (s-AC) porous scaffolds for bone repair were prepared by using the mixed powders of tetracalcium phosphate and dicalcium phosphate anhydrous, 5wt% sodium silicate water-solution as cement liquid, and NaCl particles as progens. The result shows that the composition of the s-AC scaffolds is sodium silicon apatite. The macroporous sizes of the scaffolds were in the range from 200 mu m to 600 mu m the porosity of the scaffolds is from 58% to 75%, and the macropores were interconnected with each other. The compressive strength of the s-AC scaffolds is from 1.6MPa to 3.8MPa, and the degradability of sodium silicon doped s-AC scaffolds improves significantly as compared with AC in Tris-HCI solution. When the s-AC scaffolds are implanted in femur bone defect of rabbits, the histological analysis results show that the new bone tissue is formed on the surfaces and ingrew into the interior of the scaffolds, the well interconnected macropores promoted the bone tissue ingrowth into the scaffolds. In conclusion, the s-AC scaffolds exhibit good biocompatibility, degradability and osteogenesis in vivo, which will be a good biomaterial for bone repair.
C1 [Cao Lie-Hui; Yu Bao-Qing; Wu Guo-Sheng; Su Jia-Can] Second Mil Med Univ, Changhai Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China.
RP Cao, LH (reprint author), Second Mil Med Univ, Changhai Hosp, Dept Orthopaed, Shanghai 200433, Peoples R China.
EM caoliehu@126.com
FU Shanghai Special Foundation of Nano Science and Technology Commission
   [0852nm04300]; Shanghai Personnel Bureau Talent Development Foundation
   [2009003]; Postdoctoral Science Foundation of China [20100470756]
FX Shanghai Special Foundation of Nano Science and Technology Commission
   (0852nm04300); Shanghai Personnel Bureau Talent Development Foundation
   (2009003); Postdoctoral Science Foundation of China (20100470756)
CR Bianco A, 2009, MATER RES BULL, V44, P345, DOI 10.1016/j.materresbull.2008.05.013
   Brown RF, 2009, J BIOMED MATER RES A, V88A, P392, DOI 10.1002/jbm.a.31679
   Gao Y, 2009, J BIOMATER APPL, V24, P119, DOI 10.1177/0885328208094265
   HIDEKI Y, 2009, J R SOC INTERFACE, V6, P341
   Huan ZG, 2009, J MATER SCI-MATER M, V20, P833, DOI 10.1007/s10856-008-3641-9
   Lai W, 2002, BIOMATERIALS, V23, P213, DOI 10.1016/S0142-9612(01)00097-7
   LI QL, 2010, CHINESE J INORG CHEM, V5, P879
   Lin KL, 2006, J INORG MATER, V21, P645
   Liu CS, 2003, BIOMATERIALS, V24, P2995, DOI 10.1016/S0142-9612(03)00125-X
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Ni SY, 2009, J BIOMATER APPL, V24, P139, DOI 10.1177/0885328208094745
   Shala R., 2002, BIOMATERIALS, V23, P3113
   Wei J, 2010, BIOMATERIALS, V31, P1260, DOI 10.1016/j.biomaterials.2009.11.005
   Wei J, 2009, BIOMATERIALS, V30, P1080, DOI 10.1016/j.biomaterials.2008.10.046
   Xiao B, 2006, J INORG MATER, V21, P427
   Xu SF, 2008, J INORG MATER, V23, P611, DOI 10.3724/SP.J.1077.2008.00611
   Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013
   Yang Y, 2008, CHEM J CHINESE U, V29, P2294
   Zhao XB, 2008, J INORG MATER, V23, P1021, DOI 10.3724/SP.J.1077.2008.01021
   ZHONG JP, 2002, J INORGANIC MAT, V17, P897
   Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024
NR 21
TC 3
Z9 3
U1 3
U2 22
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1000-324X
J9 J INORG MATER
JI J. Inorg. Mater.
PD JUN
PY 2011
VL 26
IS 6
BP 591
EP 596
DI 10.3724/SP.J.1077.2011.00591
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 789RQ
UT WOS:000292534400005
DA 2018-10-20
ER

PT J
AU Lin, JS
   Albrecht, JC
   Meagher, RJ
   Wang, XX
   Barron, AE
AF Lin, Jennifer S.
   Albrecht, Jennifer Coyne
   Meagher, Robert J.
   Wang, Xiaoxiao
   Barron, Annelise E.
TI Completely Monodisperse, Highly Repetitive Proteins for Bioconjugate
   Capillary Electrophoresis: Development and Characterization
SO BIOMACROMOLECULES
LA English
DT Article
ID SPIDER DRAGLINE SILK; ESCHERICHIA-COLI; DNA SEPARATIONS; EXPRESSION;
   CLONING; TAGS; TRANSLATION; MOLECULES; POLYMERS; SEQUENCE
AB Protein-based polymers are increasingly being used in biomaterial applications because of their ease of customization and potential monodispersity. These advantages make protein polymers excellent candidates for bioanalytical applications. Here we describe improved methods for producing drag-tags for free-solution conjugate electrophoresis (FSCE). FSCE utilizes a pure, monodisperse recombinant protein, tethered end-on to a ssDNA molecule, to enable DNA size separation in aqueous buffer. FSCE also provides a highly sensitive method to evaluate the polydispersity of a protein drag tag and thus its suitability for bioanalytical uses. This method is able to detect slight differences in drag tag charge or mass. We have devised an improved cloning, expression, and purification strategy that enables us to generate for the first time, a truly monodisperse 20 kDa protein polymer and a nearly monodisperse 38 kDa protein. These newly produced proteins can be used as drag tags to enable longer read DNA sequencing by free-solution microchannel electrophoresis.
C1 [Lin, Jennifer S.; Wang, Xiaoxiao; Barron, Annelise E.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
   [Albrecht, Jennifer Coyne] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.
   [Meagher, Robert J.] Sandia Natl Labs, Livermore, CA USA.
RP Barron, AE (reprint author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
EM aebarron@stanford.edu
OI Meagher, Robert/0000-0002-6262-2126
FU NIH [R01 HG002918-01]
FX We thankfully acknowledge Northwestern University's Analytical Services
   Laboratory and Stanford University's Protein and Nucleic Acid Facility
   for the use of their MALDI-TOF instruments. Additionally, we acknowledge
   the use of the CD instrument in the Keck Biophysics Facility at
   Northwestern University. This work was funded by the NIH R01
   HG002918-01.
CR Albrecht JC, 2011, ANAL CHEM, V83, P509, DOI 10.1021/ac102188p
   ARMSTRONG MD, 1949, J AM CHEM SOC, V71, P3399, DOI 10.1021/ja01178a037
   Coyne J. C., 2008, HDB CAPILLARY MICROC, P1567
   CUATRECASAS P, 1972, BIOCHEMISTRY-US, V11, P2291, DOI 10.1021/bi00762a013
   Davis NE, 2009, BIOMACROMOLECULES, V10, P1125, DOI 10.1021/bm801348g
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Garnier J, 1996, METHOD ENZYMOL, V266, P540
   Gross E., 1967, METHOD ENZYMOL, V11, P238
   Haynes RD, 2005, BIOCONJUGATE CHEM, V16, P929, DOI 10.1021/bc0496915
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ, P785
   Hert DG, 2008, ELECTROPHORESIS, V29, P4618, DOI 10.1002/elps.200800456
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4
   Kiick KL, 2007, POLYM REV, V47, P1, DOI 10.1080/15583720601109545
   KULIOPULOS A, 1994, J AM CHEM SOC, V116, P4599, DOI 10.1021/ja00090a008
   LEE TD, 1990, METHOD ENZYMOL, V193, P361, DOI 10.1016/0076-6879(90)93427-M
   MATTSON G, 1993, MOL BIOL REP, V17, P167, DOI 10.1007/BF00986726
   MAYER P, 1994, ANAL CHEM, V66, P1777, DOI 10.1021/ac00082a029
   Meagher RJ, 2006, ELECTROPHORESIS, V27, P1702, DOI 10.1002/elps.200500554
   Meagher RJ, 2005, ELECTROPHORESIS, V26, P331, DOI 10.1002/elps.200410219
   MEAGHER RJ, 2005, THESIS NW U EVANSTON
   Meagher RJ, 2008, ANAL CHEM, V80, P2842, DOI 10.1021/ac702591t
   MURPHY CM, 1995, ANAL CHEM, V67, P1644, DOI 10.1021/ac00105a027
   NOOLANDI J, 1992, ELECTROPHORESIS, V13, P394, DOI 10.1002/elps.1150130180
   NOOLANDI J, 1993, ELECTROPHORESIS, V14, P680, DOI 10.1002/elps.11501401108
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   ROBINSON M, 1984, NUCLEIC ACIDS RES, V12, P6663, DOI 10.1093/nar/12.17.6663
   ROSENBERG AH, 1993, J BACTERIOL, V175, P716
   Rydzanicz R, 2005, NUCLEIC ACIDS RES, V33, pW521, DOI 10.1093/nar/gki380
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   Vreeland WN, 2002, BIOCONJUGATE CHEM, V13, P663, DOI 10.1021/bc0155871
   Vreeland WN, 2001, ANAL CHEM, V73, P1795, DOI 10.1021/ac001380+
   Won JI, 2005, ELECTROPHORESIS, V26, P2138, DOI 10.1002/elps.200410042
   Won JI, 2004, BIOMACROMOLECULES, V5, P1624, DOI 10.1021/bm040046a
   Won JI, 2002, MACROMOLECULES, V35, P8281, DOI 10.1021/ma020892i
NR 36
TC 6
Z9 6
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2011
VL 12
IS 6
BP 2275
EP 2284
DI 10.1021/bm200358r
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 775YQ
UT WOS:000291499900038
PM 21553840
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, LQ
   Teller, S
   Clifton, RJ
   Jia, XQ
   Kiick, KL
AF Li, Linqing
   Teller, Sean
   Clifton, Rodney J.
   Jia, Xinqiao
   Kiick, Kristi L.
TI Tunable Mechanical Stability and Deformation Response of a Resilin-Based
   Elastomer
SO BIOMACROMOLECULES
LA English
DT Article
ID RUBBER-LIKE PROTEIN; VISCOELASTIC SHEAR PROPERTIES; GROWTH-FACTOR
   DELIVERY; VOCAL FOLD MUCOSA; HUMAN ELASTIN; BIOMATERIALS; MATRIX;
   POLYPEPTIDES; HYDROGELS; TISSUE
AB Resilin, the highly elastomeric protein found in specialized compartments of most arthropods, possesses superior resilience and excellent high-frequency responsiveness. Enabled by biosynthetic strategies, we have designed and produced a modular, recombinant resilin-like polypeptide bearing both mechanically active and biologically active domains to create novel biomaterial microenvironments for engineering mechanically active tissues such as blood vessels, cardiovascular tissues, and vocal folds. Preliminary studies revealed that these recombinant materials exhibit promising mechanical properties and support the adhesion of NIH 3T3 fibroblasts. In this Article, we detail the characterization of the dynamic mechanical properties of these materials, as assessed via dynamic oscillatory shear rheology at various protein concentrations and cross-linking ratios. Simply by varying the polypeptide concentration and cross-linker ratios, the storage modulus G' can be easily tuned within the range of 500 Pa to 10 kPa. Strain-stress cycles and resilience measurements were probed via standard tensile testing methods and indicated the excellent resilience (>90%) of these materials, even when the mechanically active domains are intercepted by nonmechanically active biological cassettes. Further evaluation, at high frequencies, of the mechanical properties of these materials were assessed by a custom-designed torsional wave apparatus (TWA) at frequencies close to human phonation, indicating elastic modulus values from 200 to 2500 Pa, which is within the range of experimental data collected on excised porcine and human vocal fold tissues. The results validate the outstanding mechanical properties of the engineered materials, which are highly comparable to the mechanical properties of targeted vocal fold tissues. The ease of production of these biologically active materials, coupled to their outstanding mechanical properties over a range of compositions, suggests their potential in tissue regeneration applications.
C1 [Li, Linqing; Jia, Xinqiao; Kiick, Kristi L.] Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
   [Teller, Sean; Clifton, Rodney J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
RP Kiick, KL (reprint author), Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA.
RI Li, Linqing/P-8436-2014
OI Li, Linqing/0000-0003-3003-9902
FU University of Delaware Research Foundation; National Science Foundation
   [DMR 0239744]; National Center for Research Resources (NCRR), a
   component of the National Institutes of Health [P20-RR017716,
   P20-RR015588]
FX We would like to acknowledge support by grants from the University of
   Delaware Research Foundation, the National Science Foundation (DMR
   0239744 to K.L.K), and the National Center for Research Resources
   (NCRR), a component of the National Institutes of Health (P20-RR017716
   (KL.K) and P20-RR015588 for instrument resources). We also acknowledge
   the National Institute on Deafness and Other Communication Disorders
   (NU)CD, RO1 DC008965 to X.J). We would like to acknowledge the help of
   Dr. Jeffrey Linhardt from Baush & Lomb with the tensile testing. Amino
   acid analyses to determine the cross-linking efficiencies were conducted
   at UC Davis' molecular structure facility.
CR Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3
   BAILEY K, 1961, BIOCHIM BIOPHYS ACTA, V48, P452, DOI 10.1016/0006-3002(61)90043-9
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   BENNETCLARK HC, 1967, J EXP BIOL, V47, P59
   Benninger MS, 1996, OTOLARYNG HEAD NECK, V115, P474, DOI 10.1016/S0194-5998(96)70087-6
   Burrows M., 2008, BMC BIOL, V7, P27
   Chan RW, 1999, J ACOUST SOC AM, V106, P2008, DOI 10.1121/1.427947
   Chan RW, 2000, J ACOUST SOC AM, V107, P565, DOI 10.1121/1.428354
   Charati MB, 2009, SOFT MATTER, V5, P3412, DOI 10.1039/b910980c
   Dalton PD, 2002, BIOMATERIALS, V23, P3843, DOI 10.1016/S0142-9612(02)00120-5
   Discher DE, 2008, BIORHEOLOGY, V45, P54
   ELLIOTT GF, 1965, J MOL BIOL, V13, P791, DOI 10.1016/S0022-2836(65)80144-9
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Engler A., 2006, CELL, V126, P645
   Farran AJE, 2010, TISSUE ENG PT A, V16, P1247, DOI 10.1089/ten.tea.2009.0344
   Fonseca PJ, 1998, J EXP BIOL, V201, P717
   Fukuda H., 1991, VOCAL FOLD PHYSL ACO, P7
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Hammond TH, 1998, OTOLARYNG HEAD NECK, V119, P314, DOI 10.1016/S0194-5998(98)70071-3
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hirano M, 1975, OTOLOGIA FUKUOKA  S1, V21, P239
   HOEVE CAJ, 1974, BIOPOLYMERS, V13, P677, DOI 10.1002/bip.1974.360130404
   JENSEN M, 1962, PHILOS T ROY SOC B, V245, P137, DOI 10.1098/rstb.1962.0008
   Jiao T, 2009, EXP MECH, V49, P235, DOI 10.1007/s11340-008-9126-4
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kiick KL, 2008, SOFT MATTER, V4, P29, DOI 10.1039/b711319f
   Kim M, 2007, PROTEIN EXPRES PURIF, V52, P230, DOI 10.1016/j.pep.2006.11.003
   Kriesel KJ, 2002, ANN OTO RHINOL LARYN, V111, P884, DOI 10.1177/000348940211101004
   La Greca M., 1947, ARCH ZOOL ITAL, V33, P271
   Li LQ, 2010, POLYM CHEM-UK, V1, P1160, DOI 10.1039/b9py00346k
   Lim DW, 2008, BIOMACROMOLECULES, V9, P222, DOI 10.1021/bm7007982
   Lim DW, 2007, BIOMACROMOLECULES, V8, P1463, DOI 10.1021/bm061059m
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lv S, 2010, NATURE, V465, P69, DOI 10.1038/nature09024
   Lyons RE, 2007, PROTEIN ENG DES SEL, V20, P25, DOI 10.1093/protein/gzl050
   Lyons RE, 2009, BIOMACROMOLECULES, V10, P3009, DOI 10.1021/bm900601h
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   MIN YB, 1995, ANN OTO RHINOL LARYN, V104, P563, DOI 10.1177/000348949510400711
   Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R
   Nairn KM, 2008, BIOPHYS J, V95, P3358, DOI 10.1529/biophysj.107.119107
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Nie T, 2009, ACTA BIOMATER, V5, P865, DOI 10.1016/j.actbio.2008.12.004
   Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9
   Qin GK, 2009, BIOMACROMOLECULES, V10, P3227, DOI 10.1021/bm900735g
   Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008
   Straley KS, 2009, SOFT MATTER, V5, P114, DOI 10.1039/b808504h
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   TITZE IR, 1989, J ACOUST SOC AM, V85, P901, DOI 10.1121/1.397562
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   WEISFOGH T, 1961, J MOL BIOL, V3, P520, DOI 10.1016/S0022-2836(61)80018-1
   WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   Wu XY, 2008, BIOMACROMOLECULES, V9, P1787, DOI 10.1021/bm800012x
   Xiao LX, 2010, SOFT MATTER, V6, P5293, DOI 10.1039/c0sm00511h
   YOUNG D, 1995, J EXP BIOL, V198, P1001
   Zeitels SM, 2002, ANN OTO RHINOL LARYN, V111, P21
   Zhang L, 2006, J CONTROL RELEASE, V114, P130, DOI 10.1016/j.jconrel.2006.06.005
NR 57
TC 60
Z9 62
U1 8
U2 86
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2011
VL 12
IS 6
BP 2302
EP 2310
DI 10.1021/bm200373p
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 775YQ
UT WOS:000291499900041
PM 21553895
OA Green Accepted
DA 2018-10-20
ER

PT J
AU An, B
   Hinman, MB
   Holland, GP
   Yarger, JL
   Lewis, RV
AF An, Bo
   Hinman, Michael B.
   Holland, Gregory P.
   Yarger, Jeffery L.
   Lewis, Randolph V.
TI Inducing beta-Sheets Formation in Synthetic Spider Silk Fibers by
   Aqueous Post-Spin Stretching
SO BIOMACROMOLECULES
LA English
DT Article
ID SOLID-STATE NMR; CLAVIPES DRAGLINE SILK; NEPHILA-CLAVIPES;
   CHEMICAL-SHIFTS; MECHANICAL-PROPERTIES; SECONDARY STRUCTURE; PROTEIN
   BACKBONE; MUSSEL BYSSUS; C-13 NMR; FIBROIN
AB As a promising biomaterial with numerous potential applications, various types of synthetic spider silk fibers have been produced and studied in an effort to produce man-made fibers with mechanical and physical properties comparable to those of native spider silk. In this study, two recombinant proteins based on Nephila clavipes Major ampullate Spidroin 1 (MaSp1) consensus repeat sequence were expressed and spun into fibers. Mechanical test results showed that fiber spun from the higher molecular weight protein had better overall mechanical properties (70 KD versus 46 KD), whereas postspin stretch treatment in water helped increase fiber tensile strength significantly. Carbon-13 solid-state NMR studies of those fibers further revealed that the postspin stretch in water promoted protein molecule rearrangement and the formation of beta-sheets in the polyalanine region of the silk. The rearrangement correlated with improved fiber mechanical properties and indicated that postspin stretch is key to helping the spider silk proteins in the fiber form correct secondary structures, leading to better quality fibers.
C1 [An, Bo] Univ Wyoming, Dept Mol Biol, Laramie, WY 82070 USA.
   Arizona State Univ, Magnet Resonance Res Ctr, Dept Chem & Biochem, Tempe, AZ 85287 USA.
RP An, B (reprint author), Univ Wyoming, Dept Mol Biol, 1000 E Univ Ave, Laramie, WY 82070 USA.
RI Yarger, Jeff/L-8748-2014; An, Bo/N-3466-2014
OI Yarger, Jeff/0000-0002-7385-5400; An, Bo/0000-0002-1031-3380
FU NIH [EB000490]; AFOSR [FA9550-09-1-0717, FA9550-10-1-0275]; NSF
   [DMR-0805197, CHE-1011937]
FX This material is based on work by the Lewis laboratory supported by NIH
   (EB000490) and the AFOSR (FA9550-09-1-0717) and by Jeff Yarger and Greg
   Holland by the AFOSR (FA9550-10-1-0275) and the NSF (DMR-0805197 and
   CHE-1011937) for the NMR component of this project. We would also like
   to thank Dr. Florence Teule for the methods used for postspin stretching
   and Dr. Brian Cherry for help with NMR instrumentation and student
   training. Any opinions, findings, and conclusions or recommendations
   expressed in this publication are those of the author(s) and do not
   necessarily reflect the views of the AFOSR, NSF, or NIH.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ayoub NA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000514
   Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p
   CHANG DK, 1989, J BIOMOL STRUCT DYN, V6, P851, DOI 10.1080/07391102.1989.10506517
   Coyne KJ, 1997, SCIENCE, V277, P1830, DOI 10.1126/science.277.5333.1830
   Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x
   EARL WL, 1982, J MAGN RESON, V48, P35, DOI 10.1016/0022-2364(82)90236-0
   FRASER RDB, 1973, CONFORMATION FIBROUS, pCH13
   Garb JE, 2006, SCIENCE, V312, P1762, DOI 10.1126/science.1127946
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guinea GV, 2005, J EXP BIOL, V208, P25, DOI 10.1242/jeb.01344
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Holland C, 2007, POLYMER, V48, P3388, DOI 10.1016/j.polymer.2007.04.019
   Holland GP, 2004, J AM CHEM SOC, V126, P5867, DOI 10.1021/ja031930w
   Holland GP, 2008, CHEM COMMUN, P5568, DOI 10.1039/b812928b
   Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208
   Holland GP, 2008, BIOMACROMOLECULES, V9, P651, DOI 10.1021/bm700950u
   Izdebski T, 2010, BIOMACROMOLECULES, V11, P168, DOI 10.1021/bm901039e
   Jenkins JE, 2010, CHEM COMMUN, V46, P6714, DOI 10.1039/c0cc00829j
   Jenkins JE, 2010, BIOMACROMOLECULES, V11, P192, DOI 10.1021/bm9010672
   Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LEWIS RV, 1992, ACCOUNTS CHEM RES, V25, P392, DOI 10.1021/ar00021a002
   Liivak O, 1997, MACROMOLECULES, V30, P7127, DOI 10.1021/ma970834a
   Lin JC, 2004, J AM CHEM SOC, V126, P13679, DOI 10.1021/ja047265o
   Lombardi S., 1990, J ARACHNOL, P297
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   MITA K, 1994, J MOL EVOL, V38, P583
   Palencar P, 2011, J MOL MODEL, V17, P2367, DOI 10.1007/s00894-011-0997-4
   Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7
   PEAKALL DB, 1965, NATURE, V207, P102, DOI 10.1038/207102a0
   Qin XX, 1997, J BIOL CHEM, V272, P32623, DOI 10.1074/jbc.272.51.32623
   Rathore O, 2001, J AM CHEM SOC, V123, P5231, DOI 10.1021/ja004030d
   Renugopalakrishnan V, 2006, BIONANOTECHNOLOGY PR
   SAKUMA Y, 1966, J APPL POLYM SCI, V10, P637, DOI 10.1002/app.1966.070100408
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Sponner A, 2005, BIOCHEMISTRY-US, V44, P4727, DOI 10.1021/bi047671k
   Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391
   Teule F, 2009, NAT PROTOC, V4, P341, DOI 10.1038/nprot.2008.250
   Urry D. W., 1995, CIBA F SYMP, V192, P22
   Urry DW, 1995, CIBA F SYMP, V192, P4
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vendrely C, 2007, MACROMOL BIOSCI, V7, P401, DOI 10.1002/mabi.200600255
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wishart D, 1994, J BIOMOL NMR, P4
   WISHART DS, 1994, METHOD ENZYMOL, V239, P363
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003
   Xia XX, 2010, P NATL ACAD SCI USA, V107, P14059, DOI 10.1073/pnas.1003366107
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yin JW, 2010, BIOMACROMOLECULES, V11, P2890, DOI 10.1021/bm100643q
   Yue CY, 2000, COMPOS SCI TECHNOL, V60, P421, DOI 10.1016/S0266-3538(99)00137-2
   Zhou GQ, 2009, ADV MATER, V21, P366, DOI 10.1002/adma.200800582
NR 60
TC 44
Z9 45
U1 0
U2 44
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JUN
PY 2011
VL 12
IS 6
BP 2375
EP 2381
DI 10.1021/bm200463e
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 775YQ
UT WOS:000291499900050
PM 21574576
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Chan, B
   Wong, RWK
   Rabie, B
AF Chan, B.
   Wong, R. W. K.
   Rabie, B.
TI In vivo production of mineralised tissue pieces for clinical use: a
   qualitative pilot study using human dental pulp cell
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE tissue engineering; tissue engineering methods; osteogenesis; human
   dental pulp cell; animal testing; in vivo study; in vivo transplantation
ID SELF-COMPLEMENTARY OLIGOPEPTIDE; PEPTIDE NANOFIBER SCAFFOLD; STEM-CELLS;
   EXTRACELLULAR-MATRIX; BONE-MARROW; STROMAL CELLS; DIFFERENTIATION;
   BIOREACTOR; EXPRESSION; SERUM
AB Numerous previous studies have investigated the production of mineralised tissues by transplanting human dental pulp cells with calcium based scaffolds. The potential of alternative setups remains largely uninvestigated, therefore in this study, human dental pulp cells were encapsulated into non-calcium based biomaterial self-assembling peptide nano-fibre hydrogel. The cell-gel constructs were cultured in full medium for 2 weeks. Then they were cultured in full medium supplemented with beta-glycerophosphate, dexamethasone and L-ascorbic acid for 2 more weeks. These cell-gel constructs and plain-gel constructs (with no cells) were transplanted subcutaneously into five nude mice. The gel constructs were retrieved 4 weeks after surgery. The plain-gel constructs were all completely resorbed with no new tissue formation. The cell-gel constructs were transformed into tissue pieces that were mineralised and contained blood capillaries. lmmunohistochemistry analysis confirmed the expression of multiple bone markers (osteopontin, osteocalcin, osteonectin and parathyroid hormone receptor) in these tissue pieces. Computerised analysis of the contact radiographs gave the mean radio-opaque area percentage as 78% (N = 5, P < 0.001 compared with the 0% of the control). The results demonstrate good prospects for using human dental pulp cell plus self-assembling peptide nano-fibre hydrogel to produce mineralised tissue pieces for clinical use.
C1 [Chan, B.; Wong, R. W. K.; Rabie, B.] Univ Hong Kong, Fac Dent, Dept Hlth, Govt HKSAR, Hong Kong, Hong Kong, Peoples R China.
RP Wong, RWK (reprint author), Univ Hong Kong, Prince Philip Dent Hosp, Fac Dent, PDO Dept, 2-F,34 Hosp Rd, Sai Ying Pun, Hong Kong, Peoples R China.
EM fyoung@hku.hk
FU  [20004794.22311.08003.400.01]
FX Donation A/C: 20004794.22311.08003.400.01. Clinical Trials to Induce
   Bone Formation.
CR About I, 2000, EXP CELL RES, V258, P33, DOI 10.1006/excr.2000.4909
   Amit M, 2006, METHOD ENZYMOL, V420, P37, DOI 10.1016/S0076-6879(06)20003-X
   Arnander C, 2006, J CRANIOFAC SURG, V17, P275, DOI 10.1097/00001665-200603000-00013
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020
   Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   GRONTHOS S, 1994, BLOOD, V84, P4164
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695
   Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496
   Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325
   Lee JB, 2005, BIOL REPROD, V72, P42, DOI 10.1095/biolrepod.104.033480
   Liu L, 2009, J ENDODONT, V35, P1368, DOI 10.1016/j.joen.2009.07.005
   Ljungman P, 2006, J CLIN VIROL, V37, pS87, DOI 10.1016/S1386-6532(06)70018-X
   Selvaggi TA, 1997, BLOOD, V89, P776
   Semino CE, 2003, J BIOMED BIOTECHNOL, P164, DOI 10.1155/S1110724303208019
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102
   Vacanti CA, 2006, TISSUE ENG, V12, P1137, DOI 10.1089/ten.2006.12.1137
   Wei X, 2007, J ENDODONT, V33, P703, DOI 10.1016/j.joen.2007.02.009
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
   Yang X, 2009, J DENT RES, V88, P1020, DOI 10.1177/0022034509346258
   Yang XC, 2009, TISSUE ENG PT A, V15, P367, DOI 10.1089/ten.tea.2008.0133
   Yokoi H, 2005, P NATL ACAD SCI USA, V102, P8414, DOI 10.1073/pnas.0407843102
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
   Zhang W, 2008, TISSUE ENG PT A, V14, P285, DOI 10.1089/tea.2007.0146
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
NR 34
TC 16
Z9 16
U1 1
U2 9
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JUN
PY 2011
VL 40
IS 6
BP 612
EP 620
DI 10.1016/j.ijom.2011.01.008
PG 9
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 779IR
UT WOS:000291771800010
PM 21353764
DA 2018-10-20
ER

PT J
AU Kirkland, NT
   Staiger, MP
   Nisbet, D
   Davies, CHJ
   Birbilis, N
AF Kirkland, Nicholas T.
   Staiger, Mark P.
   Nisbet, David
   Davies, Chris H. J.
   Birbilis, Nick
TI Performance-driven design of Biocompatible Mg alloys
SO JOM
LA English
DT Article
ID IN-VITRO DEGRADATION; SIMULATED BODY-FLUIDS; ZN-CA ALLOY; MAGNESIUM
   ALLOYS; MECHANICAL INTEGRITY; NEURAL-NETWORK; CORROSION; CALCIUM;
   HYDROXYAPATITE; DISSOLUTION
AB Magnesium (Mg) and its alloys provide numerous benefits as a resorptive biomaterial and present the very real possibility of replacing current metallic implant materials in a variety of roles. The development of suitable biodegradable implant alloys is a multidisciplinary challenge, since alloy design must be confined to a range of alloying additions that are biologically nontoxic, whilst still providing the requisite mechanical properties. This leaves a small number of compatible elements that can provide benefits when alloyed with Mg, including calcium (Ca) and zinc (Zn). To date, although a range of different Mg alloys have been investigated both in vitro and in vivo, little work has been performed to characterize the relationship between the composition of Mg alloys, their corrosion and resulting mechanical properties over time. Consequently it is crucial to understand how these properties may be related if alloys are to be successfully screened for implantation in the body.
C1 [Kirkland, Nicholas T.; Davies, Chris H. J.; Birbilis, Nick] Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
   [Kirkland, Nicholas T.; Staiger, Mark P.] Univ Canterbury, Dept Mech Engn, BioMATE Grp, Christchurch 8041, New Zealand.
   [Nisbet, David] Australian Natl Univ, Res Sch Engn, Acton, ACT 0200, Australia.
RP Birbilis, N (reprint author), Monash Univ, Dept Mat Engn, Clayton, Vic 3800, Australia.
EM nick.birbilis@monash.edu
RI Davies, Chris/A-2391-2009; Staiger, Mark/H-2102-2011
OI Davies, Chris/0000-0001-8910-7426; Staiger, Mark/0000-0002-1517-4404;
   Kirkland, Nicholas/0000-0001-5043-3400; Nisbet,
   David/0000-0002-1343-0769; Birbilis, Nick/0000-0002-7910-7470
CR Bamberger M, 2006, METALL MATER TRANS A, V37A, P481, DOI 10.1007/s11661-006-0019-9
   Birbilis N, 2011, CORROS SCI, V53, P168, DOI 10.1016/j.corsci.2010.09.013
   Brar HS, 2010, MAGNESIUM TECHNOLOGY, P647
   Cavanaugh MK, 2010, CORROS SCI, V52, P3070, DOI 10.1016/j.corsci.2010.05.027
   Chen Y, 2010, MAT LETT, V64
   CLARKE EGC, 1953, P ROY SOC MED, V46, P17
   Das A, 2006, MAT SCI ENG A-STRUCT, V419, P349, DOI 10.1016/j.msea.2006.01.023
   Friedrich H. E., 2006, MAGNESIUM TECHNOLOGY
   Gilbert SG, 2004, SMALL DOSE TOXICOLOG
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guan RG, 2009, ADV MATER RES-SWITZ, V79-82, P1443, DOI 10.4028/www.scientific.net/AMR.79-82.1443
   HASSEL T, 2006, MAGNESIUM TECHNOLOGY
   HELGASON CD, 2005, METHODS MOL BIOL SER, V290
   Ilich JZ, 2000, J AM COLL NUTR, V19, P715, DOI 10.1080/07315724.2000.10718070
   Kannan MB, 2008, BIOMATERIALS, V29, P2306, DOI 10.1016/j.biomaterials.2008.02.003
   Kim WC, 2008, MATER LETT, V62, P4146, DOI 10.1016/j.matlet.2008.06.028
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kirkland NT, 2010, J BIOMED MATER RES B, V95B, P91, DOI 10.1002/jbm.b.31687
   LENTECH BV, 2011, RECOMMENDED DAILY IN
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   MERRITT K, 1984, J BIOMED MATER RES, V18, P1005, DOI 10.1002/jbm.820180905
   Pietak AM, 2007, J BIOMED MATER RES, V19, P407
   Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Rosalbino F, 2010, J MATER SCI-MATER M, V21, P1091, DOI 10.1007/s10856-009-3956-1
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Sugawara M, 2003, HEMORHEOLOGY BLOOD F
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang X, 2007, T NONFERR METAL SOC, V17, pS122
   *WHO, 1996, TRAC EL HUM NUTR HLT
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Zeng RC, 2007, T NONFERR METAL SOC, V17, pS166
   Zhang H, 1999, 9 ANN VM GOLDSCHM C
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
NR 35
TC 46
Z9 47
U1 4
U2 29
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
J9 JOM-US
JI JOM
PD JUN
PY 2011
VL 63
IS 6
BP 28
EP 34
DI 10.1007/s11837-011-0089-z
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 777JD
UT WOS:000291610800007
DA 2018-10-20
ER

PT J
AU Parirokh, M
   Asgary, S
   Eghbal, MJ
   Kakoei, S
   Samiee, M
AF Parirokh, Masoud
   Asgary, Saeed
   Eghbal, Mohammad Jafar
   Kakoei, Shahla
   Samiee, Mohammad
TI A Comparative Study of Using a Combination of Calcium Chloride and
   Mineral Trioxide Aggregate as the Pulp-capping Agent on Dogs' Teeth
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Calcium chloride; mineral trioxide aggregate; pulp capping; teeth
ID PORTLAND-CEMENT; SEALING ABILITY; WHITE; MTA; PULPOTOMY;
   BIOCOMPATIBILITY; ADDITIVES; MODEL
AB Introduction: The addition of some chemicals to mineral trioxide aggregate (MTA) may improve the physical properties of the biomaterial. The aim of this study was to compare a combination of MTA with/without CaCl(2) as pulp-capping agents in dogs' teeth. Methods: The dental pulp of 32 teeth in four dogs were exposed and capped with either MTA or MTA/CaCl(2). After 2 months, the animals were sacrificed, and the teeth were prepared for histological evaluation. Pulpal response to the two capping materials was evaluated in terms of necrosis, inflammation, and formation of a calcified bridge. The chi-square test was used for data analysis. Results: Histological results showed a higher percentage of inflammation and necrosis and a lower percentage of calcified bridge formation in MTA/CaCl(2) samples compared with MTA; however, the differences were not statistically significant (P >.05). Conclusions: The addition of CaCl(2) to MTA pulp-capping agent did not improve the properties of this biomaterial. (J. Endod 2011;37:786-788)
C1 [Kakoei, Shahla] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman 7618693351, Iran.
   [Parirokh, Masoud] Kerman Univ Med Sci, Oral & Dent Dis Res Ctr, Kerman 7618693351, Iran.
   [Asgary, Saeed; Eghbal, Mohammad Jafar] Shahid Beheshti Univ Med Sci, Sch Dent, Dent Res Ctr, Iranian Ctr Endodont Res, Tehran, Iran.
   [Samiee, Mohammad] Tabriz Univ Med Sci, Sch Dent, Endodont Dept, Tabriz, Iran.
RP Kakoei, S (reprint author), Kerman Univ Med Sci, Neurosci Res Ctr, Kerman 7618693351, Iran.
EM skakoei@gmail.com
RI samiei, mohammad/M-2916-2017
OI samiei, mohammad/0000-0002-3557-0666
FU Research Committee of Kerman University of Medical Sciences; Iranian
   Center for Endodontic Research
FX Supported by the Research Committee of Kerman University of Medical
   Sciences and the Iranian Center for Endodontic Research.
CR Asgary S, 2006, J MATER SCI-MATER M, V17, P187, DOI 10.1007/s10856-006-6823-3
   Asgary S, 2005, J ENDODONT, V31, P101, DOI 10.1097/01.DON.0000133156.85164.B2
   Asgary S, 2008, ORAL SURG ORAL MED O, V106, P609, DOI 10.1016/j.tripleo.2008.06.006
   Asgary Saeed, 2006, Aust Endod J, V32, P26
   Bortoluzzi EA, 2008, J ENDODONT, V34, P172, DOI 10.1016/j.joen.2007.09.015
   Bortoluzzi EA, 2006, J ENDODONT, V32, P897, DOI 10.1016/j.joen.2006.04.006
   Bortoluzzi EA, 2006, J ENDODONT, V32, P1194, DOI 10.1016/j.joen.2006.07.018
   BORTOLUZZI FA, 2009, J ENDODONT, V35, P550
   Eghbal MJ, 2009, AUST ENDOD J, V35, P4, DOI 10.1111/j.1747-4477.2009.00166.x
   Holt DM, 2007, J ENDODONT, V33, P844, DOI 10.1016/j.joen.2007.04.006
   Hong ST, 2008, J ENDODONT, V34, P56, DOI 10.1016/j.joen.2007.09.008
   Jafarnia B, 2009, ORAL SURG ORAL MED O, V107, P739, DOI 10.1016/j.tripleo.2009.01.009
   Kogan P, 2006, J ENDODONT, V32, P569, DOI 10.1016/j.joen.2005.08.006
   McNamara RP, 2010, J ENDODONT, V36, P1851, DOI 10.1016/j.joen.2010.08.021
   Nair PNR, 2008, INT ENDOD J, V41, P128
   Parirokh M, 2005, DENT TRAUMATOL, V21, P150, DOI 10.1111/j.1600-9657.2005.00311.x
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Parirokh M, 2010, J ENDODONT, V36, P16, DOI 10.1016/j.joen.2009.09.006
   Stowe TJ, 2004, J ENDODONT, V30, P429, DOI 10.1097/00004770-200406000-00013
   Tabarsi B, 2010, INT ENDOD J, V43, P565, DOI 10.1111/j.1365-2591.2010.01711.x
   Takita T, 2006, INT ENDOD J, V39, P415, DOI 10.1111/j.1365-2591.2006.01097.x
   TORABINEJAD M, 1993, J ENDODONT, V19, P591, DOI 10.1016/S0099-2399(06)80271-2
   Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010
   Wiltbank KB, 2007, J ENDODONT, V33, P1235, DOI 10.1016/j.joen.2007.06.016
NR 24
TC 19
Z9 20
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
J9 J ENDODONT
JI J. Endod.
PD JUN
PY 2011
VL 37
IS 6
BP 786
EP 788
DI 10.1016/j.joen.2011.03.010
PG 3
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 778OF
UT WOS:000291713300012
PM 21787489
DA 2018-10-20
ER

PT J
AU Sailakshmi, G
   Mitra, T
   Gnanamani, A
   Raja, STK
   Thiruselvi, T
   Selvaraj, NV
   Ramesh, G
   Mandal, AB
AF Sailakshmi, G.
   Mitra, Tapas
   Gnanamani, A.
   Raja, S. Thirupathy Kumara
   Thiruselvi, T.
   Selvaraj, Naga Vignesh
   Ramesh, Gopal
   Mandal, A. B.
TI Bonding interactions and stability assessment of biopolymer material
   prepared using type III collagen of avian intestine and anionic
   polysaccharides
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID ALGINIC ACID; I COLLAGEN; MEMBRANE; PROPERTY; BEHAVIOR; FIBRIL; FAMILY;
   VITRO; GEL
AB The present study demonstrate bonding interactions between anionic polysaccharides, alginic acid (AA) and type III collagen extracted from avian intestine used for the preparation of thermally stable and biodegradable biopolymer material. Further the study describes, optimum conditions (pH, temperature and NaCl concentration) required for the formation of fibrils in type III collagen, assessment on degree of cross-linking, nature of bonding patterns, biocompatibility and biodegradability of the cross-linked biomaterial. Results revealed, the resultant biopolymer material exhibit high thermal stability with 5-6 fold increase in tensile strength compared to the plain AA and collagen materials. The degree of cross-linking was calculated as 75%. No cytotoxicity was observed for the cross-linked biopolymer material when tested with skin fibroblast cells and the material was biodegradable when treated with enzyme collagenase. With reference to bonding pattern analysis we found, AA cross-linked with type III collagen via (i) formation of covalent amide linkage between -COOH group of AA and epsilon-NH2 group of type-III collagen as well as (ii) intermolecular multiple hydrogen bonding between alginic acid -OH group with various amino acid functional group of type-III collagen. Comparisons were made with other cross-linking agents also. For better understanding of bonding pattern, bioinformatics analysis was carried out and discussed in detail. The results of the study emphasize, AA acts as a suitable natural crosslinker for the preparation of wound dressing biopolymer material using collagen. The tensile strength and the thermal stability further added value to the resultant biopolymer.
C1 [Sailakshmi, G.; Mitra, Tapas; Gnanamani, A.; Raja, S. Thirupathy Kumara; Thiruselvi, T.; Mandal, A. B.] Cent Leather Res Inst, Council Sci & Ind Res, Div Microbiol, Madras 600020, Tamil Nadu, India.
   [Selvaraj, Naga Vignesh; Ramesh, Gopal] Anna Univ, Res Ctr, AU KBC, Madras 600025, Tamil Nadu, India.
RP Gnanamani, A (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Div Microbiol, Madras 600020, Tamil Nadu, India.
EM gnanamani3@gmail.com
RI Mandal, Asit Baran/B-9977-2009; Selvaraj,
   ThirupathiKumaraRaja/P-1646-2014
OI Selvaraj, ThirupathiKumaraRaja/0000-0002-0502-1172; Mitra,
   Tapas/0000-0003-0813-7389
FU Department of Biotechnology, Ministry of Science and Technology, New
   Delhi [BT/PR10179/AAQ/03/385/2007]
FX All authors thank Department of Biotechnology, Ministry of Science and
   Technology, New Delhi, for the financial assistance provided in the form
   of project in vide sanction no. BT/PR10179/AAQ/03/385/2007.
CR ADERIBIGBE AO, 1987, ANIM FEED SCI TECH, V18, P209, DOI 10.1016/0377-8401(87)90072-1
   [Anonymous], 2009, ACD CHEMSKETCH VERS
   Anson SI, 2009, RUSS J APPL CHEM+, V82, P1095, DOI 10.1134/S1070427209060317
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Cameron GJ, 2002, J STRUCT BIOL, V137, P15, DOI 10.1006/jsbi.2002.4459
   CHUNG TW, 2002, BIOMATERIALS, V23, P827
   Delorenzi NJ, 1996, INT J BIOL MACROMOL, V19, P15, DOI 10.1016/0141-8130(96)01094-X
   ENGEL J, 1994, EXTRACELLULAR MATRIX, P1
   Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2
   Gough JE, 2002, J BIOMED MATER RES, V61, P121, DOI 10.1002/jbm.10145
   HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691
   Henkel W, 1996, BIOCHEM J, V318, P497, DOI 10.1042/bj3180497
   Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453
   Kuga T, 1998, SURG TODAY, V28, P385, DOI 10.1007/s005950050146
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Machado AAS, 2002, J THERM ANAL CALORIM, V67, P491
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   MOORE S, 1948, J BIOL CHEM, V176, P367
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nomura Y, 2000, J AGR FOOD CHEM, V48, P2028, DOI 10.1021/jf990773a
   Nomura Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1919, DOI 10.1271/bbb.61.1919
   Pavia D..L.G., 2001, INTRO SPECTROSCOPY
   PIEZ KA, 1982, CONNECT TISSUE RES, V10, P25, DOI 10.3109/03008208209034403
   Prockop D. J., 1994, EXTRACELLULAR MATRIX, P47
   Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6
   Sachan N.K., 2009, J PHARM RES, V2, P1191
   VANDERREST M, 1991, FASEB J, V5, P2814
   Veis A., 1994, EXTRACELLULAR MATRIX, P15
   VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Yang SR, 2007, FIBER POLYM, V8, P257, DOI 10.1007/BF02877267
   Yunoki S, 2004, J BIOSCI BIOENG, V98, P40, DOI 10.1263/jbb.98.40
   Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5
NR 33
TC 5
Z9 7
U1 2
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2011
VL 22
IS 6
BP 1419
EP 1429
DI 10.1007/s10856-011-4337-0
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KL
UT WOS:000291702500006
PM 21547588
DA 2018-10-20
ER

PT J
AU Chin, LK
   Calabro, A
   Rodriguez, ER
   Tan, CD
   Walker, E
   Derwin, KA
AF Chin, LiKang
   Calabro, Anthony
   Rodriguez, E. Rene
   Tan, Carmela D.
   Walker, Esteban
   Derwin, Kathleen A.
TI Characterization of and host response to tyramine substituted-hyaluronan
   enriched fascia extracellular matrix
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SMALL-INTESTINAL SUBMUCOSA; TISSUE RECONSTRUCTION; MACROPHAGE PHENOTYPE;
   AMPHOTERICIN-B; IN-VIVO; SCAFFOLD; REPAIR; GRAFT; FIBROBLASTS; RABBIT
AB Naturally-occurring biomaterial scaffolds derived from extracellular matrix (ECM) have been previously investigated for soft tissue repair. We propose to enrich fascia ECM with high molecular weight tyramine substituted-hyaluronan (TS-HA) to modulate inflammation associated with implantation and enhance fibroblast infiltration. As critical determinants of constructive remodeling, the host inflammatory response and macrophage polarization to TS-HA enriched fascia were characterized in a rat abdominal wall model. TS-HA treated fascia with crosslinking had a similar lymphocyte (P = 0.11) and plasma cell (P = 0.13) densities, greater macrophage (P = 0.001) and giant cell (P < 0.0001) densities, and a lower density of fibroblast-like cells (P < 0.0001) than water treated controls. Treated fascia, with or without cross-linking, exhibited a predominantly M2 pro-remodeling macrophage profile similar to water controls (P = 0.82), which is suggestive of constructive tissue remodeling. Our findings demonstrated that HA augmentation can alter the host response to an ECM, but the appropriate concentration and molecular weight needed to minimize chronic inflammation within the scaffold remains to be determined.
C1 [Chin, LiKang; Calabro, Anthony; Derwin, Kathleen A.] Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA.
   [Chin, LiKang] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   [Rodriguez, E. Rene; Tan, Carmela D.] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44195 USA.
   [Walker, Esteban] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA.
RP Derwin, KA (reprint author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, 9500 Euclid Ave,ND20, Cleveland, OH 44195 USA.
EM derwink@ccf.org
FU National Institutes of Health [R01AR056633, F31AR057305, T32AR50959];
   Ohio Third Frontier [BRTT05-30]; Musculoskeletal Transplant Foundation;
   Lifecore Biomedical
FX This study was financially supported by the National Institutes of
   Health (NIAMS Grant # R01AR056633, F31AR057305, T32AR50959) and the Ohio
   Third Frontier (Grant # BRTT05-30). The authors would like to
   acknowledge the Musculoskeletal Transplant Foundation for their fascia
   donation, Lifecore Biomedical for their TS-HA donation, and Michael
   Braun (Biomedical Engineering Histology Core, Cleveland Clinic) for the
   histologic preparation of the H&E stained sections.
CR Adams JE, 2006, ARTHROSCOPY, V22, P700, DOI 10.1016/j.arthro.2006.03.016
   Al-Shraim M, 2007, J CLIN PATHOL, V60, P1060, DOI 10.1136/jcp.2007.048330
   Aurora A, 2007, J SHOULDER ELB SURG, V16, p171S, DOI 10.1016/j.jse.2007.03.008
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2003, HEART SURG FORUM, V6, pE20
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   BADYLAK SF, 1989, J SURG RES, V47, P74, DOI 10.1016/0022-4804(89)90050-4
   Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brown AL, 2006, MACROMOL BIOSCI, V6, P648, DOI 10.1002/mabi.200600052
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Buinewicz B, 2004, ANN PLAS SURG, V52, P188, DOI 10.1097/01.sap.0000100895.41198.27
   Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273
   Campo GM, 2010, BIOCHIMIE, V92, P204, DOI 10.1016/j.biochi.2009.10.006
   Campo GM, 2010, INNATE IMMUN-LONDON, V16, P48, DOI 10.1177/1753425909340419
   Cantor Jerome O., 2006, Inflammation & Allergy Drug Targets, V5, P257, DOI 10.2174/187152806779010936
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   Derwin KA, 2008, J BIOMED MATER RES A, V84A, P500, DOI 10.1002/jbm.a.31455
   Derwin KA, 2010, J SHOULDER ELB SURG, V19, P467, DOI 10.1016/j.jse.2009.10.020
   DOCHERTY R, 1989, J CELL SCI, V92, P263
   Fox A, 2000, IMMUNOL REV, V173, P141, DOI 10.1034/j.1600-065X.2000.917313.x
   Hodde J, 2006, ANZ J SURG, V76, P1096, DOI 10.1111/j.1445-2197.2006.03948.x
   Jokela TA, 2008, CONNECT TISSUE RES, V49, P115, DOI 10.1080/03008200802148439
   Jones JS, 2005, BJU INT, V96, P103, DOI 10.1111/j.1464-410X.2005.05576.x
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200
   Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1
   Lin WQ, 1997, J HISTOCHEM CYTOCHEM, V45, P1157, DOI 10.1177/002215549704500813
   Lindholm A, 1996, ACTA VET SCAND, V37, P147
   Lyle DB, 2010, J BIOMED MATER RES A, V94A, P893, DOI 10.1002/jbm.a.32760
   Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mills CD, 2000, J IMMUNOL, V164, P6166, DOI 10.4049/jimmunol.164.12.6166
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Nakamura K, 2004, J GASTROENTEROL, V39, P346, DOI 10.1007/s00535-003-1301-x
   Noble PW, 2002, MATRIX BIOL, V21, P25, DOI 10.1016/S0945-053X(01)00184-6
   Pavcnik D, 2002, J VASC SURG, V35, P598, DOI 10.1067/mva.2002.118825
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Proctor M, 2006, AM J RHINOL, V20, P206, DOI 10.1177/194589240602000218
   Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944
   Schimizzi Aimee L, 2006, Spine J, V6, P550, DOI 10.1016/j.spinee.2005.12.005
   Sheehan KM, 2004, LIFE SCI, V75, P3087, DOI 10.1016/j.lfs.2004.02.038
   SHIRLEY SF, 1979, J IMMUNOL, V123, P2883
   Shu XZ, 2004, J BIOMED MATER RES A, V68A, P365, DOI 10.1002/jbm.a.20002
   Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342
   TAURO JC, 1991, CLIN ORTHOP RELAT R, P271
   TOOLE BP, 1971, DEV BIOL, V25, P57, DOI 10.1016/0012-1606(71)90019-4
   Valentin JE, 2006, J BONE JOINT SURG AM, V88A, P2673, DOI 10.2106/JBJS.E.01008
   Vonk AG, 1998, J ANTIMICROB CHEMOTH, V42, P469, DOI 10.1093/jac/42.4.469
   Wallet MA, 2010, CELL IMMUNOL, V262, P84, DOI 10.1016/j.cellimm.2010.02.013
   Whitlock PW, 2007, BIOMATERIALS, V28, P4321, DOI 10.1016/j.biomaterials.2007.05.029
   Yagi M, 2010, J HAND SURG-AM, V35A, P791, DOI 10.1016/j.jhsa.2010.02.010
   Yasuda T, 2007, INFLAMM RES, V56, P246, DOI 10.1007/s00011-007-6168-5
   Yasuda T, 2010, TOHOKU J EXP MED, V220, P229, DOI 10.1620/tjem.220.229
   Yim H, 2010, BURNS, V36, P322, DOI 10.1016/j.burns.2009.10.018
   Zheng MH, 2005, J BIOMED MATER RES B, V73B, P61, DOI 10.1002/jbm.b.30170
   Zhuo LS, 2006, J BIOL CHEM, V281, P20303, DOI 10.1074/jbc.M506703200
NR 59
TC 16
Z9 16
U1 1
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2011
VL 22
IS 6
BP 1465
EP 1477
DI 10.1007/s10856-011-4325-4
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KL
UT WOS:000291702500011
PM 21553156
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Zheng, K
   Li, XK
   Fu, J
   Fan, XL
   Wang, P
   Hao, YL
   Li, SJ
   Fan, HB
   Guo, Z
AF Zheng, Kai
   Li, Xiaokang
   Fu, Jun
   Fan, Xiangli
   Wang, Pan
   Hao, Yulin
   Li, Shujun
   Fan, Hongbin
   Guo, Zheng
TI Effects of Ti2448 half-pin with low elastic modulus on pin loosening in
   unilateral external fixation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SKELETAL FIXATION; STAINLESS-STEEL; TRACT INFECTION; SCHANZ SCREWS;
   BONE; COMPLICATIONS; STRENGTH; FRACTURES; INTERFACE; MOVEMENT
AB The objective of this study was to compare the benefits of titanium 2448 (Ti2448) half-pin and titanium-6 aluminium-4 vanadium (TAV) half-pin on reducing pin loosening during external fracture fixation. Although having similar strength, Ti2448 half-pin had even lower elastic modules(33 GPa) when compared with TAV half-pin (110 GPa), which was similar to that of cortical bone (20 GPa). In the external fixation of tibial model fractures and canine cadaveric tibia fractures, Ti2448 half-pin had greater recoverable deformation and less stress concentration at the pin-bone interface in compression, torsion, and four-points bending test. Then, tibial fractures were created in 24 dogs and stabilized with four half-pins of either Ti2448 or TAV in each animal. At 4 and 8 weeks post-operatively, fracture healing and pin loosening was assessed by radiographic grading scale. The scores of Ti2448 group were significantly higher than those of TAV group. Micro-CT analysis also indicated larger quantity and higher quality of newly formed bone at pin-bone interface in Ti2448 group. Histology observation showed the newly formed bone integrated well into the threads of Ti2448 half-pins. In contrast, there was a layer of necrotic tissue between the bone tissue and TAV half-pin at pin-bone interface in TAV group. The extraction torque values of Ti2448 half-pins near the fracture line were significantly higher than those TAV pins. In conclusion, the Ti2448 half-pin with low elastic modulus could enhance osseointegration and reduce pin loosening when compared with TAV half-pin. It is a promising biomaterial for constructing external fixation system in clinical application.
C1 [Zheng, Kai; Li, Xiaokang; Fu, Jun; Fan, Xiangli; Wang, Pan; Guo, Zheng] Fourth Mil Med Univ, Xi Jing Hosp, Dept Orthoped Oncol, Xian 710032, Peoples R China.
   [Fan, Hongbin] Fourth Mil Med Univ, Xi Jing Hosp, Dept Orthoped Surg, Xian 710032, Peoples R China.
   [Hao, Yulin; Li, Shujun] Chinese Acad Sci, Shenyang Natl Lab Mat Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Fan, HB (reprint author), Fourth Mil Med Univ, Xi Jing Hosp, Dept Orthoped Oncol, Xian 710032, Peoples R China.
EM fanhb@fmmu.edu.cn; guozheng@fmmu.edu.cn
FU National High Technology Research and Development Program of China (863
   Program) [2007AA03Z431]
FX This study was supported by a grant (2007AA03Z431) from National High
   Technology Research and Development Program of China (863 Program).
CR Caja VL, 1996, CLIN ORTHOP RELAT R, P269
   Campbell AA, 2000, J BIOMED MATER RES, V53, P400, DOI 10.1002/1097-4636(2000)53:4<400::AID-JBM14>3.0.CO;2-Z
   EDGERTON BC, 1990, J ORTHOPAED RES, V8, P851, DOI 10.1002/jor.1100080610
   EGGER EL, 1991, VET CLIN N AM-SMALL, V21, P705, DOI 10.1016/S0195-5616(91)50080-2
   Fricka KB, 2004, J PEDIATR ORTHOPED, V24, P167, DOI 10.1097/01241398-200403000-00006
   Ganser A, 2007, EUR J TRAUMA EMERG S, V33, P59, DOI 10.1007/s00068-007-6053-5
   Giotakis N, 2007, STRATEG TRAUMA LIMB, V2, P13, DOI 10.1007/s11751-007-0011-y
   GREEN SA, 1983, CLIN ORTHOP RELAT R, P109
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   HARARI J, 1992, VET CLIN N AM-SMALL, V22, P99, DOI 10.1016/S0195-5616(92)50006-7
   HIPP JA, 1990, J BIOMECH, V23, P1261, DOI 10.1016/0021-9290(90)90383-E
   Hyldahl C, 1991, J Orthop Trauma, V5, P485, DOI 10.1097/00005131-199112000-00017
   Li M, 2010, CLIN ORTHOP RELAT R, V468, P1978, DOI 10.1007/s11999-010-1321-9
   Moroni A, 2001, J BONE JOINT SURG AM, V83A, P717, DOI 10.2106/00004623-200105000-00010
   Moroni A, 2002, J ORTHOP TRAUMA, V16, P189, DOI 10.1097/00005131-200203000-00009
   Moroni A, 2001, CLIN ORTHOP RELAT R, P209
   Neuhoff D, 2005, J Orthop Trauma, V19, P543, DOI 10.1097/01.bot.0000164592.96724.a9
   OBERLI H, 1994, HELV CHIR ACTA, V60, P1073
   Oni O O, 1999, Afr J Med Med Sci, V28, P13
   Parameswaran AD, 2003, J ORTHOP TRAUMA, V17, P503, DOI 10.1097/00005131-200308000-00005
   Partale K, 2005, J BIOMED MATER RES B, V74B, P608, DOI 10.1002/jbm.b.30254
   PETTINE KA, 1993, CLIN ORTHOP RELAT R, P18
   Pieske O, 2008, J TRAUMA, V64, P1275, DOI 10.1097/TA.0b013e31815e40e0
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Piza G, 2004, J BONE JOINT SURG BR, V86B, P892, DOI 10.1302/0301-620x.86b6.13875
   Safinia L, 2005, BIOMATERIALS, V26, P7537, DOI 10.1016/j.biomaterials.2005.05.078
   SCHATZKER J, 1975, CLIN ORTHOP RELAT R, V111, P257
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Wang L, 2010, BIOMATERIALS, V31, P9452, DOI 10.1016/j.biomaterials.2010.08.036
   YANG CY, 1994, CLIN ORTHOP RELAT R, P286
   YANG CY, 1994, CLIN ORTHOP RELAT R, V298
NR 31
TC 6
Z9 7
U1 3
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUN
PY 2011
VL 22
IS 6
BP 1579
EP 1588
DI 10.1007/s10856-011-4313-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KL
UT WOS:000291702500021
PM 21487787
DA 2018-10-20
ER

PT J
AU Shah, J
   Girase, B
   Misra, RDK
AF Shah, Jinesh
   Girase, Bhupendra
   Misra, R. Devesh K.
TI Enhanced Fibroblasts Functions in a New Family of Hierarchically
   Organized Nanohybrid Elastomers
SO ADVANCED ENGINEERING MATERIALS
LA English
DT Article
ID FERRITE COMPOSITE NANOPARTICLES; BIOMATERIAL SYSTEM; CALCIUM-PHOSPHATE;
   IN-VITRO; TITANIUM; FIBRONECTIN; SILICONE; OSTEOBLASTS; ADHESION;
   IMPLANT
AB Fibroblasts functions in a new family of nanohybrid network elastomers with high strength-at-break involving pressure-induced curing and short chain cross-links of inorganic nanostructures have been investigated. The concept of chemical design and synthesis involves covalently linking nanometer-sized titania with a bi-functional agent, acrylic acid, which has a carboxylic group to coordinate with titania and a vinyl group to form short chain cross-links as an integral part of the silicone network structure elastomer. Interestingly, the cell-substrate interactions in the hybrid network structure elastomer are significantly different from those observed in stand alone silicone. The origin of intriguing differences in cell-substrate interactions in terms of cell attachment, viability, and proliferation and assessment of proteins actin, vinculin, and fibronectin are addressed and attributed to physico-chemical properties (topography and hydrophilicity) and to the presence of nanocrystalline titania. The end outcome of the study is a new family of soft tissue implants with desired (enhanced cell functions) and bulk properties (long term stability-high strength-at-break). The integration of cellular and molecular biology with material science and engineering described here provides an insight into the ability to modulate cellular and molecular reactions in promoting osteoinductive signaling of surface adherent cells, in the present case, fibroblasts for soft tissue reconstruction.
C1 [Shah, Jinesh; Girase, Bhupendra; Misra, R. Devesh K.] Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
RP Shah, J (reprint author), Univ Louisiana Lafayette, Biomat & Biomed Engn Res Lab, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   ARONOW MA, 1990, J CELL PHYSIOL, V143, P213, DOI 10.1002/jcp.1041430203
   Catanese J, 1999, J BIOMED MATER RES, V48, P187, DOI 10.1002/(SICI)1097-4636(1999)48:2<187::AID-JBM13>3.3.CO;2-D
   CHEN LB, 1978, CELL, V14, P377, DOI 10.1016/0092-8674(78)90123-X
   Costantino P D, 1993, Facial Plast Surg, V9, P1, DOI 10.1055/s-2008-1064591
   Daculsi G, 1999, J BIOMED MATER RES, V47, P228, DOI 10.1002/(SICI)1097-4636(199911)47:2<228::AID-JBM13>3.0.CO;2-Z
   Degidi Marco, 2003, J Oral Implantol, V29, P13, DOI 10.1563/1548-1336(2003)029<0013:BCAAIA>2.3.CO;2
   El Fray M, 2007, J MATER SCI-MATER M, V18, P501, DOI 10.1007/s10856-007-2010-4
   ELWARRAK AO, 2004, BMC MUSCULOSKEL DIS, P5
   Erlich Mark A, 2003, Facial Plast Surg, V19, P325
   Faghihi S, 2007, BIOMATERIALS, V28, P3887, DOI 10.1016/j.biomaterials.2007.05.010
   Globus RK, 1998, J CELL SCI, V111, P1385
   Goldfarb CA, 2003, J BONE JOINT SURG AM, V85A, P1869, DOI 10.2106/00004623-200310000-00001
   Hukkanen M, 1998, CLIN ORTHOP RELAT R, P53
   HYNES RO, 1974, CELL, V3, P113, DOI 10.1016/0092-8674(74)90114-7
   Kenawy ER, 2003, BIOMATERIALS, V24, P907, DOI 10.1016/S0142-9612(02)00422-2
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   LEICHTER I, 1992, BIOMATERIALS, V13, P478, DOI 10.1016/0142-9612(92)90170-S
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Matrin-Granizo R., 1997, PLAST RECONSTR SURG, V99, P2100
   NORDAHL J, 1995, CALCIFIED TISSUE INT, V57, P442, DOI 10.1007/BF00301948
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   Park S. H., 2000, BIOMEDICAL ENG HDB, V1, P44
   Polyzois G L, 1995, J Prosthodont, V4, P38, DOI 10.1111/j.1532-849X.1995.tb00313.x
   Rana S, 2006, ACTA BIOMATER, V2, P421, DOI 10.1016/j.actbio.2006.03.005
   Romo T, 1998, AESTHET PLAST SURG, V22, P211, DOI 10.1007/s002669900193
   Sahlin H, 2006, J BIOMED MATER RES A, V77A, P43, DOI 10.1002/jbm.a.30642
   Sendemir-Urkmez A, 2007, J BIOMED MATER RES A, V81A, P624, DOI 10.1002/jbm.a.31010
   Shah J, 2009, MAT SCI ENG A-STRUCT, V523, P199, DOI 10.1016/j.msea.2009.05.059
   Starch MS, 2003, J COSMET SCI, V54, P193
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   SUZIKI R, 2000, CLIN ORTHOP RELAT R, V372, P280
   SUZIKI R, 2003, J BIOMED MATER RES A, V66, P396
   Takeuchi H, 1999, MACROMOLECULES, V32, P6792, DOI 10.1021/ma990218+
   TENGVALL P, 1992, Clinical Materials, V9, P115, DOI 10.1016/0267-6605(92)90056-Y
   TENGVALL P, 1989, BIOMATERIALS, V10, P166, DOI 10.1016/0142-9612(89)90019-7
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Waris E, 2008, BIOMATERIALS, V29, P683, DOI 10.1016/j.biomaterials.2007.10.037
   WILKINS JA, 1982, CELL, V28, P83, DOI 10.1016/0092-8674(82)90377-4
   WINNARD RG, 1995, J BONE MINER RES, V10, P1969
   Yuan Q, 2008, MAT SCI ENG A-STRUCT, V480, P181, DOI 10.1016/j.msea.2007.07.019
   Zhou CR, 1999, BIOMATERIALS, V20, P2093, DOI 10.1016/S0142-9612(99)00080-0
NR 44
TC 3
Z9 3
U1 0
U2 2
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1438-1656
J9 ADV ENG MATER
JI Adv. Eng. Mater.
PD JUN
PY 2011
VL 13
IS 6
BP B234
EP B245
DI 10.1002/adem.201080130
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 775GQ
UT WOS:000291447200004
DA 2018-10-20
ER

PT J
AU Schrems, M
   Brandt, A
   Welton, T
   Liebner, F
   Rosenau, T
   Potthast, A
AF Schrems, Michael
   Brandt, Agnieszka
   Welton, Tom
   Liebner, Falk
   Rosenau, Thomas
   Potthast, Antje
TI Ionic liquids as media for biomass processing: opportunities and
   restrictions
SO HOLZFORSCHUNG
LA English
DT Article; Proceedings Paper
CT 11th European Workshop of Lignocelluloses and Pulp (EWLP)
CY AUG 16-19, 2010
CL Hamburg, GERMANY
DE cellulose; cellulose degradation; Curie-point pyrolysis gas
   chromatography/mass spectrometry (Cu-Py-GC/MS); fractionation; ionic
   liquids (ILs); lignin; molecular weight distribution (MWD); renewable
   materials; size-exclusion chromatography (SEC)
ID LIGNOCELLULOSIC MATERIALS; CELLULOSE; DISSOLUTION; WOOD; BEHAVIOR;
   CHLORIDE; SOLVENT; LIGNIN
AB The present study provides insight into the dissolution behavior of renewable materials in ionic liquids. Beech, spruce and rye straw were dissolved in 1-ethyl-3-methylimidazolium acetate as the ionic liquid of choice, which is currently one of the most frequently used cation-anion combinations among ionic liquids for biomaterial processing. The dissolution was followed by selective precipitation of cellulose, hemicelluloses, and lignin. The obtained lignin was analyzed with Curie-point pyrolysis gas chromatography/mass spectrometry (Cu-Py-GC/MS) and the separated cellulose/hemicellulose fractions with gel permeation chromatography (GPC). Time dependence of the dissolution process was studied on rye straw, eucalyptus kraft pulp and beech sulfite pulp. The results show a changing dissolution profile over time, which is due to progressing degradation of the cellulose in the ionic liquid.
C1 [Schrems, Michael; Liebner, Falk; Rosenau, Thomas; Potthast, Antje] Univ Nat Resources & Life Sci, Christian Doppler Lab Adv Cellulose Chem & Analyt, Dept Chem, A-1190 Vienna, Austria.
   [Brandt, Agnieszka; Welton, Tom] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AZ, England.
RP Potthast, A (reprint author), Univ Nat Resources & Life Sci, Christian Doppler Lab Adv Cellulose Chem & Analyt, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.
EM antje.potthast@boku.ac.at
RI Liebner, Falk/B-4690-2011; Welton, Tom/K-1322-2012; Brandt,
   Agnieszka/H-5966-2011; Potthast, Antje/Q-2816-2017
OI Welton, Tom/0000-0002-1750-1683; Brandt, Agnieszka/0000-0002-5805-0233;
   Potthast, Antje/0000-0003-1981-2271; Liebner, Falk/0000-0002-8244-8153;
   Rosenau, Thomas/0000-0002-6636-9260
CR BALENSIEFER T, 2008, Patent No. 2008090156
   Balensiefer T., 2008, Method for producing glucose by enzymatic hydrolysis of cellulose that can be pretreated with an ionic liquid containing a polyatomic anion, Patent No. [WO2008/090155, 2008090155]
   Barthel S, 2006, GREEN CHEM, V8, P301, DOI 10.1039/b513157j
   Busch Rainer, 2006, Biotechnology Journal, V1, P770, DOI 10.1002/biot.200600057
   Cao Y, 2009, CHEM ENG J, V147, P13, DOI 10.1016/j.cej.2008.11.011
   Ebner G, 2008, TETRAHEDRON LETT, V49, P7322, DOI 10.1016/j.tetlet.2008.10.052
   El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i
   Fort DA, 2007, GREEN CHEM, V9, P63, DOI 10.1039/b607614a
   Henniges U, 2011, BIOMACROMOLECULES, V12, P871, DOI 10.1021/bm101555q
   Honglu X., 2006, HOLZFORSCHUNG, V60, P509, DOI DOI 10.1515/HF.2006.084
   Jia SY, 2010, HOLZFORSCHUNG, V64, P577, DOI 10.1515/HF.2010.075
   JONES JKN, 1978, WOOD FIBER SCI, V9, P295
   Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Li B, 2010, IND ENG CHEM RES, V49, P2477, DOI 10.1021/ie901560p
   Liebert T., 2010, ACS S SERIES
   Liebner F, 2010, HOLZFORSCHUNG, V64, P161, DOI 10.1515/HF.2010.033
   Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4
   Nakamura A, 2010, HOLZFORSCHUNG, V64, P77, DOI 10.1515/HF.2010.004
   Nakamura A, 2010, HOLZFORSCHUNG, V64, P289, DOI 10.1515/HF.2010.042
   Potthast A, 2002, TETRAHEDRON LETT, V43, P7757, DOI 10.1016/S0040-4039(02)01767-7
   Pu YQ, 2007, J WOOD CHEM TECHNOL, V27, P23, DOI 10.1080/02773810701282330
   Rohrling J, 2002, BIOMACROMOLECULES, V3, P959, DOI 10.1021/bm020029q
   SCHREMS M, 2010, ACS S SERIES
   Sun N, 2009, GREEN CHEM, V11, P646, DOI 10.1039/b822702k
   Wells TP, 2008, J ORG CHEM, V73, P5585, DOI 10.1021/jo8005864
   Xie H, 2007, BIOMACROMOLECULES, V8, P3740, DOI 10.1021/bm700679s
   Zhu SD, 2006, GREEN CHEM, V8, P325, DOI 10.1039/b601395c
NR 28
TC 20
Z9 20
U1 0
U2 56
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0018-3830
J9 HOLZFORSCHUNG
JI Holzforschung
PD JUN
PY 2011
VL 65
IS 4
BP 527
EP 533
DI 10.1515/HF.2011.099
PG 7
WC Forestry; Materials Science, Paper & Wood
SC Forestry; Materials Science
GA 776KX
UT WOS:000291534600013
DA 2018-10-20
ER

PT J
AU Wang, KM
   Yin, RX
   Tong, Z
   Yu, Q
   Nie, J
AF Wang, Kemin
   Yin, Ruixue
   Tong, Zi
   Yu, Qiang
   Nie, Jun
TI Synthesis and characterization of water-soluble glucosyloxyethyl
   acrylate modified chitosan
SO INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
LA English
DT Article
DE Chitosan; Glyco-chitosan; Michael addition reaction; Biomaterial
ID CHEMICAL-MODIFICATIONS; DERIVATIVES; BIOCOMPATIBILITY; FABRICATION;
   HYDROGELS; SCAFFOLDS
AB A novel water-soluble chitosan derivative, glucosyloxyethyl acrylated chitosan was successfully synthesized by Michael addition reaction of chitosan with glucosyloxyethyl acrylate (GEA), and the obtained glyco-chitosan derivative was characterized by FT-IR, (1)H NMR, elemental analysis, XRD, TG, DSC and SEM. The FT-IR and (1)H NMR results showed that GEA residues were grafted onto the amino group of chitosan. The degree of substitution (DS) was calculated by elemental analysis. XRD data revealed that the introduced saccharide moieties decreased the crystalline structure of chitosan. TG and DSC results demonstrated that the glucosyloxyethyl acrylated chitosan was less thermal stable than chitosan. This efficient synthetic method provided an approach of preparing water-soluble glyco-chitosan derivatives. The obtained derivatives would show stronger specific affinity of lectin than chitosan thus would have potential applications in biomaterials. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Wang, Kemin; Yu, Qiang] Changzhou Univ, Sch Mat Sci & Engn, Changzhou 213164, Peoples R China.
   [Yin, Ruixue; Tong, Zi; Nie, Jun] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
   [Yin, Ruixue; Tong, Zi; Nie, Jun] Beijing Univ Chem Technol, Coll Mat Sci & Engn, Beijing 100029, Peoples R China.
RP Nie, J (reprint author), Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Beijing 100029, Peoples R China.
EM niejun@mail.buct.edu.cn
FU Natural Science Foundation of Jiangsu Province [BK2010190]; State Key
   Laboratory of Chemical Resource Engineering, Beijing University of
   Chemical Technology
FX The author would like to thank the Natural Science Foundation of Jiangsu
   Province (BK2010190) for its financial support. This study was supported
   by Open Fund from State Key Laboratory of Chemical Resource Engineering,
   Beijing University of Chemical Technology.
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Alves NM, 2008, INT J BIOL MACROMOL, V43, P401, DOI 10.1016/j.ijbiomac.2008.09.007
   Gao XY, 2010, CARBOHYD POLYM, V79, P507, DOI 10.1016/j.carbpol.2009.08.033
   Han J, 2009, INT J BIOL MACROMOL, V44, P229, DOI 10.1016/j.ijbiomac.2008.12.009
   Holappa J, 2006, MACROMOL BIOSCI, V6, P139, DOI 10.1002/mabi.200500202
   Inukai Y, 1998, ANAL CHIM ACTA, V371, P187, DOI 10.1016/S0003-2670(98)00313-4
   Jayakumar R, 2008, INT J BIOL MACROMOL, V42, P335, DOI 10.1016/j.ijbiomac.2007.12.011
   Justi KC, 2005, MACROMOL SYMP, V229, P203, DOI 10.1002/masy.200551125
   KITAZAWA S, 1990, CHEM LETT, P1733, DOI 10.1246/cl.1990.1733
   Krishnapriya KR, 2010, CARBOHYD RES, V345, P2013, DOI 10.1016/j.carres.2010.06.005
   Kumar S, 2009, INT J BIOL MACROMOL, V45, P330, DOI 10.1016/j.ijbiomac.2009.08.002
   Li QZ, 2009, INT J BIOL MACROMOL, V44, P121, DOI 10.1016/j.ijbiomac.2008.11.001
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Mourya VK, 2008, REACT FUNCT POLYM, V68, P1013, DOI 10.1016/j.reactfunctpolym.2008.03.002
   NISHIMURA SI, 1991, MACROMOLECULES, V24, P4745, DOI 10.1021/ma00017a003
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   SAMUELS RJ, 1981, J POLYM SCI POL PHYS, V19, P1081, DOI 10.1002/pol.1981.180190706
   Takashi M., 1996, MACROMOL CHEM PHYS, V197, P1135
   Ueno H, 2001, ADV DRUG DELIVER REV, V52, P105, DOI 10.1016/S0169-409X(01)00189-2
   VandeVord PJ, 2002, J BIOMED MATER RES, V59, P585, DOI 10.1002/jbm.1270
   Yang DZ, 2008, MACROMOL BIOSCI, V8, P239, DOI 10.1002/mabi.200700221
   Zheng LY, 2003, CARBOHYD POLYM, V54, P527, DOI 10.1016/j.carbpol.2003.07.009
   Zhou Y., 2007, BIOMACROMOLECULES, V9, P349
NR 24
TC 8
Z9 9
U1 0
U2 30
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0141-8130
J9 INT J BIOL MACROMOL
JI Int. J. Biol. Macromol.
PD JUN 1
PY 2011
VL 48
IS 5
BP 753
EP 757
DI 10.1016/j.ijbiomac.2011.02.018
PG 5
WC Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 774WM
UT WOS:000291417500007
PM 21382407
DA 2018-10-20
ER

PT J
AU Ueng, SWN
   Yuan, LJ
   Lin, SS
   Liu, SJ
   Chan, EC
   Chen, KT
   Lee, MS
AF Ueng, Steve W. N.
   Yuan, Li-Jen
   Lin, Song-Shu
   Liu, Shih-Jung
   Chan, Err-Cheng
   Chen, Kuei-Tien
   Lee, Mel S.
TI In Vitro and In Vivo Analysis of a Biodegradable
   Poly(lactide-co-glycolide) Copolymer Capsule and Collagen Composite
   System for Antibiotics and Bone Cells Delivery
SO JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
LA English
DT Article
DE PLGA; Collagen; Composite system; Vancomycin; MSC
ID MESENCHYMAL STEM-CELLS; BEADS LOCAL THERAPY; DIFFERENTIATION;
   OSTEOMYELITIS; BIOMATERIAL; VANCOMYCIN; MANAGEMENT; DEFECTS; RABBITS
AB The authors investigated poly(lactide-co-glycolide) (PLGA) capsule and collagen composite system for antibiotics and bone cells delivery to treat infected bone defects. Poly(lactide-co-glycolide) was mixed with vancomycin and hot compressing molded to form an antibiotic capsule. Rabbit mesenchymal stem cells (MSCs) were entrapped in collagen gel phase and dispersed throughout the void volume of capsule. In vitro study, the composite systems were cultured in complete or osteogenic medium for 21 days. The profiles of vancomycin released from the systems were evaluated using the high-performance liquid chromatography method. Relative activity of vancomycin against Staphylococcus aureus was determined by an antibiotic disk diffusion method. The expression of osteogenic gene was determined by reverse-transcription polymerase chain reaction. The alkaline phosphatase activity and calcium level of the MSCs were assessed. Analytical results demonstrated that the concentrations of vancomycin eluted from the composite system were above the minimal inhibitory concentration for 21 days. Sample inhibition zone was 10 to 24 mm, and the relative activity was 17.6% to 100%. mRNA of Cbfa1 and osteocalcin were detected, and increased alkaline phosphatase activity and calcium levels were noted. In in vivo investigation, the PKH 26-labeled MSCs and composite systems were implanted in the distal femoral cavities of four rabbits. The local concentration of vancomycin was above the minimal inhibitory concentration for 56 days. Sample inhibition zone was 9 mm to 24 mm, and the relative activity was 11.8% to 100%. Implanted PKH 26-labeled MSCs were identified in the newly formed bony trabeculae in specimens at 2 and 4 months after implantation. The results offer a potential approach to meet clinical requirements in the treatment of infected bone defects.
C1 [Ueng, Steve W. N.; Yuan, Li-Jen; Lin, Song-Shu; Lee, Mel S.] Chang Gung Mem Hosp, Dept Orthopaed, Tao Yuan, Taiwan.
   [Ueng, Steve W. N.; Yuan, Li-Jen; Lee, Mel S.] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan.
   [Lin, Song-Shu] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan.
   [Liu, Shih-Jung] Chang Gung Univ, Dept Mech Engn, Tao Yuan, Taiwan.
   [Chan, Err-Cheng; Chen, Kuei-Tien] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan.
RP Ueng, SWN (reprint author), Chang Gung Mem Hosp, Dept Orthopaed Surg, 5,Fu Hsing St 333, Tao Yuan, Taiwan.
EM wenneng@adm.cgmh.org.tw
OI Chan, Err-Cheng/0000-0001-5158-4921; Liu, Shih-Jung/0000-0003-2083-4865
FU Chang Gung Memorial Hospital; National Science Council of the Republic
   of China
FX The authors thank the Chang Gung Memorial Hospital and the National
   Science Council of the Republic of China for financial support for this
   research.
CR Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   Basle MF, 1998, J BIOMED MATER RES, V40, P350, DOI 10.1002/(SICI)1097-4636(19980605)40:3<350::AID-JBM2>3.0.CO;2-E
   CALHOUN JH, 1997, CLIN ORTHOP RELAT R, V341, P207
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Holmes DF, 2001, MICRON, V32, P273, DOI 10.1016/S0968-4328(00)00040-8
   Hou TY, 2008, TISSUE ENG PT A, V14, P1173, DOI 10.1089/ten.tea.2007.0159
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   KAPELLE H, 1996, ANAL VANCOMYCIN SERU, P430
   Lin SS, 1999, CLIN ORTHOP RELAT R, P240
   Liu SJ, 2005, BIOMATERIALS, V26, P4662, DOI 10.1016/j.biomaterials.2004.11.053
   Liu SJ, 1999, J BIOMED MATER RES, V48, P613, DOI 10.1002/(SICI)1097-4636(1999)48:5<613::AID-JBM4>3.0.CO;2-#
   Mader JT, 1997, ANTIMICROB AGENTS CH, V41, P415, DOI 10.1128/AAC.41.2.415
   Mader JT, 1999, CLIN ORTHOP RELAT R, P14
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   PATZAKIS MJ, 1993, CLIN ORTHOP RELAT R, P112
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Popham G J, 1991, Orthop Rev, V20, P331
   Ueng SWN, 2007, J ORTHOP RES, V25, P62, DOI 10.1002/jor.20286
   Ueng SWN, 2004, J ORTHOPAED RES, V22, P592, DOI 10.1016/j.orthres.2003.09.001
   Ueng SWN, 2002, J ORTHOPAED RES, V20, P654, DOI 10.1016/S0736-0266(01)00174-7
   Ueng SWN, 1999, J TRAUMA, V46, P97, DOI 10.1097/00005373-199901000-00016
   Ueng SWN, 1997, J TRAUMA, V43, P268, DOI 10.1097/00005373-199708000-00011
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   Yang XB, 2001, BONE, V29, P523, DOI 10.1016/S8756-3282(01)00617-2
NR 25
TC 5
Z9 6
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-5282
J9 J TRAUMA
JI J. Trauma-Injury Infect. Crit. Care
PD JUN
PY 2011
VL 70
IS 6
BP 1503
EP 1509
DI 10.1097/TA.0b013e3181edb873
PG 7
WC Critical Care Medicine; Surgery
SC General & Internal Medicine; Surgery
GA 775QR
UT WOS:000291478500044
PM 21336203
DA 2018-10-20
ER

PT J
AU Demento, SL
   Siefert, AL
   Bandyopadhyay, A
   Sharp, FA
   Fahmy, TM
AF Demento, Stacey L.
   Siefert, Alyssa L.
   Bandyopadhyay, Arunima
   Sharp, Fiona A.
   Fahmy, Tarek M.
TI Pathogen-associated molecular patterns on biomaterials: a paradigm for
   engineering new vaccines
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID NF-KAPPA-B; CONTROLLED-RELEASE MICROPARTICLES; MONOPHOSPHORYL-LIPID-A;
   INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTOR-5; SINGLE-DOSE VACCINE;
   SMALL-ANIMAL-MODELS; CD8(+) T-CELLS; DENDRITIC CELLS; HEPATITIS-B
AB Vaccine development has progressed significantly and has moved from whole microorganisms to subunit vaccines that contain only their antigenic proteins. Subunit vaccines are often less immunogenic than whole pathogens; therefore, adjuvants must amplify the immune response, ideally establishing both innate and adaptive immunity. Incorporation of antigens into biomaterials, such as liposomes and polymers, can achieve a desired vaccine response. The physical properties of these platforms can be easily manipulated, thus allowing for controlled delivery of immunostimulatory factors and presentation of pathogen-associated molecular patterns (PAMPs) that are targeted to specific immune cells. Targeting antigen to immune cells via PAMP-modified biomaterials is a new strategy to control the subsequent development of immunity and, in turn, effective vaccination. Here, we review the recent advances in both immunology and biomaterial engineering that have brought particulate-based vaccines to reality.
C1 [Demento, Stacey L.; Siefert, Alyssa L.; Bandyopadhyay, Arunima; Sharp, Fiona A.; Fahmy, Tarek M.] Yale Univ, Malone Engn Ctr, Dept Biomed Engn, New Haven, CT 06511 USA.
RP Fahmy, TM (reprint author), Yale Univ, Malone Engn Ctr, Dept Biomed Engn, 55 Prospect St, New Haven, CT 06511 USA.
EM Tarek.Fahmy@yale.edu
FU NHLBI NIH HHS [T32 HL007974]
CR Aaltonen LM, 1998, EUR J CANCER, V34, P1111, DOI 10.1016/S0959-8049(98)00047-1
   Aganna E, 2002, ARTHRITIS RHEUM, V46, P2445, DOI 10.1002/art.10509
   Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9
   AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5
   AKHTAR S, 1991, NUCLEIC ACIDS RES, V19, P5551, DOI 10.1093/nar/19.20.5551
   Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560
   Ali OA, 2009, NAT MATER, V8, P151, DOI [10.1038/NMAT2357, 10.1038/nmat2357]
   ALLISON AC, 1974, NATURE, V252, P252, DOI 10.1038/252252a0
   ALVING CR, 1992, RES IMMUNOL, V143, P197, DOI 10.1016/S0923-2494(92)80165-H
   Arigita C, 2005, VACCINE, V23, P5091, DOI 10.1016/j.vaccine.2005.06.001
   BANDYOPADHYAY A, 2011, BIOMATERIALS, V11, P3094
   Bartenschlager R, 2006, CURR OPIN MICROBIOL, V9, P416, DOI 10.1016/j.mib.2006.06.012
   Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4
   Beaudette TT, 2009, MOL PHARMACEUT, V6, P1160, DOI 10.1021/mp900038e
   Bekeredjian-Ding I, 2006, J IMMUNOL, V176, P7438, DOI 10.4049/jimmunol.176.12.7438
   Berner VK, 2008, APPL MICROBIOL BIOT, V80, P1053, DOI 10.1007/s00253-008-1618-8
   Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220
   Borges O, 2008, EUR J PHARM BIOPHARM, V69, P405, DOI 10.1016/j.ejpb.2008.01.019
   Bortoluci KR, 2010, CELL MOL LIFE SCI, V67, P1643, DOI 10.1007/s00018-010-0335-5
   Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104
   Bramwell VW, 2005, ADV DRUG DELIVER REV, V57, P1247, DOI 10.1016/j.addr.2005.01.010
   Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382
   Cheong C, 2007, J IMMUNOL METHODS, V324, P48, DOI 10.1016/j.jim.2007.05.001
   Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552
   Chong CSW, 2005, J CONTROL RELEASE, V102, P85, DOI 10.1016/j.jconrel.2004.09.014
   Coombes AGA, 1999, VACCINE, V17, P2410, DOI 10.1016/S0264-410X(99)00025-0
   Copland MJ, 2005, IMMUNOL CELL BIOL, V83, P97, DOI 10.1111/j.1440-1711.2005.01315.x
   Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamen.2005.10.011
   Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768
   Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034
   Di Marco M, 2010, INT J NANOMED, V5, P37
   Eisenbarth SC, 2008, CLIN EXP ALLERGY, V38, P1572, DOI 10.1111/j.1365-2222.2008.03069.x
   Elamanchili P, 2007, J IMMUNOTHER, V30, P378, DOI 10.1097/CJI.0b013e31802cf3e3
   Espuelas S, 2005, MOL IMMUNOL, V42, P721, DOI 10.1016/j.molimm.2004.09.022
   Espuelas S, 2008, BIOCONJUGATE CHEM, V19, P2385, DOI 10.1021/bc8002524
   Fahmy TM, 2005, BIOMATERIALS, V26, P5727, DOI 10.1016/j.biomaterials.2005.02.025
   Ferwerda G, 2010, VACCINE, V28, P614, DOI 10.1016/j.vaccine.2009.10.082
   Fischer S, 2009, J DRUG TARGET, V17, P652, DOI 10.1080/10611860903119656
   Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346
   Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x
   Franz J, 1998, INT J PHARM, V168, P153, DOI 10.1016/S0378-5173(98)00069-6
   Gao CM, 2009, POLYM DEGRAD STABIL, V94, P1405, DOI 10.1016/j.polymdegradstab.2009.05.011
   Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7
   Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569
   Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x
   Gupta PN, 2007, J DRUG TARGET, V15, P701, DOI 10.1080/10611860701637982
   Gupta RK, 1998, ADV DRUG DELIV REV, V32, P225
   Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324
   Gursel M, 1999, VACCINE, V17, P1376, DOI 10.1016/S0264-410X(98)00383-1
   HANSEN CB, 1995, BBA-BIOMEMBRANES, V1239, P133, DOI 10.1016/0005-2736(95)00138-S
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Heffernan MJ, 2009, BIOMATERIALS, V30, P910, DOI 10.1016/j.biomaterials.2008.10.034
   Hemmi H, 2000, NATURE, V408, P740
   HENRICSON BE, 1993, INFECT IMMUN, V61, P2325
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Heuking S, 2009, INT J PHARMACEUT, V381, P97, DOI 10.1016/j.ijpharm.2009.03.039
   Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756
   Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083
   Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531
   Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631
   Howland SW, 2008, J IMMUNOL, V180, P1576, DOI 10.4049/jimmunol.180.3.1576
   Huang HB, 2010, MBIO, V1, DOI 10.1128/mBio.00164-10
   Huang HB, 2009, INFECT IMMUN, V77, P1774, DOI 10.1128/IAI.00086-09
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   Irache JM, 2008, EXPERT OPIN DRUG DEL, V5, P703, DOI [10.1517/17425247.5.6.703, 10.1517/17425247.5.6.703 ]
   Jain V, 2009, NANOMED-NANOTECHNOL, V5, P334, DOI 10.1016/j.nano.2008.12.004
   Jain V, 2008, J DRUG TARGET, V16, P706, DOI [10.1080/10611860802295607, 10.1080/10611860802295607 ]
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Johnston D, 2007, CANCER IMMUNOL IMMUN, V56, P1133, DOI 10.1007/s00262-006-0262-3
   Joseph A, 2002, VACCINE, V20, P3342, DOI 10.1016/S0264-410X(02)00295-5
   Kanchan V, 2009, BIOMATERIALS, V30, P4763, DOI 10.1016/j.biomaterials.2009.05.075
   Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545
   Katare YK, 2003, DRUG DELIV, V10, P231, DOI 10.1080/10717540390235454
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017
   KELSO JM, 1993, J ALLERGY CLIN IMMUN, V91, P867, DOI 10.1016/0091-6749(93)90344-F
   Kipper MJ, 2006, J BIOMED MATER RES A, V76A, P798, DOI 10.1002/jbm.a.30545
   Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4
   Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755
   Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x
   Kotton CN, 2008, EXPERT REV VACCINES, V7, P663, DOI 10.1586/14760584.7.5.663
   Krieg AM, 2007, IMMUNITY, V27, P695, DOI 10.1016/j.immuni.2007.11.001
   Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17
   Li WM, 2001, VACCINE, V20, P148, DOI 10.1016/S0264-410X(01)00277-8
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200
   Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027
   Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3
   Myschik J, 2008, PHARMAZIE, V63, P686, DOI 10.1691/ph.2008.8072
   Nakanishi T, 1999, J CONTROL RELEASE, V61, P233, DOI 10.1016/S0168-3659(99)00097-8
   NAYLOR CJ, 1994, VACCINE, V12, P1225, DOI 10.1016/0264-410X(94)90248-8
   Nellore R V, 1992, J Parenter Sci Technol, V46, P176
   Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777
   Nomura N, 1994, DNA Res, V1, P27, DOI 10.1093/dnares/1.1.27
   Nwe K, 2009, CANCER BIOTHER RADIO, V24, P289, DOI 10.1089/cbr.2008.0626
   O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044
   OHAGAN DT, 1991, VACCINE, V9, P768, DOI 10.1016/0264-410X(91)90295-H
   PETROV AB, 1992, INFECT IMMUN, V60, P3897
   PETROV AB, 1994, VACCINE, V12, P1064, DOI 10.1016/0264-410X(94)90174-0
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Salkowski CA, 1997, INFECT IMMUN, V65, P3239
   Salman HH, 2009, VACCINE, V27, P4784, DOI 10.1016/j.vaccine.2009.05.091
   Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Sesardic D, 2004, VACCINE, V22, P2452, DOI 10.1016/j.vaccine.2003.11.071
   Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106
   Shen H, 2006, IMMUNOLOGY, V117, P78, DOI 10.1111/j.1365-2567.2005.02268.x
   Shimizu T, 2007, IMMUNOLOGY, V121, P473, DOI 10.1111/j.1365-2567.2007.02594.x
   Singh M, 1998, VACCINE, V16, P346, DOI 10.1016/S0264-410X(97)80912-7
   Singh M, 2001, PHARM RES-DORDR, V18, P1476, DOI 10.1023/A:1012269226066
   SINGH M, 1992, INT J PHARM, V85, pR5, DOI 10.1016/0378-5173(92)90157-W
   Singh M, 1997, INFECT IMMUN, V65, P1716
   Singh SK, 2009, MOL IMMUNOL, V47, P164, DOI 10.1016/j.molimm.2009.09.026
   Slade H B, 1998, Expert Opin Investig Drugs, V7, P437
   Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011
   Sridevi K, 2003, INT IMMUNOPHARMACOL, V3, P1589, DOI 10.1016/S1567-5769(03)00181-4
   STANO A, 2010, VACCINE, V29, P804
   Steinman RM, 2001, MT SINAI J MED, V68, P160
   Stern E, 2009, ADV FUNCT MATER, V19, P2888, DOI 10.1002/adfm.200900307
   Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10
   Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933
   Tamayo I, 2010, CLIN VACCINE IMMUNOL, V17, P1356, DOI 10.1128/CVI.00164-10
   Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175
   Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161
   Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005
   Ting JPY, 2010, SCIENCE, V327, P286, DOI 10.1126/science.1184004
   Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616
   Vajdy M, 2004, IMMUNOL CELL BIOL, V82, P617, DOI 10.1111/j.1440-1711.2004.01288.x
   van der Lubben IM, 2001, EUR J PHARM SCI, V14, P201, DOI 10.1016/S0928-0987(01)00172-5
   Veronese FM, 1999, FARMACO, V54, P497, DOI 10.1016/S0014-827X(99)00066-X
   Wee S, 1998, ADV DRUG DELIVERY RE, V4, P267, DOI DOI 10.1016/S0169-409X(97)00124-5
   Wischke C, 2009, INT J PHARMACEUT, V365, P61, DOI 10.1016/j.ijpharm.2008.08.039
   Xiang SD, 2006, METHODS, V40, P1, DOI 10.1016/j.ymeth.2006.05.016
   Yuki Y, 2009, EXPERT REV VACCINES, V8, P1083, DOI [10.1586/erv.09.61, 10.1586/ERV.09.61]
   Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335
   Zaman Mehfuz, 2010, Current Drug Delivery, V7, P118
   Zwiorek K, 2008, PHARM RES-DORDR, V25, P551, DOI 10.1007/s11095-007-9410-5
NR 137
TC 63
Z9 65
U1 0
U2 38
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD JUN
PY 2011
VL 29
IS 6
BP 294
EP 306
DI 10.1016/j.tibtech.2011.02.004
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 775YK
UT WOS:000291499200006
PM 21459467
DA 2018-10-20
ER

PT J
AU Lu, Q
   Huang, YL
   Li, MZ
   Zuo, BQ
   Lu, SZ
   Wang, JN
   Zhu, HS
   Kaplan, DL
AF Lu, Qiang
   Huang, Yongli
   Li, Mingzhong
   Zuo, Baoqi
   Lu, Shenzhou
   Wang, Jiannan
   Zhu, Hesun
   Kaplan, David L.
TI Silk fibroin electrogelation mechanisms
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Silk fibroin; Electrogelation; Nanoparticle; Microspheres; Drug delivery
ID SCAFFOLDS; FILMS; BIOMATERIAL; ENCAPSULATION; SPECTROSCOPY; HYDROGELS;
   PROTEINS
AB A silk fibroin gel system (e-gel), formed with weak electric fields, has potential utility in medical materials and devices. The mechanism of silk e-gel formation was studied to gain additional insight into the process and control of the material properties. Silk fibroin nanoparticles with sizes of tens of nanometers, composed of metastable conformations, were involved in e-gel formation. Under electric fields the nanoparticles rapidly assembled into larger nano- or microspheres with size range from tens of nanometers to several microns. Repulsive forces from the negative surface charge of the acidic groups on the protein were screened by the local decrease in solution pH in the vicinity of the positive electrode. By controlling the formation and content of silk fibroin nanoparticles e-gels could be formed even from low concentration silk fibroin solutions (1%). When e-gel formation was reversed to the solution state the aggregated nano- and microspheres dispersed into solution, a significant observation related to future applications for this process, such as drug delivery. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Lu, Qiang; Huang, Yongli; Li, Mingzhong; Zuo, Baoqi; Lu, Shenzhou; Wang, Jiannan] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Lu, Qiang] Soochow Univ, Jiangsu Prov Key Lab Stem Cell Res, Suzhou 215006, Peoples R China.
   [Lu, Qiang; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, Q (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM luqiang78@suda.edu.cn
RI Zhou, Qinghui/C-8436-2011; Lu, Shenzhou/P-6519-2015
OI Lu, Shenzhou/0000-0003-4188-2057
FU AFOSR; NSF; National Natural Science Foundation of China [30970714]
FX We thank the AFOSR, the NSF and National Natural Science Foundation of
   China (30970714) for support of this work.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Amsden JJ, 2010, ADV MATER, V22, P1746, DOI 10.1002/adma.200903166
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Lu QA, 2011, BIOMATERIALS, V32, P1059, DOI 10.1016/j.biomaterials.2010.09.072
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Martel A, 2008, J AM CHEM SOC, V130, P17070, DOI 10.1021/ja806654t
   Murphy AR, 2008, BIOMATERIALS, V29, P2829, DOI 10.1016/j.biomaterials.2008.03.039
   Rammensee S, 2008, P NATL ACAD SCI USA, V105, P6590, DOI 10.1073/pnas.0709246105
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
NR 24
TC 57
Z9 63
U1 11
U2 95
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2394
EP 2400
DI 10.1016/j.actbio.2011.02.032
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800004
PM 21345387
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Seidlits, SK
   Drinnan, CT
   Petersen, RR
   Shear, JB
   Suggs, LJ
   Schmidt, CE
AF Seidlits, Stephanie K.
   Drinnan, Charles T.
   Petersen, Rebecca R.
   Shear, Jason B.
   Suggs, Laura J.
   Schmidt, Christine E.
TI Fibronectin-hyaluronic acid composite hydrogels for three-dimensional
   endothelial cell culture
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Hyaluronic acid; Fibronectin; Endothelial cells; Angiogenesis; Hydrogels
ID IN-VITRO; PLASMA FIBRONECTIN; NEOCARTILAGE FORMATION; SIGNALING
   PATHWAYS; BINDING PROTEINS; RECEPTORS CD44; CANCER CELLS; ANGIOGENESIS;
   RGD; ADHESION
AB Biomaterials that actively promote both wound healing and angiogenesis are of critical importance for many biomedical applications, including tissue engineering. In particular, hyaluronic acid (HA) is an important player that has multiple roles throughout the angiogenic process in the body. Previously, our laboratory has developed photocrosslinkable HA-based scaffolds that promote angiogenesis when implanted in vivo. This paper reports the incorporation of a photocrosslinkable fibronectin (FN) conjugate into three-dimensional (3-D) HA hydrogel networks to enhance endothelial cell adhesion and angiogenesis. The results demonstrate significantly better retention of FN that was photocrosslinked within HA hydrogels compared to FN that was physically adsorbed within HA hydrogels. Increased viability of endothelial cells cultured in 3-D HA hydrogels with photoimmobilized FN, compared to adsorbed FN, was also observed. Endothelial cells were cultured within hydrogels for up to 6 days, a period over which cell proliferation, migration and an angiogenic phenotype were influenced by varying the concentration of incorporated FN. The results demonstrate the potential of these composite hydrogels as biomaterial scaffolds capable of promoting wound healing and angiogenesis. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Seidlits, Stephanie K.; Drinnan, Charles T.; Petersen, Rebecca R.; Suggs, Laura J.; Schmidt, Christine E.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Shear, Jason B.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas Austin, Dept Biomed Engn, 1 Univ Stn,CO800, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
FU NSF [0829166]; Gilson Longenbaugh Foundation; Welch Foundation [F-1331];
   PEO International Fellowship; University of Texas
FX We gratefully acknowledge support from an NSF CBET grant (0829166,
   C.E.S. and J.B.S.), the Gilson Longenbaugh Foundation (C.E.S.), the
   Welch Foundation (Grant F-1331) an NSF IGERT Fellowship (S.K.S.), a PEO
   International Fellowship (S.K.S.), and University of Texas Undergraduate
   Research Fellowships (R.R.P., J.M.H., M.S.). We would also like to thank
   Jillian Heisler, Karli Silverberg and Monica Salmon for their technical
   support. J.B.S. is a Fellow of the Institute for Cellular and Molecular
   Biology.
CR Akeson Wayne H, 2005, Spine J, V5, P180, DOI 10.1016/j.spinee.2004.06.019
   Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206
   Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3
   Cruise GM, 1998, BIOTECHNOL BIOENG, V57, P655, DOI 10.1002/(SICI)1097-0290(19980320)57:6<655::AID-BIT3>3.0.CO;2-K
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Day AJ, 2002, J BIOL CHEM, V277, P4585, DOI 10.1074/jbc.R100036200
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   Eliceiri BP, 1999, J CLIN INVEST, V103, P1227, DOI 10.1172/JCI6869
   Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B
   Farran AJE, 2010, TISSUE ENG PT A, V16, P1247, DOI 10.1089/ten.tea.2009.0344
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Gupta RK, 1997, VACCINE, V15, P672, DOI 10.1016/S0264-410X(96)00233-2
   Gurski LA, 2009, BIOMATERIALS, V30, P6076, DOI 10.1016/j.biomaterials.2009.07.054
   Hamilton SR, 2007, J BIOL CHEM, V282, P16667, DOI 10.1074/jbc.M702078200
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Hermanson G. T., 1996, BIOCONJUGATE TECHNIQ
   Hoffmann C, 2008, ANAL BIOCHEM, V372, P62, DOI 10.1016/j.ab.2007.07.027
   HYNES R, 1985, ANNU REV CELL BIOL, V1, P67, DOI 10.1146/annurev.cellbio.1.1.67
   IBRAHIM S, 2010, ACTA BIOMATERIALIA
   Ibrahim S, 2007, BIOMATERIALS, V28, P825, DOI 10.1016/j.biomaterials.2006.09.030
   Jansen K, 2004, BIOMATERIALS, V25, P483, DOI 10.1016/s0142-9612(03)00544-1
   Khademhosseini A, 2004, BIOMATERIALS, V25, P3583, DOI 10.1016/j.biomaterials.2003.10.033
   KNUDSON CB, 1993, FASEB J, V7, P1233
   Laurens N, 2009, ANGIOGENESIS, V12, P275, DOI 10.1007/s10456-009-9150-8
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   LOKESHWAR VB, 2000, J BIOL CHEM, V275, P27642
   Marshall KW, 1998, J RHEUMATOL, V25, P2056
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   NICOSIA RF, 1993, J CELL PHYSIOL, V154, P654, DOI 10.1002/jcp.1041540325
   Ochsenhirt SE, 2006, BIOMATERIALS, V27, P3863, DOI 10.1016/j.biomaterials.2005.12.012
   Pavesio A, 1997, Med Device Technol, V8, P20
   Petrie TA, 2006, BIOMATERIALS, V27, P5459, DOI 10.1016/j.biomaterials.2006.06.027
   Rahmanian M, 2002, INT J CANCER, V97, P601, DOI 10.1002/ijc.10087
   Rahmanian M, 1997, EXP CELL RES, V237, P223, DOI 10.1006/excr.1997.3792
   RUEGG C, 2003, ANGIOGENESIS, V6, P333
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   SAIK J, 2010, ACTA BIOMATERIALIA
   Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200
   Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125
   Serini G, 2006, EXP CELL RES, V312, P651, DOI 10.1016/j.yexcr.2005.10.020
   SKORSTENGAARD K, 1986, EUR J BIOCHEM, V161, P441, DOI 10.1111/j.1432-1033.1986.tb10464.x
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261
   Starcher B, 2001, ANAL BIOCHEM, V292, P125, DOI 10.1006/abio.2001.5050
   Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629
   WEST DC, 1989, EXP CELL RES, V183, P179, DOI 10.1016/0014-4827(89)90428-X
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   YAMADA KM, 1978, NATURE, V275, P179, DOI 10.1038/275179a0
   YAMADA KM, 1980, J BIOL CHEM, V255, P6055
   Zawko SA, 2010, LAB CHIP, V10, P379, DOI 10.1039/b917493a
NR 66
TC 40
Z9 41
U1 2
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2401
EP 2409
DI 10.1016/j.actbio.2011.03.024
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800005
PM 21439409
DA 2018-10-20
ER

PT J
AU Akpalo, E
   Bidault, L
   Boissiere, M
   Vancaeyzeele, C
   Fichet, O
   Larreta-Garde, V
AF Akpalo, E.
   Bidault, L.
   Boissiere, M.
   Vancaeyzeele, C.
   Fichet, O.
   Larreta-Garde, V.
TI Fibrin-polyethylene oxide interpenetrating polymer networks: New
   self-supported biomaterials combining the properties of both protein gel
   and synthetic polymer
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Interpenetrating polymer network; Fibrin; Polyethylene Oxide; Biogel;
   Biomaterial
ID HYDROGELS; CLOT; ELASTICITY; DELIVERY; PEPTIDE; MATRIX; PRO
AB Interpenetrating polymer network (IPN) architectures were conceived to improve the mechanical properties of a fibrin gel. Conditions allowing an enzymatic reaction to create one of the two networks in IPN architecture were included in the synthesis pathway. Two IPN series were carried out, starting from two polyethylene oxide (PEO) network precursors leading to different cross-linking densities of the PEO phase. The fibrin concentration varied from 5 to 20 wt.% in each series. The behavior of these materials during dehydration/hydration cycles was also studied. The mechanical properties of the resulting IPN were characterized in the wet and dry states. These self-supported biomaterials combine the properties of both a protein gel and a synthetic polymer. Finally, cells were grown on PEO/fibrin IPN, indicating that they are non-cytotoxic. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Akpalo, E.; Bidault, L.; Vancaeyzeele, C.; Fichet, O.] Cergy Pontoise Univ, Inst Mat, Lab Physicochim Polymeres & Interfaces LPPI, F-95000 Cergy Pontoise, France.
   [Akpalo, E.; Bidault, L.; Boissiere, M.; Larreta-Garde, V.] Cergy Pontoise Univ, Inst Mat, Equipe Rech Relat Matrice Extracellulaire Cellule, F-95000 Cergy Pontoise, France.
RP Fichet, O (reprint author), Cergy Pontoise Univ, Inst Mat, Lab Physicochim Polymeres & Interfaces LPPI, F-95000 Cergy Pontoise, France.
EM odile.fichet@u-cergy.fr
RI larreta garde, veronique/E-9356-2013; boissiere, michel/A-4598-2011
OI larreta garde, veronique/0000-0003-3500-1364; vancaeyzeele,
   cedric/0000-0002-9748-1562
FU Direction Generale de l'Armement (DGA) of France
FX This work is sponsored by the Direction Generale de l'Armement (DGA) of
   France. The authors thank more particularly Dr Philippe Masclet,
   responsible for "Materials and Chemistry" at DS MRIS.
CR Akpalo E, 2010, ACTA BIOMATER, V6, P396, DOI 10.1016/j.actbio.2009.08.001
   Alston SM, 2007, TRANSL RES, V149, P187, DOI 10.1016/j.trsl.2006.08.004
   Ariens RAS, 2002, BLOOD, V100, P743, DOI 10.1182/blood.V100.3.743
   Bao L, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044108
   Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029
   Collet JP, 2005, P NATL ACAD SCI USA, V102, P9133, DOI 10.1073/pnas.0504120102
   DEVANAND K, 1990, NATURE, V343, P739, DOI 10.1038/343739a0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   GOSAL SW, 2000, J COLLOID INTERF SCI, V5, P188
   HARRIS J, 1992, PROCEEDINGS OF THE SIXTH NORTH AMERICAN CRANE WORKSHOP, P1
   Ho W, 2006, TISSUE ENG, V12, P1587, DOI 10.1089/ten.2006.12.1587
   Krsko P, 2005, MATER TODAY, V8, P36, DOI 10.1016/S1369-7021(05)71223-2
   Larreta-Garde V., 2010, [No title captured], Patent No. [WO/2010/058132, 2010058132]
   Losi P, 2010, BIOMATERIALS, V31, P5336, DOI 10.1016/j.biomaterials.2010.03.033
   Mosesson MW, 2000, FIBRINOLYSIS PROTEOL, V14, P182, DOI 10.1054/fipr.2000.0054
   Nishinari K, 2003, CURR OPIN COLLOID IN, V8, P396, DOI 10.1016/S1359-0294(03)00099-2
   OKADA M, 1985, J BIOL CHEM, V260, P1811
   Oss-Ronen L, 2011, ACTA BIOMATER, V7, P163, DOI 10.1016/j.actbio.2010.07.017
   PETERSEN G, 1993, SOLID STATE IONICS, V60, P55, DOI 10.1016/0167-2738(93)90274-7
   Pratt KP, 1997, P NATL ACAD SCI USA, V94, P7176, DOI 10.1073/pnas.94.14.7176
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Rokhade AP, 2006, CARBOHYD POLYM, V65, P243, DOI 10.1016/j.carbpol.2006.01.013
   Rowe SL, 2007, ACTA BIOMATER, V3, P59, DOI 10.1016/j.actbio.2006.08.006
   Rowe SL, 2006, BIOMACROMOLECULES, V7, P2942, DOI 10.1021/bm0602233
   Shah JV, 1997, RHEOL ACTA, V36, P262, DOI 10.1007/BF00366667
   Shikanov A, 2009, BIOMATERIALS, V30, P5476, DOI 10.1016/j.biomaterials.2009.06.054
   SIEBENLIST KR, 2006, ANN NY ACAD SCI, V936, P11
   Sobel JH, 1996, J BIOL CHEM, V271, P19288, DOI 10.1074/jbc.271.32.19288
   Soldani G, 2010, BIOMATERIALS, V31, P2592, DOI 10.1016/j.biomaterials.2009.12.017
   Sperling LH, 1997, INTERFACIAL ASPECTS OF MULTICOMPONENT POLYMER MATERIALS, P1
   SPERLING LH, 1994, ADV CHEM SER, V239, P3
   Tasaki K, 1996, J AM CHEM SOC, V118, P8459, DOI 10.1021/ja951005c
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Zhao HG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/1/015001
NR 36
TC 18
Z9 19
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2418
EP 2427
DI 10.1016/j.actbio.2011.03.002
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800007
PM 21382527
DA 2018-10-20
ER

PT J
AU Kador, KE
   Mamedov, TG
   Schneider, M
   Subramanian, A
AF Kador, K. E.
   Mamedov, T. G.
   Schneider, M.
   Subramanian, A.
TI Sequential co-immobilization of thrombomodulin and endothelial protein C
   receptor on polyurethane: Activation of protein C
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Thrombomodulin; EPCR; Protein-C; Immobilization; Thromboelastograph
ID FLOW MODEL; SURFACE; BLOOD; COAGULATION; HEPARIN; COMPLEMENT; SUBSTRATE;
   PLASMA; IMMOBILIZATION; IDENTIFICATION
AB In an effort to control the surface-mediated activation of thrombin and clot formation, proteins and molecules which mimic the anticoagulant properties of the vascular endothelial lining were immobilized on material surfaces. When immobilized on biomaterial surfaces, thrombomodulin (TM), an endothelial glycoprotein that binds thrombin and activates protein C (PC), was shown to generate activated PC (APC) and delay clot formation. However, TM-mediated activation of PC on biomaterial surfaces was shown to be limited by the transport of PC to the surface, with maximum activation obtained at a surface density of similar to 40 fmole TM cm(-2). This work investigates surface immobilized with TM and endothelial protein C receptor (EPCR), a natural cofactor to TM which increases the rate of activation of PC on the native endothelium. A sequential and ordered immobilization of TM and EPCR on polyurethane at an enzymatically relevant distance (<10 nm) resulted in higher amounts of APC compared with surfaces with immobilized TM or with TM and EPCR immobilized randomly and at TM surface densities (1400 fmole cm(-2)) which were previously shown to be transport limited. Ordered TM and EPCR samples also showed increased time to clot formation in experiments with platelet-poor plasma, as measured by thromboelastography. Surfaces immobilized with TM and its natural cofactor EPCR at an enzymatically relevant distance are able to overcome transport limitations, increasing anticoagulant activation and time to clot formation. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Kador, K. E.; Mamedov, T. G.; Schneider, M.; Subramanian, A.] Univ Nebraska, Dept Chem & Biomol Engn, Lincoln, NE 68588 USA.
RP Subramanian, A (reprint author), Univ Nebraska, Dept Chem & Biomol Engn, 207 Othmer Hall, Lincoln, NE 68588 USA.
EM asubramanian2@unl.edu
RI Mammedov, Tarlan/J-3853-2013
FU University of Nebraska
FX This work was supported by the University of Nebraska-Lincoln Tobacco
   Settlement Fund.
CR Castilho LR, 2002, J MEMBRANE SCI, V207, P253, DOI 10.1016/S0376-7388(02)00257-0
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Dahlback B, 2005, FEBS LETT, V579, P3310, DOI 10.1016/j.febslet.2005.03.001
   Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82
   Esmon CT, 2004, CRIT CARE MED, V32, pS298, DOI 10.1097/01.CCM.0000126128.68614.81
   ESMON NL, 1983, J BIOL CHEM, V258, P5548
   Feng J, 2002, LANGMUIR, V18, P9907, DOI 10.1021/la025931y
   Fu ZF, 2006, ANAL CHEM, V78, P6999, DOI 10.1021/ac0610560
   Fukudome K, 1998, J EXP MED, V187, P1029, DOI 10.1084/jem.187.7.1029
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Han HS, 2001, J BIOMAT SCI-POLYM E, V12, P1075, DOI 10.1163/15685620152691869
   Ishihara K, 1998, J BIOMATER APPL, V13, P111, DOI 10.1177/088532829801300203
   KADOR KE, 2010, SYNTHESIS ENDOTHELIA
   Kim AY, 2002, CIRC RES, V90, P205, DOI 10.1161/hh0202.105097
   KISHIDA A, 1994, BIOMATERIALS, V15, P848, DOI 10.1016/0142-9612(94)90041-8
   Kurosawa S, 1997, J CLIN INVEST, V100, P411, DOI 10.1172/JCI119548
   Li JM, 2002, J SURG RES, V105, P200, DOI 10.1006/jsre.2002.6381
   Liaw PCY, 2000, J BIOL CHEM, V275, P5447, DOI 10.1074/jbc.275.8.5447
   Liaw PCY, 2001, J BIOL CHEM, V276, P8364, DOI 10.1074/jbc.M010572200
   Mamedov TG, 2007, J BIOTECHNOL, V131, P379, DOI 10.1016/j.jbiotec.2007.08.010
   MAMEDOV TG, APPL BIOCH BIO UNPUB
   MASON RG, 1973, AM J PATHOL, V73, P183
   MULVIHILL JN, 1990, J BIOMED MATER RES, V24, P155, DOI 10.1002/jbm.820240203
   Nojiri C, 1988, ASAIO Trans, V34, P386
   Oshita K, 1999, ANESTH ANALG, V89, P296, DOI 10.1097/00000539-199908000-00006
   PEMAWANSA KPW, 1990, BIOTECHNIQUES, V9, P352
   Perez-Casal M, 2005, BLOOD, V105, P1515, DOI 10.1182/blood-2004-05-1896
   Preston RJS, 2005, FEBS J, V272, P97, DOI 10.1111/j.1432-1033.2004.04401.x
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   Regan LM, 1996, J BIOL CHEM, V271, P17499, DOI 10.1074/jbc.271.29.17499
   Sperling C, 2004, BIOMATERIALS, V25, P5101, DOI 10.1016/j.biomaterials.2003.12.014
   StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212
   Subramanian A, 1996, J MOL RECOGNIT, V9, P528, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<528::AID-JMR296>3.0.CO;2-Q
   Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685
   Tseng PY, 2006, BIOMATERIALS, V27, P2768, DOI 10.1016/j.biomaterials.2005.11.032
   Tseng PY, 2006, BIOMATERIALS, V27, P2637, DOI 10.1016/j.biomaterials.2005.10.025
   Villoutreix BO, 1999, PROTEIN ENG, V12, P833, DOI 10.1093/protein/12.10.833
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Weber N, 2000, J BIOMATER APPL, V15, P8, DOI 10.1106/DUYU-CEL6-529C-WUL9
   WILSON FJ, 1990, ASAIO T, V36, pM340
   Wu B, 2007, BIOMATERIALS, V28, P4047, DOI 10.1016/j.biomaterials.2007.06.002
   Wu KK, 1996, ANNU REV MED, V47, P315
   Xu J, 1999, J BIOL CHEM, V274, P6704, DOI 10.1074/jbc.274.10.6704
   Ye XF, 1999, BIOCHEM BIOPH RES CO, V259, P671, DOI 10.1006/bbrc.1999.0846
   Yeh HY, 2009, J BIOMAT SCI-POLYM E, V20, P807, DOI 10.1163/156856209X426952
NR 45
TC 6
Z9 6
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2508
EP 2517
DI 10.1016/j.actbio.2011.03.015
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800017
PM 21414427
DA 2018-10-20
ER

PT J
AU Seil, JT
   Webster, TJ
AF Seil, Justin T.
   Webster, Thomas J.
TI Reduced Staphylococcus aureus proliferation and biofilm formation on
   zinc oxide nanoparticle PVC composite surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Antibacterial; Zinc; Polyvinylchloride; Composites; Bacteria
ID VENTILATOR-ASSOCIATED PNEUMONIA; ANTIBACTERIAL ACTIVITY; PARTICLE-SIZE;
   ZNO; SUSPENSIONS; OUTCOMES
AB Conventional particulate zinc oxide (ZnO) is a known antibacterial agent. Studies have shown that reducing the size of ZnO particles to nanoscale dimensions further enhances their antibacterial properties. Polymers, like all biomaterials, run the risk of harboring bacteria which may produce an antibiotic-resistant biofilm. The addition of ZnO nanoparticles to form a polymer composite material may thus reduce undesirable bacteria activity. The purpose of the present in vitro study was to investigate the antibacterial properties of ZnO nanoparticles when incorporated into a traditional polymeric biomaterial. For this purpose, Staphylococcus aureus were seeded at a known cell density onto coverslips coated with a film of polyvinyl chloride (PVC) with varying concentrations of ZnO nanoparticles. Samples were cultured for 24 or 72 h. Methods of analysis, including optical density readings and crystal violet staining, indicated a reduced presence of a biofilm on ZnO nanoparticle polymer composites compared to pure polymer controls. Live/dead bacteria assays provided images to confirm the reduced presence of active bacteria on samples with zinc oxide nanoparticles. Conditioning of the cell culture medium by the composites was also investigated by measuring concentrations of elemental zinc (Zn2+) and bacteria growth in the presence of conditioned medium. This study demonstrated that the development of ZnO polymer composites may improve biomaterial effectiveness for numerous applications, such as endotracheal tubes, catheterp and implanted biomaterials, which are prone to bacterial infection. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Seil, Justin T.; Webster, Thomas J.] Brown Univ, Sch Engn, Nanomed Labs, Providence, RI 02912 USA.
RP Webster, TJ (reprint author), Brown Univ, Sch Engn, Nanomed Labs, Providence, RI 02912 USA.
EM thomas_webster@brown.edu
FU National Science Foundation; Hermann Foundation
FX The authors thank the National Science Foundation for fellowship support
   (Brown University GK-12) and the Hermann Foundation for funding.
CR Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/rccm.2105078
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Dodd AC, 2006, J NANOPART RES, V8, P43, DOI 10.1007/s11051-005-5131-z
   Fagon JY, 1996, CLIN INFECT DIS, V23, P538, DOI 10.1093/clinids/23.3.538
   Ghule K, 2006, GREEN CHEM, V8, P1034, DOI 10.1039/b605623g
   Ibrahim EH, 2001, CHEST, V120, P555, DOI 10.1378/chest.120.2.555
   Jones N, 2008, FEMS MICROBIOL LETT, V279, P71, DOI 10.1111/j.1574-6968.2007.01012.x
   MCCARTHY TJ, 1992, J CLIN PHARM THER, V17, P51, DOI 10.1111/j.1365-2710.1992.tb01265.x
   Nair S, 2009, J MATER SCI-MATER M, V20, P235, DOI 10.1007/s10856-008-3548-5
   Padmavathy N, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/035004
   Phan TN, 2004, ORAL MICROBIOL IMMUN, V19, P31, DOI 10.1046/j.0902-0055.2003.00109.x
   Reddy KM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2742324
   Rello J, 2002, CHEST, V122, P2115, DOI 10.1378/chest.122.6.2115
   Sawai J, 1996, J CHEM ENG JPN, V29, P627, DOI 10.1252/jcej.29.627
   Seil JT, 2008, INT J NANOMED, V3, P523
   SODERBERG TA, 1990, SCAND J PLAST RECONS, V24, P193
   Teterycz D, 2010, INT J INFECT DIS, V14, pE913, DOI 10.1016/j.ijid.2010.05.014
   Yamamoto O, 2001, INT J INORG MATER, V3, P643, DOI 10.1016/S1466-6049(01)00197-0
   Zeelie JJ, 1998, ANALYST, V123, P503, DOI 10.1039/a704895e
   Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1
NR 20
TC 65
Z9 67
U1 4
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2579
EP 2584
DI 10.1016/j.actbio.2011.03.018
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800024
PM 21421087
DA 2018-10-20
ER

PT J
AU Smith, BS
   Yoriya, S
   Johnson, T
   Popat, KC
AF Smith, Barbara S.
   Yoriya, Sorachon
   Johnson, Thomas
   Popat, Ketul C.
TI Dermal fibroblast and epidermal keratinocyte functionality on titania
   nanotube arrays
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Transcutaneous implants; Titania nanotube arrays; Human dermal
   fibroblasts; Human epidermal keratinocytes; Cell differentiation
ID NANOPOROUS ALUMINA MEMBRANES; IN-VITRO; WOUND REPAIR; BIOMEDICAL
   APPLICATIONS; TISSUE REGENERATION; SURFACE-TOPOGRAPHY; TIO2 NANOTUBES;
   STEM-CELLS; IMPLANTS; SKIN
AB Transcutaneous implants that penetrate through the depth of the skin are used in numerous clinical applications, including prosthetics and dental implants. Favorable interactions between the implant surface and the respective skin layers are critical for the long-term success of transcutaneous implantable devices, hence, it is essential to understand the physiologic response elicited by skin-biomaterial interactions. Recent studies have shown that material surfaces that provide topographic cues at the nanoscale level may provide one possible solution to enhanced biomaterial integration, thus preventing biomaterial rejection. In this study titania nanotube arrays were fabricated using a simple anodization technique as potential interfaces for transcutaneous implantable devices. The in vitro functionality of human dermal fibroblasts and epidermal keratinocytes were evaluated on these nanotube arrays (diameter 70-90 nm, length 1-1.5 mu m). Cellular functionality in terms of adhesion, proliferation, orientation, viability, cytoskeletal organization, differentiation and morphology were investigated for up to 4 days in culture using fluorescence microscope imaging, a cell viability assay, indirect immunofluorescence and scanning electron microscopy. The results reported in this study indicate increased dermal fibroblast and decreased epidermal keratinocyte adhesion, proliferation and differentiation on titania nanotube arrays. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Smith, Barbara S.; Popat, Ketul C.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
   [Johnson, Thomas] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.
   [Popat, Ketul C.] Colorado State Univ, Dept Mech Engn, Ft Collins, CO 80523 USA.
   [Yoriya, Sorachon] Natl Met & Mat Technol Ctr, Div Ceram Technol, Ceram Proc Res Unit, Pathum Thani 12120, Thailand.
RP Popat, KC (reprint author), Colorado State Univ, Sch Biomed Engn, Campus Delivery 1374, Ft Collins, CO 80523 USA.
EM ketul.popat@colostate.edu
RI Yoriya, Sorachon/H-5823-2011
OI Popat, Ketul C./0000-0002-2417-7789
FU National Science Foundation [CBET 0827827]; Colorado Office of Economic
   Development and International Trade
FX Funding support for this work was provided by the National Science
   Foundation (CBET 0827827) and the Colorado Office of Economic
   Development and International Trade. The authors would like to thank
   Benjamin Bird at Colorado State University for his assistance with the
   statistical analysis; and Dr. Craig A. Grimes at The Pennsylvania State
   University for his assistance with the fabrication of the titania
   nanotube arrays.
CR Ainslie KM, 2009, J BIOMED MATER RES A, V91A, P647, DOI 10.1002/jbm.a.32262
   Bauer S, 2006, ELECTROCHEM COMMUN, V8, P1321, DOI 10.1016/j.elecom.2006.05.030
   Bauer S, 2009, INTEGR BIOL-UK, V1, P525, DOI 10.1039/b908196h
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Brammer KS, 2009, ACTA BIOMATER, V5, P3215, DOI 10.1016/j.actbio.2009.05.008
   Brunetti V, 2010, P NATL ACAD SCI USA, V107, P6264, DOI 10.1073/pnas.0914456107
   Byren I, 2009, EXPERT OPIN PHARMACO, V10, P3033, DOI 10.1517/14656560903397398
   Caceres D, 2008, ACTA BIOMATER, V4, P1545, DOI 10.1016/j.actbio.2008.04.009
   Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK RAF, 1993, DERMATOL CLIN, V11, P647, DOI 10.1016/S0733-8635(18)30218-3
   CLARK RAF, 1991, J CELL BIOCHEM, V46, P1, DOI 10.1002/jcb.240460102
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.3.CO;2-G
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X
   Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512
   Heo SJ, 1998, J LARYNGOL OTOL, V112, P537
   Howling GI, 2001, BIOMATERIALS, V22, P2959, DOI 10.1016/S0142-9612(01)00042-4
   Jokstad A, 2004, INT J PROSTHODONT, V17, P607
   Kang NV, 2010, J HAND SURG-AM, V35A, P1130, DOI 10.1016/j.jhsa.2010.03.037
   Karlsson M, 2003, BIOMATERIALS, V24, P3039, DOI 10.1016/S0142-9612(03)00146-7
   KHANG D, 2006, SELECTIVE ADHESION M, P65
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Li S, 2007, BIOCHEM SOC T, V35, P683, DOI 10.1042/BST0350683
   Liu XY, 2010, BIOMATERIALS, V31, P3063, DOI 10.1016/j.biomaterials.2009.12.054
   Liu XL, 2010, CHEMMEDCHEM, V5, P468, DOI 10.1002/cmdc.200900502
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Marionnet C, 2006, J INVEST DERMATOL, V126, P971, DOI 10.1038/sj.jid.5700230
   Messinger SD, 2009, DISABIL REHABIL, V31, P2130, DOI 10.3109/09638280902943223
   Mooney V, 1971, J BIOMED MATER RES, V5, P143
   Mor GK, 2006, SOL ENERG MAT SOL C, V90, P2011, DOI 10.1016/j.solmat.2006.04.007
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Niinomi M, 2008, J MECH BEHAV BIOMED, V1, P30, DOI 10.1016/j.jmbbm.2007.07.001
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Peng L, 2009, NANO LETT, V10, P143, DOI 10.1021/nl903043z
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Popat KC, 2007, BIOMATERIALS, V28, P3188, DOI 10.1016/j.biomaterials.2007.03.020
   Porter JR, 2009, TISSUE ENG PT A, V15, P2547, DOI 10.1089/ten.tea.2008.0476
   Porter JR, 2009, BIOTECHNOL PROGR, V25, P1539, DOI 10.1002/btpr.246
   Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022
   PRINCE RL, 1988, J BONE MINER RES, V3, P305, DOI 10.1002/jbmr.5650030309
   Puckett SD, 2010, ACTA BIOMATER, V6, P2352, DOI 10.1016/j.actbio.2009.12.016
   Riehle M. O., 2005, NANOBIOTECHNOLOGY, V1, P308
   Robert RS, 2010, PEDIATR BLOOD CANCER, V54, P990, DOI 10.1002/pbc.22419
   Ruan CM, 2005, J PHYS CHEM B, V109, P15754, DOI 10.1021/jp052736u
   Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006
   SCHMUKI AGP, 2009, CHEM COMMUN, V20, P2791
   Simpson DG, 2006, EXPERT REV MED DEVIC, V3, P471, DOI 10.1586/17434440.3.4.471
   Smith BS, 2010, J BIOMED MATER RES A, V95A, P350, DOI 10.1002/jbm.a.32853
   Smith CM, 2010, TISSUE ENG PT A, V16, P717, DOI [10.1089/ten.tea.2009.0066, 10.1089/ten.TEA.2009.0066]
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Swan EEL, 2005, J BIOMED MATER RES A, V72A, P288, DOI 10.1002/jbm.a.30223
   Tillander J, 2010, CLIN ORTHOP RELAT R, V468, P2781, DOI 10.1007/s11999-010-1370-0
   Uustal H, 2009, PHYS MED REH CLIN N, V20, P689, DOI 10.1016/j.pmr.2009.06.014
   van Dorp AGM, 1999, J BIOMED MATER RES, V47, P292, DOI 10.1002/(SICI)1097-4636(19991205)47:3<292::AID-JBM2>3.0.CO;2-B
   VANNOORT R, 1987, J MATER SCI, V22, P3801, DOI 10.1007/BF01133326
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang R R, 1996, Quintessence Int, V27, P401
   Werner S, 2009, BIOMATERIALS, V30, P2291, DOI 10.1016/j.biomaterials.2009.01.004
   WINTER GD, 1974, J BIOMED MATER RES, V8, P99, DOI 10.1002/jbm.820080311
   Yoriya S, 2009, LANGMUIR, V26, P417
   Zhang LJ, 2008, TISSUE ENG PT A, V14, P1353, DOI 10.1089/ten.tea.2006.0436
   Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014
   Zhao LZ, 2010, BIOMATERIALS, V31, P2055, DOI 10.1016/j.biomaterials.2009.11.103
NR 81
TC 41
Z9 41
U1 1
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2686
EP 2696
DI 10.1016/j.actbio.2011.03.014
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800037
PM 21414425
DA 2018-10-20
ER

PT J
AU Willumeit, R
   Fischer, J
   Feyerabend, F
   Hort, N
   Bismayer, U
   Heidrich, S
   Mihailova, B
AF Willumeit, Regine
   Fischer, Janine
   Feyerabend, Frank
   Hort, Norbert
   Bismayer, Ulrich
   Heidrich, Stefanie
   Mihailova, Boriana
TI Chemical surface alteration of biodegradable magnesium exposed to
   corrosion media
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Magnesium; Physiological corrosion; Chemical element mapping; IR
   reflection microspectroscopy; Corrosion layer
ID HUMAN SERUM-ALBUMIN; IN-VIVO CORROSION; BONE IMPLANT APPLICATION;
   CALCIUM-ION BINDING; RARE-EARTH; VITRO CORROSION; LIGAND-BINDING; ZN
   ALLOY; DEGRADATION; PH
AB The understanding of corrosion processes of metal implants in the human body is a key problem in modern biomaterial science. Because of the complicated and adjustable in vivo environment, in vitro experiments require the analysis of various physiological corrosion media to elucidate the underlying mechanism of "biological" metal surface modification. In this paper magnesium samples were incubated under cell culture conditions (i.e. including CO2) in electrolyte solutions and cell growth media, with and without proteins. Chemical mapping by high-resolution electron-induced X-ray emission spectroscopy and infrared reflection microspectroscopy revealed a complex structure of the formed corrosion layer. The presence of CO2 in concentrations close to that in blood is significant for the chemistry of the oxidised layer. The presence of proteins leads to a less dense but thicker passivation layer which is still ion and water permeable, as osmolality and weight measurements indicate. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Willumeit, Regine; Fischer, Janine; Feyerabend, Frank; Hort, Norbert] Helmholtz Zentrum Geesthacht, Inst Mat Res, D-21502 Geesthacht, Germany.
   [Bismayer, Ulrich; Heidrich, Stefanie; Mihailova, Boriana] Univ Hamburg, Dept Earth Sci, D-20146 Hamburg, Germany.
RP Willumeit, R (reprint author), Helmholtz Zentrum Geesthacht, Inst Mat Res, Max Planck Str 1, D-21502 Geesthacht, Germany.
EM regine.willumeit@hzg.de
RI Willumeit, Regine/I-8029-2013; Hort, Norbert/G-1913-2011; Feyerabend,
   Frank/A-1124-2010
OI Willumeit, Regine/0000-0002-6004-6946; Hort,
   Norbert/0000-0002-6636-1568; Feyerabend, Frank/0000-0001-9532-0207
CR ALMEIDA RM, 1992, PHYS REV B, V45, P161, DOI 10.1103/PhysRevB.45.161
   Beardmore J, 2009, J INORG BIOCHEM, V103, P205, DOI 10.1016/j.jinorgbio.2008.10.003
   Braterman PS, 2006, AM MINERAL, V91, P1188, DOI 10.2138/am.2006.2094
   COPELAND BE, 1952, J BIOL CHEM, V197, P331
   Drynda A, 2009, J BIOMED MATER RES A, V91A, P360, DOI 10.1002/jbm.a.32235
   Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8
   Feyerabend F, 2006, TISSUE ENG, V12, P3545, DOI 10.1089/ten.2006.12.3545
   Feyerabend F, 2010, ACTA BIOMATER, V6, P1834, DOI 10.1016/j.actbio.2009.09.024
   Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020
   FOGHANDERSEN N, 1977, CLIN CHEM, V23, P2122
   FRYE RM, 1974, CLIN BIOCHEM, V7, P258, DOI 10.1016/S0009-9120(74)92262-0
   Gu XN, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/6/065011
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guillaume YC, 2000, TALANTA, V53, P561, DOI 10.1016/S0039-9140(00)00536-1
   Guillaume YC, 1999, J CHROMATOGR B, V728, P167, DOI 10.1016/S0378-4347(99)00117-6
   Hort N, 2010, ACTA BIOMATER, V6, P1714, DOI 10.1016/j.actbio.2009.09.010
   HORT N, 2008, POWDER INJECTION MOU, V2, P63
   Huang BX, 2004, J AM SOC MASS SPECTR, V15, P1237, DOI 10.1016/j.jasms.2004.05.004
   Kirkland NT, 2010, CORROS SCI, V52, P287, DOI 10.1016/j.corsci.2009.09.033
   Kosa T, 1997, PHARMACEUT RES, V14, P1607, DOI 10.1023/A:1012138604016
   KRAGHHANSEN U, 1990, DAN MED BULL, V37, P57
   KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17
   KRAGHHANSEN U, 1993, CLIN CHEM, V39, P202
   KRAGHHANSEN U, 1994, BIOCHEM J, V301, P217, DOI 10.1042/bj3010217
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Lindstrom R, 2004, CORROS SCI, V46, P1141, DOI 10.1016/j.corsci.2003.09.010
   Liu CL, 2010, CORROS SCI, V52, P3341, DOI 10.1016/j.corsci.2010.06.003
   Liu CL, 2007, J MATER RES, V22, P1806, DOI 10.1557/JMR.2007.0241
   LOUDON R, 1964, ADV PHYS, V13, P423, DOI 10.1080/00018736400101051
   MERRITT K, 1984, J BIOMED MATER RES, V18, P1005, DOI 10.1002/jbm.820180905
   Michnik A, 2006, J THERM ANAL CALORIM, V84, P113, DOI 10.1007/s10973-005-7170-1
   Mueller WD, 2010, ACTA BIOMATER, V6, P1749, DOI 10.1016/j.actbio.2009.12.048
   MULLER WD, 2008, J BIOMED MATER RES A, V90, P487
   Ormiston JA, 2009, CIRC-CARDIOVASC INTE, V2, P255, DOI 10.1161/CIRCINTERVENTIONS.109.859173
   PEDERSEN KO, 1971, SCAND J CLIN LAB INV, V28, P459, DOI 10.3109/00365517109095724
   PEDERSEN KO, 1972, SCAND J CLIN LAB INV, V29, P427, DOI 10.3109/00365517209080262
   PEDERSEN KO, 1972, SCAND J CLIN LAB INV, V29, P75, DOI 10.3109/00365517209081058
   PEDERSEN KO, 1972, SCAND J CLIN LAB INV, V30, P89, DOI 10.3109/00365517209081096
   Raber L, 2011, CARDIOVASC THER, V29, P176, DOI 10.1111/j.1755-5922.2010.00144.x
   Raimund E, 2007, LANCET, V369, P1869
   Rettig R, 2008, J BIOMED MATER RES A, V85A, P167, DOI 10.1002/jbm.a.31550
   Silbernagl S., 2007, TASCHENATLAS PHYSL
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tie D, 2010, ADV ENG MATER, V12, pB699, DOI 10.1002/adem.201080070
   VANOS GAJ, 1957, RECL TRAV CHIM PAY B, V76, P390
   VORUM H, 1995, CLIN CHEM, V41, P1654
   Waksman Ron, 2006, J Interv Cardiol, V19, P414, DOI 10.1111/j.1540-8183.2006.00187.x
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wolff M, 2010, ADV ENG MATER, V12, P829, DOI 10.1002/adem.201000038
   Xin YC, 2008, ACTA BIOMATER, V4, P2008, DOI 10.1016/j.actbio.2008.05.014
   Xu LP, 2008, J MATER SCI-MATER M, V19, P1017, DOI 10.1007/s10856-007-3219-y
   Xu LP, 2007, J BIOMED MATER RES A, V83A, P703, DOI 10.1002/jbm.a.31273
   Yamamoto A, 2009, MAT SCI ENG C-BIO S, V29, P1559, DOI 10.1016/j.msec.2008.12.015
   Zeng RC, 2008, ADV ENG MATER, V10, pB3, DOI 10.1002/adem.200800035
   Zhang EL, 2009, J BIOMED MATER RES A, V90A, P882, DOI 10.1002/jbm.a.32132
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001
NR 61
TC 102
Z9 103
U1 1
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2704
EP 2715
DI 10.1016/j.actbio.2011.03.004
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800039
PM 21382530
DA 2018-10-20
ER

PT J
AU Tavangar, A
   Tan, B
   Venkatakrishnan, K
AF Tavangar, Amirhossein
   Tan, Bo
   Venkatakrishnan, K.
TI Synthesis of bio-functionalized three-dimensional titania nanofibrous
   structures using femtosecond laser ablation
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Osseointegration; Titania nanofibers; Laser ablation; Surface
   modification; Three-dimensional nanostructure
ID APATITE FORMATION; POROUS TITANIUM; TIO2 NANOTUBES; SURFACE;
   ANODIZATION; IMPLANTS; ARRAYS; OXIDATION
AB The primary objective of current tissue regeneration research is to synthesize nano-based platforms that can induce guided, controlled, and rapid healing. Titanium nanotubes have been extensively considered as a new biomaterial for biosensors, implants, cell growth, tissue engineering, and drug delivery systems. However, due to their one-dimensional structure and chemical inertness, cell adhesion to nanotubes is poor. Therefore, further surface modification is required to enhance nanotube-cell interaction. Although there have been a considerable number of studies on growing titanium nanotubes, synthesizing a three-dimensional (3-D) nano-architecture which can act as a growth support platform for bone and stem cells has not been reported so far. Therefore, we present a novel technique to synthesize and grow 3-D titania interwoven nanofibrous structures on a titanium substrate using femtosecond laser irradiation under ambient conditions. This surface architecture incorporate the functions of 3-D nano-scaled topography and modified chemical properties to improve osseointegration while at the same time leaving space to deliver other functional agents. The results indicate that laser pulse repetition can control the density and pore size of engineered nanofibrous structures. In vitro experiments reveal that the titania nanofibrous architecture possesses excellent bioactivity and can induce rapid, uniform, and controllable bone-like apatite precipitation once immersed in simulated body fluid (SBF). This approach to synthesizing 3-D titania nanofibrous structures suggests considerable promise for the promotion of Ti interfacial properties to develop new functional biomaterials for various biomedical applications. (C) 2011 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Tavangar, Amirhossein; Venkatakrishnan, K.] Ryerson Univ, Dept Mech & Ind Engn, Toronto, ON M5B 2K3, Canada.
   [Tan, Bo] Ryerson Univ, Dept Aerosp Engn, Toronto, ON M5B 2K3, Canada.
RP Venkatakrishnan, K (reprint author), Ryerson Univ, Dept Mech & Ind Engn, 350 Victoria St, Toronto, ON M5B 2K3, Canada.
EM venkat@ryerson.ca
OI Tavangar, Amirhossein/0000-0003-3272-3679; Tan, Bo/0000-0001-8141-4819;
   Venkatakrishnan, Krishnan/0000-0002-6491-3971
FU Natural Science and Engineering Research Council of Canada
FX This research was funded by Natural Science and Engineering Research
   Council of Canada.
CR Chen XB, 2009, ACTA BIOMATER, V5, P2290, DOI 10.1016/j.actbio.2009.02.027
   Choi SW, 2010, LANGMUIR, V26, P12126, DOI 10.1021/la101519b
   Christenson EM, 2007, J ORTHOP RES, V25, P11, DOI 10.1002/jor.20305
   Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028
   Das K, 2008, SCRIPTA MATER, V59, P822, DOI 10.1016/j.scriptamat.2008.06.018
   de Jonge LT, 2008, PHARM RES-DORDR, V25, P2357, DOI 10.1007/s11095-008-9617-0
   Fahim NF, 2009, CHEM MATER, V21, P1967, DOI 10.1021/cm900410x
   Jing LQ, 2006, J PHYS CHEM B, V110, P17860, DOI 10.1021/jp063148z
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Kalantarian A, 2009, LANGMUIR, V25, P14146, DOI 10.1021/la902016j
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Lei Y, 2001, APPL PHYS LETT, V78, P1125, DOI 10.1063/1.1350959
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   Liu SM, 2002, CHEM MATER, V14, P1391, DOI 10.1021/cm0115057
   Mor GK, 2005, ADV FUNCT MATER, V15, P1291, DOI 10.1002/adfm.200500096
   Oyane A, 2003, J BIOMED MATER RES A, V64A, P339, DOI 10.1002/jbm.a.10426
   Paital SR, 2009, ACTA BIOMATER, V5, P2763, DOI 10.1016/j.actbio.2009.03.004
   Palmquist A, 2010, J R SOC INTERFACE, V7, pS515, DOI 10.1098/rsif.2010.0118.focus
   RANI S, 2010, PHYS CHEM CHEM PHYS, V12, P800
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Rohanizadeh R, 2004, J BIOMED MATER RES A, V71A, P343, DOI 10.1002/jbm.a.30171
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   Uchida M, 2003, J BIOMED MATER RES A, V64A, P164, DOI 10.1002/jbm.a.10414
   Variola F, 2008, BIOMATERIALS, V29, P1285, DOI 10.1016/j.biomaterials.2007.11.040
   Vasilev K, 2010, BIOMATERIALS, V31, P532, DOI 10.1016/j.biomaterials.2009.09.074
   Wang CC, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/28/285601
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4
   Yao BD, 2003, APPL PHYS LETT, V82, P281, DOI 10.1063/1.1537518
   Yoriya S, 2008, J MATER CHEM, V18, P3332, DOI 10.1039/b802463d
   Zhang QH, 2000, APPL CATAL B-ENVIRON, V26, P207, DOI 10.1016/S0926-3373(00)00122-3
NR 31
TC 41
Z9 41
U1 1
U2 23
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUN
PY 2011
VL 7
IS 6
BP 2726
EP 2732
DI 10.1016/j.actbio.2011.02.020
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771SU
UT WOS:000291181800041
PM 21354476
DA 2018-10-20
ER

PT J
AU Kon, E
   Delcogliano, M
   Filardo, G
   Busacca, M
   Di Martino, A
   Marcacci, M
AF Kon, Elizaveta
   Delcogliano, Marco
   Filardo, Giuseppe
   Busacca, Maurizio
   Di Martino, Alessandro
   Marcacci, Maurilio
TI Novel Nano-composite Multilayered Biomaterial for Osteochondral
   Regeneration A Pilot Clinical Trial
SO AMERICAN JOURNAL OF SPORTS MEDICINE
LA English
DT Article
DE osteochondral defect; biomimetic scaffold; cartilage regeneration; knee
ID AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE REPAIR;
   SUBCHONDRAL BONE; RANDOMIZED-TRIAL; SHEEP MODEL; DEFECTS; KNEE; TISSUE;
   TRANSPLANTATION; MICROFRACTURE
AB Background: In recent years, there has been an increasing interest in and awareness of the importance of subchondral bone, for its role in the pathogenesis of articular surface damage and for the care that should be taken when treating such damage.
   Purpose: The objective of this pilot clinical study was to test the safety and performance of a newly developed type I collagen-hydroxyapatite nanostructured biomimetic osteochondral scaffold that aims to regenerate cartilage and subchondral bone.
   Study Design: Case series; Level of evidence, 4.
   Methods: A multilayer gradient nano-composite scaffold was obtained by nucleating collagen type I fibrils with hydroxyapatite nanoparticles. Thirty patients (9 female, 21 male; mean age, 29.3 years) with knee chondral or osteochondral lesions were treated with scaffold implantation. Lesion size varied from 1.5 cm(2) to 6.0 cm(2). Twenty-eight patients were followed for 2 years and were clinically evaluated using the International Knee Documentation Committee and Tegner scores. At final follow-up, magnetic resonance imaging evaluation was performed in 24 patients, and they were evaluated with the MOCART (Magnetic Resonance Observation of Cartilage Repair Tissue) score.
   Results: The Tegner and International Knee Documentation Committee objective and subjective scores improved significantly from the baseline evaluation to the 6-, 12-, and 24-month follow-ups. Further analysis showed a slower recovery but the same results for patients who presented with adverse events, for older patients, for patients who underwent previous surgery, and for those with patellar lesions. In contrast, a faster recovery was observed in active patients. At magnetic resonance imaging evaluation, complete filling of the cartilage and complete integration of the graft was shown in 70% of the lesions. However, the subchondral lamina and bone were considered intact in a minority of cases (7% and 47%, respectively).
   Conclusion: This open 1-step procedure was used for the treatment of chondral and osteochondral knee defects. The present pilot study highlighted the safety and potential clinical benefit of the graded biomimetic osteochondral scaffold in promoting bone and cartilage tissue restoration by itself and with good clinical and magnetic resonance imaging results at the 2-year follow-up.
C1 [Kon, Elizaveta] Rizzoli Orthopaed Inst, Biomech Lab Clin 3, I-40136 Bologna, Italy.
RP Kon, E (reprint author), Rizzoli Orthopaed Inst, Biomech Lab Clin 3, Via Di Barbiano 1-10, I-40136 Bologna, Italy.
EM e.kon@biomec.ior.it
OI Filardo, Giuseppe/0000-0002-8136-0977
CR AHUJA SC, 1978, J BONE JOINT SURG AM, V60, P191, DOI 10.2106/00004623-197860020-00009
   Brittberg M, 2008, INJURY, V39, pS40, DOI 10.1016/j.injury.2008.01.040
   Buma P, 2003, BIOMATERIALS, V24, P3255, DOI 10.1016/S0142-9612(03)00143-1
   Della Villa S, 2010, AM J SPORT MED, V38, P68, DOI 10.1177/0363546509348490
   Gobbi A, 2006, AM J SPORT MED, V34, P1763, DOI 10.1177/0363546506288853
   Gobbi A, 2009, AM J SPORT MED, V37, P1083, DOI 10.1177/0363546509331419
   Gomoll AH, 2010, KNEE SURG SPORT TR A, V18, P434, DOI 10.1007/s00167-010-1072-x
   Gratz KR, 2009, J ORTHOP RES, V27, P584, DOI 10.1002/jor.20762
   International Cartilage Repair Society, ICRS CART INJ EV PAC
   Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442
   Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001
   Knutsen G, 2007, J BONE JOINT SURG AM, V89A, P2105, DOI 10.2106/JBJS.G.00003
   Kocher MS, 2006, AM J SPORT MED, V34, P1181, DOI 10.1177/0363546506290127
   Kon E, 2010, J TISSUE ENG REGEN M, V4, P300, DOI 10.1002/term.243
   Kon E, 2010, INJURY, V41, P693, DOI 10.1016/j.injury.2009.11.014
   Kon E, 2010, J ORTHOP RES, V28, P116, DOI 10.1002/jor.20958
   Kon E, 2009, AM J SPORT MED, V37, p156S, DOI 10.1177/0363546509351649
   Kon E, 2008, SPORTS MED ARTHROSC, V16, P221, DOI 10.1097/JSA.0b013e31818cdbc5
   Kramer J, 2006, CELL MOL LIFE SCI, V63, P616, DOI 10.1007/s00018-005-5527-z
   Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007
   Marlovits S, 2004, EUR J RADIOL, V52, P310, DOI 10.1016/j.ejrad.2004.03.014
   Mithoefer K, 2009, AM J SPORT MED, V37, P2053, DOI 10.1177/0363546508328414
   Mithoefer K, 2009, CLIN SPORT MED, V28, P25, DOI 10.1016/j.csm.2008.09.001
   Nagura I, 2007, J BONE JOINT SURG BR, V89B, P258, DOI 10.1302/0301-620X.89B2.17754
   Nehrer S, 1999, CLIN ORTHOP RELAT R, P149
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   Pape D, 2010, KNEE SURG SPORT TR A, V18, P448, DOI 10.1007/s00167-010-1052-1
   Pascual-Garrido C, 2009, AM J SPORT MED, V37, p33S, DOI 10.1177/0363546509349605
   Peterson L, 2002, AM J SPORT MED, V30, P2, DOI 10.1177/03635465020300011601
   Peterson L, 2003, J BONE JOINT SURG AM, V85A, P17, DOI 10.2106/00004623-200300002-00003
   Schagemann JC, 2009, TISSUE ENG PT A, V15, P75, DOI 10.1089/ten.tea.2008.0087
   Schlichting K, 2008, AM J SPORT MED, V36, P2379, DOI 10.1177/0363546508322899
   Schumann Detlef, 2007, V140, P101
   Shirazi R, 2009, J BIOMECH, V42, P2458, DOI 10.1016/j.jbiomech.2009.07.022
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   TEGNER Y, 1985, CLIN ORTHOP RELAT R, P43
   Williams Riley J, 2008, Instr Course Lect, V57, P563
   Wong BL, 2010, OSTEOARTHR CARTILAGE, V18, P464, DOI 10.1016/j.joca.2009.11.008
NR 40
TC 91
Z9 94
U1 1
U2 32
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0363-5465
J9 AM J SPORT MED
JI Am. J. Sports Med.
PD JUN
PY 2011
VL 39
IS 6
BP 1180
EP 1190
DI 10.1177/0363546510392711
PG 11
WC Orthopedics; Sport Sciences
SC Orthopedics; Sport Sciences
GA 772BJ
UT WOS:000291204200015
PM 21310939
DA 2018-10-20
ER

PT J
AU Ratcliffe, A
AF Ratcliffe, Anthony
TI Difficulties in the translation of functionalized biomaterials into
   regenerative medicine clinical products
SO BIOMATERIALS
LA English
DT Article
DE Cell adhesion; Adhesive peptides; RGD; Extracellular matrix; Integrin
   binding
ID BONE MORPHOGENETIC PROTEIN-2; PARTIAL-THICKNESS BURNS; DIABETIC FOOT
   ULCERS; RANDOMIZED-TRIAL; EFFICACY; SAFETY; DIFFERENTIATION; BIOBRANE;
   DEFECTS; CULTURE
AB There are many ways to influence cell activities, and biomaterials with functional groups attached is an attractive method that clearly has the ability to modulate cell behavior. The evidence is clear that biomaterials, with or without growth factors and cells, have resulted in numerous products for the regenerative medicine field. In contrast the functionalized biomaterial products remain in the development phase. (C) 2011 Elsevier Ltd. All rights reserved.
C1 Synthasome Inc, San Diego, CA 92109 USA.
RP Ratcliffe, A (reprint author), Synthasome Inc, San Diego, CA 92109 USA.
EM anthonyratcliffe@synthasome.com
FU NIBIB NIH HHS [R01 EB008605, R01 EB008605-09]
CR Burkus JK, 2002, SPINE, V27, P2396, DOI 10.1097/01.BRS.0000030193.26290.DD
   Donohue KG, 2005, J DERMATOL, V32, P626, DOI 10.1111/j.1346-8138.2005.tb00811.x
   Glass JR, 1996, BIOMATERIALS, V17, P1101, DOI 10.1016/0142-9612(96)85911-4
   Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001
   HANSBROUGH JF, 1984, BURNS, V10, P415, DOI 10.1016/0305-4179(84)90081-0
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Herford AS, 2008, J ORAL MAXIL SURG, V66, P616, DOI 10.1016/j.joms.2007.11.021
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kumar RJ, 2004, ANZ J SURG, V74, P622, DOI 10.1111/j.1445-1433.2004.03106.x
   Mansbridge J, 1998, TISSUE ENG, V4, P403, DOI 10.1089/ten.1998.4.403
   Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701
   Noordenbos J, 1999, J BURN CARE REHABIL, V20, P275, DOI 10.1097/00004630-199907000-00002
   RUHE PR, 2008, TISSUE ENG, P1
   Saito A, 2006, J BIOMED MATER RES A, V77A, P700, DOI 10.1002/jbm.a.30662
   West J, 1997, SYNTHETIC BIODEGRADA, P83
   Whitaker IS, 2008, ANN PLAS SURG, V60, P333, DOI 10.1097/SAP.0b013e31806bf446
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
NR 18
TC 13
Z9 13
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2011
VL 32
IS 18
BP 4215
EP 4217
DI 10.1016/j.biomaterials.2011.02.028
PG 3
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 771OW
UT WOS:000291171600005
PM 21515170
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Montzka, K
   Laufer, T
   Becker, C
   Grosse, J
   Heidenreich, A
AF Montzka, Katrin
   Laeufer, Tanja
   Becker, Christoph
   Grosse, Joachim
   Heidenreich, Axel
TI Microstructure and cytocompatibility of collagen matrices for urological
   tissue engineering
SO BJU INTERNATIONAL
LA English
DT Article
DE cell proliferation; collagen; cytocompatibility; scaffold; urinary tract
ID SMALL-INTESTINAL SUBMUCOSA; SMOOTH-MUSCLE TISSUE; URINARY-TRACT;
   IN-VITRO; BLADDER; SCAFFOLDS; RECONSTRUCTION; UROTHELIUM
AB The gold standard in the reconstruction of the defect urinary system is still the transplantation of autologous gastrointestinal segments although numerous different types of biomaterials (natural/synthetic) have been investigated as possible replacements. However, the ideal biomaterial is still not identified.
   In this study, we were able to identify the engineered collagen-based OptiMaix (R) scaffolds as promising biomaterials for the reconstruction of the urinary tract.
   OBJECTIVES
   To analyse the in vitro cytocompatibility of several engineered collagen-based biomaterials for tissue engineering of the urinary tract.
   Tissue-engineered implants for the reconstruction of the urinary tract are of major interest for urological researchers as well as clinicians. Although several materials have been investigated, the ideal replacement has still to be identified.
   MATERIALS AND METHODS
   Several collagen matrices were tested.
   Electron microscopy was used to visualize the microstructure of the tested matrices.
   Examination of cell attachment and growth of primary porcine urothelial and smooth muscle cells were performed and cell phenotypes were analysed using immunohistochemical stains.
   Urea permeability was investigated using Ussing chamber experiments.
   RESULTS
   The best cytocompatibility for both urinary tract-specific cell types was obtained with OptiMaix (R) (Matricel GmbH, Herzogenrath, Germany) materials.
   Cell-specific phenotypes were maintained during culture as shown by immunohistochemical staining.
   Furthermore, simultaneous cultivation of both cell types for 7 and 14 days significantly reduced urea permeability.
   CONCLUSION
   These results show the potential of OptiMaix materials in tissue engineering approaches of urinary tract tissues.
C1 [Montzka, Katrin; Laeufer, Tanja; Becker, Christoph; Grosse, Joachim; Heidenreich, Axel] Rhein Westfal TH Aachen, Dept Urol, D-52074 Aachen, Germany.
RP Montzka, K (reprint author), Rhein Westfal TH Aachen, Dept Urol, Pauwelsstr 30, D-52074 Aachen, Germany.
EM kmontzka@ukaachen.de
FU German Federal Ministry of Economics and Technology [KF0634101SB8]
FX The authors would like to thank Matricel GmbH for providing the
   different types of scaffolds. Furthermore, the authors thank Manfred
   Bovi for the excellent technical support with the scanning-electron
   micrographs and Sonja Kranz-Vanberg for the urea measurements. This work
   was supported by the German Federal Ministry of Economics and Technology
   (KF0634101SB8).
CR Aboseif S R, 1998, Curr Opin Urol, V8, P229, DOI 10.1097/00042307-199805000-00007
   Baker SC, 2009, BIOMATERIALS, V30, P1321, DOI 10.1016/j.biomaterials.2008.11.033
   Becker C, 2006, INT J ARTIF ORGANS, V29, P764
   Brehmer B, 2007, UROL INT, V78, P23, DOI 10.1159/000096930
   DeFoor WR, 2009, J UROLOGY, V181, P2689, DOI 10.1016/j.juro.2009.02.039
   Eberli D, 2009, METHODS, V47, P109, DOI 10.1016/j.ymeth.2008.10.014
   ENGELHARDT EM, 2009, J TISSUE ENG REGEN M, V4, P123
   Farhat WA, 2008, WORLD J UROL, V26, P301, DOI 10.1007/s00345-008-0318-4
   HEISE RL, 2009, TISSUE ENG PART A, V15, P391
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim BS, 2008, WORLD J UROL, V26, P307, DOI 10.1007/s00345-008-0300-1
   Landman J, 2004, J UROLOGY, V171, P2450, DOI 10.1097/01.ju.0000127756.64619.27
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Tash JA, 2001, J UROLOGY, V166, P2536, DOI 10.1016/S0022-5347(05)65630-3
   Turner AM, 2008, EUR UROL, V54, P1423, DOI 10.1016/j.eururo.2008.03.068
   Wallis MC, 2008, TISSUE ENG PT A, V14, P339, DOI 10.1089/tea.2006.0398
NR 18
TC 6
Z9 8
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD JUN
PY 2011
VL 107
IS 12
BP 1974
EP 1981
DI 10.1111/j.1464-410X.2010.09680.x
PG 8
WC Urology & Nephrology
SC Urology & Nephrology
GA 769UE
UT WOS:000291043000020
PM 20840325
OA Bronze
DA 2018-10-20
ER

PT J
AU Potnis, PA
   Tesfamariam, B
   Wood, SC
AF Potnis, Pushya A.
   Tesfamariam, Belay
   Wood, Steven C.
TI Induction of Nicotinamide-Adenine Dinucleotide Phosphate Oxidase and
   Apoptosis by Biodegradable Polymers in Macrophages: Implications for
   Stents
SO JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
LA English
DT Article
DE drug-eluting stents; biodegradable polymers; biocompatibility; NADPH
   oxidases; oxidative stress; apoptosis; monocyte adhesion
ID NADPH OXIDASE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; IN-VITRO;
   EXPRESSION; IMPLANTATION; BIOMATERIAL; SUPEROXIDE; ACTIVATION;
   MECHANISMS
AB The drug-eluting stent platform has a limited surface area, and a polymer carrier matrix is coated to enable sufficient loading of drugs. The development of a suitable polymer has been challenging because it must exhibit biocompatibility with the intravascular milieu. The use of biodegradable polymers seems to be attractive because it enables drug release as it degrades and is eventually eliminated from the body leaving the permanent metallic stent polymer-free. The aim of this study was to investigate the biocompatibility of biodegradable polymers using the human monocyte cell line. Cultured monocytes differentiated into functional macrophages (THP-1) were incubated with various polymers including poly-L-lactide (PLA), polycaprolactone (PCL), or poly-D, L-lactide-co-glycolide (PLGA) for up to 5 days. Exposure of cells to the polymers resulted in macrophage-polymer adhesion and induced marked pro-oxidant species as measured by calcein AM uptake assay and flow cytometric analysis of 2', 7'-dichlorofluorescin fluorescence, respectively. Real-time reverse-transcription polymerase chain reaction and Western blot analysis of expression of nicotinamide-adenine dinucleotide phosphate (NADPH) oxidases revealed enhanced expression of NADPH oxidase subunits in response to PLA and PLGA compared with that of PCL. Flow cytometric analysis of fluorescein isothiocyanate-Annexin V and propium iodide-stained PLA and PGLA polymer-exposed THP-1 cells showed early and late apoptotic changes. Similarly, exposure to the PLA and PGLA polymers, but not to the PCL polymer, resulted in enhanced staining for cleaved poly(ADPribose) polymerase-1, a protein fragment produced by caspase cleavage. These results indicate that biodegradable polymers are associated with cell adhesion, NADPH oxidase-induced generation of reactive oxygen species and excess apoptosis.
C1 [Potnis, Pushya A.; Wood, Steven C.] US FDA, Div Biol, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.
   [Tesfamariam, Belay] US FDA, Div Cardiovasc & Renal Prod, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.
RP Potnis, PA (reprint author), US FDA, Off Engn & Sci Lab, CDRH, Bldg 64,Rm 3022,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
EM pushya.potnis@fda.hhs.gov
FU Office of Science and Engineering Laboratories; Food and Drug
   Administration
FX Supported by funds provided by the Office of Science and Engineering
   Laboratories and the Food and Drug Administration.
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Azad N, 2010, ANN NY ACAD SCI, V1203, P1, DOI 10.1111/j.1749-6632.2010.05608.x
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Capan Y, 2003, AAPS PHARMSCITECH, V4, P1
   Cathcart MK, 2004, ARTERIOSCL THROM VAS, V24, P23, DOI 10.1161/01.ATV.0000097769.47306.12
   Ceonzo K, 2006, TISSUE ENG, V12, P301, DOI 10.1089/ten.2006.12.301
   Chang HH, 2010, BIOMATERIALS, V31, P6917, DOI 10.1016/j.biomaterials.2010.05.059
   Chin-Quee SL, 2010, BIOMATERIALS, V31, P648, DOI 10.1016/j.biomaterials.2009.09.079
   Dworakowski R, 2008, PHARMACOL REP, V60, P21
   Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739
   Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2
   Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Haddad JJ, 2004, INT IMMUNOPHARMACOL, V4, P475, DOI 10.1016/j.intimp.2004.02.002
   He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x
   Hezi-Yamit A, 2009, J BIOMED MATER RES A, V90A, P133, DOI 10.1002/jbm.a.32057
   Hussain S, 2009, TOXICOLOGY, V260, P142, DOI 10.1016/j.tox.2009.04.001
   Juhasz A, 2009, FREE RADICAL RES, V43, P523, DOI 10.1080/10715760902918683
   Kollum M, 1997, ARTERIOSCL THROM VAS, V17, P2383, DOI 10.1161/01.ATV.17.11.2383
   Kuppan G, 2010, CYTOKINE, V49, P229, DOI 10.1016/j.cyto.2009.11.003
   Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002
   Li RS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-6
   Loukili N, 2010, J BIOL CHEM, V285, P15746, DOI 10.1074/jbc.M110.103259
   Luzardo-Alvarez A, 2005, J CONTROL RELEASE, V109, P62, DOI 10.1016/j.jconrel.2005.09.015
   Marty C, 2006, MOL CELL BIOL, V26, P5190, DOI 10.1128/MCB.01979-05
   McBane JE, 2005, J BIOMED MATER RES A, V74A, P1, DOI 10.1002/jbm.a.30311
   Morishige T, 2010, BIOMATERIALS, V31, P6833, DOI 10.1016/j.biomaterials.2010.05.036
   Ormiston JA, 2009, CIRC-CARDIOVASC INTE, V2, P255, DOI 10.1161/CIRCINTERVENTIONS.109.859173
   Park S, 2010, J PHYSIOL PHARMACOL, V61, P375
   PATERNITI I, 2010, J LEUKOCYTE BIOL, V88, P1
   Sarisozen C, 2009, J MICROENCAPSUL, V26, P501, DOI 10.1080/02652040802465792
   Shankar SP, 2010, J BIOMED MATER RES A, V92A, P791, DOI 10.1002/jbm.a.32406
   Soldani C, 2001, EXP CELL RES, V269, P193, DOI 10.1006/excr.2001.5293
   Uurto I, 2005, J ENDOVASC THER, V12, P371, DOI 10.1583/05-1525.1
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Wood SC, 2010, J CARDIOVASC PHARM, V55, P276, DOI 10.1097/FJC.0b013e3181d263f7
   Yamada M, 2010, INT J ORAL MAX IMPL, V25, P939
   Yang YW, 2008, BIOMATERIALS, V29, P2516, DOI 10.1016/j.biomaterials.2008.02.015
NR 39
TC 9
Z9 9
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0160-2446
J9 J CARDIOVASC PHARM
JI J. Cardiovasc. Pharmacol.
PD JUN
PY 2011
VL 57
IS 6
BP 712
EP 720
DI 10.1097/FJC.0b013e31821a4f1e
PG 9
WC Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy
SC Cardiovascular System & Cardiology; Pharmacology & Pharmacy
GA 772AL
UT WOS:000291201700013
PM 21436724
DA 2018-10-20
ER

PT J
AU Rakmae, S
   Ruksakulpiwat, Y
   Sutapun, W
   Suppakarn, N
AF Rakmae, Suriyan
   Ruksakulpiwat, Yupaporn
   Sutapun, Wimonlak
   Suppakarn, Nitinat
TI Physical properties and cytotoxicity of surface-modified bovine
   bone-based hydroxyapatite/poly(lactic acid) composites
SO JOURNAL OF COMPOSITE MATERIALS
LA English
DT Article
DE poly(lactic acid); composite; hydroxyapatite; silane coupling agent;
   mechanical properties; cytotoxicity
ID MECHANICAL-PROPERTIES; PART II; POLY(L-LACTIDE); POLYMER;
   NANOCOMPOSITES; FABRICATION; PARTICLES; APATITE; CA
AB This study was a preliminary observation for a potential use of the bovine bone-based hydroxyapatite (b-HA)/poly(lactic acid) (PLA) composite as a biomaterial. SEM micrographs, XRD pattern, and FTIR spectrum of calcined bovine bone revealed that the obtained powder was in a form of crystalline carbonated HA, and highly agglomerated. The surface of HA powder was modified with either 3-aminopropyltriethoxysilane (APES) or 3-methacryloxypropyltrimethoxysilane (MPTS) in order to enhance the compatibility between b-HA and PLA matrix. TGA and GPC results revealed that the incorporation of silane-treated HA into the PLA matrix significantly increased thermal stability of the composites and decreased the thermal degradation of PLA chains. SEM micrographs revealed that modification of HA with APES or MPTS eased dispersion of HA in PLA matrix and enhanced interfacial adhesion between both phases. Therefore, the mechanical properties of silane treated HA/PLA composites were improved as compared with those of b-HA/PLA composites. In addition, in vitro cytotoxicity tests indicated that the extracts from all HA/PLA composites had no toxicity to human osteoblast cell.
C1 [Rakmae, Suriyan; Ruksakulpiwat, Yupaporn; Sutapun, Wimonlak; Suppakarn, Nitinat] Suranaree Univ Technol, Sch Polymer Engn, Nakhon Ratchasima 30000, Thailand.
   [Rakmae, Suriyan; Ruksakulpiwat, Yupaporn; Sutapun, Wimonlak; Suppakarn, Nitinat] Chulalongkorn Univ, Ctr Excellence Petr Petrochem & Adv Mat, Bangkok 10330, Thailand.
RP Suppakarn, N (reprint author), Suranaree Univ Technol, Sch Polymer Engn, Nakhon Ratchasima 30000, Thailand.
EM nitinat@sut.ac.th
OI Ruksakulpiwat, Yupaporn/0000-0002-4845-6571
FU Suranaree University of Technology; Center of Excellence for Petroleum,
   Petrochemical, and Advanced materials, Chulalongkorn University,
   Thailand
FX The authors are pleased to acknowledge the financial support from
   Suranaree University of Technology and Center of Excellence for
   Petroleum, Petrochemical, and Advanced materials, Chulalongkorn
   University, Thailand.
CR Chen XF, 2008, APPL SURF SCI, V255, P466, DOI 10.1016/j.apsusc.2008.06.061
   Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Dupraz AMP, 1996, J BIOMED MATER RES, V30, P231, DOI 10.1002/(SICI)1097-4636(199602)30:2<231::AID-JBM13>3.0.CO;2-P
   EDWIN PP, 1991, SILANE COUPLING AGEN, P144
   Fathi MH, 2008, J MATER PROCESS TECH, V202, P536, DOI 10.1016/j.jmatprotec.2007.10.004
   Fukushima K, 2009, MAT SCI ENG C-BIO S, V29, P1433, DOI 10.1016/j.msec.2008.11.005
   HOFINANN GO, 1997, BIOMATERIALS, V18, P1441
   Hong ZK, 2005, BIOMATERIALS, V26, P6296, DOI 10.1016/j.biomaterials.2005.04.018
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Landi E, 2004, BIOMATERIALS, V25, P1763, DOI 10.1016/j.biomaterials.2003.08.026
   Landi E, 2003, J EUR CERAM SOC, V23, P2931, DOI 10.1016/S0955-2219(03)00304-2
   Liu Q, 1998, BIOMATERIALS, V19, P1067, DOI 10.1016/S0142-9612(98)00033-7
   Murugan R., 2003, MATER LETT, V58, P230
   Pecheva EV, 2004, APPL SURF SCI, V235, P170, DOI 10.1016/j.apsusc.2004.05.178
   Mansur AAP, 2008, MATER RES-IBERO-AM J, V11, P293, DOI 10.1590/S1516-14392008000300011
   Russias J, 2006, MAT SCI ENG C-BIO S, V26, P1289, DOI 10.1016/j.msec.2005.08.004
   Shi ZL, 2009, ACTA BIOMATER, V5, P338, DOI 10.1016/j.actbio.2008.07.023
   Shikinami Y, 2001, BIOMATERIALS, V22, P3197, DOI 10.1016/S0142-9612(01)00072-2
   SUPPAKARN N, 2006, ANN TECHN C 2006 SOC, P325
   Tadic D, 2002, BIOMATERIALS, V23, P2553, DOI 10.1016/S0142-9612(01)00390-8
   Takayama T, 2009, J MECH BEHAV BIOMED, V2, P105, DOI 10.1016/j.jmbbm.2008.06.001
   Todo M, 2006, COMPOS PART A-APPL S, V37, P2221, DOI 10.1016/j.compositesa.2005.10.001
   Tsuji H, 2004, POLYM DEGRAD STABIL, V85, P647, DOI 10.1016/j.polymdegradstab.2004.03.004
   Vainio M., 1998, POLYMER, V39, P865
   Wen JQ, 2008, MATER LETT, V62, P3307, DOI 10.1016/j.matlet.2008.02.032
   Xu JL, 2009, BIOMATERIALS, V30, P5385, DOI 10.1016/j.biomaterials.2009.07.002
   Zhang SM, 2005, CURR APPL PHYS, V5, P516, DOI 10.1016/j.cap.2005.01.023
   Zhu AP, 2008, APPL SURF SCI, V254, P3745, DOI 10.1016/j.apsusc.2007.11.042
   Zuiderduin WCJ, 2003, POLYMER, V44, P261, DOI 10.1016/S0032-3861(02)00769-3
NR 29
TC 11
Z9 11
U1 3
U2 25
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0021-9983
J9 J COMPOS MATER
JI J. Compos Mater.
PD JUN
PY 2011
VL 45
IS 12
BP 1259
EP 1269
DI 10.1177/0021998310377934
PG 11
WC Materials Science, Composites
SC Materials Science
GA 774LK
UT WOS:000291387300001
DA 2018-10-20
ER

PT J
AU Haidukewych, GJ
   Hanssen, A
   Jones, R
AF Haidukewych, George J.
   Hanssen, Arlen
   Jones, Richard Dickey
TI Metaphyseal Fixation in Revision Total Knee Arthroplasty: Indications
   and Techniques
SO JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
LA English
DT Review
ID TIBIAL BONE LOSS; POROUS TANTALUM BIOMATERIAL; STRUCTURAL ALLOGRAFT;
   TOTAL HIP; UNCONTAINED DEFECTS; MODULAR COMPONENTS; UNITED-STATES;
   STEMS; RECONSTRUCTION; AUGMENTS
AB The need for revision total knee arthroplasty (TKA) is on the rise. Challenges to attaining durable, stable, well-functioning revision TKA include bony deficiency, periarticular osteopenia, deformity, and soft-tissue imbalance. Defect management often requires the use of stems, cement, metal augmentation, or allograft. Recently, there has been interest in obtaining fixation in the metaphyseal region in an attempt to improve construct stability while managing bony deficiency. Often, the metaphyseal bone is well vascularized, which provides an opportunity for additional fixation with cement, allograft, trabecular metal cones, or stepped porous-coated sleeves. Multiple series have documented good survivorship at short-term follow-up with trabecular metal cones and porous-coated sleeves. These newer technologies offer biologic fixation and are useful for treating bony defects that are not easily managed with other methods. Long-term studies are needed to determine the durability of these constructs. Concerns persist regarding stress shielding and difficulty of removal. Familiarity with the rationale and strategies for metaphyseal fixation in revision TKA is a valuable addition to the armamentarium of the revision surgeon.
C1 [Haidukewych, George J.] Orlando Reg Med Ctr Inc, Orlando, FL USA.
   [Hanssen, Arlen] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA.
   [Jones, Richard Dickey] Orthoped Specialists, Dallas, TX USA.
RP Haidukewych, GJ (reprint author), Orlando Reg Med Ctr Inc, Orlando, FL USA.
CR Backstein D, 2006, CLIN ORTHOP RELAT R, P104, DOI 10.1097/01.blo.0000214426.52206.2c
   Barrack RL, 1999, CLIN ORTHOP RELAT R, P216
   Bauman RD, 2009, CLIN ORTHOP RELAT R, V467, P818, DOI 10.1007/s11999-008-0679-4
   Benjamin J, 2001, CLIN ORTHOP RELAT R, P62
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Clatworthy MG, 2001, J BONE JOINT SURG AM, V83A, P404, DOI 10.2106/00004623-200103000-00013
   ELIA EA, 1991, CLIN ORTHOP RELAT R, P114
   Engh G A, 1999, Instr Course Lect, V48, P167
   Engh GA, 1997, J BONE JOINT SURG AM, V79A, P1030, DOI 10.2106/00004623-199707000-00009
   Engh GA, 2004, ORTHOPEDICS, V27, P999
   Engh GA, 2007, J BONE JOINT SURG AM, V89A, P2640, DOI 10.2106/JBJS.F00865
   Fehring TK, 2003, CLIN ORTHOP RELAT R, P217, DOI 10.1097/01.blo.0000093032.56370.4b
   Ghazavi MT, 1997, J BONE JOINT SURG AM, V79A, P17, DOI 10.2106/00004623-199701000-00002
   HAAS SB, 1995, J BONE JOINT SURG AM, V77A, P1700, DOI 10.2106/00004623-199511000-00009
   HARRIS AI, 1995, J BONE JOINT SURG AM, V77A, P373, DOI 10.2106/00004623-199503000-00007
   Harrysson OLA, 2004, CLIN ORTHOP RELAT R, P162, DOI 10.1097/01.blo.0000127115.05754.ce
   Iorio R, 2008, J BONE JOINT SURG AM, V90A, P1598, DOI 10.2106/JBJS.H.00067
   Jones RE, 2001, CLIN ORTHOP RELAT R, P306
   Jones RE, 2001, J ARTHROPLASTY, V16, P279, DOI 10.1054/arth.2001.21498
   JONES RE, 2009, KNEE ARTHROPLASTY, P301
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   Long WJ, 2009, J ARTHROPLASTY, V24, P1086, DOI 10.1016/j.arth.2008.08.011
   Lonner JH, 2002, CLIN ORTHOP RELAT R, P145, DOI 10.1097/01.blo.0000036534.46246.4b
   Lotke PA, 2006, J ARTHROPLASTY, V21, P57, DOI 10.1016/j.arth.2006.01.019
   Mabry TM, 2007, J ARTHROPLASTY, V22, P56, DOI 10.1016/j.arth.2007.02.008
   Meneghini RM, 2008, J BONE JOINT SURG AM, V90A, P78, DOI 10.2106/JBJS.F.01495
   MNAYMNEH W, 1990, CLIN ORTHOP RELAT R, P144
   MURRAY PB, 1994, CLIN ORTHOP RELAT R, P116
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   Parks NL, 1997, CLIN ORTHOP RELAT R, P17
   Peters CL, 2005, J ARTHROPLASTY, V20, P302, DOI 10.1016/j.arth.2004.08.010
   Radnay CS, 2006, CLIN ORTHOP RELAT R, P83, DOI 10.1097/01.blo.0000214437.57151.41
   Rorabeck CH, 1998, ORTHOP CLIN N AM, V29, P361, DOI 10.1016/S0030-5898(05)70335-7
   Shannon BD, 2003, J ARTHROPLASTY, V18, P27, DOI 10.1054/S0883-5403(03)00301-2
   Sporer SM, 2006, J ARTHROPLASTY, V21, P83, DOI 10.1016/j.arth.2006.05.008
   TSAHAKIS PJ, 1994, CLIN ORTHOP RELAT R, P86
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Whaley AL, 2003, J ARTHROPLASTY, V18, P592, DOI 10.1016/S0883-5403(03)00200-6
   WHITESIDE LA, 1989, CLIN ORTHOP RELAT R, P80
   Whiteside LA, 2006, CLIN ORTHOP RELAT R, P140, DOI 10.1097/01.blo.0000218724.29344.89
   WILDE AH, 1990, J BONE JOINT SURG AM, V72A, P815, DOI 10.2106/00004623-199072060-00004
   Wood GC, 2009, CLIN ORTHOP RELAT R, V467, P810, DOI 10.1007/s11999-008-0621-9
NR 43
TC 30
Z9 32
U1 0
U2 4
PU AMER ACAD ORTHOPAEDIC SURGEONS
PI ROSEMENT
PA 6300 N RIVER ROAD, ROSEMENT, IL 60018-4262 USA
SN 1067-151X
J9 J AM ACAD ORTHOP SUR
JI J. Am. Acad. Orthop. Surg.
PD JUN
PY 2011
VL 19
IS 6
BP 311
EP 318
DI 10.5435/00124635-201106000-00001
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 774FL
UT WOS:000291370400001
PM 21628642
DA 2018-10-20
ER

PT J
AU Brouwer, KM
   van Rensch, P
   Harbers, VEM
   Geutjes, PJ
   Koens, MJW
   Wijnen, RMH
   Daamen, WF
   van Kuppevelt, TH
AF Brouwer, Katrien M.
   van Rensch, Paul
   Harbers, Veroniek E. M.
   Geutjes, Paul J.
   Koens, Martin J. W.
   Wijnen, Rene M. H.
   Daamen, Willeke F.
   van Kuppevelt, Toin H.
TI Evaluation of methods for the construction of collagenous scaffolds with
   a radial pore structure for tissue engineering
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE collagen; orientation; architecture; scaffolds; radial
ID SIZE; OUTCOMES; MATRIX
AB Type I collagen is used widely as a biomaterial. The structure of collagenous biomaterials, including pore sizes and general architecture, can be varied by a number of techniques. In this study, we developed a method to construct flat fibrillar type I collagen scaffolds, 6 cm in diameter and with a radially orientated pore structure, by the use of directional freezing. Different methodologies were tested, the optimal one being freezing of a collagen suspension inside-out, using a centrally positioned liquid nitrogen-cooled tube. Pore sizes could be varied by the use of different tube materials. Use of aluminium tubes resulted in radial scaffolds with a pore size of 20-30 mu m, whereas use of stainless steel produced radial scaffolds with 70-100 mu m pore sizes. Brass-and copper-based tubes produced scaffolds with less homogeneous radial pores, pore sizes being 90-100 and 50-80 mu m, respectively. Fibreglass tubes gave even less uniformity (pore size 100-150 mu m). Scaffolds were free of cracks, except in case of aluminium. Scaffolds with a radial inner structure may be especially suitable for tissue engineering of organs with a radial scaffold structure, such as the diaphragm. Copyright. (C) 2011 John Wiley & Sons, Ltd.
C1 [Brouwer, Katrien M.; van Rensch, Paul; Harbers, Veroniek E. M.; Koens, Martin J. W.; Daamen, Willeke F.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Dept Biochem 280, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.
   [Wijnen, Rene M. H.] Radboud Univ Nijmegen, Med Ctr, Dept Surg, NL-6500 HB Nijmegen, Netherlands.
   [Geutjes, Paul J.] Radboud Univ Nijmegen, Med Ctr, Dept Urol 659, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands.
RP van Kuppevelt, TH (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biochem, Nijmegen Ctr Mol Life Sci, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM A.vanKuppevelt@ncmls.ru.nl
RI Wijnen, R.M.H./L-4758-2015; Brouwer, Katrien/K-6168-2012; Geutjes,
   P.J./L-4320-2015; Kuppevelt, A.H.M.S.M./L-4463-2015; Daamen,
   Willeke/D-5854-2015
OI Brouwer, Katrien/0000-0002-6768-3358; Daamen,
   Willeke/0000-0003-3155-3030
FU EU [LSHB-CT-2006-037409]; NWO CASIMIR [018.003.023.2008]; Dutch
   Programme for Tissue Engineering [DPTE 6735]
FX This work was financially supported by EU-FP6 project EuroSTEC (soft
   tissue engineering for congenital birth defects in children: Contract
   No. LSHB-CT-2006-037409), by NWO CASIMIR Programme No. 018.003.023.2008,
   and by the Dutch Programme for Tissue Engineering (Grant No. DPTE 6735).
   The Microscopical Imaging Centre (NCMLS, RUNMC) is acknowledged for
   facilitating electron microscopical services.
CR Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116
   Faraj KA, 2007, TISSUE ENG, V13, P2387, DOI 10.1089/ten.2006.0320
   Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9
   Harley BA, 2006, BIOMATERIALS, V27, P866, DOI 10.1016/j.biomaterials.2005.07.012
   Jancelewicz T, 2010, J PEDIATR SURG, V45, P155, DOI 10.1016/j.jpedsurg.2009.10.028
   Koens MJW, 2011, TISSUE ENG PART C-ME, V17, P327, DOI 10.1089/ten.TEC.2010.0269
   Kroehne V, 2008, J CELL MOL MED, V12, P1640, DOI 10.1111/j.1582-4934.2008.00238.x
   Madaghiele M, 2008, J BIOMED MATER RES A, V85A, P757, DOI 10.1002/jbm.a.31517
   Maier F, 1999, MUSCLE NERVE, V22, P578, DOI 10.1002/(SICI)1097-4598(199905)22:5<578::AID-MUS5>3.3.CO;2-K
   Nasr A, 2010, J PEDIATR SURG, V45, P151, DOI 10.1016/j.jpedsurg.2009.10.024
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Riboldi SA, 2008, J BIOMED MATER RES A, V84A, P1094, DOI 10.1002/jbm.a.31534
   Schoof H, 2001, J BIOMED MATER RES, V58, P352, DOI 10.1002/jbm.1028
   Xie JW, 2010, ACS NANO, V4, P5027, DOI 10.1021/nn101554u
NR 14
TC 12
Z9 12
U1 0
U2 10
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2011
VL 5
IS 6
BP 501
EP 504
DI 10.1002/term.397
PG 4
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 773YX
UT WOS:000291349300015
PM 21604385
DA 2018-10-20
ER

PT J
AU Ghanaati, S
   Fuchs, S
   Webber, MJ
   Orth, C
   Barbeck, M
   Gomes, ME
   Reis, RL
   Kirkpatrick, CJ
AF Ghanaati, Shahram
   Fuchs, Sabine
   Webber, Matthew J.
   Orth, Carina
   Barbeck, Mike
   Gomes, Manuela E.
   Reis, Rui L.
   Kirkpatrick, C. James
TI Rapid vascularization of starch-poly(caprolactone) in vivo by outgrowth
   endothelial cells in co-culture with primary osteoblasts
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE outgrowth endothelial cell; osteoblast; co-culture; angiogenesis; in
   vivo; pericyte
ID HUMAN PERIPHERAL-BLOOD; PROGENITOR CELLS; GENE-REGULATION; SCAFFOLDS;
   PERICYTE; VITRO; ANGIOGENESIS; BIOMATERIALS; CONSTRUCTS
AB The successful integration of in vitro-generated tissues is dependent on adequate vascularization in vivo. Human outgrowth endothelial cells (OECs) isolated from the mononuclear cell fraction of peripheral blood represent a potent population of circulating endothelial progenitors that could provide a cell source for rapid anastomosis and scaffold vascularization. Our previous work with these cells in co-culture with primary human osteoblasts has demonstrated their potential to form perfused vascular structures within a starch-poly(caprolactone) biomaterial in vivo. In the present study, we demonstrate the ability of OECs to form perfused vascular structures as early as 48 h following subcutaneous implantation of the biomaterial in vivo. The number of OEC-derived vessels increased throughout the study, an effect that was independent of the OEC donor. This finding of rapid and thorough OEC-mediated scaffold vascularization demonstrates the great potential for OEC-based strategies to promote vascularization in tissue engineering. OECs have the potential to contribute to host-derived scaffold vascularization, and formed vascular structures at a similar density as those arising from the host. Additionally, immunohistochemical evidence demonstrated the close interaction between OECs and the co-cultured osteoblasts. In addition to the known paracrine activity osteoblasts have in modulating angiogenesis of co-cultured OECs, we demonstrate the potential of osteoblasts to provide additional structural support for OEC-derived vessels, perhaps acting in a pericyte-like role. Copyright. (C) 2010 John Wiley & Sons, Ltd.
C1 [Ghanaati, Shahram; Fuchs, Sabine; Orth, Carina; Barbeck, Mike; Kirkpatrick, C. James] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, REPAIR Lab, D-55101 Mainz, Germany.
   [Ghanaati, Shahram; Fuchs, Sabine; Orth, Carina; Barbeck, Mike; Kirkpatrick, C. James] European Inst Excellence Tissue Engn & Regenerati, D-55101 Mainz, Germany.
   [Ghanaati, Shahram] Goethe Univ Frankfurt, Clin Maxillofacial & Plast Surg, Frankfurt, Germany.
   [Webber, Matthew J.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
   [Gomes, Manuela E.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Eng, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Gomes, Manuela E.; Reis, Rui L.] PT Govt Associated Lab, IBB, Guimaraes, Portugal.
RP Ghanaati, S (reprint author), Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, REPAIR Lab, Langenbeckstr 1, D-55101 Mainz, Germany.
EM ghanaati@uni-mainz.de
RI Reis, Rui L./A-8938-2008; Gomes, Manuela/B-6282-2009; Webber,
   Matthew/D-4847-2011; Group, 3Bs/E-4374-2012
OI Reis, Rui L./0000-0002-4295-6129; Gomes, Manuela/0000-0002-2036-6291;
   Group, 3Bs/0000-0002-5195-3456; Barbeck, Mike/0000-0002-3001-1347;
   Webber, Matthew/0000-0003-3111-6228
FU European Commission [500283-2]; German Federal Ministry of Education and
   Research, BMBF [0315033]
FX The authors would like to thank Mrs B Pavic and Mrs U. Hilbig for their
   excellent technical assistance. This work was financially supported by
   grants from the European Commission (EXPERTISSUES Contract No. 500283-2)
   and the German Federal Ministry of Education and Research, BMBF
   (German-Chinese Cooperation in Regenerative Medicine; Contract No.
   0315033).
CR Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318
   BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, P287
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828
   Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465
   Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022
   Fuchs S, 2006, CELL TISSUE RES, V326, P79, DOI 10.1007/s00441-006-0222-4
   Fuchs S, 2006, BIOMATERIALS, V27, P5399, DOI 10.1016/j.biomaterials.2006.06.015
   Fuchs S, 2010, ADV BIOCHEM ENG BIOT, V123, P201, DOI 10.1007/10_2009_65
   Fuchs S, 2009, BIOMATERIALS, V30, P1329, DOI 10.1016/j.biomaterials.2008.11.028
   Fuchs S, 2009, BIOMATERIALS, V30, P526, DOI 10.1016/j.biomaterials.2008.09.058
   Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghanaati S, 2009, BIOMATERIALS, V30, P6202, DOI 10.1016/j.biomaterials.2009.07.063
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Hofmann A, 2003, J BIOMED MATER RES A, V67A, P191, DOI 10.1002/jbm.a.10594
   Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471
   Reilly TM, 1998, CLIN ORTHOP RELAT R, P95
   Santos MI, 2007, BIOMATERIALS, V28, P240, DOI 10.1016/j.biomaterials.2006.08.006
   Santos MI, 2009, BIOMATERIALS, V30, P4407, DOI 10.1016/j.biomaterials.2009.05.004
   SHEPRO D, 1993, FASEB J, V7, P1031
   Silva EA, 2008, P NATL ACAD SCI USA, V105, P14347, DOI 10.1073/pnas.0803873105
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Unger RE, 2010, BIOMATERIALS, V31, P6959, DOI 10.1016/j.biomaterials.2010.05.057
NR 26
TC 38
Z9 41
U1 0
U2 12
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2011
VL 5
IS 6
BP E136
EP E143
DI 10.1002/term.373
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 773YX
UT WOS:000291349300006
PM 21604380
OA Bronze
DA 2018-10-20
ER

PT J
AU Chen, SG
   Chen, SJ
   Jiang, S
   Mo, YM
   Tang, JN
   Ge, ZC
AF Chen, Shiguo
   Chen, Shaojun
   Jiang, Song
   Mo, Yangmiao
   Tang, Jiaoning
   Ge, Zaochuan
TI Synthesis and characterization of siloxane sulfobetaine antimicrobial
   agents
SO SURFACE SCIENCE
LA English
DT Article
DE Siloxane; Antimicrobial; Betaine; Quaternary ammonium
ID POLYMERIC BETAINES; SURFACES; CELLULOSE
AB In this paper, we report a novel antibacterial agent siloxane sulfobetaine (SSB) with reactive siloxane groups, which can be bonded onto the glass surface, rendering excellent antibacterial activity and good durability. Their antibacterial rate against Escherichia Coll and Staphylococcus aureus reach 99.96% and 99.98%, respectively, within the 24 h contact time. Their antibacterial rates of SSB coated glass surface are still beyond 95.0% after 20 washes. Moreover, SSB does not induce a skin reaction and is nontoxic to animals. Therefore, the SSB has great applications in biomaterial applications requiring durable bacteriostasis. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Chen, Shiguo; Chen, Shaojun; Jiang, Song; Mo, Yangmiao; Tang, Jiaoning; Ge, Zaochuan] Shenzhen Univ, Coll Mat Sci & Engn, Shenzhen Key Lab Special Funct Mat, Shenzhen 518060, Peoples R China.
RP Chen, SG (reprint author), Shenzhen Univ, Coll Mat Sci & Engn, Shenzhen Key Lab Special Funct Mat, Shenzhen 518060, Peoples R China.
EM csg@szu.edu.cn
RI chen, shiguo/J-3076-2014
OI chen, shiguo/0000-0002-5338-690X
FU Natural Science Foundation of China [50803037]; Natural Science
   Foundation of Guangdong [2008211]; Science and Technology Planning
   Project of Guangdong Province [2008A010500001]; Science and Technology
   Planning Project of Shenzhen City [ZYC200903250180A]
FX Financial supports by the Natural Science Foundation of China (No.
   50803037), Natural Science Foundation of Guangdong (No. 2008211),
   Science and Technology Planning Project of Guangdong Province (grant No.
   2008A010500001) and Science and Technology Planning Project of Shenzhen
   City (No. ZYC200903250180A) are gratefully acknowledged.
CR Cheng G, 2007, BIOMATERIALS, V28, P4192, DOI 10.1016/j.biomaterials.2007.05.041
   Gui ZL, 2009, EUR POLYM J, V45, P1403, DOI 10.1016/j.eurpolymj.2009.02.010
   Jampala SN, 2008, LANGMUIR, V24, P8583, DOI 10.1021/la800405x
   Kudaibergenov S, 2006, ADV POLYM SCI, V201, P157, DOI 10.1007/12_078
   Lee H, 2008, ADV MATER, V20, P1619, DOI 10.1002/adma.200702378
   Lu GQ, 2007, REACT FUNCT POLYM, V67, P355, DOI 10.1016/j.reactfunctpolym.2007.01.008
   Rankin DA, 2008, MACROMOLECULES, V41, P614, DOI 10.1021/ma701952c
   Saif MJ, 2009, LANGMUIR, V25, P377, DOI 10.1021/la802878p
   Shi Q, 2008, J MEMBRANE SCI, V319, P271, DOI 10.1016/j.memsci.2008.03.047
   Song YB, 2008, BIOMACROMOLECULES, V9, P2259, DOI 10.1021/bm800429a
   Su YL, 2008, REACT FUNCT POLYM, V68, P161, DOI 10.1016/j.reactfunctpolym.2007.10.001
   Tada S, 2009, MACROMOL BIOSCI, V9, P63, DOI 10.1002/mabi.200800150
   Ward M, 2006, J APPL POLYM SCI, V101, P1036, DOI 10.1002/app.23269
   Yuan JA, 2004, COLLOID SURFACE B, V36, P27, DOI [10.1016/j.colsurfc.2004.03.017, 10.1016/j.colsurfb.2004.03.017]
   Zhang Z, 2008, BIOMATERIALS, V29, P4719, DOI 10.1016/j.biomaterials.2008.08.030
NR 15
TC 4
Z9 4
U1 4
U2 38
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0039-6028
J9 SURF SCI
JI Surf. Sci.
PD JUN
PY 2011
VL 605
IS 11-12
BP L25
EP L28
DI 10.1016/j.susc.2011.03.013
PG 4
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 771QQ
UT WOS:000291176200001
DA 2018-10-20
ER

PT J
AU Chia, TWR
   Nguyen, VT
   McMeekin, T
   Fegan, N
   Dykes, GA
AF Chia, Teck Wah R.
   Vu Tuan Nguyen
   McMeekin, Thomas
   Fegan, Narelle
   Dykes, Gary A.
TI Stochasticity of Bacterial Attachment and Its Predictability by the
   Extended Derjaguin-Landau-Verwey-Overbeek Theory
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID CELL-SURFACE HYDROPHOBICITY; STAINLESS-STEEL; BIOMATERIAL SURFACES;
   SALMONELLA SEROVARS; DLVO INTERACTIONS; ESCHERICHIA-COLI; MEAT SURFACES;
   POROUS-MEDIA; ADHESION; RETENTION
AB Bacterial attachment onto materials has been suggested to be stochastic by some authors but nonstochastic and based on surface properties by others. We investigated this by attaching pairwise combinations of two Salmonella enterica serovar Sofia (S. Sofia) strains (with different physicochemical and attachment properties) with one strain each of S. enterica serovar Typhimurium, S. enterica serovar Infantis, or S. enterica serovar Virchow (all with similar physicochemical and attachment abilities) in ratios of 0.428, 1, and 2.333 onto glass, stainless steel, Teflon, and polysulfone. Attached bacterial cells were recovered and counted. If the ratio of attached cells of each Salmonella serovar pair recovered was the same as the initial inoculum ratio, the attachment process was deemed stochastic. Experimental outcomes from the study were compared to those predicted by the extended Derjaguin-Landau-Verwey-Overbeek (XDLVO) theory. Significant differences (P < 0.05) between the initial and the attached ratios for serovar pairs containing S. Sofia S1296a for all different ratios were apparent for all materials. For S. Sofia S1635-containing pairs, 7 out of 12 combinations of serovar pairs and materials had attachment ratios not significantly different (P > 0.05) from the initial ratio of 0.428. Five out of 12 and 10 out of 12 samples had attachment ratios not significantly different (P > 0.05) from the initial ratios of 1 and 2.333, respectively. These results demonstrate that bacterial attachment to different materials is likely to be nonstochastic only when the key physicochemical properties of the bacteria were significantly different (P < 0.05) from each other. XDLVO theory could successfully predict the attachment of some individual isolates to particular materials but could not be used to predict the likelihood of stochasticity in pairwise attachment experiments.
C1 [Dykes, Gary A.] Monash Univ, Sch Sci, Kelana Jaya 46780, Selangor, Malaysia.
   [Chia, Teck Wah R.; Vu Tuan Nguyen] CSIRO Food & Nutr Sci, Brisbane, Qld, Australia.
   [Chia, Teck Wah R.; McMeekin, Thomas] Univ Tasmania, Dept Agr Sci, Hobart, Tas 7001, Australia.
   [Vu Tuan Nguyen] Univ Queensland, Sch Land Crop & Food Sci, Brisbane, Qld, Australia.
   [Fegan, Narelle] CSIRO Food & Nutr Sci, Werribee, Vic, Australia.
RP Dykes, GA (reprint author), Monash Univ, Sch Sci, POB 8975, Kelana Jaya 46780, Selangor, Malaysia.
EM gary.dykes@sci.monash.edu.my
RI Fegan, Narelle/K-5316-2012
OI Fegan, Narelle/0000-0002-1729-9630; Dykes, Gary/0000-0001-5014-9282
FU Australian Food Safety Centre of Excellence; CSIRO (Brisbane)
FX T. W. R. Chia acknowledges scholarship support from the Australian Food
   Safety Centre of Excellence and CSIRO (Brisbane).
CR Bayoudh S, 2009, COLLOID SURFACE B, V73, P1, DOI 10.1016/j.colsurfb.2009.04.030
   Benito Y, 1997, MEAT SCI, V45, P419, DOI 10.1016/S0309-1740(96)00133-7
   Beuchat LR, 2004, FOOD MICROBIOL, V21, P683, DOI 10.1016/j.fm.2004.02.006
   Boks NP, 2008, MICROBIOL-SGM, V154, P3122, DOI 10.1099/mic.0.2008/018622-0
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Bos R, 2000, FEMS MICROBIOL LETT, V189, P311, DOI 10.1016/S0378-1097(00)00298-6
   Chen G, 2003, ENVIRON ENG SCI, V20, P237, DOI 10.1089/109287503321671447
   Chia TWR, 2009, FOOD MICROBIOL, V26, P853, DOI 10.1016/j.fm.2009.05.012
   Chia TWR, 2008, J FOOD PROTECT, V71, P2421, DOI 10.4315/0362-028X-71.12.2421
   Davos D., 2003, FOODBORNE MICROORGAN, P207
   de Kerchove AJ, 2005, LANGMUIR, V21, P6462, DOI 10.1021/la047049t
   DICKSON JS, 1989, APPL ENVIRON MICROB, V55, P832
   Dong HL, 2002, COLLOID SURFACE B, V24, P229, DOI 10.1016/S0927-7765(01)00243-0
   Frank J F, 2001, Adv Food Nutr Res, V43, P319, DOI 10.1016/S1043-4526(01)43008-7
   Habimana O, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-36
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Heuzenroeder M. W., 2001, RIRDC PUBLICATION
   Hoek EMV, 2006, J COLLOID INTERF SCI, V298, P50, DOI 10.1016/j.jcis.2005.12.031
   Hoek EMV, 2003, LANGMUIR, V19, P4836, DOI 10.1021/la027083c
   Humphries AD, 2001, FEMS MICROBIOL LETT, V201, P121, DOI 10.1016/S0378-1097(01)00250-6
   Iwabuchi N, 2003, COLLOID SURFACE B, V30, P51, DOI 10.1016/S0927-7765(03)00036-5
   Kang CK, 2007, J MATER SCI-MATER M, V18, P1389, DOI 10.1007/s10856-006-0079-9
   Khorasani MT, 2006, COLLOID SURFACE B, V51, P112, DOI 10.1016/j.colsurfb.2006.06.002
   Liao CH, 2001, CAN J MICROBIOL, V47, P25, DOI 10.1139/cjm-47-1-25
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   MCMEEKIN TA, 1978, J APPL BACTERIOL, V45, P383, DOI 10.1111/j.1365-2672.1978.tb04239.x
   MINAGI S, 1985, INFECT IMMUN, V47, P11
   Nobbs AH, 2007, J BACTERIOL, V189, P3106, DOI 10.1128/JB.01535-06
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Redman JA, 2004, ENVIRON SCI TECHNOL, V38, P1777, DOI 10.1021/es0348871
   Rivas L, 2007, INT J FOOD MICROBIOL, V115, P89, DOI 10.1016/j.ijfoodmicro.2006.10.027
   Roosjen A, 2006, MICROBIOL-SGM, V152, P2673, DOI 10.1099/mic.0.29005-0
   Sinde E, 2000, FOOD MICROBIOL, V17, P439, DOI 10.1006/fmic.2000.0339
   STENSTROM TA, 1989, APPL ENVIRON MICROB, V55, P142
   THOMAS CJ, 1977, APPL ENVIRON MICROB, V34, P456
   Vadillo-Rodriguez V, 2004, MICROBIOL-SGM, V150, P1015, DOI 10.1099/mic.0.26828-0
   van Oss CJ, 2003, J MOL RECOGNIT, V16, P177, DOI 10.1002/jmr.618
   VANOSS CJ, 1993, COLLOID SURFACE A, V78, P1, DOI 10.1016/0927-7757(93)80308-2
   VANOSS CJ, 1989, CELL BIOPHYS, V14, P1
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Wu WJ, 1999, COLLOID SURFACE B, V14, P57, DOI 10.1016/S0927-7765(99)00024-7
   Zularisam AW, 2007, J MEMBRANE SCI, V299, P97, DOI 10.1016/j.memsci.2007.04.030
NR 42
TC 18
Z9 18
U1 3
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUN
PY 2011
VL 77
IS 11
BP 3757
EP 3764
DI 10.1128/AEM.01415-10
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 767HY
UT WOS:000290847800026
PM 21478319
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Bjartell, A
   Montironi, R
   Berney, DM
   Egevad, L
AF Bjartell, Anders
   Montironi, Rodolfo
   Berney, Daniel M.
   Egevad, Lars
TI Tumour markers in prostate cancer II: Diagnostic and prognostic cellular
   biomarkers
SO ACTA ONCOLOGICA
LA English
DT Review
ID METHYLACYL-COA-RACEMASE; MEMBRANE ANTIGEN-EXPRESSION; HEAT-SHOCK
   RESPONSE; GROUP PROTEIN EZH2; NEEDLE-BIOPSY; INTRAEPITHELIAL NEOPLASIA;
   RADICAL PROSTATECTOMY; ANDROGEN RECEPTOR; TRYPSIN-INHIBITOR; BASAL-CELLS
AB The main goal of prostate cancer tissue biomarkers is to improve diagnostic and prognostic accuracy. A particularly important question is whether the cancer needs immediate treatment or if treatment can be deferred. It is highly unlikely that a single biomarker that provides comprehensive prognostic information about a newly diagnosed prostate cancer will be forthcoming. Despite extensive research efforts, very few biomarkers of prostate cancer have been successfully implemented into clinical practice today. This can be partly explained by a lack of standardised methods for performance and interpretation of immunohistochemistry, but also by poor study design with insufficient biomaterial or inappropriate statistical analysis. Also appropriate cohorts to test prostate cancer biomarkers do not exist. It must be kept in mind that unsuccessful integration of new biomarkers in nomograms can also be explained by the good performance of the clinical and pathological base model with serum PSA as the only independent biomarker. A new biomarker must be powerful enough to improve this prediction model and not merely replace. Material and methods. In this report, we focus on diagnostic and prognostic cellular biomarkers in prostate cancer, recent advances and future aspects by reviewing currently available literature. Results. Similar to other malignancies, the proliferation marker Ki-67 seems to be a prognostic tissue biomarker and a strong candidate for integration in prediction models. Circulating tumour cells are promising markers of response to treatments in patients with metastatic disease. Conclusion. Important technical advances together with histological techniques of antibody or probes conjugated with different fluorophores will certainly improve standardisation and make immunohistochemical biomarker research more reliable and precise in the future. Cellular biomarker studies are also expected to change in the future towards a complexed individualised profiling of human tumours with integrative analysis using different technologies, genome-wide scanning and expression profiling.
C1 [Bjartell, Anders] Skane Univ Hosp Malmo, Dept Urol, Malmo, Sweden.
   [Montironi, Rodolfo] Polytech Univ Marche Reg, Sch Med, Inst Pathol Anat & Histopathol, Ancona, Italy.
   [Berney, Daniel M.] Queen Mary Univ London, Inst Canc, Dept Mol Oncol & Imaging, London, England.
   [Egevad, Lars] Karolinska Univ Hosp, Dept Pathol, Stockholm, Sweden.
RP Bjartell, A (reprint author), Skane Univ Hosp, Dept Urol, S-20502 Malmo, Sweden.
EM anders.bjartell@med.lu.se
OI Egevad, Lars/0000-0001-8531-222X; Berney, Daniel/0000-0001-5474-8696
CR Ahmed Hafiz, 2010, Biomark Cancer, V2, P17, DOI 10.4137/BIC.S3187
   Ali TZ, 2008, AM J SURG PATHOL, V32, P1890, DOI 10.1097/PAS.0b013e31817ce994
   Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640
   Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248
   Berney DM, 2009, BRIT J CANCER, V100, P888, DOI 10.1038/sj.bjc.6604951
   Bertram J, 2006, PROSTATE, V66, P895, DOI 10.1002/pros.20411
   Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031
   Bostwick DG, 1998, CANCER, V82, P2256, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2256::AID-CNCR22>3.0.CO;2-S
   Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333
   Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370
   Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972
   Darson MF, 1999, UROLOGY, V53, P939, DOI 10.1016/S0090-4295(98)00637-2
   Darson MF, 1997, UROLOGY, V49, P857, DOI 10.1016/S0090-4295(97)00108-8
   de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872
   Donovan MJ, 2010, BJU INT, V105, P462, DOI 10.1111/j.1464-410X.2009.08747.x
   Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90
   Epstein JI, 2006, J UROLOGY, V175, P820, DOI 10.1016/S0022-5347(05)00337-X
   Erbersdobler A, 2009, UROLOGY, V74, P1169, DOI 10.1016/j.urology.2009.02.061
   FINE SW, MOD PATHOL
   FULLER KJ, 1994, EUR J CANCER, V30A, P1884, DOI 10.1016/0959-8049(94)00362-9
   Gandellini P, 2010, DISCOV MED, V9, P212
   Glaessgen A, 2008, APMIS, V116, P888, DOI 10.1111/j.1600-0463.2008.01051.x
   Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992
   Harvey TJ, 2000, J BIOL CHEM, V275, P37397, DOI 10.1074/jbc.M004525200
   Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634
   Kudahetti S, 2009, BJU INT, V104, P20, DOI 10.1111/j.1464-410X.2009.08407.x
   Leav I, 2010, AM J PATHOL, V176, P393, DOI 10.2353/ajpath.2010.090521
   Lee JT, 2004, CANCER RES, V64, P8397, DOI 10.1158/0008-5472.CAN-04-1612
   LEE WH, 1994, P NATL ACAD SCI USA, V91, P11733, DOI 10.1073/pnas.91.24.11733
   Leinonen KA, 2010, CLIN CANCER RES, V16, P2845, DOI 10.1158/1078-0432.CCR-09-2505
   Leversha MA, 2009, CLIN CANCER RES, V15, P2091, DOI 10.1158/1078-0432.CCR-08-2036
   Lexander H, 2005, ANAL QUANT CYTOL, V27, P263
   Li R, 2004, AM J SURG PATHOL, V28, P928, DOI 10.1097/00000478-200407000-00013
   LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105
   Lintula S, 2005, PROSTATE, V63, P324, DOI 10.1002/pros.20194
   Magi-Galluzzi C, 2003, AM J SURG PATHOL, V27, P1128, DOI 10.1097/00000478-200308000-00010
   McMenamin ME, 1999, CANCER RES, V59, P4291
   McShane LM, 2005, J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237
   Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999
   Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562
   NETO AS, J UROL
   Osunkoya AO, 2008, AM J SURG PATHOL, V32, P461, DOI 10.1097/PAS.0b013e318157020e
   Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948
   Paju A, 2006, CRIT REV CL LAB SCI, V43, P103, DOI 10.1080/10408360500523852
   Paju A, 2007, EUR UROL, V52, P1670, DOI 10.1016/j.eururo.2007.01.096
   Perner S, 2007, HUM PATHOL, V38, P696, DOI 10.1016/j.humpath.2006.11.012
   Ribeiro FR, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-33
   Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574
   Shaffer DR, 2007, CLIN CANCER RES, V13, P2023, DOI 10.1158/1078-0432.CCR-06-2701
   Shariat SF, 2008, CURR OPIN UROL, V18, P279, DOI 10.1097/MOU.0b013e3282f9b3e5
   Sutcliffe P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13050
   Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026
   Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91
   Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679
   Tomlins SA, 2008, CANCER CELL, V13, P519, DOI 10.1016/j.ccr.2008.04.016
   UGOLKOV AV, PROSTATE
   van den Hoogen C, 2010, CANCER RES, V70, P5163, DOI 10.1158/0008-5472.CAN-09-3806
   Wang WL, 2008, AM J SURG PATHOL, V32A, P851, DOI 10.1097/PAS.0b013e31815a0508
   Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200
   Wu HHJ, 2004, APPL IMMUNOHISTO M M, V12, P285, DOI 10.1097/00129039-200412000-00001
   Yoshimoto M, 2007, BRIT J CANCER, V97, P678, DOI 10.1038/sj.bjc.6603924
   Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498
   Zhou M, 2004, AM J SURG PATHOL, V28, P239, DOI 10.1097/00000478-200402000-00012
   Zhou M, 2003, AM J SURG PATHOL, V27, P365, DOI 10.1097/00000478-200303000-00010
   Zhou M, 2003, AM J SURG PATHOL, V27, P772, DOI 10.1097/00000478-200306000-00007
NR 65
TC 36
Z9 37
U1 0
U2 23
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0284-186X
EI 1651-226X
J9 ACTA ONCOL
JI Acta Oncol.
PD JUN
PY 2011
VL 50
SU 1
BP 76
EP 84
DI 10.3109/0284186X.2010.531284
PG 9
WC Oncology
SC Oncology
GA 767QL
UT WOS:000290871000013
PM 21604944
OA Bronze
DA 2018-10-20
ER

PT J
AU Wollensak, G
   Sporl, E
   Mazzotta, C
   Kalinski, T
   Sel, S
AF Wollensak, G.
   Spoerl, E.
   Mazzotta, C.
   Kalinski, T.
   Sel, S.
TI Interlamellar cohesion after corneal crosslinking using riboflavin and
   ultraviolet A light
SO BRITISH JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID KERATOCONUS CORNEAS; COLLAGEN LAMELLAE; A LIGHT; PROTEOGLYCANS;
   ORGANIZATION; ORIENTATION; MECHANISMS; STRENGTH; STROMA; EYES
AB Aims Collagen crosslinking treatment of progressive keratoconus using the photosensitiser riboflavin and ultraviolet A light of 370 nm wavelength has been shown to increase significantly the tensile strength of corneal collagen by about 300%. In keratoconus, interlamellar and interfibrillar slippage have been proposed as pathogenetic mechanisms. Therefore, the aim of this study was to assess the impact of collagen crosslinking on the interlamellar cohesive force.
   Methods 72 post mortem porcine eyes were divided into six different treatment groups: the untreated control group, the standard crosslinking group, the hypo-osmolar crosslinking group, the stromal swelling group, the formaldehyde group and the alpha-amylase group. An anterior 9X4 mm strip of 400 mm thickness was prepared using a lamellar rotating microkeratome. For interlamellar cohesive force measurements a splitting plane was created at 50% depth. Force-distance profiles were recorded using a microcomputer-controlled biomaterial testing machine.
   Results The mean interlamellar cohesive force was 0.24 N/mm in the untreated control group, 0.26 N/mm in the standard crosslinking group, 0.25 N/mm in the hypo-osmolar crosslinking group, 0.23 N/mm in hydrated corneas, 0.27 N/mm in the formaldehyde group without statistically significant difference. Only the values of the alpha-amylase group were statistically significantly lowered by 31.5% to 0.16 N/mm.
   Conclusions Surprisingly, corneal crosslinking does not increase the interlamellar cohesive force. In the alpha-amylase group the cohesive force was mainly decreased because of the digestion of proteoglycans. Crosslinking seems to stabilise only inter- and intrafibrillar, but not interlamellar cohesion.
C1 [Wollensak, G.] Eye Laser Inst, Halle, Germany.
   [Spoerl, E.] Tech Univ Dresden, Dept Ophthalmol, Dresden, Germany.
   [Mazzotta, C.] Univ Siena, Dept Ophthalmol & Neurosurg, I-53100 Siena, Italy.
   [Kalinski, T.] Univ Magdeburg, Dept Pathol, D-39106 Magdeburg, Germany.
   [Sel, S.] Univ Halle Wittenberg, Dept Ophthalmol, Halle, Germany.
RP Wollensak, G (reprint author), Wildentensteig 4, D-14195 Berlin, Germany.
EM gwollens@hotmail.com
OI Sel, Saadettin/0000-0003-3307-3305
CR Boote C, 2005, J STRUCT BIOL, V149, P1, DOI 10.1016/j.jsb.2004.08.009
   Dawson DG, 2008, OPHTHALMOLOGY, V115, P2181, DOI 10.1016/j.ophtha.2008.06.008
   EDMUND C, 1988, ACTA OPHTHALMOL, V66, P305
   Elsheikh A, 2009, CURR EYE RES, V34, P26, DOI 10.1080/02713680802535263
   Goldich Y, 2009, CORNEA, V28, P498, DOI 10.1097/ICO.0b013e318190734d
   Kohlhaas M, 2006, J CATARACT REFR SURG, V32, P279, DOI 10.1016/j.jcrs.2005.12.092
   Lewis PN, 2010, STRUCTURE, V18, P239, DOI 10.1016/j.str.2009.11.013
   Mazzotta C, 2008, AM J OPHTHALMOL, V146, P527, DOI 10.1016/j.ajo.2008.05.042
   McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738
   McMonnies CW, 2009, CORNEA, V28, P607, DOI 10.1097/ICO.0b013e318198384f
   Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253
   Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437
   Muller LJ, 2004, EXP EYE RES, V78, P493, DOI 10.1016/S0014-4835(03)00206-9
   QUINTARELLI G, 1969, HISTOCHEMISTRY, V18, P373
   Radner W, 1998, OPHTHALMIC RES, V30, P327, DOI 10.1159/000055492
   Radner W, 1998, CORNEA, V17, P537, DOI 10.1097/00003226-199809000-00012
   Radner W, 2002, CORNEA, V21, P598, DOI 10.1097/01.ICO.0000022801.81080.27
   Raiskup-Wolf F, 2008, J CATARACT REFR SURG, V34, P796, DOI 10.1016/j.jcrs.2007.12.039
   Schmack I, 2005, J REFRACT SURG, V21, P433
   SMOLEK MK, 1990, INVEST OPHTH VIS SCI, V31, P1087
   Wollensak G, 2004, CORNEA, V23, P503, DOI 10.1097/01.ico.0000105827.85025.7f
   Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3
   Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1
   Wollensak G, 2007, J CATARACT REFR SURG, V33, P516, DOI 10.1016/j.jcrs.2006.11.015
   Wollensak G, 2010, EXPERT REV OPHTHALMO, V5, P201, DOI 10.1586/EOP.10.7
NR 25
TC 44
Z9 47
U1 0
U2 14
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0007-1161
J9 BRIT J OPHTHALMOL
JI Br. J. Ophthalmol.
PD JUN
PY 2011
VL 95
IS 6
BP 876
EP 880
DI 10.1136/bjo.2010.190843
PG 5
WC Ophthalmology
SC Ophthalmology
GA 766OJ
UT WOS:000290793600025
PM 21357598
DA 2018-10-20
ER

PT J
AU Kwon, WJ
   Kim, HJ
   Jeong, YJ
   Lee, CH
   Kim, KI
   Kim, YD
   Lee, JH
AF Kwon, Woon Jung
   Kim, Hak Jin
   Jeong, Yeon Joo
   Lee, Chang Hun
   Kim, Kun-Il
   Kim, Yeong Dae
   Lee, Jong Hwa
TI Direct lipiodol injection used for a radio-opaque lung marker: stability
   and histopathologic effects
SO EXPERIMENTAL LUNG RESEARCH
LA English
DT Article
DE lung pathology; preoperative care; thoracoscopy/VATS
ID ASSISTED THORACOSCOPIC RESECTION; SMALL PULMONARY NODULES; HOOK-WIRE;
   EXPERIENCE; MARKING; CT; LOCALIZATION; GUIDANCE; CANCER; SYSTEM
AB The objective of this study was to evaluate the effects on the histopathologic findings of directly injected lipiodol into lung and to identify the existence of remaining lipiodol in the lung according to the follow-up time. Forty rats were randomly assigned to 1 of 4 groups: group I (n = 10) served as the control group and received 0.2 mL of normal saline; groups II (n = 10), III (n = 10), and IV (n = 10) served as experimental groups and received 0.1-0.2 mL of lipiodol under fluoroscopy. At 3 hours (groups I and II), 24 hours (group III), and 1 week (group IV) after injection, the radiographic presence of lipiodol and histopathologic findings of each group were evaluated. Minimal acute lung injuries developed and the radio-opaque lipiodol nodule remained in group II. In group III, acute lung injuries were the most serious. However, acute injuries disappeared and foamy macrophages accumulated within the alveolar space in group IV. In this group, remaining lipiodol was also identified on radiograph. Directly injected lipiodol caused acute lung injury, which disappeared at 1 week along with the resolving process. On radiographs, directly injected lipiodol remained after 1 week. Lipiodol could be used as a safe and stable biomaterial for marking pulmonary nodules.
C1 [Kim, Hak Jin; Jeong, Yeon Joo] Pusan Natl Univ, Dept Radiol, Pusan Natl Univ Hosp, Sch Med, Pusan 602739, South Korea.
   [Kim, Hak Jin; Jeong, Yeon Joo; Lee, Chang Hun; Kim, Yeong Dae] Pusan Natl Univ, Med Res Inst, Pusan 602739, South Korea.
   [Kwon, Woon Jung; Lee, Jong Hwa] Univ Ulsan, Sch Med, Dept Diagnost Radiol, Ulsan Univ Hosp, Ulsan 680749, South Korea.
   [Lee, Chang Hun] Pusan Natl Univ, Dept Pathol, Pusan Natl Univ Hosp, Sch Med, Pusan 602739, South Korea.
   [Kim, Kun-Il] Pusan Natl Univ, Sch Med, Dept Radiol, Pusan Natl Univ Yangsan Hosp, Yangsan, South Korea.
   [Kim, Kun-Il] Med Res Inst, Yangsan, South Korea.
   [Kim, Yeong Dae] Pusan Natl Univ, Dept Thorac & Cardiovasc Surg, Pusan Natl Univ Hosp, Sch Med, Pusan 602739, South Korea.
RP Jeong, YJ (reprint author), Pusan Natl Univ, Dept Radiol, Pusan Natl Univ Hosp, Sch Med, 1-10 Ami Dong, Pusan 602739, South Korea.
EM jeongyj@pusan.ac.kr
CR Dendo S, 2002, RADIOLOGY, V225, P511, DOI 10.1148/radiol.2252011025
   DERKS CM, 1977, AM J PATHOL, V87, P143
   FELTON WL, 1953, J THORAC SURG, V25, P530
   HERBERT A, 1986, THORAX, V41, P176, DOI 10.1136/thx.41.3.176
   Ikeda K, 2007, CHEST, V131, P502, DOI 10.1378/chest.06-1882
   Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234
   Kawanaka K, 2009, ACAD RADIOL, V16, P39, DOI 10.1016/j.acra.2008.07.012
   KERRIGAN DC, 1992, ANN THORAC SURG, V53, P163, DOI 10.1016/0003-4975(92)90783-Z
   MCALISTER WH, 1983, AM J ROENTGENOL, V140, P245, DOI 10.2214/ajr.140.2.245
   Moon SW, 1999, ANN THORAC SURG, V68, P1815, DOI 10.1016/S0003-4975(99)00764-X
   Nomori H, 1996, ANN THORAC SURG, V61, P1070, DOI 10.1016/0003-4975(96)00024-0
   Nomori H, 2002, ANN THORAC SURG, V74, P170, DOI 10.1016/S0003-4975(02)03615-9
   Okumura T, 2001, ANN THORAC SURG, V71, P439, DOI 10.1016/S0003-4975(00)02378-X
   Powell TI, 2004, ANN SURG, V240, P481, DOI 10.1097/01.sla.0000137132.01881.57
   Swensen SJ, 2005, RADIOLOGY, V235, P259, DOI 10.1148/radiol.2351041662
   Watanabe K, 2006, J THORAC CARDIOV SUR, V132, P320, DOI 10.1016/j.jtcvs.2006.04.012
   WHITAKER D, 1985, J PATHOL, V145, P159, DOI 10.1002/path.1711450204
   Wicky S, 2002, J THORAC CARDIOV SUR, V124, P401, DOI 10.1067/mtc.2002.124257
NR 18
TC 7
Z9 8
U1 0
U2 1
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0190-2148
J9 EXP LUNG RES
JI Exp. Lung Res.
PD JUN
PY 2011
VL 37
IS 5
BP 310
EP 317
DI 10.3109/01902148.2011.566672
PG 8
WC Respiratory System
SC Respiratory System
GA 765TD
UT WOS:000290730600006
PM 21574876
DA 2018-10-20
ER

PT J
AU Pritchard, EM
   Kaplan, DL
AF Pritchard, Eleanor M.
   Kaplan, David L.
TI Silk fibroin biomaterials for controlled release drug delivery
SO EXPERT OPINION ON DRUG DELIVERY
LA English
DT Review
DE biomaterials; controlled release; degradable polymer; reservoirs; silk
   fibroin; tissue engineering
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELL; IN-VITRO; ADENOSINE
   RELEASE; BIOMEDICAL APPLICATIONS; POROUS SCAFFOLDS; FILMS; HYDROGELS;
   RESPONSES; POLYMER
AB Introduction: Given the benefits of polymer drug delivery implants over traditional periodic systemic administration, the development of biomaterial systems with the necessary properties (biocompatibility, degradation, stabilization, controllability) is paramount. Silk fibroin represents a promising, naturally derived polymer for local, controlled, sustained drug release from fully degrading implants and the polymer can be processed into a broad array of material formats.
   Areas covered: This review provides an overview of silk biomaterials for drug delivery, especially those that can function as long-term depots. Fundamentals of structure and assembly, processing options, control points and specific examples of implantable silk drug delivery systems (sponges, films) and injectable systems (microspheres, hydrogels) from the 1990s and onwards are reviewed.
   Expert opinion: Owing to its unique material properties, stabilization effects and tight controllability, silk fibroin is a promising biomaterial for implantable and injectable drug delivery applications. Many promising control points have been identified, and characterization of the relationships between silk processing and/or material properties and the resulting drug loading and release kinetics will ultimately enhance the overall utility of this unique biomaterial. The ever-expanding biomaterial 'tool kit' that silk provides will eventually allow the simultaneous optimization of implant structure, material properties and drug release behavior that is needed to maximize the cost-efficiency, convenience, efficacy and safety of many new and existing therapeutics, especially those that cannot be delivered by means of traditional administration approaches.
C1 [Pritchard, Eleanor M.; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
CR Acharya Chitrangada, 2008, Biotechnol J, V3, P226, DOI 10.1002/biot.200700120
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Bayraktar O, 2005, EUR J PHARM BIOPHARM, V60, P373, DOI 10.1016/j.ejpb.2005.02.002
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Cappello J, 1998, J CONTROL RELEASE, V53, P105, DOI 10.1016/S0168-3659(97)00243-5
   Chang SQ, 2009, SOLID STATE COMMUN, V149, P1180, DOI 10.1016/j.ssc.2009.04.031
   Cheema SK, 2007, INT J PHARMACEUT, V341, P221, DOI 10.1016/j.ijpharm.2007.03.043
   CHEN B, 2010, BIOMASS BIO IN PRESS
   Chen JL, 2010, BIOMATERIALS, V31, P9438, DOI 10.1016/j.biomaterials.2010.08.011
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   CHEN JY, 1994, POLYMER, V35, P2853, DOI 10.1016/0032-3861(94)90317-4
   Choi HM, 2004, TEXT RES J, V74, P333, DOI 10.1177/004051750407400409
   DANCKWERTS M, 1991, DRUG DEV IND PHARM, V17, P1465, DOI 10.3109/03639049109026629
   DEMURA M, 1989, BIOSENSORS, V4, P361, DOI 10.1016/0265-928X(89)80002-1
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   Enomoto S, 2010, J VASC SURG, V51, P155, DOI 10.1016/j.jvs.2009.09.005
   Fang Jia-You, 2006, Chem Pharm Bull (Tokyo), V54, P156, DOI 10.1248/cpb.54.156
   Gobin AS, 2006, INT J NANOMED, V1, P81, DOI 10.2147/nano.2006.1.1.81
   Greish K, 2009, BIOMACROMOLECULES, V10, P2183, DOI 10.1021/bm900356j
   Gustafson J, 2009, J CONTROL RELEASE, V140, P256, DOI 10.1016/j.jconrel.2009.05.022
   Gustafson JA, 2010, ADV DRUG DELIVER REV, V62, P1509, DOI 10.1016/j.addr.2010.04.006
   Guziewicz N, 2011, BIOMATERIALS, V32, P2642, DOI 10.1016/j.biomaterials.2010.12.023
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   HANAWA T, 1995, CHEM PHARM BULL, V43, P872
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hardy JG, 2010, PROG POLYM SCI, V35, P1093, DOI 10.1016/j.progpolymsci.2010.04.005
   Hines DJ, 2011, BIOMACROMOLECULES, V12, P804, DOI 10.1021/bm101421r
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Hino Tomoaki, 2000, Pharmacy and Pharmacology Communications, V6, P335
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2006, J BIOMECH, V39, P2232, DOI 10.1016/j.jbiomech.2005.07.007
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Imsombut T, 2010, POWDER TECHNOL, V203, P603, DOI 10.1016/j.powtec.2010.06.027
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kaplan D., 1997, PROTEIN BASED MAT
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Katayama H, 2000, BIOL PHARM BULL, V23, P1229
   Kikuchi J, 1999, BIOMATERIALS, V20, P647, DOI 10.1016/S0142-9612(98)00220-8
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kluge JA, 2010, J MECH BEHAV BIOMED, V3, P278, DOI 10.1016/j.jmbbm.2009.12.001
   Kundu J, 2010, INT J PHARMACEUT, V388, P242, DOI 10.1016/j.ijpharm.2009.12.052
   Kwon T. K., 2010, BIOMACROMOLECULES, V12, P466
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   LANGER R, 1980, CHEM ENG COMMUN, V6, P1, DOI 10.1080/00986448008912519
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Leal-Egana A, 2010, BIOTECHNOL APPL BIOC, V55, P155, DOI 10.1042/BA20090229
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Liu XY, 2009, MATER LETT, V63, P263, DOI 10.1016/j.matlet.2008.10.006
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Madduri S, 2010, BIOMATERIALS, V31, P2323, DOI 10.1016/j.biomaterials.2009.11.073
   Makaya K, 2009, J BIOSCI BIOENG, V108, P68, DOI 10.1016/j.jbiosc.2009.02.015
   MANDAL BB, 2009, BIOMATERIALS, V14, P2826
   Mandal BB, 2009, BIOMATERIALS, V30, P5170, DOI 10.1016/j.biomaterials.2009.05.072
   Mandal BB, 2009, EUR J PHARM SCI, V37, P160, DOI 10.1016/j.ejps.2009.02.005
   Mathur AB, 2010, NANOMEDICINE-UK, V5, P807, DOI 10.2217/NNM.10.51
   Matsumoto A, 2006, J PHYS CHEM B, V110, P21630, DOI 10.1021/jp056350v
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   MIYAIRI S, 1978, AGR BIOL CHEM TOKYO, V42, P1661, DOI 10.1080/00021369.1978.10863228
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Nathwani BB, 2009, IEEE T NANOBIOSCI, V8, P72, DOI 10.1109/TNB.2009.2017295
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Numata K, 2010, ADV DRUG DELIVER REV, V62, P1497, DOI 10.1016/j.addr.2010.03.009
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Pritchard EM, 2011, BIOMATERIALS, V32, P909, DOI 10.1016/j.biomaterials.2010.09.055
   Pritchard EM, 2010, J CONTROL RELEASE, V144, P159, DOI 10.1016/j.jconrel.2010.01.035
   Puppi D, 2010, PROG POLYM SCI, V35, P403, DOI 10.1016/j.progpolymsci.2010.01.006
   Putthanarat S, 2004, POLYMER, V45, P8451, DOI 10.1016/j.polymer.2004.10.014
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Szybala C, 2009, EXP NEUROL, V219, P126, DOI 10.1016/j.expneurol.2009.05.018
   Tang X, 2009, J BIOMED MATER RES A, V91A, P166, DOI 10.1002/jbm.a.32212
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Uebersax L, 2007, BIOMATERIALS, V28, P4449, DOI 10.1016/j.biomaterials.2007.06.034
   Uebersax L, 2006, BIOMATERIALS, V27, P4599, DOI 10.1016/j.biomaterials.2006.04.025
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang XQ, 2011, MACROMOL BIOSCI, V11, P100, DOI 10.1002/mabi.201000173
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang XQ, 2009, J CONTROL RELEASE, V134, P81, DOI 10.1016/j.jconrel.2008.10.021
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Wenk E, 2011, J CONTROL RELEASE, V150, P128, DOI 10.1016/j.jconrel.2010.11.007
   Wenk E, 2010, BIOMATERIALS, V31, P1403, DOI 10.1016/j.biomaterials.2009.11.006
   Wenk E, 2009, BIOMATERIALS, V30, P2571, DOI 10.1016/j.biomaterials.2008.12.073
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
   Wongpanit P, 2010, J BIOMAT SCI-POLYM E, V21, P1403, DOI 10.1163/092050609X12517858243706
   Wu YH, 2006, ANAL CHIM ACTA, V558, P179, DOI 10.1016/j.aca.2005.11.031
   Yang YM, 2009, POLYM DEGRAD STABIL, V94, P2213, DOI 10.1016/j.polymdegradstab.2009.09.002
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
   Zhang YQ, 1998, ANAL CHIM ACTA, V369, P123, DOI 10.1016/S0003-2670(98)00236-0
NR 114
TC 120
Z9 124
U1 9
U2 134
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5247
J9 EXPERT OPIN DRUG DEL
JI Expert Opin. Drug Deliv.
PD JUN
PY 2011
VL 8
IS 6
BP 797
EP 811
DI 10.1517/17425247.2011.568936
PG 15
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 765SM
UT WOS:000290728900007
PM 21453189
DA 2018-10-20
ER

PT J
AU Kadau, D
   Andrade, JS
   Herrmann, HJ
AF Kadau, Dirk
   Andrade, Jose S., Jr.
   Herrmann, Hans J.
TI A micromechanical model of collapsing quicksand
SO GRANULAR MATTER
LA English
DT Article
DE Granular matter; Contact dynamics simulations; Distinct element method;
   Quicksand; Collapsible soil; Biomaterial
ID ARTESIAN FLOW CONDITIONS; GRANULAR MEDIA; LIVING QUICKSAND;
   LIQUEFACTION; FLUIDIZATION; POWDERS; DRY
AB The discrete element method constitutes a general class of modeling techniques to simulate the microscopic behavior (i.e. at the particle scale) of granular/soil materials. We present a contact dynamics method, accounting for the cohesive nature of fine powders and soils. A modification of the model adjusted to capture the essential physical processes underlying the dynamics of generation and collapse of loose systems is able to simulate "quicksand" behavior of a collapsing soil material, in particular of a specific type, which we call "living quicksand". We investigate the penetration behavior of an object for varying density of the material. We also investigate the dynamics of the penetration process, by measuring the relation between the driving force and the resulting velocity of the intruder, leading to a "power law" behavior with exponent 1/2, i.e. a quadratic velocity dependence of the drag force on the intruder.
C1 [Kadau, Dirk; Herrmann, Hans J.] Swiss Fed Inst Technol, Inst Bldg Mat, CH-8093 Zurich, Switzerland.
   [Andrade, Jose S., Jr.; Herrmann, Hans J.] Univ Fed Cearaa, Dept Fis, BR-60451970 Fortaleza, Ceara, Brazil.
RP Kadau, D (reprint author), Swiss Fed Inst Technol, Inst Bldg Mat, CH-8093 Zurich, Switzerland.
EM dkadau@ethz.ch
RI Andrade, Jose/C-5451-2013; Sistemas Complexos, Inct/J-8597-2013; Kadau,
   Dirk/B-4697-2010; UFC, DF/E-1564-2017; Universidade Federal do Ceara,
   Physics Department/J-4630-2016
OI Andrade, Jose/0000-0002-5571-7610; Universidade Federal do Ceara,
   Physics Department/0000-0002-9247-6780
FU CNPq; CAPES; FUNCAP; PRO-NEX-CNPq/FUNCAP
FX We are deeply indebted to Ioannis Vardoulakis for his generosity in
   sharing his ideas and the inspiring discussions about this subject. We
   thank CNPq, CAPES, FUNCAP and the PRO-NEX-CNPq/FUNCAP grant for
   financial support.
CR Bahlmann L, 2002, RESUSCITATION, V53, P101, DOI 10.1016/S0300-9572(02)00009-6
   Bartels G, 2005, GRANUL MATTER, V7, P139, DOI 10.1007/s10035-004-0184-8
   BRENDEL L, 2003, AIDIC C SER, V6, P55
   Caballero G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018001
   Castro G, 1975, J GEOTECHNICAL ENGIN, V101, P551, DOI DOI 10.1016/0148-9062(75)92422-5
   Craig R.F., 1997, SOIL MECH
   ELSHAMY U, 2005, ENG MECH, P413
   Freundlich H, 1935, T FARADAY SOC, V31, P0769, DOI 10.1039/tf9353100769
   Huerta DA, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031307
   ISHIHARA K, 1993, GEOTECHNIQUE, V43, P351, DOI 10.1680/geot.1993.43.3.351
   JEAN M, 1992, CONTACT MECHANICS : INTERNATIONAL SYMPOSIUM, PROCEEDINGS, P31
   Kadau D, 2003, PHASE TRANSIT, V76, P315, DOI 10.1080/0141159021000051460
   Kadau D, 2009, EUR PHYS J E, V30, P275, DOI 10.1140/epje/i2009-10523-6
   KADAU D, 2003, CHEM ENG T, V3, P979
   Kadau D, 2010, AIP CONF PROC, V1227, P50, DOI 10.1063/1.3435420
   Kadau D, 2009, AIP CONF PROC, V1145, P981, DOI 10.1063/1.3180096
   Kadau D, 2009, GRANUL MATTER, V11, P67, DOI 10.1007/s10035-008-0117-z
   Khaldoun A, 2005, NATURE, V437, P635, DOI 10.1038/437635a
   Kruszelnicki K, 1996, NEW SCI, V152, P26
   Lambe T.W, 1969, SOIL MECH
   Lohse D, 2004, NATURE, V432, P689, DOI 10.1038/432689a
   MATTHES GH, 1953, QUICKSAND SCI AM, V188, P97
   MOREAU JJ, 1994, EUR J MECH A-SOLID, V13, P93
   Morgeneyer M., 2006, SCHRIFTENREIHE MECH, V9, P107
   PASTOR M, 1990, INT J NUM ANAL METH, V14
   Richefeu V, 2009, POWDER TECHNOL, V190, P258, DOI 10.1016/j.powtec.2008.04.069
   Royer JR, 2005, NAT PHYS, V1, P164, DOI 10.1038/nphys175
   Smith E. R, 1946, OHIO J SCI, V46, P327
   Taboada A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.098302
   Vardoulakis I, 2004, GEOTECHNIQUE, V54, P165, DOI 10.1680/geot.54.3.165.36345
   Vardoulakis I, 2004, GEOTECHNIQUE, V54, P117, DOI 10.1680/geot.54.2.117.36342
   VARDOULAKIS I, 1989, ING ARCH, V59, P106, DOI 10.1007/BF00538364
   Yamasaki S, 2003, SCI AM, V288, P95
NR 33
TC 10
Z9 10
U1 1
U2 14
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1434-5021
J9 GRANUL MATTER
JI Granul. Matter
PD JUN
PY 2011
VL 13
IS 3
SI SI
BP 219
EP 223
DI 10.1007/s10035-010-0236-1
PG 5
WC Materials Science, Multidisciplinary; Mechanics; Physics, Applied
SC Materials Science; Mechanics; Physics
GA 765AX
UT WOS:000290676900008
DA 2018-10-20
ER

PT J
AU Ji, W
   Sun, Y
   Yang, F
   van den Beucken, JJJP
   Fan, MW
   Chen, Z
   Jansen, JA
AF Ji, Wei
   Sun, Yan
   Yang, Fang
   van den Beucken, Jeroen J. J. P.
   Fan, Mingwen
   Chen, Zhi
   Jansen, John A.
TI Bioactive Electrospun Scaffolds Delivering Growth Factors and Genes for
   Tissue Engineering Applications
SO PHARMACEUTICAL RESEARCH
LA English
DT Review
DE electrospinning; gene delivery; protein delivery; scaffold; tissue
   engineering
ID PLGA/HAP COMPOSITE SCAFFOLDS; BOVINE SERUM-ALBUMIN; DRUG-DELIVERY;
   SUSTAINED-RELEASE; IN-VITRO; DNA DELIVERY; PLASMID DNA; PROTEIN
   INTERACTIONS; FIBER MESH; NANOFIBERS
AB A biomaterial scaffold is one of the key factors for successful tissue engineering. In recent years, an increasing tendency has been observed toward the combination of scaffolds and biomolecules, e. g. growth factors and therapeutic genes, to achieve bioactive scaffolds, which not only provide physical support but also express biological signals to modulate tissue regeneration. Huge efforts have been made on the exploration of strategies to prepare bioactive scaffolds. Within the past five years, electrospun scaffolds have gained an exponentially increasing popularity in this area because of their ultrathin fiber diameter and large surface-volume ratio, which is favored for biomolecule delivery. This paper reviews current techniques that can be used to prepare bioactive electrospun scaffolds, including physical adsorption, blend electrospinning, coaxial electrospinning, and covalent immobilization. In addition, this paper also analyzes the existing challenges (i.e., protein instability, low gene transfection efficiency, and difficulties in accurate kinetics prediction) to achieve biomolecule release from electrospun scaffolds, which necessitate further research to fully exploit the biomedical applications of these bioactive scaffolds.
C1 [Ji, Wei; Sun, Yan; Yang, Fang; van den Beucken, Jeroen J. J. P.; Jansen, John A.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat Dent 309, NL-6500 HB Nijmegen, Netherlands.
   [Ji, Wei; Sun, Yan; Fan, Mingwen; Chen, Zhi] Wuhan Univ, Key Lab Oral Biomed Engn, Minist Educ, Sch Stomatol, Wuhan 430079, Hubei Province, Peoples R China.
   [Ji, Wei; Sun, Yan; Fan, Mingwen; Chen, Zhi] Wuhan Univ, Key Lab Oral Biomed Engn, Minist Educ, Hosp Stomatol, Wuhan 430079, Hubei Province, Peoples R China.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen, Med Ctr, Dept Biomat Dent 309, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM J.Jansen@dent.umcn.nl
RI Jansen, John/H-8055-2014; Tarsitano, Elisa/D-6611-2015; Yang,
   Fang/E-1937-2011; van den beucken, Jeroen/B-8790-2013; Ji,
   Wei/G-8947-2011; van den beucken, jeroen/N-2910-2013
OI Yang, Fang/0000-0002-4022-7643; Ji, Wei/0000-0002-1473-5222; van den
   beucken, jeroen/0000-0002-0301-1966; Chen, Zhi/0000-0003-2095-1324
FU Royal Netherlands Academy of Arts and Sciences [PSA 08-PSA-M-02, CEP
   09-CDP-020]
FX This work is financially supported by Royal Netherlands Academy of Arts
   and Sciences (project no. PSA 08-PSA-M-02 & CEP 09-CDP-020).
CR Abbas AO, 2008, J PHARM SCI-US, V97, P2448, DOI 10.1002/jps.21215
   Agarwal S, 2009, ADV MATER, V21, P3343, DOI 10.1002/adma.200803092
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017
   Carpenter JF, 1997, PHARMACEUT RES, V14, P969, DOI 10.1023/A:1012180707283
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   Censi R, 2009, J CONTROL RELEASE, V140, P230, DOI 10.1016/j.jconrel.2009.06.003
   Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013
   Chen FM, 2010, BIOMATERIALS, V31, P6279, DOI 10.1016/j.biomaterials.2010.04.053
   Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149
   Choi JS, 2008, BIOMATERIALS, V29, P587, DOI 10.1016/j.biomaterials.2007.10.012
   Choi JS, 2007, J BIOACT COMPAT POL, V22, P508, DOI 10.1177/0883911507081101
   Cleland J L, 1997, Pharm Biotechnol, V10, P1
   De Laporte L, 2007, ADV DRUG DELIVER REV, V59, P292, DOI 10.1016/j.addr.2007.03.017
   Dong YX, 2009, TISSUE ENG PART B-RE, V15, P333, DOI [10.1089/ten.teb.2008.0619, 10.1089/ten.TEB.2008.0619]
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Estey T, 2006, J PHARM SCI-US, V95, P1626, DOI 10.1002/jps.20625
   Fernandez CA, 2009, MOL PHARMACEUT, V6, P1277, DOI 10.1021/mp900033j
   Fu YC, 2008, BIOTECHNOL BIOENG, V99, P996, DOI 10.1002/bit.21648
   Giteau A, 2008, INT J PHARM, V350, P14, DOI 10.1016/j.ijpharm.2007.11.012
   Grafahrend D, 2008, BIOTECHNOL BIOENG, V101, P609, DOI 10.1002/bit.21928
   Grassi Mario, 2005, Current Drug Delivery, V2, P97, DOI 10.2174/1567201052772906
   Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027
   Houchin ML, 2008, J PHARM SCI-US, V97, P2395, DOI 10.1002/jps.21176
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Ji W, 2010, ACTA BIOMATER, V6, P4199, DOI 10.1016/j.actbio.2010.05.025
   Jiang HL, 2005, J CONTROL RELEASE, V108, P237, DOI 10.1016/j.jconrel.2005.08.006
   Jiang HL, 2006, J BIOMED MATER RES B, V79B, P50, DOI 10.1002/jbm.b.30510
   Jiang WL, 2001, PHARMACEUT RES, V18, P878, DOI 10.1023/A:1011009117586
   JR P, 2009, Biotechnol Prog, V25, P1539
   Kim BS, 2009, BIOMATERIALS, V30, P902, DOI 10.1016/j.biomaterials.2008.10.030
   Kim HS, 2010, J CONTROL RELEASE, V145, P264, DOI 10.1016/j.jconrel.2010.03.006
   KNOLL D, 1983, J BIOL CHEM, V258, P5710
   Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257
   Kowalczyk T, 2008, BIOMACROMOLECULES, V9, P2087, DOI 10.1021/bm800421s
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li H, 2010, J BIOMAT SCI-POLYM E, V21, P803, DOI 10.1163/156856209X445302
   Li WS, 2008, J MATER SCI-MATER M, V19, P847, DOI 10.1007/s10856-007-3087-5
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li XQ, 2009, J APPL POLYM SCI, V111, P1564, DOI 10.1002/app.29056
   Li YB, 2008, J MATER SCI-MATER M, V19, P19, DOI 10.1007/s10856-007-3123-5
   Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gnil171
   Liao IC, 2006, NANOMEDICINE-UK, V1, P465, DOI 10.2217/17435889.1.4.465
   Liao IC, 2009, J CONTROL RELEASE, V139, P48, DOI 10.1016/j.jconrel.2009.06.007
   Lin C, 2009, EXPERT OPIN DRUG DEL, V6, P421, DOI [10.1517/17425240902878010, 10.1517/17425240902878010 ]
   Lu ZL, 2010, TISSUE ENG PT A, V16, P3075, DOI 10.1089/ten.tea.2010.0204
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Ma ZW, 2006, J MEMBRANE SCI, V272, P179, DOI 10.1016/j.memsci.2005.07.038
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Mahr JA, 1999, IMMUNOL REV, V168, P121, DOI 10.1111/j.1600-065X.1999.tb01287.x
   Martins A, 2010, BIOMATERIALS, V31, P5875, DOI 10.1016/j.biomaterials.2010.04.010
   Michel R, 2005, LANGMUIR, V21, P12327, DOI 10.1021/la051726h
   Moioli EK, 2007, ADV DRUG DELIVER REV, V59, P308, DOI 10.1016/j.addr.2007.03.019
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Murugan R, 2006, TISSUE ENG, V12, P435, DOI 10.1089/ten.2006.12.435
   Nie H, 2008, BIOTECHNOL BIOENG, V99, P223, DOI 10.1002/bit.21517
   Nie HM, 2007, J CONTROL RELEASE, V120, P111, DOI 10.1016/j.jconrel.2007.03.018
   Nie H, 2009, BIOMATERIALS, V30, P892, DOI 10.1016/j.biomaterials.2008.10.029
   Noguchi P, 2003, NEW ENGL J MED, V348, P193, DOI 10.1056/NEJMp020184
   Park Y, 2010, J CONTROL RELEASE, V148, P75, DOI 10.1016/j.jconrel.2010.06.027
   Pham QP, 2006, TISSUE ENG, V12, P1197, DOI 10.1089/ten.2006.12.1197
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   Roy K, 2003, MOL THER, V7, P401, DOI 10.1016/1525-0016(03)00008-X
   Sahoo S, 2009, J BIOMED MATER RES A, V93, P1539
   Sakai S, 2009, J BIOMED MATER RES A, V88A, P281, DOI 10.1002/jbm.a.31870
   Saraf A, 2010, J CONTROL RELEASE, V143, P95, DOI 10.1016/j.jconrel.2009.12.009
   Schneider A, 2009, ACTA BIOMATER, V5, P2570, DOI 10.1016/j.actbio.2008.12.013
   Shi Y, 2009, CRIT REV THER DRUG, V26, P29, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i1.20
   Siepmann J, 2008, INT J PHARMACEUT, V364, P328, DOI 10.1016/j.ijpharm.2008.09.004
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Tabata Yasuhiko, 2000, Pharmaceutical Science and Technology Today, V3, P80, DOI 10.1016/S1461-5347(00)00242-X
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   van der Walle CF, 2009, EXPERT OPIN DRUG DEL, V6, P177, DOI [10.1517/17425240802680169 , 10.1517/17425240802680169]
   Varkey Mathew, 2004, Expert Opin Drug Deliv, V1, P19, DOI 10.1517/17425247.1.1.19
   Vasir JK, 2007, ADV DRUG DELIVER REV, V59, P718, DOI 10.1016/j.addr.2007.06.003
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Wang F, 2010, ACTA BIOMATER, V6, P1978, DOI 10.1016/j.actbio.2009.12.011
   [王建广 Wang Jianguang], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P4440
   Wang Y, 2007, J PHYS CHEM B, V111, P1222, DOI 10.1021/jp065608u
   Yang F, 2009, ACTA BIOMATER, V5, P3295, DOI 10.1016/j.actbio.2009.05.023
   YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568
   Yang Y, 2008, J BIOMED MATER RES A, V86A, P374, DOI 10.1002/jbm.a.31595
   Yang Y, 2008, EUR J PHARM BIOPHARM, V69, P106, DOI 10.1016/j.ejpb.2007.10.016
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
   Zhang YZ, 2006, BIOMACROMOLECULES, V7, P1049, DOI 10.1021/bm050743i
   Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52
NR 91
TC 179
Z9 181
U1 7
U2 200
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
J9 PHARM RES-DORDR
JI Pharm. Res.
PD JUN
PY 2011
VL 28
IS 6
BP 1259
EP 1272
DI 10.1007/s11095-010-0320-6
PG 14
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 766RK
UT WOS:000290804000003
PM 21088985
OA Other Gold, Green Published
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Wang, Y
   Wei, YT
   Zu, ZH
   Ju, RK
   Guo, MY
   Wang, XM
   Xu, QY
   Cui, FZ
AF Wang, Ying
   Wei, Yue Teng
   Zu, Zhao Hui
   Ju, Rong Kai
   Guo, Mu Yao
   Wang, Xiu Mei
   Xu, Qun Yuan
   Cui, Fu Zhai
TI Combination of Hyaluronic Acid Hydrogel Scaffold and PLGA Microspheres
   for Supporting Survival of Neural Stem Cells
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE central nervous system; controlled release; growth factor; hyaluronic
   acid hydrogel; PLGA microsphere
ID ENDOTHELIAL GROWTH-FACTOR; NEUROTROPHIC FACTOR BDNF; IN-VITRO; NEURITE
   OUTGROWTH; DELIVERY-SYSTEM; DRUG-DELIVERY; BRAIN; RECEPTOR; INJURY;
   REPAIR
AB Purpose To develop a biomaterial composite for promoting proliferation and migration of neural stem cells (NSCs), as well as angiogenesis on the materials, to rescue central nervous system (CNS) injuries.
   Methods A delivery system was constructed based on crosslinked hyaluronic acid (HA) hydrogels, containing embedded BDNF and VEGF-loaded poly(lactic-co-glycolic acid) (PLGA) microspheres for controlled delivery and support for NSCs in the CNS. The surface morphologies were evaluated by SEM and AFM, mechanical property was investigated by rheological tests, and release kinetics were performed by ELISA. Bioactivity of released BDNF and VEGF was assessed by neuron and endothelial cell culture, respectively. Compatibility with NSCs was studied by immunofluorescent staining.
   Results Release kinetics showed the delivery of BDNF and VEGF from PLGA microspheres and HA hydrogel composite were sustainable and stable, releasing similar to 20-30% within 150 h. The bioactivities preserved well to promote survival and growth of the cells. Evaluation of structure and mechanical properties showed the hydrogel composite possessed an elastic scaffold structure. Biocompatibility assay showed NSCs adhered and proliferated well on the hydrogel.
   Conclusions Our created HA hydrogel/PLGA microsphere systems have a good potential for controlled delivery of varied biofactors and supporting NSCs for brain repair and implantation.
C1 [Wang, Ying; Ju, Rong Kai; Xu, Qun Yuan] Capital Med Univ, Beijing Inst Neurosci, Beijing Ctr Neutral Regenerat & Repair, Key Lab Neurodegenerat Dis,Minist Educ, Beijing 100069, Peoples R China.
   [Wang, Ying; Wei, Yue Teng; Guo, Mu Yao; Wang, Xiu Mei; Cui, Fu Zhai] Tsinghua Univ, Inst Regenerat Med & Biomimet Mat, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
   [Zu, Zhao Hui] Capital Med Univ, FuXing Hosp, Dept Neurosurg, Beijing 100038, Peoples R China.
RP Xu, QY (reprint author), Capital Med Univ, Beijing Inst Neurosci, Beijing Ctr Neutral Regenerat & Repair, Key Lab Neurodegenerat Dis,Minist Educ, Beijing 100069, Peoples R China.
EM xuqy@ccmu.edu.cn; cuifz@mail.tsinghua.edu.cn
RI Wei, Yueteng/B-4653-2012
FU NSFC [30670656, 50973052, 30911120495, 81070977]; National Basic
   Research Program of China (973 Program) [2005CB623905, 2010CB606205]
FX We thank the NSFC (No. 30670656, No. 50973052, No. 30911120495, No.
   81070977) and the National Basic Research Program of China (973 Program)
   (No. 2005CB623905, No. 2010CB606205) for support of funding.
CR Abe K, 2000, J CEREBR BLOOD F MET, V20, P1393, DOI 10.1097/00004647-200010000-00001
   AMICO B, 1993, ANAT EMBRYOL, V188, P419
   Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015
   CHIARA P, 2008, PLOS ONE, V7, P1
   Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084
   Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x
   Hou S, 2006, NEUROSCIENCE, V137, P519, DOI 10.1016/j.neuroscience.2005.09.029
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028
   JASON MB, 2010, NAT REV, V10, P138
   JOHE KK, 1996, GENES, P3129
   Kazanis I, 2008, NEURAL STEM CELL MIC
   LAUREN L, 2008, CHEM REV, V108, P1787
   PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550
   Pardridge WM, 1998, PHARMACEUT RES, V15, P576, DOI 10.1023/A:1011981927620
   PETER AW, 2009, STEM CELL REV, V5, P283
   QIN S, 2008, CELL STEM CELL, V3, P289
   RUTLEDGE G, 2006, P NATL ACAD SCI USA, V103, P5054
   Schanzer A, 2004, BRAIN PATHOL, V14, P237
   Tang JR, 2009, NEUROL INDIA, V57, P387, DOI 10.4103/0028-3886.55583
   Taoufik E, 2008, P NATL ACAD SCI USA, V105, P6185, DOI 10.1073/pnas.0801447105
   Tian WM, 2005, J CONTROL RELEASE, V102, P13, DOI 10.1016/j.jconrel.2004.09.025
   Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867
   Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956
   YONG JR, 2009, J BIOACT COMPAT POLY, V24, P56
NR 26
TC 54
Z9 57
U1 2
U2 85
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD JUN
PY 2011
VL 28
IS 6
BP 1406
EP 1414
DI 10.1007/s11095-011-0452-3
PG 9
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 766RK
UT WOS:000290804000016
PM 21537876
DA 2018-10-20
ER

PT J
AU Hyotyla, JT
   Deng, J
   Lim, RYH
AF Hyotyla, Janne T.
   Deng, Jie
   Lim, Roderick Y. H.
TI Synthetic Protein Targeting by the Intrinsic Biorecognition
   Functionality of Poly(ethylene glycol) Using PEG Antibodies as Biohybrid
   Molecular Adaptors
SO ACS NANO
LA English
DT Article
DE biointerface; biomimetics; biomaterials; biosensing; protein microarray;
   PEGylation; polymer brush; antibody; protein targeting; nuclear pore
   complex
ID POLYMER BRUSHES; SURFACES; BIOMATERIALS; MEMBRANES
AB Biointerfaces capable of biological recognition and specificity are sought after for conferring bioinspired functionality onto synthetic biomaterials systems. This is important for biosensing, bioseparations, and biomedical materials. Here, we demonstrate how intrinsic polymer protein interactions between highly localized polyethylene glycol (PEG) brushes and PEG-binding antibodies can be used for sorting specific biomolecules from complex bulk biological fluids to synthetic nanoscale targets. A principal feature lies with the antifouling property of PEG that prevents unspecific binding. Exclusive access is provided by anti-PEG, which acts as a biohybrid molecular adaptor that sifts out and targets specific IgG "cargo" from solution to the PEG. The PEG can be reversibly washed and targeted in blood serum, which suggests potential benefits in technological applications. Moreover, anti-PEG binding triggers a stimuli-responsive conformational collapse in the PEG brush, thereby imparting an intrinsic "smart" biorecognition functionality to the PEG that can considerably impact its use as an antifouling biomaterial.
C1 [Hyotyla, Janne T.; Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hyotyla, Janne T.; Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Deng, Jie] A STAR Agency Sci Technol & Res, Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Lim, RYH (reprint author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
RI Hyotyla, Janne/C-5640-2008
OI Hyotyla, Janne/0000-0002-4323-5817; Lim, Roderick/0000-0001-5015-6087
FU National Centre of Competence in Research "Nanoscale Science"
   (NCCR-Nano); Swiss National Science Foundation; Canton Basel-Stadt
FX We especially thank S. R. Roffler for the kind gift of E11. Thanks also
   to L. Kreplak, P. Rigler, U. Silvan, and E. K. Sinner for helpful
   comments and suggestions. Further acknowledgements go to R. Schoch for
   the SPR measurements and the SERC Nanofabrication and Characterisation
   Facility (SNFC) at the Institute of Materials Research and Engineering
   (Singapore) for the usage of equipment and facilities. This work is
   supported by the National Centre of Competence in Research "Nanoscale
   Science" (NCCR-Nano), the Swiss National Science Foundation, and the
   Canton Basel-Stadt.
CR Asatekin A, 2007, J MEMBRANE SCI, V298, P136, DOI 10.1016/j.memsci.2007.04.011
   Barbey R, 2009, CHEM REV, V109, P5437, DOI 10.1021/cr900045a
   Blobel G, 2000, CHEMBIOCHEM, V1, P87
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761
   Cheng TL, 2005, BIOCONJUGATE CHEM, V16, P1225, DOI 10.1021/bc050133f
   Cheng TL, 1999, BIOCONJUGATE CHEM, V10, P520, DOI 10.1021/bc980143z
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Falconnet D, 2004, NANO LETT, V4, P1909, DOI 10.1021/nl0489438
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Granick S, 2003, J POLYM SCI POL PHYS, V41, P2755, DOI 10.1002/polb.10669
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Halperin A, 2009, LANGMUIR, V25, P11621, DOI 10.1021/la9008569
   Harris J.M., 1992, POLYETHYLENE GLYCOL
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2009, ACS NANO, V3, P2911, DOI 10.1021/nn900152m
   Mitchell P, 2002, NAT BIOTECHNOL, V20, P225, DOI 10.1038/nbt0302-225
   Morra M, 2000, J BIOMAT SCI-POLYM E, V11, P547, DOI 10.1163/156856200743869
   Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]
   Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5
   Ratner BD, 1996, J MOL RECOGNIT, V9, P617, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<617::AID-JMR310>3.0.CO;2-D
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Ruiz-Taylor LA, 2001, P NATL ACAD SCI USA, V98, P852, DOI 10.1073/pnas.98.3.852
   Su YC, 2010, BIOCONJUGATE CHEM, V21, P1264, DOI 10.1021/bc100067t
   Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204
   TOMPA P, 2010, STRUCTURE FUNCTION I
   Tugulu S, 2005, BIOMACROMOLECULES, V6, P1602, DOI 10.1021/bm050016n
   Ulbricht M, 2006, POLYMER, V47, P2217, DOI 10.1016/j.polymer.2006.01.084
   Wu P, 2008, J BIOMAT SCI-POLYM E, V19, P725, DOI 10.1163/156856208784522092
   Yoshimoto K, 2010, J AM CHEM SOC, V132, P7982, DOI 10.1021/ja910372e
NR 35
TC 9
Z9 9
U1 2
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD JUN
PY 2011
VL 5
IS 6
BP 5180
EP 5187
DI 10.1021/nn201327y
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 783AZ
UT WOS:000292055200109
PM 21627081
DA 2018-10-20
ER

PT J
AU Du, X
   Li, J
   Chen, YY
AF Du, Xin
   Li, Jun
   Chen, Yuyin
TI Proteomic analysis of sericin in Bombyx mori cocoons
SO BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
LA English
DT Article
DE bioinformatics; Bombyx mori; proteomics; PTMs; sericin
ID POLYACRYLAMIDE-GEL-ELECTROPHORESIS; SILK SERICIN; EXTRACTION METHODS;
   PROTEIN; IDENTIFICATION; GLAND; GENE; FIBROIN; PHOSPHORYLATION;
   BIOMATERIALS
AB Cocoon sericin plays an important role in the reeling of silk and serves as a valuable biomaterial in the field of biomedicine, skincare, and food industries; however, knowledge about cocoon sericin proteins has been limited. For a comprehensive study on sericin, cocoons of eight varieties of silkworm of different geographic origin and with varied cocoon color were analyzed utilizing proteomics and bioinformatics approaches. The electrophoresis pattern demonstrated some common protein bands for all silkworm varieties and distinctive protein bands for some of those examined in the present study. The Ser2 protein, a new Ser3 protein, and four other novel sericin proteins were identified in cocoons for the first time. Products of both Ser1 and Ser3 genes appear to be ubiquitous in the cocoon shell of Bombyx mori. In addition, cocoons with especially high-reelability produced by the mutant strain B84 had an unique protein product of the Ser2 gene, indicating that the protein may play an important role in cocoon reelability. A series of sequence conflicts and post-translational modifications (PTMs) were also revealed in sericin proteins. Lipid modifications of sericin proteins, which promote waterproofing of the cocoon shell, were observed. Further, hydroxylation was identified, which provided evidence for intermolecular bonds among neighboring molecules of sericin as found in collagens. The sericin proteome data obtained from this study illuminated the molecular complexity of cocoon sericin and contributed to our understanding of the properties of sericin in filature and biomaterials.
C1 [Du, Xin; Li, Jun; Chen, Yuyin] Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Zhejiang, Peoples R China.
RP Du, X (reprint author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310029, Zhejiang, Peoples R China.
EM chenyy@zju.edu.cn
FU National Hi-Tech Research and Development Program of China
   [2006AA10A118]; National Basic Research Program of China [2005CB121003]
FX This work was supported by the National Hi-Tech Research and Development
   Program of China (Grant No. 2006AA10A118) and the National Basic
   Research Program of China (Grant No. 2005CB121003).
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Aramwit P, 2010, INT J MOL SCI, V11, P2200, DOI 10.3390/ijms11052200
   Aramwit P, 2010, BIOTECHNOL APPL BIOC, V55, P91, DOI 10.1042/BA20090186
   Chen WQ, 2010, PROTEOMICS, V10, P369, DOI 10.1002/pmic.200900624
   Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619
   GAMO T, 1973, Journal of Sericultural Science of Japan, V42, P17
   GAMO T, 1977, INSECT BIOCHEM, V7, P285, DOI 10.1016/0020-1790(77)90026-9
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   JOHNSTON DA, 1984, ELECTROPHORESIS, V5, P110, DOI 10.1002/elps.1150050209
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kurioka A, 2002, BIOSCI BIOTECH BIOCH, V66, P1396, DOI 10.1271/bbb.66.1396
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x
   Martel A, 2007, BIOMACROMOLECULES, V8, P3548, DOI 10.1021/bm700935w
   MICHAILLE JJ, 1986, BIOCHIMIE, V68, P1165, DOI 10.1016/S0300-9084(86)80060-8
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Miwa N, 2010, INT DAIRY J, V20, P393, DOI 10.1016/j.idairyj.2009.12.015
   Nakajima M., 1963, B FAC AGR TOKYO, V8, P1
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   SPRAGUE KU, 1975, BIOCHEMISTRY-US, V14, P925, DOI 10.1021/bi00676a008
   Stewart RJ, 2010, BIOMACROMOLECULES, V11, P969, DOI 10.1021/bm901426d
   Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067
   Takasu Y., 2006, Sanshi Konchuu Biotec (Journal of Insect Biotechnology and Sericology), V75, P133
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Takasu Y, 2007, INSECT BIOCHEM MOLEC, V37, P1234, DOI 10.1016/j.ibmb.2007.07.009
   Takasu Yoko, 2002, Journal of Insect Biotechnology and Sericology, V71, P151
   Takasu Y, 2010, INSECT BIOCHEM MOLEC, V40, P339, DOI 10.1016/j.ibmb.2010.02.010
   Tamura Y, 2002, PHYTOCHEMISTRY, V59, P275, DOI 10.1016/S0031-9422(01)00477-0
   Tao W, 2005, MACROMOL MATER ENG, V290, P188, DOI 10.1002/mame.200400306
   Teramoto H, 2006, MACROMOLECULES, V39, P6, DOI 10.1021/ma0521147
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Teramoto H, 2004, BIOMACROMOLECULES, V5, P1392, DOI 10.1021/bm034537r
   Teramoto H, 2007, MACROMOLECULES, V40, P1562, DOI 10.1021/ma062604e
   TOKUTAKE S, 1980, BIOCHEM J, V187, P413, DOI 10.1042/bj1870413
   WEN CM, 1990, ANN ALLERGY, V65, P375
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Wu W, 2006, POLYM INT, V55, P513, DOI 10.1002/pi.1993
   Zhang PB, 2006, PROTEOMICS, V6, P2586, DOI 10.1002/pmic.200500348
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
NR 42
TC 3
Z9 4
U1 1
U2 43
PU KOREAN SOC BIOTECHNOLOGY & BIOENGINEERING
PI SEOUL
PA KOREAN SCIENCE TECHNOLOGY CENTER, #704 YEOGSAM-DONG, KANGNAM-KU, SEOUL
   135-703, SOUTH KOREA
SN 1226-8372
J9 BIOTECHNOL BIOPROC E
JI Biotechnol. Bioprocess Eng.
PD JUN
PY 2011
VL 16
IS 3
BP 438
EP 444
DI 10.1007/s12257-010-0425-0
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 785CJ
UT WOS:000292204700002
DA 2018-10-20
ER

PT J
AU Caldas, HC
   Fernandes, IMM
   Kawasaki-Oyama, RS
   Baptista, MASF
   Plepis, AMG
   Martins, VA
   Coimbra, TM
   Goloni-Bertollo, EM
   Braile, DM
   Abbud, M
AF Caldas, Heloisa C.
   Fernandes, Ida M. M.
   Kawasaki-Oyama, Rosa S.
   Baptista, Maria Alice S. F.
   Plepis, Ana Maria G.
   Martins, Virginia A.
   Coimbra, Terezila M.
   Goloni-Bertollo, Eny M.
   Braile, Domingo M.
   Abbud-Filho, Mario
TI Effect of stem cells seeded onto biomaterial on the progression of
   experimental chronic kidney disease
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE collagen; fibrosis; mesenchymal stem cell; scaffold; stem cell
ID CHRONIC-RENAL-FAILURE; REPAIR; MODEL; RATS; FIBROSIS; INJURY; TISSUE
AB Different routes for the administration of bone marrow-derived cells (BMDC) have been proposed to treat the progression of chronic renal failure (CRF). We investigated whether (1) the use of bovine pericardium (BP) as a scaffold for cell therapy would retard the progression of CAF and (2) the efficacy of cell therapy differently impacts distinct degrees of CRF. We used 2/3 and 5/6 models of renal mass reduction to simulate different stages of chronicity. Treatments consisted of BP seeded with either mesenchymal or mononuclear cells implanted in the parenchyma of remnant kidney. Renal function and proteinuria were measured at days 45 and 90 after cell implantation. BMDC treatment reduced glomerulosclerosis, interstitial fibrosis and lymphocytic infiltration. Immunohistochemistry showed decreased macrophage accumulation, proliferative activity and the expression of fibronectin and alpha-smooth muscle-actin. Our results demonstrate: (1) biomaterial combined with BMDC did retard the progression of experimental CRF; (2) cellular therapy stabilized serum creatinine (sCr), improved creatinine clearance and 1/sCr slope when administered during the less severe stages of CRF; (3) treatment with combined therapy decreased glomerulosclerosis, fibrosis and the expression of fibrogenic molecules; and (4) biomaterials seeded with BMDC can be an alternative route of cellular therapy.
C1 [Caldas, Heloisa C.; Fernandes, Ida M. M.; Kawasaki-Oyama, Rosa S.; Baptista, Maria Alice S. F.; Braile, Domingo M.; Abbud-Filho, Mario] Med Sch Sao Jose do Rio Preto FAMERP FUNFARME, Lab Immunol & Expt Transplantat LITEX, Dept Med, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Plepis, Ana Maria G.; Martins, Virginia A.] Univ Sao Paulo, Inst Quim, Dept Chem, BR-13560970 Sao Carlos, SP, Brazil.
   [Coimbra, Terezila M.] USP Med Sch Ribeirao Preto, Dept Physiol & Pathol, BR-14049900 Ribeirao Preto, SP, Brazil.
   [Goloni-Bertollo, Eny M.] FAMERP FUNFARME, Genet & Mol Biol Res Unit UPGEM, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Abbud, M (reprint author), Med Sch Sao Jose do Rio Preto, Lab Immunol & Transplantat Expt LITEX, Dept Med, Av Brigadeiro Faria Lima 5416, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mabbud@terra.com.br
RI Plepis, Ana/J-2559-2012; Goloni-Bertollo, Eny/B-8405-2012; Martins,
   Virginia/H-5832-2012; Kawasaki-Oyama, Rosa/L-3222-2015
OI Plepis, Ana/0000-0002-4360-8433; Goloni-Bertollo,
   Eny/0000-0002-2622-4673; Martins, Virginia/0000-0001-7565-9641;
   Kawasaki-Oyama, Rosa/0000-0003-4235-0925; Abbud-Filho,
   Mario/0000-0002-5079-9813; BRAILE, DOMINGO
   MARCOLINO/0000-0001-7704-2258; Caldas, Heloisa/0000-0002-0948-9821
FU FAPESP; CNPq; FAMERP/FUNFARME; FAMERP-BAP
FX We thank Rita Cavaglieri for her skilled technical assistance. This work
   received partial financial support from FAPESP, CNPq and FAMERP/FUNFARME
   and was partially supported by grants from the FAMERP-BAP.
CR Alexandre CS, 2009, STEM CELLS, V27, P682, DOI 10.1634/stemcells.2008-0496
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Atala A, 2008, PEDIATR RES, V63, P569, DOI 10.1203/PDR.0b013e3181660639
   Bet MR, 2001, BIOMACROMOLECULES, V2, P1074, DOI 10.1021/bm0001188
   Caldas HC, 2008, TRANSPL P, V40, P853, DOI 10.1016/j.transproceed.2008.03.009
   Cavaglieri RC, 2009, TRANSPL P, V41, P947, DOI 10.1016/j.transproceed.2009.01.072
   Choi S, 2009, STEM CELLS DEV, V18, P521, DOI 10.1089/scd.2008.0097
   Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x
   CURTIS JJ, 1976, NEPHRON, V17, P259, DOI 10.1159/000180730
   de Borst MH, 2009, J PHARMACOL EXP THER, V331, P896, DOI 10.1124/jpet.109.154179
   Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x
   GABIZON D, 1985, NEPHRON, V40, P349, DOI 10.1159/000183491
   Herrera MB, 2004, INT J MOL MED, V14, P1035
   Hishikawa K, 2006, HYPERTENS RES, V29, P745, DOI 10.1291/hypres.29.745
   HOSTETTER TH, 1995, ANNU REV PHYSIOL, V57, P263, DOI 10.1146/annurev.ph.57.030195.001403
   Jones KS, 2008, SEMIN IMMUNOL, V20, P130, DOI 10.1016/j.smim.2007.11.005
   KHWAJA A, 2009, NEPHRON CLIN PRACT, V113, P207
   Kim BS, 2000, WORLD J UROL, V18, P2, DOI 10.1007/s003450050002
   Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95
   Ma FY, 2009, LAB INVEST, V89, P470, DOI 10.1038/labinvest.2009.2
   Miguel FB, 2006, J BIOMED MATER RES B, V78B, P334, DOI 10.1002/jbm.b.30492
   Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Remuzzi A, 2006, KIDNEY INT, V69, P1124, DOI 10.1038/sj.ki.5000060
   RICARDO DS, 2008, J CLIN INVEST, V118, P3522
   Roessger A, 2009, BIOMATERIALS, V30, P3723, DOI 10.1016/j.biomaterials.2009.03.041
   Romagnani P, 2009, FIBROGENESIS TISSUE, V26, P3
   Semedo P, 2009, STEM CELLS, V27, P3063, DOI 10.1002/stem.214
   Szabo AJ, 2008, NEPHROL DIAL TRANSPL, V23, P2492, DOI 10.1093/ndt/gfn112
   Togel F, 2005, AM J PHYSIOL-RENAL, V289, P31
   Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474
NR 31
TC 7
Z9 8
U1 0
U2 9
PU SOC EXPERIMENTAL BIOLOGY MEDICINE
PI MAYWOOD
PA 195 WEST SPRING VALLEY AVE, MAYWOOD, NJ 07607-1727 USA
SN 1535-3702
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD JUN
PY 2011
VL 236
IS 6
BP 746
EP 754
DI 10.1258/ebm.2011.011024
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 784AZ
UT WOS:000292127300014
PM 21606119
DA 2018-10-20
ER

PT J
AU Dao, TT
   Pouletaut, P
   Goebel, JC
   Pinzano, A
   Gillet, P
   Tho, MCHB
AF Dao, T. T.
   Pouletaut, P.
   Goebel, J. -C.
   Pinzano, A.
   Gillet, P.
   Tho, M. C. Ho Ba
TI In vivo characterization of morphological properties and contact areas
   of the rat cartilage derived from high-resolution MRI
SO IRBM
LA English
DT Article
DE Rat cartilage; Osteoarthritis knee; Morphological properties; Contact
   area; High-resolution MRI
ID TOTAL KNEE ARTHROPLASTY; 3-DIMENSIONAL ASSESSMENT; NONINVASIVE
   TECHNIQUE; THICKNESS; OSTEOARTHRITIS; REPRODUCIBILITY; VOLUME; MODEL;
   JOINT
AB Knee osteoarthritis deals with the loss of cartilaginous substances. Biomaterial implant using mesenchymal stromal cells was usually used to perform cartilage regeneration. The bio-integration and biofunctionality assessments of the used biomaterial implant on the injury sites require the longitudinal monitoring of the cartilage over times. The aim of this present study was to develop a characterization framework of the cartilage in knee osteoarthritis especially its morphological properties and contact areas derived from high-resolution magnetic resonance imaging (MRI) technique. Manual segmentation procedure was applied for extracting cartilage from surrounding biological tissues. Geometrical computing techniques were applied to calculate characterization properties of the rat cartilage. As clinical case study, curvature, thickness, volume and relative contact area properties of the rat cartilage in knee osteoarthritis were quantified on each knee full model and/or its region of interest (ROI) models. We found that the cartilage thickness and volume of three cartilage compartments decrease at the beginning (from 7 to 28 days). Tibial cartilage thickness increases at the end of the osteoarthritis process (from 28 to 56 days). This is due to the fact that the cartilage swelling occurred during osteoarthritis process. These findings were confirmed when observing cartilage curvature; we noted that there is an increasing curvature due to the incurvation effect of the cartilage during osteoarthritis process. The relative contact areas of three cartilage compartments increase slightly. However, the difference between control knees and osteoarthritis knees is significant. ROIs analyses of the thickness and curvature properties were also reported on the femoral and tibial cartilages. (C) 2011 Elsevier Masson SAS. All rights reserved.
C1 [Dao, T. T.; Pouletaut, P.; Tho, M. C. Ho Ba] Univ Technol Compiegne, CNRS, UTC, UMR 6600, F-60205 Compiegne, France.
   [Goebel, J. -C.] Univ Lyon 1, INSA Lyon, CNRS UMR 5220, Inserm U360,CREATIS LRMN,Ctr Rech Imagerie Med, F-69621 Villeurbanne, France.
   [Pinzano, A.; Gillet, P.] Nancy Univ, PPIA, F-54003 Nancy, France.
RP Tho, MCHB (reprint author), Univ Technol Compiegne, CNRS, UTC, UMR 6600, BP 20529, F-60205 Compiegne, France.
EM hobatho@utc.fr
RI Tien Tuan, DAO/G-1141-2010; HO BA THO, Marie-Christine/J-1946-2012
OI HO BA THO, Marie-Christine/0000-0003-1192-0075; Dao,
   Tien-Tuan/0000-0002-5088-3433
FU Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0150-01]
FX The authors would like to thank the laboratory of Creatis-LRMN (Lyon)
   for the collection of images analyzed in this study. This project was
   granted by the Agence Nationale de la Recherche (ANR) with the reference
   ANR-09-BLAN-0150-01.
CR Akhtar S, 2007, OSTEOARTHR CARTILAGE, V15, P1070, DOI 10.1016/j.joca.2007.03.009
   ANDREISEKY LM, 2009, OSTEOARTHR CARTILAGE, V17, P871
   ATESHIAN GA, 1992, J BIOMECH, V25, P591, DOI 10.1016/0021-9290(92)90102-7
   Borjesson M, 2005, KNEE, V12, P121, DOI 10.1016/j.knee.2004.04.002
   Boulocher C, 2007, OSTEOARTHR CARTILAGE, V15, P1378, DOI 10.1016/j.joca.2007.04.012
   Bowers ME, 2008, OSTEOARTHR CARTILAGE, V16, P1167, DOI 10.1016/j.joca.2008.03.005
   Bowers ME, 2008, OSTEOARTHR CARTILAGE, V16, P572, DOI 10.1016/j.joca.2007.09.010
   Carballido-Gamio J, 2008, MED IMAGE ANAL, V12, P120, DOI 10.1016/j.media.2007.08.002
   Cohen ZA, 1999, OSTEOARTHR CARTILAGE, V7, P95, DOI 10.1053/joca.1998.0165
   Ding C, 2007, OSTEOARTHR CARTILAGE, V15, P479, DOI 10.1016/j.joca.2007.01.003
   Draper CE, 2006, OSTEOARTHR CARTILAGE, V14, P931, DOI 10.1016/j.joca.2006.03.006
   Eckstein F, 2006, OSTEOARTHR CARTIL S1, V14, P46
   Goebel JC, 2010, RHEUMATOLOGY, V49, P1654, DOI 10.1093/rheumatology/keq154
   Goebel JC, 2008, BIO-MED MATER ENG, V18, P247, DOI 10.3233/BME-2008-0533
   Harris ML, 1999, J BIOMECH, V32, P951, DOI 10.1016/S0021-9290(99)00072-X
   Haubner M, 1997, MAGN RESON IMAGING, V15, P805, DOI 10.1016/S0730-725X(97)00011-8
   Hunter DJ, 2010, OSTEOARTHR CARTILAGE, V18, P175, DOI 10.1016/j.joca.2009.08.002
   Jackson BD, 2004, J SCI MED SPORT, V7, P347, DOI 10.1016/S1440-2440(04)80030-6
   Koo S, 2005, OSTEOARTHR CARTILAGE, V13, P782, DOI 10.1016/j.joca.2005.04.013
   Li G, 2005, CLIN BIOMECH, V20, P736, DOI 10.1016/j.clinbiomech.2005.04.001
   Losch A, 1997, MAGN RESON IMAGING, V15, P795, DOI 10.1016/S0730-725X(97)00012-X
   Lu TW, 2007, GAIT POSTURE, V26, P553, DOI 10.1016/j.gaitpost.2006.12.002
   Magid E, 2007, COMPUT VIS IMAGE UND, V107, P139, DOI 10.1016/j.cviu.2006.09.007
   POULETAUT P, 2005, 20 C GRETSI LOUV LA, P45
   REJESKI WJ, 1995, OSTEOARTHR CARTILAGE, V3, P157, DOI 10.1016/S1063-4584(05)80050-0
   Swanson MS, 2010, OSTEOARTHR CARTILAGE, V18, P344, DOI 10.1016/j.joca.2009.10.004
   Szilvasi-Nagy M, 2003, MATH COMPUT MODEL, V38, P945, DOI 10.1016/S0895-7177(03)00296-6
   von Engelhardt LV, 2007, ARTHROSCOPY, V23, P496, DOI 10.1016/j.arthro.2006.12.027
   Wallace AL, 1998, J ARTHROPLASTY, V13, P923, DOI 10.1016/S0883-5403(98)90200-5
   Zuo J, 2008, MAGN RESON IMAGING, V26, P560, DOI 10.1016/j.mri.2007.10.007
   2008, AMIRA USERS GUIDE VI
NR 31
TC 7
Z9 7
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1959-0318
J9 IRBM
JI IRBM
PD JUN
PY 2011
VL 32
IS 3
BP 204
EP 213
DI 10.1016/j.irbm.2010.12.002
PG 10
WC Engineering, Biomedical
SC Engineering
GA 781VY
UT WOS:000291966500009
DA 2018-10-20
ER

PT J
AU Silva-Correia, J
   Oliveira, JM
   Caridade, SG
   Oliveira, JT
   Sousa, RA
   Mano, JF
   Reis, RL
AF Silva-Correia, J.
   Oliveira, J. M.
   Caridade, S. G.
   Oliveira, J. T.
   Sousa, R. A.
   Mano, J. F.
   Reis, R. L.
TI Gellan gum-based hydrogels for intervertebral disc tissue-engineering
   applications
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE gellan gum; hydrogels; intervertebral disc; methacrylation; nucleus
   pulposus; photo-crosslinking; tissue engineering
ID LUMBAR NUCLEUS PULPOSUS; LOW-BACK-PAIN; DEGENERATION; CELLS;
   ENCAPSULATION; REGENERATION; PERFORMANCE; TRANSITION; MEDICINE; CHITOSAN
AB Intervertebral disc (IVD) degeneration is a challenging clinical problem that urgently demands viable nucleus pulposus (NP) implant materials. The best suited biomaterial for NP regeneration has yet to be identified, but it is believed that biodegradable hydrogel-based materials are promising candidates. In this work, we have developed ionic-and photo-crosslinked methacrylated gellan gum (GG-MA) hydrogels to be used in acellular and cellular tissue-engineering strategies for the regeneration of IVDs. The physicochemical properties of the developed hydrogels were investigated by Fourier-transform infrared spectroscopy, H-1 nuclear magnetic resonance and differential scanning calorimetry. The swelling ability and degradation rate of hydrogels were also analysed in phosphate-buffered saline solution at physiological pH for a period of 30 days. Additionally, the morphology and mechanical properties of the hydrogels were assessed under a scanning electron microscope and dynamic compression, respectively. An in vitro study was carried out to screen possible cytotoxicity of the gellan gum-based hydrogels by culturing rat lung fibroblasts (L929 cells) with hydrogel leachables up to 7 days. The results demonstrated that gellan gum was successfully methacrylated. We observed that the produced GG-MA hydrogels possess improved mechanical properties and lower water uptake ability and degradation rate as compared to gellan gum. This work also revealed that GG-MA hydrogels are non-cytotoxic in vitro, thus being promising biomaterials to be used in IVD tissue-engineering strategies. Copyright. (C) 2010 John Wiley & Sons, Ltd.
C1 [Silva-Correia, J.; Oliveira, J. M.; Caridade, S. G.; Oliveira, J. T.; Sousa, R. A.; Mano, J. F.; Reis, R. L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, P-4806909 Taipas, Guimaraes, Portugal.
   [Silva-Correia, J.; Oliveira, J. M.; Caridade, S. G.; Oliveira, J. T.; Sousa, R. A.; Mano, J. F.; Reis, R. L.] PT Government Associated Lab, IBB, Guimaraes, Portugal.
RP Reis, RL (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Taipas, Guimaraes, Portugal.
EM rgreis@dep.uminho.pt
RI Silva-Correia, Joana/D-4980-2012; Caridade, Sofia/P-1925-2015; Reis, Rui
   L./A-8938-2008; Group, 3Bs/E-4374-2012; Mano, Joao/A-4418-2009;
   Oliveira, Joaquim Miguel/H-8636-2012
OI Silva-Correia, Joana/0000-0003-1312-3109; Caridade,
   Sofia/0000-0002-0448-1871; Reis, Rui L./0000-0002-4295-6129; Group,
   3Bs/0000-0002-5195-3456; Mano, Joao/0000-0002-2342-3765; Oliveira,
   Joaquim Miguel/0000-0001-7052-8837; Sousa, Rui/0000-0003-0362-7418
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/FIS/68517/2006]; European Union [NMP3-LA-2008-213904]
FX The authors are grateful for funds provided by the Portuguese Foundation
   for Science and Technology (FCT) through the POCTI and FEDER programmes,
   including Project ProteoLight (Grant No. PTDC/FIS/68517/2006). This work
   was also carried outwith the support of the European Union-funded
   Collaborative Project Disc Regeneration (Grant No. NMP3-LA-2008-213904).
CR Amsden BG, 2007, BIOMACROMOLECULES, V8, P3758, DOI 10.1021/bm700691e
   [Anonymous], 1992, ISOEN109935
   Baroli B, 2006, J CHEM TECHNOL BIOT, V81, P491, DOI 10.1002/jctb.1468
   Cheung KMC, 2008, CURR ORTHOPAED, V22, P237, DOI 10.1016/j.cuor.2008.05.004
   Chou AI, 2009, OSTEOARTHR CARTILAGE, V17, P1377, DOI 10.1016/j.joca.2009.04.012
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   Diamond S, 2006, BEST PRACT RES CL RH, V20, P707, DOI 10.1016/j.berh.2006.04.002
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Hamcerencu M, 2008, CARBOHYD POLYM, V71, P92, DOI 10.1016/j.carbpol.2007.05.021
   Holmes AD, 1996, MED ENG PHYS, V18, P99, DOI 10.1016/1350-4533(95)00047-X
   Iatridis JC, 1997, J BIOMECH, V30, P1005, DOI 10.1016/S0021-9290(97)00069-9
   Iatridis JC, 1997, J ORTHOP RES, V15, P318, DOI 10.1002/jor.1100150224
   JANSSON PE, 1983, CARBOHYD RES, V124, P135, DOI 10.1016/0008-6215(83)88361-X
   Jeon O, 2009, BIOMATERIALS, V30, P2724, DOI 10.1016/j.biomaterials.2009.01.034
   Kalson NS, 2008, REGEN MED, V3, P717, DOI 10.2217/17460751.3.5.717
   KANG KS, 1982, APPL ENVIRON MICROB, V43, P1086
   Leahy JC, 2001, J MATER SCI-MATER M, V12, P689, DOI 10.1023/A:1011212425029
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Li Q, 2003, MACROMOLECULES, V36, P2556, DOI 10.1021/ma021190w
   Miyoshi E, 1996, CARBOHYD POLYM, V30, P109, DOI 10.1016/S0144-8617(96)00093-8
   Nishinari K, 1997, COLLOID POLYM SCI, V275, P1093, DOI 10.1007/s003960050189
   Oliveira JT, 2009, J TISSUE ENG REGEN M, V3, P493, DOI 10.1002/term.184
   Oliveira J. T., 2009, J BIOMED MATER RES A, V93A, P852
   Oliveira JT, 2010, TISSUE ENG PT A, V16, P343, DOI [10.1089/ten.tea.2009.0117, 10.1089/ten.TEA.2009.0117]
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   OLIVEIRA JT, 2010, J ORTHOP RES
   OLIVEIRA JT, 2009, Patent No. 2009101518
   Peppas NA, 2006, ADV MATER, V18, P1345, DOI 10.1002/adma.200501612
   Reid JE, 2002, CLIN BIOMECH, V17, P312, DOI 10.1016/S0268-0033(02)00009-8
   Reza AT, 2010, ACTA BIOMATER, V6, P179, DOI 10.1016/j.actbio.2009.06.004
   Richardson SM, 2007, HISTOL HISTOPATHOL, V22, P1033, DOI 10.14670/HH-22.1033
   Roberts S, 2006, J BONE JOINT SURG AM, V88A, P10, DOI 10.2106/JBJS.F.00019
   Roughley P, 2006, BIOMATERIALS, V27, P388, DOI 10.1016/j.biomaterials.2005.06.037
   Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q
   Sudhamani SR, 2003, FOOD HYDROCOLLOID, V17, P245, DOI 10.1016/S0268-005X(02)00057-7
   Tako M, 2009, COLLOID POLYM SCI, V287, P1445, DOI 10.1007/s00396-009-2112-2
   Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629
   Urban JPG, 2000, AM ZOOL, V40, P53, DOI 10.1668/0003-1569(2000)040[0053:TNOTID]2.0.CO;2
   Wu X, 2010, ACTA BIOMATER, V6, P1167, DOI 10.1016/j.actbio.2009.08.041
NR 39
TC 81
Z9 81
U1 5
U2 35
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD JUN
PY 2011
VL 5
IS 6
BP E97
EP E107
DI 10.1002/term.363
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 773YX
UT WOS:000291349300002
PM 21604382
OA Bronze
DA 2018-10-20
ER

PT J
AU Park, BJ
   Kwon, BJ
   Kang, JK
   Lee, MH
   Han, I
   Kim, JK
   Park, JC
AF Park, Bong Joo
   Kwon, Byoung Ju
   Kang, Jae Kyeong
   Lee, Mi Hee
   Han, Inho
   Kim, Jeong Koo
   Park, Jong-Chul
TI Enhanced cellular responses of vascular endothelial cells on
   poly-gamma-glutamic acid/PU composite film treated with
   microwave-induced plasma at atmospheric pressure
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE poly-gamma-glutamic acid; polyurethane; human umbilical vein endothelial
   cells; microwave-induced argon plasma
ID INDUCED ARGON PLASMA; IN-VITRO; POLYURETHANE FILMS; BYPASS GRAFTS;
   ADHESION; SURFACE; PROLIFERATION; ATTACHMENT; PEPTIDES
AB Poly-gamma-glutamic acid (gamma-PGA), which is produced by microbial fermentation, is a biodegradable, hydrophilic and non-toxic biomaterial. gamma-PGA has many carboxyl groups that makes it a polyanionic biopolymer with swelling ability, biocompatibility and anticoagulant activity. On the other hand, few studies have examined the effect of gamma-PGA on the cellular activity of human umbilical vein endothelial cells (HUVECs). The present study evaluated the effects of gamma-PGA and fabricated gamma-PGA/PU composite films on the attachment and proliferation of HUVECs after treatment with microwave plasma at atmospheric pressure. The results confirmed that gamma-PGA is capable of increasing the proliferation and differentiation of HUVECs to form capillary tubes with enhanced alignment and organization. Moreover, the microwave plasma modified gamma-PGA/PU composite film was more hydrophilic and the surface roughness was enhanced. In addition, the attachment and proliferation of the HUVECs were increased by the plasma treatment. These results suggest that gamma-PGA and surface modified gamma-PGA/PU composite can be applied as bioactive and biocompatible materials in vascular tissue engineering but further testing of gamma-PGA and gamma-PGA/PU composite films will be needed to confirm the potential effects for use in vascular applications.
C1 [Kwon, Byoung Ju; Kang, Jae Kyeong; Lee, Mi Hee; Park, Jong-Chul] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
   [Park, Bong Joo; Han, Inho; Kim, Jeong Koo; Park, Jong-Chul] Yonsei Univ, Coll Med, Dept Med Engn, Seoul 120752, South Korea.
   [Park, Bong Joo; Kim, Jeong Koo] Inje Univ, Coll Biomed Sci & Engn, Bioogran Tissue Regenerat Project Team BK21, Gimhae 621749, South Korea.
   [Park, Bong Joo; Kim, Jeong Koo] Inje Univ, Coll Biomed Sci & Engn, Dept Biomed Engn, Gimhae 621749, South Korea.
RP Park, JC (reprint author), Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea.
EM parkjc@yuhs.ac
FU Ministry of Health Welfare & Family Affairs, Republic of Korea
   [A085136]; Korean Government (MEST) [2010-0002089]
FX This study was supported by a grant from the Korea Health 21 R&D
   Project, Ministry of Health Welfare & Family Affairs, Republic of Korea
   (A085136), and National Research Foundation (NRF) of Korea Grant funded
   by the Korean Government (MEST)(Grant number 2010-0002089).
CR Andrews KD, 2007, BIOMATERIALS, V28, P1014, DOI 10.1016/j.biomaterials.2006.10.014
   Arnaoutova I, 2009, ANGIOGENESIS, V12, P267, DOI 10.1007/s10456-009-9146-4
   Choi WS, 2009, MACROMOL RES, V17, P458, DOI 10.1007/BF03218892
   DEJUN L, 1994, APPL SURF SCI, V78, P195
   Feugier P, 2005, BIOMATERIALS, V26, P1457, DOI 10.1016/j.biomaterials.2004.04.050
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   ITO Y, 1989, CRIT REV BIOCOMPAT, V5, P45
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   Lelah M. D., 1986, POLYURETHANES MED
   Lim HR, 2008, SURF COAT TECH, V202, P5768, DOI 10.1016/j.surfcoat.2008.06.115
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Nakao A, 1996, SURF INTERFACE ANAL, V24, P252, DOI 10.1002/(SICI)1096-9918(199604)24:4<252::AID-SIA113>3.0.CO;2-R
   NICHOLS NK, 1981, T AM SOC ART INT ORG, V27, P208
   Otani Y, 1996, J Biomed Mater Res, V31, P158
   OZEKI E, 1990, ASAIO T, V36, P294
   Park BJ, 2003, PHYS PLASMAS, V10, P4539, DOI 10.1063/1.1613655
   Park BJ, 2010, SURF COAT TECH, V205, pS222, DOI 10.1016/j.surfcoat.2010.07.087
   PATTERSON RG, 1995, ASAIO, V41, P625
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   PROBER JS, 1986, J IMMUNOL, V137, P1893
   ROTHLEIN R, 1986, J IMMUNOL, V137, P1270
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Shen H, 2007, BIOMATERIALS, V28, P4219, DOI 10.1016/j.biomaterials.2007.06.004
   Tiwari A, 2001, EUR J VASC ENDOVASC, V21, P193, DOI 10.1053/ejvs.2001.1316
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Xu CY, 2004, J BIOMED MATER RES A, V71A, P154, DOI 10.1002/jbm.a.30143
   Zhang Z, 2004, BIOMATERIALS, V25, P177, DOI 10.1016/S0142-9612(03)00478-2
   2009, Patent No. 0186804
NR 28
TC 5
Z9 5
U1 1
U2 18
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1598-5032
J9 MACROMOL RES
JI Macromol. Res.
PD JUN
PY 2011
VL 19
IS 6
BP 537
EP 541
DI 10.1007/s13233-011-0605-6
PG 5
WC Polymer Science
SC Polymer Science
GA 782YC
UT WOS:000292047700003
DA 2018-10-20
ER

PT J
AU Schwandner, O
   Brunner, M
   Dietl, O
AF Schwandner, Oliver
   Brunner, Marion
   Dietl, Otto
TI Quality of Life and Functional Results of Submucosal Injection Therapy
   Using Dextranomer Hyaluronic Acid for Fecal Incontinence
SO SURGICAL INNOVATION
LA English
DT Article
DE fecal incontinence; injectables; bulking agents; hyaluronic acid;
   quality of life
ID INJECTABLE SILICONE BIOMATERIAL; ANAL-SPHINCTER DYSFUNCTION; SACRAL
   NERVE-STIMULATION; EFFICACY; EPIDEMIOLOGY; PTQ(TM)
AB Background and aim: The aim of this prospective study was to analyze safety and functional outcome of transanal submucosal injection of dextranomer hyaluronic acid ("bulking agents therapy") in patients with passive fecal incontinence. Methods: All patients who underwent transanal injection therapy were prospectively enrolled in this study. Inclusion criteria included fecal incontinence (internal anal sphincter dysfunction) after failed conservative treatment. The procedure was performed in a standardized technique, including submucosal injection of 4 x 1 mL dextranomer hyaluronic acid 5 mm above the dentate line. The primary endpoint focused on symptom improvement provided as the change in incontinence status and quality of life using validated scores (Wexner incontinence score, symptom-specific Fecal Incontinence Quality of Life [FIQoL] scale, and generic EQ-5D-Visual Analogue Scale [EQ-5D-VAS]). Results: Within the observation period (July 2007 to May 2009), a total of 21 patients (17 women) with passive fecal incontinence were treated. Neither morbidity nor adverse events were documented. Three months postoperatively, 61.1% (11/18) showed significant improvement of symptoms (reduction of incontinence episodes and soiling), which was sustained after 20 months in 55.6% (10/18). Wexner incontinence score decreased from 16.8 to 12.3 (P > .05). Significant improvement was documented for FIQoL and EQ-5D-VAS (P < .05). Conclusion: The current results indicate that injection therapy using hyaluronic acid is an innovative and minimally invasive procedure with no morbidity. Although Wexner incontinence score is not significantly influenced, a significant improvement in quality of life was observed in more than 50% of patients.
C1 [Schwandner, Oliver] Caritas Krankenhaus St Josef, Ctr Regensburg, Dept Surg, D-93053 Regensburg, Germany.
RP Schwandner, O (reprint author), Caritas Krankenhaus St Josef, Ctr Regensburg, Dept Surg, Pelv Floor,Landshuter Str 65, D-93053 Regensburg, Germany.
EM oschwandner@caritasstjosef.de
CR Bartlett L, 2009, WORLD J GASTROENTERO, V15, P3276, DOI 10.3748/wjg.15.3276
   Boyle DJ, 2009, DIS COLON RECTUM, V52, P1234, DOI 10.1007/DCR.0b013e31819f7400
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Gilliland R, 1998, DIS COLON RECTUM, V41, P1516, DOI 10.1007/BF02237299
   Herold A, 1996, ZBL CHIR, V121, P632
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Lightner DJ, 2010, UROLOGY, V75, P1310, DOI 10.1016/j.urology.2009.12.061
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Matzel KE, 2009, COLORECTAL DIS, V11, P636, DOI 10.1111/j.1463-1318.2008.01673.x
   Nelson RL, 2004, GASTROENTEROLOGY, V126, pS3, DOI 10.1053/j.gastro.2003.10.010
   Oliveira LCC, 2009, SURG INNOV, V16, P155, DOI 10.1177/1553350609338374
   Pares D, 2011, COLORECTAL DIS, V13, P899, DOI 10.1111/j.1463-1318.2010.02281.x
   Pickard AS, 2007, PHARMACOECONOMICS, V25, P365, DOI 10.2165/00019053-200725050-00002
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Schwandner O, 2004, CHIRURG, V75, P850, DOI 10.1007/s00104-004-0922-9
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stenberg A, 2003, J UROLOGY, V169, P1109, DOI 10.1097/01.ju.0000053013.49676.89
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
   Zutshi M, 2010, INT J COLORECTAL DIS, V25, P277, DOI 10.1007/s00384-009-0830-z
NR 25
TC 10
Z9 10
U1 0
U2 2
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1553-3506
J9 SURG INNOV
JI Surg. Innov.
PD JUN
PY 2011
VL 18
IS 2
BP 130
EP 135
DI 10.1177/1553350610392243
PG 6
WC Surgery
SC Surgery
GA 785DT
UT WOS:000292208300006
PM 21245071
DA 2018-10-20
ER

PT J
AU Hill, PS
   Apel, PJ
   Barnwell, J
   Smith, T
   Koman, LA
   Atala, A
   Van Dyke, M
AF Hill, Paulina S.
   Apel, Peter J.
   Barnwell, Jonathan
   Smith, Tom
   Koman, L. Andrew
   Atala, Anthony
   Van Dyke, Mark
TI Repair of Peripheral Nerve Defects in Rabbits Using Keratin Hydrogel
   Scaffolds
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID LAMININ-CONTAINING GEL; ENTUBULATION REPAIR; TEMPORAL PROGRESS; SILICONE
   CHAMBER; SCIATIC-NERVE; REGENERATION; GUIDES; TUBES; CULTIVATION;
   FABRICATION
AB Entubulation of transected nerves using bioabsorbable conduits is a promising alternative to sural nerve auto-grafting, but full functional recovery is rarely achieved. Numerous studies have suggested that scaffold-based conduit fillers may promote axon regeneration, but no neuroinductive biomaterial filler has been identified. We previously showed that a nerve guide filled with keratin hydrogel actively stimulates regeneration in a mouse model, and results in functional outcomes superior to empty conduits at early time points. The goal of the present study was to develop a peripheral nerve defect model in a rabbit and assess the effectiveness of a keratin hydrogel filler. Although repairs with keratin-filled conduits were not as consistently successful as autograft overall, the use of keratin resulted in a significant improvement in conduction delay compared to both empty conduits and autograft, as well as a significant improvement in amplitude recovery compared to empty conduits when measurable regeneration did occur. Taking into account all study animals (i.e., regenerated and non-regenerated), histological assessment showed that keratin-treated nerves had significantly greater myelin thickness than empty conduits. These data support the findings of our earlier study and suggest that keratin hydrogel fillers have the potential to be used clinically to improve conduit repair.
C1 [Hill, Paulina S.; Atala, Anthony; Van Dyke, Mark] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
   [Apel, Peter J.; Barnwell, Jonathan; Smith, Tom; Koman, L. Andrew] Wake Forest Univ, Bowman Gray Sch Med, Dept Orthopaed Surg, Winston Salem, NC 27157 USA.
RP Van Dyke, M (reprint author), Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM mavandyk@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
FU Errett Fisher Foundation; Department of Orthopaedic Surgery; Orthopaedic
   Research and Education Foundation
FX The authors gratefully acknowledge the funding support provided by the
   Errett Fisher Foundation, as well as the Department of Orthopaedic
   Surgery and Orthopaedic Research and Education Foundation for funding
   support of coauthors Apel and Barnwell. The authors would like to thank
   Integra Life Sciences for supplying us with the collagen nerve guides
   and Rawad Hamzi for assistance with histomorphometry.
CR Apel PJ, 2008, J HAND SURG-AM, V33A, P1541, DOI 10.1016/j.jhsa.2008.05.034
   Belkas JS, 2004, NEUROL RES, V26, P151, DOI 10.1179/016164104225013798
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Dahlin LB, 2001, NEUROSURG CLIN N AM, V12, P341, DOI 10.1016/S1042-3680(18)30059-7
   Farole A, 2008, J ORAL MAXIL SURG, V66, P2058, DOI 10.1016/j.joms.2008.06.017
   Germana G., 1992, Biological Structures and Morphogenesis, V4, P11
   Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262
   IDE C, 1983, ARCH HISTOL JAPON, V46, P243, DOI 10.1679/aohc.46.243
   Jiang BG, 2007, EUR NEUROL, V58, P12, DOI 10.1159/000102161
   Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012
   Kline DG, 2004, J NEUROSURG, V101, P361, DOI 10.3171/jns.2004.101.3.0361
   Lee DY, 2006, J CRANIO MAXILL SURG, V34, P50, DOI 10.1016/jcm.2005.07.011
   Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165
   Lundborg G, 1988, NERVE INJURY REPAIR
   MADISON R, 1985, EXP NEUROL, V88, P767, DOI 10.1016/0014-4886(85)90087-1
   MADISON RD, 1988, BRAIN RES, V447, P325, DOI 10.1016/0006-8993(88)91135-3
   MADISON RD, 1987, EXP NEUROL, V95, P378, DOI 10.1016/0014-4886(87)90146-4
   Mcdonald D, 2006, NEURON GLIA BIOL, V2, P139, DOI 10.1017/S1740925X05000347
   Midha R, 2008, NEUROL RES, V30, P997, DOI 10.1179/174313208X362550
   Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580
   RUMMLER LS, 2004, CURR OPIN ORTHOP, V15, P215
   SANDERS FK, 1946, J PHYSIOL-LONDON, V105, P152, DOI 10.1113/jphysiol.1946.sp004160
   Siebert H, 2001, J NEUROPATH EXP NEUR, V60, P85, DOI 10.1093/jnen/60.1.85
   Sierpinski P, 2008, BIOMATERIALS, V29, P118, DOI 10.1016/j.biomaterials.2007.08.023
   Tachibana A, 2005, BIOMATERIALS, V26, P297, DOI 10.1016/j.biomaterials.2004.02.032
   Tachibana A, 2002, J BIOTECHNOL, V93, P165, DOI 10.1016/S0168-1656(01)00395-9
   TERRIS DJ, 1993, ARCH OTOLARYNGOL, V119, P725
   Toba T, 2001, J BIOMED MATER RES, V58, P622, DOI 10.1002/jbm.1061
   VALENTINI RF, 1987, EXP NEUROL, V98, P350, DOI 10.1016/0014-4886(87)90247-0
   WILLIAMS LR, 1987, NEUROCHEM RES, V12, P851, DOI 10.1007/BF00966306
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
NR 32
TC 50
Z9 52
U1 3
U2 32
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2011
VL 17
IS 11-12
BP 1499
EP 1505
DI 10.1089/ten.tea.2010.0184
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 773WQ
UT WOS:000291342600004
PM 21275820
DA 2018-10-20
ER

PT J
AU Lu, ZF
   Roohani-Esfahani, SI
   Kwok, PCL
   Zreiqat, H
AF Lu, ZuFu
   Roohani-Esfahani, Seyed-Iman
   Kwok, Philip Chi Lip
   Zreiqat, Hala
TI Osteoblasts on Rod Shaped Hydroxyapatite Nanoparticles Incorporated PCL
   Film Provide an Optimal Osteogenic Niche for Stem Cell Differentiation
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID NUCLEUS PULPOSUS CELLS; SIGNALING PATHWAYS; ADIPOSE-TISSUE; IN-VITRO;
   BONE; SURFACE; GROWTH; SCAFFOLDS; IMPLANTS; LINEAGE
AB After the clinical insertion of a bone biomaterial, the surrounding osteoblasts would migrate and attach to the implant surface and foster a microenvironment that largely determines the differentiation fate of the comigrated mesenchymal stem cells. Whether the fostered microenvironment is suitable for osteogenic differentiation of mesenchymal stem cells is critical for the subsequent osseointegration. In this study, we determined (1) how the spherical or rod-shaped hydroxyapatite nanoparticles (nHA) incorporated poly(e-caprolactone) (PCL) films (PCL-spherical nHA, PCL-rod nHA) interact with primary human osteoblasts (HOBs); (2) how the microenvironment rendered by their interaction affects osteogenic differentiation of adipose tissue-derived mesenchymal stem cells (ASCs). HOBs were seeded on PCL, PCL-spherical nHA, and PCL-rod nHA films, respectively. When cultured alone, the HOBs on PCL-rod nHA films showed most efficient osteoblastic differentiation compared with those on PCL or PCL-spherical nHA films. When cocultured with ASCs in an indirect coculture system, only the HOBs on PCL-rod nHA films up-regulated the gene expression of Runx2, bone sialoprotein, and osteocalcin of ASCs. Additionally, the HOBs on PCL-rod nHA films showed significant up-regulation of bone morphogenic protein 2 gene and protein expression and induced highest phosphorylated Smad1/5 protein level in ASCs. Treatment of the coculture medium with bone morphogenic protein 2 inhibitor (Noggin) largely abolished the osteogenic differentiation of the ASCs induced by the HOBs on PCL-rod nHA films. In conclusion, HOBs can not only best display their osteoblastic phenotype by culturing on PCL-rod nHA films but also render an optimal osteogenic niche for the differentiation of stem cells.
C1 [Lu, ZuFu; Roohani-Esfahani, Seyed-Iman; Zreiqat, Hala] Univ Sydney, Biomat & Tissue Engn Res Unit, Sch AMME, Sydney, NSW 2006, Australia.
   [Kwok, Philip Chi Lip] Univ Sydney, Adv Drug Delivery Grp, Sydney, NSW 2006, Australia.
RP Zreiqat, H (reprint author), Univ Sydney, Biomat & Tissue Engn Res Unit, Sch AMME, Sydney, NSW 2006, Australia.
EM hala.zreiqat@sydney.edu.au
OI Lu, ZuFu/0000-0003-4843-4441; Kwok, Philip Chi Lip/0000-0002-5362-0671;
   Roohani, Iman/0000-0001-6618-8577
FU Australian National Health and Medical Research Council; Australian
   Research Council
FX The authors would like to acknowledge the Australian National Health and
   Medical Research Council and the Australian Research Council for funding
   this research. We acknowledge the Australian Center for Microscope and
   Microanalysis Research Facility for providing the facilities. We are
   grateful for the assistance provided by Mrs Barbara James in culturing
   the HOBs and in proof reading this manuscript.
CR Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010
   Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610
   Csaki C, 2009, HISTOCHEM CELL BIOL, V131, P251, DOI 10.1007/s00418-008-0524-6
   Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Giannoni P, 2009, INT J ARTIF ORGANS, V32, P811
   Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Ilmer M, 2009, TISSUE ENG PT A, V15, P2397, DOI 10.1089/ten.tea.2008.0427
   Ishibashi O, 2010, J CELL PHYSIOL, V222, P465, DOI 10.1002/jcp.21968
   Jadlowiec JA, 2006, J BIOL CHEM, V281, P5341, DOI 10.1074/jbc.M506158200
   Javed A, 2008, J BIOL CHEM, V283, P8412, DOI 10.1074/jbc.M705578200
   Jimbo R, 2007, BIOMATERIALS, V28, P3469, DOI 10.1016/j.biomaterials.2007.04.029
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107
   LaBarge MA, 2009, INTEGR BIOL-UK, V1, P70, DOI 10.1039/b816472j
   Lee DH, 2006, TISSUE ENG, V12, P1577, DOI 10.1089/ten.2006.12.1577
   Lu ZF, 2007, BIOCHEM BIOPH RES CO, V359, P991, DOI 10.1016/j.bbrc.2007.06.002
   Lu ZF, 2008, J CELL MOL MED, V12, P2812, DOI 10.1111/j.1582-4934.2008.00278.x
   Lu ZL, 2010, TISSUE ENG PT A, V16, P3075, DOI 10.1089/ten.tea.2010.0204
   Marie PJ, 2006, REGEN MED, V1, P539, DOI 10.2217/17460751.1.4.539
   Miron RJ, 2010, BIOMATERIALS, V31, P449, DOI 10.1016/j.biomaterials.2009.09.075
   Murphy WL, 2005, BIOMATERIALS, V26, P303, DOI 10.1016/j.biomaterials.2004.02.034
   Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106
   Oh SH, 2005, BIOMATERIALS, V26, P4938, DOI 10.1016/j.biomaterials.2005.01.048
   Olivares-Navarrete R, 2010, BIOMATERIALS, V31, P2728, DOI 10.1016/j.biomaterials.2009.12.029
   Ong J L, 1999, J Oral Implantol, V25, P95, DOI 10.1563/1548-1336(1999)025<0095:OPCRTC>2.3.CO;2
   Park IS, 2009, BIOMATERIALS, V30, P6835, DOI 10.1016/j.biomaterials.2009.08.057
   Pennisi CP, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/38/385103
   Roohani-Esfahani SI, 2010, BIOMATERIALS, V31, P5498, DOI 10.1016/j.biomaterials.2010.03.058
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018
   Ruiz-Hitzky E, 2010, ADV MATER, V22, P323, DOI 10.1002/adma.200901134
   Stylios G, 2007, INJURY, V38, pS63, DOI 10.1016/j.injury.2007.02.011
   Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051
   Wang CY, 2009, J BIOMED MATER RES A, V90A, P419, DOI 10.1002/jbm.a.32111
   Wang Y, 2007, J TISSUE ENG REGEN M, V1, P39, DOI 10.1002/term.6
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Yamashita A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009663
   Yim EKF, 2010, BIOMATERIALS, V31, P1299, DOI 10.1016/j.biomaterials.2009.10.037
   Yin Z, 2010, BIOMATERIALS, V31, P2163, DOI 10.1016/j.biomaterials.2009.11.083
   Yue JB, 1999, ONCOGENE, V18, P2033, DOI 10.1038/sj.onc.1202521
   Zreiqat H, 2005, BIOMATERIALS, V26, P7579, DOI 10.1016/j.biomaterials.2005.05.024
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 49
TC 22
Z9 23
U1 3
U2 14
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD JUN
PY 2011
VL 17
IS 11-12
BP 1651
EP 1661
DI 10.1089/ten.tea.2010.0567
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 773WQ
UT WOS:000291342600019
PM 21306280
DA 2018-10-20
ER

PT J
AU Lammers, G
   van de Westerlo, EM
   Versteeg, EM
   van Kuppevelt, TH
   Daamen, WF
AF Lammers, Gerwen
   van de Westerlo, Els M.
   Versteeg, Elly M.
   van Kuppevelt, Toin H.
   Daamen, Willeke F.
TI A Comparison of Seven Methods to Analyze Heparin in Biomaterials:
   Quantification, Location, and Anticoagulant Activity
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID CROSS-LINKING; COLLAGEN; GLYCOSAMINOGLYCANS; SULFATE; ASSAY;
   CONSTRUCTION; SCAFFOLDS; MATRICES
AB Glycosaminoglycans, like heparin, are frequently incorporated in biomaterials because of their capacity to bind and store growth factors and because of their hydrating properties. Heparin is also often used in biomaterials for its anticoagulant activity. Analysis of biomaterial-bound heparin is challenging because most assays are based on heparin in solution. In this study, seven different methods were probed to analyze heparin covalently attached to collagen scaffolds. For each method, the basic mechanism and the advantages and disadvantages are given. An analysis by the factor Xa assay and the Farndale assay clearly indicated that the amount of immobilized heparin cannot be determined correctly when the scaffold is intact. Scaffolds had to be proteolytically digested or acid treated to obtain reliable measurements. Methods used to quantify the amount of bound heparin included a hexosamine assay, an uronic acid assay, a Farndale assay, agarose gel electrophoresis, and immuno-dot blot analysis. Location and semiquantification of heparin were accomplished by immunofluorescence. Although all assays had their advantages and disadvantages, the hexosamine assay turned out to be the most robust and is recommended as the preferred assay to quantify the amount of heparin bound to scaffolds. It is applicable to all scaffolds that are acid hydrolyzable. This study may allow researchers in the field to select the most appropriate method to analyze glycosaminoglycans in biomaterials.
C1 [Lammers, Gerwen; van de Westerlo, Els M.; Versteeg, Elly M.; van Kuppevelt, Toin H.; Daamen, Willeke F.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands.
RP Daamen, WF (reprint author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 280, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM w.daamen@ncmls.ru.nl
RI Kuppevelt, A.H.M.S.M./L-4463-2015; Daamen, Willeke/D-5854-2015
OI Daamen, Willeke/0000-0003-3155-3030
FU Dutch Program for Tissue Engineering [DPTE 6735]; EU
   [LSHB-CT-2006-037409]
FX This study was funded by the Dutch Program for Tissue Engineering (grant
   DPTE 6735) and by the EU-FP6 project EuroSTEC (soft tissue engineering
   for congenital birth defects in children: contract:
   LSHB-CT-2006-037409).
CR Bezuidenhout D, 2010, J BIOMATER APPL, V24, P401, DOI 10.1177/0885328208097565
   BJORK I, 1982, MOL CELL BIOCHEM, V48, P161, DOI 10.1007/BF00421226
   Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Elson LA, 1933, BIOCHEM J, V27, P1824, DOI 10.1042/bj0271824
   Esko JD, 2009, ESSENTIALS GLYCOBIOL
   Faraj KA, 2007, TISSUE ENG, V13, P2387, DOI 10.1089/ten.2006.0320
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   GATTI G, 1979, MACROMOLECULES, V12, P1001, DOI 10.1021/ma60071a044
   Geutjes PJ, 2006, ADV EXP MED BIOL, V585, P279
   GILBERT DL, 1990, J BIOMED MATER RES, V24, P1221, DOI 10.1002/jbm.820240907
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Kreuger J, 2003, METHOD ENZYMOL, V363, P327
   Nillesen STM, 2007, BIOMATERIALS, V28, P1123, DOI 10.1016/j.biomaterials.2006.10.029
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2000, BIOMATERIALS, V21, P581, DOI 10.1016/S0142-9612(99)00222-7
   TEIEN AN, 1976, THROMB RES, V8, P413, DOI 10.1016/0049-3848(76)90034-7
   van den Hoogen BM, 1998, ANAL BIOCHEM, V257, P107, DOI 10.1006/abio.1997.2538
   van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960
   VANDELEST CHA, 1994, ANAL BIOCHEM, V221, P356, DOI 10.1006/abio.1994.1425
   VANDELEST CHA, 1994, BBA-GEN SUBJECTS, V1201, P305, DOI 10.1016/0304-4165(94)90055-8
   Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 24
TC 5
Z9 5
U1 1
U2 9
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD JUN
PY 2011
VL 17
IS 6
BP 669
EP 676
DI 10.1089/ten.tec.2011.0010
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 772AQ
UT WOS:000291202200006
PM 21375408
DA 2018-10-20
ER

PT J
AU Cao, JI
   Sun, CK
   Zhao, H
   Xiao, ZF
   Chen, B
   Gao, J
   Zheng, TZ
   Wu, W
   Wu, S
   Wang, JY
   Dai, JW
AF Cao, Jiani
   Sun, Changkai
   Zhao, Hui
   Xiao, Zhifeng
   Chen, Bing
   Gao, Jian
   Zheng, Tiezheng
   Wu, Wei
   Wu, Shuang
   Wang, Jingyu
   Dai, Jianwu
TI The use of laminin modified linear ordered collagen scaffolds loaded
   with laminin-binding ciliary neurotrophic factor for sciatic nerve
   regeneration in rats
SO BIOMATERIALS
LA English
DT Article
DE LOCS fibers; Laminin; LBD-CNTF; Nerve transection repair
ID EXTRACELLULAR-MATRIX COMPONENTS; RETINAL GANGLION-CELLS;
   PERIPHERAL-NERVE; FUNCTIONAL-EVALUATION; AXONAL REGENERATION; IN-VIVO;
   REPAIR; PROMOTES; EXPRESSION; MOLECULES
AB Nerve conduit provides a promising strategy for nerve injury repair in the peripheral nervous system (PNS). However, simply bridging the transected nerve with an empty conduit is hard to satisfy functional recovery. The regenerated axons may disperse during regeneration in the empty lumen, limiting the functional recovery. Our previous work had reported that linear ordered collagen scaffold (LOCS) could be used as a nerve guidance material. Here we cross-linked LOCS fibers with laminin which was a major component of the extracellular matrix in nervous system. Ciliary neurotrophic factor (CNTF) plays a critical role in peripheral nerve regeneration. But the lack of efficient CNTF delivery approach limits its clinical applications. To retain CNTF on the scaffold, a laminin binding domain (LBD) was fused to the N-terminal of CNTF. Compared with NAT-CNTF, LBD-CNTF exhibited specific laminin-binding ability and comparable neurotrophic bioactivity. We combined LBD-CNTF with the laminin modified LOCS fibers to construct a double-functional bio-scaffold. The functional scaffold was filled in silicon conduit and tested in the rat sciatic nerve transection model. Results showed that this functional biomaterial could guide the axon growth, retain more CNTF on the scaffolds and enhance the nerve regeneration as well as functional recovery. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Cao, Jiani; Xiao, Zhifeng; Chen, Bing; Gao, Jian; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol Dev Biol, Beijing 100080, Peoples R China.
   [Cao, Jiani] Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China.
   [Sun, Changkai; Zhao, Hui; Zheng, Tiezheng; Wu, Wei; Wu, Shuang] Dalian Med Univ, Inst Brain Disorders, Dalian 116044, Peoples R China.
   [Sun, Changkai; Zhao, Hui; Zheng, Tiezheng; Wu, Wei; Wu, Shuang] Dalian Med Univ, Prov Key Lab Brain Disorders Liaoning Prov, Dalian 116044, Peoples R China.
   [Wang, Jingyu] Dalian Med Univ, Ctr Expt Anim, Dalian 116044, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Inst Genet & Dev Biol, 3 Nanyitiao, Beijing 100190, Peoples R China.
EM cicsun110@gmail.com; jwdai@genetics.ac.cn
FU National Natural Science Foundation of China [30930032]
FX This work was supported by a grant from National Natural Science
   Foundation of China (30930032).
CR Ahmed MR, 2005, J PERIPHER NERV SYST, V10, P390, DOI 10.1111/j.1085-9489.2005.00055.x
   Al-Majed AA, 2000, J NEUROSCI, V20, P2602
   BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q
   Battiston B, 2007, ACTA NEUROCHIR SUPPL, V100, P43
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   BRUSHART TM, 1995, J HAND SURG-AM, V20A, P557, DOI 10.1016/S0363-5023(05)80267-9
   Cao QL, 2010, J NEUROSCI, V30, P2989, DOI 10.1523/JNEUROSCI.3174-09.2010
   Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6
   Chen YS, 2000, BIOMATERIALS, V21, P1541, DOI 10.1016/S0142-9612(00)00028-4
   Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068
   Chen ZY, 2001, CURR PROTEIN PEPT SC, V2, P261, DOI 10.2174/1389203013381125
   de Ruiter GC, 2008, J BIOMED MATER RES A, V84A, P643, DOI 10.1002/jbm.a.31298
   FISH JS, 1992, PLAST RECONSTR SURG, V90, P1047, DOI 10.1097/00006534-199212000-00016
   Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621
   HAGG T, 1993, J NEUROIMMUNOL, V48, P177, DOI 10.1016/0165-5728(93)90190-A
   HAGG T, 1993, P NATL ACAD SCI USA, V90, P6315, DOI 10.1073/pnas.90.13.6315
   Hamilton SK, 2011, J COMP NEUROL, V519, P21, DOI 10.1002/cne.22446
   Han QQ, 2009, TISSUE ENG PT A, V15, P2927, DOI [10.1089/ten.tea.2008.0506, 10.1089/ten.TEA.2008.0506]
   Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040
   HARRISSON F, 1989, International Journal of Developmental Biology, V33, P417
   Hu XY, 2009, TISSUE ENG PT A, V15, P3297, DOI 10.1089/ten.TEA.2009.0017
   Johnson EO, 2008, INJURY, V39, pS37, DOI 10.1016/j.injury.2008.06.015
   Koh HS, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046003
   Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298
   LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898
   Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009
   Lin H, 2006, J BIOMED MATER RES A, V79A, P591, DOI 10.1002/jbm.a.30862
   Lingor P, 2008, BRAIN, V131, P250, DOI 10.1093/brain/awm284
   LONGO FM, 1984, BRAIN RES, V309, P105, DOI 10.1016/0006-8993(84)91014-X
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Madison RD, 1999, J NEUROSCI, V19, P11007
   MARTINI R, 1994, J NEUROCYTOL, V23, P1, DOI 10.1007/BF01189813
   Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041
   MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0
   Matsushita O, 1998, J BIOL CHEM, V273, P3643, DOI 10.1074/jbc.273.6.3643
   Naumann T, 2003, BRAIN PATHOL, V13, P309
   Ngo TTB, 2003, J NEUROSCI RES, V72, P227, DOI 10.1002/jnr.10570
   NYILAS E, 1983, T AM SOC ART INT ORG, V29, P307
   Okamoto H, 2010, J BIOMED MATER RES A, V92A, P859, DOI 10.1002/jbm.a.32421
   Pfister LA, 2007, J PERIPHER NERV SYST, V12, P65, DOI 10.1111/j.1529-8027.2007.00125.x
   SECKEL BR, 1984, PLAST RECONSTR SURG, V74, P173, DOI 10.1097/00006534-198408000-00001
   Shen H, 2010, J BIOMED MATER RES B, V95B, P161, DOI 10.1002/jbm.b.31696
   Shimazaki T, 2001, J NEUROSCI, V21, P7642
   SMITH GM, 1993, EXP NEUROL, V121, P239, DOI 10.1006/exnr.1993.1091
   Soussand J, 2001, NEUROREPORT, V12, P1073, DOI 10.1097/00001756-200104170-00041
   Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422
   Sun WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006180
   Yao L, 2010, BIOMATERIALS, V31, P5789, DOI 10.1016/j.biomaterials.2010.03.081
   Yoshil S, 2009, J TISSUE ENG REGEN M, V3, P19, DOI 10.1002/term.130
NR 50
TC 60
Z9 67
U1 6
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2011
VL 32
IS 16
BP 3939
EP 3948
DI 10.1016/j.biomaterials.2011.02.020
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 758WA
UT WOS:000290196700007
PM 21397941
DA 2018-10-20
ER

PT J
AU Martin, TA
   Caliari, SR
   Williford, PD
   Harley, BA
   Bailey, RC
AF Martin, Teresa A.
   Caliari, Steven R.
   Williford, Paul D.
   Harley, Brendan A.
   Bailey, Ryan C.
TI The generation of biomolecular patterns in highly porous collagen-GAG
   scaffolds using direct photolithography
SO BIOMATERIALS
LA English
DT Article
DE Collagen; Scaffold; Micropatterning; Photolithography; Cell adhesion;
   Surface modification
ID STEM-CELL DIFFERENTIATION; GLYCOSAMINOGLYCAN SCAFFOLD; ADHESION;
   MIGRATION; GRADIENTS; MATRIX; GROWTH; MICROENVIRONMENTS; BIOMATERIALS;
   REGENERATION
AB The extracellular matrix (ECM) is a complex organization of structural proteins found within tissues and organs. Heterogeneous tissues with spatially and temporally modulated properties play an important role in organism physiology. Here we present a benzophenone (BP) based direct, photolithographic approach to spatially pattern solution phase biomolecules within collagen-GAG (CG) scaffolds and demonstrate creation of a wide range of patterns composed of multiple biomolecular species in a manner independent from scaffold fabrication steps. We demonstrate the ability to immobilize biomolecules at surface densities of up to 1000 ligands per square micron on the scaffold strut surface and to depths limited by the penetration depth of the excitation source into the scaffold structure. Importantly, while BP photopatterning does further crosslink the CG scaffold, evidenced by increased mechanical properties and collagen crystallinity, it does not affect scaffold microstructural or compositional properties or negatively influence cell adhesion, viability, or proliferation. We show that covalently photoimmobilized fibronectin within a CG scaffold significantly increases the speed of MC3T3-E1 cell attachment relative to the bare CG scaffold or non-specifically adsorbed fibronectin, suggesting that this approach can be used to improve scaffold bioactivity. Our findings, on the whole, establish the use of direct, BP photolithography as a methodology for covalently incorporating activity-improving biochemical cues within 3D collagen biomaterial scaffolds with spatial control over biomolecular deposition. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Bailey, Ryan C.] Univ Illinois, Dept Chem, Roger Adams Lab 44, Urbana, IL 61801 USA.
   [Harley, Brendan A.] Univ Illinois, Dept Chem & Biomol Engn, Inst Genom Biol, Roger Adams Lab 110, Urbana, IL 61801 USA.
RP Bailey, RC (reprint author), Univ Illinois, Dept Chem, Roger Adams Lab 44, 600 S Mathews Ave, Urbana, IL 61801 USA.
EM bharley@illinois.edu; baileyrc@illinois.edu
OI Harley, Brendan/0000-0001-5458-154X; Caliari,
   Steven/0000-0002-7506-3079; Bailey, Ryan/0000-0003-1021-4267
FU Chemical and Biomolecular Engineering Dept.; Institute for Genomic
   Biology; University of Illinois at Urbana-Champaign; NIH NIGMS
   [T32GM070421]; Roy J. Carver Charitable Trust; Camille and Henry Dreyfus
   Foundation; U.S. Department of Energy [DE-FG02-07ER46453,
   DE-FG02-07ER46471]
FX The authors would like to acknowledge Dr. Mauro Sardela (Materials
   Research Laboratory, UIUC), Karen Doty (Veterinary Sciences, UIUC) for
   sectioning of GMA embedded samples, Dr. Hyun-Joon Kong (ChBE, UIUC) for
   the use of his mechanical tester, Dr. Charles Schroeder (ChBE, UIUC) for
   the use of his fluorescence spectrophotometer, Christine Herman
   (Chemistry, UIUC) for the synthesis of BP-NCS and assistance is laser
   beam homogenization, and Manuel Ramirez (BioE, UIUC) for assistance with
   mechanical tests. We are grateful for the funding for this study
   provided by the Chemical and Biomolecular Engineering Dept. (SRC, BAH),
   the Institute for Genomic Biology (SRC, BAH) at the University of
   Illinois at Urbana-Champaign, the Chemistry-Biology Interface Training
   Program NIH NIGMS T32GM070421 (SRC), the Roy J. Carver Charitable Trust
   and the Camille and Henry Dreyfus Foundation (TAM, RCB). This research
   was carried out in part in the Frederick Seitz Materials Research
   Laboratory Central Facilities, University of Illinois, which are
   partially supported by the U.S. Department of Energy under grants
   DE-FG02-07ER46453 and DE-FG02-07ER46471.
CR Capito RM, 2007, GENE THER, V14, P721, DOI 10.1038/sj.gt.3302918
   Chan EWL, 2008, MOL BIOSYST, V4, P746, DOI 10.1039/b801394b
   DAVIDENKO N, 2010, ACTA BIOMATER
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Farrell E, 2006, TISSUE ENG, V12, P459, DOI 10.1089/ten.2006.12.459
   Gibson L. J., 2010, CELLULAR MAT NATURE
   Gray DS, 2008, EXP CELL RES, V314, P2846, DOI 10.1016/j.yexcr.2008.06.023
   Harley BA, 2004, CELLS TISSUES ORGANS, V176, P153, DOI 10.1159/000075035
   Harley BA, 2007, BIOPHYS J, V93, P2911, DOI 10.1529/biophysj.106.095471
   Harley BA, 2007, ACTA BIOMATER, V3, P463, DOI 10.1016/j.aetbio.2006.12.009
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1078, DOI 10.1002/jbm.a.32387
   Harley BA, 2010, J BIOMED MATER RES A, V92A, P1066, DOI 10.1002/jbm.a.32361
   Harley BAC, 2008, BIOPHYS J, V95, P4013, DOI 10.1529/biophysj.107.122598
   Harley BAC, 2008, CHEM ENG J, V137, P102, DOI 10.1016/j.cej.2007.09.009
   Haugh MG, 2010, TISSUE ENG PART C-ME, V16, P887, DOI 10.1089/ten.TEC.2009.0422
   Hay E, 2009, MOL CELL BIOL, V29, P953, DOI 10.1128/MCB.00349-08
   Huang JH, 2010, SOFT MATTER, V6, P3395, DOI 10.1039/b927168f
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Irimia D, 2006, LAB CHIP, V6, P191, DOI 10.1039/b511877h
   Kim TG, 2008, ACTA BIOMATER, V4, P1611, DOI 10.1016/j.actbio.2008.06.008
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Lee MH, 2007, J BIOMED MATER RES A, V81A, P150, DOI 10.1002/jbm.a.31065
   Liu HW, 2006, BONE, V39, P825, DOI 10.1016/j.bone.2006.04.027
   Lu HH, 2006, ADV BIOCHEM ENG BIOT, V102, P91, DOI 10.1007/b138509
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307
   Moffat KL, 2008, P NATL ACAD SCI USA, V105, P7947, DOI 10.1073/pnas.0712150105
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien Fergal J, 2007, Technol Health Care, V15, P3
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Petty RT, 2007, J AM CHEM SOC, V129, P8966, DOI 10.1021/ja0735709
   Sethi KK, 2002, WOUND REPAIR REGEN, V10, P397, DOI 10.1046/j.1524-475X.2002.10609.x
   Shen YH, 2008, ACTA BIOMATER, V4, P477, DOI 10.1016/j.actbio.2007.12.011
   SINSHEIMER JE, 1975, J PHARM SCI, V64, P925, DOI 10.1002/jps.2600640605
   Song YF, 2009, J AM CHEM SOC, V131, P1340, DOI 10.1021/ja807091v
   Tang J, 2010, BIOMATERIALS, V31, P2470, DOI 10.1016/j.biomaterials.2009.12.006
   Tierney CM, 2009, J BIOMED MATER RES A, V91A, P92, DOI 10.1002/jbm.a.32207
   Toh CR, 2009, LANGMUIR, V25, P8894, DOI 10.1021/la9019537
   Tse JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015978
   Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179
   Xu H, 2009, J AM CHEM SOC, V131, P797, DOI 10.1021/ja807611n
   Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015
   YANNAS IV, 1989, P NATL ACAD SCI USA, V86, P933, DOI 10.1073/pnas.86.3.933
   Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103
NR 50
TC 49
Z9 48
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JUN
PY 2011
VL 32
IS 16
BP 3949
EP 3957
DI 10.1016/j.biomaterials.2011.02.018
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 758WA
UT WOS:000290196700008
PM 21397322
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Censi, R
   van Putten, S
   Vermonden, T
   di Martino, P
   van Nostrum, CF
   Harmsen, MC
   Bank, RA
   Hennink, WE
AF Censi, Roberta
   van Putten, Sander
   Vermonden, Tina
   di Martino, Piera
   van Nostrum, Cornelus F.
   Harmsen, Martin C.
   Bank, Ruud A.
   Hennink, Wim E.
TI The tissue response to photopolymerized PEG-p(HPMAm-lactate)-based
   hydrogels
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE photopolymerized thermosensitive hydrogels; biodegradation;
   granulocytes; macrophages; angiogenesis
ID IN-VIVO BIOCOMPATIBILITY; PCL DIBLOCK COPOLYMER; DRUG-DELIVERY SYSTEMS;
   INVIVO BIOCOMPATIBILITY; RESISTANT SURFACES; PROTEIN ADSORPTION;
   TRIBLOCK COPOLYMER; FORMING HYDROGELS; RELEASE BEHAVIOR; BLOCK-COPOLYMER
AB Hydrogels are three-dimensional networks of crosslinked hydrophilic polymers widely used for protein delivery and tissue engineering. To be eligible for in vivo applications, the hydrogels should not evoke an adverse tissue response. In this study the angiogenic and inflammatory responses in vivo after implantation of photopolymerized thermosensitive poly(hydroxypropyl methacrylamide lactate)-poly(ethyl copolymer hydrogels are investigated. Hydrogels consisting of polymers with different crosslink densities were subcutaneously implanted in Balb/c mice and histological evaluation of the tissue response was performed. The implants showed an acute and localized inflammatory reaction upon implantation, mainly characterized by a strong infiltration of granulocytes. The acute inflammatory reaction was followed by a milder chronic inflammation which was characterized by infiltration of macrophages and persistent but decreasing levels of granulocytes. The number of macrophages and blood vessels was associated with the biodegradation and resorption of the biomaterial and increased in time as the degradation of the materials progressed. The observed degradation rates in vivo correlated well with previously observed in vitro degradation rates, which suggests that hydrolysis is the main mechanism governing the degradation. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 219-229, 2011.
C1 [Censi, Roberta; Vermonden, Tina; van Nostrum, Cornelus F.; Hennink, Wim E.] Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, NL-3508 TB Utrecht, Netherlands.
   [Censi, Roberta; di Martino, Piera] Univ Camerino, Dept Chem Sci, I-62032 Camerino, MC, Italy.
   [van Putten, Sander; Harmsen, Martin C.; Bank, Ruud A.] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands.
RP Hennink, WE (reprint author), Univ Utrecht, Dept Pharmaceut, Utrecht Inst Pharmaceut Sci, POB 80082, NL-3508 TB Utrecht, Netherlands.
EM W.E.Hennink@uu.nl
RI Vermonden, Tina/I-9491-2016; van Nostrum, Cornelus/I-9445-2016
OI Vermonden, Tina/0000-0002-6047-5900
CR Anderson J M, 1988, ASAIO Trans, V34, P101, DOI 10.1097/00002480-198804000-00005
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   ANDERSON JM, 1994, EUR J PHARM BIOPHARM, V40, P1
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901
   Bjugstad KB, 2008, CELL TRANSPLANT, V17, P409
   Bos GW, 2004, EUR J PHARM SCI, V21, P561, DOI 10.1016/j.ejps.2003.12.007
   Burugapalli K, 2004, J BIOMED MATER RES A, V68A, P210, DOI 10.1002/jbm.a.10117
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   Cadee JA, 2001, J BIOMED MATER RES, V56, P600, DOI 10.1002/1097-4636(20010915)56:4<600::AID-JBM1133>3.0.CO;2-I
   Censi R, 2009, J CONTROL RELEASE, V140, P230, DOI 10.1016/j.jconrel.2009.06.003
   Censi R, 2010, BIOMACROMOLECULES, V11, P2143, DOI 10.1021/bm100514p
   Censi R, 2010, MACROMOLECULES, V43, P5771, DOI 10.1021/ma100606a
   Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247
   De Jong WH, 2007, J BIOMED MATER RES A, V83A, P538, DOI 10.1002/jbm.a.31302
   Denstedt JD, 2000, WORLD J UROL, V18, P237, DOI 10.1007/PL00007074
   DRUMHELLER PD, 1995, J BIOMED MATER RES, V29, P207, DOI 10.1002/jbm.820290211
   Du H, 1997, BBA-BIOMEMBRANES, V1326, P236, DOI 10.1016/S0005-2736(97)00027-8
   Duan YR, 2006, J APPL POLYM SCI, V100, P1019, DOI 10.1002/app.22961
   GILDING D, 1981, BIOCOMPATIBILITY IMP
   Hooper KA, 1998, J BIOMED MATER RES, V41, P443, DOI 10.1002/(SICI)1097-4636(19980905)41:3<443::AID-JBM14>3.0.CO;2-J
   Hyun H, 2007, BIOMACROMOLECULES, V8, P1093, DOI 10.1021/bm060771u
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Kim MS, 2006, TISSUE ENG, V12, P2863, DOI 10.1089/ten.2006.12.2863
   Kretlow JD, 2007, ADV DRUG DELIVER REV, V59, P263, DOI 10.1016/j.addr.2007.03.013
   Lee BH, 2004, MACROMOLECULES, V37, P4533, DOI 10.1021/ma0305838
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   Lee JH, 1997, J BIOMED MATER RES, V34, P105, DOI 10.1002/(SICI)1097-4636(199701)34:1<105::AID-JBM14>3.0.CO;2-J
   MARCHANT R, 1983, J BIOMED MATER RES, V17, P301, DOI 10.1002/jbm.820170209
   Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663
   Nam K, 2004, INT J PHARM, V275, P259, DOI 10.1016/j.ijpharm.2004.02.009
   Neradovic D, 2003, MACROMOLECULES, V36, P7491, DOI 10.1021/ma034381n
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Park H, 1996, PHARMACEUT RES, V13, P1770, DOI 10.1023/A:1016012520276
   Peppas NA, 1999, J CONTROL RELEASE, V62, P81, DOI 10.1016/S0168-3659(99)00027-9
   PRESS P, 1985, SURFACE INTERFACIAL, V2
   Ritu A., 2004, CONTACT LENS ANTERIO, V27, P39
   Rucker M, 2006, BIOMATERIALS, V27, P5027, DOI 10.1016/j.biomaterials.2006.05.033
   Shaw JP, 2003, J SURG RES, V109, P37, DOI 10.1006/jsre.2002.6559
   Shim WS, 2006, BIOMATERIALS, V27, P5178, DOI 10.1016/j.biomaterials.2006.05.038
   SOCIETY AC, 1982, ACS S SERIES, V199
   Soga O, 2004, BIOMACROMOLECULES, V5, P818, DOI 10.1021/bm049955q
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Van Tomme SR, 2008, INT J PHARM, V355, P1, DOI 10.1016/j.ijpharm.2008.01.057
   VANWACHEM PB, 1994, J BIOMED MATER RES, V28, P353, DOI 10.1002/jbm.820280310
   Vermonden T, 2008, BIOMACROMOLECULES, V9, P919, DOI 10.1021/bm7013075
   Vermonden T, 2006, LANGMUIR, V22, P10180, DOI 10.1021/la062224m
   West JL, 1996, P NATL ACAD SCI USA, V93, P13188, DOI 10.1073/pnas.93.23.13188
   Williams D. F., 1999, WILLIAMS DICT BIOMAT
   Woerly S, 1996, NEUROSCI LETT, V205, P197, DOI 10.1016/0304-3940(96)12349-1
   YAMAGUCHI K, 1993, J CONTROL RELEASE, V24, P81, DOI 10.1016/0168-3659(93)90169-6
NR 53
TC 11
Z9 11
U1 0
U2 17
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 3
BP 219
EP 229
DI 10.1002/jbm.a.33048
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FQ
UT WOS:000290382700001
PM 21442723
DA 2018-10-20
ER

PT J
AU Griffin, J
   Delgado-Rivera, R
   Meiners, S
   Uhrich, KE
AF Griffin, Jeremy
   Delgado-Rivera, Roberto
   Meiners, Sally
   Uhrich, Kathryn E.
TI Salicylic acid-derived poly(anhydride-ester) electrospun fibers designed
   for regenerating the peripheral nervous system
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nerve regeneration; electrospinning; fibers; polyanhydride; salicylic
   acid
ID IN-VITRO; BIODEGRADABLE POLYMERS; NEURITE OUTGROWTH; CONTROLLED-RELEASE;
   SCIATIC-NERVE; DEGRADATION; NANOFIBERS; COLLAGEN; GROWTH; REPAIR
AB Continuous biomaterial advances and the regenerating potential of the adult human peripheral nervous system offer great promise for restoring full function to innervated tissue following traumatic injury via synthetic nerve guidance conduits (NGCs). To most effectively facilitate nerve regeneration, a tissue engineering scaffold within a conduit must be similar to the linear microenvironment of the healthy nerve. To mimic the native nerve structure, aligned poly(lactic-co-glycolic acid)/bioactive polyanhydride fibrous substrates were fabricated through optimized electrospinning parameters with diameters of 600 +/- 200 nm. Scanning electron microscopy images show fibers with a high degree of alignment. Schwann cells and dissociated rat dorsal root ganglia demonstrated elongated and healthy proliferation in a direction parallel to orientated electrospun fibers with significantly longer Schwann cell process length and neurite outgrowth when compared to randomly orientated fibers. Results suggest that an aligned polyanhydride fiber mat holds tremendous promise as a supplement scaffold for the interior of a degradable polymer NGC. Bioactive salicylic acid-based polyanhydride fibers are not limited to nerve regeneration and offer exciting promise for a wide variety of biomedical applications. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A:230-242, 2011.
C1 [Griffin, Jeremy; Uhrich, Kathryn E.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
   [Delgado-Rivera, Roberto; Uhrich, Kathryn E.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.
   [Meiners, Sally] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA.
RP Uhrich, KE (reprint author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
EM keuhrich@rci.rutgers.edu
RI Uhrich, Kathryn/I-2099-2013
OI Uhrich, Kathryn/0000-0001-7273-7528
FU National Institutes of Health (NIDCR)
FX Contract grant sponsor: National Institutes of Health (NIDCR)
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   Anastasiou TJ, 2003, J POLYM SCI POL CHEM, V41, P3667, DOI 10.1002/pola.10973
   Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   Bellamkonda RV, 2006, BIOMATERIALS, V27, P3515, DOI 10.1016/j.biomaterials.2006.02.030
   BERGSMA JE, 1995, BIOMATERIALS, V16, P25, DOI 10.1016/0142-9612(95)91092-D
   Bhattarai N, 2005, BIOMATERIALS, V26, P6176, DOI 10.1016/j.biomaterials.2005.03.027
   Bini TB, 2004, J BIOMED MATER RES A, V68A, P286, DOI 10.1002/jbm.a.20050
   Bungner OV, 1891, BEITR PATHOL ANAT, V10, P321
   Buttafoco L, 2006, BIOMATERIALS, V27, P724, DOI 10.1016/j.biomaterials.2005.06.024
   Campo CJ, 1999, POLYM BULL, V42, P61, DOI 10.1007/s002890050435
   Canton I., 2009, BIOTECHNOL BIOENG, V105, P396
   Ciardelli G, 2006, MACROMOL BIOSCI, V6, P13, DOI 10.1002/mabi.200500151
   DANG WB, 1994, J BIOMAT SCI-POLYM E, V6, P297
   Dang WB, 1996, PHARMACEUT RES, V13, P683, DOI 10.1023/A:1016035229961
   Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x
   Demir MM, 2002, POLYMER, V43, P3303, DOI 10.1016/S0032-3861(02)00136-2
   Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609
   Duncan E., 2004, NEW PRODUCTS STANDAR
   Erdmann L, 2000, BIOMATERIALS, V21, P2507, DOI 10.1016/S0142-9612(00)00118-6
   Erdmann L, 2000, BIOMATERIALS, V21, P1941, DOI 10.1016/S0142-9612(00)00073-9
   GILDING DK, 1979, POLYMER, V20, P1459, DOI 10.1016/0032-3861(79)90009-0
   Gingras M, 2003, FASEB J, V17, P2124, DOI 10.1096/fj.02-1180fje
   Griffin J, 2010, ACTA BIOMATER, V6, P1917, DOI 10.1016/j.actbio.2009.11.023
   Harten RD, 2005, J BIOMED MATER RES A, V72A, P354, DOI 10.1002/jbm.a.30184
   Ide C, 1996, NEUROSCI RES, V25, P101
   IJkema-Paassen J, 2004, BIOMATERIALS, V25, P1583, DOI 10.1016/S0142-9612(03)00504-0
   Inoguchi H, 2006, BIOMATERIALS, V27, P1470, DOI 10.1016/j.biomaterials.2005.08.029
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009
   Kim YT, 2008, BIOMATERIALS, V29, P3117, DOI 10.1016/j.biomaterials.2008.03.042
   LEACH JB, 2006, TISSUE ENG PERIPHERA
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Lide D. R., 1996, HDB CHEM PHYS
   Lu HJ, 2009, J MATER SCI-MATER M, V20, P1937, DOI 10.1007/s10856-009-3744-y
   LUNDBORG G, 1982, EXP NEUROL, V76, P361, DOI 10.1016/0014-4886(82)90215-1
   Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7
   Mahoney MJ, 1996, J PHARM SCI, V85, P1276, DOI 10.1021/js9601602
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Meiners S, 2007, POLYM INT, V56, P1340, DOI 10.1002/pi.2383
   MILLER RA, 1977, J BIOMED MATER RES, V11, P711, DOI 10.1002/jbm.820110507
   Moro MA, 2000, NEUROPHARMACOLOGY, V39, P1309, DOI 10.1016/S0028-3908(99)00226-9
   Namgung U, 2004, MOL CELL NEUROSCI, V25, P422, DOI 10.1016/j.mcn.2003.11.005
   Ngo TTB, 2003, J NEUROSCI RES, V72, P227, DOI 10.1002/jnr.10570
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816
   Panseri S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-39
   Prudencio A, 2005, MACROMOLECULES, V38, P6895, DOI 10.1021/ma048051u
   Ramon Y, 1928, DEGENERATION REGENER
   Rangappa N, 2000, J BIOMED MATER RES, V51, P625, DOI 10.1002/1097-4636(20000915)51:4<625::AID-JBM10>3.0.CO;2-U
   Schmeltzer RC, 2005, BIOMACROMOLECULES, V6, P359, DOI 10.1021/bm049544+
   Schmeltzer RC, 2003, POLYM BULL, V49, P441, DOI 10.1007/s00289-003-0123-6
   Schmeltzer RC, 2008, J BIOMAT SCI-POLYM E, V19, P1295, DOI 10.1163/156856208786052362
   Schnell E, 2007, BIOMATERIALS, V28, P3012, DOI 10.1016/j.biomaterials.2007.03.009
   Smeal RM, 2005, ANN BIOMED ENG, V33, P376, DOI 10.1007/s10439-005-1740-z
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   Steuer H, 1999, NEUROSCI LETT, V277, P165, DOI 10.1016/S0304-3940(99)00886-1
   Subbanna PKT, 2007, J BRACHIAL PLEX PERI, V2, DOI 10.1186/1749-7221-2-3
   TABATA Y, 1993, PHARMACEUT RES, V10, P487, DOI 10.1023/A:1018929531410
   Taras John S, 2005, J Hand Ther, V18, P191, DOI 10.1197/j.jht.2005.02.012
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Teo WE, 2005, NANOTECHNOLOGY, V16, P918, DOI 10.1088/0957-4484/16/6/049
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u
   VARTIANEN N, 2002, INT SOC NEUROCHEM, V82, P329
   Wang HB, 2010, ACTA BIOMATER, V6, P2970, DOI 10.1016/j.actbio.2010.02.020
   Wen XJ, 2006, J BIOMED MATER RES A, V76A, P626, DOI 10.1002/jbm.a.30520
   Whitaker-Brothers K, 2004, J BIOMED MATER RES A, V70A, P309, DOI 10.1002/jbm.a.30083
   WILLIAMS LR, 1983, J COMP NEUROL, V218, P460, DOI 10.1002/cne.902180409
   WINET H, 1993, J BIOMED MATER RES, V27, P667, DOI 10.1002/jbm.820270514
   Zhang K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/035004
   ZHAO Q, 1993, RESTOR NEUROL NEUROS, V5, P197, DOI 10.3233/RNN-1993-5304
   Zhong SP, 2006, J BIOMED MATER RES A, V79A, P456, DOI 10.1002/jbm.a.30870
NR 74
TC 37
Z9 38
U1 3
U2 23
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 3
BP 230
EP 242
DI 10.1002/jbm.a.33049
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FQ
UT WOS:000290382700002
PM 21442724
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Srivastava, GK
   Martin, L
   Singh, AK
   Fernandez-Bueno, I
   Gayoso, MJ
   Garcia-Gutierrez, MT
   Girotti, A
   Alonso, M
   Rodriguez-Cabello, JC
   Pastor, JC
AF Srivastava, Girish K.
   Martin, Laura
   Singh, Amar K.
   Fernandez-Bueno, Ivan
   Gayoso, Manuel J.
   Garcia-Gutierrez, Maria T.
   Girotti, Alessandra
   Alonso, Matilde
   Rodriguez-Cabello, Jose C.
   Pastor, Jose C.
TI Elastin-like recombinamers as substrates for retinal pigment epithelial
   cell growth
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE regenerative medicine; biomaterial; RPE cells; AMD; elastin-like
   recombinamers
ID MACULAR DEGENERATION; BRUCHS MEMBRANE; RPE CELLS; TRANSPLANTATION;
   CULTURE; TRANSDIFFERENTIATION; NEOVASCULARIZATION; TRANSLOCATION;
   REGENERATION; TRANSITION
AB The aim of this study is to investigate the use of elastin-like recombinamers (ELRs) as a substrate that can maintain the growth, phenotype, and functional characteristics of retinal pigment epithelial (RPE) cells efficiently and as a suitable carrier for the transplantation of autologous RPE cells for treatment of age-related macular degeneration (AMD). ELR films containing a bioactive sequence, RGD (ELR-RGD), and one with no specific sequence (ELR-IK) as control, were obtained by solvent-casting onto glass and subsequent cross-linking. ARPE19 cells were seeded on sterilized ELR films as well as on the control surfaces. Cells were analysed after 4, 24, 72, and 120 h to study cell adhesion, proliferation, cell viability, morphology, and specificity by staining with Trypan blue, DAPI, Rhodamin-Phalloidin and RPE65, ZO-1 antibodies and observing under fluorescence as well as electron microscope. ARPE19 cells seeded on both ELR films and controls were 100% viable and maintained their morphology and set of characteristics at the different time points studied. Cell proliferation on ELR-RGD was significantly higher than that found on ELR-IK at all time points, although it was less than the growth rate on polystyrene. ARPE19 cells grow well on ELR-RGD maintaining their phenotype. These results should be extended to further studies with fresh human RPE cells and in vivo studies to determine whether this ELR-RGD matrix could be used as a Bruch's membrane prosthesis and carrier for transplantation of RPE cells in patients suffering with AMD. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 243-250, 2011.
C1 [Srivastava, Girish K.; Singh, Amar K.; Fernandez-Bueno, Ivan; Gayoso, Manuel J.; Garcia-Gutierrez, Maria T.; Pastor, Jose C.] Univ Valladolid, Inst Appl Ophthalmobiol IOBA, Valladolid, Spain.
   [Srivastava, Girish K.] Castilla & Leon Regenerat Med & Cell Therapy Netw, Valladolid, Spain.
   [Martin, Laura; Girotti, Alessandra; Alonso, Matilde; Rodriguez-Cabello, Jose C.] Univ Valladolid, GIR BIOFORGE Grp, CIBER BBN, Valladolid, Spain.
RP Srivastava, GK (reprint author), Univ Valladolid, Inst Appl Ophthalmobiol IOBA, Valladolid, Spain.
EM girish@ioba.med.uva.es
RI Srivastava, Girish/L-7608-2014; Fernandez-Bueno, Ivan/H-4201-2015;
   Rodriguez-Cabello, Jose Carlos/G-6555-2017; Martin, Laura/J-9291-2017;
   ALONSO, MATILDE/G-6719-2017; Girotti, Alessandra/D-4325-2012; SINGH,
   AMAR/H-6569-2016; Gayoso, Manuel/L-7270-2017
OI Srivastava, Girish/0000-0002-9791-4057; Fernandez-Bueno,
   Ivan/0000-0003-3380-4040; Rodriguez-Cabello, Jose
   Carlos/0000-0002-3438-858X; Martin, Laura/0000-0002-6583-8731; ALONSO,
   MATILDE/0000-0002-6853-8427; Girotti, Alessandra/0000-0003-4754-7022;
   SINGH, AMAR/0000-0002-1767-5907; Gayoso, Manuel/0000-0001-6651-8273
FU Castilla and Leon Regenerative Medicine and Cell Therapy Network Center;
   CIBER-BBN; AECI (Part of the Spanish Ministry of Foreign Affairs); Junta
   de Castilla-Leon; National Plan of I+D+I; Spanish Institute of Health
   Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la
   Investigacion (MICNN) [PS09/00938]
FX Contract grant sponsors: Castilla and Leon Regenerative Medicine and
   Cell Therapy Network Center, CIBER-BBN, AECI (Part of the Spanish
   Ministry of Foreign Affairs), The Junta de Castilla-Leon; Contract grant
   sponsor: National Plan of I+D+I 2008-2011 and Spanish Institute of
   Health Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento
   de la Investigacion (MICNN) with confinantiation FEDER; contract grant
   number: PS09/00938
CR Alge CS, 2006, J PROTEOME RES, V5, P862, DOI 10.1021/pr050420t
   Berg MC, 2004, LANGMUIR, V20, P1362, DOI 10.1021/la0355489
   Binder S, 2002, AM J OPHTHALMOL, V133, P215, DOI 10.1016/S0002-9394(01)01373-3
   Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002
   Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003
   Rodriguez-Cabello JC, 2009, POLYMER, V50, P5159, DOI 10.1016/j.polymer.2009.08.032
   Chopdar A, 2003, BRIT MED J, V326, P485, DOI 10.1136/bmj.326.7387.485
   Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782
   da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001
   Del Priore LV, 2004, INVEST OPHTH VIS SCI, V45, P985, DOI 10.1167/iovs.03-0662
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020
   Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564
   Gaillard F, 2007, VISION RES, V47, P2815, DOI 10.1016/j.visres.2007.06.018
   GASS JDM, 1973, ARCH OPHTHALMOL-CHIC, V90, P206
   Girotti A, 2004, MACROMOLECULES, V37, P3396, DOI 10.1021/ma035603k
   GRIERSON I, 1994, EYE, V8, P255
   GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391
   Gullapalli VK, 2008, EXP EYE RES, V86, P189, DOI 10.1016/j.exer.2007.10.009
   Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X
   Knoernschild T, 2003, CURR EYE RES, V27, P25, DOI 10.1076/ceyr.27.2.25.15453
   Lee CJ, 2007, BIOMATERIALS, V28, P2192, DOI 10.1016/j.biomaterials.2007.01.018
   Lee J, 2001, J BIOMAT SCI-POLYM E, V12, P229, DOI 10.1163/156856201750180942
   Lee SC, 2001, OPHTHALMIC RES, V33, P80, DOI 10.1159/000055648
   Limb GA, 2006, CURR EYE RES, V31, P381, DOI 10.1080/02713680600681210
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Luke C, 2003, GRAEF ARCH CLIN EXP, V241, P710, DOI 10.1007/s00417-003-0709-6
   Ma ZZ, 2009, INVEST OPHTH VIS SCI, V50, P2975, DOI 10.1167/iovs.08-2573
   Maaijwee K, 2008, RETINA-J RET VIT DIS, V28, P498, DOI 10.1097/IAE.0b013e318159ec24
   Martin L, 2009, BIOMACROMOLECULES, V10, P3015, DOI 10.1021/bm900560a
   Martinez-Osorio H, 2009, CURR EYE RES, V34, P48, DOI 10.1080/02713680802542053
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Nowak JZ, 2006, PHARMACOL REP, V58, P353
   Radtke ND, 2008, AM J OPHTHALMOL, V146, P172, DOI 10.1016/j.ajo.2008.04.009
   Rak DJ, 2006, EXP EYE RES, V82, P648, DOI 10.1016/j.exer.2005.09.002
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Sheridan C, 2004, GRAEF ARCH CLIN EXP, V242, P68, DOI 10.1007/s00417-003-0800-z
   Sheridan C, 2007, EXPERT REV OPHTHALMO, V2, P1
   Tasman W, 2004, ARCH OPHTHALMOL-CHIC, V122, P648, DOI 10.1001/archopht.122.4.648
   Thumann G, 2006, CURR EYE RES, V31, P241, DOI 10.1080/02713680600556966
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   van Meurs JC, 2004, BRIT J OPHTHALMOL, V88, P110, DOI 10.1136/bjo.88.1.110
   Wong D, 2004, BRIT J OPHTHALMOL, V88, P186, DOI 10.1136/bjo.2003.019273
   Zarbin Marco A, 2003, Trans Am Ophthalmol Soc, V101, P499
NR 44
TC 21
Z9 21
U1 1
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 3
BP 243
EP 250
DI 10.1002/jbm.a.33050
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FQ
UT WOS:000290382700003
PM 21442725
DA 2018-10-20
ER

PT J
AU Falco, EE
   Coates, EE
   Li, E
   Roth, JS
   Fisher, JP
AF Falco, Erin E.
   Coates, Emily E.
   Li, Erik
   Roth, J. Scott
   Fisher, John P.
TI Fabrication and characterization of porous EH scaffolds and EH-PEG
   bilayers
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE porous scaffold; tissue engineering; cyclic acetal; mechanical strength;
   hydrolysis
ID WALL HERNIA REPAIR; POLYMERS; MESHES; BIOTECHNOLOGY; DEGRADATION;
   HYDROGELS; MEDICINE
AB Biomaterials made from synthetic polymers are becoming more pervasive in the medical field. Synthetic polymers are particularly advantageous as their chemical and mechanical properties can be easily tailored to a specific application. This work characterizes polymer scaffolds derived from the cyclic acetal monomer 5-ethyl-5-(hydroxymethyl)-beta,beta-dimethyl-1,3-dioxane-2-ethanol diacrylate (EHD). Both porous scaffolds and bilayer scaffolds based upon the EHD monomer were fabricated, and the resulting scaffolds' degradation and mechanical properties were studied. The results showed that by modifying the architecture of an EH scaffold, either by adding a porous network or a poly(ethylene glycol) PEG) coating, the degradation and Young's modulus of the biomaterial can be significant altered. However, results also indicated that these architectural modifications can be accomplished without a significant loss in the flexural strength of the scaffold. Therefore, we suggest that porous EH scaffolds, and particularly porous EH-PEG bilayers, may be especially useful in dynamic tissue environments due to their advantageous architectural and mechanical properties. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 264-271, 2011.
C1 [Coates, Emily E.; Li, Erik; Fisher, John P.] Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   [Falco, Erin E.] Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   [Roth, J. Scott] Univ Kentucky, Coll Med, Dept Surg, Lexington, KY USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
OI Li, Erik/0000-0001-6899-6201
FU National Science Foundation (NSF) [0448684]; Maryland NanoCenter;
   NispLab; MRSEC
FX Contract grant sponsor: National Science Foundation (NSF); contract
   grant number: #0448684; Contract grant sponsors: Maryland NanoCenter and
   its NispLab, The NispLab is supported in part by the NSF and as a MRSEC
   Shared Experimental Facility
CR Borrazzo E C, 2004, Hernia, V8, P108, DOI 10.1007/s10029-003-0181-6
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Capancioni S, 2003, MACROMOLECULES, V36, P6135, DOI 10.1021/ma034365q
   Choi JS, 2008, BIOMATERIALS, V29, P2899, DOI 10.1016/j.biomaterials.2008.03.031
   Delie F, 2005, MOLECULES, V10, P65, DOI 10.3390/10010065
   Emans P, 2009, ANN BIOMED ENG, V37, P410, DOI 10.1007/s10439-008-9608-7
   Falco EE, 2008, J SURG RES, V149, P76, DOI 10.1016/j.jss.2007.08.016
   Falco Erin E., 2008, Birth Defects Research, V84, P315, DOI 10.1002/bdrc.20134
   Fisher JP, 2003, BIOMACROMOLECULES, V4, P1335, DOI 10.1021/bm0300296
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gonzalez R, 2004, Hernia, V8, P213
   Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113
   Higashiura W, 2009, J VASC SURG, V49, P645, DOI 10.1016/j.jvs.2008.10.019
   HOFFMAN AS, 1995, ARTIF ORGANS, V19, P458, DOI 10.1111/j.1525-1594.1995.tb02359.x
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   Jansen PL, 2004, SURGERY, V136, P1, DOI 10.1016/j.surg.2004.01.004
   Kaihara S, 2008, EUR J PHARM BIOPHARM, V68, P67, DOI 10.1016/j.ejpb.2007.05.019
   Kaihara S, 2007, MACROMOLECULES, V40, P7625, DOI 10.1021/ma071297p
   Kayaoglu HA, 2005, J INVEST SURG, V18, P89, DOI 10.1080/08941930590926357
   Ko R, 2006, J SURG RES, V135, P9, DOI 10.1016/j.jss.2006.02.007
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lendlein A, 2005, Med Device Technol, V16, P12
   Matthews BD, 2003, J SURG RES, V114, P126, DOI 10.1016/S0022-4804(03)00158-6
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2003, EUR CELLS MATER, V5, P39
   Shen JY, 2006, J BIOMED MATER RES B, V77B, P423, DOI 10.1002/jbm.b.30449
   Song C, 2006, SURG ENDOSC, V20, P987, DOI 10.1007/s00464-005-0676-6
   Yu HY, 2008, J BIOMED MATER RES B, V86B, P541, DOI 10.1002/jbm.b.31054
NR 29
TC 1
Z9 1
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 3
BP 264
EP 271
DI 10.1002/jbm.a.33052
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FQ
UT WOS:000290382700005
PM 21442727
DA 2018-10-20
ER

PT J
AU Wei, K
   Li, Y
   Kim, KO
   Nakagawa, Y
   Kim, BS
   Abe, K
   Chen, GQ
   Kim, IS
AF Wei, Kai
   Li, Yuan
   Kim, Kyu-Oh
   Nakagawa, Yuya
   Kim, Byoung-Suhk
   Abe, Koji
   Chen, Guo-Qiang
   Kim, Ick-Soo
TI Fabrication of nano-hydroxyapatite on electrospun silk fibroin nanofiber
   and their effects in osteoblastic behavior
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silk; fibroin; nanofiber; hydroxyapatite; osteoblast
ID ALTERNATE SOAKING PROCESS; SIMULATED BODY-FLUID; SMOOTH-MUSCLE-CELLS;
   CALCIUM-PHOSPHATE; IN-VITRO; SUBSTITUTED HYDROXYAPATITE; TISSUE
   REGENERATION; REINFORCED BONE; FORMATION ON/IN; COLLAGEN
AB In this study, a novel tissue engineering scaffold material of electrospun silk fibroin/nano-hydroxyapatite (nHA) biocomposite was prepared by means of an effective calcium and phosphate (Ca-P) alternate soaking method. nHA was successfully produced on regenerated silk fibroin nanofiber as a substrate within several minutes without any pretreatments. The morphologies of both nonmineralized and mineralized nanofibers were analyzed using a field-emission scanning electron microscopy (FESEM). The crystallographic phases of the nHA were analyzed using X-ray diffraction (XRD). Fourier transform infrared (FTIR) spectrophotometer and thermogravimetry analyses (TGA) were employed to determine the type of functional groups and the amount of nHA presenting in the silk/nHA biocomposite nanofibers, respectively. The osteoblastic activities of this novel nanofibrous biocomposite scaffold were also investigated by employing osteoblastic-like MC3T3-E1 cell line. The cell functionality such as alkaline phosphatase (ALP) activity was ameliorated on mineralized nanofibers. All these results indicated that this silk/nHA biocomposite scaffold material may be a promising biomaterial for bone tissue engineering. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 272-280, 2011.
C1 [Nakagawa, Yuya; Kim, Byoung-Suhk; Kim, Ick-Soo] Shinshu Univ, Nano Fus Technol Res Grp, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
   [Wei, Kai; Kim, Kyu-Oh] Shinshu Univ, Interdisciplinary Div Sci & Technol, Grad Sch, Ueda, Nagano 3868567, Japan.
   [Li, Yuan; Abe, Koji] Shinshu Univ, Dept Funct Polymer Sci, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
   [Chen, Guo-Qiang] Soochow Univ, Coll Text & Clothing Engn, Suzhou 215021, Peoples R China.
RP Kim, BS (reprint author), Shinshu Univ, Nano Fus Technol Res Grp, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.
EM bskim@shinshu-u.ac.jp; kim@shinshu-u.ac.jp
RI Kim, Byoung-Suhk/K-1573-2015
OI Kim, Byoung-Suhk/0000-0001-8070-3424
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
   Shinshu University
FX Contract grant sponsors: "Innovation Creative Center for Advanced
   Interdisciplinary Research Area'' in Special Coordination Funds for
   Promoting Science and Technology from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan; Shinshu University
   Global COE Program "International Center of Excellence on Fiber
   Engineering''
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Aoki H, 1994, MED APPL HYDROXYAPAT, P90
   Ayers R, 2006, MAT SCI ENG C-BIO S, V26, P1333, DOI 10.1016/j.msec.2005.08.028
   Bacakova L, 2001, J BIOMED MATER RES, V54, P567
   DANDURAND J, 1990, J BIOMED MATER RES, V24, P1377, DOI 10.1002/jbm.820241009
   Doi Y, 1996, J BIOMED MATER RES, V31, P43, DOI 10.1002/(SICI)1097-4636(199605)31:1<43::AID-JBM6>3.0.CO;2-Q
   Feenstra L, 1982, BIOCERAMICS CALCIUM
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Furuzono T, 2000, J BIOMED MATER RES, V50, P344, DOI 10.1002/(SICI)1097-4636(20000605)50:3<344::AID-JBM8>3.0.CO;2-D
   Gibson IR, 2002, J BIOMED MATER RES, V59, P697, DOI 10.1002/jbm.10044
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   ISHIKAWA K, 1993, J MATER SCI-MATER M, V4, P165, DOI 10.1007/BF00120386
   Ito Y, 2005, J BIOSCI BIOENG, V100, P43, DOI 10.1263/jbb.100.43
   Kim HW, 2005, ADV FUNCT MATER, V15, P1988, DOI 10.1002/adfm.200500116
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   LeGeros RZ, 1991, CALCIUM PHOSPHATES O
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li PJ, 1998, J BIOMED MATER RES, V41, P341, DOI 10.1002/(SICI)1097-4636(19980905)41:3<341::AID-JBM1>3.0.CO;2-C
   Li SH, 1998, J BIOMED MATER RES, V40, P520
   Li YA, 2011, J MATER SCI, V46, P1396, DOI 10.1007/s10853-010-4933-2
   Liao SS, 2004, J BIOACT COMPAT POL, V19, P117, DOI 10.1177/0883911504042643
   Liu Q, 1998, J BIOMED MATER RES, V40, P257, DOI 10.1002/(SICI)1097-4636(199805)40:2<257::AID-JBM10>3.0.CO;2-J
   Marcolongo M, 1997, J BIOMED MATER RES, V37, P440
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P658, DOI 10.1007/BF00123448
   MUCALO MR, 1995, J MATER SCI-MATER M, V6, P597, DOI 10.1007/BF00121284
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674
   Ogata K, 2005, J BIOMED MATER RES A, V72A, P127, DOI 10.1002/jbm.a.30146
   Ohsawa O, 2010, POLYMER, V51, P2007, DOI 10.1016/j.polymer.2010.02.045
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Park JC, 2010, POLYM J, V42, P273, DOI 10.1038/pj.2009.340
   POURDEYHIMI B, 1986, J MATER SCI, V21, P4468, DOI 10.1007/BF01106573
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Smith IO, 2006, INT J NANOMED, V1, P189, DOI 10.2147/nano.2006.1.2.189
   Sui G, 2007, J BIOMED MATER RES A, V82A, P445, DOI 10.1002/jbm.a.31166
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   Taguchi T, 1999, J BIOMAT SCI-POLYM E, V10, P19, DOI 10.1163/156856299X00252
   Taira T, 1995, Connect Tissue Res, V33, P185, DOI 10.3109/03008209509017000
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   TENHUISEN KS, 1995, J BIOMED MATER RES, V29, P803, DOI 10.1002/jbm.820290704
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Tsukada M, 1996, J APPL POLYM SCI, V60, P1619, DOI 10.1002/(SICI)1097-4628(19960606)60:10<1619::AID-APP14>3.0.CO;2-#
   Venugopal J, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/5/055101
   Venugopal J, 2005, CELL BIOL INT, V29, P861, DOI 10.1016/j.cellbi.2005.03.026
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wei K, J POLYM RES, DOI [10.1007/s0965-010-9451-z, DOI 10.1007/S0965-010-9451-Z]
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   WILSON A D, 1991, Clinical Materials, V7, P275, DOI 10.1016/0267-6605(91)90070-V
   Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
   Zhai Y, 2006, J CRYST GROWTH, V291, P202, DOI 10.1016/j.jcrysgro.2006.03.006
   Zhang W, 2003, J AM CERAM SOC, V86, P1052, DOI 10.1111/j.1151-2916.2003.tb03422.x
   Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038
   Zhu XL, 2006, J BIOMED MATER RES A, V79A, P114, DOI 10.1002/jbm.a.30706
NR 59
TC 81
Z9 85
U1 1
U2 81
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 3
BP 272
EP 280
DI 10.1002/jbm.a.33054
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FQ
UT WOS:000290382700006
PM 21442728
DA 2018-10-20
ER

PT J
AU Choi, JS
   Kim, BS
   Kim, JY
   Kim, JD
   Choi, YC
   Yang, HJ
   Park, K
   Lee, HY
   Cho, YW
AF Choi, Ji Suk
   Kim, Beob Soo
   Kim, Jun Young
   Kim, Jae Dong
   Choi, Young Chan
   Yang, Hyun-Jin
   Park, Kinam
   Lee, Hee Young
   Cho, Yong Woo
TI Decellularized extracellular matrix derived from human adipose tissue as
   a potential scaffold for allograft tissue engineering
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE extracellular matrix; scaffold; tissue engineering; adipose tissue;
   allograft
ID PORCINE AORTIC VALVES; ENDOCRINE ORGAN; COLLAGEN-FIBERS; HEART-VALVES;
   STEM-CELLS; IN-VITRO; SUBMUCOSA; GRAFT; FAT; BIOMATERIALS
AB Decellularized tissues composed of extracellular matrix (ECM) have been clinically used to support the regeneration of various human tissues and organs. Most decellularized tissues so far have been derived from animals or cadavers. Therefore, despite the many advantages of decellularized tissue, there are concerns about the potential for immunogenicity and the possible presence of infectious agents. Herein, we present a biomaterial composed of ECM derived from human adipose tissue, the most prevalent, expendable, and safely harvested tissue in the human body. The ECM was extracted by successive physical, chemical, and enzymatic treatments of human adipose tissue isolated by liposuction. Cellular components including nucleic acids were effectively removed without significant disruption of the morphology or structure of the ECM. Major ECM components were quantified, including acid/pepsin-soluble collagen, sulfated glycosaminoglycan (GAG), and soluble elastin. In an in vivo experiment using mice, the decellularized ECM graft exhibited good compatibility to surrounding tissues. Overall results suggest that the decellularized ECM containing biological and chemical cues of native human ECM could be an ideal scaffold material not only for autologous but also for allograft tissue engineering. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 292-299, 2011.
C1 [Choi, Ji Suk; Kim, Beob Soo; Kim, Jae Dong; Choi, Young Chan; Cho, Yong Woo] Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
   [Choi, Ji Suk; Kim, Beob Soo; Kim, Jae Dong; Choi, Young Chan; Cho, Yong Woo] Hanyang Univ, Dept Bionanotechnol, Ansan 426791, Gyeonggi Do, South Korea.
   [Kim, Jun Young; Yang, Hyun-Jin; Lee, Hee Young] Kangnam Plast Surg Clin, Seoul 135120, South Korea.
   [Park, Kinam] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA.
   [Park, Kinam] Purdue Univ, Dept Pharmaceut, W Lafayette, IN 47907 USA.
RP Choi, JS (reprint author), Hanyang Univ, Dept Chem Engn, Ansan 426791, Gyeonggi Do, South Korea.
EM ywcho7@hanyang.ac.kr
FU National Research Foundation of Korea [2009-0075546,
   R11-2008-044-02001-0]
FX Contract grant sponsor: National Research Foundation of Korea; contract
   grant numbers: 2009-0075546 and R11-2008-044-02001-0
CR Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5
   Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Balachandran K, 2006, ANN BIOMED ENG, V34, P1655, DOI 10.1007/s10439-006-9167-8
   Bankowski E, 1996, EUR J OBSTET GYN R B, V66, P109, DOI 10.1016/0301-2115(96)02390-1
   Burugapalli K, 2007, BIOMACROMOLECULES, V8, P928, DOI 10.1021/bm061088x
   Chen QZ, 2008, MAT SCI ENG R, V59, P1, DOI 10.1016/j.mser.2007.08.001
   Choi JS, 2010, TISSUE ENG PART C-ME, V16, P387, DOI [10.1089/ten.tec.2009.0276, 10.1089/ten.TEC.2009.0276]
   Choi JS, 2009, J CONTROL RELEASE, V139, P2, DOI 10.1016/j.jconrel.2009.05.034
   Chun SY, 2007, BIOMATERIALS, V28, P4251, DOI 10.1016/j.biomaterials.2007.05.020
   Conklin BS, 2002, MED ENG PHYS, V24, P173, DOI 10.1016/S1350-4533(02)00010-3
   CROSS HR, 1973, J AGR FOOD CHEM, V21, P716, DOI 10.1021/jf60188a033
   Dahms SE, 1998, BRIT J UROL, V82, P411
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Fleischmann N, 2002, J UROLOGY, V168, P1265, DOI 10.1097/01.ju.0000023406.93873.08
   FLOURNOY DJ, 1982, J CLIN MICROBIOL, V16, P573
   Flynn LE, 2010, BIOMATERIALS, V31, P4715, DOI 10.1016/j.biomaterials.2010.02.046
   Fonseca-Alaniz MH, 2007, J PEDIAT, V83, pS192, DOI 10.2223/JPED.1709
   Fraser JK, 2006, TRENDS BIOTECHNOL, V24, P150, DOI 10.1016/j.tibtech.2006.01.010
   FULLMER HM, 1956, J HISTOCHEM CYTOCHEM, V4, P64, DOI 10.1177/4.1.64
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Jin CZ, 2010, J BIOMED MATER RES A, V92A, P1567, DOI 10.1002/jbm.a.32419
   Lin P, 2004, TISSUE ENG, V10, P1046, DOI 10.1089/ten.2004.10.1046
   Lumpkins SB, 2008, ACTA BIOMATER, V4, P808, DOI 10.1016/j.actbio.2008.01.016
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MacLeod TM, 2004, BURNS, V30, P431, DOI 10.1016/j.burns.2004.01.018
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Rieder E, 2005, CIRCULATION, V111, P2792, DOI 10.1161/CIRCULATIONAHA.104.473629
   Robinson KA, 2005, CIRCULATION, V112, pI135, DOI 10.1161/CIRCULATIONAHA.104.525436
   Romanowicz L, 2000, J PERINAT MED, V28, P140, DOI 10.1515/JPM.2000.019
   Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033
   Schenke-Layland K, 2003, J STRUCT BIOL, V143, P201, DOI 10.1016/j.jsb.2003.08.002
   Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011
   Spiegel JH, 2004, DERMATOL SURG, V30, P1486, DOI 10.1111/j.1524-4725.2004.30507.x
   Strem BM, 2005, TRENDS BIOTECHNOL, V23, P64, DOI 10.1016/j.tibtech.2004.12.003
   Trujillo ME, 2006, ENDOCR REV, V27, P762, DOI 10.1210/er.2006-0033
   Uriel S, 2008, BIOMATERIALS, V29, P3712, DOI 10.1016/j.biomaterials.2008.05.028
   Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109
   Walter RJ, 1998, BURNS, V24, P104, DOI 10.1016/S0305-4179(97)00110-1
   Woods T, 2005, BIOMATERIALS, V26, P7339, DOI 10.1016/j.biomaterials.2005.05.066
   Zeugolis DI, 2008, J BIOMED MATER RES A, V86A, P892, DOI 10.1002/jbm.a.31694
NR 44
TC 49
Z9 53
U1 4
U2 29
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 3
BP 292
EP 299
DI 10.1002/jbm.a.33056
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FQ
UT WOS:000290382700008
PM 21448993
DA 2018-10-20
ER

PT J
AU Kim, H
   Tator, CH
   Shoichet, MS
AF Kim, Howard
   Tator, Charles H.
   Shoichet, Molly S.
TI Chitosan implants in the rat spinal cord: Biocompatibility and
   biodegradation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE chitosan; polyglycolide; poly(tetrafluoroethylene); vicryl; Gore-Tex;
   biodegradation; biocompatibility; spinal cord
ID IN-VIVO; INFLAMMATORY RESPONSE; ENZYMATIC DEGRADATION; DRUG-DELIVERY;
   CELL-ADHESION; N-ACETYLATION; NEURAL STEM; INJURY; REPAIR; TRANSECTION
AB Biomaterials are becoming increasingly popular for use in spinal cord repair, but few studies have investigated their long-term biocompatibility in central nervous system tissue. In this study, chitosan was compared with two commercial materials, degradable polyglycolide (vicryl and polyglactin 910) and nondegradable expanded poly(tetrafluoroethylene) (Gore-Tex and ePTFE), in terms of host tissue response and biodegradation in the rat spinal cord in two different spinal cord implantation models. In an uninjured model, implants were placed in the spinal cord intrathecal space for up to 6 months. At 1 month, vicryl implants elicited an elevated macrophage/microglia response compared to chitosan and Gore-Tex, which subsided in all groups by 6 months. Fibrous encapsulation was observed for all three materials. At 6 months, the in vivo degradation of vicryl was complete, while Gore-Tex showed no signs of degradation, as assessed by mass loss and SEM. Chitosan implants showed evidence of chain degradation at 6 months as demonstrated by differential hematoxylin and eosin staining; however, this did not result in mass loss. In the second model, implants were placed directly into the spinal cord for up to 12 months. This resulted in increased immune and inflammatory responses but did not alter degradation profiles. The same trends observed for the materials in the intrathecal space were mirrored in the spinal cord tissue. These results demonstrate that chitosan is a relatively inert biomaterial that does not elicit a chronic immune response and is suitable for long-term applications for repair of the spinal cord. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 395-404, 2011.
C1 [Kim, Howard; Tator, Charles H.; Shoichet, Molly S.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.
   [Kim, Howard; Shoichet, Molly S.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 1A1, Canada.
   [Tator, Charles H.] Univ Hlth Network, Toronto Western Res Inst, Toronto, ON, Canada.
   [Shoichet, Molly S.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 1A1, Canada.
RP Shoichet, MS (reprint author), Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada.
EM molly.shoichet@utoronto.ca
FU Canadian Institute of Health Research; Natural Sciences and Engineering
   Research Council of Canada; Ontario Neurotrauma Foundation; Canadian
   Paraplegic Association, Ontario Branch
FX Contract grant sponsors: Canadian Institute of Health Research; Natural
   Sciences and Engineering Research Council of Canada; Ontario Neurotrauma
   Foundation; and Canadian Paraplegic Association, Ontario Branch
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256
   Barbolt TA, 2001, NEUROL RES, V23, P813, DOI 10.1179/016164101101199405
   Benesch J, 2002, BIOMATERIALS, V23, P2561, DOI 10.1016/S0142-9612(01)00391-X
   BETTINGER C, 1991, HISTOCHEMISTRY, V96, P215, DOI 10.1007/BF00271540
   BUNEL S, 1993, CARBOHYD RES, V244, P1, DOI 10.1016/0008-6215(93)80001-U
   Cunha-Reis C, 2007, J MATER SCI-MATER M, V18, P195, DOI 10.1007/s10856-006-0681-x
   CURRIE GA, 1976, BRIT J CANCER, V33, P51, DOI 10.1038/bjc.1976.6
   Di Vita G, 2008, INT J IMMUNOPATH PH, V21, P207, DOI 10.1177/039463200802100123
   Freier T, 2005, BIOMATERIALS, V26, P5872, DOI 10.1016/j.biomaterials.2005.02.033
   Freier T, 2005, BIOMATERIALS, V26, P4624, DOI 10.1016/j.biomaterials.2004.11.040
   Gazzeri R, 2009, ACTA NEUROCHIR, V151, P537, DOI 10.1007/s00701-009-0290-9
   Ghanaati S, 2010, ACTA BIOMATER, V6, P4476, DOI 10.1016/j.actbio.2010.07.006
   Gustafson SB, 2007, PREHOSP EMERG CARE, V11, P172, DOI 10.1080/10903120701205893
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x
   Johnson PJ, 2009, BIOTECHNOL BIOENG, V104, P1207, DOI 10.1002/bit.22476
   Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349
   Keller J T, 1989, J Spinal Disord, V2, P87
   Kim H, 2008, BIOTECHNOL PROGR, V24, P932, DOI [10.1021/bp070352a, 10.1021/bp.070352a]
   Kofuji K, 2001, BIOL PHARM BULL, V24, P205, DOI 10.1248/bpb.24.205
   Kohane DS, 2006, J BIOMED MATER RES A, V77A, P351, DOI 10.1002/jbm.a.30654
   Li GN, 2008, TISSUE ENG PT B-REV, V14, P33, DOI 10.1089/teb.2007.0181
   Mi FL, 2002, BIOMATERIALS, V23, P181, DOI 10.1016/S0142-9612(01)00094-1
   Mishra OP, 2003, J TROP PEDIATRICS, V49, P13, DOI 10.1093/tropej/49.1.13
   Nomura H, 2006, J NEUROTRAUM, V23, P496, DOI 10.1089/neu.2006.23.496
   Nomura H, 2008, TISSUE ENG PT A, V14, P649, DOI 10.1089/tea.2007.0180
   Nomura H, 2006, NEUROSURGERY, V59, P183, DOI 10.1227/NEU.0000219859.35349.EF
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Park YK, 1998, NEUROSURGERY, V42, P813, DOI 10.1097/00006123-199804000-00076
   PARK YK, 1998, NEUROSURGERY, V42, P823
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   Samadikuchaksaraei A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-15
   SHIGEMASA Y, 1994, INT J BIOL MACROMOL, V16, P43, DOI 10.1016/0141-8130(94)90010-8
   Sogias IA, 2010, MACROMOL CHEM PHYS, V211, P426, DOI 10.1002/macp.200900385
   STRALEY KS, 2010, J NEUROTRAUM, P271
   TEMEL A, 1991, ANN OPHTHALMOL, V23, P191
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Tysseling-Mattiace VM, 2008, J NEUROSCI, V28, P3814, DOI 10.1523/JNEUROSCI.0143-08.2008
   Varum KM, 1996, BBA-GEN SUBJECTS, V1291, P5, DOI 10.1016/0304-4165(96)00038-4
   Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Yoshil S, 2009, J TISSUE ENG REGEN M, V3, P19, DOI 10.1002/term.130
   Zahir T, 2008, CELL TRANSPLANT, V17, P245, DOI 10.3727/096368908784153887
   Zhang KH, 2004, NEUROSCIENCE, V128, P375, DOI 10.1016/j.neuroscience.2004.07.008
NR 49
TC 36
Z9 40
U1 2
U2 26
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 4
BP 395
EP 404
DI 10.1002/jbm.a.33070
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FY
UT WOS:000290383700003
PM 21465644
DA 2018-10-20
ER

PT J
AU Garg, K
   Ryan, JJ
   Bowlin, GL
AF Garg, K.
   Ryan, J. J.
   Bowlin, G. L.
TI Modulation of mast cell adhesion, proliferation, and cytokine secretion
   on electrospun bioresorbable vascular grafts
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE electrospinning; mast cell; immunoglobulin E; vascular tissue
   engineering
ID FC-EPSILON-RI; POLYDIOXANONE-ELASTIN BLENDS; ACQUIRED IMMUNE-RESPONSES;
   VEIN ENDOTHELIAL-CELLS; C-KIT LIGAND; BIOMEDICAL APPLICATIONS; WOUND
   REPAIR; BONE-MARROW; TNF-ALPHA; FIBRONECTIN
AB Mast cells synthesize several potent angiogenic factors and can also stimulate fibroblasts, endothelial cells, and macrophages. An understanding of how they participate in wound healing and angiogenesis is important to further our knowledge about in situ vascular prosthetic regeneration. The adhesion, proliferation, and cytokine secretion of bone marrow-derived murine mast cells (BMMC) on electrospun polydioxanone, polycaprolactone, and silk scaffolds, as well as tissue culture plastic, has been investigated in the presence or absence of IL-3, stem cell factor, IgE and IgE with a crosslinking antigen, dinitrophenol-conjugated albumin (DNP). It was previously believed that only activated BMMCs exhibit adhesion and cytokine secretion. However, this study shows nonactivated BMMC adhesion to electrospun scaffolds. Silk scaffold was not found to be conducive for mast cell adhesion and cytokine secretion. Activation by IgE and DNP significantly enhanced mast cell adhesion, proliferation, migration, and secretion of tumor necrosis factor alpha, macrophage inflammatory protein-1 alpha, and IL-13. This indicates that mast cells might play a role in the process of biomaterial integration into the host tissue, regeneration, and possibly angiogenesis. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 405-413, 2011.
C1 [Garg, K.; Bowlin, G. L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23284 USA.
   [Ryan, J. J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA.
RP Bowlin, GL (reprint author), Sch Engn, Dept Biomed Engn, East Hall,Room E1254,401W Main St,POB 843067, Richmond, VA 23284 USA.
EM glbowlin@vcu.edu
RI Bowlin, Gary/E-8617-2010
FU NIH [AI077435, AI159638]
FX Contract grant sponsor: NIH; contract grant numbers: AI077435, AI159638
CR Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Artuc M, 1999, EXP DERMATOL, V8, P1, DOI 10.1111/j.1600-0625.1999.tb00342.x
   Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1
   Ashley RA, 2009, TISSUE ENG PT A, V15, P3241, DOI [10.1089/ten.tea.2008.0699, 10.1089/ten.TEA.2008.0699]
   Berton A, 2000, CLIN EXP ALLERGY, V30, P485
   BIANCHINE PJ, 1992, J IMMUNOL, V149, P3665
   Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458
   BOCHNER BS, 1995, J IMMUNOL, V154, P799
   Boland ED, 2005, ACTA BIOMATER, V1, P115, DOI 10.1016/j.actbio.2004.09.003
   BOWALD S, 1979, SURGERY, V86, P722
   Campillo-Fernandez AJ, 2009, TISSUE ENG PT A, V15, P1331, DOI 10.1089/ten.tea.2008.0146
   CLARK RAF, 1988, ARCH DERMATOL, V124, P201, DOI 10.1001/archderm.124.2.201
   COLEMAN JW, 1993, J IMMUNOL, V150, P556
   Compton SJ, 1998, J IMMUNOL, V161, P1939
   Del Gaudio C, 2009, J BIOMED MATER RES A, V89A, P1028, DOI 10.1002/jbm.a.32048
   DiPietro LA, 1998, J CLIN INVEST, V101, P1693, DOI 10.1172/JCI1020
   Duling RR, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838033
   EADY RAJ, 1979, BRIT J DERMATOL, V100, P623, DOI 10.1111/j.1365-2133.1979.tb08065.x
   Galli SJ, 1997, J EXP MED, V186, P343, DOI 10.1084/jem.186.3.343
   GALLI SJ, 1993, AGENT ACTION SUPPL, V43, P209
   GALLI SJ, 1993, J CLIN INVEST, V91, P148, DOI 10.1172/JCI116164
   GALLI SJ, 1999, ALLERGY, P1137
   Garg K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031001
   Goebeler M, 1997, IMMUNOLOGY, V91, P450, DOI 10.1046/j.1365-2567.1997.00263.x
   GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0
   GREISLER H P, 1987, Archives of Surgery, V122, P715
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   Hiromatsu Y, 2003, MICROSC RES TECHNIQ, V60, P64, DOI 10.1002/jemt.10244
   IEMURA A, 1994, AM J PATHOL, V144, P321
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kawakami T, 2005, J IMMUNOL, V175, P4167, DOI 10.4049/jimmunol.175.7.4167
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Kruger-Krasagakes S, 1999, IMMUNOLOGY, V98, P253
   Lam V, 2003, BLOOD, V102, P1405, DOI 10.1182/blood-2002-10-3176
   Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8
   Macey MR, 2010, J IMMUNOL, V184, P4688, DOI 10.4049/jimmunol.0903477
   Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0
   Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Maurer M, 2004, INT J BIOCHEM CELL B, V36, P1882, DOI 10.1016/j.biocel.2003.10.019
   McClure MJ, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/5/055010
   McLachlan JB, 2003, NAT IMMUNOL, V4, P1199, DOI 10.1038/ni1005
   Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Metcalfe DD, 1997, PHYSIOL REV, V77, P1033
   NILSSON G, 1994, J IMMUNOL, V153, P3717
   Noli C, 2001, VET DERMATOL, V12, P303, DOI 10.1046/j.0959-4493.2001.00272.x
   Norrby K, 2002, APMIS, V110, P355, DOI 10.1034/j.1600-0463.2002.100501.x
   Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Pham EA, 2010, J BIOMED MATER RES B, V92B, P499, DOI 10.1002/jbm.b.31543
   PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0
   Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023
   RUDERMAN RJ, 1972, T AM SOC ART INT ORG, V18, P30
   Ryan JJ, 1998, J IMMUNOL, V161, P6915
   Sell SA, 2006, BIOMED MATER, V1, P72, DOI 10.1088/1748-6041/1/2/004
   Smith MJ, 2008, ACTA BIOMATER, V4, P58, DOI 10.1016/j.actbio.2007.08.001
   Smith MJ, 2010, J BIOMED MATER RES A, V93A, P793, DOI 10.1002/jbm.a.32579
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Soffer L, 2008, J BIOMAT SCI-POLYM E, V19, P653, DOI 10.1163/156856208784089607
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   THOMPSON HL, 1993, CLIN EXP ALLERGY, V23, P270, DOI 10.1111/j.1365-2222.1993.tb00321.x
   THOMPSON HL, 1989, J IMMUNOL, V143, P2323
   VALENT P, 1992, BLOOD, V80, P2237
   WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220
   WERSHIL BK, 1992, J EXP MED, V175, P245, DOI 10.1084/jem.175.1.245
   WESOLOWSKI SA, 1963, SURGERY, V53, P19
   Xiang Z, 2001, J EXP MED, V194, P1561, DOI 10.1084/jem.194.11.1561
   Yamaguchi H, 1996, BRIT J HAEMATOL, V94, P606, DOI 10.1046/j.1365-2141.1996.d01-1855.x
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 74
TC 10
Z9 11
U1 0
U2 18
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUN
PY 2011
VL 97A
IS 4
BP 405
EP 413
DI 10.1002/jbm.a.33073
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 761FY
UT WOS:000290383700004
PM 21472976
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Thesleff, T
   Lehtimaki, K
   Niskakangas, T
   Mannerstrom, B
   Miettinen, S
   Suuronen, R
   Ohman, J
AF Thesleff, Tuomo
   Lehtimaki, Kai
   Niskakangas, Tero
   Mannerstrom, Bettina
   Miettinen, Susanna
   Suuronen, Riitta
   Ohman, Juha
TI Cranioplasty With Adipose-Derived Stem Cells and Biomaterial: A Novel
   Method for Cranial Reconstruction
SO NEUROSURGERY
LA English
DT Article
DE Adipose stem cells; Beta-tricalcium phosphate; Cranial repair;
   Cranioplasty
ID STROMAL CELLS; DECOMPRESSIVE CRANIECTOMY; COMPUTED-TOMOGRAPHY; TISSUE;
   DEFECTS; THERAPIES; IMPLANTS; CHILDREN; DENSITY; SURGERY
AB BACKGROUND: There is no optimal method for reconstruction of large calvarial defects. Because of the limitations of autologous bone grafts and alloplastic materials, new methods for performing cranioplasties are needed.
   OBJECTIVE: To create autologous bone to repair cranial defects.
   METHODS: We performed a cranioplasty procedure with this new method in 4 patients who had large calvarial defects of different etiologies. We used autologous adipose-derived stem cells seeded in beta-tricalcium phosphate granules. For 2 patients, we used a bilaminate technique with resorbable mesh.
   RESULTS: During follow-up, there were no clinically relevant postoperative complications. The computed tomography scans revealed satisfactory outcome in ossification, and in the clinical examinations, the outcomes were good. The cranioplasty was measured in Hounsfield units from each computed tomography scan. The Hounsfield units increased gradually to equal the value of bone.
   CONCLUSION: The combination of scaffold material such as beta-tricalcium phosphate and autologous adipose-derived stem cells constitutes a promising model for reconstruction of human large cranial defects. The success of these clinical cases paves way for further studies and clinical applications to turn this method into a reliable treatment regimen.
C1 [Thesleff, Tuomo; Lehtimaki, Kai; Niskakangas, Tero; Ohman, Juha] Tampere Univ Hosp, Dept Neurosurg, Tampere 33521, Finland.
   [Suuronen, Riitta] Tampere Univ Hosp, Dept Eye Ear & Oral Dis, Tampere 33521, Finland.
   [Mannerstrom, Bettina; Miettinen, Susanna; Suuronen, Riitta] Univ Tampere, REGEA Inst Regenerat Med, FIN-33101 Tampere, Finland.
   [Suuronen, Riitta] Tampere Univ Technol, Inst Biomed Engn, FIN-33101 Tampere, Finland.
RP Thesleff, T (reprint author), Tampere Univ Hosp, Dept Neurosurg, POB 2000, Tampere 33521, Finland.
EM tuomo.thesleff@pshp.fi
RI Mannerstrom, Bettina/F-4002-2016
OI Mannerstrom, Bettina/0000-0001-9316-5581; Seppanen-Kaijansinkko,
   Riitta/0000-0001-5348-7121; Ohman, Juha/0000-0002-6592-1367; Miettinen,
   Susanna/0000-0002-0647-9556
CR Aust L, 2004, CYTOTHERAPY, V6, P7, DOI 10.1080/14653240310004539
   Barone CM, 1997, J CRANIOFAC SURG, V8, P43, DOI 10.1097/00001665-199701000-00015
   Baumeister S, 2008, PLAST RECONSTR SURG, V122, P195
   Bruce JN, 2003, J NEUROSURG, V98, P1203, DOI 10.3171/jns.2003.98.6.1203
   Chiarini L, 2004, J CRANIO MAXILL SURG, V32, P5, DOI 10.1016/j.jcms.2003.08.005
   Eufinger H, 2002, SCAND J PLAST RECONS, V36, P326, DOI 10.1080/028443102321096311
   European Pharmacopoeia, 2007, EUR PHARM, P155
   Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163
   Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17
   Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649
   KLINE RM, 1995, PLAST RECONSTR SURG, V95, P5, DOI 10.1097/00006534-199501000-00002
   Lagravere MO, 2006, DENTOMAXILLOFAC RAD, V35, P407, DOI 10.1259/dmfr/55276404
   LEE C, 1995, J CRANIO MAXILL SURG, V23, P133, DOI 10.1016/S1010-5182(05)80001-0
   Lendeckel S, 2004, J CRANIO MAXILL SURG, V32, P370, DOI 10.1016/j.jcms.2004.06.002
   Locke M, 2009, ANZ J SURG, V79, P235, DOI 10.1111/j.1445-2197.2009.04852.x
   Mesimaki K, 2009, INT J ORAL MAX SURG, V38, P201, DOI 10.1016/j.ijom.2009.01.001
   MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101
   RASMUSSEN S, 1990, British Journal of Neurosurgery, V4, P493, DOI 10.3109/02688699008993798
   Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2
   Sanan A, 1997, NEUROSURGERY, V40, P588, DOI 10.1097/00006123-199703000-00033
   Schaffler A, 2007, STEM CELLS, V25, P818, DOI 10.1634/stemcells.2006-0589
   Taub PJ, 2003, PLAST RECONSTR SURG, V111, P1233, DOI 10.1097/01.PRS.0000046048.77472.23
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
   Young HE, 2005, J CELL MOL MED, V9, P753, DOI 10.1111/j.1582-4934.2005.tb00510.x
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
   Zuk PA, 2008, PEDIATR RES, V63, P478, DOI 10.1203/PDR.0b013e31816bdf36
NR 27
TC 95
Z9 99
U1 1
U2 26
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0148-396X
J9 NEUROSURGERY
JI Neurosurgery
PD JUN
PY 2011
VL 68
IS 6
BP 1535
EP 1540
DI 10.1227/NEU.0b013e31820ee24e
PG 6
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA 760CK
UT WOS:000290299700042
PM 21336223
DA 2018-10-20
ER

PT J
AU Sa-Adchom, P
   Swasdisevi, T
   Nathakaranakule, A
   Soponronnarit, S
AF Sa-adchom, Poomjai
   Swasdisevi, Thanit
   Nathakaranakule, Adisak
   Soponronnarit, Somchart
TI Mathematical model of pork slice drying using superheated steam
SO JOURNAL OF FOOD ENGINEERING
LA English
DT Article
DE Drying kinetics; Mathematical model; Pork slice; Superheated steam
   drying
ID FLUIDIZED-BED; PARBOILED RICE; HOT AIR; KINETICS; QUALITY; TEMPERATURE;
   BIOMATERIAL; DIFFUSION; THICKNESS; COOKING
AB Superheated steam has received much attention as an effective technique for drying purposes because it produces dried products with high quality attributes. Although currently there are a number of works reporting the development of a mathematical model of superheated steam drying, they do not use a numerical method to estimate the effective moisture diffusivity value (D-eff value) of the product. The purposes of this work, therefore, were to develop a semi-empirical model for estimating the D-eff value of pork, and for predicting the evolution of the moisture content and the center temperature of sliced pork during superheated steam drying. The model was based on mass and energy-balance equations and was divided into three periods: heating up, constant drying rate and falling drying rate period. It was solved using an explicit finite difference method and used a grid search method to estimate the D-eff value of pork. The predicted results were compared with the experimental data of superheated steam drying of seasoned and unseasoned pork with slice thicknesses of 1 and 2 mm at a drying temperature of 140 degrees C. The comparison results showed that the developed model could estimate the ranges of the D-eff value of pork fairly well (D-eff = 3.311-12.471 x 10(-10) m(2)/s for seasoned pork, and 4.200-15.056 x 10(-10) m(2)/s for unseasoned pork) and could reasonably predict the evolution of the moisture content of the sliced pork. The predicted center temperature of the sliced pork was higher than the experimental data in the heating up period and in the first 5 min of the falling drying rate period, but it agreed well in the constant drying rate period and after the drying time of 10 min. Moreover, it was found that the slice thickness and the seasoning had an influence on the drying curves only in the constant drying rate and falling drying rate period. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Sa-adchom, Poomjai; Swasdisevi, Thanit; Nathakaranakule, Adisak; Soponronnarit, Somchart] King Mongkuts Univ Technol Thonburi, Sch Energy Environm & Mat, Bangkok 10140, Thailand.
RP Sa-Adchom, P (reprint author), King Mongkuts Univ Technol Thonburi, Sch Energy Environm & Mat, 126 Pracha U Tid Rd, Bangkok 10140, Thailand.
EM poomjai.s@gmail.com
FU Commission on Higher Education, Thailand; Thailand Research Fund (TRF);
   National Science and Technology Development Agency of Thailand (NSTDA)
FX The authors would like to thank the Commission on Higher Education,
   Thailand for supporting the grant fund under the program Strategic
   Scholarships for Frontier Research Network for the Ph.D. Program Thai
   Doctoral degree for this research. Our appreciation also acknowledge to
   the Thailand Research Fund (TRF) and the National Science and Technology
   Development Agency of Thailand (NSTDA) for financial support.
CR Afzal TM, 1998, J FOOD ENG, V37, P353, DOI 10.1016/S0260-8774(98)00111-3
   Association of Official Analytical Chemists (AOAC), 1995, OFF METH AN AOAC INT
   BEJAN A, 2004, CONVECTION HEAT TRAN, P456
   BRAUD ML, 2001, J FOOD ENG, V50, P121
   Doymaz I, 2008, CHEM ENG PROCESS, V47, P41, DOI 10.1016/j.cep.2007.09.002
   Gou P, 2003, MEAT SCI, V63, P29, DOI 10.1016/S0309-1740(02)00048-7
   Hashiba H, 2009, LWT-FOOD SCI TECHNOL, V42, P1153, DOI 10.1016/j.lwt.2009.02.002
   Hiranvarachat B, 2008, FOOD CHEM, V107, P1538, DOI 10.1016/j.foodchem.2007.10.026
   Ibanoglu S, 2002, J FOOD ENG, V54, P119, DOI 10.1016/S0260-8774(01)00192-3
   INCROPERA FP, 1990, FUNDAMENTALS HEAT MA, pA3
   Iyota H, 2001, DRY TECHNOL, V19, P1425, DOI 10.1081/DRT-100105298
   Jamradloedluk J., 2004, 2 INT C INN FOOD PRO, P267
   Jamradloedluk J, 2007, J FOOD ENG, V78, P198, DOI 10.1016/j.jfoodeng.2005.09.017
   Jena S, 2007, J FOOD ENG, V79, P92, DOI 10.1016/j.jfoodeng.2006.01.032
   KIRSCHMANN JD, 2007, NUTR ALMANAC, P101
   Kittiworrawatt S, 2009, CHEM ENG SCI, V64, P2644, DOI 10.1016/j.ces.2009.02.036
   Leeratanarak N, 2006, J FOOD ENG, V77, P635, DOI 10.1016/j.jfoodeng.2005.07.022
   Mujumdar A. S., 2000, MUJUMDARS PRACTICAL, P115
   Nguyen MH, 2007, J FOOD ENG, V79, P200, DOI 10.1016/j.jfoodeng.2006.01.063
   *OECD, 2003, OECD AGR OUTL 200320, P166
   *OECD, 2004, OECD AGR OUTL 200420, P190
   Okos MR, 1992, HDB FOOD ENG, P437
   OTT RL, 2010, INTRO STAT METHODS D, P683
   PALM WJ, 2005, INTRO MATLAB 7 ENG, P319
   Prachayawarakorn S, 2002, DRY TECHNOL, V20, P669, DOI 10.1081/DRT-120002823
   RAHMAN S, 1995, FOOD PROPERTIES HDB, P258
   RAMASWAMY H, 2006, FOOD PROCESSING PRIN, P62
   Sablani S, 2000, DRYING TECHNOLOGY AG, P35
   Shi JL, 2008, LWT-FOOD SCI TECHNOL, V41, P1962, DOI 10.1016/j.lwt.2008.01.003
   Shiby VK, 2007, FOOD BIOPROD PROCESS, V85, P193, DOI 10.1205/fbp06057
   SINGH RP, 1993, INTRO FOOD ENG, P141
   Soponronnarit S, 2006, DRY TECHNOL, V24, P1457, DOI 10.1080/07373930600952800
   Suvarnakuta P, 2007, CHEM ENG PROCESS, V46, P675, DOI 10.1016/j.cep.2006.09.002
   Swasdisevi T, 2009, J FOOD ENG, V92, P100, DOI 10.1016/j.jfoodeng.2008.10.030
   Taechapairoj C, 2003, J FOOD ENG, V58, P67, DOI 10.1016/S0260-8774(02)00335-7
   Taechapairoj C, 2006, J FOOD ENG, V76, P411, DOI 10.1016/j.jfoodeng.2005.05.040
   Uengkimbuan N, 2006, DRY TECHNOL, V24, P1665, DOI 10.1080/07373930601031513
NR 37
TC 20
Z9 24
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0260-8774
EI 1873-5770
J9 J FOOD ENG
JI J. Food Eng.
PD JUN
PY 2011
VL 104
IS 4
BP 499
EP 507
DI 10.1016/j.jfoodeng.2010.12.025
PG 9
WC Engineering, Chemical; Food Science & Technology
SC Engineering; Food Science & Technology
GA 749ER
UT WOS:000289446900004
DA 2018-10-20
ER

PT J
AU Zhou, YL
   Luo, DM
AF Zhou, Ying-Long
   Luo, Dong-Mei
TI Corrosion behavior of Ti-Mo alloys cold rolled and heat treated
SO JOURNAL OF ALLOYS AND COMPOUNDS
LA English
DT Article
DE Ti-Mo alloy; XPS; Oxide film; Corrosion resistance; Metallic biomaterial
ID ANODIC POLARIZATION PROPERTIES; HFO2 THIN-FILMS; BIOMEDICAL
   APPLICATIONS; TITANIUM-ALLOYS; PITTING CORROSION; PHYSIOLOGICAL
   SOLUTION; MECHANICAL-PROPERTIES; PASSIVE FILMS; TA ALLOYS; NB ALLOYS
AB Corrosion behavior of (alpha + beta) Ti-10Mo and beta Ti-20Mo (mass%) alloys cold rolled and solution heat treated was investigated by studying the anodic polarization curves at 310K in 5 mol% HCl solution to determine the potential use of those alloys in biomedical applications. The anodic films formed on the surfaces of the alloys were examined using X-ray photoelectron spectroscopy analysis and scanning electron microscopy. The results reveal that both of the Ti-Mo alloys cold rolled and solution treated exhibit a passive behavior in 5% HCl solution, which is attributed to the passive film formation of a mixture of MoO3 and TiO2. The cold rolling process does not influence the formation of passive films on the Ti-Mo alloys although it slightly increases the passive current densities. The corrosion resistance of the Ti-Mo alloys increases with Mo content and both of the Ti-Mo alloys exhibit better corrosion resistance than commercial pure Ti-the currently used metallic biomaterial. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Zhou, Ying-Long] Foshan Univ, Dept Mechatron Engn, Foshan 528000, Guangdong, Peoples R China.
   [Luo, Dong-Mei] Foshan Univ, Dept Civil Engn, Foshan 528000, Guangdong, Peoples R China.
RP Zhou, YL (reprint author), Foshan Univ, Dept Mechatron Engn, 18 Jiangwan Yi Rd, Foshan 528000, Guangdong, Peoples R China.
EM ylzhou@fosu.edu.cn
FU Scientific Research Foundation for the Returned Overseas Chinese
   Scholars, State Education Ministry of PR China [2008/890]
FX The work was financially supported by the Scientific Research Foundation
   for the Returned Overseas Chinese Scholars, State Education Ministry of
   PR China (Grant No. 2008/890). Kind help from Dr S.J. Li, Associate
   Professor of the Institute of Metal Research, Chinese Academy of
   Sciences, PR China was also acknowledged.
CR Alves APR, 2004, MAT SCI ENG C-BIO S, V24, P693, DOI 10.1016/j.msec.2004.08.013
   *ASM INT HDB COMM, 1987, ASM HDB CORR, V13
   BAGARIATSKII IA, 1959, TECH PHYS, P1014
   Basame SB, 2000, J ELECTROCHEM SOC, V147, P1376, DOI 10.1149/1.1393364
   BOPHCOBA EA, 1986, METALLOGRAPHY TITANI
   BURSTEIN GT, 1995, ELECTROCHIM ACTA, V40, P1881, DOI 10.1016/0013-4686(95)00126-Y
   Burstein GT, 2005, BIOMATERIALS, V26, P245, DOI 10.1016/j.biomaterials.2004.02.023
   Cabello G, 2008, J NON-CRYST SOLIDS, V354, P982, DOI 10.1016/j.jnoncrysol.2007.08.014
   Capela MV, 2008, J ALLOY COMPD, V465, P479, DOI 10.1016/j.jallcom.2007.10.115
   CASILLAS N, 1994, J ELECTROCHEM SOC, V141, P636, DOI 10.1149/1.2054783
   CASILLAS N, 1993, J ELECTROCHEM SOC, V140, pL142, DOI 10.1149/1.2220897
   Chen YY, 2006, T NONFERR METAL SOC, V16, pS824, DOI 10.1016/S1003-6326(06)60308-7
   Collings E. W., 1984, PHYS METALLURGY TITA
   CRUZ TGS, 1999, J ELECT SPECTROSC RE, V103, P397
   Davis JR, 2000, CORROSION UNDERSTAND
   DAVIS R, 1979, J MATER SCI, V14, P712
   Domaradzki J, 2006, SURF COAT TECH, V200, P6283, DOI 10.1016/j.surfcoat.2005.11.055
   Fedotov S G, 1986, PHYS MET METALLOGR, V62, P109
   Furuhara T, 1998, MATER T JIM, V39, P31, DOI 10.2320/matertrans1989.39.31
   Hao YL, 2007, ACTA BIOMATER, V3, P277, DOI 10.1016/j.actbio.2006.11.002
   He G, 2003, BIOMATERIALS, V24, P5115, DOI 10.1016/S0142-9612(03)00440-X
   Ho WF, 2008, J ALLOY COMPD, V464, P580, DOI 10.1016/j.jallcom.2007.10.054
   Ho WF, 1999, BIOMATERIALS, V20, P2115, DOI 10.1016/S0142-9612(99)00114-3
   Karayan AI, 2008, MATER LETT, V62, P1843, DOI 10.1016/j.matlet.2007.10.028
   KOLMAN DG, 1994, J ELECTROCHEM SOC, V141, P2633, DOI 10.1149/1.2059146
   Kumar S, 2008, J DENT, V36, P500, DOI 10.1016/j.jdent.2008.03.007
   LAQUE FL, 1963, CORROSION RESISTANCE
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   LEVY M, 1969, J ELECTROCHEM SOC, V116, P323, DOI 10.1149/1.2411838
   Li ZP, 2002, APPL CATAL A-GEN, V236, P163, DOI 10.1016/S0926-860X(02)00302-2
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Murry J. L., 1987, PHASE DIAGRAM BINARY
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   Okazaki Y, 1997, MATER T JIM, V38, P78, DOI 10.2320/matertrans1989.38.78
   Okazaki Y, 1997, MATER T JIM, V38, P344, DOI 10.2320/matertrans1989.38.344
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   OKAZAKI Y, 1994, MATER T JIM, V35, P58, DOI 10.2320/matertrans1989.35.58
   Oliveira NTC, 2008, CORROS SCI, V50, P938, DOI 10.1016/j.corsci.2007.09.009
   Oliveira NTC, 2009, ACTA BIOMATER, V5, P399, DOI 10.1016/j.actbio.2008.07.010
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Shreir L., 1963, CORROSION, V1
   SINGH DDN, 1985, J ELECTROCHEM SOC, V132, P378, DOI 10.1149/1.2113843
   STERN M, 1959, J ELECTROCHEM SOC, V106, P759, DOI 10.1149/1.2427493
   Tanaka Y, 2008, CORROS SCI, V50, P2111, DOI 10.1016/j.corsci.2008.06.002
   TAYLOR DF, 1969, ENCY CHEM TECHNOLOGY, V19, P630
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   Wang YJ, 2004, APPL SURF SCI, V228, P93, DOI 10.1016/j.apsusc.2003.12.028
   Zhou YL, 2008, J ALLOY COMPD, V466, P535, DOI 10.1016/j.jallcom.2007.11.090
   Zhou YL, 2009, SURF COAT TECH, V204, P180, DOI 10.1016/j.surfcoat.2009.07.006
   Zhou YL, 2009, MAT SCI ENG C-BIO S, V29, P1061, DOI 10.1016/j.msec.2008.09.012
   Zhou YL, 2005, MAT SCI ENG A-STRUCT, V398, P28, DOI 10.1016/j.msea.2005.03.032
NR 53
TC 36
Z9 39
U1 1
U2 20
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-8388
J9 J ALLOY COMPD
JI J. Alloy. Compd.
PD MAY 26
PY 2011
VL 509
IS 21
BP 6267
EP 6272
DI 10.1016/j.jallcom.2011.03.045
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Metallurgy &
   Metallurgical Engineering
SC Chemistry; Materials Science; Metallurgy & Metallurgical Engineering
GA 761ZJ
UT WOS:000290441700027
DA 2018-10-20
ER

PT J
AU Agarwal, A
   Guthrie, KM
   Czuprynski, CJ
   Schurr, MJ
   McAnulty, JF
   Murphy, CJ
   Abbott, NL
AF Agarwal, Ankit
   Guthrie, Kathleen M.
   Czuprynski, Charles J.
   Schurr, Michael J.
   McAnulty, Jonathan F.
   Murphy, Christopher J.
   Abbott, Nicholas L.
TI Polymeric Multilayers that Contain Silver Nanoparticles can be Stamped
   onto Biological Tissues to Provide Antibacterial Activity
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID THERMOTROPIC LIQUID-CRYSTALS; POLYELECTROLYTE MULTILAYER; IN-VITRO;
   ANTIMICROBIAL PROPERTIES; AQUEOUS PHASES; THIN-FILMS; INTERFACES; SKIN;
   CYTOTOXICITY; NANOREACTORS
AB The design of polyelectrolyte multilayers (PEMs) that can be prefabricated on an elastomeric stamp and mechanically transferred onto biomedically-relevant soft materials, including medical-grade silicone elastomers (E'similar to 450-1500 kPa; E'-elastic modulus) and the dermis of cadaver skin (E'similar to 200-600 kPa), is reported. Whereas initial attempts to stamp PEMs formed from poly(allylamine hydrochloride) and poly(acrylic acid) resulted in minimal transfer onto soft materials, we report that integration of micrometer-sized beads into the PEMs (thicknesses of 6-160 nm) led to their quantitative transfer within 30 seconds of contact at a pressure of similar to 196 kPa. To demonstrate the utility of this approach, PEMs were impregnated with a range of loadings of silver-nanoparticles and stamped onto the dermis of human cadaver skin (a wound-simulant) that was subsequently incubated with bacterial cultures. Skin dermis stamped with PEMs that released 0.25 +/- 0.01 mu g cm(-2) of silver ions caused a 6 log(10) reduction in colony forming units of Staphylococcus epidermidis and Pseudomonas aeruginosa within 12 h. Significantly, this level of silver release is below that which is cytotoxic to NIH 3T3 mouse fibroblast cells. Overall, this study describes a general and facile approach for the functionalization of biomaterial surfaces without subjecting them to potentially deleterious processing conditions.
C1 [Agarwal, Ankit; Abbott, Nicholas L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.
   [Murphy, Christopher J.] Univ Calif Davis, Dept Ophthalmol & Vis Sci, Sch Med, Dept Surg & Radiol Sci,Sch Vet Med, Davis, CA 95616 USA.
   [Guthrie, Kathleen M.; McAnulty, Jonathan F.] Univ Wisconsin, Dept Surg, Sch Vet Med, Madison, WI 53706 USA.
   [Czuprynski, Charles J.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol, Madison, WI 53706 USA.
   [Schurr, Michael J.] Univ Wisconsin, Sch Med, Dept Surg, Madison, WI 53706 USA.
RP Agarwal, A (reprint author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.
EM cjmurphy@ucdavis.edu; abbott@engr.wisc.edu
RI Agarwal, Ankit/G-3875-2012
OI Agarwal, Ankit/0000-0002-5956-4447
FU NIAMS [1RC2AR058971-01]; Wisconsin Institute for Discovery; Ewing Marion
   Kauffman Foundation
FX The authors thank Tyler Nelson and Adeyinka A. Lesi for assistance in
   the fabrication of PEMs, Nancy Faith and Harpreet Singh for assistance
   with antibacterial experiments, and Chris Worley for assistance with the
   ICP spectrophotometer. The funding for this study was provided by NIH
   grant# 1RC2AR058971-01 from NIAMS and the Wisconsin Institute for
   Discovery. A. A. acknowledges support via a fellowship from the Ewing
   Marion Kauffman Foundation.
CR Agarwal A, 2010, BIOMATERIALS, V31, P680, DOI 10.1016/j.biomaterials.2009.09.092
   Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   Asharani PV, 2010, ADV FUNCT MATER, V20, P1233, DOI 10.1002/adfm.200901846
   Atiyeh BS, 2007, BURNS, V33, P139, DOI 10.1016/j.burns.2006.06.010
   Babu R, 2006, BIOMATERIALS, V27, P4304, DOI 10.1016/j.biomaterials.2006.03.038
   Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007
   Brake JM, 2002, LANGMUIR, V18, P6101, DOI 10.1021/la011746t
   Diridollou S, 2000, SKIN RES TECHNOL, V6, P214, DOI 10.1034/j.1600-0846.2000.006004214.x
   Gupta JK, 2008, LANGMUIR, V24, P5534, DOI 10.1021/la800013f
   Ho CH, 2004, ADV MATER, V16, P957, DOI 10.1002/adma.200306253
   Joly S, 2000, LANGMUIR, V16, P1354, DOI 10.1021/la991089t
   Kohli N, 2005, CHEM COMMUN, P316, DOI 10.1039/b406430e
   Kristiansen S, 2008, HISTOCHEM CELL BIOL, V130, P177, DOI 10.1007/s00418-008-0415-x
   Li Z, 2006, LANGMUIR, V22, P9820, DOI 10.1021/la0622166
   Lockwood NA, 2006, ADV MATER, V18, P850, DOI 10.1002/adma.200502013
   Logar M, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/32/325601
   Lu SY, 2008, BURNS, V34, P623, DOI 10.1016/j.burns.2007.08.020
   Mao JY, 2010, ADV FUNCT MATER, V20, P209, DOI 10.1002/adfm.200900782
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Mohamed F, 2008, J PHARM SCI-US, V97, P71, DOI 10.1002/jps.21082
   Park J, 2004, ADV MATER, V16, P520, DOI 10.1002/adma.200306181
   Podsiadlo P, 2005, LANGMUIR, V21, P11915, DOI 10.1021/la051284+
   ROMANELLI M, 1995, J AM ACAD DERMATOL, V32, P188, DOI 10.1016/0190-9622(95)90124-8
   Sambhy V, 2006, J AM CHEM SOC, V128, P9798, DOI 10.1021/ja061442z
   Shi Z, 2006, J BIOMED MATER RES A, V76A, P826, DOI 10.1002/jbm.a.30597
   Skaife JJ, 1999, CHEM MATER, V11, P612, DOI 10.1021/cm9804822
   Taylor PL, 2005, BIOMATERIALS, V26, P7221, DOI 10.1016/j.biomaterials.2005.05.040
   Trop M, 2006, J TRAUMA, V60, P648, DOI 10.1097/01.ta.0000208126.22089.b6
   Van Den Plas D, 2008, EUR J DERMATOL, V18, P416, DOI 10.1684/ejd.2008.0437
   Vasilev K., 2009, NANO LETT, V10, P202
   Wang TC, 2002, LANGMUIR, V18, P3370, DOI 10.1021/la015725a
   Warriner Robert, 2005, Adv Skin Wound Care, V18 Suppl 1, P2, DOI 10.1097/00129334-200510001-00001
   Wright JB, 1998, AM J INFECT CONTROL, V26, P572, DOI 10.1053/ic.1998.v26.a93527
   Yu DG, 2007, BIOCONJUGATE CHEM, V18, P1521, DOI 10.1021/bc060098s
NR 34
TC 35
Z9 35
U1 6
U2 53
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD MAY 24
PY 2011
VL 21
IS 10
BP 1863
EP 1873
DI 10.1002/adfm.201002662
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 775HA
UT WOS:000291448300013
PM 25558188
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Tay, CY
   Irvine, SA
   Boey, FYC
   Tan, LP
   Venkatraman, S
AF Tay, Chor Yong
   Irvine, Scott Alexander
   Boey, Freddy Y. C.
   Tan, Lay Poh
   Venkatraman, Subbu
TI Micro-/Nano-engineered Cellular Responses for Soft Tissue Engineering
   and Biomedical Applications
SO SMALL
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; CORNEAL EPITHELIAL-CELLS; TIO2 NANOTUBE
   SURFACES; SMOOTH-MUSCLE ACTIN; IN-VITRO; EXTRACELLULAR-MATRIX;
   ELECTROSPUN NANOFIBERS; ENDOTHELIAL-CELLS; MICROENGINEERED HYDROGELS;
   MYOCARDIAL-INFARCTION
AB The development of biomedical devices and reconstruction of functional ex vivo tissues often requires the need to fabricate biomimetic surfaces with features of sub-micrometer precision. This can be achieved with the advancements in micro-/nanoengineering techniques, allowing researchers to manipulate a plethora of cellular behaviors at the cell-biomaterial interface. Systematic studies conducted on these 2D engineered surfaces have unraveled numerous novel findings that can potentially be integrated as part of the design consideration for future 2D and 3D biomaterials and will no doubt greatly benefit tissue engineering. In this review, recent developments detailing the use of micro-/nano-engineering techniques to direct cellular orientation and function pertinent to soft tissue engineering will be highlighted. Particularly, this article aims to provide valuable insights into distinctive cell interactions and reactions to controlled surfaces, which can be exploited to understand the mechanisms of cell growth on micro-/nano-engineered interfaces, and to harness this knowledge to optimize the performance of 3D artificial soft tissue grafts and biomedical applications.
C1 [Tay, Chor Yong; Irvine, Scott Alexander; Boey, Freddy Y. C.; Tan, Lay Poh; Venkatraman, Subbu] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore.
RP Tan, LP (reprint author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM lptan@ntu.edu.sg; assubbu@ntu.edu.sg
RI Boey, Freddy Yin Chiang/G-2618-2017; Tan, LP/A-2229-2011; Venkatraman,
   Subramanian/A-2228-2011; Tay, Chor Yong/C-8178-2013; Tay, Chor
   Yong/C-1999-2016
OI Tan, LP/0000-0002-0172-1569; Venkatraman,
   Subramanian/0000-0002-8693-1070; Irvine, Scott/0000-0002-8926-1543
FU National Research Foundation, Singapore
FX Part of this work was funded by a grant from the National Research
   Foundation, Singapore. This Review is part of the Special Issue on
   Nanotechnology with Soft Matter.
CR Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004
   Aizawa Y, 2010, ADV MATER, V22, P4831, DOI 10.1002/adma.201001855
   Alves NM, 2010, SMALL, V6, P2208, DOI 10.1002/smll.201000233
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Arnold M, 2008, NANO LETT, V8, P2063, DOI 10.1021/nl801483w
   Aubin H, 2010, BIOMATERIALS, V31, P6941, DOI 10.1016/j.biomaterials.2010.05.056
   Bahney CS, 2011, FASEB J, V25, P1486, DOI 10.1096/fj.10-165514
   Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Biggs MJP, 2010, NANOMED-NANOTECHNOL, V6, P619, DOI 10.1016/j.nano.2010.01.009
   Boland ED, 2004, FRONT BIOSCI-LANDMRK, V9, P1422, DOI 10.2741/1313
   Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Chakraborty S, 2009, ADV DRUG DELIVER REV, V61, P1043, DOI 10.1016/j.addr.2009.07.013
   Chao TI, 2010, ADV MATER, V22, P3542, DOI 10.1002/adma.201000262
   Chao TI, 2009, BIOCHEM BIOPH RES CO, V384, P426, DOI 10.1016/j.bbrc.2009.04.157
   Charest JL, 2007, BIOMATERIALS, V28, P2202, DOI 10.1016/j.biomaterials.2007.01.020
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cheng K, 2010, BIOTECHNOL PROGR, V26, P838, DOI 10.1002/btpr.391
   Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025
   Choudhary S, 2007, TISSUE ENG, V13, P1421, DOI 10.1089/ten.2006.0376
   Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660
   Connelly JT, 2007, BIOMATERIALS, V28, P1071, DOI 10.1016/j.biomaterials.2006.10.006
   Cooley J. F., 1902, U.S. Patent, Patent No. [692631, 692,631]
   Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285
   Csaderova L, 2010, SMALL, V6, P2755, DOI 10.1002/smll.201000193
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064
   Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159
   Dhimolea E, 2010, BIOMATERIALS, V31, P3622, DOI 10.1016/j.biomaterials.2010.01.077
   Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI [10.1038/nnano.2010.246, 10.1038/NNANO.2010.246]
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Feinberg AW, 2009, ACTA BIOMATER, V5, P2013, DOI 10.1016/j.actbio.2009.01.032
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fraser SA, 2008, J BIOMED MATER RES A, V86A, P725, DOI 10.1002/jbm.a.31519
   Gao L, 2010, STEM CELLS, V28, P564, DOI 10.1002/stem.308
   Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011
   Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179
   Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931
   Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hannachi IE, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/2/022002
   Harrison RG, 1911, SCIENCE, V34, P279, DOI 10.1126/science.34.870.279
   HAUTANEN A, 1989, J BIOL CHEM, V264, P1437
   Hoffmann JC, 2010, SOFT MATTER, V6, P5056, DOI 10.1039/c0sm00140f
   Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190
   Hosseinkhani H, 2006, BIOMATERIALS, V27, P4079, DOI 10.1016/j.biomaterials.2006.03.030
   Hu W, 2005, J VAC SCI TECHNOL B, V23, P2984, DOI 10.1116/1.2121729
   Huang JH, 2009, NANO LETT, V9, P1111, DOI 10.1021/nl803548b
   Huang NF, 2006, NANO LETT, V6, P537, DOI 10.1021/nl060060o
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Hwang SY, 2010, ANAL CHEM, V82, P3016, DOI 10.1021/ac100107z
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482
   Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Kaufmann T, 2010, POLYM CHEM-UK, V1, P371, DOI 10.1039/b9py00281b
   Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Kim DH, 2010, P NATL ACAD SCI USA, V107, P565, DOI 10.1073/pnas.0906504107
   Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561
   Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014
   Koh LB, 2010, BIOMATERIALS, V31, P1533, DOI 10.1016/j.biomaterials.2009.11.022
   Koh LB, 2009, ACTA BIOMATER, V5, P3411, DOI 10.1016/j.actbio.2009.06.003
   KOMORIYA A, 1991, J BIOL CHEM, V266, P15075
   Kulangara K, 2009, SOFT MATTER, V5, P4072, DOI 10.1039/b910132m
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee J, 2008, TISSUE ENG PT B-REV, V14, P61, DOI 10.1089/teb.2007.0150
   Lee JW, 2004, MOL CELLS, V17, P188
   Lee MR, 2010, BIOMATERIALS, V31, P4360, DOI 10.1016/j.biomaterials.2010.02.012
   Lee SH, 2008, BIOMATERIALS, V29, P2962, DOI 10.1016/j.biomaterials.2008.04.004
   Leong WS, 2010, BIOCHEM BIOPH RES CO, V401, P287, DOI 10.1016/j.bbrc.2010.09.052
   Liliensiek SJ, 2010, BIOMATERIALS, V31, P5418, DOI 10.1016/j.biomaterials.2010.03.045
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298
   Malda J, 2005, BIOMATERIALS, V26, P63, DOI 10.1016/j.biomaterials.2004.02.046
   MASSIA SP, 1992, J BIOL CHEM, V267, P14019
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mironov V, 2003, TRENDS BIOTECHNOL, V21, P157, DOI 10.1016/S0167-7799(03)00033-7
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Moon JJ, 2010, BIOMATERIALS, V31, P3840, DOI 10.1016/j.biomaterials.2010.01.104
   MORTON WJ, 1902, Patent No. 705691
   Murtagh J, 2004, J CELL BIOL, V166, P133, DOI 10.1083/jcb.200403020
   NERMUT MV, 1988, EMBO J, V7, P4093, DOI 10.1002/j.1460-2075.1988.tb03303.x
   Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Norman JJ, 2005, TISSUE ENG, V11, P378, DOI 10.1089/ten.2005.11.378
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Park JH, 2010, BIOTECHNOL BIOENG, V106, P138, DOI 10.1002/bit.22667
   Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d
   Park J, 2009, NANO LETT, V9, P3157, DOI 10.1021/nl9013502
   Park J, 2009, SMALL, V5, P666, DOI 10.1002/smll.200801476
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Peng L, 2009, BIOMATERIALS, V30, P1268, DOI 10.1016/j.biomaterials.2008.11.012
   Qi H, 2010, ADV MATER, V22, P5276, DOI 10.1002/adma.201002873
   Raghavan S, 2010, TISSUE ENG PT A, V16, P2255, DOI 10.1089/ten.TEA.2009.0584
   Raghavan S, 2010, J CELL SCI, V123, P2877, DOI 10.1242/jcs.055079
   Rockwood DN, 2008, BIOMATERIALS, V29, P4783, DOI 10.1016/j.biomaterials.2008.08.034
   Salinas CN, 2008, BIOMATERIALS, V29, P2370, DOI 10.1016/j.biomaterials.2008.01.035
   Sanberg PR, 2007, P NATL ACAD SCI USA, V104, P11869, DOI 10.1073/pnas.0704704104
   Sarig-Nadir O, 2009, BIOPHYS J, V96, P4743, DOI 10.1016/j.bpj.2009.03.019
   Sarkar S, 2006, BIOMATERIALS, V27, P4775, DOI 10.1016/j.biomaterials.2006.04.038
   Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8
   SHANMUGASUNDARA.S, 2008, TISSUE ENG ROLES MAT, P83
   Shim WSN, 2004, BIOCHEM BIOPH RES CO, V324, P481, DOI 10.1016/j.bbrc.2004.09.087
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Slater JH, 2008, J BIOMED MATER RES A, V87A, P176, DOI 10.1002/jbm.a.31725
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Solanki A, 2010, SMALL, V6, P2509, DOI 10.1002/smll.201001341
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tan JL, 2004, TISSUE ENG, V10, P865, DOI 10.1089/1076327041348365
   Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072
   Taupin P, 2009, CURR ALZHEIMER RES, V6, P461, DOI 10.2174/156720509790147151
   Tavella S, 1997, J CELL SCI, V110, P2261
   Tay CY, 2010, EXP CELL RES, V316, P1159, DOI 10.1016/j.yexcr.2010.02.010
   Tay CY, 2010, CARBON, V48, P1095, DOI 10.1016/j.carbon.2009.11.031
   TAY CY, 2011, SMALL, V7, DOI DOI 10.1002/SMLL.20102298
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01
   Thakar RG, 2009, BIOPHYS J, V96, P3423, DOI 10.1016/j.bpj.2008.11.074
   Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI 10.1089/ten.TEA.2009.0625
   Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417
   Venkatraman S, 2008, PROG POLYM SCI, V33, P853, DOI 10.1016/j.progpolymsci.2008.07.001
   Venugopal J, 2008, J BIOMED MATER RES B, V84B, P34, DOI 10.1002/jbm.b.30841
   Vieu C, 2000, APPL SURF SCI, V164, P111, DOI 10.1016/S0169-4332(00)00352-4
   von der Mark K, 2010, CELL TISSUE RES, V339, P131, DOI 10.1007/s00441-009-0896-5
   WAKITANI S, 1995, MUSCLE NERVE, V18, P1417, DOI 10.1002/mus.880181212
   Wang F, 2002, J NATL CANCER I, V94, P1494, DOI 10.1093/jnci/94.19.1494
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Wei GB, 2009, BIOMATERIALS, V30, P6426, DOI 10.1016/j.biomaterials.2009.08.012
   Weiss P, 1934, J EXP ZOOL, V68, P393, DOI 10.1002/jez.1400680304
   Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571
   Xie JW, 2010, NANOSCALE, V2, P35, DOI 10.1039/b9nr00243j
   Xie JW, 2009, ADV FUNCT MATER, V19, P2312, DOI 10.1002/adfm.200801904
   Xie JW, 2009, BIOMATERIALS, V30, P354, DOI 10.1016/j.biomaterials.2008.09.046
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yeong WY, 2010, TISSUE ENG PART C-ME, V16, P1011, DOI [10.1089/ten.tec.2009.0604, 10.1089/ten.TEC.2009.0604]
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
   Yoon YS, 2004, CIRCULATION, V109, P3154, DOI 10.1161/01.CIR.0000134696.08436.65
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 171
TC 78
Z9 78
U1 5
U2 112
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1613-6810
EI 1613-6829
J9 SMALL
JI Small
PD MAY 23
PY 2011
VL 7
IS 10
BP 1361
EP 1378
DI 10.1002/smll.201100046
PG 18
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 770LL
UT WOS:000291087900006
PM 21538867
DA 2018-10-20
ER

PT J
AU Zhao, YL
   Koppen, S
   Frauenheim, T
AF Zhao, Y. L.
   Koeppen, S.
   Frauenheim, T.
TI An SCC-DFTB/MD Study of the Adsorption of Zwitterionic Glycine on a
   Geminal Hydroxylated Silica Surface in an Explicit Water Environment
SO JOURNAL OF PHYSICAL CHEMISTRY C
LA English
DT Article
ID PEPTIDE-BOND FORMATION; MOLECULAR-DYNAMICS SIMULATIONS; TIGHT-BINDING
   METHOD; AMINO-ACIDS; COMPLEX MATERIALS; AMORPHOUS SILICA; L-LYSINE;
   HYDROXYAPATITE; CHEMISTRY; BIOMOLECULES
AB Theoretical work on amino acid monomers interacting with a silica surface is very important in the field of biomaterials. However, the adsorption of an amino acid monomer on the geminal silanols of silica surfaces has rarely been studied. In this work, we study zwitterionic glycine adsorption on an edingtonite surface covered by geminal silanols using molecular dynamics simulations based on the density functional tight-binding method. By introducing 140 water molecules into the systems, we directly considered the solvent effect. We found that both the amino (NH(3)(+)) and the carboxylic (COO(-)) groups of glycine can directly form hydrogen bonds with geminal silanols. However, unlike the COO(-) group, the NH(3)(+) group cannot be persistently sustained on the surface. Therefore, the dominant configuration is the COO(-) group pointing toward the surface. Our study not only provides a molecular level understanding of the interactions between inorganic materials and biochemical molecules but also demonstrates a feasible theoretical method on a quantum level for studying these interactions in biomaterial engineering.
C1 [Zhao, Y. L.; Koeppen, S.; Frauenheim, T.] Univ Bremen, Bremen Ctr Computat Mat Sci, D-28359 Bremen, Germany.
   [Zhao, Y. L.] Ocean Univ China, Inst Mat Sci & Engn, Qingdao 266100, Peoples R China.
   [Koeppen, S.] Univ Bremen, Fac Prod Engn, D-28359 Bremen, Germany.
RP Zhao, YL (reprint author), Univ Bremen, Bremen Ctr Computat Mat Sci, Fallturm 1, D-28359 Bremen, Germany.
EM monicaling@ouc.edu.cn
RI Koppen, Susan/N-8570-2015; Frauenheim, Thomas/C-5653-2015
OI Frauenheim, Thomas/0000-0002-3073-0616
FU Bremen University of Germany; ISPF-Mittel
FX The authors acknowledge the support from the BreSCA funds from the
   "ISPF-Mittel", the Bremen University of Germany. We appreciate Dr. C.
   Kohler, Dr. P. Tolle, Dr. J. Chan, Dr. B. H. Yan, and Dr. J. Knaup for
   kind suggestions and help.
CR BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Bernal JD, 1951, PHYS BASIS LIFE
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Bujdak J, 1997, J MOL EVOL, V45, P457, DOI 10.1007/PL00006250
   Chavez P, 1996, LANGMUIR, V12, P4111, DOI 10.1021/la950793g
   Civalleri B, 1999, J PHYS CHEM B, V103, P2165, DOI 10.1021/jp9829187
   COOPER JC, 1994, ELECTROANAL, V6, P957, DOI 10.1002/elan.1140061107
   Corno M, 2010, PHYS CHEM CHEM PHYS, V12, P6309, DOI 10.1039/c002146f
   Costa D, 2008, PHYS CHEM CHEM PHYS, V10, P6360, DOI 10.1039/b806501b
   Elstner M, 2003, J MOL STRUC-THEOCHEM, V632, P29, DOI 10.1016/S0166-1280(03)00286-0
   Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260
   Elstner M, 2000, PHYS STATUS SOLIDI B, V217, P357, DOI 10.1002/(SICI)1521-3951(200001)217:1<357::AID-PSSB357>3.0.CO;2-J
   Fleming GJ, 2008, SURF SCI, V602, P2029, DOI 10.1016/j.susc.2008.04.010
   Frauenheim T, 2000, PHYS STATUS SOLIDI B, V217, P41, DOI 10.1002/(SICI)1521-3951(200001)217:1<41::AID-PSSB41>3.0.CO;2-V
   Frauenheim T, 2002, J PHYS-CONDENS MAT, V14, P3015, DOI 10.1088/0953-8984/14/11/313
   Fubini B, 1998, ANN OCCUP HYG, V42, P521, DOI 10.1016/S0003-4878(98)00066-0
   Gambino GL, 2006, J PHYS CHEM B, V110, P4836, DOI 10.1021/jp0508610
   Gambino GL, 2004, J PHYS CHEM B, V108, P2600, DOI 10.1021/jp035991s
   Giacomelli CE, 1999, J COLLOID INTERF SCI, V220, P13, DOI 10.1006/jcis.1999.6479
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hu ZF, 2006, WATER RES, V40, P1474, DOI 10.1016/j.watres.2006.01.041
   Ichimura K, 2008, LANGMUIR, V24, P6470, DOI 10.1021/la8002178
   Knaup JM, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235321
   Knaup JM, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.115323
   Kohler C, 2006, SURF SCI, V600, P453, DOI 10.1016/j.susc.2005.10.044
   Kohler C, 2001, PHYS REV B, V64
   KRUEGER T, 2005, J PHYS CHEM B, V109, P5060
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   Lisman JE, 1999, SCIENCE, V283, P381
   Lomenech C, 2005, CHEMPHYSCHEM, V6, P1061, DOI 10.1002/cphc.200400608
   Long JR, 2001, BIOCHEMISTRY-US, V40, P15451, DOI 10.1021/bi010864c
   Macaskie LE, 2005, BIOCHEM SOC T, V33, P76, DOI 10.1042/BST0330076
   Meng M, 2004, LANGMUIR, V20, P914, DOI 10.1021/la035336b
   Murray DK, 2010, J COLLOID INTERF SCI, V352, P163, DOI 10.1016/j.jcis.2010.08.045
   Nonella M, 2008, CHEMPHYSCHEM, V9, P414, DOI 10.1002/cphc.200700546
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Ramaekers R, 2004, J CHEM PHYS, V120, P4182, DOI 10.1063/1.1643735
   Rimola A, 2006, CHEMPHYSCHEM, V7, P157, DOI 10.1002/cphc.200500401
   Rimola A, 2007, J AM CHEM SOC, V129, P8333, DOI 10.1021/ja070451k
   Rimola A, 2006, LANGMUIR, V22, P6593, DOI 10.1021/la0610203
   Rimola A, 2009, PHYS CHEM CHEM PHYS, V11, P9005, DOI 10.1039/b913311a
   Rimola A, 2009, J PHYS CHEM C, V113, P5741, DOI 10.1021/jp811193f
   Rimola A, 2008, LANGMUIR, V24, P14027, DOI 10.1021/la8029352
   Rimola A, 2008, J AM CHEM SOC, V130, P16181, DOI 10.1021/ja806520d
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Tarasevich YI, 2002, COLLOID J+, V64, P482, DOI 10.1023/A:1016828322434
   Tosoni S, 2008, J PHYS CONF SER, V117, DOI 10.1088/1742-6596/117/1/012026
   Ugliengo P., 2008, ADV MATER, V20, P1
   WIESSNER JH, 1988, AM REV RESPIR DIS, V138, P445, DOI 10.1164/ajrccm/138.2.445
   Yahel G, 2007, LIMNOL OCEANOGR, V52, P428, DOI 10.4319/lo.2007.52.1.0428
   Zhao Y., UNPUB
   Zhuravlev LT, 2000, COLLOID SURFACE A, V173, P1, DOI 10.1016/S0927-7757(00)00556-2
   ZHURAVLEV LT, 1987, LANGMUIR, V3, P316, DOI 10.1021/la00075a004
NR 53
TC 28
Z9 28
U1 1
U2 29
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1932-7447
J9 J PHYS CHEM C
JI J. Phys. Chem. C
PD MAY 19
PY 2011
VL 115
IS 19
BP 9615
EP 9621
DI 10.1021/jp200610p
PG 7
WC Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science,
   Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 761UV
UT WOS:000290427400039
DA 2018-10-20
ER

PT J
AU Cigognini, D
   Satta, A
   Colleoni, B
   Silva, D
   Donega, M
   Antonini, S
   Gelain, F
AF Cigognini, Daniela
   Satta, Alessandro
   Colleoni, Bianca
   Silva, Diego
   Donega, Matteo
   Antonini, Stefania
   Gelain, Fabrizio
TI Evaluation of Early and Late Effects into the Acute Spinal Cord Injury
   of an Injectable Functionalized Self-Assembling Scaffold
SO PLOS ONE
LA English
DT Article
ID NEURAL STEM-CELLS; PEPTIDE NANOFIBER SCAFFOLD; MATRIX
   METALLOPROTEINASES; ADULT-RAT; AXONAL GROWTH; SCHWANN-CELLS;
   BRAIN-TISSUE; TRACT AXONS; REGENERATION; REPAIR
AB The complex physiopathological events occurring after spinal cord injury (SCI) make this devastating trauma still incurable. Self-assembling peptides (SAPs) are nanomaterials displaying some appealing properties for application in regenerative medicine because they mimic the structure of the extra-cellular matrix (ECM), are reabsorbable, allow biofunctionalizations and can be injected directly into the lesion. In this study we evaluated the putative neurorigenerative properties of RADA16-4G-BMHP1 SAP, proved to enhance in vitro neural stem cells survival and differentiation. This SAP (RADA16-I) has been functionalized with a bone marrow homing motif (BMHP1) and optimized via the insertion of a 4-glycine-spacer that ameliorates scaffold stability and exposure of the biomotifs. We injected the scaffold immediately after contusion in the rat spinal cord, then we evaluated the early effects by semi-quantitative RT-PCR and the late effects by histological analysis. Locomotor recovery over 8 weeks was assessed using Basso, Beattie, Bresnahan (BBB) test. Gene expression analysis showed that at 7 days after lesion the functionalized SAP induced a general upregulation of GAP-43, trophic factors and ECM remodelling proteins, whereas 3 days after SCI no remarkable changes were observed. Hystological analysis revealed that 8 weeks after SCI our scaffold increased cellular infiltration, basement membrane deposition and axon regeneration/sprouting within the cyst. Moreover the functionalized SAP showed to be compatible with the surrounding nervous tissue and to at least partially fill the cavities. Finally SAP injection resulted in a statistically significant improvement of both hindlimbs' motor performance and forelimbs-hindlimbs coordination. Altogether, these results indicate that RADA16-4G-BMHP1 induced favourable reparative processes, such as matrix remodelling, and provided a physical and trophic support to nervous tissue ingrowth. Thus this biomaterial, eventually combined with cells and growth factors, may constitute a promising biomimetic scaffold for regenerative applications in the injured central nervous system.
C1 [Cigognini, Daniela; Satta, Alessandro; Colleoni, Bianca; Silva, Diego; Donega, Matteo; Antonini, Stefania; Gelain, Fabrizio] Univ Milano Bicocca, Biotechnol & Biosci Dept, Milan, Italy.
   [Cigognini, Daniela; Silva, Diego; Antonini, Stefania; Gelain, Fabrizio] Osped Niguarda Ca Granda, Ctr Nanomed & Tissue Engn, Milan, Italy.
   [Gelain, Fabrizio] Casa Sollievo della Sofferenza Hosp, San Giovanni Rotondo, Italy.
RP Cigognini, D (reprint author), Univ Milano Bicocca, Biotechnol & Biosci Dept, Milan, Italy.
EM fabrizio.gelain@unimib.it
RI Gelain, Fabrizio/K-5069-2012
OI Gelain, Fabrizio/0000-0002-2624-5853; Alessandro,
   Satta/0000-0002-3717-9337
FU CARIPLO Foundation; Regione Lombardia (Local Government)
FX This work was supported by CARIPLO Foundation and Regione Lombardia
   (Local Government). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7
   Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371
   Arcaute K, 2010, ACTA BIOMATER, V6, P1047, DOI 10.1016/j.actbio.2009.08.017
   Baptiste DC, 2007, PROG BRAIN RES, V161, P217, DOI 10.1016/S0079-6123(06)61015-7
   BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1
   Beattie MS, 1997, EXP NEUROL, V148, P453, DOI 10.1006/exnr.1997.6695
   Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322
   Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534
   Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496
   Buss A, 2007, BRAIN, V130, P940, DOI 10.1093/brain/awl374
   Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7
   Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103
   Fernandes KJL, 1999, J COMP NEUROL, V414, P495, DOI 10.1002/(SICI)1096-9861(19991129)414:4<495::AID-CNE6>3.0.CO;2-S
   Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014
   Gelain F, 2007, MACROMOL BIOSCI, V7, P544, DOI 10.1002/mabi.200700033
   Gelain F, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000119
   Gelain F, 2011, ACS NANO, V5, P227, DOI 10.1021/nn102461w
   Gelain F, 2010, J CONTROL RELEASE, V145, P231, DOI 10.1016/j.jconrel.2010.04.026
   Gros T, 2010, BIOMATERIALS, V31, P6719, DOI 10.1016/j.biomaterials.2010.04.035
   Guo J, 2007, NANOMED-NANOTECHNOL, V3, P311, DOI 10.1016/j.nano.2007.09.003
   Gupta D, 2006, BIOMATERIALS, V27, P2370, DOI 10.1016/j.biomaterials.2005.11.015
   Hagg T, 2006, J NEUROTRAUM, V23, P264, DOI 10.1089/neu.2006.23.263
   Hamid S, 2008, EUR SPINE J, V17, P1256, DOI 10.1007/s00586-008-0729-3
   Heissig B, 2010, HISTOL HISTOPATHOL, V25, P765, DOI 10.14670/HH-25.765
   Hejcl A, 2008, PHYSIOL RES, V57, pS121
   Holguin A, 2004, PAIN, V110, P517, DOI 10.1016/j.pain.2004.02.018
   Hsu JYC, 2005, J NEUROSCI RES, V82, P472, DOI 10.1002/jnr.20662
   Hu R, 2010, J NEUROSURG-SPINE, V13, P169, DOI 10.3171/2010.3.SPINE09190
   *ICCP, 2007, EXP TREATM SPIN CORD
   JOOSTEN EAJ, 1995, J NEUROSCI RES, V41, P481, DOI 10.1002/jnr.490410407
   Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987
   King VR, 2010, BIOMATERIALS, V31, P4447, DOI 10.1016/j.biomaterials.2010.02.018
   King VR, 2006, BIOMATERIALS, V27, P485, DOI 10.1016/j.biomaterials.2005.06.033
   Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x
   Kyle S, 2009, TRENDS BIOTECHNOL, V27, P423, DOI 10.1016/j.tibtech.2009.04.002
   Lu HZ, 2009, ACTA NEUROBIOL EXP, V69, P441
   Madigan NN, 2009, RESP PHYSIOL NEUROBI, V169, P183, DOI 10.1016/j.resp.2009.08.015
   Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046
   Mapili G, 2005, J BIOMED MATER RES B, V75B, P414, DOI 10.1002/jbm.b.30325
   Mautes AEM, 2000, PHYS THER, V80, P673
   McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001
   Nakamura M, 2003, EXP NEUROL, V184, P313, DOI 10.1016/S0014-4886(03)00361-3
   Nowakowski GS, 2004, STEM CELLS, V22, P1030, DOI 10.1634/stemcells.22-6-1030
   Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537
   Pizzi MA, 2007, EXP NEUROL, V204, P496, DOI 10.1016/j.expneurol.2006.12.012
   Qi XA, 2010, EXP NEUROL, V221, P353, DOI 10.1016/j.expneurol.2009.12.003
   Andrade MSR, 2010, BRAIN RES, V1346, P266, DOI 10.1016/j.brainres.2010.05.070
   Rao Shreyas S, 2009, Front Neuroeng, V2, P6, DOI 10.3389/neuro.16.006.2009
   Ringhoffer M, 2001, INT J ONCOL, V19, P983
   Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108
   Ruff RL, 2008, ANN NY ACAD SCI, V1142, P1, DOI 10.1196/annals.1444.004
   Saha K, 2007, CURR OPIN CHEM BIOL, V11, P381, DOI 10.1016/j.cbpa.2007.05.030
   Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sinescu Crina, 2010, J Med Life, V3, P254
   Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400
   Straley KS, 2010, J NEUROTRAUM, V27, P1, DOI 10.1089/neu.2009.0948
   Taraballi Francesca, 2010, Front Neuroeng, V3, P1, DOI 10.3389/neuro.16.001.2010
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Tsiper MV, 2002, J CELL SCI, V115, P1005
   Wrenzycki C, 2002, BIOL REPROD, V66, P127, DOI 10.1095/biolreprod66.1.127
   Yao L, 2010, J BIOMED MATER RES A, V92A, P484, DOI 10.1002/jbm.a.32359
   Ye JL, 2004, BRAIN RES, V997, P30, DOI 10.1016/j.brainres.2003.10.036
   Ye ZY, 2008, J PEPT SCI, V14, P152, DOI 10.1002/psc.988
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 66
TC 52
Z9 54
U1 1
U2 28
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 18
PY 2011
VL 6
IS 5
AR e19782
DI 10.1371/journal.pone.0019782
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 765PE
UT WOS:000290720200032
PM 21611127
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Holt, B
   Tripathi, A
   Morgan, JR
AF Holt, Brian
   Tripathi, Anubhav
   Morgan, Jeffrey R.
TI Designing polyHEMA substrates that mimic the viscoelastic response of
   soft tissue
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE Shear; Rheology; Viscoelastic; Poly(2-hydroxyethyl methacrylate); Soft
   tissue
ID PERCUTANEOUS DEVICES; IN-VITRO; BIOMATERIALS; SKIN; STRESS; CELLS;
   INTERFACE; RHEOLOGY; BEHAVIOR; FORCE
AB Matching the mechanical properties of a biomaterial to soft tissue is often overlooked despite the fact that it is well known that cells respond to and are capable of changing their mechanical environment. In this paper, we used NaCl and alginate beads as porogens to make a series of micro- and macro-porous pHEMA substrates (poly(2-hydroxyethly methacrylate)) and quantified their mechanical behavior under low-magnitude shear loads over physiologically relevant frequencies. Using a stress-controlled rheometer, we performed isothermal (37 C) frequency response experiments between 0.628 and 75.4 rad/s (0.01-12 Hz) at 0.1% strain. Both micro- and macro-porous pHEMA substrates were predominately elastic in nature with a narrow range of G' and G" values that mimicked the response of human skin. The magnitude of the G' and G" values of the macro-porous substrates were designed to closely match human skin. To determine how cell growth might alter their mechanical properties, pHEMA substrates were functionalized and human skin fibroblasts grown on them for fourteen days. As a result of cell growth, the magnitude of G' and G" increased at low frequencies while also altering the degree of high frequency dependence, indicating that cellular interactions with the micro-pore infrastructure has a profound effect on the viscoelastic behavior of the substrates. These data could be fit to a mathematical model describing a soft-solid. A quantitative understanding of the mechanical behavior of biomaterials in regimes that are physiologically relevant and how these mechanics may change after implantation may aid in the design of new materials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Holt, Brian; Morgan, Jeffrey R.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.
   [Holt, Brian; Tripathi, Anubhav; Morgan, Jeffrey R.] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA.
   [Tripathi, Anubhav] Brown Univ, Div Engn, Providence, RI 02912 USA.
RP Morgan, JR (reprint author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Box GB-393, Providence, RI 02912 USA.
EM jeffrey_morgan@brown.edu
OI Morgan, Jeffrey/0000-0002-7546-3443
FU National Institute of Arthritis And Musculoskeletal And Skin Diseases
   [F31AR054202]
FX The project described was supported by Grant number F31AR054202 from the
   National Institute of Arthritis And Musculoskeletal And Skin Diseases.
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institute of
   Arthritis and Musculoskeletal and Skin Diseases or the National
   Institutes of Health.
CR Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0
   Cacou C, 1995, J R Coll Surg Edinb, V40, P38
   Clark RAF, 2007, J INVEST DERMATOL, V127, P1018, DOI 10.1038/sj.jid.5700715
   Cowin SC, 2000, J BIOMECH ENG-T ASME, V122, P553, DOI 10.1115/1.1324665
   DISCHER DE, 2005, SCIENCE, V6, P214
   Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102
   Fukano Y, 2006, WOUND REPAIR REGEN, V14, P484, DOI 10.1111/j.1743-6109.2006.00138.x
   Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102
   Gheduzzi S, 2006, J MATER SCI-MATER M, V17, P421, DOI 10.1007/s10856-006-8469-6
   GROSSESIESTRUP C, 1984, J BIOMED MATER RES, V18, P357, DOI 10.1002/jbm.820180405
   Hoffman BD, 2009, ANNU REV BIOMED ENG, V11, P259, DOI 10.1146/annurev.bioeng.10.061807.160511
   Holt B, 2008, J BIOMECH, V41, P2689, DOI 10.1016/j.jbiomech.2008.06.008
   Knabe C, 1999, BIOMATERIALS, V20, P503, DOI 10.1016/S0142-9612(98)00195-1
   Kohane DS, 2008, PEDIATR RES, V63, P487, DOI 10.1203/01.pdr.0000305937.26105.e7
   Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a
   Larson R. G., 1999, STRUCTURE RHEOLOGY C
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576
   Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145
   Mandadapu KK, 2008, J BIOMECH, V41, P1467, DOI 10.1016/j.jbiomech.2008.02.014
   Narayan D, 2008, J BIOMED MATER RES A, V87A, P710, DOI 10.1002/jbm.a.31749
   Nicolle S, 2005, BIORHEOLOGY, V42, P209
   Pendegrass CJ, 2006, BIOMATERIALS, V27, P4183, DOI 10.1016/j.biomaterials.2006.03.041
   Shin JH, 2004, P NATL ACAD SCI USA, V101, P9636, DOI 10.1073/pnas.0308733101
   Stamenovic D, 2008, CELL MOL LIFE SCI, V65, P3592, DOI 10.1007/s00018-008-8292-y
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   THARMANN R, 2007, PHYS REV LETT, V98
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Tsubouchi K, 2006, SURG TODAY, V36, P701, DOI 10.1007/s00595-006-3232-7
   Wang YN, 2003, MED HYPOTHESES, V61, P29, DOI 10.1016/S0306-9877(03)00100-2
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
NR 31
TC 6
Z9 6
U1 0
U2 21
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
J9 J BIOMECH
JI J. Biomech.
PD MAY 17
PY 2011
VL 44
IS 8
BP 1491
EP 1498
DI 10.1016/j.jbiomech.2011.03.007
PG 8
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 771BA
UT WOS:000291131000010
PM 21496821
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Kumar, R
   Sripriya, R
   Balaji, S
   Kumar, MS
   Sehgal, PK
AF Kumar, Ramadhar
   Sripriya, R.
   Balaji, S.
   Kumar, M. Senthil
   Sehgal, P. K.
TI Physical characterization of succinylated type I collagen by Raman
   spectra and MALDI-TOF/MS and in vitro evaluation for biomedical
   applications
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Collagen; Succinylation; MALDI-TOF/MS; Raman spectroscopy; Fibroblasts;
   Myoblasts
ID VIBRATIONAL SPECTROSCOPY; SECONDARY STRUCTURE; MASS-SPECTROMETRY;
   MATRIX; PROTEINS; REPAIR; TISSUE; BIOMATERIAL; PEPTIDE; FILMS
AB In this study, we report on physical and in vitro biological characterization of succinylated collagen (SC). SC was prepared by succinylation of type I bovine tendon collagen. SC swells and dissolves in physiological pH buffers (pH 7.4) Biocompatibility of SC to collagen for fibroblasts was comparable but L6 myoblasts showed pronounced proliferation and differentiation with SC. Using the MALDI-TOF/MS technique, SC was found with increased molecular mass by 16,359 Da per molecule which corresponds to about 54 succinyl groups covalently linked to the collagen strand. Raman spectroscopy revealed the retention of triple helical structure conformation in the presence of linked succinyl groups. New peaks near 1737, 1675 and 1420 cm(-1) and decreased intensities near 2440 and 488 cm(-1) provides the most convenient marker bands for succinylation of collagen. The intense band regions near 2856-2934, 2724, and 1445 cm(-1) also confirms the existence of succinyl groups. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kumar, Ramadhar; Sripriya, R.; Balaji, S.; Kumar, M. Senthil; Sehgal, P. K.] Cent Leather Res Inst, Council Sci & Ind Res, Biomat Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
RP Sehgal, PK (reprint author), Cent Leather Res Inst, Council Sci & Ind Res, Biomat Div, Bioprod Lab, Madras 600020, Tamil Nadu, India.
EM sehgal_pk@yahoo.co.in
RI Muthusamy, Senthilkumar/G-7875-2015
OI Muthusamy, Senthilkumar/0000-0003-1603-9965
FU CSIR; Department of Biotechnology (DBT), Government of India
FX We are grateful to Dr. A.B. Mandal, Director, CLRI, Chennai for his kind
   permission to publish this work. The authors R.S.P, R.K and S.B
   acknowledge the CSIR for financial support in the form of Senior
   Research Associate and Senior Research Fellow. We also gratefully
   acknowledge the financial assistance received from the Department of
   Biotechnology (DBT), Government of India.
CR Ahn YH, 1999, ANAL SCI, V15, P53, DOI 10.2116/analsci.15.53
   ALIX AJP, 1988, J MOL STRUCT, V174, P159, DOI 10.1016/0022-2860(88)80151-0
   ANTONI H, 1991, MOL PATHOL, P389
   Atala A, 1999, J UROLOGY, V162, P1148, DOI 10.1016/S0022-5347(01)68105-9
   Bailey AJ, 2000, WOUND REPAIR REGEN, V8, P5, DOI 10.1046/j.1524-475x.2000.00005.x
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Chrishan SS, 2009, ENDOCRINOLOGY, V145, P4125
   El-Kassaby AW, 2003, J UROLOGY, V169, P170, DOI 10.1016/S0022-5347(05)64060-8
   FRANK SP, 1983, APPL INFRARED RAMAN, P22
   FRUSHOUR BG, 1975, BIOPOLYMERS, V14, P379, DOI 10.1002/bip.1975.360140211
   Gruener L, 1997, FOOD CHEM, V60, P357, DOI 10.1016/S0308-8146(96)00348-2
   KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   Kim SH, 2000, RAPID COMMUN MASS SP, V14, P2125, DOI 10.1002/1097-0231(20001130)14:22<2125::AID-RCM141>3.0.CO;2-6
   KIM SH, 1999, P 47 ASMS C MASS SPE
   KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8
   KSANDER GA, 1985, ANN PLAS SURG, V14, P351, DOI 10.1097/00000637-198504000-00009
   LINO K, 1996, DIABETOLOGIA, V800, P39
   MA CY, 1987, J AM OIL CHEM SOC, V64, P1726, DOI 10.1007/BF02542510
   MAUCH C, 1988, EXP CELL RES, V178, P1508
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   NOISHIKI Y, 1996, Patent No. 0742020
   NUSGENS B, 1984, COLLAGEN REL RES, V4, P351
   Overman SA, 1998, BIOCHEMISTRY-US, V37, P5654, DOI 10.1021/bi972339c
   OZAKI Y, 1975, CHEM LETT, P713, DOI 10.1246/cl.1975.713
   PATTERSON SD, 1995, ELECTROPHORESIS, V16, P1791, DOI 10.1002/elps.11501601299
   Pelton JT, 2000, ANAL BIOCHEM, V277, P167, DOI 10.1006/abio.1999.4320
   PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403
   Rault I, 1996, J MATER SCI-MATER M, V7, P215, DOI 10.1007/BF00119733
   Roman T., 2005, J RAMAN SPECTROSC, V36, P307
   ROSENBLATT J, 1999, Patent No. 5928667
   SCHOR SL, 1980, J CELL SCI, V41, P159
   Schweitzer-Stenner R, 2006, VIB SPECTROSC, V42, P98, DOI 10.1016/j.vibspec.2006.01.004
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   SEFTON MV, 1998, MED SURG, V18, P18
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   SINGH M, 1998, Patent No. 5788959
   Socrates G., 2001, INFRARED RAMAN CHARA, P50
   Sripriya R, 2003, J APPL POLYM SCI, V87, P2186, DOI 10.1002/app.11651
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
   Tu A. T., 1986, SPECTROSCOPY BIOL SY, P47
   TU AT, 1982, SPECTROSCOPY BIOL PR, P65
   Vladislav B., 2006, J BIOL CHEM, V281, P15208
   WANG CL, 1978, BIOCHIM BIOPHYS ACTA, V555, P544
   WILLIAMS W., 1983, J MOL BIO, V166, P581
   Zhao Y, 2004, J AGR FOOD CHEM, V52, P1815, DOI 10.1021/jf030577a
NR 46
TC 13
Z9 14
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-2860
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAY 17
PY 2011
VL 994
IS 1-3
BP 117
EP 124
DI 10.1016/j.molstruc.2011.03.005
PG 8
WC Chemistry, Physical
SC Chemistry
GA 770KP
UT WOS:000291085700017
DA 2018-10-20
ER

PT J
AU Kontogiannopoulos, KN
   Assimopoulou, AN
   Tsivintzelis, I
   Panayiotou, C
   Papageorgiou, VP
AF Kontogiannopoulos, Konstantinos N.
   Assimopoulou, Andreana N.
   Tsivintzelis, Ioannis
   Panayiotou, Costas
   Papageorgiou, Vassilios P.
TI Electrospun fiber mats containing shikonin and derivatives with
   potential biomedical applications
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Alkannin; Naphthoquinones; Drug delivery; Electrospinning; Electrospun
   fibers; Wound healing; Tissue engineering; Wound dressing
ID IBUPROFEN-LOADED MICROSPHERES; 4 MODEL-DRUGS; RELEASE CHARACTERISTICS;
   NATURAL-PRODUCTS; NANOFIBERS; SCAFFOLDS; DELIVERY; NANOCOMPOSITES;
   HYDROCHLORIDE; POLYLACTIDE
AB Alkannin, shikonin (A/S) and their derivatives are naturally occurring hydroxynaphthoquinones with a well-established spectrum of wound healing, antimicrobial, anti-inflammatory, antioxidant and antitumor activity. Clinical studies over the years revealed that A/S derivatives-based wound healing preparations (such as HELIXDERM (R)) are among a very small group of therapeutics that modulate both the inflammatory and proliferative phases of wound healing and present significant tissue regenerative activity. The purpose of the present work was to combine the biological properties of A/S and the advantages of electrospun meshes to prepare a potent topical/transdermal biomaterial for A/S. Four biocompatible polymers (cellulose acetate, poly(L-lactide), poly(lactide-co-glycolide) LA/GA:50/50 and 75/25) were used for the first time, to produce electrospun fiber mats containing either shikonin or A/S mixture in various amounts. Both drugs were effectively loaded into the above biomaterials. The incorporation of drugs did not considerably affect fibers morphology and their mean diameter size varied from 315 to 670 nm. High drug entrapment efficiencies (ranged from 74% to 95%) and appropriate release profiles were achieved, that render these fibers as potential A/S topical/transdermal wound healing dressings. Given the multifunctional activity of the natural products alkannins and shikonins, their consideration as bioactive constituents for tissue engineering scaffolds seems a promising strategy for repairing and regenerating tissues and mainly skin. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Kontogiannopoulos, Konstantinos N.; Assimopoulou, Andreana N.; Papageorgiou, Vassilios P.] Aristotle Univ Thessaloniki, Dept Chem Engn, Organ Chem Lab, Thessaloniki 54124, Greece.
   [Tsivintzelis, Ioannis; Panayiotou, Costas] Aristotle Univ Thessaloniki, Dept Chem Engn, Phys Chem Lab, Thessaloniki 54124, Greece.
RP Papageorgiou, VP (reprint author), Aristotle Univ Thessaloniki, Dept Chem Engn, Organ Chem Lab, Thessaloniki 54124, Greece.
EM vaspap@eng.auth.gr
RI Kontogiannopoulos, Konstantinos/M-9392-2017
OI Kontogiannopoulos, Konstantinos/0000-0001-8728-0233; ASSIMOPOULOU,
   ANDREANA/0000-0002-2833-2694; PAPAGEORGIOU,
   VASSILIOS/0000-0001-9202-1420; Tsivintzelis, Ioannis/0000-0002-4907-4794
CR Assimopoulou AN, 2009, BIOMED CHROMATOGR, V23, P182, DOI 10.1002/bmc.1101
   Bidone J, 2009, MAT SCI ENG C-BIO S, V29, P588, DOI 10.1016/j.msec.2008.10.016
   Bini TB, 2004, NANOTECHNOLOGY, V15, P1459, DOI 10.1088/0957-4484/15/11/014
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Han J, 2009, INT J PHARMACEUT, V382, P215, DOI 10.1016/j.ijpharm.2009.07.027
   HIGUCHI T, 1963, J PHARM SCI, V52, P1145, DOI 10.1002/jps.2600521210
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   Kim K, 2003, BIOMATERIALS, V24, P4977, DOI 10.1016/S0142-9612(03)00407-1
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Lanza R, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P1
   Lee YH, 2010, J CONTROL RELEASE, V145, P58, DOI 10.1016/j.jconrel.2010.03.014
   Li WJ, 2006, ACTA BIOMATER, V2, P377, DOI 10.1016/j.actbio.2006.02.005
   Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X
   Pan H, 2008, BIOMATERIALS, V29, P1583, DOI 10.1016/j.biomaterials.2007.12.005
   Papageorgiou VP, 2006, CURR ORG CHEM, V10, P2123, DOI 10.2174/138527206778742704
   Papageorgiou VP, 2008, CURR MED CHEM, V15, P3248, DOI 10.2174/092986708786848532
   PAPAGEORGIOU VP, 1980, PLANTA MED, V38, P193, DOI 10.1055/s-2008-1074864
   Papageorgiou VP, 1999, ANGEW CHEM INT EDIT, V38, P270, DOI 10.1002/(SICI)1521-3773(19990201)38:3<270::AID-ANIE270>3.0.CO;2-0
   Park PIP, 2006, J APPL POLYM SCI, V100, P1983, DOI 10.1002/app.22135
   Puppi D, 2010, ACTA BIOMATER, V6, P1258, DOI 10.1016/j.actbio.2009.08.015
   RITGER P L, 1987, Journal of Controlled Release, V5, P37, DOI 10.1016/0168-3659(87)90035-6
   Sill TJ, 2008, BIOMATERIALS, V29, P1989, DOI 10.1016/j.biomaterials.2008.01.011
   Suwantong O, 2008, POLYMER, V49, P4239, DOI 10.1016/j.polymer.2008.07.020
   Suwantong O, 2007, POLYMER, V48, P7546, DOI 10.1016/j.polymer.2007.11.019
   Taepaiboon P, 2006, NANOTECHNOLOGY, V17, P2317, DOI 10.1088/0957-4484/17/9/041
   Taepaiboon P, 2007, EUR J PHARM BIOPHARM, V67, P387, DOI 10.1016/j.ejpb.2007.03.018
   Takano-Ohmuro H, 2008, INFLAMM RES, V57, P484, DOI 10.1007/s00011-009-8067-9
   Tsimpliaraki A, 2009, IND ENG CHEM RES, V48, P4365, DOI 10.1021/ie801327z
   Tungprapa S, 2007, POLYMER, V48, P5030, DOI 10.1016/j.polymer.2007.06.061
   Verreck G, 2003, PHARMACEUT RES, V20, P810, DOI 10.1023/A:1023450006281
   Xu XL, 2008, EUR J PHARM BIOPHARM, V70, P165, DOI 10.1016/j.ejpb.2008.03.010
   Xu XL, 2009, EUR J PHARM BIOPHARM, V72, P18, DOI 10.1016/j.ejpb.2008.10.015
   Yu DG, 2009, POLYM INT, V58, P1010, DOI 10.1002/pi.2629
   Yu DG, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055104
   Zeng J, 2005, J CONTROL RELEASE, V105, P43, DOI 10.1016/j.j.conrel.2005.02.024
   Zhang LF, 2008, J MEMBRANE SCI, V319, P176, DOI 10.1016/j.memsci.2008.03.030
   Zhu KJ, 2005, J MICROENCAPSUL, V22, P25, DOI 10.1080/02652040400026350
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 43
TC 84
Z9 87
U1 3
U2 60
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD MAY 16
PY 2011
VL 409
IS 1-2
BP 216
EP 228
DI 10.1016/j.ijpharm.2011.02.004
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 758BV
UT WOS:000290135800028
PM 21316431
DA 2018-10-20
ER

PT J
AU Abdulla-Al-Mamun, M
   Kusumoto, Y
   Zannat, T
   Islam, MS
AF Abdulla-Al-Mamun, Md.
   Kusumoto, Yoshihumi
   Zannat, Tohfatul
   Islam, Md. Shariful
TI Synergistic cell-killing by photocatalytic and plasmonic photothermal
   effects of Ag@TiO2 core shell composite nanoclusters against human
   epithelial carcinoma (HeLa) cells
SO APPLIED CATALYSIS A-GENERAL
LA English
DT Article
DE Ag@TiO2; Core-shell structure; Fermi level equilibrium; E-redox
   reaction; Enhancing photocatalytic activity; Synergistic effect of
   plasmonic and photocatalytic cytotoxicity; Cancer cell (HeLa) killing
ID VISIBLE-LIGHT PHOTOCATALYST; TIO2 FILMS; SILVER NANOPARTICLES;
   CANCER-CELLS; METAL NANOPARTICLES; GOLD NANOPARTICLES; BIOMATERIAL
   SYSTEM; CHARGE SEPARATION; MAGNETIC CORE; FERMI-LEVEL
AB The Ag metal core-TiO2 shell (Ag@TiO2) composite nanocluster with uniform size, shape and core-shell structures was successfully synthesized by a new simple citrate reduction method. The core-shell structure of Ag@TiO2 nanocluster was characterized by using TEM, SEM, XPS, EDX, XRD, and photoluminescence spectra analysis. It was found that the Ag core is in metallic form which is covered by TiO2 shell within 3-5 nm thickness and the core-shell particles size was about 30 nm. The photocatalytic and photothermal cell killing efficiency of colloidal Ag@TiO2 core-shell nanocluster was evaluated against cancer (HeLa) cells under UV-vis irradiation. It was found that the Ag@TiO2 nanocluster with an adequate Ag ratio to TiO2 killed more malignant (HeLa) cells by 80% compared to TiO2 nanoparticles alone. The comparative study of the cell viability using UV only, visible only and UV-visible light revealed that the synergy effect of photocatalytic hydroxyl radical formation and Ag-plasmonic photothermal generation plays a vital role for the cancer cell killing. Based on the obtained results, a plausible mechanism was also proposed. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Abdulla-Al-Mamun, Md.; Kusumoto, Yoshihumi; Zannat, Tohfatul; Islam, Md. Shariful] Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem & Biosci, Kagoshima 8900065, Japan.
RP Kusumoto, Y (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Dept Chem & Biosci, 1-21-35 Korimoto, Kagoshima 8900065, Japan.
EM kusumoto@sci.kagoshima-u.ac.jp
RI Abdulla-Al-Mamun, Md./C-7306-2015
OI Abdulla-Al-Mamun, Md./0000-0001-5521-6472
FU Japan Society for the Promotion of Science (JSPS) [19360367, 22.10083]
FX The present work was partly supported by Grant-in-Aid for Scientific
   Research (B) (19360367) and Grant-in-Aid for JSPS Fellows (No. 22.10083)
   from Japan Society for the Promotion of Science (JSPS). The authors wish
   to thank Prof. Junichi Kurawaki for his informative discussions.
CR Abdulla-Al-Mamun M, 2010, TOP CATAL, V53, P571, DOI 10.1007/s11244-010-9489-5
   Abdulla-Al-Mamun M, 2009, CHEM LETT, V38, P980, DOI 10.1246/cl.2009.980
   Abdulla-Al-Mamun M, 2009, PHOTOCH PHOTOBIO SCI, V8, P1125, DOI 10.1039/b907524k
   Aliev FG, 1999, ADV MATER, V11, P1006, DOI 10.1002/(SICI)1521-4095(199908)11:12<1006::AID-ADMA1006>3.0.CO;2-2
   Awazu K, 2008, J AM CHEM SOC, V130, P1676, DOI 10.1021/ja076503n
   Bhatkhande DS, 2002, J CHEM TECHNOL BIOT, V77, P102, DOI 10.1002/jctb.532
   CAI R, 1992, CHEM LETT, P427, DOI 10.1246/cl.1992.427
   CAI R, 1991, B CHEM SOC JPN, V64, P1268, DOI 10.1246/bcsj.64.1268
   CAI RX, 1992, CANCER RES, V52, P2346
   Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o
   Elahifard MR, 2007, J AM CHEM SOC, V129, P9552, DOI 10.1021/ja072492m
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   Hirakawa T, 2005, J AM CHEM SOC, V127, P3928, DOI 10.1021/ja042925a
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   Hu C, 2006, J PHYS CHEM B, V110, P4066, DOI 10.1021/jp0564400
   Ishibashi K, 2000, ELECTROCHEM COMMUN, V2, P207, DOI 10.1016/S1388-2481(00)00006-0
   JAEGER CD, 1979, J PHYS CHEM-US, V83, P3146, DOI 10.1021/j100487a017
   JAFIEZICRENAULT N, 1986, J PHYS CHEM-US, V90, P2733
   Jakob M, 2003, NANO LETT, V3, P353, DOI 10.1021/nl0340071
   KAMAT PV, 1993, CHEM REV, V93, P267, DOI 10.1021/cr00017a013
   Kamat PV, 2002, J PHYS CHEM B, V106, P7729, DOI 10.1021/jp0209289
   Kohler N, 2005, LANGMUIR, V21, P8858, DOI 10.1021/la0503451
   Lahiri D, 2003, J APPL PHYS, V93, P2575, DOI 10.1063/1.1544068
   LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013
   Liu Y, 2008, MICROPOR MESOPOR MAT, V114, P431, DOI 10.1016/j.micromeso.2008.01.032
   MATSUMURA Y, 1986, CANCER RES, V46, P6387
   McFarland AD, 2003, NANO LETT, V3, P1057, DOI 10.1021/nl034372s
   MNneil SE, 2005, J LEUKOCYTE BIOL, V78, P585, DOI 10.1189/jlb.0205074
   Murphy CJ, 2002, ADV MATER, V14, P80, DOI 10.1002/1521-4095(20020104)14:1<80::AID-ADMA80>3.0.CO;2-#
   Naoi K, 2004, J AM CHEM SOC, V126, P3664, DOI 10.1021/ja039474z
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rawat J, 2007, MAT SCI ENG C-BIO S, V27, P540, DOI 10.1016/j.msec.2006.05.021
   Rhoderick E. H., 1988, METAL SEMICONDUCTOR
   Sano T, 2003, J PHOTOCH PHOTOBIO A, V160, P93, DOI 10.1016/S1010-6030(03)00226-0
   Stathatos E, 2000, LANGMUIR, V16, P2398, DOI 10.1021/la981783t
   STEVEN LJ, 1987, PHOTOCHEM PHOTOBIOL, V45, P637
   Subramanian V, 2003, LANGMUIR, V19, P469, DOI 10.1021/la026478t
   Subramanian V, 2001, J PHYS CHEM B, V105, P11439, DOI 10.1021/jp011118k
   Subramanian V, 2004, J AM CHEM SOC, V126, P4943, DOI 10.1021/ja0315199
   Sunkara BK, 2008, ACTA BIOMATER, V4, P273, DOI 10.1016/j.actbio.2007.07.002
   Tian Y, 2005, J AM CHEM SOC, V127, P7632, DOI 10.1021/ja042192u
   Ung T, 1998, LANGMUIR, V14, P3740, DOI 10.1021/la980047m
   Wagner C. D., 1979, HDB XRAY PHOTOELECTR, P82
   Wang WJ, 2008, J COLLOID INTERF SCI, V323, P182, DOI 10.1016/j.jcis.2008.03.043
   Wang WJ, 2010, RES CHEM INTERMEDIAT, V36, P163, DOI 10.1007/s11164-010-0130-9
   Yu JG, 2005, APPL CATAL B-ENVIRON, V60, P211, DOI 10.1016/j.apcatb.2005.03.009
   Yu JG, 2010, CHEMPHYSCHEM, V11, P1617, DOI 10.1002/cphc.200900993
   Yu JG, 2009, J PHYS CHEM C, V113, P6743, DOI 10.1021/jp900136q
   Zang L, 2000, CHEM-EUR J, V6, P379, DOI 10.1002/(SICI)1521-3765(20000117)6:2<379::AID-CHEM379>3.0.CO;2-Z
NR 49
TC 25
Z9 27
U1 10
U2 95
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0926-860X
EI 1873-3875
J9 APPL CATAL A-GEN
JI Appl. Catal. A-Gen.
PD MAY 15
PY 2011
VL 398
IS 1-2
BP 134
EP 142
DI 10.1016/j.apcata.2011.03.027
PG 9
WC Chemistry, Physical; Environmental Sciences
SC Chemistry; Environmental Sciences & Ecology
GA 770WA
UT WOS:000291118000016
DA 2018-10-20
ER

PT J
AU Cho, YS
   Kim, SK
   Je, JY
AF Cho, Young-Sook
   Kim, Se-Kwon
   Je, Jae-Young
TI Chitosan gallate as potential antioxidant biomaterial
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Chitosan; Gallic acid; Antioxidant activity; ROS; DNA damage
ID LIPID-PEROXIDATION; CARBOXYMETHYL CHITOSAN; DEACETYLATED CHITOSANS;
   HYDROXYL RADICALS; FLUORESCENT-PROBE; DAMAGE; DNA;
   DIPHENYL-1-PYRENYLPHOSPHINE; OXIDATION; CELLS
AB Chitosan gallate were synthesized using a free radical-induced grafting reaction. Chitosan gallate showed enhanced water-solubility compared to plain chitosan, and exhibited good thermal stability. The IC50 value of chitosan gallate against 2,2-diphenyl-1-picrylhydrazyl (DPPH) was 17.86 mu g/mL. In addition, chitosan gallate effectively inhibited the generation of intracellular reactive oxygen species (ROS), and also suppressed lipid peroxidation in RAW264.7 macrophage cells. Chitosan gallate also exhibited the protection effect on genomic DNA damage by induced hydroxyl radical, and up-regulated the protein expression of antioxidant enzymes including superoxide dismutase-1 and glutathione reductase under H2O2-mediated oxidative stress in RAW264.7 macrophage cells. These results indicate that chitosan gallate might be potential antioxidant biomaterials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kim, Se-Kwon] Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
   [Kim, Se-Kwon] Pukyong Natl Univ, Marine Bioproc Res Ctr, Pusan 608737, South Korea.
   [Cho, Young-Sook; Je, Jae-Young] Chonnam Natl Univ, Sch Food Technol & Nutr, Yeosu 550749, South Korea.
RP Kim, SK (reprint author), Pukyong Natl Univ, Dept Chem, Pusan 608737, South Korea.
EM sknkim@pknu.ac.kr; jjy1915@chonnam.ac.kr
RI Kim, Se-Kwon/B-8848-2012
OI Kim, Se-Kwon/0000-0001-6507-9539
CR Blois M. S., 1958, NATURE, V181, P1533
   BOREK C, 1991, FREE RADICAL RES COM, V12-3, P745
   Cheng ZY, 2003, J PHARM SCI-US, V92, P475, DOI 10.1002/jps.10301
   Cho YS, 2011, CARBOHYD POLYM, V83, P1617, DOI 10.1016/j.carbpol.2010.10.019
   Gennaro G, 2007, TOXICOL APPL PHARM, V219, P181
   Guo ZY, 2008, CARBOHYD POLYM, V73, P173, DOI 10.1016/j.carbpol.2007.10.021
   Jeon Y.J., 2001, J CHITIN CHITOSAN, V6, P163
   Jeon YJ, 2001, CARBOHYD POLYM, V44, P71, DOI 10.1016/S0144-8617(00)00200-9
   Kong CS, 2009, FOOD CHEM TOXICOL, V47, P1914, DOI 10.1016/j.fct.2009.05.002
   Lee SO, 2006, J MED FOOD, V9, P594, DOI 10.1089/jmf.2006.9.594
   Martinez GR, 2003, MUTAT RES-REV MUTAT, V544, P115, DOI 10.1016/j.mrrev.2003.05.005
   MILNE L, 1993, ARCH BIOCHEM BIOPHYS, V304, P102, DOI 10.1006/abbi.1993.1327
   Moskovitz L., 2002, ARCH BIOCHEM BIOPHYS, V397, P354
   Okimoto Y, 2000, FEBS LETT, V474, P137, DOI 10.1016/S0014-5793(00)01587-8
   Park PJ, 2004, CARBOHYD POLYM, V55, P17, DOI 10.1016/j.carbpol.2003.05.002
   Park PJ, 2003, J AGR FOOD CHEM, V51, P4930, DOI 10.1021/jf0340557
   ROSEN GM, 1984, METHOD ENZYMOL, V105, P198
   SUGANO M, 1992, ADVANCES IN CHITIN AND CHITOSAN, P472
   Sun T, 2008, BIOORG MED CHEM LETT, V18, P5774, DOI 10.1016/j.bmcl.2008.09.072
   Takahashi M, 2001, FREE RADICAL BIO MED, V31, P164, DOI 10.1016/S0891-5849(01)00575-5
   Xing RE, 2004, CARBOHYD RES, V339, P2515, DOI 10.1016/j.carres.2004.08.013
   You HJ, 2002, BBA-GEN SUBJECTS, V1573, P33, DOI 10.1016/S0304-4165(02)00325-2
   Zhong ZM, 2007, BIOORGAN MED CHEM, V15, P3775, DOI 10.1016/j.bmc.2007.03.036
NR 23
TC 14
Z9 16
U1 3
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD MAY 15
PY 2011
VL 21
IS 10
BP 3070
EP 3073
DI 10.1016/j.bmcl.2011.03.033
PG 4
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA 756OW
UT WOS:000290024200059
PM 21486693
DA 2018-10-20
ER

PT J
AU Sweetman, MJ
   Harding, FJ
   Graney, SD
   Voelcker, NH
AF Sweetman, Martin J.
   Harding, Frances J.
   Graney, Sean D.
   Voelcker, Nicolas H.
TI Effect of oligoethylene glycol moieties in porous silicon surface
   functionalisation on protein adsorption and cell attachment
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Porous silicon; Biomaterial; Hydrosilylation; Oligoethylene glycol; Cell
   culture
ID SELF-ASSEMBLED MONOLAYERS; OLIGO(ETHYLENE OXIDE); PHOTONIC CRYSTALS;
   THIN-FILMS; ACID; HYDROSILYLATION; IMMOBILIZATION; CHEMISTRY; CORROSION;
   ADHESION
AB We report on the synthesis of two carboxy-functional alkene compounds as modifiers of porous silicon (pSi) surface chemistry by means of thermal hydrosilylation. Both alkene compounds have hydrophobic, aliphatic carbon segments, with terminal carboxylic acid functionality appended through a thioether linkage. In one of the alkene linkers, we incorporated a short oligoethylene glycol (OEG) moiety to explore its low-fouling properties when attached to porous silicon. We examined surface stability of the surface-modified porous silicon in aqueous milieu. Albumin and fibronectin were adsorbed and, using carbodiimide chemistry, covalently immobilised to linker-modified porous silicon, and the propensity for mammalian cells to attach to these surfaces investigated. Surface chemistry was characterised by infrared spectroscopy and the stability of porous silicon in an aqueous milieu was investigated by interferometric reflectance spectroscopy (IRS). Surfaces functionalised with the alkene linker containing OEG displayed greater resistance to the adsorption of albumin. This linker also facilitated higher levels of covalent protein immobilisation to the functionalised pSi surface. Higher levels of cell attachment were observed on pSi surfaces with fibronectin covalently immobilised onto the OEG linker, than for fibronectin covalently immobilised on the non-OEG linker. Crown Copyright (C) 2011 Published by Elsevier B. V. All rights reserved.
C1 [Sweetman, Martin J.; Harding, Frances J.; Graney, Sean D.; Voelcker, Nicolas H.] Flinders Univ S Australia, Sch Chem & Phys Sci, Bedford Pk, SA 5042, Australia.
RP Voelcker, NH (reprint author), Flinders Univ S Australia, Sch Chem & Phys Sci, GPO Box 2100, Adelaide, SA 5042, Australia.
EM nico.voelcker@flinders.edu.au
RI Harding, Frances/F-3585-2013; Sweetman, Martin/F-4061-2013; Voelcker,
   Nicolas/D-6199-2012
OI Harding, Frances/0000-0002-9080-5413; Sweetman,
   Martin/0000-0002-9074-2125; Voelcker, Nicolas/0000-0002-1536-7804
FU Australian Research Council; Flinders University
FX Support from the Australian Research Council and Flinders University is
   kindly acknowledged.
CR Anderson AS, 2008, LANGMUIR, V24, P2240, DOI 10.1021/la7033438
   Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Anglin EJ, 2004, LANGMUIR, V20, P11264, DOI 10.1021/la048105t
   Archer M, 2005, SENSOR ACTUAT B-CHEM, V106, P347, DOI 10.1016/j.snb.2004.08.016
   Armarego W. L. F., 1996, PURIFICATION LAB CHE
   Boukherroub R, 2002, J ELECTROCHEM SOC, V149, pH59, DOI 10.1149/1.1432679
   Boukherroub R, 2003, J PHYS CHEM B, V107, P13459, DOI 10.1021/jp036530+
   Britcher L, 2008, LANGMUIR, V24, P7625, DOI 10.1021/la801619v
   Canham L., 1997, PROPERTIES POROUS SI
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Della EW, 2004, J ORG CHEM, V69, P3824, DOI 10.1021/jo0497306
   Gao D. J., 2005, J PHYS CHEM B, V109, P20620
   GIOVANNOZZI AM, 2007, SENSOR ACTUAT B-CHEM, V130, P795
   Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1
   Holzl M, 2007, LANGMUIR, V23, P5571, DOI 10.1021/la0627664
   JANE AO, 2008, P SOC PHOTOOPT I SPI
   Kan PYY, 2005, MAT SCI ENG B-SOLID, V118, P289, DOI 10.1016/j.mseb.2004.12.044
   Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a
   Khung YL, 2008, EXP CELL RES, V314, P789, DOI 10.1016/j.yexcr.2007.10.015
   KILIAN KA, 2007, ADV FUNCT MATER, V17, P7
   Kilian KA, 2007, BIOMATERIALS, V28, P3055, DOI 10.1016/j.biomaterials.2007.03.014
   Li LY, 2005, J PHYS CHEM B, V109, P2934, DOI 10.1021/jp0473321
   Li WK, 2007, COLLOID SURFACE A, V295, P159, DOI 10.1016/j.colsurfa.2006.08.046
   Low SP, 2009, BIOMATERIALS, V30, P2873, DOI 10.1016/j.biomaterials.2009.02.008
   Low SP, 2006, BIOMATERIALS, V27, P4538, DOI 10.1016/j.biomaterials.2006.04.015
   Mayne AH, 2000, PHYS STATUS SOLIDI A, V182, P505, DOI 10.1002/1521-396X(200011)182:1<505::AID-PSSA505>3.0.CO;2-#
   Nakanishi J, 2004, J AM CHEM SOC, V126, P16314, DOI 10.1021/ja044684c
   Orosco MM, 2006, ADV MATER, V18, P1393, DOI 10.1002/adma.200502420
   Osaki T, 2006, J PHYS CHEM B, V110, P12119, DOI 10.1021/jp061022w
   Palestino G, 2008, LANGMUIR, V24, P13765, DOI 10.1021/la8015707
   PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Qiao SZ, 2007, STUD SURF SCI CATAL, V165, P425
   Salakhutdinov I, 2008, J NANOMATER, DOI 10.1155/2008/543170
   Schwartz MP, 2005, PHYS STATUS SOLIDI A, V202, P1380, DOI 10.1002/pssa.200461106
   Sieval AB, 1998, LANGMUIR, V14, P1759, DOI 10.1021/la971139z
   Steinem C, 2004, TETRAHEDRON, V60, P11259, DOI 10.1016/j.tet.2004.06.130
   Stewart MP, 2001, J AM CHEM SOC, V123, P7821, DOI 10.1021/ja011116d
   SWEETMAN MJ, 2008, P SOC PHOTOOPT I SPI
   Torres J, 2008, MICROELECTRON J, V39, P482, DOI 10.1016/j.mejo.2007.07.026
   Vanderah DJ, 2008, LANGMUIR, V24, P826, DOI 10.1021/la7028824
   Voelcker NH, 2008, CHEMBIOCHEM, V9, P1776, DOI 10.1002/cbic.200800119
   Voicu R, 2004, LANGMUIR, V20, P11713, DOI 10.1021/la047886v
   Wadu-Mesthrige K, 2000, SCANNING, V22, P380
   Xia B, 2006, J MATER CHEM, V16, P570, DOI 10.1039/b511175g
   Xia B, 2005, CHEM LETT, V34, P226, DOI 10.1246/cl.2005.226
   XU D, 2002, NEW J CHEM, V27, P300
   Yam CM, 2004, CHEM COMMUN, P2510, DOI 10.1039/b401499e
NR 49
TC 20
Z9 20
U1 0
U2 23
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD MAY 15
PY 2011
VL 257
IS 15
BP 6768
EP 6774
DI 10.1016/j.apsusc.2011.02.122
PG 7
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 749ZN
UT WOS:000289512500071
DA 2018-10-20
ER

PT J
AU Potta, T
   Chun, C
   Song, SC
AF Potta, Thrimoorthy
   Chun, ChangJu
   Song, Soo-Chang
TI Design of Polyphosphazene Hydrogels with Improved Structural Properties
   by Use of Star-Shaped Multithiol Crosslinkers
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE biodegradable; crosslinking; hydrogels; mechanical properties; thermal
   properties
ID ALGINATE; LINKING; BIOMATERIAL; COPOLYMER; STIFFNESS; SYSTEM
AB The feasibility of using a star-shaped crosslinker to produce a hydrogel with controlled mechanical properties and degradation rates was investigated. The aqueous blends of functional polymers and crosslinkers formed a solution at low temperature and a hydrogel with desired mechanical properties at body temperature. The introduction of star-shaped crosslinkers affected the microscopic and macroscopic properties of the hydrogel. The fabricated hydrogels could be suitable for many potential biomedical applications because of their injectability, tunable mechanical properties, controlled degradation rate and gel formation under physiological conditions.
C1 [Potta, Thrimoorthy; Chun, ChangJu; Song, Soo-Chang] Korea Inst Sci & Technol, Div Life & Hlth Sci, Seoul 136791, South Korea.
   [Potta, Thrimoorthy] Univ Sci & Technol, Dept Biomol Sci, Taejon 305333, South Korea.
RP Song, SC (reprint author), Korea Inst Sci & Technol, Div Life & Hlth Sci, Seoul 136791, South Korea.
EM scsong@kist.re.kr
RI Potta, Thrimoorthy/H-6687-2012
OI Song, Soo-Chang/0000-0001-9344-0686; CHUN, CHANGJU/0000-0002-2452-6184
FU Ministry of Education, Science and Technology in Korea
FX This research was supported by the Ministry of Education, Science and
   Technology in Korea.
CR Bromberg L, 1999, LANGMUIR, V15, P8633, DOI 10.1021/la990946q
   Cellesi F, 2004, BIOMATERIALS, V25, P5115, DOI 10.1016/j.biomaterials.2003.12.015
   Cuggino JC, 2008, EUR POLYM J, V44, P3548, DOI 10.1016/j.eurpolymj.2008.09.010
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Eiselt P, 1999, MACROMOLECULES, V32, P5561, DOI 10.1021/ma990514m
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gomez CG, 2001, J APPL POLYM SCI, V79, P920
   Greenstein J.D., 1961, CHEM AMINO ACIDS, P925
   Gupta P, 2002, DRUG DISCOV TODAY, V7, P569, DOI 10.1016/S1359-6446(02)02255-9
   Hild G, 1998, PROG POLYM SCI, V23, P1019, DOI 10.1016/S0079-6700(97)00055-5
   Jin R, 2007, BIOMATERIALS, V28, P2791, DOI 10.1016/j.biomaterials.2007.02.032
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Lee BH, 2006, BIOMACROMOLECULES, V7, P2059, DOI 10.1021/bm060211h
   Lee KY, 2000, MACROMOLECULES, V33, P4291, DOI 10.1021/ma9921347
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.08.014, 10.1016/j.biomaterials.2003.10.092]
   Lutolf MP, 2003, BIOMACROMOLECULES, V4, P713, DOI 10.1021/bm025744e
   Mironov V, 2005, BIOMATERIALS, V26, P7628, DOI 10.1016/j.biomaterials.2005.05.061
   Nicolau PJ, 2007, PLAST RECONSTR SURG, V119, P2271, DOI 10.1097/01.prs.0000260710.30934.a1
   Potta T, 2010, BIOMATERIALS, V31, P8107, DOI 10.1016/j.biomaterials.2010.07.029
   Potta T, 2010, BIOMACROMOLECULES, V11, P1741, DOI 10.1021/bm100197y
   Potta T, 2009, BIOMATERIALS, V30, P6178, DOI 10.1016/j.biomaterials.2009.08.015
   Qingpu H., 2004, J MATER CHEM, V14, P1915
   Robb SA, 2007, BIOMACROMOLECULES, V8, P2294, DOI 10.1021/bm070267r
   Shapira-Schweitzer K, 2007, ACTA BIOMATER, V3, P33, DOI 10.1016/j.actbio.2006.09.003
   SOHN YS, 1995, MACROMOLECULES, V28, P7566, DOI 10.1021/ma00126a039
   Song R, 2005, J CONTROL RELEASE, V105, P142, DOI 10.1016/j.jconrel.2005.03.016
   Song SC, 1999, MACROMOLECULES, V32, P2188, DOI 10.1021/ma981190p
   Yu HQ, 2006, SOFT MATTER, V2, P343, DOI 10.1039/b517206c
NR 29
TC 6
Z9 6
U1 1
U2 26
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD MAY 12
PY 2011
VL 11
IS 5
BP 689
EP 699
DI 10.1002/mabi.201000438
PG 11
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 761ZY
UT WOS:000290443200013
PM 21448917
DA 2018-10-20
ER

PT J
AU Kim, SP
   Yang, JY
   Kang, MY
   Park, JC
   Nam, SH
   Friedman, M
AF Kim, Sung Phil
   Yang, Jun Young
   Kang, Mi Young
   Park, Jun Cheol
   Nam, Seok Hyun
   Friedman, Mendel
TI Composition of Liquid Rice Hull Smoke and Anti-inflammatory Effects in
   Mice
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE liquid rice hull smoke; composition; GC/MS; cytokines; edema;
   histochemistry; immunochemistry; inflammation; mice feeding; food
   quality; food safety
ID POLYCYCLIC AROMATIC-HYDROCARBONS; RAW 264.7 CELLS;
   LISTERIA-MONOCYTOGENES; ANTIOXIDANT ACTIVITY; INFLAMMATION; SALMON;
   PRODUCTS; EXTRACTS; FILLETS; ASSAYS
AB A new liquid rice hull smoke extract with a smoky aroma and sugar-like odor prepared by pyrolysis of rice hulls followed by liquefaction of the resulting smoke contained 161 compounds characterized by GC/MS. Antioxidative, antiallergic, and anti-inflammatory activities of the extract were assessed in vitro and in vivo. At pH 5, the extract inhibited 1-dipheny1-2-picrylhydrazyl (DPPH) free radicals and suppressed nitric oxide (NO) and beta-hexosaminidase releases from lipopolysaccharide (LPS)-induced RAW264.7 mouse macrophage leukemia cells and ionophore A23187-stimulated RBL-2H3 rat basophilic cells without significant cytotoxicity. 12-O-Tetradecanolylphorbol-13-acetate (TPA) was applied to the ears of CD-1 mice to induce inflammation (edema), which was accompanied by increases in a series of biomarkers. Topical application of 1% of the extract as well as feeding mice a standard diet with 1% extract for two weeks significantly reduced the expression of biomarkers associated with the TPA-induced inflammation. These include tumor necrosis factor-alpha (TNF-alpha), IL-1 beta, interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6), leukotriene B-4 (LTB4), prostaglandin E-2 (PGE(2)), myeloperoxidase (MPO). These in vitro and in vivo findings demonstrate the potential value of rice hull smoke extract derived from a major agricultural byproduct to serve as a new biomaterial for the improvement of food quality and safety and the environment.
C1 [Yang, Jun Young; Nam, Seok Hyun] Ajou Univ, Dept Biol Sci, Suwon 443749, South Korea.
   [Kim, Sung Phil] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea.
   [Kang, Mi Young] Kyungpook Natl Univ, Dept Food Sci & Nutr, Taegu 702701, South Korea.
   [Park, Jun Cheol] Rural Dev Adm, Natl Inst Anim Sci, Suwon 441706, South Korea.
   [Friedman, Mendel] ARS, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
RP Nam, SH (reprint author), Ajou Univ, Dept Biol Sci, Suwon 443749, South Korea.
EM shnam@ajou.ac.kr; Mendel.Friedman@ars.usda.gov
OI Friedman, Mendel/0000-0003-2582-7517
FU Rural Development Administration, Republic of Korea [200901OFT113068122]
FX This research received grant support from the Agenda Program (No.
   200901OFT113068122), Rural Development Administration, Republic of
   Korea.
CR ASITA AO, 1990, LETT APPL MICROBIOL, V10, P93, DOI 10.1111/j.1472-765X.1990.tb00273.x
   Bigby TD, 2002, MOL PHARMACOL, V62, P200, DOI 10.1124/mol.62.2.200
   Bralley E. E., 2008, J INFLAMM-LOND, V5, P1, DOI DOI 10.1186/1476-9255-5-1
   Cadwallader K. R., 2007, Handbook of meat, poultry and seafood quality, P201, DOI 10.1002/9780470277829.ch15
   Cavin A, 1998, PLANTA MED, V64, P393, DOI 10.1055/s-2006-957466
   Choi SP, 2007, J FOOD SCI, V72, pS719, DOI 10.1111/j.1750-3841.2007.00562.x
   Choi SP, 2010, J AGR FOOD CHEM, V58, P10007, DOI 10.1021/jf102224b
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Duggan KC, 2010, METHODS MOL BIOL, V644, P55, DOI 10.1007/978-1-59745-364-6_6
   Estrada-Munoz R, 1998, J FOOD SCI, V63, P150, DOI 10.1111/j.1365-2621.1998.tb15697.x
   FAITH NG, 1992, J FOOD SAFETY, V12, P303, DOI 10.1111/j.1745-4565.1992.tb00086.x
   FAOSTAT, 2010, FOOD AGR ORG UN PREL
   Foo KY, 2009, ADV COLLOID INTERFAC, V152, P39, DOI 10.1016/j.cis.2009.09.005
   Garabal JI, 2010, J DAIRY SCI, V93, P1868, DOI 10.3168/jds.2009-2749
   Guillen MD, 2007, J DAIRY SCI, V90, P2717, DOI 10.3168/jds.2006-452
   Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006
   Huang MH, 2011, FOOD CHEM, V126, P1655, DOI 10.1016/j.foodchem.2010.12.049
   Huang MT, 2006, MOL NUTR FOOD RES, V50, P115, DOI 10.1002/mnfr.200500101
   James MJ, 2000, AM J CLIN NUTR, V71, p343S, DOI 10.1093/ajcn/71.1.343s
   Jeong HJ, 2002, CELL SIGNAL, V14, P633, DOI 10.1016/S0898-6568(02)00005-0
   JODAI S, 1989, MOKUZAI GAKKAISHI, V35, P555
   Kim Y., 2001, J KOREAN SOC AGR CHE, V44, P262
   Koh YJ, 2010, J MED FOOD, V13, P870, DOI 10.1089/jmf.2009.1249
   MAGA J A, 1987, Food Reviews International, V3, P139
   MAGA JA, 1986, J AGR FOOD CHEM, V34, P249, DOI 10.1021/jf00068a023
   Martinez O, 2010, LWT-FOOD SCI TECHNOL, V43, P910, DOI 10.1016/j.lwt.2010.01.026
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Murakami A, 1999, J AGR FOOD CHEM, V47, P333, DOI 10.1021/jf980523e
   Murakawa M, 2006, BIOCHEM PHARMACOL, V71, P1331, DOI 10.1016/j.bcp.2006.01.005
   Niedziela JC, 1998, FOOD SCI TECHNOL-LEB, V31, P155, DOI 10.1006/fstl.1997.0333
   Olsen E, 2005, J AGR FOOD CHEM, V53, P7448, DOI 10.1021/jf050886w
   RAO TS, 1993, INFLAMMATION, V17, P723, DOI 10.1007/BF00920477
   Roda A, 1999, J SCI FOOD AGR, V79, P58, DOI 10.1002/(SICI)1097-0010(199901)79:1<58::AID-JSFA174>3.3.CO;2-S
   Salanti A, 2010, J AGR FOOD CHEM, V58, P10049, DOI 10.1021/jf102188k
   Schwanke SK IW, 1995, J FOOD LIPIDS, V2, P239, DOI 10.1111/j.1745-4522.1995.tb00046.x
   Soldera S, 2008, J AGR FOOD CHEM, V56, P2727, DOI 10.1021/jf072117d
   Sunen E, 1998, LETT APPL MICROBIOL, V27, P45, DOI 10.1046/j.1472-765X.1998.00387.x
   Sunen E, 2001, FOOD MICROBIOL, V18, P387, DOI 10.1006/fmic.2001.0411
   U.S. Dept. of Commerce, 2005, NIST EPA NIH NIST 05
   Varlet V, 2007, J SCI FOOD AGR, V87, P847, DOI 10.1002/jsfa.2786
   Visciano P, 2006, J FOOD PROTECT, V69, P1134, DOI 10.4315/0362-028X-69.5.1134
NR 41
TC 25
Z9 25
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD MAY 11
PY 2011
VL 59
IS 9
BP 4570
EP 4581
DI 10.1021/jf2003392
PG 12
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 757WX
UT WOS:000290120400032
PM 21438497
DA 2018-10-20
ER

PT J
AU Godier-Furnemont, AFG
   Martens, TP
   Koeckert, MS
   Wan, L
   Parks, J
   Arai, K
   Zhang, GP
   Hudson, B
   Homma, S
   Vunjak-Novakovic, G
AF Godier-Furnemont, Amandine F. G.
   Martens, Timothy P.
   Koeckert, Michael S.
   Wan, Leo
   Parks, Jonathan
   Arai, Kotaro
   Zhang, Geping
   Hudson, Barry
   Homma, Shunichi
   Vunjak-Novakovic, Gordana
TI Composite scaffold provides a cell delivery platform for cardiovascular
   repair
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE biomaterial; cardiac repair; human stem cell; cardiac patch
ID MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; ENGINEERED
   HEART-TISSUE; HUMAN BONE-MARROW; CARDIAC MYOCYTES; PROGENITOR CELLS;
   TGF-BETA; REGENERATION; EXPRESSION; THERAPY
AB Control over cell engraftment, survival, and function remains critical for heart repair. We have established a tissue engineering platform for the delivery of human mesenchymal progenitor cells (MPCs) by a fully biological composite scaffold. Specifically, we developed a method for complete decellularization of human myocardium that leaves intact most elements of the extracellular matrix, as well as the underlying mechanical properties. A cell-matrix composite was constructed by applying fibrin hydrogel with suspended cells onto decellularized sheets of human myocardium. We then implanted this composite onto the infarct bed in a nude rat model of cardiac infarction. We next characterized the myogenic and vasculogenic potential of immunoselected human MPCs and demonstrated that in vitro conditioning with a low concentration of TGF-beta promoted an arteriogenic profile of gene expression. When implanted by composite scaffold, preconditioned MPCs greatly enhanced vascular network formation in the infarct bed by mechanisms involving the secretion of paracrine factors, such as SDF-1, and the migration of MPCs into ischemic myocardium, but not normal myocardium. Echocardiography demonstrated the recovery of baseline levels of left ventricular systolic dimensions and contractility when MPCs were delivered via composite scaffold. This adaptable platform could be readily extended to the delivery of other reparative cells of interest and used in quantitative studies of heart repair.
C1 [Godier-Furnemont, Amandine F. G.; Martens, Timothy P.; Koeckert, Michael S.; Wan, Leo; Parks, Jonathan; Vunjak-Novakovic, Gordana] Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
   [Martens, Timothy P.; Zhang, Geping; Hudson, Barry] Columbia Univ, Med Ctr, Dept Surg, New York, NY 10032 USA.
   [Arai, Kotaro; Homma, Shunichi] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, New York, NY 10032 USA.
EM gv2131@columbia.edu
RI Wan, Leo/G-6145-2010; vunjak-novakovic, gordana/J-9279-2012
OI Hudson, Barry/0000-0001-7647-8121; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574; Koeckert, Michael/0000-0001-8253-4142
FU National Institutes of Health [HL076485, EB002520, HL076485-04S1]
FX We thank Angioblast Systems for providing human MPCs through a material
   transfer agreement with Columbia University and Ann Marie Schmidt for
   her insightful suggestions. This work was supported by National
   Institutes of Health Grants HL076485 and EB002520 (to G.V.-N.) and
   HL076485-04S1 (to A.G.-F.).
CR Arts T, 2001, AM J PHYSIOL-HEART C, V280, pH2222
   Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8
   Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273
   Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611
   Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680
   Chachques JC, 2008, ANN THORAC SURG, V85, P901, DOI 10.1016/j.athoracsur.2007.10.052
   De Visscher G, 2010, BIOMATERIALS, V31, P20, DOI 10.1016/j.biomaterials.2009.09.016
   Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106
   Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Gilbert TW, 2008, J SURG RES, V147, P61, DOI 10.1016/j.jss.2007.04.035
   Gilbert TW, 2007, J BONE JOINT SURG AM, V89A, P621, DOI 10.2106/JBJS.F.00742
   Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com
   Gronthos S, 2007, STEM CELLS DEV, V16, P953, DOI 10.1089/scd.2007.0069
   Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036
   Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742
   Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171
   HOU D, 2005, CIRCULATION S1, V112, P150
   Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451
   Jakab K, 2008, TISSUE ENG PT A, V14, P413, DOI 10.1089/tea.2007.0173
   Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036
   Lee BC, 2009, EUR J HEART FAIL, V11, P238, DOI 10.1093/eurjhf/hfn035
   Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706
   Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912
   Martens Timothy P, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS18, DOI 10.1038/ncpcardio0404
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Meyer GP, 2006, CIRCULATION, V113, P1287, DOI 10.1161/CIRCULATIONAHA.105.575118
   Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002
   Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446
   Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040
   Penn MS, 2009, CIRC RES, V104, P1133, DOI 10.1161/CIRCRESAHA.109.198929
   Psaltis PJ, 2010, J CELL PHYSIOL, V223, P530, DOI 10.1002/jcp.22081
   PSALTIS PJ, 2009, THESIS U ADELAIDE AD
   Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   Robinson KA, 2005, CIRCULATION, V112, pI135
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186
   See F, 2011, J CELL MOL MED, V15, P2117, DOI 10.1111/j.1582-4934.2010.01241.x
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723
   Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894
   Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
NR 48
TC 153
Z9 159
U1 3
U2 98
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 10
PY 2011
VL 108
IS 19
BP 7974
EP 7979
DI 10.1073/pnas.1104619108
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 761YN
UT WOS:000290439500064
PM 21508321
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Llopis-Hernandez, V
   Rico, P
   Ballester-Beltran, J
   Moratal, D
   Salmeron-Sanchez, M
AF Llopis-Hernandez, Virginia
   Rico, Patricia
   Ballester-Beltran, Jose
   Moratal, David
   Salmeron-Sanchez, Manuel
TI Role of Surface Chemistry in Protein Remodeling at the Cell-Material
   Interface
SO PLOS ONE
LA English
DT Article
ID FOCAL ADHESION KINASE; SELF-ASSEMBLED MONOLAYERS; SUBSTRATUM-BOUND
   FIBRONECTIN; MATRIX METALLOPROTEINASES; BIOMATERIAL INTERACTIONS;
   OSTEOBLASTIC CELLS; INTEGRIN BINDING; ADSORPTION; DIFFERENTIATION;
   MIGRATION
AB Background: The cell-material interaction is a complex bi-directional and dynamic process that mimics to a certain extent the natural interactions of cells with the extracellular matrix. Cells tend to adhere and rearrange adsorbed extracellular matrix (ECM) proteins on the material surface in a fibril-like pattern. Afterwards, the ECM undergoes proteolytic degradation, which is a mechanism for the removal of the excess ECM usually approximated with remodeling. ECM remodeling is a dynamic process that consists of two opposite events: assembly and degradation.
   Methodology/Principal Findings: This work investigates matrix protein dynamics on mixed self-assembled monolayers (SAMs) of -OH and -CH3 terminated alkanethiols. SAMs assembled on gold are highly ordered organic surfaces able to provide different chemical functionalities and well-controlled surface properties. Fibronectin (FN) was adsorbed on the different surfaces and quantified in terms of the adsorbed surface density, distribution and conformation. Initial cell adhesion and signaling on FN-coated SAMs were characterized via the formation of focal adhesions, integrin expression and phosphorylation of FAKs. Afterwards, the reorganization and secretion of FN was assessed. Finally, matrix degradation was followed via the expression of matrix metalloproteinases MMP2 and MMP9 and correlated with Runx2 levels. We show that matrix degradation at the cell material interface depends on surface chemistry in MMP-dependent way.
   Conclusions/Significance: This work provides a broad overview of matrix remodeling at the cell-material interface, establishing correlations between surface chemistry, FN adsorption, cell adhesion and signaling, matrix reorganization and degradation. The reported findings improve our understanding of the role of surface chemistry as a key parameter in the design of new biomaterials. It demonstrates the ability of surface chemistry to direct proteolytic routes at the cell-material interface, which gains a distinct bioengineering interest as a new tool to trigger matrix degradation in different biomedical applications.
C1 [Llopis-Hernandez, Virginia; Rico, Patricia; Ballester-Beltran, Jose; Moratal, David; Salmeron-Sanchez, Manuel] Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain.
   [Rico, Patricia; Salmeron-Sanchez, Manuel] CIBER Bioingn Biomat & Nanomed CIBER BBN, Valencia, Spain.
   [Salmeron-Sanchez, Manuel] Ctr Invest Principe Felipe, Regenerat Med Unit, Valencia, Spain.
RP Llopis-Hernandez, V (reprint author), Univ Politecn Valencia, Ctr Biomat & Tissue Engn, E-46071 Valencia, Spain.
EM masalsan@fis.upv.es
RI Rico, Patricia/N-2540-2014; Salmeron-Sanchez, Manuel/E-4680-2010;
   Moratal, David/D-1853-2010
OI Rico, Patricia/0000-0002-4918-9313; Salmeron-Sanchez,
   Manuel/0000-0002-8112-2100; Moratal, David/0000-0002-2825-3646;
   BALLESTER-BELTRAN, JOSE/0000-0002-3287-2925
FU Spanish Ministry of Science and Innovation [MAT2009-14440-C02-01];
   Instituto de Salud Carlos III; Conselleria de Sanidad (Generalitat
   Valenciana)
FX The support of the Spanish Ministry of Science and Innovation through
   project MAT2009-14440-C02-01 is acknowledged. CIBER-BBN is an initiative
   funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010,
   Consolider Program, CIBER Actions and financed by the Instituto de Salud
   Carlos III with assistance from the European Regional Development Fund.
   This work was supported by funds for research in the field of
   Regenerative Medicine through the collaboration agreement from the
   Conselleria de Sanidad (Generalitat Valenciana), and the Instituto de
   Salud Carlos III. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366
   Altankov G, 1997, J BIOMAT SCI-POLYM E, V8, P721, DOI 10.1163/156856297X00524
   Altankov G, 1996, J MATER SCI-MATER M, V7, P425, DOI 10.1007/BF00122012
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   AVNUR Z, 1981, CELL, V25, P121, DOI 10.1016/0092-8674(81)90236-1
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Bott K, 2010, BIOMATERIALS, V31, P8454, DOI 10.1016/j.biomaterials.2010.07.046
   BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273
   CARINO AC, 2005, J CELL BIOL, V169, P977
   Cary LA, 1996, J CELL SCI, V109, P1787
   ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403
   Chung AS, 2009, J BIOMED MATER RES A, V91A, P742, DOI 10.1002/jbm.a.32259
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084
   Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793
   Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gonzalez-Garcia C, 2010, COLLOID SURFACE B, V77, P181, DOI 10.1016/j.colsurfb.2010.01.021
   Griffin L, 2002, SCIENCE, V259, P1009
   GRINNELL F, 1986, J CELL BIOL, V103, P2697, DOI 10.1083/jcb.103.6.2697
   Gugutkov D, 2009, LANGMUIR, V25, P10893, DOI 10.1021/la9012203
   Hayami T, 2008, MATRIX BIOL, V27, P682, DOI 10.1016/j.matbio.2008.07.005
   Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200
   Heymans S, 2006, CIRCULATION, V114, P565, DOI 10.1161/CIRCULATIONAHA.105.591032
   Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Ilic Dusko, 1995, Nature (London), V377, P539
   Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459
   Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Martins MCL, 2003, J BIOMED MATER RES A, V67A, P158, DOI 10.1002/jbm.a.10096
   MCCLARY, 2000, J BIOMED MATER RES A, V50, P428
   Michael KE, 2003, LANGMUIR, V19, P8033, DOI 10.1021/la034810a
   Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076
   MITRA SK, 2005, NAT REV MOL CELL BIO, V5, P56
   Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949
   Monchaux Emmanuelle, 2010, Front Biosci (Schol Ed), V2, P239
   Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125
   Palacio MLB, 2011, J R SOC INTERFACE, V8, P630, DOI 10.1098/rsif.2010.0557
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Pompe T, 2005, EUR BIOPHYS J BIOPHY, V34, P1049, DOI 10.1007/s00249-005-0490-z
   Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   REISENAWER A, 2007, BIOL CHEM, V288, P639
   Reiske HR, 1999, J BIOL CHEM, V274, P12361, DOI 10.1074/jbc.274.18.12361
   Rico P, 2009, TISSUE ENG PT A, V15, P3271, DOI [10.1089/ten.tea.2009.0141, 10.1089/ten.TEA.2009.0141]
   Rodrigues SN, 2006, BIOMATERIALS, V27, P5357, DOI 10.1016/j.biomaterials.2006.06.010
   Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680
   Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Shin H, 2007, BIOMATERIALS, V28, P126, DOI 10.1016/j.biomaterials.2006.08.007
   Sieg DJ, 2000, NAT CELL BIOL, V2, P249
   Spie J, 2002, ANN NY ACAD SCI, V961, P1
   Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200
   Tzoneva R, 2002, J MATER SCI-MATER M, V13, P1235, DOI 10.1023/A:1021131113711
   Uchida M, 2000, J CELL PHYSIOL, V185, P207, DOI 10.1002/1097-4652(200011)185:2<207::AID-JCP5>3.0.CO;2-J
   UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039
   WAN R, 2009, TOXICOLOGY APPL PHAR, V233, P276
   Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198
   Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010
   Yang CM, 2004, J BIOL CHEM, V279, P22158, DOI 10.1074/jbc.M401343200
   Zambuzzi WF, 2009, J MOL HISTOL, V40, P301, DOI 10.1007/s10735-009-9241-2
   Zhao JH, 1998, J CELL BIOL, V143, P1997, DOI 10.1083/jcb.143.7.1997
NR 71
TC 42
Z9 42
U1 3
U2 44
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 9
PY 2011
VL 6
IS 5
AR e19610
DI 10.1371/journal.pone.0019610
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 761GX
UT WOS:000290386800023
PM 21573010
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bighamsadegh, A
   Mohammad, S
   Shafieisarvestani, Z
AF Bighamsadegh, A.
   Mohammad, S.
   Shafieisarvestani, Z.
TI Bovine fetal growth plate powder as a new osteoinduction biomaterial
SO BONE
LA English
DT Meeting Abstract
CT 3rd Joint Meeting of the
   European-Calcified-Tissue-Society/International-Bone-and-Mineral-Society
CY MAY 07-11, 2011
CL Athens, GREECE
SP European Calcified Tissue Soc, Int Bone & Mineral Soc
C1 [Bighamsadegh, A.] Shahrekord Univ, Dept Vet Surg & Radiol, Shahrekord, Iran.
   [Shafieisarvestani, Z.] Shiraz Univ, Shiraz, Iran.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD MAY 7
PY 2011
VL 48
SU 2
BP S106
EP S106
DI 10.1016/j.bone.2011.03.167
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 754TJ
UT WOS:000289879800146
DA 2018-10-20
ER

PT J
AU Palacio, MLB
   Schricker, SR
   Bhushan, B
AF Palacio, Manuel L. B.
   Schricker, Scott R.
   Bhushan, Bharat
TI Bioadhesion of various proteins on random, diblock and triblock
   copolymer surfaces and the effect of pH conditions
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE block copolymers; atomic force microscopy; protein adhesion
ID SILICON-BASED SURFACES; CLICK CHEMISTRY; RAFT POLYMERIZATION; NANOSCALE
   ADHESION; ALBUMIN ADSORPTION; BLOCK-COPOLYMERS; BLOOD-PLASMA;
   FIBRONECTIN; BIOMOLECULES; BINDING
AB The adhesive interactions of block copolymers composed of poly(methyl methacrylate) (PMMA)/poly(acrylic acid) (PAA) and poly(methyl methacrylate)/poly(2-hydroxyethyl methacrylate) (PHEMA) with the proteins fibronectin, bovine serum albumin and collagen were studied by atomic force microscopy. Adhesion experiments were performed both at physiological pH and at a slightly more acidic condition (pH 6.2) to model polymer-protein interactions under inflammatory or infectious conditions. The PMMA/PAA block copolymers were found to be more sensitive to the buffer environment than PMMA/PHEMA owing to electrostatic interactions between the ionized acrylate groups and the proteins. It was found that random, diblock and triblock copolymers exhibit distinct adhesion profiles although their chemical compositions are identical. This implies that biomaterial nanomorphology can be used to control protein-polymer interactions and potentially cell adhesion.
C1 [Schricker, Scott R.] Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
   [Palacio, Manuel L. B.; Bhushan, Bharat] Ohio State Univ, Coll Dent, Nanoprobe Lab Bio & Nanotechnol & Biomimet, Columbus, OH 43210 USA.
RP Schricker, SR (reprint author), Ohio State Univ, Coll Dent, Restorat & Prosthet Dent Sect, Columbus, OH 43210 USA.
EM schricker.1@osu.edu; bhushan.2@osu.edu
RI Bhushan, Bharat/A-9684-2013; Schricker, Scott/A-3957-2008
OI Bhushan, Bharat/0000-0001-7161-6601; Schricker,
   Scott/0000-0003-1982-1282
CR Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Bhushan B, 2005, ACTA BIOMATER, V1, P327, DOI 10.1016/j.actbio.2005.01.002
   Bhushan B, 2006, ACTA BIOMATER, V2, P39, DOI 10.1016/j.actbio.2005.08.010
   Bhushan B., 2008, NANOTRIBOLOGY NANOME
   Bhushan B., 2010, SPRINGER HDB NANOTEC
   Bhushan B, 2009, J R SOC INTERFACE, V6, P719, DOI 10.1098/rsif.2008.0398
   BOISSONVIDAL C, 1991, J BIOMED MATER RES, V25, P67, DOI 10.1002/jbm.820250106
   BOUGHTON BJ, 1984, BIOCHEM BIOPH RES CO, V119, P1174, DOI 10.1016/0006-291X(84)90899-4
   Bromberg L, 2004, INT J PHARM, V282, P45, DOI 10.1016/j.ijpharm.2004.05.030
   Castro LBR, 2006, LANGMUIR, V22, P3757, DOI 10.1021/la053080z
   de Giglio E, 2010, J BIOACT COMPAT POL, V25, P374, DOI 10.1177/0883911510372290
   De P, 2008, BIOMACROMOLECULES, V9, P1064, DOI 10.1021/bm701255v
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Ge SR, 1998, J BIOMAT SCI-POLYM E, V9, P131
   Gondi SR, 2007, MACROMOLECULES, V40, P474, DOI 10.1021/ma061959v
   Huang K, 2002, BIOMACROMOLECULES, V3, P397, DOI 10.1021/bm015650p
   Ibrahim S, 2010, LANGMUIR, V26, P2119, DOI 10.1021/la902677e
   Katti K.S., 2006, AM J BIOCH BIOTECHNO, V2, P73, DOI DOI 10.3844/AJBBSP.2006.73.79
   Klueh U, 2001, J BIOMED MATER RES, V56, P307, DOI 10.1002/1097-4636(20010905)56:3<307::AID-JBM1099>3.3.CO;2-N
   Martz EO, 1997, J BIOMED MATER RES, V38, P267, DOI 10.1002/(SICI)1097-4636(199723)38:3<267::AID-JBM12>3.0.CO;2-8
   McFarland CD, 1998, J BIOMAT SCI-POLYM E, V9, P1227, DOI 10.1163/156856298X00749
   MILLER DC, 2006, J BIOMED MATER RES A, V81, P678, DOI DOI 10.1002/JBM.A.31093
   NEWTON AV, 1966, NATURE, V209, P1146, DOI 10.1038/2091146a0
   Nicolson PC, 2001, BIOMATERIALS, V22, P3273, DOI 10.1016/S0142-9612(01)00165-X
   NIMERI G, 1994, J BIOMAT SCI-POLYM E, V6, P573, DOI 10.1163/156856294X00527
   Orefice R, 2009, J BIOMED MATER RES A, V90A, P114, DOI 10.1002/jbm.a.32080
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Palacio M, 2010, J MICROSC-OXFORD, V240, P239, DOI 10.1111/j.1365-2818.2010.03420.x
   Ranjan R, 2007, MACROMOL RAPID COMM, V28, P2084, DOI 10.1002/marc.200700428
   Ranjan R, 2007, MACROMOLECULES, V40, P6217, DOI 10.1021/ma0705873
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   SANDERS KJ, 1988, ORGANIC POLYM CHEM
   Schricker S, 2010, ULTRAMICROSCOPY, V110, P639, DOI 10.1016/j.ultramic.2010.02.025
   SMITH BAH, 1993, J BIOMED MATER RES, V27, P89, DOI 10.1002/jbm.820270112
   Snellings GMBF, 2000, ADV MATER, V12, P1959, DOI 10.1002/1521-4095(200012)12:24<1959::AID-ADMA1959>3.3.CO;2-M
   Sperling Leslie H., 2001, INTRO PHYS POLYM SCI
   Turbill P, 1996, BIOMATERIALS, V17, P1279, DOI 10.1016/0142-9612(96)88673-X
   Veiseh M, 2002, LANGMUIR, V18, P6671, DOI 10.1021/la025529j
   VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5
   Yang X., 1998, BIORELATED POLYM GEL
   Zhu J, 2007, POLYMER, V48, P6992, DOI 10.1016/j.polymer.2007.10.004
NR 42
TC 21
Z9 21
U1 0
U2 20
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD MAY 6
PY 2011
VL 8
IS 58
BP 630
EP 640
DI 10.1098/rsif.2010.0557
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 752EH
UT WOS:000289671700002
PM 21147831
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Lee, H
   Yeo, M
   Ahn, S
   Kang, DO
   Jang, CH
   Lee, H
   Park, GM
   Kim, GH
AF Lee, Hyeongjin
   Yeo, Myunggu
   Ahn, SeungHyun
   Kang, Dong-Oan
   Jang, Chul Ho
   Lee, Haengnam
   Park, Gil-Moon
   Kim, Geun Hyung
TI Designed hybrid scaffolds consisting of polycaprolactone microstrands
   and electrospun collagen-nanofibers for bone tissue regeneration
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE nanomaterials/nanophase; biomaterials availability; cell proliferation
ID COMPOSITE SCAFFOLDS; BIOMATERIALS; MORPHOLOGY; PHOSPHATE;
   OSTEOINDUCTION; PROLIFERATION; OSTEOGENESIS; FABRICATION; CELLS
AB Biomedical scaffolds used in bone tissue engineering should have various properties including appropriate bioactivity, mechanical strength, and morphologically optimized pore structures. Collagen has been well known as a good biomaterial for various types of tissue regeneration, but its usage has been limited due to its low mechanical property and rapid degradation. In this work, a new hybrid scaffold consisting of polycaprolactone (PCL) and collagen is proposed for bone tissue regeneration. The PCL enhances the mechanical properties of the hybrid scaffold and controls the pore structure. Layered collagen nanofibers were used to enhance the initial cell attachment and proliferation. The results showed that the hybrid scaffold yielded better mechanical properties of pure PCL scaffold as well as enhanced biological activity than the pure PCL scaffold did. The effect of pore size on bone regeneration was investigated using two hybrid scaffolds with pore sizes of 200 +/- 20 and 300 +/- 27 pm. After post-seeding for 7 days, the cell proliferation with pore size, 200 +/- 20 pm, was greater than that with pore size, 300 +/- 27 pm, due to the high surface area of the scaffold. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 97B: 263-270, 2011.
C1 [Lee, Hyeongjin; Yeo, Myunggu; Ahn, SeungHyun; Lee, Haengnam; Park, Gil-Moon; Kim, Geun Hyung] Chosun Univ, Bio Nanofluid Lab, Dept Mech Engn, Kwangju 501759, South Korea.
   [Kang, Dong-Oan] Chosun Univ, Sch Dent, Dept Prosthodont, Kwangju 501759, South Korea.
   [Kang, Dong-Oan] Chonnam Natl Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kwangju, South Korea.
RP Kim, GH (reprint author), Chosun Univ, Bio Nanofluid Lab, Dept Mech Engn, Kwangju 501759, South Korea.
EM gkim@chosun.ac.kr
OI Jang, Chul Ho/0000-0003-4084-2301
CR Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6
   Claase MB, 2003, J BIOMED MATER RES A, V64A, P291, DOI 10.1002/jbm.a.10418
   Cyster LA, 2005, BIOMATERIALS, V26, P697, DOI 10.1016/j.biomaterials.2004.03.017
   Dalton PD, 2009, BIOMATERIALS, V30, P2420, DOI 10.1016/j.biomaterials.2009.01.049
   Hassenkam T, 2004, BONE, V35, P4, DOI 10.1016/j.bone.2004.02.024
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   JIANKANG D, 2009, ACTA BIOMATER, V5, P453
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim G, 2008, MACROMOL RAPID COMM, V29, P1577, DOI 10.1002/marc.200800277
   Kim GH, 2006, J POLYM SCI POL PHYS, V44, P1426, DOI 10.1002/polb.20814
   Kim SJ, 2010, POLYMER, V51, P1320, DOI 10.1016/j.polymer.2010.01.025
   Kondo N, 2006, BIOMATERIALS, V27, P4419, DOI 10.1016/j.biomaterials.2006.04.016
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Li X, 2010, CARBOHYD POLYM, V79, P429, DOI 10.1016/j.carbpol.2009.08.032
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lieb E, 2003, TISSUE ENG, V9, P71, DOI 10.1089/107632703762687555
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Moroni L, 2008, ADV FUNCT MATER, V18, P53, DOI 10.1002/adfm.200601158
   Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063
   O'Brien FJ, 2004, BIOMATERIALS, V25, P1077, DOI 10.1016/S0142-9612(03)00630-6
   Ozkan S, 2010, J BIOMED MATER RES A, V92A, P1007, DOI 10.1002/jbm.a.32425
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Roosa SMM, 2010, J BIOMED MATER RES A, V92A, P359, DOI 10.1002/jbm.a.32381
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w
   Tzaphlidou M, 2005, MICRON, V36, P593, DOI 10.1016/j.micron.2005.05.009
   VENUGOPAL J, 2010, PHILOS T R SOC A, V28, P2065
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   Washburn NR, 2002, J BIOMED MATER RES, V60, P20, DOI 10.1002/jbm.10049
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Yoon H, 2009, MACROMOL RAPID COMM, V30, P1632, DOI 10.1002/marc.200900264
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   Zhang Y, 2003, TISSUE ENG, V9, P337, DOI 10.1089/107632703764664800
NR 40
TC 42
Z9 43
U1 1
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD MAY
PY 2011
VL 97B
IS 2
BP 263
EP 270
DI 10.1002/jbm.b.31809
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 750ZX
UT WOS:000289588200007
PM 21384546
DA 2018-10-20
ER

PT J
AU Yi, BQ
   Wang, ZJ
   Han, JG
   Zhao, B
   Ma, HC
AF Yi, Bing-Qiang
   Wang, Zhen-Jun
   Han, Jia-Gang
   Zhao, Bo
   Ma, Hua-Chong
TI Human Acellular Dermal Matrix in the Surgical Management of Rectal
   Anastomotic Stricture
SO HEPATO-GASTROENTEROLOGY
LA English
DT Article
DE Anastomotic stricture; Human acellular dermal matrix (HADM); Surgery;
   Rectal cancer
AB Anastomotic stricture after rectal resection is an intractable complication of rectal sugery. We present a case to introduce a new method to deal with rectal defect after dissecting anastomotic stricture by using biomaterial. The patient was diagnosed with rectal anastomotic stricture after radical resection for rectal carcinoma and was treated by reoperation. There was a defect in the posterior wall of the rectum after the anastomotic stenosis was dissected. We rapaired the defect successfully by using human acellular dermal matrix (HADM). The repair of rectal defect using HADM was easily and safely performed and provided long-term clinical success. It might be considered an innovative method for rectal defect repair.
C1 [Yi, Bing-Qiang; Wang, Zhen-Jun; Han, Jia-Gang; Zhao, Bo; Ma, Hua-Chong] Capital Med Univ, Beijing Chaoyang Hosp, Dept Gen Surg, Beijing 100020, Peoples R China.
RP Wang, ZJ (reprint author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Gen Surg, 8 Gongtinan Lu, Beijing 100020, Peoples R China.
EM wang3zj@sohu.com
CR Han JG, 2008, J PLAST RECONSTR AES, V61, P1544, DOI 10.1016/j.bjps.2008.03.063
   Han JG, 2010, DIS COLON RECTUM, V53, P219, DOI 10.1007/DCR.0b013e3181b715b5
   Mckee R, 2008, AM J SURG, V195, P526, DOI [10.1016/j.amjsurg.2007.02.030, 10.1016/j.amjsurg.2007.62.030]
   Pabst M, 2007, DIGEST SURG, V24, P12, DOI 10.1159/000100911
NR 4
TC 1
Z9 1
U1 0
U2 1
PU H G E UPDATE MEDICAL PUBLISHING S A
PI ATHENS
PA PO BOX 17257, ATHENS GR-10024, GREECE
SN 0172-6390
J9 HEPATO-GASTROENTEROL
JI Hepato-Gastroenterol.
PD MAY-JUN
PY 2011
VL 58
IS 107
BP 796
EP 797
PG 2
WC Gastroenterology & Hepatology; Surgery
SC Gastroenterology & Hepatology; Surgery
GA 801ZO
UT WOS:000293479300024
PM 21830392
DA 2018-10-20
ER

PT J
AU Scaglione, S
   Cilli, M
   Fiorini, M
   Quarto, R
   Pennesi, G
AF Scaglione, Silvia
   Cilli, Michele
   Fiorini, Mauro
   Quarto, Rodolfo
   Pennesi, Giuseppina
TI Differences in chemical composition and internal structure influence
   systemic host response to implants of biomaterials
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE Foreign body response; Leukocyte; Lymphocyte; Monocyte; Scaffold
ID GIANT-CELL REACTION; SCAFFOLD DESIGN; TISSUE
AB In reconstructive surgery, implantable devices are used to supply a missing function. In tissue engineering, biomaterials serve to guide and eventually deliver cells and/or molecules where a tissue regenerative response is needed. The host organism always reacts to implants of any biomaterial, in some instances even triggering a local cascade of events called the foreign body response (FBR), whose mechanisms are well defined. What has yet to be completely unraveled are the biomarkers systemically mirroring the FBR and the regeneration processes, which would be helpful for assessing the therapeutic efficacy of the bioscaffold. Our goal was to identify a biomarker fingerprint of the systemic reaction of host response to bioscaffold implants.
   Different biomaterials chosen for their osteoconductive properties, including collagen, hydroxyapatite, in foam or granules, and poly-e-caprolactone, were implanted in immunocompetent mice. We analyzed serum concentrations of cells and cytokines involved in the inflammatory/ immune response, and the histological features of grafts.
   Within two weeks after implantation, a wave of proinflammatory cytokines was flowing in the blood stream and the concentration of blood cells changed, revealing specific patterns depending on the chemistry and structure of the implanted biomaterials. Cells secreting pro-inflammatory, chemoactractant, and pro-angiogenic cytokines required for the early events in tissue repair were locally recruited because of the presence of a bioscaffold.
C1 [Scaglione, Silvia] Natl Council Res CNR, IEIIT Dept, I-16149 Genoa, Italy.
   [Scaglione, Silvia; Quarto, Rodolfo; Pennesi, Giuseppina] Adv Biotechnol Ctr CBA, Stem Cell Lab, Genoa, Italy.
   [Cilli, Michele] Natl Inst Canc Res, Anim Facil, Genoa, Italy.
   [Fiorini, Mauro] Fin Ceram Faenza SpA, Faenza, Italy.
   [Quarto, Rodolfo] Univ Genoa, Dept Expt Med DIMES, Genoa, Italy.
RP Scaglione, S (reprint author), Natl Council Res CNR, IEIIT Dept, Via Marini 6, I-16149 Genoa, Italy.
EM silvia.scaglione@ieiit.cnr.it
RI Scaglione, Silvia/B-7124-2014
OI Scaglione, Silvia/0000-0002-9464-3554; Quarto,
   Rodolfo/0000-0002-1146-894X
FU Italian Ministry of Education, Universities and Research (MIUR)
   [RB-PR05RSM2, RBIP068JL9]
FX This work was partially funded by the Italian Ministry of Education,
   Universities and Research (MIUR) (grant no. RB-PR05RSM2; RBIP068JL9).
CR Boschett F, 2008, INT J ARTIF ORGANS, V31, P697
   Brody S, 2007, J BIOMED MATER RES B, V83B, P16, DOI 10.1002/jbm.b.30763
   Cheng Guo-xiang, 2002, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V24, P207
   Christenson EM, 2005, J BIOMED MATER RES A, V74A, P141, DOI 10.1002/jbm.a.30317
   Ciapetti G, 2003, BIOMATERIALS, V24, P3815, DOI 10.1016/S0142-9612(03)00263-1
   COOMBES AGA, 1994, CLIN MATER, V17, P35, DOI DOI 10.1016/0267-6605(94)90046-9
   Gloria A, 2009, J APPL BIOMATER BIOM, V7, P141
   Higgins DM, 2009, AM J PATHOL, V175, P161, DOI 10.2353/ajpath.2009.080962
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Ingber DE, 2006, TISSUE ENG, V12, P3265, DOI 10.1089/ten.2006.12.3265
   Israeli E, 2009, LUPUS, V18, P1217, DOI 10.1177/0961203309345724
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer RS, 1999, SCI AM, V280, P86, DOI 10.1038/scientificamerican0499-86
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   Lypka M, 2007, J ORAL MAXIL SURG, V65, P1680, DOI 10.1016/j.joms.2006.09.030
   Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Raghunath J, 2007, BIOTECHNOL APPL BIOC, V46, P73, DOI 10.1042/BA20060134
   ROSNER M, 1992, ARCH OPHTHALMOL-CHIC, V110, P173, DOI 10.1001/archopht.1992.01080140023013
   Rudolph CM, 1999, AM J SURG PATHOL, V23, P113, DOI 10.1097/00000478-199901000-00013
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443
   Tampieri A, 2008, BIOMATERIALS, V29, P3539, DOI 10.1016/j.biomaterials.2008.05.008
   Tasso R, 2009, CARCINOGENESIS, V30, P150, DOI 10.1093/carcin/bgn234
   Vacanti JP, 2007, P AM PHILOS SOC, V151, P395
   Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531
   Vunjak-Novakovic G, 2006, TISSUE ENG, V12, P3261, DOI 10.1089/ten.2006.12.3261
   Walschus U, 2008, J MATER SCI-MATER M, V19, P1595, DOI 10.1007/s10856-007-3316-y
NR 31
TC 4
Z9 4
U1 0
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0391-3988
EI 1724-6040
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD MAY
PY 2011
VL 34
IS 5
BP 422
EP 431
DI 10.5301/IJAO.2011.7747
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 803NI
UT WOS:000293587600004
PM 21534242
DA 2018-10-20
ER

PT J
AU Solouk, A
   Cousins, BG
   Mirzadeh, H
   Solati-Hashtjin, M
   Najarian, S
   Seifalian, AM
AF Solouk, Atefeh
   Cousins, Brian G.
   Mirzadeh, Hamid
   Solati-Hashtjin, Mehran
   Najarian, Siamak
   Seifalian, Alexander M.
TI Surface modification of POSS-nanocomposite biomaterials using reactive
   oxygen plasma treatment for cardiovascular surgical implant applications
SO BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY
LA English
DT Article
DE blood biomaterial interactions; coronary artery bypass surgery;
   endothelial cells; nanocomposite; plasma surface modification;
   statistical modeling
ID OLIGOMERIC SILSESQUIOXANE NANOCOMPOSITES; HUMAN-ENDOTHELIAL CELLS; GAS
   PLASMA; BIOMEDICAL APPLICATIONS; POLYMERIC SURFACES; SERUM-PROTEINS;
   GLOW-DISCHARGE; BYPASS GRAFTS; IN-VITRO; ADHESION
AB In this study, central composite design (CCD) was used to develop predictive models to optimize operating conditions of plasma surface modification. It was concluded that out of the two process variables, power and duration of plasma exposure, the latter was significantly affecting the surface energy (gamma(s)), chemistry, and topography of polyhedral oligomeric silsesquioxane poly(carbonate-urea)urethane (POSS-PCU) films. On the basis of experimental data, CCD was used to model the gamma(s) using a quadratic modeling of the process variables to achieve optimum surface energy to improve the interaction between endothelial cells (ECs). It was found that optimal water theta for EC adhesion and retention, which was reported 55 degrees from supporting literature (equivalent to gamma(s) = 51 mN/m), was easily achievable using the following experimental conditions: (1) power output at 30 W for 75 Sec, (2) 90 W for 40 Sec, and (3) 90 W for 55 Sec in oxygen. In vitro cell culture and metabolic activity studies on optimized films [as in (1)] demonstrate increased adhesion, coverage, and growth of human umbilical vein endothelial cells that were confluent over a shorter time period (< 24 H) than controls. Such materials enhanced the EC response and promoted endothelialization on optimized films, thus demonstrating their use as bypass graft materials. (C) 2011 International Union of Biochemistry and Molecular Biology, Inc. Volume 58, Number 3, May/June 2011, Pages147-161. E-mail: b.cousins@medsch.ucl.ac.uk
C1 [Solouk, Atefeh; Cousins, Brian G.; Seifalian, Alexander M.] Univ Coll London UCL, Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London, England.
   [Solouk, Atefeh; Solati-Hashtjin, Mehran; Najarian, Siamak] Amirkabir Univ Technol, Biomed Engn Fac, Tehran, Iran.
   [Mirzadeh, Hamid] Amirkabir Univ Technol, Polymer Engn Fac, Tehran, Iran.
   [Seifalian, Alexander M.] Royal Free Hampstead NHS Trust Hosp, London, England.
RP Cousins, BG (reprint author), Univ Coll London UCL, Div Surg & Intervent Sci, Ctr Nanotechnol & Regenerat Med, London, England.
EM b.cousins@medsch.ucl.ac.uk
RI Solati-Hashjin, Mehran/A-5535-2010; Seifalian, Alexander/I-6028-2013
OI Solati-Hashjin, Mehran/0000-0002-1187-1237; Seifalian,
   Alexander/0000-0002-1180-3322
FU Amirkabir University of Technology, Tehran, Iran; Engineering and
   Physical Sciences Research Council (EPSRC); Wellcome Trust
FX This work was supported by research grants from the Amirkabir University
   of Technology, Tehran, Iran. The development and manufacture of
   nanocomposite POSS-PCU polymers for cardiovascular applications is
   funded by the Engineering and Physical Sciences Research Council (EPSRC)
   and Wellcome Trust. We would like to thank Prof. Mohammad Ali Shokrgozar
   from the Pasteur Institute of Iran for his kind assistance with and
   discussion of cell culture experiments.
CR Augustine BH, 2007, LANGMUIR, V23, P4346, DOI 10.1021/la063180k
   Baier RE, 2006, J MATER SCI-MATER M, V17, P1057, DOI 10.1007/s10856-006-0444-8
   Carrino L, 2002, J MATER PROCESS TECH, V121, P373, DOI 10.1016/S0924-0136(01)01221-3
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Chen W, 2008, APPL SURF SCI, V254, P2882, DOI 10.1016/j.apsusc.2007.10.029
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Conn G, 2006, EXPERT REV MED DEVIC, V3, P245, DOI 10.1586/17434440.3.2.245
   CURTIS ASG, 1984, J CELL SCI, V71, P17
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   de Mel Achala, 2008, Expert Rev Cardiovasc Ther, V6, P1259, DOI 10.1586/14779072.6.9.1259
   DEKKER A, 1992, Clinical Materials, V11, P157, DOI 10.1016/0267-6605(92)90042-R
   DEKKER A, 1991, BIOMATERIALS, V12, P130, DOI 10.1016/0142-9612(91)90191-C
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   DINA S, 2006, BIOTECHNOL APPL BIOC, V45, P119
   EPSILLARD P, 2003, J BIOMAT SCI-POLYM E, V14, P1005
   Fridman A, 2008, PLASMA CHEMISTRY, P1, DOI 10.1017/CBO9780511546075
   Goddard JM, 2007, PROG POLYM SCI, V32, P698, DOI 10.1016/j.progpolymsci.2007.04.002
   Gomathi N, 2009, APPL SURF SCI, V255, P7590, DOI 10.1016/j.apsusc.2009.04.034
   Grace JM, 2003, J DISPER SCI TECHNOL, V24, P305, DOI 10.1081/DIS-120021793
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hanrahan G, 2006, CRIT REV ANAL CHEM, V36, P141, DOI 10.1080/10408340600969478
   Hung CC, 2002, MICROELECTRON ENG, V63, P405, DOI 10.1016/S0167-9317(02)00555-5
   JINGRUN R, 2008, APPL SURF SCI, V255, P263
   Kannan RY, 2007, PLAST RECONSTR SURG, V119, P1653, DOI 10.1097/01.prs.0000246404.53831.4c
   Kannan RY, 2006, CELL BIOCHEM BIOPHYS, V45, P129, DOI 10.1385/CBB:45:2:129
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Khayet M, 2008, J MEMBRANE SCI, V321, P272, DOI 10.1016/j.memsci.2008.05.002
   Khayet M, 2010, J MEMBRANE SCI, V349, P113, DOI 10.1016/j.memsci.2009.11.031
   Khorasani MT, 2008, RADIAT PHYS CHEM, V77, P280, DOI 10.1016/j.radphyschem.2007.05.013
   Khorasani MT, 2006, COLLOID SURFACE B, V51, P112, DOI 10.1016/j.colsurfb.2006.06.002
   Kidane AG, 2003, MED BIOL ENG COMPUT, V41, P740, DOI 10.1007/BF02349983
   Kim SH, 2007, J BIOMAT SCI-POLYM E, V18, P609, DOI 10.1163/156856207780852514
   Kostov KG, 2010, SURF COAT TECH, V204, P3064, DOI 10.1016/j.surfcoat.2010.02.008
   LEE JLS, 2000, COLLOID SURFACE B, V230, P323
   Lin BT, 2007, APPL SURF SCI, V253, P3254, DOI 10.1016/j.apsusc.2006.07.021
   MARY BCP, 2009, J BIOMED MATER RES A, V88, P1104
   Mirzadeh H, 2007, RADIAT PHYS CHEM, V76, P1435, DOI 10.1016/j.radphyschem.2007.02.079
   Montgomery D. C., 2001, DESIGN ANAL EXPT
   Myers R. H., 2002, RESPONSE SURFACE MET
   Olbrich M, 2007, J BIOMAT SCI-POLYM E, V18, P453, DOI 10.1163/156856207780425059
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Pandiyaraj KN, 2009, MAT SCI ENG C-BIO S, V29, P796, DOI 10.1016/j.msec.2008.07.013
   Pandiyaraj KN, 2009, APPL SURF SCI, V255, P3965, DOI 10.1016/j.apsusc.2008.10.090
   Raghunath J, 2009, BIOTECHNOL APPL BIOC, V52, P1, DOI 10.1042/BA20070256
   Rhodes NP, 2007, BIOMATERIALS, V28, P4561, DOI 10.1016/j.biomaterials.2007.07.008
   Sanchis MR, 2008, POLYM TEST, V27, P75, DOI 10.1016/j.polymertesting.2007.09.002
   Sanchis MR, 2006, EUR POLYM J, V42, P1558, DOI 10.1016/j.eurpolymj.2006.02.001
   SANKARAIAH S, 2007, POLYM ADVAN TECHNOL, V18, P601
   Sarkar S, 2007, J BIOMED MATER RES B, V82B, P100, DOI 10.1002/jbm.b.30710
   Sartori S, 2008, REACT FUNCT POLYM, V68, P809, DOI 10.1016/j.reactfunctpolym.2007.12.002
   Seifalian AM, 2008, BIOMED PHARMACOTHER, V62, P491, DOI 10.1016/j.biopha.2008.07.009
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   Tao W, 2008, APPL SURF SCI, V254, P2831, DOI 10.1016/j.apsusc.2007.10.027
   Tiwari A, 2003, BIOTECHNOL APPL BIOC, V38, P35, DOI 10.1042/BA20030007
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VANWACHEM PB, 1988, BIOMATERIALS, V9, P121, DOI 10.1016/0142-9612(88)90083-X
   Wan GJ, 2007, MAT SCI ENG C-BIO S, V27, P928, DOI 10.1016/j.msec.2006.11.005
   Williams RL, 2004, BIOMATERIALS, V25, P4659, DOI 10.1016/j.biomaterials.2003.12.010
   Wilson DJ, 2003, BIOMATERIALS, V24, P5069, DOI 10.1016/S0142-9612(03)00423-X
   Wohl CJ, 2009, APPL SURF SCI, V255, P8135, DOI 10.1016/j.apsusc.2009.05.030
   Yang LQ, 2009, APPL SURF SCI, V255, P4446, DOI 10.1016/j.apsusc.2008.11.048
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 67
TC 19
Z9 19
U1 1
U2 28
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0885-4513
EI 1470-8744
J9 BIOTECHNOL APPL BIOC
JI Biotechnol. Appl. Biochem.
PD MAY-JUN
PY 2011
VL 58
IS 3
BP 147
EP 161
DI 10.1002/bab.22
PG 15
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 791LI
UT WOS:000292666300002
PM 21679238
DA 2018-10-20
ER

PT J
AU Bhola, R
   Su, FY
   Krull, CE
AF Bhola, Rahul
   Su, Fengyun
   Krull, Catherine E.
TI RETRACTED: Functionalization of titanium based metallic biomaterials for
   implant applications (Retracted article. See vol. 22, pg. 2833, 2011)
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Retracted Publication
ID SELF-ASSEMBLED MONOLAYERS; CALCIUM-PHOSPHATE COATINGS; ELECTROCHEMICAL
   IMPEDANCE SPECTROSCOPY; CHEMICALLY TREATED TITANIUM; ANODIC OXIDE
   LAYERS; COLLAGEN TYPE-I; SURFACE MODIFICATION; OSTEOBLAST ADHESION;
   DENTAL IMPLANTS; CELL-ADHESION
AB Surface immobilization with active functional molecules (AFMs) on a nano-scale is a main field in the current biomaterial research. The functionalization of a vast number of substances and molecules, ranging from inorganic calcium phosphates, peptides and proteins, has been investigated throughout recent decades. However, in vitro and in vivo results are heterogeneous. This may be attributed partially to the limits of the applied immobilization methods. Therefore, this paper highlights the advantages and limitations of the currently applied methods for the biological nano-functionalization of titanium-based biomaterial surfaces. The second part describes a newer immobilization system, using the nanomechanical fixation of at least partially single-stranded nucleic acids (NAs) into an anodic titanium oxide layer as an immobilization principle and their hybridization ability for the functionalization of the surface with active functional molecules conjugated to the respective complementary NA strands.
C1 [Bhola, Rahul; Su, Fengyun; Krull, Catherine E.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
RP Bhola, R (reprint author), Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.
EM bholar@umich.edu; krullc@umich.edu
CR Ahn JM, 2002, MINI-REV MED CHEM, V2, P463, DOI 10.2174/1389557023405828
   ALADJEM A, 1973, J MATER SCI, V8, P688, DOI 10.1007/BF00561225
   Alberti P, 2006, ORG BIOMOL CHEM, V4, P3383, DOI 10.1039/b605739j
   Andersen FF, 2008, NUCLEIC ACIDS RES, V36, P1113, DOI 10.1093/nar/gkm1124
   Auernheimer J, 2005, CHEMBIOCHEM, V6, P2034, DOI 10.1002/cbic.200500031
   Bagno A, 2007, BONE, V40, P693, DOI 10.1016/j.bone.2006.10.007
   Baleani M, 2000, ARTIF ORGANS, V24, P296, DOI 10.1046/j.1525-1594.2000.06486.x
   Beissenhirtz MK, 2006, ORG BIOMOL CHEM, V4, P3392, DOI 10.1039/b607033g
   BEUTNER R, 2007, BIOMATERIALIEN, V8, P25
   Beutner R, 2009, BIOMATERIALS, V30, P2774, DOI 10.1016/j.biomaterials.2009.01.047
   Borsari V, 2009, J BIOMED MATER RES A, V89A, P550, DOI 10.1002/jbm.a.31995
   Bozzini B, 2008, J MATER SCI-MATER M, V19, P3443, DOI 10.1007/s10856-008-3487-1
   Cheng XL, 2004, BIOMATERIALS, V25, P5395, DOI 10.1016/j.biomaterials.2003.12.045
   Clair S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2876421
   Dalsin JL, 2005, LANGMUIR, V21, P640, DOI 10.1021/la048626g
   De Giglio E, 2001, J BIOMAT SCI-POLYM E, V12, P63, DOI 10.1163/156856201744452
   De Giglio E, 2000, J BIOMAT SCI-POLYM E, V11, P1073, DOI 10.1163/156856200743580
   Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Esposito M, 1998, EUR J ORAL SCI, V106, P721, DOI 10.1046/j.0909-8836..t01-6-.x
   Feng B, 2004, BIOMATERIALS, V25, P3421, DOI 10.1016/j.biomaterials.2003.10.044
   Fujibayashi S, 2001, J BIOMED MATER RES, V56, P562, DOI 10.1002/1097-4636(20010915)56:4<562::AID-JBM1128>3.3.CO;2-D
   Gan L, 2004, BIOMATERIALS, V25, P5313, DOI 10.1016/j.biomaterials.2003.12.039
   Gao W, 1996, LANGMUIR, V12, P6429, DOI 10.1021/la9607621
   Gnauck M, 2007, LANGMUIR, V23, P377, DOI 10.1021/la0606648
   Guo KT, 2007, MINI-REV MED CHEM, V7, P701
   Guo KT, 2007, BIOMATERIALS, V28, P468, DOI 10.1016/j.biomaterials.2006.09.021
   He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597
   Henry P J, 1987, Int J Oral Maxillofac Implants, V2, P23
   Hofer R, 2001, LANGMUIR, V17, P4014, DOI 10.1021/la001756e
   Huang Hui, 2003, J Oral Implantol, V29, P73, DOI 10.1563/1548-1336(2003)029<0073:EOFORI>2.3.CO;2
   Iwasaki Y, 2003, COLLOID SURFACE B, V32, P77, DOI 10.1016/S0927-7765(03)00147-4
   Johnsen SP, 2006, J BONE JOINT SURG BR, V88B, P1303, DOI 10.1302/0301-620X.88B10.17399
   Jonasova L, 2004, BIOMATERIALS, V25, P1187, DOI 10.1016/j.biomaterials.2003.08.009
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x
   Kamkin AN, 1996, PROT MET+, V32, P214
   KASEMO B, 1986, CRIT REV BIOCOMPAT, V2, P335
   Kasemo B, 1999, Adv Dent Res, V13, P8
   Kenausis GL, 2000, J PHYS CHEM B, V104, P3298, DOI 10.1021/jp993359m
   KHALIL N, 1986, ELECTROCHIM ACTA, V31, P1279, DOI 10.1016/0013-4686(86)80148-7
   Khor KA, 2004, BIOMATERIALS, V25, P1177, DOI 10.1016/j.biomaterials.2003.08.008
   Khor KA, 2003, BIOMATERIALS, V24, P769, DOI 10.1016/S0142-9612(02)00413-1
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim TI, 2008, CURR PHARM DESIGN, V14, P2201, DOI 10.2174/138161208785740171
   Klinger MM, 1998, CRIT REV ORAL BIOL M, V9, P449, DOI 10.1177/10454411980090040401
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Krupa D, 2005, ANAL BIOANAL CHEM, V381, P617, DOI 10.1007/s00216-004-2983-5
   Kunze J, 2005, Z PHYS CHEM, V219, P1561, DOI 10.1524/zpch.2005.219.11.1561
   Kweh SWK, 2002, BIOMATERIALS, V23, P775, DOI 10.1016/S0142-9612(01)00183-1
   Lappalainen R, 2005, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.blo.0000150000.75660.ff
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Le JD, 2004, NANO LETT, V4, P2343, DOI 10.1021/nl048635+
   Lee BH, 2002, J BIOMED MATER RES, V61, P466, DOI 10.1002/jbm.10190
   Leng YX, 2003, SURF SCI, V531, P177, DOI 10.1016/S0039-6028(03)00487-4
   Leng YX, 2000, THIN SOLID FILMS, V377, P573, DOI 10.1016/S0040-6090(00)01306-7
   Li H, 2004, SURF COAT TECH, V182, P227, DOI 10.1016/j.surfcoat.2003.08.081
   Liang FH, 2003, J MATER SCI LETT, V22, P1665, DOI 10.1023/B:JMSL.0000004643.03120.ca
   Liu HB, 2008, CHEMPHYSCHEM, V9, P1979, DOI 10.1002/cphc.200800381
   Liu XY, 2004, BIOMATERIALS, V25, P1755, DOI 10.1016/j.biomaterials.2003.08.024
   Liu XY, 2003, SURF COAT TECH, V172, P270, DOI 10.1016/S0257-8972(03)00344-X
   Liu XY, 2002, BIOMATERIALS, V23, P963, DOI 10.1016/S0142-9612(01)00210-1
   Liu XY, 2001, BIOMATERIALS, V22, P2007, DOI 10.1016/S0142-9612(00)00386-0
   Liu Y, 2005, BONE, V36, P745, DOI 10.1016/j.bone.2005.02.005
   Liu Y, 2007, J DENT RES, V86, P84, DOI 10.1177/154405910708600114
   Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Maitz MF, 2002, BIOMOL ENG, V19, P269, DOI 10.1016/S1389-0344(02)00039-4
   Mani G, 2008, LANGMUIR, V24, P6774, DOI 10.1021/la8003646
   Martin SM, 2004, J BIOMED MATER RES A, V70A, P10, DOI 10.1002/jbm.a.30052
   Matsue T, 2002, VACUUM, V66, P435, DOI 10.1016/S0042-207X(02)00167-7
   Michael J, 2007, J BIOMED MATER RES B, V80B, P146, DOI 10.1002/jbm.b.30579
   Michael J, 2009, BIOCONJUGATE CHEM, V20, P710, DOI 10.1021/bc800372e
   Michel R, 2002, LANGMUIR, V18, P3281, DOI 10.1021/la011715y
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   Nishiguchi S, 2001, J BIOMED MATER RES, V54, P198, DOI 10.1002/1097-4636(200102)54:2<198::AID-JBM6>3.0.CO;2-7
   NOMIZU M, 1995, J BIOL CHEM, V270, P20583, DOI 10.1074/jbc.270.35.20583
   Ogawa T, 2003, INT J ORAL MAX IMPL, V18, P200
   Orban JM, 2000, MACROMOLECULES, V33, P4205, DOI 10.1021/ma9915780
   Park S.H., 2006, ANGEW CHEM, V118, P749
   Philippin G, 2003, APPL SURF SCI, V212, P530, DOI 10.1016/S0169-4332(03)00051-5
   Popa MV, 2008, J MATER SCI-MATER M, V19, P1, DOI 10.1007/s10856-007-3271-7
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Ratner B. D., 2001, TITANIUM MED, P1
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   Roehlecke C, 2001, CELLS TISSUES ORGANS, V168, P178, DOI 10.1159/000047833
   Roessler S, 2002, COLLOID SURFACE B, V26, P387, DOI 10.1016/S0927-7765(02)00025-5
   Roessler S, 2001, J MATER SCI-MATER M, V12, P871, DOI 10.1023/A:1012807621414
   Rossler S, 2003, J BIOMED MATER RES A, V64A, P655, DOI 10.1002/jbm.a.10330
   Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586
   Ruoslahti E, 2003, MATRIX BIOL, V22, P459, DOI 10.1016/S0945-053X(03)00083-0
   Rupp F, 2006, J BIOMED MATER RES A, V76A, P323, DOI 10.1002/jbm.a.30518
   Scharnweber D, 2007, J MATER SCI-MATER M, V18, P391, DOI 10.1007/s10856-006-0704-7
   Scharnweber D, 2002, J MATER SCI-MATER M, V13, P1215, DOI 10.1023/A:1021118811893
   Scharnweber D, 2004, BIOMATERIALS, V25, P2371, DOI 10.1016/j.biomaterials.2003.09.025
   Scharnweber D, 2009, RECENT DEV ADV MED D, P101
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   Schliephake H, 2008, J MATER CHEM, V18, P2404, DOI 10.1039/015355b
   Schliephake H, 2009, CLIN ORAL IMPLAN RES, V20, P31, DOI 10.1111/j.1600-0501.2008.01603.x
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   SCHUTZ RW, 1997, SURFACE PERFORMANCE, P1
   Schwartz Z, 2008, J BONE JOINT SURG AM, V90A, P2485, DOI 10.2106/JBJS.G.00499
   Seeman NC, 1999, TRENDS BIOTECHNOL, V17, P437, DOI 10.1016/S0167-7799(99)01360-8
   SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9
   Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406
   Silverman BM, 2005, LANGMUIR, V21, P225, DOI 10.1021/la0482271
   SODEK J, 1992, INT CONGR SER, V1002, P297
   Spori DM, 2007, LANGMUIR, V23, P8053, DOI 10.1021/la700474v
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   Szmukler-Moncler S, 2004, J BIOMED MATER RES B, V68B, P149, DOI 10.1002/jbm.b.20003
   Takebe J, 2000, J BIOMED MATER RES, V51, P398, DOI 10.1002/1097-4636(20000905)51:3<398::AID-JBM14>3.0.CO;2-#
   Takeuchi M, 2003, BIOMATERIALS, V24, P1821, DOI 10.1016/S0142-9612(02)00576-8
   Tegoulia VA, 2001, LANGMUIR, V17, P4396, DOI 10.1021/la001790t
   Teng SH, 2008, J MATER SCI-MATER M, V19, P2453, DOI 10.1007/s10856-008-3370-0
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   Uchida M, 2004, SURF COAT TECH, V177, P627, DOI 10.1016/S0257-8972(03)00937-X
   Valentin Andreas H., 2004, Keio Journal of Medicine, V53, P166, DOI 10.2302/kjm.53.166
   van Steenberghe D, 2002, CLIN ORAL IMPLAN RES, V13, P617, DOI 10.1034/j.1600-0501.2002.130607.x
   Velten D, 2003, Z METALLKD, V94, P667, DOI 10.3139/146.030668
   Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i
   VROMAN L, 1969, Journal of Biomedical Materials Research, V3, P669, DOI 10.1002/jbm.820030410
   Wach JY, 2008, CHEM-EUR J, V14, P10579, DOI 10.1002/chem.200801134
   Wang CX, 2003, BIOMATERIALS, V24, P3069, DOI 10.1016/S0142-9612(03)00154-6
   Wang CX, 2002, MATER LETT, V54, P30, DOI 10.1016/S0167-577X(01)00532-8
   Wang XX, 2002, BIOMATERIALS, V23, P1353, DOI 10.1016/S0142-9612(01)00254-X
   Wang XX, 2000, J BIOMED MATER RES, V52, P171, DOI 10.1002/1097-4636(200010)52:1<171::AID-JBM22>3.0.CO;2-O
   Wikesjo UME, 2008, J CLIN PERIODONTOL, V35, P1001, DOI 10.1111/j.1600-051X.2008.01321.x
   Xiao SJ, 1997, J MATER SCI-MATER M, V8, P867, DOI 10.1023/A:1018501804943
   Xu GC, 2003, SURF COAT TECH, V169, P299, DOI 10.1016/S0257-8972(03)00113-0
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yao C, 2006, J NANOSCI NANOTECHNO, V6, P2682, DOI 10.1166/jnn.2006.447
   Yerokhin AL, 2000, SURF COAT TECH, V130, P195, DOI 10.1016/S0257-8972(00)00719-2
   Zhang M, 2007, SURF COAT TECH, V201, P7252, DOI 10.1016/j.surfcoat.2007.01.043
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
   Zorn G, 2007, J MATER SCI-MATER M, V18, P1309, DOI 10.1007/s10856-006-0117-7
   Zorn G, 2005, CHEM MATER, V17, P4218, DOI 10.1021/cm050477f
   Zoulalian V, 2006, J PHYS CHEM B, V110, P25603, DOI 10.1021/jp066811s
NR 142
TC 16
Z9 18
U1 3
U2 35
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2011
VL 22
IS 5
BP 1147
EP 1159
DI 10.1007/s10856-011-4305-8
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KF
UT WOS:000291701900007
PM 21476077
DA 2018-10-20
ER

PT J
AU Azevedo, C
   Cenedese, P
   Dubot, P
AF Azevedo, Christophe
   Cenedese, Pierre
   Dubot, Pierre
TI Two steps bulk-surface functionalization of nanoporous alumina by methyl
   and vinyl-silane adsorption. Evidence for oxide surface highly reactive
   sites creation
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID CATALYTIC ALUMINAS; GAMMA-ALUMINA; IRON-OXIDE; FT-IR; SPECTROSCOPY;
   TRANSFORMATION; CHEMISTRY; MEMBRANES; RAIRS; WATER
AB Functionalization of a novel nanoporous monolithic alumina synthesized from amalgam is investigated. The structure is studied by X-ray diffraction, BET, MEB and IR spectroscopy, before and after chemical functionalization by trimethylethoxy silane adsorption and annealing at high temperature. These treatments retain both monolith microstructure and nanostructure while strongly improving material mechanical properties. Allyldimethoxysilane and alcohol adsorption on the annealed samples, proves that highly reactive sites are available for further polymer grafting, as demonstrated by a significant shift of allyldimethoxysilane v(SiH) to 2,215 cm(-1) and adsorbed acetate formation. Simple quantum computations on model systems support this conclusion. Chemical processes reported in this paper, allow a nanostructured alumina monoliths functionalization to optimize ceramics-polymer bonds, and to tune new hybrid biomaterial properties.
C1 [Cenedese, Pierre; Dubot, Pierre] MCMC ICMPE CNRS, F-94320 Thiais, France.
   [Azevedo, Christophe] Univ Paris 07, Coll Odontol Garanciere, F-75006 Paris, France.
RP Dubot, P (reprint author), MCMC ICMPE CNRS, 2 Rue Henri Dunant, F-94320 Thiais, France.
EM cazevedo@yahoo.com; pcenedese@glvt-cnrs.fr
CR Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014
   Aronne A, 1997, MATER CHEM PHYS, V51, P163, DOI 10.1016/S0254-0584(97)80287-8
   Aronne A, 2002, J MATER CHEM, V12, P3039, DOI 10.1039/b203859e
   BARR TL, 1991, J VAC SCI TECHNOL A, V9, P1793, DOI 10.1116/1.577464
   BENNETT JE, 1973, J MATER SCI, V8, P1189, DOI 10.1007/BF00632772
   BUSCA G, 1991, J CATAL, V131, P167, DOI 10.1016/0021-9517(91)90333-Y
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   DASTOOR HE, 1993, CHEM PHYS LETT, V209, P493, DOI 10.1016/0009-2614(93)80123-7
   Davydov AA, 1990, INFRARED SPECTROSCOP
   Dillon AC, 2006, THIN SOLID FILMS, V501, P216, DOI 10.1016/j.tsf.2005.07.182
   Dubot P, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.241402
   Dyan A, 2006, J PHYS CHEM B, V110, P10041, DOI 10.1021/jp056825i
   FH Jones, 2001, SURF SCI REP, V42, P75, DOI DOI 10.1016/S0167-5729(00)00011-X
   Flamme K E, 2007, BIOMATERIALS, V28, P2638
   Flanigen E. M., 1971, ADV CHEM SER, V101, P201
   GOLE JL, 2008, NANOSILICON, V4, P149
   Greil P, 2001, J EUR CERAM SOC, V21, P105, DOI 10.1016/S0955-2219(00)00179-5
   Hair M. L., 1967, INFRARED SPECTROSCOP
   Hoffmann R, 1988, SOLIDS SURFACES CHEM
   Ignjatovic N, 2004, APPL SURF SCI, V238, P314, DOI 10.1016/j.apsusc.2004.05.227
   Ionescu R, 2008, SENSOR ACTUAT B-CHEM, V131, P174, DOI 10.1016/j.snb.2007.11.001
   JAYASOORIYA UA, 1993, SURF SCI, V294, P131, DOI 10.1016/0039-6028(93)90166-H
   Kirchner A, 2007, J MEMBRANE SCI, V287, P264, DOI 10.1016/j.memsci.2006.10.045
   KNOZINGER H, 1978, CATAL REV, V17, P31, DOI 10.1080/03602457808080878
   LAMOTTE J, 1988, REACT KINET CATAL L, V36, P113, DOI 10.1007/BF02071150
   Little L. H., 1966, INFRARED SPECTRA ADS
   Long JW, 2004, J AM CHEM SOC, V126, P16879, DOI 10.1021/ja046044f
   Lutz W, 2002, MICROPOR MESOPOR MAT, V55, P193, DOI 10.1016/S1387-1811(02)00403-1
   MONTAGNE X, 1987, J CHEM SOC FARAD T 1, V83, P1417, DOI 10.1039/f19878301417
   Morterra C, 1996, CATAL TODAY, V27, P497, DOI 10.1016/0920-5861(95)00163-8
   MORTERRA C, 1976, P 6 INT C CAT LOND, P194
   Nakamoto K., 1970, INFRARED SPECTRA INO
   PERI JB, 1965, J PHYS CHEM-US, V69, P220, DOI 10.1021/j100885a033
   Pluedemann E. P., 1991, SILANE COUPLING AGEN
   Popat KC, 2005, BIOMATERIALS, V26, P4516, DOI 10.1016/j.biomaterials.2004.11.026
   Qi XB, 2005, J AM CHEM SOC, V127, P7666, DOI 10.1021/ja050960r
   Schultz FS, 1999, J AM CHEM SOC, V121, P4933, DOI 10.1021/ja9804767
   Shi QH, 2008, J AM CHEM SOC, V130, P5034, DOI 10.1021/ja800376t
   Shin EJ, 2005, APPL CATAL B-ENVIRON, V61, P79, DOI 10.1016/j.apcatb.2005.03.013
   Sitarz M, 1999, J MOL STRUCT, V511, P281, DOI 10.1016/S0022-2860(99)00169-6
   Tilley TD, 2002, J MOL CATAL A-CHEM, V182, P17, DOI 10.1016/S1381-1169(01)00461-7
   Tsyganenko AA, 1996, J CHEM SOC FARADAY T, V92, P4843, DOI 10.1039/ft9969204843
   Vansant EF, 2001, COLLOID SURFACE A, V179, P145, DOI 10.1016/S0927-7757(00)00650-6
   VANSANTEN RA, 1991, THEORETICAL HETEROGE
   Vignes J. L., 1997, Key Engineering Materials, V132-1361, P432
   Wang S, 2004, J SOLID STATE CHEM, V177, P4800, DOI 10.1016/j.jssc.2004.10.010
   WISLICENUS H, 1904, Z ANGEW CHEM, V25, P801
   Zhang ZR, 2002, J AM CHEM SOC, V124, P1592, DOI 10.1021/ja016974o
   ZHOU RS, 1991, ACTA CRYSTALLOGR B, V47, P617, DOI 10.1107/S0108768191002719
NR 49
TC 2
Z9 2
U1 0
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2011
VL 22
IS 5
BP 1161
EP 1169
DI 10.1007/s10856-011-4286-7
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KF
UT WOS:000291701900008
PM 21461702
DA 2018-10-20
ER

PT J
AU Khandwekar, AP
   Doble, M
AF Khandwekar, Anand P.
   Doble, Mukesh
TI Physicochemical characterisation and biological evaluation of
   polyvinylpyrrolidone-iodine engineered polyurethane (Tecoflex (R))
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID SURFACE ENTRAPMENT TECHNIQUE; URETERAL STENT BIOMATERIAL; URETHRAL
   CATHETERS; BACTERIAL ADHERENCE; URINARY CATHETERS; UROLOGICAL USE;
   ENCRUSTATION; HYDROPHOBICITY; PREVENTION; ADHESION
AB Bacterial adhesion and encrustation are the known causes for obstruction or blockage of urethral catheters and ureteral stents, which often hinders their effective use within the urinary tract. In this in vitro study, polyvinylpyrrolidone-iodine (PVP-I) complex modified polyurethane (Tecoflex (R)) systems were created by physically entrapping the modifying species during the reversible swelling of the polymer surface region. The presence of the PVP-I molecules on this surfaces were verified by ATR-FTIR, AFM and SEM-EDAX analysis, while wettability of the films was investigated by water contact angle measurements. The modified surfaces were investigated for its suitability as a urinary tract biomaterial by comparing its lubricity and ability to resist bacterial adherence and encrustation with that of base polyurethane. The PVP-I modified polyurethane showed a nanopatterned surface topography and was highly hydrophilic and more lubricious than control polyurethane. Adherence of both the gram positive Staphylococcus aureus (by 86%; **P < 0.01) and gram-negative Pseudomonas aeruginosa (by 80%; *P < 0.05) was significantly reduced on the modified surfaces. The deposition of struvite and hydroxyapatite the major components of urinary tract encrustations were significantly less on PVP-I modified polyurethane as compared to base polyurethane, especially reduction in hydroxyapatite encrustation was particularly marked. These results demonstrated that the PVP-I entrapment process can be applied on polyurethane in order to reduce/lower complications associated with bacterial adhesion and deposition of encrustation on polyurethanes.
C1 [Khandwekar, Anand P.; Doble, Mukesh] Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
RP Doble, M (reprint author), Indian Inst Technol Madras, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM mukeshd@iitm.ac.in
OI Doble, Mukeshd/0000-0002-4335-0698
FU Council of Scientific and Industrial Research (CSIR)
FX Anand P. Khandwekar would like to thank Council of Scientific and
   Industrial Research (CSIR) for providing Junior Research Fellowship
   (JRF) to pursue his doctoral studies.
CR Bhagat PR, 2008, TALANTA, V74, P1313, DOI 10.1016/j.talanta.2007.08.035
   BHAT VT, 2007, POLYM INT, V57, P124
   BREHMER B, 1972, J UROLOGY, V108, P719, DOI 10.1016/S0022-5347(17)60849-8
   BRIDGETT MJ, 1993, BIOMATERIALS, V14, P184, DOI 10.1016/0142-9612(93)90021-S
   Bruinsma GM, 2001, BIOMATERIALS, V22, P3217, DOI 10.1016/S0142-9612(01)00159-4
   Choong SKS, 2000, BJU INT, V86, P414, DOI 10.1046/j.1464-410X.2000.00861.x
   Cormio L, 1995, Scand J Urol Nephrol Suppl, V171, P1
   COX AJ, 1989, UROL RES, V17, P353, DOI 10.1007/BF00510524
   EGYHAZI T, 1984, REACT KINET CATAL L, V24, P1, DOI 10.1007/BF02069592
   ELSHERIF A, 1995, BRIT J UROL, V76, P108, DOI 10.1111/j.1464-410X.1995.tb07842.x
   Francois P, 1996, BIOMATERIALS, V17, P667, DOI 10.1016/0142-9612(96)86736-6
   Glu GB, 2005, INT J BIOL MACROMOL, V37, P249
   Gorman SP, 1998, J BIOMED MATER RES, V39, P642, DOI 10.1002/(SICI)1097-4636(19980315)39:4<642::AID-JBM20>3.0.CO;2-7
   GORMAN SP, 1987, J CLIN PHARM THER, V12, P393, DOI 10.1111/j.1365-2710.1987.tb00552.x
   Gorman SP, 1997, BIOMATERIALS, V18, P1379, DOI 10.1016/S0142-9612(97)00070-7
   Gorman SP, 1991, MECH ACTION CHEM BIO, P271
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   GOTTARDI W, 1985, J HOSP INFECT, V6, P1, DOI 10.1016/S0195-6701(85)80040-2
   Gottenbos B, 2002, J MATER SCI-MATER M, V13, P717, DOI 10.1023/A:1016175502756
   HEDELIN H, 1991, BRIT J UROL, V67, P527, DOI 10.1111/j.1464-410X.1991.tb15200.x
   HEDELIN I, 1991, UROL RES, V19, P297
   Hildebrandt P, 1997, Biomed Tech (Berl), V42 Suppl, P123, DOI 10.1515/bmte.1997.42.s2.123
   Hildebrandt P, 2001, BIOMATERIALS, V22, P503, DOI 10.1016/S0142-9612(00)00217-9
   HOLMES SAV, 1992, BRIT J UROL, V69, P383, DOI 10.1111/j.1464-410X.1992.tb15564.x
   HOLMES SAV, 1992, BRIT J UROL, V69, P651, DOI 10.1111/j.1464-410X.1992.tb15640.x
   JANSEN B, 1993, GASTROINTEST ENDOSC, V39, P670, DOI 10.1016/S0016-5107(93)70220-5
   Jones DS, 2001, J MATER SCI-MATER M, V12, P15, DOI 10.1023/A:1026744732504
   Khandwekar AP, 2011, J BIOMATER APPL, V26, P227, DOI 10.1177/0885328210367442
   Khandwekar AP, 2010, J BIOMED MATER RES A, V95A, P413, DOI 10.1002/jbm.a.32852
   Khandwekar AP, 2010, J BIOMATER APPL, V25, P119, DOI 10.1177/0885328209344004
   Khandwekar AP, 2010, J MATER SCI-MATER M, V21, P635, DOI 10.1007/s10856-009-3886-y
   Khandwekar AP, 2009, J MED BIOL ENG, V29, P84
   Khandwekar AP, 2009, J MATER SCI-MATER M, V20, P1115, DOI 10.1007/s10856-008-3655-3
   KRASOVSKAYA SM, 1991, BIOMATERIALS, V12, P817, DOI 10.1016/0142-9612(91)90067-K
   KRISTINSSON KG, 1989, J MED MICROBIOL, V28, P249, DOI 10.1099/00222615-28-4-249
   Liedberg H, 1991, Scand J Urol Nephrol Suppl, V138, P239
   Marmieri G, 1996, J BIOMED MATER RES, V33, P29, DOI 10.1002/(SICI)1097-4636(199621)33:1<29::AID-JBM5>3.3.CO;2-M
   Marshall K. C., 1976, INTERFACES MICROBIAL
   MILLER JM, 1975, J UROLOGY, V113, P530, DOI 10.1016/S0022-5347(17)59518-X
   MILROY E, 1993, J UROLOGY, V150, P1630, DOI 10.1016/S0022-5347(17)35861-5
   MIN XC, 2005, J APPL POLYM SCI, V97, P2026
   MM T, 1999, METHOD ENZYMOL, V310, P558
   OHKAWA M, 1990, J UROLOGY, V143, P717, DOI 10.1016/S0022-5347(17)40071-1
   OVSEPYAN M, 1978, KHIM FARM ZH, V12, P121
   Pijanowska A, 2007, WORLD J MICROB BIOT, V23, P677, DOI 10.1007/s11274-006-9282-6
   Qian XF, 2001, J MATER CHEM, V11, P2504, DOI 10.1039/b103708k
   QIPENG G, 1996, EUR POLYM J, V32, P423
   ROBERTS JA, 1990, J UROLOGY, V144, P264, DOI 10.1016/S0022-5347(17)39428-4
   ROSENBERG M, 1981, APPL ENVIRON MICROB, V42, P375
   RUSS IG, 1971, STP AM SOC TESTING, V485, P154
   SQUIRES B, 1995, BRIT J UROL, V75, P252, DOI 10.1111/j.1464-410X.1995.tb07327.x
   STICKLER D, 1993, UROL RES, V21, P407, DOI 10.1007/BF00300077
   STICKLER DJ, 1993, CELL MATER, V3, P315
   Tunney M. M., 1996, European Journal of Pharmaceutical Sciences, V4, pS177, DOI 10.1016/S0928-0987(97)86539-6
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
   TUNNEY MM, 1996, REV MED MICROBIOL, V7, P195
   VANDENBROEK PJ, 1985, LANCET, V1, P563
   WEISS E, 1982, CURR MICROBIOL, V7, P125, DOI 10.1007/BF01568427
   Wironen J, 1997, J LONG-TERM EFF MED, V7, P1
   ZISMAN A, 1995, J UROLOGY, V153, P718, DOI 10.1016/S0022-5347(01)67697-3
NR 62
TC 17
Z9 18
U1 0
U2 19
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2011
VL 22
IS 5
BP 1231
EP 1246
DI 10.1007/s10856-011-4285-8
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KF
UT WOS:000291701900015
PM 21437640
DA 2018-10-20
ER

PT J
AU Rosalbino, F
   Maccio, D
   Giannoni, P
   Quarto, R
   Saccone, A
AF Rosalbino, F.
   Maccio, D.
   Giannoni, P.
   Quarto, R.
   Saccone, A.
TI Study of the in vitro corrosion behavior and biocompatibility of
   Zr-2.5Nb and Zr-1.5Nb-1Ta (at%) crystalline alloys
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID MARROW STROMAL CELLS; ANODIC-OXIDE-FILMS; TITANIUM-ALLOYS; BONE
   SIALOPROTEIN; ELECTROCHEMICAL-BEHAVIOR; BIOMEDICAL APPLICATIONS;
   METALLIC BIOMATERIALS; VALVE METALS; IMPLANTS; DIFFERENTIATION
AB The in vitro corrosion behavior and biocompatibility of two Zr alloys, Zr-2.5Nb, employed for the manufacture of CANDU reactor pressure tubes, and Zr-1.5Nb-1Ta (at%), for use as implant materials have been assessed and compared with those of Grade 2 Ti, which is known to be a highly compatible metallic biomaterial. The in vitro corrosion resistance was investigated by open circuit potential and electrochemical impedance spectroscopy (EIS) measurements, as a function of exposure time to an artificial physiological environment (Ringer's solution). Open circuit potential values indicated that both the Zr alloys and Grade 2 Ti undergo spontaneous passivation due to spontaneously formed oxide film passivating the metallic surface, in the aggressive environment. It also indicated that the tendency for the formation of a spontaneous oxide is greater for the Zr-1.5Nb-1Ta alloy and that this oxide has better corrosion protection characteristics than the ones formed on Grade 2 Ti or on the Zr-2.5Nb alloy. EIS study showed high impedance values for all samples, increasing with exposure time, indicating an improvement in corrosion resistance of the spontaneous oxide film. The fit obtained suggests a single passive film presents on the metals surface, improving their resistance with exposure time, presenting the highest values to the Zr-1.5Nb-1Ta alloy. For the biocompatibility analysis human osteosarcoma cell line (Saos-2) and human primary bone marrow stromal cells (BMSC) were used. Biocompatibility tests showed that Saos-2 cells grow rapidly, independently of the surface, due to reduced dependency from matrix deposition and microenvironment recognition. BMSC instead display a reduced proliferation, possibly caused by a reduced crosstalk with the metal surface microenvironment. However, once the substrate has been colonized, BMSC seem to respond properly to osteoinduction stimuli, thus supporting a substantial equivalence in the biocompatibility among the Zr alloys and Grade 2 titanium. In summary, high in vitro corrosion resistance together with satisfactory biocompatibility make the Zr-2.5Nb and Zr-1.5Nb-1Ta crystalline alloys promising biomaterials for surgical implants.
C1 [Rosalbino, F.] Politecn Torino, Dipartimento Sci Mat & Ingn Chim, I-10129 Turin, Italy.
   [Maccio, D.; Saccone, A.] Univ Genoa, Dipartimento Chim & Chim Ind, I-16146 Genoa, Italy.
   [Giannoni, P.] Ctr Biotecnol Avanzate, Lab Cellule Staminali, I-16132 Genoa, Italy.
   [Quarto, R.] DIMES Univ Genova, Dipartimento Med Sperimentale, I-16132 Genoa, Italy.
RP Rosalbino, F (reprint author), Politecn Torino, Dipartimento Sci Mat & Ingn Chim, Corso Duca degli Abruzzi 24, I-10129 Turin, Italy.
EM francesco.rosalbino@polito.it
OI Quarto, Rodolfo/0000-0002-1146-894X; SACCONE,
   ADRIANA/0000-0002-0949-8859
CR Abriata JP, 1982, B ALLOY PHASE DIAGR, V3, P34
   BADAWY WA, 1989, ELECTROCHIM ACTA, V34, P1711, DOI 10.1016/0013-4686(89)85053-4
   Balloni S, 2009, INT J ORAL MAX IMPL, V24, P627
   Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150
   Biaggio SR, 1997, ELECTROCHIM ACTA, V42, P1751, DOI 10.1016/S0013-4686(96)00375-1
   Biehl V, 2001, MATERIALWISS WERKST, V32, P137, DOI 10.1002/1521-4052(200102)32:2<137::AID-MAWE137>3.3.CO;2-Z
   BJURSTEN LM, 1990, BIOMATERIALS, V11, P596, DOI 10.1016/0142-9612(90)90085-5
   BOCKRIS JOM, 1982, MODERN ASPECT ELECTR, V14
   Braccini A, 2005, STEM CELLS, V23, P1066, DOI 10.1634/stemcells.2005-0002
   Branzoi I. V., 2008, SURF INTERFACE ANAL, V40, P167
   Cabrini R L, 1993, Implant Dent, V2, P264, DOI 10.1097/00008505-199312000-00008
   Carvalho RS, 2002, J CELL BIOCHEM, V84, P497
   Chung JW, 2008, STEM CELLS, V26, P2114, DOI 10.1634/stemcells.2008-0370
   Cox B., 1976, ADV CORROSION SCI TE, V5
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   GERARDI S, 1993, ASTM HDB, V2
   Giannoni P, 2008, J TISSUE ENG REGEN M, V2, P253, DOI 10.1002/term.90
   Giannoni P, 2009, INT J ARTIF ORGANS, V32, P811
   Gonzalez JEG, 1999, J ELECTROANAL CHEM, V471, P109, DOI 10.1016/S0022-0728(99)00260-0
   Guglielmotti M B, 1997, Acta Odontol Latinoam, V10, P11
   Guglielmotti MB, 1999, INT J ORAL MAX IMPL, V14, P565
   HAMMAD AM, 1992, J NUCL MATER, V186, P166, DOI 10.1016/0022-3115(92)90331-E
   HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3
   Helsen J.A., 1998, METALS BIOMATERIALS
   Khan MA, 1996, BIOMATERIALS, V17, P2117, DOI 10.1016/0142-9612(96)00029-4
   KULOKAOV OB, 2005, MORFOLOGIIA, V127, P52
   Lamour V, 2007, J BIOL CHEM, V282, P36240, DOI 10.1074/jbc.M705833200
   LOHRENGEL MM, 1994, ELECTROCHIM ACTA, V39, P1265, DOI 10.1016/0013-4686(94)E0046-3
   Macdonald J. R., 1987, IMPEDANCE SPECTROSCO
   MACKIE EJ, 1996, CELL SCI, V106, P1597
   MALIK F, 1991, THIN SOLID FILMS, V206, P345, DOI 10.1016/0040-6090(91)90448-7
   Marino CE, 2001, CORROS SCI, V43, P1465, DOI 10.1016/S0010-938X(00)00162-1
   Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109
   Martins DQ, 2008, ELECTROCHIM ACTA, V53, P2809, DOI 10.1016/j.electacta.2007.10.060
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Muraglia A, 2000, J CELL SCI, V113, P1161
   Niinomi M, 1999, MAT SCI ENG A-STRUCT, V263, P193, DOI 10.1016/S0921-5093(98)01167-8
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Oliveira NTC, 2007, MAT SCI ENG A-STRUCT, V452, P727, DOI 10.1016/j.msea.2006.11.061
   Oliveira NTC, 2004, ELECTROCHIM ACTA, V49, P4563, DOI 10.1016/j.electacta.2004.04.042
   Oliveira NTC, 2002, J BRAZIL CHEM SOC, V13, P463, DOI 10.1590/S0103-50532002000400009
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P398, DOI 10.1111/j.1600-0501.2009.01863.x
   Pham QP, 2008, BIOMATERIALS, V29, P2729, DOI 10.1016/j.biomaterials.2008.02.025
   POURBAIX M, 1984, BIOMATERIALS, V5, P122, DOI 10.1016/0142-9612(84)90046-2
   Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200
   RODAN SB, 1987, CANCER RES, V47, P4961
   Rosalbino F, 2010, J SOLID STATE ELECTR, V14, P1451, DOI 10.1007/s10008-009-0971-6
   Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025
   Salot R, 1996, J ELECTROCHEM SOC, V143, P3902, DOI 10.1149/1.1837314
   Sherepo K.M., 2004, MED TEKH, V2, P22
   Shukla AK, 2006, CORROS SCI, V48, P1696, DOI 10.1016/j.corsci.2005.06.003
   Temiselvi S., 2006, ELECTROCHIM ACTA, V52, P839
   Thomsen P, 1997, J MATER SCI-MATER M, V8, P653, DOI 10.1023/A:1018579605426
   Villars P., 1995, HDB TERNARY ALLOY PH
   YTO A, 1995, J BIOMED MATER RES, V29, P943
   Yun YH, 1996, J BIOMED MATER RES, V32, P77, DOI 10.1002/(SICI)1097-4636(199609)32:1<77::AID-JBM9>3.0.CO;2-M
   Zerega B, 1999, J BONE MINER RES, V14, P1281, DOI 10.1359/jbmr.1999.14.8.1281
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 60
TC 19
Z9 19
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD MAY
PY 2011
VL 22
IS 5
BP 1293
EP 1302
DI 10.1007/s10856-011-4301-z
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 778KF
UT WOS:000291701900020
PM 21461699
DA 2018-10-20
ER

PT J
AU Das, D
   Ara, T
   Dutta, S
   Mukherjee, A
AF Das, Debasis
   Ara, Tarannum
   Dutta, Sriparna
   Mukherjee, Arup
TI New water resistant biomaterial biocide film based on guar gum
SO BIORESOURCE TECHNOLOGY
LA English
DT Article
DE Guar gum; Guar gum benzamide; Hydrophobic; Biopolymer; Biocide film
ID BARRIER PROPERTIES; CHITOSAN; CELLULOSE; POLYSACCHARIDES; BIOFILMS; OIL
AB This work was aimed to develop water resistant biocide film from renewable resources for applications in food and water technology. Guar gum, a polymeric galactomannan, was intrinsically modified to a new guar gum benzamide. Benzoylation was carried out by benzoyl chloride reaction in water medium and a propyl amine spacer was used to impart a high degree of hydrophobicity. The new guar gum benzamide was resistant to water and soluble in non aqueous solvent like dimethyl sulfoxide. Cast films of thickness 0.162 mm had a breaking point tensile strength of 21.95 Mpa. The water vapor permeability of biomaterial film was 0.28 g mm kPa(-1) h(-1) m(-2) and water contact angle on evaporative surface was 90.35 degree. Qualitative and quantitative biocide activity of film was established against Salmonella enterica, Escherichia coli, Staphylococcus aureus and Bacillus subtilis. The new guar gum benzamide absorbed strongly in UV region. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Das, Debasis; Ara, Tarannum; Dutta, Sriparna; Mukherjee, Arup] Univ Calcutta, Dept Chem Technol, Kolkata 700009, India.
RP Mukherjee, A (reprint author), Univ Calcutta, Dept Chem Technol, 92 APC Rd, Kolkata 700009, India.
EM arupm1234@gmail.com
FU UGC under Calcutta University Center for Research in Nanoscience and
   Nanotechnology; Department of Biotechnology. Govt. of India
FX Authors intend to acknowledge the financial support extended by the UGC
   special assistance grants under the Calcutta University Center for
   Research in Nanoscience and Nanotechnology and one of the authors DD
   appreciate a senior research fellowship grant extended by the Department
   of Biotechnology. Govt. of India. Authors will also like to acknowledge
   Dr. Bikash Mondal, City University of New York, USA for some suggestions
   in preparation of the manuscript.
CR ASH M, 2009, HDB PRESERVATIVES, P289
   BERNI RJ, 1969, Patent No. 3464781
   Bocchinfuso G, 2010, J PHYS CHEM B, V114, P13059, DOI 10.1021/jp105838t
   Chauhan K, 2009, BIORESOURCE TECHNOL, V100, P3599, DOI 10.1016/j.biortech.2009.03.007
   Chung YC, 2008, BIORESOURCE TECHNOL, V99, P2806, DOI 10.1016/j.biortech.2007.06.044
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Crescenzi V, 2004, BIOMACROMOLECULES, V5, P537, DOI 10.1021/bm034387k
   Cunha AG, 2007, BIOMACROMOLECULES, V8, P1347, DOI 10.1021/bm0700136
   Dutta PK, 2009, FOOD CHEM, V114, P1173, DOI 10.1016/j.foodchem.2008.11.047
   ENTSAR RI, 2003, BIOMACROMOLECULES, V4, P1457
   Fernandez-Saiz P, 2009, J AGR FOOD CHEM, V57, P3298, DOI 10.1021/jf8037709
   Hartman J, 2006, BIOMACROMOLECULES, V7, P1983, DOI 10.1021/bm060129m
   Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014
   Hornemann JA, 2008, BIOMACROMOLECULES, V9, P2322, DOI 10.1021/bm800269h
   Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X
   Krishnaiah YSR, 1998, J CONTROL RELEASE, V55, P245, DOI 10.1016/S0168-3659(98)00057-1
   Lichter JA, 2009, MACROMOLECULES, V42, P8573, DOI 10.1021/ma901356s
   Maillard JY, 2002, J APPL MICROBIOL S, V92, p16S, DOI DOI 10.1046/J.1365-2672.92.5S1.3.X.PMID:12000609
   MCKELVEY JB, 1960, J ORG CHEM, V25, P1424, DOI 10.1021/jo01078a035
   Minekus M, 2005, BIOSCI BIOTECH BIOCH, V69, P932, DOI 10.1271/bbb.69.932
   Mothe CG, 2006, J THERM ANAL CALORIM, V85, P31, DOI 10.1007/s10973-005-7339-7
   Mukherjee A., 2007, NEW HORIZONS BIOTECH, P1
   Naoi S, 2002, J THERM ANAL CALORIM, V70, P841, DOI 10.1023/A:1022260304686
   Ojagh SM, 2010, FOOD CHEM, V122, P161, DOI 10.1016/j.foodchem.2010.02.033
   Pelissari FM, 2009, J AGR FOOD CHEM, V57, P7499, DOI 10.1021/jf9002363
   RAFIQUE CM, 1950, J AM CHEM SOC, V72, P4634, DOI 10.1021/ja01166a082
   Rana D, 2010, CHEM REV, V110, P2448, DOI 10.1021/cr800208y
   Rhim JW, 2009, LWT-FOOD SCI TECHNOL, V42, P612, DOI 10.1016/j.lwt.2008.02.015
   Risica D, 2005, POLYMER, V46, P12247, DOI 10.1016/j.polymer.2005.10.083
   Roy D, 2008, BIOMACROMOLECULES, V9, P91, DOI 10.1021/bm700849j
   Saxena A, 2009, CARBOHYD POLYM, V78, P357, DOI 10.1016/j.carbpol.2009.03.039
   Song YB, 2008, BIOMACROMOLECULES, V9, P2259, DOI 10.1021/bm800429a
   Sothornvit R, 2007, FOOD RES INT, V40, P365, DOI 10.1016/j.foodres.2006.10.010
   Srinivasa PC, 2004, J FOOD ENG, V63, P79, DOI 10.1016/S0260-8774(03)00285-1
   Wood P, 1996, APPL ENVIRON MICROB, V62, P2598
NR 35
TC 29
Z9 29
U1 2
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-8524
EI 1873-2976
J9 BIORESOURCE TECHNOL
JI Bioresour. Technol.
PD MAY
PY 2011
VL 102
IS 10
BP 5878
EP 5883
DI 10.1016/j.biortech.2011.02.034
PG 6
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 770ZA
UT WOS:000291125800045
PM 21392974
DA 2018-10-20
ER

PT J
AU Singh, H
   Kumar, N
   Sharma, AK
   Kataria, M
   Munjal, A
AF Singh, Himani
   Kumar, Naveen
   Sharma, A. K.
   Kataria, Meena
   Munjal, Ashok
TI In-vitro study of matrix metalloproteinases in decellularized
   extracellular matrix of bovine diaphragm
SO INDIAN JOURNAL OF ANIMAL SCIENCES
LA English
DT Article
DE Bovine diaphragm; Gelatin zymography; MMPs; SDS-PAGE electrophoresis
ID BIOPROSTHETIC CARDIAC VALVES; TISSUE; COLLAGENASE; ENZYMES; FAMILY
AB The present study was undertaken for the identification of matrix metalloproteinases (MMPs) in the extracts obtained from a multi-step detergent-enzymatic extraction process involving 2 types of anionic and non-ionic detergents from bovine diaphragm and their possible involvement in the degradation of these biological materials. Anionic biological detergents treated bovine diaphragm expressed no band in SDS-PAGE analysis but non-ionic treated bovine diaphragm expressed almost similar bands as that of untreated treated bovine diaphragm. In gelatin zymography, anionic treated biomaterial expressed a 25 KDa band of MMPs, but in non-treated and non-ionic treated bovine diaphragm no band of MMPs was expressed. Anionic detergents played an important role in the removal of cells from bovine diaphragm and increasing MMPs activity in biomaterials as compared to non-ionic detergents.
C1 [Singh, Himani; Kumar, Naveen; Sharma, A. K.] Indian Vet Res Inst, Div Surg, Izatnagar 243122, Uttar Pradesh, India.
   [Kataria, Meena] Indian Vet Res Inst, Div Biochem, Izatnagar 243122, Uttar Pradesh, India.
RP Singh, H (reprint author), Indian Vet Res Inst, Div Surg, Izatnagar 243122, Uttar Pradesh, India.
CR BERGMANN U, 1989, J CLIN CHEM CLIN BIO, V27, P351
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   ELKINS RC, 2001, ANN THORAC SURG, V71, pS28
   FINI ME, 1987, BIOCHEMISTRY-US, V26, P6156, DOI 10.1021/bi00393a032
   GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181
   Grauss RW, 2003, J THORAC CARDIOV SUR, V126, P2003, DOI 10.1016/S0022-5223(03)00956-5
   Huessen C, 1980, ANN BIOCH, V102, P96
   Kumar ABV, 2005, BIOCHEM J, V391, P167, DOI 10.1042/BJ200580093
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   MATSUBARA M, 1991, DEV BIOL, V147, P425, DOI 10.1016/0012-1606(91)90300-R
   Simionescu A, 1996, ASAIO J, V42, pM561, DOI 10.1097/00002480-199609000-00049
   Simionescu A, 1996, CARDIOVASC PATHOL, V5, P323, DOI 10.1016/S1054-8807(96)00043-9
   VANBUERDEN PAS, 2005, BIOTECHNIQUES, V38, P73
   WOESSNER JF, 1991, FASEB J, V5, P2145
NR 15
TC 0
Z9 0
U1 0
U2 1
PU INDIAN COUNC AGRICULTURAL RES
PI NEW DELHI
PA ICAR BHAWAN PUSA, NEW DELHI 110 012, INDIA
SN 0367-8318
J9 INDIAN J ANIM SCI
JI Indian J. Anim. Sci.
PD MAY
PY 2011
VL 81
IS 5
BP 453
EP 455
PG 3
WC Agriculture, Dairy & Animal Science
SC Agriculture
GA 767UJ
UT WOS:000290883400005
DA 2018-10-20
ER

PT J
AU Rogalski, A
AF Rogalski, A.
TI Recent progress in infrared detector technologies
SO INFRARED PHYSICS & TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT International Conference on the Quantum Structure Infrared Photodetector
   (QSIP)
CY AUG 15-20, 2010
CL Istanbul, TURKEY
DE HgCdTe photodiodes; QWIPs; Type-II superlattices; Third generation
   detectors; Uncooled thermal bolometers; Novel thermal detectors
ID FOCAL-PLANE ARRAYS; AVALANCHE PHOTODIODES; HGCDTE; BAND; SUPERLATTICES;
   PERFORMANCE; MBE; PHOTODETECTOR; EPITAXY; SENSORS
AB In the paper, fundamental and technological issues associated with the development and exploitation of the most advanced infrared detector technologies are discussed. In this class of detectors both photon and thermal detectors are considered. Special attention is directed to HgCdTe ternary alloys on silicon, type-II superlattices, uncooled thermal bolometers, and novel uncooled micromechanical cantilever detectors.
   Despite serious competition from alternative technologies and slower progress than expected, HgCdTe is unlikely to be seriously challenged for high-performance applications, applications requiring multispectral capability and fast response. However, the nonuniformity is a serious problem in the case of LWIR and VLWIR HgCdTe detectors. In this context, it is predicted that type-II superlattice system seems to be an alternative to HgCdTe in long wavelength spectral region.
   In well established uncooled imaging, microbolometer arrays are clearly the most used technology. Present state-of-the-art microbolometers are based on polycrystalline or amorphous materials, typically vanadium oxide (VOx) or amorphous silicon (alpha-Si), with only modest temperature sensitivity and noise properties. Basic efforts today are mainly focused on pixel reduction and performance enhancement. Attractive alternatives consist of low-resistance alpha-SiGe monocrystalline SiGe quantum wells or quantum dots.
   In spite of successful commercialization of uncooled microbolometers, the infrared community is still searching for a platform for thermal imagers that combine affordability, convenience of operation, and excellent performance. Recent advances in MEMS systems have lead to the development of uncooled IR detectors operating as micromechanical thermal detectors. Between them the most important are biomaterial microcantilevers. (C) 2010 Elsevier B.V. All rights reserved.
C1 Mil Univ Technol, Inst Appl Phys, PL-00908 Warsaw, Poland.
RP Rogalski, A (reprint author), Mil Univ Technol, Inst Appl Phys, 2 Kaliskiego St, PL-00908 Warsaw, Poland.
EM rogan@wat.edu.pl
RI Rogalski, Antoni/H-8073-2012
OI Rogalski, Antoni/0000-0002-4985-7297
CR Abedin MN, 2004, P SOC PHOTO-OPT INS, V5543, P239, DOI 10.1117/12.559917
   AIFER EH, 2006, APPL PHYS LETT, V89
   Amantea R, 1997, P SOC PHOTO-OPT INS, V3061, P210, DOI 10.1117/12.280340
   Anderson J, 2001, P SOC PHOTO-OPT INS, V4369, P559, DOI 10.1117/12.445315
   Aqariden F, 2007, J ELECTRON MATER, V36, P900, DOI 10.1007/s11664-007-0127-3
   Arslan Y, 2009, INFRARED PHYS TECHN, V52, P399, DOI 10.1016/j.infrared.2009.06.005
   Beletic J. W., 2008, P SPIE, V7021
   BLAZEJEWSKI ER, 1992, J VAC SCI TECHNOL B, V10, P1626, DOI 10.1116/1.586259
   Bois P, 2001, INFRARED PHYS TECHN, V42, P291, DOI 10.1016/S1350-4495(01)00087-1
   Bornfreund R, 2007, J ELECTRON MATER, V36, P1085, DOI 10.1007/s11664-007-0177-6
   Brown GJ, 2005, P SOC PHOTO-OPT INS, V5783, P65, DOI 10.1117/12.606621
   CAMPBELL JC, 1980, IEEE J QUANTUM ELECT, V16, P601, DOI 10.1109/JQE.1980.1070534
   Castelein P, 2005, P SOC PHOTO-OPT INS, V5783, P804, DOI 10.1117/12.606430
   CAULFIELD JT, 2003, P 32 APPL IM PATT RE, P7
   CROSBIE MJ, 2010, P SPIE, V7660
   DATSKOS P, 2006, SPIE NEWSROOM, DOI DOI 10.1117/2.1200608.036
   DEBORNIOLA E, 2010, P SPIE, V7660
   Destefanis G, 2007, J ELECTRON MATER, V36, P1031, DOI 10.1007/s11664-007-0168-7
   Donetsky D, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3267103
   Eker SU, 2009, INFRARED PHYS TECHN, V52, P385, DOI 10.1016/j.infrared.2009.05.008
   ERDTMANN M, 2010, P SPIE, V7660
   Goldberg AC, 2001, P SOC PHOTO-OPT INS, V4369, P532, DOI 10.1117/12.445313
   Grein CH, 1995, J APPL PHYS, V78, P7143, DOI 10.1063/1.360422
   Gunapala SD, 2007, INFRARED PHYS TECHN, V50, P217, DOI 10.1016/j.infrared.2006.10.005
   Gunapala SD, 2010, IEEE J QUANTUM ELECT, V46, P285, DOI 10.1109/JQE.2009.2024550
   Gunapala SD, 2005, SEMICOND SCI TECH, V20, P473, DOI 10.1088/0268-1242/20/5/026
   Gunapala SD, 2003, IEEE T ELECTRON DEV, V50, P2353, DOI 10.1109/TED.2003.818818
   Hall DJ, 2004, P SOC PHOTO-OPT INS, V5406, P317, DOI 10.1117/12.545003
   HALL DNB, 2009, TECHNOL DEV PAPERS, V28
   HANSON CM, 2008, P SPIE, V6940
   Hoffman A, 2006, LASER FOCUS WORLD, V42, P81
   Hoffman AW, 2003, P SOC PHOTO-OPT INS, V5167, P194, DOI 10.1117/12.516509
   HOFFMAN CA, 1994, SOLID STATE ELECTRON, V37, P1203, DOI 10.1016/0038-1101(94)90389-1
   Hood AD, 2010, J ELECTRON MATER, V39, P1001, DOI 10.1007/s11664-010-1091-x
   Horn S, 2005, P SOC PHOTO-OPT INS, V5783, P401, DOI 10.1117/12.609467
   Horn S, 2004, P SOC PHOTO-OPT INS, V5406, P332, DOI 10.1117/12.548880
   HUNTER SR, 2008, P SPIE, V6940
   Jhabvala M, 2003, P SOC PHOTO-OPT INS, V5167, P175, DOI 10.1117/12.505733
   Kinch MA, 2004, J ELECTRON MATER, V33, P630, DOI 10.1007/s11664-004-0058-1
   KING DF, 2006, P SPIE, V6206
   KING DF, 2008, P SPIE, V6940
   Klipstein P, 2008, P SPIE, V6940
   Klipstein P., 2010, P SPIE, V7608, p76081V
   Kohin M, 2004, P SOC PHOTO-OPT INS, V5406, P447, DOI 10.1117/12.542482
   KOZLOWSKI LJ, 1995, HDB OPTICS, pCH23
   Kroemer H, 2004, PHYSICA E, V20, P196, DOI 10.1016/j.physe.2003.08.003
   LAVRIK N, 2007, P SOC PHOTO-OPT INS, V6542, pE1
   LEVEQUE G, 1993, SEMICOND SCI TECH, V8, P1317, DOI 10.1088/0268-1242/8/7/021
   Li C., 2009, P SPIE, V7298
   LOCKWOOD AH, 1976, INFRARED PHYS, V16, P509, DOI 10.1016/0020-0891(76)90070-1
   MAILHIOT C, 1989, J VAC SCI TECHNOL A, V7, P445, DOI 10.1116/1.576201
   Maimon S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360235
   McCarley P, 2001, P SOC PHOTO-OPT INS, V4288, P1, DOI 10.1117/12.429394
   MUNZBERG M, 2007, P SPIE, V6542
   NGUYEN BM, 2009, APPL PHYS LETT, V95
   NGUYEN BM, 2007, APPL PHYS LETT, V91, DOI DOI 10.1063/1.2800808
   Norton P, 2002, OPTO-ELECTRON REV, V10, P159
   Norton P, 2000, P SOC PHOTO-OPT INS, V4130, P226, DOI 10.1117/12.409861
   NORTON PR, 2006, OPTO-ELECTRON REV, V14, P283
   Pedrazzani JR, 2008, ELECTRON LETT, V44, P1487, DOI 10.1049/el:20082925
   Pellegrino J., 2009, P SPIE, V7298
   Perrais G., 2006, P SPIE, V6395
   Perrais G, 2007, J ELECTRON MATER, V36, P963, DOI 10.1007/s11664-007-0147-z
   Peterson JM, 2006, J ELECTRON MATER, V35, P1283, DOI 10.1007/s11664-006-0255-1
   Rajavel RD, 1998, J ELECTRON MATER, V27, P747, DOI 10.1007/s11664-998-0047-x
   Ratches JA, 2006, FERROELECTRICS, V342, P183, DOI 10.1080/00150190600946351
   Razeghi M, 2009, P IEEE, V97, P1056, DOI 10.1109/JPROC.2009.2017108
   Reago DA, 1999, P SOC PHOTO-OPT INS, V3701, P108, DOI 10.1117/12.352991
   REHM R, 2010, P SPIE, V7660
   Reine MB, 1998, P SOC PHOTO-OPT INS, V3379, P200, DOI 10.1117/12.317588
   RHIGER DR, 2010, P SPIE, V7660
   Robo J. A., 2009, P SPIE, V7298
   RODRIGUEZ JB, 2007, APPL PHYS LETT, V91
   Rogalski A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3099572
   Rogalski A., 2010, INFRARED DETECTORS
   ROXHED N, 2010, P SPIE, V7726
   RUTZ F, 2009, P SPIE, V7298
   SAKAKI H, 1977, APPL PHYS LETT, V31, P211, DOI 10.1063/1.89609
   SALERNO JP, 2007, P SPIE, V6542
   Schimert T., 2009, P SPIE, V7298
   Schneider H, 2000, P SOC PHOTO-OPT INS, V4130, P353, DOI 10.1117/12.409877
   Schneider H, 2001, INFRARED PHYS TECHN, V42, P283, DOI 10.1016/S1350-4495(01)00086-X
   SOIBEL A, 2009, P SPIE, V7298
   Tennant WE, 2008, J ELECTRON MATER, V37, P1406, DOI 10.1007/s11664-008-0426-3
   Tennant WE, 2001, J ELECTRON MATER, V30, P590, DOI 10.1007/BF02665839
   TIDROW MZ, 1999, OPTO-ELECTRON REV, V7, P283
   Ting D. Z., 2010, P SPIE, V7660
   Ting DZY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3177333
   Wachter EA, 1996, REV SCI INSTRUM, V67, P3434, DOI 10.1063/1.1147149
   Wei YJ, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.085316
   White A. M., 1987, U.S. Patent, Patent No. [4 679 063 A, 4679063]
   Wijewarnasuriya PS, 2010, IEEE T ELECTRON DEV, V57, P782, DOI 10.1109/TED.2010.2041511
   WILSON JA, 1994, P SOC PHOTO-OPT INS, V2274, P117, DOI 10.1117/12.189237
   YANG OK, 2003, P SOC PHOTO-OPT INS, V4999, P448
   Yon J., 2010, P SPIE, V7660
   Zanatta JP, 2000, P SOC PHOTO-OPT INS, V4130, P441, DOI 10.1117/12.409885
   Zhao J, 2005, P SOC PHOTO-OPT INS, V5783, P506, DOI 10.1117/12.606485
   Zheng L., P SPIE, V7660
   2006, UKTA NEWS        DEC
   2003, OPTO LASER EUROP JUN
NR 100
TC 189
Z9 196
U1 16
U2 248
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1350-4495
EI 1879-0275
J9 INFRARED PHYS TECHN
JI Infrared Phys. Technol.
PD MAY
PY 2011
VL 54
IS 3
BP 136
EP 154
DI 10.1016/j.infrared.2010.12.003
PG 19
WC Instruments & Instrumentation; Optics; Physics, Applied
SC Instruments & Instrumentation; Optics; Physics
GA 768XP
UT WOS:000290973200002
DA 2018-10-20
ER

PT J
AU Ehashi, T
   Hyun, H
   Yui, N
AF Ehashi, Tomo
   Hyun, Hoon
   Yui, Nobuhiko
TI Anti-inflammatory response of mannose-conjugated polyrotaxane
   endocytosed into macrophage
SO MACROMOLECULAR RESEARCH
LA English
DT Article
DE mannose-conjugated polyrotaxane; endocytosis; macrophage response
ID SURFACE-CHEMISTRY; IN-VIVO; J774 MACROPHAGES; EXPRESSION; RECEPTOR;
   BIOMATERIALS; PHAGOCYTOSIS; IMPLANTATION; POLYMERS; MOBILITY
AB Macrophage response to mannose-conjugated polyrotaxane (Man-PRX) was examined in terms of the morphological changes in macrophage-like J774.1 cells and their inflammation-related cytokine expression. The results obtained were compared with those by mannose-conjugated alpha-CD (Man-CD), mannan, and mannose-conjugated polyacrylamide (Man-PAAm). The largest percentage of the morphological change was observed for Man-PRX, which is presumably induced by mannose receptor-mediated endocytosis. In the cytokine expression experiments, anti-inflammatory cytokine was expressed by Man-PRX but the pro-inflammatory cytokine level was increased by Man-PAAm. Therefore, Man-PRX has great potential as anti-inflammatory biomaterial.
C1 [Ehashi, Tomo; Hyun, Hoon; Yui, Nobuhiko] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.
   [Yui, Nobuhiko] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan.
RP Yui, N (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, 1-1 Asahi Dai, Nomi, Ishikawa 9231292, Japan.
EM yui.org@tmd.ac.jp
RI EHASHI, Tomo/H-4817-2016; Kobe Univ, Engineering/D-2028-2017
FU Ministry of Education, Culture, Sports, Science and Technology (MEXT),
   Japan [19300170]
FX A part of this study was financially supported by a Grant-in-Aid for
   Scientific Research B (19300170) from the Ministry of Education,
   Culture, Sports, Science and Technology (MEXT), Japan. The
   mannose-containing polyacrylamide (Man-PAAm) supplied by Prof. Yoshiko
   Miura (Kyusyu University) is greatly appreciated. T. E. would like to
   appreciate a support from the Program for developing the supporting
   system for upgrading the education and research.
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Chang JR, 2000, VIROLOGY, V278, P346, DOI 10.1006/viro.2000.0646
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DIMENT S, 1987, J LEUKOCYTE BIOL, V42, P485
   Fiani ML, 1998, J LEUKOCYTE BIOL, V64, P85
   Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004
   HANESSIAN S, 1995, J ORG CHEM, V60, P4786, DOI 10.1021/jo00120a023
   HYUN H, 2011, MACROMOL BI IN PRESS, V11
   Hyun H, 2011, MACROMOL RAPID COMM, V32, P326, DOI 10.1002/marc.201000631
   ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107
   Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649
   Kvist PH, 2010, DIABETES TECHNOL THE, V12, P791, DOI 10.1089/dia.2010.0041
   Lammers G, 2010, BIOMATERIALS, V31, P8299, DOI 10.1016/j.biomaterials.2010.07.055
   Lehle K, 2004, BIOMATERIALS, V25, P5457, DOI 10.1016/j.biomaterials.2003.12.055
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   Mytar B, 2004, INFLAMM RES, V53, P100, DOI 10.1007/s00011-003-1233-1
   OHKI K, 1991, CELL STRUCT FUNCT, V16, P495, DOI 10.1247/csf.16.495
   Ooya T, 2003, J AM CHEM SOC, V125, P13016, DOI 10.1021/ja034583z
   Parl HD, 2003, J BIOMED MATER RES A, V66A, P596, DOI 10.1002/jbm.a.10505
   Porcaro I, 2003, J LEUKOCYTE BIOL, V74, P206, DOI 10.1189/jlb.1202608
   Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939
   Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317
   Shen MC, 2004, J BIOMED MATER RES A, V70A, P533, DOI 10.1002/jbm.a.30069
   Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9
   Ye QS, 2010, BIOMATERIALS, V31, P9192, DOI 10.1016/j.biomaterials.2010.08.049
   Yui N, 2006, CHEM-EUR J, V12, P6730, DOI 10.1002/chem.200600370
NR 30
TC 0
Z9 0
U1 1
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1598-5032
EI 2092-7673
J9 MACROMOL RES
JI Macromol. Res.
PD MAY
PY 2011
VL 19
IS 5
BP 495
EP 500
DI 10.1007/s13233-011-0506-8
PG 6
WC Polymer Science
SC Polymer Science
GA 768NM
UT WOS:000290941800012
DA 2018-10-20
ER

PT J
AU Anderson, J
   McNally, A
AF Anderson, James M.
   McNally, Amy K.
TI Biocompatibility of implants: lymphocyte/macrophage interactions
SO SEMINARS IN IMMUNOPATHOLOGY
LA English
DT Review
DE Biomaterial; Foreign body response; Inflammation; Lymphocyte; Macrophage
ID GIANT-CELL FORMATION; BIOMATERIAL SURFACE-CHEMISTRY; VENTRICULAR ASSIST
   DEVICE; HUMAN MACROPHAGE ADHESION; FOREIGN-BODY RESPONSE;
   NATURAL-KILLER-CELL; T-CELL; IN-VITRO; PROSTHETIC BIOMATERIAL; ADHERENT
   MACROPHAGES
AB The monocyte-derived macrophage is recognized as a critical determinant in biocompatibility, but its appearance in the chronic inflammatory phase is accompanied by the presence of lymphocytes, which have been much less studied in this regard. Here, we first present an overview of the physiologic continuum comprising host reactions to the surgical implantation of biomaterial. Secondly, we describe our collective research efforts, which indicate that lymphocytes are additional and key cellular determinants of biocompatible outcome. Thus, bioengineering advances will require that lymphocyte responses be regarded as integral components of innate inflammatory and immune/immunotoxic cell interactions at sites of biomaterial implantation.
C1 [Anderson, James M.; McNally, Amy K.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Anderson, J (reprint author), Case Western Reserve Univ, Dept Pathol, Wolstein Res Bldg,Room 5104,2103 Cornell Rd, Cleveland, OH 44106 USA.
EM jma6@case.edu
FU National Institutes of Health, Institute of Biomedical Imaging and
   Bioengineering [EB-00282]
FX The authors gratefully acknowledge the support of the National
   Institutes of Health, Institute of Biomedical Imaging and
   Bioengineering, Grant EB-00282.
CR Al-Saffar N, 1998, J MATER SCI-MATER M, V9, P849, DOI 10.1023/A:1008952329788
   Anderson J.M., 2008, PRINCIPLES REGENERAT, P704
   Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   ANDERSON JM, 2004, BIOMATERIALS SCI INT, P360
   ANDERSON JM, 2004, BIOMATERIALS SCI INT, P771
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   ANDERSON JM, 1991, ARTIFICIAL HEART, V3, P45
   Ankersmit HJ, 1999, LANCET, V354, P550, DOI 10.1016/S0140-6736(98)10359-8
   Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0
   Beech JT, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2077
   BENDER BS, 1984, KIDNEY INT, V26, P436, DOI 10.1038/ki.1984.193
   Berton G, 1999, CELL SIGNAL, V11, P621, DOI 10.1016/S0898-6568(99)00003-0
   Brigelius-Flohe R, 1999, FASEB J, V13, P1145
   Brodbeck WG, 2005, J BIOMED MATER RES A, V74A, P222, DOI 10.1002/jbm.a.30313
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Burger D, 2002, ANN NY ACAD SCI, V966, P464, DOI 10.1111/j.1749-6632.2002.tb04248.x
   CHAMBERS TJ, 1982, IMMUNOBIOLOGY, V161, P283, DOI 10.1016/S0171-2985(82)80084-3
   Chang CC, 1999, BIOMATERIALS, V20, P273, DOI 10.1016/S0142-9612(98)00171-9
   Chang CC, 2000, BIOMATERIALS, V21, P2305, DOI 10.1016/S0142-9612(00)00157-5
   Chang DT, 2008, J BIOMED MATER RES A, V87A, P676, DOI 10.1002/jbm.a.31630
   Chang DT, 2009, J BIOMED MATER RES A, V91A, P1210, DOI 10.1002/jbm.a.32218
   CHANG DT, 2008, J BIOMED MATER RES A, V89, P490
   Clarkson MR, 2005, TRANSPLANTATION, V80, P555, DOI 10.1097/01.tp.0000168432.60022.99
   Collier TO, 2004, J BIOMED MATER RES A, V69A, P644, DOI 10.1002/jbm.a.30030
   de Lalla C, 2004, J IMMUNOL, V173, P1417, DOI 10.4049/jimmunol.173.2.1417
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   DeFranco AL, 1998, CURR OPIN IMMUNOL, V10, P243, DOI 10.1016/S0952-7915(98)80160-X
   Di Santo JP, 2006, ANNU REV IMMUNOL, V24, P257, DOI 10.1146/annurev.immunol.24.021605.090700
   Drachman Douglas E, 2005, Curr Atheroscler Rep, V7, P44, DOI 10.1007/s11883-005-0074-5
   Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332
   Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836
   Gemmell CH, 1996, J BIOMED MATER RES, V32, P29, DOI 10.1002/(SICI)1097-4636(199609)32:1<29::AID-JBM4>3.0.CO;2-R
   Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096
   Gonzalez-Amaro R, 1999, CRIT REV IMMUNOL, V19, P389
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gordon S., 1999, INFLAMMATION BASIC P, P35
   GORDON S, 2003, NAT REV IMMUNOL, V3, P25
   GREENBERG S, 1999, BASIC PRINCIPLES CLI, P681
   Grooteman MPC, 1996, NEPHROL DIAL TRANSPL, V11, P1073
   Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19
   GUERDER S, 1994, IMMUNITY, V1, P155
   Gupta S, 2005, ANN NY ACAD SCI, V1050, P108, DOI 10.1196/annals.1313.012
   HARBERS GM, 2006, INTRO BIOMATERIALS, P15
   Horbett TA, 2004, BIOMATERIALS SCI INT, P237
   HOUSSIAU FA, 1989, J IMMUNOL, V143, P2520
   Isomaki Pia, 2005, Current Drug Targets - Inflammation and Allergy, V4, P287, DOI 10.2174/1568010054022042
   Itescu S, 2000, PROG CARDIOVASC DIS, V43, P67, DOI 10.1053/pcad.2000.7191
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Jenney CR, 1999, J BIOMED MATER RES, V44, P206, DOI 10.1002/(SICI)1097-4636(199902)44:2<206::AID-JBM11>3.0.CO;2-D
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   Joner M., 2006, J AM COLL CARDIOL, V48, P203
   Jones JA, 2007, J BIOMED MATER RES, V84, P158
   Jones JA, 2007, J BIOMED MATER RES A, V83A, P585, DOI 10.1002/jbm.a.31221
   KAO WYJ, 1995, J BIOMED MATER RES, V29, P1267, DOI 10.1002/jbm.820291014
   KAPLAN SS, 1994, J BIOMED MATER RES, V28, P377, DOI 10.1002/jbm.820280313
   Keegan AD, 2001, CYTOKINE REFERENCE
   Kirk JT, 2010, J BIOMED MATER RES A, V94A, P683, DOI 10.1002/jbm.a.32682
   Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002
   MacEwan MR, 2005, J BIOMED MATER RES A, V74A, P285, DOI 10.1002/jbm.a.30316
   Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207
   Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015
   Mantovani A, 2007, EUR J IMMUNOL, V37, P14, DOI 10.1002/eji.200636910
   McKenzie ANJ, 2001, CYTOKINE REFERENCE
   McNally AK, 2003, AM J PATHOL, V163, P1147, DOI 10.1016/S0002-9440(10)63474-8
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1995, AM J PATHOL, V147, P1487
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   MCNALLY AK, 1996, 5 WORLD BIOM C MAY 2
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   McNally AK, 2007, J BIOMED MATER RES A, V82A, P568, DOI 10.1002/bjm.a.31161
   Monaco Claudia, 2004, Current Drug Targets - Inflammation and Allergy, V3, P35, DOI 10.2174/1568010043483881
   Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170
   O'Connor GM, 2006, IMMUNOLOGY, V117, P1, DOI 10.1111/j.1365-2567.2005.02256.x
   Pesce J, 2006, J CLIN INVEST, V116, P2044, DOI 10.1172/JCI27727
   Raij L, 1987, Contrib Nephrol, V59, P17
   Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7
   Rodriguez A., 2008, J BIOMED MATER RES A, V89, P152, DOI DOI 10.1002/JBM.A.31939
   Rodriguez A, 2008, J BIOMED MATER RES A, V85A, P556, DOI 10.1002/jbm.a.31562
   Rodriguez A, 2009, J BIOMED MATER RES A, V90A, P106, DOI 10.1002/jbm.a.32050
   Rosenson-Schloss RS, 2002, J BIOMED MATER RES, V60, P8, DOI 10.1002/jbm.1278
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Santana MA, 2003, J CELL PHYSIOL, V195, P392, DOI 10.1002/jcp.10258
   Schuster M, 2001, TRANSPLANT P, V33, P1960, DOI 10.1016/S0041-1345(00)02754-8
   STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287
   Swartbol P, 1996, J BIOMED MATER RES, V32, P669, DOI 10.1002/(SICI)1097-4636(199612)32:4<669::AID-JBM21>3.0.CO;2-7
   Tan J, 2002, BIOMATERIALS, V23, P3215, DOI 10.1016/S0142-9612(02)00074-1
   Tang LP, 1998, P NATL ACAD SCI USA, V95, P8841, DOI 10.1073/pnas.95.15.8841
   Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816
   Van Kaer L, 2007, CURR OPIN IMMUNOL, V19, P354, DOI 10.1016/j.coi.2007.03.001
   Ward SG, 1998, BIOCHEM J, V333, P457, DOI 10.1042/bj3330457
   Werr J, 2000, J LEUKOCYTE BIOL, V68, P553
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Wisniewski N, 2000, FRESEN J ANAL CHEM, V366, P611, DOI 10.1007/s002160051556
   ZHAO Q, 1991, J BIOMED MATER RES, V25, P177, DOI 10.1002/jbm.820250205
   ZHAO QH, 1992, J BIOMED MATER RES, V26, P1019, DOI 10.1002/jbm.820260805
   Zingoni A, 2005, MOL IMMUNOL, V42, P451, DOI 10.1016/j.molimm.2004.07.025
NR 105
TC 82
Z9 82
U1 3
U2 57
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1863-2297
J9 SEMIN IMMUNOPATHOL
JI Semin. Immunopathol.
PD MAY
PY 2011
VL 33
IS 3
BP 221
EP 233
DI 10.1007/s00281-011-0244-1
PG 13
WC Immunology; Pathology
SC Immunology; Pathology
GA 769VN
UT WOS:000291046500002
PM 21271251
DA 2018-10-20
ER

PT J
AU Viguier, B
   Zor, K
   Kasotakis, E
   Mitraki, A
   Clausen, CH
   Svendsen, WE
   Castillo-Leon, J
AF Viguier, Bruno
   Zor, Kinga
   Kasotakis, Emmanouil
   Mitraki, Anna
   Clausen, Casper H.
   Svendsen, Winnie E.
   Castillo-Leon, Jaime
TI Development of an Electrochemical Meta-Ion Biosensor Using
   Self-Assembled Peptide Nanofibrils
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE self-assembly; peptide; nanofibrils; electrochemical biosensor; copper;
   biomaterial
ID MODIFIED GOLD ELECTRODES; GLY-GLY-HIS; SELECTIVE ELECTRODE; SENSORS;
   COPPER; MONOLAYERS; FABRICATION; FIBRILS; BIOMATERIALS; NANOTUBES
AB This article describes the combination of self-assembled peptide nanofibrils with metal electrodes for the development of an electrochemical metal-ion biosensor. The biological nanofibrils were immobilized on gold electrodes and used as biorecognition elements for the complexation with copper ions. These nanofibrils were obtained under aqueous conditions, at room temperature and outside the clean room. The functionalized gold electrode was evaluated by cyclic voltammetry, impedance spectroscopy, energy dispersive X-ray and atomic force microscopy. The obtained results displayed a layer of nanofibrils able to complex with copper ions in solution. The response of the obtained biosensor was linear up to 50 mu M copper and presented a sensitivity of 0.68 mu A cm(-2) mu M(-1). Moreover, the fabricated sensor could be regenerated to a copper-free state allowing its reutilization.
C1 [Clausen, Casper H.; Svendsen, Winnie E.; Castillo-Leon, Jaime] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark.
   [Viguier, Bruno; Zor, Kinga] Lund Univ, Dept Biotechnol, S-22100 Lund, Sweden.
   [Kasotakis, Emmanouil; Mitraki, Anna] Univ Crete, Dept Mat Sci & Technol, Iraklion, Greece.
   [Kasotakis, Emmanouil; Mitraki, Anna] IESL FORTH, Iraklion, Greece.
RP Castillo-Leon, J (reprint author), Tech Univ Denmark, Dept Micro & Nanotechnol, Bldg 345E, DK-2800 Lyngby, Denmark.
EM jaic@nanotech.dtu.dk
RI Svendsen, Winnie/A-2976-2012; Castillo-Leon, Jaime/C-2567-2011; Hyttel
   Clausen, Casper/H-7793-2012; Kasotakis, Emmanouil/M-4980-2016; MITRAKI,
   Anna/A-6034-2014; Zor, Kinga/I-4307-2012
OI Svendsen, Winnie/0000-0002-9197-6505; Castillo-Leon,
   Jaime/0000-0003-0901-5244; Kasotakis, Emmanouil/0000-0002-7263-1384;
   Zor, Kinga/0000-0002-2905-4155; Viguier, Bruno/0000-0002-1246-5505
FU European BeNatural project [BeNatural/NMP4-CT-2006-033256]
FX The authors would like to thank the European BeNatural project
   (BeNatural/NMP4-CT-2006-033256) for financial support.
CR Bi XY, 2008, BIOSENS BIOELECTRON, V23, P1442, DOI 10.1016/j.bios.2007.12.012
   Bi XY, 2009, BIOSENS BIOELECTRON, V24, P3248, DOI 10.1016/j.bios.2009.04.007
   Boncheva M, 2005, MRS BULL, V30, P736, DOI 10.1557/mrs2005.208
   Brea RJ, 2010, CHEM SOC REV, V39, P1448, DOI 10.1039/b805753m
   Castillo J, 2004, SENSOR ACTUAT B-CHEM, V102, P179, DOI 10.1016/j.snb.2004.04.084
   Chow E, 2005, SENSOR ACTUAT B-CHEM, V111, P540, DOI 10.1016/j.snb.2005.03.046
   Chow E, 2006, ELECTROANAL, V18, P1437, DOI 10.1002/elan.200603558
   CHUN A, 2007, NANOTECHNOLOGY BIOL, P1
   de la Rica R, 2010, SMALL, V6, P1753, DOI 10.1002/smll.201000489
   de la Rica R, 2010, CHEM SOC REV, V39, P3499, DOI 10.1039/b917574c
   Dinca V, 2008, PHYS STATUS SOLIDI C, V5, P3576, DOI 10.1002/pssc.200780187
   Dinca V, 2008, NANO LETT, V8, P538, DOI 10.1021/nl072798r
   Eckermann AL, 2010, COORDIN CHEM REV, V254, P1769, DOI 10.1016/j.ccr.2009.12.023
   Ghaedi M, 2007, J HAZARD MATER, V142, P272, DOI 10.1016/j.jhazmat.2006.08.012
   Goodenough J. B., 2001, STORY TAXOL NATURE P, P1
   Gooding JJ, 2001, ANAL SCI, V17, P3, DOI 10.2116/analsci.17.3
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Huster D, 2007, MOL BIOSYST, V3, P816, DOI 10.1039/b711118p
   Jakubeniene M, 2006, FORENSIC SCI INT, V161, P36, DOI 10.1016/j.forsciint.2005.10.019
   Kasotakis E, 2009, BIOPOLYMERS, V92, P164, DOI 10.1002/bip.21163
   Knecht MR, 2009, ANAL BIOANAL CHEM, V394, P33, DOI 10.1007/s00216-008-2594-7
   Liu AC, 1999, ANAL CHEM, V71, P1549, DOI 10.1021/ac980956g
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   Nie ZH, 2010, LAB CHIP, V10, P477, DOI 10.1039/b917150a
   Niu LM, 2007, J ANAL CHEM+, V62, P470, DOI 10.1134/S1061934807050140
   NUZZO RG, 1987, J AM CHEM SOC, V109, P2358, DOI 10.1021/ja00242a020
   Papanikolopoulou K, 2005, J BIOL CHEM, V280, P2481, DOI 10.1074/jbc.M406282200
   Pepe-Mooney BJ, 2009, CURR OPIN STRUC BIOL, V19, P483, DOI 10.1016/j.sbi.2009.07.001
   Rachou J, 2007, ENVIRON CHEM, V4, P90, DOI 10.1071/EN06036
   Scanlon S, 2008, NANO TODAY, V3, P22, DOI 10.1016/S1748-0132(08)70041-0
   Stern BR, 2007, J TOXICOL ENV HEAL B, V10, P157, DOI 10.1080/10937400600755911
   Tamamis P, 2009, J PHYS CHEM B, V113, P15639, DOI 10.1021/jp9066718
   Toksoz S, 2009, NANO TODAY, V4, P458, DOI 10.1016/j.nantod.2009.09.002
   Wang J, 2005, ANALYST, V130, P421, DOI 10.1039/b414248a
   Wilke N, 2002, J ELECTROANAL CHEM, V537, P67, DOI 10.1016/S0022-0728(02)01249-4
   Yan XH, 2010, CHEM SOC REV, V39, P1877, DOI 10.1039/b915765b
   Yang WR, 2003, ANALYST, V128, P712, DOI 10.1039/b212881k
   Yang WR, 2001, ANALYST, V126, P1573, DOI 10.1039/b102898g
   Zanuy D, 2006, PHYS BIOL, V3, pS80, DOI 10.1088/1478-3975/3/1/S08
   Zeng BZ, 2002, ANAL LETT, V35, P2245, DOI 10.1081/AL-120016099
   Zeng BZ, 2002, ELECTROANAL, V14, P651, DOI 10.1002/1521-4109(200205)14:10<651::AID-ELAN651>3.0.CO;2-W
   Zeng ZL, 2005, ELECTROANAL, V17, P912, DOI 10.1002/ealn.200403197
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   ZHAO XJ, 2006, POLYM REGENERATIVE M, P145
NR 44
TC 35
Z9 35
U1 2
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY
PY 2011
VL 3
IS 5
BP 1594
EP 1600
DI 10.1021/am200149h
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 767GR
UT WOS:000290843800032
PM 21443268
DA 2018-10-20
ER

PT J
AU Wang, GC
   Zheng, L
   Zhao, HS
   Miao, JY
   Sun, CH
   Liu, H
   Huang, Z
   Yu, XQ
   Wang, JY
   Tao, XT
AF Wang, Guancong
   Zheng, Lin
   Zhao, Hongshi
   Miao, Junying
   Sun, Chunhui
   Liu, Hong
   Huang, Zhen
   Yu, Xiaoqiang
   Wang, Jiyang
   Tao, Xutang
TI Construction of A Fluorescent Nanostructured Chitosan-Hydroxyapatite
   Scaffold by Nanocrystallon Induced Biomimetic Mineralization and Its
   Cell Biocompatibility
SO ACS APPLIED MATERIALS & INTERFACES
LA English
DT Article
DE surface characteristics; nanostructure; chitosan; genipin; fluorescence;
   mesenchymal stem cells; bone tissue engineering
ID MESENCHYMAL STEM-CELLS; TISSUE-ENGINEERING APPLICATIONS; IN-VITRO;
   COMPOSITE SCAFFOLDS; OSTEOGENIC DIFFERENTIATION; MEMBRANE
   CHARACTERIZATION; CROSS-LINKING; BONE; GENIPIN; BIOACTIVITY
AB Biomaterial surfaces and their nanostructures can significantly influence cell growth and viability. Thus, manipulating surface characteristics of scaffolds can be a potential strategy to control cell functions for stem cell tissue engineering. In this study, in order to construct a hydroxyapatite (HAp) coated genipin-chitosan conjugation scaffold (HGCCS) with a well-defined HAp nanostructured surface, we have developed a simple and controllable approach that allows construction of a two-level, three-dimensional (3D) networked structure to provide sufficient calcium source and achieve desired mechanical function and mass transport (permeability and diffusion) properties. Using a nontoxic cross linker (genipin) and a nanocrystallon induced biomimetic mineralization method, we first assembled a layer of HAp network like nanostructure on a 3D porous chitosan-based framework. X-ray diffraction (XRD) and high resolution transmission electron microscopy (HRTEM) analysis confirm that the continuous network-like nanostructure on the channel surface of the HGCCS is composed of crystalline HAp. Compressive testing demonstrated that the strength of the HGCCS is apparently enhanced because of the strong cross-linking of genipin and the resulting reinforcement of the HAp nanonetwork. The fluorescence properties of genipin-chitosan conjugation for convenient monitoring of the 3D porous scaffold biodegradability and cell localization in the scaffold was specifically explored using confocal laser scanning microscopy (CLSM). Furthermore, through scanning electron microscope (SEM) observation and immunofluorescence measurements of F-actin, we found that the HAp network-like nanostructure on the surface of the HGCCS can influence the morphology and integrin-mediated cytoskeleton organization of rat bone marrow-derived mesenchymal stem cells (BMSCs). Based on cell proliferation assays, rat BMSCs tend to have higher viability on HGCCS in vitro. The results of this study suggest that the fluorescent two-level 3D nanostructured chitosan-HAp scaffold will be a promising scaffold for bone tissue engineering application.
C1 [Wang, Guancong; Zhao, Hongshi; Liu, Hong; Yu, Xiaoqiang; Wang, Jiyang; Tao, Xutang] Shandong Univ, Ctr Bio & Micro Nano Funct Mat, State Key Lab Crystal Mat, Jinan 250100, Peoples R China.
   [Zheng, Lin] Shandong Univ, Sch Med, Jinan 250012, Peoples R China.
   [Miao, Junying; Sun, Chunhui] Shandong Univ, Inst Dev Biol, Coll Life Sci, Jinan 250100, Peoples R China.
   [Huang, Zhen] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.
   [Huang, Zhen] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA.
RP Liu, H (reprint author), Shandong Univ, Ctr Bio & Micro Nano Funct Mat, State Key Lab Crystal Mat, 27 Shanda Nanlu, Jinan 250100, Peoples R China.
EM hongliu@sdu.edu.cn
FU NSFC (NSFDYS) [50925205, 50872070, 50990303, 50721002]; Independent
   Innovation Foundation of Shandong University (IIFSDU) [2009JC011];
   Graduate Independent Innovation Foundation of Shandong University
   (GIIFSDU) [yzc09064]
FX This research was supported by an NSFC (NSFDYS: 50925205, 50872070,
   Grant 50990303, Innovation Research Group, 50721002), Independent
   Innovation Foundation of Shandong University (IIFSDU, 2009JC011), and
   Graduate Independent Innovation Foundation of Shandong University
   (GIIFSDU, yzc09064). Authors would like to give their heartfelt thanks
   to Prof. Si-Shen Feng (National University of Singapore) for his
   guidance and discussion, and Prof. Robert I. Boughton (Chair, Department
   of Physics and Astronomy, Bowling Green State University, USA) for his
   thorough revision.
CR Araujo ABA, 2009, J BIOMED MATER RES A, V88A, P916, DOI 10.1002/jbm.a.31949
   BECHER PF, 1991, J AM CERAM SOC, V74, P255, DOI 10.1111/j.1151-2916.1991.tb06872.x
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2
   Brammer KS, 2008, NANO LETT, V8, P786, DOI 10.1021/nl072572o
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chen HM, 2005, J BIOMED MATER RES A, V75A, P917, DOI 10.1002/jbm.a.30492
   Chen HM, 2006, BIOMACROMOLECULES, V7, P2091, DOI 10.1021/bm050862y
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593
   Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016
   Hall MJ, 2000, ADV DATA, P1
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   Jiang K, 2009, ACS APPL MATER INTER, V1, P266, DOI 10.1021/am800219r
   Johnson PC, 2007, TISSUE ENG, V13, P2827, DOI 10.1089/ten.2007.0335
   Kim IY, 2008, BIOTECHNOL ADV, V26, P1, DOI 10.1016/j.biotechadv.2007.07.009
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   Kuo YC, 2006, BIOTECHNOL BIOENG, V95, P132, DOI 10.1002/bit.21007
   Kuo YC, 2009, BIOMATERIALS, V30, P6604, DOI 10.1016/j.biomaterials.2009.08.028
   Lee KW, 2008, BIOMATERIALS, V29, P2839, DOI 10.1016/j.biomaterials.2008.03.030
   Li X., 2009, NANO LETT, V9, P2765
   Linkhart TA, 1996, BONE, V19, pS1, DOI 10.1016/S8756-3282(96)00138-X
   Malafaya PB, 2009, ACTA BIOMATER, V5, P644, DOI 10.1016/j.actbio.2008.09.017
   Manjubala I, 2006, ACTA BIOMATER, V2, P75, DOI 10.1016/j.actbio.2005.09.007
   Martin C, 1996, BIOMATERIALS, V17, P2373, DOI 10.1016/S0142-9612(96)00075-0
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Neira IS, 2008, J MATER SCI, V43, P2171, DOI 10.1007/s10853-007-2032-9
   Nukavarapu SP, 2008, BIOMACROMOLECULES, V9, P1818, DOI 10.1021/bm800031t
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055
   Ohtsuki C, 2007, J TISSUE ENG REGEN M, V1, P33, DOI 10.1002/term.3
   Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034
   Olszta MJ, 2007, MAT SCI ENG R, V58, P77, DOI 10.1016/j.mser.2007.05.001
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Qi SJ, 2009, ACS APPL MATER INTER, V1, P30, DOI 10.1021/am800027d
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang N, 2007, J CELL BIOCHEM, V100, P1548, DOI 10.1002/jcb.21139
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
   Zhang W, 2003, CHEM MATER, V15, P3221, DOI 10.1021/cm030080g
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
NR 51
TC 30
Z9 30
U1 3
U2 47
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1944-8244
J9 ACS APPL MATER INTER
JI ACS Appl. Mater. Interfaces
PD MAY
PY 2011
VL 3
IS 5
BP 1692
EP 1701
DI 10.1021/am2002185
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 767GR
UT WOS:000290843800043
PM 21491931
DA 2018-10-20
ER

PT J
AU Ibrahimkutty, S
   Kim, J
   Cammarata, M
   Ewald, F
   Choi, J
   Ihee, H
   Plech, A
AF Ibrahimkutty, Shyjumon
   Kim, Jangbae
   Cammarata, Marco
   Ewald, Friederike
   Choi, Jungkweon
   Ihee, Hyotcherl
   Plech, Anton
TI Ultrafast Structural Dynamics of the Photocleavage of Protein Hybrid
   Nanoparticles
SO ACS NANO
LA English
DT Article
DE protein-nanoparticle hybrids; photo-cleavage; thermal denaturation;
   pulsed X-ray scattering; nanobubbles
ID X-RAY-SCATTERING; TRANSIENT MOLECULAR-STRUCTURES; NEAR-FIELD ABLATION;
   GOLD NANOPARTICLES; METAL NANOPARTICLES; DIFFRACTION; NANOSCALE;
   RESONANCE; THERAPY
AB Protein-coated gold nanoparticles in suspension are excited by intense laser pulses to mimic the light-induced effect on biomolecules that occur In photothermal laser therapy with nanoparticles as photosensitizer. Ultrafast X-ray scattering employed to access the nanoscale structural modifications of the protein-nanoparticle hybrid reveals that the protein shell Is expelled as a whole without denaturation at a laser fluence that coincides with the bubble formation threshold. In this ultrafast heating mediated by the nanoparticles, time-resolved scattering data show that proteins are not denatured in terms of secondary structure even at much higher temperatures than the static thermal denaturation temperature, probably because time Is too short for the proteins to unfold and the temperature stimulus has vanished before this motion sets in. Consequently the laser pulse length has a strong influence on whether the end result is the ligand detachment (for example drug delivery) or biomaterial degradation.
C1 [Kim, Jangbae; Choi, Jungkweon; Ihee, Hyotcherl] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Dept Chem, Ctr Time Resolved Diffract, Taejon 305701, South Korea.
   [Ibrahimkutty, Shyjumon; Plech, Anton] Karlsruhe Inst Technol, Inst Synchrotron Radiat, D-76021 Karlsruhe, Germany.
   [Cammarata, Marco; Ewald, Friederike] ESRF, F-38043 Grenoble, France.
   [Plech, Anton] Univ Konstanz, Ctr Appl Photon, D-78457 Constance, Germany.
RP Ihee, H (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Dept Chem, Ctr Time Resolved Diffract, Taejon 305701, South Korea.
EM hyotcherl.ihee@kaist.ac.kr; anton.plech@kit.edu
RI Ihee, Hyotcherl/C-1614-2011; Cammarata, Marco/C-2322-2008; Plech,
   Anton/E-4895-2010
OI Cammarata, Marco/0000-0003-3013-1186; Plech, Anton/0000-0002-6290-9303;
   Choi, Jungkweon/0000-0002-9979-305X
FU Ministry of Science, Education and the Arts Baden-Wurttemberg; Creative
   Research Initiatives (Center for Time-Resolved Diffraction) of MEST/NRF;
   WCU [R31-2008-000-10071-0]; DFG
FX The research is funded by the Ministry of Science, Education and the
   Arts Baden-Wurttemberg and by Creative Research Initiatives (Center for
   Time-Resolved Diffraction) of MEST/NRF. J.K. and H.I. acknowledge
   support from the WCU program (R31-2008-000-10071-0). The European
   Synchrotron Research Facility, Grenoble, and SLS, Villigen, are
   acknowledged for provision of beamtime and funding. Support by M. Wulff,
   A. Menzel, and O. Bunk is gratefully acknowledged. A.P. acknowledges the
   support from the DFG within the Heisenberg fellowship. We would like to
   thank F. Ciesa, V. Kotaidis, and A. Siems for their help.
CR Ahn S, 2009, J PHYS CHEM B, V113, P13131, DOI 10.1021/jp906983v
   Bredenbeck J, 2003, P NATL ACAD SCI USA, V100, P6452, DOI 10.1073/pnas.1036583100
   Cammarata M, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2176617
   Cammarata M, 2008, NAT METHODS, V5, P881, DOI 10.1038/NMETH.1255
   Cammarata M, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3036983
   Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869
   Dartigalongue T, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2041467
   Dingenouts N, 1999, ADV POLYM SCI, V144, P1
   FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0
   Ge ZB, 2004, J PHYS CHEM B, V108, P18870, DOI 10.1021/jp048375k
   Guinier A, 1955, SMALL ANGLE SCATTERI
   Haldrup K, 2010, ACTA CRYSTALLOGR A, V66, P261, DOI 10.1107/S0108767309054233
   Henkel A, 2009, J PHYS CHEM C, V113, P10390, DOI 10.1021/jp810979r
   Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100
   Hu M, 2003, J PHYS CHEM B, V107, P1284, DOI 10.1021/jp027597k
   Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a
   Ihee H, 2005, SCIENCE, V309, P1223, DOI [10.1126/science.1114782, 10.1126/scheme.1114782]
   Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458
   Ihee H, 2010, INT REV PHYS CHEM, V29, P453, DOI 10.1080/0144235X.2010.498938
   Ihee H, 2009, ACCOUNTS CHEM RES, V42, P356, DOI 10.1021/ar800168v
   Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p
   Jain PK, 2006, J AM CHEM SOC, V128, P2426, DOI 10.1021/ja056769z
   Kaufman ED, 2007, LANGMUIR, V23, P6053, DOI 10.1021/la063725a
   Kim J, 2011, J PHYS CHEM LETT, V2, P350, DOI 10.1021/jz101503r
   Kim KH, 2011, CHEM COMMUN, V47, P289, DOI 10.1039/c0cc01817a
   Kim TK, 2006, P NATL ACAD SCI USA, V103, P9410, DOI 10.1073/pnas.0601958103
   Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w
   Kotaidis V, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2187476
   Kotaidis V, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2132086
   Lin MM, 2006, CHEM PHYS LETT, V420, P1, DOI 10.1016/j.cplett.2005.11.088
   Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5
   Plech A, 2006, NAT PHYS, V2, P44, DOI 10.1038/nphys191
   Plech A, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195423
   Plech A, 2005, CHEM PHYS LETT, V401, P565, DOI 10.1016/j.cplett.2004.11.072
   Plech A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125505
   Plech A, 2002, J SYNCHROTRON RADIAT, V9, P287, DOI 10.1107/S0909049502011226
   Plech A, 2009, LASER PHOTONICS REV, V3, P435, DOI 10.1002/lpor.200810044
   Siems A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043018
   Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Takeda Y, 2009, J PHYS CHEM C, V113, P5027, DOI 10.1021/jp809438d
   TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055
   Warren B. E., 1990, XRAY DIFFRACTION
   Wilson OM, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224301
   Wulff M, 1997, NUCL INSTRUM METH A, V398, P69, DOI 10.1016/S0168-9002(96)01226-0
   Yao CP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2137321
   Yao CP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253320
NR 47
TC 33
Z9 33
U1 0
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD MAY
PY 2011
VL 5
IS 5
BP 3788
EP 3794
DI 10.1021/nn200120e
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 767AD
UT WOS:000290826800044
PM 21504177
DA 2018-10-20
ER

PT J
AU Bazaka, K
   Jacob, MV
   Crawford, RJ
   Ivanova, EP
AF Bazaka, Kateryna
   Jacob, Mohan V.
   Crawford, Russell J.
   Ivanova, Elena P.
TI Plasma-assisted surface modification of organic biopolymers to prevent
   bacterial attachment
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Bacterial adhesion; Biofunctional coatings; Plasma modification;
   Anti-fouling coatings; Organic polymers
ID GRAM-NEGATIVE BACTERIA; EXTRACELLULAR POLYMERIC SUBSTANCES;
   STAPHYLOCOCCUS-AUREUS ADHESION; PSEUDOMONAS-AERUGINOSA BIOFILM;
   SELF-ASSEMBLED MONOLAYERS; ATOMIC-FORCE MICROSCOPY; PVC
   ENDOTRACHEAL-TUBES; OXYGEN GLOW-DISCHARGE; ESCHERICHIA-COLI; THIN-FILMS
AB Despite many synthetic biomaterials having physical properties that are comparable or even superior to those of natural body tissues, they frequently fail due to the adverse physiological reactions they cause within the human body, such as infection and inflammation. The surface modification of blomaterials is an economical and effective method by which biocompatibility and biofunctionality can be achieved while preserving the favorable bulk characteristics of the biomaterial, such as strength and inertness Amongst the numerous surface modification techniques available, plasma surface modification affords device manufacturers a flexible and environmentally friendly process that enables tailoring of the surface morphology, structure, composition, and properties of the material to a specific need There are a vast range of possible applications of plasma modification in biomaterial applications, however, the focus of this review paper is on processes that can be used to develop surface morphologies and chemical structures for the prevention of adhesion and proliferation of pathogenic bacteria on the surfaces of in-dwelling medical devices. As such, the fundamental principles of bacterial cell attachment and biofilm formation are also discussed. Functional organic plasma polymerised coatings are also discussed for their potential as biosensitive interfaces, connecting inorganic/metallic electronic devices with their physiological environments. (C) 2010 Acts Materialia Inc. Published by Elsevier Ltd All rights reserved.
C1 [Crawford, Russell J.; Ivanova, Elena P.] Swinburne Univ Technol, Fac Life & Social Sci, Hawthorn, Vic 3122, Australia.
   [Bazaka, Kateryna; Jacob, Mohan V.] James Cook Univ, Elect Mat Res Lab, Sch Engn & Phys Sci, Townsville, Qld 4811, Australia.
RP Ivanova, EP (reprint author), Swinburne Univ Technol, Fac Life & Social Sci, POB 218, Hawthorn, Vic 3122, Australia.
RI Bazaka, Kateryna/D-8678-2011; Crawford, Russell/E-7367-2011; Jacob,
   Mohan/B-9097-2009
OI Jacob, Mohan/0000-0002-2598-7193; Bazaka, Kateryna/0000-0003-2032-6377;
   Crawford, Russell/0000-0003-1054-5285
FU Advanced Manufacturing Co-operative Research Centre (AMCRC); Australian
   Postgraduate Award (APA); Australian Institute of Nuclear Science and
   Engineering Postgraduate Award (AINSE PGRA); Rural Industry Research and
   Development Corporation (RIRDC); Department of Agriculture, Fisheries
   and Forestry of Australia (DAFF)
FX This study was supported in part by the Advanced Manufacturing
   Co-operative Research Centre (AMCRC). K.B. Is grateful for an Australian
   Postgraduate Award (APA) and an Australian Institute of Nuclear Science
   and Engineering Postgraduate Award (AINSE PGRA) and the funding and
   support received from the Rural Industry Research and Development
   Corporation (RIRDC) and the Department of Agriculture, Fisheries and
   Forestry of Australia (DAFF) as part of a Science and Innovation Award
   for Young People in Agriculture, Fisheries and Forestry.
CR ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   Almaguer-Flores A, 2010, J BIOMED MATER RES B, V92B, P196, DOI 10.1002/jbm.b.31506
   An YH, 1995, J MICROBIOL METH, V24, P29, DOI 10.1016/0167-7012(95)00051-8
   Andrews SS, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046015
   Annarelli CC, 1999, J COLLOID INTERF SCI, V213, P386, DOI 10.1006/jcis.1999.6153
   Asadinezhad A, 2010, COLLOID SURFACE B, V77, P246, DOI 10.1016/j.colsurfb.2010.02.006
   Ashbaugh CD, 2000, CELL MICROBIOL, V2, P283, DOI 10.1046/j.1462-5822.2000.00050.x
   Atkin R, 2003, LANGMUIR, V19, P4222, DOI 10.1021/la026852p
   Balazs DJ, 2004, BIOMATERIALS, V25, P2139, DOI 10.1016/j.biomaterials.2003.08.053
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Bazaka K, 2010, BIOMACROMOLECULES, V11, P2016, DOI 10.1021/bm100369n
   Bettinger CJ, 2010, POLYM INT, V59, P563, DOI 10.1002/pi.2827
   BEVERIDGE TJ, 1991, MICROBIOL REV, V55, P684
   BEVERIDGE TJ, 1985, CAN J EARTH SCI, V22, P1893, DOI 10.1139/e85-204
   Biederman H, 2000, SURF COAT TECH, V125, P371, DOI 10.1016/S0257-8972(99)00578-2
   Boks NP, 2009, J COLLOID INTERF SCI, V331, P60, DOI 10.1016/j.jcis.2008.11.025
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Busscher HJ, 2010, CURR OPIN COLLOID IN, V15, P510, DOI 10.1016/j.cocis.2010.05.014
   CAHALAN PT, 1992, RADIO FREQUENCY GLOW
   Camesano TA, 2000, ENVIRON SCI TECHNOL, V34, P3354, DOI 10.1021/es9913176
   Cappella B, 1999, SURF SCI REP, V34, P1, DOI 10.1016/S0167-5729(99)00003-5
   Cescutti P, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P93
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   CHENG SS, 1994, J COLLOID INTERF SCI, V162, P135, DOI 10.1006/jcis.1994.1018
   Chifen AN, 2007, LANGMUIR, V23, P6294, DOI 10.1021/la0701273
   CHOUDHURY NR, 2008, NOVEL NANOCOMPOSITES, P501
   Chu PK, 2007, SURF COAT TECH, V201, P8076, DOI 10.1016/j.surfcoat.2005.12.053
   Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011
   Cordeiro AL, 2010, BIOTECHNOL LETT, V32, P489, DOI 10.1007/s10529-009-0190-3
   Cordeiro AL, 2009, SOFT MATTER, V5, P1367, DOI 10.1039/b816911j
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Covert RJ, 2003, WEAR, V255, P1064, DOI 10.1016/S0043-1648(03)00113-3
   Cywes C, 2000, J CLIN INVEST, V106, P995, DOI 10.1172/JCI10195
   Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09
   Dautov G. Yu., 1987, Journal of Engineering Physics, V53, P1434, DOI 10.1007/BF00870165
   Davies KG, 1996, PARASITOLOGY, V112, P553, DOI 10.1017/S0031182000066130
   DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73
   Decho AW, 2000, CONT SHELF RES, V20, P1257, DOI 10.1016/S0278-4343(00)00022-4
   DEJARDIN P, 2006, PROTEINS SOLID LIQUI, P175
   Denes FS, 2004, PROG POLYM SCI, V29, P815, DOI 10.1016/j.progpolymsci.2004.05.001
   Denis L, 2010, PLASMA PROCESS POLYM, V7, P172, DOI 10.1002/ppap.200900131
   Desmet T, 2009, BIOMACROMOLECULES, V10, P2351, DOI 10.1021/bm900186s
   Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004
   DICKINSON RB, 1993, J MATH BIOL, V31, P563, DOI 10.1007/BF00161199
   Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267
   Dong YC, 2010, J BIOMED MATER RES B, V93B, P185, DOI 10.1002/jbm.b.31573
   Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   Dorobantu LS, 2009, LANGMUIR, V25, P6968, DOI 10.1021/la9001237
   Edwards KJ, 2001, CHEM GEOL, V180, P19, DOI 10.1016/S0009-2541(01)00303-5
   FLEMMING HC, 1995, CHEM-ING-TECH, V67, P1425, DOI 10.1002/cite.330671103
   Flemming HC, 2001, WATER SCI TECHNOL, V43, P1
   Fletcher M, 1996, BACTERIAL ADHESION M, P1
   Forch R, 2007, CHEM VAPOR DEPOS, V13, P280, DOI 10.1002/cvde.200604035
   Geissler A, 2008, LANGMUIR, V24, P4874, DOI 10.1021/la703633k
   Gottenbos B, 2002, BIOMATERIALS, V23, P1417, DOI 10.1016/S0142-9612(01)00263-0
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   Gray JE, 2003, BIOMATERIALS, V24, P2759, DOI 10.1016/S0142-9612(03)00057-7
   Gristina R, 2009, J BIOMED MATER RES B, V88B, P139, DOI 10.1002/jbm.b.31160
   Haidopoulos M, 2005, PLASMA PROCESS POLYM, V2, P424, DOI 10.1002/ppap.200400066
   Hale P, 2008, LANGMUIR, V24, P7897, DOI 10.1021/la8002788
   Hamadi F, 2009, MAT SCI ENG C-BIO S, V29, P1302, DOI 10.1016/j.msec.2008.10.023
   Hancock V, 2010, APPL ENVIRON MICROB, V76, P3836, DOI 10.1128/AEM.00241-10
   Hanssen AD, 2002, J ARTHROPLASTY, V17, P98, DOI 10.1054/arth.2002.32458
   Hao L, 2005, APPL SURF SCI, V247, P453, DOI 10.1016/j.apsusc.2005.01.163
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   HOGE CW, 1993, JAMA-J AM MED ASSOC, V269, P1638
   Hong Y, 2010, BIOTECHNOL BIOENG, V105, P965, DOI 10.1002/bit.22606
   Hong YS, 2009, APPL ENVIRON MICROB, V75, P2346, DOI 10.1128/AEM.02671-08
   Hook AL, 2008, SURF SCI, V602, P1883, DOI 10.1016/j.susc.2008.03.029
   Huang N, 2004, SURF COAT TECH, V186, P218, DOI 10.1016/j.surfcoat.2004.04.041
   HUANG N, 2003, 30 INT C PLASM SCI J, P439
   Inbakumar S, 2010, CELLULOSE, V17, P417, DOI 10.1007/s10570-009-9369-y
   Ista LK, 2010, BIOFOULING, V26, P111, DOI 10.1080/08927010903383455
   Ivanova EP, 2008, MICRON, V39, P1197, DOI 10.1016/j.micron.2008.04.009
   Jampala SN, 2008, LANGMUIR, V24, P8583, DOI 10.1021/la800405x
   JAYARATNE P, 1993, J BACTERIOL, V175, P5384
   Jenal U, 2005, EMBO REP, V6, P615, DOI 10.1038/sj.embor.7400459
   Johnston EE, 1996, J ELECTRON SPECTROSC, V81, P303, DOI 10.1016/0368-2048(95)02666-5
   Jucker BA, 1998, COLLOID SURFACE B, V11, P33, DOI 10.1016/S0927-7765(98)00029-0
   Kapellos GE, 2007, ADV WATER RESOUR, V30, P1648, DOI 10.1016/j.advwatres.2006.05.030
   Katsikogianni M, 2008, COLLOID SURFACE B, V65, P257, DOI 10.1016/j.colsurfb.2008.04.017
   KATSIKOGIANNI M, 2004, EUR CELLS MATER, P37
   Kaufmann T, 2010, POLYM CHEM-UK, V1, P371, DOI 10.1039/b9py00281b
   Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5
   Kim MC, 2003, SURF COAT TECH, V169, P595, DOI 10.1016/S0257-8972(03)00115-4
   Kinnari TJ, 2009, J MED MICROBIOL, V58, P132, DOI 10.1099/jmm.0.002758-0
   Kirov SM, 2003, FEMS MICROBIOL LETT, V224, P151, DOI 10.1016/S0378-1097(03)00445-2
   Kluin OS, 2009, BIOMATERIALS, V30, P4738, DOI 10.1016/j.biomaterials.2009.05.012
   Korachi M, 2010, J ELECTROSTAT, V68, P508, DOI 10.1016/j.elstat.2010.06.014
   Kugel A, 2010, POLYM CHEM-UK, V1, P442, DOI 10.1039/b9py00309f
   Kugler R, 2005, MICROBIOL-SGM, V151, P1341, DOI 10.1099/mic.0.27526-0
   KUMAR V, 2010, PLASMA TECHNOLOGY HY
   Kwok DTK, 2010, SURF COAT TECH, V204, P2892, DOI 10.1016/j.surfcoat.2010.02.043
   Lahann J, 2006, POLYM INT, V55, P1361, DOI 10.1002/pi.2098
   Lauderdale KJ, 2010, J ORTHOP RES, V28, P55, DOI 10.1002/jor.20943
   LEE JH, ACTA BIOMAT IN PRESS
   Lee JH, 2011, TISSUE ENG PART C-ME, V17, P39, DOI [10.1089/ten.tec.2010.0285, 10.1089/ten.TEC.2010.0285]
   Lewis F, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/4/045310
   Liu S, 2005, LANGMUIR, V21, P8572, DOI 10.1021/la051449e
   Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Majumdar P, 2008, J COAT TECHNOL RES, V5, P405, DOI 10.1007/s11998-008-9098-4
   Marciano FR, 2009, APPL SURF SCI, V255, P8377, DOI 10.1016/j.apsusc.2009.05.091
   Mayer C, 1999, INT J BIOL MACROMOL, V26, P3, DOI 10.1016/S0141-8130(99)00057-4
   MEIER WP, 2010, POLYM MEMBRANES BIOM, P87
   Merritt PM, 2007, J BACTERIOL, V189, P8005, DOI 10.1128/JB.00566-07
   Miola M, 2009, J MATER SCI-MATER M, V20, P741, DOI 10.1007/s10856-008-3618-8
   Mitik-Dineva N, 2009, CURR MICROBIOL, V58, P268, DOI 10.1007/s00284-008-9320-8
   Mitik-Dineva Natasa, 2008, Biotechnology Journal, V3, P536, DOI 10.1002/biot.200700244
   Montanaro L, 2007, BIOMATERIALS, V28, P5155, DOI 10.1016/j.biomaterials.2007.08.003
   Muccini M, 2006, NAT MATER, V5, P605, DOI 10.1038/nmat1699
   Nawale AB, 2010, J PHYS CONF SER, V208, DOI 10.1088/1742-6596/208/1/012121
   Nelea V, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/22/225208
   Omoike A, 2004, BIOMACROMOLECULES, V5, P1219, DOI 10.1021/bm034461z
   ONG JL, 1994, J BIOMED MATER RES, V28, P1337, DOI 10.1002/jbm.820281112
   Pashkuleva I, 2010, J MATER SCI-MATER M, V21, P21, DOI 10.1007/s10856-009-3831-0
   Pavithra D, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034003
   Perrin C, 2009, APPL ENVIRON MICROB, V75, P1723, DOI 10.1128/AEM.02171-08
   Pertile RAN, 2010, CARBOHYD POLYM, V82, P692, DOI 10.1016/j.carbpol.2010.05.037
   PIGLOWSKI J, 1994, BIOMATERIALS, V15, P909, DOI 10.1016/0142-9612(94)90116-3
   Pinto S, 2010, COLLOID SURFACE B, V81, P20, DOI 10.1016/j.colsurfb.2010.06.014
   Ponsonnet L, 2003, MAT SCI ENG C-BIO S, V23, P551, DOI 10.1016/S0928-4931(03)00033-X
   Qureshi N, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-24
   Radzig MA, 2009, MOL GENET MICROBIOL+, V24, P194, DOI 10.3103/S0891416809040065
   Raynor JE, 2009, BIOINTERPHASES, V4, pFA3, DOI 10.1116/1.3089252
   RIJNAARTS HHM, 1993, APPL ENVIRON MICROB, V59, P3255
   ROBERSON EB, 1992, APPL ENVIRON MICROB, V58, P1284
   Romani AM, 2008, MICROB ECOL, V56, P427, DOI 10.1007/s00248-007-9361-8
   Roth S, 2010, J APPL MICROBIOL, V108, P521, DOI 10.1111/j.1365-2672.2009.04453.x
   Sadovskaya I, 2010, GLYCOBIOLOGY, V20, P895, DOI 10.1093/glycob/cwq047
   Sajeev US, 2006, B MATER SCI, V29, P159, DOI 10.1007/BF02704609
   SCHAKENRAAD JM, 1986, J BIOMED MATER RES, V20, P773, DOI 10.1002/jbm.820200609
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Schonherr H, 2000, CHEM MATER, V12, P3689, DOI 10.1021/cm0010351
   Schroder K, 2001, CONTRIB PLASM PHYS, V41, P562, DOI 10.1002/1521-3986(200111)41:6<562::AID-CTPP562>3.0.CO;2-Y
   Sevast'yanov VI, 2009, RUSS J GEN CHEM+, V79, P596, DOI 10.1134/S1070363209030414
   Shafahi M, 2010, AIP CONF PROC, V1254, P193, DOI 10.1063/1.3453809
   Sheng HQ, 2008, APPL ENVIRON MICROB, V74, P5015, DOI 10.1128/AEM.00743-08
   Shi FF, 1996, SURF COAT TECH, V82, P1, DOI 10.1016/0257-8972(95)02621-5
   Sohbatzadeh F, 2010, APPL BIOCHEM BIOTECH, V160, P1978, DOI 10.1007/s12010-009-8817-3
   Song B, 2006, MICROBIOL RES, V161, P355, DOI 10.1016/j.micres.2006.01.004
   Stobie N, 2008, BIOMATERIALS, V29, P963, DOI 10.1016/j.biomaterials.2007.10.057
   Strauss J, 2009, J MOL RECOGNIT, V22, P347, DOI 10.1002/jmr.955
   SU W, SURF COAT T IN PRESS
   Subbiahdoss G, 2010, EUR CELLS MATER, V19, P205, DOI 10.22203/eCM.v019a20
   Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011
   Sureshkumar A, 2010, INT J PHARMACEUT, V396, P17, DOI 10.1016/j.ijpharm.2010.05.045
   Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3
   SUTHERLAND IW, 1983, CRC CR REV MICROBIOL, V10, P173
   Swaraj S, 2005, PLASMA PROCESS POLYM, V2, P572, DOI 10.1002/ppap.200500022
   TAMADA Y, 1993, POLYMER, V34, P2208, DOI 10.1016/0032-3861(93)90752-V
   TIMMIS KN, 2010, HDB HYDROCARBON LIPI, P1615
   Triandafillu K, 2003, BIOMATERIALS, V24, P1507, DOI 10.1016/S0142-9612(02)00515-X
   Truong VK, 2009, APPL MICROBIOL BIOT, V83, P925, DOI 10.1007/s00253-009-1944-5
   van der Aa BC, 2002, COLLOID SURFACE B, V23, P173, DOI 10.1016/S0927-7765(01)00229-6
   van Heerden J, 2009, J PLAST RECONSTR AES, V62, P610, DOI 10.1016/j.bjps.2007.09.044
   van Hullebusch Eric D., 2003, Reviews in Environmental Science and Bio/Technology, V2, P9, DOI 10.1023/B:RESB.0000022995.48330.55
   VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   Veiga MC, 1997, APPL ENVIRON MICROB, V63, P403
   Velasco-Casal P, 2008, ENVIRON SCI TECHNOL, V42, P1131, DOI 10.1021/es071707p
   Wang GC, 2010, ACTA BIOMATER, V6, P990, DOI 10.1016/j.actbio.2009.09.021
   WANG IW, 1995, J BIOMED MATER RES, V29, P485, DOI 10.1002/jbm.820290408
   WESSELS MR, 1994, P NATL ACAD SCI USA, V91, P12238, DOI 10.1073/pnas.91.25.12238
   Whitehead KA, 2005, COLLOID SURFACE B, V41, P129, DOI 10.1016/j.colsurfb.2004.10.010
   Williams V, 1996, APPL ENVIRON MICROB, V62, P100
   Yang ZL, 2009, PLASMA PROCESS POLYM, V6, P498, DOI 10.1002/ppap.200800195
   YASUDA H, 1981, MACROMOL REV, V16, P199
   Yoganand CP, 2010, J PHYS CONF SER, V208, DOI 10.1088/1742-6596/208/1/012099
   Yoganand CP, 2010, CERAM INT, V36, P1757, DOI 10.1016/j.ceramint.2010.02.048
   Zaaba S. K., 2010, IEE J T FUNDAM MAT, V130, P355
   Zhang W, 2006, BIOMATERIALS, V27, P44, DOI 10.1016/j.biomaterials.2005.05.067
NR 175
TC 124
Z9 127
U1 5
U2 136
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD MAY
PY 2011
VL 7
IS 5
BP 2015
EP 2028
DI 10.1016/j.actbio.2010.12.024
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 764RH
UT WOS:000290649500010
PM 21194574
OA Green Published
DA 2018-10-20
ER

PT J
AU Rodas, ACD
   Polak, R
   Hara, PH
   Lee, EI
   Pitombo, RNM
   Higa, OZ
AF Rodas, Andrea C. D.
   Polak, Roberta
   Hara, Priscila H.
   Lee, Emily I.
   Pitombo, Ronaldo N. M.
   Higa, Olga Z.
TI Cytotoxicity and Endothelial Cell Adhesion of Lyophilized and Irradiated
   Bovine Pericardium Modified With Silk Fibroin and Chitosan
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 6th Latin American Congress of Artifiial Organs and Biomaterials
CY AUG 17-20, 2010
CL Gramado, BRAZIL
DE Bovine pericardium; Chitosan; Silk fibroin; Cytotoxicity; Endothelial
   cell adhesion
ID VALVE-REPLACEMENT; AORTIC VALVES; TISSUE; CALCIFICATION;
   BIOCOMPATIBILITY; MATRIX; SHEEP
AB Grafts of biological tissues have been used since the 1960s as an alternative to the mechanical heart prostheses. Nowadays, the most consolidated treatment to bovine pericardial (BP) bioprostheses is the crosslinking with glutaraldehyde (GA), although GA may induce calcification in vivo. In previous work, our group demonstrated that electron beam irradiation applied to lyophilized BP in the absence of oxygen promoted crosslinks among collagen fibers of BP tissue. In this work, the incorporation of silk fibroin (SF) and chitosan (CHIT) in the BP not treated with GA was studied. The samples were irradiated and then analyzed for their cytotoxicity and the ability of adhesion and growth of endothelial cells. Initially, all samples showed cytotoxicity. However, after a few washing cycles, the cytotoxicity due to acetic acid and ethanol residues was removed from the biomaterial making it suitable for the biofunctional test. The samples modified with SF/CHIT and electron beam irradiated favored the adhesion and growth of endothelial cells throughout the tissue.
C1 [Rodas, Andrea C. D.; Hara, Priscila H.; Lee, Emily I.; Higa, Olga Z.] IPEN, Ctr Biotecnol, BR-05508900 Sao Paulo, Brazil.
   [Polak, Roberta; Pitombo, Ronaldo N. M.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil.
RP Rodas, ACD (reprint author), IPEN, Ctr Biotecnol, Ave Prof Lineu Prestes 2242,Cidade Univ, BR-05508900 Sao Paulo, Brazil.
EM arodas@ipen.br
RI Polak, Roberta/E-1479-2014; Biofabris, Inct/I-2418-2013; Rodas,
   Andrea/E-1130-2012
FU FAPESP; CNPq
FX The authors gratefully acknowledge CTR-IPEN Sao Paulo, for use of the
   Electron Beam; Alexander Seixas de Souza for his technical assistance
   with confocal microscopy; and Dr. Toshie Kawano of the Laboratory of
   Parasitology from Butantan Institute. We also wish to thank FAPESP and
   CNPq for financial support.
CR Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   da Costa FDA, 2004, ARTIF ORGANS, V28, P366, DOI 10.1111/j.1525-1594.2004.47357.x
   Doenst T, 2004, J CARDIOVASC SURG, V45, P449
   GENDLER E, 1984, J BIOMED MATER RES, V18, P727, DOI 10.1002/jbm.820180703
   Grauss RW, 2005, EUR J CARDIO-THORAC, V27, P566, DOI 10.1016/j.ejcts.2004.12.052
   Gulbins H, 2006, ANN THORAC SURG, V81, P1472, DOI 10.1016/j.athoracsur.2005.11.011
   *INT ORG STAND, 2009, 109931 ISO INT ORG S
   *INT ORG STAND, 2009, 109935 ISO INT ORG S
   Jastrzebska M, 2005, J MOL STRUCT, V744, P789, DOI 10.1016/j.molstruc.2004.11.040
   Kasimir MT, 2005, THROMB HAEMOSTASIS, V94, P562, DOI 10.1160/TH05-01-0025
   Leirner AA, 2009, ARTIF ORGANS, V33, P221, DOI 10.1111/j.1525-1594.2009.00712.x
   Maizato MJS, 2003, ARTIF ORGANS, V27, P692, DOI 10.1046/j.1525-1594.2003.07275.x
   Nogueira GM, 2010, BIORESOURCE TECHNOL, V101, P8446, DOI 10.1016/j.biortech.2010.06.064
   Nogueira GM, 2010, LANGMUIR, V26, P8953, DOI 10.1021/la904741h
   Ohri R, 2004, J BIOMED MATER RES A, V70A, P328, DOI 10.1002/jbm.a.30088
   OYARZUN JR, 1996, ANN THORAC SURG, V62, P169
   PIEZ KA, 1989, ENCY POLYM SCI ENG, P699
   Rieder E, 2006, BIOMATERIALS, V27, P5634, DOI 10.1016/j.biomaterials.2006.06.020
   Rodas ACD, 2008, ARTIF ORGANS, V32, P272, DOI 10.1111/j.1525-1594.2008.00542.x
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SIMIONESCU D, 1993, J BIOMED MATER RES, V27, P697, DOI 10.1002/jbm.820270602
   Starr A, 2002, CLIN EXP PHARMACOL P, V29, P735, DOI 10.1046/j.1440-1681.1999.03710.x
   Trantina-Yates AE, 2001, BIOMATERIALS, V22, P1837, DOI 10.1016/S0142-9612(00)00365-3
NR 23
TC 9
Z9 9
U1 0
U2 16
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2011
VL 35
IS 5
BP 502
EP 507
DI 10.1111/j.1525-1594.2011.01255.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 766RW
UT WOS:000290805200015
PM 21595719
DA 2018-10-20
ER

PT J
AU da Silva, LM
   Claro, APRA
   Donato, TAG
   Arana-Chavez, VE
   Moraes, JCS
   Buzalaf, MAR
   Grandini, CR
AF da Silva, Luciano Monteiro
   Rosifini Alves Claro, Ana Paula
   Goto Donato, Tatiani Ayako
   Arana-Chavez, Victor E.
   Silos Moraes, Joao Carlos
   Rabelo Buzalaf, Marilia Afonso
   Grandini, Carlos Roberto
TI Influence of Heat Treatment and Oxygen Doping on the Mechanical
   Properties and Biocompatibility of Titanium-Niobium Binary Alloys
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 6th Latin American Congress of Artifiial Organs and Biomaterials
CY AUG 17-20, 2010
CL Gramado, BRAZIL
DE Titanium-based alloy; Elasticity modulus; Mechanical spectroscopy;
   Biomaterial; Interstitials
ID TI-NB; SPECTROSCOPY; BIOMATERIAL
AB The most commonly used titanium (Ti)-based alloy for biological applications is Ti-6Al-4V, but some studies associate the vanadium (V) with the cytotoxic effects and adverse reactions in tissues, while aluminum (Al) has been associated with neurological disorders. Ti-Nb alloys belong to a new class of Ti-based alloys with no presence of Al and V and with elasticity modulus values that are very attractive for use as a biomaterial. It is well known that the presence of interstitial elements (such as oxygen, for example) changes the mechanical properties of alloys significantly, particularly the elastic properties, the same way that heat treatments can change the microstructure of these alloys. This article presents the effect of heat treatment and oxygen doping in some mechanical properties and the biocompatibility of three alloys of the Ti-Nb system, characterized by density measurements, X-ray diffraction, optical microscopy, Vickers microhardness, in vitro cytotoxicity, and mechanical spectroscopy.
C1 [da Silva, Luciano Monteiro; Grandini, Carlos Roberto] UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
   [Rabelo Buzalaf, Marilia Afonso] Univ Sao Paulo, Dept Ciencias Biol, Fac Odontol, Bauru, Brazil.
   [Rosifini Alves Claro, Ana Paula] UNESP Univ Estadual Paulista, Dept Mat & Tecnol, Fac Engn, Guaratingueta, Brazil.
   [Goto Donato, Tatiani Ayako; Arana-Chavez, Victor E.] Univ Sao Paulo, Dept Biol Oral, Fac Odontol, Bauru, Brazil.
   [Silos Moraes, Joao Carlos] UNESP Univ Estadual Paulista, Fac Engn, Dept Fis & Quim, Sao Paulo, Brazil.
RP Grandini, CR (reprint author), UNESP Univ Estadual Paulista, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM betog@fc.unesp.br
RI Moraes, Joao/C-3406-2012; Arana-Chavez, Victor/G-4948-2012; ROSIFII
   ALVES CLARO, ANA PAULA/J-5215-2014; Buzalaf, Marilia/C-5228-2012
OI Moraes, Joao/0000-0002-7043-3157; Arana-Chavez,
   Victor/0000-0002-6767-7812; Grandini, Carlos
   Roberto/0000-0002-3336-309X; ROSIFINI ALVES CLARO, ANA
   PAULA/0000-0003-3353-4247
FU CNPq; FAPESP; FUNDUNESP
FX The authors thank the Brazilian agencies CNPq, FAPESP, and FUNDUNESP for
   financial support.
CR Almeida LH, 2009, MAT SCI ENG A-STRUCT, V521-22, P59, DOI 10.1016/j.msea.2008.09.123
   Cantelli R, 2006, MAT SCI ENG A-STRUCT, V442, P5, DOI 10.1016/j.msea.2006.03.130
   Donato TAG, 2009, MAT SCI ENG C-BIO S, V29, P1365, DOI 10.1016/j.msec.2008.10.021
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   LAING PATRICK G., 1967, J BIOMED MAT RES, V1, P135, DOI 10.1002/jbm.820010113
   Lee CM, 2002, J ORAL REHABIL, V29, P314, DOI 10.1046/j.1365-2842.2002.00825.x
   Matsumoto H, 2006, METALL MATER TRANS A, V37A, P3239, DOI 10.1007/BF02586159
   McLachlan D. R. C., 1983, BIOL ASPECTS METALS, P209
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Shapira L, 2009, CLIN ORAL IMPLAN RES, V20, P578, DOI 10.1111/j.1600-0501.2009.01707.x
   Silva LF, 2010, THESIS U ESTADUAL PA
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
NR 12
TC 12
Z9 12
U1 0
U2 19
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0160-564X
EI 1525-1594
J9 ARTIF ORGANS
JI Artif. Organs
PD MAY
PY 2011
VL 35
IS 5
BP 516
EP 521
DI 10.1111/j.1525-1594.2011.01263.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 766RW
UT WOS:000290805200017
PM 21595721
DA 2018-10-20
ER

PT J
AU Belfiore, LA
   Floren, ML
   Volpato, FZ
   Paulino, AT
   Belfiore, CJ
AF Belfiore, Laurence A.
   Floren, Michael L.
   Volpato, Fabio Z.
   Paulino, Alexandre T.
   Belfiore, Carol J.
TI Nutrient diffusion and simple n(th)-order consumption in regenerative
   tissue and biocatalytic sensors
SO BIOPHYSICAL CHEMISTRY
LA English
DT Article
DE Fick's second law; Unsteady state diffusion; Modified diffusion
   equation; Reaction-diffusion equation; Zeroth-order reaction;
   Intra-tissue Damkohler number; Critical Damkohler number; Regenerative
   tissue; Biosensors; von Karman-Pohlhausen profile method; Mass transfer
   boundary layer thickness
ID CRITERIA
AB This contribution addresses intra-tissue molar density profiles for nutrients, oxygen, growth factors, and other essential ingredients that anchorage-dependent cells require for successful proliferation on biocompatible surfaces. One-dimensional transient and steady state models of the reaction-diffusion equation are solved to correct a few deficiencies in the first illustrative example of diffusion and zeroth-order rates of consumption in tissues with rectangular geometry, as discussed in Ref. [(Griffith and Swartz, 2006) 1]. The functional form of the molar density profile for each species depends on geometry and the magnitude of the species-specific intra-tissue Damkohler number. The tissue's central core is reactant starved at high consumption rates and low rates of intra-tissue diffusion when the Damkohler number exceeds its geometry-sensitive critical value. Ideal tissue engineering designs avoid the diffusion-limited regime such that attached cells are exposed to all of the ingredients required for proliferation everywhere within a regenerative matrix. Analytical and numerical molar density profiles that satisfy the unsteady state modified diffusion equation with pseudo-homogeneous nth-order rates of intra-tissue consumption (i.e., n = 0,1,2) allow one to (i) predict von Karman-Pohlhausen mass transfer boundary layer thicknesses, measured inward from the external biomaterial surface toward its central core, and, most importantly, (ii) estimate the time required to achieve steady state conditions for regenerative tissue growth and biocatalytic sensing. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Belfiore, Laurence A.; Floren, Michael L.; Volpato, Fabio Z.; Paulino, Alexandre T.; Belfiore, Carol J.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
RP Belfiore, LA (reprint author), Univ Trent, Dept Mat Engn & Ind Technol, Via Mesiano 77, I-38050 Trento, Italy.
EM belfiore@engr.colostate.edu
RI Paulino, Alexandre/B-8075-2013; Zomer Volpato, Fabio/G-8828-2013
OI Paulino, Alexandre/0000-0001-7076-2797; 
FU Provincia Autonoma di Trento
FX LA Belfiore gratefully acknowledges the Provincia Autonoma di Trento for
   research support during his extended sabbatical at the University of
   Trento. Professor Matt Kipper in the Department of Chemical and
   Biological Engineering at Colorado State University has been a source of
   inspirational support throughout all of these tissue-based bioreactor
   simulations. Michael Floren, a PhD student in the Department of
   Materials Engineering and Industrial Technologies at the University of
   Trento, is acknowledged for helpful discussions about cell proliferation
   in porous biomaterials, and sending LA Belfiore the 2006 publication
   from Nature Reviews in Molecular and Cell Biology (i.e., Ref. [1]).
CR Baronas R., 2010, MATH MODELING BIOSEN
   Belfiore L.A., 2003, TRANSPORT PHENOMENA
   Belfiore LA, 2009, BIOPHYS CHEM, V140, P99, DOI 10.1016/j.bpc.2008.11.015
   Bird R.B., 2002, TRANSPORT PHENOMENA
   Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858
   Grzybowski B., 2009, CHEM MOTION REACTION
   Lopes JP, 2009, AICHE J, V55, P2686, DOI 10.1002/aic.11830
   Lyons MEG, 2009, INT J ELECTROCHEM SC, V4, P1196
   Peerani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006438
   SHAH YT, 1974, CHEM ENG SCI, V29, P1601, DOI 10.1016/0009-2509(74)87011-9
   Truskey G.A., 2009, TRANSPORT PHENOMENA
   Zeng Y, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2913231
NR 12
TC 2
Z9 2
U1 0
U2 7
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-4622
J9 BIOPHYS CHEM
JI Biophys. Chem.
PD MAY
PY 2011
VL 155
IS 2-3
BP 65
EP 73
DI 10.1016/j.bpc.2011.02.005
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Chemistry, Physical
SC Biochemistry & Molecular Biology; Biophysics; Chemistry
GA 767BV
UT WOS:000290831200002
PM 21470767
DA 2018-10-20
ER

PT J
AU Zhu, HX
   Jia, SR
   Yang, HJ
   Jia, YY
   Yan, L
   Li, J
AF Zhu, Huixia
   Jia, Shiru
   Yang, Hongjiang
   Jia, Yuanyuan
   Yan, Lin
   Li, Jing
TI PREPARATION AND APPLICATION OF BACTERIAL CELLULOSE SPHERE: A NOVEL
   BIOMATERIAL (vol 25, pg 2233, 2011)
SO BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
LA English
DT Correction
C1 [Zhu, Huixia; Jia, Shiru; Yang, Hongjiang; Jia, Yuanyuan; Yan, Lin; Li, Jing] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Ind Microbiol, Tianjin, Peoples R China.
   [Zhu, Huixia] Heng Shui Univ, Dept Life Sci, Hengshui, Hebei, Peoples R China.
RP Zhu, HX (reprint author), Tianjin Univ Sci & Technol, Minist Educ, Key Lab Ind Microbiol, Tianjin, Peoples R China.
CR Zhu HX, 2011, BIOTECHNOL BIOTEC EQ, V25, P2233, DOI 10.5504/BBEQ.2011.0010
NR 1
TC 0
Z9 0
U1 1
U2 8
PU DIAGNOSIS PRESS LTD
PI SOFIA
PA 67 DONDUKOV BLVD, 1504 SOFIA, BULGARIA
SN 1310-2818
J9 BIOTECHNOL BIOTEC EQ
JI Biotechnol. Biotechnol. Equip.
PD MAY
PY 2011
VL 25
IS 2
BP 2432
EP 2432
PG 1
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 766YV
UT WOS:000290823400026
DA 2018-10-20
ER

PT J
AU Widmer, RP
   Ferguson, SJ
AF Widmer, Rene P.
   Ferguson, Stephen J.
TI A Mixed Boundary Representation to Simulate the Displacement of a
   Biofluid by a Biomaterial in Porous Media
SO JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME
LA English
DT Article
ID FINITE-ELEMENT-METHOD; QUANTITATIVE COMPUTED-TOMOGRAPHY; LEVEL SET
   METHOD; CANCELLOUS BONE; PERCUTANEOUS VERTEBROPLASTY; COMPRESSION
   FRACTURES; CEMENT INFILTRATION; EXPERIMENTAL-MODEL; MULTIPHASE FLOW;
   HUMAN VERTEBRAE
AB Characterization of the biomaterial flow through porous bone is crucial for the success of the bone augmentation process in vertebroplasty. The biofluid, biomaterial, and local morphological bone characteristics determine the final shape of the filling, which is important both for the post-treatment mechanical loading and the risk of intraoperative extraosseous leakage. We have developed a computational model that describes the flow of biomaterials in porous bone structures by considering the material porosity, the region-dependent intrinsic permeability of the porous structure, the rheological properties of the biomaterial, and the boundary conditions of the filling process. To simulate the process of the substitution of a biofluid (bone marrow) by a biomaterial (bone cement), we developed a hybrid formulation to describe the evolution of the fluid boundary and properties and coupled it to a modified version of Darcy's law. The apparent rheological properties are derived from a fluid-fluid interface tracking algorithm and a mixed boundary representation. The region-specific intrinsic permeability of the bone is governed by an empirical relationship resulting from a fitting process of experimental data. In a first step, we verified the model by studying the displacement process in spherical domains, where the spreading pattern is known in advance. The mixed boundary model demonstrated, as expected, that the determinants of the spreading pattern are the local intrinsic permeability of the porous matrix and the ratio of the viscosity of the fluids that are contributing to the displacement process. The simulations also illustrate the sensitivity of the mixed boundary representation to anisotropic permeability, which is related to the directional dependent microstructural properties of the porous medium. Furthermore, we compared the nonlinear finite element model to different published experimental studies and found a moderate to good agreement (R(2) = 0.9895 for a one-dimensional bone core infiltration test and a 10.94-16.92% relative error for a three-dimensional spreading pattern study, respectively) between computational and experimental results. [DOI: 10.1115/1.4003735]
C1 [Widmer, Rene P.; Ferguson, Stephen J.] Univ Bern, Inst Surg Technol & Biomech, CH-3014 Bern, Switzerland.
RP Widmer, RP (reprint author), Univ Bern, Inst Surg Technol & Biomech, Stauffacherstr 78, CH-3014 Bern, Switzerland.
EM rene.widmer@istb.unibe.ch; stephen.ferguson@istb.unibe.ch
RI Ferguson, Stephen/A-4118-2012
OI Ferguson, Stephen/0000-0003-0650-5889
FU European Union [FP7-ICT- 223865-VPHOP]
FX Financial support has been provided by the European Union (Project No.
   FP7-ICT- 223865-VPHOP) and is gratefully acknowledged.
CR ADALSTEINSSON D, 1995, J COMPUT PHYS, V118, P269, DOI 10.1006/jcph.1995.1098
   Al-Assir I, 2000, AM J NEURORADIOL, V21, P159
   Amar AP, 2003, NEUROSURGERY, V53, P380, DOI 10.1227/01.NEU.0000073423.093308.40
   Anselmetti GC, 2008, CARDIOVASC INTER RAD, V31, P937, DOI 10.1007/s00270-008-9324-6
   ARRAMON YP, 2001, BONE MECH HDB, pCH25
   Aulisa E, 2007, J COMPUT PHYS, V225, P2301, DOI 10.1016/j.jcp.2007.03.015
   Baroud G, 2004, P I MECH ENG H, V218, P331, DOI 10.1243/0954411041932827
   Baroud G, 2004, J BIOMECH, V37, P189, DOI 10.1016/S0021-9290(03)00246-X
   Baroud G, 2003, MED ENG PHYS, V25, P283, DOI 10.1016/S1350-4533(02)00223-0
   BAROUD G, 2002, 10 ANN S COMP METH O
   Baroud G, 2006, SPINE, V31, P2562, DOI 10.1097/01.brs.0000240695.58651.62
   Bear J., 1972, DYNAMICS FLUIDS PORO
   BEAUDOIN AJ, 1991, J BIOMECH, V24, P127, DOI 10.1016/0021-9290(91)90357-S
   Bohner M, 2003, BIOMATERIALS, V24, P2721, DOI 10.1016/S0142-9612(03)00086-3
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Capon PJ, 1997, APPL MATH LETT, V10, P9, DOI 10.1016/S0893-9659(97)00025-6
   Chae SW, 2010, P I MECH ENG H, V224, P87, DOI 10.1243/09544119JEIM654
   Chevalier Y, 2008, SPINE, V33, P1722, DOI 10.1097/BRS.0b013e31817c750b
   Choe DH, 2004, AM J ROENTGENOL, V183, P1097, DOI 10.2214/ajr.183.4.1831097
   Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2
   DARCY H, 1856, FONTAINES PUBLIQUES, V647
   Delerue JF, 2003, POLYM COMPOSITE, V24, P344, DOI 10.1002/pc.10034
   DILLAMAN RM, 1991, J BIOMECH, V24, P163, DOI 10.1016/0021-9290(91)90386-2
   Eck JC, 2008, SPINE J, V8, P488, DOI 10.1016/j.spinee.2007.04.004
   Ferguson SJ, 2004, J BIOMECH, V37, P213, DOI 10.1016/S0021-9290(03)00250-1
   Fisher QJ, 2001, MAR PETROL GEOL, V18, P1063, DOI 10.1016/S0264-8172(01)00042-3
   Frei H, 2006, J BIOMECH, V39, P493, DOI 10.1016/j.jbiomech.2004.12.010
   Gao DM, 1999, INT J NUMER METH FL, V29, P877, DOI 10.1002/(SICI)1097-0363(19990415)29:7<877::AID-FLD814>3.3.CO;2-Z
   Gisep A, 2009, BIO-MED MATER ENG, V19, P415, DOI 10.3233/BME-2009-0607
   Grimm MJ, 1997, J BIOMECH, V30, P743, DOI 10.1016/S0021-9290(97)00016-X
   Habib Mohamed, 2010, SAS J, V4, P26, DOI 10.1016/j.esas.2010.01.001
   Jensen ME, 1997, AM J NEURORADIOL, V18, P1897
   Kirk BS, 2006, ENG COMPUT-GERMANY, V22, P237, DOI 10.1007/s00366-006-0049-3
   Knoll DA, 2004, J COMPUT PHYS, V193, P357, DOI 10.1016/j.jcp.2003.08.010
   Li CD, 2004, J MATER SCI-MATER M, V15, P85, DOI 10.1023/B:JMSM.0000010101.45352.d1
   Lian Z, 2008, COMPUT BIOL MED, V38, P304, DOI 10.1016/j.compbiomed.2007.10.009
   Liebschner MAK, 2001, SPINE, V26, P1547, DOI 10.1097/00007632-200107150-00009
   Lin CL, 2005, INT J NUMER METH FL, V49, P521, DOI 10.1002/fld.1006
   Lin JT, 2004, CLIN ORTHOP RELAT R, P126, DOI 10.1097/01.blo.0000132404.30139.f2
   LOEFFEL M, 2007, THESIS U BERN BERN
   Loeffel M, 2008, SPINE, V33, P1352, DOI 10.1097/BRS.0b013e3181732aa9
   Loeffel M, 2007, IEEE T BIO-MED ENG, V54, P2051, DOI 10.1109/TBME.2007.894964
   Luo J, 2009, SPINE, V34, P2865, DOI 10.1097/BRS.0b013e3181b4ea1e
   Macklin P, 2005, J COMPUT PHYS, V203, P191, DOI 10.1016/j.jcp.2004.08.010
   MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179
   Mirzaei M, 2009, J BIOMECH, V42, P1584, DOI 10.1016/j.jbiomech.2009.04.042
   Mohamed R, 2010, SPINE, V35, P353, DOI 10.1097/BRS.0b013e3181b63673
   Nauman EA, 1999, ANN BIOMED ENG, V27, P517, DOI 10.1114/1.195
   Nzihou A, 1998, POWDER TECHNOL, V99, P60, DOI 10.1016/S0032-5910(98)00091-6
   Pinder G. F., 2008, ESSENTIALS MULTIPHAS
   Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024
   REY RM, 1987, CLIN ORTHOP RELAT R, P272
   SCHUTTE HE, 1995, EUR J RADIOL, V20, P165, DOI 10.1016/0720-048X(95)00628-4
   Shepel SV, 2006, J COMPUT PHYS, V218, P479, DOI 10.1016/j.jcp.2006.02.008
   Shin S, 2002, J COMPUT PHYS, V180, P427, DOI 10.1006/jcph.2002.7086
   SILVERMAN SL, 1992, BONE, V13, pS27, DOI 10.1016/8756-3282(92)90193-Z
   Sun K, 2004, SPINE, V29, P1428, DOI 10.1097/01.BRS.0000128760.94173.90
   Sun K, 2004, ANN BIOMED ENG, V32, P77, DOI 10.1023/B:ABME.0000007793.49771.6d
   Sussman M, 1998, COMPUT FLUIDS, V27, P663, DOI 10.1016/S0045-7930(97)00053-4
   Teo JCM, 2007, MAT SCI ENG C-BIO S, V27, P333, DOI 10.1016/j.msec.2006.05.003
   Teo J, 2007, SPINE, V32, P1320, DOI 10.1097/BRS.0b013e318059af56
   TOGAWA D, 2005, INTERNET J SPINE SUR, V1
   Tryggvason G, 2001, J COMPUT PHYS, V169, P708, DOI [10.1006/jcph.2001.6726, 10.1006/jcph.2000.6726]
   Tschirhart CE, 2005, J BIOMECH, V38, P1582, DOI 10.1016/j.jbiomech.2004.07.023
   Wasnich RD, 1996, BONE, V18, pS179, DOI 10.1016/8756-3282(95)00499-8
   Whitlow CT, 2007, AM J NEURORADIOL, V28, P1036, DOI 10.3174/ajnr.A0500
   Wijayathunga VN, 2008, P I MECH ENG H, V222, P221, DOI 10.1243/09544119JEIM285
   Wyckoff RD, 1933, REV SCI INSTRUM, V4, P394, DOI 10.1063/1.1749155
   Zeiser T, 2008, P I MECH ENG H, V222, P185, DOI 10.1243/09544119JEIM261
NR 69
TC 8
Z9 8
U1 1
U2 6
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0148-0731
J9 J BIOMECH ENG-T ASME
JI J. Biomech. Eng.-Trans. ASME
PD MAY
PY 2011
VL 133
IS 5
AR 051007
DI 10.1115/1.4003735
PG 12
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 765EQ
UT WOS:000290686600007
PM 21599098
DA 2018-10-20
ER

PT J
AU Chatterjee, K
   Young, MF
   Simon, CG
AF Chatterjee, Kaushik
   Young, Marian F.
   Simon, Carl G., Jr.
TI Fabricating Gradient Hydrogel Scaffolds for 3D Cell Culture
SO COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
LA English
DT Article
DE Combinatorial methods; high-throughput screening; hydrogels; elastic
   modulus; gradients; osteoblast; tissue engineering
ID DIFFERENTIATION; BIOMATERIALS; SURFACES
AB Optimizing cell-material interactions is critical for maximizing regeneration in tissue engineering. Combinatorial and high-throughput (CHT) methods can be used to systematically screen tissue scaffolds to identify optimal biomaterial properties. Previous CHT platforms in tissue engineering have involved a two-dimensional (2D) cell culture format where cells were cultured on material surfaces. However, these platforms are inadequate to predict cellular response in a three-dimensional (3D) tissue scaffold. We have developed a simple CHT platform to screen cell-material interactions in 3D culture format that can be applied to screen hydrogel scaffolds. Herein we provide detailed instructions on a method to prepare gradients in elastic modulus of photopolymerizable hydrogels.
C1 [Chatterjee, Kaushik; Simon, Carl G., Jr.] NIST, Div Polymers, Gaithersburg, MD 20899 USA.
   [Chatterjee, Kaushik; Young, Marian F.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA.
RP Simon, CG (reprint author), NIST, Div Polymers, 100 Bur Dr, Gaithersburg, MD 20899 USA.
EM carl.simon@nist.gov
OI Chatterjee, Kaushik/0000-0002-7204-2926
FU National Research Council of the National Academy of Sciences in the
   NIH-NIBIB/NIST; NIST [NIH-NIBIB R21 EB006497-01]; NIH-NIDCR (National
   Institute of Dental and Craniofacial Research)
FX We gratefully acknowledge technical inputs from Sheng Lin-Gibson,
   William E. Wallace, Kathy Flynn, Ed Parry, Kathryn L. Beers, Sapun H.
   Parekh, Young J. Lee and Marcus T. Cicerone at NIST. This work was
   performed while K. C. held a Research Associateship Award from the
   National Research Council of the National Academy of Sciences in the
   NIH-NIBIB/NIST Joint Postdoctoral Program (National Institutes of
   Health-National Institute of Biomedical Imaging and
   Bioengineering/National Institute of Standards and Technology). This
   work was supported by NIST, NIH-NIBIB R21 EB006497-01 and the Intramural
   Program of NIH-NIDCR (National Institute of Dental and Craniofacial
   Research).
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Chatterjee K, 2010, BIOMATERIALS, V31, P5051, DOI 10.1016/j.biomaterials.2010.03.024
   Cushing MC, 2007, SCIENCE, V316, P1133, DOI 10.1126/science.1140171
   DeLong SA, 2005, J CONTROL RELEASE, V109, P139, DOI 10.1016/j.jconrel.2005.09.020
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gallant ND, 2007, ADV MATER, V19, P965, DOI 10.1002/adma.200602221
   Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17
   Kraehenbuehl TP, 2008, BIOMATERIALS, V29, P2757, DOI 10.1016/j.biomaterials.2008.03.016
   Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j
   Lin NJ, 2009, BIOMATERIALS, V30, P4480, DOI 10.1016/j.biomaterials.2009.05.019
   Lin-Gibson S, 2005, MACROMOLECULES, V38, P2897, DOI 10.1021/ma0487002
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]
   Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005
   Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217
   Simon CG, 2009, COMB CHEM HIGH T SCR, V12, P544, DOI 10.2174/138620709788681961
   SIMON CG, 2007, REV SCI INSTRUM
   Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006
   Yang J, 2009, ADV MATER, V21, P300, DOI 10.1002/adma.200801942
   Yang Y, 2008, ADV MATER, V20, P2037, DOI 10.1002/adma.200702088
NR 24
TC 10
Z9 10
U1 4
U2 25
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1386-2073
J9 COMB CHEM HIGH T SCR
JI Comb. Chem. High Throughput Screen
PD MAY
PY 2011
VL 14
IS 4
BP 227
EP 236
DI 10.2174/138620711795222455
PG 10
WC Biochemical Research Methods; Chemistry, Applied; Pharmacology &
   Pharmacy
SC Biochemistry & Molecular Biology; Chemistry; Pharmacology & Pharmacy
GA 764EO
UT WOS:000290611700001
PM 21143178
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Cruz-Olivares, J
   Ortiz-Estrada, CH
   Perez-Alonso, C
   Chaparro-Mercado, MC
   Barrera-Diaz, C
AF Cruz-Olivares, J.
   Ortiz-Estrada, C. H.
   Perez-Alonso, C.
   Chaparro-Mercado, M. C.
   Barrera-Diaz, C.
TI Solubility of Mesquite Gum in Supercritical Carbon Dioxide
SO JOURNAL OF CHEMICAL AND ENGINEERING DATA
LA English
DT Article
ID IN-WATER EMULSIONS; FLUIDS; PROSOPIS; SOLIDS
AB The solubility of mesquite gum (MG) in supercritical carbon dioxide (SC-CO2) was determined for the first time at T = (313, 323, 333, and 343) K and with pressures ranging from (138 to 345) bar. The solubility values of MG in SC-CO2 in mole fraction railed from 2.622.10(-9) to 4.189.10(-9), 2.768.10(-9) to 6.365.10(-9), 3.442.10(-9) to 7.570.10(-9), and 4.194.10(-9) to 11.886.10(-9) at (313, 323, 333, and 343) K, respectively. This biomaterial showed low solubility in SC-CO2 based on the MG molecule polarity and high molecular weight. The experimental solubility data were successfully correlated with the Bartle and Mendez-Santiago and Teja models. Using correlation results, the MG enthalpy of sublimation was Delta H-sub = 57.63 kJ.mol(-1).
C1 [Cruz-Olivares, J.; Perez-Alonso, C.] Univ Autonoma Estado Mexico, Fac Quim, Toluca 50120, Estado Mexico, Mexico.
   [Ortiz-Estrada, C. H.] Univ Iberoamer, Dept Ingn & Ciencias Quim, Alvaro Obregon 01219, DF, Mexico.
   [Chaparro-Mercado, M. C.] Univ Iberoamer, Dept Ingn, Alvaro Obregon 01219, DF, Mexico.
   [Barrera-Diaz, C.] Ctr Conjunto Invest Quim Sustentable UAEM UNAM, Unidad Rosedal, Toluca 50200, Estado Mexico, Mexico.
RP Cruz-Olivares, J (reprint author), Univ Autonoma Estado Mexico, Fac Quim, Paseo Colon Intersecc Paseo Tollocan S-N, Toluca 50120, Estado Mexico, Mexico.
EM jcruzo@uaemex.mx
OI PEREZ-ALONSO, CESAR/0000-0002-1907-4777; Barrera-Diaz, Carlos
   Eduardo/0000-0001-7547-8306; Cruz-Olivares, Julian/0000-0002-6373-527X
FU National Council for Science and Technology (CONACyT) of Mexico [83842]
FX This work was supported by the National Council for Science and
   Technology (CONACyT) of Mexico under Project 83842.
CR ANDERSON D N W, 1982, International Tree Crops Journal, V2, P15
   BARTLE KD, 1991, J PHYS CHEM REF DATA, V20, P713, DOI 10.1063/1.555893
   Brunner G, 2005, J FOOD ENG, V67, P21, DOI 10.1016/j.jfoodeng.2004.05.060
   Cocero MJ, 2009, J SUPERCRIT FLUID, V47, P546, DOI 10.1016/j.supflu.2008.08.015
   Coimbra P, 2008, J CHEM ENG DATA, V53, P1990, DOI 10.1021/je800384h
   DOXASTAKIS G, 2000, NOVEL MACROMOLECULES, P217
   Garlapati C, 2010, J CHEM THERMODYN, V42, P193, DOI 10.1016/j.jct.2009.08.001
   Ghaziaskar HS, 2008, J SUPERCRIT FLUID, V44, P148, DOI 10.1016/j.supflu.2007.10.006
   Goycoolea FM, 1997, INT J BIOL MACROMOL, V21, P29, DOI 10.1016/S0141-8130(97)00037-8
   Gupta R. B., 2007, SOLUBILITY SUPERCRIT
   HUANG Z, 2005, FLUID PHASE EQUILIBR, V237, P12
   Liu L, 2009, J CHEM ENG DATA, V54, P2780, DOI 10.1021/je801009z
   Mendez-Santiago J, 1999, FLUID PHASE EQUILIBR, V158, P501, DOI 10.1016/S0378-3812(99)00154-5
   Orozco-Villafuerte J., 2003, Carbohydrate Polymers, V54, P327, DOI 10.1016/S0144-8617(03)00187-5
   Sahihi M, 2010, J CHEM ENG DATA, V55, P2596, DOI 10.1021/je9008393
   Santoyo-Arreola JG, 2009, MACROMOL SYMP, V283-84, P230, DOI 10.1002/masy.200950930
   Vernon-Carter EJ, 1998, J TEXTURE STUD, V29, P553, DOI 10.1111/j.1745-4603.1998.tb00183.x
   VernonCarter EJ, 1996, J TEXTURE STUD, V27, P625, DOI 10.1111/j.1745-4603.1996.tb00997.x
   Yamini Y, 2010, J CHEM ENG DATA, V55, P1056, DOI 10.1021/je900520a
   2010, J CHEM ENG DATA, V55, P1437
NR 20
TC 2
Z9 2
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-9568
J9 J CHEM ENG DATA
JI J. Chem. Eng. Data
PD MAY
PY 2011
VL 56
IS 5
BP 2449
EP 2452
DI 10.1021/je2000155
PG 4
WC Thermodynamics; Chemistry, Multidisciplinary; Engineering, Chemical
SC Thermodynamics; Chemistry; Engineering
GA 761UT
UT WOS:000290427200101
DA 2018-10-20
ER

PT J
AU Gholami, A
   Tavanai, H
   Moradi, AR
AF Gholami, A.
   Tavanai, H.
   Moradi, A. R.
TI Production of fibroin nanopowder through electrospraying
SO JOURNAL OF NANOPARTICLE RESEARCH
LA English
DT Article
DE Fibroin; Electrospraying; Nanopowder; Particle size; Synthesis;
   Biomaterial
ID BOMBYX-MORI SILK; FINE POWDER; IN-VITRO; REGENERATION
AB Fibroin is a biomaterial and in the powder form, has found applications such as food and cosmetic additive as well as drug delivery. Various methods have been employed to produce fibroin powder with different particle size range. In this study, a novel and original application of electrospraying technique capable of producing fibroin nanopowder is presented. Our technique is based on electrospraying of dilute fibroin solution in formic acid. Moreover, the effect of variables in electrospraying, namely, concentration of fibroin solution, voltage, feed rate, and needle-collector distance, on average particle size of fibroin nanopowder has been studied. The result of this study showed that electrospraying is capable of producing fibroin nanopowder with average particle size as low as 80 nm. In fact in comparison to other methods reported in the literature, electrospraying alongside with the precipitation method produce fibroin nanopowder with the lowest particle size. However, nanopowder obtained through electrospraying technique enjoys a more uniform spherical shape and size. As far as the variables are concerned, it was ascertained that lower concentrations, lower feed rates and longer needle-collector distances lead to a decrease in the average particle size of fibroin nanopowder. Increasing voltage up to 20 kV decreases the particle size; but with higher voltages the average particle size increases. FT-IR and XRD studies showed that the fibroin nanopowder has a beta-sheets structure, similar to fibroin filaments but with a lower crystallinity index.
C1 [Gholami, A.; Tavanai, H.; Moradi, A. R.] Isfahan Univ Technol, Ctr Excellence Environm Nanotechnol, Dept Text Engn, Esfahan 8415683111, Iran.
RP Tavanai, H (reprint author), Isfahan Univ Technol, Ctr Excellence Environm Nanotechnol, Dept Text Engn, Esfahan 8415683111, Iran.
EM tavanai@cc.iut.ac.ir
CR Ajisawa A, 1998, J SERIC SCI JPN, V67, P91
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Chen M.-J., 2007, THESIS FLORIDA STATE
   Hino T, 2003, J COLLOID INTERF SCI, V266, P68, DOI 10.1016/S0021-9797(03)00584-8
   Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001
   Jaworek A, 1999, EXP FLUIDS, V27, P43, DOI 10.1007/s003480050327
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   PARK WH, 2001, FIBER POLYM, V2, P58, DOI DOI 10.1007/BF02875259
   Rajkhowa R, 2008, POWDER TECHNOL, V185, P87, DOI 10.1016/j.powtec.2008.01.005
   Ramakrishna S, 2005, INTRODUCTION TO ELECTROSPINNING AND NANOFIBERS, P1, DOI 10.1142/9789812567611
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Takeshita H, 2000, MACROMOL MATER ENG, V283, P126
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang H, 2006, J APPL POLYM SCI, V101, P961, DOI 10.1002/app.24024
   Xu WL, 2006, J APPL POLYM SCI, V101, P2967, DOI 10.1002/app.23529
   Yeo JH, 2003, EUR POLYM J, V39, P1195, DOI 10.1016/S0014-3057(02)00359-2
   Zhang YQ, 2007, J NANOPART RES, V9, P885, DOI 10.1007/s11051-006-9162-x
   Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049
NR 21
TC 21
Z9 23
U1 1
U2 32
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-0764
J9 J NANOPART RES
JI J. Nanopart. Res.
PD MAY
PY 2011
VL 13
IS 5
BP 2089
EP 2098
DI 10.1007/s11051-010-9965-7
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 763RO
UT WOS:000290577600027
DA 2018-10-20
ER

PT J
AU Silvestri, M
   Rasperini, G
   Milani, S
AF Silvestri, Maurizio
   Rasperini, Giulio
   Milani, Stefano
TI 120 Infrabony Defects Treated With Regenerative Therapy: Long Term
   Results
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE Biomaterials; growth factors; guided tissue regeneration; smoking
ID GUIDED TISSUE REGENERATION; ENAMEL MATRIX PROTEINS; CONTROLLED
   CLINICAL-TRIAL; PAPILLA PRESERVATION TECHNIQUE; HUMAN INTRABONY DEFECTS;
   BARRIER MEMBRANES; PERIODONTAL REGENERATION; NONRESORBABLE MEMBRANE;
   BIOABSORBABLE BARRIERS; SURGICAL APPROACH
AB Background: The aim of this study is to evaluate the long-term benefits of regenerative therapy and which factors (i.e., smoking, oral hygiene, radiographic angle, tooth, clinical center, and biomaterial) influence results.
   Methods: A total of 120 infrabony defects were treated with guided tissue regeneration using bioabsorbable and non-resorbable membranes with grafts or enamel matrix derivative (EMD) proteins. At baseline, smoking, x-ray angle, probing depth (PD), recession, and clinical attachment level (CAL) were recorded. CAL was measured 1 year post-surgery and every 2 years for <= 16 years. The participation of patients in oral hygiene protocols was recorded.
   Results: The mean +/- SD baseline CAL was 8.5 +/- 2.3 mm, baseline PD was 7.8 +/- 2.1 mm, and baseline x-ray angle was 31.8 degrees +/- 8.9 degrees. One year post-surgery, CAL gain was 4.1 +/- 2.1 mm. EMD was used in 47 defects, bioabsorbable membranes with deproteinized bovine bone were used in 41 cases, non-resorbable membranes were used in seven defects, bioabsorbable membranes and autogenous bone were used in five defects, and a combination was used in 20 defects. A total of 10% of subjects were smokers, and 20% of subjects did not participate in an oral hygiene program. The average follow-up was 9 years. A total of 90% teeth survival was achieved at 13 years, and CAL gain was maintained at 82% for 11 years. Statistical analyses demonstrated that smoking and oral hygiene maintenance influenced long-term outcomes. The x-ray angle, tooth, clinical center, and biomaterials did not influence results.
   Conclusions: Regenerative therapy provided a high percentage of long-term success. Smoking and non-participation in oral hygiene maintenance negatively influenced the prognosis, whereas other factors did not affect long-term results. J Periodontol 2011;82:668-675.
C1 [Rasperini, Giulio; Milani, Stefano] Univ Milan, Unit Periodontol, Dept Surg Reconstruct & Diagnost Sci, Unit Periodontol,Fdn IRCCS Ca Granda, Milan, Italy.
RP Rasperini, G (reprint author), Via 20 Settembre,119, I-29121 Piacenza, Italy.
EM giulio@studiorasperini.it
OI Rasperini, Giulio/0000-0003-3836-147X
CR Caton J G, 1993, Periodontol 2000, V1, P9, DOI 10.1111/j.1600-0757.1993.tb00202.x
   Cattaneo V, 2003, J PERIODONTAL RES, V38, P568, DOI 10.1034/j.1600-0765.2003.00690.x
   Cortellini P, 2007, Minerva Stomatol, V56, P519
   CORTELLINI P, 1994, J CLIN PERIODONTOL, V21, P606, DOI 10.1111/j.1600-051X.1994.tb00751.x
   Cortellini P, 1999, INT J PERIODONT REST, V19, P589
   CORTELLINI P, 1995, J PERIODONTOL, V66, P261, DOI 10.1902/jop.1995.66.4.261
   Cortellini P, 2005, J PERIODONTOL, V76, P341, DOI 10.1902/jop.2005.76.3.341
   Cortellini P, 1996, J PERIODONTOL, V67, P217, DOI 10.1902/jop.1996.67.3.217
   Cortellini P, 2004, J PERIODONTOL, V75, P672, DOI 10.1902/jop.2004.75.5.672
   Eickholz P, 2004, J PERIODONTOL, V75, P399, DOI 10.1902/jop.2004.75.3.399
   Eickholz P, 2006, J PERIODONTOL, V77, P88, DOI 10.1902/jop.2006.77.1.88
   Froum SJ, 2001, J PERIODONTOL, V72, P25, DOI 10.1902/jop.2001.72.1.25
   GOTTLOW J, 1986, J CLIN PERIODONTOL, V13, P604, DOI 10.1111/j.1600-051X.1986.tb00854.x
   Hammarstrom L, 1997, J CLIN PERIODONTOL, V24, P658, DOI 10.1111/j.1600-051X.1997.tb00247.x
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   Pontoriero R, 1999, J CLIN PERIODONTOL, V26, P833
   Pretzl B, 2008, J PERIODONTOL, V79, P1491, DOI [10.1902/jop.2008.070571, 10.1902/jop.2008.070571 ]
   Rasperini G, 2005, INT J PERIODONT REST, V25, P121
   Sanz M, 2004, J PERIODONTOL, V75, P726, DOI 10.1902/jop.2004.75.5.726
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P817, DOI 10.1111/j.1600-051X.2008.01295.x
   Sculean A, 2008, J CLIN PERIODONTOL, V35, P106, DOI 10.1111/j.1600-051X.2008.01263.x
   Silvestri M, 2003, J CLIN PERIODONTOL, V30, P386, DOI 10.1034/j.1600-051X.2003.10146.x
   Silvestri M, 2000, J CLIN PERIODONTOL, V27, P603, DOI 10.1034/j.1600-051x.2000.027008603.x
   Suzuki S, 2005, J DENT RES, V84, P510, DOI 10.1177/154405910508400605
   TAKEI HH, 1985, J PERIODONTOL, V56, P204, DOI 10.1902/jop.1985.56.4.204
   Tonetti MS, 2004, J CLIN PERIODONTOL, V31, P770, DOI 10.1111/j.1600-051X.2004.00562.x
   TONETTI MS, 1995, J CLIN PERIODONTOL, V22, P229
   Trombelli L, 2002, J CLIN PERIODONTOL, V29, P117, DOI 10.1034/j.1600-051X.29.s3.7.x
   Trombelli L, 2002, J CLIN PERIODONTO S3, V29, P160
   Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x
   Tu YK, 2010, J CLIN PERIODONTOL, V37, P59, DOI 10.1111/j.1600-051X.2009.01499.x
   Zucchelli G, 2002, J PERIODONTOL, V73, P3, DOI 10.1902/jop.2002.73.1.3
NR 34
TC 24
Z9 25
U1 0
U2 4
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD MAY
PY 2011
VL 82
IS 5
BP 668
EP 675
DI 10.1902/jop.2010.100297
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 761RC
UT WOS:000290414700004
PM 21080788
DA 2018-10-20
ER

PT J
AU Gunaydin, S
   McCusker, K
   Vijay, V
AF Gunaydin, Serdar
   McCusker, Kevin
   Vijay, Venkatramana
TI Perioperative blood conservation strategies in pediatric patients
   undergoing open-heart surgery: impact of non-autologous blood
   transfusion and surface-coated extracorporeal circuits
SO PERFUSION-UK
LA English
DT Article
DE cardiopulmonary bypass; congenital heart defects; blood
   transfusion-autologous; blood preservation; oxygenators-membrane
ID CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; HEMODILUTION
AB Background: The aim of this study was to explore the relative clinical and biomaterial effects of blood transfusions (Tx) and novel low-prime, surface-coated circuitry on perioperative outcome in a pediatric population undergoing cardiac surgery with cardiopulmonary bypass (CPB).
   Methods: Over a 12-month period, 80 patients weighing > 10 kg undergoing ventricular septal defect (VSD) repair with CPB were prospectively randomized into two groups according to the type of CBP circuit used, then each randomized group was enrolled into two groups again, according to the need for transfusion (N=20): Group 1-Tx-free procedures on low-prime, surface-coated extracorporeal circuitry (FX05, Terumo); Group 2-procedures requiring Tx on coated circuitry; Group 3-Tx-free procedures with standard uncoated circuitry (D902, Sorin); Group 4 (Control)-procedures requiring Tx on uncoated circuitry. Blood samples were collected at baseline (T1), at the end of the CPB (T2) and 24 h (T3) postoperatively. rSO(2) desaturation risk score > 6000 (Invos, Somanetics) was calculated by multiplying rSO(2) < 50% by time.
   Results: IL-6 levels (pg/ml) were significantly lower in Groups 1 and 3 versus control at T2 (13 +/- 4; 17 +/- 5 versus 33 +/- 8; p < 0.05). CD11b/CD18 levels (%) were significantly lower in Group 1 (12 +/- 4) versus control (25 +/- 8) at T2 (p < 0.05). Respiratory support time (h) was significantly less in Group 1 (11.4 +/- 6) versus control (19.8 +/- 7) (p < 0.05). rSO(2) desaturation risk > 6000 (%) was 15.7 +/- 9 in Group 1 and 26.8 +/- 11 in control (p < 0.05).
   Conclusion: Allogenic Tx amplifies the CPB-related inflammatory response. It is feasible to do congenital procedures safely without Tx for patients weighing > 10 kg by using combined blood management strategies.
C1 [Gunaydin, Serdar] Kirikkale Univ, Dept Cardiovasc Surg, TR-06800 Ankara, Turkey.
   [McCusker, Kevin] Portsmouth Reg Hosp, Portsmouth, NH USA.
RP Gunaydin, S (reprint author), Kirikkale Univ, Dept Cardiovasc Surg, Angora Evleri G-8,Bl 1, TR-06800 Ankara, Turkey.
EM sgunaydin@isnet.net.tr
CR Charette K, 2007, PERFUSION-UK, V22, P327, DOI 10.1177/0267659107086263
   Deptula Joseph, 2006, J Extra Corpor Technol, V38, P22
   Elliott MJ, 1999, PERFUSION-UK, V14, P237, DOI 10.1177/026765919901400402
   Escobar GA, 2007, ANN SURG, V246, P129, DOI 10.1097/01.sla.0000264507.79859.f9
   Ging AL, 2008, PERFUSION-UK, V23, P131, DOI 10.1177/0267659108095903
   Gunaydin S, 2002, ANN THORAC SURG, V74, P819, DOI 10.1016/S0003-4975(02)03796-7
   Gunaydin S, 2006, PERFUSION-UK, V21, P329, DOI 10.1177/0267659106070507
   Gunaydin S, 2009, PERFUSION-UK, V24, P153, DOI 10.1177/0267659109346664
   Jones TJ, 2006, PERFUSION-UK, V21, P229, DOI 10.1191/0267659106pf873oa
   Koster A, 2009, J THORAC CARDIOV SUR, V137, P1565, DOI 10.1016/j.jtcvs.2008.03.056
   Larmann Jan, 2004, Best Pract Res Clin Anaesthesiol, V18, P425
   REPO H, 1993, J IMMUNOL METHODS, V164, P193, DOI 10.1016/0022-1759(93)90312-U
   Scott BH, 2008, ANN CARD ANAESTH, V11, P15, DOI 10.4103/0971-9784.38444
   Thuys C, 2006, PERFUSION-UK, V21, P39, DOI 10.1191/0267659106pf835oa
   Valleley Melinda S, 2007, J Extra Corpor Technol, V39, P168
   Yeh T, 2005, PROG PEDIATR CARDIOL, V21, P87, DOI 10.1016/j.ppedcard.2005.09.011
NR 16
TC 3
Z9 4
U1 0
U2 1
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0267-6591
EI 1477-111X
J9 PERFUSION-UK
JI Perfusion-UK
PD MAY
PY 2011
VL 26
IS 3
BP 199
EP 205
DI 10.1177/0267659111398701
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 762YX
UT WOS:000290519400006
PM 21339244
DA 2018-10-20
ER

PT J
AU Go, DP
   Gras, SL
   Mitra, D
   Nguyen, TH
   Stevens, GW
   Cooper-White, JJ
   O'Connor, AJ
AF Go, Dewi P.
   Gras, Sally L.
   Mitra, Debapriya
   Nguyen, Thanh H.
   Stevens, Geoffrey W.
   Cooper-White, Justin J.
   O'Connor, Andrea J.
TI Multilayered Microspheres for the Controlled Release of Growth Factors
   in Tissue Engineering
SO BIOMACROMOLECULES
LA English
DT Article
ID HEPARINIZED COLLAGEN MATRICES; CONJUGATED POLYMERIC MICELLE;
   SELF-ASSEMBLED MONOLAYERS; PLGA MICROSPHERES; SUSTAINED-RELEASE;
   IN-VITRO; CARTILAGE REGENERATION; MOLECULAR-WEIGHT; CELLULAR UPTAKE;
   FACTOR DELIVERY
AB Tissue regeneration may be stimulated by growth factors but to be effective, this delivery must be sustained and requires delivery vehicles that overcome the short half-life of these molecules in vivo. One promising approach is to couple growth factors to the biomaterial surface so that they are readily bioavailable. Here the layer-by-layer process was used to construct a multilayered polyelectrolyte delivery system on the surface of poly(lactic-co-glycolic) acid constructs. The system was first optimized on a planar surface before translation to a 3D microsphere system. The layers incorporated heparin to facilitate the loading of basic fibroblast growth factor and increase growth factor stability. Cross-linked capping layers also reduced any burst release. The model growth factor was released in a sustained manner and stimulated significantly higher cell proliferation in vitro on release compared with the addition of the growth factor heparin complex free in solution, demonstrating the promise of this approach.
C1 [Go, Dewi P.; Gras, Sally L.; Mitra, Debapriya; Nguyen, Thanh H.; Stevens, Geoffrey W.; O'Connor, Andrea J.] Univ Melbourne, Particulate Fluids Proc Ctr, Dept Chem & Biomol Engn, Melbourne, Vic 3010, Australia.
   [Go, Dewi P.; Gras, Sally L.; O'Connor, Andrea J.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.
   [Cooper-White, Justin J.] Univ Queensland, Sch Chem Engn, Brisbane, Qld 4072, Australia.
RP Gras, SL (reprint author), Univ Melbourne, Particulate Fluids Proc Ctr, Dept Chem & Biomol Engn, Melbourne, Vic 3010, Australia.
EM sgras@unimelb.edu.au
RI O'Connor, Andrea/B-1225-2011; Gras, Sally/G-2025-2014
OI O'Connor, Andrea/0000-0001-6925-885X; Gras, Sally/0000-0002-4660-1245;
   Cooper-White, Justin/0000-0002-1920-8229; Stevens,
   Geoffrey/0000-0002-5788-4682
FU The University of Melbourne
FX We acknowledge the Particulate Fluids Processing Centre, a Special
   Research Centre of the Australian Research Council, for access to
   infrastructure and The University of Melbourne Research Grants Scheme.
   We also thank Mr. Adrian Knight, Dr. John Quinn, Dr. Angus Johnston, Ms.
   Effie Karavitis, and Roger Curtain for assistance with Mastersizer, QCM,
   FTIR, cell culture, and scanning electron microscopy, respectively, and
   Keren Abberton for useful discussions.
CR Anderson JM, 1997, ADV DRUG DELIVER REV, V28, P5, DOI 10.1016/S0169-409X(97)00048-3
   Aubert-Pouessel A, 2004, J CONTROL RELEASE, V95, P463, DOI 10.1016/j.jconrel.2003.12.012
   Beyerle A, 2009, TOXICOL IN VITRO, V23, P500, DOI 10.1016/j.tiv.2009.01.001
   Bezuidenhout D, 2010, J BIOMATER APPL, V24, P401, DOI 10.1177/0885328208097565
   Boudou T, 2010, ADV MATER, V22, P441, DOI 10.1002/adma.200901327
   Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029
   Casu B, 2010, MATRIX BIOL, V29, P442, DOI 10.1016/j.matbio.2010.04.003
   Chung HJ, 2006, PHARM RES, V23, P1835, DOI 10.1007/s11095-006-9039-9
   Croll T. I., 2005, SURFACE MODIFICATION
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Croll TI, 2006, TISSUE ENG, V12, P997
   Croll TI, 2006, BIOMACROMOLECULES, V7, P1610, DOI 10.1021/bm060044l
   De Cock LJ, 2010, BIOMACROMOLECULES, V11, P1002, DOI 10.1021/bm9014649
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Deng TZ, 2007, J MICROENCAPSUL, V24, P163, DOI 10.1080/02652040701233523
   Dolatshahi-Pirouz A, 2008, COLLOID SURFACE B, V66, P53, DOI 10.1016/j.colsurfb.2008.05.010
   ERIKSSON AE, 1991, P NATL ACAD SCI USA, V88, P3441, DOI 10.1073/pnas.88.8.3441
   Facca S, 2010, P NATL ACAD SCI USA, V107, P3406, DOI 10.1073/pnas.0908531107
   Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gabor F, 1999, J MICROENCAPSUL, V16, P1, DOI 10.1080/026520499289266
   Grothe C, 2001, ANAT EMBRYOL, V204, P171, DOI 10.1007/s004290100205
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Hook F, 1998, P NATL ACAD SCI USA, V95, P12271, DOI 10.1073/pnas.95.21.12271
   Hostetler MJ, 1996, LANGMUIR, V12, P3604, DOI 10.1021/la960249n
   Jaklenec A, 2008, BIOMATERIALS, V29, P1518, DOI 10.1016/j.biomaterials.2007.12.004
   Jay SM, 2009, J CONTROL RELEASE, V134, P26, DOI 10.1016/j.jconrel.2008.10.019
   Jeon O, 2006, BIOMATERIALS, V27, P1598, DOI 10.1016/j.biomaterials.2005.08.030
   Kakade S, 2009, INT J PHARM, V365, P44, DOI 10.1016/j.ijpharm.2008.08.019
   King TW, 2000, J BIOMED MATER RES, V51, P383, DOI 10.1002/1097-4636(20000905)51:3<383::AID-JBM12>3.0.CO;2-D
   Koushik K, 2004, PHARM RES-DORDR, V21, P524, DOI 10.1023/B:PHAM.0000019308.25479.a4
   Kujawa P, 2005, J AM CHEM SOC, V127, P9224, DOI 10.1021/ja044385n
   Lee JS, 2008, INT J PHARM, V346, P57, DOI 10.1016/j.ijpharm.2007.06.025
   Lee JS, 2007, J CONTROL RELEASE, V117, P204, DOI 10.1016/j.jconrel.2006.11.004
   Ma L, 2007, J BIOMED MATER RES B, V83B, P285, DOI 10.1002/jbm.b.30794
   Macdonald ML, 2011, BIOMATERIALS, V32, P1446, DOI 10.1016/j.biomaterials.2010.10.052
   Macdonald ML, 2010, BIOMACROMOLECULES, V11, P2053, DOI 10.1021/bm100413w
   Mao ZW, 2005, BIOCONJUGATE CHEM, V16, P1316, DOI 10.1021/bc049755b
   Nie T, 2007, J CONTROL RELEASE, V122, P287, DOI 10.1016/j.jconrel.2007.04.019
   Patil SD, 2007, J CONTROL RELEASE, V117, P68, DOI 10.1016/j.jconrel.2006.10.013
   PRESTRELSKI SJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P314, DOI 10.1016/0003-9861(92)90401-H
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Rodahl M, 1997, FARADAY DISCUSS, V107, P229, DOI 10.1039/a703137h
   Rosca ID, 2004, J CONTROL RELEASE, V99, P271, DOI 10.1016/j.jconrel.2004.07.007
   Rudd T., 2003, GRAVIMETRIC ANAL PRO, P349
   SAENGER W, 1987, ANNU REV BIOPHYS BIO, V16, P93
   Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3
   Schneider A, 2007, BIOMED MATER, V2, pS45, DOI 10.1088/1748-6041/2/1/S07
   Shen H, 2008, BIOMATERIALS, V29, P2388, DOI 10.1016/j.biomaterials.2008.02.008
   Somers P, 2008, GROWTH FACTORS, V26, P293, DOI 10.1080/08977190802303645
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   Tae G, 2006, J BIOMAT SCI-POLYM E, V17, P187, DOI 10.1163/156856206774879090
   Thissen H, 2006, J BIOMED MATER RES A, V77A, P590, DOI 10.1002/jbm.a.30612
   van de Weert M, 2000, PHARMACEUT RES, V17, P1159, DOI 10.1023/A:1026498209874
   Vashi AV, 2006, TISSUE ENG, V12, P3035, DOI 10.1089/ten.2006.12.3035
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   WESTALL FC, 1983, LIFE SCI, V33, P2425, DOI 10.1016/0024-3205(83)90636-7
   Wissink MJB, 2001, BIOMATERIALS, V22, P2291, DOI 10.1016/S0142-9612(00)00418-X
   Wissink MJB, 2000, J CONTROL RELEASE, V64, P103, DOI 10.1016/S0168-3659(99)00145-5
   Yang YW, 2008, BIOMATERIALS, V29, P2516, DOI 10.1016/j.biomaterials.2008.02.015
   Yee C, 1999, LANGMUIR, V15, P7111, DOI 10.1021/la990663y
   Yoon JJ, 2006, J BIOMED MATER RES A, V79A, P934, DOI 10.1002/jbm.a.30843
   Zhou J, 2009, MACROMOL BIOSCI, V9, P326, DOI 10.1002/mabi.200800188
   Zolnik BS, 2008, J CONTROL RELEASE, V127, P137, DOI 10.1016/j.jconrel.2008.01.004
NR 66
TC 34
Z9 34
U1 3
U2 43
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2011
VL 12
IS 5
BP 1494
EP 1503
DI 10.1021/bm1014574
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 759LP
UT WOS:000290246400012
PM 21413682
DA 2018-10-20
ER

PT J
AU Gomes, S
   Numata, K
   Leonor, IB
   Mano, JF
   Reis, RL
   Kapan, DL
AF Gomes, Silvia
   Numata, Keiji
   Leonor, Isabel B.
   Mano, Joao F.
   Reis, Rui L.
   Kapan, David L.
TI AFM Study of Morphology and Mechanical Properties of a Chimeric Spider
   Silk and Bone Sialoprotein Protein for Bone Regeneration
SO BIOMACROMOLECULES
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; BETA-SHEET FORMATION; SURFACE-ROUGHNESS;
   VISCOELASTIC PROPERTIES; INFRARED-SPECTROSCOPY; MOLECULAR-DYNAMICS;
   SACRIFICIAL BONDS; BLOCK-COPOLYMERS; TITANIUM; HYDROXYAPATITE
AB Atomic force microscopy (AFM) was used to assess a new chimeric protein consisting of a fusion protein of the consensus repeat for Nephila clavipes spider dragline protein and bone sialoprotein (6mer+BSP). The elastic modulus of this protein in film form was assessed through force curves, and film surface roughness was also determined. The results showed a significant difference among the elastic modulus of the chimeric silk protein, 6mer+BSP, and control films consisting of only the silk component (6mer). The behavior of the 6mer+BSP and 6mer proteins in aqueous solution in the presence of calcium (Ca) ions was also assessed to determine interactions between the inorganic and organic components related to bone interactions, anchoring, and biomaterial network formation. The results demonstrated the formation of protein networks in the presence of Ca2+ ions, characteristics that may be important in the context of controlling materials assembly and properties related to bone formation with this new chimeric silk-BSP protein.
C1 [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
   [Gomes, Silvia; Leonor, Isabel B.; Mano, Joao F.; Reis, Rui L.] PT Associated Lab, IBB, Braga, Portugal.
   [Gomes, Silvia; Kapan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Numata, Keiji] RIKEN, Enzyme Res Team, Biomass Engn Program, Wako, Saitama 3510198, Japan.
RP Reis, RL (reprint author), Univ Minho, Res Grp Biomat Biodegradables & Biomimet 3Bs, Dept Polymer Engn, Headquarters European Inst Excellence Tissue Engn, AvePk, P-4806909 Caldas Das Taipas, Guimaraes, Portugal.
EM rgreis@dep.uminho.pt; David.Kaplan@tufts.edu
RI Numata, Keiji/H-9751-2012; Leonor, Isabel/B-5260-2011; Gomes,
   Silvia/J-6099-2013; Group, 3Bs/E-4374-2012; Reis, Rui L./A-8938-2008;
   Mano, Joao/A-4418-2009
OI Numata, Keiji/0000-0003-2199-7420; Leonor, Isabel/0000-0002-4319-4883;
   Group, 3Bs/0000-0002-5195-3456; Reis, Rui L./0000-0002-4295-6129; Mano,
   Joao/0000-0002-2342-3765; Gomes, Silvia/0000-0002-4881-7808
FU Foundation for Science and Technology (FCT) [SFRH/BD/28603/2006]; FCT
   agency [NMP3-CT-2004-500283, PTDC/EBB-EBI/109093/2008]; NIH [P41
   EB002520, EB003210, DE017207]; Tissue Engineering Resource Center
FX Silvia Games thanks the Foundation for Science and Technology (FCT) for
   supporting her Ph.D. grant, SFRH/BD/28603/2006. This work was carried
   out under the scope of the European NoE EXPERTISSUES
   (NMP3-CT-2004-500283), the Chimera project (PTDC/EBB-EBI/109093/2008)
   funded by the FCT agency, the NIH (P41 EB002520) Tissue Engineering
   Resource Center, and the NIH (EB003210 and DE017207).
CR Adams J., 2008, NANOTECHNOLOGY, V19, P384008
   ALONSO DOV, 1995, J MOL BIOL, V247, P501, DOI 10.1006/jmbi.1994.0156
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3
   Baht GS, 2008, MATRIX BIOL, V27, P600, DOI 10.1016/j.matbio.2008.06.004
   Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858
   Beek J.D.v., 2002, P NATL ACAD SCI USA, V99, P10266
   Boussu K, 2005, J COLLOID INTERF SCI, V286, P632, DOI 10.1016/j.jcis.2005.01.095
   Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cerpa R, 1996, FOLD DES, V1, P91, DOI 10.1016/S1359-0278(96)00018-1
   Chauvy PF, 1998, SURF COAT TECH, V110, P48, DOI 10.1016/S0257-8972(98)00608-2
   Currey J, 2001, NATURE, V414, P699, DOI 10.1038/414699a
   Domke J, 1998, LANGMUIR, V14, P3320, DOI 10.1021/la9713006
   Fantner GE, 2005, NAT MATER, V4, P612, DOI 10.1038/nmat1428
   Fantner GE, 2007, NANO LETT, V7, P2491, DOI 10.1021/nl0712769
   FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Fulara A, 2010, J PHYS CHEM B, V114, P8278, DOI 10.1021/jp102440n
   Gadelmawla ES, 2002, J MATER PROCESS TECH, V123, P133, DOI 10.1016/S0924-0136(02)00060-2
   Ganss B, 1999, CRIT REV ORAL BIOL M, V10, P79, DOI 10.1177/10454411990100010401
   Goldberg HA, 2001, CONNECT TISSUE RES, V42, P25, DOI 10.3109/03008200109014246
   Gomes S., 2010, SOFT MATTER UNPUB
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   Gosline M., 1999, J EXP BIOL, V202, P3295
   Gupta HS, 2007, J R SOC INTERFACE, V4, P277, DOI 10.1098/rsif.2006.0172
   Gupta HS, 2005, NANO LETT, V5, P2108, DOI 10.1021/nl051584b
   Hansma P. K., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P313
   Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0
   He G, 2003, CONNECT TISSUE RES, V44, P240, DOI 10.1080/03008200390181726
   Hossain KS, 1999, LANGMUIR, V15, P4114, DOI 10.1021/la981221+
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   JACKSON AP, 1989, COMPOS SCI TECHNOL, V36, P255, DOI 10.1016/0266-3538(89)90024-9
   Johnson K. L., 1994, CONTACT MECH
   Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005
   Koinkar VN, 1997, J APPL PHYS, V81, P2472, DOI 10.1063/1.363954
   Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688
   KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Mano JF, 2008, MACROMOL BIOSCI, V8, P69, DOI 10.1002/mabi.200700139
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Mizuno M, 2000, CALCIFIED TISSUE INT, V66, P388, DOI 10.1007/s002230010078
   Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499
   Perez-Rigueiro J, 2000, POLYMER, V41, P8433, DOI 10.1016/S0032-3861(00)00179-8
   Poon CY, 1995, WEAR, V190, P76, DOI 10.1016/0043-1648(95)06697-7
   Poon CY, 1995, WEAR, V190, P89, DOI 10.1016/0043-1648(95)06764-7
   Rabotyagova OS, 2010, MACROMOL BIOSCI, V10, P49, DOI 10.1002/mabi.200900203
   Rabotyagova OS, 2009, BIOMACROMOLECULES, V10, P229, DOI 10.1021/bm800930x
   Radmacher M, 1996, BIOPHYS J, V70, P556, DOI 10.1016/S0006-3495(96)79602-9
   Schafer A, 2008, EUR BIOPHYS J BIOPHY, V37, P197, DOI [10.1007/s00249-007-0216-5, 10.1007/S00249-007-0216-5]
   Scheibel T, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-14
   Schiffer CA, 1996, CURR OPIN BIOTECH, V7, P428, DOI 10.1016/S0958-1669(96)80119-4
   Sedin DL, 2001, APPL SURF SCI, V182, P40, DOI 10.1016/S0169-4332(01)00432-9
   Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Stark M, 2007, BIOMACROMOLECULES, V8, P1695, DOI 10.1021/bm070049y
   Sun C, 2007, J EXP BIOL, V210, P1481, DOI 10.1242/jeb.02759
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Thompson JB, 2001, NATURE, V414, P773, DOI 10.1038/414773a
   Valverde P, 2008, J BONE MINER RES, V23, P1775, DOI 10.1359/JBMR.080605
   Wagh AA, 2008, AM J PHYSIOL-LUNG C, V295, pL54, DOI 10.1152/ajplung.00475.2007
   WALL JC, 1979, CALCIFIED TISSUE INT, V27, P105, DOI 10.1007/BF02441170
   WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998
   Williams R. J. P., 1980, CALCIUM BINDING PROT
   Wu Y, 2011, BIOMATERIALS, V32, P951, DOI 10.1016/j.biomaterials.2010.10.001
   Yamada K, 2003, THIN SOLID FILMS, V440, P208, DOI 10.1016/S0040-6090(03)00460-7
   Yang Y, 2010, LANGMUIR, V26, P9848, DOI 10.1021/la100192z
   Yin JW, 2010, BIOMACROMOLECULES, V11, P2890, DOI 10.1021/bm100643q
   Zanuy D, 1998, INT J BIOL MACROMOL, V23, P175, DOI 10.1016/S0141-8130(98)00047-6
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 70
TC 15
Z9 16
U1 2
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2011
VL 12
IS 5
BP 1675
EP 1685
DI 10.1021/bm2000605
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 759LP
UT WOS:000290246400032
PM 21370930
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Hu, X
   Shmelev, K
   Sun, L
   Gil, ES
   Park, SH
   Cebe, P
   Kaplan, DL
AF Hu, Xiao
   Shmelev, Karen
   Sun, Lin
   Gil, Eun-Seok
   Park, Sang-Hyug
   Cebe, Peggy
   Kaplan, David L.
TI Regulation of Silk Material Structure by Temperature-Controlled Water
   Vapor Annealing
SO BIOMACROMOLECULES
LA English
DT Article
ID SOLVENT-INDUCED CRYSTALLIZATION; SYNDIOTACTIC POLYSTYRENE GLASS;
   THERMAL-PROPERTIES; BIOMATERIAL COATINGS; MOLECULAR MECHANISM;
   CONTROLLED-RELEASE; FIBROUS PROTEINS; FORMIC-ACID; FILMS; SYSTEMS
AB We present a simple and effective method to obtain refined control of the molecular structure of silk biomaterials through physical temperature-controlled water vapor annealing (TCWVA). The silk materials can be prepared with control of crystallinity, from a low content using conditions at 4 degrees C (alpha helix dominated silk I structure), to highest content of similar to 60% crystallinity at 100 degrees C (beta-sheet dominated silk II structure). This new physical approach covers the range of structures previously reported to govern crystallization during the fabrication of silk materials, yet offers a simpler, green chemistry, approach with tight control of reproducibility. The transition kinetics, thermal, mechanical, and biodegradation properties of the silk films prepared at different temperatures were investigated and compared by Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC), uniaxial tensile studies, and enzymatic degradation studies. The results revealed that this new physical processing method accurately controls structure, in turn providing control of mechanical properties, thermal stability, enzyme degradation rate, and human mesenchymal stem cell interactions. The mechanistic basis for the control is through the temperature-controlled regulation of water vapor to control crystallization. Control of silk structure via TCWVA represents a significant improvement in the fabrication of silk-based biomaterials, where control of structure-property relationships is key to regulating material properties. This new approach to control crystallization also provides an entirely new green approach, avoiding common methods that use organic solvents (methanol, ethanol) or organic acids. The method described here for silk proteins would also be universal for many other structural proteins (and likely other biopolymers), where water controls chain interactions related to material properties.
C1 [Hu, Xiao; Shmelev, Karen; Gil, Eun-Seok; Park, Sang-Hyug; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Sun, Lin; Kaplan, David L.] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Cebe, Peggy] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Hu, Xiao/F-2403-2012
OI Hu, Xiao/0000-0002-2579-2820; Cebe, Peggy/0000-0002-8721-644X
FU NIH P41 Tissue Engineering Resource Center [P41 EB002520]; Air Force
   Office of Scientific Research
FX We thank the NIH P41 Tissue Engineering Resource Center (P41 EB002520)
   and the Air Force Office of Scientific Research for support of this
   research. We also acknowledge the assistance of Dr. Qiang Lu for the
   SEM.
CR Agarwal N, 1997, J APPL POLYM SCI, V63, P401
   Chen H, 2008, J THERM ANAL CALORIM, V93, P201, DOI 10.1007/s10973-007-8885-y
   FLORY PJ, 1953, PRINCIPLES POLYM CHE
   Fu CJ, 2009, MACROMOLECULES, V42, P7877, DOI 10.1021/ma901321k
   Gupper A, 2004, MACROMOLECULES, V37, P6498, DOI 10.1021/ma049313v
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2007, THERMOCHIM ACTA, V461, P137, DOI 10.1016/j.tca.2006.12.011
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Hu XA, 2010, BIOMACROMOLECULES, V11, P3178, DOI 10.1021/bm1010504
   Hu XA, 2010, BIOMATERIALS, V31, P8121, DOI 10.1016/j.biomaterials.2010.07.044
   Hu X, 2009, J THERM ANAL CALORIM, V96, P827, DOI 10.1007/s10973-009-0049-9
   Hu X, 2009, MACROMOLECULES, V42, P2079, DOI 10.1021/ma802481p
   Jeong L, 2006, INT J BIOL MACROMOL, V38, P140, DOI 10.1016/j.ijbiomac.2006.02.009
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lammel AS, 2010, BIOMATERIALS, V31, P4583, DOI 10.1016/j.biomaterials.2010.02.024
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Lawrence BD, 2010, MACROMOL BIOSCI, V10, P393, DOI 10.1002/mabi.200900294
   Leisk GG, 2010, ADV MATER, V22, P711, DOI 10.1002/adma.200902643
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu Q, 2010, MACROMOL BIOSCI, V10, P289, DOI 10.1002/mabi.200900258
   MCGRATH K, 1996, PROTEIN BASED MAT
   MCPEAK JL, 1999, THESIS VIRGINIA POLY
   Mo CL, 2009, VIB SPECTROSC, V51, P105, DOI 10.1016/j.vibspec.2008.11.004
   Motta A, 2009, J BIOMAT SCI-POLYM E, V20, P1875, DOI 10.1163/156856208X399936
   Omenetto FG, 2008, NAT PHOTONICS, V2, P641, DOI 10.1038/nphoton.2008.207
   Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028
   Porter D, 2008, SOFT MATTER, V4, P328, DOI 10.1039/b713972a
   Pyda M, 2008, MACROMOLECULES, V41, P4786, DOI 10.1021/ma8003357
   REBENFELD L, 1976, J MACROMOL SCI R M C, VC15, P279, DOI 10.1080/15321797608065780
   Sammon C, 2000, POLYMER, V41, P2521, DOI 10.1016/S0032-3861(99)00405-X
   Tashiro K, 2002, MACROMOLECULES, V35, P410, DOI 10.1021/ma011509x
   Tashiro K, 2001, MACROMOLECULES, V34, P310, DOI 10.1021/ma001659s
   Tretinnikov O.N., 2001, LANGMUIR, V17, P7406
   Um IC, 2003, INT J BIOL MACROMOL, V33, P203, DOI 10.1016/j.ijbiomac.2003.08.004
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Wang XY, 2007, J CONTROL RELEASE, V121, P190, DOI 10.1016/j.jconrel.2007.06.006
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang X, 2007, BIOMATERIALS, V28, P4161, DOI 10.1016/j.biomaterials.2007.05.036
   Wang XQ, 2010, BIOMATERIALS, V31, P1025, DOI 10.1016/j.biomaterials.2009.11.002
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Yucel T, 2010, J STRUCT BIOL, V170, P406, DOI 10.1016/j.jsb.2009.12.012
   Yucel T, 2009, BIOPHYS J, V97, P2044, DOI 10.1016/j.bpj.2009.07.028
   Zhang XH, 2009, ADV DRUG DELIVER REV, V61, P988, DOI 10.1016/j.addr.2009.07.005
NR 49
TC 209
Z9 213
U1 13
U2 109
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2011
VL 12
IS 5
BP 1686
EP 1696
DI 10.1021/bm200062a
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 759LP
UT WOS:000290246400033
PM 21425769
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Saino, E
   Focarete, ML
   Gualandi, C
   Emanuele, E
   Cornaglia, AI
   Imbriani, M
   Visai, L
AF Saino, Enrica
   Focarete, Maria Letizia
   Gualandi, Chiara
   Emanuele, Enzo
   Cornaglia, Antonia I.
   Imbriani, Marcello
   Visai, Livia
TI Effect of Electrospun Fiber Diameter and Alignment on Macrophage
   Activation and Secretion of Proinflammatory Cytokines and Chemokines
SO BIOMACROMOLECULES
LA English
DT Article
ID MULTINUCLEATED GIANT-CELLS; IN-VITRO BIOCOMPATIBILITY; ACQUIRED
   IMMUNE-RESPONSES; NANOFIBROUS SCAFFOLDS; BIOMEDICAL APPLICATIONS; M-CSF;
   BIOMATERIALS; FIBROBLASTS; COLLAGEN; DIFFERENTIATION
AB Macrophage activation can be modulated by biomaterial topography according to the biological scale (micrometric and nanometric range). In this study, we investigated the effect of fiber diameter and fiber alignment of electrospun poly(L-lactic) (PLLA) scaffolds on macrophage RAW 264.7 activation and secretion of pro inflammatory cytokines and chemokines at 24 h and 7 days. Macrophages were cultured on four different types of fibrous PLLA scaffold (aligned microfibers, aligned nanofibers, random microfibers, and random nanofibers) and on PLLA film (used as a reference). Substrate topography was found to influence the immune response activated by macrophages, especially in the early inflammation stage. Secretion of proinflammatory molecules by macrophage cells was chiefly dependent on fiber diameter. In particular, nanofibrous PLLA scaffolds minimized the inflammatory response when compared with films and microfibrous scaffolds. The histological evaluation demonstrated a higher number of foreign body giant cells on the PLLA film than on the micro- and nanofibrous scaffolds. In summary, our results indicate that the diameter of electrospun PLLA fibers, rather than fiber alignment, plays a relevant role in influencing in vitro macrophage activation and secretion of proinflammatory molecules.
C1 [Visai, Livia] Univ Pavia, Dept Biochem, Med Sect, I-27100 Pavia, Italy.
   [Emanuele, Enzo] Univ Pavia, Dept Hlth Sci, I-27100 Pavia, Italy.
   [Cornaglia, Antonia I.] Univ Pavia, Dept Expt Med, I-27100 Pavia, Italy.
   [Imbriani, Marcello] Univ Pavia, Dept Publ Hlth & Neurosci, I-27100 Pavia, Italy.
   [Focarete, Maria Letizia; Gualandi, Chiara] Univ Bologna, Dept Chem G Ciamician, I-40126 Bologna, Italy.
   [Focarete, Maria Letizia; Gualandi, Chiara] Univ Bologna, Natl Consortium Mat Sci & Technol, INSTM, RU Bologna, I-40126 Bologna, Italy.
   [Imbriani, Marcello; Visai, Livia] Salvatore Maugeri Fdn IRCCS, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Ctr Tissue Engn CIT, I-27100 Pavia, Italy.
RP Visai, L (reprint author), Univ Pavia, Dept Biochem, Med Sect, Via Taramelli 3-B, I-27100 Pavia, Italy.
EM lvisai@unipv.it
RI Focarete, Maria Letizia/B-2369-2009; gualandi, chiara/A-5935-2015
OI Focarete, Maria Letizia/0000-0002-0458-7836; gualandi,
   chiara/0000-0002-2020-1892; Emanuele, Enzo/0000-0002-4356-9366;
   IMBRIANI, MARCELLO/0000-0002-2752-1565; Icaro Cornaglia,
   Antonia/0000-0001-6083-3133
FU Italian Ministry of Education, University and Research [MIUR PAIN
   2006091907, RBIP06FH7J]; Regione Lombardia [SAL-45]; Fondazione Alma
   Mater Ticinensis; Spinner Consortium of Regione Emilia Romagna
FX This work was supported by a PRIN grant (MIUR PAIN 2006091907) from the
   Italian Ministry of Education, University and Research to L.V. and M.L.F
   and by a FIRE grant (RBIP06FH7J) from the Italian Ministry of Education,
   University and Research to L.V. We would like to acknowledge financial
   support from "Project SAL-45" financed by the Regione Lombardia and by a
   project entitled "Nanomedicine in ageing-associated prototypic diseases:
   activation of a scientific and technological platform challenging
   seminal aspects of pathogenesis, diagnosis and therapy" (2010) financed
   by the Fondazione Alma Mater Ticinensis (2010). C.G. is the recipient of
   a fellowship awarded from the Spinner Consortium of Regione Emilia
   Romagna. We are grateful to D. Picenoni for technical assistance in the
   SEM studies. A special thanks to Laurene Kelly for correcting the
   English. Finally, we would like to thank the referees for their helpful
   comments and suggestions.
CR Agarwal S, 2008, POLYMER, V49, P5603, DOI 10.1016/j.polymer.2008.09.014
   Anderson J.M., 1994, PROB GEN SURG, V11, P147
   ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7
   Ayres CE, 2008, J BIOMAT SCI-POLYM E, V19, P603, DOI 10.1163/156856208784089643
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brown E. J., 2003, FUNDAMENTAL IMMUNOLO, P1105
   Cao HQ, 2010, J BIOMED MATER RES A, V93A, P1151, DOI 10.1002/jbm.a.32609
   Cao HQ, 2009, ADV DRUG DELIVER REV, V61, P1055, DOI 10.1016/j.addr.2009.07.009
   CARDONA MA, 1992, J BIOMED MATER RES, V26, P851, DOI 10.1002/jbm.820260703
   Chen PR, 2005, BIOMATERIALS, V26, P6579, DOI 10.1016/j.biomaterials.2005.03.037
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chew SY, 2006, CURR PHARM DESIGN, V12, P4751, DOI 10.2174/138161206779026326
   Corey JM, 2008, ACTA BIOMATER, V4, P863, DOI 10.1016/j.actbio.2008.02.020
   Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220
   DeFife KM, 1997, J IMMUNOL, V158, P3385
   Deng XL, 2007, J BIOMAT SCI-POLYM E, V18, P117, DOI 10.1163/156856207779146123
   Dimitrievska S, 2008, J BIOMED MATER RES A, V84A, P44, DOI 10.1002/jbm.a.31338
   Fink J, 2008, CLIN HEMORHEOL MICRO, V39, P205, DOI 10.3233/CH-2008-1090
   Focarete ML, 2009, NANOTECHNOL SCI TECH, P19
   Focarete ML, 2010, J BIOMAT SCI-POLYM E, V21, P1283, DOI 10.1163/092050609X12517190417597
   Garg K, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/3/031001
   Godek ML, 2006, PLASMA PROCESS POLYM, V3, P485, DOI 10.1002/ppap.200600007
   Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646
   Hansen JC, 2007, J BIOMECH, V40, P2865, DOI 10.1016/j.jbiomech.2007.03.018
   Holt DJ, 2010, BIOMATERIALS, V31, P9382, DOI 10.1016/j.biomaterials.2010.07.101
   Huang Ruo-Pan, 2004, Methods Mol Biol, V264, P215
   Huhtala A, 2007, J BIOMED MATER RES A, V83A, P407, DOI 10.1002/jbm.a.31319
   Ikeda T, 1998, BIOCHEM BIOPH RES CO, V253, P265, DOI 10.1006/bbrc.1998.9702
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Kou PM, 2011, J BIOMED MATER RES A, V96A, P239, DOI 10.1002/jbm.a.32971
   Lemaire I, 1996, J LEUKOCYTE BIOL, V60, P509
   Liang D, 2007, ADV DRUG DELIVER REV, V59, P1392, DOI 10.1016/j.addr.2007.04.021
   MILLER KM, 1988, J BIOMED MATER RES, V22, P713, DOI 10.1002/jbm.820220805
   Mitchell R.N., 2004, BIOMATERIALS SCI, P304
   Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448
   Ratner B. D., 2004, BIOMATERIALS SCI INT
   REMES A, 1992, BIOMATERIALS, V13, P731, DOI 10.1016/0142-9612(92)90010-L
   Saino E, 2010, TISSUE ENG PT A, V16, P995, DOI [10.1089/ten.tea.2009.0051, 10.1089/ten.TEA.2009.0051]
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Sanders JE, 2003, J BIOMED MATER RES A, V65A, P462, DOI 10.1002/jbm.a.10525
   Schmidt DR, 2007, BIOMATERIALS, V28, P371, DOI 10.1016/j.biomaterials.2006.08.041
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Sell SA, 2009, ADV DRUG DELIVER REV, V61, P1007, DOI 10.1016/j.addr.2009.07.012
   Shiffman JD, 2008, POLYM REV, V48, P317
   Smith MJ, 2007, J ENG FIBER FABR, V2, P41
   Smith MJ, 2010, J BIOMED MATER RES A, V93A, P793, DOI 10.1002/jbm.a.32579
   Smith MJ, 2009, BIOMATERIALS, V30, P149, DOI 10.1016/j.biomaterials.2008.09.019
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   Spiller D, 2009, J MATER SCI-MATER M, V20, P2511, DOI 10.1007/s10856-009-3823-0
   Sui G, 2007, J BIOMED MATER RES A, V82A, P445, DOI 10.1002/jbm.a.31166
   Teo W. E., 2006, NANOTECHNOLOGY, V17, P89, DOI DOI 10.1088/0957-4484/17/14/R01
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Zahedi P, 2010, POLYM ADVAN TECHNOL, V21, P77, DOI 10.1002/pat.1625
   Zhang YZ, 2005, BIOMACROMOLECULES, V6, P2583, DOI 10.1021/bm050314k
   Zhong X., 2005, BIOMATERIALS, V26, P5330
   Zucchelli A, 2009, J MATER SCI, V44, P4969, DOI 10.1007/s10853-009-3759-2
NR 58
TC 102
Z9 103
U1 2
U2 51
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD MAY
PY 2011
VL 12
IS 5
BP 1900
EP 1911
DI 10.1021/bm200248h
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 759LP
UT WOS:000290246400057
PM 21417396
DA 2018-10-20
ER

PT J
AU Peterson, SC
   Jong, L
AF Peterson, Steven C.
   Jong, Lei
TI Effect of Shearing on the Reinforcement Properties of Vital Wheat Gluten
SO JOURNAL OF ELASTOMERS AND PLASTICS
LA English
DT Article
DE particle-reinforcement; rheological properties; vital wheat gluten
ID HYDROGEN-ION EQUILIBRIA; RUBBER COMPOSITES; LATEX FILMS; VISCOELASTIC
   PROPERTIES; MECHANICAL-PROPERTIES; ELASTOMER COMPOSITES; PROTEIN;
   FUNCTIONALITY; BIOPLASTICS; FLOUR
AB An aqueous dispersion of vital wheat gluten and styrene-butadiene rubber was subjected to high-shear mixing in an attempt to reduce the aggregate size and enhance filler-matrix interactions with the goal of improving contributions of the reinforcement to the overall composite properties. Composites were formulated using 10-40% vital wheat gluten by mixing aqueous suspensions of the gluten and rubber, then freeze-drying and compression molding the resulting composite. Rheological experiments indicated that vital wheat gluten reinforced the rubber up to a factor of roughly 30. Subjecting the gluten suspension to high shearing reduced the particle size from approximately 5.2-4.5 mu m, and 16 min was the optimum shearing time since shearing the dispersions longer did not result in any additional size reduction. Composites with 10% vital wheat gluten have good potential in applications requiring high elasticity since they were equal to or better than the carbon black control in terms of Young's modulus, percent elongation, and toughness. Isolated vital wheat gluten was studied in order to determine its relative merit as one of the two reinforcing components of wheat flour (the other being wheat starch), and vital wheat gluten's reinforcing ability was a factor of 10 weaker than wheat flour, indicating that wheat starch is a much more effective biomaterial filler in terms of rigidity, but vital wheat gluten may be more suitable for applications requiring more elasticity.
C1 [Peterson, Steven C.; Jong, Lei] USDA, Natl Ctr Agr Utilizat Res, Peoria, IL 61604 USA.
RP Peterson, SC (reprint author), USDA, Natl Ctr Agr Utilizat Res, 1815N Univ St, Peoria, IL 61604 USA.
EM Steve.Peterson@ars.usda.gov
CR Auvergne R, 2008, BIOMACROMOLECULES, V9, P664, DOI 10.1021/bm7009834
   CORNEC M, 1994, J CEREAL SCI, V19, P131, DOI 10.1006/jcrs.1994.1018
   COUGHLIN ETA, 1936, Patent No. 2056958
   Dicharry RM, 2006, BIOMACROMOLECULES, V7, P2837, DOI 10.1021/bm060432n
   DIMLER RJ, 1963, BAKERS DIG, V37, P52
   Domenek S, 2004, CHEMOSPHERE, V54, P551, DOI 10.1016/S0045-6535(03)00760-4
   FLINK JM, 1983, INTRO FREEZE DRYING
   GENNADIOS A, 1993, J AGR FOOD CHEM, V41, P1835, DOI 10.1021/jf00035a006
   ISAACS MR, 1938, Patent No. 2127298
   Jong L, 2007, COMPOS PART A-APPL S, V38, P252, DOI 10.1016/j.compositesa.2006.05.003
   Jong L, 2006, COMPOS PART A-APPL S, V37, P438, DOI 10.1016/j.compositesa.2005.05.042
   Jong L, 2005, J APPL POLYM SCI, V98, P353, DOI 10.1002/app.22094
   Jong L, 2005, COMPOS PART A-APPL S, V36, P675, DOI 10.1016/j.compositesa.2004.07.010
   Jong L, 2009, J APPL POLYM SCI, V114, P2280, DOI 10.1002/app.30653
   Kan CS, 1996, MACROMOLECULES, V29, P6853, DOI 10.1021/ma9515487
   Lagrain B, 2010, BIOMACROMOLECULES, V11, P533, DOI 10.1021/bm100008p
   LEON LR, 1960, Patent No. 2931845
   LOADMAN MJR, 1986, J THERM ANAL, V31, P1183, DOI 10.1007/BF02119273
   MAGNUSON KM, 1985, CEREAL FOOD WORLD, V30, P179
   Mellor J. D., 1978, FUNDAMENTALS FREEZE
   PENCE JW, 1953, CEREAL CHEM, V30, P115
   Peterson SC, 2008, COMPOS PART A-APPL S, V39, P1909, DOI 10.1016/j.compositesa.2008.09.017
   Pommet M, 2003, MACROMOL SYMP, V197, P207, DOI 10.1002/masy.200350719
   RICHARD J, 1992, POLYMER, V33, P562, DOI 10.1016/0032-3861(92)90733-D
   SCHOFIELD JD, 1983, J CEREAL SCI, V1, P241, DOI 10.1016/S0733-5210(83)80012-5
   WU YV, 1974, J FOOD SCI, V39, P218, DOI 10.1111/j.1365-2621.1974.tb02861.x
   WU YV, 1963, ARCH BIOCHEM BIOPHYS, V102, P230, DOI 10.1016/0003-9861(63)90175-9
   WU YV, 1963, ARCH BIOCHEM BIOPHYS, V103, P310, DOI 10.1016/0003-9861(63)90420-X
   Zhang XQ, 2006, BIOMACROMOLECULES, V7, P3466, DOI 10.1021/bm0604698
   ZOSEL A, 1993, MACROMOLECULES, V26, P2222, DOI 10.1021/ma00061a013
NR 30
TC 2
Z9 2
U1 1
U2 11
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0095-2443
EI 1530-8006
J9 J ELASTOM PLAST
JI J. Elastomer Plast.
PD MAY
PY 2011
VL 43
IS 3
BP 207
EP 220
DI 10.1177/0095244310397740
PG 14
WC Materials Science, Multidisciplinary; Polymer Science
SC Materials Science; Polymer Science
GA 761XH
UT WOS:000290434600001
DA 2018-10-20
ER

PT J
AU Creamer, NJ
   Mikheenko, IP
   Johnson, C
   Cottrell, SP
   Macaskie, LE
AF Creamer, Neil J.
   Mikheenko, Iryna P.
   Johnson, Clive
   Cottrell, Stephen P.
   Macaskie, Lynne E.
TI Local magnetism in palladium bionanomaterials probed by muon
   spectroscopy
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Desulfovibrio desulfuricans; Electronic magnetism; Muon spin rotation
   spectroscopy; Nanoparticles; Palladium bionanoparticles
ID SULFATE-REDUCING BACTERIA; DESULFOVIBRIO-DESULFURICANS; BIOINORGANIC
   CATALYST; AROMATIC-COMPOUNDS; PRECIOUS METALS; FUEL-CELLS; PD;
   HYDROGENATION; PARTICLES; BIOMASS
AB Palladium bionanomaterial was manufactured using the sulfate-reducing bacterium, Desulfovibrio desulfuricansm, to reduce soluble Pd(II) ions to cell-bound Pd(0) in the presence of hydrogen. The biomaterial was examined using a Superconducting Quantum Interference Device (SQUID) to measure bulk magnetisation and by Muon Spin Rotation Spectroscopy (A mu SR) which is uniquely able to probe the local magnetic environment inside the sample. Results showed behaviour attributable to interaction of muons both with palladium electrons and the nuclei of hydrogen trapped in the particles during manufacture. Electronic magnetism, also suggested by SQUID, is not characteristic of bulk palladium and is consistent with the presence of nanoparticles previously seen in electron micrographs. We show the first use of mu SR as a tool to probe the internal magnetic environment of a biologically-derived nanocatalyst material.
C1 [Creamer, Neil J.; Mikheenko, Iryna P.; Macaskie, Lynne E.] Univ Birmingham Edgbaston, Unit Funct Bionanomat, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
   [Johnson, Clive; Cottrell, Stephen P.] Rutherford Appleton Lab, ISIS, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England.
RP Macaskie, LE (reprint author), Univ Birmingham Edgbaston, Unit Funct Bionanomat, Sch Biosci, Birmingham B15 2TT, W Midlands, England.
EM L.E.Macaskie@bham.ac.uk
OI Mikheenko, Iryna/0000-0001-6361-6740
FU EU [G5RD-CT-2002-0075]; BBSRC [BB/C516195/2, BB/E003788/1]; EPSRC
   [EP/D05768X/1, EP/E034888/1]; Biotechnology and Biological Sciences
   Research Council [BB/C516195/2, BB/E003788/1]; Engineering and Physical
   Sciences Research Council [EP/D05768X/1, EP/J006483/1]
FX We acknowledge with thanks the financial support of the EU (Contract No.
   G5RD-CT-2002-0075), the BBSRC (Grant Nos BB/C516195/2 and BB/E003788/1)
   and the EPSRC (Grant Nos EP/D05768X/1 and EP/E034888/1).
CR Baxter-Plant V, 2003, BIODEGRADATION, V14, P83, DOI 10.1023/A:1024084611555
   Bennett JA, 2010, CHEM ENG SCI, V65, P282, DOI 10.1016/j.ces.2009.06.069
   Bewley RI, 1998, PHYS REV B, V58, P11544, DOI 10.1103/PhysRevB.58.11544
   COX SFJ, 1987, J PHYS C SOLID STATE, V20, P3187, DOI 10.1088/0022-3719/20/22/005
   Creamer NJ, 2007, ADV MATER RES-SWITZ, V20-21, P603, DOI 10.4028/www.scientific.net/AMR.20-21.603
   Deplanche K, 2009, ENVIRON TECHNOL, V30, P681, DOI 10.1080/09593330902860712
   deReotier PD, 1997, J PHYS-CONDENS MAT, V9, P9113, DOI 10.1088/0953-8984/9/43/002
   Eberhardt W, 2002, SURF SCI, V500, P242, DOI 10.1016/S0039-6028(01)01564-3
   HARRIS RK, 1996, ENCY NUCL MAGNETIC R
   Hori H, 1999, PHYS LETT A, V263, P406, DOI 10.1016/S0375-9601(99)00742-2
   Kaiser CT, 2003, PHYSICA B, V326, P484, DOI 10.1016/S0921-4526(02)01673-3
   Kemali M, 1997, J ALLOY COMPD, V253, P420, DOI 10.1016/S0925-8388(96)02993-3
   Lloyd JR, 1998, APPL ENVIRON MICROB, V64, P4607
   Lord JS, 2005, J PHYS CONF SER, V17, P81, DOI 10.1088/1742-6596/17/1/014
   Ma L, 2007, J APPL PHYS, V102, DOI 10.1063/1.2800996
   Mabbett AN, 2006, ENVIRON SCI TECHNOL, V40, P1015, DOI 10.1021/es0509836
   Macaskie LE, 2005, BIOCHEM SOC T, V33, P76, DOI 10.1042/BST0330076
   Mertens B, 2007, CHEMOSPHERE, V66, P99, DOI 10.1016/j.chemosphere.2006.05.018
   Mikheenko I.P., 2001, BIOHYDROMETALLURGY F, P525
   Mikheenko IP, 2008, APPL ENVIRON MICROB, V19, P6144
   MIKHEENKO IP, 2004, THESIS U BIRMINGHAM
   Nishimura S.-i., 2001, HDB HETEROGENEOUS CA
   Orozco RL, 2010, BIOTECHNOL LETT, V32, P1837, DOI 10.1007/s10529-010-0383-9
   Redwood MD, 2008, BIOTECHNOL BIOENG, V99, P1045, DOI 10.1002/bit.21689
   Schuth C, 1998, APPL CATAL B-ENVIRON, V18, P215, DOI 10.1016/S0926-3373(98)00037-X
   SKIBAR W, 2005, NOVEL PRECIOUS METAL
   Staunton JB, 2000, PHYS REV B, V62, P1075, DOI 10.1103/PhysRevB.62.1075
   Taniyama T, 1997, PHYSICA B, V237, P286, DOI 10.1016/S0921-4526(97)00172-5
   VEGA A, 2003, HDB MAGNETIC MAT, V15, P199
   Vitos L, 2000, PHYS REV B, V62, P11957, DOI 10.1103/PhysRevB.62.R11957
   Wood J, 2010, IND ENG CHEM RES, V49, P980, DOI 10.1021/ie900663k
   Yong P, 2007, BIOTECHNOL LETT, V29, P539, DOI 10.1007/s10529-006-9283-4
   Yong P, 2010, BIOTECHNOL LETT, V32, P1821, DOI 10.1007/s10529-010-0378-6
NR 33
TC 2
Z9 2
U1 0
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAY
PY 2011
VL 33
IS 5
BP 969
EP 976
DI 10.1007/s10529-011-0532-9
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 754ZT
UT WOS:000289897100015
PM 21331587
DA 2018-10-20
ER

PT J
AU Nomura, Y
   Sharma, V
   Yamamura, A
   Yokobayashi, Y
AF Nomura, Yoko
   Sharma, Vandana
   Yamamura, Asami
   Yokobayashi, Yohei
TI Selection of silk-binding peptides by phage display
SO BIOTECHNOLOGY LETTERS
LA English
DT Article
DE Fibroin fiber; Peptide; Phage display; Silk
ID BIOMATERIALS
AB Peptides that bind to silkworm-derived silk fibroin fiber were selected from a phage-displayed random peptide library. The selected silk-binding peptides contained a consensus sequence QSWS which is important for silk-binding as confirmed by binding assays using phage and synthetic peptides. With further optimization, we anticipate that the silk-binding peptides will be useful for functionalization of silk for biomaterial applications.
C1 [Nomura, Yoko; Sharma, Vandana; Yamamura, Asami; Yokobayashi, Yohei] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
RP Yokobayashi, Y (reprint author), Univ Calif Davis, Dept Biomed Engn, 451 Hlth Sci Dr, Davis, CA 95616 USA.
EM yoko@ucdavis.edu
RI Yokobayashi, Yohei/B-5898-2009
OI Yokobayashi, Yohei/0000-0002-2417-1934
FU University of California, Davis
FX This research was supported by University of California, Davis through
   Academic Federation Research Grant Program-Innovative Developmental
   Award.
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Mori H, 2000, J Biotechnol, V74, P95
   Murphy AR, 2009, J MATER CHEM, V19, P6443, DOI 10.1039/b905802h
   Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004
   Robson RM, 1999, INT J BIOL MACROMOL, V24, P145, DOI 10.1016/S0141-8130(98)00081-6
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Serizawa T, 2005, J AM CHEM SOC, V127, P13780, DOI 10.1021/ja054402o
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
NR 8
TC 3
Z9 3
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD MAY
PY 2011
VL 33
IS 5
BP 1069
EP 1073
DI 10.1007/s10529-011-0519-6
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 754ZT
UT WOS:000289897100028
PM 21259034
OA Other Gold, Green Published
DA 2018-10-20
ER

PT J
AU Chen, CT
   Lin, MF
   Chan, WP
   Lai, WFT
AF Chen, Chien-Tsu
   Lin, Min-Fong
   Chan, Wing P.
   Lai, Wen-Fu T.
TI MRI and histology of collagen template implantation and regeneration in
   rabbit knee meniscus
SO EUROPEAN JOURNAL OF ORTHOPAEDIC SURGERY AND TRAUMATOLOGY
LA English
DT Article
DE Biomaterial; Knee; Magnetic resonance imaging; Meniscus; Collagen;
   Regeneration
ID TEMPOROMANDIBULAR-JOINT
AB To evaluate, using magnetic resonance (MR) imaging and histology, the regeneration of injured knee menisci following reconstituted collagen template implantation in rabbits.
   Twenty adult rabbits were divided into five groups: (A) partial meniscectomy of the medial meniscus (1/3 of the anterior horn) with collagen template implantation in the left knee (n = 4); (B) partial meniscectomy of the medial meniscus (1/3 of the anterior horn) with collagen template implantation in the right knee (n = 4); (C) partial meniscectomy (1/3 of the anterior horn) of the medial meniscus of the left knee (n = 4); (D) sham operation (n = 4); (E) no operation (n = 4). All rabbits were killed after follow-up MR imaging at 8 weeks for histologic analysis.
   In groups A and B, the signal intensity decreased, and the last MR imaging showed homogeneous low signal intensity in 6 of 7 injured menisci, suggestive of regeneration. One rabbit in group B died. The seventh rabbit showed higher signal intensity in the injured meniscus than in the control meniscus, indicating failure of regeneration. Group C animals showed irregular margins and high signal intensity in the injured meniscus without regeneration.
   Implantation of reconstituted collagen template can facilitate the regeneration of injured knee menisci in rabbits. The gradually decreased MR signal of the meniscus indicates the maturation of regeneration.
C1 [Lin, Min-Fong; Chan, Wing P.] Taipei Med Univ, Wan Fang Hosp, Dept Radiol, Taipei 116, Taiwan.
   [Chen, Chien-Tsu] Taipei Med Univ, Sch Med, Dept Biochem, Taipei 116, Taiwan.
   [Chan, Wing P.] Taipei Med Univ, Sch Med, Dept Radiol, Taipei 116, Taiwan.
   [Lai, Wen-Fu T.] Taipei Med Univ, Inst Med Sci, Taipei 110, Taiwan.
RP Chan, WP (reprint author), Taipei Med Univ, Wan Fang Hosp, Dept Radiol, 111 Hsing Long Rd,Sec 3, Taipei 116, Taiwan.
EM wp.chan@msa.hinet.net; laitw@tmu.edu.tw
RI leu, borwen/K-8547-2012
FU National Science Council in Taiwan [NSC 93-2314-B-038-030]; Taipei
   Medical University [97-TMU-WF-12]
FX The authors are grateful to the support by grants (NSC
   93-2314-B-038-030) from the National Science Council in Taiwan and
   (97-TMU-WF-12) from Taipei Medical University.
CR Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244
   Chan WP, 2004, TRANSPLANT P, V36, P1610, DOI 10.1016/j.transproceed.2004.05.049
   Genovese E, 2007, RADIOL MED, V112, P1036, DOI 10.1007/s1547-007-0204-y
   Lai W. - F, 1999, U. S. Patent, Patent No. [5,876,444 A, 5876444]
   Lai WFT, 2005, INT J ORAL MAX SURG, V34, P311, DOI 10.1016/j.ijom.2004.05.003
   Rodkey WG, 2008, J BONE JOINT SURG AM, V90A, P1413, DOI 10.2106/JBJS.G.00656
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
NR 7
TC 0
Z9 0
U1 1
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1633-8065
J9 EUR J ORTHOP SURG TR
JI Eur. J. Orthop. Surg. Traumatol.
PD MAY
PY 2011
VL 21
IS 4
BP 231
EP 234
DI 10.1007/s00590-010-0705-6
PG 4
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 756TD
UT WOS:000290036700002
DA 2018-10-20
ER

PT J
AU Moraes, C
   Zhao, RG
   Likhitpanichkul, M
   Simmons, CA
   Sun, Y
AF Moraes, Christopher
   Zhao, Ruogang
   Likhitpanichkul, Morakot
   Simmons, Craig A.
   Sun, Yu
TI Semi-confined compression of microfabricated polymerized biomaterial
   constructs
SO JOURNAL OF MICROMECHANICS AND MICROENGINEERING
LA English
DT Article
ID ARTICULAR-CARTILAGE; CELL-CULTURE; MECHANOBIOLOGY; BIOREACTORS;
   HYDROGELS; DIFFERENTIATION; STIMULATION; CHONDROCYTE; MECHANICS;
   ADHESION
AB Mechanical forces are critical parameters in engineering functional tissue because of their established influence on cellular behaviour. However, identifying ideal combinations of mechanical, biomaterial and chemical stimuli to obtain a desired cellular response requires high-throughput screening technologies, which may be realized through microfabricated systems. This paper reports on the development and characterization of a MEMS device for semi-confined biomaterial compression. An array of these devices would enable studies involving mechanical deformation of three-dimensional biomaterials, an important parameter in creating physiologically relevant microenvironments in vitro. The described device has the ability to simultaneously apply a range of compressive mechanical stimuli to multiple polymerized hydrogel microconstructs. Local micromechanical strains generated within the semi-confined hydrogel cylinders are characterized and compared with those produced in current micro-and macroscale technologies. In contrast to previous work generating unconfined compression in microfabricated devices, the semi-confined compression model used in this work generates uniform regions of strain within the central portion of each hydrogel, demonstrated here to range from 20% to 45% across the array. The uniform strains achieved simplify experimental analysis and improve the utility of the compression platform. Furthermore, the system is compatible with a wide variety of polymerizable biomaterials, enhancing device versatility and usability in tissue engineering and fundamental cell biology studies.
C1 [Moraes, Christopher; Likhitpanichkul, Morakot; Simmons, Craig A.; Sun, Yu] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada.
   [Moraes, Christopher; Zhao, Ruogang; Simmons, Craig A.; Sun, Yu] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
RP Simmons, CA (reprint author), Univ Toronto, Dept Mech & Ind Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada.
EM simmons@mie.utoronto.ca; sun@mie.utoronto.ca
RI Simmons, Craig/A-5880-2008
OI Simmons, Craig/0000-0001-7729-1772; Moraes,
   Christopher/0000-0002-8950-2212; Sun, Yu/0000-0001-7895-0741; Zhao,
   Ruogang/0000-0002-5351-0843
FU National Sciences and Engineering Research Council of Canada; Canadian
   Institutes of Health Research [CHRPJ 323533-06]; Ontario Graduate
   Scholarship; Heart and Stroke Foundation of Canada; Canada Research
   Chairs in Mechanobiology; Micro and Nano Engineering Systems
FX The authors gratefully thank Professor Christopher Yip and Gary Mo from
   the Centre for Studies in Molecular Imaging for helpful advice,
   discussion and use of confocal microscopy equipment. They acknowledge
   microfabrication support from the Emerging Communications Technology
   Institute and the Toronto Microfluidics Foundry. They also acknowledge
   financial support from the National Sciences and Engineering Research
   Council of Canada and the Canadian Institutes of Health Research (CHRPJ
   323533-06); the Ontario Graduate Scholarship program to CM; the Heart
   and Stroke Foundation of Canada to RZ; and the Canada Research Chairs in
   Mechanobiology to CAS, and in Micro and Nano Engineering Systems to YS.
CR Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Berry JL, 2010, ANN BIOMED ENG, V38, P3272, DOI 10.1007/s10439-010-0148-6
   Bilodeau K, 2006, TISSUE ENG, V12, P2367, DOI 10.1089/ten.2006.12.2367
   Bonassar LJ, 2001, J ORTHOPAED RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   Carter DR, 2003, PHILOS T ROY SOC B, V358, P1461, DOI 10.1098/rstb.2003.1346
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   DALE PJ, 1980, J BIOMECH, V13, P865, DOI 10.1016/0021-9290(80)90174-8
   De Hart J, 2003, J BIOMECH, V36, P103, DOI 10.1016/S0021-9290(02)00244-0
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Gefen A, 1999, J BIOMECH, V32, P891, DOI 10.1016/S0021-9290(99)00092-5
   Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w
   Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6
   Jo BH, 2000, J MICROELECTROMECH S, V9, P76, DOI 10.1109/84.825780
   Kamotani Y, 2008, BIOMATERIALS, V29, P2646, DOI 10.1016/j.biomaterials.2008.02.019
   Kim YC, 2007, SENSOR ACTUAT B-CHEM, V128, P108, DOI 10.1016/j.snb.2007.05.050
   Kim YC, 2008, ANALYST, V133, P1432, DOI 10.1039/b805355c
   Kloxin AM, 2010, ADV MATER, V22, P3484, DOI 10.1002/adma.200904179
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Lee WCC, 2007, BIOMECH MODEL MECHAN, V6, P265, DOI 10.1007/s10237-006-0053-y
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   Moraes C, 2010, LAB CHIP, V10, P227, DOI 10.1039/b914460a
   Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068
   Moraes C, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065015
   Pelaez D, 2009, STEM CELLS DEV, V18, P93, DOI 10.1089/scd.2008.0030
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Rehfeldt F, 2007, ADV DRUG DELIVER REV, V59, P1329, DOI 10.1016/j.addr.2007.08.007
   Setton LA, 2004, SPINE, V29, P2710, DOI 10.1097/01.brs.0000146050.57722.2a
   Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o
   Tabata Y, 2009, J R SOC INTERFACE, V6, pS311, DOI 10.1098/rsif.2008.0448.focus
   Tan W, 2008, BIOMED MICRODEVICES, V10, P869, DOI 10.1007/s10544-008-9201-8
   Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z
   Yanagisawa M, 2007, LIFE SCI, V81, P405, DOI 10.1016/j.lfs.2007.06.004
   Young EWK, 2007, LAB CHIP, V7, P1759, DOI 10.1039/b712486d
   Zandstra PW, 2004, BIOTECHNOL BIOENG, V88, P263, DOI 10.1002/bit.20303
   Zhang WY, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/7/075020
NR 40
TC 4
Z9 4
U1 1
U2 13
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0960-1317
J9 J MICROMECH MICROENG
JI J. Micromech. Microeng.
PD MAY
PY 2011
VL 21
IS 5
AR 054014
DI 10.1088/0960-1317/21/5/054014
PG 10
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Instruments & Instrumentation; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Instruments &
   Instrumentation; Physics
GA 756BL
UT WOS:000289986600015
DA 2018-10-20
ER

PT J
AU Mueller, TL
   Wirth, AJ
   van Lenthe, GH
   Goldhahn, J
   Schense, J
   Jamieson, V
   Messmer, P
   Uebelhart, D
   Weishaupt, D
   Egermann, M
   Muller, R
AF Mueller, Thomas L.
   Wirth, Andreas J.
   van Lenthe, G. Harry
   Goldhahn, Joerg
   Schense, Jason
   Jamieson, Virginia
   Messmer, Peter
   Uebelhart, Daniel
   Weishaupt, Dominik
   Egermann, Marcus
   Mueller, Ralph
TI Mechanical stability in a human radius fracture treated with a novel
   tissue-engineered bone substitute: a non-invasive, longitudinal
   assessment using high-resolution pQCT in combination with finite element
   analysis
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE fracture healing; bone graft substitute; biomaterial; parathyroid
   hormone; peripheral quantitative computed tomography; finite element
   method
ID QUANTITATIVE COMPUTED-TOMOGRAPHY; DISTAL RADIUS; OSTEOPOROSIS; QUALITY;
   MODELS; IMAGES; REPRODUCIBILITY; PREDICTION; PEPTIDES; STRENGTH
AB The clinical gold standard in orthopaedics for treating fractures with large bone defects is still the use of autologous, cancellous bone autografts. While this material provides a strong healing response, the use of autografts is often associated with additional morbidity. Therefore, there is a demand for off-the-shelf biomaterials that perform similar to autografts. Biomechanical assessment of such a biomaterial in vivo has so far been limited. Recently, the development of high-resolution peripheral quantitative computed tomography (HR-pQCT) has made it possible to measure bone structure in humans in great detail. Finite element analysis (FEA) has been used to accurately estimate bone mechanical function from three-dimensional CT images. The aim of this study was therefore to determine the feasibility of these two methods in combination, to quantify bone healing in a clinical case with a fracture at the distal radius which was treated with a new bone graft substitute. Validation was sought through a conceptional ovine model. The bones were scanned using HR-pQCT and subsequently biomechanically tested. FEA-derived stiffness was validated relative to the experimental data. The developed processing methods were then adapted and applied to in vivo follow-up data of the patient. Our analyses indicated an 18% increase of bone stiffness within 2 months. To our knowledge, this was the first time that microstructural finite element analyses have been performed on bone-implant constructs in a clinical setting. From this clinical case study, we conclude that HR-pQCT-based micro-finite element analyses show high potential to quantify bone healing in patients. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Mueller, Thomas L.; Wirth, Andreas J.; van Lenthe, G. Harry; Mueller, Ralph] Swiss Fed Inst Technol, Inst Biomech, CH-8093 Zurich, Switzerland.
   [Goldhahn, Joerg] Schulthess Clin, Zurich, Switzerland.
   [Schense, Jason; Jamieson, Virginia] Kuros Biosurg AG, Zurich, Switzerland.
   [Messmer, Peter; Uebelhart, Daniel; Weishaupt, Dominik; Egermann, Marcus] Univ Zurich Hosp, CH-8091 Zurich, Switzerland.
RP Muller, R (reprint author), Swiss Fed Inst Technol, Inst Biomech, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
EM ram@ethz.ch
RI Muller, Ralph/A-1198-2008; van Lenthe, Harry (GH)/C-1030-2008; AO CPP
   Osteoporosis, Fracture Treatment/A-8537-2010; Goldhahn, Jorg/A-8302-2008
OI Muller, Ralph/0000-0002-5811-7725; van Lenthe, Harry
   (GH)/0000-0001-8303-4959; 
FU CTI/KTI [6976.1 MTS-LS]; Swiss National Science Foundation [FP
   620-58097.99, PP-104317/1]; Swiss National Supercomputing Centre CSCS
   (Manno, TI, Switzerland)
FX This work was partly funded by CTI/KTI (Grant No. 6976.1 MTS-LS) and the
   Swiss National Science Foundation (Grant Nos FP 620-58097.99 and
   PP-104317/1). Computing time was granted by the Swiss National
   Supercomputing Centre CSCS (Manno, TI, Switzerland).
CR Arbenz P, 2008, INT J NUMER METH ENG, V73, P927, DOI 10.1002/nme.2101
   Arrighi I, 2009, BIOMATERIALS, V30, P1763, DOI 10.1016/j.biomaterials.2008.12.023
   Benevolenskaia LI, 2003, VESTN ROS AKAD MED+, V7, P15
   Boutroy S, 2005, J CLIN ENDOCR METAB, V90, P6508, DOI 10.1210/jc.2005-1258
   Boutroy S, 2008, J BONE MINER RES, V23, P392, DOI 10.1359/JBMR.071108
   Burge R, 2007, J BONE MINER RES, V22, P465, DOI 10.1359/JBMR.061113
   Dalzell N, 2009, OSTEOPOROSIS INT, V20, P1683, DOI 10.1007/s00198-008-0833-6
   Egermann M, 2005, OSTEOPOROSIS INT, V16, pS120, DOI 10.1007/s00198-004-1817-9
   Jakob M, 2000, J BONE JOINT SURG BR, V82B, P340, DOI 10.1302/0301-620X.82B3.10099
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Lill CA, 2003, J ORTHOPAED RES, V21, P836, DOI 10.1016/S0736-0266(02)00266-8
   MacNeil JA, 2008, MED ENG PHYS, V30, P792, DOI 10.1016/j.medengphy.2007.11.003
   MacNeil JA, 2008, BONE, V42, P1203, DOI 10.1016/j.bone.2008.01.017
   MacNeil JA, 2007, MED ENG PHYS, V29, P1096, DOI 10.1016/j.medengphy.2006.11.002
   MacNeil JA, 2007, BONE, V41, P129, DOI 10.1016/j.bone.2007.02.029
   MARTIN B, 1993, CALCIFIED TISSUE INT, V53, pS34, DOI 10.1007/BF01673400
   Mueller TL, 2009, BONE, V44, P364, DOI 10.1016/j.bone.2008.10.045
   MULLER R, 1995, MED ENG PHYS, V17, P126, DOI 10.1016/1350-4533(95)91884-J
   Peine R, 2000, J HAND SURG-AM, V25A, P29
   Pistoia W, 2002, BONE, V30, P842, DOI 10.1016/S8756-3282(02)00736-6
   Rikli D A, 2003, Ther Umsch, V60, P745, DOI 10.1024/0040-5930.60.12.745
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schense JC, 1999, BIOCONJUGATE CHEM, V10, P75, DOI 10.1021/bc9800769
   Shefelbine SJ, 2005, BONE, V36, P480, DOI 10.1016/j.bone.2004.11.007
   Skoff H D, 1995, Am J Orthop (Belle Mead NJ), V24, P40
   Ulrich D, 1997, ST HEAL T, V40, P97
   van Lenthe GH, 2006, BONE, V39, P1182, DOI 10.1016/j.bone.2006.06.033
   van Lenthe G Harry, 2006, Drug Discov Today Technol, V3, P221, DOI 10.1016/j.ddtec.2006.06.001
   Van Staa TP, 2001, BONE, V29, P517, DOI 10.1016/S8756-3282(01)00614-7
   VANRIETBERGEN B, 1995, J BIOMECH, V28, P69
   Wark JD, 1996, MATURITAS, V23, P193, DOI 10.1016/0378-5122(95)00974-4
NR 31
TC 9
Z9 9
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD MAY
PY 2011
VL 5
IS 5
BP 415
EP 420
DI 10.1002/term.325
PG 6
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 756GG
UT WOS:000289999100010
PM 20827669
DA 2018-10-20
ER

PT J
AU Brunelli, G
   Carinci, F
   Palmieri, A
   Girardi, A
   Carnevali, G
   Vazzoler, G
   Magnabosco, F
   Sollazzo, V
AF Brunelli, G.
   Carinci, F.
   Palmieri, A.
   Girardi, A.
   Carnevali, G.
   Vazzoler, G.
   Magnabosco, F.
   Sollazzo, V.
TI BlO-OSS (R) STIMULATES OSTEOBLASTS DIFFERENTIATION IN DENTAL PULP
   DERIVED STEM CELLS
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Biosso; dental pulp; stem cells; gene expression; osteoblast
   differentiation
AB Bio-Oss (R) an anorganic bovine bone largely employed in maxillary surgery for regeneration procedures is identical to human bone from chemical and physical point of view and promotes osteogenesis. In order to get more inside how this biomaterial alters osteoblast gene expression to promote bone formation, the mRNA levels of bone related genes were compared in human osteoblasts and dental pulp stem cells, using real time RT-PCR. The obtained results demonstrated that Bio-Oss (R) enhance stem cells differentiation and deposition of matrix by the activation of osteoblast related genes SP7, FOSL1 and SPP1 and the disappearance of the mesenchymal stem cells marker, ENG.
C1 [Brunelli, G.; Vazzoler, G.; Magnabosco, F.] Don Orione Inst, Dept Dent & Maxillofacial Surg, Bergamo, Italy.
   [Carinci, F.; Palmieri, A.; Carnevali, G.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, I-44100 Ferrara, Italy.
   [Girardi, A.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
FU Don Orione Service s.r.l., Bergamo, Italy
FX This work was partially supported by by Don Orione Service s.r.l.,
   Bergamo, Italy.
CR Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025
   Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282
   Lensch MW, 2006, STEM CELL REV, V2, P185, DOI 10.1007/s12015-006-0047-2
   Maiorana C, 2003, INT J PERIODONT REST, V23, P227
   Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027
   Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022
   Ohtsuki C, 2009, J R SOC INTERFACE, V6, pS349, DOI 10.1098/rsif.2008.0419.focus
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rodriguez A, 2003, J ORAL MAXIL SURG, V61, P157, DOI 10.1053/joms.2003.50041
   Sollazzo Vincenzo, 2011, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V9, P1, DOI 10.4028/www.scientific.net/JBBTE.9.1
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
NR 11
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD MAY-AUG
PY 2011
VL 9
IS 2
SU 2
BP 91
EP 94
PG 4
WC Immunology
SC Immunology
GA V37BJ
UT WOS:000209251000017
DA 2018-10-20
ER

PT J
AU Brunelli, G
   Carinci, F
   Palmieri, A
   Girardi, A
   Zollino, I
   Vazzoler, G
   Magnabosco, F
   Sollazzo, V
AF Brunelli, G.
   Carinci, F.
   Palmieri, A.
   Girardi, A.
   Zollino, I.
   Vazzoler, G.
   Magnabosco, F.
   Sollazzo, V.
TI MEDPOR (R) STIMULATES ADIPOSE TISSUE-DERIVED STEM CELLS DIFFERENTIATION
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Medpor (R); gene expression; differentiation; stern cells
AB Medpor (R) is an alloplastic material largely employed for correcting cranial and facial defects. Implants make with this biomaterial are flexible, stable, and exhibit rapid soft-tissue growth. To better understand the molecular mechanism by which this biomaterial promote bone formation, the expression levels of bone related genes were analyzed in human stem cells isolated from adipose tissue and cultivated on Medpor (R). Medpor (R) enhances proliferation, differentiation and deposition of matrix in stem cells by the activation of osteoblast related genes SP7, COL3A1 and ALPL.
C1 [Brunelli, G.; Vazzoler, G.; Magnabosco, F.] Don Orione Inst, Dept Dent & Maxillofacial Surg, Bergamo, Italy.
   [Carinci, F.; Palmieri, A.; Zollino, I.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, I-44100 Ferrara, Italy.
   [Girardi, A.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
FU Don Orione Service s.r.l., Bergamo, Italy
FX This work was partially supported by by Don Orione Service s.r.l.,
   Bergamo, Italy.
CR De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150
   Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X
   Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138
   Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022
   Sollazzo Vincenzo, 2011, Journal of Biomimetrics, Biomaterials, and Tissue Engineering, V9, P1, DOI 10.4028/www.scientific.net/JBBTE.9.1
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387
   WELLISZ T, 1993, AESTHET PLAST SURG, V17, P339, DOI 10.1007/BF00437109
NR 8
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD MAY-AUG
PY 2011
VL 9
IS 2
SU 2
BP 101
EP 104
PG 4
WC Immunology
SC Immunology
GA V37BJ
UT WOS:000209251000019
DA 2018-10-20
ER

PT J
AU Brunelli, G
   Carinci, F
   Palmieri, A
   Girardi, A
   Vazzoler, G
   Magnabosco, F
   Sollazzo, V
AF Brunelli, G.
   Carinci, F.
   Palmieri, A.
   Girardi, A.
   Vazzoler, G.
   Magnabosco, F.
   Sollazzo, V.
TI TRABECULAR TITANIUM INDUCES OSTEOBLASTIC BONE MARROW STEM CELLS
   DIFFERENTIATION
SO EUROPEAN JOURNAL OF INFLAMMATION
LA English
DT Article
DE Trabecular titanium; stem cells; gene expression; bone; differentiation
AB Pure titanium and titanium alloys are materials widely used in orthopedics and dental surgery because of their mechanical properties, chemical stability and biocompatibility. Although excellent clinical results have been shown, traditional porous metals have several inherent limitations (low volumetric porosity, relatively high modulus of elasticity and availability as a coating only). With the aim of going over these limits, improving the potentiality of osteointegration, a new highly porous titanium biomaterial (Trabecular Titanium(TM), TT) has been developed. Because the molecular events due to TT and able to alter osteoblast activity to promote bone formation are poorly understood, expression of osteoblastic related genes in mesenchymal stem cells exposed to TT was investigated. The expression levels of bone related genes like RUNX2, SPP1, COL1A1, COL3A1, BGLAP, ALPL, and FOSL1) and mesenchymal stem cells marker (CD105) were analyzed, using real time Reverse Transcription-Polymerase Chain Reaction. TT causes induction of bone related genes osteopontin (SPP1), osteocalcin (BGLAP) alkaline phosphatase (ALPL) and indicating the differentiation effect of this biomaterial on mesenchymal stem cells. The obtained results can be relevant to better understand the molecular mechanism of bone regeneration and as a model for comparing other materials with similar clinical effects.
C1 [Brunelli, G.; Vazzoler, G.; Magnabosco, F.] Don Orione Inst, Dept Dent & Maxillofacial Surg, Bergamo, Italy.
   [Carinci, F.; Palmieri, A.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, I-44100 Ferrara, Italy.
   [Girardi, A.] Univ Bologna, Dept Histol Embryol & Appl Biol, Bologna, Italy.
   [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial Surg, I-44100 Ferrara, Italy.
EM crc@unife.it
FU Don Orione Service s.r.l., Bergamo, Italy
FX This work was partially supported by by Don Orione Service s.r.l.,
   Bergamo, Italy.
CR Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552
   Bachle M, 2007, CLIN ORAL IMPLAN RES, V18, P53, DOI 10.1111/j1600-0501.2006.01292.x
   Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620
   BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9
   Boyan BD, 1998, J BIOMED MATER RES, V39, P77, DOI 10.1002/(SICI)1097-4636(199801)39:1<77::AID-JBM10>3.0.CO;2-L
   Carinci F, 2003, J BIOMED MATER RES B, V66B, P341, DOI 10.1002/jbm.b.10021
   Clem WC, 2008, BIOMATERIALS, V29, P3461, DOI 10.1016/j.biomaterials.2008.04.045
   Gapski R, 2003, CLIN ORAL IMPLAN RES, V14, P515, DOI 10.1034/j.1600-0501.2003.00950.x
   Gastaldi G, J BIOMED MAT RES A, V94, P790
   Gotfredsen K, 2000, Clin Implant Dent Relat Res, V2, P120, DOI 10.1111/j.1708-8208.2000.tb00002.x
   HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Jin HJ, 2009, BIOCHEM BIOPH RES CO, V381, P676, DOI 10.1016/j.bbrc.2009.02.118
   Kim IS, 2008, DEV GROWTH DIFFER
   Kim JM, 2008, J CELL BIOCHEM, V104, P1906, DOI 10.1002/jcb.21760
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   LIAN JB, 2003, PRIMER METABOLIC BON, P13
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Puleo David A, 2006, Dent Clin North Am, V50, P323, DOI 10.1016/j.cden.2006.03.001
   Sollazzo V, 2008, J BIOMED MATER RES B, V85B, P29, DOI 10.1002/jbm.b.30912
NR 26
TC 0
Z9 0
U1 0
U2 4
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1721-727X
J9 EUR J INFLAMM
JI Eur. J. Inflamm.
PD MAY-AUG
PY 2011
VL 9
IS 2
SU 2
BP 115
EP 120
PG 6
WC Immunology
SC Immunology
GA V37BJ
UT WOS:000209251000022
DA 2018-10-20
ER

PT J
AU Bumgardner, JD
   Adatrow, P
   Haggard, WO
   Norowski, PA
AF Bumgardner, Joel D.
   Adatrow, Pradeep
   Haggard, Warren O.
   Norowski, P. Andrew
TI Emerging Antibacterial Biomaterial Strategies for the Prevention of
   Pen-implant Inflammatory Diseases
SO INTERNATIONAL JOURNAL OF ORAL & MAXILLOFACIAL IMPLANTS
LA English
DT Article
DE antimicrobial; biomaterials; dental implants; peri-implantitis;
   peri-mucositis; surfaces
ID 10-YEAR PROSPECTIVE COHORT; FIXED PARTIAL DENTURES; LEAST 5 YEARS;
   IN-VITRO; BACTERIAL ADHESION; CONTROLLED-RELEASE; HYDROXYAPATITE
   COATINGS; TECHNICAL COMPLICATIONS; SURFACE MODIFICATIONS; INCREASED
   OSTEOBLAST
AB Purpose: Peri-implantitis is an inflammatory disease due to bacteria and plaque formation on implant surfaces which can lead to bone resorption and loss of osseointegration. Biomaterial strategies to prevent or eliminate initial bacterial attachment, in favor of host tissue attachment may have a positive effect on decreasing peri-implantitis, particularly for at risk patient goups. This study provides a brief overview of some of the experimental biomaterial strategies aimed at suppressing or inhibiting bacterial colonization of implant surfaces in favor or host cells and tissues. Materials and Methods: These biomaterial strategies have different mechanisms of action from interfering with bacterial adhesion by modifying surface energies, immobilizing antimicrobials on implant surfaces, creating photocatalytic surfaces, as well as modifying surfaces to deliver antimicrobial agents either prophylactically or in response to bacterial challenge. This is not a comprehensive review, rather a review of studies that serve to illustrate many of the different approaches being investigated. Results: While many of these strategies have demonstrated the potential to significantly reduce bacterial attachment on implant surfaces in vitro, it is unclear if these same reductions will be adequate clinically since even a few adhering bacteria may over time develop into inflammatory inducing biofilms or plaque. Also, data on the ability of the antibacterial modified biomaterials to support osseointegration and permuosal seal formation is still needed. Conclusion: Given the complex and multivariate causes of peri-implant disease, it is likely that combinations of these strategies (eg, antimicrobial surfaces and or delivery mechanisms coupled with methods to favor stable osseointegration and permucosal seal) will be most effective in developing implants resistant to peri-implant disease. INT J ORAL MAXILLOFAC IMPLANTS 2011;26:553-560
C1 [Bumgardner, Joel D.; Haggard, Warren O.] Univ Memphis, Herff Coll Engn, Joint Biomed Engn Program,Hlth Sci Ctr, Univ Tennessee,Herbert Herff Chair Excellence, Memphis, TN 38152 USA.
   [Adatrow, Pradeep] Univ Tennessee, Ctr Hlth Sci, Coll Dent, Memphis, TN 38163 USA.
RP Bumgardner, JD (reprint author), Univ Memphis, Herff Coll Engn, Joint Biomed Engn Program,Hlth Sci Ctr, Univ Tennessee,Herbert Herff Chair Excellence, ET330, Memphis, TN 38152 USA.
EM jbmgrdnr@memphis.edu
FU United States Army; Biomaterials Applications of Memphis (BAM) Research
   Labs at the Joint University of Memphis-University of Tennessee Health
   Science Center, Memphis, Tennessee
FX This work was supported in part by the United States Army Orthopaedic
   Trauma Research Program and the Biomaterials Applications of Memphis
   (BAM) Research Labs at the Joint University of Memphis-University of
   Tennessee Health Science Center Biomedical Engineering Program, Memphis,
   Tennessee.
CR Aglietta M, 2009, CLIN ORAL IMPLAN RES, V20, P441, DOI 10.1111/j.1600-0501.2009.01706.x
   Aita H, 2009, BIOMATERIALS, V30, P1015, DOI 10.1016/j.biomaterials.2008.11.004
   Berglundh T, 2002, J CLIN PERIODONTOL, V29, P197, DOI 10.1034/j.1600-051X.29.s3.12.x
   Blake DM, 1999, SEPAR PURIF METHOD, V28, P1, DOI 10.1080/03602549909351643
   Bragger U, 2001, CLIN ORAL IMPLAN RES, V12, P26, DOI 10.1034/j.1600-0501.2001.012001026.x
   Bragger U, 2005, CLIN ORAL IMPLAN RES, V16, P326, DOI 10.1111/j.1600-0501.2005.01105.x
   Bumgardner JD, 2007, IMPLANT DENT, V16, P66, DOI 10.1097/ID.0b013e3180312011
   Chen W, 2007, J BIOMED MATER RES A, V82A, P899, DOI 10.1002/jbm.a.31197
   Chen W, 2006, BIOMATERIALS, V27, P5512, DOI 10.1016/j.biomaterials.2006.07.003
   Colon G, 2006, J BIOMED MATER RES A, V78A, P595, DOI 10.1002/jbm.a.30789
   Darouiche RO, 2007, J BONE JOINT SURG AM, V89A, P792, DOI 10.2106/JBJS.F.00414
   Das K, 2008, J BIOMED MATER RES B, V87B, P455, DOI 10.1002/jbm.b.31125
   Del Curto B, 2005, INT J ARTIF ORGANS, V28, P718
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Diefenbeck M, 2006, INJURY, V37, P95, DOI 10.1016/j.injury.2006.04.015
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Greene AH, 2008, CLIN ORTHOP RELAT R, V466, P1699, DOI 10.1007/s11999-008-0269-5
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   Heidenau F, 2005, J MATER SCI-MATER M, V16, P883, DOI 10.1007/s10856-005-4422-3
   Heitz-Mayfield LJA, 2008, J CLIN PERIODONTOL, V35, P292, DOI 10.1111/j.1600-051X.2008.01275.x
   Heydenrijk K, 2002, INT J ORAL MAX IMPL, V17, P829
   Jemt T, 2006, CLIN IMPLANT DENT R, V8, P61, DOI 10.1111/j.1708-8208.2006.00003.x
   Jung RE, 2008, CLIN ORAL IMPLAN RES, V19, P119, DOI 10.1111/j.1600-0501.2007.01453.x
   Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193
   Karoussis IK, 2004, CLIN ORAL IMPLAN RES, V15, P8, DOI 10.1111/j.1600-0501.2004.00983.x
   Klinge Bjorn, 2005, Dent Clin North Am, V49, P661, DOI 10.1016/j.cden.2005.03.007
   Lambert FE, 2009, J PERIODONTOL, V80, P1220, DOI 10.1902/jop.2009.090109
   Legeay G, 2006, INT J ARTIF ORGANS, V29, P453
   Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x
   Maddikeri RR, 2008, J BIOMED MATER RES A, V84A, P425, DOI 10.1002/jbm.a.31323
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   Mombelli A, 1997, CURR OPIN PERIODONT, V4, P127
   Montanaro L, 2008, INT J ARTIF ORGANS, V31, P771
   Norowski PA, 2009, J BIOMED MATER RES B, V88B, P530, DOI 10.1002/jbm.b.31152
   Norowski PA, 2011, IMPLANT DENT, V20, P56, DOI 10.1097/ID.0b013e3182087ac4
   Oka Y, 2008, J BIOMED MATER RES B, V86B, P530, DOI 10.1002/jbm.b.31053
   PACHECO JE, 1993, J SOL ENERG-T ASME, V115, P123, DOI 10.1115/1.2930038
   Pecora GE, 2009, IMPLANT DENT, V18, P57, DOI 10.1097/ID.0b013e31818c5a6d
   Petrini P, 2006, INT J ARTIF ORGANS, V29, P434
   Popat KC, 2007, BIOMATERIALS, V28, P4880, DOI 10.1016/j.biomaterials.2007.07.037
   Pye AD, 2009, J HOSP INFECT, V72, P104, DOI 10.1016/j.jhin.2009.02.010
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   Radin S, 2005, BIOMATERIALS, V26, P1043, DOI 10.1016/j.biomaterials.2004.04.004
   Radin S, 2007, BIOMATERIALS, V28, P1721, DOI 10.1016/j.biomaterials.2006.11.035
   Rehman S, 2009, J HAZARD MATER, V170, P560, DOI 10.1016/j.jhazmat.2009.05.064
   Romeo E, 2004, Minerva Stomatol, V53, P215
   Roos-Jansaker AM, 2006, J CLIN PERIODONTOL, V33, P290, DOI 10.1111/j.1600.051X.2006.00906.x
   Schuler M, 2006, BIOMATERIALS, V27, P4003, DOI 10.1016/j.biomaterials.2006.03.009
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   Sollazzo V, 2007, J CRANIOFAC SURG, V18, P806, DOI 10.1097/scs.0b013e3180a7728f
   Stigter M, 2004, J CONTROL RELEASE, V99, P127, DOI 10.1016/j.jconrel.2004.06.011
   Suketa N, 2005, CLIN IMPLANT DENT R, V7, P105, DOI 10.1111/j.1708-8208.2005.tb00053.x
   Sumita T, 2002, APPL SURF SCI, V200, P21, DOI 10.1016/S0169-4332(02)00614-1
   Suzuki Y, 1998, J BIOMED MATER RES, V42, P112, DOI 10.1002/(SICI)1097-4636(199810)42:1<112::AID-JBM14>3.0.CO;2-N
   Tosatti S, 2003, BIOMATERIALS, V24, P4949, DOI 10.1016/S0142-9612(03)00420-4
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Verran J, 2005, INT J ARTIF ORGANS, V28, P1138
   Wong MS, 2006, APPL ENVIRON MICROB, V72, P6111, DOI 10.1128/AEM.02580-05
   Woo GLY, 2000, BIOMATERIALS, V21, P1235, DOI 10.1016/S0142-9612(00)00003-X
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x
NR 64
TC 18
Z9 20
U1 0
U2 24
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0882-2786
EI 1942-4434
J9 INT J ORAL MAX IMPL
JI Int. J. Oral Maxillofac. Implants
PD MAY-JUN
PY 2011
VL 26
IS 3
BP 553
EP 560
PG 8
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 780XC
UT WOS:000291893100011
PM 21691602
DA 2018-10-20
ER

PT J
AU Liou, YB
   Tsay, RY
AF Liou, Yu-Bing
   Tsay, Ruey-Yug
TI Adsorption of PEO-PPO-PEO triblock copolymers on a gold surface
SO JOURNAL OF THE TAIWAN INSTITUTE OF CHEMICAL ENGINEERS
LA English
DT Article
DE Pluronic; Block copolymer surfactant; Ellipsometry; Surface plasma
   resonance
ID OXIDE)-POLY(PROPYLENE OXIDE)-POLY(ETHYLENE OXIDE); BLOCK-COPOLYMERS;
   PROTEIN ADSORPTION; PLASMON RESONANCE; AQUEOUS-SOLUTIONS; HYDROPHOBIC
   SURFACES; HYDROPHILIC SURFACES; BEHAVIOR; FILMS; THERMODYNAMICS
AB Water-soluble triblock copolymers of Poly(ethylene oxide) and Poly(propylene oxide) (PEOn-PPOm-PEOn) are nonionic amphiphilic macromolecules, commercially available under the names of Pluronics and Poloxamers. Recently interest has been focused on studying their roles in reducing nonspecific protein adsorption and cell adhesion on biomaterial/biosensor surfaces. Although the ability of the adsorbed PEO-PPO-PEO triblock copolymer to reduce protein adsorption has been observed frequently, its detailed mechanism of functioning is yet to be clarified. In order to delineate this detailed mechanism, one first needs to know the adsorption behavior of Pluronics on various substrates. Although gold is a commonly used substrate for the probes of various biosensors, there is no direct data reporting the adsorption behavior of Pluronics on it. In this study, we use surface plasma resonance (SPR) technique and Ellipsometry to detect the adsorption isotherms of various Pluronics on a gold surface. The adsorption isotherm of Pluronics of P103, P104 and F108 all exhibit two plateaus that corresponding to the desorption of the EO and the micellization in bulk solution. At bulk concentration of 1 x 10(-2) mg/ml, the total adsorbed amount of the copolymer increases with the increase of the molar mass of the polymer and with the decrease of the EO/PO ratio that suggests the strong influence of the hydrophobic PPO on the adsorbed amount of the polymer. At the CMC, the plateau value of adsorbed amount of Pluronics on Au is independent of molar mass and EO/PO ratio of copolymer. Protein adsorption on gold surfaces modified with various Pluronics shows good correlation between the amounts of protein adsorbed and the value of the reduced surface coverage, sigma* of the Pluronic adlayer. In general, by increasing sigma*, the nonspecific adsorption of human serum albumin can be reduced. (C) 2010 Taiwan Institute of Chemical Engineers. Published by Elsevier B.V. All rights reserved.
C1 [Liou, Yu-Bing; Tsay, Ruey-Yug] Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
RP Tsay, RY (reprint author), Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
EM tsay@ym.edu.tw
FU National Science Council of Taiwan, R.O.C. [NSC 97-2221-E010-009]
FX The authors thank for the support of the National Science Council of
   Taiwan, R.O.C. (NSC 97-2221-E010-009).
CR ALEXANDRIDIS P, 1994, MACROMOLECULES, V27, P2414, DOI 10.1021/ma00087a009
   ALEXANDRIDIS P, 1995, COLLOID SURFACE A, V96, P1, DOI 10.1016/0927-7757(94)03028-X
   AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   BARANOWSKI R, 1995, J CHEM PHYS, V103, P2343, DOI 10.1063/1.469656
   Blomqvist BR, 2005, LANGMUIR, V21, P5061, DOI 10.1021/la0468040
   Brandani P, 2004, MACROMOLECULES, V37, P6640, DOI 10.1021/ma035448+
   Brandani P, 2003, MACROMOLECULES, V36, P9492, DOI 10.1021/ma0342675
   Chang Y, 2010, J BIOMED MATER RES A, V93A, P400, DOI 10.1002/jbm.a.32558
   CLAESSON PM, 1995, ADV COLLOID INTERFAC, V57, P161, DOI 10.1016/0001-8686(95)00241-H
   Eliseeva OV, 2006, J COLLOID INTERF SCI, V301, P210, DOI 10.1016/j.jcis.2006.04.044
   Elisseeva OV, 2005, LANGMUIR, V21, P4954, DOI 10.1021/la046933g
   Eskilsson K, 1998, MACROMOLECULES, V31, P5075, DOI 10.1021/ma9715637
   Eskilsson K, 1997, MACROMOLECULES, V30, P6323, DOI 10.1021/ma961785p
   Green RJ, 1997, LANGMUIR, V13, P6510, DOI 10.1021/la962098u
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Green RJ, 2000, BIOMATERIALS, V21, P1823, DOI 10.1016/S0142-9612(00)00077-6
   Green RJ, 1998, J BIOMED MATER RES, V42, P165, DOI 10.1002/(SICI)1097-4636(199811)42:2<165::AID-JBM1>3.0.CO;2-N
   Inami T, 1999, NANOSTRUCT MATER, V12, P657, DOI 10.1016/S0965-9773(99)00210-X
   Jung LS, 1998, LANGMUIR, V14, P5636, DOI 10.1021/la971228b
   Kiss E, 2004, J ADHESION, V80, P815, DOI 10.1080/00218460490480815
   Kozlov MY, 2000, MACROMOLECULES, V33, P3305, DOI 10.1021/ma991634x
   Lazos D, 2005, LANGMUIR, V21, P8774, DOI 10.1021/la051049r
   Lee S, 2004, MACROMOLECULES, V37, P8349, DOI 10.1021/ma049076w
   Lopes JR, 1998, LANGMUIR, V14, P750, DOI 10.1021/la9709655
   MALMSTEN M, 1992, MACROMOLECULES, V25, P2474, DOI 10.1021/ma00035a028
   MARQUES C, 1988, MACROMOLECULES, V21, P1051, DOI 10.1021/ma00182a035
   Munoz MG, 2000, LANGMUIR, V16, P1094, DOI 10.1021/la9901433
   Norde W, 2004, LANGMUIR, V20, P4162, DOI 10.1021/la030417t
   Ozkumur E, 2009, BIOSENS BIOELECTRON, V25, P167, DOI 10.1016/j.bios.2009.06.033
   Pavey KD, 1999, BIOMATERIALS, V20, P885, DOI 10.1016/S0142-9612(98)00245-2
   Rippner B, 2002, LANGMUIR, V18, P5213, DOI 10.1021/la0118614
   SCHROEN CGPH, 1995, LANGMUIR, V11, P3068, DOI 10.1021/la00008a036
   Shar JA, 1999, COLLOID SURFACE A, V150, P15, DOI 10.1016/S0927-7757(98)00572-X
   Shar JA, 1998, COLLOID SURFACE A, V136, P21, DOI 10.1016/S0927-7757(97)00182-9
   Shi HW, 2004, COLLOID SURFACE A, V246, P81, DOI 10.1016/j.colsurfa.2004.07.019
   Skladal P, 2003, J BRAZIL CHEM SOC, V14, P491, DOI 10.1590/S0103-50532003000400002
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   VIG JR, 1985, J VAC SCI TECHNOL A, V3, P1027, DOI 10.1116/1.573115
   WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016
NR 39
TC 14
Z9 14
U1 3
U2 36
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1876-1070
EI 1876-1089
J9 J TAIWAN INST CHEM E
JI J. Taiwan Inst. Chem. Eng.
PD MAY
PY 2011
VL 42
IS 3
BP 533
EP 540
DI 10.1016/j.jtice.2010.09.011
PG 8
WC Engineering, Chemical
SC Engineering
GA 783YL
UT WOS:000292120700025
DA 2018-10-20
ER

PT J
AU Foty, R
AF Foty, Ramsey
TI A Simple Hanging Drop Cell Culture Protocol for Generation of 3D
   Spheroids
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 51; 3D; hanging drop cultures; cell sorting-out;
   differential adhesion
AB Studies of cell-cell cohesion and cell-substratum adhesion have historically been performed on monolayer cultures adherent to rigid substrates. Cells within a tissue, however, are typically encased within a closely packed tissue mass in which cells establish intimate connections with many near-neighbors and with extracellular matrix components. Accordingly, the chemical milieu and physical forces experienced by cells within a 3D tissue are fundamentally different than those experienced by cells grown in monolayer culture. This has been shown to markedly impact cellular morphology and signaling. Several methods have been devised to generate 3D cell cultures including encapsulation of cells in collagen gels(1)or in biomaterial scaffolds(2). Such methods, while useful, do not recapitulate the intimate direct cell-cell adhesion architecture found in normal tissues. Rather, they more closely approximate culture systems in which single cells are loosely dispersed within a 3D meshwork of ECM products. Here, we describe a simple method in which cells are placed in hanging drop culture and incubated under physiological conditions until they form true 3D spheroids in which cells are in direct contact with each other and with extracellular matrix components. The method requires no specialized equipment and can be adapted to include addition of any biological agent in very small quantities that may be of interest in elucidating effects on cell-cell or cell-ECM interaction. The method can also be used to co-culture two (or more) different cell populations so as to elucidate the role of cell-cell or cell-ECM interactions in specifying spatial relationships between cells. Cell-cell cohesion and cell-ECM adhesion are the cornerstones of studies of embryonic development, tumor-stromal cell interaction in malignant invasion, wound healing, and for applications to tissue engineering. This simple method will provide a means of generating tissue-like cellular aggregates for measurement of biomechanical properties or for molecular and biochemical analysis in a physiologically relevant model.
C1 UMDNJ Robert Wood Johnson Med Sch, Dept Surg, Piscataway, NJ USA.
RP Foty, R (reprint author), UMDNJ Robert Wood Johnson Med Sch, Dept Surg, Piscataway, NJ USA.
EM fotyra@umdnj.edu
FU Department of Defense Prostate Cancer Research Program [PC-030482,
   PC-991552]; NCI/NIH [R01CA118755]
FX The author would like to thank Dr. Dongxuan Jia for technical
   assistance. Some of the images appearing in this article were in
   collaboration with Dr. Malcolm S. Steinberg, Department of Molecular
   Biology, Princeton University. The author would also like to thank the
   Department of Defense Prostate Cancer Research Program (grants PC-030482
   and PC-991552) and the NCI/NIH (grant R01CA118755) for their generous
   support.
CR Berry DP, 1998, PLAST RECONSTR SURG, V102, P124, DOI 10.1097/00006534-199807000-00019
   Bissell M. J., CANC RES, V59, P1757
   Boudreau N, 1996, P NATL ACAD SCI USA, V93, P3509, DOI 10.1073/pnas.93.8.3509
   Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2
   Davis GS, 1997, DEV BIOL, V192, P630, DOI 10.1006/dbio.1997.8741
   Foty RA, 1996, DEVELOPMENT, V122, P1611
   Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Jia D, 2007, DEV DYNAM, V236, P2039, DOI 10.1002/dvdy.21207
   Li DX, 1999, J BIOL CHEM, V274, P32988, DOI 10.1074/jbc.274.46.32988
   Marrero B, 2009, IN VITRO CELL DEV-AN, V45, P523, DOI 10.1007/s11626-009-9217-2
   Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591
   Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315
   Schotz EM, 2008, HFSP J, V2, P42, DOI 10.2976/1.2834817
   StCroix B, 1996, JNCI-J NATL CANCER I, V88, P1285, DOI 10.1093/jnci/88.18.1285
   Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231
   Wendt D, 2009, ADV MATER, V21, P3352, DOI 10.1002/adma.200802748
NR 19
TC 105
Z9 105
U1 7
U2 31
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAY
PY 2011
IS 51
AR e2720
DI 10.3791/2720
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36MA
UT WOS:000209214800034
PM 21587162
OA Green Published
DA 2018-10-20
ER

PT J
AU Lopez-Cebral, R
   Martin-Pastor, M
   Parraga, JE
   Zorzi, GK
   Seijo, B
   Sanchez, A
AF Lopez-Cebral, Rita
   Martin-Pastor, M.
   Evelin Parraga, Jenny
   Konat Zorzi, Giovanni
   Seijo, Begona
   Sanchez, Alejandro
TI Chemically Modified Gelatin as Biomaterial in the Design of New
   Nanomedicines
SO MEDICINAL CHEMISTRY
LA English
DT Article
DE Chemically modified protein; gelatin; nanoparticles; nanomedicines; gene
   delivery
ID SYNTHETIC POLYMERIC BIOMATERIALS; AMINATED GELATIN; DRUG-DELIVERY; GENE
   DELIVERY; NANOPARTICLES; CHITOSAN; PROTEIN; NANOSTRUCTURES;
   MICROSPHERES; SPECTROSCOPY
AB The synthesis of new polymers has led to dramatic enhancements in the medical field. In particular, new chemical entities provided new prospects in tissue engineering, cellular therapy and drug delivery. However, significant efforts still need to be taken in consideration in order to achieve diverse clinical applications in these fields, which is challenging because of the lack of suitable materials with desired microstructure, permeability, degradation rates, products, and suitable mechanical properties. For these reasons some chemical strategies are focused in back to the nature approaches or, in other words, in improving the properties of natural polymers by chemical modifications.
   We report that by using a simple chemical modification technique we can obtain new biomaterials, specifically suitable for biomedical applications. Concretely, we describe the chemical modification of gelatin and the suitable characteristics of the modified protein to develop new nanomedicines. This protein was selected because of its enormous potential in biomedicine, which is currently limited due to the difficulty of its use without toxic chemical crosslinkers. The modification of the protein was based on the transformation of the carboxylic group into amido groups after their reaction with polyamines, leading to a positively charged biopolymer. To cationize the gelatin two polyamines where used: ethylenediamine and spermine, the latter being one of the endogenous polyamines which has a very positive influence over cells. This modification was monitored by physico-chemical techniques such as NMR, spectrophotometry and potentiometry.
   With the most promising modified gelatins we were able to develop nanoparticles using the ionotropic gelation technique. In order to determine the ability of these new nanosystems to associate bioactive molecules we selected a model plasmid DNA. The developed nanosystems were characterized corroborating their ability to associate the genetic material. In conclusion, we were able to obtain a semi-synthetic biomaterial with tunable physico-chemical properties, which can be used to develop new nanosystems with the ability to associate genetic material. We therefore propose that the gelatin, with its chemical modification, provide a unique biomaterial for the development of new nanomedicines.
C1 [Lopez-Cebral, Rita; Evelin Parraga, Jenny; Konat Zorzi, Giovanni; Seijo, Begona; Sanchez, Alejandro] Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Santiago De Compostela 15706, A Coruna, Spain.
   [Martin-Pastor, M.] Univ Santiago de Compostela, RIADT, Nucl Magnet Resonance Unit, Santiago De Compostela 15706, A Coruna, Spain.
RP Sanchez, A (reprint author), Univ Santiago de Compostela, Fac Pharm, Dept Pharm & Pharmaceut Technol, Campus Sur, Santiago De Compostela 15782, Spain.
EM alejandro.sanchez@usc.es
RI Lopez-Cebral, Rita/O-8833-2015; Lopez Cebral, Rita/D-1325-2016
OI Lopez-Cebral, Rita/0000-0003-1387-4391; Lopez Cebral,
   Rita/0000-0003-1387-4391; Martin-Pastor, Manuel/0000-0001-6024-1656
CR Baldwin AD, 2010, BIOPOLYMERS, V94, P128, DOI 10.1002/bip.21334
   BUBNIS WA, 1992, ANAL BIOCHEM, V207, P129, DOI 10.1016/0003-2697(92)90513-7
   Cha EJ, 2009, EUR J PHARM SCI, V38, P341, DOI 10.1016/j.ejps.2009.08.006
   Colonna C, 2007, J MICROENCAPSUL, V24, P553, DOI 10.1080/02652040701449608
   *COMM METH TEST PH, 2006, PAGI METHOD
   Csaba N, 2006, J CONTROL RELEASE, V113, P164, DOI 10.1016/j.jconrel.2006.03.017
   d'Angelo I, 2010, J MICROENCAPSUL, V27, P57, DOI 10.3109/02652040902954729
   de la Fuente M, 2010, ADV DRUG DELIVER REV, V62, P100, DOI 10.1016/j.addr.2009.11.026
   Dong W, 2010, BIOMACROMOLECULES, V11, P1527, DOI 10.1021/bm100158p
   Fischer D, 2001, INT J PHARM, V225, P97, DOI 10.1016/S0378-5173(01)00765-7
   Greindl M, 2006, PHARM RES-DORDR, V23, P2183, DOI 10.1007/s11095-006-9087-1
   Grenha A, 2008, J NANOSCI NANOTECHNO, V8, P358, DOI 10.1166/jnn.2008.005
   Hitchcock DI, 1931, J GEN PHYSIOL, V14, P685, DOI 10.1085/jgp.14.6.685
   Kayser O, 2005, CURR PHARM BIOTECHNO, V6, P3
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   Kuijpers AJ, 1999, MACROMOLECULES, V32, P3325, DOI 10.1021/ma981929v
   MEJILLANO MR, 1991, J BIOL CHEM, V266, P657
   Melnyk O, 2000, BIOPOLYMERS, V55, P165, DOI 10.1002/1097-0282(2000)55:2<165::AID-BIP50>3.0.CO;2-#
   Morille M, 2008, BIOMATERIALS, V29, P3477, DOI 10.1016/j.biomaterials.2008.04.036
   Morimoto K, 2008, DRUG DELIV, V15, P113, DOI [10.1080/10717540801905124, 10.1080/10717540801905124 ]
   Ofner CM, 1996, PHARM RES-DORDR, V13, P1821
   Paolicelli P, 2009, EXPERT OPIN DRUG DEL, V6, P239, DOI 10.1517/17425240902762818
   Petersen Line Barrett, 2010, Ugeskr Laeger, V172, P1756
   Ravina M, 2010, MINI-REV MED CHEM, V10, P73, DOI 10.2174/138955710791112569
   ROWE RC, 2006, HDB PHARM EXCIPIENTS, P295
   SCHMIDT JJ, J BIOMED MAT RES A, V87, P1113
   Seki T, 2006, J PHARM SCI-US, V95, P1393, DOI 10.1002/jps.20616
   Walter NG, 2007, BIOPOLYMERS, V85, P103, DOI 10.1002/bip.20633
   Wang J, 2001, J CONTROL RELEASE, V73, P223, DOI 10.1016/S0168-3659(01)00288-7
   WARD AG, 1954, BRIT J APPL PHYS, V5, P85, DOI 10.1088/0508-3443/5/3/302
   WU DH, 1995, J MAGN RESON SER A, V115, P260, DOI 10.1006/jmra.1995.1176
NR 31
TC 13
Z9 13
U1 5
U2 21
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4064
J9 MED CHEM
JI Med. Chem.
PD MAY
PY 2011
VL 7
IS 3
BP 145
EP 154
DI 10.2174/157340611795564277
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 784UK
UT WOS:000292183500001
PM 21486207
DA 2018-10-20
ER

PT J
AU Lin, HS
   Wang, HS
   Yang, RS
   Huang, TH
AF Lin, Hsin-Shih
   Wang, Ho-Seng
   Yang, Rong-Sen
   Huang, Tsang-Hai
TI Landing Produced Different Adaptation Behaviors On Bone Biomaterial
   Between Fore-limb And Hind-limb In Rats
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the American-College-of-Sports-Medicine / 2nd
   World Congress on Exercise is Medicine
CY MAY 31-JUN 04, 2011
CL Denver, CO
SP Amer Coll Sports Med
C1 [Lin, Hsin-Shih; Wang, Ho-Seng] Natl Taiwan Normal Univ, Taipei, Taiwan.
   [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Taipei, Taiwan.
   [Huang, Tsang-Hai] Natl Cheng Kung Univ, Tainan 70101, Taiwan.
EM 897300180@ntnu.edu.tw
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0195-9131
EI 1530-0315
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD MAY
PY 2011
VL 43
IS 5
SU 1
MA 1268
BP 245
EP 245
DI 10.1249/01.MSS.0000400668.76197.f5
PG 1
WC Sport Sciences
SC Sport Sciences
GA V34IG
UT WOS:000209079501025
DA 2018-10-20
ER

PT J
AU Guo, LT
   Lin, HS
   Hsieh, SYS
   Chang, MS
   Yang, RS
   Huang, TH
AF Guo, Liang-Tong
   Lin, Hsin-Shih
   Hsieh, Shen-Yu Sandy
   Chang, Ming-Shi
   Yang, Rong-Sen
   Huang, Tsang-Hai
TI Effects of Endurance Exercise Training and Zoledronic Acid Treatment on
   Biomaterial Properties of Femora in Ovariectomized Rats
SO MEDICINE AND SCIENCE IN SPORTS AND EXERCISE
LA English
DT Meeting Abstract
CT 58th Annual Meeting of the American-College-of-Sports-Medicine / 2nd
   World Congress on Exercise is Medicine
CY MAY 31-JUN 04, 2011
CL Denver, CO
SP Amer Coll Sports Med
C1 [Guo, Liang-Tong; Chang, Ming-Shi; Huang, Tsang-Hai] Natl Cheng Kung Univ, Tainan 70101, Taiwan.
   [Lin, Hsin-Shih; Hsieh, Shen-Yu Sandy] Natl Taiwan Normal Univ, Taipei, Taiwan.
   [Yang, Rong-Sen] Natl Taiwan Univ Hosp, Taipei, Taiwan.
EM yanshishn@yahoo.com.tw
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0195-9131
EI 1530-0315
J9 MED SCI SPORT EXER
JI Med. Sci. Sports Exerc.
PD MAY
PY 2011
VL 43
IS 5
SU 1
MA 1272
BP 246
EP 246
DI 10.1249/01.MSS.0000400672.29563.9b
PG 1
WC Sport Sciences
SC Sport Sciences
GA V34IG
UT WOS:000209079501029
DA 2018-10-20
ER

PT J
AU David, B
   Bonnefont-Rousselot, D
   Oudina, K
   Degat, MC
   Deschepper, M
   Viateau, V
   Bensidhoum, M
   Oddou, C
   Petite, H
AF David, Bertrand
   Bonnefont-Rousselot, Dominique
   Oudina, Karim
   Degat, Marie-Christelle
   Deschepper, Mickael
   Viateau, Veronique
   Bensidhoum, Morad
   Oddou, Christian
   Petite, Herve
TI A Perfusion Bioreactor for Engineering Bone Constructs: An In Vitro and
   In Vivo Study
SO TISSUE ENGINEERING PART C-METHODS
LA English
DT Article
ID MARROW STROMAL CELLS; MINERALIZED MATRIX DEPOSITION; MESENCHYMAL
   STEM-CELLS; FLOW PERFUSION; SHEAR-STRESS; FLUID SHEAR; OSTEOGENIC
   DIFFERENTIATION; BIODEGRADABLE SCAFFOLDS; 3-DIMENSIONAL CULTURE;
   OSTEOBLASTIC CELLS
AB A perfusion bioreactor, which was designed based on fluidized bed concepts, was validated for the culture of bone constructs of clinically relevant size. For this study, natural coral has been used as three-dimensional scaffolds. This biomaterial is a microporous, biocompatible, osteoconductive, and absorbable scaffold. This perfusion bioreactor provided a stable environment in terms of osmolarity, pH, and, most importantly, oxidative stress. Bone constructs engineered in this system resulted in significantly higher cell proliferation and homogenous cell distribution than those cultured under static conditions. Particularly relevant to the production of bioengineered bone in a clinical setting, custom-made bone constructs (each one with volume up to 30 cm 3) could be produced using a such perfusion bioreactor. Last, but not least, the bone constructs of clinically relevant volume thus produced were shown to be osteogenic when transplanted subcutaneously in sheep.
C1 [Bonnefont-Rousselot, Dominique] Univ Paris 05, Dept Biol Expt Metab & Clin, EA 4466, Fac Sci Pharmaceut & Biol, Paris, France.
   [Bonnefont-Rousselot, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Biochim Metab, F-75634 Paris, France.
   [Oudina, Karim; Degat, Marie-Christelle; Deschepper, Mickael; Viateau, Veronique; Bensidhoum, Morad; Petite, Herve] Univ Paris 07, CNRS, UMR 7052, Lab Bioingn & Biomecan Osteoarticulaire, Paris, France.
   [Oddou, Christian] Univ Paris Est Creteil, CNRS, UMR 8208, Lab Modelisat & Simulat Multi Echelle, Creteil, France.
   [David, Bertrand] Ecole Cent Paris, Charge Rech CNRS CR1, Ecole Cent Arts & Mfg, Lab Mecan Sols Struct & Mat,UMR CNRS 8579, F-92295 Chatenay Malabry, France.
RP David, B (reprint author), Ecole Cent Paris, Charge Rech CNRS CR1, Ecole Cent Arts & Mfg, Lab Mecan Sols Struct & Mat,UMR CNRS 8579, F-92295 Chatenay Malabry, France.
EM bertrand.david@ecp.fr
RI Petite, Herve/E-3478-2016
OI Petite, Herve/0000-0003-1694-5060; Bensidhoum, Morad/0000-0002-6621-6010
FU Fonds d'Amorcage Biotherapie [BTH06003]; ANR Therabone; Contrat
   d'interface AP-HP/INSERM
FX The authors thank Biocoral, Inc., for donating the coral implants and
   Prof. R. Bizios for her comments on the article. The authors also
   acknowledge the financial support from Fonds d'Amorcage Biotherapie
   BTH06003, the ANR Therabone, and Contrat d'interface AP-HP/INSERM. Apart
   from the donation of the implants, no financial support was received
   from Biocoral, Inc.
CR AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bensaid W, 2005, TISSUE ENG, V11, P814, DOI 10.1089/ten.2005.11.814
   Bilodeau K, 2006, TISSUE ENG, V12, P2367, DOI 10.1089/ten.2006.12.2367
   BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3
   Chen HC, 2006, BIOTECHNOL LETT, V28, P1415, DOI 10.1007/s10529-006-9111-x
   Chiu JJ, 1997, ARTERIOSCL THROM VAS, V17, P3570, DOI 10.1161/01.ATV.17.12.3570
   David B, 2004, INT J ARTIF ORGANS, V27, P284
   DAVID B, 2009, BIOMECHANICAL FUNCTI, P693
   De Keulenaer GW, 1998, CIRC RES, V82, P1094, DOI 10.1161/01.RES.82.10.1094
   FREED LE, 1994, BIOTECHNOL BIOENG, V43, P605, DOI 10.1002/bit.260430710
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2006, TISSUE ENG, V12, P177, DOI 10.1089/ten.2006.12.177
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   GOTZ ME, 1994, PHARMACOL THERAPEUT, V63, P37, DOI 10.1016/0163-7258(94)90055-8
   Granet C, 1998, MED BIOL ENG COMPUT, V36, P513, DOI 10.1007/BF02523224
   GUILLEMIN G, 1989, J BIOMED MATER RES, V23, P765, DOI 10.1002/jbm.820230708
   HASSELL T, 1991, APPL BIOCHEM BIOTECH, V30, P29, DOI 10.1007/BF02922022
   Hillsley MV, 1997, CALCIFIED TISSUE INT, V60, P48, DOI 10.1007/s002239900185
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Holy CE, 2000, J BIOMED MATER RES, V51, P376, DOI 10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G
   Hsieh HJ, 1998, J CELL PHYSIOL, V175, P156, DOI 10.1002/(SICI)1097-4652(199805)175:2<156::AID-JCP5>3.3.CO;2-G
   HUNG CT, 1995, CLIN ORTHOP RELAT R, P256
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Janssen FW, 2006, J BIOMED MATER RES A, V79A, P338, DOI 10.1002/jbm.a.30794
   Jin QM, 2000, J BIOMED MATER RES, V52, P841, DOI 10.1002/1097-4636(20001215)52:4<841::AID-JBM31>3.0.CO;2-3
   Kim BS, 1998, BIOTECHNOL BIOENG, V57, P46
   Leclerc E, 2006, BIOMATERIALS, V27, P586, DOI 10.1016/j.biomaterials.2005.06.002
   Li Y, 2001, BIOTECHNOL PROGR, V17, P935, DOI 10.1021/bp0100878
   Liegibel UM, 2004, EXP CLIN ENDOCR DIAB, V112, P356, DOI 10.1055/s-2004-821014
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   Logeart-Avramoglou D, 2010, TISSUE ENG PART C-ME, V16, P447, DOI [10.1089/ten.tec.2009.0004, 10.1089/ten.TEC.2009.0004]
   Lovell MA, 2000, BRAIN RES, V855, P116, DOI 10.1016/S0006-8993(99)02335-5
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002
   Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011
   Molnar G, 1997, IN VITRO CELL DEV-AN, V33, P386
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   OZTURK SS, 1992, BIOTECHNOL BIOENG, V39, P418, DOI 10.1002/bit.260390408
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   REZNIKOFF CA, 1973, CANCER RES, V33, P3231
   RIPAMONTI U, 1992, MATRIX, V12, P202, DOI 10.1016/S0934-8832(11)80063-6
   SAMPATH TK, 1984, J CELL BIOL, V98, P2192, DOI 10.1083/jcb.98.6.2192
   Schneider M, 1996, J BIOTECHNOL, V46, P161, DOI 10.1016/0168-1656(95)00196-4
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Singh H, 2007, BIOTECHNOL BIOENG, V97, P1291, DOI 10.1002/bit.21327
   Stiehler M, 2009, J BIOMED MATER RES A, V89A, P96, DOI 10.1002/jbm.a.31967
   van den Dolder J, 2003, J BIOMED MATER RES A, V64A, P235, DOI 10.1002/jbm.a.10365
   Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x
   Viateau V, 2007, J ORTHOP RES, V25, P741, DOI 10.1002/jor.20352
   WEINBAUM S, 1994, J BIOMECH, V27, P339, DOI 10.1016/0021-9290(94)90010-8
   Yu XJ, 2004, P NATL ACAD SCI USA, V101, P11203, DOI 10.1073/pnas.0402532101
   Zhang ZY, 2009, BIOMATERIALS, V30, P2694, DOI 10.1016/j.biomaterials.2009.01.028
   Zhao F, 2007, BIOTECHNOL BIOENG, V96, P584, DOI 10.1002/bit.21184
NR 57
TC 15
Z9 15
U1 2
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3384
EI 1937-3392
J9 TISSUE ENG PART C-ME
JI Tissue Eng. Part C-Methods
PD MAY
PY 2011
VL 17
IS 5
BP 505
EP 516
DI 10.1089/ten.tec.2010.0468
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 755MV
UT WOS:000289937100001
PM 21171934
DA 2018-10-20
ER

PT J
AU Kluge, JA
   Leisk, GG
   Cardwell, RD
   Fernandes, AP
   House, M
   Ward, A
   Dorfmann, AL
   Kaplan, DL
AF Kluge, Jonathan A.
   Leisk, Gary G.
   Cardwell, Robyn D.
   Fernandes, Alexander P.
   House, Michael
   Ward, Andrew
   Dorfmann, A. Luis
   Kaplan, David L.
TI Bioreactor System Using Noninvasive Imaging and Mechanical Stretch for
   Biomaterial Screening
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE 3D tissue culture; Tissue engineering; Scaffolds; Mechanical
   stimulation; Optical assessment
ID STROMAL CELL; OPTICAL CHARACTERIZATION; REPAIR BIOMECHANICS;
   GENE-EXPRESSION; TENDON REPAIR; SILK FIBERS; STEM-CELLS; IN-VITRO;
   MICROSCOPY; STIMULATION
AB Screening of biomaterial and tissue systems in vitro, for guidance of performance in vivo, remains a major requirement in the field of tissue engineering. It is critical to understand how culture stimulation affects both tissue construct maturation and function, with the goal of eliminating resource-intensive trial-and-error screening and better matching specifications for various in vivo needs. In this article a multifunctional and robust bioreactor design that addresses this need is presented. The design enables a range of mechanical inputs, durations, and frequencies to be applied in coordination with noninvasive optical assessments. A variety of biomaterial systems, including micro- and nano-fiber and porous sponge biomaterials, as well as cell-laden tissue engineering constructs were used in validation studies to demonstrate the versatility and utility of this new bioreactor design. The silk-based biomaterials highlighted in these studies offered several unique optical signatures for use in label-free nondestructive imaging that allowed for sequential profiling. Both short- and long-term culture studies were conducted to evaluate several practical scenarios of usage: on a short-term basis, the authors demonstrate that construct cellularity can be monitored by usage of nonpermanent dyes; on a more long-term basis, the authors show that cell ingrowth can be monitored by green-fluorescent protein (GFP)-labeling, and construct integrity probed with concurrent load/displacement data. The ability to nondestructively track cells, biomaterials, and new matrix formation without harvesting designated samples at each time point will lead to less resource-intensive studies and should enhance our understanding and the discovery of biomaterial designs related to functional tissue engineering.
C1 [Kluge, Jonathan A.; House, Michael; Dorfmann, A. Luis; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Kluge, Jonathan A.; House, Michael; Dorfmann, A. Luis; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Leisk, Gary G.; Fernandes, Alexander P.; Ward, Andrew] Tufts Univ, Dept Mech Engn, Medford, MA 02155 USA.
   [Cardwell, Robyn D.] Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
   [Dorfmann, A. Luis] Tufts Univ, Dept Civil Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Dorfmann, Luis/A-8717-2008
FU US National Institutes of Health (NIH) [P41 EB002520, R25 GM073177-01,
   F31 AR055872]
FX The authors thank those at Tufts University for their technical
   assistance: Amy Thurber for support with cell culture experiments;
   Minchul Shin, Kosta Tsioris, and Rob White for their help in gasket
   fabrication techniques; Scott MacCorkle, Dennis Dupuis, and Larry
   McMaster in the Department of Physics machine shop. Electrospinning of
   scaffolds and subsequent DNA analysis were performed in the laboratory
   of Aaron Goldstein at Virginia Tech. Funding supplied by the US National
   Institutes of Health (NIH) (P41 EB002520, R25 GM073177-01, and F31
   AR055872).
CR Abraham LC, 2007, EXP CELL RES, V313, P1045, DOI 10.1016/j.yexcr.2006.12.019
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Altman Greg, 2002, FASEB Journal, V16, P270
   Balestrini JL, 2006, J BIOMECH, V39, P2983, DOI 10.1016/j.jbiomech.2005.10.025
   Bashur CA, 2009, TISSUE ENG PT A, V15, P2435, DOI 10.1089/ten.tea.2008.0295
   Bayan C, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116626
   Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456
   Caruso AB, 2004, J BIOMED MATER RES A, V69A, P164, DOI 10.1002/jbm.a.20136
   Chen JS, 2006, TISSUE ENG, V12, P3085, DOI 10.1089/ten.2006.12.3085
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Georgakoudi I, 2008, TISSUE ENG PART B-RE, V14, P321, DOI 10.1089/ten.teb.2008.0248
   Gilbert TW, 2007, TISSUE ENG, V13, P1313, DOI 10.1089/ten.2006.0318
   Gupta S, 2008, BIOMATERIALS, V29, P2359, DOI 10.1016/j.biomaterials.2008.01.034
   Gupta S, 2009, APPL OPTICS, V48, pD45, DOI 10.1364/AO.48.000D45
   Hagenmuller H, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3284787
   Heijne A, 2004, MED SCI SPORT EXER, V36, P935, DOI 10.1249/01.MSS.0000128185.55587.A3
   House M, 2010, TISSUE ENG PT A, V16, P2101, DOI [10.1089/ten.tea.2009.0457, 10.1089/ten.TEA.2009.0457]
   Hu JJ, 2009, TISSUE ENG PT A, V15, P1553, DOI 10.1089/ten.tea.2008.0287
   Humphrey JD, 2008, BIOMECH MODEL MECHAN, V7, P323, DOI 10.1007/s10237-007-0099-5
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kim HJ, 2007, MACROMOL BIOSCI, V7, P643, DOI 10.1002/mabi.200700030
   Kluge JA, 2010, J MECH BEHAV BIOMED, V3, P538, DOI 10.1016/j.jmbbm.2010.06.008
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Niklason LE, 2010, P NATL ACAD SCI USA, V107, P3335, DOI 10.1073/pnas.0907813106
   Nirmalanandhan VS, 2009, TISSUE ENG PT A, V15, P2103, DOI 10.1089/ten.tea.2008.0335
   Pins GD, 1997, BIOPHYS J, V73, P2164, DOI 10.1016/S0006-3495(97)78247-X
   Pully VV, 2010, ANAL CHEM, V82, P1844, DOI 10.1021/ac902515c
   Rice WL, 2008, BIOMATERIALS, V29, P2015, DOI 10.1016/j.biomaterials.2007.12.049
   Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075
   Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117
   Shearn JT, 2007, J BIOMECH ENG-T ASME, V129, P848, DOI 10.1115/1.2800769
   Webb AR, 2007, ANN BIOMED ENG, V35, P1357, DOI 10.1007/s10439-007-9304-z
NR 38
TC 15
Z9 17
U1 3
U2 31
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2011
VL 39
IS 5
BP 1390
EP 1402
DI 10.1007/s10439-010-0243-8
PG 13
WC Engineering, Biomedical
SC Engineering
GA 746JR
UT WOS:000289243100002
PM 21298345
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Olender, G
   Pfeifer, R
   Muller, CW
   Gosling, T
   Barcikowski, S
   Hurschler, C
AF Olender, Gavin
   Pfeifer, Ronny
   Mueller, Christian W.
   Goesling, Thomas
   Barcikowski, Stephan
   Hurschler, Christof
TI A Preliminary Study of Bending Stiffness Alteration in Shape Changing
   Nitinol Plates for Fracture Fixation
SO ANNALS OF BIOMEDICAL ENGINEERING
LA English
DT Article
DE Nitinol; Equivalent stiffness; SME
ID LOCKING PLATES; BONE; SCOLIOSIS; RELEASE; STENTS; NICKEL
AB Nitinol is a promising biomaterial based on its remarkable shape changing capacity, biocompatibility, and resilient mechanical properties. Until now, very limited applications have been tested for the use of Nitinol plates for fracture fixation in orthopaedics. Newly designed fracture-fixation plates are tested by four-point bending to examine a change in equivalent bending stiffness before and after shape transformation. The goal of stiffness alterable bone plates is to optimize the healing process during osteosynthesis in situ that is customized in time of onset, percent change as well as being performed non-invasively for the patient. The equivalent bending stiffness in plates of varying thicknesses changed before and after shape transformation in the range of 24-73% (p values < 0.05 for all tests). Tests on a Nitinol plate of 3.0 mm increased in stiffness from 0.81 to 0.98 Nm(2) (corresponding standard deviation 0.08 and 0.05) and shared a good correlation to results from numerical calculation. The stiffness of the tested fracture-fixation plates can be altered in a consistent matter that would be predicted by determining the change of the cross-sectional area moment of inertia.
C1 [Olender, Gavin; Hurschler, Christof] Hannover Med Sch, Dept Orthopaed, Lab Biomech & Biomat, D-30625 Hannover, Germany.
   [Pfeifer, Ronny; Barcikowski, Stephan] Laser Zentrum Hannover, D-30419 Hannover, Germany.
   [Mueller, Christian W.; Goesling, Thomas] Hannover Med Sch, Trauma Dept, D-30625 Hannover, Germany.
RP Olender, G (reprint author), Hannover Med Sch, Dept Orthopaed, Lab Biomech & Biomat, Anna von Borries Str 1-7, D-30625 Hannover, Germany.
EM gavin.olender@ddh-gruppe.de
RI Barcikowski, Stephan/I-4754-2012
OI Barcikowski, Stephan/0000-0002-9739-7272; Muller, Christian
   W./0000-0002-3263-9576
FU Collaborative Research Center 599 for Biomedical Technology, a Center of
   the German Research Foundation (DFG)
FX This research project was funded by the Collaborative Research Center
   599 for Biomedical Technology, a Center of the German Research
   Foundation (DFG). The following author, Ronny Pfeifer, made an equal
   contribution to this manuscript.
CR Augat P, 2005, OSTEOPOROSIS INT, V16, pS36, DOI 10.1007/s00198-004-1728-9
   Bottlang M, 2010, J BONE JOINT SURG AM, V92A, P1652, DOI 10.2106/JBJS.I.01111
   Braun JT, 2006, SPINE, V31, P1776, DOI 10.1097/01.brs.0000227263.43060.50
   Chen G, 2009, J BIOMECH, V42, P2575, DOI 10.1016/j.jbiomech.2009.07.010
   CLAES LE, 1995, CLIN BIOMECH, V10, P227, DOI 10.1016/0268-0033(95)99799-8
   Epari DR, 2006, BONE, V38, P864, DOI 10.1016/j.bone.2005.10.023
   Gardner MJ, 2010, INJURY, V41, P652, DOI 10.1016/j.injury.2010.02.022
   Gautier E, 2003, INJURY, V34, P63, DOI 10.1016/j.injury.2003.09.026
   Grigoriev I. S., 1997, HDB PHYS QUANTITIES, P147
   Hontzsch D, 1996, Versicherungsmedizin, V48, P96
   Kauffman GB, 1996, CHEM ED, V2, P1
   Lienau J, 2005, J ORTHOP RES, V23, P639, DOI 10.1016/j.orthres.2004.09.006
   Muller C. W., 2010, J ORTHOP RES, V21, P110
   Otsuka K, 2002, MRS BULL, V27, P91, DOI 10.1557/mrs2002.43
   Pandis N, 2009, AM J ORTHOD DENTOFAC, V136, DOI [10.1016/j.ajodo.2009.03.030, 10.1016/j.ajodo.2008.08.022]
   Peitsch T, 2007, J BIOMED MATER RES A, V82A, P731, DOI 10.1002/bjm.a.31097
   Pelton AR, 2008, J MECH BEHAV BIOMED, V1, P153, DOI 10.1016/j.jmbbm.2007.08.001
   Pfeifer R., 2010, J MATER PROCESS TECH, V21, P110
   Pfeifer R., 2008, INT C APPL LAS EL TE, P288
   Prymak O, 2005, BIOMATERIALS, V26, P5801, DOI 10.1016/j.biomaterials.2005.02.029
   Stoffel K, 2007, CLIN BIOMECH, V22, P100, DOI 10.1016/j.clinbiomech.2006.07.008
   Tang RG, 1996, BIO-MED MATER ENG, V6, P307
   Tarnita D, 2010, ROM J MORPHOL EMBRYO, V51, P315
   Verschuur EML, 2008, AM J GASTROENTEROL, V103, P304, DOI 10.1111/j.1572-0241.2007.01542.x
   Wever DJ, 2002, EUR SPINE J, V11, P100, DOI 10.1007/s005860100347
   Wu W, 2007, J BIOMECH, V40, P3034, DOI 10.1016/j.jbiomech.2007.02.024
   Xiong Y, 2009, INT ORTHOP, V33, P1415, DOI 10.1007/s00264-008-0713-x
NR 27
TC 11
Z9 11
U1 2
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0090-6964
EI 1573-9686
J9 ANN BIOMED ENG
JI Ann. Biomed. Eng.
PD MAY
PY 2011
VL 39
IS 5
BP 1546
EP 1554
DI 10.1007/s10439-011-0257-x
PG 9
WC Engineering, Biomedical
SC Engineering
GA 746JR
UT WOS:000289243100015
PM 21286815
DA 2018-10-20
ER

PT J
AU Hsu, SH
   Chan, SH
   Chiang, CM
   Chen, CCC
   Jiang, CF
AF Hsu, Shan-hui
   Chan, Shan-Ho
   Chiang, Chih-Ming
   Chen, Clayton Chi-Chang
   Jiang, Ching-Fen
TI Peripheral nerve regeneration using a microporous polylactic acid
   asymmetric conduit in a rabbit long-gap sciatic nerve transection model
SO BIOMATERIALS
LA English
DT Article
DE Nerve regeneration; Asymmetric nerve conduit; Magnetic resonance imaging
   (MRI); Functional recovery
ID WALKING TRACK ANALYSIS; IN-VIVO EVALUATION; WALLERIAN DEGENERATION;
   SCHWANN-CELLS; GUIDE CONDUIT; RECOVERY; HISTOLOGY; DEFECTS; MUSCLE;
   REPAIR
AB The performance of an asymmetric conduit made of microporous polylactic acid (PLA) in promoting the long-term peripheral nerve regeneration across a 20-mm-long sciatic nerve gap was evaluated by a rabbit sciatic nerve transection model. Magnetic resonance imaging (MRI) was employed to monitor the nerve regeneration process. The extents of nerve regeneration and conduit degradation were quantified by image analysis. Functional and histological analyses were followed to assess nerve reinnervation. MR images showed that the transected nerve was connected at about 4 months. The diameter of the regenerated nerve continued to increase while the conduit was gradually degraded. The conduit was completely degraded in 18 months. The degradation kinetics in vivo was estimated based on MR images. The functional recovery after 18 months was similar to 82% based on electrophysiology. The extension range of the operated limb was slowly recuperated to similar to 81% at 18 months. Histology showed that nerve bundles were self-assembled after 16-18 months, but the morphologies were still different from those of normal sciatic nerve. This was the first work on the long-term evaluation of peripheral nerve regeneration in a rabbit model, and the first to report the use of MRI to obtain the real-time images of regenerated nerve in a biomaterial conduit as well as to define the degradation rate of the conduit in vivo. The platform established in this study serves to evaluate the regeneration of larger-diameter (>3-mm) nerve across a long-gap bridged by a conduit. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Hsu, Shan-hui] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
   [Hsu, Shan-hui] Natl Taiwan Univ, Rehabil Engn Res Ctr, Taipei 10617, Taiwan.
   [Chan, Shan-Ho] Natl Chung Hsing Univ, Dept Chem Engn, Taichung 40227, Taiwan.
   [Chan, Shan-Ho; Chiang, Chih-Ming; Chen, Clayton Chi-Chang] Taichung Vet Gen Hosp, Dept Radiol, Taichung, Taiwan.
   [Jiang, Ching-Fen] I Shou Univ, Dept Biomed Engn, Kaohsiung, Taiwan.
RP Hsu, SH (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, 1,Sec 4 Roosevelt Rd, Taipei 10617, Taiwan.
EM shhsu@ntu.edu.tw
OI Hsu, Shan-hui/0000-0003-3399-055X
FU Taichung Veterans General Hospital/National Chung Hsing University
   [TCVGH-NCHU 977608]; National Science Council [NSC 99-2321-B-002-043]
FX The authors thank Dr. Su Jing Yang and the MRI center, Department of
   Radiology, Taichung Veterans General Hospital, for their group support.
   This work was supported by grants from the Taichung Veterans General.
   Hospital/National Chung Hsing University (grant number TCVGH-NCHU
   977608) and the National Science Council (grant number NSC
   99-2321-B-002-043).
CR Ansselin AD, 1997, NEUROPATH APPL NEURO, V23, P387
   Bendszus M, 2004, EXP NEUROL, V188, P171, DOI 10.1016/j.expneurol.2004.03.025
   Bendszus M, 2002, AM J NEURORADIOL, V23, P1427
   BENDSZUS M, 2003, AM J NEURORADIOL, V24, P1273
   Chang CJ, 2006, BIOMATERIALS, V27, P1035, DOI 10.1016/j.biomaterials.2005.07.003
   Chang JY, 2007, MACROMOL BIOSCI, V7, P500, DOI 10.1002/mabi.200600257
   Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248
   CORNBROOKS CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3850, DOI 10.1073/pnas.80.12.3850
   Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002
   Faweett J, 1990, ANNU REV NEUROSCI, V13, P43
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   Guertin AD, 2005, J NEUROSCI, V25, P3478, DOI 10.1523/JNEUROSCI.3766-04.2005
   HARE GMT, 1992, PLAST RECONSTR SURG, V89, P251, DOI 10.1097/00006534-199202000-00009
   Hsu SH, 2009, TISSUE ENG PT A, V15, P1381, DOI 10.1089/ten.tea.2008.0175
   Ichihara S, 2009, TISSUE ENG PART C-ME, V15, P387, DOI 10.1089/ten.tec.2008.0508
   Ignatiadis IA, 2007, ACTA NEUROCHIR SUPPL, V100, P73
   Ignatiadis IA, 2007, MICROSURG, V27, P98, DOI 10.1002/micr.20313
   Kobayashi J, 1997, MUSCLE NERVE, V20, P858, DOI 10.1002/(SICI)1097-4598(199707)20:7<858::AID-MUS10>3.0.CO;2-O
   Li XC, 2008, CAN ASSOC RADIOL J, V59, P123
   MACKINNON S E, 1990, Journal of Reconstructive Microsurgery, V6, P117, DOI 10.1055/s-2007-1006810
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Oh SH, 2008, BIOMATERIALS, V29, P1601, DOI 10.1016/j.biomaterials.2007.11.036
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SIPRASKY GL, 2001, ACS SYM SER, V764, P230
   STROMAN FW, 1999, MAGN RESON MED, V42, P210
   Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0
   TSCHAKALO TA, 1994, INT J ORAL MAXILLOF, V23, P443
   Valentine HL, 2007, NEUROTOXICOLOGY, V28, P645, DOI 10.1016/j.neuro.2007.01.009
   Vargas ME, 2007, ANNU REV NEUROSCI, V30, P153, DOI 10.1146/annurev.neuro.30.051606.094354
   Veraa S, 2010, CAN VET J, V51, P519
   Wang XD, 2005, BRAIN, V128, P1897, DOI 10.1093/brain/awh517
   YOUNG YC, 2002, BR J PLAST SURG, V55, P235
NR 32
TC 41
Z9 42
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2011
VL 32
IS 15
BP 3764
EP 3775
DI 10.1016/j.biomaterials.2011.01.065
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 751IK
UT WOS:000289610500008
PM 21396706
DA 2018-10-20
ER

PT J
AU Heng, BC
   Bezerra, PP
   Preiser, PR
   Law, SKA
   Xia, Y
   Boey, F
   Venkatraman, SS
AF Heng, Boon Chin
   Bezerra, Paula Porto
   Preiser, Peter Rainer
   Law, S. K. Alex
   Xia, Yun
   Boey, Freddy
   Venkatraman, Subbu S.
TI Effect of cell-seeding density on the proliferation and gene expression
   profile of human umbilical vein endothelial cells within ex vivo culture
SO CYTOTHERAPY
LA English
DT Article
DE endothelial; gelatin; gene expression; poly-L-lactic acid; polystyrene;
   seeding density
ID VON-WILLEBRAND-FACTOR; BLOOD-VESSEL FORMATION; ADHESION; GROWTH;
   SURFACES; IMMOBILIZATION; POLYMERS; MOLECULE; BIOLOGY; LINES
AB Background aims. Characterization of endothelial cell-biomaterial interaction is crucial for the development of blood-contacting biomedical devices and implants. However, a crucial parameter that has largely been overlooked is the cell-seeding density. Methods. This study investigated how varying cell-seeding density influences human umbilical vein endothelial cell (HUVEC) proliferation on three different substrata: gelatin, tissue culture polystyrene (TCPS) and poly-L-lactic acid (PLLA). Results. The fastest proliferation was seen on gelatin, followed by TCPS and PLLA, regardless of seeding density. On both TCPS and gelatin, maximal proliferation was attained at an initial seeding density of 1000 cells/cm(2). At seeding densities above and below 1000 cells/cm(2), the proliferation rate decreased sharply. On PLLA, there was a decrease in cell numbers over 7 days of culture, below a certain threshold seeding density (c. 2500-3000 cells/cm(2)), which meant that some of the cells were dying off rather than proliferating. Above this threshold seeding density, HUVEC displayed slow proliferation. Subsequently, quantitative real-time polymerase chain reaction (RT-qPCR) analysis of eight gene markers associated with adhesion and endothelial functionality (VEGF-A, integrin-alpha 5, VWF, ICAM1, ICAM2, VE-cadherin, endoglin and PECAM1) was carried out on HUVEC seeded at varying densities on the three substrata. A significant downregulation of gene expression was observed at an ultralow cell-seeding density of 100 cells/cm(2). This was accompanied by an extremely slow proliferation rate, probably because of an acute lack of intercellular contacts and paracrine signaling. Conclusion. Hence, this study demonstrates that seeding density has a profound effect on the proliferation and gene expression profile of endothelial cells seeded on different biomaterial surfaces.
C1 [Heng, Boon Chin] Nanyang Technol Univ, Div Mat Sci, Sch Mat Sci & Engn, Singapore 639798, Singapore.
   [Preiser, Peter Rainer; Law, S. K. Alex] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.
RP Heng, BC (reprint author), Nanyang Technol Univ, Div Mat Sci, Sch Mat Sci & Engn, Nanyang Ave, Singapore 639798, Singapore.
EM Alexishengbc@ntu.edu.sg
RI Heng, Boon Chin/E-5462-2016; Boey, Freddy Yin Chiang/G-2618-2017;
   Venkatraman, Subramanian/A-2228-2011; Preiser, Peter/A-2201-2011; Law,
   Alex/A-2212-2011
OI Heng, Boon Chin/0000-0003-2541-3699; Venkatraman,
   Subramanian/0000-0002-8693-1070; , Peter/0000-0003-4331-7000
CR Anamelechi CC, 2009, LANGMUIR, V25, P5725, DOI 10.1021/la803963r
   Bordenave L, 1999, ENDOTHELIUM-J ENDOTH, V6, P267, DOI 10.3109/10623329909078494
   BRUCK SD, 1977, J BIOMED MATER RES, V11, P1, DOI 10.1002/jbm.820110103
   Choi WS, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044104
   Chu CFL, 1999, BBA-GEN SUBJECTS, V1472, P479, DOI 10.1016/S0304-4165(99)00151-8
   Consigny PM, 2000, J LONG-TERM EFF MED, V10, P79
   Crampton S. P., 2007, JOVE-J VIS EXP, V183, DOI [10.3791/183, DOI 10.3791/183]
   de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898
   De Meyer Simon F., 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P9
   Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5
   Denis CV, 2002, INT J HEMATOL, V75, P3, DOI 10.1007/BF02981972
   Fonsatti E, 2003, CURR CANCER DRUG TAR, V3, P427, DOI 10.2174/1568009033481741
   Franchini M, 2008, SEMIN THROMB HEMOST, V34, P663, DOI 10.1055/s-0028-1104545
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Inamori M, 2009, TISSUE ENG PT A, V15, P2029, DOI 10.1089/ten.tea.2008.0403
   Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9
   Jung KH, 2009, NUCL MED BIOL, V36, P967, DOI 10.1016/j.nucmedbio.2009.06.010
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   KIM K, 2009, BIOMACROMOLECULES
   Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009
   Lidington EA, 1999, TRANSPL IMMUNOL, V7, P239, DOI 10.1016/S0966-3274(99)80008-2
   Liu Z, 2009, J CELL SCI, V122, P3294, DOI 10.1242/jcs.048942
   Ma ZW, 2002, J BIOMED MATER RES, V63, P838, DOI 10.1002/jbm.10470
   Melero I, 2002, CANCER RES, V62, P3167
   Merx MW, 2005, BASIC RES CARDIOL, V100, P208, DOI 10.1007/s00395-005-0516-9
   Nakagawa M, 2006, J BIOMED MATER RES A, V77A, P112, DOI 10.1002/jbm.a.30521
   Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0
   Palm MD, 2009, J DRUGS DERMATOL, V8, pS15
   Patel S, 2007, J BIOMED MATER RES A, V83A, P423, DOI 10.1002/jbm.a.31320
   Simamora Pahala, 2006, J Drugs Dermatol, V5, P436
   SMEETS EF, 1992, BIOTECH HISTOCHEM, V67, P241, DOI 10.3109/10520299209110072
   Striker G E, 1980, Methods Cell Biol, V21A, P135, DOI 10.1016/S0091-679X(08)60763-3
   Takami Y, 1998, ARTIF ORGANS, V22, P753, DOI 10.1046/j.1525-1594.1998.6184R.x
   Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434
   van de Stolpe Avan der Saag PT, 1996, J MOL MED, V74, P13, DOI DOI 10.1007/BF00202069
   Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014
   Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456
   Yla-Herttuala S, 2009, BIOCHEM SOC T, V37, P1198, DOI 10.1042/BST0371198
   Zhu YB, 2004, TISSUE ENG, V10, P53, DOI 10.1089/107632704322791691
NR 39
TC 9
Z9 11
U1 1
U2 20
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1465-3249
J9 CYTOTHERAPY
JI Cytotherapy
PD MAY
PY 2011
VL 13
IS 5
BP 606
EP 617
DI 10.3109/14653249.2010.542455
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Hematology; Medicine, Research & Experimental
SC Cell Biology; Biotechnology & Applied Microbiology; Hematology; Research
   & Experimental Medicine
GA 750PG
UT WOS:000289559900012
PM 21171823
DA 2018-10-20
ER

PT J
AU Boennelycke, M
   Christensen, L
   Nielsen, LF
   Everland, H
   Lose, G
AF Boennelycke, Marie
   Christensen, Lise
   Nielsen, Lene Feldskov
   Everland, Hanne
   Lose, Gunnar
TI Tissue response to a new type of biomaterial implanted subcutaneously in
   rats (vol 22, pg 191, 2011)
SO INTERNATIONAL UROGYNECOLOGY JOURNAL
LA English
DT Correction
C1 [Boennelycke, Marie; Lose, Gunnar] Copenhagen Univ Hosp Herlev, Dept Obstet & Gynecol, DK-2730 Herlev, Denmark.
   [Christensen, Lise] Copenhagen Univ Hosp Bispebjerg, Dept Pathol, Copenhagen, Denmark.
   [Nielsen, Lene Feldskov; Everland, Hanne] Coloplast AS, Humlebaek, Denmark.
RP Boennelycke, M (reprint author), Copenhagen Univ Hosp Herlev, Dept Obstet & Gynecol, Herlev Ringvej 75, DK-2730 Herlev, Denmark.
EM boennelycke@dadlnet.dk
CR Boennelycke M, 2011, INT UROGYNECOL J, V22, P191, DOI 10.1007/s00192-010-1257-3
NR 1
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-3462
EI 1433-3023
J9 INT UROGYNECOL J
JI Int. Urogynecol. J.
PD MAY
PY 2011
VL 22
IS 5
BP 633
EP 633
DI 10.1007/s00192-011-1371-x
PG 1
WC Obstetrics & Gynecology; Urology & Nephrology
SC Obstetrics & Gynecology; Urology & Nephrology
GA 747AO
UT WOS:000289292700019
OA Bronze
DA 2018-10-20
ER

PT J
AU Townsend, KL
   Race, A
   Keane, M
   Miller, W
   Dishaw, L
   Fisher, ER
   Russell, DS
   Allen, MJ
AF Townsend, Katy L.
   Race, Amos
   Keane, Michael
   Miller, William
   Dishaw, Laura
   Fisher, Erica R.
   Russell, Duncan S.
   Allen, Matthew J.
TI A Novel Hydrogel-Coated Polyester Mesh Prevents Postsurgical Adhesions
   in a Rat Model
SO JOURNAL OF SURGICAL RESEARCH
LA English
DT Article
DE adhesions; animal model; histology; biomaterial; mesh
ID VENTRAL HERNIA REPAIR; INTRAABDOMINAL ADHESIONS; INTRAPERITONEAL
   ADHESIONS; POSTOPERATIVE ADHESIONS; PERITONEAL ADHESIONS; NUCLEUS
   PULPOSUS; TISSUE-RESPONSE; REPLACEMENT; COATINGS; ACID
AB Background. The specific aim of this study was to determine the whether a novel, hydrogel-coated polyester mesh (Scout) can be used to reduce the incidence and severity of adhesion formation in vivo.
   Methods. An established rat model of post-surgical adhesion formation was used in which adhesions are generated through surgical trauma to the surfaces of the cecum and the adjacent abdominal wall. Thirty-seven rats were randomly allocated either to a control group (no intervention; n = 14 rats) or to one of two treatment groups in which the abraded surfaces were separated with either the Scout material (n = 11 rats) or an FDA-approved form of expanded polytetrafluorethylene (PTFE) (PRECLUDE Vessel Guard; n = 12 rats). Animals were euthanized 7 d after surgery and gross necropsy examinations were performed. Mechanical testing was used to measure the strength of any adhesions that were identified, and histology was used to characterize within the adhesion tissue and on the surface(s) of the barrier materials.
   Results. Five animals were excluded because of surgical failure (1 control; 2 PRECLUDE Vessel Guard; 2 Scout). Adhesions were seenin 10 of 13 control animals (77%). There were no adhesions in any of the animals treated with either PRECLUDE Vessel Guard or Scout material. Histology demonstrated mild cellular adhesion to both the PRECLUDE Vessel Guard and the Scout material. Although there was a sub-acute to chronic inflammatory response to the surgical trauma, there was no evidence of delamination, shearing, or degradation of either the Scout material or PRECLUDE Vessel Guard.
   Conclusions. The hydrogel-coated Scout material was as effective as the approved predicate material in this model. Both materials were well tolerated. Further testing of the Scout material is now warranted. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Townsend, Katy L.; Allen, Matthew J.] Ohio State Univ, Dept Vet Clin Sci, Coll Vet Med, Columbus, OH 43210 USA.
   [Race, Amos; Dishaw, Laura; Fisher, Erica R.] Upstate Med Univ, Dept Orthoped Surg, Syracuse, NY USA.
   [Keane, Michael; Miller, William] Synthes Spine, W Chester, PA USA.
   [Russell, Duncan S.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.
RP Allen, MJ (reprint author), Ohio State Univ, Dept Vet Clin Sci, Coll Vet Med, 601 Vernon L Tharp St, Columbus, OH 43210 USA.
EM Matthew.Allen@cvm.osu.edu
OI Dishaw, Laura/0000-0003-1609-8922
FU Synthes Spine (West Chester, PA)
FX The authors acknowledge support for this work by a research grant from
   Synthes Spine (West Chester, PA).
CR Allen MJ, 2004, SPINE, V29, P515, DOI 10.1097/01.BRS.0000113871.67305.38
   Alpay Z, 2008, SEMIN REPROD MED, V26, P313, DOI 10.1055/s-0028-1082389
   ArRajab A, 1996, J SURG RES, V61, P143, DOI 10.1006/jsre.1996.0095
   Ates U, 2008, J OBSTET GYNAECOL RE, V34, P12, DOI 10.1111/j.1447-0756.2007.00684.x
   Avital S, 2005, DIS COLON RECTUM, V48, P153, DOI 10.1007/s10350-004-0748-z
   Bhatia DS, 1997, AM SURGEON, V63, P775
   Buckenmaier CC, 1999, AM SURGEON, V65, P274
   Burger JWA, 2006, SURG ENDOSC, V20, P1320, DOI 10.1007/s00464-005-0706-4
   Burns JW, 1996, FERTIL STERIL, V66, P814, DOI 10.1016/S0015-0282(16)58642-7
   Celebioglu B, 1999, ANESTH ANALG, V88, P939, DOI 10.1097/00000539-199904000-00048
   Ellis H, 1997, EUR J SURG S, V577, P5
   Emans P, 2009, ANN BIOMED ENG, V37, P410, DOI 10.1007/s10439-008-9608-7
   Gonzalez R, 2004, Hernia, V8, P213
   HARRIS ES, 1995, SURGERY, V117, P663, DOI 10.1016/S0039-6060(95)80010-7
   Hellebrekers BWJ, 2005, FERTIL STERIL, V83, P122, DOI 10.1016/j.fertnstert.2004.06.060
   Holmdahl L, 1997, Eur J Surg Suppl, P56
   Kaptanoglu L, 2008, EUR SURG RES, V41, P203, DOI 10.1159/000134919
   Klopp LS, 2009, SPINE J, V9, P411, DOI 10.1016/j.spinee.2009.01.001
   Liakakos T, 2001, DIGEST SURG, V18, P260, DOI 10.1159/000050149
   Lim R, 2009, J GASTROINTEST SURG, V13, P35, DOI 10.1007/s11605-008-0724-3
   Matthews BD, 2005, J SURG RES, V123, P227, DOI 10.1016/j.jss.2004.08.012
   MENZIES D, 1990, ANN ROY COLL SURG, V72, P60
   Pierce RA, 2009, SURG INNOV, V16, P46, DOI 10.1177/1553350608330479
   RAY NF, 1993, SURG GYNECOL OBSTET, V176, P271
   Risberg B, 1997, EUR J SURG S, V577, P32
   SCHNEIDER A, 2006, COLLAGEN DIG DIS SCI, V51, P56
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   SHUSHAN A, 1994, J REPROD MED, V39, P398
   Thomas J, 2003, J BIOMED MATER RES A, V67A, P1329, DOI 10.1002/jbm.a.10119
   Tran HS, 2000, J SURG RES, V88, P78, DOI 10.1006/jsre.1999.5714
   van Goor H, 2007, COLORECTAL DIS, V9, P25, DOI 10.1111/j.1463-1318.2007.01358.x
   van't Riet M, 2004, SURG ENDOSC, V18, P681, DOI 10.1007/s00464-003-9054-4
   Wallwiener M, 2006, FERTIL STERIL, V86, P1266, DOI 10.1016/j.fertnstert.2006.05.023
   Yelimlies B, 2003, Hernia, V7, P130, DOI 10.1007/s10029-003-0125-1
NR 34
TC 5
Z9 5
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0022-4804
EI 1095-8673
J9 J SURG RES
JI J. Surg. Res.
PD MAY
PY 2011
VL 167
IS 2
BP E117
EP E124
DI 10.1016/j.jss.2009.09.024
PG 8
WC Surgery
SC Surgery
GA 748RG
UT WOS:000289407800008
PM 20031154
DA 2018-10-20
ER

PT J
AU Ali, OA
   Doherty, E
   Bell, WJ
   Fradet, T
   Hudak, J
   Laliberte, MT
   Mooney, DJ
   Emerich, DF
AF Ali, Omar A.
   Doherty, Ed
   Bell, William J.
   Fradet, Tracie
   Hudak, Jebecka
   Laliberte, Marie-Therese
   Mooney, David J.
   Emerich, Dwaine F.
TI Biomaterial-Based Vaccine Induces Regression of Established Intracranial
   Glioma in Rats
SO PHARMACEUTICAL RESEARCH
LA English
DT Article
DE brain tumor; cancer vaccine; glioma; immunotherapy; PLG
ID CONTROLLED DELIVERY; IMMUNOTHERAPY; RESPONSES; ANTIGEN; SYSTEMS; GROWTH;
   CANCER; BRAIN; CELLS; TRIAL
AB The prognosis for glioma patients is poor, and development of new treatments is critical. Previously, we engineered polymer-based vaccines that control GM-CSF, CpG-oligonucleotide, and tumor-lysate presentation to regulate immune cell trafficking and activation, which promoted potent immune responses against peripheral tumors. Here, we extend the use of this system to glioma.
   Rats were challenged with an intracranial injection of glioma cells followed (1 week) by administration of the polymeric vaccine (containing GM-CSF, CpG, and tumor-lysate) in the tumor bed. Control rats were treated with blank matrices, matrices with GM-CSF and CpG, or intra-tumoral bolus injections of GM-CSF, CpG, and tumor lysate. Rats were monitored for survival and tested for neurological function.
   Survival studies confirmed a benefit of the polymeric vaccine as 90% of vaccinated rats survived for > 100 days. Control rats exhibited minimal benefit. Motor tests revealed that vaccination protected against the loss of forelimb use produced by glioma growth. Histological analysis quantitatively confirmed a robust and rapid reduction in tumor size. Long-term immunity was confirmed when 67% of survivors also survived a second glioma challenge.
   These studies extend previous reports regarding this approach to tumor therapy and justify further development for glioma treatment.
C1 [Ali, Omar A.; Doherty, Ed; Bell, William J.; Fradet, Tracie; Hudak, Jebecka; Laliberte, Marie-Therese; Mooney, David J.; Emerich, Dwaine F.] InCytu Inc, Lincoln, RI 02865 USA.
   [Ali, Omar A.; Doherty, Ed; Mooney, David J.] Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.
   [Ali, Omar A.; Mooney, David J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.
RP Emerich, DF (reprint author), InCytu Inc, 701 George Washington Highway, Lincoln, RI 02865 USA.
EM ED3FJM@aol.com
CR ALI OA, 2009, NAT MATER, V2, P151
   Ali OA, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000359
   Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833
   Banchereau J, 2007, NATURE, V49, P419
   BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   EMERICH DF, 2010, NEUROTOX RES, V1, P66
   Gilboa E, 2007, J CLIN INVEST, V117, P1195, DOI 10.1172/JCI31205
   Grauer OM, 2008, J IMMUNOL, V181, P6720, DOI 10.4049/jimmunol.181.10.6720
   Grauer OM, 2009, BRAIN PATHOL, V19, P674, DOI 10.1111/j.1750-3639.2009.00315.x
   Gu F, 2005, J CONTROL RELEASE, V102, P607, DOI 10.1016/j.jconrel.2004.10.020
   HOLGER K, 2007, NAT MED, V13, P552
   Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604
   INGRAM M, 1990, Neurological Research, V12, P265
   Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382
   Morrone FB, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-226
   Nair RE, 2006, J IMMUNOTHER, V29, P10, DOI 10.1097/01.cji.0000175489.19314.d2
   Neelapu SS, 2004, CLIN CANCER RES, V10, P8309, DOI 10.1158/1078-0432.CCR-04-1071
   Okada H, 2009, ANN NY ACAD SCI, V1174, P18, DOI 10.1111/j.1749-6632.2009.04932.x
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Yamanaka R, 2003, BRIT J CANCER, V89, P1172, DOI 10.1038/sj.bjc.6601268
   Yu JS, 2004, CANCER RES, V64, P4973, DOI 10.1158/0008-5472.CAN-03-3505
   Zaharoff DA, 2009, CANCER RES, V69, P6192, DOI 10.1158/0008-5472.CAN-09-1114
NR 23
TC 14
Z9 14
U1 1
U2 14
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0724-8741
EI 1573-904X
J9 PHARM RES-DORDR
JI Pharm. Res.
PD MAY
PY 2011
VL 28
IS 5
BP 1074
EP 1080
DI 10.1007/s11095-010-0361-x
PG 7
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 747EB
UT WOS:000289302000012
PM 21225320
DA 2018-10-20
ER

PT J
AU Lambert, F
   Leonard, A
   Drion, P
   Sourice, S
   Layrolle, P
   Rompen, E
AF Lambert, France
   Leonard, Angelique
   Drion, Pierre
   Sourice, Sophie
   Layrolle, Pierre
   Rompen, Eric
TI Influence of space-filling materials in subantral bone augmentation:
   blood clot vs. autogenous bone chips vs. bovine hydroxyapatite
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article
DE animal experiments; autogenous bone chips; biomaterials; bone
   regeneration; bone substitutes; bovine hydroxyapatite;
   re-pneumatization; sinus floor elevation; tissue physiology
ID SINUS FLOOR ELEVATION; X-RAY MICROTOMOGRAPHY; TISSUE-ENGINEERED BONE;
   MAXILLARY SINUS; IMAGE-ANALYSIS; HISTOMORPHOMETRIC EVALUATION;
   RADIOGRAPHIC EVALUATION; GRAFTING MATERIAL; DENTAL IMPLANTS; FOLLOW-UP
AB Aim
   The first objective of the present study was to compare the short- and long-term 3D volume stability of sub-sinusal bone regeneration in rabbits using different space fillers. The second objective was to assess qualitatively and quantitatively the early bone formation process and long-term behavior of the regenerated bone.
   Materials and methods
   Fifteen rabbits underwent a double sinus lift procedure using: blood clot (Clot), autogenous bone chips (Auto) and bovine hydroxyapatite (BHA). Animals were euthanized at 1 week, 5 weeks and 6 months. Samples were subjected to X-ray microtomography and histology. Variations in the volume of bone augmentations were calculated at different time points. Qualitative analysis was performed using 7 mu m sections and quantitative histomorphometric analyses were carried out using scanning electron microscopy.
   Results
   From baseline (100%) to 5 weeks, the augmented volumes declined to 17.3% (Clot), 57.6% (Auto) and 90.6% (BHA). After 6 months, only 19.4% (Clot) and 31.4% (Auto) of initial volumes were found, while it remained more stable in the BHA group (84%). At 1 week, an initial osteogenesis process could be observed in the three groups along the bone walls. At 5 weeks, despite a significant decline in the volume, newly formed bone density was higher with Clot and Auto than with BHA. At 6 months, bone densities were statistically similar in the three groups. However, after 6 months, the surface invaded by newly formed bone (regenerated area) was significantly higher when BHA was used as space filler. In the BHA group, the biomaterial area slightly decreased from 42.7% (1 week) to 40% (5 weeks) and 34.9% (6 months) and the density of the composite regenerated tissue (bone+BHA) reached > 50% at 6 months.
   Conclusions and clinical implications
   The three space fillers allowed bone formation to occur. Nevertheless, augmented volumes declined in the Clot and Auto groups, while they remained stable with BHA. A slowly resorbable biomaterial might be suitable in sub-sinusal bone augmentation for preventing the re-expansion process and for augmenting the density of the regenerated tissues.
   To cite this article:Lambert F, Leonard A, Drion P, Sourice S, Layrolle P, Rompen E. Influence of space-filling materials in subantral bone augmentation: blood clot vs. autogenous bone chips vs. bovine hydroxyapatite.Clin. Oral Impl. Res. 22, 2011; 538-545doi: 10.1111/j.1600-0501.2010.02069.x.
C1 [Lambert, France; Rompen, Eric] Univ Liege, Fac Med, Dept Periodontol & Oral Surg, B-4000 Liege, Belgium.
   [Leonard, Angelique] Univ Liege, Dept Appl Chem, B-4000 Liege, Belgium.
   [Drion, Pierre] Univ Liege, Cent Anim Facil, Giga R, B-4000 Liege, Belgium.
   [Sourice, Sophie] Univ Nantes, Lab Osteoarticular & Dent Tissue Engn, INSERM 791, F-44035 Nantes, France.
   [Layrolle, Pierre] Univ Nantes, Fac Med, INSERM, U957, F-44035 Nantes, France.
RP Lambert, F (reprint author), Serv Med Dent Domaine Sart Tilman, Bat B-35, B-4000 Liege, Belgium.
EM france.lambert@chu.ulg.ac.be
RI Layrolle, Pierre/K-9257-2015
OI Layrolle, Pierre/0000-0001-9800-5210
FU University of Liege, Belgium [C-08/77]; Geistlich (Switzerland)
FX This study was supported by the University of Liege, Belgium (Classical
   funds: C-08/77), and by Geistlich (Switzerland). The authors wish to
   express their gratitude to Paul Pilet for his assistance in
   histomorphometric analysis, to Laurent Fraikin for the X-ray
   microtomographic scanning, to Laurence Seidel for statistical analysis,
   to Luc Duwez for his outstanding involvement in animal care and to
   Tommie Van de Velde for his valuable advices. The surgical procedures
   could not have been properly conducted without the assistance of
   Geoffrey Lecloux, Vanessa Vanhoutte and Kim Vincent.
CR Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Asai S, 2002, CLIN ORAL IMPLAN RES, V13, P405, DOI 10.1034/j.1600-0501.2002.130409.x
   Blacher S, 2004, COLLOID SURFACE A, V241, P201, DOI 10.1016/j.colsurfa.2004.04.006
   Blacher S, 2002, STUD SURF SCI CATAL, V144, P331
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   CHANAVAZ M, 1990, Journal of Oral Implantology, V16, P199
   Commission on Life Sciences NRC, 1996, GUID CAR US LAB AN
   Cordaro L, 2010, INT J ORAL MAX SURG, V39, P350, DOI 10.1016/j.ijom.2010.02.016
   Gabbert O, 2009, J CLIN PERIODONTOL, V36, P177, DOI 10.1111/j.1600-051X.2008.01357.x
   GAREY D J, 1991, Journal of Oral Implantology, V17, P404
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Hatano N, 2004, CLIN ORAL IMPLAN RES, V15, P339, DOI 10.1111/j.1600-0501.2004.00996.x
   Leonard A, 2007, J MICROSC-OXFORD, V225, P258, DOI 10.1111/j.1365-2818.2007.01740.x
   Leonard A, 2005, J MICROSC-OXFORD, V218, P247, DOI 10.1111/j.1365-2818.2005.01485.x
   Leonard A, 2008, J POROUS MAT, V15, P397, DOI 10.1007/s10934-006-9094-y
   Leonard A, 2008, J FOOD ENG, V85, P154, DOI 10.1016/j.jfoodeng.2007.07.017
   Nedir R, 2006, CLIN ORAL IMPLAN RES, V17, P679, DOI 10.1111/j.1600-0501.2006.01264.x
   Nedir R, 2009, CLIN ORAL IMPLAN RES, V20, P701, DOI 10.1111/j.1600-0501.2008.01696.x
   Norton MR, 2003, CLIN ORAL IMPLAN RES, V14, P775, DOI 10.1046/j.0905-7161.2003.00952.x
   Ohya M, 2005, CLIN ORAL IMPLAN RES, V16, P622, DOI 10.1111/j.1600-0501.2005.01136.x
   Pjetursson BE, 2008, J CLIN PERIODONTOL, V35, P216, DOI 10.1111/j.1600-051X.2008.01272.x
   Sartori S, 2003, CLIN ORAL IMPLAN RES, V14, P369, DOI 10.1034/j.1600-0501.2003.140316.x
   Sbordone L, 2009, INT J ORAL MAX SURG, V38, P1059, DOI 10.1016/j.ijom.2009.06.024
   Scarano A, 2004, J PERIODONTOL, V75, P1161, DOI 10.1902/jop.2004.75.8.1161
   SCHARF KE, 1995, LARYNGOSCOPE, V105, P570, DOI 10.1288/00005537-199506000-00002
   Schlegel KA, 2006, CLIN ORAL IMPLAN RES, V17, P673, DOI 10.1111/j.1600-0501.2006.01186.x
   Sharan A, 2008, INT J ORAL MAX IMPL, V23, P48
   Sun XJ, 2008, CLIN ORAL IMPLAN RES, V19, P804, DOI 10.1111/j.1600-0501.2008.01577.x
   Tondi G, 2009, MICROSC MICROANAL, V15, P384, DOI 10.1017/S1431927609990444
   Traini T, 2007, J PERIODONTOL, V78, P955, DOI 10.1902/jop.2007.060308
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
   Zijderveld SA, 2009, CLIN ORAL IMPLAN RES, V20, P691, DOI [10.1111/j.1600-0501.2008.01697.x, 10.1111/j.1600-0501.2009.01697.x]
NR 35
TC 36
Z9 38
U1 2
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD MAY
PY 2011
VL 22
IS 5
BP 538
EP 545
DI 10.1111/j.1600-0501.2010.02069.x
PG 8
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 746NE
UT WOS:000289253200013
PM 21198906
DA 2018-10-20
ER

PT J
AU Capretto, L
   Carugo, D
   Cheng, W
   Hill, M
   Zhang, XL
AF Capretto, Lorenzo
   Carugo, Dario
   Cheng, Wei
   Hill, Martyn
   Zhang, Xunli
TI Continuous-flow production of polymeric micelles in microreactors:
   Experimental and computational analysis
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Polymeric micelles; Microfluidic reactors; Nanoprecipitation; Pluronic,
   CFD
ID MICROFLUIDIC SYNTHESIS; BLOCK-COPOLYMERS; NANOPARTICLES; SYSTEM; DRUG;
   DELIVERY; PLATFORM; ROUTES
AB We report the development of a microfluidic-based process for the production of polymeric micelles (PMs) in continuous-flow microreactors where Pluronie (R) tri-block copolymer is used as model polymeric biomaterial relating to drug delivery applications. A flow focusing configuration is used enabling a controllable, and fast mixing process to assist the formation of polymeric micelles through nanoprecipitation which is triggered by a solvent exchange process when organic solutions of the polymer mixed with a non-solvent. We experientially investigate the effect of polymer concentration, flow rate ratio and microreactor dimension on the PMs size characteristics. The mixing process within the microfluidic reactors is further analyzed by computational modeling in order to understand the hydrodynamic process and its implication for the polymeric micells formation process. The results obtained show that besides the effect of the flow rate ratio, the chemical environment in which the aggregation takes place plays an important role in determining the dimensional characteristics of the produced polymeric micelles. It is demonstrated that microfluidic reactors provide a useful platform for the continuous-flow production of polymeric micelles with improved controllability, reproducibility, and homogeneity of the size characteristics. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Capretto, Lorenzo; Carugo, Dario; Cheng, Wei; Zhang, Xunli] Univ Southampton, Sch Engn Sci, Bioengn Grp, Southampton SO17 1BJ, Hants, England.
RP Zhang, XL (reprint author), Univ Southampton, Sch Engn Sci, Bioengn Grp, Southampton SO17 1BJ, Hants, England.
EM XL.Zhang@soton.ac.uk
RI Hill, Martyn/B-4727-2008
OI Hill, Martyn/0000-0001-6448-9448
FU UK Engineering and Physical Sciences Research Council (EPSRC);
   Engineering and Physical Sciences Research Council [EP/G009732/1]
FX The authors would like to thank the UK Engineering and Physical Sciences
   Research Council (EPSRC) for supporting this study financially. BASF
   Chem Trade GmbH is thanked for providing polymer Plutonic (R) F127. Dr
   Maurits de Planque of School of Electronics and Computer Science,
   University of Southampton, is thanked for assistance in nanoparticle
   characterization.
CR Ali HSM, 2009, INT J PHARMACEUT, V375, P107, DOI 10.1016/j.ijpharm.2009.03.029
   BATES FS, 1990, ANNU REV PHYS CHEM, V41, P525, DOI 10.1146/annurev.pc.41.100190.002521
   Chastek TQ, 2008, LAB CHIP, V8, P950, DOI 10.1039/b718235j
   Cottam BF, 2007, LAB CHIP, V7, P167, DOI 10.1039/b616068a
   Cui HG, 2007, SCIENCE, V317, P647, DOI 10.1126/science.1141768
   Dreher S, 2008, PROCEEDINGS OF THE 6TH INTERNATIONAL CONFERENCE ON NANOCHANNELS, MICROCHANNELS, AND MINICHANNELS, PTS A AND B, P1923
   Edel JB, 2002, CHEM COMMUN, P1136, DOI 10.1039/b202998g
   Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566
   Fletcher PDI, 2002, LAB CHIP, V2, P102, DOI 10.1039/b201685k
   Gaucher G, 2010, EUR J PHARM BIOPHARM, V76, P147, DOI 10.1016/j.ejpb.2010.06.007
   Hardt S, 2003, AICHE J, V49, P578, DOI 10.1002/aic.690490305
   Hou HH, 2009, ELECTROPHORESIS, V30, P2507, DOI 10.1002/elps.200900012
   Jahn A, 2010, ACS NANO, V4, P2077, DOI 10.1021/nn901676x
   Jasch K, 2009, CHEM ENG TECHNOL, V32, P1806, DOI 10.1002/ceat.200900318
   Johnson BK, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.118302
   Johnson BK, 2003, AUST J CHEM, V56, P1021, DOI 10.1071/CH03115
   Karnik R, 2008, NANO LETT, V8, P2906, DOI 10.1021/nl801736q
   Khan SA, 2004, LANGMUIR, V20, P8604, DOI 10.1021/la0499012
   Krishnadasan S, 2007, LAB CHIP, V7, P1434, DOI 10.1039/b711412e
   Kwon GS, 2003, CRIT REV THER DRUG, V20, P357, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i5.20
   Lee GB, 2006, J MICROMECH MICROENG, V16, P1024, DOI 10.1088/0960-1317/16/5/020
   Luk VN, 2008, LANGMUIR, V24, P6382, DOI 10.1021/la7039509
   Nishiyama N, 2006, PHARMACOL THERAPEUT, V112, P630, DOI 10.1016/j.pharmthera.2006.05.006
   Peng XG, 2000, NATURE, V404, P59
   Rapoport N, 2007, PROG POLYM SCI, V32, P962, DOI 10.1016/j.progpolymsci.2007.05.009
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Shestopalov I, 2004, LAB CHIP, V4, P316, DOI 10.1039/b403378g
   Shiraishi Y, 2010, LANGMUIR, V26, P17505, DOI 10.1021/la1028993
   Song H, 2003, ANGEW CHEM, V115, P792, DOI DOI 10.1002/ANGE.200390172
   Song YJ, 2008, SMALL, V4, P698, DOI 10.1002/smll.200701029
   Song YJ, 2006, CHEM MATER, V18, P2817, DOI 10.1021/cm052811d
   SOURIART T, 2007, LAB CHIP, V7, P908
   Tsai CH, 2008, MICROFLUID NANOFLUID, V5, P827, DOI 10.1007/s10404-008-0284-6
   Tyrrell ZL, 2010, PROG POLYM SCI, V35, P1128, DOI 10.1016/j.progpolymsci.2010.06.003
   Wagner J, 2005, NANO LETT, V5, P685, DOI 10.1021/nl050097t
   Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006/1211
   Yokoyama M, 2010, EXPERT OPIN DRUG DEL, V7, P145, DOI 10.1517/17425240903436479
   Zhang LF, 1999, MACROMOLECULES, V32, P2239, DOI 10.1021/ma981039f
   Zhang SH, 2008, CHEM ENG SCI, V63, P5600, DOI 10.1016/j.ces.2008.08.005
   Zhang X, 2008, CHEM ENG J, V135, pS82, DOI 10.1016/j.cej.2007.07.054
NR 40
TC 20
Z9 21
U1 3
U2 54
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD MAY 1
PY 2011
VL 357
IS 1
BP 243
EP 251
DI 10.1016/j.jcis.2011.01.085
PG 9
WC Chemistry, Physical
SC Chemistry
GA 740EC
UT WOS:000288773400035
PM 21353232
DA 2018-10-20
ER

PT J
AU Hong, Y
   Huber, A
   Takanari, K
   Amoroso, NJ
   Hashizume, R
   Badylak, SF
   Wagner, WR
AF Hong, Yi
   Huber, Alexander
   Takanari, Keisuke
   Amoroso, Nicholas J.
   Hashizume, Ryotaro
   Badylak, Stephen F.
   Wagner, William R.
TI Mechanical properties and in vivo behavior of a biodegradable synthetic
   polymer microfiber-extracellular matrix hydrogel biohybrid scaffold
SO BIOMATERIALS
LA English
DT Article
DE Electrospinning; Electrospray; Polyurethane; Extracellular matrix;
   Hydrogel
ID SMALL-INTESTINAL SUBMUCOSA; URINARY-BLADDER MATRIX; MACROPHAGE
   PHENOTYPE; ELECTROSPUN; INFILTRATION; DEGRADATION; CONSTRUCTS;
   ELASTOMER; PRODUCTS; REPAIR
AB A biohybrid composite consisting of extracellular matrix (ECM) gel from porcine dermal tissue and biodegradable elastomeric fibers was generated and evaluated for soft tissue applications. ECM gel possesses attractive biocompatibility and bioactivity with weak mechanical properties and rapid degradation, while electrospun biodegradable poly(ester urethane)urea (PEUU) has good mechanical properties but limited cellular infiltration and tissue integration. A concurrent gel electrospray/polymer electrospinning method was employed to create ECM gel/PEUU fiber composites with attractive mechanical properties, including high flexibility and strength. Electron microscopy revealed a structure of interconnected fibrous layers embedded in ECM gel. Tensile mechanical properties could be tuned by altering the PEUU/ECM weight ratio. Scaffold tensile strengths for PEUU/ECM ratios of 67/33, 72/28 and 80/20 ranged from 80 to 187 kPa in the longitudinal axis (parallel to the collecting mandrel axis) and 41-91 kPa in the circumferential axis with 645-938% breaking strains. The 72/28 biohybrid composite and a control scaffold generated from electrospun PEUU alone were implanted into Lewis rats, replacing a full-thickness abdominal wall defect. At 4 wk, no infection or herniation was found at the implant site. Histological staining showed extensive cellular infiltration into the biohybrid scaffold with the newly developed tissue well integrated with the native periphery, while minimal cellular ingress into the electrospun PEUU scaffold was observed. Mechanical testing of explanted constructs showed evidence of substantial remodeling, with composite scaffolds adopting properties more comparable to the native abdominal wall. The described elastic biohybrid material imparts features of ECM gel bioactivity with PEUU strength and handling to provide a promising composite biomaterial for soft tissue repair and replacement. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Hong, Yi; Huber, Alexander; Takanari, Keisuke; Amoroso, Nicholas J.; Hashizume, Ryotaro; Badylak, Stephen F.; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Hong, Yi; Huber, Alexander; Takanari, Keisuke; Hashizume, Ryotaro; Badylak, Stephen F.; Wagner, William R.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA.
   [Amoroso, Nicholas J.; Badylak, Stephen F.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.
   [Wagner, William R.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15219 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
RI Amoroso, Nicholas/G-8093-2011; TAKANARI, Keisuke/E-4431-2015
OI Amoroso, Nicholas/0000-0003-4659-5604; Badylak,
   Stephen/0000-0003-3555-0689
FU Armed Forces Institute for Regenerative Medicine (AFIRM)
   [W81XWH-08-2-0032]; NIH [R01 HL-068816]
FX This work was supported in part by the Armed Forces Institute for
   Regenerative Medicine (AFIRM, #W81XWH-08-2-0032) and NIH R01 HL-068816.
   We also thank Prof. Michael S. Sacks for use of the biaxial mechanical
   testing device and Deanna Rhoads for histological sectioning.
CR Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013
   Brennan EP, 2008, J TISSUE ENG REGEN M, V2, P491, DOI 10.1002/term.123
   Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040
   Cornwell Kevin G, 2009, Clin Podiatr Med Surg, V26, P507, DOI 10.1016/j.cpm.2009.08.001
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Freytes DO, 2008, BIOMATERIALS, V29, P1630, DOI 10.1016/j.biomaterials.2007.12.014
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051
   He W, 2010, BIOMATERIALS, V31, P8235, DOI 10.1016/j.biomaterials.2010.07.034
   Hong Y, 2008, BIOMACROMOLECULES, V9, P1200, DOI 10.1021/bm701201w
   Hong Y, 2009, BIOMATERIALS, V30, P2457, DOI 10.1016/j.biomaterials.2009.01.013
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Lai PH, 2005, J SURG RES, V127, P85, DOI 10.1016/j.jss.2005.03.016
   Leong MF, 2009, J BIOMED MATER RES A, V91A, P231, DOI 10.1002/jbm.a.32208
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Nam J, 2007, TISSUE ENG, V13, P2249, DOI 10.1089/ten.2006.0306
   Okada M, 2010, BIOMATERIALS, V31, P7678, DOI 10.1016/j.biomaterials.2010.06.056
   Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]
   Stankus JJ, 2008, J BIOMAT SCI-POLYM E, V19, P635, DOI 10.1163/156856208784089599
   Stankus JJ, 2007, BIOMATERIALS, V28, P2738, DOI 10.1016/j.biomaterials.2007.02.012
   Tottey S, 2011, TISSUE ENG PT A, V17, P37, DOI [10.1089/ten.tea.2010.0188, 10.1089/ten.TEA.2010.0188]
   Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419
   Vorotnikova E, 2010, MATRIX BIOL, V29, P690, DOI 10.1016/j.matbio.2010.08.007
   Yoon H, 2010, J BIOMAT SCI-POLYM E, V21, P553, DOI 10.1163/156856209X429166
   Zeugolis DI, 2008, BIOMATERIALS, V29, P2293, DOI 10.1016/j.biomaterials.2008.02.009
NR 28
TC 86
Z9 88
U1 7
U2 119
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2011
VL 32
IS 13
BP 3387
EP 3394
DI 10.1016/j.biomaterials.2011.01.025
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 741SM
UT WOS:000288884800005
PM 21303718
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Liu, BR
   Huang, YW
   Winiarz, JG
   Chiang, HJ
   Lee, HJ
AF Liu, Betty R.
   Huang, Yue-wern
   Winiarz, Jeffrey G.
   Chiang, Huey-Jenn
   Lee, Han-Jung
TI Intracellular delivery of quantum dots mediated by a histidine- and
   arginine-rich HR9 cell-penetrating peptide through the direct membrane
   translocation mechanism
SO BIOMATERIALS
LA English
DT Article
DE Cell-penetrating peptides (CPPs); Cellular internalization; Protein
   transduction domains (PTDs); Quantum dots (QDs); Semiconductor
ID NONCOVALENT PROTEIN TRANSDUCTION; TAT-FUSION PROTEINS; LIVING CELLS;
   PLANT-CELLS; PLASMA-MEMBRANE; PORE FORMATION; STEM-CELLS; ENDOCYTOSIS;
   MACROPINOCYTOSIS; INTERNALIZATION
AB Functional peptides that transfer biomaterials, such as semiconductor quantum dots (QDs), into cells in biomaterial research have been developed in recent years. Delivery of QDs conjugated with cell-penetrating peptides (CPPs) into cells by the endocytic pathway was problematic in biomedical applications because of lysosomal trapping. Here, we demonstrate that histidine- and arginine-rich CPPs (HR9 peptides) stably and noncovalently combined with QDs are able to enter into cells in an extremely short period (4 min). Interrupting both F-actin polymerization and active transport did not inhibit the entry of HR9/QD complexes into cells, indicating that HR9 penetrates cell membrane directly. Subcellular colocalization studies indicated that QDs delivered by HR9 stay in cytosol without any organelle capture. Dimethyl sulphoxide, ethanol and oleic acid, but not pyrenebutyrate, enhanced HR9-mediated intracellular delivery of QDs by promoting the direct membrane translocation pathway. HR9 and HR9/QDs were not cytotoxic. These findings suggest that HR9 could be an efficient carrier to deliver drugs without interfering with their therapeutic activity. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Liu, Betty R.; Lee, Han-Jung] Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, Shoufeng 97401, Hualien, Taiwan.
   [Liu, Betty R.; Chiang, Huey-Jenn] Natl Dong Hwa Univ, Grad Inst Biotechnol, Shoufeng 97401, Hualien, Taiwan.
   [Huang, Yue-wern] Missouri Univ Sci & Technol, Dept Biol Sci, Rolla, MO 65409 USA.
   [Winiarz, Jeffrey G.] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA.
RP Lee, HJ (reprint author), Natl Dong Hwa Univ, Dept Nat Resources & Environm Studies, 1,Sec 2,Da Hsueh Rd, Shoufeng 97401, Hualien, Taiwan.
EM huangy@mst.edu; hjlee@mail.ndhu.edu.tw
FU National Institutes of Health [R15EB009530]; National Science Council of
   Taiwan [NSC 97-2621-B-259-003-MY3]
FX We are grateful to Dr. Robert S. Aronstam for technical editing. This
   work was supported by Award Number R15EB009530 from the National
   Institutes of Health (to Y.-W. H.) and the National Science Council (NSC
   97-2621-B-259-003-MY3) of Taiwan (to H.-J. L).
CR ARMSTRONG KM, 1993, P NATL ACAD SCI USA, V90, P11337, DOI 10.1073/pnas.90.23.11337
   Bharali DJ, 2005, J AM CHEM SOC, V127, P11364, DOI 10.1021/ja051455x
   Bhatia KS, 1999, INT J PHARMACEUT, V180, P235, DOI 10.1016/S0378-5173(99)00013-7
   Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x
   Chen B, 2008, LANGMUIR, V24, P11866, DOI 10.1021/la802048s
   Chen CP, 2007, FEBS LETT, V581, P1891, DOI 10.1016/j.febslet.2007.03.076
   Chen FQ, 2004, NANO LETT, V4, P1827, DOI 10.1021/nl049170q
   Delehanty JB, 2009, ANAL BIOANAL CHEM, V393, P1091, DOI 10.1007/s00216-008-2410-4
   Eiriksdottir E, 2010, BIOCONJUGATE CHEM, V21, P1662, DOI 10.1021/bc100174y
   Eiriksdottir E, 2010, BBA-BIOMEMBRANES, V1798, P1119, DOI 10.1016/j.bbamem.2010.03.005
   El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2
   FERVARI A, 2003, MOL THER, V8, P284
   Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200
   FRIEND DR, 1990, CRIT REV THER DRUG, V7, P149
   Goda T, 2010, BIOMATERIALS, V31, P2380, DOI 10.1016/j.biomaterials.2009.11.095
   GOODMAN M, 1988, J INVEST DERMATOL, V91, P323, DOI 10.1111/1523-1747.ep12475655
   Gurtovenko AA, 2007, J PHYS CHEM B, V111, P10453, DOI 10.1021/jp073113e
   Herce HD, 2009, BIOPHYS J, V97, P1917, DOI 10.1016/j.bpj.2009.05.066
   Holzer AK, 2006, CANCER RES, V66, P10944, DOI 10.1158/0008-5472.CAN-06-1710
   Hu JW, 2009, PEPTIDES, V30, P1669, DOI 10.1016/j.peptides.2009.06.006
   Jablonski AE, 2010, J PHYS CHEM LETT, V1, P1312, DOI 10.1021/jz100248c
   Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309
   Jo JI, 2008, EUR J PHARM BIOPHARM, V68, P90, DOI 10.1016/j.ejpb.2007.04.021
   Jones NL, 1999, ANAT REC, V255, P57
   Katayama S, 2011, J CONTROL RELEASE, V149, P29, DOI 10.1016/j.jconrel.2010.02.004
   Kawamura KS, 2006, BIOCHEMISTRY-US, V45, P1116, DOI 10.1021/bi051338e
   Koshman YE, 2008, J MOL CELL CARDIOL, V45, P853, DOI 10.1016/j.yjmcc.2008.08.006
   Lazaro-Dieguez F, 2008, AUTOPHAGY, V4, P717, DOI 10.4161/auto.6345
   Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685
   Li SH, 2010, J PHYS CHEM B, V114, P4063, DOI 10.1021/jp912283r
   Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P7897, DOI 10.1166/jnn.2010.3012
   Liu BR, 2010, J NANOSCI NANOTECHNO, V10, P6534, DOI 10.1166/jnn.2010.2637
   Liu BR, 2008, J MEMBRANE BIOL, V222, P1, DOI 10.1007/s00232-008-9096-6
   Liu K, 2007, J PLANT GROWTH REGUL, V26, P278, DOI 10.1007/s00344-007-9015-6
   Lo SL, 2008, BIOMATERIALS, V29, P2408, DOI 10.1016/j.biomaterials.2008.01.031
   Lu SW, 2010, J AGR FOOD CHEM, V58, P2288, DOI 10.1021/jf903039j
   Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546
   MAK VHW, 1990, PHARMACEUT RES, V7, P835, DOI 10.1023/A:1015960815578
   Malliri A, 1998, J CELL BIOL, V143, P1087, DOI 10.1083/jcb.143.4.1087
   Manabe E, 1996, INT J PHARM, V129, P211, DOI 10.1016/0378-5173(95)04328-4
   Mastrangelo AM, 1998, J IMMUNOL, V161, P4268
   Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274
   Midoux P, 1999, BIOCONJUGATE CHEM, V10, P406, DOI 10.1021/bc9801070
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   Mukherjee S, 1997, PHYSIOL REV, V77, P759
   Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010
   ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121
   Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k
   Shurety W, 1996, J CELL SCI, V109, P2927
   Smythe E, 2006, J CELL SCI, V119, P4589, DOI 10.1242/jcs.03247
   Stewart KM, 2008, ORG BIOMOL CHEM, V6, P2242, DOI 10.1039/b719950c
   SUDHAKARAN PR, 1982, J BIOSCIENCE, V4, P413, DOI 10.1007/BF02704633
   Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019
   Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m
   Tang M, 2007, J AM CHEM SOC, V129, P11438, DOI 10.1021/ja072511s
   Tuunnemann G, 2008, J PEPT SCI, V14, P469, DOI 10.1002/psc.968
   Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com
   Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996
   Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7
   Wagstaff KM, 2006, CURR MED CHEM, V13, P1371, DOI 10.2174/092986706776872871
   Wang YH, 2007, J BIOCHEM BIOPH METH, V70, P579, DOI 10.1016/j.jbbm.2007.01.010
   Wei YF, 2009, BIOCONJUGATE CHEM, V20, P1752, DOI 10.1021/bc8003777
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Wiesman Z, 2007, J BIOTECHNOL, V130, P85, DOI 10.1016/j.jbiotec.2007.01.040
   Wright LR, 2003, CURR PROTEIN PEPT SC, V4, P105, DOI 10.2174/1389203033487252
   Xu Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/948543
   Xue FL, 2007, J FLUORESC, V17, P149, DOI 10.1007/s10895-006-0152-2
   Yang S, 2009, J CONTROL RELEASE, V135, P159, DOI 10.1016/j.jconrel.2008.12.015
   Yukawa H, 2010, BIOMATERIALS, V31, P4094, DOI 10.1016/j.biomaterials.2010.01.134
   Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005
   Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010
NR 71
TC 102
Z9 105
U1 7
U2 68
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2011
VL 32
IS 13
BP 3520
EP 3537
DI 10.1016/j.biomaterials.2011.01.041
PG 18
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 741SM
UT WOS:000288884800018
PM 21329975
DA 2018-10-20
ER

PT J
AU Hinds, S
   Bian, WN
   Dennis, RG
   Bursac, N
AF Hinds, Sara
   Bian, Weining
   Dennis, Robert G.
   Bursac, Nenad
TI The role of extracellular matrix composition in structure and function
   of bioengineered skeletal muscle
SO BIOMATERIALS
LA English
DT Article
DE Skeletal myoblasts; Myogenesis; Hydrogel; Contractile force
ID MUSCULAR-DYSTROPHY; TISSUE; INTEGRIN; DIFFERENTIATION; TRANSMISSION;
   FIBROBLASTS; EXPRESSION; LOCOMOTION; RECEPTOR; TENSION
AB One of the obstacles to the potential clinical utility of bioengineered skeletal muscle is its limited force generation capacity. Since engineered muscle, unlike most native muscle tissue, is composed of relatively short myofibers, we hypothesized that, its force production and transmission would be profoundly influenced by cell-matrix interactions. To test this hypothesis, we systematically varied the matrix protein type (collagen I/fibrin/Matrigel) and concentration in engineered, hydrogel-based neonatal rat skeletal muscle bundles and assessed the resulting tissue structure, generation of contractile force, and intracellular Ca2+ handling. After two weeks of culture, the muscle bundles consisted of highly aligned and cross-striated myofibers and exhibited standard force-length and force-frequency relationships achieving tetanus at 40 Hz. The use of 2 mg/ml fibrin (control) yielded isometric tetanus amplitude of 1.4 +/- 0.3 mN as compared to 0.9 +/- 0.4 mN measured in collagen I-based bundles. Higher fibrin and Matrigel concentrations synergistically yielded further increase in active force generation to 2.8 +/- 0.5 mN without significantly affecting passive mechanical properties, tetanus-to-twitch ratio, and twitch kinetics. Optimized matrix composition yielded significant cellular hypertrophy (protein/DNA ratio = 11.4 +/- 4.1 vs. 6.5 +/- 1.9 mu g/mu g in control) and a prolonged Ca2+ transient half-width (Cam = 232.8 +/- 33.3 vs. 101.7 +/- 19.8 ms). The use of growth-factor-reduced Matrigel, instead of standard Matrigel did not alter the obtained results suggesting enhanced cell-matrix interactions rather than growth factor supplementation as an underlying cause for the measured increase in contractile force. In summary, biomaterial-based manipulation of cell-matrix interactions represents an important target for improving contractile force generation in engineered skeletal muscle. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Hinds, Sara; Bian, Weining; Bursac, Nenad] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   [Dennis, Robert G.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27514 USA.
RP Bursac, N (reprint author), Duke Univ, Dept Biomed Engn, 3000 Sci Dr,Hudson Hall Room 136, Durham, NC 27708 USA.
EM nbursac@duke.edu
RI Bian, Weining/G-3146-2011
OI Bursac, Nenad/0000-0002-5688-6061
FU NIH, National Institute of Arthritis and Musculoskeletal and Skin
   Disease [AR055226]
FX We acknowledge Dr. George Truskey, Caroline Rhim and Cindy Cheng for
   their advice on the muscle bundle preparation protocol. This work was
   supported by NIH grant AR055226 from National Institute of Arthritis and
   Musculoskeletal and Skin Disease to N.B.
CR Alsberg E, 2001, CRIT REV ORAL BIOL M, V12, P64, DOI 10.1177/10454411010120010501
   Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Bian WN, 2008, IEEE ENG MED BIOL, V27, P109, DOI 10.1109/MEMB.2008.928460
   Bian WN, 2009, NAT PROTOC, V4, P1522, DOI 10.1038/nprot.2009.155
   Bian WN, 2009, BIOMATERIALS, V30, P1401, DOI 10.1016/j.biomaterials.2008.11.015
   Carson JA, 2000, J APPL PHYSIOL, V88, P337
   CLARK RAF, 1995, J CELL SCI, V108, P1251
   DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039
   Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047
   Frueh BR, 2001, J NEUROPHYSIOL, V85, P1027
   Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004
   KATAGIRI Y, 1995, J BIOL CHEM, V270, P1785, DOI 10.1074/jbc.270.4.1785
   Khodabukus A, 2009, TISSUE ENG PART C-ME, V15, P501, DOI [10.1089/ten.tec.2008.0286, 10.1089/ten.TEC.2008.0286]
   King AM, 2004, IEEE J OCEANIC ENG, V29, P684, DOI 10.1109/JOE.2004.833205
   KJAER, 2004, PHYSIOL REV, V84, P649
   KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427
   Kwon MS, 2000, MOL BIOL CELL, V11, P1433, DOI 10.1091/mbc.11.4.1433
   Lam MT, 2009, BIOMATERIALS, V30, P1150, DOI 10.1016/j.biomaterials.2008.11.014
   Liao H, 2009, TISSUE ENG PART B-RE, V15, P319, DOI 10.1089/ten.teb.2009.0092
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   Lorentz KM, 2011, BIOMATERIALS, V32, P430, DOI 10.1016/j.biomaterials.2010.08.109
   Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200
   Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318
   MENKO AS, 1987, CELL, V51, P51, DOI 10.1016/0092-8674(87)90009-2
   Monti RJ, 1999, J BIOMECH, V32, P371, DOI 10.1016/S0021-9290(98)00189-4
   Okano T, 1997, ASAIO J, V43, pM749
   Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110
   Osses N, 2002, AM J PHYSIOL-CELL PH, V282, pC383, DOI 10.1152/ajpcell.00322.2001
   Patel T J, 1997, Exerc Sport Sci Rev, V25, P321
   Paul AC, 2002, CELL TISSUE RES, V308, P255, DOI 10.1007/s00441-002-0526-y
   Powell Courtney, 2002, Methods Mol Med, V69, P219
   Rhim C, 2007, MUSCLE NERVE, V36, P71, DOI 10.1002/mus.20788
   Rhim C, 2010, TISSUE ENG PT A, V16, P3589, DOI 10.1089/ten.TEA.2009.0601
   Rooney JE, 2009, P NATL ACAD SCI USA, V106, P7991, DOI 10.1073/pnas.0811599106
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SIEGAL GP, 1993, CANCER LETT, V69, P123, DOI 10.1016/0304-3835(93)90164-5
   Stern MM, 2009, BIOMATERIALS, V30, P2393, DOI 10.1016/j.biomaterials.2008.12.069
   Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931
   Velleman SG, 1999, POULTRY SCI, V78, P778, DOI 10.1093/ps/78.5.778
   Vilquin J T, 2005, Acta Myol, V24, P119
   VUKICEVIC S, 1992, EXP CELL RES, V202, P1, DOI 10.1016/0014-4827(92)90397-Q
   Wilschut KJ, 2010, EXP CELL RES, V316, P341, DOI 10.1016/j.yexcr.2009.10.014
   Yamamoto Y, 2011, TISSUE ENG PT A, V17, P107, DOI [10.1089/ten.tea.2010.0312, 10.1089/ten.TEA.2010.0312]
   Yan W, 2007, TISSUE ENG, V13, P2781, DOI 10.1089/ten.2006.0408
   Yao CC, 1996, J CELL SCI, V109, P3139
   Young M, 2000, J MORPHOL, V245, P130, DOI 10.1002/1097-4687(200008)245:2<130::AID-JMOR4>3.0.CO;2-R
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
NR 47
TC 112
Z9 112
U1 1
U2 47
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2011
VL 32
IS 14
BP 3575
EP 3583
DI 10.1016/j.biomaterials.2011.01.062
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 743LU
UT WOS:000289020600004
PM 21324402
OA Green Accepted
DA 2018-10-20
ER

PT J
AU McBane, JE
   Battiston, KG
   Wadhwani, A
   Sharifpoor, S
   Labow, RS
   Santerre, JP
AF McBane, Joanne E.
   Battiston, Kyle G.
   Wadhwani, Aman
   Sharifpoor, Soroor
   Labow, Rosalind S.
   Santerre, J. Paul
TI The effect of degradable polymer surfaces on co-cultures of monocytes
   and smooth muscle cells
SO BIOMATERIALS
LA English
DT Article
DE Monocyte; Vascular smooth muscle cells; Surface chemistry; Polyurethane;
   Poly-lactic-glycolic acid
ID ENGINEERED VASCULAR GRAFTS; SELF-ASSEMBLED MONOLAYERS; IN-VITRO;
   POLY(LACTIC-CO-GLYCOLIC ACID); POLYURETHANE SCAFFOLDS;
   MECHANICAL-PROPERTIES; ENDOTHELIAL-CELLS; PROGENITOR CELLS; COLLAGEN;
   BIOMATERIALS
AB Strategies to optimize biomaterial chemistry for applications in vascular tissue engineering attempt to promote endothelial and smooth muscle cell recruitment into porous material constructs. The primary objective is to facilitate relevant tissue formation in a wound healing versus pro-inflammatory manner. The present work investigated the interactive co-cellular response of human monocytes and human vascular smooth muscle cells (VSMCs) with a novel degradable, polar/hydrophobic/ionic (D-PHI) polyurethane and compared it to a commercially available biomaterial, poly-lactic-glycolic acid (PLGA) as well as tissue culture polystyrene (TCPS). D-PHI triggered a smaller pro-inflammatory response (acid phosphatase, esterase, tumor necrosis factor-alpha) at later time points (>14 d) than PLGA suggesting that monocytes may be transitioning to a more wound-healing phenotype on the D-PHI surface. When D-PHI was coated with collagen, monocyte cell attachment did not differ with the native D-PHI; however, PLGA showed significant differences between collagen coated versus uncoated surfaces. There were more VSMCs and monocytes attached in co-culture to D-PHI when compared to PLGA. Co-cultures on D-PHI released more IL-10 (anti-inflammatory) than monocytes cultured alone, while the VSMCs retained the expression of its marker protein calponin. Together the above data suggest that co-culturing monocytes with VSMCs may aid in stimulating the attachment of VSMCs to D-PHI while eliciting the desired functional phenotypes for both monocytes (i.e. low inflammation based on IL-10 values) and VSMCs (expressing calponin, a marker of contractility). Moreover, the results of this study demonstrated that D-PHI performed equally or better to PLGA in terms of the assayed biological parameters. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [McBane, Joanne E.; Battiston, Kyle G.; Sharifpoor, Soroor; Santerre, J. Paul] Univ Toronto, Fac Dent, Toronto, ON M5G 1G6, Canada.
   [McBane, Joanne E.; Battiston, Kyle G.; Sharifpoor, Soroor; Santerre, J. Paul] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.
   [McBane, Joanne E.; Wadhwani, Aman; Labow, Rosalind S.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada.
   [Wadhwani, Aman; Labow, Rosalind S.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.
RP Santerre, JP (reprint author), Univ Toronto, Fac Dent, Room 460, Toronto, ON M5G 1G6, Canada.
EM paul.santerre@dentistry.utoronto.ca
FU NSERC/CIHR [337246/83459]; Canadian Heart & Stroke Foundation; NSERC;
   CIHR; Ontario graduate scholarship in science and technology (OGSST)
FX This study was funded by an NSERC/CIHR collaborative grant #337246/83459
   (J.P. Santerre, R.S. Labow). Thanks to Jian Wang and Nancy Valiquette
   for assistance with the SEM sample preparation. J.E. McBane was funded
   by a Canadian Heart & Stroke Foundation Focus on Stroke post-doctoral
   fellowship. A. Wadhwani was funded by an NSERC summer student research
   award. S. Sharifpoor was partially funded by CIHR strategic training
   program (Cell signalling in mucosal inflammation and repair) and an
   Ontario graduate scholarship in science and technology (OGSST).
CR Agrawal CM, 1997, J BIOMED MATER RES, V38, P105, DOI 10.1002/(SICI)1097-4636(199722)38:2<105::AID-JBM4>3.0.CO;2-U
   Allen J, 2008, TISSUE ENG PT A, V14, P183, DOI 10.1089/ten.a.2007.0265
   Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004
   Araujo JC, 2003, J ELECTRON MICROSC, V52, P429, DOI 10.1093/jmicro/52.4.429
   Arima Y, 2007, BIOMATERIALS, V28, P3074, DOI 10.1016/j.biomaterials.2007.03.013
   Bacakova L, 1999, PHYSIOL RES, V48, P341
   Barrias CC, 2009, BIOMATERIALS, V30, P307, DOI 10.1016/j.biomaterials.2008.09.048
   Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999
   Bune AJ, 2001, IMMUNOLOGY, V102, P103, DOI 10.1046/j.1365-2567.2001.01145.x
   CAHALON L, 1994, CELL ADHES COMMUN, V2, P269, DOI 10.3109/15419069409004447
   Caplice NM, 2005, STEM CELLS DEV, V14, P122, DOI 10.1089/scd.2005.14.122
   Chana RS, 2003, KIDNEY INT, V63, P889, DOI 10.1046/j.1523-1755.2003.00828.x
   Chen L, 2009, AM J PHYSIOL-HEART C, V296, pH987, DOI 10.1152/ajpheart.01158.2008
   Chlupac J, 2009, PHYSIOL RES, V58, pS119
   Choi SH, 2002, J BIOMAT SCI-POLYM E, V13, P1163, DOI 10.1163/156856202320813864
   de Waal MR, 1991, J EXP MED, V174, P1209, DOI DOI 10.1084/JEM.174.5.1209
   Dinnes DLM, 2008, DIFFERENTIATION, V76, P232, DOI 10.1111/j.1432-0436.2007.00221.x
   Douglas T, 2008, J MATER SCI-MATER M, V19, P2713, DOI 10.1007/s10856-008-3393-6
   Fromstein JD, 2008, TISSUE ENG PT A, V14, P369, DOI 10.1089/tea.2006.0410
   Grenier S, 2007, J BIOMED MATER RES A, V82A, P802, DOI 10.1002/jbm.a.31194
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Jeong SI, 2007, BIOMATERIALS, V28, P1115, DOI 10.1016/j.biomaterials.2006.10.025
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   LA Matheson, 2007, BIOTECHNIQUES, V42, P746
   Labow RS, 2001, BIOMATERIALS, V22, P3025, DOI 10.1016/S0142-9612(01)00049-7
   Labow RS, 2001, J BIOMED MATER RES, V54, P189, DOI 10.1002/1097-4636(200102)54:2<189::AID-JBM5>3.0.CO;2-8
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15
   MARCHANT RE, 1984, J BIOMED MATER RES, V18, P1169, DOI 10.1002/jbm.820180917
   Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   McBane JE, 2009, BIOMATERIALS, V30, P5497, DOI 10.1016/j.biomaterials.2009.07.010
   McBane JE, 2009, J BIOMAT SCI-POLYM E, V20, P437, DOI 10.1163/156856209X416467
   McNally AK, 2008, J BIOMED MATER RES A, V86A, P535, DOI 10.1002/jbm.a.31658
   MEYER H, 1979, Z NATURFORSCH C, V34, P13
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Miyake K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2234648
   Mocellin S, 2004, CYTOKINE GROWTH F R, V15, P61, DOI 10.1016/j.cytog.fr.2003.11.001
   Motlagh D, 2007, J BIOMED MATER RES A, V82A, P907, DOI 10.1002/jbm.a.31211
   NAKAGAWARA A, 1981, J CLIN INVEST, V68, P1243, DOI 10.1172/JCI110370
   NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   OSTBERG CO, 1995, FEBS LETT, V367, P93, DOI 10.1016/0014-5793(95)00509-8
   Ozolanta I, 1998, MED ENG PHYS, V20, P523, DOI 10.1016/S1350-4533(98)00050-2
   Peyton SR, 2006, BIOMATERIALS, V27, P4881, DOI 10.1016/j.biomaterials.2006.05.012
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   REPOUX M, 1992, SURF INTERFACE ANAL, V18, P567, DOI 10.1002/sia.740180719
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918
   Rose SL, 2008, J BIOMED MATER RES A, V84A, P661, DOI 10.1002/jbm.a.31305
   Schubert SY, 2008, ARTERIOSCL THROM VAS, V28, P97, DOI 10.1161/ATVBAHA.107.157537
   Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863
   Schutte RJ, 2009, BIOMATERIALS, V30, P160, DOI 10.1016/j.biomaterials.2008.09.026
   Serrano MC, 2008, J BIOMED MATER RES A, V87A, P964, DOI 10.1002/jbm.a.31728
   SHARIFPOOR S, 2010, KINGST ON CAN 28 CAN
   Sharifpoor S, 2010, ACTA BIOMATER, V6, P4218, DOI 10.1016/j.actbio.2010.06.018
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Shearer H, 2006, TISSUE ENG, V12, P2717, DOI 10.1089/ten.2006.12.2717
   Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126
   van Andel C.J., 2003, ANN THORAC SURG, V76, P64
   van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7
   Wiegand C, 2009, ARCH DERMATOL RES, V302, P419
   Wiegand C, 2009, J BIOMED MATER RES B, V90B, P710, DOI 10.1002/jbm.b.31338
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
   Williamson MR, 2006, BIOMATERIALS, V27, P3608, DOI 10.1016/j.biomaterials.2006.02.025
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   YAMAMOTO M, 1993, EXP CELL RES, V204, P121, DOI 10.1006/excr.1993.1016
   Yang L, 2009, J BIOMED MATER RES A, V91A, P1089, DOI 10.1002/jbm.a.32331
   Yoshioka T, 2008, BIOMATERIALS, V29, P3438, DOI 10.1016/j.biomaterials.2008.04.011
NR 72
TC 24
Z9 24
U1 2
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2011
VL 32
IS 14
BP 3584
EP 3595
DI 10.1016/j.biomaterials.2011.01.069
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 743LU
UT WOS:000289020600005
PM 21345489
DA 2018-10-20
ER

PT J
AU Piascik, JR
   Wolter, SD
   Stoner, BR
AF Piascik, Jeffrey R.
   Wolter, Scott D.
   Stoner, Brian R.
TI Development of a novel surface modification for improved bonding to
   zirconia
SO DENTAL MATERIALS
LA English
DT Article
DE Zirconia; Surface modification; Adhesion; Shear bond strength;
   Silanation
ID RESIN CEMENT; STRENGTH; CERAMICS; RESTORATIONS; BIOMATERIAL; DIAMOND;
   ALUMINA; GLASS
AB Objective. This report presents a novel pretreatment technique, whereby the zirconia surface is converted to a more reactive zirconium oxyfluoride, enabling improved chemical bonding to other dental substrates via conventional silanation approaches.
   Methods. The study leverages a novel gas-phase fluorination process that creates a thin oxyfluoride conversion layer on the surface of zirconia, making it more reactive for conventional adhesive bonding techniques. Zirconia specimens, polished and roughened, were pretreated and composite cylinders bonded using conventional adhesive techniques. All specimens were subjected to a force at a crosshead speed of 0.5mm/min in an electromechanical testing device. Single-factor analysis of variance (ANOVA) at a 5% confidence level was performed for the bonding strength data. Optical microscopy and scanning electron microscopy (SEM) were used to evaluate and quantify failure surfaces.
   Results. Shear bond strengths were analyzed using single-factor ANOVA (p < 0.05). Mechanical testing results revealed that fluorinated zirconia specimens (both rough and polished) displayed the highest shear bond strengths as compared to other commercially available treatments. X-ray photoelectron spectroscopy analysis helped determine that this novel pretreatment created a more reactive, 2-4nm thick oxyfluoride conversion layer with approximate stoichiometry, ZrO3F4.
   Conclusion. Simple shear bond mechanical tests demonstrated that a fluorination pretreatment is a viable method to chemically modify zirconia to produce a reactive surface for adhesive bonding. (C) 2011 Academy of Dental Materials. Published by Elsevier Ltd. All rights reserved.
C1 [Piascik, Jeffrey R.; Stoner, Brian R.] RTI Int, Ctr Mat & Elect Technol, Durham, NC 27709 USA.
   [Piascik, Jeffrey R.] Univ N Carolina, Dept Operat Dent, Chapel Hill, NC USA.
   [Wolter, Scott D.; Stoner, Brian R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.
RP Piascik, JR (reprint author), RTI Int, Ctr Mat & Elect Technol, Durham, NC 27709 USA.
EM jpiascik@rti.org
RI Stoner, Brian/D-9747-2011
FU RTI International research and development fund
FX This research was supported through RTI International research and
   development fund. YSZ materials were generously provided by
   Ivoclar-Vivadent.
CR ABOUSHELIB MN, 2010, J PROSTHOD, P1
   Aboushelib MN, 2008, DENT MATER, V24, P1268, DOI 10.1016/j.dental.2008.02.010
   Aboushelib MN, 2009, DENT MATER, V25, P989, DOI 10.1016/j.dental.2009.02.011
   Aboushellib MN, 2007, J PROSTHET DENT, V98, P379, DOI 10.1016/S0022-3913(07)60123-1
   ALAMLEH B, 2010, J ORAL REHAB
   Amaral R, 2006, DENT MATER, V22, P283, DOI 10.1016/j.dental.2005.04.021
   AMARAL R, 2007, J BIOMED MATER RES B, P1
   Atsu SS, 2006, J PROSTHET DENT, V95, P430, DOI 10.1016/j.prosdent.2006.03.016
   Bayne Stephen C, 2005, J Dent Educ, V69, P571
   Blatz MB, 2007, QUINTESSENCE INT, V38, P745
   Blatz MB, 2003, J PROSTHET DENT, V89, P381, DOI 10.1067/mpr.2003.89
   Blatz MB, 2003, J PROSTHET DENT, V89, P268, DOI 10.1067/mpr.2003.50
   Bottino MA, 2005, INT J PROSTHODONT, V18, P60
   Cavalcanti AN, 2009, OPER DENT, V34, P344, DOI 10.2341/08-79
   Chakrapani V, 2007, SCIENCE, V318, P1424, DOI 10.1126/science.1148841
   Della Bona A, 2006, J DENT RES, V85, P1037
   Della Bona A, 2008, J AM DENT ASSOC, V139, p8S
   Denry IL, 1996, CRIT REV ORAL BIOL M, V7, P134, DOI 10.1177/10454411960070020201
   Denry I, 2008, DENT MATER, V24, P299, DOI 10.1016/j.dental.2007.05.007
   Derand T, 2005, DENT MATER, V21, P1158, DOI 10.1016/j.dental.2005.02.005
   Valandro LF, 2006, J ADHES DENT, V8, P175
   GARVIE RC, 1975, NATURE, V258, P703, DOI 10.1038/258703a0
   Guess PC, 2010, J DENT RES, V89, P592, DOI 10.1177/0022034510363253
   Hess A, 1997, APPL CATAL A-GEN, V149, P373, DOI 10.1016/S0926-860X(96)00247-5
   Hisbergues M, 2009, J BIOMED MATER RES B, V88B, P519, DOI 10.1002/jbm.b.31147
   Kealey CP, 2001, J MATER CHEM, V11, P879, DOI 10.1039/b006800o
   Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005
   Kern M, 1998, DENT MATER, V14, P64, DOI 10.1016/S0109-5641(98)00011-6
   Lawn BR, 2002, J DENT RES, V81, P433, DOI 10.1177/154405910208100615
   Magne P, 2010, DENT MATER, V26, P345, DOI 10.1016/j.dental.2009.12.005
   Manicone PF, 2007, J DENT, V35, P819, DOI 10.1016/j.jdent.2007.07.008
   PANTANO CG, 1988, J AM CERAM SOC, V71, P577, DOI 10.1111/j.1151-2916.1988.tb05922.x
   Piascik JR, 2009, DENT MATER, V25, P1116, DOI 10.1016/j.dental.2009.03.008
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   VANNOORT R, 1989, J DENT, V17, P61, DOI 10.1016/0300-5712(89)90131-0
   Wegner S M, 2000, J Adhes Dent, V2, P139
NR 36
TC 43
Z9 47
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0109-5641
J9 DENT MATER
JI Dent. Mater.
PD MAY
PY 2011
VL 27
IS 5
BP E99
EP E105
DI 10.1016/j.dental.2011.01.005
PG 7
WC Dentistry, Oral Surgery & Medicine; Materials Science, Biomaterials
SC Dentistry, Oral Surgery & Medicine; Materials Science
GA 742KL
UT WOS:000288941300003
PM 21353693
DA 2018-10-20
ER

PT J
AU Abbadi, M
   Hahner, P
   Belouettar, S
   Zenasni, M
AF Abbadi, M.
   Hahner, P.
   Belouettar, S.
   Zenasni, M.
TI Fatigue crack growth in nickel-based superalloys at elevated
   temperatures
SO MATERIALS & DESIGN
LA English
DT Article
DE Hot isostatic pressing; Fracture; Elastic behaviour
ID STRESS-CORROSION CRACKING; POTENTIAL METHOD; WATER
AB In the present work, fatigue crack growth in two nickel-base mono-materials and one bi-material has been investigated at 450 and 550 degrees C. The electric potential drop technique was found to better estimate the crack length during cycling as compared to the compliance method. This finding is supported by microscopic observations of the fracture surface and also by the numerical simulation using finite element code Castem2000. The crack was found to grow faster in the coarse grained material than in the fine grained one. The fracture surface observation showed that the performance of the bi-material is linked to the mono-material content at the interface. In addition, the content of each mono-material at the interface was found to be very stochastic. This heterogeneity, due to the assembly process, strongly affects the behaviour of the biomaterial. Finite element computation showed a good agreement between numerical and experimental results in term of stress intensity factor. (C) 2011 Elsevier Ltd All rights reserved.
C1 [Abbadi, M.; Zenasni, M.] Univ Mohammed 1, ENSA, Equipe Mecan & Calcul Sci, Oujda, Morocco.
   [Abbadi, M.; Belouettar, S.] CRP Henri Tudor, LTI, L-1855 Luxembourg, Luxembourg.
   [Hahner, P.] European Commiss, DG Joint Res Ctr, Inst Energy, NL-1755 ZG Petten, Netherlands.
RP Abbadi, M (reprint author), Univ Mohammed 1, ENSA, Equipe Mecan & Calcul Sci, BP 696, Oujda, Morocco.
EM mabbadi@ensa.ump.ma
FU National Research Fund of Luxembourg [FNR/09/AM2c/01]
FX Dr. Abbadi acknowledges the mobility financial support provided by the
   National Research Fund of Luxembourg referenced FNR/09/AM2c/01.
CR Abbadi M, 2007, MEASUREMENT, V40, P383, DOI 10.1016/j.measurement.2006.06.019
   ANDERSEN PL, 2007, T ASME, V129, P488
   *ASTM, 2001, ANN BOOK ASTM STAND
   Elber W., 1970, Engineering Fracture Mechanics, V2, P37
   HARTT WH, 1991, 910057 TAR OCS MMS
   HICKS MA, 1982, INT J FRACTURE, V20, P91, DOI 10.1007/BF01141259
   JOHNSON HH, 1965, MATER RES STANDARD, V5, P442
   REBAK RB, 1994, CORROSION, V50, P378, DOI 10.5006/1.3294347
   Rebak RB, 1996, CORROS SCI, V38, P971, DOI 10.1016/0010-938X(96)00183-7
   RITCHIE RO, 1982, P 1 INT C STOCKH, V1, P503
   Rosenhain W, 1913, J I MET, V10, P119
   SCHWALBE KH, 1981, J TEST EVAL, V9, P218
   Turnbull A, 1995, FATIGUE FRACT ENG M, V18, P1455, DOI 10.1111/j.1460-2695.1995.tb00868.x
   WESTERGAARD HM, 1939, ASME, pA49
   Williams M.L, 1957, J APPLIED MECHANICS, V24, P109
NR 15
TC 4
Z9 4
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0261-3069
J9 MATER DESIGN
JI Mater. Des.
PD MAY
PY 2011
VL 32
IS 5
BP 2710
EP 2716
DI 10.1016/j.matdes.2011.01.018
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 745OE
UT WOS:000289174000024
DA 2018-10-20
ER

PT J
AU Tsai, IY
   Tomczyk, N
   Eckmann, JI
   Composto, RJ
   Eckmann, DM
AF Tsai, Irene Y.
   Tomczyk, Nancy
   Eckmann, Joshua I.
   Composto, Russell J.
   Eckmann, David M.
TI Human plasma protein adsorption onto dextranized surfaces: A
   two-dimensional electrophoresis and mass spectrometry study
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Two-dimensional electrophoresis; Mass spectrometry; Human plasma
   proteins; Protein adsorption
ID SOLID-LIPID-NANOPARTICLES; GEL-ELECTROPHORESIS; PROTEOMIC ANALYSIS;
   BIOMATERIAL INTERACTION; ENDOTHELIAL GLYCOCALYX; COMPLEMENT ACTIVATION;
   COLLOIDAL CARRIERS; DERIVATIVE LAYERS; PATTERNS; BLOOD
AB Protein adsorption is fundamental to thrombosis and to the design of biocompatible materials. We report a two-dimensional electrophoresis and mass spectrometry study to characterize multiple human plasma proteins adsorbed onto four different types of model surfaces: silicon oxide, dextranized silicon, polyurethane and dextranized polyurethane. Dextran was grafted onto the surfaces of silicon and polyurethane to mimic the blood-contacting endothelial cell glycocalyx surface. Surface topography and hydrophobicity/hydrophilicity were determined and analyzed using atomic force microscopy and water contact angle measurements, respectively. Using two-dimensional electrophoresis, we show that, relative to the unmodified surfaces, dextranization significantly inhibits the adsorption of several human plasma proteins including IGHG1 protein, fibrinogen, haptoglobin, Apo A-IV, Apo A-I, immunoglobulin, serum retinal-binding protein and truncated serum albumin. We further demonstrate the selectivity of plasma protein adsorbed onto the different functionalized surfaces and the potential to control and manipulate proteins adsorption on the surfaces of medical devices, implants and microfluidic devices. This result shows that adsorption experiments using a single protein or a binary mixture of proteins are consistent with competitive protein adsorption studies. In summary, these studies indicate that coating blood-contacting biomedical applications with dextran is an effective route to reduce thrombo-inflammatory responses and to surface-direct biological activities. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Tsai, Irene Y.; Tomczyk, Nancy; Eckmann, Joshua I.; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.
   [Tsai, Irene Y.; Composto, Russell J.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA.
RP Eckmann, DM (reprint author), Univ Penn, Dept Anesthesiol & Crit Care, 3400 Spruce St,6 Dulles HUP, Philadelphia, PA 19104 USA.
EM eckmanndm@uphs.upenn.edu
FU NIH [R01-HL060230, T32-GM007612]; NSF [DMR09-07493]
FX This work was supported by NIH grants R01-HL060230 and T32-GM007612. We
   thank our blood donors. RJC acknowledges partial support from NSF/NSEC
   (DMR08-32802 for facility use) and NSF/Polymer Program (DMR09-07493). We
   thank Thomas P. Russell and Jack Hirsch (Materials Research Science and
   Engineering Center at University of Massachusetts) for XPS measurements;
   and Chao-Xing Yuan of The Proteomics Facility at University of
   Pennsylvania for useful discussion on mass spectrometry.
CR Allemann E, 1997, J BIOMED MATER RES, V37, P229, DOI 10.1002/(SICI)1097-4636(199711)37:2<229::AID-JBM12>3.0.CO;2-9
   Ball V, 1996, LANGMUIR, V12, P1614, DOI 10.1021/la950735v
   Baskin JL, 2009, LANCET, V374, P159, DOI 10.1016/S0140-6736(09)60220-8
   Bech L, 2007, J POLYM SCI POL CHEM, V45, P2172, DOI 10.1002/pola.21983
   Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.20040900
   BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214
   Bonomini M, 2006, J PROTEOME RES, V5, P2666, DOI 10.1021/pr060150u
   Carrillo-Conde B, 2010, J BIOMED MATER RES A, V95A, P40, DOI 10.1002/jbm.a.32815
   COLMAN RW, 1987, ANN NY ACAD SCI, V516, P253, DOI 10.1111/j.1749-6632.1987.tb33046.x
   Cornelius RM, 2002, J BIOMED MATER RES, V60, P622, DOI 10.1002/jbm.10117
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   Derhami K, 2001, J BIOMED MATER RES, V56, P234, DOI 10.1002/1097-4636(200108)56:2<234::AID-JBM1090>3.3.CO;2-R
   Du YJ, 2007, J BIOMED MATER RES A, V80A, P216, DOI 10.1002/jbm.a.30977
   Dubois J, 2009, COLLOID SURFACE B, V71, P293, DOI 10.1016/j.colsurfb.2009.03.002
   Fadeev AY, 1998, LANGMUIR, V14, P5586, DOI 10.1021/la980512f
   Fang F, 2001, BIOPHYS J, V80, P2568, DOI 10.1016/S0006-3495(01)76228-5
   Farrell M, 2010, COLLOID SURFACE B, V81, P468, DOI 10.1016/j.colsurfb.2010.07.059
   Feng L, 1996, COLLOID SURFACE B, V6, P149
   Ferrer MCC, 2010, LANGMUIR, V26, P14126, DOI 10.1021/la102315j
   Gallagher WM, 2006, BIOMATERIALS, V27, P5871, DOI 10.1016/j.biomaterials.2006.07.040
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Gessner A, 2002, EUR J PHARM BIOPHARM, V54, P165, DOI 10.1016/S0939-6411(02)00081-4
   Gibson DS, 2009, J PROTEOMICS, V72, P656, DOI 10.1016/j.jprot.2009.01.022
   Goppert TM, 2005, INT J PHARMACEUT, V302, P172, DOI 10.1016/j.ijpharm.2005.06.025
   Goppert TM, 2005, EUR J PHARM BIOPHARM, V60, P361, DOI 10.1016/j.ejpb.2005.02.006
   Goppert TM, 2005, J DRUG TARGET, V13, P179, DOI 10.1080/10611860500071292
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   HERRMANN K, 1994, J MATER SCI-MATER M, V5, P728, DOI 10.1007/BF00120365
   HO CH, 1991, J BIOMED MATER RES, V25, P423, DOI 10.1002/jbm.820250402
   Holland NB, 1998, NATURE, V392, P799
   Howarter JA, 2006, LANGMUIR, V22, P11142, DOI 10.1021/la061240g
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P825, DOI 10.1002/1097-4636(20001215)52:4<825::AID-JBM28>3.0.CO;2-M
   Kim HR, 2007, ELECTROPHORESIS, V28, P2252, DOI 10.1002/elps.200600694
   Klomp AJA, 1999, BIOMATERIALS, V20, P1203, DOI 10.1016/S0142-9612(99)00009-5
   Kopp R, 2002, ASAIO J, V48, P598, DOI 10.1097/01.MAT.0000033639.23941.7E
   Li L, 2006, J PHYS CHEM B, V110, P16763, DOI 10.1021/jp062442o
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   Mares J, 2009, KIDNEY INT, V76, P404, DOI 10.1038/ki.2009.138
   Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b
   McArthur SL, 2000, COLLOID SURFACE B, V17, P37, DOI 10.1016/S0927-7765(99)00086-7
   McLean KM, 2000, COLLOID SURFACE B, V18, P221, DOI 10.1016/S0927-7765(99)00149-6
   McLean RS, 1997, MACROMOLECULES, V30, P8314, DOI 10.1021/ma970350e
   McNamara LE, 2010, J R SOC INTERFACE, V7, pS107, DOI 10.1098/rsif.2009.0177.focus
   Miksa D, 2006, BIOMACROMOLECULES, V7, P557, DOI 10.1021/bm050601o
   Monchaux E, 2008, J BIOMED MATER RES A, V85A, P1052, DOI 10.1002/jbm.a.31580
   Ombelli M, 2005, J CHROMATOGR B, V826, P198, DOI 10.1016/j.jchromb.2005.09.002
   Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Seferovic MD, 2008, J CHROMATOGR B, V865, P147, DOI 10.1016/j.jchromb.2008.01.052
   Sen Gupta A, 2006, BIOMATERIALS, V27, P3084, DOI 10.1016/j.biomaterials.2006.01.002
   Sihlbom C, 2008, J PROTEOME RES, V7, P4191, DOI 10.1021/pr800340c
   Stile RA, 2002, J BIOMED MATER RES, V61, P391, DOI 10.1002/jbm.10154
   Strader MB, 2006, ANAL CHEM, V78, P125, DOI 10.1021/ac051348l
   Takami Y, 1998, J BIOMED MATER RES, V40, P24, DOI 10.1002/(SICI)1097-4636(199804)40:1<24::AID-JBM3>3.3.CO;2-U
   VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002
   Vogler EA, 2009, BIOMATERIALS, V30, P1857, DOI 10.1016/j.biomaterials.2008.12.041
   VROMAN L, 1974, SCIENCE, V184, P585, DOI 10.1126/science.184.4136.585
   WADSWORTH GR, 1953, BRIT MED J, V2, P1138, DOI 10.1136/bmj.2.4846.1138
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939
   Zhu YB, 2004, BIOMATERIALS, V25, P423, DOI 10.1016/S0142-9612(03)00549-0
NR 63
TC 16
Z9 17
U1 1
U2 27
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
EI 1873-4367
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2011
VL 84
IS 1
BP 241
EP 252
DI 10.1016/j.colsurfb.2011.01.006
PG 12
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 739QI
UT WOS:000288732500033
PM 21277175
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Matsumoto, E
   Fukuda, T
   Miura, Y
AF Matsumoto, Erino
   Fukuda, Tomohiro
   Miura, Yoshiko
TI Bioinert surface to protein adsorption with higher generation of
   dendrimer SAMs
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article
DE Dendrimer; Self-assembled monolayer; Protein adsorption; Polymer brush
ID GOLD SURFACES; LANGMUIR-BLODGETT; GRAFTING DENSITY; CHAIN DENSITY;
   POLY(ETHYLENE; RESISTANCE; LAYER
AB Interactions between proteins and biomaterial surfaces correlate with many important phenomena in biological systems. Such interactions have been used to develop various artificial biomaterials and applications, in which regulation of non-specific protein adsorption has been achieved with bioinert properties. In this research, we investigated the protein adsorption behavior of polymer brushes of dendrimer self-assembled monolayers (SAMs) with other generations. The surface adsorption properties of proteins with different pI values were examined on gold substrates modified with poly(amidoamine) dendrimer SAMs. The amount of fibrinogen adsorption was greater than that of lysozyme, potentially because of the surface electric charge. However, as the generations increased, protein adsorption decreased regardless of the surface charge, suggesting that protein adsorption was also affected by density of terminal group. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Fukuda, Tomohiro; Miura, Yoshiko] Kyushu Univ, Dept Chem Engn, Grad Sch Engn, Nishi Ku, Fukuoka 8190395, Japan.
   [Matsumoto, Erino; Fukuda, Tomohiro; Miura, Yoshiko] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.
RP Miura, Y (reprint author), Kyushu Univ, Dept Chem Engn, Grad Sch Engn, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.
EM miuray@chem-eng.kyushu-u.ac.jp
FU  [20106003]
FX This work was supported by a Grant-in-Aid for Scientific Research on
   Innovative Areas (20106003). We thank Prof. Shinichi Ikushiro (Toyama
   Pref. Univ.) for the SPR measurement and Dr. Tatsuya Murakami (JAIST)
   for the XPS measurement.
CR Ajikumar PK, 2007, LANGMUIR, V23, P5670, DOI 10.1021/la063717u
   Benhabbour SR, 2008, MACROMOLECULES, V41, P2567, DOI 10.1021/ma702074v
   Chen H, 2008, PROG POLYM SCI, V33, P1059, DOI 10.1016/j.progpolymsci.2008.07.006
   Corkery RW, 1997, LANGMUIR, V13, P3591, DOI 10.1021/la9701743
   Ejaz M, 1998, MACROMOLECULES, V31, P5934, DOI 10.1021/ma980240n
   Fukuda T, 2010, CHEM LETT, V39, P923, DOI 10.1246/cl.2010.923
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hamilton-Brown P, 2009, LANGMUIR, V25, P9149, DOI 10.1021/la900703e
   Hierlemann A, 1998, J AM CHEM SOC, V120, P5323, DOI 10.1021/ja974283f
   Holland NB, 1998, NATURE, V392, P799
   Holmlin RE, 2001, LANGMUIR, V17, P2841, DOI 10.1021/la0015258
   JEON SI, 1991, J COLLOID INTERF SCI, V142, P149, DOI 10.1016/0021-9797(91)90043-8
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Li J, 2000, LANGMUIR, V16, P5613, DOI 10.1021/la000035c
   Liu GD, 2006, ANAL CHEM, V78, P835, DOI 10.1021/ac051559q
   Martwiset S, 2006, LANGMUIR, V22, P8192, DOI 10.1021/la061064b
   Matsumoto E, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/3/034605
   MILNER ST, 1988, MACROMOLECULES, V21, P2610, DOI 10.1021/ma00186a051
   Muller M, 2006, BIOMACROMOLECULES, V7, P1285, DOI 10.1021/bm050631r
   Pathak S, 2004, LANGMUIR, V20, P6075, DOI 10.1021/la036271f
   Singh N, 2007, BIOMATERIALS, V28, P763, DOI 10.1016/j.biomaterials.2006.09.036
   Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l
   Syahir A, 2009, LANGMUIR, V25, P3667, DOI 10.1021/la8028275
   Tokuhisa H, 1998, J AM CHEM SOC, V120, P4492, DOI 10.1021/ja9742904
   Tomalia DA, 2004, ALDRICHIM ACTA, V37, P39
   Unsworth LD, 2008, LANGMUIR, V24, P1924, DOI 10.1021/la702310t
   Yang Q, 2010, LANGMUIR, V26, P5746, DOI 10.1021/la903895q
   Yeh PYJ, 2008, LANGMUIR, V24, P4907, DOI 10.1021/la702867t
   Yoshimoto K, 2009, MACROMOL RAPID COMM, V30, P2136, DOI 10.1002/marc.200900484
NR 29
TC 8
Z9 8
U1 1
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD MAY 1
PY 2011
VL 84
IS 1
BP 280
EP 284
DI 10.1016/j.colsurfb.2011.01.003
PG 5
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 739QI
UT WOS:000288732500038
PM 21256721
DA 2018-10-20
ER

PT J
AU Galli, D
   Benedetti, L
   Bongio, M
   Maliardi, V
   Silvani, G
   Ceccarelli, G
   Ronzoni, F
   Conte, S
   Benazzo, F
   Graziano, A
   Papaccio, G
   Sampaolesi, M
   De Angelis, MGC
AF Galli, Daniela
   Benedetti, Laura
   Bongio, Matilde
   Maliardi, Valentina
   Silvani, Giulia
   Ceccarelli, Gabriele
   Ronzoni, Flavio
   Conte, Silvio
   Benazzo, Francesco
   Graziano, Antonio
   Papaccio, Gianpaolo
   Sampaolesi, Maurilio
   De Angelis, Maria Gabriella Cusella
TI In vitro osteoblastic differentiation of human mesenchymal stem cells
   and human dental pulp stem cells on poly-L-lysine-treated
   titanium-6-aluminium-4-vanadium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE Ti6Al4V; poly-L-lysine; osteoblastic differentiation; FAK
ID INTEGRIN-MEDIATED ADHESION; OSTEOGENIC DIFFERENTIATION; TITANIUM
   SURFACES; IMPLANT MATERIALS; ORGANOAPATITE; VITRONECTIN; HYALURONAN;
   ACTIVATION; LAMININ-5; ALLOY
AB Three-dimensional (3D) titanium-6-aluminium-4-vanadium (Ti6Al4V) is a widely used biomaterial for orthopedic prosthesis and dental implants; thanks to its very high-mechanical strength and resistance to corrosion. Human mesenchymal stem cells (hMSCs) and dental pulp stem cells (hDPSCs) are responsible for bone regeneration following colonization of prosthesis or dental implants. Both hMSCs and hDPSCs have lower ability to colonize this biomaterial in comparison with tissue culture-treated plastic. Both hMSCs and hDPSCs show lack of focal adhesion kinase (FAK) activation when grown on Ti6Al4V. This signal is restored in the presence of poly-L-lysine (poly-L-lys). Poly-L-lys has been used as part of organoapatite or together with zinc and calcium ions. Our results suggest that poly-L-lys alone induces FAK activation through beta 1-INTEGRIN, because the presence of beta 1-INTEGRIN blocking antibody avoided FAK autophosphorylation. Presence of poly-L-lys also increases expression of osteoblastic differentiation marker genes in hMSCs and hDPSCs grown on Ti6Al4V. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 118-126, 2011.
C1 [Galli, Daniela; Silvani, Giulia; Ceccarelli, Gabriele; Ronzoni, Flavio; Sampaolesi, Maurilio; De Angelis, Maria Gabriella Cusella] Univ Pavia, Interdept Ctr Tissue Engn, I-27100 Pavia, Italy.
   [Benedetti, Laura; Bongio, Matilde; Maliardi, Valentina; Conte, Silvio; Sampaolesi, Maurilio; De Angelis, Maria Gabriella Cusella] Univ Pavia, Dept Expt Med, Human Anat Unit, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, Orthopaed Clin, IRCCS Policlin San Matteo, I-27100 Pavia, Italy.
   [Graziano, Antonio; Papaccio, Gianpaolo] Secondo Ateneo Napoli, Dipartimento Discipline Odontostomatol Ortodont &, Naples, Italy.
   [Sampaolesi, Maurilio] Katholieke Univ Leuven, Interdept Stem Cell Inst, Louvain, Belgium.
RP De Angelis, MGC (reprint author), Univ Pavia, Interdept Ctr Tissue Engn, I-27100 Pavia, Italy.
EM dgalli05@yahoo.it; dgalli05@yahoo.it
RI Bongio, Matilde/G-3460-2015; Sampaolesi, Maurilio/H-6509-2013; Galli,
   Daniela/L-3179-2015
OI Bongio, Matilde/0000-0002-8066-9286; Sampaolesi,
   Maurilio/0000-0002-2422-3757; Galli, Daniela/0000-0003-0200-5852;
   Cusella De Angelis, Maria Gabriella/0000-0003-2642-3346; Papaccio,
   Gianpaolo/0000-0002-4014-5306
FU FIRB [RBIP06FH7J]; PRIN [20084XRSBS]; Italian Ministry of University;
   Cariplo Foundation
FX Contract grant sponsor: "FIRB"; contract grant number: RBIP06FH7J;
   Contract grant sponsor: "PRIN"; contract grant number: 20084XRSBS;
   Contract grant sponsor: Italian Ministry of University; Contract grant
   sponsor: Cariplo Foundation
CR Avanzini MA, 2009, HAEMATOL-HEMATOL J, V94, P1649, DOI 10.3324/haematol.2009.006171
   Carinci F, 2008, J CRANIOFAC SURG, V19, P616, DOI 10.1097/SCS.0b013e31816aabc8
   Cohen M, 2006, EMBO J, V25, P302, DOI 10.1038/sj.emboj.7600960
   Colman H, 2006, AM J SURG PATHOL, V30, P657, DOI 10.1097/01.pas.0000202048.28203.25
   Curran JM, 2010, J MATER SCI-MATER M, V21, P1021, DOI 10.1007/s10856-009-3976-x
   Giuliani N, 2009, EXP HEMATOL, V37, P879, DOI 10.1016/j.exphem.2009.04.004
   Graziano A, 2008, J CELL PHYSIOL, V214, P166, DOI 10.1002/jcp.21175
   Gronowicz G, 1996, J ORTHOPAED RES, V14, P878, DOI 10.1002/jor.1100140606
   Guo LK, 2008, J BIOMED MATER RES A, V87A, P903, DOI 10.1002/jbm.a.31834
   Huang CH, 2009, J CELL BIOCHEM, V108, P1263, DOI 10.1002/jcb.22356
   Huang GTJ, 2009, J DENT RES, V88, P792, DOI 10.1177/0022034509340867
   HUANG GTJ, 2002, J DENT RES, V88, P792
   Hwang JJ, 1999, J BIOMED MATER RES, V47, P504, DOI 10.1002/(SICI)1097-4636(19991215)47:4<504::AID-JBM6>3.0.CO;2-O
   Jackson L, 2007, J POSTGRAD MED, V53, P121
   Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826
   Klees RF, 2007, MATRIX BIOL, V26, P106, DOI 10.1016/j.matbio.2006.10.001
   Krause A, 2000, J BIOMED MATER RES, V52, P738, DOI 10.1002/1097-4636(20001215)52:4<738::AID-JBM19>3.0.CO;2-F
   Ku Y, 2005, BIOMATERIALS, V26, P5153, DOI 10.1016/j.biomaterials.2005.01.060
   Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70
   Kundu AK, 2006, BIOCHEM BIOPH RES CO, V347, P347, DOI 10.1016/j.bbrc.2006.06.110
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214
   Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076
   Nebe B, 2007, BIOMOL ENG, V24, P447, DOI 10.1016/j.bioeng.2007.07.004
   Reyes CD, 2007, BIOMATERIALS, V28, P3228, DOI 10.1016/j.biomaterials.2007.04.003
   Salasznyk RM, 2007, J CELL BIOCHEM, V100, P499, DOI 10.1002/jcb.21074
   Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013
   Saldana L, 2005, J BIOMED MATER RES A, V73A, P97, DOI 10.1002/jbm.a.30264
   Sikiric MD, 2009, J BIOMED MATER RES A, V89A, P759, DOI 10.1002/jbm.a.32021
   Spoerke ED, 2005, BIOMATERIALS, V26, P5120, DOI 10.1016/j.biomaterials.2005.01.039
   Storrie H, 2005, BIOMATERIALS, V26, P5492, DOI 10.1016/j.biomaterials.2005.01.043
   Tognarini I, 2008, BIOMATERIALS, V29, P809, DOI 10.1016/j.biomaterials.2007.10.043
   Zimmerman E, 2002, BIOPHYS J, V82, P1848, DOI 10.1016/S0006-3495(02)75535-5
NR 33
TC 18
Z9 18
U1 0
U2 13
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2011
VL 97A
IS 2
BP 118
EP 126
DI 10.1002/jbm.a.32996
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 741JP
UT WOS:000288860300003
PM 21370441
DA 2018-10-20
ER

PT J
AU Gu, Y
   Chen, LA
   Yang, HL
   Luo, ZP
   Tang, TS
AF Gu, Yong
   Chen, Liang
   Yang, Hui-Lin
   Luo, Zong-Ping
   Tang, Tian-Si
TI Evaluation of an injectable silk fibroin enhanced calcium phosphate
   cement loaded with human recombinant bone morphogenetic protein-2 in
   ovine lumbar interbody fusion
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bone grafts; calcium phosphate cement; silk fibroin; bone morphogenetic
   protein
ID SPINAL-FUSION; SCAFFOLDS; AUTOGRAFT; RHBMP-2; SHEEP; GRAFT; DELIVERY;
   VIVO; REINFORCEMENT; SUBSTITUTE
AB The objective of this study was to investigate the efficacy of an injectable calcium phosphate cement/silk fibroin/human recombinant bone morphogenetic protein-2 composite (CPC/SF/rhBMP-2) in an ovine interbody fusion model. Twenty-four mature sheep underwent anterior lumbar interbody fusion at the levels of L1/2, L3/4, and L5/6 with random implantation of CPC/SF, CPC/rhBMP-2, CPC/SF/rhBMP-2, or autogenous iliac bone. After the sheep were sacrificed, the fusion segments were evaluated by manual palpation, CT scan, undestructive biomechanical testing, undecalcified histology, and histomorphology. The fusion rates of CPC/SF/rhBMP-2 were 55.56% and 77.78% at 6 and 12 months, respectively. The fusion was superior to all the biomaterial grafts in stiffness, and reached the same stiffness as the autograft at 12 months. The new bone formation was less than autograft at 6 months, but similar with that at 12 months. However, the ceramic residue volume of CPC/SF/rhBMP-2 was significantly decreased compared with CPC/SF and CPC/rhBMP-2 at both times. The results indicated that CPC/SF/rhBMP-2 composite had excellent osteoconduction and osteoinduction, and balanced degradation and osteogenesis. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 177-185, 2011.
C1 [Gu, Yong; Chen, Liang; Yang, Hui-Lin; Luo, Zong-Ping; Tang, Tian-Si] Soochow Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Suzhou 215006, Peoples R China.
RP Chen, LA (reprint author), Soochow Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Suzhou 215006, Peoples R China.
EM chenliangsuzhou@163.com
FU Jiangsu Provincial Government [RC2007078]; Foundation of Natural Science
   from Jiangsu Provincial Government [BK2008170, BK2008008]; National
   Natural Science Foundation [30672140]; Special Purpose Foundation of
   Public Welfare Vocation from Ministry of Health of China [200802152]
FX Contract grant sponsor: Key Talented Man Project from Jiangsu Provincial
   Government; contract grant number: RC2007078; Contract grant sponsor:
   Foundation of Natural Science from Jiangsu Provincial Government;
   contract grant numbers: BK2008170, BK2008008; Contract grant sponsor:
   National Natural Science Foundation; contract grant number: 30672140;
   Contract grant sponsor: Special Purpose Foundation of Public Welfare
   Vocation from Ministry of Health of China; contract grant number:
   200802152; Contract grant sponsor: Jiangsu Provincial Government
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Athanasiou VT, 2010, MED SCI MONITOR, V16, pBR24
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bessa PC, 2010, J TISSUE ENG REGEN M, V4, P349, DOI 10.1002/term.245
   Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]
   Blattert TR, 2003, EUR SPINE J, V12, P216, DOI 10.1007/s00586-002-0471-1
   Blattert TR, 2002, SPINE, V27, P2697, DOI 10.1097/00007632-200212010-00009
   Bodde EWH, 2007, J BIOMED MATER RES B, V83B, P161, DOI 10.1002/jbm.b.30780
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   Buchanan F, 2007, P I MECH ENG H, V221, P203, DOI 10.1243/09544119JEIM235
   Calori GM, 2009, INJURY, V40, P67
   Carreon LY, 2009, SPINE, V34, P238, DOI 10.1097/BRS.0b013e31818ffabe
   [Chen Xiaoqing 陈晓庆], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P8985
   Cloyd JM, 2010, J NEUROSURG-SPINE, V12, P402, DOI 10.3171/2009.10.SPINE08741
   Dai LY, 2008, SPINE, V33, P1299, DOI 10.1097/BRS.0b013e3181732a8e
   Dimar JR, 2009, J BONE JOINT SURG AM, V91A, P1377, DOI 10.2106/JBJS.H.00200
   Grauer JN, 2005, ORTHOPEDICS, V28, P573
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1825, DOI 10.1007/s10529-009-0100-8
   Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x
   Hofmann S, 2007, BIOMATERIALS, V28, P1152, DOI 10.1016/j.biomaterials.2006.10.019
   Jeon O, 2008, BIOCHEM BIOPH RES CO, V369, P774, DOI 10.1016/j.bbrc.2008.02.099
   Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim BH, 2009, ASIAN SPINE J, V3, P1, DOI 10.4184/asj.2009.3.1.1
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kong XD, 2004, J CRYST GROWTH, V270, P197, DOI 10.1016/j.jcrysgro.2004.06.007
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   LLHARREBORDE B, 2008, J PEDIATR ORTHOPED, V28, P347
   Ma PX, 2008, ADV DRUG DELIVER REV, V60, P184, DOI 10.1016/j.addr.2007.08.041
   Magin MN, 2001, SPINE, V26, P469, DOI 10.1097/00007632-200103010-00009
   Mandal BB, 2009, ACTA BIOMATER, V5, P2579, DOI 10.1016/j.actbio.2009.02.033
   Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006
   Marukawa E, 2001, BRIT J ORAL MAX SURG, V39, P452, DOI 10.1054/bjom.2001.0673
   Minamide A, 2004, J ORTHOP SCI, V9, P142, DOI 10.1007/s00776-003-0749-0
   Miyazaki M, 2009, EUR SPINE J, V18, P783, DOI 10.1007/s00586-009-0924-x
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Motomiya M, 2007, EUR SPINE J, V16, P2215, DOI 10.1007/s00586-007-0501-0
   Nunez S, 2010, EUR SPINE J, V19, P513, DOI 10.1007/s00586-010-1350-9
   Sandhu HS, 2002, SPINE, V27, P567, DOI 10.1097/00007632-200203150-00003
   Smoljanovic T, 2009, EUR SPINE J, V18, P920, DOI 10.1007/s00586-009-0959-z
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wilke HJ, 1997, ANAT REC, V247, P542, DOI 10.1002/(SICI)1097-0185(199704)247:4<542::AID-AR13>3.0.CO;2-P
   Xu HHK, 2002, BIOMATERIALS, V23, P193, DOI 10.1016/S0142-9612(01)00095-3
NR 46
TC 22
Z9 29
U1 2
U2 28
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD MAY
PY 2011
VL 97A
IS 2
BP 177
EP 185
DI 10.1002/jbm.a.33018
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 741JP
UT WOS:000288860300010
PM 21381189
DA 2018-10-20
ER

PT J
AU Nishiyama, H
   Takana, H
   Shinohara, K
   Mizuki, K
   Katagiri, K
   Ohta, M
AF Nishiyama, Hideya
   Takana, Hidemasa
   Shinohara, Keisuke
   Mizuki, Kotoe
   Katagiri, Kazunari
   Ohta, Makoto
TI Experimental analysis on MR fluid channel flow dynamics with complex
   fluid-wall interactions
SO JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS
LA English
DT Article; Proceedings Paper
CT 12th International Conference on Magnetic Fluids (ICMF12)
CY AUG 01-05, 2010
CL Sendai, JAPAN
SP Magnetic Fluid Assoc
DE Magnetorheological fluid; Flow control; Complex channel flow;
   Viscoelasticity; Wall structure; Biomaterial
ID MAGNETORHEOLOGICAL FLUIDS
AB MR fluid plugging performance by aggregation of magnetized particles in MR fluid is recently expected to be one of the most promising applications in medical or safety devices, such as blood flow control, steam issuing shut-down valve and fuel supply control for automobile. In this study, dynamic response of MR fluid plugging and its break down in a pressure mode with complex fluid-wall interactions was experimentally investigated, considering the effects of magnetic flux density, wall surface structure, wall permeability and wall elasticity of tube. Higher endurance pressure is obtained for wall surface groove structure and for steel wall due to a strong anchoring effect by rigid cluster formation in a concave region and strong MR fluid column formation in a channel core region, respectively. Furthermore, MR fluid plugging performance and the fluid storage characteristic of PVA tube as a bio-material was clarified. Because of the large radial expansion of the tube at the applied magnetic region in a pressure mode, PVA tube shows unique characteristics, such as storing MR fluid under magnetic field and MR fluid jet issuing under releasing magnetic field. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Nishiyama, Hideya; Takana, Hidemasa; Shinohara, Keisuke; Mizuki, Kotoe; Katagiri, Kazunari; Ohta, Makoto] Tohoku Univ, Inst Fluid Sci, Aoba Ku, Sendai, Miyagi 9808577, Japan.
RP Nishiyama, H (reprint author), Tohoku Univ, Inst Fluid Sci, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM nishiyama@ifs.tohoku.ac.jp
RI Ohta, Makoto/I-7104-2018
OI Ohta, Makoto/0000-0001-8571-6400
CR Cook E, 2007, J INTEL MAT SYST STR, V18, P1197, DOI 10.1177/1045389X07083127
   GORDANINEJAD F, 2004, P 9 INT C EL MAGN SU, P314
   Kosukegawa H, 2008, J FLUID SCI TECHNOL, V3, P533
   LEMAIRE E, 1991, J PHYS D APPL PHYS, V24, P1473, DOI 10.1088/0022-3727/24/8/037
   Liu J, 2002, JSME INT J B-FLUID T, V45, P55, DOI 10.1299/jsmeb.45.55
   Lloyd JR, 2007, J FLUID ENG-T ASME, V129, P423, DOI 10.1115/1.2436588
   NISHIYAMA H, 2009, J PHYS C SER, V194
   Nishiyama H, 2008, AIP CONF PROC, V982, P592, DOI 10.1063/1.2897863
   Saito T, 2006, J INTEL MAT SYST STR, V17, P341, DOI 10.1177/1045389X06055630
   Sheng R, 1999, J MAGN MAGN MATER, V194, P167, DOI 10.1016/S0304-8853(98)00565-4
NR 10
TC 4
Z9 4
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-8853
J9 J MAGN MAGN MATER
JI J. Magn. Magn. Mater.
PD MAY
PY 2011
VL 323
IS 10
BP 1293
EP 1297
DI 10.1016/j.jmmm.2010.11.033
PG 5
WC Materials Science, Multidisciplinary; Physics, Condensed Matter
SC Materials Science; Physics
GA 726PM
UT WOS:000287738100022
DA 2018-10-20
ER

PT J
AU Bouten, CVC
   Dankers, PYW
   Driessen-Mol, A
   Pedron, S
   Brizard, AMA
   Baaijens, FPT
AF Bouten, C. V. C.
   Dankers, P. Y. W.
   Driessen-Mol, A.
   Pedron, S.
   Brizard, A. M. A.
   Baaijens, F. P. T.
TI Substrates for cardiovascular tissue engineering
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Scaffolds; Bioactive materials; Heart valves; Artery; Myocardium;
   Extracellular matrix; Cellular microenvironment; Substrate testing;
   Computational modeling; Imageable materials
ID HEART-VALVE TISSUE; MESENCHYMAL STEM-CELLS; ASSEMBLING PEPTIDE
   NANOFIBERS; SMALL-INTESTINAL SUBMUCOSA; FINITE-ELEMENT APPROACH; CALIBER
   VASCULAR GRAFT; SMALL ANIMAL-MODEL; IN-VIVO; CARDIAC TISSUE;
   MYOCARDIAL-INFARCTION
AB Cardiovascular tissue engineering aims to find solutions for the suboptimal regeneration of heart valves. arteries and myocardium by creating 'living' tissue replacements outside (in vitro) or inside (in situ) the human body. A combination of cells, biomaterials and environmental cues of tissue development is employed to obtain tissues with targeted structure and functional properties that can survive and develop within the harsh hemodynamic environment of the cardiovascular system. This paper reviews the up-to-date status of cardiovascular tissue engineering with special emphasis on the development and use of biomaterial substrates. Key requirements and properties of these substrates, as well as methods and readout parameters to test their efficacy in the human body, are described in detail and discussed in the light of current trends toward designing biologically inspired microenviroments for in situ tissue engineering purposes. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Bouten, C. V. C.; Dankers, P. Y. W.] Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands.
   [Dankers, P. Y. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands.
   [Pedron, S.; Brizard, A. M. A.] Philips Res, BioMol Engn, NL-5656 AE Eindhoven, Netherlands.
RP Bouten, CVC (reprint author), Eindhoven Univ Technol, Dept Biomed Engn, Biol Chem Lab, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM c.v.c.bouten@tue.nl; p.y.w.dankers@tue.nl; a.driessen@tue.nl;
   sara.pedron@philips.com; aurelie.brizard@philips.com;
   f.p.t.baaijens@tue.nl
RI Brizard, Aurelie/F-1572-2011; Pedron, Sara/E-6404-2015
OI Bouten, Carlijn/0000-0003-1035-5094
CR ADLER CP, 1981, PATHOL RES PRACT, V172, P25, DOI 10.1016/S0344-0338(81)80120-3
   Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121
   Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Akhyari P, 2002, CIRCULATION, V106, P1137
   Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062
   Anversa P, 2006, CIRCULATION, V113, P1451, DOI 10.1161/CIRCULATIONAHA.105.595181
   ANVERSA P, 1980, J MOL CELL CARDIOL, V12, P781, DOI 10.1016/0022-2828(80)90080-2
   Aper T, 2007, EUR J VASC ENDOVASC, V33, P33, DOI 10.1016/j.ejvs.2006.08.008
   ARTS T, 1991, BIOPHYS J, V59, P93, DOI 10.1016/S0006-3495(91)82201-9
   Au HTH, 2007, BIOMATERIALS, V28, P4277, DOI 10.1016/j.biomaterials.2007.06.001
   Ausoni S, 2009, TRENDS MOL MED, V15, P543, DOI 10.1016/j.molmed.2009.10.002
   Baaijens FPT, 2005, ANN BIOMED ENG, V33, P494, DOI 10.1007/s10439-005-2506-3
   Baar K, 2005, EXP PHYSIOL, V90, P799, DOI 10.1113/expphysiol.2005.031377
   Balguid A, 2007, TISSUE ENG, V13, P1501, DOI 10.1089/ten.2006.0279
   Balguid A, 2009, CIRCULATION, V119, P290, DOI 10.1161/CIRCULATIONAHA.107.749853
   Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Barocas VH, 1997, J BIOMECH ENG-T ASME, V119, P137, DOI 10.1115/1.2796072
   Bayrak A, 2010, BIOMATERIALS, V31, P3793, DOI 10.1016/j.biomaterials.2010.01.120
   Beard DA, 2001, ANN BIOMED ENG, V29, P298, DOI 10.1114/1.1359450
   Beeres SLMA, 2007, J AM COLL CARDIOL, V49, P1137, DOI 10.1016/j.jacc.2006.10.072
   Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031
   Birla RK, 2005, TISSUE ENG, V11, P803, DOI 10.1089/ten.2005.11.803
   Boccaccini AR, 2003, COMPOS SCI TECHNOL, V63, P2417, DOI 10.1016/S0266-3538(03)00275-6
   Boerboom RA, 2008, ANN BIOMED ENG, V36, P244, DOI 10.1007/s10439-007-9413-8
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   BORG TK, 1981, FED PROC, V40, P2037
   Bouten CVC, 2003, BIORHEOLOGY, V40, P383
   Brennan MP, 2008, ANN SURG, V248, P370, DOI 10.1097/SLA.0b013e318184dcbd
   Breuls RGM, 2002, J BIOMECH ENG-T ASME, V124, P198, DOI 10.1115/1.1449492
   Bull SR, 2005, BIOCONJUGATE CHEM, V16, P1343, DOI 10.1021/bc050153h
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Butcher JT, 2008, J HEART VALVE DIS, V17, P62
   Butcher JT, 2006, BIOMATERIALS, V27, P5252, DOI 10.1016/j.biomaterials.2006.05.040
   Butcher JT, 2006, TISSUE ENG, V12, P905, DOI 10.1089/ten.2006.12.905
   Buxton DB, 2009, WIRES NANOMED NANOBI, V1, P149, DOI 10.1002/wnan.008
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Capps SB, 2000, J THORAC CARDIOV SUR, V119, P975, DOI 10.1016/S0022-5223(00)70092-4
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011
   Chen QZ, 2007, WOODHEAD PUBL MATER, P335, DOI 10.1533/9781845693817.2.335
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267
   Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Choi CK, 2010, TRENDS CELL BIOL, V20, P705, DOI 10.1016/j.tcb.2010.09.007
   Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5
   Christman KL, 2006, J AM COLL CARDIOL, V48, P907, DOI 10.1016/j.jacc.2006.06.005
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Collier JH, 2008, SOFT MATTER, V4, P2310, DOI 10.1039/b805563g
   Cooke JP, 2000, VASC MED, V5, P49, DOI 10.1191/135886300674617951
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   Cox MAJ, 2010, TISSUE ENG PT A, V16, P1527, DOI 10.1089/ten.TEA.2009.0263
   Cui HG, 2010, BIOPOLYMERS, V94, P1, DOI 10.1002/bip.21328
   Cui WG, 2010, SCI TECHNOL ADV MAT, V11, DOI 10.1088/1468-6996/11/1/014108
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   CURRIER JW, 1995, J AM COLL CARDIOL, V25, P516, DOI 10.1016/0735-1097(95)98445-J
   Cushing MC, 2007, BIOMATERIALS, V28, P3378, DOI 10.1016/j.biomaterials.2007.04.005
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Dankers PYW, 2007, B CHEM SOC JPN, V80, P2047, DOI 10.1246/bcsj.80.2047
   Dankers PYW, 2007, EUR J ORG CHEM, P3622, DOI 10.1002/ejoc.200700191
   Dankers PYW, 2006, MACROMOLECULES, V39, P8763, DOI 10.1021/ma061078o
   Dankers PYW, 2006, BIOMATERIALS, V27, P5490, DOI 10.1016/j.biomaterials.2006.07.011
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k
   De Visscher G, 2008, J THORAC CARDIOV SUR, V135, P395, DOI 10.1016/j.jtcvs.2007.09.016
   De Visscher G, 2007, EUR HEART J, V28, P1389, DOI 10.1093/eurheartj/ehl422
   Deshpande VS, 2007, P ROY SOC A-MATH PHY, V463, P787, DOI 10.1098/rspa.2006.1793
   Dohmen PM, 2006, CIRC RES, V99, pE10, DOI 10.1161/01.RES.0000234909.24367.a9
   Dohmen PM, 2009, ANN THORAC CARDIOVAS, V15, P362
   Driessen NJB, 2007, J BIOMECH, V40, P325, DOI 10.1016/j.jbiomech.2006.01.009
   Driessen NJB, 2004, J THEOR BIOL, V226, P53, DOI 10.1016/j.jtbi.2003.08.004
   Driessen NJB, 2003, J BIOMECH ENG-T ASME, V125, P549, DOI 10.1115/1.1590361
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Ehrbar M, 2008, NAT MATER, V7, P800, DOI 10.1038/nmat2250
   Ehrlich HP, 2006, CELL BIOCHEM FUNCT, V24, P63, DOI 10.1027/cbf.1188
   Eitan Y, 2010, TISSUE ENG PART C-ME, V16, P671, DOI [10.1089/ten.tec.2009.0111, 10.1089/ten.TEC.2009.0111]
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   Engler AJ, 2008, J CELL SCI, V121, P3794, DOI 10.1242/jcs.029678
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   Erdbrugger W, 2006, TISSUE ENG, V12, P2059, DOI 10.1089/ten.2006.12.2059
   Eschenhagen T, 1997, FASEB J, V11, P683
   Fatemi M, 1998, SCIENCE, V280, P82, DOI 10.1126/science.280.5360.82
   Flanagan TC, 2007, BIOMATERIALS, V28, P3388, DOI 10.1016/j.biomaterials.2007.04.012
   Flanagan TC, 2009, TISSUE ENG PT A, V15, P2965, DOI [10.1089/ten.tea.2009.0018, 10.1089/ten.TEA.2009.0018]
   Folmer BJB, 2000, ADV MATER, V12, P874, DOI 10.1002/1521-4095(200006)12:12<874::AID-ADMA874>3.3.CO;2-3
   Freed LE, 1997, IN VITRO CELL DEV-AN, V33, P381
   Freed LE, 2006, TISSUE ENG, V12, P3285, DOI 10.1089/ten.2006.12.3285
   Freytes DO, 2009, J CELL BIOCHEM, V108, P1047, DOI 10.1002/jcb.22355
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   Fuchs JR, 2006, SURGERY, V140, P100, DOI 10.1016/j.surg.2006.01.016
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fukuda Keiichi, 2003, Hum Cell, V16, P83, DOI 10.1111/j.1749-0774.2003.tb00138.x
   Galler KM, 2010, J AM CHEM SOC, V132, P3217, DOI 10.1021/ja910481t
   Gaudette GR, 2006, CIRCULATION, V114, P2575, DOI 10.1161/CIRCULATIONAHA.106.668707
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Giraud MN, 2007, TISSUE ENG, V13, P1825, DOI 10.1089/ten.2006.0110
   Gottlieb D, 2010, J THORAC CARDIOV SUR, V139, P723, DOI 10.1016/j.jtcvs.2009.11.006
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Hahn MS, 2007, ANN BIOMED ENG, V35, P190, DOI 10.1007/s10439-006-9099-3
   Haines-Butterick L, 2007, P NATL ACAD SCI USA, V104, P7791, DOI 10.1073/pnas.0701980104
   Ham H.Y., 2010, BIOMATERIALS, V31, P8081
   Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458
   Hauser CAE, 2010, CHEM SOC REV, V39, P2780, DOI 10.1039/b921448h
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hibino G., 2010, J THORAC CARDIOVASC, V139, P431
   Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030
   Hirano Y, 2004, ADV MATER, V16, P17, DOI 10.1002/adma.200300383
   Hjortnaes J, 2009, TISSUE ENG PART B-RE, V15, P307, DOI [10.1089/ten.teb.2008.0565, 10.1089/ten.TEB.2008.0565]
   Hlatky MA, 2004, CIRCULATION, V110, P1960, DOI 10.1161/01.CIR.0000143379.26342.5C
   Hoerstrup S. P., 2000, CIRCULATION, V102, P11144
   Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4
   Hoerstrup SP, 2000, TISSUE ENG, V6, P75, DOI 10.1089/107632700320919
   Hoerstrup SP, 2006, CIRCULATION S1, V114, P1159
   Hofman A.S., 2002, ADV DRUG DELIV REV, V54, P3
   Hong Y., 2009, BIOMATERIALS, V13, P2457
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Humphrey JD, 2002, MATH MOD METH APPL S, V12, P407, DOI 10.1142/S0218202502001714
   Huynh TN, 2010, ANN BIOMED ENG, V38, P2226, DOI 10.1007/s10439-010-0045-z
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Institute A.N.S., 2000, ANSI 2000 CARD IMPL
   Isenberg BC, 2006, MATER TODAY, V9, P54, DOI 10.1016/S1369-7021(06)71743-6
   Ismagilov RF, 2007, CURR OPIN CHEM BIOL, V11, P604, DOI 10.1016/j.cbpa.2007.10.003
   Iwai A., 2005, ANN THORAC SURG, V80, P1821
   Iwai S, 2004, J THORAC CARDIOV SUR, V128, P472, DOI 10.1016/j.jtcvs.2004.04.013
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Iyer RK, 2009, J BIOMED MATER RES A, V89A, P616, DOI 10.1002/jbm.a.32014
   James NR, 2006, BIOMATERIALS, V27, P160, DOI 10.1016/j.biomaterials.2005.05.099
   Jawad H, 2007, J TISSUE ENG REGEN M, V1, P327, DOI 10.1002/term.46
   Jawad H, 2008, BRIT MED BULL, V87, P31, DOI 10.1093/bmb/ldn026
   Jin JY, 2009, EUR J HEART FAIL, V11, P147, DOI 10.1093/eurjhf/hfn017
   Jockenhoevel S, 2001, THORAC CARDIOV SURG, V49, P287, DOI 10.1055/s-2001-17807
   Jung JP, 2009, BIOMATERIALS, V30, P2400, DOI 10.1016/j.biomaterials.2009.01.033
   Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102
   Ke Qingen, 2005, Shengli Xuebao, V57, P673
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kloxin AM, 2010, BIOMATERIALS, V31, P1, DOI 10.1016/j.biomaterials.2009.09.025
   Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494
   Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051
   Kofidis T, 2002, J THORAC CARDIOV SUR, V124, P63, DOI 10.1067/mtc.2002.121971
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kong HJ, 2004, ADV MATER, V16, P1917, DOI 10.1002/adma.200400014
   Kortsmit J, 2009, TISSUE ENG PART C-ME, V15, P707, DOI [10.1089/ten.tec.2008.0658, 10.1089/ten.TEC.2008.0658]
   Kortsmit J, 2009, TISSUE ENG PT A, V15, P797, DOI 10.1089/ten.tea.2008.0197
   Krahn KN, 2006, ANAL BIOCHEM, V350, P177, DOI 10.1016/j.ab.2006.01.013
   Kraitchman DL, 2003, CIRCULATION, V107, P2290, DOI 10.1161/01.CIR.0000070931.62772.4E
   Krenning G, 2007, BIOMATERIALS, V28, P1470, DOI 10.1016/j.biomaterials.2006.11.017
   Krenning G, 2008, TRENDS CARDIOVAS MED, V18, P312, DOI 10.1016/j.tcm.2009.01.004
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   L'Hereux N., 2001, FASEB J, V15, P515
   L'Hereux N., 2006, NAT MED, V12, P361
   Landa N, 2008, CIRCULATION, V117, P1388, DOI 10.1161/CIRCULATIONAHA.107.727420
   LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72
   Lee KY, 2000, NATURE, V408, P998
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Leor J, 2009, J AM COLL CARDIOL, V54, P1014, DOI 10.1016/j.jacc.2009.06.010
   Li M, 2006, J BIOMED MATER RES A, V79A, P963, DOI 10.1002/jbm.a.30833
   Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532
   Lin YD, 2010, CIRCULATION, V122, pS132, DOI 10.1161/CIRCULATIONAHA.110.939512
   Liu JY, 2007, CARDIOVASC RES, V75, P618, DOI 10.1016/j.cardiores.2007.04.018
   Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Ma HY, 2010, ADV FUNCT MATER, V20, P2833, DOI 10.1002/adfm.201000922
   Madden L.R., 2010, P NATL ACAD SCI AUG, DOI [10.1073/Proc.Nat.Acad.Sci.1006442107, DOI 10.1073/PROC.NAT.ACAD.SCI.1006442107]
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Maidhof R., 2010, BIOTECHNOL PROGR, V22, P565
   Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8
   Marler JJ, 1998, ADV DRUG DELIVER REV, V33, P165, DOI 10.1016/S0169-409X(98)00025-8
   Martens TP, 2009, CELL TRANSPLANT, V18, P297, DOI 10.3727/096368909788534915
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   Matsubayashi K., 2003, CIRCULATION S1, V108, P11219
   Matsumura G, 2003, BIOMATERIALS, V24, P2303, DOI 10.1016/S0142-9612(03)00043-7
   Matsumura G, 2006, TISSUE ENG, V12, P3075, DOI 10.1089/ten.2006.12.3075
   McDevitt T, 2002, J BIOMATER RES A, V66A, P586
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   Mirensky TL, 2010, J PEDIATR SURG, V45, P1299, DOI 10.1016/j.jpedsurg.2010.02.102
   Mirensky TL, 2009, J PEDIATR SURG, V44, P1127, DOI 10.1016/j.jpedsurg.2009.02.035
   Mol A, 2005, ANN BIOMED ENG, V33, P1778, DOI 10.1007/s10439-005-8025-4
   Mol A, 2006, CIRCULATION, V114, P1152
   Mol A, 2009, EXPERT REV MED DEVIC, V6, P259, DOI [10.1586/erd.09.12, 10.1586/ERD.09.12]
   Mulder WJM, 2006, NANO LETT, V6, P1, DOI 10.1021/nl051935m
   Naito H, 2006, CIRCULATION, V114, P172, DOI DOI 10.1161/CIRCULATIONAHA.105.001560
   Narita Y, 2004, TISSUE ENG, V10, P1224, DOI 10.1089/ten.2004.10.1224
   Nemir S, 2010, ANN BIOMED ENG, V38, P2, DOI 10.1007/s10439-009-9811-1
   NEREM RM, 1991, ANN BIOMED ENG, V19, P529, DOI 10.1007/BF02367396
   Nieponice A, 2010, TISSUE ENG PT A, V16, P1215, DOI 10.1089/ten.TEA.2009.0427
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Oh SH, 2009, BIOMATERIALS, V30, P757, DOI 10.1016/j.biomaterials.2008.09.065
   Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684
   Pallante Benedetta A, 2006, Am Heart Hosp J, V4, P95, DOI 10.1111/j.1541-9215.2006.04651.x
   Patterson J, 2010, BIOMATERIALS, V31, P7836, DOI 10.1016/j.biomaterials.2010.06.061
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pektok E, 2008, CIRCULATION, V118, P2563, DOI 10.1161/CIRCULATIONAHA.108.795732
   Phelps EA, 2010, P NATL ACAD SCI USA, V107, P3323, DOI 10.1073/pnas.0905447107
   Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]
   Place ES, 2009, CHEM SOC REV, V38, P1139, DOI 10.1039/b811392k
   Plouffe BD, 2007, LANGMUIR, V23, P5050, DOI 10.1021/la0700220
   Poirier-Quinot M., 2009, TISSUE ENG PART C-ME, V16, P185
   Puvimanasinghe JPA, 2004, HEART, V90, P1172, DOI 10.1136/hrt.2003.013102
   Rabkin E, 2002, J HEART VALVE DIS, V11, P308
   Radisic M, 2005, AM J PHYSIOL-HEART C, V288, pH1278, DOI 10.1152/ajpheart.00787.2004
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2008, NAT PROTOC, V3, P719, DOI 10.1038/nprot.2008.40
   Radisic M, 2006, TISSUE ENG, V12, P2077, DOI 10.1089/ten.2006.12.2077
   Rajangam K, 2008, BIOMATERIALS, V29, P3298, DOI 10.1016/j.biomaterials.2008.04.008
   Rajangam K, 2006, NANO LETT, V6, P2086, DOI 10.1021/nl0613555
   Ravi S, 2010, REGEN MED, V5, P107, DOI 10.2217/RME.09.77
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Robinson PS, 2008, TISSUE ENG PT A, V14, P83, DOI 10.1089/ten.a.2007.0148
   Rodriguez H, 2003, ADV EXP MED BIOL, V534, P129
   Roh JD, 2010, P NATL ACAD SCI USA, V107, P4669, DOI 10.1073/pnas.0911465107
   ROSS DN, 1967, LANCET, V2, P956
   Ruiz CE, 2005, J THORAC CARDIOV SUR, V130, P477, DOI 10.1016/j.jtcvs.2005.04.008
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Sacks MS, 2009, ANNU REV BIOMED ENG, V11, P289, DOI 10.1146/annurev-bioeng-061008-124903
   Sacks MS, 2009, J BIOMECH, V42, P1804, DOI 10.1016/j.jbiomech.2009.05.015
   Sales VL, 2007, TISSUE ENG, V13, P525, DOI 10.1089/ten.2006.0128
   Sales VL, 2007, CIRCULATION, V116, P155
   SANDUSKY GE, 1995, J SURG RES, V58, P415, DOI 10.1006/jsre.1995.1064
   SANDUSKY GE, 1992, AM J PATHOL, V140, P317
   Schenke-Layland K, 2003, CARDIOVASC RES, V60, P497, DOI 10.1016/j.cardiores.2003.09.002
   Schmidt D, 2010, J AM COLL CARDIOL, V56, P510, DOI 10.1016/j.jacc.2010.04.024
   Schnell AM, 2001, THORAC CARDIOV SURG, V49, P221, DOI 10.1055/s-2001-16113
   Schoen FJ, 2008, CIRCULATION, V118, P1864, DOI 10.1161/CIRCULATIONAHA.108.805911
   SCHWARTZ SM, 1984, PROG CARDIOVASC DIS, V26, P355, DOI 10.1016/0033-0620(84)90010-0
   Scott-Burden T., 1998, CIRCULATION, V10, P11339
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Sengers BG, 2004, J BIOMECH ENG-T ASME, V126, P82, DOI 10.1115/1.1645526
   Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543
   Shi JW, 2009, J HUAZHONG U SCI-MED, V29, P503, DOI 10.1007/s11596-009-0422-8
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Shin MK, 2008, LANGMUIR, V24, P12107, DOI 10.1021/la802155a
   Shin'oka T, 2005, J THORAC CARDIOV SUR, V129, P1330, DOI 10.1016/j.jtcvs.2004.12.047
   Shin'oka T, 2001, NEW ENGL J MED, V344, P532, DOI 10.1056/NEJM200102153440717
   Shoichet MS, 2010, MACROMOLECULES, V43, P581, DOI 10.1021/ma901530r
   Shroff K, 2010, SOFT MATTER, V6, P5064, DOI 10.1039/c0sm00321b
   Siepe M, 2007, ARTIF ORGANS, V31, P425, DOI 10.1111/j.1525-1594.2007.00385.x
   Sievers HH, 2007, J THORAC CARDIOV SUR, V134, P20, DOI 10.1016/j.jtcvs.2007.03.028
   Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601
   Silva EA, 2010, BIOMATERIALS, V31, P1235, DOI 10.1016/j.biomaterials.2009.10.052
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Simonet M, 2011, WOODHEAD PUBL MATER, P202
   Singelyn JM, 2010, J CARDIOVASC TRANSL, V3, P478, DOI 10.1007/s12265-010-9202-x
   Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146
   Sodian R, 2000, ASAIO J, V46, P107, DOI 10.1097/00002480-200001000-00025
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   Sodian R., 2000, CIRCULATION, V102, P11122
   Song YS, 2009, ANAL BIOANAL CHEM, V395, P185, DOI 10.1007/s00216-009-2935-1
   Soulls JV, 2006, J BIOMECH, V39, P742, DOI 10.1016/j.jbiomech.2004.12.026
   Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007
   Stamatialis DF, 2008, J MEMBRANE SCI, V308, P1, DOI 10.1016/j.memsci.2007.09.059
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Stegemann JP, 2007, TISSUE ENG, V13, P2601, DOI 10.1089/ten.2007.0196
   Stekelenburg M, 2009, TISSUE ENG PT A, V15, P1081, DOI 10.1089/ten.tea.2008.0183
   Stella JA, 2008, BIOMATERIALS, V29, P3228, DOI 10.1016/j.biomaterials.2008.04.029
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stickler P, 2010, ACTA BIOMATER, V6, P2448, DOI 10.1016/j.actbio.2010.01.041
   Stroman PW, 1999, MAGNET RESON MED, V42, P210, DOI 10.1002/(SICI)1522-2594(199907)42:1<210::AID-MRM29>3.0.CO;2-Q
   Stupp S.I., 2010, NANO LETT, V2010, DOI [10.1021/nl103567y, DOI 10.1021/NI103567Y]
   Sutherland FWH, 2005, CIRCULATION, V111, P2783, DOI 10.1161/CIRCULATIONAHA.104.498378
   SWANSON WM, 1974, CIRC RES, V35, P871, DOI 10.1161/01.RES.35.6.871
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, P1451
   Sy JC, 2010, J CARDIOVASC TRANSL, V3, P461, DOI 10.1007/s12265-010-9210-x
   Syedain Z. H., 2010, BIOMATERIALS, V32, P714
   Syedain ZH, 2008, P NATL ACAD SCI USA, V105, P6537, DOI 10.1073/pnas.0711217105
   Syedain ZH, 2009, BIOMATERIALS, V30, P4078, DOI 10.1016/j.biomaterials.2009.04.027
   Takahashi H, 2009, ANN THORAC SURG, V88, P1269, DOI 10.1016/j.athoracsur.2009.04.087
   Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263
   TERRACIO L, 1988, IN VITRO CELL DEV B, V24, P53
   Toh YC, 2006, NANO TODAY, V1, P34, DOI 10.1016/S1748-0132(06)70078-0
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Torikai K, 2008, J THORAC CARDIOV SUR, V136, P37, DOI 10.1016/j.jtcvs.2007.06.039
   Tschoeke B, 2009, TISSUE ENG PT A, V15, P1909, DOI 10.1089/ten.tea.2008.0499
   Uhlenheuer DA, 2010, CHEM SOC REV, V39, P2817, DOI 10.1039/b820283b
   Ulijn RV, 2006, J MATER CHEM, V16, P2217, DOI 10.1039/b601776m
   VACANTI JP, 1999, LANCET S1, V354, pS132
   van Andel CJ, 2003, ANN THORAC SURG, V76, P58, DOI 10.1016/S0003-4975(03)00263-7
   Van Lieshout MI, 2006, J BIOMAT SCI-POLYM E, V17, P77, DOI 10.1163/156856206774879153
   Vaz CM, 2005, ACTA BIOMATER, V1, P575, DOI 10.1016/j.actbio.2005.06.006
   Vaziri A, 2008, NAT MATER, V7, P15, DOI 10.1038/nmat2040
   VESELY I, 1992, J BIOMECH, V25, P101, DOI 10.1016/0021-9290(92)90249-Z
   Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002
   Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI 10.1089/ten.TEB.2009.0352
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   Wall ST, 2006, CIRCULATION, V114, P2627, DOI 10.1161/CIRCULATIONAHA.106.657270
   Wan ACA, 2010, ADV DRUG DELIVER REV, V62, P731, DOI 10.1016/j.addr.2010.02.002
   Wang HB, 2010, J CELL MOL MED, V14, P1044, DOI 10.1111/j.1582-4934.2010.01046.x
   Webber MJ, 2010, J INTERN MED, V267, P71, DOI 10.1111/j.1365-2796.2009.02184.x
   Webber MJ, 2010, J TISSUE ENG REGEN M, V4, P600, DOI 10.1002/term.273
   Webber MJ, 2010, ACTA BIOMATER, V6, P3, DOI 10.1016/j.actbio.2009.07.031
   WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4
   Weinberg EJ, 2010, BIOMECH MODEL MECHAN, V9, P373, DOI 10.1007/s10237-009-0181-2
   White JK, 2005, ANN THORAC SURG, V80, P704, DOI 10.1016/j.athoracsur.2004.08.063
   Winter EM, 2009, CIRC-HEART FAIL, V2, P643, DOI 10.1161/CIRCHEARTFAILURE.108.843722
   Woolfson DN, 2010, CHEM SOC REV, V39, P3464, DOI 10.1039/c0cs00032a
   World Health Organization, 2009, 317 WHO
   Xiang Z, 2006, TISSUE ENG, V12, P2467, DOI 10.1089/ten.2006.12.2467
   Xu HH, 2008, J BIOSCI BIOENG, V106, P515, DOI 10.1263/jbb.106.515
   Yang MC, 2009, BIOMATERIALS, V30, P3757, DOI 10.1016/j.biomaterials.2009.03.057
   Yokota T, 2008, J THORAC CARDIOV SUR, V136, P900, DOI 10.1016/j.jtcvs.2008.02.058
   Yuen WW, 2010, P NATL ACAD SCI USA, V107, P17933, DOI 10.1073/pnas.1001192107
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
   Zammaretti P, 2004, CURR OPIN BIOTECH, V15, P430, DOI 10.1016/j.copbio.2004.08.007
   Zelzer M, 2010, CHEM SOC REV, V39, P3351, DOI 10.1039/c0cs00035c
   Zhang G, 2006, TISSUE ENG, V12, P9, DOI 10.1089/ten.2006.12.9
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhao XB, 2010, CHEM SOC REV, V39, P3480, DOI 10.1039/b915923c
   Zhong SP, 2005, BIOMACROMOLECULES, V6, P2998, DOI 10.1021/bm050318p
   Zhou M, 2009, BIOMATERIALS, V30, P2523, DOI 10.1016/j.biomaterials.2009.01.010
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
   Zuurbier CJ, 1999, CARDIOVASC RES, V44, P488, DOI 10.1016/S0008-6363(99)00231-X
NR 329
TC 115
Z9 117
U1 2
U2 108
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR 30
PY 2011
VL 63
IS 4-5
SI SI
BP 221
EP 241
DI 10.1016/j.addr.2011.01.007
PG 21
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 788GI
UT WOS:000292433000005
PM 21277921
DA 2018-10-20
ER

PT J
AU Feil, G
   Daum, L
   Amend, B
   Maurer, S
   Renninger, M
   Vaegler, M
   Seibold, J
   Stenzl, A
   Sievert, KD
AF Feil, Gerhard
   Daum, Lisa
   Amend, Bastian
   Maurer, Sabine
   Renninger, Markus
   Vaegler, Martin
   Seibold, Joerg
   Stenzl, Arnulf
   Sievert, Karl-Dietrich
TI From tissue engineering to regenerative medicine in urology - The
   potential and the pitfalls
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE Cell-based therapy; Biomaterial; Bioartificial tissue; Urothelium;
   Urinary tract; Kidney; Bladder; Urethra; Urethral sphincter; Stem cells
ID ANTERIOR URETHRAL STRICTURES; MESENCHYMAL STEM-CELLS; BLADDER WASHINGS;
   SMOOTH-MUSCLE; UROTHELIUM; BIOMATERIALS; MATRIX; DIFFERENTIATION;
   RECONSTRUCTION; INCONTINENCE
AB Tissue engineering is a promising technique for the development of biological substitutes that can restore, maintain, or improve tissue function. The creation of human tissue-engineered products, generated of autologous somatic cells or adult stem cells with or without seeding of biocompatible matrices is a vision to resolve the lack of tissues and organs for transplantation and to offer new options for reconstructive surgery. Tissue engineering in urology aims at the reconstruction of the urinary tract by creating anatomically and functionally equal tissue. It is a rapidly evolving field in basic research and the transfer into the clinic has yet to be realized. Necessary steps from bench to bed are the proof of principle in animal models and the proof of concept in clinical trials following good manufacturing practice and ethical and legal requirements for human tissue-engineered products. Up to now, obstacles still occur in the neovascularization of implants and ingrowth of nerves in vivo. Moreover the harvesting of mesenchymal stem cells out of bone marrow as well as the explant of urothelial cells yet demands rather invasive surgery to achieve a successful outcome. Thus, other cell sources and harvesting techniques like placenta and adipose tissue for mesenchymal stem cells and bladder irrigation for urothelial cells require closer investigation. (C) 2010 Published by Elsevier B.V.
C1 [Feil, Gerhard; Daum, Lisa; Amend, Bastian; Maurer, Sabine; Renninger, Markus; Vaegler, Martin; Seibold, Joerg; Stenzl, Arnulf; Sievert, Karl-Dietrich] Univ Tubingen, Dept Urol, D-72076 Tubingen, Germany.
RP Sievert, KD (reprint author), Univ Tubingen, Dept Urol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.
EM karl.sievert@med.uni-tuebingen.de
CR Albersen M, 2010, J SEX MED, V7, P3331, DOI 10.1111/j.1743-6109.2010.01875.x
   Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Azzarello J, 2007, BIOMED MATER, V2, P55, DOI 10.1088/1748-6041/2/2/001
   Cannon G. M., 2010, J PEDIAT UROL, V6, pS82
   CONOLLY SS, 2008, WORLD J UROL, V26, P333
   Dankers PYW, 2010, MACROMOL BIOSCI, V10, P1345, DOI 10.1002/mabi.201000146
   Davis NF, 2010, J UROLOGY, V184, P2246, DOI 10.1016/j.juro.2010.07.038
   Drost AC, 2009, ANN NY ACAD SCI, V1176, P135, DOI 10.1111/j.1749-6632.2009.04610.x
   EBERLI D, 2007, UROLOGE A, V46, pS32
   El Kassaby A, 2008, J UROLOGY, V179, P1432, DOI 10.1016/j.juro.2007.11.101
   Feil G, 2008, UROLOGE, V47, P1091, DOI 10.1007/s00120-008-1849-4
   FEIL G, 2008, UROLOGE A, V47, P1094, DOI DOI 10.1007/S00120-008-1849-4
   Feil G, 2008, EUR UROL, V53, P1066, DOI 10.1016/j.eururo.2007.10.026
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   Fiala R, 2007, EUR UROL, V51, P1702, DOI 10.1016/j.eururo.2007.01.099
   Fuchs JR, 2001, ANN THORAC SURG, V72, P577, DOI 10.1016/S0003-4975(01)02820-X
   HUANG HC, 2010, J UROLOGY, V183, P1232
   JOHN H, 2009, J UROL UROGYNAKOL, V16, P7
   Joraku A, 2009, METHODS, V47, P129, DOI 10.1016/j.ymeth.2008.09.005
   Lanza RP, 2002, NAT BIOTECHNOL, V20, P689, DOI 10.1038/nbt703
   Lin CS, 2010, HISTOL HISTOPATHOL, V25, P807, DOI 10.14670/HH-25.807
   Liu Y, 2009, BIOMATERIALS, V30, P3865, DOI 10.1016/j.biomaterials.2009.04.008
   Mauney JR, 2011, BIOMATERIALS, V32, P808, DOI 10.1016/j.biomaterials.2010.09.051
   Maurer S, 2005, UROLOGE, V44, P738, DOI 10.1007/s00120-005-0847-z
   Mitterberger M, 2008, EUR UROL, V53, P169, DOI 10.1016/j.eururo.2007.07.026
   Mitterberger M, 2007, BJU INT, V100, P1081, DOI 10.1111/j.1464-410X.2007.07119.x
   Nagele U, 2008, EUR UROL, V54, P1414, DOI 10.1016/j.eururo.2008.01.072
   Ram-Liebig G, 2006, WORLD J UROL, V24, P429, DOI 10.1007/s00345-006-0104-0
   Selim M, 2011, BJU INT, V107, P296, DOI 10.1111/j.1464-410X.2010.09310.x
   Sharma AK, 2010, BIOMATERIALS, V31, P6207, DOI 10.1016/j.biomaterials.2010.04.054
   Sievert KD, 2007, UROLOGE, V46, P1224, DOI 10.1007/s00120-007-1486-3
   Sievert KD, 2001, J UROLOGY, V165, P2096, DOI 10.1016/S0022-5347(05)66301-X
   Soker S, 2000, WORLD J UROL, V18, P10, DOI 10.1007/PL00007070
   Sutherland RS, 1996, J UROLOGY, V156, P571, DOI 10.1016/S0022-5347(01)65755-0
   Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001
   Wood D, 2008, CURR OPIN UROL, V18, P564, DOI 10.1097/MOU.0b013e32830f9402
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Yoo HS, 2009, ADV DRUG DELIVER REV, V61, P1033, DOI 10.1016/j.addr.2009.07.007
NR 38
TC 12
Z9 16
U1 3
U2 21
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD APR 30
PY 2011
VL 63
IS 4-5
SI SI
BP 375
EP 378
DI 10.1016/j.addr.2010.12.003
PG 4
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 788GI
UT WOS:000292433000017
PM 21167237
DA 2018-10-20
ER

PT J
AU Oh, ST
   Kim, WR
   Kim, SH
   Chung, YC
   Park, JS
AF Oh, Seung-Taek
   Kim, Woo-Ram
   Kim, Sung-Hoon
   Chung, Yong-Chan
   Park, Jong-Shin
TI The Preparation of Polyurethane Foam Combined with pH-sensitive
   Alginate/Bentonite Hydrogel for Wound Dressings
SO FIBERS AND POLYMERS
LA English
DT Article
DE pH-sensitive; Hydrogel; Polyurethane; Wound healing; Alginate; Bentonite
ID DRUG-DELIVERY; ALGINATE HYDROGELS; CONTROLLED-RELEASE; INTERNAL
   GELATION; CROSS-LINKING; BENTONITE; MICROSPHERES; BEHAVIOR; BEADS
AB Polyurethane (PU) foam was combined with protein drug-loaded pH-sensitive alginate-bentonite hydrogel for wound dressings. Alginate is a linear copolymer composed of 1-4-linked beta-D-mannuronic acid (M) and its c-5-epimer alpha-L-guluronic acid (G). The amount of (M) and (G) and their sequential distribution are varied depending on the alginate source. Soluble sodium alginate can become a hydrogel when cross-linked with divalent cations and has widespread applications in the food, drink, pharmaceutical and bioengineering industries. Recently, it has been also proposed as a biomaterial for drug delivery systems. Bentonites are the natural inorganic polymers consisting of a large proportion of expandable clay minerals with a three-layer structure such as montmorillonite, beidellite, nontronite, etc. They are important adjutants and supports for medical products, and they have many useful physicochemical, mechanical, and biological properties such as absence of toxicity, indifference to other raw materials, sorption, swelling, and complex formation properties. Alginate-bentonite hydrogels were prepared at concentration ratios of 10/0, 7/3, 5/5, 3/7. PU foams were prepared using hydrophilic polyols. We investigated the controlled release of a protein drug from PU foam combined with alginate-bentonite hydrogel at different pH values of 4.2, 5.2, 7.2, 8.2. The mechanical properties and cytotoxicity tests of this foam were also studied.
C1 [Oh, Seung-Taek; Kim, Woo-Ram; Kim, Sung-Hoon; Park, Jong-Shin] Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 151742, South Korea.
   [Oh, Seung-Taek; Kim, Woo-Ram; Kim, Sung-Hoon; Park, Jong-Shin] Intelligent Text Syst Res Ctr, Seoul 151742, South Korea.
   [Oh, Seung-Taek; Kim, Woo-Ram; Kim, Sung-Hoon; Park, Jong-Shin] Res Inst Agr & Life Sci, Seoul 151742, South Korea.
   [Chung, Yong-Chan] Univ Suwon, Dept Chem, Suwon 445743, South Korea.
RP Park, JS (reprint author), Seoul Natl Univ, Dept Biosyst & Biomat Sci & Engn, Seoul 151742, South Korea.
EM jongshin@snu.ac.kr
FU Ministry of Education, Science and Technology [R11-2005-065]
FX This research was supported by Basic Science Research Program through
   the National Research Foundation of Korea (NRF) funded by the Ministry
   of Education, Science and Technology (R11-2005-065).
CR Aslani P, 1996, J CONTROL RELEASE, V42, P75, DOI 10.1016/0168-3659(96)01369-7
   Chan LW, 2006, CARBOHYD POLYM, V63, P176, DOI 10.1016/j.carbpol.2005.07.033
   Chan LW, 2002, INT J PHARM, V242, P259, DOI 10.1016/S0378-5173(02)00170-9
   Chen SC, 2004, J CONTROL RELEASE, V96, P285, DOI 10.1016/j.jconrel.2004.02.002
   Chretien C, 2005, INT J PHARM, V304, P18, DOI 10.1016/j.ijpharm.2005.06.030
   Dong ZF, 2006, J MEMBRANE SCI, V280, P37, DOI 10.1016/j.memsci.2006.01.002
   Eiselt P, 2000, BIOMATERIALS, V21, P1921, DOI 10.1016/S0142-9612(00)00033-8
   Finotelli PV, 2004, MAT SCI ENG C-BIO S, V24, P625, DOI 10.1016/j.msec.2004.08.005
   GRAY CJ, 1988, BIOTECHNOL BIOENG, V31, P607, DOI 10.1002/bit.260310613
   Hennink WE, 2002, ADV DRUG DELIVER REV, V54, P13, DOI 10.1016/S0169-409X(01)00240-X
   Herrera F.J.G., 2006, J AGR FOOD CHEM, V54, P10053
   HODSDON AC, 1995, J CONTROL RELEASE, V33, P143, DOI 10.1016/0168-3659(94)00076-7
   Hoffman A. S., 2002, ADV DRUG DELIVERY RE, V43, P3, DOI DOI 10.1016/S0169-409X(01)00239-3
   KIM CK, 1992, INT J PHARM, V79, P11, DOI 10.1016/0378-5173(92)90088-J
   Kown JY, 2006, FIBER POLYM, V7, P12
   LEMMA F, 2006, INT J PHARMACEUT, V312, P151
   LIENMANN P, 1982, INORG CHEM, V21, P1586
   Liu YH, 2006, MACROMOL CHEM PHYSIC, V207, P1842, DOI 10.1002/macp.200600241
   Mostafa BA, 2007, J APPL POLYM SCI, V104, P3886, DOI 10.1002/app.26005
   Oh ST, 2009, FIBER POLYM, V10, P21, DOI 10.1007/s12221-009-0021-0
   Paciorek-Sadowska J, 2006, J APPL POLYM SCI, V102, P5918, DOI 10.1002/app.25093
   PEREZ MF, 2000, CHEMOSPHERE, V41, P1495
   Sakai S, 2004, BIOCHEM ENG J, V22, P19, DOI 10.1016/j.bej.2004.07.010
   Seo WJ, 2006, J APPL POLYM SCI, V101, P2879, DOI 10.1002/app.23357
   Tada D, 2007, MAT SCI ENG C-BIO S, V27, P870, DOI 10.1016/j.msec.2006.10.008
   THOMSON T, 2000, DESIGN APPL HYDROPHI, P11
   Tien YM, 2007, POWDER TECHNOL, V173, P140, DOI 10.1016/j.powtec.2006.11.023
   Yilgor I, 1999, POLYMER, V40, P5575, DOI 10.1016/S0032-3861(98)00766-6
NR 28
TC 19
Z9 20
U1 5
U2 110
PU KOREAN FIBER SOC
PI SEOUL
PA KOREA SCIENCE TECHNOLOGY CTR #501 635-4 YEOGSAM-DONG, KANGNAM-GU, SEOUL
   135-703, SOUTH KOREA
SN 1229-9197
J9 FIBER POLYM
JI Fiber. Polym.
PD APR 30
PY 2011
VL 12
IS 2
BP 159
EP 165
DI 10.1007/s12221-011-0159-4
PG 7
WC Materials Science, Textiles; Polymer Science
SC Materials Science; Polymer Science
GA 746BP
UT WOS:000289216900002
DA 2018-10-20
ER

PT J
AU Li, DH
   Ma, Y
AF Li, Dehai
   Ma, Ying
TI Impact of enzymatic hydrolysis on the crystal structure, and thermal and
   textural properties of corn starch
SO AFRICAN JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE Corn starch; crystal structure; thermal properties; textural properties
ID AMYLOPECTIN FRACTIONS; MAIZE STARCHES; AMYLOSE; STRANDS; POLYMER; POTATO
AB Corn starch has been widely used in biomaterial industry as one of the raw materials. The properties of starch such as annealing and the different ratio of amylose and amylopectin in different starch limit its application in production. These properties play a vital role in establishing relationships between other starches in structures and functions. Normal corn starches were treated with isoamylase for different hours and the gelatinization phenomena was observed with differential scanning calorimetry (DSC). The parameters of fracturability, cohesiveness, springiness and adhesive force were all detected by textural profiles analysis. After treatment with isoamylase, the content of amylose chains was increased, hardness and springiness of starch were all enhanced, while cohesiveness and adhesive presented an opposite trend. It was the different ratio of amylose and amylopectin that led to changes in physicochemical properties.
C1 [Li, Dehai; Ma, Ying] Harbin Inst Technol, Sch Food Sci & Engn, Harbin 150090, Heilongjiang, Peoples R China.
   [Li, Dehai] NE Forestry Univ, Coll Forestry, Harbin 150040, Heilongjiang, Peoples R China.
RP Ma, Y (reprint author), Harbin Inst Technol, Sch Food Sci & Engn, 202 Haihe Rd, Harbin 150090, Heilongjiang, Peoples R China.
EM maying@hit.edu.cn
FU Critical Project of Heilongjiang Province, China [GA06B401-4]
FX This study was supported by the Critical Project of Heilongjiang
   Province, China, under the contact No. GA06B401-4.
CR ATSUO K, 1996, CARBOHYD RES, V287, P255
   Canigueral N, 2009, CHEM ENG SCI, V64, P2651, DOI 10.1016/j.ces.2009.02.006
   Cheetham NWH, 1997, CARBOHYD POLYM, V33, P251, DOI 10.1016/S0144-8617(97)00033-7
   CHRASTIL J, 1987, CARBOHYD RES, V159, P154, DOI 10.1016/S0008-6215(00)90013-2
   DANIELE CB, 2009, ULTRAMICROSCOPY, V109, P1089
   Fringant C, 1996, POLYMER, V37, P2663, DOI 10.1016/0032-3861(96)87626-9
   GAO QY, 1993, FOOD SCI, V165, P8
   GUPTA PK, 2007, J TEXTURE STUD, V38, P153
   HIERONIM S, 2005, SURFACE COATINGS TEC, V200, P539
   JIIRGEN L, 1998, POLYM DEGRADARION ST, V59, P245
   Karakatsanis A, 2000, J FOOD ENG, V46, P251, DOI 10.1016/S0260-8774(00)00085-6
   Kim JO, 1997, STARCH-STARKE, V49, P71, DOI 10.1002/star.19970490207
   Kyungsoo Woo, 1997, Carbohydrate Polymers, V33, P263, DOI 10.1016/S0144-8617(97)00037-4
   LOHMAR RL, 1954, NO UTILIZATION RES B, V76, P4608
   Ma Y, 2006, J FOOD ENG, V73, P297, DOI 10.1016/j.jfoodeng.2005.01.023
   Matveev YI, 2001, CARBOHYD POLYM, V44, P151, DOI 10.1016/S0144-8617(00)00211-3
   Mua JP, 1997, J AGR FOOD CHEM, V45, P3848, DOI 10.1021/jf9608783
   Mua JP, 1997, J AGR FOOD CHEM, V45, P3840, DOI 10.1021/jf960877a
   NARA S, 1983, STARKE, V35, P407, DOI 10.1002/star.19830351202
   NORMAN WH, 1998, CARBOHYD POLYM, V36, P277
   OLIVIA VL, 2010, J FOOD ENG, V100, P160
   ROSANE MD, 2005, MACROMOLECULAR S, V229, P258
   Sakina Khatoon, 2009, Food Research International, V42, P1426
   TZANKOVA DN, 2007, POLYM DEGRADATION ST, V92, P630
   Vilaseca F, 2007, PROCESS BIOCHEM, V42, P329, DOI 10.1016/j.procbio.2006.09.004
   Wang LF, 2001, STARCH-STARKE, V53, P570, DOI 10.1002/1521-379X(200111)53:11<570::AID-STAR570>3.0.CO;2-S
   Wang XL, 2004, ACTA MATER, V52, P4899, DOI 10.1016/j.actamat.2004.06.044
NR 27
TC 2
Z9 2
U1 0
U2 9
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1684-5315
J9 AFR J BIOTECHNOL
JI Afr. J. Biotechnol.
PD APR 25
PY 2011
VL 10
IS 17
BP 3430
EP 3435
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 764XF
UT WOS:000290667200020
DA 2018-10-20
ER

PT J
AU Rai, R
   Keshavarz, T
   Roether, JA
   Boccaccini, AR
   Roy, I
AF Rai, R.
   Keshavarz, T.
   Roether, J. A.
   Boccaccini, A. R.
   Roy, I.
TI Medium chain length polyhydroxyalkanoates, promising new biomedical
   materials for the future
SO MATERIALS SCIENCE & ENGINEERING R-REPORTS
LA English
DT Review
DE Polyhydroxyalkanoates; Biomedical applications; Polyesters;
   Poly(3-hydroxyoctanoate); Tissue engineering; Composites
ID ARTICULAR-CARTILAGE CHONDROCYTES; TISSUE ENGINEERING APPLICATIONS;
   PSEUDOMONAS-OLEOVORANS; IN-VITRO; MECHANICAL-PROPERTIES; BACTERIAL
   POLYESTERS; COMPOSITE SCAFFOLDS; MICROBIAL SYNTHESIS; DRUG-DELIVERY;
   POLY 3-HYDROXYBUTYRATE-CO-3-HYDROXYHEXANOATE
AB Medium chain length polyhydroxyalkanoates, mcl-PHAs (C-6-C-14 carbon atoms), are polyesters of hydroxyalkanoates produced mainly by fluorescent Pseudomonads under unbalanced growth conditions. These mcl-PHAs which can be produced using renewable resources are biocompatible, biodegradable and thermoprocessable. They have low crystallinity, low glass transition temperature, low tensile strength and high elongation to break, making them elastomeric polymers. Mcl-PHAs and their copolymers are suitable for a range of biomedical applications where flexible biomaterial:. are required, such as heart valves and other cardiovascular applications as well as matrices for controlled drug delivery. Mcl-PHAs are more structurally diverse than short chain length PHAs and hence can be more readily tailored for specific applications. Composites have also been fabricated using mcl-PHAs and their copolymers, such as poly (3-hydroxyoctanoate) [P(3HO)] combined with single walled carbon nanotubes and poly(3-hydroxbutyrate-co-3-hydroxyhexanoate) [P(3HB-co-3HHx)] combined with hydroxyapatite. Because of these attractive properties of biodegradability, biocompatibility and tailorability, Mcl-PHAs and their composites are being increasingly used for biomedical applications. However, studies remain limited mainly to P(3HO) and the copolymer P(3HB-co-3HHx), which are the only mcl-PHAs available in large quantities. In this review we have consolidated current knowledge on the properties and biomedical applications of these elastomeric mcl-PHAs, their copolymers and their composites. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Rai, R.; Keshavarz, T.; Roy, I.] Univ Westminster, Dept Mol & Appl Biosci, Sch Biosci, London W1W 6UW, England.
   [Roether, J. A.; Boccaccini, A. R.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2BP, England.
   [Boccaccini, A. R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, D-91058 Erlangen, Germany.
RP Roy, I (reprint author), Univ Westminster, Dept Mol & Appl Biosci, Sch Life Sci, London W1W 6UW, England.
EM aldo.boccaccini@ww.uni-erlangen.de; royi@wmin.ac.uk
RI Boccaccini, Aldo/C-7905-2013
FU Quintin Hogg Foundation of the University of Westminster (London, UK)
FX RR would like to thank Quintin Hogg Foundation of the University of
   Westminster (London, UK) for the financial support. Support from Dr. Ian
   Locke for the HaCaT cell culture work (University of Westminster,
   London, UK) and from Dr. Vehid Salih and Dr. Nicola Mordon (UCL Eastman
   Dental Institute, London, UK) for the SEM analysis of the HaCaT cells is
   also greatly appreciated.
CR Abraham GA, 2001, BIOMACROMOLECULES, V2, P562, DOI 10.1021/bm010018h
   ANDERSON AJ, 1990, INT J BIOL MACROMOL, V12, P102, DOI 10.1016/0141-8130(90)90060-N
   ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   ANDERSON AJ, 1992, FEMS MICROBIOL LETT, V103, P93, DOI 10.1111/j.1574-6968.1992.tb05826.x
   Arostegui SM, 1999, MACROMOLECULES, V32, P2889, DOI 10.1021/ma981482q
   Asrar J, 2002, BIOMACROMOLECULES, V3, P1006, DOI 10.1021/bm025543a
   BABU GN, 1996, INT S BACT POL
   Ballistreri A, 2001, INT J BIOL MACROMOL, V29, P107, DOI 10.1016/S0141-8130(01)00154-4
   Barbuzzi T, 2004, BIOMACROMOLECULES, V5, P2469, DOI 10.1021/bm049583l
   Bayram C, 2008, J BIOACT COMPAT POL, V23, P334, DOI 10.1177/0883911508092790
   BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977
   BYROM D, 1987, TRENDS BIOTECHNOL, V5, P246, DOI 10.1016/0167-7799(87)90100-4
   Casini E, 1997, J ENVIRON POLYM DEGR, V5, P153
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen GQ, 2001, APPL MICROBIOL BIOT, V57, P50
   Chen Q, 2008, TOPICS TISSUE ENG
   Cromwick AM, 1996, APPL MICROBIOL BIOT, V46, P464, DOI 10.1007/s002530050845
   Curley JM, 1996, MACROMOLECULES, V29, P1762, DOI 10.1021/ma951185a
   de Roo G, 2002, BIOTECHNOL BIOENG, V77, P717, DOI 10.1002/bit.10134
   Deng Y, 2003, BIOMATERIALS, V24, P4273, DOI 10.1016/S0142-9612(03)00367-3
   DESMET MJ, 1983, J BACTERIOL, V154, P870
   DOI Y, 1990, MACROMOLECULES, V23, P3705, DOI 10.1021/ma00217a027
   DOI Y, 1995, MACROMOLECULES, V28, P4822, DOI 10.1021/ma00118a007
   Dong Y, 2010, BIOMATERIALS, V31, P8921, DOI 10.1016/j.biomaterials.2010.08.001
   Durner R, 2001, BIOTECHNOL BIOENG, V72, P278, DOI 10.1002/1097-0290(20010205)72:3<278::AID-BIT4>3.3.CO;2-7
   Eggink G, 1992, IND CROP PROD, V1, P157
   Elbahloul Y, 2009, APPL ENVIRON MICROB, V75, P643, DOI 10.1128/AEM.01869-08
   FRITZSCHE K, 1990, INT J BIOL MACROMOL, V12, P92, DOI 10.1016/0141-8130(90)90059-J
   FRITZSCHE K, 1990, MAKROMOL CHEM, V191, P1957
   Furrer P, 2007, J MICROBIOL METH, V69, P206, DOI 10.1016/j.mimet.2007.01.002
   Furrer P, 2007, J CHROMATOGR A, V1143, P199, DOI 10.1016/j.chroma.2007.01.002
   GAGNON KD, 1992, RUBBER CHEM TECHNOL, V65, P761, DOI 10.5254/1.3538640
   Gao Y, 2006, EUR POLYM J, V42, P764, DOI 10.1016/j.eurpolymj.2005.09.028
   GROSS RA, 1989, MACROMOLECULES, V22, P1106, DOI 10.1021/ma00193a018
   HAHN SK, 1995, APPL ENVIRON MICROB, V61, P34
   Hang XM, 2002, FEMS MICROBIOL LETT, V212, P71, DOI 10.1016/S0378-1097(02)00713-9
   Hartmann R, 2006, BIOTECHNOL BIOENG, V93, P737, DOI 10.1002/bit.20756
   HAYWOOD GW, 1990, APPL ENVIRON MICROB, V56, P3354
   He WN, 1998, FEMS MICROBIOL LETT, V169, P45, DOI 10.1111/j.1574-6968.1998.tb13297.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Holmes P. A., 1998, DEV CRYSTALLINE POLY, V2, P1
   Imamura T, 2001, INT J BIOL MACROMOL, V29, P295, DOI 10.1016/S0141-8130(01)00179-9
   Jiang X, 2006, J MICROBIOL METH, V67, P212, DOI 10.1016/j.mimet.2006.03.015
   Jung K, 2000, MACROMOLECULES, V33, P8571, DOI 10.1021/ma000829y
   Kai Z, 2003, BIOCH ENG J, V16, P115
   Kathiraser Y, 2007, J CHEM TECHNOL BIOT, V82, P847, DOI 10.1002/jctb.1751
   Kato M, 1996, B CHEM SOC JPN, V69, P515, DOI 10.1246/bcsj.69.515
   Kim DY, 2007, J MICROBIOL, V45, P87
   Kim DY, 1998, MACROMOLECULES, V31, P4760, DOI 10.1021/ma980208t
   Kim HW, 2005, INT J BIOL MACROMOL, V36, P84, DOI 10.1016/j.ijbiomac.2005.03.016
   Kim HW, 2005, INT J BIOL MACROMOL, V35, P47, DOI 10.1016/j.ijbiomac.2004.11.007
   Kim HW, 2002, INT J BIOL MACROMOL, V30, P129, DOI 10.1016/S0141-8130(02)00012-0
   KIM SN, 1996, MACROMOLECULES, V29, P4572
   Kim YB, 1999, MACROMOLECULES, V32, P6058
   KIM YB, 1992, MACROMOLECULES, V25, P1852, DOI 10.1021/ma00033a002
   Kim YB, 1996, MACROMOLECULES, V29, P3432
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P75, DOI 10.1034/j.1600-0501.1994.050203.x
   LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LEE EY, 1995, APPL MICROBIOL BIOT, V42, P901
   Lee S.Y., 1995, BIOTECHNOL BIOENG, V49, P1
   LENZ RW, 1992, FEMS MICROBIOL LETT, V103, P207, DOI 10.1111/j.1574-6968.1992.tb05839.x
   LENZ RW, 1994, BACTERIAL SYNTHESIS
   Li HY, 2004, J MATER SCI-MATER M, V15, P1089, DOI 10.1023/B:JMSM.0000046390.09540.c2
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   LI ZT, 2008, BIOMATERIALS, V29, P3720
   Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271
   MARCHESSAULT RH, 1990, INT J BIOL MACROMOL, V12, P158
   MAROIS Y, 1999, TISSUE ENG, V5, P216
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   Matsusaki H, 1998, J BACTERIOL, V180, P6459
   Mei N, 2006, J MATER SCI-MATER M, V17, P749, DOI 10.1007/s10856-006-9686-8
   Misra SK, 2008, BIOMATERIALS, V29, P1750, DOI 10.1016/j.biomaterials.2007.12.040
   Misra SK, 2007, BIOMACROMOLECULES, V8, P2112, DOI 10.1021/bm0701954
   Misra SK, 2006, BIOMACROMOLECULES, V7, P2249, DOI 10.1021/bm060317c
   Misra SK, 2010, ACTA BIOMATER, V6, P735, DOI 10.1016/j.actbio.2009.09.023
   Misra SK, 2010, J R SOC INTERFACE, V7, P453, DOI 10.1098/rsif.2009.0255
   Misra SK, 2009, J R SOC INTERFACE, V6, P401, DOI 10.1098/rsif.2008.0278
   Mochizuki M, 1997, POLYM ADVAN TECHNOL, V8, P203
   Mosahebi A, 2002, EXP NEUROL, V173, P213, DOI 10.1006/exnr.2001.7846
   Nair LS, 2006, ADV BIOCHEM ENG BIOT, V102, P47, DOI 10.1007/b137240
   Ouyang SP, 2007, BIOMACROMOLECULES, V8, P2504, DOI 10.1021/bm0702307
   Philip S, 2007, J CHEM TECHNOL BIOT, V82, P233, DOI 10.1002/jctb.1667
   Pouton CW, 1996, ADV DRUG DELIVER REV, V18, P133, DOI 10.1016/0169-409X(95)00092-L
   PREUSTING H, 1990, MACROMOLECULES, V23, P4220, DOI 10.1021/ma00221a007
   Qu XH, 2006, BIOMATERIALS, V27, P3540, DOI 10.1016/j.biomaterials.2006.02.015
   Qu XH, 2006, BIOMATERIALS, V27, P2944, DOI 10.1016/j.biomaterials.2006.01.013
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Qu XH, 2006, J BIOMAT SCI-POLYM E, V17, P1107, DOI 10.1163/156856206778530704
   RAI R, 2010, TIMES POLYM COMPOSIT
   RAI R, 2010, THESIS U WESTMINSTER, P291
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   RAMSAY JA, 1994, BIOTECHNOL TECH, V8, P589, DOI 10.1007/BF00152152
   Renard E, 2003, MACROMOL SYMP, V197, P11, DOI 10.1002/masy.200350702
   Rhim C, 2006, PROG PEDIATR CARDIOL, V21, P185, DOI 10.1016/j.ppedcard.2005.11.006
   Sanchez RJ, 2003, EUR POLYM J, V39, P1385, DOI 10.1016/S0014-3057(03)00019-3
   Schmack G, 1998, MACROMOLECULES, V31, P644, DOI 10.1021/ma970864d
   Shangguan YY, 2006, BIOMATERIALS, V27, P2349, DOI 10.1016/j.biomaterials.2005.11.024
   Sodian R, 2002, ASAIO J, V48, P12, DOI 10.1097/00002480-200201000-00004
   Sodian R, 2000, CIRCULATION, V102, P22
   Steinbuchel A, 2003, BIOCHEM ENG J, V16, P81, DOI 10.1016/S1369-703X(03)00036-6
   Stock UA, 2000, J THORAC CARDIOV SUR, V119, P732, DOI 10.1016/S0022-5223(00)70008-0
   Stock UA, 2001, J CELL BIOCHEM, V81, P220, DOI 10.1002/1097-4644(20010501)81:2<220::AID-JCB1037>3.0.CO;2-O
   Sudesh K, 2000, PROG POLYM SCI, V25, P1503, DOI 10.1016/S0079-6700(00)00035-6
   Sun J, 2007, BIOMATERIALS, V28, P3896, DOI 10.1016/j.biomaterials.2007.05.011
   Tang HY, 2008, BIOMATERIALS, V29, P1307
   TIM DS, 1999, ANN THORAC SURG, V68, P2298
   TIMM A, 1990, APPL ENVIRON MICROB, V56, P3360
   Tobin KM, 2005, FEMS MICROBIOL LETT, V253, P111, DOI 10.1016/j.femsle.2005.09.025
   Tokiwa Y, 2004, BIOTECHNOL LETT, V26, P1181, DOI 10.1023/B:BILE.0000036599.15302.e5
   Valappil SP, 2006, EXPERT REV MED DEVIC, V3, P853, DOI 10.1586/17434440.3.6.853
   VALAPPIL SP, 2007, J APPL MICROBIOL, V104, P1624
   van der Walle GAM, 2001, ADV BIOCHEM ENG BIOT, V71, P263
   Wang L, 2010, BIOMATERIALS, V31, P1691, DOI 10.1016/j.biomaterials.2009.11.053
   Wang YW, 2005, BIOMACROMOLECULES, V6, P566, DOI 10.1021/bm049342d
   Wang YW, 2005, BIOMATERIALS, V26, P899, DOI 10.1016/j.biomaterials.2004.03.035
   Wang YW, 2005, BIOMATERIALS, V26, P755, DOI 10.1016/j.biomaterials.2004.03.023
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang ZX, 2003, J BIOSCI BIOENG, V95, P541, DOI 10.1016/S1389-1723(03)80059-2
   Ward PG, 2005, APPL ENVIRON MICROB, V71, P2046, DOI 10.1128/AEM.71.4.2046-2052.2005
   Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
   WILLIAMS SF, 2005, APPL PHAS MED PHARM
   Witholt B, 1999, CURR OPIN BIOTECH, V10, P279, DOI 10.1016/S0958-1669(99)80049-4
   Woo KM, 2002, J BONE MINER RES, V17, pS407
   Wu S, 2007, ARTIF ORGANS, V31, P689, DOI 10.1111/j.1525-1594.2007.00442.x
   Xi J, 2008, J BIOMATER APPL, V22, P293, DOI 10.1177/0885328207075425
   Xu XY, 2010, BIOMATERIALS, V31, P3967, DOI 10.1016/j.biomaterials.2010.01.132
   Yang F, 2002, J BIOMED ENG, V19, P25
   Yang M, 2004, BIOMATERIALS, V25, P1365, DOI 10.1016/j.biomaterials.2003.08.018
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Yasotha K, 2006, BIOCHEM ENG J, V30, P260, DOI 10.1016/j.bej.2006.05.008
   Young RC, 2002, BRIT J PLAST SURG, V55, P235, DOI 10.1054/bjps.2002.3798
   YUN SI, 2008, POLYM B, V6, P267
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
   Zhang L, 2007, EUR POLYM J, V43, P2975, DOI 10.1016/j.eurpolymj.2007.04.007
   Zhao K, 2003, BIOMATERIALS, V24, P1041, DOI 10.1016/S0142-9612(02)00426-X
   Zhao K, 2002, J MATER SCI-MATER M, V13, P849, DOI 10.1023/A:1016596228316
   Zheng Z, 2005, BIOMATERIALS, V26, P3537, DOI 10.1016/j.biomaterials.2004.09.041
   Zinn M, 2001, ADV DRUG DELIVER REV, V53, P5, DOI 10.1016/S0169-409X(01)00218-6
NR 140
TC 124
Z9 132
U1 3
U2 107
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0927-796X
EI 1879-212X
J9 MAT SCI ENG R
JI Mater. Sci. Eng. R-Rep.
PD APR 22
PY 2011
VL 72
IS 3
BP 29
EP 47
DI 10.1016/j.mser.2010.11.002
PG 19
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 748PE
UT WOS:000289401700001
DA 2018-10-20
ER

PT J
AU Hoffmann, N
   Mittnacht, U
   Hartmann, H
   Baumer, Y
   Kjems, J
   Oberhoffner, S
   Schlosshauer, B
AF Hoffmann, Nadine
   Mittnacht, Ursula
   Hartmann, Hanna
   Baumer, Yvonne
   Kjems, Jorgen
   Oberhoffner, Sven
   Schlosshauer, Burkhard
TI Neuronal and glial responses to siRNA-coated nerve guide implants in
   vitro
SO NEUROSCIENCE LETTERS
LA English
DT Article
DE Axonal growth; Inflammation; Migration; Polydioxanone filaments; Rat
   Schwann cells; siRNA nanoparticles
ID SCHWANN-CELLS
AB The manipulation of gene expression by RNA interference could play a key role in future neurotherapies, for example in the development of biohydrid implants to bridge nerve and spinal cord lesion gaps. Such resorbable biomaterial prostheses could serve as growth substrates together with specific siRNA to foster neuronal regeneration. To the best of our knowledge, we are the first to biofunctionalize neuronal prostheses with siRNA. We analyzed neuronal and Schwann cell responses to scrambled siRNA coated polydioxanone polymer filaments designed to imitate pro-regenerative bands of Bfingner for oriented axonal regrowth. With a view to future clinical applications we were especially interested in potentially detrimental side effects. We employed a variety of in vitro methods, including a novel impedance electrode microchamber assay, fluorescence and scanning electron microscopy, metabolic labeling and RT-PCR. We found that the application of chitosan/siRNA nanoparticles (1) did not affect glial cell motility or (2) axonal growth in contrast to other formulations, (3) only slightly reduced proliferation, and (4) did not induce inflammatory responses that might hamper axonal regeneration. The data suggest that chitosan/siRNA nanoparticle-coated polymer filaments are suitable for use in biohybrid implants with no significant side effects on neuronal and glial cells. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
C1 [Hoffmann, Nadine; Mittnacht, Ursula; Hartmann, Hanna; Baumer, Yvonne; Schlosshauer, Burkhard] Univ Tubingen, NMI Nat & Med Sci Inst, D-72770 Reutlingen, Germany.
   [Kjems, Jorgen] Univ Aarhus, Dept Mol Biol, iNANO Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark.
   [Oberhoffner, Sven] ITV Denkendorf Prod Serv GmbH, D-73770 Denkendorf, Germany.
RP Schlosshauer, B (reprint author), Univ Tubingen, NMI Nat & Med Sci Inst, Markwiesenstr 55, D-72770 Reutlingen, Germany.
EM schlosshauer@nmi.de
OI Baumer, Yvonne/0000-0001-7400-0773; Kjems, Jorgen/0000-0003-4128-9317
FU European Union EU [FP7/BMBF 13N11036]
FX We are grateful to Drs. M. Doser and A. Ullrich (ITV Denkendorf,
   Germany) for providing polymer structures, and A. P. Pego (INEB,
   Portugal) for chitosan fractions, L Grupp, E. Tetling and S. Vollmer for
   technical assistance and Ms. D. Blaurock for correcting the manuscript.
   Partially supported by the European Union EU FP7/BMBF 13N11036.
CR Funk D, 2007, EUR J CELL BIOL, V86, P207, DOI 10.1016/j.ejcb.2006.12.006
   Hajosch R, 2010, J NEUROSCI METH, V189, P205, DOI 10.1016/j.jneumeth.2010.04.007
   Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010
   LIETZ M, 2006, J BIOTECH BIOENG, V5, P99
   McCormack AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012122
   Mittnacht U, 2010, NANO LETT, V10, P3933, DOI 10.1021/nl1016909
   Oliveira H, 2010, J BIOMED MATER RES A, V95A, P801, DOI 10.1002/jbm.a.32874
   Ribeiro-Resende VT, 2009, BIOMATERIALS, V30, P5251, DOI 10.1016/j.biomaterials.2009.07.007
   Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007
   Saito Y, 2005, J BIOL CHEM, V280, P42826, DOI 10.1074/jbc.M507685200
   San Juan A, 2009, BIOMACROMOLECULES, V10, P3074, DOI 10.1021/bm900740g
   Sinis N, 2005, J NEUROSURG, V103, P1067, DOI 10.3171/jns.2005.103.6.1067
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
NR 13
TC 9
Z9 10
U1 0
U2 12
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0304-3940
EI 1872-7972
J9 NEUROSCI LETT
JI Neurosci. Lett.
PD APR 20
PY 2011
VL 494
IS 1
BP 14
EP 18
DI 10.1016/j.neulet.2011.02.043
PG 5
WC Neurosciences
SC Neurosciences & Neurology
GA 751IA
UT WOS:000289609500004
PM 21352894
DA 2018-10-20
ER

PT J
AU Shen, JF
   Yan, B
   Shi, M
   Ma, HW
   Li, N
   Ye, MX
AF Shen, Jianfeng
   Yan, Bo
   Shi, Min
   Ma, Hongwei
   Li, Na
   Ye, Mingxin
TI Synthesis of graphene oxide-based biocomposites through
   diimide-activated amidation
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE Graphene oxide; Diimade-activated amidation; Biomaterial; Bioactivity
ID CARBON NANOTUBES; DELIVERY; BIOSENSORS; SHEETS; DRUGS; CELLS
AB In this work, a novel and facile method for covalent attachment of biomaterials to graphene oxide sheets (GUS) was developed. Four conjugates were obtained via the diimide-activated amidation reaction under ambient conditions. Final products were characterized by FT-IR spectroscopy, atomic force microscopy and transmission electron microscopy. Electrochemical characterization of the composite showed that the covalently bonded biomaterial retained its bioactivity. This method may provide a way for further preparation of graphene-based biodevices. (C) 2011 Elsevier Inc. All rights reserved.
C1 [Shen, Jianfeng; Yan, Bo; Shi, Min; Ma, Hongwei; Li, Na; Ye, Mingxin] Fudan Univ, Ctr Special Mat & Technol, Shanghai 200433, Peoples R China.
RP Ye, MX (reprint author), 220 Handan Rd, Shanghai 200433, Peoples R China.
EM mxye@fudan.edu.cn
CR Agarwal S, 2010, LANGMUIR, V26, P2244, DOI 10.1021/la9048743
   Akhavan O, 2009, J PHYS CHEM C, V113, P20214, DOI 10.1021/jp906325q
   Alwarappan S, 2009, J PHYS CHEM C, V113, P8853, DOI 10.1021/jp9010313
   Compton OC, 2010, SMALL, V6, P711, DOI 10.1002/smll.200901934
   Emtsev KV, 2009, NAT MATER, V8, P203, DOI [10.1038/NMAT2382, 10.1038/nmat2382]
   He FA, 2010, CARBON, V48, P3139, DOI 10.1016/j.carbon.2010.04.052
   Huang WJ, 2002, NANO LETT, V2, P311, DOI 10.1021/n1010095i
   Huang X, 2010, SMALL, V6, P513, DOI 10.1002/smll.200902001
   HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017
   Jiang KY, 2004, J MATER CHEM, V14, P37, DOI 10.1039/b310359e
   Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719
   Li HJ, 2009, TALANTA, V79, P165, DOI 10.1016/j.talanta.2009.03.020
   Li J, 2005, ANAL BIOANAL CHEM, V383, P918, DOI 10.1007/s00216-005-0106-6
   LI X, 2009, SCIENCE, V324, P1530
   Liu Z, 2008, J AM CHEM SOC, V130, P10876, DOI 10.1021/ja803688x
   Lu CH, 2009, ANGEW CHEM INT EDIT, V48, P4785, DOI 10.1002/anie.200901479
   Murugan AV, 2009, CHEM MATER, V21, P5004, DOI 10.1021/cm902413c
   Myung S, 2010, ADV MATER, V22, P2045, DOI 10.1002/adma.200903267
   Park S, 2009, NANO LETT, V9, P1593, DOI 10.1021/nl803798y
   Patil AJ, 2009, ADV MATER, V21, P3159, DOI 10.1002/adma.200803633
   Qi XY, 2010, SMALL, V6, P663, DOI 10.1002/smll.200902221
   Rao CNR, 2010, J PHYS CHEM LETT, V1, P572, DOI 10.1021/jz9004174
   Rao CNR, 2009, ANGEW CHEM INT EDIT, V48, P7752, DOI 10.1002/anie.200901678
   Ruoff R, 2008, NAT NANOTECHNOL, V3, P10, DOI 10.1038/nnano.2007.432
   Shan CS, 2010, BIOSENS BIOELECTRON, V25, P1070, DOI 10.1016/j.bios.2009.09.024
   Shan CS, 2009, LANGMUIR, V25, P12030, DOI 10.1021/la903265p
   Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571
   Shen JF, 2010, NANO RES, V3, P339, DOI 10.1007/s12274-010-1037-x
   Shen JF, 2009, SMALL, V5, P82, DOI 10.1002/smll.200800988
   Song YJ, 2010, ADV MATER, V22, P2206, DOI 10.1002/adma.200903783
   Sun XM, 2008, NANO RES, V1, P203, DOI 10.1007/s12274-008-8021-8
   Wang DH, 2010, ACS NANO, V4, P1587, DOI 10.1021/nn901819n
   Wu JF, 2010, ELECTROCHEM COMMUN, V12, P175, DOI 10.1016/j.elecom.2009.11.020
   Wu JS, 2007, CHEM REV, V107, P718, DOI 10.1021/cr068010r
   [严兵华 Yan Binghua], 2003, [浙江大学学报. 理学版, Journal of Zhejiang University], V30, P56
   Yang HF, 2010, LANGMUIR, V26, P6708, DOI 10.1021/la100365z
   Yang WR, 2010, ANGEW CHEM INT EDIT, V49, P2114, DOI 10.1002/anie.200903463
   Yang XY, 2008, J PHYS CHEM C, V112, P17554, DOI 10.1021/jp806751k
   Yin ZY, 2010, SMALL, V6, P307, DOI 10.1002/smll.200901968
   Zhang F, 2010, J PHYS CHEM C, V114, P8469, DOI 10.1021/jp101073b
   Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680
   Zhang WT, 2009, OPT ENG, V48, DOI 10.1117/1.3081058
   Zhu J, 2008, NAT NANOTECHNOL, V3, P528, DOI 10.1038/nnano.2008.249
NR 43
TC 38
Z9 39
U1 1
U2 52
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD APR 15
PY 2011
VL 356
IS 2
BP 543
EP 549
DI 10.1016/j.jcis.2011.01.052
PG 7
WC Chemistry, Physical
SC Chemistry
GA 736XH
UT WOS:000288527800022
PM 21329939
DA 2018-10-20
ER

PT J
AU Wisse, E
   Spiering, AJH
   Dankers, PYW
   Mezari, B
   Magusin, PCMM
   Meijer, EW
AF Wisse, Eva
   Spiering, A. J. H.
   Dankers, Patricia Y. W.
   Mezari, Brahim
   Magusin, Pieter C. M. M.
   Meijer, E. W.
TI Multicomponent Supramolecular Thermoplastic Elastomer with
   Peptide-Modified Nanofibers
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE bioactive; biomaterial; nanofibers; peptide-modified; supramolecular
   thermoplastic elastomer
ID MONODISPERSE HARD SEGMENTS; POLYMERS; COPOLYMERS; POLYDIMETHYLSILOXANE;
   POLYURETHANE; BIOMATERIALS; SCAFFOLDS; CELLS; END
AB Bioactive nanofibers present a promising synthetic niche for in vivo applications due to their morphological and functional resemblance to the extracellular matrix. Potentially interesting nanofibers are constructed from the hard-segment regimes in well-defined thermoplastic elastomers (TPEs). The supramolecular interactions between these hard segments cause physical crosslinking by the formation of nanofibers and provide excellent mechanical properties. Here, we make use of a new class of biocompatible supramolecular TPEs, in which both the formation of the main chain and the hard block is based on multiple hydrogen-bonding interactions. A self-assembly process is explored to arrive at well-defined peptide-modified nanofibers embedded in a biocompatible soft matrix. Crucial for the success in the synthetic design is the use of an exact match between the molecular recognition units of the peptide and the supramolecular unit that takes care of forming the supramolecular nanofibers of the TPE. Evidence for the strong anchoring of the modified peptides in the hard-segment nanofibers of the supramolecular TPE is provided by simple extraction experiments. (C) 2011 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 49:1764-1771, 2011
C1 [Wisse, Eva; Spiering, A. J. H.; Dankers, Patricia Y. W.; Meijer, E. W.] Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
   [Wisse, Eva; Spiering, A. J. H.; Dankers, Patricia Y. W.; Meijer, E. W.] Eindhoven Univ Technol, Biol Chem Lab, NL-5600 MB Eindhoven, Netherlands.
   [Dankers, Patricia Y. W.; Meijer, E. W.] Eindhoven Univ Technol, Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands.
   [Mezari, Brahim; Magusin, Pieter C. M. M.] Eindhoven Univ Technol, Schuit Inst Catalysis, NL-5600 MB Eindhoven, Netherlands.
RP Meijer, EW (reprint author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM e.w.meijer@tue.nl
RI Magusin, Pieter/F-5724-2016; Meijer, E.W./K-7632-2013
OI Magusin, Pieter/0000-0003-1167-3764; Meijer, E.W./0000-0003-4126-7492
FU Council for Chemical Sciences of the Netherlands Organization for
   Scientific Research (NWO-CW)
FX This research has been financially supported by the Council for Chemical
   Sciences of the Netherlands Organization for Scientific Research
   (NWO-CW). Jorg Roosma is kindly acknowledged for synthesizing the
   4-Methyl-caprolactonemonomer.
CR Aneja A, 2003, POLYMER, V44, P7221, DOI 10.1016/j.polymer.2003.07.007
   Brunsveld L, 2001, CHEM REV, V101, P4071, DOI 10.1021/cr990125q
   Celiz AD, 2010, J POLYM SCI POL CHEM, V48, P5833, DOI 10.1002/pola.24391
   Ciferri A., 2005, SUPRAMOLECULAR POLYM
   Dankers PYW, 2011, BIOMATERIALS, V32, P723, DOI 10.1016/j.biomaterials.2010.09.020
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Feldman KE, 2008, MACROMOLECULES, V41, P4694, DOI 10.1021/ma800375r
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Folmer BJB, 2000, ADV MATER, V12, P874, DOI 10.1002/1521-4095(200006)12:12<874::AID-ADMA874>3.3.CO;2-3
   GALLI E, 1986, PLAST COMPOUNDING, V9, P20
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kautz H, 2006, MACROMOLECULES, V39, P4265, DOI 10.1021/ma060706z
   Li WJ, 2005, J BIOMED NANOTECHNOL, V1, P259, DOI 10.1166/jbn.2005.032
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Magusin PCMM, 2005, MACROMOL SYMP, V230, P126, DOI 10.1002/masy.200551151
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   MERKX M, UNPUB
   Montarnal D, 2010, J POLYM SCI POL CHEM, V48, P1133, DOI 10.1002/pola.23870
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Sanda F, 2002, MACROMOLECULES, V35, P680, DOI 10.1021/ma011341f
   Sauer BB, 2004, J POLYM SCI POL PHYS, V42, P1783, DOI 10.1002/polb.20060
   Sheth JP, 2005, POLYMER, V46, P7317, DOI 10.1016/j.polymer.2005.04.041
   Sheth JP, 2005, MACROMOLECULES, V38, P10074, DOI 10.1021/ma051063a
   Sheth JP, 2004, POLYMER, V45, P6919, DOI 10.1016/j.polymer.2004.06.057
   Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Tanner KE, 2003, MATER SCI FORUM, V440-4, P19, DOI 10.4028/www.scientific.net/MSF.440-441.19
   Wisse E, 2006, MACROMOLECULES, V39, P7425, DOI 10.1021/ma060986i
   Yilgor E, 2000, POLYMER, V41, P849, DOI 10.1016/S0032-3861(99)00245-1
   Zhang YZ, 2005, J MATER SCI-MATER M, V16, P933, DOI 10.1007/s10856-005-4428-x
NR 31
TC 19
Z9 19
U1 7
U2 55
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD APR 15
PY 2011
VL 49
IS 8
BP 1764
EP 1771
DI 10.1002/pola.24598
PG 8
WC Polymer Science
SC Polymer Science
GA 738BJ
UT WOS:000288614000004
DA 2018-10-20
ER

PT J
AU de Almeida, LH
   Caram, R
   Moreno-Gobbi, AO
   Grandini, CR
AF de Almeida, L. H.
   Caram, R.
   Moreno-Gobbi, A. O.
   Grandini, C. R.
TI Anelastic relaxation due to hydrogen in Ti-35Nb-7Zr-5Ta alloy
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE Ti alloys; Hydrogen; Interstitials; Biomaterials
ID FREQUENCY INTERNAL-FRICTION; TA-H ALLOYS; NB-H; V-H; TI; COMPLEXES; ZR
AB Titanium and its alloys are frequently used in the production of prostheses and dental implants due to their properties, such as high corrosion resistance, low elasticity modulus, and high mechanical strength/density relation. Among the Ti-based alloys, Ti-35Nb-7Zr-5Ta (TNZT) is one that presents the smallest elasticity modulus (around 45 GPa), making it an excellent alternative to be used as a biomaterial. In this paper, mechanical spectroscopy measurements were made of TNZT alloys containing several quantities of hydrogen in solid solution. Mechanical spectroscopy measurements were made by using a torsion pendulum, operating at an oscillation frequency in the interval 2-20 Hz, temperature in the range 100-300K, heating rate of about 1 K/min, and vacuum lower than 10(-5) Torr. A relaxation structure and a reduction in the elasticity modulus were observed for the heat-treated and doped samples. The observed peak was associated with the interaction of hydrogen trapped by oxygen atoms around the titanium atom of the metallic matrix. (C) 2011 Elsevier B.V. All rights reserved.
C1 [de Almeida, L. H.; Grandini, C. R.] Univ Estadual Paulista, UNESP, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
   [Caram, R.] Univ Estadual Campinas, Dept Mat Engn, BR-13083970 Campinas, SP, Brazil.
   [Moreno-Gobbi, A. O.] UDELAR, Fac Ciencias, Inst Fis, Montevideo 11400, Uruguay.
RP Grandini, CR (reprint author), Univ Estadual Paulista, UNESP, Lab Anelasticidade & Biomat, BR-17033360 Bauru, SP, Brazil.
EM betog@fc.unesp.br
RI Grandini, Carlos Roberto/A-3790-2008; Caram, Rubens/C-2068-2012
OI Grandini, Carlos Roberto/0000-0002-3336-309X; Caram,
   Rubens/0000-0001-6996-5116
FU Capes; CNPq; FAPESP
FX The authors wish to thank the Brazilian agencies Capes, CNPq, and FAPESP
   for their financial support.
CR Almeida LH, 2009, MAT SCI ENG A-STRUCT, V521-22, P59, DOI 10.1016/j.msea.2008.09.123
   Blanter MS, 2007, SPRINGER SER MATER S, V90, pVII, DOI 10.1007/978-3-540-68758-0
   BLANTER MS, 1994, PHYS REV B, V50, P3603, DOI 10.1103/PhysRevB.50.3603
   CANNELLI G, 1994, J ALLOY COMPD, V211, P80, DOI 10.1016/0925-8388(94)90452-9
   CANNELLI G, 1982, PHILOS MAG A, V46, P483, DOI 10.1080/01418618208239573
   CANNELLI G, 1977, P 2 INT C HYDR MET, P395
   CANNELLI G, 1998, TUNNELING SYSTEMS AM
   CANTELLI R, 2006, ENGINEERING, V442, P5
   De Batist R, 1972, INTERNAL FRICTION ST
   Fast J.D., 1976, GASES METALS
   Fukai Y., 2005, METAL HYDROGEN SYSTE
   Grandini C.R., 2002, REV BRAS APL VACUO, V21, P13
   GRANDINI CR, 1994, J ALLOY COMPD, V211, P226, DOI 10.1016/0925-8388(94)90488-X
   MATTAS RF, 1975, ACTA METALL MATER, V23, P973, DOI 10.1016/0001-6160(75)90011-5
   Mugishima T, 2006, MAT SCI ENG A-STRUCT, V442, P114, DOI 10.1016/j.msea.2006.03.121
   Nowick A. S., 1972, ANELASTIC RELAXATION
   Puskar A., 2001, INTERNAL FRICTION MA
   SCHALLER R, 2001, MECH SPECTROSCOPY 20
   TANAKA S, 1981, SCRIPTA METALL MATER, V15, P403, DOI 10.1016/0036-9748(81)90219-2
   VOKL J, 1981, HYPERFINE INTERACT, V8, P631
   Weller M, 2006, MAT SCI ENG A-STRUCT, V442, P21, DOI 10.1016/j.msea.2006.02.232
   WELLER M, 1992, PHYS STATUS SOLIDI B, V172, P145, DOI 10.1002/pssb.2221720115
   Wipf H, 2000, J ALLOY COMPD, V310, P190, DOI 10.1016/S0925-8388(00)00945-2
   YOSHINARI O, 1982, ACTA METALL MATER, V30, P1979, DOI 10.1016/0001-6160(82)90101-8
   YOSHINARI O, 1991, ACTA METALL MATER, V39, P2657, DOI 10.1016/0956-7151(91)90082-C
   YOSHINARI O, 1982, ACTA METALL MATER, V30, P1987, DOI 10.1016/0001-6160(82)90102-X
   YOSHINARI O, 1985, J PHYS-PARIS, V46, P95, DOI 10.1051/jphyscol:19851021
NR 27
TC 1
Z9 1
U1 0
U2 16
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
EI 1873-4936
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD APR 15
PY 2011
VL 528
IS 9
BP 3326
EP 3329
DI 10.1016/j.msea.2011.01.012
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 738HC
UT WOS:000288629900007
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Hung, JM
   Lin, LH
   Shih, YH
   Liu, CM
   Cheng, HC
   Ou, KL
AF Hung, Jing-Ming
   Lin, Li-Hsiang
   Shih, Yung-Hsun
   Liu, Chung-Ming
   Cheng, Hsin-Chung
   Ou, Keng-Liang
TI Research of microstructural characteristics on nanocrystalline diamond
   by microwave plasma CVD
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE Nanocrystalline diamond; Microwave plasma; Chemical vapor deposition;
   Microstructure; Wettability
ID AR/CH4/H-2 GAS-MIXTURES; ULTRANANOCRYSTALLINE DIAMOND; THIN-FILMS;
   RAMAN-SPECTRA; DEPOSITION; GROWTH
AB In this study, the nanocrystalline diamond (NCD) films were carried out by microwave plasma chemical vapor deposition (CVD) with CH4/Ar/H-2 gas concoction on Si substrate at moderate temperatures. The characteristics of NCD films were evaluated using scanning electron microscopy, Raman spectroscopy, transmission electron microscopy, optical emission spectroscopy and optical contact angle meter. The analytical results revealed that C-2 radial was the dominant species in the deposited process. From TEM observation, the NCD films were formed via the etching of hydrocarbons and a small amount of H-2 content additive into gas mixture has improved the aggregation of the nucleation film to form the NCD films. The more hydrophobic surfaces imply that NCD films are the potential biomaterial in the application of article heart valve or stent. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Ou, Keng-Liang] Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei 110, Taiwan.
   [Hung, Jing-Ming; Shih, Yung-Hsun; Cheng, Hsin-Chung] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei 110, Taiwan.
   [Hung, Jing-Ming; Lin, Li-Hsiang; Shih, Yung-Hsun; Liu, Chung-Ming; Cheng, Hsin-Chung; Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Devices, Taipei 110, Taiwan.
   [Hung, Jing-Ming; Lin, Li-Hsiang; Shih, Yung-Hsun; Liu, Chung-Ming; Cheng, Hsin-Chung; Ou, Keng-Liang] Taipei Med Univ, Res Ctr Biomed Implants & Microsurg Devices, Taipei 110, Taiwan.
   [Lin, Li-Hsiang; Cheng, Hsin-Chung] Taipei Med Univ Hosp, Dept Dent, Taipei 110, Taiwan.
   [Shih, Yung-Hsun] Taipei Med Univ, Dept Dent, Wan Fang Hosp, Taipei 110, Taiwan.
   [Liu, Chung-Ming] LungHwa Univ Sci & Technol, Grad Sch Engn Technol, Tao Yuan 306, Taiwan.
   [Liu, Chung-Ming] LungHwa Univ Sci & Technol, Dept Chem & Mat Engn, Tao Yuan 306, Taiwan.
RP Ou, KL (reprint author), Taipei Med Univ, Grad Inst Biomed Mat & Engn, Taipei 110, Taiwan.
EM klou@tmu.edu.tw
FU Taipei Medical University Hospital [97TMU-TMUH-02]; Department of
   Health, Executive Yuan, Taiwan [DOH100-TD-N-111-04]; ComMed Technologies
   Co., Ltd. [AZ-04-04-08-98]
FX The authors would like to thank the Taipei Medical University Hospital
   for financially supporting this research under contract 97TMU-TMUH-02
   and supported partly by Department of Health, Executive Yuan, Taiwan
   under contract No. DOH100-TD-N-111-04. The authors would also like to
   thank ComMed Technologies Co., Ltd. for financially supporting this
   research under contract No. AZ-04-04-08-98.
CR Azevedo AF, 2005, SURF COAT TECH, V194, P271, DOI 10.1016/j.surfcoat.2004.10.007
   Birrell J, 2005, DIAM RELAT MATER, V14, P86, DOI 10.1016/j.diamond.2004.07.012
   Chen M, 2002, J MATER PROCESS TECH, V129, P81, DOI 10.1016/S0924-0136(02)00580-0
   Chen YC, 2009, BIOMATERIALS, V30, P3428, DOI 10.1016/j.biomaterials.2009.03.058
   CHENG HC, 2009, J ALLOY COMPD, V77, P931
   Fox OJL, 2009, DIAM RELAT MATER, V18, P750, DOI 10.1016/j.diamond.2009.01.004
   Gruen DM, 1999, ANNU REV MATER SCI, V29, P211, DOI 10.1146/annurev.matsci.29.1.211
   Hiramatsu M, 2002, THIN SOLID FILMS, V407, P18, DOI 10.1016/S0040-6090(02)00006-8
   Hong SP, 2002, DIAM RELAT MATER, V11, P877, DOI 10.1016/S0925-9635(01)00634-3
   Lechleitner T, 2008, BIOMATERIALS, V29, P4275, DOI 10.1016/j.biomaterials.2008.07.023
   LIN T, 2000, APPL PHYS LETT AM I
   Liu YK, 2004, DIAM RELAT MATER, V13, P1859, DOI 10.1016/j.diamond.2004.05.006
   Lombardi G, 2004, J APPL PHYS, V96, P6739, DOI 10.1063/1.1814174
   May PW, 2006, J APPL PHYS, V99, DOI 10.1063/1.2195347
   May PW, 2006, DIAM RELAT MATER, V15, P345, DOI 10.1016/j.diamond.2005.06.044
   May PW, 2000, PHILOS T ROY SOC A, V358, P473, DOI 10.1098/rsta.2000.0542
   Miyake M, 2007, THIN SOLID FILMS, V515, P4258, DOI 10.1016/j.tsf.2006.02.048
   Popov C, 2007, DIAM RELAT MATER, V16, P735, DOI 10.1016/j.diamond.2006.12.001
   Ren Wei-hong, 2003, Zhonghua Kou Qiang Yi Xue Za Zhi, V38, P306
   Talin AA, 1996, APPL PHYS LETT, V69, P3842, DOI 10.1063/1.117123
   Tang W, 2003, THIN SOLID FILMS, V429, P63, DOI 10.1016/S0040-6090(03)00056-7
   Williams OA, 2006, DIAM RELAT MATER, V15, P654, DOI 10.1016/j.diamond.2005.12.009
   Yang WS, 2002, NAT MATER, V1, P253, DOI 10.1038/nmat779
   Zhou D, 1998, J APPL PHYS, V84, P1981, DOI 10.1063/1.368331
   Zhou D, 1998, J APPL PHYS, V83, P540, DOI 10.1063/1.366668
   Zhou HY, 2007, DIAM RELAT MATER, V16, P675, DOI 10.1016/j.diamond.2006.11.074
NR 26
TC 6
Z9 8
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 15
PY 2011
VL 257
IS 13
BP 5508
EP 5512
DI 10.1016/j.apsusc.2010.12.134
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 732RE
UT WOS:000288205800008
DA 2018-10-20
ER

PT J
AU Mangano, C
   Paino, F
   d'Aquino, R
   De Rosa, A
   Iezzi, G
   Piattelli, A
   Laino, L
   Mitsiadis, T
   Desiderio, V
   Mangano, F
   Papaccio, G
   Tirino, V
AF Mangano, Carlo
   Paino, Francesca
   d'Aquino, Riccardo
   De Rosa, Alfredo
   Iezzi, Giovanna
   Piattelli, Adriano
   Laino, Luigi
   Mitsiadis, Thimios
   Desiderio, Vincenzo
   Mangano, Francesco
   Papaccio, Gianpaolo
   Tirino, Virginia
TI Human Dental Pulp Stem Cells Hook into Biocoral Scaffold Forming an
   Engineered Biocomplex
SO PLOS ONE
LA English
DT Article
ID BONE; DIFFERENTIATION; REGENERATION; POROSITY; REPAIR
AB The aim of this study was to evaluate the behavior of human Dental Pulp Stem Cells (DPSCs), as well as human osteoblasts, when challenged on a Biocoral scaffold, which is a porous natural hydroxyapatite. For this purpose, human DPSCs were seeded onto a three-dimensional (3D) Biocoral scaffold or on flask surface (control). Either normal or rotative (3D) cultures were performed. Scanning electron microscopic analyses, at 8, 24 and 48 h of culture showed that cells did not adhere on the external surface, but moved into the cavities inside the Biocoral structure. After 7, 15 and 30 days of culture, morphological and molecular analyses suggested that the Biocoral scaffold leads DPSCs to hook into the cavities where these cells quickly start to secrete the extra cellular matrix (ECM) and differentiate into osteoblasts. Control human osteoblasts also moved into the internal cavities where they secreted the ECM. Histological sections revealed a diffuse bone formation inside the Biocoral samples seeded with DPSCs or human osteoblasts, where the original scaffold and the new secreted biomaterial were completely integrated and cells were found within the remaining cavities. In addition, RT-PCR analyses showed a significant increase of osteoblast-related gene expression and, above all, of those genes highly expressed in mineralized tissues, including osteocalcin, OPN and BSP. Furthermore, the effects on the interaction between osteogenesis and angiogenesis were observed and substantiated by ELISA assays. Taken together, our results provide clear evidence that DPSCs differentiated into osteoblasts, forming a biocomplex made of Biocoral, ECM and differentiated cells.
C1 [Mangano, Carlo; Mangano, Francesco] Univ Insubria, Dept Biomat Sci, Varese, Italy.
   [Paino, Francesca; d'Aquino, Riccardo; Desiderio, Vincenzo; Papaccio, Gianpaolo; Tirino, Virginia] Univ Naples 2, Dept Expt Med, Sect Histol & Embryol, Tissue Engn & Regenerat Med TERM Div, Naples, Italy.
   [De Rosa, Alfredo; Laino, Luigi] Univ Naples 2, Dept Odontol, Naples, Italy.
   [Iezzi, Giovanna; Piattelli, Adriano] Univ G dAnnunzio, Dept Odontol, Chieti, Italy.
   [Mitsiadis, Thimios] Univ Zurich, Inst Oral Biol, Zurich, Switzerland.
RP Mangano, C (reprint author), Univ Insubria, Dept Biomat Sci, Varese, Italy.
EM gianpaolo.papaccio@unina2.it
RI Mitsiadis, Thimios/B-5564-2016; Mitsiadis, Thimios/B-9249-2008
OI Mitsiadis, Thimios/0000-0002-9812-9982; Mangano,
   Francesco/0000-0001-5488-4268; desiderio, vincenzo/0000-0003-1819-6083;
   Papaccio, Gianpaolo/0000-0002-4014-5306; Paino,
   Francesca/0000-0002-3186-1888
FU Leader Italia (Cinisello Balsamo, Milan, Italy)
FX The authors kindly acknowledge Leader Italia (Cinisello Balsamo, Milan,
   Italy) for funding (to GP) and assistance. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   d'Aquino R, 2007, CELL DEATH DIFFER, V14, P1162, DOI 10.1038/sj.cdd.4402121
   d'Aquino R, 2009, EUR CELLS MATER, V18, P75, DOI 10.22203/eCM.v018a07
   Groeneveld EHJ, 1999, J BIOMED MATER RES, V48, P393, DOI 10.1002/(SICI)1097-4636(1999)48:4<393::AID-JBM1>3.3.CO;2-3
   Hing KA, 2005, INT J APPL CERAM TEC, V2, P184, DOI 10.1111/j.1744-7402.2005.02020.x
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526
   Laino G, 2005, J BONE MINER RES, V20, P1394, DOI 10.1359/JBMR.050325
   Mangano Carlo, 2006, J Oral Implantol, V32, P122, DOI 10.1563/796.1
   Mangano C, 2010, BIOMATERIALS, V31, P3543, DOI 10.1016/j.biomaterials.2010.01.056
   Mygind T, 2007, BIOMATERIALS, V28, P1036, DOI 10.1016/j.biomaterials.2006.10.003
   OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Spath L, 2010, J CELL MOL MED, V14, P1635, DOI 10.1111/j.1582-4934.2009.00848.x
   Tai K, 2008, TISSUE ENG PT A, V14, P1709, DOI 10.1089/ten.tea.2007.0241
   Yan Q, 1999, J HISTOCHEM CYTOCHEM, V47, P1495, DOI 10.1177/002215549904701201
   Zhang YF, 2007, BIOMATERIALS, V28, P1515, DOI 10.1016/j.biomaterials.2006.11.040
   Zhao LA, 2010, BIOMATERIALS, V31, P6502, DOI 10.1016/j.biomaterials.2010.05.017
NR 21
TC 40
Z9 41
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 11
PY 2011
VL 6
IS 4
AR e18721
DI 10.1371/journal.pone.0018721
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 747XH
UT WOS:000289354100034
PM 21494568
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Bettinger, CJ
AF Bettinger, Christopher J.
TI Biodegradable Elastomers for Tissue Engineering and Cell-Biomaterial
   Interactions
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Review
DE biomaterials; elastomers; polymer; tissue engineering
ID IN-VITRO DEGRADATION; SMOOTH-MUSCLE-CELLS; POLY(GLYCEROL SEBACATE);
   CONTACT GUIDANCE; MECHANICAL-PROPERTIES; POLY(ESTER-URETHANE) ELASTOMER;
   EPSILON-CAPROLACTONE; NERVOUS-SYSTEM; DRUG-DELIVERY; STEM-CELLS
AB Synthetic biomaterials serve as a cornerstone in the development of clinically focused regenerative medicine therapies that aim to reduce suffering and prolong life. Recent improvements in biodegradable elastomeric materials utilize natural extracellular matrix proteins as inspiration to yield a new class of materials with superior degradation kinetics, desirable biocompatibility profiles, and mechanical properties that closely match those of soft tissues. This review describes several classes of synthetic biodegradable elastomers and associated fabrication techniques that are relevant to scaffold development. The application of these materials to select tissue engineering models is also discussed.
C1 Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15232 USA.
RP Bettinger, CJ (reprint author), Carnegie Mellon Univ, Dept Biomed Engn, 5000 Forbes Ave, Pittsburgh, PA 15232 USA.
EM cbetting@andrew.cmu.edu
RI Bettinger, Christopher/A-3895-2009
FU Carnegie Mellon University; Berkman Faculty Development Fund
FX This work was supported by start-up funds from Carnegie Mellon
   University and a Berkman Faculty Development Fund.
CR Amsden B, 2007, SOFT MATTER, V3, P1335, DOI 10.1039/b707472g
   Ashby MF, 2004, MATER DESIGN, V25, P51, DOI 10.1016/S0261-3069(03)00159-6
   BAKKER D, 1988, J BIOMED MATER RES, V22, P423, DOI 10.1002/jbm.820220506
   Batycky RP, 1997, J PHARM SCI, V86, P1464, DOI 10.1021/js9604117
   BELLAMKONDA R, 1994, BIOTECHNOL BIOENG, V43, P543, DOI 10.1002/bit.260430703
   Bettinger CJ, 2008, BIOMATERIALS, V29, P2315, DOI 10.1016/j.biomaterials.2008.01.029
   Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487
   Bettinger CJ, 2010, POLYM INT, V59, P563, DOI 10.1002/pi.2827
   Bettinger CJ, 2010, ADV MATER, V22, P651, DOI 10.1002/adma.200902322
   Bettinger CJ, 2007, PRINCIPLES OF TISSUE ENGINEERING, 3RD EDITION, P341, DOI 10.1016/B978-012370615-7/50028-7
   Bettinger CJ, 2009, J BIOMED MATER RES A, V91A, P1077, DOI 10.1002/jbm.a.32306
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Bettinger CJ, 2009, TISSUE ENG PT A, V15, P1321, DOI 10.1089/ten.tea.2008.0134
   Bettinger Christopher J., 2008, P87
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Bettinger CJ, 2006, ADV MATER, V18, P165, DOI 10.1002/adma.200500438
   Bhadra S, 2009, PROG POLYM SCI, V34, P783, DOI 10.1016/j.progpolymsci.2009.04.003
   Biggs MJP, 2007, J MATER SCI-MATER M, V18, P399, DOI 10.1007/s10856-006-0705-6
   Borkenhagen M, 1998, BIOMATERIALS, V19, P2155, DOI 10.1016/S0142-9612(98)00122-7
   BRUIN P, 1988, MAKROMOL CHEM-RAPID, V9, P589
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Cao XD, 1999, BIOMATERIALS, V20, P329, DOI 10.1016/S0142-9612(98)00172-0
   Chen GP, 2000, ADV MATER, V12, P455, DOI 10.1002/(SICI)1521-4095(200003)12:6<455::AID-ADMA455>3.0.CO;2-C
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen QZ, 2008, BIOMATERIALS, V29, P47, DOI 10.1016/j.biomaterials.2007.09.010
   COHEN S, 1991, PHARMACEUT RES, V8, P713, DOI 10.1023/A:1015841715384
   Cooke MN, 2003, J BIOMED MATER RES B, V64B, P65, DOI 10.1002/jbm.b.10485
   Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013
   DENBESTEN C, 1990, TOXICOL IN VITRO, V4, P518, DOI 10.1016/0887-2333(90)90110-F
   Dey J, 2008, BIOMATERIALS, V29, P4637, DOI 10.1016/j.biomaterials.2008.08.020
   Edwards DA, 1997, SCIENCE, V276, P1868, DOI 10.1126/science.276.5320.1868
   Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316
   ESCHENHAGEN T, 2002, BASIC RES CARDIOL S1, V97, P146, DOI DOI 10.1007/S003950200043
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Gafni Y, 2006, TISSUE ENG, V12, P3021, DOI 10.1089/ten.2006.12.3021
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Gopferich A, 1996, BIOMATERIALS, V17, P103, DOI 10.1016/0142-9612(96)85755-3
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998
   Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254
   Gu F, 2005, J CONTROL RELEASE, V102, P607, DOI 10.1016/j.jconrel.2004.10.020
   Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747
   Hales TC, 2006, DISCRETE COMPUT GEOM, V36, P5, DOI 10.1007/s00454-005-1210-2
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Hong Y, 2010, BIOMATERIALS, V31, P4249, DOI 10.1016/j.biomaterials.2010.02.005
   Hsu SH, 2004, ARTIF ORGANS, V28, P693, DOI 10.1111/j.1525-1594.2004.00046.x
   HUBBELL JA, 1995, BIO-TECHNOL, V13, P565, DOI 10.1038/nbt0695-565
   Ifkovits JL, 2009, ACS APPL MATER INTER, V1, P1878, DOI 10.1021/am900403k
   Ilagan BG, 2009, ACTA BIOMATER, V5, P2429, DOI 10.1016/j.actbio.2009.03.023
   Jeong CG, 2010, TISSUE ENG PT A, V16, P3759, DOI 10.1089/ten.TEA.2010.0103
   Jeong CG, 2011, ACTA BIOMATER, V7, P505, DOI 10.1016/j.actbio.2010.08.027
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kemppainen JM, 2010, J BIOMED MATER RES A, V94A, P9, DOI 10.1002/jbm.a.32653
   Keohan F, 2007, J BIOMAT SCI-POLYM E, V18, P1057, DOI 10.1163/156856207781494395
   Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361
   Kim BYS, 2008, NANO LETT, V8, P3887, DOI 10.1021/nl802311t
   Kylma J, 1997, MACROMOLECULES, V30, P2876, DOI 10.1021/ma961569g
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Li MY, 2006, BIOMATERIALS, V27, P2705, DOI 10.1016/j.biomaterials.2005.11.037
   Liang SL, 2010, BIOMATERIALS, V31, P8516, DOI 10.1016/j.biomaterials.2010.07.105
   Liu QY, 2009, POLYM DEGRAD STABIL, V94, P1427, DOI 10.1016/j.polymdegradstab.2009.05.023
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Lu Y, 2006, J BIOMED MATER RES A, V77A, P396, DOI 10.1002/jbm.a.30601
   Lu Y, 2003, P 30 ANN M EXP GLASG
   Mahdavi A, 2008, P NATL ACAD SCI USA, V105, P2307, DOI 10.1073/pnas.0712117105
   Mathur AM, 1996, J MACROMOL SCI R M C, VC36, P405
   Matsuda T, 2000, MACROMOLECULES, V33, P795, DOI 10.1021/ma991404i
   McCullough LA, 2009, MACROMOLECULES, V42, P8129, DOI 10.1021/ma901560k
   Motlagh D, 2006, BIOMATERIALS, V27, P4315, DOI 10.1016/j.biomaterials.2006.04.010
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   MV JC, 2001, CHEM COMMUN, V19, P1897
   Nagata M, 2004, POLYMER, V45, P87, DOI 10.1016/j.polymer.2003.11.003
   Nagata M, 2009, J POLYM SCI POL CHEM, V47, P2422, DOI 10.1002/pola.23333
   Neeley WL, 2008, BIOMATERIALS, V29, P418, DOI 10.1016/j.biomaterials.2007.10.007
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Nuttelman CR, 2002, BIOMATERIALS, V23, P3617, DOI 10.1016/S0142-9612(02)00093-5
   Okada M, 2002, PROG POLYM SCI, V27, P87, DOI 10.1016/S0079-6700(01)00039-9
   Palmgren R, 1997, J POLYM SCI POL CHEM, V35, P1635, DOI 10.1002/(SICI)1099-0518(19970715)35:9<1635::AID-POLA5>3.0.CO;2-Q
   Pitt CG, 1984, J CONTROL RELEASE, V1, P3
   POIRIER Y, 1995, BIO-TECHNOL, V13, P142, DOI 10.1038/nbt0295-142
   Pomerantseva I, 2009, J BIOMED MATER RES A, V91A, P1038, DOI 10.1002/jbm.a.32327
   Qiu HJ, 2006, BIOMATERIALS, V27, P5845, DOI 10.1016/j.biomaterials.2006.07.042
   Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578
   ROSENBERG MD, 1962, P NATL ACAD SCI USA, V48, P1342, DOI 10.1073/pnas.48.8.1342
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   SINCLAIR RG, 1977, Patent No. 4045418
   SIPOS L, 1995, MACROMOL RAPID COMM, V16, P935, DOI 10.1002/marc.1995.030161209
   Sodian R, 2000, TISSUE ENG, V6, P183, DOI 10.1089/107632700320793
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   STOREY RF, 1994, POLYMER, V35, P830, DOI 10.1016/0032-3861(94)90882-6
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Tamai H, 2000, CIRCULATION, V102, P399
   Tatai L, 2007, BIOMATERIALS, V28, P5407, DOI 10.1016/j.biomaterials.2007.08.035
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tobias IS, 2010, J CONTROL RELEASE, V146, P356, DOI 10.1016/j.jconrel.2010.05.036
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wang J, 2010, ORGANOGENESIS, V6, P212, DOI 10.4161/org6.4.12909
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WEISS P, 1945, J EXP ZOOL, V100, P353, DOI 10.1002/jez.1401000305
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang J, 2004, ADV MATER, V16, P511, DOI 10.1002/adma.200306264
   Yang J, 2006, BIOMATERIALS, V27, P1889, DOI 10.1016/j.biomaterials.2005.05.106
   Yang J, 2005, TISSUE ENG, V11, P1876, DOI 10.1089/ten.2005.11.1876
   Yang J, 2009, P NATL ACAD SCI USA, V106, P10086, DOI 10.1073/pnas.0900004106
   Yi F, 2008, MACROMOL BIOSCI, V8, P803, DOI 10.1002/mabi.200800041
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031
   Younes HM, 2004, BIOMATERIALS, V25, P5261, DOI 10.1016/j.biomaterials.2003.12.024
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
   Zong XH, 1999, MACROMOLECULES, V32, P8107, DOI 10.1021/ma990630p
NR 122
TC 59
Z9 59
U1 3
U2 106
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-5187
EI 1616-5195
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD APR 8
PY 2011
VL 11
IS 4
BP 467
EP 482
DI 10.1002/mabi.201000397
PG 16
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 748FA
UT WOS:000289374200001
PM 21229578
DA 2018-10-20
ER

PT J
AU Kim, SH
   Oh, SA
   Lee, WK
   Shin, US
   Kim, HW
AF Kim, So-Hee
   Oh, Sun-Ae
   Lee, Woo-Kul
   Shin, Ueon Sang
   Kim, Hae-Won
TI Poly(lactic acid) porous scaffold with calcium phosphate mineralized
   surface and bone marrow mesenchymal stem cell growth and differentiation
SO MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS
LA English
DT Article
DE Calcium phosphate; Surface modification; Polymer scaffold; Bone marrow
   mesenchymal stem cells; Osteogenic differentiation
ID OCTACALCIUM PHOSPHATE; BIOACTIVE GLASS; STROMAL CELLS; HYDROXYAPATITE;
   RESPONSES; BIOMATERIAL; COMPOSITES; FILMS
AB This work aims to modify the surface of a poly(lactic acid) (PLA) porous scaffold with calcium phosphate (CaP) via a simple solution-based technique, and to evaluate the effects of this modification on the responses of rat bone marrow mesenchymal stem cells (rBMMSCs). Under appropriate modification conditions involving stepwise-treatments in the Ca-and-P supersaturated solution under gentle agitation, a thin, poorly crystallized CaP layer was deposited. The BMMSCs derived from adult rats were shown to adhere quite well to the CaP-coated scaffold, and to proliferate actively with culturing time, although some down-regulation was noted with regard to the unmodified PLA scaffold. The osteogenic differentiation of rBMMSCs was significantly higher on the CaP-modified scaffold than on the unmodified scaffold, as confirmed by alkaline phosphatase (ALP) activity. Moreover, the expression of genes associated with bone, including collagen type I, osteopontin and bone sialoprotein, was stimulated better on the Cap-modified PLA scaffold. Based on these results, the currently used CaP-treatment was deemed effective in stimulating the osteogenic development of rBMMSCs on the PLA-based scaffold, and the CaP-treated PLA scaffold may be useful for future bone tissue engineering. (C) 2010 Elsevier B.V. All rights reserved.
EM kimhw@dku.edu
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771
FU Korean government [2009-0093829, KRF-2007-314-E00183,
   M10755080002-07N5508-00212]
FX This work was supported by the grants of the Korean government: No.
   2009-0093829 (Priority Research Centers Program by NRF), No.
   KRF-2007-314-E00183, and No. M10755080002-07N5508-00212.
CR Ambrosio AMA, 2001, J BIOMED MATER RES, V58, P295, DOI 10.1002/1097-4636(2001)58:3<295::AID-JBM1020>3.3.CO;2-#
   BELLOWS CG, 1992, BONE MINER, V17, P15, DOI 10.1016/0169-6009(92)90707-K
   BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0
   Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958
   Friedman CD, 1998, J BIOMED MATER RES, V43, P428, DOI 10.1002/(SICI)1097-4636(199824)43:4<428::AID-JBM10>3.0.CO;2-0
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Jang JH, 2009, ADV DRUG DELIVER REV, V61, P1065, DOI 10.1016/j.addr.2009.07.008
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HW, 2008, J BIOMED MATER RES A, V85A, P651, DOI 10.1002/jbm.a.31339
   Kretlow JD, 2007, TISSUE ENG, V13, P927, DOI 10.1089/ten.2006.0394
   Lee HH, 2008, ACTA BIOMATER, V4, P622, DOI 10.1016/j.actbio.2007.10.013
   Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019
   Marra KG, 1999, J BIOMED MATER RES, V47, P324, DOI 10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y
   Martina M, 2005, BIOMATERIALS, V26, P5609, DOI 10.1016/j.biomaterials.2005.02.011
   MATHIEU HJ, 2001, ANAL SURF INTERFACE, V32, P3
   Mo MJ, 2005, J IND ENG CHEM, V11, P507
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Shin HY, 2006, J IND ENG CHEM, V12, P476
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WILSON T, 2010, J TISS ENG, P9
   YAMAGUCHI M, 2004, J ARTIF ORGANS, V7, P187
   Yu HS, 2009, J BIOMED MATER RES A, V88A, P747, DOI 10.1002/jbm.a.31709
NR 22
TC 13
Z9 13
U1 3
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
EI 1873-0191
J9 MAT SCI ENG C-MATER
JI Mater. Sci. Eng. C-Mater. Biol. Appl.
PD APR 8
PY 2011
VL 31
IS 3
BP 612
EP 619
DI 10.1016/j.msec.2010.11.028
PG 8
WC Materials Science, Biomaterials
SC Materials Science
GA 730PE
UT WOS:000288045600017
DA 2018-10-20
ER

PT J
AU Nishida, A
   Yamada, M
   Kanazawa, T
   Takashima, Y
   Ouchi, K
   Okada, H
AF Nishida, Ayumu
   Yamada, Masaki
   Kanazawa, Takanori
   Takashima, Yuuki
   Ouchi, Kiyohisa
   Okada, Hiroaki
TI Sustained-release of protein from biodegradable sericin film, gel and
   sponge
SO INTERNATIONAL JOURNAL OF PHARMACEUTICS
LA English
DT Article
DE Sericin; Sustained release; Film; Gel; Sponge; Biodegradable
ID SECRETES RECOMBINANT PROTEINS; MORI SILK SERICIN; BOMBYX-MORI;
   TRANSGENIC SILKWORM; SKIN FIBROBLASTS; DRUG-DELIVERY; GROWTH-FACTOR;
   HYDROGELS; COCOON; GENE
AB A silk protein, sericin, contains 18 kinds of amino acids, mostly polar side chains forming a complex of three principal polypeptides. The major polypeptides exhibit hydrophobic characteristics by forming a beta-sheet structure in a hydrate state. As a drug-releasing biomaterial made by an aqueous process without using any cross linker, sericin is expected to form various hydrophobic dosage forms. However, its dosage form, with respect to the molecular weight and concentration of sericin, and its biodegradation behavior has not been studied in detail. In this study, the film, gel and sponge of sericin were prepared and examined to determine the release properties of the charged protein, fluorescein isothiocyanate-albumin (FA). The film and gel, as solid and semisolid forms, respectively, were also evaluated for their biodegradation behavior. For in vitro release, FA was sustained-released from these preparations. The concentration and dosage form markedly affected FA release. For in vivo biodegradation, the sericin preparations implanted subcutaneously in rats gradually decreased in size and weight. Histological examination indicated no marked inflammation at the site. As for in vivo release, FA remained for 3-6 weeks or more in rats. These findings suggest that sericin is suitable for use as a drug-releasing biomaterial. (C) 2011 Elsevier B.V. All rights reserved.
C1 [Nishida, Ayumu; Yamada, Masaki; Ouchi, Kiyohisa] Kissei Pharmaceut Co Ltd, Pharmaceut Technol Labs, Hotaka, Azumino 3998304, Japan.
   [Kanazawa, Takanori; Takashima, Yuuki; Okada, Hiroaki] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Pharmaceut & Drug Delivery, Tokyo 1920392, Japan.
RP Nishida, A (reprint author), Kissei Pharmaceut Co Ltd, Pharmaceut Technol Labs, 4365-1 Kashiwabara, Hotaka, Azumino 3998304, Japan.
EM ayumu_nishida@pharm.kissei.co.jp
CR Aramwit P., 2007, BIOSCI BIOTECH BIOCH, V71, P70243
   Aramwit P, 2010, INT J BIOL MACROMOL, V47, P668, DOI 10.1016/j.ijbiomac.2010.08.015
   Bhattarai N, 2010, ADV DRUG DELIVER REV, V62, P83, DOI 10.1016/j.addr.2009.07.019
   Capar G, 2008, J MEMBRANE SCI, V325, P920, DOI 10.1016/j.memsci.2008.09.020
   Dash BC, 2009, J BIOTECHNOL, V144, P321, DOI 10.1016/j.jbiotec.2009.09.019
   Dash R, 2008, BMB REP, V41, P236, DOI 10.5483/BMBRep.2008.41.3.236
   Dash R, 2008, MOL CELL BIOCHEM, V311, P111, DOI 10.1007/s11010-008-9702-z
   Freddi G, 2003, J BIOTECHNOL, V106, P101, DOI 10.1016/j.jbiotec.2003.09.006
   GAMO T, 1982, BIOCHEM GENET, V20, P165, DOI 10.1007/BF00484944
   Garel A, 1997, INSECT BIOCHEM MOLEC, V27, P469, DOI 10.1016/S0965-1748(97)00022-2
   Hori K, 2007, J CONTROL RELEASE, V118, P169, DOI 10.1016/j.jconrel.2006.12.011
   Kanazawa T, 2009, INT J PHARMACEUT, V379, P187, DOI 10.1016/j.ijpharm.2009.06.015
   Kang GD, 2008, INT J PHARM, V349, P188, DOI 10.1016/j.ijpharm.2007.08.010
   Kato N, 1998, BIOSCI BIOTECH BIOCH, V62, P145, DOI 10.1271/bbb.62.145
   Kobayashi M, 2009, J BIOSCI BIOENG, V108, pS18, DOI 10.1016/j.jbiosc.2009.08.490
   Komatsu K, 1975, J SERIC SCI JPN, V44, P105
   Komatsu K., 1975, STUDIES DISSOLUTION, V26, P135
   Kundu SC, 2008, PROG POLYM SCI, V33, P998, DOI 10.1016/j.progpolymsci.2008.08.002
   Kushibiki T, 2006, J CONTROL RELEASE, V112, P249, DOI 10.1016/j.jconrel.2006.02.003
   MAKINO K, 1985, CHEM PHARM BULL, V33, P1195
   Mandal BB, 2009, ACTA BIOMATER, V5, P3007, DOI 10.1016/j.actbio.2009.03.026
   Mase Keisuke, 2006, Journal of Insect Biotechnology and Sericology, V75, P85
   MICHAILLE JJ, 1990, GENE, V86, P177, DOI 10.1016/0378-1119(90)90277-X
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   Miyamoto Y., 2009, J CRYOBIOL, V59, P376
   Nishida A, 2010, CHEM PHARM BULL, V58, P1480, DOI 10.1248/cpb.58.1480
   Ogawa S, 2007, J BIOTECHNOL, V128, P531, DOI 10.1016/j.jbiotec.2006.10.019
   OKADA H, 1994, PHARMACEUT RES, V11, P1143, DOI 10.1023/A:1018936815654
   OKADA H, 1995, CRIT REV THER DRUG, V12, P1
   OKAMOTO H, 1982, J BIOL CHEM, V257, P5192
   Tabata Y, 1999, TISSUE ENG, V5, P127, DOI 10.1089/ten.1999.5.127
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   Takabayashi C., 2009, [No title captured], Patent No. 3840541
   Takasu Y, 2002, BIOSCI BIOTECH BIOCH, V66, P2715, DOI 10.1271/bbb.66.2715
   Takekawa Y., 2010, PEDIAT SURG INT, V26, P575
   Takeoka M., 2004, SER S NE IND RES CTR
   Takeuchi A, 2005, J ROY SOC INTERFACE, V2, P373, DOI 10.1098/rsif.2005.0052
   Tao W, 2005, MACROMOL MATER ENG, V290, P188, DOI 10.1002/mame.200400306
   Teramoto H, 2005, BIOMACROMOLECULES, V6, P2049, DOI 10.1021/bm0500547
   Teramoto H, 2005, BIOSCI BIOTECH BIOCH, V69, P845, DOI 10.1271/bbb.69.845
   Teramoto H, 2007, MACROMOLECULES, V40, P1562, DOI 10.1021/ma062604e
   Teramoto H, 2008, BIOSCI BIOTECH BIOCH, V72, P3189, DOI 10.1271/bbb.80375
   Tomita M, 2007, TRANSGENIC RES, V16, P449, DOI 10.1007/s11248-007-9087-x
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   Tsubouchi K, 1999, Japan patent, Patent No. [11-070160A, 11070160]
   Wang S., 1998, J SERIC SCI JPN, V4, P295
   Zhang YQ, 2004, BIOMATERIALS, V25, P3751, DOI 10.1016/j.biomaterials.2003.10.019
   Zhang YQ, 2002, BIOTECHNOL ADV, V20, P91, DOI 10.1016/S0734-9750(02)00003-4
   Zhu Liang Jun, 1995, Journal of Sericultural Science of Japan, V64, P415
NR 49
TC 34
Z9 36
U1 1
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-5173
J9 INT J PHARMACEUT
JI Int. J. Pharm.
PD APR 4
PY 2011
VL 407
IS 1-2
BP 44
EP 52
DI 10.1016/j.ijpharm.2011.01.006
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 740FQ
UT WOS:000288777400006
PM 21238562
DA 2018-10-20
ER

PT J
AU Salam, A
   Venditti, RA
   Pawlak, JJ
   El-Tahlawy, K
AF Salam, Abdus
   Venditti, Richard A.
   Pawlak, Joel J.
   El-Tahlawy, Khaled
TI Crosslinked hemicellulose citrate-chitosan aerogel foams
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE Hemicellulose; Citrate; Chitosan; Foam; Water absorption; Saline
   absorption
ID HYDROGELS; LINKING; ACID
AB The applications for hemicellulose are currently very narrow, because of its low molecular weight and varying chemical composition. In this research, novel applications for modified hemicellulose are developed making it a valuable biomaterial for absorbency applications in health care and medical textiles. The incorporation of carboxylic acid groups into hemicellulose via reaction with citric acid followed by cross linking with chitosan greatly improve the properties relative to hemicellulose, chitosan, a cellulose sponge product, and hemicellulose citrate alone. Optimum conditions for the cross linking of the hemicellulose citrate-chitosan include a 2.5 h reaction time at 110 degrees C with pH 3.5, a solid to liquid ratio of 1:100 and a hemicellulose citrate to chitosan ratio of 1:1 (w/w). The hemicellulose citrate-chitosan crosslinked foam is elastic, very soft, highly porous and durable. The hemicellulose citrate-chitosan can absorb up to 100g of a saline solution per gram of material and up to 80g of water per gram of material. Analysis of the hemicellulose citrate-chitosan foams with FTIR, DMA, and SEM confirms the crosslinked and hygroscopic behavior of the materials. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Salam, Abdus; Venditti, Richard A.; Pawlak, Joel J.] N Carolina State Univ, Forest Biomat Dept, Raleigh, NC 27695 USA.
   [El-Tahlawy, Khaled] N Carolina State Univ, Dept Text Engn Chem & Sci, Raleigh, NC 27695 USA.
RP Venditti, RA (reprint author), Room 1204,Biltmore Hall,Campus Box 8005, Raleigh, NC 27695 USA.
EM Richard_Venditti@ncsu.edu
FU Consortium for Plant Biotechnology Research; United States Department of
   Energy [DE-FG36-02GO12026]; North Carolina Forestry Foundation
FX This research project was funded by the Consortium for Plant
   Biotechnology Research and the United States Department of Energy
   (DE-FG36-02GO12026) and the North Carolina Forestry Foundation.
CR Alonso D, 2009, CARBOHYD POLYM, V77, P536, DOI 10.1016/j.carbpol.2009.01.027
   BADAL CS, 2003, J IND MICROBIOL BIOT, V30, P279
   Bernabe P, 2005, POLYM BULL, V55, P367, DOI 10.1007/s00289-005-0439-5
   Demitri C, 2008, J APPL POLYM SCI, V110, P2453, DOI 10.1002/app.28660
   Dobrynin AV, 2004, J POLYM SCI POL PHYS, V42, P3513, DOI 10.1002/polb.20207
   Ebringerova A, 1999, BIOTECHNOL GENET ENG, V16, P325, DOI 10.1080/02648725.1999.10647982
   Edlund U, 2008, J BIOACT COMPAT POL, V23, P171, DOI 10.1177/0883911507088400
   El-Tahlawy K, 2007, CARBOHYD POLYM, V67, P319, DOI 10.1016/j.carbpol.2006.05.029
   Gabrielii I, 1998, J APPL POLYM SCI, V69, P1661, DOI 10.1002/(SICI)1097-4628(19980822)69:8<1661::AID-APP19>3.3.CO;2-K
   Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2
   Kumar MNVR, 2004, CHEM REV, V104, P6017, DOI 10.1021/cr030441b
   MUZZARELLI R, 1990, ANTIMICROB AGENTS CH, V34, P2019, DOI 10.1128/AAC.34.10.2019
   Nie QL, 2006, NANOTECHNOLOGY, V17, P140, DOI 10.1088/0957-4484/17/1/022
   PARK JW, 1983, B KOR CHEM SOC, V4, P68
   Prade RA, 1996, BIOTECHNOL GENET ENG, V13, P101, DOI 10.1080/02648725.1996.10647925
   ROGACHEVA VB, 1983, POLYM SCI USSR, V25, P1771
   SALAM A, CELLULOSE IN PRESS
   Salam A, 2010, BIOMACROMOLECULES, V11, P1453, DOI 10.1021/bm1000235
   SJOSTROM E, 1981, WOOD CHEM FUNDAMENTA
   Sun XF, 2004, J SCI FOOD AGR, V84, P800, DOI 10.1002/jsfa.1735
   Umemura K, 2008, J APPL POLYM SCI, V108, P2481, DOI 10.1002/app.27842
   Walker LC, 2001, THERMOCHIM ACTA, V367, P407, DOI 10.1016/S0040-6031(00)00666-3
   Yin JB, 2006, CARBOHYD POLYM, V63, P238, DOI 10.1016/j.carbpol.2005.08.041
   Zheng L. Y., 2000, MATER SCI ENG, V18, P22
NR 24
TC 48
Z9 49
U1 8
U2 164
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD APR 2
PY 2011
VL 84
IS 4
BP 1221
EP 1229
DI 10.1016/j.carbpol.2011.01.008
PG 9
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 744VN
UT WOS:000289123300002
DA 2018-10-20
ER

PT J
AU Hegewald, AA
   Enz, A
   Endres, M
   Sittinger, M
   Woiciechowsky, C
   Thome, C
   Kaps, C
AF Hegewald, Aldemar Andres
   Enz, Andreas
   Endres, Michaela
   Sittinger, Michael
   Woiciechowsky, Christian
   Thome, Claudius
   Kaps, Christian
TI Engineering of polymer-based grafts with cells derived from human
   nucleus pulposus tissue of the lumbar spine
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE spine; intervertebral disc; nucleus pulposus; biomaterial; disc cells;
   tissue engineering; regeneration
ID INTERVERTEBRAL DISC DEGENERATION; LOW-BACK-PAIN; MESENCHYMAL STEM-CELLS;
   IN-VITRO; REGENERATION; MATRIX; DIFFERENTIATION; PATHOGENESIS;
   REPLACEMENT; IMPLANTS
AB Intervertebral disc degeneration is considered a major source of low back pain. We therefore examined an absorbable polyglycolic acid (PGA) biomaterial for its utility to support disc tissue regeneration. Microdiscectomy for lumbar disc herniation was performed in six patients. Intervertebral disc cells were isolated and in vitro cell expansion was accomplished using human serum and FGF2. In a fibrin-hyaluronan solution, disc cells were loaded on PGA scaffolds and cultured for 2 weeks. Formation of disc tissue was documented by histological staining of the extracellular matrix as well as gene expression analysis of typical disc marker genes. The use of human serum and FGF2 ensures efficient isolation and expansion of human disc cells. During this phase, dedifferentiation of the disc cells was observed. Subsequent 3D tissue culture of disc cells in PGA scaffolds, however, is accompanied by the induction of typical disc marker genes, resulting in tissue containing glycosaminoglycans and collagens. Propidium iodide/fluorescein diacetate (PI/FDA) staining documented that 3D assembly of disc cells in PGA scaffolds allows prolonged culture and high viability of disc cells. Disc cells from tissue of the nucleus compartment can be reliably isolated and expanded in vitro with FGF. In combination with a fibrin-hyaluronan solution and loaded on a PGA scaffold, disc cells from expansion culture commence a redifferentiation process. PGA-based scaffolds could be useful as temporal matrices for regenerative disc repair approaches. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Hegewald, Aldemar Andres; Thome, Claudius] Innsbruck Med Univ, Dept Neurosurg, A-6020 Innsbruck, Austria.
   [Hegewald, Aldemar Andres] Univ Heidelberg, Dept Neurosurg, Univ Mannheim, D-6800 Mannheim, Germany.
   [Enz, Andreas; Endres, Michaela; Kaps, Christian] TransTissue Technol GmbH, Berlin, Germany.
   [Endres, Michaela; Sittinger, Michael] Charite Univ Med Berlin, Tissue Engn Lab, Dept Rheumatol, Berlin, Germany.
   [Sittinger, Michael] Berlin Brandbenburg Ctr Regenerat Therapies, Berlin, Germany.
   [Woiciechowsky, Christian] Charit Univ Med Berlin, Dept Neurosurg, Berlin, Germany.
RP Hegewald, AA (reprint author), Innsbruck Med Univ, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria.
EM aldemar.hegewald@uki.at
OI Hegewald, Aldemar Andres/0000-0002-2022-2060
FU Investitionsbank Berlin; European Regional Development Fund [10138665];
   Stiftung Neurochirurgische Forschung
FX Supported by the Investitionsbank Berlin, the European Regional
   Development Fund (Grant No. 10138665) and the Stiftung Neurochirurgische
   Forschung.
CR Abbushi A, 2008, SPINE, V33, P1527, DOI 10.1097/BRS.0b013e3181788760
   Bertram H, 2005, BIOCHEM BIOPH RES CO, V331, P1185, DOI 10.1016/j.bbrc.2005.04.034
   BRINCKMANN P, 1991, SPINE, V16, P641, DOI 10.1097/00007632-199106000-00008
   Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511
   Erggelet C, 2007, BIOMATERIALS, V28, P5570, DOI 10.1016/j.biomaterials.2007.09.005
   Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1
   Gilbertson L, 2008, SPINE J, V8, P449, DOI 10.1016/j.spinee.2006.11.006
   Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0
   Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290
   Haberstroh K, 2009, TISSUE CELL, V41, P414, DOI 10.1016/j.tice.2009.05.006
   Haefeli M, 2006, SPINE, V31, P1522, DOI 10.1097/01.brs.0000222032.52336.8e
   Halloran DO, 2008, BIOMATERIALS, V29, P438, DOI 10.1016/j.biomaterials.2007.10.009
   Hegewald AA, 2004, TISSUE CELL, V36, P431, DOI 10.1016/j.tice.2004.07.003
   HEGEWALD AA, 2006, POTENTIAL MESENCHYMA
   Hegewald Aldemar A, 2009, J Orthop Surg Res, V4, P25, DOI 10.1186/1749-799X-4-25
   Hegewald AA, 2008, FRONT BIOSCI-LANDMRK, V13, P1507, DOI 10.2741/2777
   Heuer F, 2008, J NEUROSURG-SPINE, V9, P307, DOI 10.3171/SPI/2008/9/9/307
   Kluba T, 2005, SPINE, V30, P2743, DOI 10.1097/01.brs.0000192204.89160.6d
   Li CQ, 2010, J MATER SCI-MATER M, V21, P741, DOI 10.1007/s10856-009-3871-5
   Masuda K, 2004, SPINE, V29, P2757, DOI 10.1097/01.brs.0000146048.14946.af
   McNally DS, 1996, SPINE, V21, P2580, DOI 10.1097/00007632-199611150-00007
   Meisel HJ, 2006, EUR SPINE J, V15, pS397, DOI 10.1007/s00586-006-0169-x
   Mizuno H, 2006, BIOMATERIALS, V27, P362, DOI 10.1016/j.biomaterials.2005.06.042
   Mulleman D, 2006, JOINT BONE SPINE, V73, P151, DOI 10.1016/j.jbspin.2005.03.003
   PANJABI MM, 1984, SPINE, V9, P707, DOI 10.1097/00007632-198410000-00010
   Panjabi MM, 2003, J ELECTROMYOGR KINES, V13, P371, DOI 10.1016/S1050-6411(03)00044-0
   Peng B, 2005, J BONE JOINT SURG BR, V87B, P62
   Peng BG, 2006, SPINE, V31, P560, DOI 10.1097/01.brs.0000201324.45537.46
   Pollintine P, 2004, SPINE, V29, P774, DOI 10.1097/01.BRS.0000119401.23006.D2
   Pratsinis H, 2007, EUR SPINE J, V16, P1858, DOI 10.1007/s00586-007-0408-9
   Revell PA, 2007, J MATER SCI-MATER M, V18, P303, DOI 10.1007/s10856-006-0693-6
   Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1
   Sizer P S Jr, 2001, Pain Pract, V1, P255, DOI 10.1046/j.1533-2500.2001.01027.x
   Solchaga LA, 2005, J CELL PHYSIOL, V203, P398, DOI 10.1002/jcp.20238
   Tsai TT, 2007, SPINE, V32, P495, DOI 10.1097/01.brs.0000257341.88880.f1
   Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x
NR 36
TC 13
Z9 15
U1 0
U2 15
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2011
VL 5
IS 4
BP 275
EP 282
DI 10.1002/term.312
PG 8
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 737HD
UT WOS:000288558800009
PM 20661901
DA 2018-10-20
ER

PT J
AU Wang, CM
   Lau, TT
   Loh, WL
   Su, K
   Wang, DA
AF Wang, Chunming
   Lau, Ting Ting
   Loh, Wei Li
   Su, Kai
   Wang, Dong-An
TI Cytocompatibility study of a natural biomaterial crosslinker-Genipin
   with therapeutic model cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE cytotoxicity; cell proliferation; tissue engineering
ID BIOLOGICAL TISSUE FIXATION; IN-VITRO; MECHANICAL-PROPERTIES; LINKING
   REAGENT; BLUE PIGMENTS; NITRIC-OXIDE; PC12H CELLS; APOPTOSIS;
   METHYLAMINE; ACTIVATION
AB Genipin has been widely used as a natural crosslinker to substitute chemical crosslinkers such as glutaraldehyde to crosslink various biomaterials like gelatin, collagen, and chitosan. However, there are contradicting views on the cytotoxicity and safety of genipin in tissue engineering. Therefore in this study, we aimed to evaluate the toxicity of genipin on skeletal tissues cells osteoblasts and chondrocytes as they are also representatives of typical anchorage-dependent cells (ADCs) and nontypical ADCs. Results suggest that genipin toxicity is dose dependent and acute but not time dependent on both osteoblasts and chondrocytes. In particular, chondrocytes exhibit substantial alterations in the gene expression when exposed to Maximum nontoxic concentration (MaxNC) of genipin but there were no significant changes in the genes tested in osteoblasts. Since osteoblasts are typical ADCs, cellular focal adhesion assessment was carried out with F-actin being more contracted and unorganized when exposed to minimum toxic concentration (MinTC) of genipin. The mechanisms involved in cell deaths in both cell types are believed to be similar and hence using osteoblast as the model, cells were stained positive for Annexin-V and Reactive oxygen species (ROS) level were elevated at MinTC of genipin. Collectively, genipin induced cell apoptosis via ROS production, and apparently, gene expressions could also be altered at MaxNC. For this reason, we recommend the dose of genipin to be controlled within 0.5 mM. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 97B: 58-65, 2011.
C1 [Wang, Chunming; Lau, Ting Ting; Loh, Wei Li; Su, Kai; Wang, Dong-An] Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore, Singapore.
RP Wang, DA (reprint author), Nanyang Technol Univ, Div Bioengn, Sch Chem & Biomed Engn, Singapore, Singapore.
EM DAWang@ntu.edu.sg
RI Wang, Chunming/I-3392-2013; Wang, Dong-an/G-6195-2010
OI Wang, Chunming/0000-0001-9185-9678; 
FU Ministry of Education (MoE), Singapore [AcRF Tier 1 RG 64/08]; National
   Medical Research Council, Singapore [NMRC/EDG/1001/2010]
FX Contract grant sponsor: Ministry of Education (MoE), Singapore; contract
   grant number: AcRF Tier 1 RG 64/08.; Contract grant sponsor: National
   Medical Research Council, Singapore; contract grant number:
   NMRC/EDG/1001/2010
CR Chen YS, 2005, BIOMATERIALS, V26, P3911, DOI 10.1016/j.biomaterials.2004.09.060
   Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022
   DAVID J, 2002, VET RES, V33, P383
   Dyson JA, 2007, TISSUE ENG, V13, P2891, DOI 10.1089/ten.2007.0124
   HARRIS SA, 1995, J BONE MINER RES, V10, P178
   Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0
   Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025
   Ko CS, 2009, J BIOSCI BIOENG, V107, P177, DOI 10.1016/j.jbiosc.2008.09.020
   Kuo YC, 2006, BIOTECHNOL BIOENG, V95, P132, DOI 10.1002/bit.21007
   Lee SW, 2003, ANAL CHIM ACTA, V480, P267, DOI 10.1016/S0003-2670(03)00023-0
   Liang HC, 2003, J BIOMED MATER RES A, V65A, P271, DOI 10.1002/jbm.a.10476
   Lima EG, 2009, J BIOMED MATER RES A, V91A, P692, DOI 10.1002/jbm.a.32305
   Moffat KL, 2004, J BIOMED MATER RES B, V71B, P181, DOI 10.1002/jbm.b.30070
   Morozevich GE, 2006, BIOCHEMISTRY-MOSCOW+, V71, P489, DOI 10.1134/S000629790605004X
   Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49
   Sundararaghavan HG, 2008, J BIOMED MATER RES A, V87A, P308, DOI 10.1002/jbm.a.31715
   Sung HW, 1999, J BIOMED MATER RES, V46, P520
   Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289
   Sung HW, 1998, J BIOMED MATER RES, V42, P560, DOI 10.1002/(SICI)1097-4636(19981215)42:4<560::AID-JBM12>3.0.CO;2-I
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P1571
   TOUYAMA R, 1994, CHEM PHARM BULL, V42, P668
   Wang CM, 2009, BIOMATERIALS, V30, P2259, DOI 10.1016/j.biomaterials.2008.12.072
   Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31
   Yamazaki M, 2005, J HEALTH SCI, V51, P687, DOI 10.1248/jhs.51.687
   Yamazaki M, 1996, BIOL PHARM BULL, V19, P791
   Yamazaki M, 2001, J NEUROCHEM, V79, P45, DOI 10.1046/j.1471-4159.2001.00533.x
   Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010
NR 27
TC 48
Z9 55
U1 3
U2 34
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2011
VL 97B
IS 1
BP 58
EP 65
DI 10.1002/jbm.b.31786
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 735KT
UT WOS:000288413900007
PM 21381191
DA 2018-10-20
ER

PT J
AU Wei, YH
   Chen, WC
   Wu, HS
   Janarthanan, OM
AF Wei, Yu-Hong
   Chen, Wei-Chuan
   Wu, Ho-Shing
   Janarthanan, Om-Murugan
TI Biodegradable and Biocompatible Biomaterial, Polyhydroxybutyrate,
   Produced by an Indigenous Vibrio sp BM-1 Isolated from Marine
   Environment
SO MARINE DRUGS
LA English
DT Article
DE polyhydroxybutyrate; biomaterial; marine microorganisms; Vibrio sp BM-1
ID HALOFERAX-MEDITERRANEI; CARBON SOURCE; POLYHYDROXYALKANOATES; PHB;
   DEGRADATION; GRANULES; CULTURE; STARCH
AB Polyhydroxybutyrate (PHB) is one of the polyhydroxyalkanoates (PHAs) which has biodegradable and biocompatible properties. They are adopted in the biomedical field, in, for example, medical implants and drug delivery carriers. This study seeks to promote the production of PHB by Vibrio sp. BM-1, isolated from a marine environment by improving constituents of medium and implementing an appropriate fermentation strategy. This study successfully developed a glycerol-yeast extract-tryptone (GYT) medium that can facilitate the growth of Vibrio sp. BM-1 and lead to the production of 1.4 g/L PHB at 20 h cultivation. This study also shows that 1.57 g/L PHB concentration and 16% PHB content were achieved, respectively, when Vibrio sp. BM-1 was cultivated with MS-GYT medium (mineral salts-supplemented GYT medium) for 12 h. Both cell dry weight (CDW) and residual CDW remained constant at around 8.2 g/L and 8.0 g/L after the 12 h of cultivation, until the end of the experiment. However, both 16% of PHB content and 1.57 g/L of PHB production decreased rapidly to 3% and 0.25 g/L, respectively from 12 h of cultivation to 40 h of cultivation. The results suggest that the secretion of PHB depolymerase that might be caused by the addition of mineral salts reduced PHB after 12 h of cultivation. However, work will be done to explain the effect of adding mineral salts on the production of PHB by Vibrio sp. BM-1 in the near future.
C1 [Wei, Yu-Hong; Chen, Wei-Chuan; Janarthanan, Om-Murugan] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Tao Yuan 320, Taiwan.
   [Wu, Ho-Shing] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Tao Yuan 320, Taiwan.
RP Wei, YH (reprint author), Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Tao Yuan 320, Taiwan.
EM yhwei@saturn.yzu.edu.tw; itispay@gmail.com; cehswu@saturn.yzu.edu.tw;
   murugan_jana@yahoo.co.in
FU National Science Council of the Republic of China [NSC
   96-2221-E-155-044-MY2, NSC 98-2221-E-155-026, NSC 99-2622-E-155-001-CC2]
FX The authors gratefully acknowledge the financial support by the National
   Science Council of the Republic of China under grant numbers NSC
   96-2221-E-155-044-MY2, NSC 98-2221-E-155-026 and NSC
   99-2622-E-155-001-CC2.
CR Brandl H, 1990, Adv Biochem Eng Biotechnol, V41, P77
   BRAUNEGG G, 1978, EUR J APPL MICROBIOL, V6, P29, DOI 10.1007/BF00500854
   Chen CW, 2006, PROCESS BIOCHEM, V41, P2289, DOI 10.1016/j.procbio.2006.05.026
   Chien CC, 2007, J BIOTECHNOL, V132, P259, DOI 10.1016/jjbiotee.2007.03.002
   Don TM, 2006, J BIOMAT SCI-POLYM E, V17, P1425, DOI 10.1163/156856206778937208
   Ghanem NB, 2005, J GEN APPL MICROBIOL, V51, P151, DOI 10.2323/jgam.51.151
   HIGGINS DG, 1989, COMPUT APPL BIOSCI, V5, P151
   Huang TY, 2006, J IND MICROBIOL BIOT, V33, P701, DOI 10.1007/s10295-006-0098-z
   Jendrossek D, 2002, ANNU REV MICROBIOL, V56, P403, DOI 10.1146/annurev.micro.56.012302.160838
   Jendrossek D, 2007, APPL ENVIRON MICROB, V73, P586, DOI 10.1128/AEM.01839-06
   Keshavarz T, 2010, CURR OPIN MICROBIOL, V13, P321, DOI 10.1016/j.mib.2010.02.006
   Khanna S, 2005, PROCESS BIOCHEM, V40, P607, DOI 10.1016/j.procbio.2004.01.053
   Merrick JM, 1999, INT J BIOL MACROMOL, V25, P129, DOI 10.1016/S0141-8130(99)00026-4
   Mokhtari-Hosseini ZB, 2009, BIORESOURCE TECHNOL, V100, P2436, DOI 10.1016/j.biortech.2008.11.024
   Quillaguaman J, 2007, APPL MICROBIOL BIOT, V74, P981, DOI 10.1007/s00253-006-0754-2
   Reddy CSK, 2003, BIORESOURCE TECHNOL, V87, P137, DOI 10.1016/S0960-8524(02)00212-2
   SUN WQ, 1994, J BIOL CHEM, V269, P20785
   Taran M, 2010, INT J BIOL MACROMOL, V47, P632, DOI 10.1016/j.ijbiomac.2010.08.008
   Wei YH, 2011, INT J MOL SCI, V12, P252, DOI 10.3390/ijms12010252
   Weiner RM, 1997, TRENDS BIOTECHNOL, V15, P390, DOI 10.1016/S0167-7799(97)01099-8
NR 20
TC 16
Z9 16
U1 0
U2 10
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1660-3397
J9 MAR DRUGS
JI Mar. Drugs
PD APR
PY 2011
VL 9
IS 4
BP 615
EP 624
DI 10.3390/md9040615
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 791AN
UT WOS:000292632300010
PM 21731553
OA DOAJ Gold, Green Published
DA 2018-10-20
ER

PT J
AU Vargas-Nieto, C
   Carriazo, JG
   Castillo, E
AF Vargas-Nieto, C.
   Carriazo, J. G.
   Castillo, E.
TI A study of low-cost adsorbent materials for removing Cr(VI) from aqueous
   waste effluent
SO INGENIERIA E INVESTIGACION
LA English
DT Article
DE Chromium removal; chromium adsorption; waste water treatment; adsorption
   on compost; adsorption on alumina
ID HEAVY-METALS; HEXAVALENT CHROMIUM; ACTIVATED CARBONS; WATER;
   BIOSORPTION; ADSORPTION; CR; BIOMATERIAL; MECHANISMS; COMPOST
AB The present paper shows very high potential for two types of solid (a commercial alumina and material obtained by composting, i.e. matured compost) on Cr(VI) adsorption/elimination in aqueous solution using a concentration range close to those previously detected in waste-water from Colombian industries. Both had important properties for eliminating Cr(VI), the compost being more important as it represents low-cost material. Optimal conditions for chromium adsorption on alumina and compost were established. Initial Cr(VI) alumina concentration was 10 mgL(-1), with 100 mL/g volume of solution per adsorbent mass, pH=2.0, 1 hour equilibrium time and 150 rpm stirring. For compost, initial Cr(VI) concentration was = 3 mg L-1, 50 mL/g volume of solution per adsorbent mass, pH=2.5, 3 hour equilibrium time and 150 rpm stirring. The experiments showed that compost adsorption properties could be enhanced by adding small quantities of alumina. Compost could thus be chosen as a promising material for use in bioremediation chromium-containing waste water in a management programme for using solid waste in for minimising environmental impact.
C1 [Vargas-Nieto, C.; Carriazo, J. G.; Castillo, E.] Univ Nacl Colombia, Dept Chem, Bogota, Colombia.
RP Vargas-Nieto, C (reprint author), Univ Nacl Colombia, Dept Chem, Bogota, Colombia.
EM claudiavargasn@gmail.com; jcarriazog@unal.edu.co; ecastillo@unal.edu.co
OI CARRIAZO, Jose G./0000-0002-1740-5552
FU Universidad Nacional de Colombia (Bogota) [DIB 20201007535]
FX The authors would like to acknowledge the Universidad Nacional de
   Colombia (Bogota) for financing the project (DIB 20201007535).
CR Ahluwalia SS, 2007, BIORESOURCE TECHNOL, V98, P2243, DOI 10.1016/j.biortech.2005.12.006
   American Public Health Association (APHA), 1995, METH 3500 CR D COL M, P3
   Bhattacharya AK, 2008, CHEM ENG J, V137, P529, DOI 10.1016/j.cej.2007.05.021
   Blazquez G, 2009, CHEM ENG J, V148, P473, DOI 10.1016/j.cej.2008.09.026
   Boni M., 2009, J HAZARD MATER, P1087
   Castillo E., 2006, CONVOCATORIA NACL IN
   Cieslak-Golonka M, 1995, POLYHEDRON, V15, P3667
   Fiol N, 2006, SEP PURIF TECHNOL, V50, P132, DOI 10.1016/j.seppur.2005.11.016
   Fritzen MB, 2006, J COLLOID INTERF SCI, V296, P465, DOI 10.1016/j.jcis.2005.09.037
   Gibert O, 2005, APPL GEOCHEM, V20, P1648, DOI 10.1016/j.apgeochem.2005.04.012
   Gomez V, 2006, TRAC-TREND ANAL CHEM, V25, P1006, DOI 10.1016/j.trac.2006.06.010
   Han RP, 2006, J HAZARD MATER, V137, P1569, DOI 10.1016/j.jhazmat.2006.04.045
   Kumpiene J, 2008, WASTE MANAGE, V28, P215, DOI 10.1016/j.wasman.2006.12.012
   Levina A, 2005, COORDIN CHEM REV, V249, P281, DOI 10.1016/j.ccr.2004.02.017
   Malcok E. Y., 2006, J HAZARD MAT B, VB138, P142
   Mohan D, 2006, J HAZARD MATER, V137, P762, DOI 10.1016/j.jhazmat.2006.06.060
   Mor S, 2007, BIORESOURCE TECHNOL, V98, P954, DOI 10.1016/j.biortech.2006.03.018
   Park D, 2008, J COLLOID INTERF SCI, V317, P54, DOI 10.1016/j.jcis.2007.09.049
   Park D, 2006, J HAZARD MATER, V137, P1254, DOI 10.1016/j.jhazmat.2006.04.007
   Santos M., 2003, ADV ENVIRON RES, V7, P263
   Smith SR, 2009, ENVIRON INT, V35, P142, DOI 10.1016/j.envint.2008.06.009
   Suman M., 2007, BIORESOURCE TECHNOLO, V98, P954
   Tarley CRT, 2004, CHEMOSPHERE, V54, P987, DOI 10.1016/j.chemosphere.2003.09.001
   Wei YL, 2005, CHEMOSPHERE, V61, P1051, DOI 10.1016/j.chemosphere.2005.03.037
   Zhu SJ, 2008, APPL CLAY SCI, V40, P171, DOI 10.1016/j.clay.2007.08.001
NR 25
TC 2
Z9 5
U1 0
U2 2
PU UNIV NAC COLOMBIA, FAC INGENIERIA
PI BOGOTA
PA CALLE 44, NO 45-67, UNIDAD CAMILO TORRES, BLOQUE B5, OFICINA 401,
   BOGOTA, 00000, COLOMBIA
SN 0120-5609
J9 ING INVEST
JI Ing. Invest.
PD APR
PY 2011
VL 31
IS 1
BP 154
EP 162
PG 9
WC Engineering, Multidisciplinary
SC Engineering
GA 777OH
UT WOS:000291630700017
OA DOAJ Gold
DA 2018-10-20
ER

PT J
AU Manuel, MV
   Hort, N
AF Manuel, Michele V.
   Hort, Norbert
TI Magnesium: An Essential Nutrient for a Good Biomaterial
SO JOM
LA English
DT Editorial Material
C1 [Manuel, Michele V.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
   [Hort, Norbert] Inst Mat Res, MagIC Magnesium Innovat Ctr, Magnesium Proc Grp, Geesthacht, Germany.
RP Manuel, MV (reprint author), Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
RI Hort, Norbert/G-1913-2011; Manuel, Michele/A-8795-2009
OI Hort, Norbert/0000-0002-6636-1568; Manuel, Michele/0000-0002-3495-7826
CR Davis J. R., 2003, HDB MAT MED DEVICES
   Hamid Huda, 2007, Mcgill J Med, V10, P105
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   MUCH M, 2008, INVESTORS BUSINESS D, pA9
   Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1
   *US CENS BUR AM CO, 2008, 2008 SEL CHAR US
NR 6
TC 4
Z9 4
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1047-4838
J9 JOM-US
JI JOM
PD APR
PY 2011
VL 63
IS 4
BP 99
EP 99
DI 10.1007/s11837-011-0066-6
PG 1
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Mineralogy; Mining & Mineral Processing
SC Materials Science; Metallurgy & Metallurgical Engineering; Mineralogy;
   Mining & Mineral Processing
GA 777IO
UT WOS:000291609300016
OA Bronze
DA 2018-10-20
ER

PT J
AU Xie, XW
   Tang, ZP
   Chen, J
   Yang, J
   Zeng, WG
   Liu, N
   Liu, YM
AF Xie, Xuewei
   Tang, Zhouping
   Chen, Juan
   Yang, Jie
   Zeng, Wengao
   Liu, Na
   Liu, Yongming
TI Neurogenesis of Adipose-derived Stem Cells in Hydrogel
SO JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL
   SCIENCES
LA English
DT Article
DE adipose-derived stem cells; hydrogel; neurogenesis; tissue engineering
ID STROMAL CELLS; IN-VITRO; TISSUE; RECONSTRUCTION; SCAFFOLDS
AB Adipose tissue is a readily available source of adult stem cells with multipotent properties suitable for tissue engineering and regenerative medical applications. Peptide hydrogel is a novel biomaterial which provides three-dimensional microenvironments for a variety of cells for tissue grafting. In this study, adipose-derived stem cells (ADSCs) were isolated from rats, seeded into the peptide hydrogel polymer scaffolds and cultured in Neurobasal (NB) media supplemented with B27, basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF). Ten days after the culture, some cells were expanded into clonal populations in which the expression of both Nestin and Brdu was detected but only Brdu expression was detected in the cells that were not expanded into clonal populations. Our results suggested that ADSCs in peptide hydrogel polymer scaffolds can be induced to differentiate into cells capable of expressing the neuron-associated markers, self-renewal and self-propagation.
C1 [Xie, Xuewei; Tang, Zhouping; Chen, Juan; Yang, Jie; Zeng, Wengao; Liu, Na; Liu, Yongming] Huazhong Univ Sci & Technol, Tongji Med Univ, Tongji Hosp, Dept Neurol, Wuhan 430030, Peoples R China.
   [Xie, Xuewei] Second Mil Med Univ, Changzheng Hosp, Dept Neurol, Shanghai 200003, Peoples R China.
RP Tang, ZP (reprint author), Huazhong Univ Sci & Technol, Tongji Med Univ, Tongji Hosp, Dept Neurol, Wuhan 430030, Peoples R China.
EM xueweixie@163.com; ddjtzp@163.com
FU National Natural Sciences Foundation of China [30770751]; Scientific
   Research Foundation of Department of Hubei Province [JX4A03]
FX This project was supported by grants from the National Natural Sciences
   Foundation of China (No. 30770751) and the Scientific Research
   Foundation of Department of Hubei Province (No. JX4A03).
CR Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Arrigoni E, 2009, CELL TISSUE RES, V338, P401, DOI 10.1007/s00441-009-0883-x
   Drury JL, 2003, BIOMATERIALS, V24
   Dutta RC, 2009, BIOTECHNOL ADV, V27, P334, DOI 10.1016/j.biotechadv.2009.02.002
   Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270
   Fierz FC, 2008, BIOMATERIALS, V29, P3799, DOI 10.1016/j.biomaterials.2008.06.012
   Halvorsen YDC, 2001, METABOLISM, V50, P407, DOI 10.1053/meta.2001.21690
   Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264
   Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.010
   Li H, 2010, J SURG RES, V158, P293
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S
   Tan HP, 2009, BIOMATERIALS, V30, P6844, DOI 10.1016/j.biomaterials.2009.08.058
   The Ministry of Science and Technology of the People's Republic of China, 2006, GUID SUGG CAR US LAB
   Xu YF, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-21
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 16
TC 3
Z9 3
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1672-0733
EI 1993-1352
J9 J HUAZHONG U SCI-MED
JI J. Huazhong Univ. Sci. Tech.-Med.
PD APR
PY 2011
VL 31
IS 2
BP 174
EP 177
DI 10.1007/s11596-011-0246-1
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 779NU
UT WOS:000291785900006
PM 21505979
DA 2018-10-20
ER

PT J
AU Yang, HJ
   Xu, HY
   Zhu, GC
   Ouyang, CX
   Wang, XG
   Xu, WL
AF Yang, H-J
   Xu, H-Y
   Zhu, G-C
   Ouyang, C-X
   Wang, X-G
   Xu, W-L
TI Composite membranes of native silk fibroin powder and biomedical
   polyurethane for controlled release of heparin
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE blood compatibility; composite membrane; controlled drug release;
   polyurethane; silk powder; heparin
ID VITRO BLOOD COMPATIBILITY; PLASMA GLOW-DISCHARGE; BOND HIGH AMOUNTS;
   WOOL POWDER; HEMOCOMPATIBILITY; BIOMATERIAL; MICROSPHERES; FORMULATION;
   FABRICATION; COPOLYMERS
AB Native silk fibroin powder (NSFP) carrying heparin was blended with biomedical polyurethane (BPU) to fabricate novel composite membranes for the controlled release of heparin. The NSFP/BPU composite membranes exhibited excellent hydrophilicity, water vapour permeability, and water absorption. The release of heparin from the composite membranes was evaluated by immersing the membranes in phosphate-buffered saline at 37 degrees C. The release of heparin from the composite membrane could be controlled by adjusting the blend ratios of NSFP and BPU, the amount of heparin in the membrane, and the membrane thickness. The bioactivity of heparin released from the composite membrane (NSFP/BPU 30/70, thickness 110 mu m, length 2 cm, width 0.5 cm) with different amounts of heparin was evaluated by immersing the novel release system (composite membranes) in 0.5 mL of platelet-poor plasma for 1 h at 37 degrees C. The thrombin time, activated partial thromboplastin time, and prothrombin time were measured, the three parameters all exceeding the measurement limit of the clot detection instrument. The results suggest that heparin has excellent bioactivity, and the novel heparin release system can improve the blood compatibility of BPU.
C1 [Xu, H-Y; Zhu, G-C; Xu, W-L] Wuhan Text Univ, Text Res Ctr, Wuhan 430073, Peoples R China.
   [Yang, H-J] Donghua Univ, Coll Text, Shanghai, Peoples R China.
   [Ouyang, C-X] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Vasc Surg, Wuhan 430074, Peoples R China.
   [Wang, X-G] Deakin Univ, Ctr Mat & Fibre Innovat, Geelong, Vic 3217, Australia.
RP Xu, WL (reprint author), Wuhan Text Univ, Text Res Ctr, Wuhan 430073, Peoples R China.
EM weilin-xu@wuse.edu.cn
FU 973 project of China [2009CB526402]; National Natural Science Foundation
   of China [50873079]
FX This work was supported by the 973 project (No. 2009CB526402) of China
   and the National Natural Science Foundation of China (No. 50873079).
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Bernacca GM, 1998, BIOMATERIALS, V19, P1151, DOI 10.1016/S0142-9612(98)00016-7
   Cao ZB, 2007, SOFT MATTER, V3, P910, DOI 10.1039/b703139d
   Chen JH, 1999, J BIOMED MATER RES, V48, P235, DOI 10.1002/(SICI)1097-4636(1999)48:3<235::AID-JBM6>3.0.CO;2-3
   Chen Z, 2000, J APPL POLYM SCI, V76, P382, DOI 10.1002/(SICI)1097-4628(20000418)76:3<382::AID-APP13>3.0.CO;2-A
   Christensen K, 2001, BIOMATERIALS, V22, P349, DOI 10.1016/S0142-9612(00)00190-3
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Garner B, 1999, J BIOMED MATER RES, V44, P121, DOI 10.1002/(SICI)1097-4636(199902)44:2<121::AID-JBM1>3.0.CO;2-A
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Huang JH, 2007, POLYM TEST, V26, P685, DOI 10.1016/j.polymertesting.2007.04.005
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Kang IK, 1997, BIOMATERIALS, V18, P1099, DOI 10.1016/S0142-9612(97)00035-5
   Keogh JR, 1996, BIOMATERIALS, V17, P1987, DOI 10.1016/0142-9612(96)00005-1
   Khorasani MT, 2006, J BIOMED MATER RES A, V77A, P253, DOI 10.1002/jbm.a.30613
   Lee YK, 1998, THROMB RES, V92, P149, DOI 10.1016/S0049-3848(98)00124-8
   Lin WC, 2005, MACROMOL BIOSCI, V5, P1013, DOI 10.1002/mabi.200500077
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   Lv Q, 2005, POLYM INT, V54, P1076, DOI [10.1002/pi.1814, 10.1002/pi.l814]
   Lv Q, 2003, BIOMATERIALS, V24, P3915, DOI 10.1016/S0142-9612(03)00266-7
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   MARCONI W, 1995, BIOMATERIALS, V16, P449, DOI 10.1016/0142-9612(95)98817-X
   Marconi W, 1996, BIOMATERIALS, V17, P1795, DOI 10.1016/0142-9612(95)00359-2
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Moon HT, 2001, BIOMATERIALS, V22, P281
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   PARK KD, 1988, J BIOMED MATER RES, V22, P977, DOI 10.1002/jbm.820221103
   Rajkhowa R, 2008, POWDER TECHNOL, V185, P87, DOI 10.1016/j.powtec.2008.01.005
   Scheibel T, 2006, APPL PHYS A-MATER, V82, P191, DOI 10.1007/s00339-005-3434-7
   SMITH PK, 1980, ANAL BIOCHEM, V109, P466, DOI 10.1016/0003-2697(80)90679-X
   Takeshita H, 2000, MACROMOL MATER ENG, V283, P126
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Tanzi MC, 2005, EXPERT REV MED DEVIC, V2, P473, DOI 10.1586/17434440.2.4.473
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wan M, 2004, J MATER SCI-MATER M, V15, P1079, DOI 10.1023/B:JMSM.0000046389.87287.3f
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Xu WL, 2006, POLYM ENG SCI, V46, P617, DOI 10.1002/pen.20511
   Xu WL, 2004, POWDER TECHNOL, V140, P136, DOI 10.1016/j.powtec.2003.12.010
   Xu WL, 2003, J APPL POLYM SCI, V87, P2372, DOI 10.1002/app.11991
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Yang JH, 2003, POLYMER, V44, P3251, DOI 10.1016/S0032-3861(03)00260-X
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
NR 46
TC 7
Z9 8
U1 1
U2 18
PU PROFESSIONAL ENGINEERING PUBLISHING LTD
PI WESTMINISTER
PA 1 BIRDCAGE WALK, WESTMINISTER SW1H 9JJ, ENGLAND
SN 0954-4119
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD APR
PY 2011
VL 225
IS H4
BP 421
EP 433
DI 10.1243/09544119JEIM845
PG 13
WC Engineering, Biomedical
SC Engineering
GA 772VU
UT WOS:000291266600009
DA 2018-10-20
ER

PT J
AU Arvidson, K
   Abdallah, BM
   Applegate, LA
   Baldini, N
   Cenni, E
   Gomez-Barrena, E
   Granchi, D
   Kassem, M
   Konttinen, YT
   Mustafa, K
   Pioletti, DP
   Sillat, T
   Finne-Wistrand, A
AF Arvidson, K.
   Abdallah, B. M.
   Applegate, L. A.
   Baldini, N.
   Cenni, E.
   Gomez-Barrena, E.
   Granchi, D.
   Kassem, M.
   Konttinen, Y. T.
   Mustafa, K.
   Pioletti, D. P.
   Sillat, T.
   Finne-Wistrand, A.
TI Bone regeneration and stem cells
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Review
DE bone regeneration; stem cells; biomaterials; polymers; regenerative
   medicine
ID PLATELET-RICH PLASMA; MARROW STROMAL CELLS; TISSUE-ENGINEERED BONE;
   OSTEOBLAST-LIKE CELLS; CRITICAL-SIZE DEFECTS; GROWTH-FACTOR-BETA;
   BIODEGRADABLE POLYMER SCAFFOLDS; SIMULTANEOUS IMPLANT PLACEMENT;
   MESENCHYMAL PROGENITOR CELLS; UMBILICAL-CORD BLOOD
AB Introduction
   Bone fracture healing and healing problems
   Biomaterial scaffolds and tissue engineering in bone formation
   Bone tissue engineering
   Biomaterial scaffolds
   Synthetic scaffolds
   Micro- and nanostructural properties of scaffolds
   Conclusion
   Mesenchymal stem cells and osteogenesis
   Bone tissue
   Origin of osteoblasts
   Isolation and characterization of bone marrow derived MSC
   In vitro differentiation of MSC into osteoblast lineage cells
   In vivo differentiation of MSC into bone
   Factors and pathways controlling osteoblast differentiation of hMSC
   Defining the relationship between osteoblast and adipocyte differentiation from MSC
   MSC and sex hormones
   Effect of aging on osteoblastogenesis
   Conclusion
   Embryonic, foetal and adult stem cells in osteogenesis
   Cell-based therapies for bone
   Specific features of bone cells needed to be advantageous for clinical use
   Development of therapeutic biological agents
   Clinical application concerns
   Conclusion
   Platelet-rich plasma (PRP), growth factors and osteogenesis
   PRP effects in vitro on the cells involved in bone repair
   PRP effects on osteoblasts
   PRP effects on osteoclasts
   PRP effects on endothelial cells
   PRP effects in vivo on experimental animals
   The clinical use of PRP for bone repair
   Non-union
   Distraction osteogenesis
   Spinal fusion
   Foot and ankle surgery
   Total knee arthroplasty
   Odontostomatology and maxillofacial surgery
   Conclusion
   Molecular control of osteogenesis
   TGF-beta signalling
   FGF signalling
   IGF signalling
   PDGF signalling
   MAPK signalling pathway
   Wnt signalling pathway
   Hedgehog signalling
   Notch signalling
   Ephrin signalling
   Transcription factors regulating osteoblast differentiation
   Conclusion
   Summary
   This invited review covers research areas of central importance for orthopaedic and maxillofacial bone tissue repair, including normal fracture healing and healing problems, biomaterial scaffolds for tissue engineering, mesenchymal and foetal stem cells, effects of sex steroids on mesenchymal stem cells, use of platelet-rich plasma for tissue repair, osteogenesis and its molecular markers. A variety of cells in addition to stem cells, as well as advances in materials science to meet specific requirements for bone and soft tissue regeneration by addition of bioactive molecules, are discussed.
C1 [Arvidson, K.; Mustafa, K.] Univ Bergen, Fac Med & Dent, Clin Res Ctr, Dept Clin Dent, N-5009 Bergen, Norway.
   [Abdallah, B. M.; Kassem, M.] Univ So Denmark, Odense Univ Hosp, Dept Endocrinol, Mol Endocrinol Lab, Odense, Denmark.
   [Applegate, L. A.; Pioletti, D. P.] Univ Lausanne Hosp, Cellular Therapy Unit, Serv Plast & Reconstruct Surg, Dept Musculoskeletal Med, Lausanne, Switzerland.
   [Baldini, N.; Cenni, E.; Granchi, D.] Ist Ortoped Rizzoli, Lab Orthopaed Pathophysiol & Regenerat Med, Bologna, Italy.
   [Gomez-Barrena, E.] Univ Autonoma Madrid, Hosp Univ La Paz, Serv Cirurg Ortoped & Traumatol, Madrid, Spain.
   [Kassem, M.] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia.
   [Konttinen, Y. T.; Sillat, T.] Univ Helsinki, Cent Hosp, Dept Med, Helsinki, Finland.
   [Konttinen, Y. T.] ORTON Orthopaed Hosp, ORTON Fdn, Helsinki, Finland.
   [Konttinen, Y. T.] COXA Hosp Joint Replacement, Tampere, Finland.
   [Pioletti, D. P.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Biomech Orthoped, Lausanne, Switzerland.
   [Finne-Wistrand, A.] Royal Inst Technol, Sch Chem Sci & Engn, Stockholm, Sweden.
   [Abdallah, B. M.; Kassem, M.] Univ So Denmark, Ctr Med Biotechnol, Odense, Denmark.
RP Arvidson, K (reprint author), Univ Bergen, Fac Med & Dent, Clin Res Ctr, Dept Clin Dent, Arstadsv 17, N-5009 Bergen, Norway.
EM kristina.arvidson@iko.uib.no
RI Kassem, Moustapha/J-7688-2013; Pioletti, Dominique/C-5697-2008; Baldini,
   Nicola/J-4806-2016; GOMEZ-BARRENA, ENRIQUE/A-2799-2008; Granchi,
   Donatella/J-3647-2016; Abdallah, Basem/G-5667-2017
OI Kassem, Moustapha/0000-0003-1557-0869; Pioletti,
   Dominique/0000-0001-5535-5296; Baldini, Nicola/0000-0003-2228-3833;
   GOMEZ-BARRENA, ENRIQUE/0000-0003-1065-6137; Granchi,
   Donatella/0000-0001-7225-0023; Abdallah, Basem/0000-0003-0324-8055;
   Sillat, Tarvo/0000-0003-3950-5121
FU Swiss National Science Foundation; Foundation S.A.N.T.E; Sandoz Family
   Foundation; Danish Medical Research Council; Novo Nordisk Foundation;
   Vellux Foundation; Danish Center for Stem Cell Research (DASC);
   University Hospital of Odense, Denmark; EU [241879, HEALTH-2009-1.4.2,
   242175 HEALTH-2009-1.4.2]; Italian Ministry of the Health; Regione
   Emilia-Romagna; Danish Council for Strategic Research; Sigrid Juselius
   Foundation; Finska Lakaresallskapet, evo; Helsinki University Central
   Hospital; ORTON Orthopedic Hospital of the Orton Foundation; Research
   Council of Norway [17734/V50, 156744, 180383/V40]
FX D.P. and L.A. were financially supported by several grants from the
   Swiss National Science Foundation and in part from the Foundation
   S.A.N.T.E and Sandoz Family Foundation. M.K., B.M.A. and the study were
   support by grants from the Danish Medical Research Council, the Novo
   Nordisk Foundation, the Vellux Foundation and Danish Center for Stem
   Cell Research (DASC) and by a local grant from the University Hospital
   of Odense, Denmark. E.G.B. was financially supported by The EU by means
   of the 7th Frame Program in the REBORNE project ('Regenerating Bone
   defects using New biomedical Engineering approaches', EC-GA
   n<SUP>o</SUP>241879, HEALTH-2009-1.4.2). N.B., E.C. and D.G. were
   supported by grants from Italian Ministry of the Health for research
   activities of the Rizzoli Orthopaedic Institute, and from 'Regione
   Emilia-Romagna' for the research program on 'Regenerative Medicine in
   Osteo-articular Diseases'. Y.T.K. and T.S. were financially supported by
   the EU MATERA project 'Bioactive Nanocomposite Constructs for
   Regeneration of Articular Cartilage', EU MNT ERA Net project 'New
   Generation Titania', Danish Council for Strategic Research
   'Individualized Musculoskeletal Medicine', Sigrid Juselius Foundation,
   Finska Lakaresallskapet, evo grants, Helsinki University Central
   Hospital and ORTON Orthopedic Hospital of the Orton Foundation. A.F.W.,
   K.M., K.A. were financially supported by The EU support, the 7th Frame
   Program, VascuBone project ('Construction kit for tailor-made
   vascularized boneimplants', EC-GA n degrees 242175 HEALTH-2009-1.4.2)
   and by The Research Council of Norway ([FRIMED, 17734/V50], [156744],
   [Stem Cell 180383/V40]).
CR Abdallah BM, 2008, GENE THER, V15, P109, DOI 10.1038/sj.gt.3303067
   Abdallah BM, 2007, ENDOCRINOLOGY, V148, P3111, DOI 10.1210/en.2007-0171
   Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200
   Abdallah BM, 2004, J BONE MINER RES, V19, P841, DOI 10.1359/JBMR.040118
   Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059
   Abdallah BM, 2006, BONE, V39, P181, DOI 10.1016/j.bone.2005.12.082
   Aghaloo TL, 2004, INT J ORAL MAX IMPL, V19, P59
   Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900
   ALSOUSOU J, 2009, INT J ORAL MAX SURG, V91, P987, DOI DOI 10.1016/J.IJOM2007.05.023
   Anitua E, 2008, J BIOMED MATER RES B, V84B, P415, DOI 10.1002/jbm.b.30886
   Anitua E, 2007, BIOMATERIALS, V28, P4551, DOI 10.1016/j.biomaterials.2007.06.037
   Applegate LA, 2009, SKIN PHARMACOL PHYS, V22, P63, DOI 10.1159/000178865
   Azevedo MC, 2003, J MATER SCI-MATER M, V14, P103, DOI 10.1023/A:1022051326282
   Bai ST, 2000, J BIOL CHEM, V275, P8267, DOI 10.1074/jbc.275.12.8267
   BarrettConnor E, 1996, DIABETES CARE, V19, P1388, DOI 10.2337/diacare.19.12.1388
   Barrow CR, 2005, FOOT ANKLE INT, V26, P458, DOI 10.1177/107110070502600606
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Benayahu D, 2007, CURR MED CHEM, V14, P173, DOI 10.2174/092986707779313363
   Berghoff WJ, 2006, ORTHOPEDICS, V29, P590
   BERTRANDDUCHESN.MP, 2009, J PERIODONTAL RES, V45, P87, DOI DOI 10.1016/S8756-3282(03)00215-1
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Bibbo Christopher, 2005, J Surg Orthop Adv, V14, P17
   Bielecki T, 2008, EUR SURG RES, V40, P289, DOI 10.1159/000114967
   Bir SC, 2009, J VASC SURG, V50, P870, DOI 10.1016/j.jvs.2009.06.016
   Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077
   Boissy P, 2005, CANCER RES, V65, P9943, DOI 10.1158/0008-5472.CAN-05-0651
   Bouletreau PJ, 2002, PLAST RECONSTR SURG, V109, P2384, DOI 10.1097/00006534-200206000-00033
   Brandi ML, 2006, J BONE MINER RES, V21, P183, DOI 10.1359/JBMR.050917
   BROCKSTEDT H, 1993, BONE, V14, P681, DOI 10.1016/8756-3282(93)90092-O
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   Butcher A, 2009, J ORTHOP TRAUMA, V23, P195, DOI 10.1097/BOT.0b013e31819b35db
   Cai ZY, 2009, ACTA BIOMATER, V5, P628, DOI 10.1016/j.actbio.2008.09.016
   Calori GM, 2008, INJURY, V39, P1391, DOI 10.1016/j.injury.2008.08.011
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Carreon LY, 2005, SPINE, V30, pE243, DOI 10.1097/01.brs.0000160846.85397.44
   Carter DR, 1998, CLIN ORTHOP RELAT R, V355S, P41, DOI DOI 10.1097/00003086-199810001-00006)
   Cenni E, 2010, J ORTHOP RES, V28, P792, DOI 10.1002/jor.21073
   Cenni E, 2009, J ORTHOP RES, V27, P1493, DOI 10.1002/jor.20896
   Cenni E, 2009, J MATER SCI-MATER M, V20, P45, DOI 10.1007/s10856-008-3544-9
   Chan GK, 2002, GERONTOLOGY, V48, P62, DOI 10.1159/000048929
   Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000
   Chau JFL, 2009, HISTOL HISTOPATHOL, V24, P1593, DOI 10.14670/HH-24.1593
   Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890
   Chiquet M, 1999, MATRIX BIOL, V18, P417, DOI 10.1016/S0945-053X(99)00039-6
   Choi BH, 2004, INT J ORAL MAX SURG, V33, P56, DOI 10.1045/ijom.2003.0466
   Chung UI, 2001, J CLIN INVEST, V107, P295, DOI 10.1172/JCI11706
   Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005
   Claes L, 2002, J ORTHOP RES, V20, P1099, DOI 10.1016/S0736-0266(02)00044-X
   Coetzee JC, 2005, FOOT ANKLE INT, V26, P840, DOI 10.1177/107110070502601009
   Compston J, 2002, J CLIN ENDOCR METAB, V87, P5398, DOI 10.1210/jc.2002-021420
   Compston JE, 2001, PHYSIOL REV, V81, P419
   CONNOLLY J, 1989, J BONE JOINT SURG AM, V71A, P684, DOI 10.2106/00004623-198971050-00007
   CONNOLLY JF, 1991, CLIN ORTHOP RELAT R, P259
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003
   Dallari D, 2006, J ORTHOP RES, V24, P877, DOI 10.1002/jor.20112
   DALLARI D, 2007, CLIN ORAL IMPLAN RES, V89, P2413, DOI DOI 10.1111/J.1600-0501.2008.01525.X
   Danmark S, 2010, J BIOACT COMPAT POL, V25, P207, DOI 10.1177/0883911509358812
   Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016
   Day TF, 2008, SCI SIGNAL, V90, P19
   Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002
   Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe37, DOI 10.1016/j.tripleo.2005.07.008
   Dohan David M, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V101, pe51, DOI 10.1016/j.tripleo.2005.07.010
   Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
   Douchi T, 1997, MATURITAS, V27, P55, DOI 10.1016/S0378-5122(97)01112-2
   EINHORN TA, 1995, J BONE MINER RES, V10, P1272
   Engin FZ, 2008, NAT MED, V14, P299, DOI 10.1038/nm1712
   Esposito M, 2006, INT J ORAL MAX IMPL, V21, P696
   Fennis JPM, 2004, INT J ORAL MAX SURG, V33, P48, DOI 10.1054/ijom.2003.0452
   Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2
   Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105
   Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219
   Foster LJ, 2005, STEM CELLS, V23, P1367, DOI 10.1634/stemcells.2004-0372
   Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921
   FRIEDENSTEIN AJ, 1978, EXP HEMATOL, V6, P440
   FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x
   Friedenstein AJ, 1991, BONE MINER, V7, P243
   Frost H. M., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P121
   Fuerst G, 2003, INT J ORAL MAX IMPL, V18, P685
   FUJITA K, 2007, MOL CANCER, V6, pNIL1, DOI DOI 10.1016/J.GENE.2004.06.044
   Galasso O, 2008, J ORTHOP TRAUMATOL, V9, P129, DOI 10.1007/s10195-008-0021-7
   Gandhi Ankur, 2005, Foot Ankle Clin, V10, P621, DOI 10.1016/j.fcl.2005.06.009
   Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504
   Gartner LP, 2007, COLOR TXB HISTOLOGY, P19103
   Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200
   Gerard D, 2007, J ORAL MAXIL SURG, V65, P721, DOI 10.1016/j.joms.2006.09.025
   Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435
   Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584
   Geuze RE, 2009, TISSUE ENG PT A, V15, P3231, DOI 10.1089/ten.TEA.2009.0023
   Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2
   Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777
   Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036
   Glenny AM, 2004, COCHRANE DB SYST REV
   Granchi D, 2010, TISSUE ENG PART C-ME, V16, P511, DOI [10.1089/ten.tec.2009.0405, 10.1089/ten.TEC.2009.0405]
   Griffin XL, 2009, INJURY, V40, P158, DOI 10.1016/j.injury.2008.06.025
   Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806
   Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369
   Gronthos S, 2003, J BONE MINER RES, V18, P716, DOI 10.1359/jbmr.2003.18.4.716
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Gruber R, 2006, CLIN ORAL IMPLAN RES, V17, P188, DOI 10.1111/j.1600-0501.2005.01216.x
   Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999
   Gruber R, 2002, CLIN ORAL IMPLAN RES, V13, P529, DOI 10.1034/j.1600-0501.2002.130513.x
   Gruber R, 2002, BONE, V30, P726, DOI 10.1016/S8756-3282(02)00697-X
   Guarino V, 2008, ACTA BIOMATER, V4, P1778, DOI 10.1016/j.actbio.2008.05.013
   Guarino V, 2007, EXPERT REV MED DEVIC, V4, P406
   Guarino V, 2008, J BIOMED MATER RES B, V86B, P548, DOI 10.1002/jbm.b.31055
   Guillot PV, 2007, J CELL MOL MED, V11, P935, DOI 10.1111/j.1582-4934.2007.00106.x
   Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200
   Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660
   Hartmann C, 2009, CURR OPIN GENET DEV, V19, P437, DOI 10.1016/j.gde.2009.09.001
   He L, 2009, ORAL SURG ORAL MED O, V108, P707, DOI 10.1016/j.tripleo.2009.06.044
   Heim M, 2004, ENDOCRINOLOGY, V145, P848, DOI 10.1210/en.2003-1014
   Heinonen M, 2005, TISSUE ENG, V11, P1905, DOI 10.1089/ten.2005.11.1905
   Hirt-Burri N, 2008, PEDIATR SURG INT, V24, P37, DOI 10.1007/s00383-007-2040-5
   Hohlfeld J, 2005, LANCET, V366, P840, DOI 10.1016/S0140-6736(05)67107-3
   Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955
   Hong L, 2006, TISSUE ENG, V12, P2747, DOI 10.1089/ten.2006.12.2747
   Huang W, 2007, FRONT BIOSCI-LANDMRK, V12, P3068, DOI 10.2741/2296
   Idris SB, 2010, J BIOACT COMPAT POL, V25, P567, DOI 10.1177/0883911510381368
   Idris SB, 2010, J BIOMED MATER RES A, V94A, P631, DOI 10.1002/jbm.a.32726
   Ikeda E, 2006, BIOCHEM BIOPH RES CO, V342, P1257, DOI 10.1016/j.bbrc.2006.02.101
   Intini G, 2009, BIOMATERIALS, V30, P4956, DOI 10.1016/j.biomaterials.2009.05.055
   Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200
   Ito K, 2006, CLIN ORAL IMPLAN RES, V17, P579, DOI 10.1111/j.1600-0501.2005.01246.X
   Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007
   Jacob AL, 2006, DEV BIOL, V296, P315, DOI 10.1016/j.ydbio.2006.05.031
   Jenis Louis G, 2006, Spine J, V6, P14, DOI 10.1016/j.spinee.2005.08.014
   Jensen TB, 2004, J ORTHOPAED RES, V22, P653, DOI 10.1016/j.orthres.2003.10.006
   Justesen J, 2002, CALCIFIED TISSUE INT, V71, P36, DOI 10.1007/s00223-001-2059-x
   Kandler B, 2004, J PERIODONTOL, V75, P1255, DOI 10.1902/jop.2004.75.9.1255
   KASSEM M, 1993, J BONE MINER RES, V8, P1453
   Kasten P, 2008, BIOMATERIALS, V29, P3983, DOI 10.1016/j.biomaterials.2008.06.014
   Kaviani A, 2001, J PEDIATR SURG, V36, P1662, DOI 10.1053/jpsu.2001.27945
   Kaviani A, 2002, J PEDIATR SURG, V37, P995, DOI 10.1053/jpsu.2002.33828
   Kelly CM, 2001, CLIN ORTHOP RELAT R, P42
   Kent J, 2006, BRIT MED J, V332, P866, DOI 10.1136/bmj.332.7546.866
   KERSHAW CJ, 1993, CLIN ORTHOP RELAT R, P28
   Khan Y, 2008, J BONE JOINT SURG AM, V90A, P36, DOI 10.2106/JBJS.G.01260
   Kilian O, 2004, EUR J MED RES, V9, P337
   Kitoh H, 2007, BONE, V40, P522, DOI 10.1016/j.bone.2006.09.019
   Kitoh Hiroshi, 2009, J Pediatr Orthop, V29, P643, DOI 10.1097/BPO.0b013e3181b2afb2
   Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270
   Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5
   Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627
   Kroeze RJ, 2009, MATERIALS, V2, P833, DOI 10.3390/ma2030833
   Kruyt M, 2008, TISSUE ENG PT A, V14, P1081, DOI 10.1089/ten.tea.2007.0111
   Kulterer B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-70
   Kumar A, 2010, TISSUE ENG PT A, V16, P983, DOI [10.1089/ten.tea.2009.0230, 10.1089/ten.TEA.2009.0230]
   Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133
   Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335
   Kwong FNK, 2008, J AM ACAD ORTHOP SUR, V16, P619, DOI 10.5435/00124635-200811000-00001
   Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200
   Langman J, 1975, MED EMBRYOLOGY HUMAN
   Larsen KH, 2010, J BONE MINER RES, V25, P796, DOI 10.1359/jbmr.091018
   Lecka-Czernik B, 2002, ENDOCRINOLOGY, V143, P2376, DOI 10.1210/en.143.6.2376
   Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047
   Leskela HV, 2006, BONE, V39, P1026, DOI 10.1016/j.bone.2006.05.003
   Li F, 2007, LANGMUIR, V23, P2778, DOI 10.1021/la0629025
   Li XM, 2007, J CELL BIOCHEM, V100, P527, DOI 10.1002/jcb.21017
   Li XM, 2005, J CELL BIOCHEM, V95, P189, DOI 10.1002/jcb.20373
   Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1
   LIEBERMAN JR, 2002, ACTA BIOMATER, V84, P1032, DOI DOI 10.1016/J.ACTBIO.2009.01.009
   Loboa EG, 2001, J ORTHOPAED RES, V19, P1067, DOI 10.1016/S0736-0266(01)00028-6
   Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006
   Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5
   LURIA EA, 1971, TRANSFUSION, V11, P345, DOI 10.1111/j.1537-2995.1971.tb04426.x
   Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359
   Mariconda M, 2008, J ORTHOP TRAUMA, V22, P342, DOI 10.1097/BOT.0b013e318172cea5
   Marie PJ, 2008, ARCH BIOCHEM BIOPHYS, V473, P98, DOI 10.1016/j.abb.2008.02.030
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Marx RE, 2009, J ORAL MAXIL SURG, V67, P107, DOI 10.1016/j.joms.2008.12.007
   Matsubara T, 2005, J BONE MINER RES, V20, P399, DOI 10.1359/JBMR.041117
   Mazzucco L, 2008, VOX SANG, V94, P202, DOI 10.1111/j.1423-0410.2007.01027.x
   Mazzucco L, 2009, VOX SANG, V97, P110, DOI 10.1111/j.1423-0410.2009.01188.x
   Mirmalek-Sani SH, 2006, STEM CELLS, V24, P1042, DOI 10.1634/stemcells.2005-0368
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102
   Mondrinos MJ, 2006, BIOMATERIALS, V27, P4399, DOI 10.1016/j.biomaterials.2006.03.049
   Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641
   Montjovent MO, 2009, TISSUE ENG PT A, V15, P1523, DOI 10.1089/ten.tea.2008.0222
   Montjovent MO, 2005, TISSUE ENG, V11, P1640, DOI 10.1089/ten.2005.11.1640
   Montjovent MO, 2004, BONE, V35, P1323, DOI 10.1016/j.bone.2004.07.001
   Moojen DJF, 2008, J ORTHOP RES, V26, P404, DOI 10.1002/jor.20519
   Mossey PA, 2009, LANCET, V9703, P1773
   Mukherjee A, 2004, HORM RES, V62, P35, DOI 10.1159/000080497
   Mundy GR, 2006, CELL, V126, P441, DOI 10.1016/j.cell.2006.07.015
   Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008
   Nagata M, 2009, BONE, V45, P339, DOI 10.1016/j.bone.2009.04.246
   Nagata MJH, 2009, J CLIN PERIODONTOL, V36, P775, DOI 10.1111/j.1600-051X.2009.01450.x
   Nair MB, 2009, ACTA BIOMATER, V5, P1742, DOI 10.1016/j.actbio.2009.01.009
   Nair MB, 2009, TISSUE ENG PT A, V15, P1619, DOI 10.1089/ten.tea.2008.0229
   Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452
   Nakao A, 1997, NATURE, V389, P631
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487
   Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293
   Ogino Y, 2006, ORAL SURG ORAL MED O, V101, P724, DOI 10.1016/j.tripleo.2005.08.016
   Ogino Y, 2009, J PERIODONTAL RES, V44, P217, DOI 10.1111/j.1600-0765.2008.01109.x
   Onichtchouk D, 1999, NATURE, V401, P480
   Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003
   Papachroni KK, 2009, TRENDS MOL MED, V15, P208, DOI 10.1016/j.molmed.2009.03.001
   PARFITT AM, 1991, BONE OSTEOBLAST OSTE, P351
   Pelin Irina M, 2009, MATER SCI ENG, V29, P2188
   Pena WA, 2009, PEDIATR DENT, V31, P329
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Phillips AM, 2005, INJURY, V36, P5, DOI 10.1016/j.injury.2005.07.027
   Piersanti S, 2006, CALCIFIED TISSUE INT, V78, P372, DOI 10.1007/s00223-006-0001-y
   Pilkington MF, 2001, J BONE MINER RES, V16, P1237, DOI 10.1359/jbmr.2001.16.7.1237
   Pino AM, 2006, J ENDOCRINOL, V191, P715, DOI 10.1677/joe.1.07026
   Pioletti DP, 2006, SWISS MED WKLY, V136, P557
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Plachokova AS, 2008, CLIN ORAL IMPLAN RES, V19, P539, DOI 10.1111/j.1600-0501.2008.01525.x
   Post S, 2008, BONE, V43, P32, DOI 10.1016/j.bone.2008.03.011
   Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721
   Quintin A, 2007, CELL TRANSPLANT, V16, P675, DOI 10.3727/000000007783465127
   Quintin A, 2009, J CELL MOL MED, V13, P2559, DOI 10.1111/j.1582-4934.2008.00630.x
   Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3
   Ramalho AC, 2001, CYTOKINE, V16, P126, DOI 10.1006/cyto.2001.0956
   Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray
   Rickard DJ, 1996, J BONE MINER RES, V11, P312
   Rifas L, 2007, J CELL BIOCHEM, V100, P824, DOI 10.1002/jcb.21132
   Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480
   Roldan JC, 2004, BONE, V34, P80, DOI 10.1016/j.bone.2003.09.011
   Rosada C, 2003, CALCIFIED TISSUE INT, V72, P135, DOI 10.1007/s00223-002-2002-9
   Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070
   Ryner M, 2002, J POLYM SCI POL CHEM, V40, P2049, DOI 10.1002/pola.10304
   Ryner M, 2002, BIOMACROMOLECULES, V3, P601, DOI 10.1021/bm015658z
   Sabatakos G, 2000, NAT MED, V6, P985
   Sasaki K, 2007, J BIOMED MATER RES B, V80B, P491, DOI 10.1002/jbm.b.30622
   Schander K, 2010, J BIOACT COMPAT POL, V25, P584, DOI 10.1177/0883911510383684
   Schieker M, 2006, EUR J TRAUMA, V32, P114, DOI DOI 10.1007/S00068-006-6047-8
   Schindler O S, 2008, J Orthop Surg (Hong Kong), V16, P66
   Shi S, 2005, Orthod Craniofac Res, V8, P191, DOI 10.1111/j.1601-6343.2005.00331.x
   Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696
   Shikinami Y, 2006, J R SOC INTERFACE, V3, P805, DOI 10.1098/rsif.2006.0144
   Sillat T, 2009, J CELL MOL MED, V13, P3296, DOI 10.1111/j.1582-4934.2009.00729.x
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Smith Simon E, 2009, Clin Podiatr Med Surg, V26, P559, DOI 10.1016/j.cpm.2009.07.002
   Stenderup K, 2001, J BONE MINER RES, V16, P1120, DOI 10.1359/jbmr.2001.16.6.1120
   Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005
   Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890
   Suba Z, 2004, INT J ORAL MAX IMPL, V19, P832
   Suzuki O, 2008, CURR MED CHEM, V15, P305, DOI 10.2174/092986708783497283
   Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137
   Takai H, 1998, J BIOL CHEM, V273, P27091, DOI 10.1074/jbc.273.42.27091
   Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8
   Tchkonia T, 2002, AM J PHYSIOL-REG I, V282, pR1286, DOI 10.1152/ajpregu.00653.2001
   Ten Cate A.R., 1980, ORAL HISTOLOGY DEV S
   Thor A, 2007, INT J ORAL MAX SURG, V36, P1164, DOI 10.1016/j.ijom2007.05.023
   Tobita M, 2008, TISSUE ENG PT A, V14, P945, DOI 10.1089/ten.tea.2007.0048
   Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409
   Towler Dwight A, 2008, Curr Osteoporos Rep, V6, P67, DOI 10.1007/s11914-008-0012-x
   Trommelmans L, 2007, TISSUE ENG, V13, P667, DOI 10.1089/ten.2006.0089
   Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006
   Ueda M, 2005, INT J PERIODONT REST, V25, P129
   Urist MR, 1943, J BONE JOINT SURG, V25, P375
   Vogel JP, 2006, PLATELETS, V17, P462, DOI 10.1080/09537100600758867
   von Schroeder HP, 2003, BONE, V33, P673, DOI 10.1016/S8756-3282(03)00215-1
   Wagner W, 2005, EXP HEMATOL, V33, P1402, DOI 10.1016/j.exphem.2005.07.003
   Wan Mei, 2005, Biochemical and Biophysical Research Communications, V328, P651, DOI 10.1016/j.bbrc.2004.11.067
   Wang SG, 2005, ANAL BIOANAL CHEM, V381, P547, DOI 10.1002/s00216-004-27712
   Weicht B, 2007, J CELL BIOCHEM, V102, P1300, DOI 10.1002/jcb.21360
   Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044
   Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x
   Yamada Y, 2004, CLIN ORAL IMPLAN RES, V15, P589, DOI 10.1111/j.1600-0501.2004.01038.x
   Yamada Y, 2004, CELL TRANSPLANT, V13, P343, DOI 10.3727/000000004783983909
   Yamada Y, 2004, TISSUE ENG, V10, P955, DOI 10.1089/1076327041348284
   Yoshimura Y, 2001, J BONE MINER RES, V16, P876, DOI 10.1359/jbmr.2001.16.5.876
   Zhang ZM, 1998, BIOCHEM BIOPH RES CO, V251, P190, DOI 10.1006/bbrc.1998.9412
   Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012
   Zhou YF, 2007, POLYM INT, V56, P333, DOI 10.1002/pi.2138
   Zhuang HM, 1996, BIOCHEM BIOPH RES CO, V229, P449, DOI 10.1006/bbrc.1996.1824
NR 280
TC 148
Z9 154
U1 3
U2 151
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD APR
PY 2011
VL 15
IS 4
BP 718
EP 746
DI 10.1111/j.1582-4934.2010.01224.x
PG 29
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 760GL
UT WOS:000290312700003
PM 21129153
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Du, MC
   Zhu, PL
   Yan, XH
   Su, Y
   Song, WX
   Li, JB
AF Du, Mingchun
   Zhu, Pengli
   Yan, Xuehai
   Su, Ying
   Song, Weixing
   Li, Junbai
TI Honeycomb Self-Assembled Peptide Scaffolds by the Breath Figure Method
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE breath figure; peptides; scaffolds; self-assembly; supra-molecular
   chemistry
ID MESOPOROUS MATERIALS; BUILDING-BLOCKS; THIN-FILM; NANOTUBES; OSTEOBLAST;
   DIPEPTIDE; NANOSTRUCTURES; AMPHIPHILES; TOPOGRAPHY; MORPHOLOGY
AB The self-assembly of molecules into desired architectures is currently a challenging subject for the development of supramolecular chemistry. Here we present a facile "breath figure" assembly process through the use of the self-assembled peptide building block diphenylalanine (L-Phe-L-Phe, FF). Macroporous honeycomb scaffolds were fabricated, and average pore size could be regulated, from (1.00 +/- 0.18) mm to (2.12 +/- 0.47) mu m, through the use of different air speeds. It is indicated that the honeycomb formation is humidity-, solvent-, concentration-, and substrate-dependent. Moreover, water molecules introduced from "breath figure" intervene in the formation of hydrogen bonds during FF molecular self-assembly, which results in a hydrogen bond configuration transition from antiparallel beta sheet to parallel beta sheet. Meanwhile, as a result of the higher polarity of water molecules, the FF molecular array is transformed from laminar stacking into a hexagonal structure. These findings not only elucidate the FF molecule self-assembly process, but also strongly support the mechanism of breath figure array formation. Finally, human embryo skin fibroblast (ESF) culture experiments suggest that FF honeycomb scaffolds are an attractive biomaterial for growth of adherent cells with great potential applications in tissue engineering.
C1 [Du, Mingchun; Zhu, Pengli; Yan, Xuehai; Su, Ying; Li, Junbai] Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, Int Joint Lab,BNLMS, Beijing 100190, Peoples R China.
   [Yan, Xuehai] Max Planck Inst Colloids & Interfaces, D-14476 Potsdam, Germany.
   [Song, Weixing] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China.
RP Li, JB (reprint author), Chinese Acad Sci, Inst Chem, Key Lab Colloid & Interface Sci, Int Joint Lab,BNLMS, Beijing 100190, Peoples R China.
EM jbli@iccas.ac.cn
RI Li, Junbai/M-4351-2016; Yan, Xuehai/E-8722-2012; zhu, pengli/K-9613-2014
OI Li, Junbai/0000-0001-9575-3125; Yan, Xuehai/0000-0002-0890-0340; 
FU National Basic Research Program of China [2009CB930100]; National
   Natural Science Foundation of China [NNSFC 20833010]; Alexander von
   Humboldt Foundation
FX This work was financially supported by the National Basic Research
   Program of China (973 program 2009CB930100) and the National Natural
   Science Foundation of China (NNSFC 20833010). X.H.Y. acknowledges
   support in the form of a research fellowship from the Alexander von
   Humboldt Foundation.
CR Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Ariga K., 2008, ANGEW CHEM, V120, P7364
   Babu SS, 2009, CHEM-ASIAN J, V4, P824, DOI 10.1002/asia.200900145
   Ball M, 2008, J BIOMED MATER RES A, V86A, P637, DOI 10.1002/jbm.a.31652
   Barbetta A, 2005, ADV FUNCT MATER, V15, P118, DOI 10.1002/adfm.200400072
   Behanna HA, 2005, J AM CHEM SOC, V127, P1193, DOI 10.1021/ja044863u
   Bunz UHF, 2006, ADV MATER, V18, P973, DOI 10.1002/adma.200501131
   Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586
   Carny O, 2006, NANO LETT, V6, P1594, DOI 10.1021/nl060468l
   Connal LA, 2008, LANGMUIR, V24, P556, DOI 10.1021/la702495p
   Connal LA, 2007, SOFT MATTER, V3, P837, DOI 10.1039/b700597k
   Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n
   Daniel C, 2005, ADV MATER, V17, P1515, DOI 10.1002/adma.200401762
   Dasgupta D, 2005, MACROMOLECULES, V38, P5602, DOI 10.1021/ma050582a
   denBraber ET, 1996, BIOMATERIALS, V17, P1093, DOI 10.1016/0142-9612(96)85910-2
   Du C, 2005, SCIENCE, V307, P1450, DOI 10.1126/science.1105675
   Englert BC, 2005, CHEM-EUR J, V11, P995, DOI 10.1002/chem.200400921
   Fukuhira Y, 2006, BIOMATERIALS, V27, P1797, DOI 10.1016/j.biomaterials.2005.10.019
   Gao XY, 2005, ADV MATER, V17, P2037, DOI 10.1002/adma.200401849
   Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp
   Gazit E, 2007, CHEM SOC REV, V36, P1263, DOI 10.1039/b605536m
   GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0
   Gin DL, 2001, ADV MATER, V13, P1407, DOI 10.1002/1521-4095(200109)13:18<1407::AID-ADMA1407>3.0.CO;2-0
   Gristina R, 2009, J BIOMED MATER RES B, V88B, P139, DOI 10.1002/jbm.b.31160
   Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z
   Gupta M, 2007, ADV MATER, V19, P858, DOI 10.1002/adma.200601774
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Haswell S, 2000, TRAC-TREND ANAL CHEM, V19, P389, DOI 10.1016/S0165-9936(00)00012-1
   Hedrick JL, 1998, ADV MATER, V10, P1049, DOI 10.1002/(SICI)1521-4095(199809)10:13<1049::AID-ADMA1049>3.0.CO;2-F
   Hendler N, 2007, ADV MATER, V19, P1485, DOI 10.1002/adma.200602265
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Ismail FSM, 2007, J MATER SCI-MATER M, V18, P705, DOI 10.1007/s10856-006-0012-2
   Isozaki K., 2007, ANGEW CHEM, V119, P2913
   Isozaki K, 2007, ANGEW CHEM INT EDIT, V46, P2855, DOI 10.1002/anie.200605067
   Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522
   Kay S, 2002, TISSUE ENG, V8, P753, DOI 10.1089/10763270260424114
   KELLY MM, 1977, J AM CHEM SOC, V99, P3264, DOI 10.1021/ja00452a010
   Kim JK, 2007, J AM CHEM SOC, V129, P6082, DOI 10.1021/ja071394y
   Kuhn P., 2008, ANGEW CHEM, V120, P3499
   Kuhn P, 2008, ANGEW CHEM INT EDIT, V47, P3450, DOI 10.1002/anie.200705710
   Lamm MS, 2005, J AM CHEM SOC, V127, P16692, DOI 10.1021/ja05472ff
   Lee M, 2004, ANGEW CHEM INT EDIT, V43, P6465, DOI 10.1002/anie.200460378
   Lee M., 2004, ANGEW CHEM, V116, P6627
   Lee SH, 2009, SOFT MATTER, V5, P2343, DOI 10.1039/b817477f
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Li J, 2005, LANGMUIR, V21, P2017, DOI 10.1021/la0476521
   Limaye AV, 1996, PHYS REV LETT, V76, P3762, DOI 10.1103/PhysRevLett.76.3762
   Lin VSY, 1997, SCIENCE, V278, P840, DOI 10.1126/science.278.5339.840
   Mahler A, 2006, ADV MATER, V18, P1365, DOI 10.1002/adma.200501765
   MARTORELL J, 1990, PHYS REV LETT, V65, P1877, DOI 10.1103/PhysRevLett.65.1877
   Painter O, 1999, SCIENCE, V284, P1819, DOI 10.1126/science.284.5421.1819
   Palmer LC, 2008, ACCOUNTS CHEM RES, V41, P1674, DOI 10.1021/ar8000926
   Peng J, 2004, POLYMER, V45, P447, DOI 10.1016/j.polymer.2003.11.019
   Percec V, 2004, NATURE, V430, P764, DOI 10.1038/nature02770
   Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073
   Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387
   Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139
   Ryu J, 2008, ADV MATER, V20, P3754, DOI 10.1002/adma.200800364
   Ryu J, 2008, CHEM MATER, V20, P4284, DOI 10.1021/cm800015p
   Schuth F, 2002, ADV MATER, V14, P629, DOI 10.1002/1521-4095(20020503)14:9<629::AID-ADMA629>3.0.CO;2-B
   Sedman VL, 2006, J AM CHEM SOC, V128, P6903, DOI 10.1021/ja060358g
   Shastri VP, 2000, P NATL ACAD SCI USA, V97, P1970, DOI 10.1073/pnas.97.5.1970
   Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j
   Srinivasarao M, 2001, SCIENCE, V292, P79, DOI 10.1126/science.1057887
   Stalmach U, 2000, J AM CHEM SOC, V122, P5464, DOI 10.1021/ja000160a
   Stepanenko V, 2008, SMALL, V4, P2158, DOI 10.1002/smll.200801069
   Sun S, 1996, J PHYS CHEM-US, V100, P13348, DOI 10.1021/jp960739o
   SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001
   WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191
   Yan X. H., 2007, ANGEW CHEM, V119, P2483
   Yan XH, 2008, SMALL, V4, P1687, DOI 10.1002/smll.200800960
   Yan XH, 2008, CHEM MATER, V20, P1522, DOI 10.1021/cm702931b
   Yan XH, 2007, ANGEW CHEM INT EDIT, V46, P2431, DOI 10.1002/anie.200603387
   Yan XH, 2010, CHEM SOC REV, V39, P1877, DOI 10.1039/b915765b
   Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E
   YING JY, 1999, ANGEW CHEM, V111, P58
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao G, 2007, BIOMATERIALS, V28, P2821, DOI 10.1016/j.biomaterials.2007.02.024
   Zhu PL, 2010, CHEM-EUR J, V16, P3176, DOI 10.1002/chem.200902139
NR 81
TC 47
Z9 51
U1 2
U2 90
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD APR
PY 2011
VL 17
IS 15
BP 4238
EP 4245
DI 10.1002/chem.201003021
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 757PZ
UT WOS:000290101500023
PM 21387428
DA 2018-10-20
ER

PT J
AU Jo, EH
   Lee, GY
   Cho, SJ
   Yoo, H
   Kim, OY
   Seong, K
   Kang, YS
   Lee, D
   Khang, G
AF Jo, Eun Hye
   Lee, Ga Young
   Cho, Su Jin
   Yoo, Hanna
   Kim, On You
   Seong, Kyeongyeol
   Kang, Young Sun
   Lee, Dongwon
   Khang, Gilson
TI ATTACHMENT AND PROLIFERATION OF RETINAL PIGMENT EPITHELIAL CELLS ON
   SMALL INTESTINE SUBMUCOSA POWDER IMPREGNATED
   POLY(L-LACTIDE-CO-GLYCOLIDE) FILM
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE Small intestine submucosa; Retinal pigment epithelium;
   Poly(lactic-co-glycolic acid)
ID TISSUE ENGINEERED BONE; SCHWANN-CELL; SIS SPONGE; SCAFFOLDS; CULTURE;
   TRANSPLANTATION; MICROSPHERES; REGENERATION; SURFACE; SHEETS
AB The retinal pigment epithelium (RPE) closely interacts with photoreceptors in the maintenance of visual function. The native RPEs exist as a monolayer structure and have a mottled brown color due to the presence of melanin and other pigments including lipofuscin granules, which accumulate with age. In age-related macular degeneration (AMD), RPE's dysfunction and changes in Bruch's membrane occur. Thus, small intestine submucosa/poly(lactic-co-glycolic acid) (SIS/PLGA) film is a biomimetic transplant consisting of a layer of healthy RPE cells cultured on a support membrane. The goals of this study were to evaluate the effects of attachment and proliferation of RPEs on SIS/PLGA films. Porcine SIS is an acellular tissue and widely used as a biomaterial without immunorejection responses, whereas PLGA is a biodegradable synthetic polymer with acceptable mechanical strength and well-controlled degradation rate. We fabricated SIS/PLGA films using 20 wt% of SIS. We measured MTT to confirm cellular adhesion of cell number attached on film at 1, 3, 5, and 7 days. Morphology of cellular adhesion on films was confirmed by scanning electron microscopy at 1, 3, and 7 days. Further, reverse transcription polymerase chain reaction (RT-PCR) was conducted to confirm messenger RNA expression of RPE65 as RPE's marker and expression of cytokeratin, and RPE65 were determined by AEC immunocytochemical staining. These results suggest that SIS provides suitable surface to RPEs.
C1 [Jo, Eun Hye; Lee, Ga Young; Cho, Su Jin; Yoo, Hanna; Kim, On You; Seong, Kyeongyeol; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Dept BIN Fus Technol, Dept Polymer Nano Sci & Technol, Jeonju 561756, South Korea.
   [Jo, Eun Hye; Lee, Ga Young; Cho, Su Jin; Yoo, Hanna; Kim, On You; Seong, Kyeongyeol; Lee, Dongwon; Khang, Gilson] Chonbuk Natl Univ, Polymer Fus Res Ctr, Jeonju 561756, South Korea.
   [Kang, Young Sun] Konkuk Univ, Inst Biomed Sci & Technol, Seoul, South Korea.
RP Lee, D (reprint author), Chonbuk Natl Univ, Dept BIN Fus Technol, Dept Polymer Nano Sci & Technol, 664-14 Dukjin, Jeonju 561756, South Korea.
EM dlee@jbnu.ac.kr; gskhang@jbnu.ac.kr
RI Khang, Gilson/B-2109-2013
FU SCRC [SC4110]; WCU [R31-20029]; KRF [2008-314-D00115]
FX This research was supported by SCRC (SC4110), WCU (R31-20029), and KRF
   (2008-314-D00115).
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.3.CO;2-A
   Badylak SF, 1998, J BIOMAT SCI-POLYM E, V9, P863, DOI 10.1163/156856298X00208
   Choi HS, 2002, INT J PHARM, V234, P195, DOI 10.1016/S0378-5173(01)00968-1
   Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041
   Hong HK, 2010, POLYM-KOREA, V34, P282, DOI 10.7317/pk.2010.34.3.282
   Huang W, 2010, BIOMATERIALS, V31, P4278, DOI 10.1016/j.biomaterials.2010.01.059
   Khang G, 2002, MACROMOL RES, V10, P158, DOI 10.1007/BF03218266
   Khang G, 2000, KOREA POLYM J, V8, P276
   Kim CM, 2008, POLYM-KOREA, V32, P49
   Kim KS, 2010, BIOMATERIALS, V31, P1104, DOI 10.1016/j.biomaterials.2009.10.020
   Kim MS, 2007, BIOMATERIALS, V28, P5137, DOI 10.1016/j.biomaterials.2007.08.014
   Ko YK, 2008, POLYM-KOREA, V32, P109
   Ko YK, 2007, POLYM-KOREA, V31, P14
   Kubota A, 2006, BIOMATERIALS, V27, P3639, DOI 10.1016/j.biomaterials.2006.02.018
   Lee CJ, 2007, BIOMATERIALS, V28, P2192, DOI 10.1016/j.biomaterials.2007.01.018
   Lee MS, 2006, POLYM-KOREA, V30, P259
   Lu JT, 2007, BIOMATERIALS, V28, P1486, DOI 10.1016/j.biomaterials.2006.11.023
   Lu LC, 2001, BIOMATERIALS, V22, P3345, DOI 10.1016/S0142-9612(01)00172-7
   Oh AY, 2008, POLYM-KOREA, V32, P403
   Oh AY, 2009, POLYM-KOREA, V33, P118
   Park KS, 2005, POLYM-KOREA, V29, P501
   Radtke ND, 2002, AM J OPHTHALMOL, V133, P544, DOI 10.1016/S0002-9394(02)01322-3
   STRAMM LE, 1983, EXP EYE RES, V36, P91, DOI 10.1016/0014-4835(83)90092-1
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Woch G, 2001, INVEST OPHTH VIS SCI, V42, P1669
   Wu LB, 2004, BIOMATERIALS, V25, P5821, DOI 10.1016/j.biomaterials.2004.01.038
NR 27
TC 2
Z9 2
U1 1
U2 18
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD APR
PY 2011
VL 23
IS 2
BP 119
EP 126
DI 10.4015/S1016237211002438
PG 8
WC Engineering, Biomedical
SC Engineering
GA 757QG
UT WOS:000290102200005
DA 2018-10-20
ER

PT J
AU Ullah, S
   Tayyab, M
   Arsalani-Zadeh, R
   Duthie, GS
AF Ullah, Sana
   Tayyab, M.
   Arsalani-Zadeh, Reza
   Duthie, G. S.
TI Injectable Anal Bulking Agent for the Management of Faecal Incontinence
SO JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
LA English
DT Article
DE Anal bulking agents; Faecal incontinence; Anal collagen plug
ID SILICONE BIOMATERIAL; INJECTION; COLLAGEN
AB This study was conducted to determine the safety and efficacy of injectable bulking agents. A total of 13 procedures were performed on 11 patients with faecal incontinence during 2002 to 2007. Patients with internal anal sphincter defect and low incontinence score (Cleveland score < 10) revealed improvement. Patients with higher incontinence score and external sphincter defect secondary to obstetric damage required further intervention. At a median follow-up of 43 months, 7 (63%) patients showed improvement in incontinence score and 4 (32%) showed marked improvement in their symptoms. Fifty six percent of the patients described this as an effective procedure, though the level of effectiveness varied from person to person. Anal injectable collagen was found safe and effective in the management of faecal incontinence. Long-term follow-ups are required to re assess and consider definitive procedure in failed cases.
C1 [Ullah, Sana; Tayyab, M.; Arsalani-Zadeh, Reza; Duthie, G. S.] Castle Hill Hosp, Dept Surg, Cottingham, Yorks, England.
RP Ullah, S (reprint author), Castle Hill Hosp, Acad Surg Unit, Cottingham HU16 5JQ, Yorks, England.
EM drsanavri@hotmail.com
CR Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Johanson JF, 1996, AM J GASTROENTEROL, V91, P33
   Kumar D, 1998, BRIT J SURG, V85, P978
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   *NIH CLIN EXC, INJ BULK AG FAEC INC
   Norton C, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002111.PUB2
   ROCKWOOD TH, 2008, DIS COLON RECTUM, V51, P1432
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Stojkovic SG, 2006, BRIT J SURG, V93, P1514, DOI 10.1002/bjs.5394
   STOJKOVIC SG, 2007, BRIT J SURG, V94, P643
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
NR 13
TC 4
Z9 4
U1 0
U2 1
PU COLL PHYSICIANS & SURGEONS PAKISTAN
PI KARACHI
PA SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN
SN 1022-386X
J9 JCPSP-J COLL PHYSICI
JI JCPSP-J. Coll. Physicians Surg.
PD APR
PY 2011
VL 21
IS 4
BP 227
EP 229
PG 3
WC Medicine, General & Internal
SC General & Internal Medicine
GA 755TP
UT WOS:000289960200009
PM 21453620
DA 2018-10-20
ER

PT J
AU Rodriguez, M
   Pascual, G
   Sotomayor, S
   Perez-Kohler, B
   Cifuentes, A
   Bellon, JM
AF Rodriguez, Marta
   Pascual, Gemma
   Sotomayor, Sandra
   Perez-Koehler, Barbara
   Cifuentes, Alberto
   Bellon, Juan M.
TI Chemical Adhesion Barriers: Do They Affect the Intraperitoneal Behavior
   of a Composite Mesh?
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
ID VENTRAL INCISIONAL HERNIA; ABDOMINAL-WALL; POLYPROPYLENE MESH; REPAIR;
   MODEL; BIOMATERIAL; PROSTHESIS; PREVENTION; SEPRAMESH; SEPRAFILM
AB Introduction: The intraperitoneal behavior of a prosthetic material used to repair a hernia is key to the success of the postimplant repair process. This study was designed to laparoscopically examine the real-time behavior of three composite meshes incorporating a chemical adhesion barrier when placed in contact with the visceral peritoneum. Material and Methods: The defects of 7 xx 5 cm were created in the ventral abdominal wall of 18 New Zealand White rabbits and repaired using Parietex Composite (R) A (R) (n == 6), Sepramesh (R) A (R) (n == 6), or Proceed (R) A (R) (n == 6). At 24 hr, 3, 7, and 14 days postimplant, adhesion formation was quantified by subjecting photographs obtained during laparoscopy to image analysis. At 14 days, specimens of the implants and surrounding host tissue were obtained for histologic, morphometric, and immunohistochemical analyses. Results: There were no cases of infection and/or rejection of the implant. Adhesion formation followed by laparoscopy 3, 7, and 14 days after implant was significantly lower for Parietex (R) A (R) than the other biomaterials. Degradation of the chemical barrier occurred earliest in Sepramesh (R) A (R), this barrier being most stable at 14 days for the Parietex (R) A (R) implants. Macrophage counts were significantly greater for Sepramesh (R) A (R). The thickness of the neoformed peritoneum formed on the three implants varied significantly (p < .05): 276.89 +/-+/- 38.87 mu mu m, 84.49 +/-+/- 19.05 mu mu m, and 161.97 +/-+/- 47.05 mu mu m, respectively for Paritex (R) A (R), Sepramesh (R) A (R), and Proceed (R) A (R). Conclusions: (a) The most stable barrier against biodegradation was that of Parietex (R) A (R); (b) the first postimplant week was the most critical period for adhesion formation; and (c) all three biomaterials showed good intraperitoneal behavior.
C1 [Rodriguez, Marta; Sotomayor, Sandra; Bellon, Juan M.] Univ Alcala De Henares, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Fac Med, Dept Surg, Madrid 28871, Spain.
   [Pascual, Gemma; Perez-Koehler, Barbara; Cifuentes, Alberto] Univ Alcala De Henares, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Fac Med, Dept Med Specialties, Madrid 28871, Spain.
RP Bellon, JM (reprint author), Univ Alcala De Henares, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Fac Med, Dept Surg, Ctra Madrid Barcelona,Km 33600, Madrid 28871, Spain.
EM juanm.bellon@uah.es
OI PASCUAL, GEMMA/0000-0002-1623-4384; Cifuentes,
   Alberto/0000-0003-2383-6479; Perez Kohler, Barbara/0000-0002-5061-1526;
   BELLON, JUAN M./0000-0002-6071-5011
CR Alponat A, 1997, AM SURGEON, V63, P818
   AMID PK, 1994, J BIOMED MATER RES, V28, P373, DOI 10.1002/jbm.820280312
   Baptista ML, 2000, SURGERY, V128, P86, DOI 10.1067/msy.2000.106810
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8
   Bellon JM, 2000, J MATER SCI-MATER M, V11, P25, DOI 10.1023/A:1008981517743
   Bellon JM, 1996, BIOMATERIALS, V17, P1369, DOI 10.1016/0142-9612(96)87276-0
   Bellon JM, 1996, J MATER SCI-MATER M, V7, P331, DOI 10.1007/BF00154544
   Burger JWA, 2004, ANN SURG, V240, P578
   Chew DKW, 2000, SURGERY, V127, P352, DOI 10.1067/msy.2000.100886
   Chuback JA, 2000, SURGERY, V127, P475, DOI 10.1067/msy.2000.104122
   Felemovicius I, 2004, J AM COLL SURGEONS, V198, P543, DOI 10.1016/j.jamcollsurg.2003.12.004
   Gaertner WB, 2010, HERNIA, V14, P375, DOI 10.1007/s10029-010-0659-y
   Gomez-Gil V, 2010, SURGERY, V147, P378, DOI 10.1016/j.surg.2009.10.011
   Gray SH, 2008, SURG CLIN N AM, V88, P17, DOI 10.1016/j.suc.2007.11.007
   Greenawalt KE, 2000, J SURG RES, V94, P92, DOI 10.1006/jsre.2000.6020
   Israelsson L A, 2003, Hernia, V7, P114, DOI 10.1007/s10029-003-0119-z
   Judge TW, 2007, J AM COLL SURGEONS, V204, P276, DOI 10.1016/j.jamcollsurg.2006.11.003
   KARAKOUSIS CP, 1995, J AM COLL SURGEONS, V181, P11
   Lucas PA, 1996, J SURG RES, V62, P229, DOI 10.1006/jsre.1996.0200
   Luijendijk RW, 2000, NEW ENGL J MED, V343, P392, DOI 10.1056/NEJM200008103430603
   Mutsaers SE, 2000, J PATHOL, V190, P86
   NAIN JO, 1993, J LAPAROENDOSC SURG, V3, P187
   Schreinemacher MHF, 2009, BRIT J SURG, V96, P305, DOI 10.1002/bjs.6446
   Schug-Pass C, 2009, SURG ENDOSC, V23, P487, DOI 10.1007/s00464-008-0085-8
   Walker AP, 1993, J SURG RES, V55, P27
NR 26
TC 10
Z9 10
U1 4
U2 7
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PD APR
PY 2011
VL 24
IS 3
BP 115
EP 122
DI 10.3109/08941939.2011.555059
PG 8
WC Surgery
SC Surgery
GA 755PL
UT WOS:000289946500005
PM 21524177
DA 2018-10-20
ER

PT J
AU Yang, SP
   Lee, TM
AF Yang, Shih-Ping
   Lee, Tzer-Min
TI The effect of substrate topography on hFOB cell behavior and initial
   cell adhesion evaluated by a cytodetacher
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BIOMATERIAL SURFACES; HUMAN FIBROBLASTS; FOCAL ADHESIONS; SHEAR FORCE;
   EXPRESSION; SCALE; SHAPE; FIBRONECTIN; POLYSTYRENE; ATTACHMENT
AB This study examined human fetal osteoblast (hFOB) cell morphology, adhesion force, and proliferation on a titanium-coated grooved surface. V-shaped grooves with a depth of 2.4 mu m (T1) or 4.8 mu m (T2) were produced in silicon wafers using photolithography and wet etching techniques. The grooved substrates were coated with a 200-nm-thick layer of titanium using a sputtering system. Smooth Ti-coated Si wafers were used as control surfaces. Analysis of the scanning electron microscopy observations shows that the cells responded to the micropattern by spreading out and becoming elongated. The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay indicated that the grooved specimens had a significantly larger number of cells than did the control group after 5- and 15-day cultures. The cytocompatibility of specimens was quantitatively evaluated by a cytodetacher, which directly measures the detachment shear force of an individual cell to the substrate. After 30-min culture, the cell adhesion forces were 48.4, 136.6, and 103.3 nN for the smooth specimen, the T1 specimen, and the T2 specimen, respectively. The cell adhesion strengths were 294, 501, and 590 Pa for the smooth specimen, the T1 specimen, and the T2 specimen, respectively. The cell adhesion force and cell adhesion strength indicate the quality of cell adhesion, explaining the largest number of cells on grooved specimens. The experimental results suggest that the grooved patterns affect the cell shape and cytoskeletal structure, and thus influence the cell proliferation and cell adhesion force. The cytodetachment test with nanonewton resolution is a sensitive method for studying cell-biomaterial interaction.
C1 [Yang, Shih-Ping; Lee, Tzer-Min] Natl Cheng Kung Univ, Inst Oral Med, Tainan 701, Taiwan.
RP Lee, TM (reprint author), Natl Cheng Kung Univ, Inst Oral Med, Tainan 701, Taiwan.
EM tmlee@mail.ncku.edu.tw
RI Lee, Tzer-Min/G-3713-2011
FU National Science Council, Taiwan [NSC-96-2221-E-006-277]
FX This study was supported by the National Science Council, Taiwan, under
   grant NSC-96-2221-E-006-277.
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Athanasiou KA, 1999, BIOMATERIALS, V20, P2405, DOI 10.1016/S0142-9612(99)00168-4
   Attard NJ, 2005, J PROSTHET DENT, V94, P242, DOI 10.1016/j.prosdent.2005.04.015
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964
   Bodhak S, 2009, ACTA BIOMATER, V5, P2178, DOI 10.1016/j.actbio.2009.02.023
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Chou LS, 1998, J BIOMED MATER RES, V39, P437, DOI 10.1002/(SICI)1097-4636(19980305)39:3<437::AID-JBM13>3.0.CO;2-7
   CHOU LS, 1995, J CELL SCI, V108, P1563
   Comella BT, 2000, J MATER SCI, V35, P567, DOI 10.1023/A:1004712007729
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Furukawa KS, 2001, MAT SCI ENG C-BIO S, V17, P55, DOI 10.1016/S0928-4931(01)00336-8
   Garcia AJ, 1997, BIOMATERIALS, V18, P1091, DOI 10.1016/S0142-9612(97)00042-2
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   Kelly S, 2008, BIOMATERIALS, V29, P2573, DOI 10.1016/j.biomaterials.2008.03.001
   Kim YJ, 2003, J BIOMAT SCI-POLYM E, V14, P1311, DOI 10.1163/156856203322599662
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   LIN JM, 2007, TISSUE ENG, V13, P1879
   Liu XM, 2007, BIOMATERIALS, V28, P4535, DOI 10.1016/j.biomaterials.2007.06.016
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   SCHNEIDER G, 1994, EXP CELL RES, V214, P264, DOI 10.1006/excr.1994.1257
   Schneider GB, 2003, J DENT RES, V82, P372, DOI 10.1177/154405910308200509
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Thevenot P, 2008, CURR TOP MED CHEM, V8, P270
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang CC, 2009, J BIOMED MATER RES A, V88A, P370, DOI 10.1002/jbm.a.31604
   WANG CC, 2008, NANOTECHNOLOGY, V19
   WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576
   WERB Z, 1986, J CELL BIOL, V102, P697, DOI 10.1083/jcb.102.3.697
   Yamamoto A, 1998, BIOMATERIALS, V19, P871, DOI 10.1016/S0142-9612(97)00248-2
   Yamamoto A, 2000, J BIOMED MATER RES, V50, P114, DOI 10.1002/(SICI)1097-4636(200005)50:2<114::AID-JBM4>3.3.CO;2-Y
   YIM KF, 2005, BIOMATERIALS, V26, P5405
NR 38
TC 9
Z9 9
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD APR
PY 2011
VL 22
IS 4
BP 1027
EP 1036
DI 10.1007/s10856-011-4255-1
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 756VY
UT WOS:000290044000029
PM 21331605
DA 2018-10-20
ER

PT J
AU Webster, NS
   Cobb, RE
   Soo, R
   Anthony, SL
   Battershill, CN
   Whalan, S
   Evans-Illidge, E
AF Webster, Nicole S.
   Cobb, Rose E.
   Soo, Rochelle
   Anthony, Shelley L.
   Battershill, Christopher N.
   Whalan, Steve
   Evans-Illidge, Elizabeth
TI Bacterial Community Dynamics in the Marine Sponge Rhopaloeides odorabile
   Under In Situ and Ex Situ Cultivation
SO MARINE BIOTECHNOLOGY
LA English
DT Article
DE Sponge; Cultivation; Marine; Symbiosis; Bacteria; Aquaria
ID BARRIER-REEF SPONGE; 16S RIBOSOMAL-RNA; MICROBIAL COMMUNITY;
   ALPHA-PROTEOBACTERIUM; NATURAL-PRODUCTS; AQUACULTURE; DIVERSITY;
   POPULATIONS; ENVIRONMENT; PROFILES
AB Cultivation of sponges is being explored to supply biomaterial for the pharmaceutical and cosmetics industries. This study assesses the impact of various cultivation methods on the microbial community within the sponge Rhopaloeides odorabile during: (1) in situ cultivation under natural environmental conditions, (2) ex situ cultivation in small flow-through aquaria and (3) ex situ cultivation in large mesocosm systems. Principal components analysis of denaturing gradient gel electrophoresis profiles indicated a stable microbial community in sponges cultured in situ (grown in the wild) and in sponges cultured ex situ in small flow-through aquaria over 12 weeks. In contrast, a shift in the microbial community was detected in sponges cultivated ex situ in large mesocosm aquaria for 12 months. This shift included (1) a loss of some stable microbial inhabitants, including members of the Poribacteria, Chloroflexi and Acidobacteria and (2) the addition of new microbes not detected in the wild sponges. Many of these acquired bacteria had highest similarity to known sponge-associated microbes, indicating that the sponge may be capable of actively selecting its microbial community. Alternatively, long-term ex situ cultivation may cause a shift in the dominant microbes that facilitates the growth of the more rare species. The microbial community composition varied between sponges cultivated in mesocosm aquaria with different nutrient concentrations and seawater chemistry, suggesting that these variables play a role in structuring the sponge-associated microbes. The high growth and symbiont stability in R. odorabile cultured in situ confirm that this is the preferred method of aquaculture for this species at this time.
C1 [Webster, Nicole S.; Cobb, Rose E.; Soo, Rochelle; Battershill, Christopher N.; Whalan, Steve; Evans-Illidge, Elizabeth] Australian Inst Marine Sci, Townsville Mail Ctr, Townsville, Qld 4810, Australia.
   [Anthony, Shelley L.] Great Barrier Reef Marine Pk Author, Townsville, Qld, Australia.
   [Anthony, Shelley L.] James Cook Univ N Queensland, Townsville, Qld, Australia.
RP Webster, NS (reprint author), Australian Inst Marine Sci, Townsville Mail Ctr, PMB 3, Townsville, Qld 4810, Australia.
EM n.webster@aims.gov.au
RI Webster, Nicole/G-4980-2011; Battershill, Christopher/G-2663-2013
OI Webster, Nicole/0000-0002-4753-5278; Battershill,
   Christopher/0000-0002-5586-0417; Whalan, Steve/0000-0001-6786-8945; Soo,
   Rochelle/0000-0002-8927-2066
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7
   Duckworth A, 2003, AQUACULTURE, V221, P311, DOI 10.1016/S0044-8486(03)00070-X
   Duckworth A., 2009, WORLD AQUACULTURE WO, V40, P20
   Duckworth AR, 2007, AQUACULTURE, V271, P188, DOI 10.1016/j.aquaculture.2007.06.037
   EVANSILLIDGE E, 2006, PALM ISLAND AQUACULT
   FELSENSTEIN J, 1993, PHYLIP PHYLOGENETIC
   Ferris MJ, 1996, APPL ENVIRON MICROB, V62, P340
   Friedrich AB, 2001, FEMS MICROBIOL ECOL, V38, P105, DOI 10.1016/S0168-6496(01)00185-4
   Furnas M., 1995, NITROGEN PHOSPHORUS
   Gerce B, 2009, MICROB ECOL, V58, P865, DOI 10.1007/s00248-009-9560-6
   Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002
   Hoffmann F, 2006, MAR BIOTECHNOL, V8, P373, DOI 10.1007/s10126-006-5152-3
   Isaacs LT, 2009, MAR BIOTECHNOL, V11, P758, DOI 10.1007/s10126-009-9192-3
   Louden D, 2007, AQUACULTURE, V270, P57, DOI 10.1016/j.aquaculture.2007.02.038
   Ludwig W, 1998, ELECTROPHORESIS, V19, P554, DOI 10.1002/elps.1150190416
   Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P4133, DOI 10.1128/AEM.00454-08
   Mohamed NM, 2008, APPL ENVIRON MICROB, V74, P1209, DOI 10.1128/AEM.02047-07
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695
   Newbold RW, 1999, AQUAT MICROB ECOL, V19, P279, DOI 10.3354/ame019279
   Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v
   Newman DJ, 2006, CURR DRUG TARGETS, V7, P279, DOI 10.2174/138945006776054960
   Osinga R, 1998, TRENDS BIOTECHNOL, V16, P130, DOI 10.1016/S0167-7799(97)01164-5
   PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183
   Pronzato R, 1999, AQUAT CONSERV, V9, P485, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<485::AID-AQC362>3.0.CO;2-N
   Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x
   Thacker RW, 1998, ECOLOGY, V79, P1740
   Thakur NL, 2003, AQUAT MICROB ECOL, V31, P77, DOI 10.3354/ame031077
   THOMAS S, 2008, ADV CORAL HUSBANDRY
   Thoms C, 2003, MAR BIOL, V142, P685, DOI 10.1007/s00227-002-1000-9
   Webster NS, 2008, ISME J, V2, P830, DOI 10.1038/ismej.2008.42
   Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x
   Webster NS, 2001, ENVIRON MICROBIOL, V3, P19, DOI 10.1046/j.1462-2920.2001.00155.x
   Webster NS, 2004, ENVIRON MICROBIOL, V6, P288, DOI 10.1111/j.1462-2920.2004.00570.x
   Webster NS, 2001, APPL ENVIRON MICROB, V67, P434, DOI 10.1128/AEM.67.1.434-444.2001
   Webster NS, 2001, MAR BIOL, V138, P843, DOI 10.1007/s002270000503
   Webster NS, 2002, MAR ECOL PROG SER, V232, P305, DOI 10.3354/meps232305
   Webster NS, 2001, MAR BIOTECHNOL, V3, P600, DOI 10.1007/s10126-001-0065-7
NR 38
TC 36
Z9 36
U1 0
U2 21
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1436-2228
J9 MAR BIOTECHNOL
JI Mar. Biotechnol.
PD APR
PY 2011
VL 13
IS 2
BP 296
EP 304
DI 10.1007/s10126-010-9300-4
PG 9
WC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
SC Biotechnology & Applied Microbiology; Marine & Freshwater Biology
GA 756UD
UT WOS:000290039300019
PM 20544249
DA 2018-10-20
ER

PT J
AU Wells, LA
   Furukawa, S
   Sheardown, H
AF Wells, Laura A.
   Furukawa, Stephanie
   Sheardown, Heather
TI Photoresponsive PEG-Anthracene Grafted Hyaluronan as a
   Controlled-Delivery Biomaterial
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE ENGINEERING SCAFFOLDS; DRUG-DELIVERY; MACULAR DEGENERATION;
   POSTERIOR SEGMENT; PROTEIN RELEASE; ACID HYDROGELS; SYSTEMS;
   PHARMACOKINETICS; RANIBIZUMAB; DEGRADATION
AB Ophthalmic drug delivery to the posterior segment of the eye could benefit from a responsive controlled drug-delivery system with. light or laser inducible changes. For example, the. delivery of age-related macular degeneration drugs requires invasive monthly injections-making long-term photoresponsive drug delivery a, desirable option. The feasibility of this may be facilitated by both the transparency of the eye and the advanced technology in ophthalmic lasers. Hyaluronic acid photogels that : are compatible with retinal pigment epithelial cell lines are shown here to deliver a variety of small and large model drugs over, the long term (months). Varying UV exposures resulted in decreases/increases or the turning off and on of delivery, potentially allowing the therapy to be tailored to suit the patient and the disease.
C1 [Sheardown, Heather] McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Sch Biomed Engn, Hamilton, ON L8S 4L7, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM sheardow@mcmaster.ca
FU NSERC; 20/20 NSERC Ophthalmic Materials Network
FX Funding support from NSERC and 20/20 NSERC Ophthalmic Materials Network
   is gratefully acknowledged. Dr. John Preston and Gabriel Devenyi are
   acknowledged for excimer laser expertise.
CR Ahmadi MA, 2008, EXPERT OPIN PHARMACO, V9, P3045, DOI 10.1517/14656560802473480 
   Anderson OA, 2010, DRUG DISCOV TODAY, V15, P272, DOI 10.1016/j.drudis.2010.02.004
   Bhawalkar JD, 1996, REP PROG PHYS, V59, P1041, DOI 10.1088/0034-4885/59/9/001
   Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6
   Blick SKA, 2007, DRUGS, V67, P1199, DOI 10.2165/00003495-200767080-00007
   Booth BA, 2007, DRUG AGING, V24, P581, DOI 10.2165/00002512-200724070-00006
   Bouas-Laurent H, 2001, CHEM SOC REV, V30, P248, DOI 10.1039/b006013p
   Bratschkov C, 2001, POLYM BULL, V46, P345, DOI 10.1007/s002890170041
   BRAY JC, 1973, J APPL POLYM SCI, V17, P3779, DOI 10.1002/app.1973.070171219
   Choonara YE, 2010, J PHARM SCI-US, V99, P2219, DOI 10.1002/jps.21987
   CHORNY RC, 1966, IND ENG CHEM PROC DD, V5, P206, DOI 10.1021/i260018a019
   de Jong SJ, 2001, J CONTROL RELEASE, V71, P261, DOI 10.1016/S0168-3659(01)00228-0
   del Amo EM, 2008, DRUG DISCOV TODAY, V13, P135, DOI 10.1016/j.drudis.2007.11.002
   Fletcher EC, 2008, OPHTHALMOLOGY, V115, P2192, DOI 10.1016/j.ophtha.2008.07.018
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   Garg H.G., 2004, CHEM BIOL HYALURONAN
   Hartner S, 2007, J POLYM SCI POL CHEM, V45, P2443, DOI 10.1002/pola.22007
   Holz FG, 2010, INVEST OPHTH VIS SCI, V51, P405, DOI 10.1167/iovs.09-3813
   JAFFE GJ, 2006, INTRAOCULAR DRUG DEL
   Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002
   Kaur M, 2002, J MACROMOL SCI-POL R, VC42, P481, DOI 10.1081/MC-120015988
   KHORLIN AY, 1973, FEBS LETT, V31, P107, DOI 10.1016/0014-5793(73)80084-5
   KUMAR GS, 1989, CHEM REV, V89, P1915, DOI 10.1021/cr00098a012
   Kurz Daryl, 2002, Ophthalmol Clin North Am, V15, P405, DOI 10.1016/S0896-1549(02)00034-2
   Lalwani GA, 2009, AM J OPHTHALMOL, V148, P43, DOI 10.1016/j.ajo.2009.01.024
   Landa G, 2009, OPHTHALMOLOGICA, V223, P370, DOI 10.1159/000227783
   LANG JC, 1995, ADV DRUG DELIVER REV, V16, P39, DOI 10.1016/0169-409X(95)00012-V
   Laude A, 2010, PROG RETIN EYE RES, V29, P466, DOI 10.1016/j.preteyeres.2010.04.003
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Li CY, 2005, SOFT MATTER, V1, P238, DOI 10.1039/b506876b
   Molokhia SA, 2010, VISION RES, V50, P680, DOI 10.1016/j.visres.2009.10.013
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   RITGER P L, 1987, Journal of Controlled Release, V5, P23, DOI 10.1016/0168-3659(87)90034-4
   Schmidt-Erfurth U, 2000, SURV OPHTHALMOL, V45, P195, DOI 10.1016/S0039-6257(00)00158-2
   Schwartz DM, 1996, CURR EYE RES, V15, P1156, DOI 10.3109/02713689608995150
   Skupinska K, 2006, ACTA BIOCHIM POL, V53, P101
   THOMPSON KP, 1992, P IEEE, V80, P838, DOI 10.1109/5.149448
   Urtti A, 2006, ADV DRUG DELIVER REV, V58, P1131, DOI 10.1016/j.addr.2006.07.027
   Weiner AL, 2008, OCULAR THERAPEUTICS: EYE ON NEW DISCOVERIES, P7, DOI 10.1016/B978-012370585-3.50004-2
   WELLS LA, 2011, EUR J PHARM BI UNPUB
   WELLS LA, 2011, MACROMOL BIOSC UNPUB
   Yasukawa T, 2005, ADV DRUG DELIVER REV, V57, P2033, DOI 10.1016/j.addr.2005.09.005
   Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003
NR 44
TC 19
Z9 19
U1 3
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2011
VL 12
IS 4
BP 923
EP 932
DI 10.1021/bm101233m
PG 10
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746DT
UT WOS:000289223500009
PM 21401018
DA 2018-10-20
ER

PT J
AU Baker, DW
   Liu, XC
   Weng, H
   Luo, C
   Tang, LP
AF Baker, David W.
   Liu, Xinchuan
   Weng, Hong
   Luo, Cheng
   Tang, Liping
TI Fibroblast/Fibrocyte: Surface Interaction Dictates Tissue Reactions to
   Micropillar Implants
SO BIOMACROMOLECULES
LA English
DT Article
ID PERIPHERAL-BLOOD FIBROCYTES; GRANULATION-TISSUE; BONE-MARROW;
   EXTRACELLULAR-MATRIX; SUBSTRATE TOPOGRAPHY; FIBROBLASTS;
   DIFFERENTIATION; MYOFIBROBLASTS; MECHANISMS; EXPRESSION
AB Micropillar technology has shown great promise for medical implants or sensors in recent years. To study the influence of surface topography on cellular responses, polydimethylsiloxane (PDMS) micropllar arrays with pillar spacing (20-70 mu m) and height (14-25 mu m)have been fabricated. The influence of micropillar arrays on cellular behavior was tested both in vitro and in VIVO; Interestingly, in vitro, we observe a distinct response for 3T3 fibroblasts and RAW 264.7. macrophages to the topographical cues tested. Attachment and proliferation of fibroblasts was substantially enhanced by increasing pillar height, whereas macrophage adherence is significantly diminished by reduced pillar spacing. When implanted in the subcutaneous cavity of BALB/c mice for 14 days, we find a prevailing trend with capsule Cell density and capsule, thickness increasing, as both pillar height and spacing rise. Collagen deposition and neoangiogenesis, two pivotal factors in granulation tissue maturation, are also observed to have a stronger response to the increase in both pillar height and spacing. In contradiction to our.,. original hypothesis, we observed that fibroblasts rather than macrophages are a key contributor to the in vivo outcome of micropillar arrays Investigation into fibroblast activation, however, revealed that recruited fibrocytes, rather than resident fibroblasts, correspond to the in vivo outcome. The results from this work support the critical and often overlooked role of fibrocytes: in tissue response to.. biomaterial implants with varying topography.
C1 [Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
   Univ Texas Arlington, Dept Mech & Aerosp Engn, Arlington, TX 76019 USA.
RP Tang, LP (reprint author), Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
EM ltang@uta.edu
FU NIH [RO1 EB007271];  [NSF-CMMI-0811888];  [NSF-CMMI-090059]
FX This work was supported by a NIH grant RO1 EB007271 and in part by
   grants NSF-CMMI-0811888 and NSF-CMMI-090059.
CR Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556
   ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074
   Chesney J, 2000, Curr Rheumatol Rep, V2, P501, DOI 10.1007/s11926-000-0027-5
   Chesney J, 1998, J IMMUNOL, V160, P419
   Davidson PM, 2010, J MATER SCI-MATER M, V21, P939, DOI 10.1007/s10856-009-3950-7
   Fang GP, 2008, LANGMUIR, V24, P11651, DOI 10.1021/la802033q
   Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526
   Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487
   Ghibaudo M, 2009, BIOPHYS J, V97, P357, DOI 10.1016/j.bpj.2009.04.024
   Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340
   Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004
   Ishii GH, 2005, STEM CELLS, V23, P699, DOI 10.1643/stemcells.2004-0183
   Khandurina J, 2002, J CHROMATOGR A, V943, P159, DOI 10.1016/S0021-9673(01)01451-0
   Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014
   LIN CQ, 1993, FASEB J, V7, P737
   Liu XC, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/2/025029
   Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017
   Luo C, 2006, MICROELECTRON J, V37, P5, DOI 10.1016/j.mejo.2005.06.012
   McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005
   McClain SA, 1996, AM J PATHOL, V149, P1257
   Metz CN, 2003, CELL MOL LIFE SCI, V60, P1342, DOI 10.1007/s00018-003-2328-0
   Mogford JE, 2009, WOUND REPAIR REGEN, V17, P405, DOI 10.1111/j.1524-475X.2009.00481.x
   Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011
   Moyer KE, 2002, J CELL PHYSIOL, V193, P173, DOI 10.1002/jcp.10160
   Mussig E, 2008, ADV FUNCT MATER, V18, P2919, DOI 10.1002/adfm.200800381
   Nair A, 2010, TISSUE ENG PART C-ME, V16, P23, DOI 10.1089/ten.TEC.2009.0094
   Panaro NJ, 2005, BIOMOL ENG, V21, P157, DOI 10.1016/j.bioeng.2004.11.001
   Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR
   Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380
   Schulte VA, 2009, BIOMACROMOLECULES, V10, P2795, DOI 10.1021/bm900631s
   Shi-wen X, 2009, ARTHRITIS RHEUM-US, V60, P234, DOI 10.1002/art.24223
   Spyrou GE, 1998, BRIT J PLAST SURG, V51, P455, DOI 10.1016/S0007-1226(97)90277-0
   Steinberg T, 2007, NANO LETT, V7, P287, DOI 10.1021/nl06227z
   STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591
   Su WT, 2010, J BIOMED MATER RES A, V93A, P1463, DOI 10.1002/jbm.a.32643
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   Tang LP, 1999, MOL MED, V5, P351, DOI 10.1007/BF03402124
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Thevenot P, 2008, TISSUE ENG PART C-ME, V14, P319, DOI 10.1089/ten.tec.2008.0221
   Thevenot PT, 2010, BIOMATERIALS, V31, P3997, DOI 10.1016/j.biomaterials.2010.01.144
   Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3
   TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299
   Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277
NR 44
TC 25
Z9 25
U1 1
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2011
VL 12
IS 4
BP 997
EP 1005
DI 10.1021/bm1013487
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746DT
UT WOS:000289223500017
PM 21332193
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Lu, QA
   Zhang, B
   Li, MZ
   Zuo, BQ
   Kapan, DL
   Huang, YL
   Zhu, HS
AF Lu, Qiang
   Zhang, Bing
   Li, Mingzhong
   Zuo, Baoqi
   Kapan, David L.
   Huang, Yongli
   Zhu, Hesun
TI Degradation Mechanism and Control of Silk Fibroin
SO BIOMACROMOLECULES
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; IN-VITRO; FILMS; SCAFFOLDS; BIOMATERIAL;
   RELEASE; CYTOCOMPATIBILITY; ENCAPSULATION; FIBERS; ROBUST
AB Controlling the degradation process of silk is an important and interesting subject in the field of biomaterials. In the present study, silk fibroin films with different secondary conformations and nanostructures were used to study degradation behavior in buffered protease XIV solution. Different from previous studies, silk fibroin films with highest beta-sheet content achieved the highest degradation rate in our research. A new degradation mechanism revealed that degradation behavior of silk fibroin was related to not only crystal content but also hydrophilic interaction and then crystal-noncrystal alternate nanostructures. First, hydrophilic blocks of silk fibroin were degraded. Then, hydrophobic crystal blocks that were formerly surrounded and immobilized by hydrophilic blocks became free particles and moved into solution. Therefore, on the basis of the mechanism, which enables the process to be more controllable and flexible, controlling the degradation behavior of silk fibroin without affecting other performances such as its mechanical or hydrophilic properties becomes feasible, and this would greatly expand the applications of silk as a biomedical material.
C1 [Lu, Qiang; Zhang, Bing; Li, Mingzhong; Zuo, Baoqi; Huang, Yongli] Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
   [Lu, Qiang] Soochow Univ, Jiangsu Prov Key Lab Stem Cell Res, Suzhou 215006, Peoples R China.
   [Kapan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   [Zhu, Hesun] Beijing Inst Technol, Res Ctr Mat Sci, Beijing 100081, Peoples R China.
RP Lu, QA (reprint author), Soochow Univ, Coll Text & Clothing Engn, Natl Engn Lab Modern Silk, Suzhou 215123, Peoples R China.
EM Lvqiang78@suda.edu.cn
FU NIH [EB002520]; National Natural Science Foundation of China [30970714]
FX We thank the NIH (EB002520) and National Natural Science Foundation of
   China (30970714) for support of this research.
CR Alessandrino A, 2008, ENG LIFE SCI, V8, P219, DOI 10.1002/elsc.200700067
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Forlani G, 2000, INT BIODETER BIODEGR, V46, P271, DOI 10.1016/S0964-8305(00)00099-8
   Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Hu X, 2008, MACROMOLECULES, V41, P3939, DOI 10.1021/ma071551d
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Lawrence BD, 2008, BIOMACROMOLECULES, V9, P1214, DOI 10.1021/bm701235f
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Liu HF, 2008, BIOMATERIALS, V29, P662, DOI 10.1016/j.biomaterials.2007.10.035
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lu Q, 2010, MACROMOL BIOSCI, V10, P359, DOI 10.1002/mabi.200900388
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Lv Q, 2008, J APPL POLYM SCI, V109, P1577, DOI 10.1002/app.24546
   Lv Q, 2008, J BIOMED MATER RES A, V84A, P198, DOI 10.1002/jbm.a.31366
   Mandal BB, 2008, MACROMOL BIOSCI, V8, P807, DOI 10.1002/mabi.200800113
   Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Seves A, 1998, INT BIODETER BIODEGR, V42, P203, DOI 10.1016/S0964-8305(98)00050-X
   Taddei P, 2006, BIOMACROMOLECULES, V7, P259, DOI 10.1021/bm0506290
   Uebersax L, 2008, J CONTROL RELEASE, V127, P12, DOI 10.1016/j.jconrel.2007.11.006
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XQ, 2008, BIOMATERIALS, V29, P1054, DOI 10.1016/j.biomaterials.2007.11.003
   Wang XQ, 2007, J CONTROL RELEASE, V117, P360, DOI 10.1016/j.jconrel.2006.11.021
   Wang Y, 2008, BIOMATERIALS, V29, P3415, DOI 10.1016/j.biomaterials.2008.05.002
   Wilz A, 2008, BIOMATERIALS, V29, P3609, DOI 10.1016/j.biomaterials.2008.05.010
NR 36
TC 107
Z9 112
U1 7
U2 83
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2011
VL 12
IS 4
BP 1080
EP 1086
DI 10.1021/bm101422j
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746DT
UT WOS:000289223500027
PM 21361368
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Li, GC
   Yang, P
   Liao, YZ
   Huang, N
AF Li, Guicai
   Yang, Ping
   Liao, Yuzhen
   Huang, Nan
TI Tailoring of the Titanium Surface by Immobilization of
   Heparin/Fibronectin Complexes for Improving Blood Compatibility and
   Endothelialization: An in Vitro Study
SO BIOMACROMOLECULES
LA English
DT Article
ID COVALENT IMMOBILIZATION; PROTEIN ADSORPTION; FIBRONECTIN ADSORPTION;
   PLATELET-ADHESION; CELL ATTACHMENT; HEPARIN; BIOMATERIAL; FIBRINOGEN;
   INTEGRIN; BINDING
AB To improve the blood compatibility and endothelialization simultaneously and to ensure the long-term effectiveness of the cardiovascular implants, we developed a surface modification method, enabling the coimmobilization of biomolecules to metal surfaces. In the present study, a heparin and fibronectin mixture (Hep/Fn) covalently immobilized on a titanium (Ti) substrate for biocompatibility was investigated. Different systems [N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide and N-hydroxysuccinimide, electrostatic] were used for the formation of Hep/Fn layers. Atomic force microscopy (AFM) showed that the roughness of the silanized Ti surface decreased after the immobilization of Hep/Fn. Fourier transform infrared spectroscopy (FTIR), Toluidine Blue O (TBO) test, and immunochemistry assay showed that Hep/Fn mixture was successfully immobilized on Ti surface. Blood compatibility tests (hemolysis rate, APTT, platelet adhesion, fibrinogen conformational change) showed that the coimmobilized films of Hep/Fn mixture reduced blood hemolysis rate, prolonged blood coagulation time, reduced platelets activation and aggregation, and induced less fibrinogen conformational change compared with a bare Ti surface. Endothelial cell (EC) seeding showed more EC with better morphology on pH 4 samples than on pH 7 and EDC/NHS samples, which showed rounded and aggregated cells. Systematic evaluation showed that the pH 4 samples also had much better blood compatibility. All results suggest that the coimmobilized films of Hep/Fn can confer excellent antithrombotic properties and with good endothelialization. We envisage that this method will provide a potential and effective solution for the surface modification of cardiovascular implant materials.
C1 [Li, Guicai; Yang, Ping; Liao, Yuzhen; Huang, Nan] SW Jiaotong Univ, Minist Educ, Inst Biomat & Surface Engn, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
RP Yang, P (reprint author), SW Jiaotong Univ, Minist Educ, Inst Biomat & Surface Engn, Key Lab Adv Technol Mat, Chengdu 610031, Peoples R China.
EM yangpingswjtu@163.com
FU Fundamental Research Funds for the Central Universities [2010XS32]; Key
   Basic Research Program [2011CB606204]; National Physiological Science
   Foundation of China [30870629]; NSFC-RGC [30831160509]
FX We gratefully acknowledge the financial support of Fundamental Research
   Funds for the Central Universities (2010XS32), Key Basic Research
   Program (2011CB606204), National Physiological Science Foundation of
   China (30870629), and NSFC-RGC (30831160509) and the kind language
   assistance from Professor Pankaj Vadgama (England), Professor Ian Brown
   (U.S.), Miss Jie Liu, Dr. Zhilu Yang, Lisa Schoeller (Germany), and Matt
   Mlamore (U.S.).
CR Adil D, 1999, J APPL SCI, V74, P655
   Balasubramanian V, 1998, J BIOMAT SCI-POLYM E, V9, P1349, DOI 10.1163/156856298X00433
   Baldwin SP, 1996, TRENDS POLYM SCI, V4, P177
   Bos GW, 1999, J BIOMED MATER RES, V44, P330, DOI 10.1002/(SICI)1097-4636(19990305)44:3<330::AID-JBM12>3.0.CO;2-O
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chiu LLY, 2010, BIOMATERIALS, V31, P226, DOI 10.1016/j.biomaterials.2009.09.039
   Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168
   DAMUS PS, 1973, NATURE, V246, P355, DOI 10.1038/246355a0
   Frisch T, 2002, J BIOMECH, V35, P1137, DOI 10.1016/S0021-9290(02)00075-1
   Gong FR, 2010, ACTA BIOMATER, V6, P534, DOI 10.1016/j.actbio.2009.07.013
   Grigoriou V, 2005, J BIOL CHEM, V280, P1733, DOI 10.1074/jbc.M402550200
   Guarnieri D, 2010, ACTA BIOMATER, V6, P2532, DOI 10.1016/j.actbio.2009.12.050
   Hauert R, 2003, DIAM RELAT MATER, V12, P583, DOI 10.1016/S0925-9635(03)00081-5
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Huang N, 2003, BIOMATERIALS, V24, P2177, DOI 10.1016/S0142-9612(03)00046-2
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   KLOCZEWIAK M, 1984, BIOCHEMISTRY-US, V23, P1767, DOI 10.1021/bi00303a028
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   LUYN MJA, 1992, J BIOMED MATER RES, V26, P1091
   Meng S, 2009, BIOMATERIALS, V30, P2276, DOI 10.1016/j.biomaterials.2008.12.075
   Middleton CA, 2007, J BIOMED MATER RES A, V83A, P1032, DOI 10.1002/jbm.a.31382
   Morelli S, 2010, BIOMATERIALS, V31, P7000, DOI 10.1016/j.biomaterials.2010.05.079
   Muller R, 2005, BIOMATERIALS, V26, P6962, DOI 10.1016/j.biomaterials.2005.05.013
   NOJIRI C, 1987, J THORAC CARDIOV SUR, V93, P867
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   PARISE P, 1991, BLOOD COAGUL FIBRIN, V2, P749, DOI 10.1097/00001721-199112000-00009
   Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010
   Peterson JA, 2005, J BIOL CHEM, V280, P6915, DOI 10.1074/jbc.M406625200
   Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026
   Plant SD, 2005, BIOMATERIALS, V26, P5359, DOI 10.1016/j.biomaterials.2005.01.067
   Potts JR, 1996, MATRIX BIOL, V15, P313, DOI 10.1016/S0945-053X(96)90133-X
   Richert L, 2004, LANGMUIR, V20, P448, DOI 10.1021/la035415n
   Rigberg D, 2009, J VASC SURG, V50, P375, DOI 10.1016/j.jvs.2009.03.028
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   RUOSLAHTI E, 1988, ANNU REV CELL BIOL, V4, P229, DOI 10.1146/annurev.cellbio.4.1.229
   SANCHEZ J, 1995, J BIOMED MATER RES, V29, P655, DOI 10.1002/jbm.820290513
   Shi DY, 2010, BIOSCIENCE REP, V30, P149, DOI 10.1042/BSR20090026
   SMITH RK, 1980, ANAL BIOCHEM, V109, P466
   STEMBERGER A, 1990, HAMOSTASEOLOGIE, V10, P164
   Suri CR, 1996, BIOSENS BIOELECTRON, V11, P1199, DOI 10.1016/0956-5663(96)88084-5
   Toworfe GK, 2009, J TISSUE ENG REGEN M, V3, P26, DOI 10.1002/term.131
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Tsai WB, 2003, J BIOMED MATER RES A, V67A, P1255, DOI 10.1002/jbm.a.20024
   Tsai WB, 2002, J BIOMED MATER RES, V60, P348, DOI 10.1002/jbm.10048
   Uygun BE, 2009, TISSUE ENG PT A, V15, P3499, DOI 10.1089/ten.TEA.2008.0405
   WACHEM PB, 1994, BIOMATERIALS, V17, P230
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
   Wang X, 2008, BIOMATERIALS, V29, P894, DOI 10.1016/j.biomaterials.2007.10.055
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wissink M.J.B., 1999, THESIS U TWENTE ENSC
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
   Wittmer CR, 2007, BIOMATERIALS, V28, P851, DOI 10.1016/j.biomaterials.2006.09.037
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
   Zhu AP, 2002, BIOMATERIALS, V23, P4657, DOI 10.1016/S0142-9612(02)00215-6
NR 56
TC 55
Z9 61
U1 6
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2011
VL 12
IS 4
BP 1155
EP 1168
DI 10.1021/bm101468v
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746DT
UT WOS:000289223500035
PM 21332186
DA 2018-10-20
ER

PT J
AU Ahmed, S
   Yang, HK
   Ozcam, AE
   Efimenko, K
   Weiger, MC
   Genzer, J
   Haugh, JM
AF Ahmed, Shoeb
   Yang, Hyun-kwan
   Ozcam, Ali E.
   Efimenko, Kirill
   Weiger, Michael C.
   Genzer, Jan
   Haugh, Jason M.
TI Poly(vinylmethylsiloxane) Elastomer Networks as Functional Materials for
   Cell Adhesion and Migration Studies
SO BIOMACROMOLECULES
LA English
DT Article
ID DIRECTIONAL PERSISTENCE; PROTEIN ADSORPTION; SUBSTRATE; SURFACE;
   FIBRONECTIN; FIBROBLASTS; RGD; ATTACHMENT; LOCOMOTION; STIFFNESS
AB Cell migration is central to physiological responses to injury and infection and in the design of biomaterial implants. The ability to tune the properties of adhesive materials and relate those properties in a quantitative way to the dynamics of intracellular processes remains a definite challenge in the manipulation of cell migration. Here, we propose the use of poly(vinylmethylsiloxane) (PVMS) networks as novel substrata for cell adhesion and migration. These materials offer the ability to tune independently chemical functionality and elastic modulus. Importantly, PVMS networks are compatible with total internal reflection fluorescence (TIRF) microscopy, which is ideal for interrogating the cell-substratum interface; this latter characteristic presents a distinct advantage over polyacrylamide gels and other materials that swell with water. To demonstrate these capabilities, adhesive peptides containing the arginyl-glycyl-aspartic acid (RGD) tripeptide motif were successfully grafted to the surface of PVMS network using a carboxyl-terminated thiol as a linker. Peptide-specific adhesion, spreading, and random migration of NIH 3T3 mouse fibroblasts were characterized. These experiments show that a peptide containing the synergy sequence of fibronectin (PHSRN) in addition to RGD promotes more productive cell migration without markedly enhancing cell adhesion strength. Using TIRF microscopy, the dynamics of signal transduction through the phosphoinositide 3-kinase pathway were monitored in cells as they migrated on peptide-grafted PVMS surfaces. This approach offers a promising avenue for studies of directed migration and mechanotransduction at the level of intracellular processes.
C1 [Ahmed, Shoeb; Yang, Hyun-kwan; Ozcam, Ali E.; Efimenko, Kirill; Weiger, Michael C.; Genzer, Jan; Haugh, Jason M.] N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
RP Genzer, J (reprint author), N Carolina State Univ, Dept Chem & Biomol Engn, Raleigh, NC 27695 USA.
EM jan_genzer@ncsu.edu; jason_haugh@ncsu.edu
OI Haugh, Jason/0000-0002-2476-4027
FU Army Research Office/Defense Threat Reduction Agency [AB07CBT016]
FX This work was supported by the Army Research Office/Defense Threat
   Reduction Agency (AB07CBT016).
CR Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005
   BURMEISTER JS, 1996, SCIENCE, V30, P13
   Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079
   Cavalcanti-Adam EA, 2007, BIOPHYS J, V92, P2964, DOI 10.1529/biophysj.106.089730
   Crowe-Willoughby JA, 2010, POLYMER, V51, P763, DOI 10.1016/j.polymer.2009.11.070
   Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8
   Diehl KA, 2005, J BIOMED MATER RES A, V75A, P603, DOI 10.1002/jbm.a.30467
   DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Efimenko K, 2005, POLYMER, V46, P9329, DOI 10.1016/j.polymer.2005.07.046
   Fang F, 2001, BIOPHYS J, V80, P2568, DOI 10.1016/S0006-3495(01)76228-5
   Fournier MF, 2010, J CELL BIOL, V188, P287, DOI 10.1083/jcb.200906139
   Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441
   GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039
   Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021
   KIM DH, 2009, SCIENCE, V30, P5433
   KOO LY, 2002, SCIENCE, V115, P1423
   Krylyshkina O, 2003, J CELL BIOL, V161, P853, DOI 10.1083/jcb.200301102
   KUHLMAN W, 2007, SCIENCE, V8, P3206
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lee MH, 2006, BIOMATERIALS, V27, P1907, DOI 10.1016/j.biomaterials.2005.11.003
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   MAHESHWARI G, 2000, CELL ADHESION, V113, P1677
   NAYAL A, 2006, SCIENCE, V173, P587
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   Rajagopalan P, 2004, BIOPHYS J, V87, P2818, DOI 10.1529/biophysj.103.037218
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670
   SCHNEIDER IC, 2005, SCIENCE, V171, P883
   SCHWARTZ MA, 2006, CELL, V25, P1361
   WANG Y, 2007, SCI STKE, V377, pPE10, DOI DOI 10.1126/STKE.3772007PE10
   Ware MF, 1998, J CELL SCI, V111, P2423
   WEIGER MC, 2009, SCIENCE, V122, P313
   Weiger MC, 2010, BIOPHYS J, V98, P67, DOI 10.1016/j.bpj.2009.09.051
NR 43
TC 8
Z9 8
U1 3
U2 37
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD APR
PY 2011
VL 12
IS 4
BP 1265
EP 1271
DI 10.1021/bm101549y
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 746DT
UT WOS:000289223500047
PM 21361274
DA 2018-10-20
ER

PT J
AU Nosrat, A
   Seifi, A
   Asgary, S
AF Nosrat, Ali
   Seifi, Amir
   Asgary, Saeed
TI Regenerative Endodontic Treatment (Revascularization) for Necrotic
   Immature Permanent Molars: A Review and Report of Two Cases with a New
   Biomaterial
SO JOURNAL OF ENDODONTICS
LA English
DT Article
DE Apexification; calcium enriched mixture; CEM cement; open apex;
   regenerative treatment; revascularization; triple antibiotic paste
ID MINERAL TRIOXIDE AGGREGATE; CALCIUM-ENRICHED MIXTURE; ROOT-CANAL DENTIN;
   PULP REVASCULARIZATION; APICAL PERIODONTITIS; RETROSPECTIVE ANALYSIS;
   TEETH; TOOTH; END; CEMENT
AB Introduction: Revascularization is a valuable treatment in immature necrotic teeth that allows the continuation of root development. In this article we describe successful revascularization treatment of 2 necrotic immature first mandibular molars. Methods: The clinical and radiographic examinations showed extensive coronal caries, immature roots, and periapical radiolucencies in mandibular first molars of a 9-year-old boy and an 8-year-old girl. The exam findings suggested revascularization treatment in both cases, which was started with irrigation of the canals by using NaOCl 5.25% for 20 minutes, followed by 3 weeks of triple antibiotic (metronidazole, ciprofloxacin, and minocycline) paste dressing. Next, the antibiotic paste was removed, bleeding was induced in the canals, and calcium enriched mixture (CEM) cement was placed over blood clots. Results: In radiographic and clinical follow-ups both cases were asymptomatic and functional, periapical radiolucencies were healed, and roots continued to develop. Conclusions: Revascularization is a realistic treatment in immature necrotic molars. In addition, placing CEM cement as a new endodontic biomaterial over the blood clot formed inside the canals provided good seal and favorable outcomes. (l Endod 2011;37:562-567)
C1 [Nosrat, Ali] Rafsanjan Univ Med Sci, Sch Dent, Dept Endodont, Rafsanjan, Kerman, Iran.
   [Seifi, Amir] Univ Washington, Sch Med, Dept Oral Biol, Seattle, WA USA.
   [Asgary, Saeed] Shahid Beheshti Univ Med Sci, Sch Dent, Dent Res Ctr, Iranian Ctr Endodont Res, Tehran, Iran.
RP Nosrat, A (reprint author), Rafsanjan Univ Med Sci, Sch Dent, Dept Endodont, Aliebneabitaleb Blvd, Rafsanjan, Kerman, Iran.
EM ansrt2@yahoo.com
OI Nosrat, Ali/0000-0003-4768-9717
CR Andreasen JO, 2002, DENT TRAUMATOL, V18, P134, DOI 10.1034/j.1600-9657.2002.00097.x
   Asgary S, 2010, J DENT RES, V89, P1080, DOI 10.1177/0022034510374057
   Asgary S, 2008, J BIOMED MATER RES A, V87A, P706, DOI 10.1002/jbm.a.31678
   Asgary S, 2008, ORAL SURG ORAL MED O, V106, P609, DOI 10.1016/j.tripleo.2008.06.006
   Asgary S, 2008, J ENDODONT, V34, P990, DOI 10.1016/j.joen.2008.05.006
   Asgary Saeed, 2009, J Conserv Dent, V12, P31, DOI 10.4103/0972-0707.53340
   Asgary S, 2010, J ENDODONT, V36, P837, DOI 10.1016/j.joen.2010.03.005
   Asgary S, 2009, AUST ENDOD J, V35, P147, DOI 10.1111/j.1747-4477.2008.00137.x
   Asgary Saeed, 2008, J Oral Sci, V50, P469
   Asgary S, 2009, J ENDODONT, V35, P243, DOI 10.1016/j.joen.2008.10.026
   Banchs F, 2004, J ENDODONT, V30, P196, DOI 10.1097/00004770-200404000-00003
   da Silva LAB, 2010, ORAL SURG ORAL MED O, V109, P779, DOI 10.1016/j.tripleo.2009.12.046
   Bose R, 2009, J ENDODONT, V35, P1343, DOI 10.1016/j.joen.2009.06.021
   Camp J, 2006, PATHWAYS PULP, P822
   Chueh LH, 2009, J ENDODONT, V35, P160, DOI 10.1016/j.joen.2008.10.019
   Chueh LH, 2006, J ENDODONT, V32, P1205, DOI 10.1016/j.joen.2006.07.010
   Cotti E, 2008, J ENDODONT, V34, P611, DOI 10.1016/j.joen.2008.02.029
   Ding RY, 2009, J ENDODONT, V35, P745, DOI 10.1016/j.joen.2009.02.009
   Ghorbani Zahra, 2009, Iran Endod J, V4, P87
   Hargreaves K, 2011, PATHWAYS PULP, P602
   Hargreaves KM, 2008, J ENDODONT, V34, pS51, DOI 10.1016/j.joen.2008.02.032
   Holden DT, 2008, J ENDODONT, V34, P812, DOI 10.1016/j.joen.2008.04.003
   Hoshino E, 1996, INT ENDOD J, V29, P125, DOI 10.1111/j.1365-2591.1996.tb01173.x
   Huang GTJ, 2009, INT ENDOD J, V42, P855, DOI 10.1111/j.1365-2591.2009.01577.x
   Huang GTJ, 2008, J ENDODONT, V34, P645, DOI 10.1016/j.joen.2008.03.001
   Kim JH, 2010, J ENDODONT, V36, P1086, DOI 10.1016/j.joen.2010.03.031
   Mente J, 2009, J ENDODONT, V35, P1354, DOI 10.1016/j.joen.2009.05.025
   MOZAYENI M, AUST ENDOD J
   Nosrat A, 2010, INT ENDOD J, V43, P940, DOI 10.1111/j.1365-2591.2010.01777.x
   Nosrat A, 2010, J ENDODONT, V36, P912, DOI 10.1016/j.joen.2009.11.025
   Parirokh M, 2010, J ENDODONT, V36, P400, DOI 10.1016/j.joen.2009.09.009
   Petrino JA, 2010, J ENDODONT, V36, P536, DOI 10.1016/j.joen.2009.10.006
   Rafter M, 2005, DENT TRAUMATOL, V21, P1, DOI 10.1111/j.1600-9657.2004.00284.x
   Rajabalian Saeed, 2009, Indian J Dent Res, V20, P169, DOI 10.4103/0970-9290.52894
   Reynolds K, 2009, INT ENDOD J, V42, P84, DOI 10.1111/j.1365-2591.2008.01467.x
   Ring KC, 2008, J ENDODONT, V34, P1474, DOI 10.1016/j.joen.2008.09.001
   Roberts-Clark DJ, 2000, ARCH ORAL BIOL, V45, P1013, DOI 10.1016/S0003-9969(00)00075-3
   Samiee M, 2010, CLIN ORAL INVEST, V14, P653, DOI 10.1007/s00784-009-0351-8
   Sato I, 1996, INT ENDOD J, V29, P118, DOI 10.1111/j.1365-2591.1996.tb01172.x
   Shabahang S, 1999, J ENDODONT, V25, P1
   Shah N, 2008, J ENDODONT, V34, P919, DOI 10.1016/j.joen.2008.05.001
   Sharma S, 2010, ANN NEUROSCI, V17, P31, DOI 10.5214/ans.0972.7531.2010.170109
   Sheehy EC, 1997, BRIT DENT J, V183, P241, DOI 10.1038/sj.bdj.4809477
   Shin SY, 2009, INT ENDOD J, V42, P1118, DOI 10.1111/j.1365-2591.2009.01633.x
   Slots J, 2002, J PERIODONTAL RES, V37, P389, DOI 10.1034/j.1600-0765.2002.00004.x
   Sonoyama W, 2008, J ENDODONT, V34, P166, DOI 10.1016/j.joen.2007.11.021
   Sonoyama W, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000079
   Thibodeau B, 2007, PEDIATR DENT, V29, P47
   Thibodeau B, 2007, J ENDODONT, V33, P680, DOI 10.1016/j.joen.2007.03.001
   Torabinejad M, 2010, J ENDODONT, V36, P190, DOI 10.1016/j.joen.2009.09.010
   Wang XJ, 2010, J ENDODONT, V36, P56, DOI 10.1016/j.joen.2009.09.039
   Windley W, 2005, J ENDODONT, V31, P439, DOI 10.1097/01.don.0000148143.80283.ea
   Witherspoon DE, 2008, J ENDODONT, V34, P1171, DOI 10.1016/j.joen.2008.07.005
NR 53
TC 99
Z9 104
U1 6
U2 32
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0099-2399
EI 1878-3554
J9 J ENDODONT
JI J. Endod.
PD APR
PY 2011
VL 37
IS 4
BP 562
EP 567
DI 10.1016/j.joen.2011.01.011
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 747KL
UT WOS:000289318600026
PM 21419310
DA 2018-10-20
ER

PT J
AU Nunes, LSD
   De Oliveira, RV
   Holgado, LA
   Nary, H
   Ribeiro, DA
   Matsumoto, MA
AF De Souza Nunes, Leandro Soeiro
   De Oliveira, Renato Victor
   Holgado, Leandro Andrade
   Nary Filho, Hugo
   Ribeiro, Daniel Araki
   Matsumoto, Mariza Akemi
TI Use of Bovine Hydroxyapatite With or Without Biomembrane in Sinus Lift
   in Rabbits: Histopathologic Analysis and Immune Expression of Core
   Binding Factor 1 and Vascular Endothelium Growth Factor
SO JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
ID BONE BIO-OSS; FLOOR ELEVATION; HISTOLOGICAL-EVALUATION; IMPLANT
   PLACEMENT; AUGMENTATION; GRAFTS; ANGIOGENESIS; BIOMATERIAL; OSTEOBLASTS;
   SUBSTITUTES
AB Purpose: Considering the clinical discussion on the necessity of using a barrier membrane in the osteotomy area of sinus lift procedures to prevent fibrous tissue formation in this area and as a physical limit, the aim of this study was to analyze and compare the use of bovine hydroxyapatite (HA) with and without a biologic membrane by histopathologic analysis and immune expression of core binding factor 1 and vascular endothelium growth factor in the sinus lift in rabbits.
   Materials and Methods: Sixteen male rabbits underwent bilateral sinus lift procedures and were divided into 2 groups according to the sinus filling material: group 1 received bovine HA (Bio-Oss; Geistlich Pharma AG, Wohlhusen, Switzerland) and group 2 received bovine HA and a nonporous polytetrafluorethylene membrane. All groups were sacrificed after 7, 14, 30, and 60 days for microscopic, histomorphometric, and immunohistochemical analyses.
   Results: Microscopic analysis showed a similar bone repair pattern between the tested groups. New bone formation, soft tissue, and the remaining material were analyzed by histomorphometric analysis. No statistically significant differences (P > .05) were detected between groups for all periods analyzed. In addition, no remarkable differences were noticed in core binding factor 1 or vascular endothelium growth factor immune expression.
   Conclusion: Taken together, these results show that using a biologic membrane does not improve bone repair induced by bovine HA, as shown by histopathologic and immunohistochemical analyses. (C) 2011 American Association of Oral and Maxillofacial Surgeons J Oral Maxillofac Surg 69:1064-1069, 2011
C1 [Ribeiro, Daniel Araki] Univ Fed Sao Paulo, Dept Biociencias, BR-11060001 Santos, SP, Brazil.
   [De Souza Nunes, Leandro Soeiro; De Oliveira, Renato Victor; Holgado, Leandro Andrade; Matsumoto, Mariza Akemi] Sagrado Coracao Univ, Discipline Oral & Maxillofacial Surg, Sch Dent, Dept Hlth Sci, Bauru, SP, Brazil.
   [Nary Filho, Hugo] PI Branemark Inst, Bauru, SP, Brazil.
RP Ribeiro, DA (reprint author), Univ Fed Sao Paulo, Dept Biociencias, Av Ana Costa 95, BR-11060001 Santos, SP, Brazil.
EM daribeiro@unifesp.br
RI Matsumoto, Mariza/C-5183-2012
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2007/04767-3];
   CNPq
FX The authors are grateful to Maira Cristina Rondina Couto for histology
   assistance, Wilson Aparecido Orcini for morphometry assistance, and
   Sergio Henrique Mourn for animal care. This work was supported by grant
   2007/04767-3 from the Fundacao de Amparo a Pesquisa do Estado de Sao
   Paulo. D.A.R. is a recipient of the CNPq fellowship.
CR Adeyemo WL, 2008, INT J ORAL MAX SURG, V37, P651, DOI 10.1016/j.ijom.2008.02.005
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Cancian DCJ, 1999, INT J ORAL MAX IMPL, V14, P859
   Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6
   Garant PR, 2003, ORAL CELLS TISSUES, P195
   HSIONG SX, 2006, PERIODONTOLOGY, V41, P2322
   Karring T, 1993, Periodontol 2000, V1, P26, DOI 10.1111/j.1600-0757.1993.tb00204.x
   LYNCH SE, 2008, TISSUE ENG APPL ORAL, P296
   Lysiak-Drwal K, 2008, POSTEP HIG MED DOSW, V62, P282
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Miranda SR, 2006, CLIN ORAL IMPLAN RES, V17, P694, DOI 10.1111/j.1600-0501.2006.01272.x
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Ozyuvaci H, 2003, J PERIODONTOL, V74, P909, DOI 10.1902/jop.2003.74.6.909
   Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Pratap J, 2003, CANCER RES, V63, P5357
   Scarano A, 2007, IMPLANT DENT, V16, P195, DOI 10.1097/ID.0b013e3180587ad8
   SPECTOR M, 2008, TISSUE ENG APPL ORAL, P23
   Stavropoulos Andreas, 2004, Clin Oral Investig, V8, P226, DOI 10.1007/s00784-004-0277-0
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   SUGIMOTO T, 1993, J BONE MINER RES, V8, P1445
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Tawil G, 2001, INT J ORAL MAX IMPL, V16, P713
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   Velich N, 2004, J CRANIOFAC SURG, V15, P38, DOI 10.1097/00001665-200401000-00013
   Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Xu H, 2005, BRIT J ORAL MAX SURG, V43, P40, DOI 10.1016/j.bjoms.2004.10.004
NR 29
TC 9
Z9 10
U1 3
U2 3
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0278-2391
EI 1531-5053
J9 J ORAL MAXIL SURG
JI J. Oral Maxillofac. Surg.
PD APR
PY 2011
VL 69
IS 4
BP 1064
EP 1069
DI 10.1016/j.joms.2010.02.057
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 744VR
UT WOS:000289123800025
PM 20727643
DA 2018-10-20
ER

PT J
AU Tarala, M
   Janssen, D
   Verdonschot, N
AF Tarala, M.
   Janssen, D.
   Verdonschot, N.
TI Balancing incompatible endoprosthetic design goals: A combined ingrowth
   and bone remodeling simulation
SO MEDICAL ENGINEERING & PHYSICS
LA English
DT Article
DE Cementless implant; Micromotions; Ingrowth; Bone remodeling
ID TOTAL HIP-ARTHROPLASTY; FINITE-ELEMENT MODELS; CEMENTLESS FEMORAL STEMS;
   POROUS-SURFACED IMPLANTS; PRIMARY STABILITY; INTERFACE MECHANICS;
   STIFFNESS; REPLACEMENT; FRICTION; BIOMATERIAL
AB In order to design a good cementless femoral implant many requirements need to be fulfilled. For instance, the range of micromotions at the bone-implant interface should not exceed a certain threshold and a good ratio between implant-bone stiffness that does not cause bone resorption, needs to be ensured. Stiff implants are known to evoke lower interface micromotions but at the same time they may cause extensive resorption of the surrounding bone. Composite stems with reduced stiffness give good remodeling results but implant flexibility is likely to evoke high micromotions proximally. Finding a good balance between these incompatible design goals is very challenging. The current study proposes a finite element methodology that employs subsequent ingrowth and remodeling simulations and can be of assistance when designing new implants. The results of our simulations for the Epoch stem were in a good agreement with the clinical data. The proposed implant design made of porous tantalum with an inner CoCrMo core performed slightly better with respect to the Epoch stem and considerably better with respect to a Ti alloy stem. Our combined ingrowth and remodeling simulation can be a useful tool when designing a new implant that well balances mentioned incompatible design goals. (C) 2010 IPEM. Published by Elsevier Ltd. All rights reserved.
C1 [Tarala, M.; Janssen, D.; Verdonschot, N.] Radboud Univ Nijmegen, Med Ctr, Orthopaed Res Lab, NL-6500 HB Nijmegen, Netherlands.
   [Verdonschot, N.] Univ Twente, Lab Biomech Engn, NL-7500 AE Enschede, Netherlands.
RP Tarala, M (reprint author), Radboud Univ Nijmegen, Med Ctr, Orthopaed Res Lab, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM M.Tarala@orthop.umcn.nl
RI Verdonschot, N.J.J./H-8104-2014; Janssen, Dennis/C-3665-2009
OI Janssen, Dennis/0000-0003-0743-9975
FU Zimmer, Inc., Warsaw, IN, USA
FX This study was funded in part by Zimmer, Inc., Warsaw, IN, USA.
CR Akhavan S, 2006, J BONE JOINT SURG AM, V88A, P1308, DOI 10.2106/JBJS.E.00316
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Boden HSG, 2006, ACTA ORTHOP, V77, P877, DOI 10.1080/17453670610013169
   Buhler DW, 1997, CLIN BIOMECH, V12, P75, DOI 10.1016/S0268-0033(96)00059-9
   Cameron H U, 1977, Acta Orthop Belg, V43, P71
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   ENGH CA, 1992, J BONE JOINT SURG AM, V74A, P1009, DOI 10.2106/00004623-199274070-00007
   Fernandes PR, 2002, J BIOMECH, V35, P167, DOI 10.1016/S0021-9290(01)00204-4
   Folgado J, 2009, COMPUT METHOD BIOMEC, V12, P135, DOI [10.1080/10255840802546754, 10.1080/10255840903081123]
   Friedman RJ, 1996, J ORTHOPAED RES, V14, P455, DOI 10.1002/jor.1100140316
   Glassman AH, 2001, CLIN ORTHOP RELAT R, P128
   Gotze C, 2002, CLIN BIOMECH, V17, P267, DOI 10.1016/S0268-0033(02)00012-8
   GRUEN TA, 1979, CLIN ORTHOP RELAT R, P17
   Hartzband MA, 2010, CLIN ORTHOP RELAT R, V468, P433, DOI 10.1007/s11999-009-0950-3
   Harvey EJ, 1999, J BONE JOINT SURG AM, V81A, P93, DOI 10.2106/00004623-199901000-00013
   HEAD WC, 1995, CLIN ORTHOP RELAT R, P85
   Heller MO, 2001, J BIOMECH, V34, P883, DOI 10.1016/S0021-9290(01)00039-2
   HUISKES R, 1993, ACTA ORTHOP SCAND, V64, P699, DOI 10.3109/17453679308994602
   HUISKES R, 1987, J BIOMECH, V20, P1135, DOI 10.1016/0021-9290(87)90030-3
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010
   Karrholm J, 2002, J BONE JOINT SURG AM, V84A, P1651
   Kerner J, 1999, J BIOMECH, V32, P695, DOI 10.1016/S0021-9290(99)00041-X
   Keyak JH, 2003, MED ENG PHYS, V25, P781, DOI 10.1016/S1350-4533(03)00081-X
   Kienapfel H, 1999, J ARTHROPLASTY, V14, P355, DOI 10.1016/S0883-5403(99)90063-3
   Kuiper JH, 1996, J ORTHOPAED RES, V14, P36, DOI 10.1002/jor.1100140108
   Levine BR, 2006, BIOMATERIALS, V27, P4671, DOI 10.1016/j.biomaterials.2006.04.041
   MARTIN RB, 1984, CRIT REV BIOMED ENG, V10, P179
   Mueller LA, 2010, ACTA ORTHOP, V81, P171, DOI 10.3109/17453671003635843
   Pancanti A, 2003, J BIOMECH, V36, P777, DOI 10.1016/S0021-9290(03)00011-3
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Prymka M, 2006, ARCH ORTHOP TRAUM SU, V126, P36, DOI 10.1007/s00402-005-0080-7
   RANCOURT D, 1990, J BIOMED MATER RES, V24, P1503, DOI 10.1002/jbm.820241107
   Regglani B, 2007, J BIOMECH, V40, P2552, DOI 10.1016/j.jbiomech.2006.10.042
   Sandborn P M, 1988, J Arthroplasty, V3, P337, DOI 10.1016/S0883-5403(88)80034-2
   Schileo E, 2008, J BIOMECH, V41, P2483, DOI 10.1016/j.jbiomech.2008.05.017
   SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200
   SHIRAZIADL A, 1993, J BIOMED MATER RES, V27, P167, DOI 10.1002/jbm.820270205
   Taddei F, 2004, MED ENG PHYS, V26, P61, DOI 10.1016/S1350-4533(03)00138-3
   Trabelsi N, 2009, J BIOMECH, V42, P234, DOI 10.1016/j.jbiomech.2008.10.039
   Turner AWL, 2005, J ORTHOP RES, V23, P705, DOI 10.1016/j.orthres.2005.02.002
   VANRIETBERGEN B, 1993, J BIOMECH, V26, P369, DOI 10.1016/0021-9290(93)90001-U
   Viceconti M, 2006, J BIOMECH, V39, P1169, DOI 10.1016/j.jbiomech.2005.03.024
   Waanders D, 2009, J BIOMECH, V42, P2513, DOI 10.1016/j.jbiomech.2009.07.014
   WEINANS H, 1992, J ORTHOPAED RES, V10, P845, DOI 10.1002/jor.1100100614
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
NR 46
TC 17
Z9 18
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1350-4533
EI 1873-4030
J9 MED ENG PHYS
JI Med. Eng. Phys.
PD APR
PY 2011
VL 33
IS 3
BP 374
EP 380
DI 10.1016/j.medengphy.2010.11.005
PG 7
WC Engineering, Biomedical
SC Engineering
GA 744VV
UT WOS:000289124200015
PM 21145777
OA Bronze
DA 2018-10-20
ER

PT J
AU Costa, F
   Carvalho, IF
   Montelaro, RC
   Gomes, P
   Martins, MCL
AF Costa, Fabiola
   Carvalho, Isabel F.
   Montelaro, Ronald C.
   Gomes, P.
   Martins, M. Cristina L.
TI Covalent immobilization of antimicrobial peptides (AMPs) onto
   biomaterial surfaces
SO ACTA BIOMATERIALIA
LA English
DT Review
DE Antimicrobial peptides; Bacterial adhesion; Biofilms; Surface
   functionalization; Nanostructured surfaces
ID BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; RESISTANT
   STAPHYLOCOCCUS-AUREUS; SELF-ASSEMBLED MONOLAYERS; BIOFILM FORMATION;
   PSEUDOMONAS-AERUGINOSA; BACTERIAL-COLONIZATION; ANTIBACTERIAL SURFACES;
   ADJUNCTIVE TREATMENT; TITANIUM SURFACES; CATIONIC-PEPTIDE
AB Bacterial adhesion to biomaterials remains a major problem in the medical devices field. Antimicrobial peptides (AMPS) are well-known components of the innate immune system that can be applied to over-come biofilm-associated infections. Their relevance has been increasing as a practical alternative to conventional antibiotics, which are declining in effectiveness. The recent interest focused on these peptides can be explained by a group of special features, including a wide spectrum of activity, high efficacy at very low concentrations, target specificity, anti-endotoxin activity, synergistic action with classical antibiotics, and low propensity for developing resistance. Therefore, the development of an antimicrobial coating with such properties would be worthwhile. The immobilization of AMPS onto a biomaterial surface has further advantages as it also helps to circumvent AMPs' potential limitations, such as short half-life and cytotoxicity associated with higher concentrations of soluble peptides. The studies discussed in the current review report on the impact of covalent immobilization of AMPs onto surfaces through different chemical coupling strategies, length of spacers, and peptide orientation and concentration. The overall results suggest that immobilized AMPs may be effective in the prevention of biofilm formation by reduction of microorganism survival post-contact with the coated biomaterial. Minimal cytotoxicity and long-term stability profiles were obtained by optimizing immobilization parameters, indicating a promising potential for the use of immobilized AMPs in clinical applications. On the other hand, the effects of tethering on mechanisms of action of AMPs have not yet been fully elucidated. Therefore, further studies are recommended to explore the real potential of immobilized AMPs in health applications as antimicrobial coatings of medical devices. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Costa, Fabiola; Martins, M. Cristina L.] Univ Porto, INEB Inst Engn Biomed, Div Biomat, P-4150180 Oporto, Portugal.
   [Carvalho, Isabel F.] Univ Porto, IBMC Inst Biol Celular & Mol, P-4150180 Oporto, Portugal.
   [Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA.
   [Gomes, P.] Univ Porto, CIQ UP, Dept Quim & Bioquim, Fac Ciencias, P-4169007 Oporto, Portugal.
RP Martins, MCL (reprint author), Univ Porto, INEB Inst Engn Biomed, Div Biomat, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM cmartins@ineb.up.pt
RI Martins, M. Cristina/J-8284-2013; Gomes, Paula/C-6698-2008;
   Fidalgo-Carvalho, Isabel/P-5192-2015; Fidalgo-Carvalho,
   Isabel/E-1335-2011
OI Martins, M. Cristina/0000-0002-6574-4794; Gomes,
   Paula/0000-0002-6018-4724; Fidalgo-Carvalho, Isabel/0000-0002-7882-3555;
   Costa, Fabiola/0000-0001-8981-7049
FU Portuguese Foundation for Science and Technology (FCT)
   [PTDC/CTM/101484/2008]; FEDER [FCOMP-01-0124-FEDER-009400]
FX The authors would like to thank the Portuguese Foundation for Science
   and Technology (FCT) (Ref. PTDC/CTM/101484/2008) and FEDER (Ref.
   FCOMP-01-0124-FEDER-009400) for co-funding the research project.
CR Abad JM, 2002, J AM CHEM SOC, V124, P12845, DOI 10.1021/ja026658p
   Ahmed NA, 2009, ANTIMICROB AGENTS CH, V53, P4258, DOI 10.1128/AAC.00546-09
   Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D
   Appendini P, 2001, J APPL POLYM SCI, V81, P609, DOI 10.1002/app.1476
   Aumsuwan N, 2008, BIOMACROMOLECULES, V9, P1712, DOI 10.1021/bm800176t
   Aumsuwan N, 2007, BIOMACROMOLECULES, V8, P713, DOI 10.1021/bm061050k
   Bach A, 1996, INTENS CARE MED, V22, P1066, DOI 10.1007/BF01699229
   Bagge N, 2004, ANTIMICROB AGENTS CH, V48, P1175, DOI 10.1128/AAC.48.4.1175-1187.2004
   Bagheri M, 2009, ANTIMICROB AGENTS CH, V53, P1132, DOI 10.1128/AAC.01254-08
   Bastos M, 2008, BIOPHYS J, V94, P2128, DOI 10.1529/biophysj.107.119032
   Batista MKS, 2009, SYNTHETIC COMMUN, V39, P1228, DOI 10.1080/00397910802517855
   Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098
   Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004
   Cevher E, 2006, INT J PHARM, V317, P127, DOI 10.1016/j.ijpharm.2006.03.014
   Chapman RG, 2001, LANGMUIR, V17, P1225, DOI 10.1021/la001222d
   Chen RX, 2009, BIOFOULING, V25, P517, DOI 10.1080/08927010902954207
   Cho WM, 2007, BIOORG MED CHEM LETT, V17, P5772, DOI 10.1016/j.bmcl.2007.08.056
   CHUANG HF, 2009, STRUCTURES INCLUDING
   Chung DW, 2003, INT J FOOD SCI TECH, V38, P165, DOI 10.1046/j.1365-2621.2003.00657.x
   Clarke SR, 2008, INFECT IMMUN, V76, P1518, DOI 10.1128/IAI.01530-07
   Cole N, 2010, INVEST OPHTH VIS SCI, V51, P390, DOI 10.1167/iovs.09-4068
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   de Carvalho Carla C C R, 2007, Recent Pat Biotechnol, V1, P49
   Dee K. C., 2002, INTRO TISSUE BIOMATE
   Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P3208, DOI 10.1128/AAC.49.8.3208-3216.2005
   Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005
   Deslouches B, 2007, J ANTIMICROB CHEMOTH, V60, P669, DOI 10.1093/jac/dkm253
   ENDO Y, 1987, APPL ENVIRON MICROB, V53, P2050
   Faber C, 2005, ANTIMICROB AGENTS CH, V49, P2438, DOI 10.1128/AAC.49.6.2438-2444.2005
   Fey PD, 2010, FUTURE MICROBIOL, V5, P917, DOI 10.2217/FMB.10.56
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Flemming RG, 2000, BIOMATERIALS, V21, P273, DOI 10.1016/S0142-9612(99)00176-3
   Gabriel M, 2006, BIOCONJUGATE CHEM, V17, P548, DOI 10.1021/bc050091v
   Gallardo-Moreno AM, 2009, ACTA BIOMATER, V5, P181, DOI 10.1016/j.actbio.2008.07.028
   Giroir BP, 2001, CRIT CARE MED, V29, pS130, DOI 10.1097/00003246-200107001-00039
   Glinel K, 2009, BIOCONJUGATE CHEM, V20, P71, DOI 10.1021/bc800280u
   Goncalves IC, 2009, J BIOMED MATER RES A, V89A, P642, DOI 10.1002/jbm.a.32011
   Gooderham WJ, 2008, J BACTERIOL, V190, P5624, DOI 10.1128/JB.00594-08
   Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637
   Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004
   Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7
   Harbers GM, 2007, CHEM MATER, V19, P4405, DOI 10.1021/cm070509u
   HAYNIE SL, 1995, ANTIMICROB AGENTS CH, V39, P301, DOI 10.1128/AAC.39.2.301
   Hetrick EM, 2006, CHEM SOC REV, V35, P780, DOI 10.1039/b515219b
   Hilpert K, 2009, CHEM BIOL, V16, P58, DOI 10.1016/j.chembiol.2008.11.006
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Hudalla GA, 2010, LANGMUIR, V26, P6449, DOI 10.1021/la1008208
   Humblot V, 2009, BIOMATERIALS, V30, P3503, DOI 10.1016/j.biomaterials.2009.03.025
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kilic D, 2007, ANZ J SURG, V77, P256, DOI 10.1111/j.1445-2197.2007.04029.x
   Lee MR, 2005, ANGEW CHEM INT EDIT, V44, P2881, DOI 10.1002/anie.200462720
   Leung D, 2005, BIOMATERIALS, V26, P7145, DOI 10.1016/j.biomaterials.2005.05.014
   Levin M, 2000, LANCET, V356, P961, DOI 10.1016/S0140-6736(00)02712-4
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x
   Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104
   Martins MCL, 2003, J BIOMAT SCI-POLYM E, V14, P439, DOI 10.1163/156856203766652057
   Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095
   Monteiro DR, 2009, INT J ANTIMICROB AG, V34, P103, DOI 10.1016/j.ijantimicag.2009.01.017
   Murata H, 2007, BIOMATERIALS, V28, P4870, DOI 10.1016/j.biomaterials.2007.06.012
   Novak KF, 2007, ANTIMICROB AGENTS CH, V51, P1837, DOI 10.1128/AAC.00924-06
   Otto M, 2009, CONTRIB MICROBIOL, V16, P136, DOI 10.1159/000219377
   Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786
   Perron GG, 2006, P ROY SOC B-BIOL SCI, V273, P251, DOI 10.1098/rspb.2005.3301
   Peschel A, 2001, J EXP MED, V193, P1067, DOI 10.1084/jem.193.9.1067
   Peschel A, 2001, PEPTIDES, V22, P1651, DOI 10.1016/S0196-9781(01)00500-9
   Ravikumar T, 2006, BIOMACROMOLECULES, V7, P2762, DOI 10.1021/bm060476w
   Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005
   Rivas L, 2009, BBA-BIOMEMBRANES, V1788, P1570, DOI 10.1016/j.bbamem.2008.11.002
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Statz AR, 2008, BIOFOULING, V24, P439, DOI 10.1080/08927010802331829
   Steven MD, 2008, J APPL POLYM SCI, V110, P2665, DOI 10.1002/app.27638
   Subramani K, 2009, INT J ORAL MAX IMPL, V24, P616
   van 't Hof W, 2001, BIOL CHEM, V382, P597, DOI 10.1515/BC.2001.072
   VENTER JC, 1982, PHARMACOL REV, V34, P153
   VILA J, 2008, ENFERM INFEC MICR CL, V26, P55
   Vila J, 2008, ENFERM INFEC MICR CL, V26, P48, DOI 10.1157/13114395
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Willcox MDP, 2008, J APPL MICROBIOL, V105, P1817, DOI 10.1111/j.1365-2672.2008.03942.x
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang F, 2008, BIOMATERIALS, V29, P4751, DOI 10.1016/j.biomaterials.2008.08.043
   Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463
NR 85
TC 240
Z9 248
U1 22
U2 305
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2011
VL 7
IS 4
BP 1431
EP 1440
DI 10.1016/j.actbio.2010.11.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 742US
UT WOS:000288971300001
PM 21056701
OA Green Published
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Neffe, AT
   Loebus, A
   Zaupa, A
   Stoetzel, C
   Muller, FA
   Lendlein, A
AF Neffe, Axel T.
   Loebus, Axel
   Zaupa, Alessandro
   Stoetzel, Christian
   Mueller, Frank A.
   Lendlein, Andreas
TI Gelatin functionalization with tyrosine derived moieties to increase the
   interaction with hydroxyapatite fillers
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Gelatin; Hydroxyapatite; Composite; Hydrogel; Biomaterial
ID MECHANICAL-PROPERTIES; PARTICLE-SIZE; COMPOSITE; COLLAGEN;
   NANOCOMPOSITES; POLYPROPYLENE; DEGRADATION; ADHESION; SILICA
AB Combining gelatins functionalized with the tyrosine-derived groups desaminotyrosine or desaminotyrosyl tyrosine with hydroxyapatite (HAp) led to the formation of composite materials with much lower swelling ratios than those of the pure matrices. Shifts of the infra-red (IR) bands related to the free carboxyl groups could be observed in the presence of HAp, which suggested a direct interaction of matrix and filler that formed additional physical cross-links in the material. In tensile tests and rheological measurements the composites equilibrated in water had increased Young's moduli (from 200 kPa up to 2 MPa) and tensile strengths (from 57 kPa up to 1.1 MPa) compared with the matrix polymers without affecting the elongation at break. Furthermore, an increased thermal stability of the networks from 40 to 85 degrees C could be demonstrated. The differences in the behaviour of the functionalized gelatins compared with pure gelatin as a matrix suggested an additional stabilizing bond between the incorporated aromatic groups and the HAp as supported by the IR results. The composites can potentially be applied as bone fillers. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Neffe, Axel T.; Loebus, Axel; Zaupa, Alessandro; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, D-14513 Teltow, Germany.
   [Neffe, Axel T.; Loebus, Axel; Zaupa, Alessandro; Lendlein, Andreas] Helmholtz Zentrum Geesthacht, Berlin Brandenburg Ctr Regenerat Therapies, Polymer Res Inst, D-14513 Teltow, Germany.
   [Neffe, Axel T.; Zaupa, Alessandro; Lendlein, Andreas] Univ Potsdam, Inst Chem, D-14476 Potsdam, Germany.
   [Loebus, Axel; Stoetzel, Christian; Mueller, Frank A.] Univ Jena, Inst Mat Sci & Technol IMT, D-07743 Jena, Germany.
RP Neffe, AT (reprint author), Helmholtz Zentrum Geesthacht, Ctr Biomat Dev, Kantstr 55, D-14513 Teltow, Germany.
EM axel.neffe@hzg.de
RI Zaupa, Alessandro/I-2682-2013; Neffe, Axel/H-6997-2013; Lendlein,
   Andreas/K-9553-2013
OI Zaupa, Alessandro/0000-0003-4062-403X; Neffe, Axel/0000-0002-5056-3990;
   Lendlein, Andreas/0000-0003-4126-4670
FU Deutsche Forschungsgemeinschaft (DFG) [B5]
FX We thank Ben Pierce and Karolin Schmalzlin for language checks and
   administrative support in the preparation of the manuscript. This work
   was partially funded by the Deutsche Forschungsgemeinschaft (DFG)
   through SFB subproject B5. The funding agency did not participate in the
   study design, the collection, analysis or interpretation of data,
   writing of the report or in the decision to submit the paper for
   publication.
CR Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7
   BARBIERI D, 2010, EUR CELLS MATER, V1, P252
   Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044
   FAHNESTOCK SR, 2003, BIOPOLYMERS, V8
   Fu SY, 2008, COMPOS PART B-ENG, V39, P933, DOI 10.1016/j.compositesb.2008.01.002
   Kanungo BP, 2010, ACTA BIOMATER, V6, P344, DOI 10.1016/j.actbio.2009.09.012
   Kilian O, 2008, BIOMATERIALS, V29, P3429, DOI 10.1016/j.biomaterials.2008.05.003
   Lau KT, 2006, COMPOS PART B-ENG, V37, P425, DOI 10.1016/j.compositesb.2006.02.020
   Lendlein A, 1998, MACROMOL CHEM PHYSIC, V199, P2785, DOI 10.1002/macp.1998.021991222
   Lendlein A, 2001, MACROMOL CHEM PHYSIC, V202, P2702, DOI 10.1002/1521-3935(20010901)202:13<2702::AID-MACP2702>3.0.CO;2-I
   Lendlein A, 2009, BIOMACROMOLECULES, V10, P975, DOI 10.1021/bm900038e
   Madbouly SA, 2010, ADV POLYM SCI, V226, P41, DOI 10.1007/12_2009_28
   Montero A, 2004, CHEM BIODIVERS, V1, P442, DOI 10.1002/cbdv.200490037
   NAKAMURA Y, 1992, J APPL POLYM SCI, V45, P1281, DOI 10.1002/app.1992.070450716
   Neffe AT, 2010, MACROMOL RAPID COMM, V31, P1534, DOI 10.1002/marc.201000274
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Padilla S, 2008, CHEM MATER, V20, P5942, DOI 10.1021/cm801626k
   Peroglio M, 2010, ACTA BIOMATER, V6, P3808, DOI 10.1016/j.actbio.2010.03.018
   PIERCE BF, PHOTOCROSSLINK UNPUB
   Reddy AS, 2005, J PHYS CHEM A, V109, P8893, DOI 10.1021/jp0525179
   Shastri VP, 2009, ADV MATER, V21, P3231, DOI 10.1002/adma.200902200
   Simon P, 2005, J MATER CHEM, V15, P4992, DOI 10.1039/b504977f
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   Teng SH, 2006, COMPOS SCI TECHNOL, V66, P1532, DOI 10.1016/j.compscitech.2005.11.021
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P2668, DOI 10.1016/j.actbio.2009.04.029
   Thein-Han WW, 2009, ACTA BIOMATER, V5, P1182, DOI 10.1016/j.actbio.2008.11.025
   Thio YS, 2004, POLYMER, V45, P3139, DOI 10.1016/j.polymer.2004.02.064
   Tronci G, 2010, J MATER CHEM, V20, P8875, DOI 10.1039/c0jm00883d
   Wu CL, 2005, COMPOS SCI TECHNOL, V65, P635, DOI 10.1016/j.compscitech.2004.09.004
   Young AM, 2009, ACTA BIOMATER, V5, P2072, DOI 10.1016/j.actbio.2009.02.022
   Yu Haiying, 2009, J Orthop Surg Res, V4, P5, DOI 10.1186/1749-799X-4-5
   Yu HS, 2009, ADV ENG MATER, V11, pB162, DOI 10.1002/adem.200900106
   Zahn D, 2007, J MATER SCI, V42, P8966, DOI 10.1007/s10853-007-1586-x
   Zaupa A, 2011, INT J ARTIF ORGANS, V34, P139, DOI 10.5301/IJAO.2010.6083
   Zaupa A, 2011, BIOMACROMOLECULES, V12, P75, DOI 10.1021/bm101029k
   Zhang Q, 2004, J APPL POLYM SCI, V94, P2341, DOI 10.1002/app.21037
NR 36
TC 34
Z9 34
U1 1
U2 36
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2011
VL 7
IS 4
BP 1693
EP 1701
DI 10.1016/j.actbio.2010.11.025
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 742US
UT WOS:000288971300029
PM 21109029
DA 2018-10-20
ER

PT J
AU Wu, CT
   Fan, W
   Gelinsky, M
   Xiao, Y
   Simon, P
   Schulze, R
   Doert, T
   Luo, YX
   Cuniberti, G
AF Wu, Chengtie
   Fan, Wei
   Gelinsky, Michael
   Xiao, Yin
   Simon, Paul
   Schulze, Renate
   Doert, Thomas
   Luo, Yongxiang
   Cuniberti, Gianaurelio
TI Bioactive SrO-SiO2 glass with well-ordered mesopores: Characterization,
   physiochemistry and biological properties
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mesoporous Sr-Si glass; Drug delivery; Bioactivity; Bone repair;
   Scaffolds
ID IN-VITRO BIOACTIVITY; DRUG-DELIVERY RATE; SUBSTITUTED HYDROXYAPATITES;
   MEDICAL APPLICATIONS; STRONTIUM; BONE; MICROSPHERES; SCAFFOLDS;
   CERAMICS; RELEASE
AB For a biomaterial to be considered suitable for bone repair it should ideally be both bioactive and have a capacity for controllable drug delivery: as such, mesoporous SiO2 glass has been proposed as a new class of bone regeneration material by virtue of its high drug-loading ability and generally good biocompatibility. It does, however, have less than optimum bioactivity and controllable drug delivery properties. In this study, we incorporated strontium (Sr) into mesoporous SiO2 in an effort to develop a bioactive mesoporous SrO-SiO2 (Sr-Si) glass with the capacity to deliver Sr2+ ions, as well as a drug, at a controlled rate, thereby producing a material better suited for bone repair. The effects of Sr on the structure, physiochemistry, drug delivery and biological properties of mesoporous Sr-Si glass were investigated. The prepared mesoporous Sr-Si glass was found to have an excellent release profile of bioactive Sr2+ ions and dexamethasone, and the incorporation of Sr2+ improved structural properties, such as mesopore size, pore volume and specific surface area, as well as rate of dissolution and protein adsorption. The mesoporous Sr-Si glass had no cytotoxic effects and its release of Sr2+ and SiO44- ions enhanced alkaline phosphatase activity - a marker of osteogenic cell differentiation - in human bone mesenchymal stem cells. Mesoporous Sr-Si glasses can be prepared to porous scaffolds which show a more sustained drug release. This study suggests that incorporating Sr2+ into mesoporous SiO2 glass produces a material with a more optimal drug delivery profile coupled with improved bioactivity, making it an excellent material for bone repair applications. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Wu, Chengtie; Gelinsky, Michael; Luo, Yongxiang; Cuniberti, Gianaurelio] Tech Univ Dresden, Inst Mat Sci, D-01069 Dresden, Germany.
   [Wu, Chengtie; Gelinsky, Michael; Luo, Yongxiang; Cuniberti, Gianaurelio] Tech Univ Dresden, Max Bergmann Ctr Biomat, D-01069 Dresden, Germany.
   [Wu, Chengtie; Fan, Wei; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia.
   [Simon, Paul] Max Planck Inst Chem Phys Solids, D-01187 Dresden, Germany.
   [Schulze, Renate; Doert, Thomas] Tech Univ Dresden, Dept Chem & Food Chem, Fac Sci, D-01062 Dresden, Germany.
   [Cuniberti, Gianaurelio] POSTECH, Natl Ctr Nanomat Technol, Pohang 790784, South Korea.
RP Wu, CT (reprint author), Tech Univ Dresden, Inst Mat Sci, Budapester Str 27, D-01069 Dresden, Germany.
EM chengtie.wu@qut.edu.au
RI Gelinsky, Michael/A-9680-2012; Cuniberti, Gianaurelio/B-7192-2008
OI Gelinsky, Michael/0000-0001-9075-5121; Cuniberti,
   Gianaurelio/0000-0002-6574-7848; Xiao, Yin/0000-0003-1785-3491
FU Alexander von Humboldt Foundation; South Korean Ministry of Education,
   Science, and Technology [R31-2008-000-10100-0]
FX Funding for this study was provided by a research grant from the
   Alexander von Humboldt Foundation (C.W.) and the South Korean Ministry
   of Education, Science, and Technology Program, Project WCU ITCE No.
   R31-2008-000-10100-0 (G.C.). The authors would like to thank Mr Thor
   Friis, of the Queensland University of Technology, for his assistance
   with the final draft of this manuscript.
CR [Anonymous], 109935 ISOEN
   Arcos D, 2009, CHEM MATER, V21, P1000, DOI 10.1021/cm801649z
   Bajpai AK, 2003, J MATER SCI-MATER M, V14, P347, DOI 10.1023/A:1022983932548
   Balas F, 2006, J AM CHEM SOC, V128, P8116, DOI 10.1021/ja062286z
   Garcia A, 2009, CHEM MATER, V21, P4135, DOI 10.1021/cm9012816
   Gentleman E, 2010, BIOMATERIALS, V31, P3949, DOI 10.1016/j.biomaterials.2010.01.121
   Horcajada P, 2004, MICROPOR MESOPOR MAT, V68, P105, DOI 10.1016/j.micromeso.2003.12.012
   Kokubo T, 2006, BIOMATERIALS, V27, P2907, DOI 10.1016/j.biomaterials.2006.01.017
   Landi E, 2008, ACTA BIOMATER, V4, P656, DOI 10.1016/j.actbio.2007.10.010
   Landi E, 2007, ACTA BIOMATER, V3, P961, DOI 10.1016/j.actbio.2007.05.006
   Lao J, 2008, CHEM MATER, V20, P4969, DOI 10.1021/cm800993s
   LIKINS RC, 1959, ARCH BIOCHEM BIOPHYS, V83, P472, DOI 10.1016/0003-9861(59)90055-4
   Lopez-Noriega A, 2006, CHEM MATER, V18, P3137, DOI 10.1021/cm060488o
   Marie PJ, 2001, CALCIFIED TISSUE INT, V69, P121, DOI 10.1007/s002230010055
   Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q
   Mateus AYP, 2008, J BIOMED MATER RES A, V86A, P483, DOI 10.1002/jbm.a.31.634
   Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Simmons A, 2008, BIOMATERIALS, V29, P2987, DOI 10.1016/j.biomaterials.2008.04.007
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vallet-Regi MA, 2006, J MATER CHEM, V16, P26, DOI 10.1039/b509744d
   Verberckmoes SC, 2003, KIDNEY INT, V64, P534, DOI 10.1046/j.1523-1755.2003.00123.x
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Wu CT, 2007, BIOMATERIALS, V28, P3171, DOI 10.1016/j.biomaterials.2007.04.002
   Wu CT, 2010, J BIOMED MATER RES B, V94B, P32, DOI 10.1002/jbm.b.31621
   Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061
   Wu CT, 2010, ACTA BIOMATER, V6, P820, DOI 10.1016/j.actbio.2009.09.025
   Wu CT, 2006, J BIOMED MATER RES A, V76A, P73, DOI 10.1002/jbm.a.30496
   Xia W, 2008, MICROPOR MESOPOR MAT, V108, P345, DOI 10.1016/j.micromeso.2007.04.013
   Xm H, 1992, NATURE, V358, P209
   Yan Y, 2008, MICROPOR MESOPOR MAT, V113, P305, DOI 10.1016/j.micromeso.2007.11.028
   Yang Y, 2009, BIOMATERIALS, V30, P1947, DOI 10.1016/j.biomaterials.2008.12.044
   Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhong H, 2009, MICROPOR MESOPOR MAT, V123, P63, DOI 10.1016/j.micromeso.2009.03.024
   Zhu YF, 2008, MICROPOR MESOPOR MAT, V112, P494, DOI 10.1016/j.micromeso.2007.10.029
NR 36
TC 68
Z9 70
U1 0
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2011
VL 7
IS 4
BP 1797
EP 1806
DI 10.1016/j.actbio.2010.12.018
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 742US
UT WOS:000288971300041
PM 21185955
DA 2018-10-20
ER

PT J
AU Gu, XN
   Li, N
   Zhou, WR
   Zheng, YF
   Zhao, X
   Cai, QZ
   Ruan, LQ
AF Gu, X. N.
   Li, N.
   Zhou, W. R.
   Zheng, Y. F.
   Zhao, X.
   Cai, Q. Z.
   Ruan, Liquan
TI Corrosion resistance and surface biocompatibility of a microarc
   oxidation coating on a Mg-Ca alloy
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Mg-Ca alloy; Microarc oxidation; Surface modification; Corrosion
   resistance; Biocompatibility
ID PLASMA ELECTROLYTIC OXIDATION; AZ91D MAGNESIUM ALLOY; SIMULATED
   BODY-FLUID; IN-VITRO; ORTHOPEDIC IMPLANTS; BEHAVIOR; BONE;
   HYDROXYAPATITE; ELECTRODEPOSITION; DEGRADATION
AB The Mg-Ca alloy system has been proposed as a potential new kind of degradable biomaterial with possible application within bone. Here microarc oxidation (MAO) coatings were fabricated on top of a Mg-Ca alloy using different applied voltages and the effect of applied voltage on the surface morphology and phase constitution, hydrogen evolution, pH variation in the immersion solution and in vitro biocompatibility of the MAO coating on the Mg-Ca alloy were extensively studied. It was found that the thickness and pore size of the MAO coating increased with the increasing applied voltage, whereas some micropores could be seen inside the 400 V treated MAO coating. The 360 V treated MAO coating gave the best long-term corrosion resistance during a 50 days immersion test. All the MAO coatings could promote MG63 cell adhesion, proliferation and differentiation in comparison with the uncoated Mg-Ca alloy sample, due to significantly reduced Mg ion release and pH value variations in the culture medium. After 5 days culture well-spread and elongated MG63 cells could be seen on the surface of the 360 V and 400V MAO coatings, in contrast to no cells on the uncoated Mg-Ca alloy sample. In summary, MAO showed beneficial effects on the corrosion resistance of, and thus improved cell adhesion to, the Mg-Ca alloy, and should be a good surface modification method for other biomedical magnesium alloys. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Gu, X. N.; Li, N.; Zhou, W. R.; Zheng, Y. F.] Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.
   [Gu, X. N.; Li, N.; Zhou, W. R.; Zheng, Y. F.] Peking Univ, Dept Adv Mat & Nanotechnol, Coll Engn, Beijing 100871, Peoples R China.
   [Gu, X. N.; Li, N.; Zhou, W. R.; Zheng, Y. F.] Peking Univ, Ctr Biomed Mat & Tissue Engn, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China.
   [Zhao, X.; Cai, Q. Z.] Huazhong Univ Sci & Technol, State Key Lab Plast Forming Simulat & Dies Mould, Fac Mat Sci & Engn, Wuhan 430074, Peoples R China.
   [Ruan, Liquan] Kumamoto Univ, Dept Mech Syst Engn, Grad Sch Sci & Technol, Kumamoto 8608555, Japan.
RP Zheng, YF (reprint author), Peking Univ, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.
EM yfzheng@pku.edu.cn
RI Gu, Xuenan/F-5354-2011; Zheng, Yufeng/A-4146-2010; Zhao,
   Xuan/F-4442-2014
OI Zheng, Yufeng/0000-0002-7402-9979; Zhao, Xuan/0000-0002-4528-9587
FU Beijing Municipal Natural Science Foundation [2082010]; Research Funds
   for the Central Universities [PKUJC2009001]; Foundation of the Key
   Laboratory for Advanced Materials Processing Technology, Ministry of
   Education [2008001]; National Natural Science Foundation of China
   [30670560, 30770580]; Program for New Century Excellent Talents in
   University [NCET-07-0033]
FX This work was supported by the Beijing Municipal Natural Science
   Foundation (2082010), Research Funds for the Central Universities
   (PKUJC2009001), Foundation of the Key Laboratory for Advanced Materials
   Processing Technology, Ministry of Education (2008001), National Natural
   Science Foundation of China (Nos. 30670560 and 30770580) and Program for
   New Century Excellent Talents in University (NCET-07-0033).
CR ASTM, 2004, ANN BOOK ASTM STAND
   BANAI S, 1990, CIRC RES, V67, P645, DOI 10.1161/01.RES.67.3.645
   Chiu KY, 2007, SURF COAT TECH, V202, P590, DOI 10.1016/j.surfcoat.2007.06.035
   Dietrich E, 2009, J BIOMED MATER RES A, V88A, P1087, DOI 10.1002/jbm.a.31901
   Duan HP, 2006, ELECTROCHIM ACTA, V51, P2898, DOI 10.1016/j.electacta.2005.08.026
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Gu XN, 2010, ACTA BIOMATER, V6, P4605, DOI 10.1016/j.actbio.2010.07.026
   Gu XN, 2009, ACTA BIOMATER, V5, P2790, DOI 10.1016/j.actbio.2009.01.048
   Gu XN, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/044109
   Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021
   Guo HF, 2005, APPL SURF SCI, V246, P229, DOI 10.1016/j.apsusc.2004.11.031
   Hanzi AC, 2010, ACTA BIOMATER, V6, P1824, DOI 10.1016/j.actbio.2009.10.008
   Hallab NJ, 2002, J BIOMED MATER RES, V60, P420, DOI 10.1002/jbm.10106
   Khaselev O, 1999, J ELECTROCHEM SOC, V146, P1757, DOI 10.1149/1.1391838
   Kokubo T, 1996, THERMOCHIM ACTA, V280, P479, DOI 10.1016/0040-6031(95)02784-X
   LAI MB, 2008, NANOTECHNOLOGY, V2, P130
   Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023
   Li LC, 2004, SURF COAT TECH, V185, P92, DOI 10.1016/j.surfcoat.2004.01.004
   Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021
   Liang J, 2007, APPL SURF SCI, V253, P4490, DOI 10.1016/j.apsusc.2006.09.064
   Luo HH, 2008, J ALLOY COMPD, V464, P537, DOI 10.1016/j.jallcom.2007.10.072
   OBATA A, 2007, J BIOMED RES A, V85, P140
   Park JW, 2010, CLIN ORAL IMPLAN RES, V21, P1278, DOI 10.1111/j.1600-0501.2010.01944.x
   Patel N, 2002, J MATER SCI-MATER M, V13, P1199, DOI 10.1023/A:1021114710076
   Paul W, 2006, AM J BIOCH BIOTECHNO, V2, P41, DOI DOI 10.3844/AJBBSP.2006.41.48
   Pereda MD, 2010, ACTA BIOMATER, V6, P1772, DOI 10.1016/j.actbio.2009.11.004
   Rucdi T. P., 2002, AO PRINCIPLE FRACTUR, P13
   SHARMA AK, 1997, MET FINISH, V95, P45
   Song GL, 2007, CORROS SCI, V49, P1696, DOI 10.1016/j.corsci.2007.01.001
   Song Y, 2010, ACTA BIOMATER, V6, P1736, DOI 10.1016/j.actbio.2009.12.020
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   SUL YT, 2002, BIOMATERIALS, V23
   Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009
   Wang YM, 2009, APPL SURF SCI, V255, P9124, DOI 10.1016/j.apsusc.2009.06.116
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012
   Witte F, 2008, CURR OPIN SOLID ST M, V12, P63, DOI 10.1016/j.cossms.2009.04.001
   Wong HM, 2010, BIOMATERIALS, V31, P2084, DOI 10.1016/j.biomaterials.2009.11.111
   Xu LP, 2009, J MATER SCI-MATER M, V20, P859, DOI 10.1007/s10856-008-3648-2
   Xu S. T., 2005, PRATICAL ORTHOPAEDIC
   Yao ZP, 2009, APPL SURF SCI, V255, P6724, DOI 10.1016/j.apsusc.2009.02.082
   Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028
   Zhang XP, 2007, J MATER SCI, V42, P8523, DOI 10.1007/s10853-007-1738-z
   Zreiqat H, 2002, J BIOMED MATER RES, V62, P175, DOI 10.1002/jbm.10270
NR 44
TC 206
Z9 222
U1 24
U2 209
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2011
VL 7
IS 4
BP 1880
EP 1889
DI 10.1016/j.actbio.2010.11.034
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 742US
UT WOS:000288971300050
PM 21145440
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Calzado-Martin, A
   Mendez-Vilas, A
   Multigner, M
   Saldana, L
   Gonzalez-Carrasco, JL
   Gonzalez-Martin, ML
   Vilaboa, N
AF Calzado-Martin, A.
   Mendez-Vilas, A.
   Multigner, M.
   Saldana, L.
   Gonzalez-Carrasco, J. L.
   Gonzalez-Martin, M. L.
   Vilaboa, N.
TI On the role of RhoA/ROCK signaling in contact guidance of bone-forming
   cells on anisotropic Ti6Al4V surfaces
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Contact guidance; Mesenchymal stem cells; Osteoblasts; Rho GTPase;
   Ti6Al4V
ID OSTEOBLAST-LIKE CELLS; DEFINED BIOMATERIAL SURFACES; CONNECTIVE-TISSUE
   RESPONSES; RHO-GTPASES; ACTIN CYTOSKELETON; EPITHELIAL-CELLS;
   STEM-CELLS; ADHESION; TITANIUM; ALIGNMENT
AB Patterned surfaces direct cell spatial dynamics, yielding cells oriented along the surface geometry, in a process known as contact guidance. The Rho family of GTPases controls the assembly of focal adhesions and cytoskeleton dynamics, but its role in modulating bone-cell alignment on patterned surfaces remains unknown. This article describes the interactions of two human cell types involved in osseointegration, specifically mesenchymal stem cells and osteoblasts, with submicron-or nano-scale Ti6Al4V grooved surfaces generated by mechanical abrasion. The surface chemistry of the alloy was not affected by grinding, ensuring that the differences found in cellular responses were exclusively due to changes in topography. Patterned surfaces supported cell growth and stimulated mesenchymal stem cell viability. Anisotropic surfaces promoted cell orientation and elongation along the grates. Both cell types oriented on nanometric surfaces with grooves of 150 nm depth and 2 mu m width. The number of aligned cells increased by approximately 30% on submicrometric grooves with sizes of about 1 mu m depth and 10 gm width. Cells were treated with drugs that attenuate the activities of the GTPase RhoA and one of its downstream effectors, Rho-associated kinase (ROCK), and contact guidance of treated cells on the grooved surfaces was investigated. The data indicate that the RhoA/ROCK pathway is a key modulator of both mesenchymal stem cell and osteoblast orientation on nanometric surface features. RhoA and its effector participate in the alignment of mesenchymal stem cells on submicrometric grooves, but not of osteoblasts. These findings show that RhoA/ROCK signaling is involved in contact guidance of bone-related cells on metallic substrates, although to a varying extent depending on the specific cell type and the dimensions of the pattern. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Calzado-Martin, A.; Saldana, L.; Vilaboa, N.] Hosp Univ La Paz IdiPAZ, Madrid 28046, Spain.
   [Calzado-Martin, A.; Mendez-Vilas, A.; Multigner, M.; Saldana, L.; Gonzalez-Carrasco, J. L.; Gonzalez-Martin, M. L.; Vilaboa, N.] CIBER BBN, Barcelona, Spain.
   [Mendez-Vilas, A.; Gonzalez-Martin, M. L.] Univ Extremadura, Dept Fis Aplicada, Badajoz 06006, Spain.
   [Multigner, M.; Gonzalez-Carrasco, J. L.] CENIM CSIC, Ctr Nacl Invest Met, Madrid 28040, Spain.
RP Vilaboa, N (reprint author), Hosp Univ La Paz IdiPAZ, Paseo Castellana 261, Madrid 28046, Spain.
EM nvilaboa.hulp@salud.madrid.org
RI Calzado-Martin, Alicia/M-1878-2014; Vilaboa, Nuria/L-1727-2014; Zhou,
   Feng/E-9510-2011; Multigner, Marta/H-5210-2015; Gonzalez Martin, Maria
   Luisa/L-3476-2014; Saldana, Laura/N-2412-2014
OI Calzado-Martin, Alicia/0000-0001-6305-8267; Multigner,
   Marta/0000-0002-1584-0163; Gonzalez Martin, Maria
   Luisa/0000-0002-9207-444X; Saldana, Laura/0000-0003-3057-4649;
   Gonzalez-Carrasco, Jose Luis/0000-0003-2004-4505
FU Ministerio de Ciencia e Innovacion (Spain) [MAT2009-14695-004-01-02-04];
   Fundacion Mutua Madrilena (Spain) [PRI08A124]; Consejeria de Economia,
   Comercio e Innovacion de la Junta de Extremadura (Spain); Fundacion para
   la Investigacion Biomedica del Hospital Universitario La Paz (Madrid,
   Spain); Fondo de Investigaciones Sanitarias (Spain)
FX This work was supported by grants MAT2009-14695-004-01-02-04 from the
   Ministerio de Ciencia e Innovacion (Spain), grants from Fundacion Mutua
   Madrilena (Spain) and grant PRI08A124 from Consejeria de Economia,
   Comercio e Innovacion de la Junta de Extremadura (Spain). A.
   Calzado-Martin is supported by Fundacion para la Investigacion Biomedica
   del Hospital Universitario La Paz (Madrid, Spain). N. Vilaboa is
   supported by Program I3SNS from Fondo de Investigaciones Sanitarias
   (Spain). The authors are greatly indebted to Alba Bore (Unidad de
   Investigacion, Hospital Universitario La Paz and CIBER-BBN), to the SEM
   laboratory (National Museum of Science and Technology, MNCT, Madrid) for
   excellent technical support, to the clinical staff of the Orthopaedic
   Department for providing us with bone samples, and to the Section of
   Biostatistics (Hospital Universitario La Paz) for help with statistical
   analysis.
CR Allen WE, 1997, J CELL SCI, V110, P707
   Anselme K, 2002, J BIOMED MATER RES, V60, P529, DOI 10.1002/jbm.10101
   Ball M, 2008, J BIOMED MATER RES A, V86A, P637, DOI 10.1002/jbm.a.31652
   Bettinger CJ, 2006, BIOMATERIALS, V27, P2558, DOI 10.1016/j.biomaterials.2005.11.029
   Biggs MJP, 2008, J R SOC INTERFACE, V5, P1231, DOI 10.1098/rsif.2008.0035
   CHAPLET M, 2004, BIOCHEM J, V15, P591
   Crouch AS, 2009, BIOMATERIALS, V30, P1560, DOI 10.1016/j.biomaterials.2008.11.041
   Dalby MJ, 2008, BIOMATERIALS, V29, P282, DOI 10.1016/j.biomaterials.2007.09.030
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003
   Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148
   Fujita S, 2009, J R SOC INTERFACE, V6, pS269, DOI 10.1098/rsif.2008.0428.focus
   Geetha M, 2009, PROG MATER SCI, V54, P397, DOI 10.1016/j.pmatsci.2008.06.004
   Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027
   Grew JC, 2008, J BIOMED MATER RES A, V85A, P326, DOI 10.1002/jbm.a.31378
   Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632
   Ishizaki T, 2001, NAT CELL BIOL, V3, P8
   Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721
   Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Lamers E, 2010, BIOMATERIALS, V31, P3307, DOI 10.1016/j.biomaterials.2010.01.034
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Liao DK, 2007, J CARDIOVASC PHARM, V50, P17
   Loesberg WA, 2007, BIOMATERIALS, V28, P3944, DOI 10.1016/j.biomaterials.2007.05.030
   Lu J, 2008, ACTA BIOMATER, V4, P192, DOI 10.1016/j.actbio.2007.07.008
   Mendez-Vilas A, 2006, COLLOID SURFACE B, V52, P157, DOI 10.1016/j.colsurfb.2006.05.002
   Monsees TK, 2005, CELLS TISSUES ORGANS, V180, P81, DOI 10.1159/000086749
   Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235
   Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035
   Rajnicek AM, 2008, BIOMATERIALS, V29, P2082, DOI 10.1016/j.biomaterials.2008.01.015
   Rajnicek AM, 2007, DEV BIOL, V312, P448, DOI 10.1016/j.ydbio.2007.09.051
   Ren XD, 2000, J CELL SCI, V113, P3673
   Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578
   Ricci JL, 2008, J BIOMED MATER RES A, V85A, P313, DOI 10.1002/jbm.a.31379
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Saldana L, 2005, J BIOMED MATER RES A, V73A, P97, DOI 10.1002/jbm.a.30264
   Saldana L, 2010, ACTA BIOMATER, V6, P1649, DOI 10.1016/j.actbio.2009.10.033
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   TIPLER PA, 1978, FISICA
   Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y
   Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107
   WEISS P, 1952, P NATL ACAD SCI USA, V38, P264, DOI 10.1073/pnas.38.3.264
   Zhao JM, 2008, J BIOMED MATER RES A, V84A, P988, DOI 10.1002/jbm.a.31426
   Zhou F, 2009, CHINESE SCI BULL, V54, P3200, DOI [10.1007/s11434-009-0366-1, 10.1007/S11434-009-0366-1]
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
NR 46
TC 29
Z9 29
U1 4
U2 37
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2011
VL 7
IS 4
BP 1890
EP 1901
DI 10.1016/j.actbio.2010.11.035
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 742US
UT WOS:000288971300051
PM 21115140
DA 2018-10-20
ER

PT J
AU Shirai, T
   Shimizu, T
   Ohtani, K
   Zen, Y
   Takaya, M
   Tsuchiya, H
AF Shirai, T.
   Shimizu, T.
   Ohtani, K.
   Zen, Y.
   Takaya, M.
   Tsuchiya, H.
TI Antibacterial iodine-supported titanium implants
SO ACTA BIOMATERIALIA
LA English
DT Article
DE Iodine-supported titanium; Antibacterial implant; Biocompatibility;
   Infection; Cytotoxicity
ID TOTAL KNEE REPLACEMENT; PIN TRACT INFECTIONS; EXTERNAL FIXATION;
   IN-VITRO; BACTERIAL ADHERENCE; STAINLESS-STEEL; LOWER-EXTREMITY;
   BONE-CEMENT; COATED PINS; OXIDE-FILMS
AB Deep infection remains a serious complication in orthopedic implant surgery. In order to reduce the incidence of implant-associated infections, several biomaterial surface treatments have been proposed. This study focused on evaluating the antibacterial activity of iodine-supported titanium (Ti-I(2)) and its impact on post-implant infection, as well as determining the potential suitability of Ti-I(2) as a biomaterial. External fixation pins were used in this experiment as trial implants because of the ease of making the septic models. The antibacterial activity of the metal was measured using a modification of the Japanese Industrial Standards method. Activity was evaluated by exposing the implants to Staphylococcus aureus or Escherichia call and comparing reaction of pathogens to Ti-I(2) vs. stainless steel and titanium controls. Ti-I(2) clearly inhibited bacterial colonization more than the control metals. In addition, cytocompatibility was assessed by counting the number of colonies that formed on the metals. The three metals showed the same amount of fibroblast colony formation. Japanese white rabbits were used as an in vivo model. Three pins were inserted into both femora of six rabbits for histological analysis. Pin sites were inspected and graded for infection and inflammation. Fewer signs of infection and inflammatory changes were observed in conjunction with the Ti-I(2) pins. Furthermore, osteoconductivity of the implant was evaluated with osteoid formation surface of the pin. Consecutive bone formation was observed around the Ti-I(2) and titanium pins, while little osteoid formation was found around the stainless steel pins. These findings suggest that Ti-I(2) has antimicrobial activity and exhibits cytocompatibility. Therefore, Ti-I(2) substantially reduces the incidence of implant infection and shows particular promise as a biomaterial. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Shirai, T.; Tsuchiya, H.] Kanazawa Univ, Dept Orthopaed Surg, Kanazawa, Ishikawa 9208641, Japan.
   [Zen, Y.] Kanazawa Univ, Dept Pathol, Kanazawa, Ishikawa 9208641, Japan.
   [Takaya, M.] Chiba Inst Technol, Narashino, Chiba 2750016, Japan.
RP Tsuchiya, H (reprint author), Kanazawa Univ, Dept Orthopaed Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208641, Japan.
EM tsuchi@med.kanazawa-u.ac.jp
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   An YH, 1996, J ORTHOPAED RES, V14, P846, DOI 10.1002/jor.1100140526
   ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   BRAUSE BD, 1989, INFECT ASSOCIATED IN
   CAPANNA R, 1994, J BONE JOINT SURG BR, V76B, P178
   Cen L, 2004, J BIOMED MATER RES A, V71A, P70, DOI 10.1002/jbm.a.30125
   COLLINGE CA, 1994, ORTHOPEDICS, V17, P445
   Darouiche RO, 1998, J BONE JOINT SURG AM, V80A, P1336, DOI 10.2106/00004623-199809000-00013
   DEBASTIANI G, 1984, J BONE JOINT SURG BR, V66, P538
   DeJong ES, 2001, J TRAUMA, V50, P1008
   Ewald A, 2006, BIOMED ENG ONLINE, P5
   Gosheger G, 2004, BIOMATERIALS, V25, P5547, DOI 10.1016/j.biomaterials.2004.01.008
   Hanssen A D, 1997, Instr Course Lect, V46, P555
   Harris LG, 2006, J BIOMED MATER RES A, V78A, P50, DOI 10.1002/jbm.a.30611
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   Hashimoto K, 1999, INORG MATER, V6, P457
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193
   KEATING J F, 1991, Journal of the Royal College of Surgeons of Edinburgh, V36, P272
   Kinnari TJ, 2005, OTOL NEUROTOL, V26, P380, DOI 10.1097/01.mao.0000169767.85549.87
   KOTOURA Y, 1985, ARCH ORTHOP TRAUM SU, V104, P15, DOI 10.1007/BF00449950
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   Li PLS, 1999, J BONE JOINT SURG BR, V81B, P647, DOI 10.1302/0301-620X.81B4.9262
   MAHAN J, 1991, ORTHOPEDICS, V14, P305
   MALAWER MM, 1995, J BONE JOINT SURG AM, V77A, P1154, DOI 10.2106/00004623-199508000-00003
   Masse A, 2000, J BIOMED MATER RES, V53, P600, DOI 10.1002/1097-4636(200009)53:5<600::AID-JBM21>3.0.CO;2-D
   Mittermayer F, 2001, CLIN ORTHOP RELAT R, P167
   Moroni A, 1998, CLIN ORTHOP RELAT R, P171
   NASSER S, 1992, ORTHOP CLIN N AM, V23, P265
   NOHR RS, 1994, J BIOMAT SCI-POLYM E, V5, P607, DOI 10.1163/156856294X00239
   Okada M, 2006, J BIOMED MATER RES A, V76A, P95, DOI 10.1002/jbm.a.30513
   RITSCHL P, 1992, Z ORTHOP GRENZGEB, V130, P290, DOI 10.1055/s-2008-1039620
   ROMMENS P, 1989, J TRAUMA, V29, P630, DOI 10.1097/00005373-198905000-00018
   ROMMENS PM, 1988, INJURY, V19, P432, DOI 10.1016/0020-1383(88)90141-6
   Safran Marc R., 1994, Contemporary Orthopaedics, V29, P15
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   Schreckenbach JP, 1999, J MATER SCI-MATER M, V10, P453, DOI 10.1023/A:1008988706980
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   Tiller JC, 2002, BIOTECHNOL BIOENG, V79, P465, DOI 10.1002/bit.10299
   Tyagi M, 1997, Biomed Sci Instrum, V33, P240
   Wassall MA, 1997, J BIOMED MATER RES, V36, P325, DOI 10.1002/(SICI)1097-4636(19970905)36:3<325::AID-JBM7>3.3.CO;2-L
   Wirganowicz PZ, 1999, CLIN ORTHOP RELAT R, P64
   Yorganci K, 2002, EUR J CLIN MICROBIOL, V21, P379, DOI 10.1007/s10096-002-0719-z
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
   Zhu XL, 2001, BIOMATERIALS, V22, P2199, DOI 10.1016/S0142-9612(00)00394-X
NR 49
TC 62
Z9 64
U1 3
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD APR
PY 2011
VL 7
IS 4
BP 1928
EP 1933
DI 10.1016/j.actbio.2010.11.036
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 742US
UT WOS:000288971300054
PM 21115142
DA 2018-10-20
ER

PT J
AU Horton, RB
   Duranty, E
   McConico, M
   Vogt, F
AF Horton, Rebecca B.
   Duranty, Edward
   McConico, Morgan
   Vogt, Frank
TI Fourier Transform Infrared (FT-IR) Spectroscopy and Improved Principal
   Component Regression (PCR) for Quantification of Solid Analytes in
   Microalgae and Bacteria
SO APPLIED SPECTROSCOPY
LA English
DT Article
DE Fourier transform infrared spectroscopy; FT-IR spectral database;
   Biological compounds; Solid analytes; Bacteria; Microalgae;
   Quantification; Chemometrics
ID ULTRAVIOLET/VISIBLE ABSORPTION SPECTROPHOTOMETRY; BASE-LINE CORRECTION;
   OPTICAL-SPECTRA; BIODIVERSITY; TOOL; MICROSPECTROSCOPY; DISCRIMINATION;
   CHEMOMETRICS; ALGORITHM; STRAINS
AB In bioanalytical chemistry, a detailed chemical understanding of biomaterials is often difficult to obtain due to the sheer number of analytes contained in a sample along with the samples' generally low reproducibility. This study presents a Fourier transform infrared (FT-IR) spectroscopic technique in conjunction with innovations in sample preparation and chemometric data preprocessing to overcome these limitations. These methodologies were applied to quantitative analyses of 31 representative compounds commonly found in biomaterial, which have been incorporated into a spectroscopic calibration database, that is, albumin (protein); D-alanine, glycine, histidine, valine, arginine, cysteine, phenylalanine, tyrosine, methionine, L-glutamine, and glutamic acid, (amino acids); glucose, fructose, galactose, mannose, sucrose, lactose, glycogen, agarose, and starch (carbohydrates); DNA (salmon sperm), sulphonoquinovosyl diglyceride (sulpho-lipid), and 1,2-diacyl-sn-glycero-3-phospho-L-serine (phospho-lipid); succinic acid and malic acid (carboxylic acids); glycolic acid (alpha-hydroxy acid), sodium pyruvate, beta-carotene, frustules (microalgae silica-shells), and ammonium formate. Two proof-of-principle applications were based on calibration models incorporating these solids, i.e., characterization of E. coli and microalgae. The former aims for detection of bacterial contamination and the latter to enable investigations of changes in chemical composition of microalgae cells in response to shifting environmental conditions. Chemometric preprocessing steps have been developed for handling sample-to-sample fluctuations of absorption path lengths and baselines; the former incorporated mass normalization while the latter utilized a novel baseline correction method that requires no a priori information. Data preprocessing, chemometric calibration, and evaluation algorithms have been combined, together with an extensive spectral database of the aforementioned compounds (approximate to 1500 samples), for quantitative calibration purposes through the remotely accessible Virtual Chemometrics Lab, which can be utilized for a multitude of applications through a graphical user interface.
C1 [Horton, Rebecca B.; Duranty, Edward; McConico, Morgan; Vogt, Frank] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA.
RP Vogt, F (reprint author), Univ Tennessee, Dept Chem, 552 Buehler Hall, Knoxville, TN 37996 USA.
EM fvogt@utk.edu
FU National Science Foundation [CHE-0832612]
FX This work was supported by the National Science Foundation under
   contract CHE-0832612. All algae species utilized in this study were
   provided by The Culture Collection of Algae at the University of Texas,
   Austin. Special thanks to Carol Hirschmugl and Mario Giordano for
   valuable discussions regarding algae preparation and for providing
   frustule samples. We also acknowledge Michael K. Gilbert for preparation
   and analysis of bacteria samples.
CR Belgrader P, 1999, SCIENCE, V284, P449, DOI 10.1126/science.284.5413.449
   Berges JA, 2001, J PHYCOL, V37, P1138, DOI 10.1046/j.1529-8817.2001.01052.x
   Bu DS, 2005, APPL SPECTROSC, V59, P575, DOI 10.1366/0003702053946010
   Cody SH, 1999, ANN INTERN MED, V130, P202, DOI 10.7326/0003-4819-130-3-199902020-00005
   Domenighini A, 2009, J PHYCOL, V45, P522, DOI 10.1111/j.1529-8817.2009.00662.x
   Galloway CM, 2009, APPL SPECTROSC, V63, P1370, DOI 10.1366/000370209790108905
   Gilbert MK, 2008, J CHEM EDUC, V85, P135, DOI 10.1021/ed085p135
   Gilbert MK, 2009, APPL SPECTROSC, V63, P6, DOI 10.1366/000370209787169849
   Giordano M, 2001, J PLANT PHYSIOL, V158, P577, DOI 10.1078/0176-1617-00234
   Giordano M, 2001, J PHYCOL, V37, P271, DOI 10.1046/j.1529-8817.2001.037002271.x
   Giordano M, 2009, PLANT ECOL DIVERS, V2, P155, DOI 10.1080/17550870903353088
   Haaland DM, 2001, APPL SPECTROSC, V55, P1, DOI 10.1366/0003702011951353
   Hirschmugl CJ, 2006, INFRARED PHYS TECHN, V49, P57, DOI 10.1016/j.infrared.2006.01.032
   Jolliffe I, 2002, PRINCIPAL COMPONENT
   Kansiz M, 1999, PHYTOCHEMISTRY, V52, P407, DOI 10.1016/S0031-9422(99)00212-5
   Koch A, 1998, APPL SPECTROSC, V52, P970, DOI 10.1366/0003702981944607
   KOFLER M, 2005, DEFINITE GUIDE MYSQL
   Lieber CA, 2003, APPL SPECTROSC, V57, P1363, DOI 10.1366/000370203322554518
   Malinowski E.R, 2002, FACTOR ANAL CHEM
   Marcilla A, 2009, THERMOCHIM ACTA, V484, P41, DOI 10.1016/j.tca.2008.12.005
   MARTENS H, 1991, MULTIVARIATE CALIBRA
   Massart DL, 1997, HDB CHEMOMETRICS QUA
   Metting FB, 1996, J IND MICROBIOL BIOT, V17, P477, DOI 10.1007/BF01574779
   Murdock JN, 2009, APPL SPECTROSC REV, V44, P335, DOI 10.1080/05704920902907440
   Ojeda CB, 2004, ANAL CHIM ACTA, V518, P1, DOI 10.1016/j.aca.2004.05.036
   Patil V, 2008, INT J MOL SCI, V9, P1188, DOI 10.3390/ijms9071188
   Petibois C, 2006, ANALYST, V131, P640, DOI 10.1039/b518076g
   PEYRONEL G, 1984, SPECTROCHIM ACTA A, V40, P63, DOI 10.1016/0584-8539(84)80030-6
   Posten C, 2009, J BIOTECHNOL, V142, P64, DOI 10.1016/j.jbiotec.2009.03.015
   PRESS W, 2002, NUMERICAL RECIPES C
   Rojas FS, 2009, ANAL CHIM ACTA, V635, P22, DOI 10.1016/j.aca.2008.12.039
   Salomaa IK, 1998, APPL SPECTROSC, V52, P579, DOI 10.1366/0003702981943905
   Shao L, 2007, ENVIRON SCI TECHNOL, V41, P7054, DOI 10.1021/es062188d
   STRANG G, 1997, WAVELETS FILTER BANK
   Takahashi H, 2009, J MICROBIOL METH, V79, P124, DOI 10.1016/j.mimet.2009.08.002
   Vaneechoutte M, 1997, J MED MICROBIOL, V46, P188, DOI 10.1099/00222615-46-3-188
   Vogt F, 2004, APPL SPECTROSC, V58, P683, DOI 10.1366/000370204873051
   Vogt F, 2003, J CHEMOMETR, V17, P346, DOI 10.1002/cem.813
   Vogt F, 2000, CHEMOMETR INTELL LAB, V50, P175, DOI 10.1016/S0169-7439(99)00060-X
   VOGT F, 1999, APPL SPECTROSC, V53, P1350
   Walczak B, 1997, TRAC-TREND ANAL CHEM, V16, P451, DOI 10.1016/S0165-9936(97)00065-4
NR 41
TC 17
Z9 17
U1 2
U2 37
PU SOC APPLIED SPECTROSCOPY
PI FREDERICK
PA 5320 SPECTRUM DRIVE SUITE C, FREDERICK, MD 21703 USA
SN 0003-7028
J9 APPL SPECTROSC
JI Appl. Spectrosc.
PD APR
PY 2011
VL 65
IS 4
BP 442
EP 453
DI 10.1366/10-06122
PG 12
WC Instruments & Instrumentation; Spectroscopy
SC Instruments & Instrumentation; Spectroscopy
GA 743IX
UT WOS:000289013100014
PM 21396193
DA 2018-10-20
ER

PT J
AU Sarve, H
   Lindblad, J
   Borgefors, G
   Johansson, CB
AF Sarve, Hamid
   Lindblad, Joakim
   Borgefors, Gunilla
   Johansson, Carina B.
TI Extracting 3D information on bone remodeling in the proximity of
   titanium implants in SR mu CT image volumes
SO COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE
LA English
DT Article
DE Image analysis; 3D image volume; Bone remodeling; SR mu CT; Feature
   estimation; Osseointegration
ID MICRO-COMPUTED TOMOGRAPHY; QUANTIFICATION; BIOMATERIALS; ALGORITHM
AB Bone-implant integration is measured in several ways. Traditionally and routinely, 2D histological sections of samples, containing bone and the biomaterial, are stained and analyzed using a light microscope. Such histological section provides detailed cellular information about the bone regeneration in the proximity of the implant. However, this information reflects the integration in only a very small fraction, a 10 mu m thick slice, of the sample. In this study, we show that feature values quantified on 2D sections are highly dependent on the orientation and the placement of the section, suggesting that a 3D analysis of the whole sample is of importance for a more complete judgment of the bone structure in the proximity of the implant. We propose features describing the 3D data by extending the features traditionally used for 20-analysis. We present a method for extracting these features from 3D image data and we measure them on five 3D SR mu CT image volumes.
   We also simulate cuts through the image volume positioned at all possible section positions. These simulations show that the measurement variations due to the orientation of the section around the center line of the implant are about 30%. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
C1 [Sarve, Hamid; Lindblad, Joakim; Borgefors, Gunilla] Swedish Univ Agr Sci, Ctr Image Anal, Uppsala, Sweden.
   [Johansson, Carina B.] Univ Orebro, Sch Hlth & Med Sci, Orebro, Sweden.
RP Sarve, H (reprint author), Swedish Univ Agr Sci, Ctr Image Anal, Uppsala, Sweden.
EM hamid@cb.uu.se; joakim@cb.uu.se; gunilla@cb.uu.se;
   carina.johansson@oru.se
RI Lindblad, Joakim/F-1960-2016
OI Lindblad, Joakim/0000-0001-7312-8222
FU Swedish Research Council [621-2005-3402]; IA-SFS project
   [RII3-CT-2004-506008]
FX Research technicians Petra Hammarstrom-Johansson and Ann Albrektsson are
   acknowledged for skillful sample preparations. Also Dr. Ricardo
   Bernhardt is acknowledged. We gratefully acknowledge HASYLAB for
   offering beam time and we specially thank Dr. Felix Beckmann. This work
   was supported by grants from The Swedish Research Council, 621-2005-3402
   and was partly supported by the IA-SFS project RII3-CT-2004-506008 of
   the Framework Programme 6.
CR Balto K, 2000, J DENT RES, V79, P35, DOI 10.1177/00220345000790010401
   Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821
   Bernhardt R, 2004, Eur Cell Mater, V7, P42
   BERNHARDT R, 2006, P SOC PHOTO-OPT INS, V7, P6318
   Borgefors G, 1996, COMPUT VIS IMAGE UND, V64, P368, DOI 10.1006/cviu.1996.0065
   CANDECCA R, 2007, BIOMATERIALS, V28, P2506
   Gavrilovic M, 2009, J MICROSC-OXFORD, V234, P311, DOI 10.1111/j.1365-2818.2009.03170.x
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   HOPPER TAJ, 2005, THESIS QUEENSLAND U
   Ito M, 2005, J BONE MINER METAB, V23, P115, DOI 10.1007/BF03026335
   Ito M, 2003, J BONE MINER METAB, V21, P287, DOI 10.1007/s00774-003-0422-x
   JOHANSSON C, 1991, THESIS GOTEBORG U SW
   JOHANSSON CB, 1995, BIOMATERIALS, V16, P1037, DOI 10.1016/0142-9612(95)94913-6
   JOHNSON RA, 1998, APPL MULTIVARIATE ST
   Lindblad J, 2003, LECT NOTES COMPUT SC, V2886, P348
   Liu PT, 2009, SKELETAL RADIOL, V38, P797, DOI 10.1007/s00256-008-0630-5
   NUMATA Y, 2007, J HARD TISSUE BIOL, V16, P91
   OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076
   PEYRIN E, 2002, IEEE ISBI, P365
   Ruegsegger R., 1996, CALCIF TISSUE, V58, P24
   SARVE H, 2008, LNCS, V5358, P1081
   Sarve H, 2009, LECT NOTES COMPUT SC, V5575, P770
   van Lenthe GH, 2008, IBMS BONEKEY, V5, P410
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
NR 24
TC 14
Z9 15
U1 0
U2 9
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0169-2607
J9 COMPUT METH PROG BIO
JI Comput. Meth. Programs Biomed.
PD APR
PY 2011
VL 102
IS 1
BP 25
EP 34
DI 10.1016/j.cmpb.2010.12.011
PG 10
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Theory & Methods; Engineering, Biomedical; Medical Informatics
SC Computer Science; Engineering; Medical Informatics
GA 745RW
UT WOS:000289184500003
PM 21269725
DA 2018-10-20
ER

PT J
AU Floerkemeier, T
   Thorey, F
   Daentzer, D
   Lerch, M
   Klages, P
   Windhagen, H
   von Lewinski, G
AF Floerkemeier, Thilo
   Thorey, Fritz
   Daentzer, Dorothea
   Lerch, Matthias
   Klages, Phillip
   Windhagen, Henning
   von Lewinski, Gabriela
TI Clinical and radiological outcome of the treatment of osteonecrosis of
   the femoral head using the osteonecrosis intervention implant
SO INTERNATIONAL ORTHOPAEDICS
LA English
DT Article
ID POROUS TANTALUM BIOMATERIAL; CORE DECOMPRESSION; NECROSIS; HIP
AB The aim of this study was to evaluate the clinical and radiological outcome of the treatment of osteonecrosis of the femoral head by implantation of an osteonecrosis intervention rod. In this retrospective study the follow-up of 19 patients with 23 osteonecrotic femoral heads treated with implantation of an osteonecrosis intervention implant was assessed. From 19 patients with 23 necrotic femoral heads, there were 13 cases in which a total hip replacement was necessary. This implies a survival rate of 44% after implantation of an osteonecrosis intervention rod after a mean follow-up of 1.45 years. The outcome after core decompression combined with the insertion of a tantalum osteonecrosis intervention implant did not show superior results compared to core decompression alone. This is in contrast to existing studies. In addition, this study showed that in cases of total hip replacement, no problems appeared during explantation of the tantalum rod.
C1 [Floerkemeier, Thilo; Thorey, Fritz; Daentzer, Dorothea; Lerch, Matthias; Klages, Phillip; Windhagen, Henning; von Lewinski, Gabriela] Hannover Med Sch, Dept Orthopaed Surg, D-3000 Hannover, Germany.
RP Floerkemeier, T (reprint author), Hannover Med Sch, Dept Orthopaed Surg, D-3000 Hannover, Germany.
EM Thilo.floerkemeier@annastift.de
CR Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   CAMP JF, 1986, J BONE JOINT SURG AM, V68A, P1313, DOI 10.2106/00004623-198668090-00002
   FICAT RP, 1985, J BONE JOINT SURG BR, V67, P3
   Gangji V, 2009, INT ORTHOP, V33, P639, DOI 10.1007/s00264-008-0518-y
   Hungerford MW, 2000, ORTHOPADE, V29, P442
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   Mont Michael A, 2007, Instr Course Lect, V56, P197
   Mont Michael A, 2007, Instr Course Lect, V56, P213
   Nadeau Melissa, 2007, Mcgill J Med, V10, P4
   Rijnen WHC, 2005, INT ORTHOP, V29, P140, DOI 10.1007/s00264-005-0639-5
   Shuler MS, 2007, J ARTHROPLASTY, V22, P26, DOI 10.1016/j.arth.2006.03.007
   Tanzer M, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000194728.62996.2d
   TOOKE SMT, 1988, CLIN ORTHOP RELAT R, P99
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Veillette CJH, 2006, J BONE JOINT SURG AM, V88A, P48, DOI 10.2106/JBJS.F.00538
   Wang BL, 2010, INT ORTHOP, V34, P635, DOI 10.1007/s00264-009-0822-1
   Zhao FC, 2010, INT ORTHOP, V34, P799, DOI 10.1007/s00264-009-0829-7
NR 18
TC 31
Z9 39
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0341-2695
J9 INT ORTHOP
JI Int. Orthop.
PD APR
PY 2011
VL 35
IS 4
BP 489
EP 495
DI 10.1007/s00264-009-0940-9
PG 7
WC Orthopedics
SC Orthopedics
GA 742QU
UT WOS:000288960300004
PM 20119747
OA Green Published
DA 2018-10-20
ER

PT J
AU Wang, W
   Lin, YF
   Huang, Y
AF Wang, Wei
   Lin, Yafu
   Huang, Yong
TI Modeling of Thermoelastic Stress Wave in Laser-Assisted Cell Direct
   Writing
SO JOURNAL OF MANUFACTURING SCIENCE AND ENGINEERING-TRANSACTIONS OF THE
   ASME
LA English
DT Article
ID LIQUIDS; ABLATION; GENERATION; ABSORPTION; MECHANISMS; WATER
AB Laser-assisted cell direct-write technique has been a promising biomaterial direct-write method. For safe and reproducible cell direct writing, cell injury due to process-induced external stress must be understood in addition to biological property research. The objective of this study is to model the thermoelastic stress wave propagation inside the coating in laser-assisted cell direct writing when vaporization and/or optical breakdown of coating materials is/are not available. It is found that a bipolar pressure pair, with peak magnitudes on the order of 1 MPa or higher, has been developed within a finite thin coating medium. Shorter duration laser pulses lead to higher thermoelastic stresses. This study will help to understand the photomechanical stress and its relevance with biomaterial damage in laser-assisted cell direct writing. [DOI: 10.1115/1.4003612]
C1 [Wang, Wei; Lin, Yafu; Huang, Yong] Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
RP Huang, Y (reprint author), Clemson Univ, Dept Mech Engn, Clemson, SC 29634 USA.
EM yongh@clemson.edu
OI Lin, Yafu/0000-0003-2309-5930
FU National Textile Center; National Science Foundation [CMMI-CAREER
   0747959]
FX This study was partially supported by the National Textile Center and
   the National Science Foundation (Grant No. CMMI-CAREER 0747959). The
   constructive comments by Dr. L. Thompson of Clemson University are also
   highly appreciated.
CR ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   CAROME EF, 1964, APPL PHYS LETT, V4, P95, DOI 10.1063/1.1753985
   DINGUS RS, 1991, P SOC PHOTO-OPT INS, V1427, P45, DOI 10.1117/12.44088
   DINGUS RS, 1994, P SOC PHOTO-OPT INS, V2134, P434
   Frenz M, 1996, PHYS REV LETT, V76, P3546, DOI 10.1103/PhysRevLett.76.3546
   Georgiou S, 2003, CHEM REV, V103, P349, DOI 10.1021/cr010429o
   Gusev V. E., 1993, LASER OPTOACOUSTICS
   Kim D, 1998, APPL PHYS A-MATER, V67, P169, DOI 10.1007/s003390050756
   Lin YF, 2009, J APPL PHYS, V106, DOI 10.1063/1.3202388
   Noack J, 1999, IEEE J QUANTUM ELECT, V35, P1156, DOI 10.1109/3.777215
   Odde DJ, 1999, TRENDS BIOTECHNOL, V17, P385, DOI 10.1016/S0167-7799(99)01355-4
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.3.CO;2-6
   Paltauf G, 1998, J ACOUST SOC AM, V104, P890, DOI 10.1121/1.423334
   Paltauf G, 1997, J APPL PHYS, V82, P1525, DOI 10.1063/1.365953
   Paltauf G, 2003, CHEM REV, V103, P487, DOI 10.1021/cr010436c
   Park HK, 1996, J APPL PHYS, V80, P4072, DOI 10.1063/1.363370
   PARK HK, 1994, THESIS U CALIFORNIA
   SIGRIST MW, 1978, J ACOUST SOC AM, V64, P1652, DOI 10.1121/1.382132
   Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n
   Wang W, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.4000101
NR 21
TC 3
Z9 3
U1 1
U2 3
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 1087-1357
J9 J MANUF SCI E-T ASME
JI J. Manuf. Sci. Eng.-Trans. ASME
PD APR
PY 2011
VL 133
IS 2
AR 024502
DI 10.1115/1.4003612
PG 6
WC Engineering, Manufacturing; Engineering, Mechanical
SC Engineering
GA 745EO
UT WOS:000289148700018
DA 2018-10-20
ER

PT J
AU Farley, C
   Turnbull, T
   Pantoya, ML
   Hunt, EM
AF Farley, Cory
   Turnbull, Travis
   Pantoya, Michelle L.
   Hunt, Emily M.
TI Self-propagating high-temperature synthesis of nanostructured titanium
   aluminide alloys with varying porosity
SO ACTA MATERIALIA
LA English
DT Article
DE Porous metallic alloy; Aluminum; Titanium; Fluorocarbon; Nanocomposite
ID ACTIVATED COMBUSTION SYNTHESIS; NANOPARTICLES; FOAMS
AB Metallic foams were synthesized by means of a self-propagating high-temperature reaction producing a highly porous solid metal alloy with customizable material properties. Nanoscale aluminum (nAl) and nanoscale titanium (nTi) particles were mixed with either nanoscale aluminum passivated with a gasifying agent such as perfluoroalkyl carboxylic acid (C13F27COOH) or polytetrafluoroethylene (Teflon) (C2F4)(n) particles and pressed into pellets. These samples were then ignited with a laser producing a reaction product composed of an AlTi alloy that has a highly porous structure. Objectives of this study were to use combustion synthesis to create a functionally graded porous AlTi alloy and identify correlations between the product microstructure and parameters such as type and amount of gasifying agent present in the reactants. Photographic data allowed interpretation of the reaction propagation while characterization of the final product indicated porosity and morphology. Results from this study may have applications in biomaterial development by tailoring porosity throughout the matrix. (C) 2010 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 [Farley, Cory; Turnbull, Travis; Pantoya, Michelle L.] Texas Tech Univ, Dept Mech Engn, Lubbock, TX 79424 USA.
   [Hunt, Emily M.] W Texas A&M Univ, Canyon, TX 79015 USA.
RP Pantoya, ML (reprint author), Texas Tech Univ, Dept Mech Engn, Lubbock, TX 79424 USA.
EM michelle.pantoya@ttu.edu
FU Army Research Office [W911NF-04-1-0217]; Indian Head NSWC
FX M.L.P. and C.F. gratefully acknowledge the support from the Army
   Research Office under grant number W911NF-04-1-0217 and our ARO program
   manager, Dr. Ralph Anthenien. All authors gratefully acknowledge the
   donation of materials by and helpful discussions with Dr. R.J. Jouet
   from Indian Head NSWC.
CR Ayers RA, 2007, J BIOMED MATER RES A, V81A, P634, DOI 10.1002/jbm.a.31017
   Fischer S. H., 1998, SAND981176C
   Granier JJ, 2004, COMBUST FLAME, V138, P373, DOI 10.1016/j.combustflame.2004.05.006
   Hunt EM, 2006, INTERMETALLICS, V14, P620, DOI 10.1016/j.intermet.2005.10.011
   Jouet RJ, 2005, CHEM MATER, V17, P2987, DOI 10.1021/cm048264y
   MERZHANOV AG, 1975, COMBUST SCI TECHNOL, V10, P195, DOI 10.1080/00102207508946671
   MOORE JJ, 1995, PROG MATER SCI, V39, P243, DOI 10.1016/0079-6425(94)00011-5
   NAPLOCHA K, 2008, J ACHIEV MAT MANUF E, V26, P203
   Orru R, 1999, CHEM ENG SCI, V54, P3349, DOI 10.1016/S0009-2509(98)00459-X
   Orru R, 1999, METALL MATER TRANS A, V30, P1101, DOI 10.1007/s11661-999-0162-1
   Pantoya ML, 2009, J PROPUL POWER, V25, P465, DOI 10.2514/1.36436
   Sun J, 2006, THERMOCHIM ACTA, V444, P117, DOI 10.1016/j.tca.2006.03.001
   Vardurnyan LE, 2008, J ALLOY COMPD, V454, P389, DOI 10.1016/j.jallcom.2006.12.114
   Varma A, 2000, SCI AM, V283, P58, DOI 10.1038/scientificamerican0800-58
   Yang YQ, 2004, J APPL PHYS, V95, P3667, DOI 10.1063/1.1652250
NR 15
TC 6
Z9 6
U1 0
U2 24
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6454
EI 1873-2453
J9 ACTA MATER
JI Acta Mater.
PD APR
PY 2011
VL 59
IS 6
BP 2447
EP 2454
DI 10.1016/j.actamat.2010.12.044
PG 8
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 737KU
UT WOS:000288568500019
DA 2018-10-20
ER

PT J
AU Tu, Q
   Li, L
   Zhang, YR
   Wang, JC
   Liu, R
   Li, ML
   Liu, WM
   Wang, XQ
   Ren, L
   Wang, JY
AF Tu, Qin
   Li, Li
   Zhang, Yanrong
   Wang, Jianchun
   Liu, Rui
   Li, Manlin
   Liu, Wenming
   Wang, Xueqin
   Ren, Li
   Wang, Jinyi
TI The effect of acetylcholine-like biomimetic polymers on neuronal growth
SO BIOMATERIALS
LA English
DT Article
DE Click chemistry; Free radical polymerization; Acetylcholine; Biomimetic
   material; Hippocampus neuron
ID CLICK CHEMISTRY; OXYANIONIC POLYMERIZATION; ALIPHATIC POLYESTERS;
   SURFACE MODIFICATION; HIPPOCAMPAL-NEURONS; NEURITE OUTGROWTH; NMDA
   RECEPTOR; COPOLYMERS; NEUROTRANSMITTERS; POLY(DIMETHYLSILOXANE)
AB Driven by clinical needs, nerve regeneration studies have recently become the focus of research and area of growth in tissue engineering. Biomimetic polymer synthesis and functional interface construction is a promising solution to induce neuritic sprouting and guide the regenerating nerve. However, few studies have been made on primary hippocampal neurons. In this study, a new type of acetylcholine-like biomimetic polymers for their potential in biomaterial-modulated nerve regeneration application is synthesized using click chemistry and free radical polymerization. The structure of the synthesized polymers includes a "bioactive" unit (acetylcholine-like unit) and a "bioinert" unit [poly(ethylene glycol) unit]. To explore the effects of the bioactive unit and the bioinert unit on neuronal growth, different ratios of the two initial monomers poly(ethylene glycol) monomethyl ether-glycidyl methacrylate (MePEG-GMA) and dimethylaminoethyl methacrylate (DMAEMA) were employed and five different polymers were synthesized. Their chemical structures were characterized using (1)H nuclear magnetic resonance and Fourier-transform infrared spectroscopy, and their physical properties (including molecular weight, polydispersity, glass transition temperature, and melting point) were determined using gel permeation chromatography and differential scanning calorimetry. Culturing of the primary rat hippocampal neurons on the polymeric surfaces show that the ratio of the two initial monomers utilized for polymer synthesis significantly affects neuronal growth. Rat hippocampal neurons show different growth morphologies on different polymeric surfaces. The polymeric surface prepared with 1:60 (mol/mol) of MePEG-GMA to DMAEMA induces neuronal regenerative responses similar to that on poly-L-lysine, a very common benchmark material for nerve cell cultures. These results suggest that acetylcholine-like biomimetic polymers are potential biomaterials for neural engineering applications, particularly in modulating the growth of hippocampal neurons. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Tu, Qin; Li, Li; Zhang, Yanrong; Wang, Jianchun; Liu, Rui; Li, Manlin; Liu, Wenming; Wang, Xueqin; Ren, Li; Wang, Jinyi] NW A&F Univ, Coll Sci & Vet Med, Yangling 712100, Shaanxi, Peoples R China.
   [Wang, Jinyi] NW A&F Univ, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China.
RP Wang, JY (reprint author), NW A&F Univ, Coll Sci & Vet Med, Yangling 712100, Shaanxi, Peoples R China.
EM jywang@nwsuaf.edu.cn
FU National Natural Science Foundation of China [209 750 82, 207 750 59];
   Ministry of Education of the People's Republic of China [NCET-08-0464];
   State Forestry Administration of the People's Republic of China
   [200904004]; Scientific Research Foundation for the Returned Overseas
   Chinese Scholars; State Education Ministry; Northwest AF University
FX This work was supported by the National Natural Science Foundation of
   China (Nos. 209 750 82 and 207 750 59), the Ministry of Education of the
   People's Republic of China (No. NCET-08-0464), the State Forestry
   Administration of the People's Republic of China (No. 200904004), the
   Scientific Research Foundation for the Returned Overseas Chinese
   Scholars, State Education Ministry, and Northwest A&F University.
CR Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371
   Aramakis VB, 1998, J NEUROSCI, V18, P8485
   Bernardini N, 2004, J NEUROCHEM, V88, P1533, DOI 10.1046/j.1471-4159.2003.02292.x
   Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179
   Buddle M, 2003, BRAIN RES, V978, P38, DOI 10.1016/S0006-8993(03)02758-6
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Chalfoun CT, 2006, J CELL MOL MED, V10, P309, DOI 10.1111/j.1582-4934.2006.tb00401.x
   CHINI M, 1990, TETRAHEDRON LETT, V31, P5641, DOI 10.1016/S0040-4039(00)97921-8
   Coronas V, 2000, NEUROSCIENCE, V98, P213, DOI 10.1016/S0306-4522(00)00143-3
   Dag A, 2008, J POLYM SCI POL CHEM, V46, P6969, DOI 10.1002/pola.23007
   Dietz GPH, 2007, BRAIN RES, V1164, P136, DOI 10.1016/j.brainres.2007.06.025
   Dong R, 2010, BIOMACROMOLECULES, V11, P2027, DOI 10.1021/bm1003702
   Durmaz H, 2007, MACROMOLECULES, V40, P191, DOI 10.1021/ma0618191
   Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9
   Gabi M, 2010, COLLOID SURFACE B, V79, P365, DOI 10.1016/j.colsurfb.2010.04.019
   Gumera CB, 2007, ADV MATER, V19, P4404, DOI 10.1002/adma.200701747
   Ivins KJ, 1998, NEUROBIOL DIS, V5, P365, DOI 10.1006/nbdi.1998.0228
   Jin L, 2004, J POLYM SCI POL CHEM, V42, P6081, DOI 10.1002/pola.20453
   LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F
   Lee BS, 2007, BIOMACROMOLECULES, V8, P744, DOI 10.1021/bm060782+
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mailliot C, 1998, NEUROSCI LETT, V255, P13, DOI 10.1016/S0304-3940(98)00693-4
   MATTSON MP, 1989, BRAIN RES, V478, P337, DOI 10.1016/0006-8993(89)91514-X
   Natalia O. G., 2005, ANNU REV NEUROSCI, V28, p191 
   Nguyen L, 2001, CELL TISSUE RES, V305, P187, DOI 10.1007/s004410000343
   Opsteen JA, 2005, CHEM COMMUN, P57, DOI 10.1039/b412930j
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Qin WP, 2010, ANN NY ACAD SCI, V1211, P66, DOI 10.1111/j.1749-6632.2010.05806.x
   Rana S, 2010, POLYM BULL, V64, P401, DOI 10.1007/s00289-009-0175-3
   Riva R, 2005, CHEM COMMUN, P5334, DOI 10.1039/b5102182k
   Roerig B, 1997, J NEUROSCI, V17, P8353
   Sabitha G, 2002, ORG LETT, V4, P343, DOI 10.1021/ol016979q
   Samanta S, 2009, MACROMOLECULES, V42, P3112, DOI 10.1021/ma9003117
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SIEGWARD ME, 1995, J NEUROSCI, V15, P1419
   Suggs LJ, 1997, MACROMOLECULES, V30, P4318, DOI 10.1021/ma970312v
   Sui GD, 2006, ANAL CHEM, V78, P5543, DOI 10.1021/ac060605z
   Tata AM, 2003, J NEUROSCI RES, V73, P227, DOI 10.1002/jnr.10650
   Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777
   Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v
   Tong YW, 2001, BIOMATERIALS, V22, P1029, DOI 10.1016/S0142-9612(00)00338-0
   Tsarevsky NV, 2007, MACROMOLECULES, V40, P4439, DOI 10.1021/ma070705m
   Vamvakaki M, 1999, MACROMOLECULES, V32, P2088, DOI 10.1021/ma981779o
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Yang LY, 2010, ANAL CHEM, V82, P6430, DOI 10.1021/ac100544x
   Yuk SH, 1997, MACROMOLECULES, V30, P6856, DOI 10.1021/ma970725w
NR 47
TC 17
Z9 17
U1 4
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2011
VL 32
IS 12
BP 3253
EP 3264
DI 10.1016/j.biomaterials.2011.01.044
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 738GZ
UT WOS:000288629600010
PM 21303719
DA 2018-10-20
ER

PT J
AU Dou, XC
   Zhu, XP
   Zhou, JA
   Cai, HQ
   Tang, JA
   Li, QL
AF Dou, Xiao-Chen
   Zhu, Xiao-Peng
   Zhou, Jian
   Cai, Hua-Qiong
   Tang, Jian
   Li, Quan-Li
TI Minocycline-released hydroxyapatite-gelatin nanocomposite and its
   cytocompatibility in vitro
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID CARBONATE; APATITE; TETRACYCLINES; DOXYCYCLINE
AB The incorporation of antibacterial agents into biomaterials is extremely desirable for repairing bone defects. Minocycline, a semi-synthetic tetracycline antibiotic, is active against aerobic, anaerobic, Gram-positive and Gram-negative bacteria, and can enhance bone formation, decrease connective tissue breakdown and diminish bone resorption. In this study, a novel minocycline-releasing biomaterial was synthesized using a biomimetic method. A measured amount of an acidic hydroxyapatite and minocycline solution was respectively added to a gelatin solution and kept at 40 degrees C and pH 7-8 for 2 h. The mixture was aged overnight, lyophilized and a hydroxyapatite-gelatin-minocycline composite was obtained. The composite was co-cultured with rat bone marrow stromal cells (BMSCs) in vitro. Our results show that nanohydroxyapatite was distributed evenly in the fibrils of the gelatin. Minocycline was incorporated into the composite and could be released from the composite particles slowly over 2 weeks in vitro. The composite promoted BMSC adhesion, proliferation and differentiation in vitro. The approach described here may provide a basis for the preparation of an antibacterial biomaterial for bone regeneration.
C1 [Dou, Xiao-Chen; Zhu, Xiao-Peng; Zhou, Jian; Cai, Hua-Qiong; Li, Quan-Li] Anhui Med Univ, Stomatol Hosp & Collage, Key Lab Oral Dis Res Anhui Prov, Hefei, Peoples R China.
   [Tang, Jian] Anhui Med Univ, Hosp 1, Dept Orthoped Surg, Hefei, Peoples R China.
RP Li, QL (reprint author), Anhui Med Univ, Stomatol Hosp & Collage, Key Lab Oral Dis Res Anhui Prov, Hefei, Peoples R China.
EM ql-li@126.com
FU National Natural Science Foundation of China [30772440]; key programs
   for science and technology development of Anhui province, China
   [08010302196]
FX This study was supported in part by the National Natural Science
   Foundation of China (grant 30772440) and by key programs for science and
   technology development of Anhui province, China (grant no 08010302196).
   We also thank American Journal Experts for revising the English used in
   this paper.
CR BRION M, 1981, INORG CHIM A-BIOINOR, V55, P47, DOI 10.1016/S0020-1693(00)90781-3
   Chang MC, 2003, BIOMATERIALS, V24, P2853, DOI 10.1016/S0142-9612(03)00115-7
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Eiden-Assmann S, 2002, J INORG BIOCHEM, V91, P481, DOI 10.1016/S0162-0134(02)00481-6
   Fleet ME, 2005, BIOMATERIALS, V26, P7548, DOI 10.1016/j.biomaterials.2005.05.025
   Fleet ME, 2007, BIOMATERIALS, V28, P916, DOI 10.1016/j.biomaterials.2006.11.003
   GOEGAN P, 1995, TOXICOL IN VITRO, V9, P257, DOI 10.1016/0887-2333(95)00004-R
   Gomes PS, 2008, ACTA BIOMATER, V4, P630, DOI 10.1016/j.actbio.2007.12.006
   Gomes PS, 2007, ARCH ORAL BIOL, V52, P251, DOI 10.1016/j.archoralbio.2006.10.005
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Oyane A, 2006, BIOMATERIALS, V27, P3295, DOI 10.1016/j.biomaterials.2006.01.029
   Shu Y, 2011, J NANOMATER, DOI 10.1155/2011/423686
   Sivakumar M, 2002, BIOMATERIALS, V23, P3175, DOI 10.1016/S0142-9612(02)00066-2
   Sundar M, 2005, TRENDS BIOMATER ARTI, V18, P213
   Yao F, 2009, ACTA BIOMATER, V5, P2169, DOI 10.1016/j.actbio.2009.02.007
   ZUCCHELLI G, 1999, J PERIODONTOL, V70, P39
NR 16
TC 10
Z9 11
U1 0
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2011
VL 6
IS 2
AR 025002
DI 10.1088/1748-6041/6/2/025002
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740IX
UT WOS:000288787300003
PM 21293054
DA 2018-10-20
ER

PT J
AU James, R
   Kumbar, SG
   Laurencin, CT
   Balian, G
   Chhabra, AB
AF James, R.
   Kumbar, S. G.
   Laurencin, C. T.
   Balian, G.
   Chhabra, A. B.
TI Tendon tissue engineering: adipose-derived stem cell and GDF-5 mediated
   regeneration using electrospun matrix systems
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID MARROW STROMAL CELLS; GROWTH-DIFFERENTIATION FACTOR-5; ANTERIOR CRUCIATE
   LIGAMENT; RABBIT ACHILLES-TENDON; ROTATOR CUFF REPAIR; BONE-MARROW;
   GENE-EXPRESSION; FLEXOR TENDON; RAT MODEL; IN-VITRO
AB Tendon tissue engineering with a biomaterial scaffold that mimics the tendon extracellular matrix (ECM) and is biomechanically suitable, and when combined with readily available autologous cells, may provide successful regeneration of defects in tendon. Current repair strategies using suitable autografts and freeze-dried allografts lead to a slow repair process that is sub-optimal and fails to restore function, particularly in difficult clinical situations such as zone II flexor tendon injuries of the hand. We have investigated the effect of GDF-5 on cell proliferation and gene expression by primary rat adipose-derived stem cells (ADSCs) that were cultured on a poly(DL-lactide-co-glycolide) PLAGA fiber scaffold and compared to a PLAGA 2D film scaffold. The electrospun scaffold mimics the collagen fiber bundles present in native tendon tissue, and supports the adhesion and proliferation of multipotent ADSCs. Gene expression of scleraxis, the neotendon marker, was upregulated seven- to eightfold at 1 week with GDF-5 treatment when cultured on a 3D electrospun scaffold, and was significantly higher at 2 weeks compared to 2D films with or without GDF-5 treatment. Expression of the genes that encode the major tendon ECM protein, collagen type I, was increased by fourfold starting at 1 week on treatment with 100 ng mL(-1) GDF-5, and at all time points the expression was significantly higher compared to 2D films irrespective of GDF-5 treatment. Thus stimulation with GDF-5 can modulate primary ADSCs on a PLAGA fiber scaffold to produce a soft, collagenous musculoskeletal tissue that fulfills the need for tendon regeneration.
C1 [Balian, G.; Chhabra, A. B.] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22908 USA.
   [James, R.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA.
   [Balian, G.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.
   [Kumbar, S. G.; Laurencin, C. T.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, Farmington, CT 06030 USA.
RP Chhabra, AB (reprint author), Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA 22908 USA.
EM ac2h@hscmail.mcc.virginia.edu
RI James, Roshan/J-3163-2014
OI James, Roshan/0000-0002-2951-9637
FU NIH (NIAMS) [R03 AR052891]; National Science Foundation (NSF)
   [NSF-(EFRI-0736002)]
FX We acknowledge funding from NIH R03 AR052891 (NIAMS) awarded to Abhinav
   B Chhabra, MD and from NSF-(EFRI-0736002) to Cato T Laurencin, MD, PhD.
   Dr Laurencin was the recipient of a Presidential Faculty Fellow Award
   from the National Science Foundation.
CR Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3
   Aspenberg P, 2007, INT ORTHOP, V31, P783, DOI 10.1007/s00264-007-0398-6
   Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267
   Basile P, 2008, MOL THER, V16, P466, DOI 10.1038/sj.mt.6300395
   BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0
   Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630
   Bolt P, 2007, J BONE JOINT SURG AM, V89A, P1315, DOI 10.2106/JBJS.F.00257
   Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240
   BUTLER DL, 2004, CLIN ORTHOP S, V427, pS190
   Calve S, 2004, TISSUE ENG, V10, P755, DOI 10.1089/1076327041348464
   Carlberg B, 2009, BIOMED MATER, V4, DOI 10.1088/1748-6041/4/4/045004
   Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197
   Chen JM, 2009, EXPERT REV MED DEVIC, V6, P61, DOI 10.1586/17434440.6.1.61
   Chhabra A, 2003, J ORTHOPAED RES, V21, P826, DOI 10.1016/S0736-0266(03)00049-4
   Chong AKS, 2007, J BONE JOINT SURG AM, V89A, P74, DOI 10.2106/JBJS.E.01396
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cui M, 2008, SPINE J, V8, P287, DOI 10.1016/j.spinee.2007.05.012
   Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307
   Dines JS, 2007, J SHOULDER ELB SURG, V16, p215S, DOI 10.1016/j.jse.2007.03.001
   FRIEDENSTEIN AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009
   Ge ZG, 2005, CELL TRANSPLANT, V14, P573, DOI 10.3727/000000005783982819
   Gulotta LV, 2009, AM J SPORT MED, V37, P2126, DOI 10.1177/0363546509339582
   Haddad-Weber M, 2010, CYTOTHERAPY, V12, P505, DOI 10.3109/14653241003709652
   Hankemeier S, 2009, TISSUE ENG PT A, V15, P1019, DOI 10.1089/ten.tea.2008.0046
   Hong SJ, 2010, CURR OPIN ORGAN TRAN, V15, P86, DOI 10.1097/MOT.0b013e328334f074
   Hui JHP, 2005, ANN ACAD MED SINGAP, V34, P206
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   James R, 2008, J HAND SURG-AM, V33A, P102, DOI 10.1016/j.jhsa.2007.09.007
   Jenner JMGT, 2007, TISSUE ENG, V13, P1573, DOI 10.1089/ten.2006.0208
   Kajiyama H, 2010, INT J DEV BIOL, V54, P699, DOI 10.1387/ijdb.092953hk
   Kang SK, 2004, J CELL SCI, V117, P4289, DOI 10.1242/jcs.01264
   Kolambkar YM, 2010, TISSUE ENG PT A, V16, P3219, DOI [10.1089/ten.tea.2010.0004, 10.1089/ten.TEA.2010.0004]
   Kumbar SG, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/3/034002
   Kumbar Sangamesh Q., 2008, Recent Patents on Biomedical Engineering, V1, P68
   Kumbar SG, 2008, BIOMATERIALS, V29, P4100, DOI 10.1016/j.biomaterials.2008.06.028
   Kursa K, 2006, J ORTHOP RES, V24, P763, DOI 10.1002/jor.20110
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li XD, 2005, OSTEOPOROSIS INT, V16, P101, DOI 10.1007/s00198-004-1649-7
   Liang L, 2009, HEPATOL RES, V39, P822, DOI 10.1111/j.1872-034X.2009.00506.x
   Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005
   Lou JR, 2001, J ORTHOPAED RES, V19, P1199, DOI 10.1016/S0736-0266(01)00042-0
   Maffulli N, 2008, J BONE JOINT SURG AM, V90A, P1348, DOI 10.2106/JBJS.G.01241
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129
   Mikic B, 2004, ANN BIOMED ENG, V32, P466, DOI 10.1023/B:ABME.0000017549.57126.51
   Mikic B, 2001, J ORTHOPAED RES, V19, P365, DOI 10.1016/S0736-0266(00)90018-4
   Mikic B, 2008, J ORTHOP RES, V26, P834, DOI 10.1002/jor.20581
   Mikic B, 2009, ANAT REC, V292, P396, DOI 10.1002/ar.20852
   Mizuno Hiroshi, 2009, Journal of Nippon Medical School, V76, P56
   Moffat KL, 2009, TISSUE ENG PT A, V15, P115, DOI 10.1089/ten.tea.2008.0014
   Montzka K, 2010, BJU INT, V105, P309, DOI 10.1111/j.1464-410X.2009.09077.x
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Moreau J, 2006, TISSUE ENG, V12, P2905, DOI 10.1089/ten.2006.12.2905
   Moreau JE, 2008, TISSUE ENG PT A, V14, P1161, DOI [10.1089/ten.tea.2007.0147, 10.1089/tea.2007.0147]
   Mortenson R A, 1972, Surg Forum, V23, P470
   Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933
   Nakamura T, 2003, J PERIODONTAL RES, V38, P597, DOI 10.1034/j.1600-0765.2003.00695.x
   Nirmalanandhan VS, 2009, TISSUE ENG PT A, V15, P2103, DOI 10.1089/ten.tea.2008.0335
   Ouyang HW, 2003, TISSUE ENG, V9, P431, DOI 10.1089/107632703322066615
   Pacini S, 2007, TISSUE ENG, V13, P2949, DOI 10.1089/ten.2007.0108
   Park A, 2010, TISSUE ENG PT A, V16, P2941, DOI 10.1089/ten.tea.2009.0710
   Park K, 2007, J BIOMAT SCI-POLYM E, V18, P369, DOI 10.1163/156856207780424997
   Petrigliano FA, 2007, TISSUE ENG, V13, P2721, DOI 10.1089/ten.2006.0434
   PLATT MA, 2005, CLIN PODIATR MED SUR, V22, pR6
   Platt Marc A, 2005, Clin Podiatr Med Surg, V22, P553, DOI 10.1016/j.cpm.2005.08.001
   Rickert M, 2005, CONNECT TISSUE RES, V46, P175, DOI 10.1080/03008200500237120
   Rickert M, 2001, GROWTH FACTORS, V19, P115, DOI 10.3109/08977190109001080
   Rickert M, 2008, J BONE JOINT SURG AM, V90A, P445
   Sahoo S, 2006, TISSUE ENG, V12, P91, DOI 10.1089/ten.2006.12.91
   Sahoo S, 2007, BIOMED MATER, V2, P169, DOI 10.1088/1748-6041/2/3/001
   Sahoo S, 2010, J BIOMED MATER RES A, V93A, P1539, DOI 10.1002/jbm.a.32645
   Sahoo S, 2010, BIOMATERIALS, V31, P2990, DOI 10.1016/j.biomaterials.2010.01.004
   Salingcarnboriboon R, 2003, EXP CELL RES, V287, P289, DOI 10.1016/S0014-4827(03)00107-1
   SCHUIND F, 1992, J HAND SURG-AM, V17A, P291, DOI 10.1016/0363-5023(92)90408-H
   Schweitzer R, 2001, DEVELOPMENT, V128, P3855
   Seyedjafari E, 2011, J MATER SCI-MATER M, V22, P165, DOI 10.1007/s10856-010-4174-6
   Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036
   Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241
   Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072
   Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537
   Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042
   Xu YF, 2008, BRAIN RES, V1239, P49, DOI 10.1016/j.brainres.2008.08.088
   Zeng Q, 2006, CONNECT TISSUE RES, V47, P264, DOI 10.1080/03008200600980769
   Zhang YZ, 2007, INT J NANOMED, V2, P623
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 88
TC 88
Z9 92
U1 2
U2 44
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
EI 1748-605X
J9 BIOMED MATER
JI Biomed. Mater.
PD APR
PY 2011
VL 6
IS 2
AR 025011
DI 10.1088/1748-6041/6/2/025011
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 740IX
UT WOS:000288787300012
PM 21436509
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Esteban, J
   Cordero-Ampuero, J
AF Esteban, Jaime
   Cordero-Ampuero, Jose
TI Treatment of prosthetic osteoarticular infections
SO EXPERT OPINION ON PHARMACOTHERAPY
LA English
DT Review
DE biofilm; bone and joint infection; daptomycin; intracellular; linezolid;
   multidrug-resistant; prosthesis; treatment
ID RESISTANT STAPHYLOCOCCUS-AUREUS; TOTAL KNEE ARTHROPLASTY; GRAM-POSITIVE
   INFECTIONS; TOTAL HIP-ARTHROPLASTY; SMALL-COLONY VARIANTS;
   DEVICE-ASSOCIATED INFECTIONS; TOTAL JOINT INFECTIONS; ONE-STAGE
   REVISION; 2-STAGE REIMPLANTATION; ORTHOPEDIC IMPLANTS
AB Introduction: Despite being relatively infrequent, prosthetic joint infections are a devastating medical complication. However, recent advances in surgical techniques, new antibiotics, and knowledge about pathogenic mechanisms have improved the outcome for affected patients.
   Areas covered: We have analyzed recent advances in pathogenesis, medical and surgical therapy of prosthetic joint infections, with special focus on new antibiotics useful for this disease. Recent studies focused on the important role of biofilms and intracellular bacteria in the pathogenesis of biomaterial-related infections. These advances must guide the management of the patients. Together with more classical antibiotics, linezolid and daptomycin have shown their usefulness for the treatment of these infections. Recently developed lipoglycopeptides have the potential to be used for these infections. In this sense, the possibility of treating patients with oral antibiotics without lack of efficacy is of great interest.
   Expert opinion: Individualized therapies that take into account the microbial etiology, pathogenesis of the disease, antimicrobial susceptibility, and efficacy of antibiotics against biofilms and intracellular organisms make it possible to treat even those infections caused by multidrug-resistant organisms. A multidisciplinary approach (including a surgeon, infectious diseases specialist and microbiologist) provides the best possible management of patients.
C1 [Esteban, Jaime] Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Madrid 28040, Spain.
   [Cordero-Ampuero, Jose] Univ Autonoma Madrid, Hosp La Princesa, Dept Orthopaed, Madrid 28040, Spain.
RP Esteban, J (reprint author), Univ Autonoma Madrid, IIS Fdn Jimenez Diaz, Dept Clin Microbiol, Av Reyes Catolicos 2, Madrid 28040, Spain.
EM jestebanmoreno@gmail.com
RI Esteban, Jaime/S-6554-2018
OI Esteban, Jaime/0000-0002-8971-3167; Cordero-Ampuero,
   Jose/0000-0001-7843-3971
FU Spanish Ministry of Science; Comunidad de Madrid [S2009/MAT-1472]
FX This work was funded by grants from the Spanish Ministry of Science
   (CONSOLIDER-INGENIO Program FUNCOAT-CSD20008-00023) and by the Comunidad
   de Madrid (S2009/MAT-1472). No other conflicts of interests for both
   authors.
CR Achermann Y, 2010, J CLIN MICROBIOL, V48, P1208, DOI 10.1128/JCM.00006-10
   Andollina Agnese, 2008, Chir Organi Mov, V91, P153, DOI 10.1007/s12306-007-0025-0
   Anguita-Alonso P, 2007, ANTIMICROB AGENTS CH, V51, P2594, DOI 10.1128/AAC.00580-06
   Baciewicz AM, 2008, AM J MED SCI, V335, P126, DOI 10.1097/MAJ.0b013e31814a586a
   BARBERAN J, 2006, AM J MED, V119, pNIL15, DOI DOI 10.1016/J.AMJMED.2006.03.036
   Bassetti M, 2005, J ANTIMICROB CHEMOTH, V55, P387, DOI 10.1093/jac/dki016
   Bassetti M, 2001, J INFECTION, V43, P148, DOI 10.1053/jinf.2001.0863
   Bernard L, 2003, CLIN INFECT DIS, V36, P1197, DOI 10.1086/374558
   Biedenbach DJ, 2009, DIAGN MICR INFEC DIS, V64, P177, DOI 10.1016/j.diagmicrobio.2008.12.019
   Billeter M, 2008, CLIN INFECT DIS, V46, P577, DOI 10.1086/526772
   Blondel-Hill E, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P734
   BOOTH RE, 1989, CLIN ORTHOP RELAT R, P57
   Bouza E, 2010, INT J ANTIMICROB AG, V36, P401, DOI 10.1016/j.ijantimicag.2010.06.048
   Brandt CM, 1997, CLIN INFECT DIS, V24, P914, DOI 10.1093/clinids/24.5.914
   Callaghan JJ, 1999, CLIN ORTHOP RELAT R, P139
   Carpenter CF, 2004, CLIN INFECT DIS, V38, P994, DOI 10.1086/383472
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Cierny G, 2002, CLIN ORTHOP RELAT R, P23, DOI 10.1097/01.blo.0000030334.53928.23
   COLYER RA, 1994, CLIN ORTHOP RELAT R, P75
   CORDERO J, 1999, EUROPEAN INSTRUCTION, V4, P165
   Cordero J, 2000, HIP INT, V10, P139
   Cordero-Ampuero J, 2007, ACTA ORTHOP, V78, P511, DOI 10.1080/17453670710014167
   Cordero-Ampuero J, 2010, CLIN ORTHOP RELAT R, V468, P1229, DOI 10.1007/s11999-009-1224-9
   Cordero-Ampuero J, 2009, CLIN ORTHOP RELAT R, V467, P2335, DOI 10.1007/s11999-009-0808-8
   Costerton J W, 2007, BIOFILM PRIMER
   Costerton JW, 2005, INT J ARTIF ORGANS, V28, P1062
   Costerton JW, 2005, CLIN ORTHOP RELAT R, P7, DOI 10.1097/01.blo.0000175128.44966.d9
   COSTERTON JW, 1978, SCI AM, V238, P86, DOI 10.1038/scientificamerican0178-86
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Decousser JW, 2007, EXPERT REV ANTI-INFE, V5, P557, DOI 10.1586/14787210.5.4.557
   Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029
   Denton M, 1998, CLIN MICROBIOL REV, V11, P57
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972
   DRANCOURT M, 1993, ANTIMICROB AGENTS CH, V37, P1214, DOI 10.1128/AAC.37.6.1214
   Ellington JK, 2006, J ORTHOP RES, V24, P87, DOI 10.1002/jor.20003
   ESTEBAN J, 2010, ACTA ORTHOP IN PRESS
   Esteban J, 2008, J CLIN MICROBIOL, V46, P488, DOI 10.1128/JCM.01762-07
   Falagas ME, 2007, INT J ANTIMICROB AG, V30, P202, DOI 10.1016/j.ijantimicag.2007.02.012
   Figueroa DA, 2009, CLIN INFECT DIS, V49, P177, DOI 10.1086/600039
   Finney MS, 2005, CURR MED RES OPIN, V21, P1923, DOI 10.1185/030079905X74961
   Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09
   French G, 2003, J ANTIMICROB CHEMOTH, V51, P45, DOI 10.1093/jac/dkg253
   Frippiat F, 2004, J ANTIMICROB CHEMOTH, V54, P1158, DOI 10.1093/jac/dkh451
   FRIPPIAT F, 2004, J ANTIMICROB CHEMOTH, V54, P1159
   Garvin K L, 1993, Instr Course Lect, V42, P293
   GARVIN KL, 1994, CLIN ORTHOP RELAT R, P97
   Ghannoum M, 2004, MICROBIAL BIOFILMS
   Goldstein BP, 2007, ANTIMICROB AGENTS CH, V51, P1150, DOI 10.1128/AAC.00620-06
   Goldstein EJC, 2006, ANTIMICROB AGENTS CH, V50, P2875, DOI 10.1128/AAC.00286-06
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   GRISTINA AG, 1991, ORTHOP CLIN N AM, V22, P363
   Haddad FS, 1999, CLIN ORTHOP RELAT R, P144
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004
   Hanssen A D, 1999, Instr Course Lect, V48, P111
   Harwood PJ, 2006, INJURY, V37, P818, DOI 10.1016/j.injury.2006.02.007
   Hayden MK, 2005, J CLIN MICROBIOL, V43, P5285, DOI 10.1128/JCM.43.10.5285-5287.2005
   Hirakawa K, 1998, J ARTHROPLASTY, V13, P22, DOI 10.1016/S0883-5403(98)90071-7
   Hoad-Reddick DA, 2005, J BONE JOINT SURG BR, V87B, P171, DOI 10.1320/0301-620X.87B2.15640
   HOPE PG, 1989, J BONE JOINT SURG BR, V71, P851
   Katsikogianni M, 2004, Eur Cell Mater, V8, P37
   Kilgus DJ, 2002, CLIN ORTHOP RELAT R, P116, DOI 10.1097/01.blo.0000030492.43495.63
   Kordelle J, 2000, Z ORTHOP GRENZGEB, V138, P240, DOI 10.1055/s-2000-10143
   Kuli B, 2009, INT J ANTIMICROB AG, V33, P491, DOI 10.1016/j.ijantimicag.2008.11.002
   KURTZ SM, 2008, J ARTHROPLASTY, V12, P984
   Lai KA, 1996, ACTA ORTHOP SCAND, V67, P325, DOI 10.3109/17453679609002324
   Lalani T, 2008, J ANTIMICROB CHEMOTH, V61, P177, DOI 10.1093/jac/dkm437
   LaPlante KL, 2004, EXPERT OPIN PHARMACO, V5, P2321, DOI 10.1517/14656566.5.11.2321
   Leone James M, 2006, Instr Course Lect, V55, P449
   Lewis G, 2009, J BIOMED MATER RES B, V89B, P558, DOI 10.1002/jbm.b.31220
   Lieberman JR, 1994, CLIN ORTHOP RELAT R, V301, P205
   Livermore DM, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg249
   MacGowan AP, 2003, J ANTIMICROB CHEMOTH, V51, P17, DOI 10.1093/jac/dkg248
   Mader Jon T, 2002, Instr Course Lect, V51, P539
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   MARTINSTEXEIRA L, 2007, MANUAL CLIN MICROBIO, P430
   MAURIN M, 1994, J INFECT DIS, V169, P330, DOI 10.1093/infdis/169.2.330
   MCDONALD DJ, 1989, J BONE JOINT SURG AM, V71A, P828, DOI 10.2106/00004623-198971060-00005
   Mittal Y, 2007, J BONE JOINT SURG AM, V89A, P1227, DOI 10.2106/JBJS.E.01192
   Moellering RC, 2003, ANN INTERN MED, V138, P135, DOI 10.7326/0003-4819-138-2-200301210-00015
   Mont MA, 2000, J BONE JOINT SURG AM, V82A, P1552, DOI 10.2106/00004623-200011000-00006
   Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574
   Murillo O, 2009, ANTIMICROB AGENTS CH, V53, P4252, DOI 10.1128/AAC.00208-09
   Murillo O, 2008, J INFECTION, V57, P229, DOI 10.1016/j.jinf.2008.07.003
   Olson ME, 2002, CAN J VET RES, V66, P86
   Papadopoulos A, 2009, J CHEMOTHERAPY, V21, P165, DOI 10.1179/joc.2009.21.2.165
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   Pope SD, 2006, PHARMACOTHERAPY, V26, P908, DOI 10.1592/phco.26.7.908
   PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95
   Quetglas EG, 2009, INT J ARTIF ORGANS, V32, P299
   Raad I, 2007, ANTIMICROB AGENTS CH, V51, P1656, DOI 10.1128/AAC.00350-06
   Rao N, 2004, CLIN ORTHOP RELAT R, P67, DOI 10.1097/01.blo.0000144860.11193.5e
   Rao N, 2007, DIAGN MICR INFEC DIS, V59, P173, DOI 10.1016/j.diagmicrobio.2007.04.006
   RAUT VV, 1994, J BONE JOINT SURG BR, V76B, P721
   Rayner CR, 2004, INFECTION, V32, P8, DOI 10.1007/s15010-004-3029-9
   Razonable RR, 2004, MAYO CLIN PROC, V79, P1137
   Rice DAK, 2009, ARCH ORTHOP TRAUM SU, V129, P1495, DOI 10.1007/s00402-008-0772-x
   Rissing JP, 1997, CLIN INFECT DIS, V25, P1327, DOI 10.1086/516150
   Roecker AM, 2008, EXPERT OPIN PHARMACO, V9, P1745, DOI [10.1517/14656560802166910, 10.1517/14656566.9.10.1745 ]
   Salvati Eduardo A, 2003, Instr Course Lect, V52, P223
   Sauermann R, 2008, PHARMACOLOGY, V81, P79, DOI 10.1159/000109868
   Segawa H, 1999, J BONE JOINT SURG AM, V81A, P1434, DOI 10.2106/00004623-199910000-00008
   Sendi P, 2006, CLIN INFECT DIS, V43, P961, DOI 10.1086/507633
   Senneville E, 2006, CLIN THER, V28, P1155, DOI 10.1016/j.clinthera.2006.08.001
   Soriano A, 2007, EUR J CLIN MICROBIOL, V26, P353, DOI 10.1007/s10096-007-0289-1
   SOUTHWOOD RT, 1987, CLIN ORTHOP RELAT R, P33
   Stein A, 1998, ANTIMICROB AGENTS CH, V42, P3086, DOI 10.1128/AAC.42.12.3086
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Stockley I, 2008, J BONE JOINT SURG BR, V90B, P145, DOI 10.1302/0301-620X.90B2.19855
   Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588
   Trampuz A, 2006, INJURY, V37, P59, DOI 10.1016/j.injury.2006.04.010
   Trampuz A, 2006, CURR OPIN INFECT DIS, V19, P349, DOI 10.1097/01.qco.0000235161.85925.e8
   Trebse R, 2005, J BONE JOINT SURG BR, V87B, P249, DOI 10.1302/0301-620X.87B2.15618
   Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005
   Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047
   Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281
   Vallet-Regi Maria, 2007, Drug Metab Lett, V1, P37, DOI 10.2174/187231207779814382
   Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488
   Venugopalan V, 2007, ORTHOPEDICS, V30, P832
   Vikram HR, 2005, J CLIN MICROBIOL, V43, P5384, DOI 10.1128/JCM.43.10.5384-5387.2005
   Volin SJ, 2004, CLIN ORTHOP RELAT R, P94, DOI 10.1097/01.blo.0000143559.34143.3d
   Wallace RJ, 2001, ANTIMICROB AGENTS CH, V45, P764, DOI 10.1128/AAC.45.3.764-767.2001
   Weiss BD, 2009, ANTIMICROB AGENTS CH, V53, P264, DOI 10.1128/AAC.00258-08
   WILDE AH, 1988, CLIN ORTHOP RELAT R, P23
   Younger ASE, 1997, J ARTHROPLASTY, V12, P615, DOI 10.1016/S0883-5403(97)90133-9
   Zhanel GG, 2008, EXPERT REV ANTI-INFE, V6, P67, DOI 10.1586/14787210.6.1.67
   Zhanel GG, 2010, DRUGS, V70, P859, DOI 10.2165/11534440-000000000-00000
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
   Zimmerli W, 1998, JAMA-J AM MED ASSOC, V279, P1537, DOI 10.1001/jama.279.19.1537
NR 133
TC 20
Z9 21
U1 0
U2 6
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1465-6566
J9 EXPERT OPIN PHARMACO
JI Expert Opin. Pharmacother.
PD APR
PY 2011
VL 12
IS 6
BP 899
EP 912
DI 10.1517/14656566.2011.543676
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 735TK
UT WOS:000288441000006
PM 21405943
DA 2018-10-20
ER

PT J
AU Wu, YQ
   Qu, HC
   Sfyroera, G
   Tzekou, A
   Kay, BK
   Nilsson, B
   Ekdahl, KN
   Ricklin, D
   Lambris, JD
AF Wu, You-Qiang
   Qu, Hongchang
   Sfyroera, Georgia
   Tzekou, Apostolia
   Kay, Brian K.
   Nilsson, Bo
   Ekdahl, Kristina Nilsson
   Ricklin, Daniel
   Lambris, John D.
TI Protection of Nonself Surfaces from Complement Attack by Factor
   H-Binding Peptides: Implications for Therapeutic Medicine
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID ALTERNATIVE PATHWAY AMPLIFICATION; TRANSLATIONAL MINIREVIEW SERIES;
   MODEL BIOMATERIAL SURFACE; WHOLE-BLOOD MODEL; IN-VITRO;
   EXTRACORPOREAL-CIRCULATION; INHIBITS COMPLEMENT; COFACTOR ACTIVITY;
   ACTIVATION; HEPARIN
AB Exposure of nonself surfaces such as those of biomaterials or transplanted cells and organs to host blood frequently triggers innate immune responses, thereby affecting both their functionality and tolerability. Activation of the alternative pathway of complement plays a decisive role in this unfavorable reaction. Whereas previous studies demonstrated that immobilization of physiological regulators of complement activation (RCA) can attenuate this foreign body-induced activation, simple and efficient approaches for coating artificial surfaces with intact RCA are still missing. The conjugation of small molecular entities that capture RCA with high affinity is an intriguing alternative, as this creates a surface with autoregulatory activity upon exposure to blood. We therefore screened two variable cysteine-constrained phage-displayed peptide libraries for factor H-binding peptides. We discovered three peptide classes that differed with respect to their main target binding areas. Peptides binding to the broad middle region of factor H (domains 5-18) were of particular interest, as they do not interfere with either regulatory or binding activities. One peptide in this group (5C6) was further characterized and showed high factor H-capturing activity while retaining its functional integrity. Most importantly, when 5C6 was coated to a model polystyrene surface and exposed to human lepirudin-anticoagulated plasma, the bound peptide captured factor H and substantially inhibited complement activation by the alternative pathway. Our study therefore provides a promising and novel approach to produce therapeutic materials with enhanced biocompatibility. The Journal of Immunology, 2011, 186: 4269-4277.
C1 [Wu, You-Qiang; Qu, Hongchang; Sfyroera, Georgia; Tzekou, Apostolia; Ricklin, Daniel; Lambris, John D.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
   [Kay, Brian K.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA.
   [Nilsson, Bo; Ekdahl, Kristina Nilsson] Univ Uppsala Hosp, Rudbeck Lab C5, Clin Immunol Sect, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden.
   [Ekdahl, Kristina Nilsson] Linnaeus Univ, Sch Nat Sci, SE-39182 Kalmar, Sweden.
RP Lambris, JD (reprint author), Univ Penn, Dept Pathol & Lab Med, 401 Stellar Chance,422 Curie Blvd, Philadelphia, PA 19104 USA.
EM lambris@upenn.edu
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012; Ricklin,
   Daniel/F-5104-2011
OI Nilsson, Bo/0000-0003-0057-2730; Ricklin, Daniel/0000-0001-6140-0233;
   Lambris, John/0000-0002-9370-5776
FU National Institutes of Health [EB003968, AI068730, AI030040]; Swedish
   Research Council [60761701, 2009-4462, 2009-4675]; Natural Science
   Faculty, Linnaeus University
FX This work was supported by National Institutes of Health Grants
   EB003968, AI068730, and AI030040; Swedish Research Council Grants
   60761701, 2009-4462, and 2009-4675; and by grants from the Natural
   Science Faculty, Linnaeus University.
CR ALSENZ J, 1984, BIOCHEM J, V224, P389, DOI 10.1042/bj2240389
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   Barilla-LaBarca ML, 2002, J IMMUNOL, V168, P6298, DOI 10.4049/jimmunol.168.12.6298
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   DODDS AW, 1993, METHOD ENZYMOL, V223, P46
   Engberg AE, 2009, BIOMATERIALS, V30, P2653, DOI 10.1016/j.biomaterials.2009.01.001
   Engstad CS, 1997, THROMB HAEMOSTASIS, V77, P690
   Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038
   Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008
   KEIL LB, 1995, AM J HEMATOL, V50, P254, DOI 10.1002/ajh.2830500406
   Kopp R, 2005, INT J ARTIF ORGANS, V28, P1272
   Korsgren O, 2009, CURR OPIN ORGAN TRAN, V14, P683, DOI 10.1097/MOT.0b013e328332c44c
   Kourtzelis I, 2010, BLOOD, V116, P631, DOI 10.1182/blood-2010-01-264051
   Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333
   LAMBRIS JD, 1982, J IMMUNOL, V128, P186
   Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824
   Lappegard KT, 2005, ANN THORAC SURG, V79, P917, DOI 10.1016/j.athoracsur.2004.08.015
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   LIU L, 1994, J BIOMED MATER RES, V28, P767, DOI 10.1002/jbm.820280703
   Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048
   Mirow N, 2007, ARTIF ORGANS, V31, P466, DOI 10.1111/j.1525-1594.2007.00386.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Nilsson B, 1998, BLOOD, V92, P1661
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nilsson B, 2010, TRENDS IMMUNOL, V31, P32, DOI 10.1016/j.it.2009.09.005
   Nilsson PH, 2010, BIOMATERIALS, V31, P4484, DOI 10.1016/j.biomaterials.2010.02.036
   Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010
   Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x
   Pickering MC, 2008, CLIN EXP IMMUNOL, V151, P210, DOI 10.1111/j.1365-2249.2007.03574.x
   Prosser BE, 2007, J EXP MED, V204, P2277, DOI 10.1084/jem.20071069
   Ratner BD, 2007, BIOMATERIALS, V28, P5144, DOI 10.1016/j.biomaterials.2007.07.035
   Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   ROSS GD, 1982, J IMMUNOL, V129, P2051
   Sahu A, 1996, J IMMUNOL, V157, P884
   Sahu A, 2000, J IMMUNOL, V165, P2491, DOI 10.4049/jimmunol.165.5.2491
   Schmidt CQ, 2008, CLIN EXP IMMUNOL, V151, P14, DOI 10.1111/j.1365-2249.2007.03553.x
   Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610
   Schmidt CQ, 2010, J MOL BIOL, V395, P105, DOI 10.1016/j.jmb.2009.10.010
   Schmidt S, 2003, J BIOMED MATER RES A, V66A, P491, DOI 10.1002/jbm.a.10031
   Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769
   Scholle MD, 2005, COMB CHEM HIGH T SCR, V8, P545, DOI 10.2174/1386207054867337
   Sperling C, 2006, J BIOMED MATER RES A, V76A, P681, DOI 10.1002/jbm.a.30519
   Sperling C, 2007, BIOMATERIALS, V28, P3617, DOI 10.1016/j.biomaterials.2007.04.041
   Tengvall P, 1996, BIOMATERIALS, V17, P1001, DOI 10.1016/0142-9612(96)84675-8
   Videm V, 1996, SCAND J IMMUNOL, V43, P385, DOI 10.1046/j.1365-3083.1996.d01-57.x
   Wahba A, 2000, THROMB RES, V97, P379, DOI 10.1016/S0049-3848(99)00181-4
   Watkins NJ, 1997, IMMUNOPHARMACOLOGY, V38, P111, DOI 10.1016/S0162-3109(97)00068-4
   Williams DF, 2009, BIOMATERIALS, V30, P5897, DOI 10.1016/j.biomaterials.2009.07.027
   Wu J, 2009, NAT IMMUNOL, V10, P728, DOI 10.1038/ni.1755
   Yu HN, 2005, BBA-GEN SUBJECTS, V1726, P168, DOI 10.1016/j.bbagen.2005.08.003
   Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620
NR 60
TC 49
Z9 49
U1 1
U2 13
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD APR 1
PY 2011
VL 186
IS 7
BP 4269
EP 4277
DI 10.4049/jimmunol.1003802
PG 9
WC Immunology
SC Immunology
GA 739WH
UT WOS:000288751200052
PM 21339361
OA Green Accepted, Bronze
DA 2018-10-20
ER

PT J
AU Saunders, M
   Kong, C
   Shaw, JA
   Clode, PL
AF Saunders, Martin
   Kong, Charlie
   Shaw, Jeremy A.
   Clode, Peta L.
TI Matrix-Mediated Biomineralization in Marine Mollusks: A Combined
   Transmission Electron Microscopy and Focused Ion Beam Approach
SO MICROSCOPY AND MICROANALYSIS
LA English
DT Article
DE FIB; STEM; EFTEM; chiton; teeth; magnetite; goethite; lepidocrocite;
   apatite; interface
ID CHITON ACANTHOPLEURA-HIRTOSA; RADULA TEETH; ORGANIC MATRIX;
   POLYPLACOPHORA
AB The teeth of the marine mollusk Acanthopleura hirtosa are an excellent example of a complex, organic, matrix-mediated biomineral, with the fully mineralized teeth comprising layers of iron oxide and iron oxyhydroxide minerals around a calcium apatite core. To investigate the relationship between the various mineral layers and the organic matrix fibers on which they grew, sections have been prepared from specific features in the teeth at controlled orientations using focused ion beam processing. Compositional and microstructural details of heterophase interfaces, and the fate of the organic matrix fibers within the mineral layers, can then be analyzed by a range of transmission electron microscopy (TEM) techniques. Energy-filtered TEM highlights the interlocking nature of the various mineral phases, while high-angle annular dark-field scanning TEM imaging demonstrates that the organic matrix continues to exist in the fully mineralized teeth. These new insights into the structure of this complex biomaterial are an important step in understanding the relationship between its structural and physical properties and may help explain its high strength and crack-resistance behavior.
C1 [Saunders, Martin; Shaw, Jeremy A.; Clode, Peta L.] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia.
   [Kong, Charlie] Univ New S Wales, Electron Microscopy Unit, Sydney, NSW 2052, Australia.
RP Saunders, M (reprint author), Univ Western Australia, Ctr Microscopy Characterisat & Anal, Perth, WA 6009, Australia.
EM Martin.Saunders@uwa.edu.au
RI Clode, Peta/C-4482-2011; Shaw, Jeremy/B-4156-2011; Saunders,
   Martin/B-3082-2011
OI Shaw, Jeremy/0000-0002-5140-457X; Saunders, Martin/0000-0001-6873-7816;
   Clode, Peta/0000-0002-5188-4737
FU ARC [DP0559858]; UWA
FX The authors acknowledge the facilities and the scientific and technical
   assistance of the Australian Microscopy & Microanalysis Research
   Facility at both the Centre for Microscopy, Characterisation & Analysis,
   UWA, and the Electron Microscopy Centre, UNSW, facilities funded by the
   Universities, State and Commonwealth Governments. Financial support was
   provided by an ARC Discovery Grant (DP0559858) and a UWA Research
   Development Award to J.A.S.
CR Addadi L., 2006, CHEM-EUR J, V12, P980, DOI [10.1002/chem.200500980, DOI 10.1002/CHEM.200500980]
   Birchall J. D., 1989, BIOMINERALIZATION CH, P491
   EVANS LA, 1994, ACTA ZOOL-STOCKHOLM, V75, P75, DOI 10.1111/j.1463-6395.1994.tb00963.x
   EVANS LA, 1990, PHILOS T ROY SOC B, V329, P87, DOI 10.1098/rstb.1990.0153
   Fratzl P, 2007, J R SOC INTERFACE, V4, P637, DOI 10.1098/rsif.2007.0218
   Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601
   KIM KS, 1989, PROC R SOC SER B-BIO, V237, P335, DOI 10.1098/rspb.1989.0052
   Lee AP, 1998, J BIOL INORG CHEM, V3, P614, DOI 10.1007/s007750050274
   LOWENSTAM HA, 1967, SCIENCE, V156, P1373, DOI 10.1126/science.156.3780.1373
   Lowenstam HA, 1989, BIOMINERALIZATION
   Macey D.J., 1994, Bulletin de l'Institut Oceanographique Numero Special (Monaco), V14, P191
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Mann S, 2001, BIOMINERALIZATION PR
   Nesson M. H., 1985, MAGNETITE BIOMINERAL, P333
   Saunders M., 2010, MICROSCOPY TODAY, V18, P24
   Saunders M, 2009, J STRUCT BIOL, V167, P55, DOI 10.1016/j.jsb.2009.03.003
   Shaw JA, 2008, J MAR BIOL ASSOC UK, V88, P597, DOI 10.1017/S0025315408000969
   Shaw JA, 2010, BIOL BULL-US, V218, P132, DOI 10.1086/BBLv218n2p132
   Shaw JA, 2009, J MORPHOL, V270, P588, DOI 10.1002/jmor.10705
   Shaw JA, 2009, MICROSC MICROANAL, V15, P154, DOI 10.1017/S1431927609090230
   Sone ED, 2007, J STRUCT BIOL, V158, P428, DOI 10.1016/j.jsb.2007.01.001
   van der Wal P, 2000, MAT SCI ENG C-BIO S, V7, P129, DOI 10.1016/S0928-4931(99)00129-0
   van der Wal P., 1989, ORIGIN EVOLUTION MOD, P153
   Wealthall RJ, 2005, J MORPHOL, V265, P165, DOI 10.1002/jmor.10348
   Weaver JC, 2010, MATER TODAY, V13, P13
   Weiner S, 2005, SCIENCE, V309, P1027, DOI 10.1126/science.1114920
   Weiner S, 2002, SCIENCE, V298, P375, DOI 10.1126/science.1078093
   Weiner S, 2008, J STRUCT BIOL, V163, P229, DOI 10.1016/j.jsb.2008.02.001
NR 28
TC 8
Z9 8
U1 2
U2 21
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1431-9276
EI 1435-8115
J9 MICROSC MICROANAL
JI Microsc. microanal.
PD APR
PY 2011
VL 17
IS 2
BP 220
EP 225
DI 10.1017/S1431927610094547
PG 6
WC Materials Science, Multidisciplinary; Microscopy
SC Materials Science; Microscopy
GA 738BE
UT WOS:000288613500009
PM 21371372
DA 2018-10-20
ER

PT J
AU Kawano, T
   Kidoaki, S
AF Kawano, Takahito
   Kidoaki, Satoru
TI Elasticity boundary conditions required for cell mechanotaxis on
   microelastically-patterned gels
SO BIOMATERIALS
LA English
DT Article
DE Mechanotaxis; Durotaxis; Cell migration; Styrenated gelatin;
   Microelasticity patterning
ID MIGRATION; GRADIENT; MOTILITY; FORCE; REGENERATION; HAPTOTAXIS;
   MOLECULES; SCAFFOLDS; HYDROGELS; KINASE
AB Directional cell migration induced by a mechanical gradient on a substrate surface toward a harder region, so-called mechanotaxis or durotaxis, has recently drawn attention not only in the field of mechanobiology but also for possible cell manipulation in biomedical engineering. Before we can use mechanotaxis to control cell migration on a biomaterial surface, quantitative design criteria for a microelasticity gradient should be established. To clarify the conditions required to induce mechanotaxis, the effects of a microelasticity boundary on cell culture hydrogels have been systematically assessed with regard to fibroblast migration based on a custom-built reduction projection-type photolithographic microelasticity patterning system with elasticity-tunable photocurable styrenated gelatins, which is a thoroughly-improved system of our previous simple photomasking method [41]. As a result, the conditions required to induce mechanotaxis were found to include a certain threshold jump in elasticity (30-40 kPa) and a sufficiently narrow width of the elasticity boundary (50 pm) comparable to a single cell's adhered area, i.e., a sufficiently high gradient strength (30-40 kPa/50 pm in our gelatinous gel system). A significant asymmetric distribution of the number and size of focal adhesions across the elasticity boundary was confirmed to be one of the driving factors of mechanotaxis by indirect immunofluorescence microscopy, and mechanistic considerations in the design criteria are discussed. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Kawano, Takahito; Kidoaki, Satoru] Kyushu Univ, Inst Mat Chem & Engn, Div Biomol Chem, Fukuoka 8190395, Japan.
RP Kidoaki, S (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Div Biomol Chem, Fukuoka 8190395, Japan.
EM kidoaki@ms.ifoc.kyushu-u.ac.jp
RI U-ID, Kyushu/C-5291-2016
FU Japan Science Technology (JST) Agency; Ministry of Education, Culture,
   Sports, Science and Technology (MEXT) of Japan
FX This work was supported the following grants: Grants-in-aid for the
   PRESTO program "Nanosystems and Emergent Functions" from the Japan
   Science Technology (JST) Agency to S. K. the Scientific Research on
   Priority Area "System Cell Engineering", the Global COE program "Science
   for Future Molecular Systems", and the Management Expenses Grants for
   National Universities Corporations "Nano-Macro Materials, Devices and
   System Research Alliancefrom" from the Ministry of Education, Culture,
   Sports, Science and Technology (MEXT) of Japan. The authors sincerely
   thank Prof. Takehisa Matsuda of Kanazawa institute of Technology, Japan,
   for his assistance with the synthesis of styrenated gelatins.
CR Anderson EJ, 2007, TISSUE ENG, V13, P2525, DOI 10.1089/ten.2006.0443
   Andres V, 2004, CARDIOVASC RES, V63, P11, DOI 10.1016/j.cardiores.2004.02.009
   BERSTEIN LR, 1994, CURR OPIN ONCOL, V6, P106
   BRANDLEY BK, 1989, DEV BIOL, V135, P74, DOI 10.1016/0012-1606(89)90159-0
   Burdick JA, 2004, LANGMUIR, V20, P5153, DOI 10.1021/la049298n
   CARTER SB, 1965, NATURE, V208, P1183, DOI 10.1038/2081183a0
   CARTER SB, 1967, NATURE, V213, P256, DOI 10.1038/213256a0
   CHEUNG YK, 2009, ANGEW CHEM INT EDIT, V48, P1
   Cooper LA, 2003, MOL CELL BIOL, V23, P8030, DOI 10.1128/MCB.23.22.8030-8041.2003
   Cornwell KG, 2004, J BIOMED MATER RES A, V71A, P55, DOI 10.1002/jbm.a.30132
   del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912
   ERICKSON CA, 1984, J CELL BIOL, V98, P296, DOI 10.1083/jcb.98.1.296
   Frey MT, 2009, SOFT MATTER, V5, P1918, DOI 10.1039/b818104g
   Furuike S, 2001, FEBS LETT, V498, P72, DOI 10.1016/S0014-5793(01)02497-8
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   Hadjipanayi E, 2009, CELL MOTIL CYTOSKEL, V66, P121, DOI 10.1002/cm.20331
   Hahn MS, 2006, ADV MATER, V18, P2679, DOI 10.1002/adma.200600647
   Hale NA, 2010, ACS APPL MATER INTER, V2, P2317, DOI 10.1021/am100346k
   Hayakawa K, 2008, J CELL SCI, V121, P496, DOI 10.1242/jcs.022053
   Hertz H., 1881, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRIL.1882.92.156>
   Isenberg BC, 2009, BIOPHYS J, V97, P1313, DOI 10.1016/j.bpj.2009.06.021
   JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577
   Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700
   Kidoaki A, 2008, J BIOTECHNOL, V133, P225, DOI 10.1016/j.jbiotec.2007.08.015
   Kim DH, 2009, BIOMATERIALS, V30, P5433, DOI 10.1016/j.biomaterials.2009.06.042
   Kim DH, 2009, ADV FUNCT MATER, V19, P1579, DOI 10.1002/adfm.200801174
   Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023
   Leclerc E, 2007, BIOMATERIALS, V28, P1820, DOI 10.1016/j.biomaterials.2006.11.044
   Lee KW, 2010, BIOMACROMOLECULES, V11, P682, DOI 10.1021/bm901260y
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lowe B, 1997, J EXP BIOL, V200, P1593
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   MCCARTHY JB, 1983, J CELL BIOL, V97, P772, DOI 10.1083/jcb.97.3.772
   Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018
   Munevar S, 2004, J CELL SCI, V117, P85, DOI 10.1242/jcs.00795
   Nain AS, 2008, SMALL, V4, P1153, DOI 10.1002/smll.200800101
   Nemir S, 2010, BIOTECHNOL BIOENG, V105, P636, DOI 10.1002/bit.22574
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   Orive G, 2009, NAT REV NEUROSCI, V10, P682, DOI 10.1038/nrn2685
   PARENTE L, 1979, AGENTS ACTIONS, V9, P196, DOI 10.1007/BF02024734
   PARENTE L, 1979, AGENTS ACTIONS, V9, P190, DOI 10.1007/BF02024733
   Rhoads DS, 2007, EXP CELL RES, V313, P3859, DOI 10.1016/j.yexcr.2007.06.005
   Saranak J, 1997, NATURE, V387, P465, DOI 10.1038/387465a0
   Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044
   Sneddon I. N., 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Tayalia P, 2008, ADV MATER, V20, P4494, DOI 10.1002/adma.200801319
   Tjia JS, 2002, TISSUE ENG, V8, P247, DOI 10.1089/107632702753725012
   UEDAYUKOSHI T, 1995, LANGMUIR, V11, P4135, DOI 10.1021/la00010a080
   Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013
   Weisenhorn A. L., 1993, Nanotechnology, V4, P106, DOI 10.1088/0957-4484/4/2/006
   WEISS P, 1985, INT REV CYTOL, V7, P391
   WEISS P, 1945, YALE J BIOL MED, V19, P239
   Wilkinson P. C., 1996, Methods (Orlando), V10, P74, DOI 10.1006/meth.1996.0081
   Wong JY, 2003, LANGMUIR, V19, P1908, DOI 10.1021/la026403p
   Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005
   Zaari N, 2004, ADV MATER, V16, P2133, DOI 10.1002/adma.200400883
NR 56
TC 38
Z9 38
U1 3
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2011
VL 32
IS 11
BP 2725
EP 2733
DI 10.1016/j.biomaterials.2011.01.009
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736BY
UT WOS:000288465800005
PM 21276611
DA 2018-10-20
ER

PT J
AU Bhang, SH
   Cho, SW
   La, WG
   Lee, TJ
   Yang, HS
   Sun, AY
   Baek, SH
   Rhie, JW
   Kim, BS
AF Bhang, Suk Ho
   Cho, Seung-Woo
   La, Wan-Geun
   Lee, Tae-Jin
   Yang, Hee Seok
   Sun, Ah-Young
   Baek, Sang-Hong
   Rhie, Jong-Won
   Kim, Byung-Soo
TI Angiogenesis in ischemic tissue produced by spheroid grafting of human
   adipose-derived stromal cells
SO BIOMATERIALS
LA English
DT Article
DE Human adipose stromal cells; Spheroid; Therapeutic angiogenesis
ID ENDOTHELIAL PROGENITOR CELLS; HEPATOCYTE GROWTH-FACTOR; STEM-CELLS;
   ADHESION MOLECULE-1; MYOCARDIAL-INFARCTION; MONOLAYER-CULTURES; CARDIAC
   REPAIR; CYTOCHROME-C; TRANSPLANTATION; BCL-2
AB Stem cells offer significant therapeutic promise for the treatment of ischemic disease. However, stem cells transplanted into ischemic tissue exhibit limited therapeutic efficacy due to poor engraftment in vivo. Several strategies for improving the survival and engraftment of stem cells in ischemic tissue have been developed including transplantation in combination with growth factor delivery, genetic modification of stem cells, and the use of cell-transplantation scaffolds. Here, we demonstrate that human adipose-derived stromal cells (hADSCs) cultured and grafted as spheroids exhibit improved therapeutic efficacy for ischemia treatment. hADSCs were cultured in monolayer or spheroids. Spheroid cultures were more effective in preconditioning hADSCs to a hypoxic environment, upregulating hypoxia-adaptive signals (i.e., stromal cell-derived factor-la and hypoxia-inducible factor-le), inhibiting apoptosis, and enhancing secretion of both angiogenic and anti-apoptotic factors (i.e., hepatocyte growth factor, vascular endothelial growth factor, and fibroblast growth factor 2) compared to monolayer cultures. Moreover, cell harvesting following spheroid cultures avoided damage to extracellular matrices due to harsh proteolytic enzyme treatment, thereby preventing anoikis (apoptosis induced by a lack of cell matrix interaction). Following intramuscular transplantation to ischemic hindlimbs of athymic mice, hADSC spheroids showed improved cell survival, angiogenic factor secretion, neovascularization, and limb survival as compared to hADSCs grafted as dissociated cells. Taken together, spheroid cultures precondition hADSCs to a hypoxic environment, and grafting hADSCs as spheroids to ischemic limbs improves therapeutic efficacy for ischemia treatment due to enhanced cell survival and paracrine effects. Spheroid-based cell delivery could be a simple and effective strategy for improving stem cell therapy for ischemic diseases, eliminating the need for growth factor delivery, biomaterial scaffolds or genetic modification. Crown Copyright (C) 2011 Published by Elsevier Ltd. All rights reserved.
C1 [Bhang, Suk Ho; La, Wan-Geun; Kim, Byung-Soo] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea.
   [Cho, Seung-Woo] Yonsei Univ, Dept Biotechnol, Seoul 120749, South Korea.
   [Lee, Tae-Jin; Yang, Hee Seok; Sun, Ah-Young] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
   [Baek, Sang-Hong] Catholic Univ Korea, Coll Med, Div Cardiovasc Med, Seoul 137701, South Korea.
   [Rhie, Jong-Won] Catholic Univ Korea, Coll Med, Dept Plast Surg, Seoul 137701, South Korea.
RP Kim, BS (reprint author), Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151744, South Korea.
EM byungskim@snu.ac.kr
RI Kim, Byung-Soo/O-2352-2013; Rhie, Jong Won/C-4652-2012
OI Rhie, Jong Won/0000-0002-9398-8059; Lee, Tae-Jin/0000-0001-6091-542X
FU Ministry of Health and Welfare [A050082]; Ministry of Education, Science
   and Technology, Republic of Korea [SC3220]; National Research Foundation
   of Korea [2010-0020352]
FX This work was supported by a grant (#A050082) from the Korean Health 21
   R&D Project, Ministry of Health and Welfare, a grant (#SC3220) from the
   Stem Cell Research Center of the 21st Century Frontier Program funded by
   the Ministry of Education, Science and Technology, Republic of Korea,
   and a grant (2010-0020352) from the National Research Foundation of
   Korea.
CR Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370
   Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779
   BALDWIN HS, 1994, DEVELOPMENT, V120, P2539
   Basile DP, 1997, AM J PHYSIOL-RENAL, V272, pF640
   Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9
   Bhang SH, 2007, J BIOMAT SCI-POLYM E, V18, P223, DOI 10.1163/156856207779116711
   Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   Cai L, 2007, STEM CELLS, V25, P3234, DOI 10.1634/stemcells.2007-0388
   Cai LY, 2009, STEM CELLS, V27, P230, DOI 10.1634/stemcells.2008-0273
   Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075
   Cho SW, 2007, CIRCULATION, V116, P2409, DOI 10.1161/CIRCULATIONAHA.106.687038
   Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905
   Deuse T, 2009, CIRCULATION, V120, pS247, DOI 10.1161/CIRCULATIONAHA.108.843680
   Entenmann G, 1996, AM J PHYSIOL-CELL PH, V270, pC1011
   FERRERO E, 1995, FEBS LETT, V374, P323, DOI 10.1016/0014-5793(95)01110-Z
   Fitzpatrick JR, 2010, J THORAC CARDIOV SUR, V140, P667, DOI 10.1016/j.jtcvs.2009.12.037
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Gaedtke L, 2007, J PROTEOME RES, V6, P4111, DOI 10.1021/pr0700596
   Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20085
   Gwak SJ, 2008, BIOMATERIALS, V29, P844, DOI 10.1016/j.biomaterials.2007.10.050
   Hill E, 2006, P NATL ACAD SCI USA, V103, P2494, DOI 10.1073/pnas.0506004103
   Jay SM, 2008, FASEB J, V22, P2949, DOI 10.1096/fj.08-108803
   Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997
   Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC
   Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132
   KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0
   Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com
   Pinter E, 1997, AM J PATHOL, V150, P1523
   Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677
   Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1
   Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009
   Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104
   Ryu JH, 2004, J BIOMED MATER RES A, V71A, P128, DOI 10.1002/jbm.a.30141
   SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0
   Takahashi T, 1999, NAT MED, V5, P434
   Tapp H, 2009, EXP BIOL MED, V234, P1, DOI [10.3181/0805-MR-170, 10.3181/0805/MR-170]
   Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8
   Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475
   Wang CC, 2009, STEM CELLS, V27, P724, DOI 10.1634/stemcells.2008-0944
   Ward JP, 2003, MATH BIOSCI, V181, P177, DOI 10.1016/S0025-5564(02)00148-7
   Wilson Carolyn A., 2009, V506, P477, DOI 10.1007/978-1-59745-409-4_32
   Yoon CH, 2006, ARTERIOSCL THROM VAS, V26, P1066, DOI 10.1161/01.ATV.0000215001.92941.6c
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105
   Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859
NR 47
TC 165
Z9 167
U1 1
U2 33
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2011
VL 32
IS 11
BP 2734
EP 2747
DI 10.1016/j.biomaterials.2010.12.035
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736BY
UT WOS:000288465800006
PM 21262528
DA 2018-10-20
ER

PT J
AU Yang, S
   Tian, YS
   Lee, YJ
   Yu, FH
   Kim, HM
AF Yang, Seungwon
   Tian, Yu-Shun
   Lee, Yun-Jung
   Yu, Frank H.
   Kim, Hyun-Man
TI Mechanisms by which the inhibition of specific intracellular signaling
   pathways increase osteo blast proliferation on apatite surfaces
SO BIOMATERIALS
LA English
DT Article
DE Cell adhesion; Calcium phosphate; Cell proliferation; Cell signaling
ID CELL-CYCLE PROGRESSION; FOCAL ADHESION KINASE; ACTIN CYTOSKELETON;
   RHO-KINASE; THIN-FILM; LIM-KINASE; PTEN; PHOSPHORYLATION; PROTEIN;
   ACTIVATION
AB Osteoblasts proliferate slowly on the surface of calcium phosphate apatite which is widely used as a substrate biomaterial in bone regeneration. Owing to poor adhesion signaling in the cells grown on the calcium phosphate surface, inadequate growth factor signaling is generated to trigger cell cycle progression. The present study investigated an intracellular signal transduction pathway involved in the slow cell proliferation in osteoblasts grown on the calcium phosphate surface. Small GTPase RhoA and phosphatase and tensin homolog (PTEN) were more activated in cells grown on the surface of calcium phosphate apatite than on tissue culture plate. Specific inhibition of RhoA and PTEN induced the cells on calcium phosphate apatite surface to proliferate at a similar rate as cells on tissue culture plate surface. Specific inhibition of ROCK, which is a downstream effector of RhoA and an upstream activator of PTEN also increased proliferation of these osteoblasts. Present results indicate that physical property of calcium phosphate crystals that impede cell proliferation may be surmounted by the inhibition of the RhoA/ROCK/PTEN pathway to rescue delayed proliferation of osteoblasts on the calcium phosphate apatite surface. In addition, specific inhibition of ROCK promoted cell migration and osteoblast differentiation. Inhibition of the RhoA/ROCK/PTEN intracellular signaling pathway is expected to enhance cell activity to promote and accelerate bone regeneration on the calcium phosphate apatite surface. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Yang, Seungwon; Tian, Yu-Shun; Lee, Yun-Jung; Kim, Hyun-Man] Seoul Natl Univ, Lab Study Mol Biointerfaces, Dept Oral Histol & Dev Biol, Program Cell & Dev Biol,Sch Dent, Seoul 110749, South Korea.
   [Yang, Seungwon; Tian, Yu-Shun; Lee, Yun-Jung; Yu, Frank H.; Kim, Hyun-Man] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
   [Yu, Frank H.] Seoul Natl Univ, Sch Dent, Program Neurosci, Seoul 110749, South Korea.
RP Kim, HM (reprint author), Seoul Natl Univ, Lab Study Mol Biointerfaces, Dept Oral Histol & Dev Biol, Program Cell & Dev Biol,Sch Dent, Seoul 110749, South Korea.
EM hyunmkim@snu.ac.kr
OI Yu, Frank/0000-0001-9306-1731
FU Ministry for Health, Welfare & Family Affairs, Republic of Korea
   [A084359]
FX This work was supported by a research grant from the Korea Healthcare
   Technology R&D Project, Ministry for Health, Welfare & Family Affairs,
   Republic of Korea; contract grant number: A084359. The authors would
   also like to express appreciation to Ms. Hyun-Jung Kim for the
   preparation of the calcium phosphate surface, to Ms. Hye-Jung Choi for
   the confocal microscopy, and Mr. Ji-Woong Kim for FE-SEM operation.
CR Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295
   Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200
   Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308
   Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246
   Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819
   Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5
   Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X
   Guasch RM, 2003, J NEUROSCI RES, V72, P487, DOI 10.1002/jnr.10594
   HANSEN LK, 1994, MOL BIOL CELL, V5, P967
   Hong JY, 2003, BIOMATERIALS, V24, P2977, DOI 10.1016/S0142-9612(02)00121-2
   Huang S, 2002, EXP CELL RES, V275, P255, DOI 10.1006/excr.2002.5504
   Kandel ES, 2002, MOL CELL BIOL, V22, P7831, DOI 10.1128/MCB.22.22.7831-7841.2002
   Kane LP, 2003, IMMUNOL REV, V192, P7, DOI 10.1034/j.1600-065X.2003.00008.x
   Kim HM, 2000, BIOMATERIALS, V21, P1129, DOI 10.1016/S0142-9612(99)00265-3
   Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245
   Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025
   Lee YJ, 2006, BIOMATERIALS, V27, P3738, DOI 10.1016/j.biomaterials.2006.02.032
   Leyton L, 2001, CURR BIOL, V11, P1028, DOI 10.1016/S0960-9822(01)00262-7
   Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236
   Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761
   Lim JY, 2007, BIOMATERIALS, V28, P1787, DOI 10.1016/j.biomaterials.2006.12.020
   Liu Y, 2007, BIOMATERIALS, V28, P2677, DOI 10.1016/j.biomaterials.2007.02.003
   Lohez OD, 2003, J CELL BIOL, V161, P67, DOI 10.1083/jcb.200208140
   Loster K, 2001, BIOCHEM J, V356, P233, DOI 10.1042/0264-6021:3560233
   Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Morra M, 2006, EUR CELLS MATER, V12, P1
   Munoz CM, 2002, FREE RADICAL BIO MED, V33, P1061, DOI 10.1016/S0891-5849(02)00988-7
   Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577
   Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110
   Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128
   Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0
   Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013
   Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009
   Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   Tian YS, 2009, BIOCHEM BIOPH RES CO, V386, P499, DOI 10.1016/j.bbrc.2009.06.087
   Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200
   Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659
   Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000
   Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222
   Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310
   Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021
NR 47
TC 19
Z9 19
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2011
VL 32
IS 11
BP 2851
EP 2861
DI 10.1016/j.biomaterials.2011.01.015
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736BY
UT WOS:000288465800015
PM 21288570
DA 2018-10-20
ER

PT J
AU Baraniak, PR
   Nelson, DM
   Leeson, CE
   Katakam, AK
   Friz, JL
   Cress, DE
   Hong, Y
   Guan, JJ
   Wagner, WR
AF Baraniak, Priya R.
   Nelson, Devin M.
   Leeson, Cory E.
   Katakam, Anand K.
   Friz, Jennifer L.
   Cress, Dean E.
   Hong, Yi
   Guan, Jianjun
   Wagner, William R.
TI Spatial control of gene expression within a scaffold by localized
   inducer release
SO BIOMATERIALS
LA English
DT Article
DE Gene expression; Controlled release; Spatial control; Elastomer; Tissue
   engineering
ID IN-VITRO; ECDYSONE RECEPTOR; MYOCARDIAL-INFARCTION; SMOOTH-MUSCLE;
   STEM-CELLS; DELIVERY; TISSUE; THERAPY; SYSTEMS; GROWTH
AB Gene expression can be controlled in genetically modified cells by employing an inducer/promoter system where presence of the inducer molecule regulates the timing and level of gene expression. By applying the principles of controlled release, it should be possible to control gene expression on a biomaterial surface by the presence or absence of inducer release from the underlying material matrix, thus avoiding alternative techniques that rely upon uptake of relatively labile DNA from material surfaces. To evaluate this concept, a modified ecdysone-responsive gene expression system was transfected into B16 murine cells and the ability of an inducer ligand, which was released from elastomeric poly(ester urethane) urea (PEUU), to initiate gene expression was studied. The synthetic inducer ligand was first loaded into PEUU to demonstrate extended release of the bioactive molecule at various loading densities over a one year period in vitro. Patterning films of PEUU variably-loaded with inducer resulted in spatially controlled cell expression of the gene product (green fluorescent protein, GFP). In porous scaffolds made from PEUU by salt leaching, where the central region was exclusively loaded with inducer, cells expressed GFP predominately in the loaded central regions whereas expression was minimal in outer regions where ligand was omitted. This scaffold system may ultimately provide a means to precisely control progenitor cell commitment in a spatially-defined manner in vivo for soft tissue repair and regeneration. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Baraniak, Priya R.; Nelson, Devin M.; Hong, Yi; Guan, Jianjun; Wagner, William R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
   [Baraniak, Priya R.; Nelson, Devin M.; Leeson, Cory E.; Wagner, William R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA.
   [Katakam, Anand K.; Friz, Jennifer L.; Cress, Dean E.] Intrexon Corp, Blacksburg, VA 24060 USA.
RP Wagner, WR (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 450 Technol Dr,Suite 300, Pittsburgh, PA 15219 USA.
EM wagnerwr@upmc.edu
FU National Institutes of Health (NIH) [HL069368, T32-EB001026-01,
   T32-HL076124]
FX This work was supported by the National Institutes of Health (NIH) grant
   #HL069368. Dr. Baraniak and Mr. Nelson were supported by NIH training
   grants #T32-EB001026-01 and #T32-HL076124, respectively. We appreciate
   lntrexon Corporation's provision of B16 cells, RSL1, and technical
   support.
CR Alexander HK, 2007, ARCH IMMUNOL THER EX, V55, P139, DOI 10.1007/s00005-007-0025-7
   Amsden BG, 2008, EXPERT OPIN DRUG DEL, V5, P175, DOI 10.1517/17425247.5.2.175
   Baker RE, 2007, MATH BIOSCI, V209, P30, DOI 10.1016/j.mbs.2007.01.006
   Campbell PG, 2005, BIOMATERIALS, V26, P6762, DOI 10.1016/j.biomaterials.2005.04.032
   Campbell PG, 2007, EXPERT OPIN BIOL TH, V7, P1123, DOI 10.1517/14712598.7.8.1123
   Cho YW, 2004, J CONTROL RELEASE, V97, P249, DOI 10.1016/j.jconrel.2004.03.013
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Clackson T, 2000, GENE THER, V7, P120, DOI 10.1038/sj.gt.3301120
   Cress DE, 2008, EXP NEUROL, V209, P30, DOI 10.1016/j.expneurol.2007.08.015
   DELAPORTE L, 2010, ACTA BIOMATER, V6, P1889
   DeLise AM, 2002, J CELL BIOCHEM, V87, P342, DOI 10.1002/jcb.10308
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Fischbach C, 2007, BIOMATERIALS, V28, P2069, DOI 10.1016/j.biomaterials.2006.12.029
   Fujimoto KL, 2007, J AM COLL CARDIOL, V49, P2292, DOI 10.1016/j.jacc.2007.02.050
   Fujimoto KL, 2007, ANN THORAC SURG, V83, P648, DOI 10.1016/j.athoracsur.2006.06.085
   Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5
   GOVERDHANA P, 2005, MOL THER, V12, P189
   Grad S, 2003, BIOMATERIALS, V24, P5163, DOI 10.1016/S0142-9612(03)00462-9
   Guan J, 2007, J CONTROL RELEASE, V120, P70, DOI 10.1016/j.jconrel.2007.04.002
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028
   Hashizume R, 2010, BIOMATERIALS, V31, P3253, DOI 10.1016/j.biomaterials.2010.01.051
   Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269
   Hong S, 2007, LANGMUIR, V23, P12261, DOI 10.1021/la7014397
   Houchin-Ray T, 2007, BIOMATERIALS, V28, P2603, DOI 10.1016/j.biomaterials.2007.01.042
   Huang YH, 2009, CANCER RES, V69, P6184, DOI 10.1158/0008-5472.CAN-09-0061
   Jang JH, 2004, EXPERT REV MED DEVIC, V1, P127, DOI 10.1586/17434440.1.1.127
   Karzenowski D, 2005, BIOTECHNIQUES, V39, P191, DOI 10.2144/05392ST01
   KARZENOWSKI D, 2005, BIOTECHNIQUES, V39, P194
   KARZENOWSKI D, 2005, BIOTECHNIQUES, V39, P196
   Kennedy TE, 2006, J NEUROSCI, V26, P8866, DOI 10.1523/JNEUROSCI.5191-05.2006
   Kim DN, 2008, ANAL CHIM ACTA, V609, P59, DOI 10.1016/j.aca.2007.12.024
   Kumar MB, 2004, J BIOL CHEM, V279, P27211, DOI 10.1074/jbc.M403839200
   Lao LL, 2009, J BIOMED MATER RES A, V90A, P1054, DOI 10.1002/jbm.a.32171
   LAPORTE LD, 2008, MOL THER, V17, P318
   leda M, 2010, CELL, V142, P375
   Lessard J, 2007, PROSTATE, V67, P808, DOI 10.1002/pros.20559
   Li Y, 2001, BIOTECHNOL PROGR, V17, P935, DOI 10.1021/bp0100878
   Liu JB, 2004, J PHARM SCI-US, V93, P132, DOI 10.1002/jps.10533
   Makanya AN, 2005, MICROSC RES TECHNIQ, V66, P275, DOI 10.1002/jemt.20169
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Miller ED, 2006, BIOMATERIALS, V27, P2213, DOI 10.1016/j.biomaterials.2005.10.021
   Nieponice A, 2010, TISSUE ENG PT A, V16, P1215, DOI 10.1089/ten.TEA.2009.0427
   Palli SR, 2003, EUR J BIOCHEM, V270, P1308, DOI 10.1046/j.1432-1033.2003.03501.x
   Phillippi JA, 2008, STEM CELLS, V26, P127, DOI 10.1634/stemcells.2007-0520
   Raftery LA, 2003, TRENDS GENET, V19, P701, DOI 10.1016/j.tig.2003.10.009
   Rashid ST, 2008, FASEB J, V22, P2084, DOI 10.1096/fj.07-096586
   Schneider IC, 2005, J CELL BIOL, V171, P883, DOI 10.1083/jcb.200509028
   Sharifpoor S, 2009, BIOMACROMOLECULES, V10, P2729, DOI 10.1021/bm9004194
   Solomon O. F., 1962, J APPL POLYM SCI, V24, P683
   Stankus JJ, 2006, BIOMATERIALS, V27, P735, DOI 10.1016/j.biomaterials.2005.06.020
   Storrie H, 2006, ADV DRUG DELIVER REV, V58, P500, DOI 10.1016/j.addr.2006.03.004
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039
   Veitia RA, 2007, TRENDS ENDOCRIN MET, V18, P261, DOI 10.1016/j.tem.2007.08.002
   Vilaboa N, 2006, CURR GENE THER, V6, P421, DOI 10.2174/156652306777934829
   Wescoe KE, 2008, CELL BIOCHEM BIOPHYS, V52, P85, DOI 10.1007/s12013-008-9029-0
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   Wright D., 2007, J BIOMED MATER RES A, V85A, P530
   Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314
NR 61
TC 12
Z9 12
U1 0
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2011
VL 32
IS 11
BP 3062
EP 3071
DI 10.1016/j.biomaterials.2010.12.037
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 736BY
UT WOS:000288465800036
PM 21269687
OA Green Accepted
DA 2018-10-20
ER

PT J
AU Colacino, KR
   Dong, SP
   Roman, M
   Lee, YW
AF Colacino, Katelyn Rose
   Dong, Shuping
   Roman, Maren
   Lee, Yong Woo
TI Cellulose nanocrystals: a novel biomaterial for targeted drug delivery
   applications
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting 2011
CY APR 09-13, 2011
CL Washington, DC
SP Amer Assoc Anatomists (AAA), Amer Physiolog Soc (APS), Amer Soc Biochem & Mol Biol (ASBMB), Amer Soc Investigat Pathol (ASIP), Amer Soc Nutrit (ASN), Amer Soc Pharmacol & Expt Therapeut (ASPET)
C1 [Colacino, Katelyn Rose; Lee, Yong Woo] Virginia Tech, Sch Biomed Engn & Sci, Blacksburg, VA USA.
   [Dong, Shuping; Roman, Maren] Virginia Tech, Dept Wood Sci & Forest Prod, Blacksburg, VA USA.
   [Lee, Yong Woo] Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA.
NR 0
TC 1
Z9 1
U1 1
U2 6
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2011
VL 25
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 032IE
UT WOS:000310708404832
DA 2018-10-20
ER

PT J
AU Sollazzo, V
   Lucchese, A
   Palmieri, A
   Carnevali, G
   Iaccarino, C
   Zollino, I
   della Valle, M
   Pezzetti, F
   Brunelli, G
   Carinci, F
AF Sollazzo, V.
   Lucchese, A.
   Palmieri, A.
   Carnevali, G.
   Iaccarino, C.
   Zollino, I.
   della Valle, M.
   Pezzetti, F.
   Brunelli, G.
   Carinci, F.
TI CALCIUM SULFATE STIMULATES PULP STEM CELLS TOWARDS OSTEOBLASTS
   DIFFERENTIATION
SO INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LA English
DT Article
DE calcium sulfate; stem cells; biomaterial; gene expression;
   differentiation
AB Calcium sulfate (CaS) is a highly biocompatible material and enhances bone formation in vivo. However, how CaS alters osteoblast activity to promote bone formation is poorly understood. To study how CaS can induce osteoblast differentiation in mesenchymal stem cells, the expression levels of bone related genes and mesenchymal stem cells marker were compared in normal osteoblasts and dental pulp stem cells, using real time Reverse Transcription-Polymerase Chain Reaction. Gene differentially expressed between the two cells type were the trascriptional factor RUNX2, osteopontin (SPP1), COL1A1 (collagen type 1 alpha 1) and alkaline phosphatase (ALPL). The obtained results demonstrated that CaS strongly influences the behavior of DPSCs in vitro enhancing proliferation, differentiation and deposition of matrix.
C1 [Sollazzo, V.] Univ Ferrara, Orthoped Clin, I-44100 Ferrara, Italy.
   [Lucchese, A.; Palmieri, A.; Carnevali, G.; Zollino, I.; della Valle, M.; Brunelli, G.; Carinci, F.] Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, I-44100 Ferrara, Italy.
   Univ Hosp Parma, Emergency Dept, Hub & Spoke Neurosurg Unit, Parma, Italy.
   [Iaccarino, C.] Univ Bologna, CARISBO Fdn, Ctr Mol Genet, Dept Histol Embryol & Appl Biol, Bologna, Italy.
RP Carinci, F (reprint author), Univ Ferrara, Dept DMCCC, Sect Maxillofacial & Plast Surg, Corso Giovecca 203, I-44100 Ferrara, Italy.
EM crc@unife.it
RI Iaccarino, Corrado/L-3190-2013
OI Iaccarino, Corrado/0000-0002-5133-6327
FU FAR from the University of Ferrara (FC), Ferrara, Italy; Regione Emilia
   Romagna, Programma di Ricerca Regione Universita [14]; PRIN
FX This work was supported by FAR from the University of Ferrara (FC),
   Ferrara, Italy, and from Regione Emilia Romagna, Programma di Ricerca
   Regione Universita, 2007-2009, Area 1B: Patologia osteoarticolare:
   ricerca pre-clinica e applicazioni cliniche della medicina rigenerativa
   Unita Operativa n. 14, and PRIN 2008 (F.C.).
CR Alexander DI, 2001, CAN J SURG, V44, P262
   Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Boo JS, 2002, J CRANIOFAC SURG, V13, P40
   Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797
   Guarnieri R, 2002, INT J PERIODONT REST, V22, P503
   HARRIS SE, 1994, J BONE MINER RES, V9, P855
   Laino G, 2006, J CELL PHYSIOL, V206, P693, DOI 10.1002/jcp.20526
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maragos P, 2002, INT J PERIODONT REST, V22, P493
   MCKEE MD, 1993, J BONE MINER RES, V8, P485
   Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027
   Papaccio G, 2006, J CELL PHYSIOL, V208, P319, DOI 10.1002/jcp.20667
   Ricci J, 2000, BIOL MECH CALCIUM SU
   Tay BKB, 1999, ORTHOP CLIN N AM, V30, P615, DOI 10.1016/S0030-5898(05)70114-0
   TURKSEN K, 1992, J HISTOCHEM CYTOCHEM, V40, P1339, DOI 10.1177/40.9.1506671
   Ziros PG, 2008, INT J BIOCHEM CELL B, V40, P1659, DOI 10.1016/j.biocel.2007.05.024
NR 17
TC 3
Z9 3
U1 0
U2 1
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0394-6320
J9 INT J IMMUNOPATH PH
JI Int. J. Immunopathol. Pharmacol.
PD APR-JUN
PY 2011
VL 24
IS 2
SU S
BP 51
EP 57
DI 10.1177/03946320110240S210
PG 7
WC Immunology; Pathology; Pharmacology & Pharmacy
SC Immunology; Pathology; Pharmacology & Pharmacy
GA V38JH
UT WOS:000209339200010
PM 21781446
OA Bronze
DA 2018-10-20
ER

PT J
AU Ring, A
   Tilkorn, D
   Ottomann, C
   Geomelas, M
   Steinstraesser, L
   Langer, S
   Goertz, O
AF Ring, Andrej
   Tilkorn, Daniel
   Ottomann, Christian
   Geomelas, Menedimos
   Steinstraesser, Lars
   Langer, Stefan
   Goertz, Ole
TI Intravital monitoring of microcirculatory and angiogenic response to
   lactocapromer terpolymer matrix in a wound model
SO INTERNATIONAL WOUND JOURNAL
LA English
DT Article
DE Angiogenesis; Burn; Suprathel; Vascularization; Wound dressing
ID SKIN SUBSTITUTES; SUPRATHEL(R); MANAGEMENT; BURNS
AB The aim of this study was to assess the impact of an epidermal substitute, a lactocapromer terpolymer matrix, on microcirculation in wounds. Lactocapromer terpolymer matrices were placed into the dorsal skinfold chamber of mice (n = 10). Untreated chamber preparations served as controls (n = 10). The microcirculation in tissue adjacent to the implant was observed by intravital fluorescence microscopy. Alongside the stable microhaemodynamics, a strong induction of angiogenesis adjacent to the implants was observed. A progressive increase in the functional vessel density was detected throughout the observation time of 10 days. Additionally, a stable and increasing perfusion within the newly developed vascular network in the outer circumference of the matrix was noted. The lactocapromer terpolymer matrix showed no adverse effect on the microcirculation in the host tissue. In contrast, as detected by intravital microscopy, the biomaterial protected the microcirculation and induced angiogenesis.
C1 [Ring, Andrej; Tilkorn, Daniel; Steinstraesser, Lars; Langer, Stefan; Goertz, Ole] Ruhr Univ Bochum, Dept Plast & Hand Surg, Burn Ctr, BG Univ Hosp Bergmannsheil, D-44789 Bochum, Germany.
   [Ottomann, Christian] BG Trauma Hosp Berlin, Ctr Severe Burns Injuries, Berlin, Germany.
   [Geomelas, Menedimos] Klinikum Ernst Von Bergmann, Dept Plast Surg, Potsdam, Germany.
RP Ring, A (reprint author), Ruhr Univ Bochum, Dept Plast & Hand Surg, Burn Ctr, BG Univ Hosp Bergmannsheil, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.
EM andrej.ring@ruhr-uni-bochum.de
CR Bullock AJ, 2010, REGEN MED, V5, P55, DOI 10.2217/RME.09.67
   Goertz O, 2010, EUR SURG RES, V44, P96, DOI 10.1159/000276303
   Goertz Ole, 2009, Eplasty, V9, pe13
   Goertz O, 2010, ANN PLAS SURG, V64, P217, DOI 10.1097/SAP.0b013e3181a1473b
   GRUNWALD T, 2008, PLAST RECONSTR SURG, V121
   Morellini NM, 2008, WOUND REPAIR REGEN, V16, P682, DOI 10.1111/j.1524-475X.2008.00418.x
   Nolte D, 1995, INT J MICROCIRC, V15, P244, DOI 10.1159/000179025
   Ring A, 2007, EUR SURG RES, V39, P75, DOI 10.1159/000099146
   Saffle JR, 2009, CLIN PLAST SURG, V36, P627, DOI 10.1016/j.cps.2009.05.005
   Schwarze H, 2007, BURNS, V33, P850, DOI 10.1016/j.burns.2006.10.393
   Schwarze H, 2008, ANN PLAS SURG, V60, P181, DOI 10.1097/SAP.0b013e318056bbf6
   Shakespeare P, 2001, BURNS, V27, P517, DOI 10.1016/S0305-4179(01)00017-1
   Shakespeare PG, 2005, CLIN DERMATOL, V23, P413, DOI 10.1016/j.clindermatol.2004.07.015
   Singh V, 2007, ANN PLAS SURG, V59, P109, DOI 10.1097/01.sap.0000252065.90759.e6
   Steinstraesser L, 2006, ANN PLAS SURG, V56, P93, DOI 10.1097/01.sap.0000190883.30005.91
   Uhlig C, 2007, HANDCHIR MIKROCHIR P, V39, P314, DOI 10.1055/s-2007-965234
   Uhlig C, 2007, BURNS, V33, P221, DOI 10.1016/j.burns.2006.04.024
   Vogt PM, 2007, CHIRURG, V78, P335, DOI 10.1007/s00104-007-1325-5
   WASSIAK J, 2008, COCHRANE DB SYST REV, V4
NR 19
TC 3
Z9 3
U1 0
U2 1
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1742-4801
J9 INT WOUND J
JI Int. Wound J.
PD APR
PY 2011
VL 8
IS 2
BP 112
EP 117
DI 10.1111/j.1742-481X.2010.00742.x
PG 6
WC Dermatology; Surgery
SC Dermatology; Surgery
GA 735YW
UT WOS:000288457700004
PM 21306564
DA 2018-10-20
ER

PT J
AU Granito, RN
   Renno, AC
   Ravagnani, C
   Bossini, PS
   Mochiuti, D
   Jorgetti, V
   Driusso, P
   Peitl, O
   Zanotto, ED
   Parizotto, NA
   Oishi, J
AF Granito, Renata N.
   Renno, Ana Claudia
   Ravagnani, Christian
   Bossini, Paulo S.
   Mochiuti, Daniel
   Jorgetti, Vanda
   Driusso, Patricia
   Peitl, Oscar
   Zanotto, Edgar D.
   Parizotto, Nivaldo A.
   Oishi, Jorge
TI In vivo biological performance of a novel highly bioactive glass-ceramic
   (Biosilicate (R)): A biomechanical and histomorphometric study in rat
   tibial defects
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE bioactive glass and glass-ceramic; particulate biomaterial; bone
   histomorphometry; mechanical properties; animal study
ID HUMAN OSTEOBLASTS; IONIC PRODUCTS; BONE-FORMATION; MESSENGER-RNA; VITRO;
   EXPRESSION; BIOGLASS; REGENERATION; DISSOLUTION; SCAFFOLDS
AB This study aimed to investigate bone responses to a novel bioactive fully crystallized glass-ceramic of the quaternary system P2O5-Na2O-CaO-SiO2 (Biosilicates (R)). Although a previous study demonstrated positive effects of Biosilicate (R) on in vitro bone-like matrix formation, its in vivo effect was not studied yet. Male Wistar rats (n = 40) with tibial defects were used. Four experimental groups were designed to compare this novel biomaterial with a gold standard bioactive material (Bioglass (R) 45S5), unfilled defects and intact controls. A three-point bending test was performed 20 days after the surgical procedure, as well as the histomorphometric analysis in two regions of interest: cortical bone and medullary canal where the particulate biomaterial was implanted. The biomechanical test revealed a significant increase in the maximum load at failure and stiffness in the Biosilicate group (R) (vs. control defects), whose values were similar to uninjured bones. There were no differences in the cortical bone parameters in groups with bone defects, but a great deal of woven bone was present surrounding Biosilicate (R) and Bioglass (R) 45S5 particulate. Although both bioactive materials supported significant higher bone formation; Biosilicate (R) was superior to Bioglass (R) 45S5 in some histomorphometric parameters (bone volume and number of osteoblasts). Regarding bone resorption, Biosilicate (R) group showed significant higher number of osteoclasts per unit of tissue area than defect and intact controls, despite of the non-significant difference in the osteoclastic surface as percentage of bone surface. This study reveals that the fully crystallized Biosilicate (R) has good bone-forming and bone-bonding properties. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 978: 139-147, 2011.
C1 [Granito, Renata N.; Bossini, Paulo S.; Driusso, Patricia; Parizotto, Nivaldo A.] Univ Fed Sao Carlos, Dept Physiotherapy, Postgrad Program Physiotherapy, BR-13560 Sao Carlos, SP, Brazil.
   [Renno, Ana Claudia] Univ Fed Sao Paulo, Dept Biosci, Santos, SP, Brazil.
   [Ravagnani, Christian; Peitl, Oscar; Zanotto, Edgar D.] Univ Fed Sao Carlos, Dept Mat Engn, Vitreous Mat Lab, BR-13560 Sao Carlos, SP, Brazil.
   [Mochiuti, Daniel] Univ Fed Sao Carlos, Dept Physiol Sci, BR-13560 Sao Carlos, SP, Brazil.
   [Jorgetti, Vanda] Univ Sao Paulo, Sch Med, Dept Nephrol, Sao Paulo, Brazil.
   [Oishi, Jorge] Univ Fed Sao Carlos, Dept Stat, BR-13560 Sao Carlos, SP, Brazil.
RP Granito, RN (reprint author), Univ Fed Sao Carlos, Dept Physiotherapy, Postgrad Program Physiotherapy, BR-13560 Sao Carlos, SP, Brazil.
EM re_neyes@yahoo.com.br
RI JORGETTI, VANDA/C-9470-2012; Driusso, Patricia/D-8592-2012; Granito,
   Renata/F-3407-2014; Parizotto, Nivaldo/D-5347-2014; Renno, Ana
   Claudia/C-1266-2015; Bossini, Paulo/G-2333-2014; Zanotto,
   Edgar/A-7992-2011
OI JORGETTI, VANDA/0000-0002-4824-8879; Driusso,
   Patricia/0000-0001-8067-9786; Parizotto, Nivaldo/0000-0003-1774-9053;
   Zanotto, Edgar/0000-0003-4931-4505
FU Capes, Brazil
FX Authors would like to thank Keico Okino Monaka, Ph.D., from the
   Department of Physiology, Federal University of Sao Carlos. They are
   also grateful to Rosimeire Costa, for her Technical Assistance. This
   study was supported by grants from Capes, Brazil.
CR Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Dieudonne SC, 2002, BIOMATERIALS, V23, P3041, DOI 10.1016/S0142-9612(02)00068-6
   Domaschke H, 2006, TISSUE ENG, V12, P949, DOI 10.1089/ten.2006.12.949
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Hench LL, 2000, MATER RES INNOV, V3, P313, DOI 10.1007/s100190000055
   Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352
   Hench LL, 2003, GLASS TECHNOL, V44, P1
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1996, LIFE CHEM REPORTS, V13, P187
   Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610
   Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793
   MARSH JL, 2006, SURGERY, V24, P207
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Nakagawa K, 2004, TISSUE ENG, V10, P93, DOI 10.1089/107632704322791736
   Nandi SK, 2009, RES VET SCI, V86, P162, DOI 10.1016/j.rvsc.2008.04.008
   Olivera MI, 2009, ARCH ORAL BIOL, V54, P6, DOI 10.1016/j.archoralbio.2008.08.004
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PEITL O, 1995, THESIS
   Reilly GC, 2007, BIOMATERIALS, V28, P4091, DOI 10.1016/j.biomaterials.2007.05.038
   Vallet-Regi M, 2001, J CHEM SOC DALTON, P97, DOI 10.1039/b007852m
   Vargas GE, 2009, ACTA BIOMATER, V5, P374, DOI 10.1016/j.actbio.2008.07.016
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   ZANOTTO ED, 2004, Patent No. 2004074199
NR 28
TC 28
Z9 29
U1 0
U2 13
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD APR
PY 2011
VL 97B
IS 1
BP 139
EP 147
DI 10.1002/jbm.b.31795
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 735KT
UT WOS:000288413900016
PM 21290592
DA 2018-10-20
ER

PT J
AU Walschus, U
   Hoene, A
   Kochanowski, A
   Neukirch, B
   Patrzyk, M
   Wilhelm, L
   Schroder, K
   Schlosser, M
AF Walschus, U.
   Hoene, A.
   Kochanowski, A.
   Neukirch, B.
   Patrzyk, M.
   Wilhelm, L.
   Schroeder, K.
   Schlosser, M.
TI Quantitative immunohistochemical examination of the local cellular
   reactions following implantation of biomaterials
SO JOURNAL OF MICROSCOPY
LA English
DT Article
DE Biomaterials; digital image analysis; immunohistochemistry; implantation
ID MACROPHAGE ACTIVATION; TISSUE-RESPONSE; IN-VIVO; TITANIUM; SECRETION
AB P>Examining the biocompatibility of implant materials includes the in vivo investigation of the local tissue response following implantation in experimental animals. By contrast to qualitative and semi-quantitative approaches often used in this field, a quantitative technique would facilitate a more accurate determination and better comparability of different studies. Therefore, this study aimed at evaluating the applicability of the free image analysis software ImageJ for fast, easy and reproducible quantification of the tissue response following implantation of titanium samples in rats with subsequent immunohistochemical examination of peri-implant tissue samples for monocytes and macrophages (ED1) and MHC class II positive antigen presenting cells (OX6). The quantification of positively stained cells in the vicinity of the implant pockets was based on a grid-supported manual count carried out using two ImageJ plugins (CellCounter, Grid) and resulted in a mean coefficient of variation of 13.8% (ED1) and 19.6% (OX6) between different investigators and 10.0% (ED1) and 13.8% (OX6) for repeated counting by the same investigator. In conclusion, ImageJ was found to be suitable for morphometric evaluation of the tissue response following implantation, particularly the analysis of discrete cellular events at the tissue-biomaterial interface. The procedure which was used is described in detail, and its advantages and disadvantages are discussed.
C1 [Walschus, U.; Kochanowski, A.; Neukirch, B.; Schlosser, M.] Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Res Grp Predict Diagnost, D-17495 Karlsburg, Germany.
   [Hoene, A.; Patrzyk, M.] Ernst Moritz Arndt Univ Greifswald, Dept Surg, D-17495 Karlsburg, Germany.
   [Wilhelm, L.] Hosp Demmin, Dept Surg, Demmin, Germany.
   [Schroeder, K.] Leibniz Inst Plasma Sci & Technol INP, Greifswald, Germany.
RP Schlosser, M (reprint author), Ernst Moritz Arndt Univ Greifswald, Dept Med Biochem & Mol Biol, Res Grp Predict Diagnost, Greifswalder Str 11C, D-17495 Karlsburg, Germany.
EM schlosse@uni-greifswald.de
OI Walschus, Uwe/0000-0001-9368-8315
FU Federal state of Mecklenburg-Vorpommern; Helmholtz Association of German
   Research Centres [VII-MV1]; Federal Ministry of Education and Research
   [13N9779]
FX We are grateful to Kirsten Tornow for excellent technical support. This
   study was supported by the Federal state of Mecklenburg-Vorpommern and
   the Helmholtz Association of German Research Centres (grant no. VII-MV1)
   and by the Federal Ministry of Education and Research (grant no.
   13N9779, Campus PlasmaMed).
CR ANDERSON JM, 1993, CARDIOVASC PATHOL, V2, pS33
   Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264
   Burugapalli K, 2004, J BIOMED MATER RES A, V68A, P210, DOI 10.1002/jbm.a.10117
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
   Hunt JA, 1996, J BIOMED MATER RES, V31, P139, DOI 10.1002/(SICI)1097-4636(199605)31:1<139::AID-JBM15>3.0.CO;2-I
   Marchisio M, 2005, J BIOMED MATER RES B, V75B, P251, DOI 10.1002/jbm.b.30287
   Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692
   MCMASTER WR, 1979, EUR J IMMUNOL, V9, P426, DOI 10.1002/eji.1830090603
   Pesskova V, 2007, J MATER SCI-MATER M, V18, P465
   Pribila JT, 2004, ANNU REV IMMUNOL, V22, P157, DOI 10.1146/annurev.immunol.22.012703.104649
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Schroder K, 2010, J ADHES SCI TECHNOL, V24, P1191, DOI 10.1163/016942409X12619870771501
   Suska F, 2005, BIOMATERIALS, V26, P519, DOI 10.1016/j.biomaterials.2004.02.066
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   WALSCHUS U, 2008, ACTA BIOMATER, V5, P776
   WILLIAMS DF, 1989, J BIOMED ENG, V11, P185, DOI 10.1016/0141-5425(89)90138-6
   Zippel R, 2006, MICROSC MICROANAL, V12, P366, DOI 10.1017/S1431927606060545
NR 18
TC 7
Z9 7
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc..
PD APR
PY 2011
VL 242
IS 1
BP 94
EP 99
DI 10.1111/j.1365-2818.2010.03445.x
PG 6
WC Microscopy
SC Microscopy
GA 734XZ
UT WOS:000288377600011
PM 21118237
OA Bronze
DA 2018-10-20
ER

PT J
AU Jo, YJ
   Kim, KH
   Koo, KT
   Kim, TI
   Seol, YJ
   Lee, YM
   Ku, Y
   Chung, CP
   Rhyu, IC
AF Jo, Young-Jae
   Kim, Kyoung-Hwa
   Koo, Ki-Tae
   Kim, Tae-Il
   Seol, Yang-Jo
   Lee, Yong-Moo
   Ku, Young
   Chung, Chong-Pyoung
   Rhyu, In-Chul
TI Initial adhesion of bone marrow stromal cells to various bone graft
   substitutes
SO JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE
LA English
DT Article
DE Bone substitutes; Cell adhesion; Fibronectins; Stem cells
AB Purpose: The aim of this study is to determine whether certain biomaterials have the potential to support cell attachment. After seeding bone marrow stromal cells onto the biomaterials, we investigated their responses to each material in vitro.
   Methods: Rat bone marrow derived stromal cells were used. The biomaterials were deproteinized bovine bone mineral (DBBM), DBBM coated with fibronectin (FN), synthetic hydroxyapatite (HA), HA coated with FN, HA coated with beta-tricalcium phosphate (TCP), and pure beta-TCP. With confocal laser scanning microscopy, actin filaments and vinculin were observed after 6, 12, and 24 hours of cell seeding. The morphological features of cells on each biomaterial were observed using scanning electron microscopy at day 1 and 7.
   Results: The cells on HA/ FN and HA spread widely and showed better defined actin cytoskeletons than those on the other biomaterials. At the initial phase, FN seemed to have a favorable effect on cell adhesion. In DBBM, very few cells adhered to the surface.
   Conclusions: Within the limitations of this study, we can conclude that in contrast with DBBM not supporting cell attachment, HA provided a more favorable environment with respect to cell attachment.
C1 [Jo, Young-Jae; Kim, Kyoung-Hwa; Koo, Ki-Tae; Kim, Tae-Il; Seol, Yang-Jo; Lee, Yong-Moo; Ku, Young; Chung, Chong-Pyoung; Rhyu, In-Chul] Seoul Natl Univ, Sch Dent, Dept Periodontol, Seoul, South Korea.
RP Rhyu, IC (reprint author), Seoul Natl Univ, Dent Hosp, Sch Dent, Dept Periodontol, 275-1 Yeongeon Dong, Seoul 110768, South Korea.
EM icrhyu@snu.ac.kr
OI KIM, TAE-IL/0000-0003-4087-8021; Seol, Yang-Jo/0000-0002-2076-5452; Ku,
   Young/0000-0001-5682-0604
FU National Research Foundation of Korea - Government of the Republic of
   Korea [2008-E00580]
FX This work was supported by a National Research Foundation of Korea Grant
   funded by the Government of the Republic of Korea (2008-E00580).
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Brodie JC, 2005, J BIOMED MATER RES A, V73A, P409, DOI 10.1002/jbm.a.30279
   Burmeister JS, 1996, J BIOMED MATER RES, V30, P13, DOI 10.1002/(SICI)1097-4636(199601)30:1<13::AID-JBM3>3.0.CO;2-U
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Carmagnola D, 2003, CLIN ORAL IMPLAN RES, V14, P137, DOI 10.1034/j.1600-0501.2003.140201.x
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Grzesik WJ, 1998, J DENT RES, V77, P1606, DOI 10.1177/00220345980770080801
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   Herten M, 2009, CLIN ORAL INVEST, V13, P149, DOI 10.1007/s00784-008-0214-8
   Ignjatovic N, 2006, MICROSC RES TECHNIQ, V69, P976, DOI 10.1002/jemt.20374
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Kubler Alexander, 2004, Implant Dent, V13, P171
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marino G, 2010, J MATER SCI-MATER M, V21, P353, DOI 10.1007/s10856-009-3840-z
   OHGUSHI H, 1990, J BIOMED MATER RES, V24, P1563, DOI 10.1002/jbm.820241202
   Okumura A, 2001, BIOMATERIALS, V22, P2263, DOI 10.1016/S0142-9612(00)00415-4
   Petrovic L, 2006, INT J ORAL MAX IMPL, V21, P225
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Stephan EB, 1999, J PERIODONTOL, V70, P364, DOI 10.1902/jop.1999.70.4.364
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Turhani D, 2005, INT J ORAL MAX SURG, V34, P543, DOI 10.1016/j.ijom.2004.10.023
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   Wiedmann-Al-Ahmad M, 2005, J MATER SCI-MATER M, V16, P57, DOI 10.1007/s10856-005-6447-z
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Zitzmann N U, 2001, Int J Periodontics Restorative Dent, V21, P288
NR 30
TC 5
Z9 5
U1 0
U2 1
PU KOREAN ACAD PERIODONTOLOGY
PI SEOUL
PA OFFICIAL B-D 2212, 163 SINMUNRO 1-GA, JONGNO-GU, SEOUL, 110-990, SOUTH
   KOREA
SN 2093-2278
EI 2093-2286
J9 J PERIODONTAL IMPLAN
JI J. Periodontal Implant Sci.
PD APR
PY 2011
VL 41
IS 2
BP 67
EP 72
DI 10.5051/jpis.2011.41.2.67
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA V34GM
UT WOS:000209074900004
PM 21556256
OA Green Published, Other Gold
DA 2018-10-20
ER

PT J
AU Ye, Q
   van Amerongen, MJ
   Sandham, JA
   Bank, RA
   van Luyn, MJA
   Harmsen, MC
AF Ye, Q.
   van Amerongen, M. J.
   Sandham, J. A.
   Bank, R. A.
   van Luyn, M. J. A.
   Harmsen, M. C.
TI Site-specific tissue inhibitor of metalloproteinase-1 governs the matrix
   metalloproteinases-dependent degradation of crosslinked collagen
   scaffolds and is correlated with interleukin-10
SO JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE
LA English
DT Article
DE matrix metalloproteinase; tissue inhibitors of metalloproteinase;
   interleukin-10; foreign body reaction; degradation; collagen scaffold
ID FOREIGN-BODY REACTION; REGENERATIVE MEDICINE; EXTRACELLULAR-MATRIX;
   PROPEPTIDE DOMAIN; IFN-GAMMA; IN-VITRO; ACTIVATION; CYTOKINE; RATS;
   EXPRESSION
AB We have previously shown that the foreign body reaction (FBR) against crosslinked collagen type I (Col-I) differs between subcutaneous and epicardial implantation sites; Col-I was quickly degraded epicardially, whereas degradation was attenuated subcutaneously. The current study set out to dissect the nature and regulation of the MMP-based degradation of implanted Col-I in mice during the FBR. Immunohistochemistry showed that MMP-2, MMP-8 and MMP-13 were present in subcutaneous and epicardial implants, whereas only MMP-9 was also present epicardially. Western blotting showed that MMP-8 and MMP-9 were mainly present in their inactive proform. In contrast, collagenase MMP-13 and gelatinase MMP-2 were the predominant active MMPs at both sites. Interestingly, the major MMP inhibitor TIMP-1 was solely observed in subcutaneous implants, which is why MMP-13 and MMP-2 are not able to degrade the collagen scaffold at the subcutaneous implantation site. Interleukin 10 (IL-10), a potent inducer of TIMP-1 expression, was also mainly detected subcutaneously; giant cells were the main source. Therefore, we surmise that IL-10, through regulation of the balance between MMPs and TIMP-1, suppresses the FBR against implanted biomaterials. Together, our findings would provide cues and clues to improve future therapies in regenerative medicine that are based on the tuned regulation of the degradation of biomaterial scaffolds. Copyright (C) 2010 John Wiley & Sons, Ltd.
C1 [Ye, Q.] Univ Groningen, Dept Orthodont, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands.
   [Ye, Q.; van Amerongen, M. J.; Bank, R. A.; van Luyn, M. J. A.; Harmsen, M. C.] Univ Groningen, Stem Cell & Tissue Engn Res Grp, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands.
RP Ye, Q (reprint author), Univ Groningen, Dept Orthodont, Univ Med Ctr Groningen, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands.
EM qingsongye@hotmail.com; m.c.harmsen@med.umcg.nl
OI Ye, Qingsong/0000-0002-2868-9247
FU RuG Jan Kornelis de Cock-Stiching [De-Cock-08-69]
FX This study was supported by RuG Jan Kornelis de Cock-Stiching for Q. Ye
   (Grant No. De-Cock-08-69). The authors wish to acknowledge the excellent
   technical support of Dr Ben Stulp, Mrs Marja Brinker, Mrs Linda Brouwer
   and Mr Xavier Gallego y van Seijen.
CR Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763
   Cao J, 2005, J BIOL CHEM, V280, P10974, DOI 10.1074/jbc.M412370200
   Cao J, 1998, J BIOL CHEM, V273, P34745, DOI 10.1074/jbc.273.52.34745
   Cao J, 1999, ANN NY ACAD SCI, V878, P710, DOI 10.1111/j.1749-6632.1999.tb07769.x
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   Hedrick MH, 2003, CLIN PLAST SURG, V30, P499, DOI 10.1016/S0094-1298(03)00068-3
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783
   Jones JA, 2008, J BIOMED MATER RES A, V84A, P158, DOI 10.1002/jbm.a.31220
   Khouw IMSL, 1998, J BIOMED MATER RES, V41, P202, DOI 10.1002/(SICI)1097-4636(199808)41:2<202::AID-JBM4>3.0.CO;2-M
   Khouw IMSL, 2000, J BIOMED MATER RES, V49, P297, DOI 10.1002/(SICI)1097-4636(20000305)49:3<297::AID-JBM1>3.0.CO;2-0
   Kyriakides TR, 2004, AM J PATHOL, V165, P2157, DOI 10.1016/S0002-9440(10)63265-8
   Kyriakides TR, 2003, THROMB HAEMOSTASIS, V90, P986, DOI 10.1160/TH03-06-0399
   LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286
   Luttikhuizen DT, 2007, J TISSUE ENG REGEN M, V1, P398, DOI 10.1002/term.50
   Luttikhuizen DT, 2006, BIOMATERIALS, V27, P5763, DOI 10.1016/j.biomaterials.2006.07.004
   Luttikhuizen DT, 2006, TISSUE ENG, V12, P1955, DOI 10.1089/ten.2006.12.1955
   Mason C, 2007, Med Device Technol, V18, P25
   Mather ML, 2007, REGEN MED, V2, P145, DOI 10.2217/174607451.2.2.145
   Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949
   MOSTAFA ME, 2001, CARDIOVASC RES, V49, P882
   Munirah S, 2008, EUR CELLS MATER, V15, P41, DOI 10.22203/eCM.v015a04
   Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491
   Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9
   Paquette Jean-Sebastien, 2004, Eur Cell Mater, V7, P1
   Petersen T, 2007, BIOMATERIALS, V28, P3751, DOI 10.1016/j.biomaterials.2007.05.012
   Popi AF, 2004, IMMUNOLOGY, V113, P348, DOI 10.1111/j.1365-2567.2004.01969.x
   Rivron NC, 2008, EUR CELLS MATER, V15, P27, DOI 10.22203/eCM.v015a03
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sachlos E, 2006, TISSUE ENG, V12, P2479, DOI 10.1089/ten.2006.12.2479
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463
   STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331
   Tai HY, 2007, EUR CELLS MATER, V14, P64, DOI 10.22203/eCM.v014a07
   Tziakas DN, 2003, INT J CARDIOL, V92, P169, DOI 10.1016/S0167-5273(03)00084-6
   van Amerongen MJ, 2006, BIOMATERIALS, V27, P2247, DOI 10.1016/j.biomaterials.2005.11.002
   Wahl DA, 2007, J MATER SCI-MATER M, V18, P201, DOI 10.1007/s10856-006-0682-9
NR 37
TC 7
Z9 7
U1 0
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1932-6254
J9 J TISSUE ENG REGEN M
JI J. Tissue Eng. Regen. Med.
PD APR
PY 2011
VL 5
IS 4
BP 264
EP 274
DI 10.1002/term.311
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology; Engineering, Biomedical
SC Cell Biology; Biotechnology & Applied Microbiology; Engineering
GA 737HD
UT WOS:000288558800008
PM 20661871
DA 2018-10-20
ER

PT J
AU Lee, KW
   Wang, YD
AF Lee, Kee-Won
   Wang, Yadong
TI Elastomeric PGS Scaffolds in Arterial Tissue Engineering
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Bioengineering; Issue 50; blood vessel; tissue engineering; bioreactor;
   smooth muscle cell
AB Cardiovascular disease is one of the leading cause of mortality in the US and especially, coronary artery disease increases with an aging population and increasing obesity(1). Currently, bypass surgery using autologous vessels, allografts, and synthetic grafts are known as a commonly used for arterial substitutes(2). However, these grafts have limited applications when an inner diameter of arteries is less than 6 mm due to low availability, thrombotic complications, compliance mismatch, and late intimal hyperplasia(3,4). To overcome these limitations, tissue engineering has been successfully applied as a promising alternative to develop small-diameter arterial constructs that are nonthrombogenic, robust, and compliant. Several previous studies have developed small-diameter arterial constructs with tri-lamellar structure, excellent mechanical properties and burst pressure comparable to native arteries(5,6). While high tensile strength and burst pressure by increasing collagen production from a rigid material or cell sheet scaffold, these constructs still had low elastin production and compliance, which is a major problem to cause graft failure after implantation. Considering these issues, we hypothesized that an elastometric biomaterial combined with mechanical conditioning would provide elasticity and conduct mechanical signals more efficiently to vascular cells, which increase extracellular matrix production and support cellular orientation.
   The objective of this report is to introduce a fabrication technique of porous tubular scaffolds and a dynamic mechanical conditioning for applying them to arterial tissue engineering. We used a biodegradable elastomer, poly (glycerol sebacate) (PGS) 7 for fabricating porous tubular scaffolds from the salt fusion method. Adult primary baboon smooth muscle cells (SMCs) were seeded on the lumen of scaffolds, which cultured in our designed pulsatile flow bioreactor for 3 weeks. PGS scaffolds had consistent thickness and randomly distributed macro-and micro-pores. Mechanical conditioning from pulsatile flow bioreactor supported SMC orientation and enhanced ECM production in scaffolds. These results suggest that elastomeric scaffolds and mechanical conditioning of bioreactor culture may be a promising method for arterial tissue engineering.
C1 [Lee, Kee-Won; Wang, Yadong] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.
   [Wang, Yadong] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15260 USA.
RP Wang, YD (reprint author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.
EM yaw20@pitt.edu
OI Lee, Kee-Won/0000-0002-1571-276X; Wang, Yadong/0000-0003-2067-382X
FU National Institutes of Health [R01 HL089658]
FX The author thanks Dr. Jin Gao for PGS synthesis, Dr. Peter Crapo for
   insightful discussion for bioreactor setup, Drs. Mohamed Ezzelarab and
   Wei Wu for explanting baboon carotid arteries. This study was supported
   by a grant from the National Institutes of Health (R01 HL089658).
CR Conte MS, 1998, FASEB J, V12, P43
   Crapo PM, 2008, J BIOMED MATER RES A, V86A, P354, DOI 10.1002/jbm.a.31598
   Gao J, 2006, TISSUE ENG, V12, P917, DOI 10.1089/ten.2006.12.917
   Gao J, 2007, J BIOMED MATER RES A, V83A, P1070, DOI 10.1002/jbm.a.31434
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   L'Heureux N, 1998, FASEB J, V12, P47
   LEUNG DYM, 1976, SCIENCE, V191, P475
   Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nieponice A, 2008, BIOMATERIALS, V29, P825, DOI 10.1016/j.biomaterials.2007.10.044
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Stankus JJ, 2007, BIOMATERIALS, V28, P2738, DOI 10.1016/j.biomaterials.2007.02.012
   Wang XW, 2007, WORLD J SURG, V31, P682, DOI 10.1007/s00268-006-0731-z
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   WILSON E, 1993, J CELL BIOL, V123, P741, DOI 10.1083/jcb.123.3.741
   Yang J, 2005, TISSUE ENG, V11, P1876, DOI 10.1089/ten.2005.11.1876
NR 17
TC 1
Z9 1
U1 0
U2 24
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2011
IS 50
AR e2691
DI 10.3791/2691
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V36LZ
UT WOS:000209214700041
PM 21505410
OA Green Published, Bronze
DA 2018-10-20
ER

PT J
AU Yue, TM
   Huang, KJ
AF Yue, T. M.
   Huang, K. J.
TI Laser Forming of Zr-Based Coatings on AZ91D Magnesium Alloy Substrates
   for Wear and Corrosion Resistance Improvement
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE laser processing; magnesium; biomaterial; zirconium coating; wear;
   corrosion
AB To improve the wear and corrosion resistance of AZ91D magnesium alloy. Zr-based coatings were fabricated on the alloy substrate using laser forming. They were prepared from (i) Zr+Mg powders (5 : 1 mass%), and (ii) an undercoating of Zr+Mg powders (5 : 1 mass%) with a top layer of Zr powder. The Zr+Mg powder coating was found to consist primarily of Zr particles with some Zr-based intermetallic compounds in a Mg-Al matrix; while that with an extra top coating of Zr powder had an outer layer composed of Zr oxides and Zr aluminides. With regard to wear and corrosion resistance, the highest improvement was obtained for the specimen that was clad with a top layer of Zr powder. Compared to the AZ91D specimen without a laser formed coating, a fivefold decrease in weight loss and around three orders of magnitude decrease in corrosion current density respectively were obtained. [doi:10.2320/matertrans.M2010274]
C1 [Yue, T. M.; Huang, K. J.] Hong Kong Polytech Univ, Adv Mfg Technol Res Ctr, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
RP Yue, TM (reprint author), Hong Kong Polytech Univ, Adv Mfg Technol Res Ctr, Dept Ind & Syst Engn, Hong Kong, Hong Kong, Peoples R China.
OI YUE, Tai Man/0000-0001-9380-5067
FU Research Grants Council of the Hong Kong Special Administrative Region,
   China [PolyU 5345/08E]
FX The work was substantially supported by the Research Grants Council of
   the Hong Kong Special Administrative Region, China (Project No. PolyU
   5345/08E). The authors also would like to thank the Hong Kong
   Polytechnic University and Huazhong University of Science and Technology
   for providing facilities for this research work.
CR ASM International, 1992, ASM HDB, V3
   Han Y, 2009, J BIOMED MATER RES A, V88A, P117, DOI 10.1002/jbm.a.31859
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Jacobs JJ, 2003, CLIN ORTHOP RELAT R, P139, DOI 10.1097/01.blo.0000096810.78689.62
   Lambotte A., 1932, B MEM SOC NAT CHIR, V28, P1325
   LENZ U, 1998, P MAGN ALL THEIR APP, P445
   Namgung S, 2010, KOREAN J MET MATER, V48, P813, DOI 10.3365/KJMM.2010.48.09.813
   Nguyen-Manh D, 1999, INTERMETALLICS, V7, P1095, DOI 10.1016/S0966-9795(99)00040-0
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Teoh S. H., 2004, ENG MAT BIOMEDICAL A
   Tsutsumi Y, 2010, ACTA BIOMATER, V6, P4161, DOI 10.1016/j.actbio.2010.05.010
   Witte F, 2007, BIOMATERIALS, V28, P2163, DOI 10.1016/j.biomaterials.2006.12.027
   Xue L, 2000, J LASER APPL, V12, P160, DOI 10.2351/1.521927
   Zhang E, 2005, SCRIPTA MATER, V53, P523, DOI 10.1016/j.scriptamat.2005.05.009
NR 15
TC 4
Z9 4
U1 1
U2 21
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD APR
PY 2011
VL 52
IS 4
SI SI
BP 810
EP 813
DI 10.2320/matertrans.M2010274
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 785KH
UT WOS:000292227400042
OA Bronze
DA 2018-10-20
ER

PT J
AU Yamamoto, K
   Kimura, T
   Nam, K
   Funamoto, S
   Ito, Y
   Shiba, K
   Katoh, A
   Shimizu, S
   Kurita, K
   Higami, T
   Masuzawa, T
   Kishida, A
AF Yamamoto, Kenji
   Kimura, Tsuyoshi
   Nam, Kwangwoo
   Funamoto, Seiichi
   Ito, Yukiko
   Shiba, Kumiko
   Katoh, Ayako
   Shimizu, Shigeru
   Kurita, Kimio
   Higami, Tetsuya
   Masuzawa, Toru
   Kishida, Akio
TI Synthetic polymer-tissue adhesion using an ultrasonic scalpel
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article
DE Adhesions; Coagulation; Harmonic Scalpel; Polymer; Tissue; Vascular
   (blood vessels)
ID COLLAGEN; SURGERY; GLUE
AB Interface phenomena such as encapsulation and formation of dead space around implanted biomaterials lower biomaterial performance. To advance tissue adhesive technology, understanding the interactions between tissue (collagen) and polymer is indispensable. Adhesion between tissue and polymer was studied using an ultrasonically activated scalpel (UAS).
   The Harmonic Scalpel was used as an ultrasonically activated scalpel for polymer and tissue adhesion. A piece of porcine aorta and a polymeric film were layered and placed between the blades of the Harmonic Scalpel. Then the samples were gripped with 20 kgf of force for 1-10 s to adhere the porcine aorta and polymeric films. The adhesion was characterized by macro- and microscopic observation, thermographic analysis, and measurement of bonding strength, static contact angle (SCA), and surface properties.
   Cellulose, vinylon, polyethylene telephthalate, nylon, and Pellethane(A (R)) could be bonded to the aorta. Bonding was not observed for the polyethylene, polypropylene, polyvinyl chloride, or polytetrafluoroethylene. This suggests that the existence of functional groups such as hydroxyl, carbonyl, carboxyl, and amide groups in the polymer structure are key factors in adhesion. Harmonic Scalpel modification of the polyethylene surface during corona discharge treatment further indicated that the functional groups of the polymers are one of the essential factors for tissue adhesion. The temperatures of adhesion were 90-150A degrees C for the polymers, and the melting temperatures (Tm) were 193-306A degrees C. This suggests that adhesion was formed by the interaction between the melted polymer surface and the tissue collagen.
   Both polar functional groups and adequate thermal characteristics are necessary for polymers to bond with tissues. These findings should be useful for the development of novel polymers that can be bonded to living tissues with UAS treatment, which can be applied for endoscopic surgery.
C1 [Katoh, Ayako; Masuzawa, Toru] Ibaraki Univ, Fac Engn, Hitachi, Ibaraki 3068511, Japan.
   [Higami, Tetsuya] Sapporo Med Univ, Dept Thorac & Cardiac Surg, Sapporo, Hokkaido, Japan.
   [Kimura, Tsuyoshi; Nam, Kwangwoo; Funamoto, Seiichi; Ito, Yukiko; Kishida, Akio] JST CREST, Tokyo, Japan.
   [Kimura, Tsuyoshi; Nam, Kwangwoo; Funamoto, Seiichi; Ito, Yukiko; Shiba, Kumiko; Kishida, Akio] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan.
   [Yamamoto, Kenji; Shimizu, Shigeru; Kurita, Kimio] Nihon Univ, Coll Sci & Technol, Tokyo 101, Japan.
RP Masuzawa, T (reprint author), Ibaraki Univ, Fac Engn, 4-12-1 Nakanarusawa Chyou, Hitachi, Ibaraki 3068511, Japan.
EM masuzawa.mx@ibaraki.ac.jp; kishida.fm@tmd.ac.jp
RI Nam, Kwangwoo/E-1540-2011
FU Health and Labour Sciences Research Grants; Ministry of Health, Labour,
   and Welfare, Japan; Core Research for Evolutional Science and Technology
   (CREST) of the Japan Science and Technology Agency (JST)
FX This study was supported partially by research on medical devices for
   analyzing, supporting, and substituting the function of the human body;
   Health and Labour Sciences Research Grants; and the Ministry of Health,
   Labour, and Welfare, Japan. This work also was supported partly by Core
   Research for Evolutional Science and Technology (CREST) of the Japan
   Science and Technology Agency (JST).
CR *AICELLO CHEM CO L, VIN FILM
   ALEJANDRA G, 2009, J AAPOS, V13, P357
   Basterra J, 2006, OTOLARYNG HEAD NECK, V135, P933, DOI 10.1016/j.otohns.2006.07.030
   EMAM TA, 2003, ANN SURG, V237, P186
   Foschi D, 2002, SURG ENDOSC, V16, P814, DOI 10.1007/s00464-001-9074-x
   Higami T, 2000, J THORAC CARDIOV SUR, V120, P1142, DOI 10.1067/mtc.2000.110189
   IWATA H, 1988, J POLYM SCI POL CHEM, V26, P3309, DOI 10.1002/pola.1988.080261216
   Katoh A, 2010, MED ENG PHYS, V32, P304, DOI 10.1016/j.medengphy.2009.12.005
   Kinoshita T, 1999, SURG ENDOSC-ULTRAS, V13, P621, DOI 10.1007/s004649901055
   Massarweh NN, 2006, J AM COLL SURGEONS, V202, P520, DOI 10.1016/j.jamcollsurg.2005.11.017
   *MATWEB MAT PROP D, PELL TECHN DAT SHEET
   Srinivasan S, 2009, BRIT J OPHTHALMOL, V93, P215, DOI 10.1136/bjo.2008.145516
   Taguchi T, 2006, MAT SCI ENG C-BIO S, V26, P9, DOI 10.1016/j.msec.2005.03.006
   Taguchi T, 2004, MAT SCI ENG C-BIO S, V24, P775, DOI 10.1016/j.msec.2004.08.037
   WILLIAM L, 2009, SURG ENDOSC, V23, P90
   YAMAMOTO K, 1986, SOC POLYM SCI JAPAN, P511
NR 16
TC 6
Z9 6
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0930-2794
EI 1432-2218
J9 SURG ENDOSC
JI Surg. Endosc.
PD APR
PY 2011
VL 25
IS 4
BP 1270
EP 1275
DI 10.1007/s00464-010-1357-7
PG 6
WC Surgery
SC Surgery
GA 735WO
UT WOS:000288451500043
PM 20927542
DA 2018-10-20
ER

PT J
AU Peng, HF
   Liu, JY
   Andreadis, ST
   Swartz, DD
AF Peng, Hao-Fan
   Liu, Jin Yu
   Andreadis, Stelios T.
   Swartz, Daniel D.
TI Hair Follicle-Derived Smooth Muscle Cells and Small Intestinal Submucosa
   for Engineering Mechanically Robust and Vasoreactive Vascular Media
SO TISSUE ENGINEERING PART A
LA English
DT Article
ID BLOOD-VESSELS; PROGENITOR CELLS; AORTIC TISSUE; STEM-CELLS; GRAFTS;
   CONTAMINATION; EQUIVALENTS; SCAFFOLDS; MATRIX; VIVO
AB Our laboratory recently reported a new source of smooth muscle cells (SMCs) derived from hair follicle (HF) mesenchymal stem cells. HF-SMCs demonstrated high proliferation and clonogenic potential as well as contractile function. In this study, we aimed at engineering the vascular media using HF-SMCs and a natural biomaterial, namely small intestinal submucosa (SIS). Engineering functional vascular constructs required application of mechanical force, resulting in actin reorganization and cellular alignment. In turn, cell alignment was necessary for development of receptor-and nonreceptor-mediated contractility as soon as 24 h after cell seeding. Within 2 weeks in culture, the cells migrated into SIS and secreted collagen and elastin, the two major extracellular matrix components of the vessel wall. At 2 weeks, vascular reactivity increased significantly up to three-to fivefold and mechanical properties were similar to those of native ovine arteries. Taken together, our data demonstrate that the combination of HF-SMCs with SIS resulted in mechanically strong, biologically functional vascular media with potential for arterial implantation.
C1 [Swartz, Daniel D.] SUNY Buffalo, Womens & Childrens Hosp, Dept Pediat, Amherst, NY 14260 USA.
   [Peng, Hao-Fan; Liu, Jin Yu; Andreadis, Stelios T.] SUNY Buffalo, Dept Chem & Biol Engn, Bioengn Lab, Amherst, NY 14260 USA.
   SUNY Buffalo, Womens & Childrens Hosp, Ctr Excellence Bioinformat & Life Sci, Amherst, NY 14260 USA.
   [Andreadis, Stelios T.] SUNY Buffalo, Womens & Childrens Hosp, Dept Biomed Engn, Amherst, NY 14260 USA.
RP Swartz, DD (reprint author), SUNY Buffalo, Womens & Childrens Hosp, Dept Pediat, Amherst, NY 14260 USA.
EM sandread@buffalo.edu; swartzda@buffalo.edu
OI Swartz, Daniel/0000-0003-1674-1527
FU National Institutes of Health [R01 HL086582]; New York State Stem Cell
   Science (NYSTEM) [C024316]
FX This work was supported by grants from the National Institutes of Health
   (R01 HL086582) and the New York State Stem Cell Science (NYSTEM Contract
   No. C024316) to S.T. Andreadis and D.D. Swartz. The authors thank Evan
   Schlaich for help with histology and immunostaining.
CR ABBOTT WM, 1987, J VASC SURG, V5, P376, DOI 10.1067/mva.1987.avs0050376
   Bader A, 2000, TRANSPLANTATION, V70, P7
   Flavahan NA, 2005, AM J PHYSIOL-HEART C, V288, pH660, DOI 10.1152/ajpheart.00608.2004
   Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908
   Gaudino M, 2005, CIRCULATION, V112, pI265, DOI 10.1161/CIRCULATIONAHA.104.512905
   Gong ZD, 2006, TRENDS CARDIOVAS MED, V16, P153, DOI 10.1016/j.tcm.2006.02.006
   Grenier G, 2005, TISSUE ENG, V11, P90, DOI 10.1089/ten.2005.11.90
   Gui LQ, 2009, TISSUE ENG PT A, V15, P2665, DOI [10.1089/ten.tea.2008.0526, 10.1089/ten.TEA.2008.0526]
   Heise RL, 2009, TISSUE ENG PT A, V15, P3951, DOI [10.1089/ten.tea.2009.0044, 10.1089/ten.TEA.2009.0044]
   Hoogduijn MJ, 2006, STEM CELLS DEV, V15, P49, DOI 10.1089/scd.2006.15.49
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Isenberg BC, 2003, ANN BIOMED ENG, V31, P937, DOI 10.1114/1.1590662
   Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x
   Jernigan TW, 2004, ANN SURG, V239, P733, DOI 10.1097/01.sla.0000124447.30808.c7
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kim BS, 1999, NAT BIOTECHNOL, V17, P979, DOI 10.1038/13671
   Kim HR, 2008, AM J PHYSIOL-CELL PH, V295, pC768, DOI 10.1152/ ajpcell. 00174.2008
   Liu JY, 2008, CARDIOVASC RES, V79, P24, DOI 10.1093/cvr/cvn059
   Liu JY, 2007, CARDIOVASC RES, V75, P618, DOI 10.1016/j.cardiores.2007.04.018
   Liu JY, 2010, TISSUE ENG PT A, V16, P2553, DOI [10.1089/ten.tea.2009.0833, 10.1089/ten.TEA.2009.0833]
   Long JL, 2003, MATRIX BIOL, V22, P339, DOI 10.1016/S0945-053X(03)00052-0
   McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Nemcova S, 2001, J INVEST SURG, V14, P321, DOI 10.1080/089419301753435693
   Opitz F, 2004, CARDIOVASC RES, V63, P719, DOI 10.1016/j.cardiores.2004.05.002
   Poh M, 2005, LANCET, V365, P2122, DOI 10.1016/S0140-6736(05)66735-9
   Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268
   Roeder R, 1999, J BIOMED MATER RES, V47, P65, DOI 10.1002/(SICI)1097-4636(199910)47:1<65::AID-JBM9>3.0.CO;2-F
   Roeder R. A., 2001, Biomedical Instrumentation and Technology, V35, P110
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Shell DH, 2005, ANN SURG, V241, P995, DOI 10.1097/01.sla.0000165186.79097
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Yazdani SK, 2009, TISSUE ENG PT A, V15, P827, DOI 10.1089/ten.tea.2008.0092
   Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002
NR 34
TC 30
Z9 33
U1 0
U2 7
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3341
EI 1937-335X
J9 TISSUE ENG PT A
JI Tissue Eng. Part A
PD APR
PY 2011
VL 17
IS 7-8
BP 981
EP 990
DI 10.1089/ten.tea.2010.0109
PG 10
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 741GX
UT WOS:000288853300010
PM 21083418
OA Green Published
DA 2018-10-20
ER

PT J
AU Waterhouse, A
   Wise, SG
   Ng, MKC
   Weiss, AS
AF Waterhouse, Anna
   Wise, Steven G.
   Ng, Martin K. C.
   Weiss, Anthony S.
TI Elastin as a Nonthrombogenic Biomaterial
SO TISSUE ENGINEERING PART B-REVIEWS
LA English
DT Article
ID STENT THROMBOSIS; EXTRACELLULAR-MATRIX; COLLAGEN SCAFFOLDS; HUMAN
   TROPOELASTIN; ENDOTHELIAL-CELLS; PLATELET-ADHESION; SOLUBLE ELASTIN;
   VASCULAR GRAFT; ALPHA-ELASTIN; BIOCOMPATIBILITY
AB Surface-induced thrombosis is a significant issue for artificial blood-contacting materials used in the treatment of cardiovascular diseases. The development of biomaterials and tissue-engineered constructs that mimic the vasculature represents a way to overcome this problem. Elastin is an extracellular matrix macromolecule that imparts arterial elasticity where it comprises up to 50% of the nonhydrated mass of the vessel. In addition to its critical role in maintaining vessel integrity and elastic properties under pulsatile flow, elastin plays an important role in signaling and regulating luminal endothelial cells and smooth muscle cells in the arterial wall. Despite its well-established significance in the vasculature and its growing use as a biomaterial in tissue engineering, the hemocompatibility of elastin is often overlooked. Past studies pointing to the potential of arterial elastin and decellularized elastin as nonthrombogenic materials have begun to be realized, with elastin scaffolds and coatings displaying increased hemo-comptibility. This review explores the mechanisms of elastin's nonthrombogenicity and highlights the current problems limiting its wider application as a biomaterial. We discuss the benefits of constructing biomaterials encompassing the relevant mechanical and biological features of elastin to provide enhanced hemocompatibility to biomaterials.
C1 [Waterhouse, Anna; Weiss, Anthony S.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.
   [Wise, Steven G.] Heart Res Inst, Sydney, NSW, Australia.
   [Ng, Martin K. C.] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia.
RP Weiss, AS (reprint author), Univ Sydney, Sch Mol Biosci, Biochem Bldg G08, Sydney, NSW 2006, Australia.
EM tony.weiss@sydney.edu.au
RI Waterhouse, Anna/E-2464-2011; Wise, Steven/B-1858-2009; Wise,
   Steven/G-2630-2018
OI Waterhouse, Anna/0000-0003-1498-9393; Wise, Steven/0000-0001-7964-819X;
   Wise, Steven/0000-0001-7964-819X; WEISS, ANTHONY/0000-0002-8106-4836
CR Almine JF, 2010, CHEM SOC REV, V39, P3371, DOI 10.1039/b919452p
   BANNISTER LH, 1995, GRAYS ANATOMY, P1454
   BARNES MJ, 1979, HAEMOSTASIS, V8, P158
   BAUMGARTNER HR, 1976, THROMB HAEMOSTASIS, V35, P124, DOI 10.1055/s-0038-1647919
   BAUMGARTNER HR, 1972, ANN NY ACAD SCI, V201, P22, DOI 10.1111/j.1749-6632.1972.tb16285.x
   Bax DV, 2009, J BIOL CHEM, V284, P28616, DOI 10.1074/jbc.M109.017525
   Bennett JS, 2009, J THROMB HAEMOST, V7, P200, DOI 10.1111/j.1538-7836.2009.03378.x
   Brooke BS, 2003, TRENDS CARDIOVAS MED, V13, P176, DOI 10.1016/S1050-1738(03)00065-3
   Chaikof EL, 2007, NEW ENGL J MED, V357, P1368, DOI 10.1056/NEJMp078175
   COLMAN RW, 2006, HEMOSTASIS THROMBOSI, P437
   Cook S, 2009, CIRCULATION, V119, P657, DOI 10.1161/CIRCULATIONAHA.108.842757
   Cutlip DE, 2001, CIRCULATION, V103, P1967
   Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025
   Daamen WF, 2001, BIOMATERIALS, V22, P1997, DOI 10.1016/S0142-9612(00)00383-5
   Davis EC, 1998, MATRIX BIOL, V17, P245, DOI 10.1016/S0945-053X(98)90078-6
   Defife KM, 1999, J BIOMAT SCI-POLYM E, V10, P1063, DOI 10.1163/156856299X00685
   Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9
   Hinds MT, 2006, J BIOMED MATER RES A, V77A, P458, DOI 10.1002/jbm.a.30571
   Hinds MT, 2004, J BIOMED MATER RES A, V69A, P55, DOI 10.1002/jbm.a.20109
   Ito S, 1998, ANGIOLOGY, V49, P289, DOI 10.1177/000331979804900407
   Jordan SW, 2007, J VASC SURG, V45, p104A, DOI 10.1016/j.jvs.2007.02.048
   Jordan SW, 2007, BIOMATERIALS, V28, P1191, DOI 10.1016/j.biomaterials.2006.09.048
   KABEMBA JM, 1973, SURGERY, V73, P438
   KAGAN HM, 1982, METHOD ENZYMOL, V82, P637
   Kapadia MR, 2008, CIRCULATION, V117, P1873, DOI 10.1161/CIRCULATIONAHA.107.714170
   Karnik SK, 2003, MATRIX BIOL, V22, P409, DOI 10.1016/S0945-053X(03)00076-3
   Karnik SK, 2003, DEVELOPMENT, V130, P411, DOI 10.1242/dev.00223
   KIMURA Y, 1988, THROMB RES, V52, P61, DOI 10.1016/0049-3848(88)90041-2
   LEE RG, 1974, J BIOMED MATER RES, V8, P393, DOI 10.1002/jbm.820080607
   Lee SJ, 2007, J BIOMED MATER RES A, V83A, P999, DOI 10.1002/jbm.a.31287
   LEGRAND YJ, 1983, BLOOD CELLS, V9, P263
   Li DY, 1998, NATURE, V393, P276, DOI 10.1038/30522
   Liu SQ, 2004, BIOMATERIALS, V25, P1869, DOI 10.1016/j.biomaterials.2003.08.044
   LONG MM, 1989, J CELL PHYSIOL, V140, P512, DOI 10.1002/jcp.1041400316
   Lu QJ, 2004, BIOMATERIALS, V25, P5227, DOI 10.1016/j.biomaterials.2003.12.019
   MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327
   MARTIN SL, 1995, GENE, V154, P159, DOI 10.1016/0378-1119(94)00848-M
   Maurer LM, 2010, THROMB RES, V125, P287, DOI 10.1016/j.thromres.2009.12.017
   Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nivison-Smith L, 2009, ACTA BIOMATER, V6, P354
   PALMAZ JC, 1993, AM J ROENTGENOL, V160, P613, DOI 10.2214/ajr.160.3.8430566
   Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266
   Patel A, 2006, CARDIOVASC RES, V71, P40, DOI 10.1016/j.cardiores.2006.02.021
   Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613
   Rodgers UR, 2005, PATHOL BIOL, V53, P390, DOI 10.1016/j.patbio.2004.12.022
   Sallach RE, 2010, BIOMATERIALS, V31, P779, DOI 10.1016/j.biomaterials.2009.09.082
   SEKIYA K, 1984, BIOCHIM BIOPHYS ACTA, V797, P348, DOI 10.1016/0304-4165(84)90256-3
   SENIOR RM, 1984, J CELL BIOL, V99, P870, DOI 10.1083/jcb.99.3.870
   Seyama Yoshiyuki, 2004, J Atheroscler Thromb, V11, P236
   Simionescua DT, 2006, BIOMATERIALS, V27, P702, DOI 10.1016/j.biomaterials.2005.06.013
   Singh R, 2007, J MATER SCI-MATER M, V18, P725, DOI 10.1007/s10856-006-0016-y
   Spaet T H, 1966, Thromb Diath Haemorrh Suppl, V21, P67
   SPRIO RG, 1970, ANNU REV BIOCHEM, V39, P599
   Srokowski EM, 2011, J BIOMAT SCI-POLYM E, V22, P41, DOI 10.1163/092050609X12578498935594
   Stemerman M B, 1974, Prog Hemost Thromb, V2, P1
   TAMBURRO AM, 1978, J BIOL CHEM, V253, P2893
   Tieche C, 2004, FRONT BIOSCI, V9, P2205, DOI 10.2741/1391
   Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Vyas SP, 2009, EXPERT OPIN DRUG DEL, V6, P499, DOI [10.1517/17425240902878002 , 10.1517/17425240902878002]
   WACHI, 2004, J ATHEROSCLER THROMB, V11, P159
   Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008
   Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062
   Werner C, 2007, J MATER CHEM, V17, P3376, DOI 10.1039/b703416b
   Williams DF, 2008, BIOMATERIALS, V29, P2941, DOI 10.1016/j.biomaterials.2008.04.023
   Wise SG, 2011, ACTA BIOMATER, V7, P295, DOI 10.1016/j.actbio.2010.07.022
   Wise SG, 2009, ADV PROTEIN CHEM STR, V78, P1, DOI [10.1016/S1876-1623(08)78001-5, 10.1016/S1876-1623(09)78001-5]
   Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Yin YB, 2009, BIOMATERIALS, V30, P1675, DOI 10.1016/j.biomaterials.2008.11.009
NR 73
TC 41
Z9 43
U1 0
U2 29
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1937-3368
J9 TISSUE ENG PART B-RE
JI Tissue Eng. Part B-Rev.
PD APR
PY 2011
VL 17
IS 2
BP 93
EP 99
DI 10.1089/ten.teb.2010.0432
PG 7
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell
   Biology
SC Cell Biology; Biotechnology & Applied Microbiology
GA 741HS
UT WOS:000288855400002
PM 21166482
DA 2018-10-20
ER

PT J
AU Catros, S
   Guillotin, B
   Bacakova, M
   Fricain, JC
   Guillemot, F
AF Catros, Sylvain
   Guillotin, Bertrand
   Bacakova, Marketa
   Fricain, Jean-Christophe
   Guillemot, Fabien
TI Effect of laser energy, substrate film thickness and bioink viscosity on
   viability of endothelial cells printed by Laser-Assisted Bioprinting
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT E-MRS Symposium R on Laser Processing and Diagnostics for Micro and Nano
   Applications
CY JUN 07-11, 2010
CL Strasbourg, FRANCE
SP E MRS
DE Laser Assisted Bioprinting; Cell viability; Hydrogels
ID TISSUE; FATE
AB Biofabrication of three dimensional tissues by Laser-Assisted Bioprinting (LAB) implies to develop specific strategies for assembling the extracellular matrix (ECM) and cells. Possible strategies consist in (i) printing cells onto or in the depth of ECM layer and/or (ii) printing bioinks containing both cells and ECM-like printable biomaterial. The aim of this article was to evaluate combinatorial effects of laser pulse energy, ECM thickness and viscosity of the bioink on cell viability. A LAB workstation was used to print Ea.hy926 endothelial cells onto a quartz substrate covered with a film of ECM mimicking Matrigel (TM). Hence, effect of laser energy, Matrigel (TM) film thickness and bioink viscosity was addressed for different experimental conditions (8-24 mu J, 20-100 mu m and 40-110mPas, respectively). Cell viability was assessed by live/dead assay performed 24 h post-printing. Results show that increasing the laser energy tends to augment the cell mortality while increasing the thickness of the Matrigel (TM) film and the viscosity of the bioink support cell viability. Hence, critical printing parameters influencing high cell viability have been related to the cell landing conditions and more specifically to the intensity of the cell impacts occurring at the air-ECM interface and at the ECM-glass interface. (C) 2010 Elsevier B.V. All rights reserved.
C1 [Catros, Sylvain; Fricain, Jean-Christophe] Univ Bordeaux 2, Fac Dent, F-33076 Bordeaux, France.
   [Catros, Sylvain; Guillotin, Bertrand; Bacakova, Marketa; Fricain, Jean-Christophe; Guillemot, Fabien] INSERM, U577, F-33076 Bordeaux, France.
RP Catros, S (reprint author), Univ Bordeaux 2, Fac Dent, Bat 4A,Case Postale 45,146 Rue Leo Saignat, F-33076 Bordeaux, France.
EM sylvaincatros@hotmail.com
RI Guillemot, Fabien/F-5174-2012; Bacakova, Marketa/K-5728-2017
OI Guillemot, Fabien/0000-0002-4263-4365; 
FU Region Aquitaine, GIS Advanced Materials in Aquitaine; French Institute
   for Dental Research (IFRO); EU
FX The authors would like to thank the Region Aquitaine, GIS Advanced
   Materials in Aquitaine and the French Institute for Dental Research
   (IFRO) for financial support. Marketa Bacakova acknowledges a mobility
   grant from the EU ERASMUS program.
CR Barron JA, 2004, THIN SOLID FILMS, V453, P383, DOI 10.1016/j.tsf.2003.11.161
   Barron JA, 2004, BIOMED MICRODEVICES, V6, P139, DOI 10.1023/B:BMMD.0000031751.67267.9f
   Duocastella M, 2008, APPL PHYS A-MATER, V93, P453, DOI 10.1007/s00339-008-4781-y
   Grant G. M., 1994, METHODS CELL SCI, V16, P189
   Guillemot F, 2010, ACTA BIOMATER, V6, P2494, DOI 10.1016/j.actbio.2009.09.029
   Guillemot F, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/1/010201
   Guillemot F, 2010, NANOMEDICINE-UK, V5, P507, DOI [10.2217/nnm.10.14, 10.2217/NNM.10.14]
   Guillotin B, 2010, BIOMATERIALS, V31, P7250, DOI 10.1016/j.biomaterials.2010.05.055
   Hopp B, 2005, TISSUE ENG, V11, P1817, DOI 10.1089/ten.2005.11.1817
   Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]
   Hutmacher DW, 2007, J TISSUE ENG REGEN M, V1, P245, DOI 10.1002/term.24
   KLEBE RJ, 1988, EXP CELL RES, V179, P362, DOI 10.1016/0014-4827(88)90275-3
   Koch L, 2010, TISSUE ENG PART C-ME, V16, P847, DOI [10.1089/ten.tec.2009.0397, 10.1089/ten.TEC.2009.0397]
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin YF, 2010, RAPID PROTOTYPING J, V16, P202, DOI 10.1108/13552541011034870
   Mezel C, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3276101
   Mironov V, 2006, TISSUE ENG, V12, P631, DOI 10.1089/ten.2006.12.631
   Nair Kalyani, 2009, Biotechnology Journal, V4, P1168, DOI 10.1002/biot.200900004
   Nakamura M, 2005, TISSUE ENG, V11, P1658, DOI 10.1089/ten.2005.11.1658
   Norotte C, 2009, BIOMATERIALS, V30, P5910, DOI 10.1016/j.biomaterials.2009.06.034
   Ringeisen BR, 2004, TISSUE ENG, V10, P483, DOI 10.1089/107632704323061843
   Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Saunders RE, 2008, BIOMATERIALS, V29, P193, DOI 10.1016/j.biomatei-ials.2007.09.032
   Vozzi G, 2003, BIOMATERIALS, V24, P2533, DOI 10.1016/S0142-9612(03)00052-8
   Wang W, 2009, J MANUF SCI E-T ASME, V131, DOI 10.1115/1.4000101
   Wang W, 2008, J MANUF SCI E-T ASME, V130, DOI 10.1115/1.2896118
NR 27
TC 31
Z9 31
U1 0
U2 52
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 1
PY 2011
VL 257
IS 12
BP 5142
EP 5147
DI 10.1016/j.apsusc.2010.11.049
PG 6
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 730CH
UT WOS:000288007500005
DA 2018-10-20
ER

PT J
AU Palla-Papavlu, A
   Dinca, V
   Ion, V
   Moldovan, A
   Mitu, B
   Luculescu, C
   Dinescu, M
AF Palla-Papavlu, A.
   Dinca, V.
   Ion, V.
   Moldovan, A.
   Mitu, B.
   Luculescu, C.
   Dinescu, M.
TI Characterization of polymer thin films obtained by pulsed laser
   deposition
SO APPLIED SURFACE SCIENCE
LA English
DT Article; Proceedings Paper
CT E-MRS Symposium R on Laser Processing and Diagnostics for Micro and Nano
   Applications
CY JUN 07-11, 2010
CL Strasbourg, FRANCE
SP E MRS
DE Pulsed laser deposition; Polyepichlorhydrin polymer; Thin films
ID CONSTANTS; SENSOR; TARGET
AB The development of laser techniques for the deposition of polymer and biomaterial thin films on solid surfaces in a controlled manner has attracted great attention during the last few years. Here we report the deposition of thin polymer films, namely Polyepichlorhydrin by pulsed laser deposition. Polyepichlorhydrin polymer was deposited on flat substrate (i.e. silicon) using an NdYAG laser (266 nm, 5 ns pulse duration and 10 Hz repetition rate).
   The obtained thin films have been characterized by atomic force microscopy, scanning electron microscopy, Fourier transform infrared spectroscopy and spectroscopic ellipsometry.
   It was found that for laser fluences up to 1.5 J/cm(2) the chemical structure of the deposited polyepichlorhydrin polymer thin layers resembles to the native polymer, whilst by increasing the laser fluence above 1.5 J/cm(2) the polyepichlorohydrin films present deviations from the bulk polymer.
   Morphological investigations (atomic force microscopy and scanning electron microscopy) reveal continuous polyepichlorhydrin thin films for a relatively narrow range of fluences (1-1.5 J/cm(2)).
   The wavelength dependence of the refractive index and extinction coefficient was determined by ellipsometry studies which lead to new insights about the material.
   The obtained results indicate that pulsed laser deposition method is potentially useful for the fabrication of polymer thin films to be used in applications including electronics, microsensor or bioengineering industries. (C) 2010 Elsevier B. V. All rights reserved.
C1 [Palla-Papavlu, A.; Dinca, V.; Ion, V.; Moldovan, A.; Mitu, B.; Luculescu, C.; Dinescu, M.] NILPRP, RO-077125 Bucharest, Romania.
RP Palla-Papavlu, A (reprint author), NILPRP, 409 Atomistilor St,POB MG 16, RO-077125 Bucharest, Romania.
EM apalla@nipne.ro
RI Palla-Papavlu, Alexandra/C-4946-2011; Dinescu, Maria/C-4775-2011;
   Luculescu, Catalin/A-7999-2010; Mitu, Bogdana/D-4584-2011; Ion,
   valentin/A-5375-2008; Dinca, Valentina Carmen/C-3953-2011; Dinca,
   Valentina/O-7420-2014; Moldovan, Antoniu/I-8411-2012
OI Dinescu, Maria/0000-0001-7327-8714; Luculescu,
   Catalin/0000-0001-6852-401X; Mitu, Bogdana/0000-0002-0603-4864; Ion,
   valentin/0000-0002-4501-8365; Dinca, Valentina/0000-0002-3641-5342;
   Moldovan, Antoniu/0000-0001-7953-9268
FU NATO SfP [982671];  [PN09 39];  [73 EU (eLIFT)]
FX Financial support from the NATO SfP 982671 project and the National
   Projects PN09 39 and 73 EU (eLIFT) are gratefully acknowledged.
CR Beck K, 1999, SENSOR ACTUAT A-PHYS, V76, P103, DOI 10.1016/S0924-4247(98)00359-8
   Bekkar F, 2009, CHINESE J CHEM, V27, P1174, DOI 10.1002/cjoc.200990197
   Bendrea AD, 2010, POLYM INT, V59, P624, DOI 10.1002/pi.2738
   BRODOCEANU D, 2004, PLASMA PRODUCTION LA, V2003, P41
   Bruggeman DAG, 1935, ANN PHYS-BERLIN, V24, P636
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   Eroglu MS, 1996, J APPL POLYM SCI, V60, P1361, DOI 10.1002/(SICI)1097-4628(19960531)60:9<1361::AID-APP11>3.0.CO;2-5
   Fernandez-Pradas JM, 2001, APPL PHYS A-MATER, V72, P613, DOI 10.1007/s003390100726
   Fuchs B, 2010, APPL PHYS A-MATER, V98, P711, DOI 10.1007/s00339-009-5525-3
   Fujiwara H., 2007, SPECTROSCOPIC ELLIPS
   GAO Y, 2006, J MAT RES, V21
   Herzinger CM, 1998, J APPL PHYS, V83, P3323, DOI 10.1063/1.367101
   Joo BS, 2007, SENSOR ACTUAT B-CHEM, V121, P47, DOI 10.1016/j.snb.2006.09.013
   Kecskemeti G, 2006, APPL SURF SCI, V253, P1185, DOI 10.1016/j.apsusc.2006.01.084
   Rebollar E, 2006, APPL PHYS A-MATER, V84, P171, DOI 10.1007/s00339-006-3593-1
   Schou J, 2009, APPL SURF SCI, V255, P5191, DOI 10.1016/j.apsusc.2008.10.101
   Schubert DW, 2003, MATER RES INNOV, V7, P314, DOI 10.1007/s10019-003-0270-2
   Suske E, 2006, J APPL PHYS, V100, DOI 10.1063/1.2209434
   Tompkins H. G., 1999, SPECTROSCOPIC ELLIPS
   Youngblood JP, 2001, THIN SOLID FILMS, V382, P95, DOI 10.1016/S0040-6090(00)01683-7
NR 20
TC 8
Z9 8
U1 0
U2 37
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
EI 1873-5584
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD APR 1
PY 2011
VL 257
IS 12
BP 5303
EP 5307
DI 10.1016/j.apsusc.2010.11.140
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 730CH
UT WOS:000288007500039
DA 2018-10-20
ER

PT J
AU Rajkhowa, R
   Levin, B
   Redmond, SL
   Li, LH
   Wang, LJ
   Kanwar, JR
   Atlas, MD
   Wang, XG
AF Rajkhowa, Rangam
   Levin, Brett
   Redmond, Sharon L.
   Li, Lu Hua
   Wang, Lijing
   Kanwar, Jagat R.
   Atlas, Marcus D.
   Wang, Xungai
TI Structure and properties of biomedical films prepared from aqueous and
   acidic silk fibroin solutions
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE silk fibroin film; tensile properties; degradation; biomaterial
ID CONFORMATION TRANSITION KINETICS; BOMBYX-MORI; IN-VITRO; CASTING
   TEMPERATURE; PHYSICAL-PROPERTIES; FORMIC-ACID; HEAVY-CHAIN; MEMBRANE;
   BIOMATERIALS; SPECTROSCOPY
AB Silk fibroin films are promising materials for a range of biomedical applications. To understand the effects of casting solvents on film properties, we used water (W), formic acid (FA), and trifluoroacetic acid (TFA) as solvents. We characterized molecular weight, secondary structure, mechanical properties, and degradation behavior of cast films. Significant degradation of fibroin was observed for TFA-based film compared to W and TA-based films when analyzed by SDS-PAGE. Fibroin degradation resulted in a significant reduction in tensile strength and modulus of TFA-based films. Compared to water, TFA-based films demonstrated lower water solubility (19.6% vs. 62.5% in 12 h) despite having only a marginal increase in their beta-sheet content (26.9% vs. 23.7%). On the other hand, FA-based films with 34.3% beta-sheet were virtually water insoluble. Following solubility treatment, beta-sheet content in FA-based films increased to 50.9%. On exposure to protease XIV, water-annealed FA-based films lost 74% mass in 22 days compared to only 30% mass loss by ethanol annealed FA films. This study demonstrated that a small variation in the beta-sheet percentage and random coil conformations resulted in a significant change in the rates of enzymatic degradation without alteration to their tensile properties. The film surface roughness changed with the extent of enzymatic hydrolysis. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 37-45, 2011.
C1 [Rajkhowa, Rangam; Li, Lu Hua; Kanwar, Jagat R.; Wang, Xungai] Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
   [Levin, Brett; Redmond, Sharon L.; Atlas, Marcus D.] Univ Western Australia, Ctr Earth Sci, Sch Surg, Perth, WA 6009, Australia.
   [Redmond, Sharon L.; Atlas, Marcus D.] Ear Sci Inst Australia, Perth, WA, Australia.
   [Wang, Lijing] RMIT Univ, Sch Fash & Text, Brunswick, Vic 3056, Australia.
RP Wang, XG (reprint author), Deakin Univ, Inst Technol Res & Innovat, Geelong, Vic 3217, Australia.
EM xwang@deakin.edu.au
RI Redmond, Sharon/B-8701-2009; Li, Luhua/B-4863-2013; Wang,
   Lijing/O-3130-2018
OI Li, Luhua/0000-0003-2435-5220; Wang, Lijing/0000-0002-7300-9271
CR Acharya C, 2009, ACTA BIOMATER, V5, P429, DOI 10.1016/j.actbio.2008.07.003
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Arai T, 2004, J APPL POLYM SCI, V91, P2383, DOI 10.1002/app.13393
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   Chen X, 2007, PROTEINS, V68, P223, DOI 10.1002/prot.21414
   Chen X, 2009, SOFT MATTER, V5, P2777, DOI 10.1039/b900908f
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Das S., 2005, AUTEX RES J, V5, P81
   Domachuk P, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3275719
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   Ghanaati S, 2010, J TISSUE ENG REGEN M, V4, P464, DOI 10.1002/term.257
   Ghassemifar R, 2010, J BIOMATER APPL, V24, P591, DOI 10.1177/0885328209104289
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Gupta MK, 2007, LANGMUIR, V23, P1315, DOI 10.1021/la062047p
   Ha SW, 2005, BIOMACROMOLECULES, V6, P2563, DOI 10.1021/bm050294m
   Ha SW, 2005, BIOMACROMOLECULES, V6, P1722, DOI 10.1021/bm050010y
   Hardy JG, 2008, POLYMER, V49, P4309, DOI 10.1016/j.polymer.2008.08.006
   Hu X, 2006, MACROMOLECULES, V39, P6161, DOI 10.1021/ma0610109
   IIZUKA E, 1969, BIOCHIM BIOPHYS ACTA, V181, P477, DOI 10.1016/0005-2795(69)90284-0
   Iridag Y, 2006, J APPL POLYM SCI, V100, P4260, DOI 10.1002/app.23810
   Jiang CY, 2007, ADV FUNCT MATER, V17, P2229, DOI 10.1002/adfm.200601136
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Kawahara Y, 2006, MACROMOL MATER ENG, V291, P458, DOI 10.1002/mame.200500350
   Kimura T, 2007, J APPL SCI RES, V3, P1306
   Kundu J, 2011, J BIOMAT SCI-POLYM E, V22, P519, DOI 10.1163/092050610X487864
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Levin B, 2010, OTOLARYNG HEAD NECK, V142, pS33, DOI 10.1016/j.otohns.2009.06.746
   Levin B, 2009, EXPERT REV MED DEVIC, V6, P653, DOI [10.1586/erd.09.47, 10.1586/ERD.09.47]
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Lu SZ, 2010, BIOMACROMOLECULES, V11, P143, DOI 10.1021/bm900993n
   Lv Q, 2005, J APPL POLYM SCI, V96, P2168, DOI 10.1002/app.21682
   MAGOSHI J, 1985, J POLYM SCI POL PHYS, V23, P227, DOI 10.1002/pol.1985.180230120
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Min BM, 2006, MACROMOL BIOSCI, V6, P285, DOI 10.1002/mabi.200500246
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   MORTON WE, 1993, PHYS PROPERTIES TEXT
   Omenetto FG, 2010, SCIENCE, V329, P528, DOI 10.1126/science.1188936
   Peng XN, 2005, BIOMACROMOLECULES, V6, P302, DOI 10.1021/bm049598j
   Rajkhowa R, 2008, POWDER TECHNOL, V185, P87, DOI 10.1016/j.powtec.2008.01.005
   Rajkhowa R, 2011, J APPL POLYM SCI, V119, P1339, DOI 10.1002/app.31981
   Rajkhowa R, 2010, MACROMOL BIOSCI, V10, P599, DOI 10.1002/mabi.200900358
   SHIMURA K, 1976, J BIOCHEM-TOKYO, V80, P693, DOI 10.1093/oxfordjournals.jbchem.a131328
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Tsubouchi Kozo, 2003, Journal of Insect Biotechnology and Sericology, V72, P65
   TSUKADA M, 1986, J POLYM SCI POL PHYS, V24, P457, DOI 10.1002/polb.1986.090240219
   Um IC, 2001, INT J BIOL MACROMOL, V29, P91, DOI 10.1016/S0141-8130(01)00159-3
   Vasconcelos A, 2008, BIOMACROMOLECULES, V9, P1299, DOI 10.1021/bm7012789
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Wenk E, 2008, J CONTROL RELEASE, V132, P26, DOI 10.1016/j.jconrel.2008.08.005
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou GQ, 2009, ADV MATER, V21, P366, DOI 10.1002/adma.200800582
   Zuo B, 2006, J MATER SCI, V41, P3357, DOI 10.1007/s10853-005-5384-z
   Zuo BQ, 2007, J APPL POLYM SCI, V106, P53, DOI 10.1002/app.26653
NR 64
TC 40
Z9 43
U1 2
U2 47
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2011
VL 97A
IS 1
BP 37
EP 45
DI 10.1002/jbm.a.33021
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 734AL
UT WOS:000288305500005
PM 21308983
DA 2018-10-20
ER

PT J
AU Fink, H
   Hong, J
   Drotz, K
   Risberg, B
   Sanchez, J
   Selborn, A
AF Fink, Helen
   Hong, Jaan
   Drotz, Kristoffer
   Risberg, Bo
   Sanchez, Javier
   Selborn, Anders
TI An in vitro study of blood compatibility of vascular grafts made of
   bacterial cellulose in comparison with conventionally-used graft
   materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bacterial cellulose; blood compatibility; coagulation; complement
   activation; Chandler loop; PET; ePTFE
ID ANTITHROMBIN-BINDING-CAPACITY; REAL-TIME MEASUREMENTS; COMPLEMENT
   ACTIVATION; CARDIOPULMONARY BYPASS; ARTIFICIAL SURFACES;
   PLATELET-ADHESION; 2 PARTS; BIOMATERIAL; COAGULATION; HEPARIN
AB In this study we analyzed the blood compatibility of bacterial cellulose (BC) as a new biosynthetic material for use as a vascular graft. As reference materials we used expanded polytetrafluoroethylene (ePTFE) and poly(ethylene terephthalate) (PET) vascular grafts. These materials are in clinical use today. Tubes with inner diameters of both 4 (not PET) and 6 mm were tested. Heparin-coated PVC tubes (hepPVC) were used as a negative control. Platelet consumption and thrombin-antithrombin complex (TAT) were used as parameters of coagulation and for complement activation, sC3a and sC5b-9 were used. The investigated parameters were measured after 1-h exposure to freshly drawn human blood supplemented with a low dose of heparin in a Chandler loop system. The results showed that BC exhibits no significant difference in platelet consumption, as compared with PET 16 mm), ePTFE and hepPVC. The PET material consumed more platelets than any of the other materials. The TAT generation for 4 mm tubes was not significantly different between BC and the other materials. For 6 mm tubes, however, differences were observed between hepPVC and PET (p < 0.0001); BC and hepPVC (p = 0.0016); ePTFE and PET (p < 0.0001); BC and ePTFE (p = 0.0029); BC and PET (p = 0.0141). Surprisingly, considering the low platelet consumption, the complement activation parameters (sC3a and sC5b-9) were much higher for BC, as compared with the other materials for both 4 and 6 mm tubes. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 52-58,2011.
C1 [Fink, Helen; Risberg, Bo; Selborn, Anders] Sahlgrens Acad, Inst Clin Sci, Gothenburg, Sweden.
   [Fink, Helen; Risberg, Bo; Selborn, Anders] Univ Gothenburg, Gothenburg, Sweden.
   [Hong, Jaan; Sanchez, Javier] Univ Hosp, Rudbeck Lab, Div Clin Immunol, Dept Radiol Oncol & Clin Immunol, Uppsala, Sweden.
   [Drotz, Kristoffer] Chalmers, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.
RP Selborn, A (reprint author), Sahlgrens Acad, Inst Clin Sci, Gothenburg, Sweden.
EM Anders.Sellborn@gu.se
FU LUA (University of Gothenburg); Swedish Foundation for Strategic
   Research (SSF); Swedish Research Council (VR); Swedish Government Agency
   for Innovation Systems (VINNOVA)
FX Contract grant sponsors: LUA (University of Gothenburg); Swedish
   Foundation for Strategic Research (SSF); Swedish Research Council (VR);
   Swedish Government Agency for Innovation Systems (VINNOVA)
CR Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Bengtsson A, 1998, XENOTRANSPLANTATION, V5, P176, DOI 10.1111/j.1399-3089.1998.tb00025.x
   Bodin A, 2005, ABSTR PAP AM CHEM S, V229, pU297
   Bodin A, 2007, BIOTECHNOL BIOENG, V97, P425, DOI 10.1002/bit.21314
   BOON GD, 1993, TOXICOL PATHOL, V21, P170, DOI 10.1177/019262339302100209
   Cabric S, 2008, TISSUE ENG PT C-METH, V14, P141, DOI 10.1089/ten.tec.2007.0312
   DeHeer DH, 2001, J BIOMED MATER RES, V54, P12, DOI 10.1002/1097-4636(200101)54:1<12::AID-JBM2>3.0.CO;2-X
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   EMERY RW, 1993, J CARDIAC SURG, V8, P439, DOI 10.1111/j.1540-8191.1993.tb00391.x
   FERNANDEZ HN, 1978, J BIOL CHEM, V253, P6955
   Ferraz N, 2008, J BIOMED MATER RES A, V87A, P575, DOI 10.1002/jbm.a.31818
   Fink H, 2010, ACTA BIOMATER, V6, P1125, DOI 10.1016/j.actbio.2009.09.019
   Frank RD, 2001, KIDNEY INT, V60, P1972, DOI 10.1046/j.1523-1755.2001.00009.x
   Fushimi F, 1998, ARTIF ORGANS, V22, P821, DOI 10.1046/j.1525-1594.1998.06046.x
   Georgopoulos LJ, 2009, MOL IMMUNOL, V46, P2911, DOI 10.1016/j.molimm.2009.07.008
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   GYONGYOSSYISSA MIC, 1994, J LAB CLIN MED, V123, P859
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hunt BJ, 1997, BLOOD COAGUL FIBRIN, V8, P223, DOI 10.1097/00001721-199706000-00003
   Johnell M, 2005, BIOMATERIALS, V26, P1731, DOI 10.1016/j.biomaterials.2004.05.029
   Kalltorp M, 1999, J BIOMED MATER RES, V47, P251, DOI 10.1002/(SICI)1097-4636(199911)47:2<251::AID-JBM16>3.0.CO;2-O
   Katritsis D, 2007, PROG CARDIOVASC DIS, V49, P307, DOI 10.1016/j.pcad.2006.11.001
   Kim HI, 2009, CELL TRANSPLANT, V18, P31, DOI 10.3727/096368909788237113
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Lappegard KT, 2004, ANN THORAC SURG, V78, P44, DOI 10.1016/j.athoracsur.2004.02.005
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   Mangsbo SM, 2009, J IMMUNOL, V183, P6724, DOI 10.4049/jimmunol.0902374
   MCCULLOUGH JN, 1990, ANN THORAC SURG, V50, P663, DOI 10.1016/0003-4975(90)90214-Q
   Moen O, 1997, ANN THORAC SURG, V63, P105
   MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x
   Nilsson B, 2007, MOL IMMUNOL, V44, P82, DOI 10.1016/j.molimm.2006.06.020
   Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101
   Peerschke EIB, 2006, J THROMB HAEMOST, V4, P2035, DOI 10.1111/j.1538-7836.2006.02065.x
   SANTOS MT, 1991, J CLIN INVEST, V87, P571, DOI 10.1172/JCI115032
   Tang LP, 1998, J BIOMED MATER RES, V41, P333, DOI 10.1002/(SICI)1097-4636(199808)41:2<333::AID-JBM19>3.0.CO;2-L
   Thomas S, 2008, J Wound Care, V17, P349
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P287, DOI 10.1053/ejvs.2002.1810
   Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406
   Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506
   Wippermann J, 2009, EUR J VASC ENDOVASC, V37, P592, DOI 10.1016/j.ejvs.2009.01.007
NR 44
TC 20
Z9 20
U1 1
U2 24
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2011
VL 97A
IS 1
BP 52
EP 58
DI 10.1002/jbm.a.33031
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 734AL
UT WOS:000288305500007
PM 21308986
DA 2018-10-20
ER

PT J
AU Soria, JM
   Sancho-Tello, M
   Esparza, MAG
   Mirabet, V
   Bagan, JV
   Monleon, M
   Carda, C
AF Miguel Soria, Jose
   Sancho-Tello, Maria
   Garcia Esparza, M. Angeles
   Mirabet, Vicente
   Vicente Bagan, Jose
   Monleon, Manuel
   Carda, Carmen
TI Biomaterials coated by dental pulp cells as substrate for neural stem
   cell differentiation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell culture; cell adhesion; nerve growth factor; neural cell; stem cell
ID CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN BRAIN; SUBVENTRICULAR ZONE;
   NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; IN-VITRO; TRIGEMINAL GANGLION;
   PROGENITOR CELLS; SENSORY NEURONS; MIGRATION
AB This study is focused on the development of an in vitro hybrid system, consisting in a polymeric biomaterial covered by a dental pulp cellular stroma that acts as a scaffold offering a neurotrophic support for the subsequent survival and differentiation of neural stem Cells. In the first place, the behavior of dental pulp stroma on the polymeric biomaterial based on ethyl acrylate and hydroxy ethyl acrylate copolymer was studied. For this purpose, cells from normal human third molars were grown onto 0.5-mm-diameter biomaterial discs. After cell culture, quantification of neurotrophic factors generated by the stromal cells was performed by means of an ELISA assay. In the second place, survival and differentiation of adult murine neural stem cells on the polymeric biomaterials covered by dental pulp stromal cells was studied. The results show the capacity of dental pulp cells to uniformly coat the majority of the material's surface and to secrete neurotrophic factors that become crucial for a subsequent differentiation of neural stem cells. The use of stromal cells cultured on scaffolding biomaterials provides neurotrophic pumps that may suggest new criteria for the design of cell therapy experiments in animal models to assist the repair of lesions in Central Nervous System. (C) 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 97A: 85-92, 2011.
C1 [Miguel Soria, Jose; Garcia Esparza, M. Angeles] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Valencia 46113, Spain.
   [Sancho-Tello, Maria; Carda, Carmen] Univ Valencia, Fac Med & Odontol, Dept Patol, Valencia 46010, Spain.
   [Mirabet, Vicente] Generalitat Valenciana, Ctr Transfus, Conselleria Sanitat, Valencia 46014, Spain.
   [Vicente Bagan, Jose] Univ Valencia, Fac Med & Odontol, Dept Estomatol, Valencia 46010, Spain.
   [Monleon, Manuel] Univ Politecn Valencia, Ctr Biomat & Ingn Tisular, Valencia 46022, Spain.
   [Monleon, Manuel] Ctr Invest Principe Felipe, Valencia 46012, Spain.
RP Soria, JM (reprint author), Univ CEU Cardenal Herrera, Fac Ciencias Salud, Dept Fisiol Farmacol & Toxicol, Ave Seminario, Valencia 46313, Spain.
EM jose.soria@uch.ceu.es
RI Soria Lopez, Jose Miguel/M-5266-2017; duan, hf/F-9166-2011;
   Sancho-Tello, Maria/F-8566-2016; Garcia Esparza, M.Angeles/L-1121-2014;
   soria, jose/K-6722-2014; Carda Batalla, Carmen/E-9885-2017
OI Soria Lopez, Jose Miguel/0000-0001-9144-5096; Sancho-Tello,
   Maria/0000-0002-7080-2979; Garcia Esparza,
   M.Angeles/0000-0001-6510-0879; soria, jose/0000-0001-9144-5096; Carda
   Batalla, Carmen/0000-0002-5130-136X
FU Spanish Ministry of Science and Innovation [MAT2008-06434];
   Copernicus-Santander Universidad CEU-Cardenal Herrera
   [PRCEU-UCH/COP01/08]; Programa de ayudas a la Investigacion Universidad
   CEU-Cardenal Herrera [PRCEU-UCH16/09]; Programa de ayudas a la
   Investigacion cientifica Raman Areces; convenio de colaboracion entre el
   Instituto de Salud Carlos III; la Conselleria de Sanidad de la
   Generalitat Valenciana y la Fundacion de la Comunidad Valenciana Centro
   de Investigacion Principe Felipe para la investigacion basica y
   traslacional en medicina regenerative
FX Contract grant sponsor: Spanish Ministry of Science and Innovation;
   contract grant number: MAT2008-06434; Contract grant sponsor:
   Copernicus-Santander Universidad CEU-Cardenal Herrera; contract grant
   number: PRCEU-UCH/COP01/08; Contract grant sponsor: Programa de ayudas a
   la Investigacion Universidad CEU-Cardenal Herrera; contract grant
   number: PRCEU-UCH16/09; Contract grant sponsors: Programa de ayudas a la
   Investigacion cientifica Raman Areces; convenio de colaboracion entre el
   Instituto de Salud Carlos III, la Conselleria de Sanidad de la
   Generalitat Valenciana y la Fundacion de la Comunidad Valenciana Centro
   de Investigacion Principe Felipe para la investigacion basica y
   traslacional en medicina regenerative
CR Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582
   ANGELUS, 2008, J ORAL SCI, V50, P397
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x
   Deister C, 2006, J NEURAL ENG, V3, P172, DOI 10.1088/1741-2560/3/2/011
   Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004
   Doetsch F, 2001, BRAIN BEHAV EVOLUT, V58, P306, DOI 10.1159/000057572
   Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144
   Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7
   Fried A, 1996, J CELL BIOCHEM, V61, P246
   Fried K, 2005, EXP CELL RES, V307, P329, DOI 10.1016/j.yexcr.2005.04.009
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E
   GORDON T, 2009, NEUROSURG FOCUS, V26, P3
   Gorski JA, 2003, J NEUROSCI, V23, P6856
   GRITTI A, 2001, PROTOCOLS NEURAL CEL, P173, DOI DOI 10.1385/1-59259-207-4:173
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Ichikawa H, 2006, BRAIN RES, V1081, P113, DOI 10.1016/j.brainres.2006.01.027
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Kim NR, 2009, ORAL SURG ORAL MED O, V108, P94
   Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998
   Lillesaar C, 2003, NEUROSCIENCE, V119, P443, DOI 10.1016/S0306-4522(02)00938-7
   Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978
   LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U
   Martinez-Ramos C, 2008, TISSUE ENG PT A, V14, P1365, DOI 10.1089/ten.tea.2007.0295
   Nielsen J, 2009, J NEUROSCI, V29, P11360, DOI 10.1523/JNEUROSCI.3239-09.2009
   Nojiri Yukiko, 2008, J Med Dent Sci, V55, P121
   Nosrat IV, 2004, EUR J NEUROSCI, V19, P2388, DOI 10.1111/j.1460-9568.2004.03314.x
   Pascual A, 2008, NAT NEUROSCI, V11, P755, DOI 10.1038/nn.2136
   Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   SALOM D, 2008, INVESTIG OPHTHALMOL, V8, P3499
   Soria JM, 2007, J BIOMED MATER RES A, V83A, P463, DOI 10.1002/jbm.a.31297
   Soria JM, 2006, J BIOMED MATER RES A, V79A, P495, DOI 10.1002/jbm.a.30803
   Stewart AL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-73
   Trubiani O, 2006, INT J IMMUNOPATH PH, V19, P451, DOI 10.1177/039463200601900301
   Wissel K, 2008, OTOL NEUROTOL, V29, P475, DOI 10.1097/MAO.0b013e318164d110
   Wu ZZ, 2010, BIOTECHNOL BIOENG, V106, P649, DOI 10.1002/bit.22715
   Xu Q, 2003, CEREB CORTEX, V13, P670, DOI 10.1093/cercor/13.6.670
   Yoong LF, 2009, MOL CELL NEUROSCI, V41, P464, DOI 10.1016/j.mcn.2009.05.002
   ZHANG W, 2006, FOLIA ANAT JPN, V83, P15
   Zhang WB, 2006, BIOMATERIALS, V27, P5658, DOI 10.1016/j.biomaterials.2006.07.013
   Zhang WB, 2006, TISSUE ENG, V12, P2813, DOI 10.1089/ten.2006.12.2813
NR 46
TC 15
Z9 15
U1 0
U2 9
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD APR
PY 2011
VL 97A
IS 1
BP 85
EP 92
DI 10.1002/jbm.a.33032
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 734AL
UT WOS:000288305500011
PM 21319296
DA 2018-10-20
ER

PT J
AU Tirapelli, C
   Panzeri, H
   Lara, EHG
   Soares, RG
   Peitl, O
   Zanotto, ED
AF Tirapelli, C.
   Panzeri, H.
   Lara, E. H. G.
   Soares, R. G.
   Peitl, O.
   Zanotto, E. D.
TI The effect of a novel crystallised bioactive glass-ceramic powder on
   dentine hypersensitivity: a long-term clinical study
SO JOURNAL OF ORAL REHABILITATION
LA English
DT Article
DE biomaterial; clinical study; dentine hypersensitivity
ID IN-VITRO; DP-BIOGLASS; S53P4; BIOSILICATE(R); SENSITIVITY; EFFICACY;
   AGENTS; LASER
AB P>The aim of this comparative clinical study was to evaluate a novel bioactive glass-ceramic (Biosilicate (R) 1-20 mu m particles) to treat dentine hypersensitivity (DH). Volunteers (n = 120 patients/ 230 teeth) received the following treatments: G1-Sensodyne (R), G2-SensiKill (R), G3-Biosilicate (R) incorporated in a 1% water-free-gel and G4-Biosilicate (R) mixed with distilled water at 1:10 ratio. G1 and G3 were applied at home, daily for 30 days; G2 and G4 were applied once a week by a dentist (four applications). A visual analogue scale (VAS) was employed to evaluate pain for each quadrant in one sensitive tooth at baseline, weekly during treatment and during a 6-month follow-up period. Dentine hypersensitivity values (G1/n = 52), (G2/n = 62), (G3/n = 59) and (G4/n = 59) were analysed with Kruskal-Wallis/Dunn tests. All the products were efficient in reducing DH after 4 weeks. Among the four materials tested, G4 demonstrated the best clinical performance and provided the fastest treatment to reduce DH pain. Distilled water proved to be an adequate vehicle to disperse Biosilicate (R). Low DH scores were maintained during the 6-month follow-up period. The hypothesis that the novel bioactive glass-ceramic may be an efficient treatment for DH was confirmed.
C1 [Tirapelli, C.; Panzeri, H.; Soares, R. G.] Univ Sao Paulo, Dept Dent Mat & Prosthesis, Fac Dent Ribeirao Preto, BR-14040090 Sao Paulo, Brazil.
   [Lara, E. H. G.] Univ Sao Paulo, Fac Pharmaceut Sci Ribeirao Preto, BR-14040090 Sao Paulo, Brazil.
   [Peitl, O.; Zanotto, E. D.] Univ Fed Sao Carlos, Dept Mat Engn, Vitreous Mat Lab, Sao Paulo, Brazil.
RP Tirapelli, C (reprint author), Univ Sao Paulo, Dept Dent Mat & Prosthesis, Fac Dent Ribeirao Preto, Ave Cafe S-N, BR-14040090 Sao Paulo, Brazil.
EM catirapelli@forp.usp.br
RI Tirapelli, Camila/I-8860-2012; PANZERI, HEITOR/B-3497-2013; Rastelli,
   Marcio/B-8034-2011; Zanotto, Edgar/A-7992-2011
OI Zanotto, Edgar/0000-0003-4931-4505; Tirapelli,
   Camila/0000-0001-5020-6515
FU FAPESP, State of Sao Paulo Research Foundation [04/05133-0, 07/08179-9];
   CNPq, National Council for Scientific and Technological Development
   [0400604/2004-3]; Capes
FX The authors are grateful to FAPESP, the State of Sao Paulo Research
   Foundation (contract number 04/05133-0 and 07/08179-9), and CNPq, the
   National Council for Scientific and Technological Development (contract
   number 0400604/2004-3) and Capes, for financial support of this work.
CR ADDY M, 1983, J CLIN PERIODONTOL, V10, P351, DOI 10.1111/j.1600-051X.1983.tb01284.x
   Bamise Cornelius T, 2007, Oral Health Prev Dent, V5, P49
   Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299
   Brannstrom M, 1992, Proc Finn Dent Soc, V88 Suppl 1, P7
   Canadian Advisory Board on Dentin Hypersensitivity, 2003, J CAN DENT ASSOC, V69, P221
   CARNALI JO, 1992, COLLOID POLYM SCI, V270, P183, DOI 10.1007/BF00652185
   Chabanski MB, 1996, J CLIN PERIODONTOL, V23, P989, DOI 10.1111/j.1600-051X.1996.tb00525.x
   Corona SAM, 2003, J ORAL REHABIL, V30, P1183, DOI 10.1111/j.1365-2842.2003.01185.x
   *DFL, SENS KILL INSTR MAN
   Di Fede Olga, 2005, Recenti Progressi in Medicina, V96, P445
   Duran I, 2004, J ORAL REHABIL, V31, P351, DOI 10.1046/j.1365-2842.2003.01241.x
   Efflandt SE, 2002, J MATER SCI-MATER M, V13, P557, DOI 10.1023/A:1015174726415
   Forsback AP, 2004, ACTA ODONTOL SCAND, V62, P14, DOI 10.1080/00016350310008012
   Frechoso SC, 2003, J CLIN PERIODONTOL, V30, P315, DOI 10.1034/j.1600-051X.2003.20077.x
   GILLAM GD, 2002, J ORAL REHABIL, V29, P305
   Granito RN, 2009, J MATER SCI-MATER M, V20, P2521, DOI 10.1007/s10856-009-3824-z
   Hench LL, 2006, J MATER SCI-MATER M, V17, P967, DOI 10.1007/s10856-006-0432-z
   Holland GR, 1997, J CLIN PERIODONTOL, V24, P808, DOI 10.1111/j.1600-051X.1997.tb01194.x
   Kakaboura A, 2005, AM J DENT, V18, P291
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P825, DOI 10.1002/1097-4636(20001215)52:4<825::AID-JBM28>3.0.CO;2-M
   KING C, USE NOVAMIN CONTAINI
   Lee BS, 2007, DENT MATER J, V26, P52, DOI 10.4012/dmj.26.52
   Lee BS, 2005, DENT MATER, V21, P511, DOI 10.1016/j.dental.2004.08.002
   Lin CP, 2000, BIOMATERIALS, V21, P637, DOI 10.1016/S0142-9612(99)00234-3
   Lo Russo L, 2008, ORAL DIS, V14, P479, DOI 10.1111/j.1601-0825.2007.01422.x
   MARINI I, PILOT CLIN STUDY EVA
   Min Q Du, 2008, AM J DENT, V21, P210
   Moura J, 2007, J BIOMED MATER RES A, V82A, P545, DOI 10.1002/jbm.a.31165
   Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321
   Roriz VM, 2010, CLIN ORAL IMPLAN RES, V21, P148, DOI 10.1111/j.1600-0501.2009.01812.x
   SHARMA N, RANDOMIZED PARALLEL
   TIRAPELLI C, 2010, BRAZ ORAL R IN PRESS
   Vollenweider M, 2007, ACTA BIOMATER, V3, P936, DOI 10.1016/j.actbio.2007.04.003
   ZANOTTO ED, 2004, Patent No. 2004074199
   Zehnder M, 2006, INT ENDOD J, V39, P952, DOI 10.1111/j.1365-2591.2006.01173.x
   Zehnder M, 2006, ORAL SURG ORAL MED O, V101, P530, DOI 10.1016/j.tripleo.2005.03.014
NR 36
TC 17
Z9 20
U1 1
U2 12
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0305-182X
J9 J ORAL REHABIL
JI J. Oral Rehabil.
PD APR
PY 2011
VL 38
IS 4
BP 253
EP 262
DI 10.1111/j.1365-2842.2010.02157.x
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 732EM
UT WOS:000288167700003
PM 20868428
DA 2018-10-20
ER

PT J
AU Lacoste-Ferre, MH
   Demont, P
   Dandurand, J
   Dantras, E
   Duran, D
   Lacabanne, C
AF Lacoste-Ferre, M. -H.
   Demont, Ph
   Dandurand, J.
   Dantras, E.
   Duran, D.
   Lacabanne, C.
TI Dynamic mechanical properties of oral mucosa: Comparison with polymeric
   soft denture liners
SO JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS
LA English
DT Article
DE Creep recovery; Dynamic mechanical analysis; Polyacrylic; Polyisoprene;
   Polysiloxane; Oral mucosa; Denture soft liner
ID LINING MATERIALS; VISCOELASTIC PROPERTIES; THERMAL-ANALYSIS; DENTAL
   POLYMERS; BUCCAL MUCOSA; RESINS; TISSUE; PERMEABILITY; EPITHELIUM;
   RHEOLOGY
AB The purpose of this work was to characterize the viscoelastic behaviour of oral mucosa and compare it with the dynamic mechanical properties of different soft liners. For this purpose, a sample of pig oral mucosa and six commercialized soft liner samples have been investigated. A comparison was also carried with the first suitable hard rubber for dental prosthetics: vulcanite. Creep recovery (CR) and dynamic mechanical analysis (DMA) have been used to determine the mechanical modulus of oral mucosa and soft liners respectively. The Poisson ratio is used to compare mucosa bulk modulus and soft liner shear modulus. The biomechanical concept of conventional complete dentures needs a good adjustment of dynamic mechanical impedance between the base and oral mucosa. The viscoelastic mechanical property of the oral mucosa as a referent biopolymer has been confirmed in vitro. The modulus value, adjusted for old patients in physiological conditions, is in the order of 3 MPa. This study underlines the plasticization effect of absorbed water on the mechanical properties of the underlying tissue. This study allows us to define some characteristics of the most adapted biomaterial according to the clinical exigency. The required biomaterial must display the following properties: compatibility and chemical resistance with biological environment perpetuated mechanical properties during physiological conditions and clinical use, good adjustment of dynamic mechanical impedance with supporting mucosa and easy sample processing. (C) 2010 Elsevier Ltd. All rights reserved.
C1 [Lacoste-Ferre, M. -H.; Demont, Ph; Dandurand, J.; Dantras, E.; Lacabanne, C.] Univ Toulouse 3, CIRIMAT, Inst Carnot, F-31062 Toulouse, France.
   [Lacoste-Ferre, M. -H.; Duran, D.] CHU, Toulouse, France.
RP Dantras, E (reprint author), Univ Toulouse 3, CIRIMAT, Inst Carnot, 118 Route Narbonne, F-31062 Toulouse, France.
EM dantras@cict.fr
CR Braden M, 1995, Eur J Prosthodont Restor Dent, V3, P163
   BRADEN M, 1997, POLYM DENT MAT
   Buch D, 1995, Int J Prosthodont, V8, P285
   CLARKE RL, 1989, BIOMATERIALS, V10, P494, DOI 10.1016/0142-9612(89)90092-6
   CLARKE RL, 1989, BIOMATERIALS, V10, P549, DOI 10.1016/0142-9612(89)90061-6
   De Caro V, 2008, EUR J PHARM BIOPHARM, V70, P869, DOI 10.1016/j.ejpb.2008.06.025
   Inoue K, 1985, Dent Mater J, V4, P47
   Jagger DC, 1997, BRIT DENT J, V182, P313, DOI 10.1038/sj.bdj.4809374
   JEROLIMOV V, 1991, J DENT, V19, P245, DOI 10.1016/0300-5712(91)90128-L
   Kulkarni U, 2009, J PHARM SCI-US, V98, P471, DOI 10.1002/jps.21436
   KYDD WL, 1971, INT DENT J, V21, P430
   KYDD WL, 1982, J PROSTHET DENT, V47, P317, DOI 10.1016/0022-3913(82)90162-7
   McCabe J F, 1996, Eur J Prosthodont Restor Dent, V4, P77
   McCabe JF, 2002, BIOMATERIALS, V23, P1347, DOI 10.1016/S0142-9612(01)00253-8
   McCrum N.G., 1991, ANELASTIC DIELECTRIC
   MCGREGOR AR, 1984, J DENT, V12, P146
   Mesquita RV, 2006, DENT MATER, V22, P258, DOI 10.1016/j.dental.2005.04.019
   Murata H, 1998, J PROSTHET DENT, V79, P188, DOI 10.1016/S0022-3913(98)70215-X
   Murata H, 2000, BIOMATERIALS, V21, P1421, DOI 10.1016/S0142-9612(00)00010-7
   Murata H, 2002, J DENT RES, V81, P123, DOI 10.1177/154405910208100208
   Murata H, 1998, J PROSTHET DENT, V80, P714, DOI 10.1016/S0022-3913(98)70060-5
   Rueggeberg FA, 2002, J PROSTHET DENT, V87, P364, DOI 10.1067/mpr.2002.123400
   Saber-Sheikh K, 1999, BIOMATERIALS, V20, P817, DOI 10.1016/S0142-9612(98)00236-1
   Shojaei A H, 1998, J Pharm Pharm Sci, V1, P15
   Sloan P, 1991, Dent Update, V18, P208
   SQUIER CA, 1993, ADV DRUG DELIVERY RE, V12, P12
   Stafford G D, 1975, J Dent, V3, P193, DOI 10.1016/0300-5712(75)90120-7
   STAFFORD GD, 1986, J DENT, V14, P18, DOI 10.1016/0300-5712(86)90097-7
   Takahashi T, 2001, RHEOL ACTA, V40, P490, DOI 10.1007/s003970100173
   Tamura Fumiyo, 2002, J Prosthodont, V11, P270, DOI 10.1111/j.1532-849X.2002.00270.x
   Van Krevelen D. W., 1972, PROPERTIES POLYM COR
   WARD IM, 1971, MECH PROPERTIES SOLI
   Waters M, 1996, BIOMATERIALS, V17, P1627, DOI 10.1016/0142-9612(95)00330-4
   Waters MGJ, 1999, J DENT, V27, P197, DOI 10.1016/S0300-5712(98)00046-3
   WERTZ PW, 1993, ADV DRUG DELIVER REV, V12, P1, DOI 10.1016/0169-409X(93)90037-5
   WILLIAMS KR, 1996, J DENT, V24, P3018
   WRIGHT PS, 1984, J DENT, V12, P319, DOI 10.1016/0300-5712(84)90090-3
   WRIGHT PS, 1981, J DENT, V9, P210, DOI 10.1016/0300-5712(81)90057-9
   WRIGHT PS, 1994, J PROSTHET DENT, V72, P385, DOI 10.1016/0022-3913(94)90558-4
   WRIGHT PS, 1976, J DENT, V6, P247
NR 40
TC 9
Z9 9
U1 0
U2 22
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1751-6161
J9 J MECH BEHAV BIOMED
JI J. Mech. Behav. Biomed. Mater.
PD APR
PY 2011
VL 4
IS 3
BP 269
EP 274
DI 10.1016/j.jmbbm.2010.10.005
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 733BV
UT WOS:000288236300006
PM 21316614
DA 2018-10-20
ER

PT J
AU Le Guillou-Buffello, D
   Gindre, M
   Johnson, P
   Laugier, P
   Migonney, V
AF Le Guillou-Buffello, Delphine
   Gindre, Marcel
   Johnson, Paul
   Laugier, Pascal
   Migonney, Veronique
TI An Alternative Quantitative Acoustical and Electrical Method for
   Detection of Cell Adhesion Process in Real-Time
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE quartz crystal resonator; biosensors; thickness shear mode; impedance
   analysis; cell adhesion
ID QUARTZ-CRYSTAL MICROBALANCE; EXTRACELLULAR-MATRIX; MAMMALIAN-CELLS;
   ADHERENT CELLS; WAVE SENSORS; ATTACHMENT; DYNAMICS; MODE; RESONATORS;
   PROLIFERATION
AB Sauerbrey [(1956), Z Phys 55:206-222] showed that the shift in resonance frequency of thickness shear mode (TSM) of a quartz crystal sensor is proportional to the mass, which is deposited on it. However, new powerful electrical circuits were developed that are capable of operating TSM quartz crystal sensors in fluids which enabled this method to be introduced into electrochemical and biological applications. These applications include the detection of virus capsids, bacteria, mammalian cells, the interaction of DNA and RNA with complementary strands, specific recognition of protein ligands by immobilized receptors, and last but not least the study of complete immunosensors. Piezoelectric quartz transducers allow a label-free identification of molecules; they are more than mass sensors since the biosensor response is also influenced by the surface charge of adsorbed proteins, interfacial phenomena, surface roughness and viscoelastic properties of the adhered biomaterial. These new characteristics have recently been used to investigate cell, liposome, and protein adhesion onto surfaces, thus permitting the rapid determination of morphological cell changes as a response to pharmacological substances, and changes in the water content of biopolymers avoiding of time-consuming methods. We validated an alternative quantitative acoustical engineering for cell adhesion process monitored by the TSM. Shear acoustical results (motional resistance) are further correlated to cell counting procedures and are sensitive of adhesion processes in real-time. Biotechnol. Bioeng. 2011;108: 947-962. (C) 2010 Wiley Periodicals, Inc.
C1 [Le Guillou-Buffello, Delphine; Gindre, Marcel; Laugier, Pascal] Univ Paris 06, UPMC, UMR 7623, LIP, F-75005 Paris, France.
   [Le Guillou-Buffello, Delphine; Gindre, Marcel; Laugier, Pascal] CNRS, UMR 7623, Lab Imagerie Parametr, F-75006 Paris, France.
   [Johnson, Paul] Los Alamos Natl Lab, Geophys Grp, Los Alamos, NM USA.
   [Migonney, Veronique] Univ Paris 13, Lab Biomat & Polymeres Specialite, Inst Galilee, LBPS CSPBAT CNRS FRE 3043, F-93430 Villetaneuse, France.
RP Le Guillou-Buffello, D (reprint author), Univ Paris 06, UPMC, UMR 7623, LIP, F-75005 Paris, France.
EM delphine.le_guillou@upmc.fr
RI Laugier, Pascal/P-1658-2017
OI Laugier, Pascal/0000-0002-7498-0262; Johnson, Paul/0000-0002-0927-4003;
   MIGONNEY, VERONIQUE/0000-0002-1055-3720
FU Ministere de l'Education Nationale de la Jeunesse de la Recherche et de
   la Technologie (MENJRT)
FX This study was supported by the Ministere de l'Education Nationale de la
   Jeunesse de la Recherche et de la Technologie (MENJRT).
CR Bandey HL, 1999, ANAL CHEM, V71, P2205, DOI 10.1021/ac981272b
   Boulter E, 2006, EUR J CELL BIOL, V85, P255, DOI 10.1016/j.ejcb.2005.09.002
   Cavalcanti-Adam EA, 2006, EUR J CELL BIOL, V85, P219, DOI 10.1016/j.ejcb.2005.09.011
   Channavajjala LS, 1997, J CELL SCI, V110, P249
   Cuvelier D, 2007, CURR BIOL, V17, P694, DOI 10.1016/j.cub.2007.02.058
   EBERSOLE RC, 1991, BIO-TECHNOL, V9, P450, DOI 10.1038/nbt0591-450
   Eibl KH, 2006, INVEST OPHTH VIS SCI, V47, P364, DOI 10.1167/iovs.05-0657
   Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592
   Fohlerova Z, 2007, BIOSENS BIOELECTRON, V22, P1896, DOI 10.1016/j.bios.2006.08.015
   Guo ML, 2008, BIOSENS BIOELECTRON, V23, P865, DOI 10.1016/j.bios.2007.09.006
   Haider L, 2004, IEEE SENS J, V4, P535, DOI 10.1109/JSEN.2004.832856
   Hasmim M, 2005, THROMB HAEMOSTASIS, V94, P1060, DOI 10.1160/TH05-02-0108
   Heitmann V, 2007, ANAL CHEM, V79, P3392, DOI 10.1021/ac062433b
   Hynes RO, 1999, TRENDS GENET, V15, pM33, DOI 10.1016/S0168-9525(99)01891-0
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Kamath AB, 1998, TOXICOL APPL PHARM, V150, P117, DOI 10.1006/taap.1998.8390
   Karakecili AG, 2007, J BIOSCI BIOENG, V104, P69, DOI 10.1263/jbb.104.69
   LADAU LD, 1991, HYDRODYNAMIK, P113
   Le Guillou-Buffello D, 2005, BIOMATERIALS, V26, P4197, DOI 10.1016/j.biomaterials.2004.10.024
   Le Guillou-Buffello D., 2004, ITBM RBM, V25, P34
   Le Guillou-Buffello D, 2008, TISSUE ENG PT A, V14, P1445, DOI 10.1089/ten.tea.2007.0292
   Levitan I, 2000, ANN BIOMED ENG, V28, P1184, DOI 10.1114/1.1317529
   Li F, 2007, BIOSENS BIOELECTRON, V23, P42, DOI 10.1016/j.bios.2007.03.018
   Li J, 2005, BIOSENS BIOELECTRON, V20, P1333, DOI 10.1016/j.bios.2004.05.004
   Lord MS, 2008, BIOMATERIALS, V29, P2581, DOI 10.1016/j.biomaterials.2008.03.002
   MARTIN SJ, 1991, ANAL CHEM, V63, P2272, DOI 10.1021/ac00020a015
   Marx KA, 2003, BIOTECHNOL PROGR, V19, P987, DOI 10.1021/bp0201096
   McClary KB, 1999, BIOMATERIALS, V20, P2435, DOI 10.1016/S0142-9612(99)00171-4
   McGarry JP, 2008, J MECH PHYS SOLIDS, V56, P1554, DOI 10.1016/j.jmps.2007.08.001
   Morgan AW, 2008, BIOMATERIALS, V29, P2556, DOI 10.1016/j.biomaterials.2008.02.007
   Nicolas A, 2006, BIOPHYS J, V91, P61, DOI 10.1529/biophysj.105.077115
   Park S, 2006, J NEUROPHYSIOL, V96, P486, DOI 10.1152/jn.01163.2005
   RAJAKOVIC LV, 1991, ANAL CHEM, V63, P615, DOI 10.1021/ac00006a012
   REED CE, 1990, J APPL PHYS, V68, P1993, DOI 10.1063/1.346548
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   SAUERBREY G, 1956, Z PHYS, V55, P206
   Thid D, 2007, LANGMUIR, V23, P11693, DOI 10.1021/la701159u
   Tilghman RW, 2008, SEMIN CANCER BIOL, V18, P45, DOI 10.1016/j.semcancer.2007.08.002
   Toral C, 2007, LIFE SCI, V81, P255, DOI 10.1016/j.lfs.2007.05.014
   Viigipuu K, 2004, ATLA-ALTERN LAB ANIM, V32, P417
   Wang XM, 2008, ANALYST, V133, P85, DOI 10.1039/b714210b
   Wegener J, 2000, BIOPHYS J, V78, P2821, DOI 10.1016/S0006-3495(00)76825-1
   Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180
   Wei XL, 2007, COLLOID SURFACE B, V59, P100, DOI 10.1016/j.colsurfb.2007.04.016
   Welle A, 2007, BIOMOL ENG, V24, P87, DOI 10.1016/j.bioeng.2006.05.027
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Zhao T, 2009, LANGMUIR, V25, P1540, DOI 10.1021/la8026804
NR 47
TC 10
Z9 10
U1 0
U2 17
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD APR
PY 2011
VL 108
IS 4
BP 947
EP 962
DI 10.1002/bit.23005
PG 16
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 730LL
UT WOS:000288034700022
PM 21404267
DA 2018-10-20
ER

PT J
AU Lo, KWH
   Ashe, KM
   Kan, HM
   Lee, DA
   Laurencin, CT
AF Lo, Kevin W. -H.
   Ashe, Keshia M.
   Kan, Ho Man
   Lee, Duron A.
   Laurencin, Cato T.
TI Activation of Cyclic AMP/Protein Kinase: A Signaling Pathway Enhances
   Osteoblast Cell Adhesion on Biomaterials for Regenerative Engineering
SO JOURNAL OF ORTHOPAEDIC RESEARCH
LA English
DT Article
DE cAMP; cell adhesion; bone regeneration; poly(lactide-co-glycolide);
   tissue engineering
ID EXTRACELLULAR-MATRIX; PROTEIN-KINASE; BONE REPAIR; TISSUE; POLYMERS;
   EPAC; INTEGRIN; RAP1; PROLIFERATION; CAMP/PKA
AB Osteoblast cell adhesion on biomaterials is an important goal for implants to be useful in bone regeneration technologies. The adhesion of osteoblastic cells to biomaterials has been investigated in the field of bone regenerative engineering. Previous work from our group demonstrated that osteoblastic cells adhering to biodegradable biomaterials require the expression of integrins on the cell surface. However, the underlying molecular signaling mechanism is still not fully clear. We report here that cyclic adenosine monophosphate (cAMP), a small signaling molecule, regulates osteoblast cell adhesion to biomaterial surfaces. We used an in vitro cell adhesion assay to demonstrate that at 0.1 mM, 8-Br-cAMP, a cell-permeable cAMP analog, significantly enhances osteoblast-like cells' (MC3T3-E1) adherence to biomaterials. Moreover, we demonstrate that a commonly used cAMP-elevating agent, forskolin, promotes cell adhesion similar to that of the cell permeable cAMP analog. By using different target-specific cAMP analogs: 8-CPT-2Me-cAMP which specifically activates exchange protein activated by cAMP (Epac), and 6-Bnz-cAMP which specifically activates protein kinase A (PKA), we observed that the PKA signaling pathway plays a dominant role in this process. Thus, this report suggests a new method to enhance osteoblast cell adhesion on biodegradable biomaterials for bone regenerative engineering applications. (C) 2010 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 29:602-608, 2011
C1 [Lo, Kevin W. -H.; Kan, Ho Man; Laurencin, Cato T.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, New England Musculoskeletal Inst, Farmington, CT 06030 USA.
   [Ashe, Keshia M.; Laurencin, Cato T.] Univ Connecticut, Dept Chem Engn, Storrs, CT 06268 USA.
   [Lee, Duron A.] Drexel Univ, Dept Biomed Engn, Philadelphia, PA 19104 USA.
RP Laurencin, CT (reprint author), Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, New England Musculoskeletal Inst, Farmington, CT 06030 USA.
EM laurencin@uchc.edu
FU NSF;  [NIH-AR052536];  [NSF-EFRI 0736002]
FX We thank Dr. Cyril Pilane for his assistance with this work. We would
   like to thank Dr. Yusuf Khan and Mr. James Veronick for comments. Dr.
   Laurencin was the recipient of a Presidential Faculty Fellowship Award
   from NSF. This work was supported by NSF-EFRI 0736002 and NIH-AR052536.
CR Arrington ED, 1996, CLIN ORTHOP RELAT R, P300
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Borden M, 2003, BIOMATERIALS, V24, P597, DOI 10.1016/S0142-9612(02)00374-5
   Borden M, 2002, J BIOMED MATER RES, V61, P421, DOI 10.1002/jbm.10201
   Bos JL, 2003, BIOCHEM SOC T, V31, P83, DOI 10.1042/bst0310083
   Carmona G, 2008, BLOOD, V111, P2640, DOI 10.1182/blood-2007-04-086231
   Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200
   DALY JW, 1984, ADV CYCLIC NUCL PROT, V17, P81
   de Rooij J, 1998, NATURE, V396, P474
   El-Amin SF, 2004, CLIN ORTHOP RELAT R, P220, DOI 10.1097/01.blo.0000137556.51604.0c
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   El-Amin SF, 2006, J BIOMED MATER RES A, V76A, P439, DOI 10.1002/jbm.a.30411
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Enserink JM, 2004, J BIOL CHEM, V279, P44889, DOI 10.1074/jbc.M404599200
   Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874
   FRIEDLAENDER GE, 1983, CLIN ORTHOP RELAT R, P58
   Gazdag A.R., 1995, J AM ACAD ORTHOP SUR, V3, P1, DOI DOI 10.5435/00124635-199501000-00001
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   HARADA S, 1991, J BONE MINER RES, V6, P903
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005
   Humphries Martin J., 2009, V522, P203, DOI 10.1007/978-1-59745-413-1_14
   IKADA Y, 1994, BIOMATERIALS, V15, P725, DOI 10.1016/0142-9612(94)90025-6
   Jabbarzadeh E, 2008, P NATL ACAD SCI USA, V105, P11099, DOI 10.1073/pnas.0800069105
   Kofron MD, 2003, J ORTHOP RES, V21, P1005, DOI 10.1016/S0736-0266(03)00103-7
   Laurencin CT, 1996, BONE, V19, pS93, DOI 10.1016/S8756-3282(96)00132-9
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lee Duron A., 2008, P163, DOI 10.1201/9781420051834.ch6
   Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200
   Marquis ME, 2009, FRONT BIOSCI-LANDMRK, V14, P1023, DOI 10.2741/3293
   Mooney DT, 1996, BIOMATERIALS, V17, P115, DOI 10.1016/0142-9612(96)85756-5
   Morwood SR, 2006, ARCH IMMUNOL THER EX, V54, P367, DOI 10.1007/s00005-006-0043-x
   Netherton SJ, 2007, CIRC RES, V101, P768, DOI 10.1161/CIRCRESAHA.106.146159
   Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105
   ROSALES C, 1995, BBA-REV CANCER, V1242, P77, DOI 10.1016/0304-419X(95)00005-Z
   Sepulveda JL, 2005, CURR TOP DEV BIOL, V68, P183, DOI 10.1016/S0070-2153(05)68007-6
   Siddappa R, 2008, P NATL ACAD SCI USA, V105, P7281, DOI 10.1073/pnas.0711190105
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.biochem.59.1.971
   Wadhwa S, 2002, BIOCHEM BIOPH RES CO, V297, P46, DOI 10.1016/S0006-291X(02)02124-1
   Whittard JD, 2001, J CELL SCI, V114, P3265
NR 44
TC 10
Z9 12
U1 0
U2 11
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0736-0266
J9 J ORTHOP RES
JI J. Orthop. Res.
PD APR
PY 2011
VL 29
IS 4
BP 602
EP 608
DI 10.1002/jor.21276
PG 7
WC Orthopedics
SC Orthopedics
GA 731LV
UT WOS:000288109300020
PM 20957743
OA Bronze
DA 2018-10-20
ER

PT J
AU Harkin, DG
   George, KA
   Madden, PW
   Schwab, IR
   Hutmacher, DW
   Chirila, TV
AF Harkin, Damien G.
   George, Karina A.
   Madden, Peter W.
   Schwab, Ivan R.
   Hutmacher, Dietmar W.
   Chirila, Traian V.
TI Silk fibroin in ocular tissue reconstruction
SO BIOMATERIALS
LA English
DT Article
DE Silk; Fibroin; Cornea; Retina; Transplantation
ID HUMAN CORNEAL FIBROBLASTS; BOMBYX-MORI SILK; SIDE-POPULATION CELLS;
   LIMBAL STEM-CELLS; MACULAR DEGENERATION; EPITHELIAL-CELLS;
   ENDOTHELIAL-CELLS; TRANSPLANTATION; BIOMATERIALS; SCAFFOLDS
AB The silk structural protein fibroin displays potential for use in tissue engineering. We present here our opinion of its value as a biomaterial for reconstructing tissues of clinical significance within the human eye. We review the strengths and weaknesses of using fibroin in those parts of the eye that we believe are most amenable to cellular reconstruction, namely the corneoscleral limbus, corneal stroma, corneal endothelium and outer blood-retinal barrier (Ruysch's complex). In these areas we find that by employing the range of manufacturing products afforded by fibroin, relevant structural assemblies can be made for cells expanded ex vivo. Significant questions now need to be answered concerning the effect of this biomaterial on the phenotype of key cell types and the biocompatibility of fibroin within the eye. We conclude that fibroin's strength, structural versatility and potential for modification, combined with the relative simplicity of associated manufacturing processes, make fibroin a worthy candidate for further exploration. (C) 2011 Elsevier Ltd. All rights reserved.
C1 [Harkin, Damien G.; George, Karina A.] Queensland Univ Technol, Discipline Med Sci, Fac Sci & Technol, Brisbane, Qld 4000, Australia.
   [Harkin, Damien G.; George, Karina A.; Hutmacher, Dietmar W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Australia.
   [Harkin, Damien G.; George, Karina A.; Madden, Peter W.; Schwab, Ivan R.; Chirila, Traian V.] Queensland Eye Inst, Brisbane, Qld, Australia.
   [Madden, Peter W.; Chirila, Traian V.] Univ Queensland, Sch Med, Herston, Qld, Australia.
   [Schwab, Ivan R.] Univ Calif Davis, UC Davis Hlth Serv Eye Ctr, Sacramento, CA 95817 USA.
   [Chirila, Traian V.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld, Australia.
   [Chirila, Traian V.] Queensland Univ Technol, Fac Sci & Technol, Discipline Chem, Brisbane, Qld 4000, Australia.
RP Harkin, DG (reprint author), Queensland Univ Technol, Discipline Med Sci, Fac Sci & Technol, 2 George St, Brisbane, Qld 4000, Australia.
EM d.harkin@qut.edu.au
RI Harkin, Damien/A-3501-2011
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134; Harkin,
   Damien/0000-0002-7358-7987
FU National Health & Medical Research Council of Australia [553038]
FX This work was supported by funding received from the National Health &
   Medical Research Council of Australia (Project Grant ID: 553038) awarded
   to authors DGH, TVC, DWH and IRS. The authors acknowledge Professor
   David Kaplan (Tufts University, Boston, USA) for his advice and
   encouragement. Thanks are also extended to Dr Sunil Kale (presently of
   Sahajanand Medical Technologies Pvt. Ltd, Gujarat, India) for assistance
   with creating the mat of electrospun fibres of fibroin (presented in
   Fig. 4 panel L) during his time as a visiting postgraduate student in
   our laboratory. Clinical images of cornea (Fig. 2 panels A, B, C and E;
   Fig. 3 panels F and G) are courtesy of Professor Lawrence Hirst
   (Queensland Eye Institute, Brisbane, Australia). Fundus images (Fig. 2
   panels F and G) were provided by Associate Professor Tony Kwan
   (Queensland Eye Institute, Brisbane, Australia). Images of procedure and
   outcomes for transplantation of cultured limbal epithelial cells (Fig. 3
   panels B to E) were produced by DGH in collaboration with Dr Andrew Apel
   (Queensland Eye Hospital, Brisbane, Australia). Images presented in Fig.
   6. were produced with assistance from Ms Cassie Rayner (Institute for
   Health and Biomedical Innovation, Queensland University of Technology,
   Brisbane, Australia). We further acknowledge that all studies involving
   animals or humans referred to in this manuscript were performed with
   appropriate institutional research ethics committee approvals.
CR Ainscough SL, 2011, EXP EYE RES, V92, P10, DOI 10.1016/j.exer.2010.10.004
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Ashwin PT, 2009, CLIN EXP OPTOM, V92, P333, DOI 10.1111/j.1444-0938.2009.00393.x
   Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003
   Bashshur ZF, 2006, AM J OPHTHALMOL, V142, P1, DOI 10.1016/j.ajo.2006.02.037
   Binder S, 2007, PROG RETIN EYE RES, V26, P516, DOI 10.1016/j.preteyeres.2007.02.002
   Bondar B, 2008, BIOMATERIALS, V29, P561, DOI 10.1016/j.biomaterials.2007.10.002
   Booij JC, 2010, PROG RETIN EYE RES, V29, P1, DOI 10.1016/j.preteyeres.2009.08.003
   Buchholz DE, 2009, STEM CELLS, V27, P2427, DOI 10.1002/stem.189
   Carrier P, 2008, INVEST OPHTH VIS SCI, V49, P1376, DOI 10.1167/iovs.07-0904
   Chirila T, 2007, MATER SCI FORUM, V561-565, P1549, DOI 10.4028/www.scientific.net/MSF.561-565.1549
   Chirila TV, 2008, TISSUE ENG PT A, V14, P1203, DOI 10.1089/tea.2007.0224
   Chirila TV, 2001, BIOMATERIALS, V22, P3311, DOI 10.1016/S0142-9612(01)00168-5
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Deng C, 2010, ACTA BIOMATER, V6, P187, DOI 10.1016/j.actbio.2009.07.027
   Di lorio E, 2005, P NATL ACAD SCI USA, V102, P9523
   Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Fagerholm P, 2009, CTS-CLIN TRANSL SCI, V2, P162, DOI 10.1111/j.1752-8062.2008.00083.x
   Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017
   Gil ES, 2010, MACROMOL BIOSCI, V10, P664, DOI 10.1002/mabi.200900452
   Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216
   Hadlock T, 1999, TISSUE ENG, V5, P187, DOI 10.1089/ten.1999.5.187
   Harkin DG, 2004, BRIT J OPHTHALMOL, V88, P1154, DOI 10.1136/bjo.2003.037853
   HARKIN DG, 2010, ANN M ASS RES VIS OP
   HEIER JS, 2006, OPHTHALMOLOGY, V113, P641
   Higa K., J BIOMATER IN PRESS
   Hofmann S, 2006, TISSUE ENG, V12, P2729, DOI 10.1089/ten.2006.12.2729
   Hussain AA, 2010, EXP EYE RES, V90, P703, DOI 10.1016/j.exer.2010.02.013
   Hynes SR, 2010, GRAEF ARCH CLIN EXP, V248, P763, DOI 10.1007/s00417-009-1263-7
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Joyce Nancy C, 2004, Cornea, V23, pS8, DOI 10.1097/01.ico.0000136666.63870.18
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim HJ, 2008, BONE, V42, P1226, DOI 10.1016/j.bone.2008.02.007
   Lawrence BD, 2008, J MATER SCI, V43, P6967, DOI 10.1007/s10853-008-2961-y
   Lawrence BD, 2009, BIOMATERIALS, V30, P1299, DOI 10.1016/j.biomaterials.2008.11.018
   Liu W, 2008, BIOMATERIALS, V29, P1147, DOI 10.1016/j.biomaterials.2007.11.011
   Lovett M, 2007, BIOMATERIALS, V28, P5271, DOI 10.1016/j.biomterials.2007.08.008
   Lu Q, 2010, ACTA BIOMATER, V6, P1380, DOI 10.1016/j.actbio.2009.10.041
   Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406
   MCNAB AA, 1993, AUST NZ J OPHTHALMOL, V21, P1
   Mimura T, 2004, INVEST OPHTH VIS SCI, V45, P2992, DOI 10.1167/iovs.03-1174
   Orwin EJ, 2003, J BIOMECH ENG-T ASME, V125, P439, DOI 10.1115/1.1589773
   Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51
   Park SY, 2010, TISSUE ENG PT A, V16, P1271, DOI [10.1089/ten.tea.2009.0328, 10.1089/ten.TEA.2009.0328]
   Pei Y, 2004, EXP EYE RES, V79, P705, DOI 10.1016/j.exer.2004.08.002
   Perry H, 2008, ADV MATER, V20, P3070, DOI 10.1002/adma.200800011
   Price MO, 2010, CLIN EXP OPHTHALMOL, V38, P128, DOI 10.1111/j.1442-9071.2010.02213.x
   Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002
   Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955
   SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49
   Schlotzer-Schrehardt U, 2007, EXP EYE RES, V85, P845, DOI 10.1016/j.exer.2007.08.020
   Schwab I R, 1999, Trans Am Ophthalmol Soc, V97, P891
   SINFIELD LJ, 2010, ANN M ASS RES VIS OP
   Sonoda S, 2010, AGING-US, V2, P28
   Steindl K, 2008, SPEKTRUM AUGENHEILKD, V22, P357, DOI 10.1007/s00717-008-0292-7
   Stepp MA, 2005, OCUL SURF, V3, P15, DOI 10.1016/S1542-0124(12)70119-2
   Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Torbet J, 2007, BIOMATERIALS, V28, P4268, DOI 10.1016/j.biomaterials.2007.05.024
   Toti P, 2002, OPHTHALMOLOGY, V109, P1167, DOI 10.1016/S0161-6420(02)01042-4
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202
   Umemoto T, 2006, STEM CELLS, V24, P86, DOI 10.1634/stemcells.2005-0064
   Unger RE, 2007, BIOMATERIALS, V28, P3965, DOI 10.1016/j.biomaterials.2007.05.032
   Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013
   VIEIRA A, 2010, ANN M ASS RES VIS OP
   Wang YZ, 2006, BIOMATERIALS, V27, P6064, DOI 10.1016/j.biomaterials.2006.07.008
   Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064
   Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4
   Yeung AMH, 2008, ARCH OPHTHALMOL-CHIC, V126, P665, DOI 10.1001/archopht.126.5.665
   Zakaria N, 2010, TISSUE ENG PART C-ME, V16, P921, DOI [10.1089/ten.tec.2009.0634, 10.1089/ten.TEC.2009.0634]
   Zhang XH, 2008, BIOMATERIALS, V29, P2217, DOI 10.1016/j.biomaterials.2008.01.022
NR 75
TC 63
Z9 64
U1 2
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD APR
PY 2011
VL 32
IS 10
BP 2445
EP 2458
DI 10.1016/j.biomaterials.2010.12.041
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 725EG
UT WOS:000287627400001
PM 21251709
DA 2018-10-20
ER

PT J
AU Bhat, S
   Tripathi, A
   Kumar, A
AF Bhat, Sumrita
   Tripathi, Anuj
   Kumar, Ashok
TI Supermacroprous chitosan-agarose-gelatin cryogels: in vitro
   characterization and in vivo assessment for cartilage tissue engineering
SO JOURNAL OF THE ROYAL SOCIETY INTERFACE
LA English
DT Article
DE chitosan-agarose-gelatin cryogels; cartilage tissue engineering;
   mechanical compression; three-dimensional scaffolds; biocompatibility
ID SCAFFOLD; CHONDROCYTES; HYALURONAN; GROWTH; REPAIR; BIOMATERIAL;
   CULTURE; MATRIX; BEADS
AB The study focuses on the synthesis of a novel polymeric scaffold having good porosity and mechanical characteristics synthesized by using natural polymers and their optimization for application in cartilage tissue engineering. The scaffolds were synthesized via cryogelation technology using an optimized ratio of the polymer solutions (chitosan, agarose and gelatin) and cross-linker followed by the incubation at sub-zero temperature (-12 degrees C). Microstructure examination of the chitosan-agarose-gelatine (CAG) cryogels was done using scanning electron microscopy (SEM) and fluorescent microscopy. Mechanical analysis, such as the unconfined compression test, demonstrated that cryogels with varying chitosan concentrations, i.e. 0.5-1% have a high compression modulus. In addition, fatigue tests revealed that scaffolds are suitable for bioreactor studies where gels are subjected to continuous cyclic strain. In order to confirm the stability, cryogels were subjected to high frequency (5 Hz) with 30 per cent compression of their original length up to 1 x 10(5) cycles, gels did not show any significant changes in their mass and dimensions during the experiment. These cryogels have exhibited degradation capacity under aseptic conditions. CAG cryogels showed good cell adhesion of primary goat chondrocytes examined by SEM. Cytotoxicity of the material was checked by MTT assay and results confirmed the biocompatibility of the material. In vivo biocompatibility of the scaffolds was checked by the implantation of the scaffolds in laboratory animals. These results suggest the potential of CAG cryogels as a good three-dimensional scaffold for cartilage tissue engineering.
C1 [Bhat, Sumrita; Tripathi, Anuj; Kumar, Ashok] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
RP Kumar, A (reprint author), Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India.
EM ashokkum@iitk.ac.in
RI Kumar, Ashok/G-8515-2015
OI Tripathi, Anuj/0000-0001-5800-300X
FU Department of Biotechnology, Ministry of Science and Technology,
   Government of India; India-UK (DST-UKIERI); Indo-US Science and
   Technology Forum
FX The authors would like to acknowledge Department of Biotechnology,
   Ministry of Science and Technology, Government of India; India-UK
   (DST-UKIERI) award project and Indo-US Science and Technology Forum.
CR Adrados BP, 2001, J CHROMATOGR A, V930, P73, DOI 10.1016/S0021-9673(01)01142-6
   ASTON JE, 1986, J BONE JOINT SURG BR, V68, P29
   Bhat S., 2009, EUROPEAN CELLS MAT J, V18, P46
   BUCKLEY CT, 2004, TOPICS BIOMECHANICAL, P147
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Capito RM, 2003, IEEE ENG MED BIOL, V22, P42, DOI 10.1109/MEMB.2003.1256271
   Chang CH, 2004, J BIOMED MATER RES B, V71B, P313, DOI 10.1002/jbm.b.30090
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Coutts RD, 2001, CLIN ORTHOP RELAT R, pS271, DOI 10.1097/00003086-200110001-00025
   Goodstone NJ, 2004, TISSUE ENG, V10, P621, DOI 10.1089/107632704323061979
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   Kathuria N, 2009, ACTA BIOMATER, V5, P406, DOI 10.1016/j.actbio.2008.07.009
   Li JS, 2005, J BIOMATER APPL, V19, P253, DOI 10.1177/0885328205047219
   Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002
   Lozinsky VI, 2001, BIOSEPARATION, V10, P163, DOI 10.1023/A:1016386902611
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Muller FA, 2006, BIOMATERIALS, V27, P3955, DOI 10.1016/j.biomaterials.2006.02.031
   Ng KW, 2005, J ORTHOP RES, V23, P134, DOI 10.1016/j.orthres.2004.05.015
   Pianigiani E, 1999, BIOMATERIALS, V20, P1689, DOI 10.1016/S0142-9612(99)00056-3
   Sachlos E., 2003, European Cells & Materials, V5, P29
   Sechriest VF, 2000, J BIOMED MATER RES, V49, P534, DOI 10.1002/(SICI)1097-4636(20000315)49:4<534::AID-JBM12>3.0.CO;2-#
   Srivastava A, 2007, MAT SCI ENG A-STRUCT, V464, P93, DOI 10.1016/j.msea.2007.03.057
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Swieszkowski W, 2006, BIOMATERIALS, V27, P1534, DOI 10.1016/j.biomaterials.2005.08.032
   Tripathi A, 2009, J BIOMED MATER RES A, V90A, P680, DOI 10.1002/jbm.a.32127
   Waldman SD, 2007, EUR CELLS MATER, V13, P66, DOI 10.22203/eCM.v013a07
   Xue W, 2004, EUR POLYM J, V40, P703, DOI 10.1016/j.eurpolymj.2003.10.021
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Zelent Mark E, 2005, J Foot Ankle Surg, V44, P406, DOI 10.1053/j.jfas.2005.07.008
   Zhuang H, 2007, J MATER SCI-MATER M, V18, P951, DOI 10.1007/s10856-006-0093-y
NR 32
TC 97
Z9 98
U1 1
U2 40
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1742-5689
EI 1742-5662
J9 J R SOC INTERFACE
JI J. R. Soc. Interface
PD APR
PY 2011
VL 8
IS 57
BP 540
EP 554
DI 10.1098/rsif.2010.0455
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 725NV
UT WOS:000287653100009
PM 20943683
OA Bronze, Green Published
DA 2018-10-20
ER

PT J
AU Suehiro, T
   Tada, T
   Waku, T
   Tanaka, N
   Hongo, C
   Yamamoto, S
   Nakahira, A
   Kojima, C
AF Suehiro, Tomoyuki
   Tada, Tomoko
   Waku, Tomonori
   Tanaka, Naoki
   Hongo, Chizuru
   Yamamoto, Shinya
   Nakahira, Atsushi
   Kojima, Chie
TI Temperature-Dependent Higher Order Structures of the
   (Pro-Pro-Gly)(10)-Modified Dendrimer
SO BIOPOLYMERS
LA English
DT Article
DE collagen; dendrimer; peptide; hydrogel; biomimetic material
ID COLLAGEN-MIMETIC DENDRIMERS; CROSS-LINKED COLLAGEN; TRIPLE-HELIX;
   PEPTIDES; DELIVERY; MODEL
AB Collagen is the most abundant protein in mammals and is widely used as a biomaterial for tissue engineering and drug delivery. We previously reported that dendrimers and linear polymers, modified with collagen model peptides (Pro-Pro-Gly)(5), form a collagen-like triple-helical structure; however, its triple helicity needs improvement. In this study, a collagen-mimic dendrimer modified with the longer collagen model peptides, (Pro-Pro-Gly)(10), was synthesized and named PPG10-den. Circular dichroism analysis shows that the efficiency of the triple helix formation in PPG10-den was much improved over the original. The X-ray diffraction analysis suggests that the higher order structure was similar to the collagen triple helix. The thermal stability of the triple helix in PPG10-den was higher than in the PPG10 peptide itself and our previous collagen-mimic polymers using (Pro-Pro-Gly)(5). Interestingly, PPG10-den also assembled at low temperatures. Self-assembled structures with spherical and rod-like shapes were observed by transmission electron microscopy. Furthermore, a hydrogel of PPG10-den was successfully prepared which exhibited the sol-gel transition around 45 degrees C. Therefore, the collagen-mimic dendrimer is a potential temperature-dependent biomaterial. (C) 2010 Wiley Periodicals, Inc. Biopolymers 95: 270-277, 2011.
C1 [Kojima, Chie] Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, Osaka 5998570, Japan.
   [Suehiro, Tomoyuki] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Osaka 5998531, Japan.
   [Tada, Tomoko; Waku, Tomonori; Tanaka, Naoki] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.
   [Hongo, Chizuru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan.
   [Yamamoto, Shinya; Nakahira, Atsushi] Osaka Prefecture Univ, Grad Sch Engn, Dept Mat Sci, Naka Ku, Osaka 5998531, Japan.
RP Kojima, C (reprint author), Osaka Prefecture Univ, Res Org 21st Century, Nanosci & Nanotechnol Res Ctr, Naka Ku, 1-2 Gakuen Cho, Osaka 5998570, Japan.
EM c-kojima@21c.osakafu-u.ac.jp
RI Hongo, Chizuru/E-5996-2016; Liu, Yifei/L-7828-2014; Kobe Univ,
   Engineering/D-2028-2017
OI Liu, Yifei/0000-0002-1087-9827; 
FU Ministry of Education, Culture, Sports, Science, and Technology of Japan
   (MEXT); Cosmetology Research Foundation
FX Contract grant sponsors: Ministry of Education, Culture, Sports,
   Science, and Technology of Japan (MEXT), Cosmetology Research Foundation
CR Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Crespo L, 2005, CHEM REV, V105, P1663, DOI 10.1021/cr030449l
   Duan X, 2006, BIOMATERIALS, V27, P4608, DOI 10.1016/j.biomaterials.2006.04.022
   Fields GB, 2010, ORG BIOMOL CHEM, V8, P1237, DOI 10.1039/b920670a
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002
   Grinstaff MW, 2008, J POLYM SCI POL CHEM, V46, P383, DOI 10.1002/pola.22525
   Kar K, 2006, J BIOL CHEM, V281, P33283, DOI 10.1074/jbc.M605747200
   Khew ST, 2008, BIOMATERIALS, V29, P3034, DOI 10.1016/j.biomaterials.2008.03.023
   Kinberger GA, 2002, J AM CHEM SOC, V124, P15162, DOI 10.1021/ja021203l
   Kinberger GA, 2006, TETRAHEDRON, V62, P5280, DOI 10.1016/j.tet.2006.01.107
   KOBAYASHI Y, 1973, J MOL BIOL, V81, P337, DOI 10.1016/0022-2836(73)90145-9
   Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518
   Kojima C, 2009, J AM CHEM SOC, V131, P6052, DOI 10.1021/ja809639c
   Kono K, 2008, POLYMER, V49, P2832, DOI 10.1016/j.polymer.2008.04.048
   Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171
   LONG CG, 1993, BIOCHEMISTRY-US, V32, P11688, DOI 10.1021/bi00094a027
   Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j
   Melacini G, 1996, J AM CHEM SOC, V118, P10359, DOI 10.1021/ja9612615
   Menjoge AR, 2010, DRUG DISCOV TODAY, V15, P171, DOI 10.1016/j.drudis.2010.01.009
   Miles CA, 2004, J MOL BIOL, V337, P917, DOI 10.1016/j.jmb.2004.02.012
   OLSEN BR, 1971, J MOL BIOL, V57, P589, DOI 10.1016/0022-2836(71)90111-2
   Przybyla DE, 2010, BIOCHEMISTRY-US, V49, P4411, DOI 10.1021/bi902129p
   Suehiro T, 2010, BIOPOLYMERS, V93, P640, DOI 10.1002/bip.21413
   Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018
   Tekade RK, 2009, CHEM REV, V109, P49, DOI 10.1021/cr068212n
   Tomalia DA, 2010, SOFT MATTER, V6, P456, DOI 10.1039/b917370f
   Tomalia DA, 2009, J NANOPART RES, V11, P1251, DOI 10.1007/s11051-009-9632-z
   Wallace DG, 2003, ADV DRUG DELIVER REV, V55, P1631, DOI 10.1016/j.addr.2003.08.004
   Wang AY, 2008, BIOMACROMOLECULES, V9, P1755, DOI 10.1021/bm701378k
   Wolinsky JB, 2008, ADV DRUG DELIVER REV, V60, P1037, DOI 10.1016/j.addr.2008.02.012
   Yamazaki CM, 2008, BIOPOLYMERS, V90, P816, DOI 10.1002/bip.21100
   Yuba E, 2008, J CONTROL RELEASE, V130, P77, DOI 10.1016/j.jconrel.2008.05.007
NR 34
TC 17
Z9 17
U1 0
U2 35
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PD APR
PY 2011
VL 95
IS 4
BP 270
EP 277
DI 10.1002/bip.21576
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 719NT
UT WOS:000287212200006
PM 21280022
DA 2018-10-20
ER

PT J
AU Karajanagi, SS
   Lopez-Guerra, G
   Park, H
   Kobler, JB
   Galindo, M
   Aanestad, J
   Mehta, DD
   Kumai, Y
   Giordano, N
   d'Almeida, A
   Heaton, JT
   Langer, RS
   Herrera, VLM
   Faquin, W
   Hillman, RE
   Zeitels, SM
AF Karajanagi, Sandeep S.
   Lopez-Guerra, Gerardo
   Park, Hyoungshin
   Kobler, James B.
   Galindo, Marilyn
   Aanestad, Jon
   Mehta, Daryush D.
   Kumai, Yoshihiko
   Giordano, Nicholas
   d'Almeida, Anthony
   Heaton, James T.
   Langer, Robert S.
   Herrera, Victoria L. M.
   Faquin, William
   Hillman, Robert E.
   Zeitels, Steven M.
TI Assessment of a new biomaterial designed to restore pliability to
   scarred vocal folds
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 241st National Meeting and Exposition of the American-Chemical-Society
   (ACS)
CY MAR 27-31, 2011
CL Anaheim, CA
SP Amer Chem Soc
C1 Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Dept Surg, Ctr Laryngeal Surg & Voice Rehabil, Boston, MA 02114 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.
   Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
   Boston Univ, Sch Engn, Boston, MA 02215 USA.
NR 0
TC 0
Z9 0
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 27
PY 2011
VL 241
MA 10-BIOT
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 782BO
UT WOS:000291982801857
DA 2018-10-20
ER

PT J
AU Gustafson, EK
   Elgue, G
   Hughes, RD
   Mitry, RR
   Sanchez, J
   Haglund, U
   Meurling, S
   Dhawan, A
   Korsgren, O
   Nilsson, B
AF Gustafson, Elisabet K.
   Elgue, Graciela
   Hughes, Robin D.
   Mitry, Ragai R.
   Sanchez, Javier
   Haglund, Ulf
   Meurling, Staffan
   Dhawan, Anil
   Korsgren, Olle
   Nilsson, Bo
TI The Instant Blood-Mediated Inflammatory Reaction Characterized in
   Hepatocyte Transplantation
SO TRANSPLANTATION
LA English
DT Article
DE IBMIR; Islet transplantation; Cell transplantation; Innate immunity;
   Engraftment
ID CLINICAL ISLET TRANSPLANTATION; WEIGHT DEXTRAN SULFATE; HEPATIC
   SINUSOIDAL ENDOTHELIUM; COMPLEMENT ACTIVATION; TISSUE FACTOR; RAT-LIVER;
   CELL ENGRAFTMENT; DEFICIENT RAT; INHIBITION; BIOMATERIAL
AB Background. Hepatocyte transplantation (HcTx) has proven to be a safe procedure, although the functional results have been unsatisfactory, probably due to insufficient engraftment or a loss of transplanted mass or function. In this study, we investigate whether hepatocytes in contact with blood induce an inflammatory reaction leading to, similar to what happens in clinical islet transplantation, an instant blood-mediated inflammatory reaction (IBMIR) resulting in an early loss of transplanted cells.
   Methods. By using an experimental model that mimics the portal vein blood flow, we could study different parameters reflecting the effects on the innate immunity elicited by hepatocytes in contact with ABO-matched human blood.
   Results. We report that all aspects of the IBMIR such as platelet and granulocyte consumption, coagulation, and complement activation were demonstrated. Addition of various specific inhibitors of coagulation allowed us to clearly delineate the various stages of the hepatocyte-triggered IBMIR and show that the reaction was triggered by tissue factor. Analysis of a case of clinical HcTx showed that hepatocyte-induced IBMIR also occurs in vivo. Both the inflammatory and the coagulation aspects were controlled by low-molecular-weight dextran sulfate.
   Conclusion. Isolated hepatocytes in contact with blood induce the IBMIR in vitro, and there are indications that these events are also relevant in vivo. According to these findings, HcTx would benefit from controlling a wider range of signals from the innate immune system.
C1 [Nilsson, Bo] Uppsala Univ, Dept Clin Immunol, Rudbeck Lab C5, SE-75185 Uppsala, Sweden.
   [Gustafson, Elisabet K.; Meurling, Staffan] Univ Uppsala Hosp, Dept Womens & Childrens Hlth, Uppsala, Sweden.
   [Hughes, Robin D.; Mitry, Ragai R.; Dhawan, Anil] Kings Coll Hosp London, Inst Liver Studies, London SE5 8RX, England.
   [Haglund, Ulf] Univ Uppsala Hosp, Dept Surg, S-75185 Uppsala, Sweden.
RP Nilsson, B (reprint author), Uppsala Univ, Dept Clin Immunol, Rudbeck Lab C5, Dag Hammarskolds Vag 20, SE-75185 Uppsala, Sweden.
EM bo.nilsson@klinimm.uu.se
RI Dhawan, Anil/B-6730-2009; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730; Dhawan, Anil/0000-0002-4942-0845
FU HRH the Crown Princess Louise's Fund for Scientific Research (Sweden)
FX This work was supported by HRH the Crown Princess Louise's Fund for
   Scientific Research (Sweden).
CR Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907
   DEMETRIOU AA, 1988, HEPATOLOGY, V8, P1006, DOI 10.1002/hep.1840080505
   Dhawan A, 2004, TRANSPLANTATION, V78, P1812, DOI 10.1097/01.TP.0000146386.77076.47
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   Fox IJ, 2004, AM J TRANSPLANT, V4, P7, DOI 10.1111/j.1600-6135.2004.0340.x
   Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Goto M, 2004, TRANSPLANTATION, V77, P741, DOI 10.1097/01.TP.0000114872.26990.4F
   GROTH CG, 1977, TRANSPLANT P, V9, P313
   Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213
   Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x
   Hjortoe G, 2005, J THROMB HAEMOST, V3, P2264, DOI 10.1111/j.1538-7836.2005.01542.x
   Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262
   Johansson H, 2006, AM J TRANSPLANT, V6, P305, DOI 10.1111/j.1600-6143.2005.01186.x
   Johansson H, 2005, DIABETES, V54, P1755, DOI 10.2337/diabetes.54.6.1755
   Joseph B, 2002, GASTROENTEROLOGY, V123, P1677, DOI 10.1053/gast.2002.36592
   Kobayashi N, 2000, HEPATOLOGY, V31, P851, DOI 10.1053/he.2000.5636
   KREAMER BL, 1986, IN VITRO CELL DEV B, V22, P201
   Krohn N, 2009, GASTROENTEROLOGY, V136, P1806, DOI 10.1053/j.gastro.2009.01.063
   Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7
   Leja J, 2007, CLIN CANCER RES, V13, P2455, DOI 10.1158/1078-0432.CCR-06-2532
   Malhi H, 2002, HEPATOLOGY, V36, P112, DOI 10.1053/jhep.2002.33896
   MATAS AJ, 1976, SCIENCE, V192, P892, DOI 10.1126/science.818706
   MITO M, 1992, TRANSPLANT P, V24, P3052
   Moberg L, 2002, LANCET, V360, P2039, DOI 10.1016/S0140-6736(02)12020-4
   Muraca M, 2002, LANCET, V359, P317, DOI 10.1016/S0140-6736(02)07529-3
   Nava S, 2005, DIFFERENTIATION, V73, P249, DOI 10.1111/j.1432-0436.2005.00019.x
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   Puppi J, 2008, AM J TRANSPLANT, V8, P452, DOI 10.1111/j.1600-6143.2007.02058.x
   Quaglia A, 2008, CELL TRANSPLANT, V17, P1403, DOI 10.3727/096368908787648083
   Rajvanshi P, 1996, HEPATOLOGY, V23, P482
   Rosenthal RJ, 1996, SURG ENDOSC-ULTRAS, V10, P1075, DOI 10.1007/s004649900243
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Schmidt P, 2008, TRANSPLANTATION, V86, P1523, DOI 10.1097/TP.0b013e3181890593
   Slehria S, 2002, HEPATOLOGY, V35, P1320, DOI 10.1053/jhep.2002.33201
   Stephenne X, 2007, LIVER TRANSPLANT, V13, P599, DOI 10.1002/lt.21128
   Strom SC, 1996, METHOD ENZYMOL, V272, P388, DOI 10.1016/S0076-6879(96)72044-X
   Strom SC, 1997, TRANSPLANTATION, V63, P559, DOI 10.1097/00007890-199702270-00014
   Strom SC, 1999, SEMIN LIVER DIS, V19, P39, DOI 10.1055/s-2007-1007096
   Strom SC, 1997, TRANSPLANT P, V29, P2103, DOI 10.1016/S0041-1345(97)00252-2
   Vermehren D, 2002, TRANSPLANTATION, V74, P1479, DOI 10.1097/01.TP.0000040003.89413.A6
   WILLINGHAM AK, 1989, CELL MOL BIOL, V35, P421
NR 42
TC 42
Z9 43
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD MAR 27
PY 2011
VL 91
IS 6
BP 632
EP 638
DI 10.1097/TP.0b013e31820ae459
PG 7
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 731NM
UT WOS:000288115800016
PM 21289595
OA Bronze
DA 2018-10-20
ER

PT J
AU Burdick, JA
   Prestwich, GD
AF Burdick, Jason A.
   Prestwich, Glenn D.
TI Hyaluronic Acid Hydrogels for Biomedical Applications
SO ADVANCED MATERIALS
LA English
DT Article
ID SYNTHETIC EXTRACELLULAR-MATRIX; MESENCHYMAL STEM-CELLS; VALVULAR
   INTERSTITIAL-CELLS; TISSUE ENGINEERING SCAFFOLDS; CROSS-LINKED
   HYDROGELS; IN-SITU; GLYCOSAMINOGLYCAN HYDROGELS; NEOCARTILAGE FORMATION;
   BIOACTIVE HYDROGELS; CONTROLLED-RELEASE
AB Hyaluronic acid (HA), an immunoneutral polysaccharide that is ubiquitous in the human body, is crucial for many cellular and tissue functions and has been in clinical use for over thirty years. When chemically modified, HA can be transformed into many physical forms-viscoelastic solutions, soft or stiff hydrogels, electrospun fibers, non-woven meshes, macroporous and fibrillar sponges, flexible sheets, and nanoparticulate fluids-for use in a range of preclinical and clinical settings. Many of these forms are derived from the chemical crosslinking of pendant reactive groups by addition/condensation chemistry or by radical polymerization. Clinical products for cell therapy and regenerative medicine require crosslinking chemistry that is compatible with the encapsulation of cells and injection into tissues. Moreover, an injectable clinical biomaterial must meet marketing, regulatory, and financial constraints to provide affordable products that can be approved, deployed to the clinic, and used by physicians. Many HA-derived hydrogels meet these criteria, and can deliver cells and therapeutic agents for tissue repair and regeneration. This progress report covers both basic concepts and recent advances in the development of HA-based hydrogels for biomedical applications.
C1 [Burdick, Jason A.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.
   [Prestwich, Glenn D.] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA.
   [Prestwich, Glenn D.] Univ Utah, Ctr Therapeut Biomat, Salt Lake City, UT 84108 USA.
RP Burdick, JA (reprint author), Univ Penn, Dept Bioengn, 210 S 33th St, Philadelphia, PA 19104 USA.
EM burdick2@seas.upenn.edu; gprestwich@pharm.utah.edu
FU David and Lucile Packard Fellowship in Science and Engineering; Utah
   Centers of Excellence; National Science Foundation [EF-0526854];
   National Institutes of Health [EB008722, DC004336]
FX The authors gratefully acknowledge funding from a David and Lucile
   Packard Fellowship in Science and Engineering (JAB), the Utah Centers of
   Excellence (GDP), the National Science Foundation (EF-0526854, GDP) and
   the National Institutes of Health (EB008722, JAB; DC004336, GDP; SBIRs
   to Sentrx Surgical and Glycosan BioSystems, GDP). We also thank our many
   co-workers and colleagues for their assistance in developing the
   figures.
CR Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49
   Bae KH, 2006, BIOTECHNOL PROGR, V22, P297, DOI 10.1021/bp050312b
   Baker BM, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3192140
   Baksh D, 2004, J CELL MOL MED, V8, P301, DOI 10.1111/j.1582-4934.2004.tb00320.x
   Bencherif SA, 2008, BIOMATERIALS, V29, P1739, DOI 10.1016/j.biomaterials.2007.11.047
   Brey DM, 2008, ACTA BIOMATER, V4, P207, DOI 10.1016/j.actbio.2007.10.002
   Brigham MD, 2009, TISSUE ENG PT A, V15, P1645, DOI 10.1089/ten.tea.2008.0441
   Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805
   Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131
   Cai SS, 2005, BIOMATERIALS, V26, P6054, DOI 10.1016/j.biomaterials.2005.03.012
   Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245
   Chun KW, 2005, BIOMATERIALS, V26, P3319, DOI 10.1016/j.biomaterials.2004.07.055
   Chung C, 2006, J BIOMED MATER RES A, V77A, P518, DOI 10.1002/jbm.a.30660
   Chung C, 2008, TISSUE ENG PT A, V14, P1121, DOI [10.1089/ten.tea.2007.0291, 10.1089/tea.2007.0291]
   Chung C, 2009, BIOMATERIALS, V30, P4287, DOI 10.1016/j.biomaterials.2009.04.040
   Chung C, 2009, TISSUE ENG PT A, V15, P243, DOI 10.1089/ten.tea.2008.0067
   Compte M, 2009, STEM CELLS, V27, P753, DOI 10.1634/stemcells.2008-0831
   Condie R, 2011, WOODHEAD PUBL MATER, P3
   Crescenzi V, 2007, BIOMACROMOLECULES, V8, P1844, DOI 10.1021/bm0700800
   Darr A, 2009, J MATER SCI-MATER M, V20, P33, DOI 10.1007/s10856-008-3540-0
   DeForest CA, 2009, NAT MATER, V8, P659, DOI [10.1038/NMAT2473, 10.1038/nmat2473]
   Ekaputra A., UNPUB
   Ekaputra AK, 2008, BIOMACROMOLECULES, V9, P2097, DOI 10.1021/bm800565u
   Elia R, 2010, BIOMATERIALS, V31, P4630, DOI 10.1016/j.biomaterials.2010.02.043
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Erickson IE, 2009, OSTEOARTHR CARTILAGE, V17, P1639, DOI 10.1016/j.joca.2009.07.003
   Erickson IE, 2009, TISSUE ENG PT A, V15, P1041, DOI 10.1089/ten.tea.2008.0099
   Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175
   Figallo E, 2007, LAB CHIP, V7, P710, DOI 10.1039/b700063d
   Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x
   Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104
   Ghosh K, 2007, BIOMATERIALS, V28, P671, DOI 10.1016/j.biomaterials.2006.09.038
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   Hanjaya-Putra D, 2010, J CELL MOL MED, V14, P2436, DOI 10.1111/j.1582-4934.2009.00981.x
   Hosack LW, 2008, BIOMATERIALS, V29, P2336, DOI 10.1016/j.biomaterials.2008.01.033
   Ifkovits JL, 2007, TISSUE ENG, V13, P2369, DOI 10.1089/ten.2007.0093
   Ifkovits JL, 2010, P NATL ACAD SCI USA, V107, P11507, DOI 10.1073/pnas.1004097107
   Jha AK, 2009, BIOMATERIALS, V30, P6964, DOI 10.1016/j.biomaterials.2009.09.009
   Jha AK, 2009, MACROMOLECULES, V42, P537, DOI 10.1021/ma8019442
   Ji Y, 2006, BIOMATERIALS, V27, P3782, DOI 10.1016/j.biomaterials.2006.02.037
   Jia XQ, 2004, MACROMOLECULES, V37, P3239, DOI 10.1021/ma035970w
   Jin Y, 2001, J CONTROL RELEASE, V73, P173, DOI 10.1016/S0168-3659(01)00234-6
   Kasyanov V. A., 2008, J MATER SCI-MATER M, V20, P329
   Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102
   Khademhosseini A, 2006, J BIOMED MATER RES A, V79A, P522, DOI 10.1002/jbm.a.30821
   Khetan S, 2010, BIOMATERIALS, V31, P8228, DOI 10.1016/j.biomaterials.2010.07.035
   Khetan S, 2009, SOFT MATTER, V5, P1601, DOI 10.1039/b820385g
   Kuo JW, 2010, MAT BIOL ORIGIN MAT
   Kuo JW, 2006, PRACTICAL ASPECTS HY
   LAURENT TC, 1986, CIBA F SYMP, V124, P9
   Leach JB, 2004, J BIOMED MATER RES A, V70A, P74, DOI 10.1002/jbm.a.30063
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee J., 2010, ACTA BIOMAT IN PRESS, V2010
   Lee KY, 2009, ADV DRUG DELIVER REV, V61, P1020, DOI 10.1016/j.addr.2009.07.006
   Li JX, 2006, MACROMOL RAPID COMM, V27, P114, DOI 10.1002/marc.200500726
   Liu YC, 2006, TISSUE ENG, V12, P3405, DOI 10.1089/ten.2006.12.3405
   Liu YC, 2007, TISSUE ENG, V13, P1091, DOI 10.1089/ten.2006.0297
   Lord MS, 2009, J BIOMED MATER RES A, V91A, P635, DOI 10.1002/jbm.a.32219
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Marklein RA, 2010, SOFT MATTER, V6, P136, DOI 10.1039/b916933d
   Marrero B, 2009, IN VITRO CELL DEV-AN, V45, P523, DOI 10.1007/s11626-009-9217-2
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   Mauck RL, 2009, TISSUE ENG PART B-RE, V15, P171, DOI [10.1089/ten.teb.2008.0652, 10.1089/ten.TEB.2008.0652]
   Miki D, 2002, CORNEA, V21, P393, DOI 10.1097/00003226-200205000-00012
   Mironov V, 2005, BIOMATERIALS, V26, P7628, DOI 10.1016/j.biomaterials.2005.05.061
   Mironov V, 2008, EXPERT OPIN BIOL TH, V8, P143, DOI 10.1517/14712598.8.2.143 
   Mironov V, 2007, J MATER CHEM, V17, P2054, DOI 10.1039/b617903g
   Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084
   Miyamoto K, 2004, J BIOMED MATER RES A, V70A, P550, DOI 10.1002/jbm.a.30112
   Nettles DL, 2004, ANN BIOMED ENG, V32, P391, DOI 10.1023/B:ABME.0000017552.65260.94
   Nisbet DR, 2009, J BIOMATER APPL, V24, P7, DOI 10.1177/0885328208099086
   Pan Z, 2009, BIOPHYS J, V96, P4286, DOI 10.1016/j.bpj.2009.02.039
   Pangarkar N, 2010, REGEN MED, V5, P823, DOI 10.2217/RME.10.66
   Patterson J, 2009, IEEE T MED IMAGING, V28, P74, DOI 10.1109/TMI.2008.927356
   Peattie RA, 2008, DRUG DELIV, V15, P389, DOI 10.1080/10717540802035442 
   Piantino J, 2005, J NEUROTRAUM, V22, P1243
   Pitarresi G, 2006, BIOMACROMOLECULES, V7, P1302, DOI 10.1021/bm050697m
   POUYANI T, 1994, BIOCONJUGATE CHEM, V5, P339, DOI 10.1021/bc00028a010
   Prata JE, 2010, BIOMACROMOLECULES, V11, P769, DOI 10.1021/bm901373x
   Prestwich G. D., 2001, GLYCOFORUM
   Prestwich GD, 2008, ACCOUNTS CHEM RES, V41, P139, DOI 10.1021/ar7000827
   Prestwich GD, 2007, J CELL BIOCHEM, V101, P1370, DOI 10.1002/jeb.21386
   Prestwich GD, 2011, REGENERATIVE NEPHROLOGY, P245, DOI 10.1016/B978-0-12-380928-5.10016-8
   Prestwich Glenn D, 2008, Organogenesis, V4, P42
   Ratliff BB, 2010, AM J PHYSIOL-RENAL, V299, pF178, DOI 10.1152/ajprenal.00102.2010
   Sahoo S, 2008, BIOMACROMOLECULES, V9, P1088, DOI 10.1021/bm800051m
   Scaife CL, 2008, J GASTROINTEST SURG, V12, P1074, DOI 10.1007/s11605-007-0425-3
   Schmelzer E, 2010, TISSUE ENG PT A, V16, P2007, DOI [10.1089/ten.tea.2009.0569, 10.1089/ten.TEA.2009.0569]
   Seib FP, 2009, BIOCHEM BIOPH RES CO, V389, P663, DOI 10.1016/j.bbrc.2009.09.051
   Seidlits SK, 2009, ADV FUNCT MATER, V19, P3543, DOI 10.1002/adfm.200901115
   Serban MA, 2008, METHODS, V45, P93, DOI 10.1016/j.ymeth.2008.01.010
   Serban MA, 2007, BIOMACROMOLECULES, V8, P2821, DOI 10.1021/bm700595S
   Shah DN, 2008, BIOMATERIALS, V29, P2060, DOI 10.1016/j.biomaterials.2008.01.001
   Shu XZ, 2006, J BIOMED MATER RES A, V79A, P902, DOI 10.1002/jbm.a.30831
   Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c
   Shu XZ, 2003, BIOMATERIALS, V24, P3825, DOI 10.1016/S0142-9612(03)00267-9
   Skardal A, 2010, TISSUE ENG PT A, V16, P2675, DOI [10.1089/ten.tea.2009.0798, 10.1089/ten.TEA.2009.0798]
   Skardal A, 2010, ADV MATER, V22, P4736, DOI 10.1002/adma.201001436
   Skardal A, 2010, BIOMATERIALS, V31, P8426, DOI 10.1016/j.biomaterials.2010.07.047
   Skardal A, 2010, BIOMATERIALS, V31, P6173, DOI 10.1016/j.biomaterials.2010.04.045
   Smeds KA, 1999, J MACROMOL SCI PURE, VA36, P981, DOI 10.1081/MA-100101577
   Stachowiak AN, 2005, ADV MATER, V17, P399, DOI 10.1002/adma.200400507
   Sundararaghavan H. G., 2009, MACROMOL BIOSCI
   Suri S, 2009, ACTA BIOMATER, V5, P2385, DOI 10.1016/j.actbio.2009.05.004
   Tan AR, 2008, J BIOMED MATER RES A, V87A, P1034, DOI 10.1002/jbm.a.31853
   Toh WS, 2010, BIOMATERIALS, V31, P6968, DOI 10.1016/j.biomaterials.2010.05.064
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391
   Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1
   Turner WS, 2008, STEM CELLS, V26, P1547, DOI 10.1634/stemcells.2007-0863
   Van Hoof D, 2008, STEM CELLS, V26, P2777, DOI 10.1634/stemcells.2008-0365
   Vanderhooft JL, 2007, BIOMACROMOLECULES, V8, P2883, DOI 10.1021/bm0703564
   Vanderhooft JL, 2009, MACROMOL BIOSCI, V9, P20, DOI 10.1002/mabi.200800141
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Weng LH, 2008, BIOMATERIALS, V29, P2153, DOI 10.1016/j.biomaterials.2008.01.012
   Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015
   Xu XY, 2009, PROSTAG OTH LIPID M, V89, P140, DOI 10.1016/j.prostaglandins.2009.07.006
   Yeh J, 2006, BIOMATERIALS, V27, P5391, DOI 10.1016/j.biomaterials.2006.06.005
   Zawko SA, 2010, ACTA BIOMATER, V6, P2415, DOI 10.1016/j.actbio.2010.02.021
   Zawko SA, 2009, ACTA BIOMATER, V5, P14, DOI 10.1016/j.actbio.2008.09.012
   Zhang HL, 2009, CANCER RES, V69, P5441, DOI 10.1158/0008-5472.CAN-09-0302
   Zhang JX, 2008, BIOMATERIALS, V29, P4521, DOI 10.1016/j.biomaterials.2008.08.008
   Zhang QZ, 2009, PLOS ONE, V4, pA192, DOI 10.1371/journal.pone.0007798
   Zhao J, 2008, MACROMOL BIOSCI, V8, P836, DOI 10.1002/mabi.200700334
   Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958
NR 135
TC 551
Z9 560
U1 44
U2 494
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0935-9648
EI 1521-4095
J9 ADV MATER
JI Adv. Mater.
PD MAR 25
PY 2011
VL 23
IS 12
BP H41
EP H56
DI 10.1002/adma.201003963
PG 16
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 739GA
UT WOS:000288701300004
PM 21394792
OA Green Accepted
HC Y
HP N
DA 2018-10-20
ER

PT J
AU Graf, W
   Mellgren, A
   Matzel, KE
   Hull, T
   Johansson, C
   Bernstein, M
AF Graf, Wilhelm
   Mellgren, Anders
   Matzel, Klaus E.
   Hull, Tracy
   Johansson, Claes
   Bernstein, Mitch
CA NASHA Dx Study Grp
TI Efficacy of dextranomer in stabilised hyaluronic acid for treatment of
   faecal incontinence: a randomised, sham-controlled trial
SO LANCET
LA English
DT Article
ID INJECTABLE SILICONE BIOMATERIAL; QUALITY-OF-LIFE; INJECTION
   SCLEROTHERAPY; CLINICAL-TRIAL; ADULTS; HEMORRHOIDS; MANAGEMENT;
   IMPLANTS; CHILDREN; PTQ(TM)
AB Background Injection of a bulking agent in the anal canal is an increasingly used treatment for faecal incontinence, but efficacy has not been shown in a controlled trial. We aimed to assess the efficacy of injection of dextranomer in stabilised hyaluronic acid (NASHA Dx) for treatment of faecal incontinence.
   Methods In this randomised, double-blind, sham-controlled trial, patients aged 18-75 years from centres in USA and Europe were randomly assigned (2:1) to receive either transanal submucosal injections of NASHA Dx or sham injections. Randomisation was stratified by sex and region in blocks of six, and managed with a computer generated, real-time, web-based system. Patients and investigators were masked to assignment for 6 months when the effect on severity of faecal incontinence and quality of life was assessed with a 2-week diary and clinical assessments. The primary endpoint was response to treatment based on the number of incontinence episodes. A response to treatment was defined as a reduction in number of episodes by 50% or more. Patients in the active treatment group are still being followed up. This trial was registered with ClinicalTrials.gov, number NCT00605826.
   Findings 278 patients were screened for inclusion, of whom 206 were randomised assigned to receive NASHA Dx (n=136) or sham treatment (n=70). 71 patients who received NASHA Dx (52%) had a 50% or more reduction in the number of incontinence episode, compared with 22 patients who received sham treatment (31%; odds ratio 2.36, 95% CI 1.24-4.47, p=0.0089). We recorded 128 treatment-related adverse events, of which two were serious (1 rectal abscess and 1 prostatic abscess).
   Interpretation Anal injection of NASHA Dx is an effective treatment for faecal incontinence. A refinement of selection criteria for patients, optimum injected dose, ideal site of injection, and long-term results might further increase the acceptance of this minimally invasive treatment.
C1 [Graf, Wilhelm] Uppsala Univ, Akad Sjukhuset, Dept Surg, S-75185 Uppsala, Sweden.
   [Mellgren, Anders] Univ Minnesota, Minneapolis, MN USA.
   [Matzel, Klaus E.] Univ Erlangen Nurnberg, Erlangen, Germany.
   [Hull, Tracy] Cleveland Clin Fdn, Cleveland, OH 44195 USA.
   [Johansson, Claes] Danderyds Sjukhus, Dept Surg, Stockholm, Sweden.
   [Bernstein, Mitch] St Lukes Roosevelt Hosp, New York, NY 10025 USA.
RP Graf, W (reprint author), Uppsala Univ, Akad Sjukhuset, Dept Surg, S-75185 Uppsala, Sweden.
EM wilhelm.graf@akademiska.se
FU Q-Med AB
FX WG, KEM, and AM have received travel grants and honoraria from Q-Med AB.
   TH has received travel grants from Q-Med AB. No other conflicts of
   interest have been declared.
CR Aigner F, 2009, DIS COLON RECTUM, V52, P293, DOI 10.1007/DCR.0b013e318197d755
   Al-Ghnaniem R, 2001, ANN ROY COLL SURG, V83, P325
   Alkan M, 2008, UROL INT, V81, P41, DOI 10.1159/000137639
   Alkan M, 2007, PEDIATR SURG INT, V23, P183, DOI 10.1007/s00383-006-1818-1
   Bond C, 2007, J CLIN GASTROENTEROL, V41, P45, DOI 10.1097/MCG.0b013e31802dcba5
   Bordeianou L, 2008, COLORECTAL DIS, V10, P273, DOI 10.1111/j.1463-1318.2007.01288.x
   Chan MKY, 2006, DIS COLON RECTUM, V49, P433, DOI 10.1007/s10350-005-0307-2
   Danielson J, 2009, DIS COLON RECTUM, V52, P1101, DOI 10.1007/DCR.0b013e31819f5cbf
   ENGEL AF, 1995, INT J COLORECTAL DIS, V10, P152, DOI 10.1007/BF00298538
   Ganio E, 2008, TECH COLOPROCTOL, V12, P99, DOI 10.1007/s10151-008-0406-x
   Kaman L, 1999, DIS COLON RECTUM, V42, P419, DOI 10.1007/BF02236363
   Luo C, 2010, COLORECTAL DIS, V12, P296, DOI 10.1111/j.1463-1318.2009.01828.x
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Maeda Y, 2010, COCHRANE DB SYST REV, V12
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Molitierno Joseph A, 2008, J Pediatr Urol, V4, P221, DOI 10.1016/j.jpurol.2007.11.015
   Naimy N, 2007, DIS COLON RECTUM, V50, P2040, DOI 10.1007/s10350-007-9075-5
   Osterberg A, 2004, BRIT J SURG, V91, P1131, DOI 10.1002/bjs.4577
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   SHAFIK A, 1993, INT SURG, V78, P159
   Siproudhis L, 2007, ALIMENT PHARM THERAP, V25, P1125, DOI 10.1111/j.1365-2036.2007.03293.x
   Soerensen MM, 2009, COLORECTAL DIS, V11, P73, DOI 10.1111/j.1463-1318.2008.01544.x
   Stenberg AM, 1997, J UROLOGY, V158, P1937, DOI 10.1016/S0022-5347(01)64185-5
   Tan JJY, 2007, DIS COLON RECTUM, V50, P1950, DOI 10.1007/s10350-007-9009-2
   Tjandra JJ, 2009, COLORECTAL DIS, V11, P382, DOI 10.1111/j.1463-1318.2008.01634.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Whitehead WE, 2009, GASTROENTEROLOGY, V137, P512, DOI 10.1053/j.gastro.2009.04.054
NR 27
TC 118
Z9 119
U1 0
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0140-6736
J9 LANCET
JI Lancet
PD MAR 19
PY 2011
VL 377
IS 9770
BP 997
EP 1003
DI 10.1016/S0140-6736(10)62297-0
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 740FA
UT WOS:000288775800028
PM 21420555
DA 2018-10-20
ER

EF